0001144204-14-021344.txt : 20140408 0001144204-14-021344.hdr.sgml : 20140408 20140408133509 ACCESSION NUMBER: 0001144204-14-021344 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 11 FILED AS OF DATE: 20140408 DATE AS OF CHANGE: 20140408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stevia Corp CENTRAL INDEX KEY: 0001439813 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] IRS NUMBER: 980537233 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-195123 FILM NUMBER: 14750707 BUSINESS ADDRESS: STREET 1: 7117 US 31 S CITY: INDIANAPOLIS STATE: IN ZIP: 46227 BUSINESS PHONE: 888-250-2566 MAIL ADDRESS: STREET 1: 7117 US 31 S CITY: INDIANAPOLIS STATE: IN ZIP: 46227 FORMER COMPANY: FORMER CONFORMED NAME: Interpro Management Corp DATE OF NAME CHANGE: 20110307 FORMER COMPANY: FORMER CONFORMED NAME: Stevia Corp. DATE OF NAME CHANGE: 20110303 FORMER COMPANY: FORMER CONFORMED NAME: INTERPRO MANAGEMENT CORP. DATE OF NAME CHANGE: 20080711 S-1 1 v372818_s1.htm FORM S-1

 

As filed with the Securities and Exchange Commission on April 8, 2014

 

Registration No. 333-______

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-1

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 

STEVIA CORP.

(Exact name of registrant as specified in its charter)

 

Nevada   700   98-0537233
(State or jurisdiction of   (Primary Standard Industrial   (I.R.S. Employer
incorporation or organization)   Classification Code Number)   Identification No.)

 

7117 US 31S

Indianapolis, IN 46227

(888) 250-2566

(Address and telephone number of principal executive offices and principal place of business)

  

CSC Services of Nevada, Inc.

2215-B Renaissance Drive

Las Vegas, NV 89119

(702) 740-4244

 (Name, address and telephone number of agent for service) 

 

Copies to:

Mark C. Lee

Saxon Peters

GREENBERG TRAURIG, LLP

1201 K Street, Suite 1100

Sacramento, California 95814

Telephone: (916) 442-1111

Facsimile: (916) 448-1709

 

Approximate date of proposed sale to the public:

 

From time to time after the effective date of this registration statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. þ

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.        ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.       ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.       ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer  ¨ Accelerated filer  ¨ Non-accelerated filer  ¨ Smaller reporting company  þ
    (Do not check if a smaller reporting company)  

  

 

 
 

  

CALCULATION OF REGISTRATION FEE

 

 

 

 

 

   Amount of shares   Proposed maximum   Proposed maximum   Amount of 
Title of each class of  to be   offering price   aggregate   Registration 
securities to be registered  Registered   per share   offering price   Fee 
Common Stock Underlying the Principal of Convertible Notes   10,674,182(1)  $0.266(2)  $2,839,332.41   $365.71 
Common Stock Underlying the Interest of Convertible Notes   508,905(3)  $0.266(2)  $135,368.73   $17.44 
Common Stock Underlying the Principal of Convertible Notes   12,809,018(4)  $0.266(2)  $3,407,198.79   $438.85 
Common Stock Underlying the Interest of Convertible Notes   610,687(5)  $0.266(2)  $162,442.74   $20.92 
Common Stock Underlying Warrants   20,296,139(6)  $0.053365   $1,083,103.46   $139.50 
Common Stock Underlying a Convertible Note   3,000,000(7)  $0.266(2)  $798,000.00   $102.78 
Total   47,898,931        $8,425,446.13   $1085.20 

 

  (1) Represents shares of common stock issuable by the registrant upon the conversion of the principal amount of the registrant’s Senior Convertible Note issued March 3, 2014 (the “Initial Nomis Bay Note”).

 

  (2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, based on the average high and low prices of the common stock as reported on the OTCQB on March 26, 2014.
     
  (3) Represents shares of common stock issuable by the registrant upon the conversion of interest accrued under the Initial Nomis Bay Note.
     
  (4) Represents shares of common stock issuable by the registrant upon the conversion of the principal amount of the registrant’s Senior Convertible Note to be issued to Nomis Bay Ltd. (the “Secondary Nomis Bay Note”) after the effectiveness of this registration statement upon the terms and conditions set forth in the Securities Purchase Agreement dated March 3, 2014.
     
  (5) Represents shares of common stock issuable by the registrant upon the conversion of interest to be accrued under the Secondary Nomis Bay Note.

 

  (6) Represents the number of shares of common stock offered for resale following the exercise of certain warrants to purchase common stock.

 

  (7) Represents shares of common stock issuable by the registrant upon the conversion of the registrant’s promissory note issued July 10, 2013 (the “JMJ Note Shares”)

  

In the event of stock splits, stock dividends, or similar transactions involving the Registrant’s common stock, the number of Shares registered shall, unless otherwise expressly provided, automatically be deemed to cover the additional securities to be offered or issued pursuant to Rule 416 promulgated under the Securities Act of 1933, as amended (the “Securities Act”); provided however that any additional shares received due to subsequent equity issuances by the Registrant at a lower price per share than the current exercise price of any applicable warrants would not be covered by this registration statement and would require separate registration or an exemption prior to sale.

 

We hereby amend this registration statement on such date or dates as may be necessary to delay its effective date until we shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 
 

   

SUBJECT TO COMPLETION, DATED APRIL 8, 2014

 

PROSPECTUS

 

47,898,931 Shares of Common Stock

 

STEVIA CORP.

 

Common Stock

 

This prospectus relates to the resale of 47,898,931 shares of common stock, by the selling stockholders named in this prospectus. The shares of common stock subject to this prospectus include:

 

(i)24,602,792 shares of common stock issuable upon conversion of the principal amount of the registrant’s Senior Convertible Note issued March 3, 2014 (the “Nomis Bay Note Shares”). Based upon current market price of the Company’s common stock, the amount of Nomis Bay Note Shares being registered may be in excess of the number of shares into which the Senior Convertible Note may currently be converted, however the parties have agreed upon the aggregate number of shares to be registered to account for market fluctuations;

   

(ii)23,026,318 shares of common stock issuable following the exercise of certain warrants issued in accordance with a Warrant Exercise Reset Offer Letter Agreement entered into on May 3, 2013 as adjusted pursuant to its terms for certain dilutive issuances, less 5,290,665 shares of common stock previously registered pursuant to the registrant’s Registration Statement on Form S-1/A filed December 30, 2013 (the “Anson Reset Shares”);

  

(iii)2,560,486 shares of common stock issuable following the exercise of certain warrants issued to a selling stockholder in accordance with a Securities Purchase Agreement entered into on August 1, 2012, as adjusted pursuant to the anti-dilution provision contained therein and the Common Stock Purchase Warrant issued February 20, 2014, less 683,202 shares of common stock previously registered pursuant to the registrant’s Registration Statement on Form S-1/A filed December 30, 2013, plus an additional 683,202 shares of common stock issuable following the exercise of the warrant issued February 20, 2014 with an exercise price of $0.053365 per share (the “Cranshire Warrant Shares”); and

  

(iv)3,000,000 shares of common stock issuable upon the conversion of the registrant’s $400,000 Promissory Note issued July 10, 2013 (the “JMJ Note Shares”);

 

We will not receive any proceeds from the resale of any of the shares offered hereby. We may receive gross proceeds of up to $1,083,103.46 if all of the warrants set forth above (the “Warrants”) are exercised for cash. The proceeds will be used for working capital or general corporate purposes. We will bear all costs associated with this registration.

 

Our common stock is quoted on the OTCQB under the symbol “STEV.” On March 26, 2014, the closing bid price of our common stock was $0.28 per share.

 

INVESTING IN OUR COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. SEE “RISK FACTORS” BEGINNING ON PAGE 2 OF THIS PROSPECTUS.

 

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE.  ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

The information in this Prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission becomes effective. This Prospectus is not an offer to sell these securities and we are not soliciting an offer to buy these securities in any state where the offer or sale is not permitted or would be unlawful prior to registration or qualification under the securities laws of any such state.

 

 
 

   

TABLE OF CONTENTS

 

  Page
   
PART I - INFORMATION REQUIRED IN PROSPECTUS  
   
PROSPECTUS SUMMARY 1
DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS 7
RISK FACTORS 7
RISKS RELATED TO OUR BUSINESS AND INDUSTRY 7
RISKS RELATED TO DOING BUSINESS IN VIETNAM AND OTHER DEVELOPING COUNTRIES 12
RISKS RELATED TO AN INVESTMENT IN OUR SECURITIES 14
USE OF PROCEEDS 15
DETERMINATION OF OFFERING PRICE 15
SELLING SECURITY HOLDER 15
PLAN OF DISTRIBUTION 17
DESCRIPTION OF SECURITIES TO BE REGISTERED 18
INTERESTS OF NAMED EXPERTS AND COUNSEL 20
INFORMATION WITH RESPECT TO THE REGISTRANT 20
PROPERTIES 32
LEGAL PROCEEDINGS 32
MARKET FOR COMMON EQUITY AND RELATED SHAREHOLDER MATTERS 32
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 33
DIRECTORS AND EXECUTIVE OFFICERS 37
EXECUTIVE COMPENSATION 38
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 39
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS AND DIRECTOR INDEPENDENCE 40
DISCLOSURE OF COMMISSION POSITION OF INDEMNIFICATION FOR SECURITIES ACT LIABILITIES 41
WHERE YOU CAN FIND MORE INFORMATION 41
FINANCIAL STATEMENTS F-1
 
PART II - INFORMATION NOT REQUIRED IN PROSPECTUS 42
 
OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION 42
INDEMNIFICATION OF DIRECTORS AND OFFICERS 42
RECENT SALES OF UNREGISTERED SECURITIES 44
EXHIBIT INDEX 49
UNDERTAKINGS 50
SIGNATURES 53

 

 
 

  

You should rely only on the information contained in this Prospectus. We have not authorized anyone to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted.

 

PROSPECTUS SUMMARY

 

You should read the following summary together with the more detailed information and the financial statements appearing elsewhere in this Prospectus. This Prospectus contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth under “Risk Factors” and elsewhere in this Prospectus.  Unless the context indicates or suggests otherwise, references to “we,” “our,” “us,” the “Company,” “Stevia” or the “Registrant” refer to Stevia Corp., a Nevada corporation and its subsidiaries.

 

Overview

 

Stevia Corp. was incorporated on May 21, 2007 in the State of Nevada. On June 23, 2011, we closed a voluntary share exchange transaction with Stevia Ventures International Ltd., a business company incorporated in the British Virgin Islands, pursuant to which we acquired the rights to purchase certain strains of stevia leaf growing in Vietnam, including certain assignable exclusive purchase contracts and an assignable supply agreement related to the stevia leaf.

 

We are a farm management company primarily focused on crop agronomics from plant breeding to good agricultural practices to development of crop derived products, which can be used for human consumption as well as for aquaculture and agriculture applications.

 

We have established a field test research center in Vietnam on 10 Ha (25 acres) of leased land which is designed to support our commercial field trials that are on-going in Vietnam and began our first commercial trial harvests in March 2012. We confirmed elite plant varieties, developed propagation techniques, conducted field trials across several provinces, documented local operating procedures and post-harvest techniques, and began commercial harvests in February 2013.

 

In July 2012 we formed a joint venture with Tech-New Bio-Technology, a technology company in Hong Kong and acquired intellectual property covering several formulations utilizing stevia extracts together with probiotics and enzymes which have applications for agriculture, aquaculture and post harvest processing. We do not operate an extraction facility, but Tech-New Bio-Technology’s affiliate company in China has technologies and the facility for the extraction and refinement of high purity stevia; we entered into a multi-year supply contract in March 2012 where they are committed to purchase all of our stevia leaf production for the first two years and we also have the ability to use the resulting stevia extract to formulate our products. While we believe that our joint venture with Tech-New Bio-Technology will increase the visibility of our intended services and products, there is no guarantee that such visibility will occur.

 

Our formulated products consist of ecological fertilizers that address soil acidification, compaction and fertility decline caused by chemical fertilizer overuse; foliar fertilizers that help plants resist infection and disease; feed formulations for livestock, fish and shrimp that enhance digestion and help strengthen immunity; microbiological preparations that address pollution in marine environments that negatively impact aquaculture activities; and natural preparations which aid in the preservation of crops after harvest and during processing. We also provide private label pure stevia extracts which are suitable for food and beverage applications.

 

In August of 2012 we began to use our formulated products as feed and fertilizer inputs under our farm management model and currently service several commercial operations providing feed supplements for shrimp and fish production and fertilizer inputs for farmland as well as using it on our own trial farms.

 

In September 2012 we began providing samples of stevia extract to food and beverage companies and we are working closely with local parties in several South East Asian countries to provide technical information in support of recipe development. Although we believe that this product line will have growth potential, there is no guarantee that a high volume of stevia will be utilized by our customers. We expect companies will take another year to plan product launches.

 

In January 2014 we entered into a Farm Management and Technology Agreement with ebbu LLC to provide farm management consultancy and technical expertise related to growing the cannabis plant and extracting its cannabinoids. The cannabis plant produces many chemical compounds called cannabinoids and there are more than 85 different cannabinioids that have been identified and isolated from the cannabis plant that exhibit varied effects and many of these are being studied for their psychoactive and medical properties. Cannabis plants that have been bred to produce high levels of tetrahydrocannabinol (“THC”), a psychoactive constituent, are commonly referred to as marijuana. Current federal and most state regulations prevent us from participating directly in the marijuana industry and we cannot guarantee that our services or technology will provide value if the laws do not evolve in favor of marijuana production and the commercial sale of marijuana derived products.

 

In February 2014 we registered a wholly owned subsidiary, Real Hemp LLC, as part of our strategy to enter the US hemp industry to import, manufacture and license products containing hemp seeds, oil, protein, milk, fiber and cannabidiol. Hemp is the common term for cannabis plants that produce very low levels of THC and are grown for industrial purposes and foodstuff products. Cannabidiol (“CBD”) is one of the active cannabinoids in the cannabis plant and is a major constituent of hemp, accounting for up to 40% of the plants extract, and is considered to have a wider scope of medical applications than THC. Hemp products, including CBD extracts, can be legally imported and traded in the United States. We are currently exploring product opportunities and expect to launch our first products during 2014. There is no guarantee that we will launch products containing hemp or that such products will be successful.

 

1
 

  

All of our formulated products used for agriculture and aquaculture are approved for use in our areas of operation and the largest obstacle we will face will be farmer confidence to use new products. We believe that we can overcome this obstacle by building a successful and demonstrable track record working with the current operations of Tech-New Bio-Technology and its affiliates. All of the ingredients in the products are natural compounds and are approved by the major developed countries if we choose to expand to other markets in the future. A list of the major developed countries that have approved the use of stevia as a food additive can be found on page 29.

 

The stevia industry is segmented into several business processes, which can broadly be categorized as i) plant breeding and propagation, ii) farming, iii) extraction and refining, iv) product formulation, v) distribution and retail. As we achieve vertical integration along the supply chain we will continue to focus on acquisitions and intellectual property development to support further downstream integration into the agriculture and aquaculture sectors. We believe that over the long-run this will position the Company to become an industry leader, producing a number of value-added stevia-enhanced products.

 

Our Business

 

We are a farm management company primarily focused on stevia agronomics from plant breeding to good agricultural practices to development of stevia derived products which can be used for human consumption as well as for aquaculture and agriculture applications. We plan to invest in research and development and intellectual property acquisition and provide farm management services to contract growers and other industry growers integrating our stevia focused research and development and intellectual property acquisitions.

 

Our farm management services include training the farmers on the correct protocols and methodologies and providing ongoing technical assistance during the crop cycle as well as providing inputs such as the seedlings, fertilizers and additives they are required to use.

 

We employ our services under three business models which we classify as 1) contract farming model, 2) revenue share model and 3) product supply model.

 

Under the contract farming and revenue share models we do not charge for the services and inputs, but rather our services provide us with a competitive advantage to secure growers who are willing to dedicate their land and resources to grow crops with an expectation of high yielding, high quality crops and guaranteed purchase prices. Under these models we will generate our revenue from the crops that are grown and we only enter into production agreements with growers when there is already a committed buyer for the end crop. Under the contract farming model we will purchase the crop from the grower at a fixed price and sell to our own customer.  Under the revenue share model, the grower already has their own buyer and we will share the revenue.

 

Under the product supply model we will market our products in combination with technical services to buyers and charge a fee. We believe that this model will contribute a small part of our overall revenue initially until we establish a proven track record and solid reputation for our services and products under the first two models.  We do not expect to focus on providing strictly farm management or technical services for a fee and it is difficult to estimate what we would charge for such services.

 

We continue to focus on research and development to further evolve and develop new protocols, methodologies and intellectual properties and believe that this will be key to maintain our competitive advantage.

 

We utilize the contract farming model to produce stevia leaf for our trial harvests and use the stevia extracts to produce our proprietary formulated products, which we are applying under the revenue share model to an aquaculture operation beginning August 2012 and a chili operation beginning October 2012.

  

Our mission is to maximize stockholder value by consistently developing and acquiring the latest intellectual property and expanding our suite of formulated products and their applications and leveraging our farm management business model to maximize market penetration and revenue margins.

 

To achieve these goals we intend to develop a suite of intellectual property relating to stevia and its extracts that will enhance the value of our farm management operations. Through our relationships with Tech-New Bio-Technology, Growers Synergy and local institutes, we are exploring the market for commercial applications of stevia which will be vertically integrated into our services and production. We have engaged Growers Synergy, a regional farm management services provider, to provide farm management operations and back-office and regional logistical support for our Vietnam and Indonesia operations for a period of two years. George Blankenbaker, our president, director and stockholder is the managing director of Growers Synergy. Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and Mr. Blankenbaker controls a 49% interest in Growers Fresh.

 

2
 

  

Our current burn rate is approximately $150,000 per month and we currently have approximately $350,000 in cash on hand. We are dependent on additional capital to continue to operate. Failure to complete a financing will have an adverse effect on our ability to operate and execute our business plan. We believe that $3 million of funding is sufficient for us to break-even and achieve self-sufficiency on a cash flow basis. Based on the current burn rate, the Company does not currently have sufficient capital to operate and we are doing so on a very limited budget, relying primarily on our goodwill with Growers Synergy and our other vendors, and during this period we will need to raise additional capital and generate revenue. As a result, our accounts payable are expected to grow. However, there are no assurances that Growers Synergy or our other vendors will continue to extend credit to the Company, and if they cease extending credit to us, and we are unable to raise capital or generate sufficient revenue, we will have to liquidate or sell certain assets.

 

Our target markets are initially Vietnam, Indonesia and China where we have contracted with growers and have established our own nurseries and test fields. In China we are producing our proprietary formulated products and applying them to aquaculture projects under our revenue share model. Although our priority is Asia, our services are not limited to specific countries and we plan to pursue viable opportunities in other markets.

 

Our operations to-date have primarily consisted of securing purchase and supply contracts, office space and a research center, developing relationships with potential partners, and developing products derived from the stevia plant. We have earned limited revenues since inception. For the nine month period ended December 31, 2013 we incurred a net loss of $2,017,484 and for the period from inception (April 11, 2011) to March 31, 2013, we have incurred a net loss of $4,359,415. Our assets total $3,641,781 and $2,194,251 as of as of December 31, 2013 and March 31, 2013, respectively. Further, our auditors have issued a going concern opinion in their audit report dated July 15, 2013. This means that there is substantial doubt that we can continue as an on-going business for the next twelve months unless we obtain additional capital.

 

Recent Developments

 

The table below sets forth shares of our common stock that have been recently issued in exchange for certain services and rights.

 

Date   Issuance of Shares for Services and/or Rights
February 26, 2014  

We issued an aggregate of 28,300,000 shares of our common stock to various service providers in exchange for services rendered, including 20,000,000 shares to Blankenbaker Ventures (Asia) Pte. Ltd. on behalf of George Blankenbaker, our president, director and stockholder and 3,000,000 shares to Growers Synergy Pte Ltd., a corporation organized under the laws of Singapore (“Growers Synergy”). Thomas Ong, a director of the Company is a director of Growers Synergy and is also a 25% shareholder of Agriventure Pte Ltd., which is a 49% shareholder of Growers Synergy. Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and Mr. Blankenbaker controls a 49% interest in Growers Fresh.

 

February 26, 2014   We issued 16,744,682 shares of our common stock to Blankenbaker Ventures (Asia) Pte. Ltd. on behalf of George Blankenbaker, our president, director and stockholder, in exchange for the cancellation of approximately $893,579.93 of working capital advances provided by Mr. Blankenbaker and his affiliated companies.
     

 

Corporate Information

 

Our principal executive offices are located at 7117 US 31 S., Indianapolis, IN, 46227. Our telephone number is 888-250-2566. We maintain a corporate website at http://www.steviacorp.us.

 

Stock Transfer Agent

 

Our stock transfer agent is Securities Transfer Corporation, and is located at 2591 Dallas Parkway, Suite 102, Frisco, Texas 75034.  The agent’s telephone number is 469-633-0101.

 

3
 

 

The Offering

 

Issuer   Stevia Corp.
     
Securities Offered for Resale   47,898,931 shares of Common Stock underling convertible notes and warrants to purchase Common Stock
     
Common Stock Outstanding Before the Offering   145,972,713 shares
     
Common Stock to be Outstanding After the Offering assuming all of the Securities are Resold   193,871,644 shares
     
Use of Proceeds   We will not receive any proceeds from the resale of the shares of common stock underlying the Warrants.  We may receive proceeds in the event the Warrants are exercised for cash.  Such proceeds from the offering will be used for working capital and general corporate purposes.  See “Use of Proceeds.”
     
Trading   Our common stock is quoted on the OTCQB under the symbol “STEV.”
     
Risk Factors   You should carefully consider the information set forth in the section entitled “Risk Factors” beginning on page 2 of this prospectus in deciding whether or not to invest in our common stock.

 

Nomis Bay Note Shares

 

This offering, with respect to the Nomis Bay Note Shares, relates to the resale of shares of common stock of the Company underlying a Senior Convertible Note, issued March 3, 2014 (the “Nomis Bay Note”). On March 3, 2014, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with Nomis Bay Ltd., a Bermuda company (“Nomis Bay”), we issued the Nomis Bay Note with an initial principal amount of $500,000 for a purchase price of $340,000.  The Nomis Bay Note matures on December 27, 2014 (subject to extension as provided in the Nomis Bay Note) and, in addition to the 32% original issue discount, accrues interest at the rate of 8% per annum. The Purchase Agreement also provides that, upon the terms and subject to the conditions set forth therein, the Company may require Nomis Bay to purchase from the Company on or prior to the 10th trading day after the effective date of the registration statement registering the shares issuable upon conversion of the Initial Convertible Note, an additional senior convertible note with an initial principal amount of $600,000 (the “Additional Convertible Note” and together with the Nomis Bay Note, the “Convertible Notes”) for a purchase price of $600,000. If issued, the Additional Convertible Note will mature on the date that is the 10-month anniversary of the date of issuance of the Additional Convertible Note (subject to extension as provided in the Initial Convertible Note) and will accrue interest at the rate of 8% per annum. The Nomis Bay Note is convertible at any time, in whole or in part, at Nomis Bay’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to the lesser of (i) the product of (x) the arithmetic average of the lowest three (3) volume weighted average prices of the Common Stock during the 10 consecutive trading days ending and including the trading day immediately preceding the applicable conversion date and (y) 40% (the “Variable Conversion Price”), and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). If issued, the Additional Convertible Note will be convertible at any time, in whole or in part, at Nomis Bay’s option into shares of Common Stock at a conversion price that will be equal to the lesser of (i) the Variable Conversion Price and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). At no time will Nomis Bay be entitled to convert any portion of the Convertible Notes to the extent that after such conversion, Nomis Bay (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. The shares of common stock underlying the Nomis Bay Note were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

Anson Reset Shares

  

This offering, with respect to the Anson Reset Shares, relates to the resale of shares of common stock of the Company underlying three warrants in the amounts of 1,877,333, 1,066,666 and 2,346,666, with exercise prices of $0.20, $0.25 and $0.25 per share (the “Anson Warrants”). Pursuant to the terms of a warrant exercise reset offer letter between the Company and the investor, the Anson Warrants were issued in consideration for the investor’s agreement to immediately cash exercise an existing warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share for aggregate consideration to the Company of $170,666 originally issued pursuant to the terms of the Securities Purchase Agreement, dated August 1, 2012 (the “Purchase Agreement”). Each Anson Warrant has a five year term and was issued on May 3, 2013. Each Anson Warrant provides for adjustment of the exercise price and share amount in the event of certain dilutive issuances by the Company. On February 20, 2014, the Company issued a notice to the holder that the aggregate number of Anson Warrants had been adjusted to 23,026,318 and the exercise price of each had been adjusted to $0.053365 as a result of certain other offerings of the Company. 5,290,665 of the shares underlying the Anson Warrants were previously registered by the Company pursuant to the Registration Statement on Form S-1/A filed December 30, 2013. The warrants and the shares of common stock underlying the warrants were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

4
 

  

Cranshire Warrant Shares

 

This offering, with respect to the Cranshire Warrant Shares, relates to the resale of the shares of common stock underlying a warrant in the amount of 2,560,486 with an exercise price of $0.053365. The warrant has a five (5) year term and was issued pursuant to the terms of the Purchase Agreement. The warrant was originally issued in the amount of 213,334 shares at an exercise price of $0.6405. Pursuant to the anti-dilution adjustment provision contained therein, on February 20, 2014, the Company issued a notice to the holder that the total share amount had been increased to 2,560,486 and the exercise price had been reduced to $0.053365 as a result of certain other offerings of the Company. 683,202 of the shares underlying the Cranshire Warrants were previously registered by the Company pursuant to the Registration Statement on Form S-1/A filed December 30, 2013. Additionally, on February 20, 2014 in consideration for the investor’s agreement to immediately cash exercise a portion of the Cranshire Warrants for aggregate consideration to the Company of $36,459, the Company agreed to issue the investor an additional warrant to purchase 683,202 shares of common stock. The warrants and the shares of common stock underlying the warrants were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.  

 

JMJ Note Shares

 

This offering, with respect to the JMJ Note Shares, relates to the resale of 3,000,000 shares of common stock of the Company underlying a $400,000 Promissory Note issued July 10, 2013 (the “JMJ Note”). The JMJ Note is subject to a one-time interest charge equal to 12% of the principal sum and is due and payable July 10, 2014. The JMJ Note provides that it may be converted into common stock of the Company at any time at the election of the holder, at a conversion price equal to the lesser of $0.26 or 65% of the lowest trade price in the 25 trading days previous to the conversion. The JMJ Note and the shares of common stock underlying the JMJ Note were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

SUMMARY OF FINANCIAL INFORMATION

 

The following selected financial information is derived from the Company’s Financial Statements appearing elsewhere in this Prospectus and should be read in conjunction with the Company’s Financial Statements, including the notes thereto, appearing elsewhere in this Prospectus.

 

5
 

  

Summary of Statements of Operations

 

For the Three Months Ended December 31, 2013:  

 

Total revenue  $388,746 
      
Net income   (831,410)
      
Net income per common share (basic and diluted)  $(0.01)
      
Weighted average common shares   79,632,959 

 

For the Nine Months Ended December 31, 2013:  

 

Total revenue  $1,893,865 
      
Net loss   (2,017,484)
      
Net loss per common share (basic and diluted)  $(0.03)
      
Weighted average common shares   72,842,975 

 

For the Fiscal Year Ended March 31, 2013:  

 

Total revenue  $2,168,093 
      
Net loss   (2,035,864)
      
Net loss per common share (basic and diluted)  $(0.03)
      
Weighted average common shares   62,092,487 

 

Statement of Financial Position

 

   December 31, 2013 
     
Cash  $85,366 
      
Accounts receivable  $164,988 
      
Seeds  $1,807,000 
      
Prepayments and other current assets  $74,946 
      
Total current assets  $2,132,300 
      
Total assets  $3,641,781 
      
Total current liabilities  $2,591,869 
      
Stockholders’ equity  $798,339 
      
Non-controlling interest  $(345,946)
      
Equity  $452,393 
      
Total liabilities and equity  $3,641,781 

 

6
 

 

   March 31,
2013
 
     
Cash  $424,475 
      
Accounts Receivable   158,008 
      
Prepayments and other current assets   33,096 
      
Total current assets   615,579 
      
Total assets  $2,194,251 
      
Total current liabilities  $1,457,531 
      
Stockholders’ equity  $464,765 
      
Non-controlling interest  $(214,158)
      
Equity  $250,607 
      
Total liabilities and equity  $2,194,251 

 

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS

 

Except for statements of historical facts, this Prospectus contains forward-looking statements involving risks and uncertainties. The words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan” or the negative of these terms and similar expressions or variations thereof are intended to forward looking statements. Such statements reflect the current view of the Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors (including the risks contained in the section of this registration statement on Form S-1 entitled “Risk Factors”) relating to the Registrant’s industry, the Registrant’s operations and results of operations and any businesses that may be acquired by the Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

 

Although the Registrant believes that the expectations reflected in the forward looking statements are reasonable, the Registrant cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, the Registrant does not intend to update any of the forward-looking statements to conform these statements to actual results. The following discussion should be read in conjunction with the Registrant’s financial statements and the related notes included in this registration statement on Form S-1.

 

RISK FACTORS

 

You should carefully consider the risks described below together with all of the other information included in our public filings before making an investment decision with regard to our securities. If any of the following events described in these risk factors actually occurs, our business, financial condition or results of operations could be harmed. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment.

 

RISKS RELATING TO OUR BUSINESS AND INDUSTRY

 

We have a limited operating history on which to evaluate our business or base an investment decision.

 

Our business prospects are difficult to predict because of our limited operating history, early stage of development and unproven business strategy. Stevia is still a relatively new product in the sweetener marketplace and it has historically not been commercially grown in Vietnam or many of our other target locations. Both the continued growth of the stevia market in general, and our ability to introduce commercial development of stevia to new regions, face numerous risks and uncertainties. In particular, we have not proven that we can produce stevia in a manner that enables us to be profitable and meet manufacturer requirements, develop intellectual property to enhance stevia production, develop and maintain relationships with key growers and strategic partners to extract value from our intellectual property, raise sufficient capital in the public and/or private markets, or respond effectively to competitive pressures. If we are unable to accomplish these goals, our business is unlikely to succeed and you should consider our prospects in light of these risks, challenges and uncertainties.

 

7
 

 

We have incurred significant losses and our auditors have expressed uncertainty about our ability to continue as a going concern.

 

Our auditors have expressed uncertainty as to our ability to continue as a going concern as of our fiscal year ended March 31, 2013. As of December 31, 2013, we had an accumulated deficit of $6,376,899. We anticipate that our existing cash and cash equivalents will not be sufficient to fund our longer term business needs and we will need to generate additional revenue or receive additional investment in the Company to continue operations. Such financing may not be available in sufficient amounts, or on terms acceptable to us and may dilute existing stockholders.

 

If we fail to raise additional capital, our ability to implement our business model and strategy could be compromised.

 

We have limited capital resources and operations. On March 3, 2014, we raised $340,000 (subject to certain fees) through the issuance of a convertible promissory note (the “Initial Convertible Note”), pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with Nomis Bay Ltd., a Bermuda company (“Nomis Bay”).  The Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, we may require Nomis Bay to purchase from the Company on or prior to the 10th trading day after the effective date of the registration statement registering the shares issuable upon conversion of the Initial Convertible Note, an additional senior convertible note with an initial principal amount of $600,000 (the “Additional Convertible Note”) for a purchase price of $600,000. There is no guarantee that we will be able to meet the conditions for the funding of the Additional Convertible Note and investors should not expect us to be able to do so.

 

To date, our operations have been funded entirely from the proceeds from debt and equity financings. We expect to require substantial additional capital in the near future to develop our intellectual property base and to establish the targeted levels of commercial production of stevia. We may not be able to obtain additional financing on terms acceptable to us, or at all. Even if we obtain financing for our near term operations, we expect that we will require additional capital beyond the near term. If we are unable to raise capital when needed, our business, financial condition and results of operations would be materially adversely affected, and we could be forced to reduce or discontinue our operations.

 

We face intense competition which could prohibit us from developing a customer base and generating revenue.

 

The industries within which we compete, including the sweetener industry and the fertilizer and feed industries, are highly competitive with companies that have greater capital resources, facilities and diversity of product lines. Additionally, if demand for stevia continues to grow, we expect many new competitors to enter the market as there are no significant barriers to stevia production. More established agricultural companies with much greater financial resources which do not currently compete with us may be able to easily adapt their existing operations to production of stevia. Due to this competition, there is no assurance that we will not encounter difficulties in obtaining revenues and market share or in the positioning of our services or that competition in the industry will not lead to reduced prices for the stevia leaf. Our competitors may also introduce new non-stevia based low-calorie sweeteners or be successful in developing a fermentation-derived stevia ingredient or other alternative production method which could also increase competition and decrease demand for stevia-based products.

 

Inability to protect our proprietary rights could damage our competitive position.

 

Our business will be heavily dependent upon the intellectual property we develop or acquire. Any infringement or misappropriation of our intellectual property could damage its value and limit our ability to compete. We will rely on patents, copyrights, trademarks, trade secrets, confidentiality provisions and licensing arrangements to establish and protect our intellectual property. We may have to engage in litigation to protect the rights to our intellectual property, which could result in significant litigation costs and require a significant amount of our time. In addition, our ability to enforce and protect our intellectual property rights may be limited in certain countries outside the United States, which could make it easier for competitors to capture market position in such countries by utilizing technologies that are similar to those developed or licensed by us.

 

Competitors may also harm our sales by designing products that mirror the capabilities of our products or technology without infringing our intellectual property rights. If we do not obtain sufficient protection for our intellectual property, or if we are unable to effectively enforce our intellectual property rights, our competitiveness could be impaired, which would limit our growth and future revenue.

 

A successful claim of infringement against us could result in a substantial damage award and materially harm our financial condition. Even if a claim against us is unsuccessful, we would likely have to devote significant time and resources to defending against it.

 

We may also find it necessary to bring infringement or other actions against third parties to seek to protect our intellectual property rights. Litigation of this nature, even if successful, is often expensive and disruptive of a company’s management’s attention, and in any event may not lead to a successful result relative to the resources dedicated to any such litigation.

 

We may be unable to effectively develop an intellectual property portfolio or may fail to keep pace with advances in technology.

 

We have a limited operating history in the agriculture industry and there is no certainty that we will be able to effectively develop a viable portfolio of intellectual property. The success of our farm management services, which are the core of our business, depends upon our ability to create such intellectual property.

 

8
 

  

Even if we are able to develop, manufacture and obtain any regulatory approvals and clearances necessary for our technologies and methods, the success of such services will depend upon market acceptance. Levels of market acceptance for our services could be affected by several factors, including:

 

  · the availability of alternative services from our competitors;
  · the price and reliability of the our services relative to that of our competitors; and
  · the timing of our market entry.

 

Additionally, our intellectual property must keep pace with advances by our competitors. Failure to do so could cause our position in the industry to erode rapidly.

 

Confidentiality agreements with employees and others may not adequately prevent disclosure of our trade secrets and other proprietary information.

 

Our success depends upon the skills, knowledge and experience of our technical personnel, our consultants and advisors as well as our licensors and contractors. Because we operate in a highly competitive field, we will rely significantly on trade secrets to protect our proprietary technology and processes. However, trade secrets are difficult to protect. We enter into confidentiality and intellectual property assignment agreements with our corporate partners, employees, consultants, outside scientific collaborators, developers and other advisors. These agreements generally require that the receiving party keep confidential and not disclose to third parties confidential information developed by us during the course of the receiving party’s relationship with us. These agreements also generally provide that inventions conceived by the receiving party in the course of rendering services to us will be our exclusive property. However, these agreements may be breached and may not effectively assign intellectual property rights to us. Our trade secrets also could be independently discovered by competitors, in which case we would not be able to prevent use of such trade secrets by our competitors. The enforcement of a claim alleging that a party illegally obtained and was using our trade secrets could be difficult, expensive and time consuming and the outcome would be unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets. The failure to obtain or maintain meaningful trade secret protection could adversely affect our competitive position.

 

We will produce products for consumption by consumers that may expose us to litigation based on consumer claims and product liability.

 

The stevia produced at our farms will be integrated into stevia-based products which will be consumed by the general public. Additionally, we may manufacture and sell private label stevia-based food products. Even though we intend to grow and sell products that are safe, we have potential product risk from the consuming public. We could be party to litigation based on consumer claims, product liability or otherwise that could result in significant liability for us and adversely affect our financial condition and operations.

 

If our services do not gain acceptance among stevia growers, we may not be able to recover the cost of our intellectual property development.

 

Our business model relies on the assumption that we will be able to develop methods and protocols, secure valuable plant strains and develop other intellectual property for stevia farming that will be attractive to both stevia growers and manufacturers. We spent $383,360 for this purpose as of March 31, 2013 and issued 3,000,000 shares to acquire intellectual property related to stevia and we estimate spending approximately fifteen percent of our operating expense budget to continue developing and improving this intellectual property portfolio. If we are unable to secure such intellectual property or if our methods and protocols do not gain acceptance among growers or manufacturers, our intellectual property will have limited value. A number of factors may affect the market acceptance of our products and services, including, among others, the perception by growers of the effectiveness of our intellectual property, the perception among manufacturers of the quality of stevia produced using our intellectual property, our ability to fund marketing efforts, and the effectiveness of such marketing efforts. If such products and services do not gain acceptance by growers and/or manufacturers, we may not be able to fund future operations, including the expansion of our own farming projects and development and/or acquisition of additional intellectual property, which inability would have a material adverse effect on our business, financial condition and operating results.

 

Any failure to adequately establish a network of growers and manufacturers will impede our growth.

 

We expect to be substantially dependent on manufacturers to purchase the stevia produced both at our own farms and at those of our customers. We have entered into a supply agreement with a manufacturer and two purchase agreements with growers and are in the process of establishing a network of growers to produce stevia using the methods and protocols we are developing. The relationship with this manufacturer and its perception of the stevia produced using our farm management services will determine its willingness to enter into purchase contracts with us and our customers on attractive terms. Our ability to secure such contracts will influence our attractiveness to growers who are potentially interested in partnering with us. Achieving significant growth in revenue will depend, in large part, on our success in establishing this production network. If we are unable to develop an efficient production network, it will make our growth more difficult and our business could suffer.

 

9
 

  

If we are unable to deliver a consistent, high quality stevia leaf at sufficient volumes, our relationship with our manufacturers may suffer and our operating results will be adversely affected.

 

Manufacturers will expect us to be able to consistently deliver stevia at sufficient volumes, while meeting their established quality standards. If we are unable to consistently deliver such volumes either from our own farms, or those of our grower partners, our relationship with these manufacturers could be adversely affected which could have a negative impact on our operating results.

 

Laws and regulations affecting the cannabis and marijuana industries are constantly changing, which could detrimentally affect our contemplated business, and we cannot predict the impact that future regulations may have on us.

 

Local, state and federal cannabis and marijuana laws and regulations are constantly changing and they are subject to evolving interpretations, which could require us to incur substantial costs associated with compliance or to alter one or more of our contemplated service offerings. In addition, violations of these laws, or allegations of such violations, could disrupt our contemplated business and result in a material adverse effect on our revenues, profitability, and financial condition. We cannot predict the nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have on our contemplated business.  Any change in law or interpretation could have a material adverse effect on our contemplated business, financial condition, and results of operations.

 

Marijuana remains illegal under federal law.

 

Marijuana remains illegal under federal law.  It is a schedule-I controlled substance.  Even in those jurisdictions in which the use of medical marijuana has been legalized at the state level, its prescription is a violation of federal law.  Federal law criminalizing the use of marijuana trumps state laws that legalize its use for medicinal purposes, although the current President’s administration has expressed a reluctance to enforce federal law in this regard in jurisdictions where it conflicts with state law. However, a change in the federal attitude towards enforcement could occur at any time and could cripple the industry.

 

It is possible that our contemplated activities could be deemed to be facilitating the selling or distribution of marijuana in violation of the federal Controlled Substances Act, or to constitute aiding or abetting, or being an accessory to, a violation of that Act. Federal authorities have not focused their resources on such tangential or secondary violations of the Act, nor have they threatened to do so. However, if the federal government were to change its practices, or were to expend its resources attacking providers of services or equipment that could be usable by participants in the marijuana industry, such action could have a materially adverse effect on our contemplated business, financial condition, and results of operations.

 

Hemp remains illegal to grow under federal law.

 

Hemp remains illegal to grow in the United States under federal law due to its relation to marijuana. However, it may be legally imported and sold in the United States. In certain states, the cultivation of hemp is legal, however federal law criminalizing such cultivation trumps state laws in this regard. The current President’s administration has expressed a reluctance to enforce federal law in this regard in jurisdictions where it conflicts with state law. However, a change in the federal attitude towards enforcement could occur at any time and could cripple the industry.

 

It is possible that our contemplated activities could be deemed to be facilitating hemp cultivation in violation of the federal Controlled Substances Act, or to constitute aiding or abetting, or being an accessory to, a violation of that Act. Federal authorities have not focused their resources on such tangential or secondary violations of the Act, nor have they threatened to do so. However, if the federal government were to change its practices, or were to expend its resources attacking providers of services or equipment that could be usable by participants in the hemp cultivation industry, such action could have a materially adverse effect on our contemplated business, financial condition, and results of operations.

 

Changes in consumer preferences or negative publicity or rumors may reduce demand for our products.

 

Recent data suggests consumers are adopting stevia as a sweetener in many products. However, stevia is a relatively new ingredient in consumer products and many consumers are not familiar with it. Therefore, any negative reports or rumors regarding either the taste or perceived health effects of stevia, whether true or not, could have a severe impact on the demand for stevia-based products. Manufacturers may decide to rely on alternative sweeteners which have a more established history with consumers. Primarily operating at the grower level, we will have little opportunity to influence these perceptions and there can be no assurance that the increased adoption of stevia in consumer food and beverage products will continue. Additionally, new sweeteners with similar characteristics to stevia may emerge which could be cheaper to produce or be perceived to have other qualities superior to stevia. Any of these factors could adversely affect our ability to produce revenues and our business, financial condition and results of operations would suffer.

 

10
 

  

Failure to effectively manage growth of internal operations and business may strain our financial resources.

 

We intend to significantly expand the scope of our farming operations and our research and development activities in the near term. Our growth rate may place a significant strain on our financial resources for a number of reasons, including, but not limited to, the following:

 

  · The need for continued development of our financial and information management systems;
  · The need to manage strategic relationships and agreements with manufacturers, growers and partners; and
  · Difficulties in hiring and retaining skilled management, technical and other personnel necessary to support and manage our business.

 

Additionally, our strategy envisions a period of rapid growth that may impose a significant burden on our administrative and operational resources. Our ability to effectively manage growth will require us to substantially expand the capabilities of our administrative and operational resources and to attract, train, manage and retain qualified management and other personnel. Our failure to successfully manage growth could result in our sales not increasing commensurately with capital investments. Our inability to successfully manage growth could materially adversely affect our business.

 

Adverse weather conditions, natural disasters, crop disease, pests and other natural conditions can impose significant costs and losses on our business.

 

Weather-related events could significantly affect our results of operations. We do not currently maintain insurance to cover weather-related losses and if we do obtain such insurance it likely will not cover all weather-related events and, even when an event is covered, our retention or deductible may be significant. Cooler temperatures in the regions where we operate could negatively affect us, while not affecting our competitors in other regions.

 

Our crops, and those of our grower partners, could also be affected by drought, temperature extremes, hurricanes, windstorms and floods. In addition, such crops could be vulnerable to crop disease and to pests, which may vary in severity and effect, depending on the stage of agricultural production at the time of infection or infestation, the type of treatment applied and climatic conditions. Unfavorable growing conditions caused by these factors can reduce both crop size and crop quality. In extreme cases, entire harvests may be lost. These factors may result in lower production and, in the case of farms we own or manage, increased costs due to expenditures for additional agricultural techniques or agrichemicals, the repair of infrastructure, and the replanting of damaged or destroyed crops. We may also experience shipping interruptions, port damage and changes in shipping routes as a result of weather-related disruptions.

 

Competitors and industry participants may be affected differently by weather-related events based on the location of their production and supply. If adverse conditions are widespread in the industry, it may restrict supplies and lead to an increase in prices for stevia leaf, but our typical fixed-price supply contracts may prevent us from recovering these higher costs.

 

Our operations and products are regulated in the areas of food safety and protection of human health and the environment.

 

Our operations and products are subject to inspections by environmental, food safety, health and customs authorities and to numerous governmental regulations, including those relating to the use and disposal of agrichemicals, the documentation of food shipments, the traceability of food products, and labeling of our products for consumers, all of which involve compliance costs. Changes in regulations or laws may require, operational modifications or capital improvements at various locations. If violations occur, regulators can impose fines, penalties and other sanctions. The costs of these modifications and improvements and of any fines or penalties could be substantial. We can be adversely affected by actions of regulators or if consumers lose confidence in the safety and quality of stevia, even if our products are not implicated.

 

If we are unable to continually innovate and increase efficiencies, our ability to attract new customers may be adversely affected.

 

In the area of innovation, we must be able to develop new processes, plant strains, and other technologies that appeal to stevia growers. This depends, in part, on the technological and creative skills of our personnel and on our ability to protect our intellectual property rights. We may not be successful in the development, introduction, marketing and sourcing of new technologies or innovations, that satisfy customer needs, achieve market acceptance or generate satisfactory financial returns.

 

Global economic conditions may adversely affect our industry, business and result of operations.

 

Disruptions in the global credit and financial market could result in diminished liquidity and credit availability, a decline in consumer confidence, a decline in economic growth, an increased unemployment rate, and uncertainty about economic stability. These economic uncertainties can affect businesses such as ours in a number of ways, making it difficult to accurately forecast and plan our future business activities. Such conditions can lead consumers to postpone spending, which can cause manufacturers to cancel, decrease or delay orders with us. We are unable to predict the likelihood of the occurrence, duration or severity of such disruptions in the credit and financial markets and adverse global economic conditions and such economic conditions could materially and adversely affect our business and results of operations.

 

Our business depends substantially on the continuing efforts of our executive officers and our business may be severely disrupted if we lose their services.

 

Our future success depends substantially on the continued services of our executive officers, especially our President and director, Mr. George Blankenbaker. We do not maintain key man life insurance on any of our executive officers and directors. If one or more of our executive officers are unable or unwilling to continue in their present positions, we may not be able to replace them readily, if at all. Therefore, our business may be severely disrupted, and we may incur additional expenses to recruit and retain new officers. In addition, if any of our executives joins a competitor or forms a competing company, we may lose some of our customers.

 

11
 

  

Our engagement of Growers Synergy Pte Ltd. may represent a potential conflict of interest.

 

We have engaged Growers Synergy Pte Ltd, a regional farm management services provider, to provide farm management operations and back-office and regional logistical support for our Vietnam and Indonesia operations for a period of two years. During the fiscal year ended March 31, 2012, Growers Synergy received $180,000 for consulting services rendered to the Company and during the fiscal year ended March 31, 2013, Growers Synergy received $240,000 for consulting services rendered to the Company. George Blankenbaker, our president, director and stockholder is the managing director of Growers Synergy. Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and Mr. Blankenbaker controls a 49% interest in Growers Fresh. As a result, there is a potential conflict of interest on Mr. Blankenbaker’s role in the Company and Growers Synergy and such potential conflict could materially affect the terms of any engagement entered into by the Company and Growers Synergy. Such terms, if not negotiated at arms length may not be in the best interest of the Company and our stockholders.

 

Litigation may adversely affect our business, financial condition and results of operations.

 

From time to time in the normal course of our business operations, we may become subject to litigation that may result in liability material to our financial statements as a whole or may negatively affect our operating results if changes to our business operation are required. The cost to defend such litigation may be significant and may require a diversion of our resources. There also may be adverse publicity associated with litigation that could negatively affect customer perception of our business, regardless of whether the allegations are valid or whether we are ultimately found liable. As a result, litigation may adversely affect our business, financial condition and results of operations.

 

We may be required to incur significant costs and require significant management resources to evaluate our internal control over financial reporting as required under Section 404 of the Sarbanes-Oxley Act, and any failure to comply or any adverse result from such evaluation may have an adverse effect on our stock price.

 

As a smaller reporting company as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, we are required to evaluate our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”). Section 404 requires us to include an internal control report with our Annual Report on Form 10-K. This report must include management’s assessment of the effectiveness of our internal control over financial reporting as of the end of the fiscal year. This report must also include disclosure of any material weaknesses in internal control over financial reporting that we have identified. Failure to comply, or any adverse results from such evaluation could result in a loss of investor confidence in our financial reports and have an adverse effect on the trading price of our equity securities. As of December 31, 2013, the management of the Company assessed the effectiveness of the Company’s internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) and SEC guidance on conducting such assessments. Management concluded, as of the quarter ended December 31, 2013, that its internal controls and procedures were not effective to detect the inappropriate application of U.S. GAAP rules. Management realized there were deficiencies in the design or operation of our internal control that adversely affected our internal controls which management considers to be material weaknesses including those described below:

 

  · We have not achieved the optimal level of segregation of duties relative to key financial reporting functions.
  · We do not have an audit committee or an independent audit committee financial expert. While not being legally obligated to have an audit committee or independent audit committee financial expert, it is the management’s view that to have an audit committee, comprised of independent board members, and an independent audit committee financial expert is an important entity-level control over our financial statements.

 

Achieving continued compliance with Section 404 may require us to incur significant costs and expend significant time and management resources. No assurance can be given that we will be able to fully comply with Section 404 or that we and our independent registered public accounting firm would be able to conclude that our internal control over financial reporting is effective at fiscal year end. As a result, investors could lose confidence in our reported financial information, which could have an adverse effect on the trading price of our securities, as well as subject us to civil or criminal investigations and penalties. In addition, our independent registered public accounting firm may not agree with our management’s assessment or conclude that our internal control over financial reporting is operating effectively.

 

RISKS RELATED TO DOING BUSINESS IN VIETNAM AND OTHER DEVELOPING COUNTRIES

 

Our international operations will be subject to the laws of the jurisdictions in which we operate.

 

A significant portion of our initial business operations will occur in Vietnam.  We will be generally subject to laws and regulations applicable to foreign investment in Vietnam.  The Vietnamese legal system is based, at least in part, on written statutes.  However, since these laws and regulations are relatively new and the Vietnamese legal system continues to rapidly evolve, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involves uncertainties.

 

12
 

  

In April 2012, we announced plans to begin field tests in Indonesia. Similar to Vietnam, the modern Indonesia legal system was formed relatively recently and is continuing to evolve. As we continue our expansion into Indonesia and other developing countries, we will face similar risks and uncertainties regarding the legal system as we currently face in Vietnam.

 

We cannot predict the effect of future developments in the legal systems of developing countries, including the promulgation of new laws, changes to existing laws or the interpretation or enforcement thereof, the preemption of local regulations by national laws, or the overturn of local government’s decisions by the superior government.  These uncertainties may limit legal protections available to us.

 

Our international operations involve the use of foreign currencies, which subjects us to exchange rate fluctuations and other currency risks.

 

The revenues and expenses of our international operations are generally denominated in local currencies, which subjects us to exchange rate fluctuations between such local currencies and the U.S. dollar.  These exchange rate fluctuations will subject us to currency translation risk with respect to the reported results of our international operations, as well as to other risks sometimes associated with international operations.  In the future, we could experience fluctuations in financial results from our operations outside of the United States, and there can be no assurance we will be able, contractually or otherwise, to reduce the currency risks associated with our international operations.

 

We may be adversely affected by economic and political conditions in the countries where we operate.

 

We operate in Vietnam and other countries throughout the world.  Economic and political changes in these countries, such as inflation rates, recession, foreign ownership restrictions, restrictions on transfer of funds into or out of a country and similar factors may adversely affect results of operations.

 

While it is our understanding that the economy in Vietnam has grown significantly in the past 20 years, the growth has been uneven, both geographically and among various economic sectors.  The government of Vietnam has implemented various measures to encourage or control economic growth and guide the allocation of resources.  Some of these measures benefit the overall Vietnamese economy, but may also have a negative effect on us.  For example, our financial condition and results of operations may be adversely affected by government control over capital investments or changes in tax regulations that are applicable to us.

 

The Vietnamese economy has been transitioning from a planned economy to a more market-oriented economy.  Although in recent years the Vietnamese government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets and the establishment of sound corporate governance in business enterprises, a substantial portion of the productive assets in Vietnam are still owned by the Vietnamese government.  The continued control of these assets and other aspects of the national economy by Vietnam government could materially and adversely affect our business.  The Vietnamese government also exercises significant control over Vietnamese economic growth through the allocation of resources, controlling payment of foreign currency-denominated obligations, setting monetary policy and providing preferential treatment to particular industries or companies.  Efforts by the Vietnamese government to slow the pace of growth of the Vietnamese economy could negatively affect our business.

 

Our insurance coverage may be inadequate to cover all significant risk exposures.

 

We will be exposed to liabilities that are unique to the products we provide.  While we intend to maintain insurance for certain risks, the amount of our insurance coverage may not be adequate to cover all claims or liabilities, and we may be forced to bear substantial costs resulting from risks and uncertainties of our business.  It is also not possible to obtain insurance to protect against all operational risks and liabilities.  The failure to obtain adequate insurance coverage on terms favorable to us, or at all, could have a material adverse effect on our business, financial condition and results of operations.  In addition, because the insurance industry in Vietnam and other developing countries are still in their early stages of development, business interruption insurance available in such countries relating to our intended services and products offers limited coverage compared to that offered in many other developed countries.  We do not have any business interruption insurance.  Any business disruption or natural disaster could result in substantial costs and diversion of resources.

 

It will be extremely difficult to acquire jurisdiction and enforce liabilities against our officers, directors and assets outside the United States.

 

Substantially all of our assets are currently located outside of the United States and a significant number of our officers and directors may reside outside of the United States as well.  As a result, it may not be possible for United States investors to enforce their legal rights, to effect service of process upon our directors or officers or to enforce judgments of United States courts predicated upon civil liabilities and criminal penalties of our directors and officers under Federal securities laws. Moreover, we have been advised that Vietnam in particular does not have treaties providing for the reciprocal recognition and enforcement of judgments of courts with the United States. Further, it is unclear if extradition treaties now in effect between the United States and Vietnam would permit effective enforcement of criminal penalties of the Federal securities laws.

 

13
 

  

RISKS RELATED TO AN INVESTMENT IN OUR SECURITIES

 

The relative lack of public company experience of our management team may put us at a competitive disadvantage.

 

Our management team lacks public company experience and is generally unfamiliar with the requirements of the United States securities laws and U.S. Generally Accepted Accounting Principles, which could impair our ability to comply with legal and regulatory requirements such as those imposed by Sarbanes-Oxley Act of 2002. The individuals who now constitute our senior management team have never had responsibility for managing a publicly traded company. Such responsibilities include complying with federal securities laws and making required disclosures on a timely basis. Our senior management may not be able to implement programs and policies in an effective and timely manner that adequately responds to such increased legal, regulatory compliance and reporting requirements. Our failure to comply with all applicable requirements could lead to the imposition of fines and penalties and distract our management from attending to the growth of our business.

 

Our stock is categorized as a penny stock. Trading of our stock may be restricted by the SEC’s penny stock regulations which may limit a stockholder’s ability to buy and sell our stock.

 

Our stock is categorized as a “penny stock”. The SEC has adopted Rule 15g-9 which generally defines “penny stock” to be any equity security that has a market price (as defined) less than $4.00 per share or an exercise price of less than $5.00 per share, subject to certain exceptions. Our securities are covered by the penny stock rules, which impose additional sales practice requirements on broker-dealers who sell to persons other than established customers and accredited investors. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction and monthly account statements showing the market value of each penny stock held in the customer’s account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer’s confirmation. In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities. We believe that the penny stock rules discourage investor interest in and limit the marketability of our common stock.

 

FINRA sales practice requirements may also limit a stockholder’s ability to buy and sell our stock.

 

In addition to the “penny stock” rules described above, the Financial Industry Regulatory Authority (“FINRA”) has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares.

 

We expect to experience volatility in our stock price, which could negatively affect stockholders’ investments.

 

Although our common stock is quoted on the OTCQB under the symbol “STEV”, there is a limited public market for our common stock.  No assurance can be given that an active market will develop or that a stockholder will ever be able to liquidate its shares of common stock without considerable delay, if at all.  Many brokerage firms may not be willing to effect transactions in the securities.  Even if a purchaser finds a broker willing to effect a transaction in these securities, the combination of brokerage commissions, state transfer taxes, if any, and any other selling costs may exceed the selling price.  Furthermore, our stock price may be impacted by factors that are unrelated or disproportionate to our operating performance.  These market fluctuations, as well as general economic, political and market conditions, such as recessions, interest rates or international currency fluctuations may adversely affect the market price and liquidity of our common stock.

 

In the past, securities class action litigation has often been brought against a company following periods of volatility in the market price of its securities.  Due to the volatility of our common stock price, we may be the target of securities litigation in the future.  Securities litigation could result in substantial costs and divert management’s attention and resources.

 

Stockholders should also be aware that, according to SEC Release No. 34-29093, the market for “penny stock”, such as our common stock, has suffered in recent years from patterns of fraud and abuse.  Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses.  Our management is aware of the abuses that have occurred historically in the penny stock market.  Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities. The occurrence of these patterns or practices could increase the future volatility of our share price.

 

14
 

  

To date, we have not paid any cash dividends and no cash dividends will be paid in the foreseeable future.

 

We do not anticipate paying cash dividends on our common stock in the foreseeable future and we may not have sufficient funds legally available to pay dividends. Even if the funds are legally available for distribution, we may nevertheless decide not to pay any dividends. We presently intend to retain all earnings for our operations.to pay dividends. Even if the funds are legally available for distribution, we may nevertheless decide not to pay any dividends. We presently intend to retain all earnings for our operations.

 

The elimination of monetary liability against our directors, officers and employees under Nevada law and the existence of indemnification rights to our directors, officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors, officers and employees.

 

Our Articles of Incorporation contain a provision permitting us to eliminate the personal liability of our directors to our company and stockholders for damages for breach of fiduciary duty as a director or officer to the extent provided by Nevada law. We may also have contractual indemnification obligations under our employment agreements with our officers. The foregoing indemnification obligations could result in the Company incurring substantial expenditures to cover the cost of settlement or damage awards against directors and officers, which we may be unable to recoup. These provisions and resultant costs may also discourage our company from bringing a lawsuit against directors and officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation by our stockholders against our directors and officers even though such actions, if successful, might otherwise benefit our company and stockholders.

 

If the Company’s outstanding warrants and convertible notes are exercised and/or converted it will result in the dilution of our existing stockholders.

 

The outstanding warrants and convertible notes being registered hereunder are exercisable for an aggregate of 47,898,931 shares of our common stock. Although the Company has a call right or repayment right with respect to certain of the notes and warrants, the Company may not be financially capable of exercising such call right or may otherwise choose not to do so, and therefore the Company may not control if and when the notes and warrants are exercised and/or converted. The exercise of the notes and warrants would result in dilution to our existing stockholders and could contribute to a reduction in the market price of the outstanding shares of our common stock.

 

USE OF PROCEEDS

 

The “Selling Security Holders” set forth in “The Selling Security Holders Table” below may sell all of the common stock underlying the Warrants offered by this Prospectus from time-to-time. We will not receive any proceeds from the sale of those shares of common stock. We may, however, receive gross proceeds of up to $1,083,103.46 upon the cash exercise of the Warrants. Any such proceeds we receive will be used for working capital and general corporate matters.

 

DETERMINATION OF OFFERING PRICE

 

There currently is a limited public market for our common stock. Selling Security Holders will determine at what price they may sell the offered shares, and such sales may be made at prevailing market prices or at privately negotiated prices. See “Plan of Distribution” below for more information.

 

SELLING SECURITY HOLDERS

 

Nomis Bay Note Shares

 

This offering, with respect to the Nomis Bay Note Shares, relates to the resale of shares of common stock of the Company underlying a Senior Convertible Note, issued March 3, 2014 (the “Nomis Bay Note”). On March 3, 2014, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with Nomis Bay Ltd., a Bermuda company (“Nomis Bay”), we issued the Nomis Bay Note with an initial principal amount of $500,000 for a purchase price of $340,000.  The Nomis Bay Note matures on December 27, 2014 (subject to extension as provided in the Nomis Bay Note) and, in addition to the 32% original issue discount, accrues interest at the rate of 8% per annum. The Purchase Agreement also provides that, upon the terms and subject to the conditions set forth therein, the Company may require Nomis Bay to purchase from the Company on or prior to the 10th trading day after the effective date of the registration statement registering the shares issuable upon conversion of the Initial Convertible Note, an additional senior convertible note with an initial principal amount of $600,000 (the “Additional Convertible Note” and together with the Nomis Bay Note, the “Convertible Notes”) for a purchase price of $600,000. If issued, the Additional Convertible Note will mature on the date that is the 10-month anniversary of the date of issuance of the Additional Convertible Note (subject to extension as provided in the Initial Convertible Note) and will accrue interest at the rate of 8% per annum. The Nomis Bay Note is convertible at any time, in whole or in part, at Nomis Bay’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to the lesser of (i) the product of (x) the arithmetic average of the lowest three (3) volume weighted average prices of the Common Stock during the 10 consecutive trading days ending and including the trading day immediately preceding the applicable conversion date and (y) 40% (the “Variable Conversion Price”), and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). If issued, the Additional Convertible Note will be convertible at any time, in whole or in part, at Nomis Bay’s option into shares of Common Stock at a conversion price that will be equal to the lesser of (i) the Variable Conversion Price and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). At no time will Nomis Bay be entitled to convert any portion of the Convertible Notes to the extent that after such conversion, Nomis Bay (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. The shares of common stock underlying the Nomis Bay Note were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

15
 

  

Anson Reset Shares

  

This offering, with respect to the Anson Reset Shares, relates to the resale of shares of common stock of the Company underlying three warrants in the amounts of 1,877,333, 1,066,666 and 2,346,666, with exercise prices of $0.20, $0.25 and $0.25 per share (the “Anson Warrants”). Pursuant to the terms of a warrant exercise reset offer letter between the Company and the investor, the Anson Warrants were issued in consideration for the investor’s agreement to immediately cash exercise an existing warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share for aggregate consideration to the Company of $170,666 originally issued pursuant to the terms of the Securities Purchase Agreement, dated August 1, 2012 (the “Purchase Agreement”). Each Anson Warrant has a five year term and was issued on May 3, 2013. Each Anson Warrant provides for adjustment of the exercise price and share amount in the event of certain dilutive issuances by the Company. On February 20, 2014, the Company issued a notice to the holder that the aggregate number of Anson Warrants had been adjusted to 23,026,318 and the exercise price of each had been adjusted to $0.053365 as a result of certain other offerings of the Company. 5,290,665 of the shares underlying the Anson Warrants were previously registered by the Company pursuant to the Registration Statement on Form S-1/A filed December 30, 2013. The warrants and the shares of common stock underlying the warrants were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

Cranshire Warrant Shares

 

This offering, with respect to the Cranshire Warrant Shares, relates to the resale of the shares of common stock underlying a warrant in the amount of 2,560,486 with an exercise price of $0.053365. The warrant has a five (5) year term and was issued pursuant to the terms of the Purchase Agreement. The warrant was originally issued in the amount of 213,334 shares at an exercise price of $0.6405. Pursuant to the anti-dilution adjustment provision contained therein, on February 20, 2014, the Company issued a notice to the holder that the total share amount had been increased to 2,560,486 and the exercise price had been reduced to $0.053365 as a result of certain other offerings of the Company. 683,202 of the shares underlying the Cranshire Warrants were previously registered by the Company pursuant to the Registration Statement on Form S-1/A filed December 30, 2013. Additionally, on February 20, 2014 in consideration for the investor’s agreement to immediately cash exercise a portion of the Cranshire Warrants for aggregate consideration to the Company of $36,459, the Company agreed to issue the investor an additional warrant to purchase 683,202 shares of common stock. The warrants and the shares of common stock underlying the warrants were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.  

 

JMJ Note Shares

 

This offering, with respect to the JMJ Note Shares, relates to the resale of 3,000,000 shares of common stock of the Company underlying a $400,000 Promissory Note issued July 10, 2013. The JMJ Note is subject to a one-time interest charge equal to 12% of the principal sum and is due and payable July 10, 2014. The JMJ Note provides that it may be converted into common stock of the Company at any time at the election of the holder, at a conversion price equal to the lesser of $0.26 or 65% of the lowest trade price in the 25 trading days previous to the conversion. The JMJ Note and the shares of common stock underlying the JMJ Note were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

The Selling Security Holders Table

 

The following table sets forth the names of the Selling Security Holders, the number of shares of common stock beneficially owned by each Selling Security Holder as of the date hereof and the number of shares of common stock being offered by each Selling Security Holder.  The shares being offered hereby are being registered to permit public secondary trading, and the Selling Security Holders may offer all or part of the shares for resale from time to time. However, the Selling Security Holders are under no obligation to sell all or any portion of such shares nor are the Selling Security Holders obligated to sell any shares immediately upon effectiveness of this prospectus. All information with respect to share ownership has been furnished by the Selling Security Holders.  The “Amount Beneficially Owned After Offering” column assumes the sale of all shares offered.

 

   Shares       Amount   Percent 
   Beneficially       Beneficially   Beneficially 
   Owned Prior To   Shares to   Owned After   Owned 
Name  Offering(1)   be Offered   Offering(1)(5)   After Offering(6) 
Nomis Bay Ltd.(2)   6,361,323    24,602,792    0    0%
                     
Anson Investments Master Fund LP(3)   17,735,653    17,735,653    0    0%
                     
Cranshire Capital Master Fund, Ltd.(4)   2,560,486    2,560,486    0    0%
                     
JMJ Financial   0    3,000,000    0    0%

 

16
 

 

(1)Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Pursuant to the rules of the SEC, shares of common stock which an individual or group has a right to acquire within 60 days pursuant to the exercise of options or warrants are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group, but are not deemed to be beneficially owned and outstanding for the purpose of computing the percentage ownership of any other person shown in the table.

 

(2)Includes 6,361,323 shares of common stock issuable to Nomis Bay Ltd. upon the conversion of the principal amount of the registrant’s Senior Convertible Note issued March 3, 2014, based upon a current conversion price of $0.0786. EOM Management Ltd. (“EOM”) is the investment manager of Nomis Bay Ltd. and has voting control and investment discretion over securities held by Nomis Bay Ltd. Chaja Carlebach (“Ms. Carlebach”) owns all of the outstanding equity of EOM and has voting control over EOM. As a result, each of Ms. Carlebach and EOM may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the securities held by Nomis Bay Ltd.  We have been advised that neither EOM nor Nomis Bay Ltd. is a member of the Financial Industry Regulatory Authority (“FINRA”) or an independent broker-dealer, and that neither EOM, Nomis Bay Ltd. or any of their respective affiliates is an affiliate or an associated person of any FINRA member or independent broker-dealer.

  

(3)Moez Kassam has voting and dispositive control over the shares beneficially owned by Anson Investments Master Fund LP.

 

(4)Cranshire Capital Advisors, LLC (“CCA”) is the investment manager of Cranshire Capital Master Fund, Ltd. (“Cranshire Master Fund”) and has voting control and investment discretion over securities held by Cranshire Master Fund. Mitchell P. Kopin (“Mr. Kopin”), the president, the sole member and the sole member of the Board of Managers of CCA, has voting control over CCA. As a result, each of Mr. Kopin and CCA may be deemed to have beneficial ownership (as determined under Section 13(d) of the Securities Exchange Act of 1934, as amended) of the securities held by Cranshire Master Fund.

 

(5)Includes the shares of common stock issuable upon exercise of the Warrants.

 

(6)Applicable percentage ownership is based on 145,972,713 shares of our common stock outstanding as of March 26, 2014.

 

All expenses incurred with respect to the registration of the common stock will be borne by us, but we will not be obligated to pay any underwriting fees, discounts, commission or other expenses incurred by the Selling Security Holders in connection with the sale of the Shares.

 

Neither the Selling Security Holders nor any of their associates or affiliates has held any position, office, or other material relationship with us in the past three years.

 

PLAN OF DISTRIBUTION

 

This prospectus relates to the resale of 47,898,931 shares of common stock, by the Selling Security Holders listed under “Selling Security Holders” on page 15, issuable upon the exercise of the outstanding convertible notes and warrants.

 

The Selling Security Holders and any of their respective pledges, donees, assignees and other successors-in-interest may, from time to time, sell any or all of their shares of our common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions.  The Selling Security Holders may use any one or more of the following methods when selling shares:

 

·ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

·block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;

 

·purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

·an exchange distribution in accordance with the rules of the applicable exchange;

 

·privately negotiated transactions;

 

·broker-dealers may agree with a Selling Security Holder to sell a specified number of such shares at a stipulated price per share;

 

·through the writing of options on the shares;

 

·a combination of any such methods of sale; and

 

any other method permitted pursuant to applicable law.

  

17
 

 

The Selling Security Holders or their respective pledgees, donees, transferees or other successors in interest, may also sell the shares directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers.  Such broker-dealers may receive compensation in the form of discounts, concessions or commissions from the Selling Security Holders and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which compensation as to a particular broker-dealer might be in excess of customary commissions. Market makers and block purchasers purchasing the shares will do so for their own account and at their own risk.  It is possible that the Selling Security Holders will attempt to sell shares of common stock in block transactions to market makers or other purchasers at a price per share which may be below the then market price.  The Selling Security Holders cannot assure that all or any of the shares offered in this prospectus will be issued to, or sold by, the Selling Security Holders.  In addition, the Selling Security Holders and any brokers, dealers or agents, upon effecting the sale of any of the shares offered in this prospectus may be deemed “underwriters” as that term is defined under the Securities Act or the Exchange Act, or the rules and regulations under such acts.  In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

 

Discounts, concessions, commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by a Selling Security Holder. The Selling Security Holders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the shares if liabilities are imposed on that person under the Securities Act.

 

The Selling Security Holders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them, and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under Rule 424(b)(3) or any other applicable provision of the Securities Act amending the list of Selling Security Holders to include the pledgee, transferee or other successors in interest as Selling Security Holder under this prospectus.

 

The Selling Security Holders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of common stock from time to time under this prospectus after we have filed an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of Selling Security Holders to include the pledgee, transferee or other successors in interest as a Selling Security Holder under this prospectus.

 

The Selling Security Holders acquired or will acquire the securities offered hereby in the ordinary course of business and have advised us that they have not entered into any agreements, understandings or arrangements with any underwriters or broker-dealers regarding the sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection with a proposed sale of shares of common stock by any Selling Security Holder.  We will file a supplement to this prospectus if a Selling Security Holder enters into a material arrangement with a broker-dealer for sale of common stock being registered.  If the Selling Security Holders use this prospectus for any sale of the shares of common stock, it will be subject to the prospectus delivery requirements of the Securities Act.

 

Pursuant to a requirement by the Financial Industry Regulatory Authority, or FINRA, the maximum commission or discount to be received by any FINRA member or independent broker/dealer may not be greater than eight percent (8%) of the gross proceeds received by us for the sale of any securities being registered pursuant to SEC Rule 415 under the Securities Act.

 

The anti-manipulation rules of Regulation M under the Exchange Act, may apply to sales of our common stock and activities of the Selling Security Holders.  The Selling Security Holders will act independently of us in making decisions with respect to the timing, manner and size of each sale.

 

We will pay all expenses incident to the registration, offering and sale of the shares of our common stock to the public hereunder other than commissions, fees and discounts of underwriters, brokers, dealers and agents.   We estimate that the expenses of the offering to be borne by us will be approximately $16,145.53.  We will not receive any proceeds from the resale of any of the shares of our common stock in this Offering, other than $1,083,103.46 of potential proceeds upon the exercise of the Warrants for cash.   

 

DESCRIPTION OF SECURITIES TO BE REGISTERED

 

General

 

The following summary includes a description of material provisions of our capital stock.

Authorized and Outstanding Securities

 

The Company is authorized to issue 250,000,000 shares of common stock, par value $0.001 per share.  As of March 26, 2014, there were issued and outstanding 145,972,713 shares of our common stock.

 

Common Stock

 

The holders of our common stock are entitled to one vote for each share on all matters to be voted on by the stockholders. Holders of common stock do not have cumulative voting rights. Holders of common stock are entitled to share ratably in dividends, if any, as may be declared from time to time by the board of directors in its discretion from funds legally available therefore. In the event of a liquidation, dissolution or winding up of the Company, the holders of common stock are entitled to share pro rata all assets remaining after payment in full of all liabilities. Holders of common stock have no preemptive rights to purchase the Company’s common stock. There are no conversion or redemption rights or sinking fund provisions with respect to the common stock.

 

18
 

  

Dividends

 

Dividends, if any, will be contingent upon our revenues and earnings, if any, capital requirements and financial conditions. The payment of dividends, if any, will be within the discretion of our board of directors. We intend to retain earnings, if any, for use in its business operations and accordingly, the board of directors does not anticipate declaring any dividends in the foreseeable future.

 

Convertible Notes and Warrants

 

Nomis Bay Note Shares

 

This offering, with respect to the Nomis Bay Note Shares, relates to the resale of shares of common stock of the Company underlying a Senior Convertible Note, issued March 3, 2014 (the “Nomis Bay Note”). On March 3, 2014, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with Nomis Bay Ltd., a Bermuda company (“Nomis Bay”), we issued the Nomis Bay Note with an initial principal amount of $500,000 for a purchase price of $340,000.  The Nomis Bay Note matures on December 27, 2014 (subject to extension as provided in the Nomis Bay Note) and, in addition to the 32% original issue discount, accrues interest at the rate of 8% per annum. The Purchase Agreement also provides that, upon the terms and subject to the conditions set forth therein, the Company may require Nomis Bay to purchase from the Company on or prior to the 10th trading day after the effective date of the registration statement registering the shares issuable upon conversion of the Initial Convertible Note, an additional senior convertible note with an initial principal amount of $600,000 (the “Additional Convertible Note” and together with the Nomis Bay Note, the “Convertible Notes”) for a purchase price of $600,000. If issued, the Additional Convertible Note will mature on the date that is the 10-month anniversary of the date of issuance of the Additional Convertible Note (subject to extension as provided in the Initial Convertible Note) and will accrue interest at the rate of 8% per annum. The Nomis Bay Note is convertible at any time, in whole or in part, at Nomis Bay’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to the lesser of (i) the product of (x) the arithmetic average of the lowest three (3) volume weighted average prices of the Common Stock during the 10 consecutive trading days ending and including the trading day immediately preceding the applicable conversion date and (y) 40% (the “Variable Conversion Price”), and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). If issued, the Additional Convertible Note will be convertible at any time, in whole or in part, at Nomis Bay’s option into shares of Common Stock at a conversion price that will be equal to the lesser of (i) the Variable Conversion Price and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). At no time will Nomis Bay be entitled to convert any portion of the Convertible Notes to the extent that after such conversion, Nomis Bay (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. The shares of common stock underlying the Nomis Bay Note were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

Anson Reset Shares

 

 

This offering, with respect to the Anson Reset Shares, relates to the resale of shares of common stock of the Company underlying three warrants in the amounts of 1,877,333, 1,066,666 and 2,346,666, with exercise prices of $0.20, $0.25 and $0.25 per share (the “Anson Warrants”). Pursuant to the terms of a warrant exercise reset offer letter between the Company and the investor, the Anson Warrants were issued in consideration for the investor’s agreement to immediately cash exercise an existing warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share for aggregate consideration to the Company of $170,666 originally issued pursuant to the terms of the Securities Purchase Agreement, dated August 1, 2012 (the “Purchase Agreement”). Each Anson Warrant has a five year term and was issued on May 3, 2013. Each Anson Warrant provides for adjustment of the exercise price and share amount in the event of certain dilutive issuances by the Company. On February 20, 2014, the Company issued a notice to the holder that the aggregate number of Anson Warrants had been adjusted to 23,026,318 and the exercise price of each had been adjusted to $0.053365 as a result of certain other offerings of the Company. 5,290,665 of the shares underlying the Anson Warrants were previously registered by the Company pursuant to the Registration Statement on Form S-1/A filed December 30, 2013. The warrants and the shares of common stock underlying the warrants were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

Cranshire Warrant Shares

 

This offering, with respect to the Cranshire Warrant Shares, relates to the resale of the shares of common stock underlying a warrant in the amount of 2,560,486 with an exercise price of $0.053365. The warrant has a five (5) year term and was issued pursuant to the terms of the Purchase Agreement. The warrant was originally issued in the amount of 213,334 shares at an exercise price of $0.6405. Pursuant to the anti-dilution adjustment provision contained therein, on February 20, 2014, the Company issued a notice to the holder that the total share amount had been increased to 2,560,486 and the exercise price had been reduced to $0.053365 as a result of certain other offerings of the Company. 683,202 of the shares underlying the Cranshire Warrants were previously registered by the Company pursuant to the Registration Statement on Form S-1/A filed December 30, 2013. Additionally, on February 20, 2014 in consideration for the investor’s agreement to immediately cash exercise a portion of the Cranshire Warrants for aggregate consideration to the Company of $36,459, the Company agreed to issue the investor an additional warrant to purchase 683,202 shares of common stock. The warrants and the shares of common stock underlying the warrants were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.  

 

19
 

  

JMJ Note Shares

 

This offering, with respect to the JMJ Note Shares, relates to the resale of 3,000,000 shares of common stock of the Company underlying a $400,000 Promissory Note issued July 10, 2013. The JMJ Note is subject to a one-time interest charge equal to 12% of the principal sum and is due and payable July 10, 2014. The JMJ Note provides that it may be converted into common stock of the Company at any time at the election of the holder, at a conversion price equal to the lesser of $0.26 or 65% of the lowest trade price in the 25 trading days previous to the conversion. The JMJ Note and the shares of common stock underlying the JMJ Note were issued in reliance upon an exemption from the registration requirements of the Securities Act and/or Rule 506 of Regulation D promulgated thereunder.

 

Registration Rights

 

Nomis Bay Registration Rights Agreement

 

In connection with the execution of the Purchase Agreement, the Company and Nomis Bay also entered into a registration rights agreement (the “Registration Rights Agreement”) dated March 3, 2014 (the “Closing Date”). Pursuant to the Registration Rights Agreement, the Company has agreed to file this registration statement (“Registration Statement”) with the SEC to register the resale of 24,602,792 shares of Common Stock into which the Convertible Notes may be converted, on or prior to the 45th calendar day after the Closing Date and have it declared effective at the earlier of (i) the 120th calendar day after the Closing Date and (ii) the fifth business day after the date the Company is notified by the SEC that such Registration Statement will not be reviewed or will not be subject to further review.  

 

If at any time all of the shares of Common Stock underlying the Convertible Notes are not covered by the initial Registration Statement, the Company has agreed to file with the SEC one or more additional Registration Statements so as to cover all of the shares of Common Stock underlying the Convertible Notes not covered by such initial Registration Statement, in each case, as soon as practicable, but in no event later than the applicable filing deadline for such additional Registration Statements as provided in the Registration Rights Agreement.

 

Piggyback Registration Rights

 

The JMJ Note contains a provision whereby the Company agreed to include on its next registration statement all shares issuable upon conversion of such debentures and notes. Such conversion shares are included on this registration statement. All fees and expenses incident to the performance of or compliance with such registration rights shall be borne by the Company.

 

INTERESTS OF NAMED EXPERTS AND COUNSEL

 

No expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering of the common stock was employed on a contingency basis, or had, or is to receive, in connection with the offering, a substantial interest, direct or indirect, in the registrant or any of its parents or subsidiaries. Nor was any such person connected with the registrant or any of its parents or subsidiaries as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.

 

The consolidated financial statements included in this prospectus and in the registration statement have been audited by Li and Company, PC, and are included in reliance upon such report given upon the authority of said firm as experts in auditing and accounting.

 

The validity of the issuance of the common stock hereby will be passed upon for us by Greenberg Traurig, LLP.

 

INFORMATION WITH RESPECT TO THE REGISTRANT

 

Background

 

We are a farm management company primarily focused on agronomics from plant breeding to good agricultural practices and the development of stevia derived products which can be used for human consumption as well as for aquaculture and agriculture applications.

 

We were incorporated on May 21, 2007 in the State of Nevada under the name Interpro Management Corp. On March 4, 2011, we changed our name to Stevia Corp. and effectuated a 35 for 1 forward stock split of all of our issued and outstanding shares of common stock. Effective November 15, 2013,we filed a Certificate of Amendment to the Company’s Articles of Incorporation to increase the total number of authorized shares of Common Stock from one hundred million (100,000,000) shares of Common Stock to two hundred fifty million (250,000,000) shares of Common Stock, each with a par value of $0.001.

 

On June 23, 2011, we closed a voluntary share exchange transaction (the “Share Exchange Transaction”) with Stevia Ventures International Ltd., a business company incorporated in the British Virgin Islands, pursuant to which we acquired certain rights relating to stevia production, including certain exclusive purchase contracts and a supply agreement related to stevia. In connection with the Share Exchange Transaction, on June 23, 2011, Mohanad Shurrab, a stockholder of the Company, surrendered 33,000,000 shares of the Company’s common stock to the Company for cancellation.

 

20
 

  

On March 19, 2012, we formed a wholly-owned subsidiary, Stevia Asia Limited, a company incorporated under the companies ordinance of Hong Kong (“Stevia Asia”) that will allow the Company to expand its China operations. Hero Tact Limited, a wholly-owned subsidiary of Stevia Asia, was incorporated under the companies ordinance of Hong Kong and renamed Stevia Technew Limited on April 28, 2012.

 

On July 5, 2012, Stevia Asia entered into a Cooperative Agreement with Technew Technology Limited (“Technew Technology”), a company incorporated under the companies ordinance of Hong Kong, and Zhang Ji, a Chinese citizen (together with Technew Technology, the “Partners”) pursuant to which Stevia Asia and Partners have agreed to engage in a joint venture to be owned 70% by Stevia Asia and 30% by Technew Technology, through the entity Stevia Technew Limited (the “Joint Venture”). The Partners will be responsible for managing the Joint Venture and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing to be applied on a project by project basis and subject to those projects remaining on target to generate positive EBITDA (earnings before interest, tax, depreciation and amortization) of at least 1.5 times the investment in any particular project and subject to Stevia Asia’s financial capabilities in terms of completing a financing or series of financings that provides the Company with the ability to contribute at least $200,000 in any given month. Completion of a financing or series of financings depends on the size of any private placements with investors that the Company may complete. Although Stevia Asia or Technew Technology may believe that a project is on target to generate positive EBITDA of at least 1.5 times the investment, there is no guarantee that any particular project will generate revenue. Stevia Asia contributed $200,000 to the Joint Venture in August 2012 which was applied to a specific aquaculture project that is ongoing but has not and will not contribute additional funds until it completes a financing or series of financings that provides the Company the ability to contribute at least $200,000 in any given month. The aquaculture project is focused on producing prawns and fish using the Company’s formulated products. The Joint Venture will participate in the revenue of specific ponds based on the pro-rata capital contribution allowing the flexibility to expand its participation as and when it has the ability to contribute additional funds. The Joint Venture also participated in an agriculture project in Vietnam where 102.5 acres of chili were cultivated using the Company’s formulated products. Part of the harvest occurred during the last quarter of the 2013 fiscal year generating revenue of $2,167,812.54 for the Company. The delay of additional capital is permissible pursuant to the joint venture agreement and will only impact the number and size of specific projects and the companies continue to explore potential stevia commercial applications but failure to complete a financing or series of financings sufficient to make additional contributions will have an adverse effect on our ability to execute our business plan. The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a stockholder in the Joint Venture, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.

 

On October 1, 2013, we formed SC Brands Pte. Ltd., a Singapore corporation and a subsidiary in which we own a 70% equity interest. SC Brands will allow us to develop consumer brand products.

 

On February 24, 2014, we formed Real Hemp LLC, a wholly owned Indiana limited liability company that will focus on application of our proprietary processes to the commercial farming of the cannabis plant.

 

On February 26, 2014, we entered into a farm management and technology agreement with ebbu LLC to advise on scaling commercial extraction of identified cannabinoids from the cannabis plant.

 

The following diagram illustrates our corporate structure:

 

21
 

 

 

 

Overview

 

Our focus is on implementing quality agribusiness solutions to our partners, contract growers and customers to maximize the production of agri-products and the economic development of stevia and its extracts.

 

Our mission is to maximize shareholder value by consistently developing and acquiring the latest intellectual property and expanding our suite of formulated products and their applications and leveraging our farm management business model to maximize market penetration and revenue margins.

 

To achieve these goals we intend to develop a suite of intellectual property relating to stevia and its extracts that will enhance the value of our farm management operations. Through our relationships with Tech-New Bio-Technology, Growers Synergy and local institutes, we are exploring the market for commercial applications of stevia which will be vertically integrated into our services and production.

  

Our target markets are initially Vietnam, Indonesia and China. In Vietnam and Indonesia we have contracted with growers and have established our own nurseries and test fields. In China we are producing our proprietary formulated products and applying them to aquaculture projects under our revenue share model. Although our priority is Asia, our services are not limited to specific countries and we plan to pursue viable opportunities in other markets.

 

The Industry and Our Opportunity

 

Stevia as a Food Additive

 

We believe that health issues created by the modern diet are causing consumers to look for more natural products and simpler ingredient lines on the foods and beverages they purchase and causing governments to put pressure on the food industry to offer products with reduced calories.

 

In evaluating potential sweetener alternatives, manufacturers focus on taste, pricing, and a sustainable and scalable supply. We believe stevia fulfills these four criteria and has the added advantage of contributing no calories to food and beverage with a near zero glycemic index, making it safe for diabetics.

 

Originating from Paraguay, stevia leaf has been valued for centuries because of its sweetening and herbal properties and has been used as an approved sweetener in Japan and Korea for decades. Extracts from stevia contain a mixture of different molecules that vary depending upon climate and growing conditions and it was historically impossible to come up with clear and consistent specifications of the product needed to make it a reliable ingredient as well as conduct clinical trials required by the FDA for the approval process. This issue was only overcome in recent years by identifying the steviol glycoside molecules with the best taste profiles and by developing innovative and unique process technologies to separate and purify stevia extract to pharmaceutical levels of purity on a reliable and consistent basis: and, importantly, to do so in commercially viable volumes.

 

22
 

  

In 2008, Rebaudioside A, a steviol glycoside, was granted GRAS (Generally Recognized as Safe) status by the U.S. Food and Drug Administration following applications by Cargill and Merisant. Since then, approval by legislators across the world has opened the door to new formulations and reformulations of foods and beverages with zero or reduced calorie content. In 2009, stevia was incorporated into leading soft drinks brands manufactured by Coca-Cola and PepsiCo and has since been incorporated into many categories of food and beverages.

 

The stevia industry is segmented into several business processes, which can broadly be categorized as i) plant breeding and propagation, ii) farming, iii) extraction and refining, iv) product formulation, v) distribution and retail.

 

A significant portion of the cost of Rebaudioside A is a result of the leaf cost and we believe there remains considerable opportunity to build value in the supply chain by focusing on stevia agronomics. The stevia genus includes more than 100 species and each species contains unique sweet compounds. However, only two of these species contain steviol glycosides and of these two the variety with the sweetest compounds is stevia rebaudiana bertoni. There is relatively little technical knowledge of this species and almost all commercial growing of stevia has occurred in China because of the traditional Japanese and Korean markets. Now with the global market demand for high TSG (total steviol glycoside) and high Reb-A (Rebaudioside A) producing plants, there is an increased demand for agronomic and farm management expertise to establish new plantations and rapidly scale leaf production.

 

The primary competitors within this market segment include: PureCircle, which has extensive operations in China as well as subsidiaries in South America (Paraguay) and Africa (Kenya); Stevia One, an independent grower established in Peru; S&W Seed Company, who signed a supply agreement with PureCircle in July of 2010 to grow stevia in North America under its subsidiary, Stevia California; and GLG Life Tech Corporation, a China-centric company which has chosen to continue to focus on building and expanding its supply chain within China.

 

Stevia as a Commercial Product for Agriculture Use

 

Stevia is classified as a medicinal herb in China where more than 80% of the world’s supply of stevia is grown and stevia has been used as a medicinal herb as well as a sweetener for centuries in its native country of Paraguay. Japan is the largest consumer of stevia extract and stevia has accounted for more than 40% of Japan’s entire sweetener market consumption since 1992. Research articles studying the efficacy of stevia as a feed supplement and fertilizer have been published by several universities in Japan, China and South Korea for more than ten years. There are also several small local companies in Japan, South Korea and China that produce feed and fertilizer products that are formulated using stevia extracts and they have been supplying these products to their local markets for several years. We believe that the feed and fertilizer markets provide additional growth opportunities for stevia.

 

In July 2012, we obtained the rights to product formulations that add stevia extracts to an existing probiotic and enzyme product line produced by our technology partner, Tech-New Bio-Technology. We then obtained government approval in Vietnam to use the stevia product formulations for agricultural use such as fertilizer and animal feed supplement.

 

The first commercial application was started in August of 2012 for the production of approximately 2.5 acres of shrimp in China under the revenue share model with the intention to expand as we confirm available funding. In October 2012, a commercial application was started for the production of 102.5 acres of chili in Vietnam which was harvested during the first and second quarter of 2013. We are also using the formulations for the commercial stevia trial fields in Vietnam.

 

Our product line includes aquaculture feed for shrimp and fish, feed for livestock, granular fertilizers and foliar spray, each of which, we believe, holds the potential to open new revenue opportunities to us.

 

By vertically integrating down the supply chain, we believe we significantly enhance our revenue potential. An average hectare of stevia will produce approximately 6 tons of dry leaf per year. We have entered into a five year supply contract with an option to renew for an additional four years with a leaf buyer. Under the agreement, we will set a fixed price for the leaf each year based on the yearly average market prices for the quality of leaf provided. We are growing elite strains and we believe prices for high quality leaf will continue to be more stable than lower quality leaf, and as such, we believe our leaf prices will be more stable and predictable. We expect to generate approximately $2,000 for each ton of dry leaf, so each hectare will potentially produce $12,000 of dry stevia leaf. On average, dry stevia leaf produces approximately 10% of net usable extract by weight and the average price for the extract is approximately $100,000 per ton, so each hectare can potentially produce $60,000 of extract (6 tons x 10% x $100,000) which is five times the value of the dry stevia leaf and when we use the extracts to create our proprietary formulations, we can increase our revenue potential further.

 

Alternative Applications of Our Technology – Commercial Farming of Cannabis

 

We believe our expertise growing stevia to produce specific types of extracts and our technologies for post-harvest processing, extraction and product formulation may be applicable to the cannabis industry. In February 2014 we entered into a farm management and technology agreement with ebbu LLC to provide farm management consultancy and technical expertise related to growing the cannabis plant and extracting its cannabinoids. The cannabis plant produces many chemical compounds called cannabinoids and there are more than 85 different cannabinioids that have been identified and isolated from the cannabis plant that exhibit varied effects and many of these are being studied for their psychoactive and medical properties. Cannabis plants that have been bred to produce high levels of tetrahydrocannabinol (“THC”), a psychoactive constituent, are commonly referred to as marijuana. In 2004 the United Nations estimated that global consumption of marijuana indicated that approximately 4% of the adult world population (162 million people) used marijuana annually, and that approximately 0.6% (22.5 million) people used marijuana daily. Current federal and most state regulations prevent us from participating directly in the marijuana industry and we cannot guarantee that our services or technology will provide value if the laws do not evolve in favor of marijuana production and the commercial sale of marijuana derived products, but it is our goal to position the Company to take advantage of the shifting regulatory landscape where possible.

 

23
 

  

Cannabis plants that produce very low levels of THC and are grown for industrial purposes and foodstuff products are commonly referred to as hemp. Hemp products such as seeds, oil, protein, milk, fiber and cannabidiol (“CBD”) can be legally imported and traded in the United States, but it is not legal for a U.S. company to grow hemp because of its relationship to marijuana.  Seventy percent of the world’s hemp production is currently produced in China. In February 2014 we registered a wholly owned subsidiary, Real Hemp LLC, to import, manufacture, license and sell hemp products in the U.S. The 2012 retail value of North American hemp food, vitamin and body care products was estimated to be in the range of $156 to $171 million by the Hemp Industries Association (HIA). When clothing, auto parts, building materials and other non-food or body care products are included, the HIA estimates that the total retail value of U.S. hemp products is about $500 million.  Food and fiber uses for industrial hemp are growing rapidly and have increased over 300 percent, to an estimated 25,000 products, in the past few years.  Much of that growth is coming from the increased sales of hemp food products. CBD is one of the active cannabinoids in the cannabis plant and is a major constituent of hemp, accounting for up to 40% of the plants extract, and is considered to have a wider scope of medical applications than THC. Similar to our goals in the marijuana industry, we intend to position the Company to take advantage of regulatory changes in the hemp industry. 

 

Products and Services

 

Our farm management services include training the farmers on the correct protocols and methodologies and providing ongoing technical assistance during the crop cycle as well as providing inputs such as the seedlings, fertilizers and additives they are required to use. We apply our services under three business models which we classify as 1) contract farming model, 2) revenue share model and 3) product supply model.

 

Under the contract farming and revenue share models we do not charge for the services and inputs, but rather our services provide us with a competitive advantage to secure growers who are willing to dedicate their land and resources to grow crops with an expectation of high yielding, high quality crops and guaranteed purchase prices. Under these models we will generate our revenue from the crops that are grown and we only enter into production agreements with growers when there is already a committed buyer for the end crop. Under the contract farming model we will purchase the crop from the grower at a fixed price and sell to our own customer. Under the revenue share model, the grower already has their own buyer and we will share the revenue.

 

Under the product supply model we will market our products in combination with technical services to buyers and charge a fee. We believe that this model will contribute a small part of our overall revenue initially until we establish a proven track record and solid reputation for our services and products under the first two models. We do not expect to focus on providing strictly farm management or technical services for a fee and it is difficult to estimate what we would charge for such services.

 

To support our farm management services we established a research center in Vietnam on 25 acres of leased land. We confirmed elite plant varieties, developed propagation techniques, conducted field trials across several provinces, documented local operating procedures and post-harvest techniques, and began trial harvests in March 2012.

 

We continue to focus on research and development to further evolve and develop new protocols, methodologies and intellectual properties and believe that this will be key to maintain our competitive advantage.

 

We utilize the contract farming model to produce stevia leaf for our trial harvests and use the stevia extracts to produce our proprietary formulated products, which we are applying under the revenue share model to an aquaculture operation beginning August 2012 and a chili operation beginning October 2012.

 

In September 2012 we began providing samples of stevia extract to food and beverage companies and we are working closely with local parties in several South East Asian countries to provide technical information in support of recipe development. Although we believe that this product line will have growth potential, there is no guarantee that a high volume of stevia will be utilized by our customers. We expect companies will take another year to plan product launches.

 

Growth Cycle - The stevia plant is a perennial but the growing cycle varies greatly depending on the particular strain and location.  Stevia is sensitive to frost and in China where most stevia is grown today, it is common to only have one or two harvests.  Closer to the equator it is possible to harvest year round with some dormancy during the winter months.  It is also possible to manipulate the harvest cycle and in developing countries where manual labor is the preferred method, a short cycle of as little as 45 to 60 days between harvests is preferred.  However, in more developed countries where mechanization is the focus, a longer growing cycle is preferred and cycles of more than 120 days have been achieved.

 

Yield - Expected annual dry leaf yields of plant varieties commonly sourced from China is three to six tons per hectare (“Ha”). Field trial data indicates that six tons or more per Ha can be achieved working with elite strains. By continuing to build our inventory of elite strains and refine our farm management practices and technologies, we plan to improve yield and plant performance and exploit the economic value of our intellectual property.

 

24
 

  

Harvest - Stevia is a very labor intensive plant and traditionally has been harvested by hand. As larger commercial operations have begun to focus on stevia, a considerable amount of research is being put into the mechanization of planting, harvesting and leaf removal.  While we will need to maximize mechanization in the United States to be economical, in many Asian locations there is both an abundance of low cost labor and an expectation that stevia will provide an economic stimulus and employ many of the farmers in poor rural areas.  So the adoption of mechanization will need to consider both economic and social factors.

 

Location - Currently over 80% of stevia is grown in China and almost all of the high Reb-A variety stevia leaf is being produced in China. China is the center of commercial stevia growing for historical reasons due to its proximity to Japan and Korea, which have historically been the major markets for stevia. Due to its climate, we believe China is likely not the most geographically optimal location to grow stevia, as stevia is sensitive to frost and China typically produces only one or two crops per year, requiring leaf processors to purchase and store sufficient leaf for an entire year of production.

 

We believe that diversifying the supply chain of stevia leaf would provide several advantages:

 

  · Incorporating Southern Hemisphere production provides two major growing seasons;
  · Incorporation Equatorial production provides for year round production;
  · Enables better control of leaf quality where major propagation of stevia varieties is controlled;
  · Provides protection against country-specific political, regulatory, disease, and natural disaster risk; and
  · Provides operations closer to end markets.

 

We believe infrastructure is a major criteria for field site selection and can be especially challenging in developing countries.  In addition, we believe a viable site must have the proper weather and soil that is suitable for plant growth as well as being in a location that satisfies logistical business considerations, such as being easily accessible and in close proximity to a capable labor pool.  It is our belief that access to water can often be a challenge and greatly limits the areas where an irrigation model can be applied.  We believe Vietnam has excellent road infrastructure and our fields are easily accessible by passenger car or lorry and most potential growing areas are located within hours of a major port city. Indonesia has an abundance of low cost labor and land available for acquisition that is suitable for new varieties of stevia that we are breeding and/or acquiring to grow in the equatorial zone.

 

Land Use and Capital Requirements - As we expand our operations, there are two primary business models available to manage farm operations. The plantation model will involve us controlling the land and assets through lease or purchase arrangements and hiring the necessary workers which will require higher upfront capital cost but enable rigorous control over operations with potentially higher revenue per acre. The contract farm model involves entering into agreements with existing farmers to utilize our agriculture inputs and protocols in order to produce specified crops under contract at negotiated prices. The contract farm model requires lower upfront capital and enables us to more quickly scale over larger areas in those instances where we are able to efficiently manage operations and implement supervisory control. If successfully implemented, we believe the contract farming model provides the fastest ramp to positive cash flow while also conserving capital.

 

We are managing our trial harvest stevia farms under the contract farming model and plan to continue using this model.

 

Under the revenue share model the grower owns, leases or contracts the land and we provide our farm management services and products as part of the agriculture inputs and then we share the revenue. This does not require us to have any obligations or liability for land and enables us to expand rapidly and maximize revenue by leveraging existing operations with minimal capital commitment.

 

We intend to scale the use of our formulated products using both the contract farm model and revenue share model which we started implementing in August of 2012. We will initially work on projects with our joint venture partner.

 

Labor and Research and Development - Our initial research and development funding was used to establish our research center and engage specialists who have secured elite plant varieties, culled the original planted varieties, developed propagation techniques, conducted field trials, documented local operating procedures and developed post-harvest techniques. We target spending approximately fifteen percent of our operating expense budget towards research and development to continue improving and develop new intellectual properties.

 

Financial - The value of the stevia leaf fluctuates based on supply and demand and the quality of the leaf.  Wide seasonal variances on the open market are common and can make long-term planning difficult.  Because we have entered into a long-term supply contract with a leaf buyer and we are growing elite strains, we believe our prices will be more stable and predictable and we will be able to plan our growth and commit to large contract growers.  In addition, buyers of leaf pay a substantial premium for high quality leaf.  This places strong economic value on our intellectual property, including our elite stevia strains, and our farm management solutions.

 

Current contracted selling price for leaf that meets the minimum standards is set at a fixed price. Leaf exceeding the minimum standards will receive a premium for which the benchmarks and price tiers will be reviewed each year based on comparative market leaf quality and supply and demand.

 

25
 

  

Historically, leaf that produced 13% TSG and 70% Reb-A was purchased at a premium. Elite strains can potentially deliver TSG well above 12% and Reb-A above 80% providing significant economic advantage. Minimum standards require a TSG of 12% or more, Reb-A to be at least 60% of TSG, maximum of 5% impurities and a maximum moisture content of 10%. During the refining process, the net yields of usable extract will be slightly lower.

 

Our Key Contracts and Relationships

 

Growers Synergy

 

Effective November 1, 2011, we engaged Growers Synergy Pte Ltd, a regional farm management services provider (“Growers Synergy”), to provide farm management operations and back-office and regional logistical support for our Vietnam and Indonesia operations for a period of two years at a cost of $20,000 per month and the agreement was renewed on November 1, 2013 for an additional year. In addition, Growers Synergy will enter into an agreement to purchase from us all the non-stevia crops produced at the farms for which they are providing management services.

 

We believe that the relationship with Growers Synergy will provide us with a strategic advantage and potential synergistic partnership by providing us with guaranteed off-take agreements for agriculture crops other than stevia, which will be produced as part of inter-cropping practices to maintain optimal soil conditions for stevia farming. Growers Synergy will work with us and our technology partner, Tech-New Bio-Technology, to combine the agronomy protocol with the farming models. Models and their related protocols have been commercially field tested during the first two years working with the provincial and national programs and establishing 100 Ha of field trials.

 

A local farm management service, such as Growers Synergy, is critical to assist us in training local teams with the documented protocol sufficient to scale to 1,000 Ha to create a turnkey project. Our goal is to be vested with fully documented protocols, local teams of trained staff capable of supporting the scale up to 1,000 Ha and farmer communities that are capable of growing stevia and other crops. To help us achieve this Growers Synergy will provide the necessary resources and assign staff to fill certain managerial and support staff positions.

 

Tech-New Bio-Technology

 

In March 2012, we entered into both a Supply Agreement and Cooperative Agreement with Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology (“TechNew”). TechNew is a developer and manufacturer of hi-tech biotechnology products which offers a series of specialized ecological fertilizers, microbiological preparations and management systems for the agriculture and aquaculture industry as well as technologies for the extraction and refinement of high purity stevia. Under the terms of the Supply Agreement, we are able to sell dry stevia plant product exclusively to TechNew including all leaf and stem for a term of five years with an option to renew for a further four years with the price to be negotiated by the parties on a yearly basis to reflect changes in the specifications and market price. During the first two years TechNew is obligated to purchase all of our production with quantity to be negotiated from the third year onwards. Under the terms of the Cooperative Agreement, we agreed to explore potential technology partnerships with TechNew, with the intent to formalize a joint venture to pursue promising technologies and businesses. These include the inclusion of stevia extracts in its current product formulations for use in agriculture and aquaculture applications including fertilizers and feed.

 

Through our cooperative agreement with TechNew, we will also explore a potential relationship to integrate extraction and refining technology to produce high purity Reb-A and other steviol glycosides for the consumer market. We believe that vertically integrating our technologies for both commercial and consumer products may provide advantages of a diversified market, but we do not intend to enter the consumer market with a finished stevia product. It is our goal to develop core strengths in farm management and developing technologies for production and post harvest processes, and we believe that the consumer market for stevia is extremely competitive.

 

We supplied leaf to TechNew from our trial harvests and all of the leaf we have supplied has been used to produce products formulated with stevia extract. It is our intention to apply as much leaf as possible towards producing the higher value added products rather than sell the leaf as a commodity under the supply contract.

 

TechNew Technology Limited

 

On July 5, 2012, our wholly-owned subsidiary, Stevia Asia entered into a Cooperative Agreement with Technew Technology Limited (“Technew Technology”), a company incorporated under the companies ordinance of Hong Kong, and Zhang Ji, a Chinese citizen (together with Technew Technology, the “Partners”) pursuant to which Stevia Asia and Partners have agreed to engage in a joint venture to be owned 70% by Stevia Asia and 30% by Technew Technology (the “Joint Venture”), through the entity Stevia Technew Limited. The Joint Venture will allow us to further explore potential stevia commercial applications, which we would integrate into our farm management services and our own stevia production.

 

Independent Grower Relationships

 

We plan to develop a network of partner growers who we can market our production methods and technologies to and who will also help supply us with the stevia product necessary to fulfill our supply obligations. To date we have entered into initial purchase agreements for stevia under the contract farming model where we provide the seedlings, fertilizer additives, protocols and technical supervision with an obligation to purchase the stevia leaf at a fixed price per ton and the grower is responsible for the land, labor and all other inputs. The agreements are reviewed annually to negotiate price and quantity for the subsequent renewal year to reflect changes in specifications, market prices and demand. We have also entered into revenue share agreements with growers where we provide our proprietary feed or fertilizer additives and farm management services in return for a share of the revenue. These agreements are reviewed each growing/harvest cycle with renewal terms to be negotiated and confirmed for each subsequent cycle.

 

26
 

  

Our Farm Management Services and Intellectual Property

 

Our objective is to provide a full spectrum of farm management services to manage our contract farms, service industry growers and provide for optimal production. To achieve this objective, our focus is on intellectual property development and continued development and improvement of cultivar varieties for intended growing sites, propagation protocol, cultivation technology including an intercropping system and regional adaptability test, and post-harvest and refinery processes.

 

We are also continuing to develop and improve local SOP (standard operating procedures) manuals specific to each growing location and plant variety, which document the proper use of all inputs including a proprietary crop production system that we believe is more efficient and cost effective than traditional methods. We believe these customized operating manuals will result in advanced propagation and growing techniques that can improve the quality and efficiency of a variety of crops.

 

We are also developing a wide portfolio of highly efficient and environmentally friendly crop nutrition products. These products are performance minerals, plant phyto-chemicals, functional nutrients and microbial formulations. All products are derived from natural sources and can be used as sustainable agriculture solutions and/or for organic farming. While it is our intent to develop the foregoing highly efficient and environmentally friendly crop nutrition products, there is no guarantee we will be successful in developing such a portfolio of products.

 

We are still developing protocols regarding stevia production and we plan to provide a wide spectrum of agricultural consulting and solutions for stevia growers, including:

 

TechNew Suite of Products - through our technology partner, TechNew, we are able to contract manufacture the extraction and refinement of high purity stevia and we acquired their formulas for using stevia extract in feed and fertilizer applications. We have also entered into a joint venture with Technew Technology to further explore potential stevia commercial applications, which we would integrate into our farm management services and our own stevia production.

 

Elite Germplasm - high performance mother stock suitable for varied regions and environment.

 

Advanced Propagation Techniques - methods that are efficient, more cost effective, and produce a higher quality plant.

 

To date we have not filed patents or registered trademarks and we do not license any of our technologies. We previously had a license arrangement with Agro-Genesis, however, such license was cancelled when we partnered with TechNew.

 

Our Competitive Advantage

 

We believe our intellectual property suite that we are developing and our ability to serve across a wide spectrum of agricultural consulting and solutions will provide us with a competitive advantage against our competitors.

 

We also believe our intellectual property, particularly our fertilizers and feed additives and other input products used in our protocols, have the potential to create a dedicated customer base because the protocols once implemented on a farm call for continual use of our fertilizers and feed additives and other products as a mandatory production input. We believe this long-term customer relationship can enable us to create a substantial barrier to entry to potential new competitors, while at the same time providing networking benefits that could further propagate our business.

 

Our ability to fully develop our suite of products and apply them to a customer base is dependent on our ability to raise sufficient capital to fund our business operations.

  

Market Trends

 

The original products launched that used stevia were zero calorie beverages. Subsequent product launches included a blend of sugar and stevia that advertised reduced calories. Stevia is now used across 38 categories of food and beverages with most of the applications involving a blend of sugar and stevia for a reduced calorie product using all natural sweeteners.

 

Our Properties

 

Our primary focus is on providing farm management services to our contract growers. We have acquired two grower supply contracts and three nursery fields in Vietnam. More than twenty fields have been established in five provinces in the northern half of Vietnam with total propagation exceeding 100 Ha (250 acres).

 

The provincial locations include Vinh Phuc, Tuyen Quang, Thanh Hoa, Ha Tinh and Lai Chau.

 

27
 

  

On December 14, 2011 we entered into a land lease agreement with Stevia Ventures Corporation, one of our Suppliers, and Vinh Phuc Province People’s Committee Tam Dao Agriculture & Industry Co., Ltd (“Vinh Phuc”) whereby Stevia Ventures Corporation leased 10 Ha (25 acres) of land over 5 years and we developed a research facility that will also serve as a propagation center for farms located in the surrounding provinces and particularly those serving the provincial and national sponsored projects.

 

To better service multiple farms located across the many provinces stretching from north central Vietnam to the Chinese border, we will utilize the greenhouse facilities of our local grower partners in a decentralized model that more efficiently addresses the logistical challenges presented by the contract farming model. It is assumed that the commercial fields will be scaled by stem cutting and we will provide the seedlings to the growers as one of the inputs.

 

In addition to our Vietnam operations, in April 2012, we established a 1 Ha (2.5 acres) initial field trial in Indonesia which utilizes our intercropping model.

 

We lease office space with Leverage Investments, LLC, an entity owned and controlled by our President, for $500 per month on a month-to-month basis since July 1, 2011.

 

Regulation

 

Stevia extracts may be used in a wide variety of consumer products including soft drinks, vegetable products, tabletop sweeteners, confectioneries, fruit products and processed seafood products, in a wide range of countries, including almost all major markets, and as a dietary supplement in others.  Clinical studies have supported the safety and stability of stevia’s various high purity compounds used in food and beverages. There is no documented health threat.

 

Cargill and Merisant each submitted applications to the United Stated Food and Drug Administration (FDA) in 2008 for GRAS approval. On December 17, 2008 the stevia extract, Rebaudioside A (Reb-A), received GRAS approval.

 

In December 2008, Australia and New Zealand approved highly purified forms of stevia extracts as safe for use in food and beverages. Previously, such extracts had only been permitted for use as a dietary supplement in these countries.

 

Stevia extracts have been sanctioned by the Ministry of Health of China to be used as a food additive, and are listed in the Sanitation Standard of Food Additives.

 

In July 2010 the FDA issued GRAS clearance for PureCircle’s high purity SG95 stevia product which opened up opportunities for many more applications as well as more cost effective solutions.

 

In November 2011, the European Union cleared stevia for use as a food additive in its twenty seven member states.

 

Further regulatory clearances were secured for Reb-A in nearly all of the developed countries and South East Asian countries confirming the growing regulatory support for high purity stevia.

 

Our proprietary fertilizer and feed additive products are approved for use in China and South East Asia and we have started using them in commercial operations. All of the ingredients in the products are natural compounds and are approved by the major developed countries, but registration of the products will be required in each country before importation is allowed.

 

Foreign Currency Exchange Rate

 

The Company expects that international revenues will account for a majority of our total revenues. Our international operations expose the Company to foreign currency fluctuations. Revenues and related expenses generated from our international subsidiaries will generally be denominated in the functional currencies of the local countries. For example, revenues derived from the People’s Republic of China (“PRC”) will be denominated in Renminbi, or RMB.

 

Our statements of income of our international operations are translated into United States dollars at the average exchange rates in each applicable period. To the extent the United States dollar strengthens against foreign currencies, the translation of foreign currency denominated transactions will result in reduced revenues, operating expenses and net income for our business. Similarly, our revenues, operating expenses and net income will increase if the United States dollar weakens against foreign currencies.

 

We are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries and our investments in equity interests into United States dollars in consolidation. If there is a change in foreign currency exchange rates, the conversion of the foreign subsidiaries’ financial statements into United States dollars will lead to a translation gain or loss which is recorded as a component of accumulated other comprehensive income which is part of stockholders’ equity. In addition, we may have certain assets and liabilities that are denominated in currencies other than the relevant entity’s functional currency. Changes in the functional currency value of these assets and liabilities create fluctuations that will lead to a transaction gain or loss.

 

28
 

  

China – The Company expects to derive revenue from China. Pursuant to the Foreign Currency Administration Rules promulgated in 1996 and amended in 2008 and various regulations issued by the State Administration of Foreign Exchange (“SAFE”), and other relevant PRC government authorities, RMB is freely convertible only to the extent of current account items, such as trade-related receipts and payments, interest and dividends. Capital account items, such as direct equity investments, loans and repatriation of investments, require the prior approval from the SAFE or its local counterpart for conversion of RMB into a foreign currency, such as U.S. dollars, and remittance of the foreign currency outside the PRC.

 

Payments for transactions that take place within the PRC must be made in RMB. Unless otherwise approved, PRC companies must repatriate foreign currency payments received from abroad. Foreign-invested enterprises may retain foreign exchange in accounts with designated foreign exchange banks subject to a cap set by the SAFE or its local counterpart. Unless otherwise approved, domestic enterprises must convert all of their foreign currency receipts into RMB. The value of the RMB against the U.S. dollar and other currencies is affected by, among other things, changes in China’s political and economic conditions. Since July 2005, the RMB has no longer been pegged to the U.S. dollar. The RMB may appreciate or depreciate significantly in value against the U.S. dollar in the medium to long term. Moreover, it is possible that in the future, PRC authorities may lift restrictions on fluctuations in the RMB exchange rate and lessen intervention in the foreign exchange market.

 

Because some of our revenue is expected to come from China, appreciation or depreciation in the value of the RMB relative to the U.S. dollar would affect our financial results reported in U.S. dollar terms without giving effect to any underlying change in our business or results of operations. As a result, we face exposure to adverse movements in currency exchange rates as the financial results of our Chinese derived revenue are translated from local currency into U.S. dollar upon consolidation. Our operations are subject to risks typical of international business, including, but not limited to, differing economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility.  

 

International Laws

 

A significant portion of our initial business operations will occur in Vietnam.  We will be generally subject to laws and regulations applicable to foreign investment in Vietnam.  Similarly, as we expand into Indonesia and other markets, we will be subject to the laws and regulations of such jurisdictions. The Vietnam legal system is based, at least in part, on written statutes.  However, since these laws and regulations are relatively new and the Vietnamese legal system continues to rapidly evolve, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involves uncertainties.  Similar to Vietnam, the modern Indonesia legal system was formed relatively recently and is continuing to evolve.

 

Country   Type of Approval
     
North America    
USA   Food additive
Canada   Food additive
Mexico   Food additive
Latin America    
Argentina   Food additive
Brazil   Food additive
Chile   Food additive
Colombia   Food additive
Ecuador   Food additive
Paraguay   Food additive
Peru   Food additive
Uruguay   Food additive
Venezuela   Food additive

 

Asia Pacific

   
Australia   Food additive
Brunei   Food additive
China   Food additive
Hong Kong   Food additive
Indonesia   Food additive
Japan   Food additive
Malaysia   Food additive
New Zealand   Food additive
Singapore   Food additive
South Korea   Food additive
Taiwan   Food additive
Thailand   Food additive
Vietnam   Food additive

 

29
 

 

Europe    
Austria   Food additive
Belgium   Food additive
Bulgaria   Food additive
Cyprus   Food additive
Czech Republic   Food additive
Denmark   Food additive
Estonia   Food additive
Finland   Food additive
France   Food additive
Germany   Food additive
Hungary   Food additive
Ireland   Food additive
Italy   Food additive
Latvia   Food additive
Lithuania   Food additive
Luxembourg   Food additive
Malta   Food additive
The Netherlands   Food additive
Poland   Food additive
Portugal   Food additive
Romania   Food additive
Slovakia   Food additive
Slovenia   Food additive
Spain   Food additive
Sweden   Food additive
Switzerland   Food additive
Russia   Food additive
United Kingdom   Food additive

 

We cannot predict the effect of future developments in the legal systems of developing countries, including the promulgation of new laws, changes to existing laws or the interpretation or enforcement thereof, the preemption of local regulations by national laws, or the overturn of local government’s decisions by the superior government.  These uncertainties may limit legal protections available to us.

 

Marketing

 

We believe it is important to educate the local governments and farmer communities on the merits of stevia becoming a new commercial crop and its potential as a new economic stimulus for rural farmers. Our President, Mr. George Blankenbaker, and our local partner have been conducting talks and training sessions for more than three years in Vietnam and have fostered local support at many levels. To support the farmer’s transition to stevia farming and provide an opportunity to showcase the stevia opportunity to farmers’ communities, the Vietnam government provided financial support at both the provincial and national level to plant 20 Ha (50 acres) and 50 Ha (125 acres) respectively, both of which were completed in 2012. The fields were small plots located in several villages and served as demonstration fields and stepping stones to gain wide support from growers in several villages.

 

We have entered into formal cooperative agreements with several local institutes, including the National Institute of Medicinal Materials in Hanoi and the Agricultural Science Institute of Northern Central Vietnam. The terms of these agreements generally provide that we will provide stevia seedlings and other products and services, at prices and in quantities as will be mutually agreed by the parties, at the clients’ nurseries and provide the clients with off-take agreements for crops produced using our systems. As part of our services, we provide technical assistance to assure the clients adhere to our established growing protocols. We also agree to work cooperatively with the clients on research projects relating to stevia development, the cost of such projects to be shared between the parties as may be mutually agreed. These agreements provide local technical assistance for our grower partners and also provide additional credibility when our grower partners present the stevia opportunity to the local farmers’ communities.

 

We are also in contact with non-governmental organizations (NGO) that are seeking programs to bring to the communities that they serve which are generally located in poor rural areas in need of economically sound projects. If the stevia model proves to be viable for these locations, the NGOs have indicated that they will be interested in introducing and funding stevia farming programs. However, many of these poor rural areas are located in areas of poor soil quality, that lack adequate access to water or that suffer from other environmental constraints which limit the opportunities for this approach.

 

We also hope to generate many local testimonials from our field trials and the farmers in Vietnam are very fluid and willing to adopt new crops if the new crops are proven to be more economically viable than their current crops.

 

In connection with commercial opportunities for stevia derived products, we intend to develop a mark that can be applied to a buyer’s brand which would signify premium quality stevia-derived products.

 

30
 

  

Currently our marketing efforts are focused on educating our growers on our new proprietary formulations. These efforts are more administrative in nature and we do not currently anticipate a need for a large marketing budget to support current operations.

 

Product Alternatives

 

As a full service stevia farm management service provider we will face competition from both non-stevia sweetener products and from other service providers within the stevia industry.

 

Food Additive Product Alternatives - We believe stevia is the leader among natural zero calorie sweeteners at this time and it takes years to develop and bring to market new sweeteners of which few end up possessing all the qualities needed to be adopted mainstream. At this time we are not aware of any proven and viable alternative which possesses all of the positive qualities of stevia. As discussed above, the other sweeteners currently on the market lack many of the qualities that make stevia attractive to consumers and manufacturers, including the zero calorie/near zero glycemic index combination.

 

Therefore, we believe that the most likely threat to stevia growers will come from alternative “natural” methods to produce stevia extracts that obviate the need to farm stevia, such as fermentation-derived stevia.

 

A fermentation-derived stevia ingredient can be produced in a lab where low cost plant materials are converted into sweet steviol glycosides through controlled fermentation methods that duplicate the natural biochemical pathways that are involved in the natural production of the sweet components of the stevia leaf and would still meet the requirements to be classified as a “natural” ingredient and when done at volume could potentially be produced more economically than the farming method and without impurities.

 

Major known companies that are progressing down this track include Evolva Holding SA of Switzerland who has acquired San Francisco based Abunda Nutrition, Inc., Blue California of Rancho Santa Margarita, California and Stevia First Corporation of Yuba City, California.

 

There are four areas on which we will focus to reduce the risk and/or impact of alternative methods of stevia ingredient production.

 

  1. Increase farming efficiencies . The more efficient and scaled farming becomes, the higher the economic hurdle will be for other methods of production. We believe that our intellectual property and continued research and development activities will allow our farms and those of our customers to increase efficiencies, decrease cost of production and produce better quality leaf.

 

  2. Intellectual Property Protections. We have a strong focus on developing protectable intellectual property which we believe should create barriers to entry and protect our methodologies. Additionally, where applicable we will continue to consider the acquisition of potentially synergistic intellectual property.

  

  3. Crop Diversification. Our farm management infrastructure and the majority of our intellectual property is applicable to most crops providing us with the flexibility to diversify our crops and the customer base for our farm management solutions.

 

  4. Product Diversification . We will explore additional markets and uses for stevia and seek to acquire technology to diversify its applications.

 

Commercial Product Alternatives

 

Small regional companies in Japan, China, and South Korea have been producing commercial stevia products for several years, focusing on their local markets. We believe with the awareness of stevia on a global scale, this will provide an opportunity to develop a large commercial market. Once the market reaches critical mass, large companies will likely enter the market.

 

We intend to protect our market by positioning ourselves as both the primary provider of raw extract to companies as well as establishing our own vertical markets utilizing our farm management core competency to contract farm using our commercial stevia products.

 

Employees

 

George Blankenbaker, our President and a director, is our sole employee.

 

Our relationship with our farm management partner, Growers Synergy, currently provides the staffing necessary to operate our farms and our technology partner, TechNew, provides the staffing for our technical operations.

 

We chose to outsource the operations management during our development phase to minimize expenses and provide a team of qualified experienced staff to lead us through the development phase until we are ready to commercialize. As we begin commercialization and revenue generation, we intend to begin to hire full time staff.

 

31
 

  

Summary Plan of Operation

 

The following table provides our current and intended plan of operation, including our goals, estimated costs and timelines in connection with our aim of expanding our operations to provide farm management services and products in China and South East Asia. There can be no assurance that our plan of operation and goals will be accomplished on the timelines set forth below, at the costs noted, or at all.

 

Goals  Status  Requirements  Timeline  Estimated
Budget
 
Build elite strains of Stevia  Completed (Continue Improving)  -  Ongoing   *
Develop Intellectual Property  Completed (Continue Improving)  -  Ongoing   *
Develop Farming Protocols  Completed (Continue Improving)  -  Ongoing   *
Develop Operating Manuals  Completed (Continue Improving)  -  Ongoing   *
Conduct Product Testing  Completed (Continue Improving)  Continue R&D  Ongoing  $10,000/month 
Trial harvests (multiple countries)  Completed (Continue Improving)  Continue R&D  Ongoing  $100,000/year 
Feed Product approvals  Approved in South East Asia & China  Register in other countries  by 2015   negligible 
Fertilizer Product approvals  Approved in South East Asia & China  Register in other countries  by 2015   negligible 
Hire Additional Full Time Staff  Staff are Identified  Adequate working capital  2nd Quarter 2014 (est)  $50,000/month 
Increase  revenue by expanding farm management operations under joint venture with Technew  Begun in August 2012  Adequate working capital  1st Quarter 2015 (est)  $3,000,000**

 

   

* These goals have initially been completed but improvements are ongoing and the costs will depend on opportunities to make such improvements as they arise.

** This is what the Company is targeting through a combination of revenue generation and external financing.

 

PROPERTIES

 

Our international corporate office is located at 14 Chin Bee Road, Singapore 619824. We also maintain an office in Vietnam at No. 602, CC2A, Thanh Ha‘s building, Bac Linh Dam, Hoang Mai district, Hanoi, Vietnam and in Hong Kong, at 19/F Kam Chung Comm Bldg 19-21, Hennessy Rd, Hong Kong and in the United States, at 7117 US 31 South, Indianapolis, IN 46227.

 

We have also developed a research facility on 10 Ha (25 Acres) of land leased by Stevia Ventures Corporation and have prepaid the first year lease payment of $30,000 and the six month lease payment of $15,000 as security deposit.

 

LEGAL PROCEEDINGS

 

None.

 

MARKET FOR COMMON EQUITY AND RELATED SHAREHOLDER MATTERS

 

Market Information

 

Our common stock is quoted on the OTCQB under the symbol STEV. The closing bid price for our stock as of March 26, 2014, was $0.28.

 

The following is the range of high and low bid prices for our common stock for the periods indicated. The quotations reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not represent actual transactions.

 

Interim Period From April 1, 2013 to March 26, 2014  High   Low 
First Quarter (April 1, 2013 to June 30, 2013)  $.349   $.20 
Second Quarter (July 1, 2013 to September 30, 2013)  $.2595   $.1234 
Third Quarter (October 1, 2013 to December 31, 2013)  $.164   $.097 
Fourth Quarter (January 1, 2014 to March 26, 2014)  $.28   $.083 

 

Fiscal Year Ended March 31, 2013  High   Low 
First Quarter (June 30, 2012)  $1.69   $.75 
Second Quarter (September 30, 2012)  $.83   $.26 
Third Quarter (December 31, 2012)  $.341   $.101 
Fourth Quarter (March 31, 2013)  $.41   $.146 

 

Fiscal Year Ended March 31, 2012  High   Low 
First Quarter (June 30, 2011)  $1.60   $.25 
Second Quarter (September 30, 2011)  $1.00   $.85 
Third Quarter (December 31, 2011)  $1.05   $.56 
Fourth Quarter (March 31, 2012)  $2.75   $.667 

 

32
 

 

Stockholders

 

As of March 26, 2014, there were 145,972,713 shares of common stock issued and outstanding held by 19 stockholders of record (including street name holders).

 

Dividends

 

We have not paid dividends to date and do not anticipate paying any dividends in the foreseeable future. Our Board of Directors intends to follow a policy of retaining earnings, if any, to finance our growth. The declaration and payment of dividends in the future will be determined by our Board of Directors in light of conditions then existing, including our earnings, financial condition, capital requirements and other factors.

  

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of the results of operations and financial condition for the fiscal years ended March 31, 2012 and 2013, and the three and nine months ended December 31, 2013, should be read in conjunction with the financial statements and related notes and the other financial information that are included elsewhere in this Prospectus. This discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors, including those set forth under the Risk Factors, Cautionary Notice Regarding Forward-Looking Statements and Business sections in this registration statement on Form S-1. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions to identify forward-looking statements.

 

The following discussion should be read in conjunction with our consolidated financial statements and notes thereto included elsewhere in this Registration Statement on Form S-1. Forward looking statements are statements not based on historical information and which relate to future operations, strategies, financial results or other developments. Forward-looking statements are based upon estimates, forecasts, and assumptions that are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by us, or on our behalf. We disclaim any obligation to update forward-looking statements.

 

Overview

 

We were incorporated on May 21, 2007 in the State of Nevada under the name Interpro Management Corp. On March 4, 2011, we changed our name to Stevia Corp. and effectuated a 35 for 1 forward stock split of all of our issued and outstanding shares of common stock. Effective November 15, 2013,we filed a Certificate of Amendment to the Company’s Articles of Incorporation to increase the total number of authorized shares of Common Stock from one hundred million (100,000,000) shares of Common Stock to two hundred fifty million (250,000,000) shares of Common Stock, each with a par value of $0.001.

 

We generated revenues during the 2013 fiscal year. We expect our primary sources of revenue will be (i) providing farm management services, which will provide protocols and other services to agriculture, aquaculture, and livestock operators, (ii) the sale of inputs such as fertilizer and feed additives to agriculture, aquaculture and livestock operators, (iii) the sale of crops and seafood produced under contract farming, (iv) the sale of products derived from the stevia plant and other agriculture crops, (v) providing extraction and refining technology services related to stevia and other medicinal herbs and (v) the sale of branded consumer products made from natural ingredients.

 

During 2012, we completed our first commercial trials of stevia production in Vietnam. In connection with such production we have entered into supply agreements for the off-take of the stevia we produce and entered into an agreement with Growers Synergy Pte Ltd to assist in the management of our Asia day-to-day operations. We have also developed commercial applications of stevia derived products and have developed and acquired certain proprietary technology relating to stevia development which we can integrate into our own stevia production and our farm management services. In connection with our intellectual property development efforts we have engaged TechNew Technology Limited (“TechNew), as our technology partner in Vietnam and on July 5, 2012 we entered into a Cooperative Agreement (the “Cooperative Agreement”) through our subsidiary Stevia Asia Limited (“Stevia Asia”), with Technew and Zhang Ji, a Chinese citizen (together with Technew, the “Partners”) pursuant to which Stevia Asia and Partners have agreed to engage in a joint venture to develop certain intellectual property related to stevia development, such joint venture to be owned 70% by Stevia Asia and 30% by Technew (the “Joint Venture”). Pursuant to the Cooperative Agreement Stevia Asia agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of the Joint Venture and Stevia Asia’s financial capabilities.

 

We have also continued to establish research and production relationships with local institutions and companies in Vietnam. In April, 2012 we announced plans to begin field trials in Indonesia.

 

On March 19, 2012, we formed a wholly-owned subsidiary, Stevia Asia Limited, a company incorporated under the companies ordinance of Hong Kong (“Stevia Asia”) that will allow the Company to expand its China operations. Hero Tact Limited, a wholly-owned subsidiary of Stevia Asia, was incorporated under the companies ordinance of Hong Kong and renamed Stevia Technew Limited on April 28, 2012.

 

On October 1, 2013, we formed SC Brands Pte. Ltd., a Singapore corporation and a subsidiary in which we own a 70% equity interest. SC Brands will allow us to develop branded consumer products. 

On February 24, 2014, we formed Real Hemp LLC, a wholly owned Indiana limited liability company that will focus on developing hemp products to be sold in the US.

 

33
 

  

Results of Operations

 

The following discussion of the financial condition, results of operations, cash flows, and changes in our financial position should be read in conjunction with our audited consolidated financial statements and notes included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2013, filed July 15, 2013. Such financial statements have been prepared in conformity with U.S. GAAP and are stated in United States dollars.

 

Comparison of Three Month Periods Ended December 31, 2013 and December 31, 2012

 

For the three month period ended December 31, 2013 we incurred a net loss of $831,410, compared to a net loss of $364,601 for the three month period ended December 31, 2012. The increase was mainly attributed to a $561,077 loss attributed to debt settlement during the three month period ended December 31, 2013.

 

General and administration expenses and professional fees for the three month period ended December 31, 2013 amounted to $133,641 and $178,135 respectively, compared to $69,302 and $123,356 during the three month period ended December 31, 2012. Research and development fees for the three month period ended December 31, 2013 were $71,930 compared to $0 during the three month period ended December 31, 2012. Directors fees, officer salary and compensation and other salary and compensation were $7,813, $0 and $378 respectively, compared to $93,750, $0 and $59,105 during the three month period ended December 31, 2012.

 

Comparison of Nine Month Periods Ended December 31, 2013 and December 31, 2012

 

For the nine month period ended December 31, 2013 we incurred a net loss of $2,017,484, compared to a net loss of $1,342,473 for the nine month period ended December 31, 2012. The increase was mainly attributed to an increase in officer salary and compensation expense from $0 to $600,000, an increase in other income/expenses from a gain of $247,341 to a loss of $786,508, and offset by a an increase in revenues from $0 to $758,809.

 

General and administration expenses and professional fees for the nine month period ended December 31, 2013 amounted to $387,040 and $487,867 respectively, compared to $204,616 and $281,250 during the nine month period ended December 31, 2012. Research and development fees for the nine month period ended December 31, 2013 were $262,810 compared to $118,669 during the nine month period ended December 31, 2012. Directors fees, officer salary and compensation and other salary and compensation were $195,313, $600,000 and $66,556 respectively, compared to $281,250, $0 and $110,982 during the nine month period ended December 31, 2012.

 

Results of Operations for the Fiscal Years Ended March 31, 2012 and 2013

 

For the fiscal year ended March 31, 2013, we incurred a net loss of $2,035,864 and for the fiscal year ended March 31, 2012, we incurred a net loss of $2,323,551.

 

Revenues

 

Our revenues during the fiscal year ended March 31, 2013 totaled $2,168,093, compared to $1,300 in the fiscal year ended March 31, 2012.  This increase in revenue was the result of the Company successfully completing its first commercial crop harvest in Vietnam.

 

Cost of Revenues

 

Cost of revenues during the fiscal year ended March 31, 2013 totaled $2,617,381, compared to $711,246 during the fiscal year ended March 31, 2012.  The largest components of our cost of revenues are farm produce, which was $1,789,034 and farm management services – related parties, which was $712,550.

 

Gross Margin

 

Gross margin for the fiscal year ended March 31, 2013 was negative $449,288, compared to a negative $709,946 for the fiscal year ended March 31, 2012.  The decrease was attributable to the significant increase in revenues during the fiscal year ended March 31, 2013.

 

General and Administrative Expenses, Salary and Compensation and Directors’ and Professional Fees

 

General and administration expenses for the fiscal year ended March 31, 2013, amounted to $412,409 compared to $113,742 in the fiscal year ended March 31, 2012. Research and development fees for the fiscal year ended March 31, 2013 were $177,169 compared to $206,191 for the fiscal year ended March 31, 2012. Salary and compensation expenses amounted to $190,549, directors’ fees amounted to $375,000 and professional fees amounted to $454,958 in the fiscal year ended March 31, 2013 compared to $0, $187,500 and $255,959 for the fiscal year ended March 31, 2012.

 

34
 

  

Liquidity and Capital Resources

 

As at December 31, 2013 we have $2,132,300 in current assets, and $2,591,869 in current liabilities. As at December 31, 2013 we have $85,366 in cash. As at December 31, 2013, our total assets were $3,641,781 and our total liabilities were $3,189,388. Our net working capital deficit as at December 31, 2013 was $459,569.

 

During the nine month period ended December 31, 2013, we used cash of $895,651 in operating activities and used cash of $16,475 in investing activities, respectively. During the nine month period ended December 31, 2013, we funded our operations from revenue from operations and the proceeds of private sales of convertible notes and the exercise proceeds of warrants. During the nine month period ended December 31, 2013, we raised $431,500 through the issuance of convertible notes and $152,012 through the proceeds of warrant exercises.

 

As of December 31, 2013, convertible promissory notes, net of discount, in the aggregate amount of $1,071,569 remained outstanding.

 

In July, 2012 outstanding convertible promissory notes in the principal amount of $500,000 were converted into an aggregate of 634,193 shares of our common stock.

 

On August 1, 2012, we entered into a Securities Purchase Agreement with certain accredited investors (the “Financing Stockholders”) to raise $500,000 in a private placement financing (the “Offering”). On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Financing Stockholders: (i) an aggregate of 1,066,667 shares of the Company's common stock at a price per share of $0.46875 and (ii) warrants to purchase an equal number of shares of the Company's common stock at an exercise price of $0.6405 with a term of five (5) years, for gross proceeds of $500,000. Garden State Securities, Inc. (“GSS”) served as the placement agent for such equity financing. Per the engagement agreement signed between GSS and the Company on June 18, 2012, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to $40,000, or 8.0% of the gross proceeds received in the equity financing, and (ii) issue to GSS or its designee, a warrant to purchase up to 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering) with an exercise price of $0.6405 per share and a term of five (5) years. Pursuant to the anti-dilution adjustment provision included in the Offering, the total share amount under the Cranshire Warrant has been increased to 2,036,381 and the exercise price has been reduced to $0.0671 as a result of certain other offerings of the Company. We may receive gross proceeds of up to $136,640.40 upon the cash exercise of the Cranshire Warrants. Any such proceeds we receive will be used for working capital and general corporate matters.

 

On May 3, 2013, in consideration for the immediate cash exercise of outstanding warrants to purchase 853,333 shares of common stock of the Company at a price per share of $0.20, the Company issued the Anson Warrants which are included in this registration statement. The warrant to purchase 1,877,333 shares of common stock is subject to a right of repurchase by the Company upon the satisfaction of certain conditions, at a price of $0.001 per warrant share. The warrant to purchase 2,346,666 shares is only exercisable upon the investor’s exercise in full of the warrant to purchase 1,877,333 shares. We will not receive any proceeds from the sale of those shares of common stock. We may, however, receive gross proceeds of up to $1,228,799.60 upon the cash exercise of the Anson Warrants. Any such proceeds we receive will be used for working capital and general corporate matters.

 

On July 16, 2013, the Company entered into a $400,000 Promissory Note (the “June 2013 Note”) with an accredited investor (the “Investor”) whereby the Investor agreed to loan to the Company up to $400,000 pursuant to the terms of the June 2013 Note. The June 2013 Note provides for the first $100,000 to be advanced upon closing and additional amounts will be advanced at the Investor’s sole discretion. Each advance is subject to a 10% original issue discount, such that the total amount which may actually be received by the Company pursuant to the June 2013 Note is only $360,000. The maturity date for each advance made under the June 2013 Note is one year from the date of such advance. If the Company repays the June 2013 Note on or before 90 days from the effective date, the interest rate shall be 0%, otherwise a one-time interest charge of l2% shall be applied to the principal sum. The June 2013 Notes are convertible into common stock of the Company on a cashless basis at any time, at a conversion price equal to the lesser of $0.26 or 65% of the lowest trade price in the 25 trading days prior to the conversion. If the conversion shares are not deliverable by DWAC an additional 10% discount will apply, and if the shares are ineligible for deposit into the DTC system and only eligible for Xclearing deposit an additional 5% discount will apply. So long as the June 2013 Note is outstanding, upon any issuance by the Company or any of its subsidiaries of any security with any term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly provided to the Investor in the June 2013 Note, then the Company shall notify the Investor of such additional or more favorable term and such term, at the Investor's option, shall become a part of the transaction documents with the Company.

 

On August 22, 2013, we issued a convertible promissory note to Asher Enterprises, Inc. in the principal amount of $153,500 (the “Asher Note”), pursuant to the terms of a Securities Purchase Agreement. The Note matures on May 26, 2014, incurs interest at the rate of 8% per annum, and is convertible into shares of our common stock at a 35% discount to the average of the lowest three trading prices for our common stock during the 30 day trading period prior to the conversion date.

 

On September 26, 2013, we issued a convertible note in the principal amount of $27,778 with a 10% original issuance discount and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.

 

35
 

  

On October 15, 2013, we issued a Convertible Debenture in the principal amount of $58,000 (the “Debenture”), to Black Mountain Equities, Inc. (“Black Mountain”). On March 31, 2014, the Debenture was converted in full into 1,119,299 shares of common stock. The Debenture provides that on the next registration statement the Company files, the Company will include the shares issuable upon conversion of the Debenture. Black Mountain also received a warrant to purchase 1,000,000 shares of our common stock with an exercise price of $0.25 per share, subject to adjustment, and a term of five years.

 

On November 21, 2013, we issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.

 

On December 9, 2013, we issued a convertible note in the principal amount of $55,556 with a 10% original issuance discount and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.

 

Subsequent to the three months ended December 31, 2013, on February 7, 2014, we issued a Convertible Debenture to an investor in the principal amount of $80,000. The Convertible Debenture matures on February 6, 2015, incurs interest at the rate of 8% per annum, and is convertible into shares of our common stock at a conversion price of $0.10 per share.

 

Subsequent to the three months ended December 31, 2013, on February 13, 2014, an investor exercised warrants to purchase 1,877,333 shares of the Company’s common stock with an exercise price of $0.0585 per share, yielding aggregate gross proceeds to the Company of $109,824 in cash.

 

Subsequent to the three months ended December 31, 2013, on February 20, 2014, an investor exercised warrants to purchase 683,202 shares of the Company’s common stock with an exercise price of $0.053365 per share, yielding aggregate gross proceeds to the Company of $36,459 in cash.

 

Subsequent to the three months ended December 31, 2013, on February 24, 2014, an investor exercised warrants to purchase 1,413,326 shares of the Company’s common stock with an exercise price of $0.053365 per share, yielding aggregate gross proceeds to the Company of $75,422 in cash.

 

Subsequent to the three months ended December 31, 2013, on February 26, 2014, the Company converted $893,579 of working capital advances, provided to the Company by George Blankenbaker and his affiliated companies, into an aggregate of 16,744,682 shares of common stock.

 

Subsequent to the three months ended December 31, 2013, on February 28, 2014, an investor exercised warrants to purchase 250,000 shares of the Company’s common stock with an exercise price of $0.053365 per share, yielding aggregate gross proceeds to the Company of $13,341 in cash.

 

Subsequent to the three months ended December 31, 2013, on March 3, 2014, an investor exercised warrants to purchase 1,750,006 shares of the Company’s common stock with an exercise price of $0.053365 per share, yielding aggregate gross proceeds to the Company of $93,389 in cash.

 

Subsequent to the three months ended December 31, 2013, on March 3, 2014, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with Nomis Bay Ltd., a Bermuda company (“Nomis Bay”).  The Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, (i) Nomis Bay shall purchase from the Company on the Closing Date a senior convertible note with an initial principal amount of $500,000 (the “Initial Convertible Note”) for a purchase price of $340,000 (a 32% original issue discount) and (ii) the Company shall have the right to require Nomis Bay to purchase from the Company on or prior to the 10th trading day after the effective date of this registration statement an additional senior convertible note with an initial principal amount of $600,000 (the “Additional Convertible Note” and, together with the Initial Convertible Note, the “Convertible Notes”) for a purchase price of $600,000. The Initial Convertible Note matures on December 27, 2014 (subject to extension as provided in the Initial Convertible Note) and, in addition to the 32% original issue discount, accrues interest at the rate of 8% per annum. If issued, the Additional Convertible Note will mature on the date that is the 10-month anniversary of the date of issuance of the Additional Convertible Note (subject to extension as provided in the Initial Convertible Note) and will accrue interest at the rate of 8% per annum. The Initial Convertible Note is convertible at any time, in whole or in part, at Nomis Bay’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to the lesser of (i) the product of (x) the arithmetic average of the lowest three (3) volume weighted average prices of the Common Stock during the 10 consecutive trading days ending and including the trading day immediately preceding the applicable conversion date and (y) 40% (the “Variable Conversion Price”), and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). If issued, the Additional Convertible Note will be convertible at any time, in whole or in part, at Nomis Bay’s option into shares of Common Stock at a conversion price that will be equal to the lesser of (i) the Variable Conversion Price and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). At no time will Nomis Bay be entitled to convert any portion of the Convertible Notes to the extent that after such conversion, Nomis Bay (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date. The Company has the right at any time to redeem all, but not less than all, of the total outstanding amount then remaining under the Initial Convertible Note and/or the Additional Convertible Note in cash at a price equal to 140% of the total amount of such Convertible Note then outstanding.

 

We do not expect that our revenues from operations will be wholly sufficient to fund our operating plan, so we are currently seeking further financing and we believe that, along with our revenues, will provide sufficient working capital to fund our operations for at least the next six months. Changes in our operating plans, increased expenses, acquisitions, or other events, may cause us to seek additional equity or debt financing in the future.

 

36
 

  

Our current cash requirements are significant due to the planned development and expansion of our business. The successful implementation of our business plan is dependent upon our ability to develop valuable intellectual property relating to stevia through our research programs, as well as our ability to develop and manage our own crop and aquaculture production operations. These planned research and agricultural development activities require significant cash expenditures. We do not expect to generate the necessary cash from our operations during the next 6 to 12 months to expand our business as desired. As such, in order to fund our operations during the next 6 to 12 months, we anticipate that we will have to raise additional capital through debt and/or equity financings, which may result in substantial dilution to our existing stockholders. There are no assurances that we will be able to raise the required working capital on terms favorable, or that such working capital will be available on any terms when needed. In addition, the terms of the Securities Purchase Agreement contain certain restrictions on our ability to engage in financing transactions. Specifically, for a period of two years after the effective date of the Securities Purchase Agreement, the Securities Purchase Agreement contains restrictions on certain types of financing transactions. The Securities Purchase Agreement contains carveouts to such financing restrictions for certain exempted transactions including (i) issuances pursuant to a stock option plan, (ii) securities issued upon the conversion of outstanding securities, (iii) securities issued pursuant to acquisitions or other strategic transactions, (iv) up to $500,000 in stock and warrants on the same terms as set forth in the Securities Purchase Agreement, and (v) up to $3,000,000 of the Company’s securities.

 

Contractual Obligations and Off-Balance Sheet Arrangements

 

As of March 31, 2013, the end of our latest fiscal year, we did not have any long-term debt or purchase obligations.

 

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholder’s equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

 

Critical Accounting Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles of the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the year. The more significant areas requiring the use of estimates include asset impairment, stock-based compensation, and future income tax amounts. Management bases its estimates on historical experience and on other assumptions considered to be reasonable under the circumstances. However, actual results may differ from the estimates.

 

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with GAAP. We believe certain critical accounting policies affect our more significant judgments and estimates used in the preparation of the financial statements. A description of our critical accounting policies is set forth in our Annual Report on Form 10-K for the fiscal year ended March 31, 2013, filed on July 16, 2013. As of, and for the three months ended December 31, 2013, there have been no material changes or updates to our critical accounting policies.

 

DIRECTORS AND EXECUTIVE OFFICERS

 

The following table sets forth the names and ages of our current directors and executive officers, the principal offices and positions held by each person:

 

Person   Age   Position
George Blankenbaker   48   Director, President, Secretary and Treasurer
Dr. Pablo Erat   42   Director
Thomas Ong   42   Director

 

The information below with respect to our directors includes such director’s experience, qualifications, attributes, and skills that led us to the conclusion that they should serve as a director.

 

George Blankenbaker - President, Secretary, Treasurer and Director

 

Mr. Blankenbaker became our President, Secretary, Treasurer and Director in June, 2011. Since November 2008, Mr. Blankenbaker has been leading the development of high Reb-A stevia farming in Vietnam. Mr. Blankenbaker was raised on a farm and became involved in large scale commercial agriculture in 2002 when he began working with the Agri-Food Veterinary Authority of Singapore (AVA) to provide strategically important food supplies to Singapore and has extensive experience managing agriculture projects in South East Asia. Mr. Blankenbaker received a Bachelors of Science in Business Finance from Indiana University in 1988, where he also studied Asian Political Science. Mr. Blankenbaker’s recent activities and experience in Vietnam have laid the groundwork for the Company’s current business strategy, and his in-depth knowledge of such matters are invaluable to our Board of Directors.

 

37
 

  

Dr. Pablo Erat - Director

 

Dr. Erat was elected to our board of directors on October 4, 2011. Since January 2009, Dr. Erat has served as CEO of Pal & Partners AG, a Swiss-based group domiciled in Zug with offices in Zurich and Mumbai and with a focus on the Indian agriculture industry. Prior to joining Pal & Partners AG, in 2008 Dr. Erat served as a consultant to corporations and start-up companies in various industries to assist in the development and implementation of innovative strategies. In April 2001, he co-founded Executive Insight, a strategy consulting firm and in January 2003, he co-founded DocsLogic, a company specialized on the development of knowledge applications, where he remained through 2007. Dr. Erat is also Assistant Professor at the ETH Zurich and regularly delivers speeches and workshops on strategic management principles for educational and business communities. Dr. Erat received a Doctorate from the University of St. Gallen in Switzerland in June 2003. Dr. Erat’s extensive knowledge and experience working for and advising early stage companies as well as his experience in the agriculture industry will be extremely relevant to the Board of Directors.

 

Thomas Ong - Director

 

Since November 1, 2011, Mr. Ong has served as our Director of Operations, Asia. Since November 6, 2009, Mr. Ong also serves as a Director of the Singapore registered farm management firm Growers Synergy Pte Ltd, an agriculture consultancy and farm management company producing and trading crops for the domestic and export markets. He is a member of the SPRING Start-up Enterprise Development Scheme (SPRING SEEDS) Investment Panel, a wholly owned subsidiary of SPRING Singapore, a statutory board under the Singapore Ministry of Trade and Industry, that provides equity-based co-financing options for Singapore-based early-stage companies. Prior to focusing on the food supply sector, Mr. Ong was a director of A.D. Venture Limited, a Singapore-registered fund investment and management company with operating arms in Hong Kong and the People's Republic of China (PRC). Previously, Mr. Ong served 5 years with the Ministry of the Environment and subsequently joined the National Environment Agency (NEA) and worked with the Economic Development Board (EDB), International Enterprise Singapore (IE Singapore), Workforce Development Agency (WDA) and related industry groups to promote high value environmental services to the domestic and international markets. Mr. Ong received his Bachelor of Business Administration from the National University of Singapore in 1995 and his Master of Science in Information Studies from Nanyang Technological University in 2000. Mr. Ong's familiarity with our operations specifically and Asian farm management generally will be of great value to our Board of Directors.

 

Involvement In Certain Legal Proceedings

 

No director, executive officer, significant employee or control person of the Company has been involved in any legal proceeding listed in Item 401(f) of Regulation S-K in the past 10 years.

 

Term of Office

 

Our directors are appointed for a one-year term to hold office until the next annual general meeting of our stockholders or until removed from office in accordance with our bylaws. Our officers are appointed by our Board of Directors and hold office until removed by the Board, absent an employment agreement.

 

EXECUTIVE COMPENSATION

 

Executive Compensation

 

The summary compensation table below shows certain compensation information for services rendered in all capacities to us by our principal executive officer and principal financial officer and by each other executive officer whose total annual salary and bonus exceeded $100,000 during the fiscal periods ended March 31, 2012 and March 31, 2013.  Other than as set forth below, no executive officer’s total annual compensation exceeded $100,000 during our last fiscal period.

  

Summary Compensation Table

 

Name and Principal Position (a)  Year
(b)
   Salary
($)
(c)
   Bonus
($)
(d)
   Stock
Awards
($)
(e)
   Option
Awards
($)
(f)
   Non
Equity
Incentive
Plan
Compensation
($)
(g)
   Non-qualified
Deferred
Compensation
Earnings
($)
(h)
   All Other
Compensation
($)
(i)
   Total
($)
(j)
 
George Blankenbaker   2013   $0   $0   $0   $0   $0   $0   $0   $0 
President, Secretary, Treasurer, Director (Principal Executive Officer and Principal Financial Officer)   2012   $0   $0   $0   $0   $0   $0   $750,000   $750,000 

  

38
 

 

On June 23, 2011, as a result of the Share Exchange Agreement, the sole stockholder of Stevia Ventures International Ltd. (“Stevia Ventures”) received 12,000,000 shares of our common stock in exchange for 100% of the issued and outstanding common stock of Stevia Ventures. Mr. Blankenbaker, our President and director, was the sole stockholder and officer of Stevia Ventures. Accordingly, he was a recipient of 12,000,000 shares of our common stock issued in connection with the Share Exchange Transaction, 6,000,000 of which were to be held in escrow pending the achievement by the Company of certain business milestones (the “Escrow Shares”). On December 23, 2011, 3,000,000 of the 6,000,000 Escrow Shares were earned and released to Mr. Blankenbaker upon achievement of certain business objectives by the Company. Those shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation. The remaining 3,000,000 Escrow Shares were earned and released from escrow on July 12, 2013 upon achievement of certain business objectives by the Company. Those shares were valued at $0.20 per share or $600,000 on the date of release and recorded as compensation.

 

Other than as set forth above, none of our executive officers received, nor do we have any arrangements to pay out, any bonus, stock awards, option awards, non-equity incentive plan compensation, or non-qualified deferred compensation.

 

Director Compensation

 

On October 14, 2011 we issued 1,500,000 shares to each of Rodney L. Cook and Pablo Erat, as newly appointed members of our Board of Directors, as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock for each director on each of the first two anniversaries of the date of grant, subject to the director’s continuous service to the Company. These shares were valued at $0.25 per share, or an aggregate of $750,000, on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.

 

We recorded $187,500 in directors’ fees for the period from April 11, 2011 (inception) through March 31, 2012 and $375,000 in directors’ fees for the fiscal year ended March 31, 2013.

 

We have no standard arrangement to compensate directors for their services in their capacity as directors. Except as set forth above, directors are not paid for meetings attended. All travel and lodging expenses associated with corporate matters are reimbursed by us, if and when incurred.

 

Employment Agreements

 

None of our executive officers currently have employment agreements with us and the manner and amount of compensation for the above-referenced new officer and director has not yet been determined.

 

Potential Payments Upon Termination or Change-in-Control

 

We currently have no employment agreements with any of our executive officers, nor any compensatory plans or arrangements resulting from the resignation, retirement or any other termination of any of our executive officers, from a change-in-control, or from a change in any executive officer’s responsibilities following a change-in-control. As a result, we have omitted this table.

 

Compensation Committee Interlocks and Insider Participation

 

No interlocking relationship exists between our Board of Directors and the Board of Directors or compensation committee of any other company, nor has any interlocking relationship existed in the past.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

The following table sets forth certain information as of March 26, 2014 with respect to the beneficial ownership of our common stock for (i) each director and officer, (ii) all of our directors and officers as a group, and (iii) each person known to us to own beneficially 5% or more of the outstanding shares of our common stock. To our knowledge, except as indicated in any footnotes to this table or pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with respect to the shares of common stock indicated.

 

39
 

   

Name and Address of Beneficial
Owner (1)
  Amount and Nature of
Beneficial Ownership
   Percentage of Class
(2)
 
George Blankenbaker(3)   52,244,682    35.79%
President, Secretary, Treasurer,          
and Director          
6451 Buck Creek Pkwy          
Indianapolis, IN 46227          
           
Thomas Ong(4)   5,000,000    3.42%
Director          
7117 US 31S          
Indianapolis, IN 46227          
           
Pablo Erat   1,500,000    1.03%
Director          
Ludretikonerstrasse 53          
880 Thalwil          
Switzerland          
           
All Officers and Directors as a Group   55,244,982    40.24%
           

 

(1) Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. Pursuant to the rules of the SEC, shares of common stock which an individual or group has a right to acquire within 60 days pursuant to the exercise of options or warrants are deemed to be outstanding for the purpose of computing the percentage ownership of such individual or group, but are not deemed to be beneficially owned and outstanding for the purpose of computing the percentage ownership of any other person shown in the table.

 

(2) Based on 145,972,713 shares of our common stock outstanding as of March 26, 2014.

 

(3) Mr. Blankenbaker is the beneficial owner of 52,244,982 shares of common stock. Mr. Blankenbaker owns 12,000,000 shares of common stock directly. 3,500,000 shares of common stock are owned by Growers Synergy Pte Ltd. (“Growers Synergy”). Mr. Blankenbaker is the managing director of Growers Synergy.  Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and the Reporting Person controls a 49% interest in Growers Fresh.  Mr. Blankenbaker may be deemed to be the indirect beneficial owner of the shares held by Growers Synergy under Rule 13d-3(a) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”). However, pursuant to Rule 13d-4 promulgated under the Exchange Act, Mr. Blankenbaker disclaims that he is a beneficial owner of such shares, except to the extent of his pecuniary interest herein. 36,744,682 shares of common stock are owned by Blankenbaker Ventures (Asia) Pte. Ltd. (“BV Asia”). Mr. Blankenbaker owns a 65% controlling interest in BV Asia.

 

(4) Mr. Ong is the beneficial owner of 5,000,000 shares of common stock. Mr. Ong owns 1,500,000 shares of common stock directly and 3,500,000 shares of common stock are owned by Growers Synergy. Mr. Ong, a director of the Company, is a director of Growers Synergy and is also a 25% shareholder of Agriventure Pte Ltd., which is a 49% shareholder of Growers Synergy. Mr. Ong may be deemed to be the indirect beneficial owner of the shares held by Growers Synergy under Rule 13d-3(a) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”). However, pursuant to Rule 13d-4 promulgated under the Exchange Act, Mr. Ong disclaims that he is a beneficial owner of such shares, except to the extent of his pecuniary interest herein.

 

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

AND DIRECTOR INDEPENDENCE

 

Certain Relationships and Related Party Transactions

 

On June 23, 2011, as a result of the Share Exchange Agreement, the sole stockholder of Stevia Ventures International Ltd. (“Stevia Ventures”) received 12,000,000 shares of our common stock in exchange for 100% of the issued and outstanding common stock of Stevia Ventures. Mr. Blankenbaker, our President and director, was the sole stockholder and officer of Stevia Ventures. Accordingly, he was a recipient of 12,000,000 shares of our common stock issued in connection with the Share Exchange Transaction, 6,000,000 of which were to be held in escrow pending the achievement by the Company of certain business milestones (the “Escrow Shares”). On December 23, 2011, 3,000,000 of the 6,000,000 Escrow Shares were earned and released to Mr. Blankenbaker upon achievement of certain business objectives by the Company. Those shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation. The remaining 3,000,000 Escrow Shares were earned and released from escrow on July 12, 2013 upon achievement of certain business objectives by the Company. Those shares were valued at $0.20 per share or $600,000 on the date of release and recorded as compensation.

 

On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("Growers Synergy"), a Singapore corporation. Mr. Ong, a director of the Company, is a director of Growers Synergy and is also a 25% shareholder of Agriventure Pte Ltd., which is a 49% shareholder of Growers Synergy. Mr. Blankenbaker is the managing director of Growers Synergy.  Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and Mr. Blankenbaker controls a 49% interest in Growers Fresh. Under the terms of the Management Agreement, the Company engaged Growers Synergy to supervise the Company's farm management operations, recommend quality farm management programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. Growers Synergy will provide services for a term of two (2) years from the date of signing, at $20,000 per month. The Management Agreement may be terminated by the Company upon 30 day notice. In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby Growers Synergy agreed to purchase all of the non-stevia crops produced at the Company's Growers Synergy supervised farms. On July 5, 2012, the Company issued 500,000 shares of its common stock to Growers Synergy as consideration for services rendered by Growers Synergy to the Company. On February 26, 2014, the Company issued 3,000,000 shares of its common stock to Growers Synergy as consideration for services rendered by Growers Synergy to the Company.

 

40
 

  

On February 26, 2014, we issued 20,000,000 shares to Blankenbaker Ventures (Asia) Pte. Ltd., on behalf of George Blankenbaker, our president, director and stockholder in exchange for services to be rendered by Mr. Blankenbaker. 4,000,000 of the shares were fully vested at the time of grant and the remainder vest in four equal installments on each anniversary of February 26, 2014. Mr. Blankenbaker owns a 65% controlling interest in BV Asia.

 

On February 26, 2014, we issued 16,744,682 shares of our common stock to Blankenbaker Ventures (Asia) Pte. Ltd., on behalf of George Blankenbaker, our president, director and stockholder, in exchange for the cancellation of approximately $893,579.93 of working capital advances received from Mr. Blankenbaker and his affiliated companies.

 

Review, Approval or Ratification of Transactions with Related Persons

 

Although we have adopted a Code of Ethics, we still rely on our Board to review related party transactions on an ongoing basis to prevent conflicts of interest. Our Board reviews a transaction in light of the affiliations of the director, officer or employee and the affiliation’s of such person’s immediate family. Transactions are presented to our Board for approval before they are entered into or, if this is not possible, for ratification after the transaction has occurred. If our Board finds that a conflict of interest exists, then it will determine the appropriate remedial action, if any. Our Board approves or ratifies a transaction if it determines that the transaction is consistent with the best interests of the Company.

 

Director Independence

 

During the year ended March 31, 2013, we had two independent directors on our Board, Dr. Erat and Mr. Cook. Mr. Blankenbaker is not independent. We evaluate independence by the standards for director independence established by applicable laws, rules, and listing standards including, without limitation, the standards for independent directors established by The New York Stock Exchange, Inc., the NASDAQ National Market, and the SEC.

 

Subject to some exceptions, these standards generally provide that a director will not be independent if (a) the director is, or in the past three years has been, an employee of ours; (b) a member of the director’s immediate family is, or in the past three years has been, an executive officer of ours; (c) the director or a member of the director’s immediate family has received more than $120,000 per year in direct compensation from us other than for service as a director (or for a family member, as a non-executive employee); (d) the director or a member of the director’s immediate family is, or in the past three years has been, employed in a professional capacity by our independent public accountants, or has worked for such firm in any capacity on our audit; (e) the director or a member of the director’s immediate family is, or in the past three years has been, employed as an executive officer of a company where one of our executive officers serves on the compensation committee; or (f) the director or a member of the director’s immediate family is an executive officer of a company that makes payments to, or receives payments from, us in an amount which, in any twelve-month period during the past three years, exceeds the greater of $1,000,000 or 2% of that other company’s consolidated gross revenues.

 

DISCLOSURE OF COMMISSION POSITION OF

INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

 

Sections 78.7502 and 78.751 of the Nevada Revised Statutes authorizes a court to award, or a corporation’s board of directors to grant indemnity to directors and officers in terms sufficiently broad to permit indemnification, including reimbursement of expenses incurred, under certain circumstances for liabilities arising under the Securities Act of 1933, as amended.  In addition, the registrant’s Bylaws provide that the registrant has the authority to indemnify the registrant’s directors and officers and may indemnify the registrant’s employees and agents (other than officers and directors) against liabilities to the fullest extent permitted by Nevada law. The registrant is also empowered under the registrant’s Bylaws to purchase insurance on behalf of any person whom the registrant is required or permitted to indemnify.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed a registration statement on Form S-1, together with all amendments and exhibits, with the SEC. This Prospectus, which forms a part of that registration statement, does not contain all information included in the registration statement. Certain information is omitted and you should refer to the registration statement and its exhibits. With respect to references made in this Prospectus to any of our contracts or other documents, the references are not necessarily complete and you should refer to the exhibits attached to the registration statement for copies of the actual contracts or documents. You may read and copy any document that we file at the Commission’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference rooms. Our filings and the registration statement can also be reviewed by accessing the SEC’s website at http://www.sec.gov. We maintain a website at http://www.steviacorp.us

 

41
 

  

FINANCIAL STATEMENTS

 

Our interim unaudited consolidated financial statements as of and for the three and nine months ended December 31, 2013 and 2012, and audited consolidated financial statements as of and for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) to March 31, 2012 are included herewith.

    


Stevia Corp.

March 31, 2013 and 2012

Index to the Consolidated Financial Statements


Contents
Page(s)
 
 
Report of Independent Registered Public Accounting Firm
F-2
   
Consolidated Balance Sheets at March 31, 2013 and 2012
F-3
   
Consolidated Statements of Operations for the Fiscal Year Ended March 31, 2013 and for the Period from April 11, 2011 (Inception) through March 31, 2012
F-4
   
Consolidated Statement of Equity (Deficit) for the Fiscal Year Ended March 31, 2013 and for the Period from April 11, 2011 (Inception) through March 31, 2012
F-5
   
Consolidated Statements of Cash Flows for the Fiscal Year Ended March 31, 2013 and for the Period from April 11, 2011 (Inception) through March 31, 2012
F-6
   
Notes to the Consolidated Financial Statements
F-7


 
F-1

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of
Stevia Corp.
Indianapolis, Indiana

We have audited the accompanying consolidated balance sheets of Stevia Corp. (the “Company”) as of March 31, 2013 and 2012, and the related consolidated statements of operations, equity (deficit) and cash flows for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012.  These consolidated financial statements are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purposes of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.  An audit includes examining on a test basis, evidence supporting the amount and disclosures in the consolidated financial statements.  An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of March 31, 2013 and 2012, and the related consolidated statements of operations, equity (deficit) and cash flows for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012 in conformity with accounting principles generally accepted in the United States of America.

The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.  As discussed in Note 3 to the consolidated financial statements, the Company had an accumulated deficit at March 31, 2013, a net loss and net cash used in operating activities for the fiscal year then ended.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.  Management’s plans in regards to these matters are also described in Note 3.  The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.



/s/Li and Company, PC         
Li and Company, PC

Skillman, New Jersey
July 15, 2013
 

 
F-2

 
 
 Stevia Corp.
 
 Consolidated Balance Sheets

   
March 31, 2013
   
March 31, 2012
 
             
 Assets
           
 Current assets:
           
Cash
  $ 424,475     $ 15,698  
 Accounts receivable
    158,008       -  
 Prepayments and other current assets
    33,096       168,874  
                 
    Total current assets
    615,579       184,572  
                 
 Non-current assets:
               
 Property and equipment
    7,925       3,036  
 Accumulated depreciation
    (1,234 )     -  
                 
 Property and equipment, net
    6,691       3,036  
                 
 Acquired technology
    1,635,300       -  
 Accumulatd amortization
    (81,765 )     -  
                 
 Acquired technology, net
    1,553,535       -  
                 
 Website development costs
    5,315       5,315  
 Accumulated amortization
    (1,869 )     (801 )
                 
 Website development costs, net
    3,446       4,514  
                 
 Security deposit
    15,000       15,000  
                 
       Total assets   $ 2,194,251     $ 207,122  
                 
 Liabilities and equity (deficit)
               
 Current liabilities:
               
 Accounts payable
  $ 948,073     $ 237,288  
 Accounts payable - president and CEO
    89,193       20,220  
 Accrued expenses
    19,700       5,400  
 Accrued interest
    21,627       15,521  
                 
 Advances from president and significant stockholder
    21,238       19,138  
 Convertible notes payable - net of discount
    357,700       700,000  
                 
 Current portion of derivative liability
    -       -  
                 
    Total current liabilities
    1,457,531       997,567  
                 
 Non-Current liabilities:
               
 Derivative liability
    486,113       -  
                 
   Total non-current liabilities
    486,113       -  
                 
Total liabilities
    1,943,644       997,567  
                 
 Equity (Deficit)
               
 Stevia Corp stockholders' equity (deficit):
               
 Preferred stock at $0.001 par value: 1,000,000 shares authorized;
               
 none issued or outstanding
    -       -  
 Common stock at $0.001 par value: 100,000,000 shares authorized,
               
 63,555,635 and 58,354,775 shares issued and outstanding, respectively
    63,556       58,355  
 Additional paid-in capital
    4,760,624       1,474,751  
 Accumulated deficit
    (4,359,415 )     (2,323,551 )
                 
    Total Stevia Corp stockholders' equity (deficit)
    464,765       (790,445 )
                 
 Non-controlling interest in subsidiary
    (214,158 )     -  
                 
 Total Equity (Deficit)
    250,607       (790,445 )
                 
         Total Liabilities and Equity (Deficit)   $ 2,194,251     $ 207,122  
 
 
 
 See accompanying notes to the consolidated financial statements.
 
 
F-3

 
 
 Stevia Corp.
 
 Consolidated Statements of Operations

 
             
For the Period from
 
     
For the Fiscal Year
   
April 11, 2011
 
     
Ended
   
(inception) through
 
     
March 31, 2013
   
March 31, 2012
 
                   
 Revenues
   
 $
                                   2,168,093
   
 $
                                                 1,300
 
                   
 Cost of revenues
               
 Farm produce
   
                                   1,789,034
     
                                                               -
 
 Farm expenses
   
                                            94,547
     
                                        523,746
 
 Farm field lease
   
                                             21,250
     
                                                7,500
 
 Farm management services - related parties
   
                                         712,550
     
                                         180,000
 
                   
    Total cost of revenues    
                                    2,617,381
     
                                          711,246
 
                   
 Gross margin
   
                                   (449,288)
     
                                   (709,946)
 
                   
 Operating expenses:
               
 Directors' fees
   
                                        375,000
     
                                         187,500
 
 Professional fees
   
                                        454,958
     
                                        255,959
 
 Research and development
   
                                          177,169
     
                                          206,191
 
 Salary and compensation - officer
   
                                                               -
     
                                        750,000
 
 Salary and compensation - others
   
                                         190,549
     
                                                               -
 
 General and administrative expenses
   
                                         412,409
     
                                          113,742
 
                   
    Total operating expenses    
                                    1,610,085
     
                                    1,513,392
 
                   
 Loss from operations
   
                             (2,059,373)
     
                             (2,223,338)
 
                   
 Other (income) expense:
               
 Change in fair value of derivative liability
   
                                            74,308
     
                                                               -
 
 Financing cost
   
                                            28,625
     
                                            70,500
 
 Foreign currency transaction gain (loss)
   
                                                  1,316
     
                                                               -
 
 Interest expense
   
                                            86,400
     
                                            29,757
 
 Interest income
   
                                                               -
     
                                                     (44)
 
                   
    Total other (income) expense    
                                         190,649
     
                                          100,213
 
                   
 Loss before income tax provision and non-controlling interest
   
                             (2,250,022)
     
                              (2,323,551)
 
                   
 Income tax provision
   
                                                               -
     
                                                               -
 
                   
 Net loss before non-controlling interest
   
                             (2,250,022)
     
                              (2,323,551)
 
 Net loss attributable to the non-controlling interest
   
                                     (214,158)
     
                                                               -
 
                   
 Net loss attributable to Stevia Corp.
 
 $
                             (2,035,864)
   
 $
                              (2,323,551)
 
                   
 Net loss per common share
               
 - Basic and diluted:
 
 $
                                               (0.03)
   
 $
                                               (0.05)
 
                   
Weighted average common shares outstanding                
    - basic and diluted    
                              62,092,487
     
                               45,093,271
 
 
 
 
 See accompanying notes to the consolidated financial statements.
 
 
F-4

 
 
Stevia Corp.
 
Consolidated Statement of Equity (Deficit)
For the Fiscal Year Ended March 31, 2013 and for the Period from April 11, 2011 (Inception) through March 31, 2012

 
                           
Total STEV
             
    Common Stock, $0.001 Par Value    
Additional
    Accumulated    
Stockholders'
   
Non-controlling
   
Total
 
   
Number of Shares
   
Amount
   
paid-in Capital
   
Deficit
   
Equity (Deficit)
   
Interest
   
Equity (Deficit)
 
 Balance, April 11, 2011 (inception)
    6,000,000     $ 6,000     $ (5,900 )   $ -     $ 100     $ -     $ 100  
                                                         
Common shares deemed issued in reverse acquisition
    79,800,000       79,800       (198,088 )             (118,288 )             (118,288 )
                                                         
Common shares cancelled in reverse acquisition
    (33,000,000 )     (33,000 )     33,000               -               -  
                                                         
Common shares issued for cash at $0.25 per share
                                                       
on October 4, 2011
    400,000       400       99,600               100,000               100,000  
                                                         
Common shares issued for notes conversion
                                                       
at $0.25 per share on October 4, 2011
    1,400,000       1,400       348,600               350,000               350,000  
                                                         
Common shares issued for conversion of accrued interest
                                                       
at $0.25 per share on October 4, 2011
    74,850       75       18,638               18,713               18,713  
                                                         
Common shares cancelled by significant stockholder
                                                       
on October 4, 2011
    (3,000,000 )     (3,000 )     3,000               -               -  
                                                         
Common shares issued for future director
                                                       
services on October 4, 2011
    3,000,000       3,000       747,000               750,000               750,000  
                                                         
Common shares issued for future director
                                                       
services on October 4, 2011
                    (750,000 )             (750,000 )             (750,000 )
                                                         
Common shares issued for future director
                                                       
services on October 4, 2011
                                                       
earned during the period
                    187,500               187,500               187,500  
                                                         
Make good shares released to officer for achieving
                                                       
the first milestone on December 23, 2011
    3,000,000       3,000       747,000               750,000               750,000  
                                                         
Common shares issued for notes conversion
                                                       
at $0.25 per share on January 18, 2012
    600,000       600       149,400               150,000               150,000  
                                                         
Common shares issued for conversion of accrued interest
                                                       
at $0.25 per share on January 18, 2012
    17,425       17       4,339               4,356               4,356  
                                                         
Common shares issued for financing services upon agreement
                                                       
at $1.50 per share on January 26, 2012
    35,000       35       52,465               52,500               52,500  
                                                         
Common shares issued for consulting services
                                                       
at $1.39 per share on March 31, 2012
    27,500       28       38,197               38,225               38,225  
                                                         
Net loss
                            (2,323,551 )     (2,323,551 )             (2,323,551 )
                                                         
Balance, March 31, 2012
    58,354,775       58,355       1,474,751       (2,323,551 )     (790,445 )     -       (790,445 )
                                                         
Restricted common shares issued for farm management services to a relatd party
                                                       
valued at $0.79 per share discounted at 69% on July 5, 2012
    500,000       500       272,050               272,550               272,550  
                                                         
 Restricted common shares issued for technology rights
                                                       
valued at $0.79 per share discounted at 69% on July 5, 2012
    3,000,000       3,000       1,632,300               1,635,300               1,635,300  
                                                         
Common shares issued for notes conversion
                                                       
at $0.832143 per share on July 6, 2012
    600,858       601       499,399               500,000               500,000  
                                                         
Common shares issued for conversion of accrued interest
                                                       
at $0.832143 per share on July 6, 2012
    33,335       33       27,707               27,740               27,740  
                                                         
Common shares and warrants issued to two investors for cash
                                                       
at $0.46875 per unit on August 6, 2012
    1,066,667       1,067       498,933               500,000               500,000  
                                                         
Warrants issued to investors in connection with the sale of
                                                       
equity units on August 6, 2012 classified as derivative liability
                    (381,300 )             (381,300 )             (381,300 )
                                                         
Commissions and legal fees paid in connection with the sale of
                                                       
equity units on August 6, 2012
                    (52,500 )             (52,500 )             (52,500 )
                                                         
Warrants issued to placement agent in connection with the sale of
                                                       
equity units on August 6, 2012 classified as derivative liability
                    (30,504 )             (30,504 )             (30,504 )
                                                         
Issuance of warrants in connection with
                                                       
convertible note payable issued in February and March 2013
                    220,438               220,438               220,438  
                                                         
Beneficial conversion feature in connection with
                                                       
convertible note payable issued in February and March 2013
                    224,350               224,350               224,350  
                                                         
Common shares issued for future director
                                                       
services on October 4, 2011 earned during the period
                    375,000               375,000               375,000  
                                                         
Net loss
                            (2,035,864 )     (2,035,864 )     (214,158 )     (2,250,022 )
                                                         
Balance, March 31, 2013
    63,555,635     $ 63,556     $ 4,760,624     $ (4,359,415 )   $ 464,765     $ (214,158 )   $ 250,607  
 
 
 
 See accompanying notes to the consolidated financial statements.
 
 
F-5

 
 
 Stevia Corp.
 
 Consolidated Statements of Cash Flows

           
For the Period from
 
   
For the Fiscal Year
   
April 11, 2011
 
    Ended    
(inception) through
 
   
March 31, 2013
   
March 31, 2012
 
 Cash flows from operating activities:
               
 Adjustments to reconcile net loss to net cash used in operating activities
               
 Depreciation expense
   
                                                   1,234
     
                                                                 -
 
 Amortization expense - acquired technology
   
                                               81,765
     
                                                                 -
 
 Amortization expense - website development costs
   
                                                   1,068
     
                                                         801
 
 Discount of convertible notes payable
   
                                      (412,738
   
                                                                 -
 
 Change in fair value of derivative liability
   
                                              74,308
     
                                                                 -
 
 Common shares issued for compensation
   
                                                                 -
     
                                          750,000
 
 Common shares issued for director services earned during the period
   
                                          375,000
     
                                           187,500
 
 Common shares issued for services-related party
   
                                          272,550
     
                                                                 -
 
 Common shares issued for outside services
   
                                                                 -
     
                                              90,725
 
 Changes in operating assets and liabilities:
               
 Accounts receivable
   
                                      (158,008
   
                                                                 -
 
 Prepaid expenses
   
                                           135,778
     
                                      (168,874
 Accounts payable
   
                                           710,785
     
                                            141,530
 
 Accounts payable - President and CEO
   
                                              68,973
     
                                              20,220
 
 Accrued expenses
   
                                               14,300
     
                                              (1,290
 Accrued interest
   
                                              54,284
     
                                              38,589
 
                 
 Net cash used in operating activities
   
                                (1,030,723
   
                                (1,279,350
                 
 Cash flows from investing activities:
               
 Purchases of property, plant and equipment
   
                                             (4,889
   
                                             (3,036
 Website development costs
   
                                                                 -
     
                                              (5,315
 Cash received from reverse acquisition
   
                                                                 -
     
                                                   3,199
 
                 
 Net cash used in investing activities
   
                                             (4,889
   
                                              (5,152
                 
 Cash flows from financing activities:
               
 Advances from president and stockholder
   
                                                   2,100
     
                                                        200
 
 Proceeds from issuance of convertible notes
   
                                          550,000
     
                                     1,200,000
 
 Proceeds from sale of common stock, net of costs
   
                                          892,289
     
                                           100,000
 
                 
 Net cash provided by financing activities
   
                                     1,444,389
     
                                     1,300,200
 
                 
 Net change in cash
   
                                          408,777
     
                                               15,698
 
                 
 Cash at beginning of the fiscal year
   
                                               15,698
     
                                                                 -
 
                 
 Cash at end of the fiscal year
 
 $
                                          424,475
   
 $
                                               15,698
 
                 
 Supplemental disclosure of cash flows information:
               
 Interest paid
 
 $
                                                                 -
   
 $
                                                                 -
 
                 
 Income tax paid
 
 $
                                                                 -
   
 $
                                                                 -
 
                 
                 
 Non-cash investing and financing activities:
               
 Issuance of common stock for conversion of convertible notes
 
 $
                                          500,000
   
 $
                                          500,000
 
                 
 Converstion of accrued interest to convertible notes
 
 $
                                              20,438
   
 $
                                                                 -
 
                 
 Issuance of common stock for conversion of accrued interest
 
 $
                                              27,740
   
 $
                                              23,068
 
 
 
 
 See accompanying notes to the consolidated financial statements.
 
 
F-6

 

Stevia Corp.

March 31, 2013 and 2012
Notes to the Consolidated Financial Statements

Note 1 – Organization and Operations

Stevia Corp. (Formerly Interpro Management Corp.)

Interpro Management Corp (“Interpro”) was incorporated under the laws of the State of Nevada on May 21, 2007.   Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization’s efficiency through planning and monitoring the daily operations of a business. The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011.

On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. (“Stevia” or the “Company”) and effectuated a 35 for 1 (1:35) forward stock split of all of its issued and outstanding shares of common stock (the “Stock Split”).

All shares and per share amounts in the consolidated financial statements have been adjusted to give retroactive effect to the Stock Split.

Stevia Ventures International Ltd.

Stevia Ventures International Ltd. (“Ventures”) was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands (“BVI”).  Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia.

Acquisition of Stevia Ventures International Ltd. Recognized as a Reverse Acquisition

On June 23, 2011 (the “Closing Date”), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the “Share Exchange Agreement”) by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the “Ventures Stockholder”).

Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company’s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares were being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the “Milestones”), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures’ Stockholder (the “Escrow Agreement”).  Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock immediately after the consummation of the Share Exchange Agreement the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition.

As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification.  The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition.  The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost.  The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction.
 
 
F-7

 

Formation of Stevia Asia Limited

On March 19, 2012, the Company formed Stevia Asia Limited (“Stevia Asia”) under the laws of the Hong Kong Special Administrative Region (“HK SAR”) of the People’s Republic of China (“PRC”), a wholly-owned subsidiary.

Formation of Stevia Technew Limited (Formerly Hero Tact Limited)/Cooperative Agreement

On April 28, 2012, Stevia Asia formed Hero Tact Limited, a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited (“Stevia Technew”).  Stevia Technew intends to facilitate a joint venture relationship with the Company’s technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou’s affiliates Technew Technology Limited.  Prior to July 5, 2012, the date of entry into the Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities.

On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% of the shares (representing 30% of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities.

The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Principles of Consolidation

The Company applies the guidance of Topic 810 “Consolidation” of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.  Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.  Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.  The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent’s power to control exists.

The Company's consolidated subsidiaries and/or entities are as follows:

Name of consolidated
subsidiary or entity
 
State or other jurisdiction of
incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable interest
             
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
 
100%
             
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
 
100%
             
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
 
   70%


 
F-8

 

The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.

All inter-company balances and transactions have been eliminated.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.

Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

The Company’s significant estimates and assumptions include the fair value of financial instruments; the carrying value, recoverability and impairment of long-lived assets, including the values assigned to and the estimated useful lives of website development costs; interest rate; revenue recognized or recognizable; sales returns and allowances; foreign currency exchange rate; income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; expected term of share options and similar instruments, expected volatility of the entity’s shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s); and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.

Fair Value of Financial Instruments

The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1
 
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2
 
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3
 
Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
 
 
 
F-9

 
 
The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable, accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.

The Company’s convertible notes payable approximates the fair value of such instrument based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangements at March 31, 2013 and March 31, 2012.

The Company’s Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.  The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.  These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

It is not, however, practical to determine the fair value of advances from president and significant stockholder, if any, due to their related party nature.

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities – Derivative Warrant Liabilities

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability at every reporting period and recognizes gains or losses in the consolidated statements of operations and comprehensive income (loss) that are attributable to the change in the fair value of the derivative warrant liability.

Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company’s long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

The key assumptions used in management’s estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.  These forecasts are typically based on historical trends and take into account recent developments as well as management’s plans and intentions.  Other factors, such as increased competition or a decrease in the desirability of the Company’s products or services, could lead to lower projected sales levels, which would adversely impact cash flows.  A significant change in cash flows in the future could result in an impairment of long lived assets.

The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.


 
F-10

 

Fiscal Year End

The Company elected March 31 as its fiscal year ending date.

Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.

Property and Equipment

Property and equipment is recorded at cost.  Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred.  Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

Intangible Assets Other Than Goodwill

The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.  Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill inclusive of acquired technology and website development costs on a straight-line basis over their relevant estimated useful lives of fifteen (15) and five (5) years, respectively.  Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:  a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Derivative Instruments and Hedging Activities

The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification (“Paragraph 810-10-05-4”). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.  The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.  For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.

 
F-11

 

From time to time, the Company may employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates.  The Company does not use derivatives for speculation or trading purposes.  Changes in the fair value of derivatives are recorded each period in current earnings or through other comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and the type of hedge transaction.  The ineffective portion of all hedges is recognized in current earnings.  The Company has sales and purchase commitments denominated in foreign currencies.  Foreign currency forward contracts are used to hedge against the risk of change in the fair value of these commitments attributable to fluctuations in exchange rates (“Fair Value Hedges”).  Changes in the fair value of the derivative instrument are generally offset in the income statement by changes in the fair value of the item being hedged.

The Company did not employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates for the fiscal year ended March 31, 2013 or 2012.

Derivative Liability

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.  The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.  In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.  Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.  Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.  Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock.  Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions.   The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).

The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.  The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.  Therefore, the fair value may not be appropriately captured by simple models.  In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).  The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.  Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).  Projections were then made on the underlying factors which led to potential scenarios.  Probabilities were assigned to each scenario based on management projections.  This led to a cash flow projection and a probability associated with that cash flow.  A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.


 
F-12

 

Beneficial Conversion Feature

When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company's common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.

Commitment and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.  The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.  Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

Non-controlling Interest

The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interest in Stevia Technew Limited, its majority owned subsidiary in the consolidated statements of balance sheets within the equity section, separately from the Company’s stockholders’ equity.  Non-controlling interest represents the non-controlling interest holder’s proportionate share of the equity of the Company’s majority-owned subsidiary, Stevia Technew Limited. Non-controlling interest is adjusted for the non-controlling interest holder’s proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

Revenue Recognition

The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.

Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 “Accounting for Research and Development Costs”) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 “Research and Development Arrangements”) for research and development costs.  Research and development costs are charged to expense as incurred.  Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.


 
F-13

 

Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities

The research and development arrangements usually involve specific research and development projects.  Often times, the Company makes non-refundable advances upon signing of these arrangements.  The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 “Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities”) for those non-refundable advances.  Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.  Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.  The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.  If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.

Stock-Based Compensation for Obtaining Employee Services

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company’s most recent private placement memorandum ("PPM”), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.  Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.  Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity’s shares and the method used to estimate it.  Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.  The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 
 
F-14

 
 
The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.

Equity Instruments Issued to Parties other than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification (“Subtopic 505-50”).

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company’s most recent private placement memorandum ("PPM”), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder’s expected exercise behavior into the fair value (or calculated value) of the instruments.  The Company uses historical data to estimate holder’s expected exercise behavior.  If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity’s shares and the method used to estimate it.  An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.  A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.

Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.
 
 
 
F-15

 
 
Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.  Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the fiscal year ended March 31, 2013 or for the period from April 11, 2011 (Inception) through December 31, 2012.


 
F-16

 

Limitation on Utilization of NOLs due to Change in Control

Pursuant to the Internal Revenue Code Section 382 (“Section 382”), certain ownership changes may subject the NOL’s to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation’s ability to utilize NOLs if it experiences an “ownership change.”  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

Net Income (Loss) per Common Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification.   Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:
 
   
Potentially Outstanding Dilutive Common Shares
   
For Fiscal Year Ended
March 31, 2013
 
For the Period
from April 11, 2011
(inception) through
March 31, 2012
           
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the “Milestones”).
    3,000,000     6,000,000    
                 
Sub-total Make Good Escrow Shares
    3,000,000     6,000,000    
                 
Convertible Note Shares
               
                 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.
    881,752     -    
                 
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at  $0.46875 per share with gross proceeds of at least $100,000.
    426,667     -    
                 
On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share
    1,400,000     -    
                 
Sub-total Convertible Note Shares
    2,708,419     -    
 
 
 
F-17

 
 
 
                 
Warrant Shares
               
                 
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company’s common stock to the investors (the “investors warrants”) and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the new warrants issued triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.
    2,951,424     -    
                 
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company’s common stock to two notes holders in connection with the issuance of convertible notes.
    1,400,000     -    
                 
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company’s common stock to the note holder in connection with the issuance of the convertible note.
    881,753          
                 
Sub-total Warrant Shares
    5,233,177     -    
                 
Total potentially outstanding dilutive common shares
    10,941,596     6,000,000    

Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.  The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.

Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Recently Issued Accounting Pronouncements

In January 2013, the FASB issued ASU No. 2013-01, "Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities". This ASU clarifies that the scope of ASU No. 2011-11, "Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities." applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in FASB Accounting Standards Codification or subject to a master netting arrangement or similar agreement. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013.

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." The ASU adds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.
 
 
 
F-18

 
 
In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date."  This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05, "Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU 2013-07, “Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting.” The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity’s governing documents from the entity’s inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity’s inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity’s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Note 3 – Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the accompanying consolidated financial statements, the Company had an accumulated deficit at March 31, 2013, a net loss and net cash used in operating activities for the fiscal year then ended. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

While the Company is attempting to generate sufficient revenues, the Company’s cash position may not be sufficient enough to support the Company’s daily operations.  Management intends to raise additional funds by way of a public or private offering.  Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues provide the opportunity for the Company to continue as a going concern.  While the Company believes in the viability of its strategy to generate sufficient revenues and in its ability to raise additional funds, there can be no assurances to that effect.  The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenues.

The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.


 
F-19

 

Note 4 – Prepaid Expenses

Prepaid expenses consisted of the following:

   
March 31, 2013
   
March 31, 2012
 
                 
Prepaid research and development
 
$
25,546
   
$
128,445
 
                 
Prepaid rent
   
6,667
     
21,250
 
                 
Retainer
   
451
     
15,000
 
                 
Other
   
432
     
4,179
 
             
   
$
33,096
   
$
168,874
 

Note 5 – Property and Equipment

Property and equipment, stated at cost, less accumulated depreciation consisted of the following:

 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Property and equipment
5
 
7,925
   
$
3,036
 
               
Less accumulated depreciation
     
(1,234
)
   
(-
)
               
     
6,691
   
$
3,036
 

Depreciation Expense

The Company acquired furniture and fixture near the end of February 2012 and started to depreciate as of April 1, 2012. Depreciation expense for the fiscal year ended March 31, 2013 was $1,234.

Note 6 – Acquired Technology

On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company's common stock.  These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market for a total value of $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years.

 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Technology right
15
 
$
1,635,300
   
$
-
 
               
Less accumulated amortization
     
(81,765
)
   
(-
)
               
     
$
1,553,535
   
$
-
 

Amortization Expense

Amortization expense for the fiscal year ended March 31, 2013 was $81,765.

Note 7 – Website Development Costs

Website development costs, stated at cost, less accumulated amortization consisted of the following:

 
F-20

 


 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Website development costs
5
 
5,315
   
$
5,315
 
               
Accumulated amortization
     
(1,869
)
   
(801
)
               
     
3,446
   
$
4,514
 

Amortization expense

Amortization expense was $1,068 and $801 for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through December 31, 2012, respectively.

Note 8 – Related Party Transactions

Related parties

Related parties with whom the Company had transactions are:

Related Parties
 
Relationship
     
George Blankenbaker
 
President and significant stockholder of the Company
     
Leverage Investments LLC
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Technew Technology Limited
 
Non-controlling interest holder
     
Growers  Synergy Pte Ltd.
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Guangzhou Health Technology Development Company Limited
 
An entity owned and controlled by Non-controlling interest holder

Advances from Stockholder

From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.

Lease of Certain Office Space from Leverage Investments, LLC

The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011.  For the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through December 31, 2012, the Company recorded $6,000 and $4,500 in rent expenses due Leverage Investment LLC, respectively.

Farm Management and Off-Take Agreement with Growers Synergy Pte Ltd.

For the period from July 1, 2011 through October 31, 2011, the Company engaged Growers Synergy Pte Ltd. to provide farm management services on a month-to-month basis, at $20,000 per month.

On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the “Management Agreement”) with Growers Synergy Pte Ltd. (“GSPL”), a Singapore corporation owned and controlled by the president and major stockholder of the Company.  Under the terms of the Management Agreement,  the Company will engage GSPL to supervise the Company’s farm management operations, recommend quality farm management  programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization  targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services for a term of two (2) years from the date of signing, at $20,000 per month.  The Management Agreement may be terminated by the Company upon 30 day notice.  In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company’s GSPL supervised farms.


 
F-21

 

Farm management services provided by Growers Synergy Pte Ltd. is as follows:

   
For the Fiscal Year
Ended
March 31, 2013
   
For the Period from
April 11, 2011 (inception)
through
March 31, 2012
 
                 
Farm management services – related parties
 
$
240,000
   
$
180,000
 
             
   
$
240,000
   
$
180,000
 

Future minimum payments required under this agreement were as follows:

Fiscal Year Ending March 31:
       
         
2014
 
$
140,000
 
       
   
$
140,000
 

Cash Commitment in Connection with the Operations of Stevia Technew

On July 5, 2012, Stevia Asia, entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% shares (representing 30% of the of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to provide $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities.

For the fiscal year ended March 31, 2013, Stevia Asia provided Stevia Technew $230,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related parties.

Note 9 – Convertible Notes Payable

On February 14, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,890.41 at $0.25 per share to 1,000,000 shares and 63,561 shares of the Company’s common stock, respectively.

On June 23, 2011, the Company issued a convertible note in the amount of $100,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $100,000 and accrued interest through the date of conversion of $2,821.92 at $0.25 per share to 400,000 shares and 11,288 shares of the Company’s common stock.

On October 4, 2011, the Company issued a convertible note in the amount of $150,000 with interest at 10% per annum due one (1) year from the date of issuance.  On January 18, 2012, the note holder converted the entire principal of $150,000 and accrued interest through the date of conversion of $4,356 at $0.25 per share to 617,425 shares of the Company’s common stock.

(i) February 26, 2013 issuance of convertible notes with warrants

On February 26, 2013, the Company entered into two (2) 12% convertible notes payable of $350,000 in aggregate (“Convertible Notes”) with two investors (the “Payees”) maturing on September 30, 2013. The Payees have the option to convert the outstanding notes and interest due into the Company’s common shares at $0.25 per share at any time prior to September 30, 2013. In connection with the issuance of the Convertible Notes, the Company granted to the Payees a warrant to purchase 1,400,000 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance.

The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 
F-22

 


Expected option life (year)
   
3.00
 
         
Expected volatility
   
74.53
%
         
Risk-free interest rate
   
0.37
%
         
Dividend yield
   
0.00
%
       

The relative fair value of these warrants granted, estimated on the date of grant, was $110,425 in aggregate, which was recorded as a discount to the convertible notes payable. After allocating the $110,425 portion of the proceeds to the warrants as a discount to the Convertible Note, an additional $113,925 was allocated to a beneficial conversion feature by crediting additional $113,925 to additional paid-in capital and debiting the same amount to the beneficial conversion feature.  The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Notes. The amortization of the discount and beneficial conversion feature amounted to $32,050 for the fiscal year ended March 31, 2013.

(ii) March 15, 2013 issuance of convertible note with warrant

On March 15, 2013, the Company cancelled a prior convertible note and entered into a 12% convertible note payable of $220,438, which is the total amount of the prior note principal and accrued interest, with the existing investor (the “Payee”), maturing on September 30, 2013. The Payee has the option to convert the outstanding note into the Company’s common shares at $0.25 per share at any time prior to payment in full of the principal balance of the Convertible Note. In connection with the issuance of the Convertible Note, the Company granted the Payee a warrant to purchase 881,753 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance.

The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
         
Expected volatility
   
75.11
%
         
Risk-free interest rate
   
0.40
%
         
Dividend yield
   
0.00
%
       

The relative fair value of these warrants was $98,095, which was recorded as a discount to the convertible note payable. After allocating the $98,095, portion of the proceeds to the warrants as a discount to the Convertible Note, the effective conversion price of the convertible notes payable was lower than the market price at the date of issuance and per calculation the remaining balance of the face amount was allocated to a beneficial conversion feature by crediting $122,343 to additional paid-in capital and debiting the same amount to the beneficial conversion feature. The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Note and began to amortize the amount from April 1, 2013.

Convertible notes payable consisted of the following:

 
 
   
 
   
   
March 31, 2013
   
March 31, 2012
 
             
On November 16, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.  On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,959 to 319,607 shares of the Company’s common stock at $0.83 per share.
-
 
250,000
 
             
On January 16, 2012, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.  On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $11,781 to 314,586 shares of the Company’s common stock at $0.83 per share.
 
-
   
250,000
 
 
 
 
F-23

 
 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price $0.25 per share
 
220,438
   
200,000
 
             
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.
 
200,000
   
-
 
             
On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company’s common stock.
 
350,000
   
-
 
             
Sub-total: convertible notes payable
 
770,438
   
700,000
 
             
Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features
 
(444,788
)
 
-
 
             
Accumulated amortization of discount on convertible notes payable
 
32,050
   
-
 
             
Remaining discount
 
(412,738
)
 
-
 
             
 
$
357,770
 
$
700,000
 

Note 10 – Derivative Instruments and the Fair Value of Financial Instruments

(i) Warrants Issued on August 6, 2012

Description of Warrants and Fair Value on Date of Grant

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company’s common stock to the investors (the “investors warrants”) and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments, pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. The Company issued the warrants on February 26 and March 15, 2013 with an exercise price of $0.25 per share. Pursuant to Section 3(b) Subsequent Equity Sales of the SPA those warrants’ exercise price was reset to $0.25 per share and the number of warrant shares was increased to 2,732,801 and 218,623, respectively, for a total of 2,951,424.

Derivative Analysis

The exercise price of the August 6, 2012 warrants and the number of shares issuable upon exercise is subject to reset adjustment in the event of stock splits, stock dividends, recapitalization, most favored nation status and similar corporate events.  Pursuant to Section 3(b) Subsequent Equity Sales of the SPA, if the Company issues any common stock or securities other than the excepted issuances,  to any person or entity at a purchase or exercise price per share less than the share purchase price of the August 6, 2012 Unit Offering without the consent of the subscriber holding purchased shares, warrants or warrant shares of the August 6, 2012 Unit Offering, then the subscriber shall have the right to apply the lowest such purchase price or exercise price of the offering or sale of such new securities to the purchase price of the purchased shares then held by the subscriber (and, if necessary, the Company will issue additional shares), the reset adjustments are also referred to as full reset adjustments.

 
F-24

 

Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification (“Section 815-40-15”) (formerly FASB Emerging Issues Task Force (“EITF”) Issue No. 07-5: Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity's Own Stock (“EITF 07-5”)). Section 815-40-15 became effective on January 1, 2009 and the Warrants issued in the August 6, 2012 Unit Offering have been measured at fair value using a Lattice model at each reporting period with gains and losses from the change in fair value of derivative liabilities recognized on the consolidated statement of income and comprehensive income.

Valuation of Derivative Liability

(a) Valuation Methodology

The Company’s August 6, 2012 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset.

Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections.

Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability.

(b) Valuation Assumptions

The Company’s 2012 derivative warrants were valued at each period ending date with the following assumptions:

·  
The stock price would fluctuate with the Company projected volatility.

·  
The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods.

·  
The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price.

·  
The Holder would exercise the warrant at maturity if the stock price was above the project reset prices.

·  
A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market

·  
The 2,732,801 Investor Warrants with an exercise price of $0.25 per share (1,066,667 Investor Warrants with an exercise price  of $0.6405 per share prior to the occurrence of the February 26, 2013 reset event) is projected to reset to $0.095 at maturity; and the 218,623 Placement Agent Warrants with an exercise price of  $0.25 per share (85,333 Placement Agent Warrants with an exercise price of $0.6405 per share prior to the occurrence of the February 26, 2013 reset event) is projected to reset to $0.095 at maturity.

·  
No warrants have been exercised or expired.

·  
The projected volatility curve for the valuation dates was:

 
 
F-25

 


 
 
1 Year
   
2 Tear
   
3 Year
   
4 Year
   
5 Year
 
                               
August 6, 2012
 
129%
   
178%
   
218%
   
252%
   
281%
 
                               
September 30, 2012
 
127%
   
173%
   
211%
   
244%
   
272%
 
                               
March 31, 2013
 
122%
   
167%
   
205%
   
236%
   
264%
 
 
(c) Fair Value of Derivative Warrants
The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 shares of the Company’s common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).
 
     Fair Value Measurement Using Level 3 Inputs
    Derivative warrants         
   
Assets (Liability)
   
Total
 
             
Balance, August 6, 2012
  $ (411,805 )   $ (411,805 )
                 
Total gains or losses (realized/unrealized) included in:
               
                 
Net income (loss)
    231,521       231,521  
                 
Other comprehensive income (loss)
    -       -  
                 
Purchases, issuances and settlements
    -       -  
                 
Transfers in and/or out of Level 3
    -       -  
                 
Balance, August 6, 2012
    (180,284 )     (180,284 )
                 
Total gains or losses (realized/unrealized) included in:
               
                 
Net income (loss)
    (305,829 )     (305,829 )
                 
Other comprehensive income (loss)
    -       -  
                 
Purchases, issuances and settlements
    -       -  
                 
Transfers in and/or out of Level 3
    -       -  
                 
Balance, March 31, 2013
  $ (486,113 )   $ (486,113 )

(d) Warrants Outstanding

As of March 31, 2013 no warrants have been exercised and warrants to purchase 2,951,424shares of Company common stock remain outstanding.

The table below summarizes the Company’s derivative warrant activity:

 
F-26

 


   
2012 Warrant Activities
 
APIC
 
(Gain) Loss
 
   
Derivative
Shares
 
Non-derivative
Shares
 
Total Warrant
Shares
 
Fair Value of
Derivative
Warrants
 
Reclassification
of Derivative
Liability
 
Change in
Fair Value of
Derivative
Liability
 
                                       
Derivative warrant at August 6, 2012
   
1,152,000
   
-
   
1,152,000
   
(411,805
 
-
   
-
 
                                       
Mark to market
                     
231,521
         
(231,521
)
                                       
Derivative warrant at September 30, 2012
   
1,152,000
   
-
   
1,152,000
   
(180,284
)
       
(231,521
)
                                       
Mark to market
                     
(73,723
)
       
(73,723
)
                                       
Derivative warrant at December 31, 2012
   
1,152,000
   
-
   
1,152,000
   
(106,561
)
       
(305,244
)
                                       
Reset of warrant shares
   
1,799,424
                               
                                       
Mark to market
                     
(379,552
)
       
379,552
 
                                       
Derivative warrant at March 31, 2013
   
2,951,424
   
-
   
2,951,424
   
(486,113
)
       
74,308
 

(ii) Warrant Activities

The table below summarizes the Company’s warrant activities through March 31, 2013:

Summary of the Company’s Warrant Activities

The table below summarizes the Company’s warrant activities:

    Number of     Exercise Price      Weighted Average     Fair Value at Date     Aggregate  
   
Warrant Shares
   
Range Per Share
   
Exercise Price
   
of Issuance
   
Intrinsic Value
 
                               
Balance, March 31, 2012
    -     $ -     $ -     $ -     $ -  
                                         
Granted
    5,233,177       0.25       0.25       620,350       -  
                                         
Canceled
    -       -       -               -  
                                         
Exercised
    -       -       -               -  
                                         
Expired
    -       -       -               -  
                                         
Balance, March 31, 2013
    5,233,177     $ 0.25     $ 0.25     $ 620,350     $ -  
                                         
Earned and exercisable, March 31, 2013
    5,233,177     $ 0.25     $ 0.25     $ 620,350     $ -  
                                         
Unvested, March 31, 2013
    -     $ -     $ -     $ -     $ -  

The following table summarizes information concerning outstanding and exercisable warrants as of March 31, 2013:

   
Warrants Outstanding
 
Warrants Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Average Remaining
Contractual Life
(in years)
 
Weighted Average Exercise Price
 
Number
Exercisable
 
Average Remaining Contractual Life
(in years)
 
Weighted Average Exercise Price
 
                                       
$0.25
   
5,233,177
   
3.73
 
$
0.25
   
5,233,177
   
3.73
 
$
0.25
 
                                       
$0.25
   
5,233,177
   
3.73
 
$
0.25
   
5,233,177
   
3.73
 
$
0.25
 


 
F-27

 

Note 14 – Commitments and Contingencies

Supply Agreement – between Stevia Ventures International Ltd. and Asia Stevia Investment Development Company Ltd.

On April 12, 2011, Stevia Ventures International Ltd, a subsidiary of the Company entered into a Supply Agreement (the “Supply Agreement”) with Asia Stevia Investment Development Company Ltd (“ASID”), a foreign-invested limited liability company incorporated in Vietnam.

(I) Scope of Services

Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID.

(ii) Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term").

(iii) Purchase Price

ASID and the Company shall review and agree, on or before September 30th of each year, on the quantity of the Products to be supplied by ASID to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Supply Agreement – between Stevia Ventures International Ltd. And Stevia Ventures Corporation

On April 12, 2011, Stevia Ventures International Ltd, a subsidiary of the Company also entered into a Supply Agreement (the “Supply Agreement”) with Stevia Ventures Corporation (“SVC”), a foreign-invested limited liability company incorporated in Vietnam.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC.

(ii) Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term").

(iii) Purchase Price

SVC and the Company shall review and agree, on or before September 30th, of each Year on the quantity of the Products to be supplied by SVC to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Consulting Agreement – Dorian Banks


 
F-28

 

Entry into Consulting Agreement

On July 1, 2011 the Company entered into a consulting agreement (the “Consulting Agreement”) with Dorian Banks (“Banks”).

(i) Scope of Services

Under the terms of the Consulting Agreement, the Company engaged the Consultant to provide advice in general business development, strategy, assistance with new business and land acquisition, introductions, and assistance with Public Relations (“PR”) and Investor Relations (“IR”).

(ii) Term

The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continue until December 31, 2011. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Service performed by Consultant through the date of termination.

(iii) Compensation

The Company shall pay the Consultant a fee of $3,000 per month.

Extension of the Consulting Agreement

On December 30, 2011, the Consulting Agreement was extended with the same terms and conditions to expire on March 31, 2013.

Expiration of the Consulting Agreement

The Consulting Agreement expired on March 31, 2013 with no further extension.

Summary of the Consulting Fees

For the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, the Company recorded $41,250 and $27,000 in consulting fees under the Consulting Agreement, respectively.

Financing Consulting Agreement – David Clifton

Entry into Financial Consulting Agreement

On July 1, 2011 the Company entered into a consulting agreement (the “Consulting Agreement”) with David Clifton ( “Clifton”).

(i) Scope of Services

Under the terms of the Consulting Agreement, the Company engaged Clifton to introduce interested investors to the Company, advise the Company on available financing options and provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake.

(ii) Term

The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continuing until December 31, 2011. This Agreement may be terminated by either the Company or Clifton at any time prior to the end of the consulting period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Clifton for all service performed by him through the date of termination.

On December 31, 2011, the financial consulting agreement expired.

(iii) Compensation

The Company shall pay Clifton a fee of $3,000 per month.

 
 
F-29

 
 
Summary of the Consulting Fees

For the period from April 11, 2011 (inception) through December 31, 2011, the Company recorded $18,000 in financing cost under this Financing Consulting Agreement.

Entry into Engagement Agreement – Garden State Securities Inc.

On June 18, 2012, the Company entered into an engagement agreement (the “Agreement”) with Garden State Securities Inc. (“GSS”) for GSS to act as a selling/placement agent for the Company.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company on a “best efforts” Private Placement offering of debt or equity securities to fulfill the Company’s business plan, and contacts for the Company possible financing sources.

(ii) Term

GSS shall act as the Company’s exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the “Exclusive Period”). GSS shall act as the Company’s non-exclusive placement agent after the Exclusive Period until terminated.

(iii) Compensation

The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company’s common stock (the “Securities Financing”) during the Exclusive Period; (i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the “Warrants”) with “piggy back” registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investors’ warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors.  The Company will also pay, at closing, the expense of GSS’s legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company.  In addition, the Company shall cause, at its cost and expense, the “Blue sky filing” and Form D in due and proper form and substance and in a timely manner.

Note 11 – Equity

Shares Authorized

Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share.

Common Stock

Reverse Acquisition Transaction

Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company’s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company’s common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares are being held in escrow (“Escrow Shares”) pending the achievement by the Company of certain post-Closing business milestones (the “Milestones”), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures’ Stockholder (the “Escrow Agreement”).


 
F-30

 

Make Good Agreement Shares

(i) Duration of Escrow Agreement

The Make Good Escrow Agreement shall terminate on the sooner of (i) the distribution of all escrow shares, or (ii) December 31, 2013.

(ii) Disbursement of Make Good Shares

Upon achievement of any Milestone on or before the date associated with such Milestone on Exhibit A, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such achievement (each a “COMPLETION NOTICE”). Upon the passage of any Milestone date set forth on Exhibit A for which the Company has not achieved the associated Milestone, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such failure to achieve the milestone (each a “NON-COMPLETION NOTICE”).

(iii) Exhibit A – Schedule of Milestones

 Milestones    
Completion Date
   
Number of
Escrow Shares
 
               
I.
 
(1)Enter into exclusive international license agreement for all Agro Genesis intellectual property and products as it applies to stevia
(2)Enter into cooperative agreements to work with Vietnam Institutes (a) Medical Plant Institute in Hanoi; (b) Agricultural Science Institute of Northern Central Vietnam
(3)Enter into farm management agreements with local growers including the Provincial and National projects;
(4)Take over management of three existing nurseries
   
Within 180 days
of the Closing Date
   
3,000,000 shares
only if and when ALL four (4) milestones reached (*)
 
               
II.   Achieve 100 Ha field trials and first test shipment of dry leaf
   
Within two (2) years
of the Closing Date
   
1,500,000 shares (**)
 
               
III.  Test shipment of dry leaf to achieve minimum specs for contracted base price (currently $2.00 per kilogram)
   
Within two (2) years
of the Closing Date
   
1,500,000 shares (**)
 

*
On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.  These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation.

**
On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.

Common Shares Surrendered for Cancellation

On October 4, 2011, a significant stockholder of the Company, Mohanad Shurrab, surrendered another 3,000,000 shares of the Company’s common stock to the Company for cancellation.  The Company recorded this transaction by debiting common stock at par of $3,000 and crediting additional paid-in capital of the same.

Common Shares Issued for Cash

On October 4, 2011 the Company sold 400,000 shares of its common stock to one investor at $0.25 per share or $100,000.
 
 
 
F-31

 
 
 
Common Shares Issued for Obtaining Employee and Director Services

On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director’s continuous service to the Company as directors.  These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.  The Company recorded $187,500 in directors’ fees for the period from April 11, 2011 (inception) through March 31, 2012.  The Company recorded $375,000 in directors’ fees for the fiscal year ended March 31, 2013.

Common Shares Issued to Parties other than Employees for Acquiring Goods or Services

Equity Purchase Agreement and Related Registration Rights Agreement

(i) Equity Purchase Agreement

On January 26, 2012, the Company entered into an equity purchase agreement (“Equity Purchase Agreement”) with Southridge Partners II, LP, a Delaware limited partnership (The “Investor”). Upon the terms and subject to the conditions contained in the agreement, the Company shall issue and sell to the Investor, and the Investor shall purchase, up to Twenty Million Dollars ($20,000,000) of its common stock, par value $0.001 per share.

At any time and from time to time during the Commitment Period, the period commencing on the effective date, and ending on the earlier of (i) the date on which investor shall have purchased put shares pursuant to this agreement for an aggregate purchase price of the maximum commitment amount, or (ii) the date occurring thirty six (36) months from the date of commencement of the commitment period. the Company may exercise a put by the delivery of a put notice, the number of put shares that investor shall purchase pursuant to such put shall be determined by dividing the investment amount specified in the put notice by the purchase price with respect to such put notice. However, that the investment amount identified in the applicable put notice shall not be greater than the maximum put amount and, when taken together with any prior put notices, shall not exceed the maximum commitment The purchase price shall mean 93% of the market price on such date on which the purchase price is calculated in accordance with the terms and conditions of this Agreement.

(ii) Registration Rights Agreement

In connection with the Equity Purchase Agreement, on January 26, 2012, the Company entered into a registration rights agreement (“Registration Rights Agreement”) with Southridge Partners II, LP, a Delaware limited partnership (the “Investor”). To induce the investor to execute and deliver the equity purchase agreement which the Company has agreed to issue and sell to the investor shares (the “put shares”) of its common stock, par value $0.001 per share (the “common stock”) from time to time for an aggregate investment price of up to twenty million dollars ($20,000,000) (the “registrable securities”), the Company has agreed to provide certain registration rights under the securities act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, “securities act”), and applicable state securities laws with respect to the registrable securities.

(iii) Common Shares Issued Upon Signing

As a condition for the execution of this agreement by the investor, the company issued to the investor 35,000 shares of restricted common stock (the “restricted shares”) upon the signing of this agreement. The restricted shares shall have no registration rights.  These shares were valued at $1.50 per share or $52,500 on the date of issuance and recorded as financing cost.

Marketing Service Agreement – Empire Relations Group, Inc.

On March 14, 2012 the Company entered into a consulting agreement (the “Consulting Agreement”) with Empire Relations Group, Inc. (“Empire”).

(i) Scope of Services

Under the terms of the Consulting Agreement, the Company engaged Empire to introduce interested investors to the Company, advise the Company on available financing options, provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake.

(ii) Term

The term of this agreement were consummated from the date hereof, and automatically terminated on May 30, 20 12.

 
 
F-32

 

(iii) Compensation

For the term of this agreement, the consultant shall be paid an upfront, non-refundable, non-cancellable retainer fee of 27,500 restricted shares. For the purposes of this agreement, these shares shall be considered to be fully earned by March 31, 2012. These shares were valued at $1.39 per share or $38,225 on March 31, 2012, the date when they were earned.

Common Shares Issued in Connection with Entry into Technology Acquisition Agreement

On July 5, 2012, the Company entered into a Technology Acquisition Agreement (the "Technology Acquisition Agreement") with Technew Technology Limited (“Technew”), pursuant to which the Company acquired the rights to certain technology from Technew in exchange for 3,000,000 restricted shares of the Company's common stock. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market or $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years.

Common Shares Issued to a Related Party

On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party in the consolidated statements of operations.

Sale of Equity Unit Inclusive of Common Stock and Warrants

Entry into Securities Purchase Agreement

On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667 shares of the Company's common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company's common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000.

At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,(“GSS”), who served as placement agent for the Company in the offering, (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the  "agent warrants") to GSS  or its  designee.

The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for gross proceeds of $500,000.  In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500.

The Company intended to use the net  proceeds  from the Offering to advance the Company's  ability to execute its growth  strategy and to aid in the commercial  development  of the  recently  announced  launch  of  the  Company's majority-owned subsidiary, Stevia Technew Limited.

Entry into Registration Rights Agreement

In connection with the equity financing on August 1, 2012, the Company also entered into a registration rights agreement with the Purchasers (the "rights agreement").  The Rights Agreement requires the Company to file a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company's entrance into the rights agreement (the "filing date") for the resale by the Purchasers of all of the Shares and all of the shares of common stock issuable upon exercise of the Warrants (the "registrable securities"). The Company filed the Registration Statement with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company's entrance into the rights agreement.


 
F-33

 

The registration statement must be declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments.  If the  registration statement is not filed prior to the filing date, the Company will be required to pay certain liquidated damages, not to exceed in the aggregate 6% of the purchase price paid by the Purchasers pursuant to the SPA. The Registration Statement was declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments.

Warrants

Issuances of Warrants in Connection with Entry into Securities Purchase Agreement

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company’s common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Issuance of Warrants to the Placement Agent as Compensation

Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS  or its  designee,  a warrant  to  purchase  85,333  shares  of  the  Company's  common  stock representing  8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Note 12 – Non-controlling Interest

Non-controlling interest consisted of the following:

   
Contributed
and additional
paid-in
capital
   
Earnings
and losses
   
Other
Comprehensive
Income
   
Total
non-controlling
interest
 
                         
Balance at March 31, 2012
  $ -     $ -     $ -     $ -  
                                 
Current period earnings and losses
    -       (214,082 )     -       (214,082 )
                                 
Balance at March 31, 2013
  $ -     $ (214,082 )   $ -     $ (214,082 )

Note 13 – Research and Development

Agribusiness Development Agreement – Agro Genesis Pte Ltd.

Entry into Agribusiness Development Agreement

On July 16, 2011, the Company entered into an Agribusiness Development Agreement (the “Agribusiness Development Agreement”) with Agro Genesis Pte Ltd. (“AGPL”), a corporation organized under the laws of the Republic of Singapore expiring two (2) years from the date of signing.

Under the terms of the Agreement, the Company engaged AGPL to be the Company’s technology provider consultant for stevia propagation and cultivation in Vietnam, and potentially other countries for a period of two (2) years. AGPL will be tasked with developing stevia propagation and cultivation technology in Vietnam, recommend quality agronomic programs for stevia cultivation, harvest and post harvest, alert findings on stevia propagation and cultivation that may impact profitability and develop a successful model in Vietnam that can be replicated elsewhere (the “Project”). The Project will be on-site at stevia fields in Vietnam and will have a term of at least two (2) years. For its services, AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated at $274,000 as specified in Appendix A to the Agribusiness Development Agreement. Additionally, the Company will be AGPL’s exclusive distributor
 
 
F-34

 
 
for AGPL’s g'farm system (a novel crop production system) for stevia growing resulting from the Project. AGPL will receive a commission of no less than 2% of the price paid for crops other than stevia, from cropping systems that utilize the g'farm system resulting from the Project. All technology-related patents resulting from the Project will be jointly owned by AGPL and the Company, with the Company holding a right of first offer for the use and distribution rights to registered patents resulting from the Project.

Addendum to Agribusiness Development Agreement

On August 26, 2011, in accordance with Appendix A , 3(a), the Company and AGPL have mutually agreed to add to the current Project budget $100,000 per annum for one, on-site resident AGPL expert for 2 (two) years effective September 1, 2011, or $200,000 in aggregate for the term of the contract as specified in Appendix C.  In-country accommodation for the resident expert will be born separately by the Company and is excluded from the above amount.  The expert, Dr. Cho, Young-Cheol, Director, Life Sciences has been appointed and commenced on September 1, 2011.

Termination of Agribusiness Development Agreement

On March 31, 2012, the Company and AGPL mutually agreed to terminate the Agribusiness Development Agreement, effective immediately.

Lease of Agricultural Land

On December 14, 2011, the Company and Stevia Ventures Corporation (“Stevia Ventures”) entered into a Land Lease Agreement with Vinh Phuc Province People's Committee Tam Dao Agriculture & Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the “Leased Property”) for a term expiring five (5) years from the date of signing.

The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement.

Future minimum payments required under this agreement at March 31, 2013 were as follows:

Fiscal Year Ending March 31:
       
         
2014
 
$
30,000
 
         
2015
   
30,000
 
         
2016
   
30,000
 
       
   
$
90,000
 

Supply and Cooperative Agreement – Guangzhou Health Technology Development Company Limited

Entry into Supply Agreement

On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People's Republic of China (the "Guangzhou Health").

Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years.

Entry into Cooperative Agreement

On February 21, 2012, the Company also entered into Cooperative Agreement (the “Cooperative Agreement”) with Guangzhou Health Technology Development Company Limited.

 
 
F-35

 

Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company's business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing.

Note 14 – Income Tax Provision

United States Income Tax

Stevia Corp is the parent Company which incorporated in the State of Nevada and is subjected to United States of America tax law.

Hong Kong SAR Income Tax

Stevia Asia Limited, a wholly-owned subsidiary of the Company, is registered in the Hong Kong Special Administrative Region (“HK SAR”) of the People’s Republic of China (“PRC”) and is subject to HK SAR tax law.  Armco HK’s statutory income tax rate is 16.5% and there were no significant differences between income reported for financial reporting purposes and income reported for income tax purposes for the year ended March 31, 2013.

Stevia Technew Limited, a majority owned subsidiary of the Company, is registered in the Hong Kong Special Administrative Region (“HK SAR”) of the People’s Republic of China (“PRC”) and is subject to HK SAR tax law.  Armco HK’s statutory income tax rate is 16.5% and there were no significant differences between income reported for financial reporting purposes and income reported for income tax purposes for the year ended March 31, 2013.

Deferred Tax Assets

At March 31, 2013, the Company has available for federal income tax purposes net operating loss (“NOL”) carry-forwards of $3,857,505 that may be used to offset future taxable income through the fiscal year ending March 31, 2033.  No tax benefit has been reported with respect to these net operating loss carry-forwards in the accompanying financial statements since the Company believes that the realization of its net deferred tax asset of approximately $1,317,552 was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are fully offset by the full valuation allowance.

Deferred tax assets consist primarily of the tax effect of NOL carry-forwards.  The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability.  The valuation allowance increased approximately $521,545 and $790,007 for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, respectively.

Components of deferred tax assets are as follows:

   
March 31, 2013
   
March 31, 2012
 
Net deferred tax assets – Non-current:
               
                 
Expected income tax benefit from NOL carry-forwards
   
1,311,552
     
790,007
 
                 
Less valuation allowance
   
(1,311,552
)
   
(790,007
)
             
Deferred tax assets, net of valuation allowance
 
$
-
   
$
-
 

Limitation on Utilization of NOLs due to Change in Control

The Company had ownership changes as defined by the Internal Revenue Code Section 382 (“Section 382”), which may subject the NOL’s to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation’s ability to utilize NOLs if it experiences an “ownership change.”  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

 
 
F-36

 
 
Income Tax Provision in the Consolidated Statement of Operations

A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income taxes is as follows:

   
For the Fiscal Year
Ended
 March 31, 2013
   
For the Period from
April 11, 2011 (inception)
through
March 31, 2012
 
                 
Federal statutory income tax rate
   
34.0
%
   
34.0
%
                 
Change in valuation allowance on net operating loss carry-forwards
   
(34.0
)
   
(34.0
)
                 
Effective income tax rate
   
0.0
%
   
0.0
%

Note 15 – Concentrations and Credit Risk

Credit Risk

Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents.

As of March 31, 2013, substantially all of the Company’s cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation (“FDIC”).  However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

Customers and Credit Concentrations

One (1) customer accounted for all of the sales for the fiscal year ended March 31, 2013 and the accounts receivable balance at March 31, 2013.  A reduction in sales from or loss of such customer would have a material adverse effect on the Company’s results of operations and financial condition.

Vendors and Accounts Payable Concentrations

Vendor purchase concentrations and accounts payable concentration are as follows:

   
Accounts Payable at
 
Net Purchases
 
   
March 31, 2013
   
March 31, 2012
   
March 31, 2013
   
March 31, 2012
 
                         
Growers Synergy Pte. Ltd. – related party
    50.1 %     16.4 %     26.4 %     13.5 %
                                 
Stevia Ventures Corporation
    16. 9 %     54.1 %     55.7 %     14.4 %
                                 
      67.0 %     70.5 %     82.1 %     27.9 %

Note 16 – Subsequent Events

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.  The Management of the Company determined that there were certain reportable subsequent events to be disclosed as follows:


 
F-37

 

On April 30, 2013, the Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation (“Mountain Sky”), in partial consideration for consulting services rendered by Mountain Sky.  500,000 of the shares vested at the time of grant, and 500,000 will vest on the one year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.

On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the "Reset Letter") with an investor (the  "Investor")  whereby the Company and the Investor agreed that the Investor would immediately exercise his warrant to purchase 853,333  shares of common stock of the Company at an exercise price of $0.20 per share for the aggregate of $170,667.  In  consideration  for the Investor's  immediate  exercise,  the Company agreed to issue to the Investor three new warrants in the amounts of 1,877,333, 1,066,666  and  2,346,666,  with exercise  prices of $0.20,  $0.25 and $0.25 per share, respectively (the "Series A Warrants",  "Series B Warrants" and "Series C Warrants",  respectively,  and collectively  the "New  Warrants").  The Series A Warrants are subject to the Company's call right, and the Series C Warrants are only exercisable upon the Investor's exercise in full of the Series A Warrants. In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the "Registration Statement") with the Securities  and Exchange  Commission  (the "SEC") within ten (10) business days. The Company will  use its best  efforts  to have  the  Registration  Statement declared effective by the SEC within thirty (30) days. The Company filed a registration statement (the "Registration Statement") with the Securities  and Exchange  Commission  (the "SEC") within ten (10) business days which was declared effective by the SEC within thirty (30) days.

Garden State Securities, Inc. (the "Placement  Agent")  served  as the placement agent of the Company for the Offering.  In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,600, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company,  the  Placement  Agent will receive additional  warrants  equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the "Agent Warrants").

On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned by Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.

 
F-38

 



 

Stevia Corp.

December 31, 2013 and 2012

Index to the Consolidated Financial Statements

Contents
 
Page(s)
     
Consolidated Balance Sheets at December 31, 2013 (Unaudited) and March 31, 2013
 
5
     
Consolidated Statements of Operations for the Nine Months and Three Months Ended December 31, 2013 and 2012 (Unaudited)
 
6
     
Consolidated Statement of Equity (Deficit) for the Interim Period Ended December 31, 2013 (Unaudited) and for the Fiscal Year Ended March 31, 2013
 
7
     
Consolidated Statements of Cash Flows for the Nine Months Ended December 31, 2013 and 2012 (Unaudited)
 
8
     
Notes to the Consolidated Financial Statements (Unaudited)
 
9


 
4

 
 
 Stevia Corp.
 Consolidated Balance Sheets
 
 
     
December 31, 2013
   
March 31, 2013
 
     
(Unaudited)
         
 Assets
                 
                   
 Current assets:
                 
 Cash
   
 $
                                            85,366
   
 $
                                        424,475
 
 Accounts receivable
   
                                         164,988
     
                                         158,008
 
 Seeds
     
                                   1,807,000
     
                                                               -
 
 Prepayments and other current assets
   
                                            74,946
     
                                            33,096
 
    Total current assets    
                                   2,132,300
     
                                         615,579
 
                   
 Non-current assets:
               
 Property and equipment
   
                                            24,400
     
                                                7,925
 
 Accumulated depreciation
   
                                           (4,334)
     
                                            (1,234)
 
    Property and equipment, net    
                                            20,066
     
                                                 6,691
 
Acquired technology
   
                                   1,635,300
     
                                   1,635,300
 
Accumulatd amortization
   
                                    (163,530)
     
                                        (81,765)
 
                   
    Acquired technology, net    
                                    1,471,770
     
                                   1,553,535
 
                   
Website development costs    
                                                 5,315
     
                                                 5,315
 
Accumulated amortization    
                                           (2,670)
     
                                            (1,869)
 
                   
    Website development costs, net    
                                                2,645
     
                                                3,446
 
                   
Security deposit    
                                             15,000
     
                                             15,000
 
                   
    Total assets  
 $
                                    3,641,781
   
 $
                                    2,194,251
 
                   
 Liabilities and equity
               
                 
 Current liabilities:
               
Accounts payable
 
 $
                                   1,092,237
   
 $
                                        948,073
 
Accounts payable - president and CEO
   
                                        262,576
     
                                             89,193
 
Accrued expenses
   
                                                9,600
     
                                             19,700
 
Accrued interest
   
                                          145,144
     
                                             21,627
 
Advances from president and significant stockholder
   
                                             10,743
     
                                             21,238
 
Convertible notes payable - net of discount
   
                                    1,071,569
     
                                        357,700
 
Current portion of derivative liability
   
                                                               -
     
                                                               -
 
    Total current liabilities    
                                   2,591,869
     
                                    1,457,531
 
                   
 Non-Current liabilities:
               
Derivative note liabilities
   
                                        227,772
     
                                                               -
 
Derivative warrant liabilities
   
                                        369,747
     
                                          486,113
 
    Total non-current liabilities    
                                         597,519
     
                                          486,113
 
                   
    Total liabilities    
                                   3,189,388
     
                                   1,943,644
 
                   
Equity
                 
Stevia Corp stockholders' equity:
               
Preferred stock par value $0.001: 1,000,000 shares authorized;
               
     none issued or outstanding    
                                                               -
     
                                                               -
 
Common stock par value $0.001: 250,000,000 shares authorized,
               
    82,695,634 and 63,555,635 shares issued and outstanding, respectively    
                                            82,695
     
                                            63,556
 
Additional paid-in capital
   
                                    6,813,321
     
                                  4,760,624
 
Common stock to be issued
   
                                        279,222
     
                                                               -
 
Accumulated deficit
   
                             (6,376,899)
     
                              (4,359,415)
 
    Total Stevia Corp stockholders' equity    
                                        798,339
     
                                        464,765
 
                   
 Non-controlling interest in subsidiary
               
 Noncontrolling interest - retained earnings in consolidated subsidiaries
   
                                   (345,946)
     
                                     (214,158)
 
                   
 Non-controlling interest in subsidiary
   
                                   (345,946)
     
                                     (214,158)
 
                   
    Total Equity    
                                        452,393
     
                                        250,607
 
                   
    Total Liabilities and Equity  
 $
                                    3,641,781
   
 $
                                    2,194,251
 
 
 
 
 
 See accompanying notes to the consolidated financial statements.

 
5

 
 
 Stevia Corp.
 Consolidated Statements of Operations
 

   
For the Nine Months
   
For the Three Months
   
For the Nine Months
   
For the Three Months
 
   
Ended
   
Ended
   
Ended
   
Ended
 
   
December 31, 2013
   
December 31, 2013
   
December 31, 2012
   
December 31, 2012
 
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
   
(Unaudited)
 
                         
 Revenues
  $ 1,893,865     $ 388,746     $ 120,939     $ 8,142  
                                 
 Cost of revenues
                               
 Farm produce
    758,809       -       -       -  
 Farm expenses
    318,234       4,925       66,743       66,743  
 Farm field lease
    -       -       21,250       6,250  
 Farm management services - related parties
    180,000       60,000       652,550       60,000  
 Total cost of revenues
    1,257,043       64,925       740,543       132,993  
                                 
 Gross margin
    636,822       323,821       (619,604 )     (124,851 )
                                 
 Operating expenses:
                               
 Directors' fees
    195,313       7,813       281,250       93,750  
 Professional fees
    487,867       178,135       352,031       123,356  
 Research and development
    262,810       71,930       118,669       -  
 Salary and compensation - officer
    600,000       -       -       -  
 Salary and compensation - others
    66,556       378       110,982       59,105  
 General and administrative expenses
    387,040       133,641       204,616       69,302  
 Total operating expenses
    1,999,586       391,897       1,067,548       345,513  
                                 
 Loss from operations
    (1,362,764 )     (68,076 )     (1,687,152 )     (470,364 )
                                 
 Other (income) expense:
                               
 Change in fair value of derivative liability
    (675,949 )     (40,105 )     (305,244 )     (73,723 )
 Debt discount
    626,446       63,263       -       -  
 Debt settlement loss
    561,077       561,077       -       -  
 Excess of fair value of warrants over notes, net of OID
    38,075       38,075       -       -  
 Financing cost
    30,000       8,000       16,125       2,807  
 Foreign currency transaction gain (loss)
    -       -       1,316       1  
 Interest expense
    123,516       75,613       40,462       10,130  
 Other (income) expense
    83,343       83,343       -       -  
 Total other (income) expense
    786,508       789,266       (247,341 )     (60,785 )
                                 
 Loss before income tax provision and non-controlling interest
    (2,149,272 )     (857,342 )     (1,439,811 )     (409,579 )
                                 
 Income tax provision
    -       -       -       -  
                                 
 Net loss
                               
 Net loss before non-controlling interest
    (2,149,272 )     (857,342 )     (1,439,811 )     (409,579 )
 Net loss attributable to the non-controlling interest
    (131,788 )     (25,932 )     (97,338 )     (44,978 )
                                 
 Net income (loss) attributable to Stevia Corp.
  $ (2,017,484 )   $ (831,410 )   $ (1,342,473 )   $ (364,601 )
                                 
 Net income (loss) per common share
                               
 - Basic and diluted:
  $ (0.03 )   $ (0.01 )   $ (0.02 )   $ (0.01 )
                                 
Weighted average common shares outstanding
                               
 - basic and diluted
    72,842,975       79,632,959       61,613,572       63,225,253  
 
 
 
 See accompanying notes to the consolidated financial statements.

 
6

 
 
Stevia Corp.
Consolidated Statement of Equity (Deficit)
For the Interim Period Ended December 31, 2013 (Unaudited) and for the Fiscal Year Ended March 31, 2013
 
 
   
Common Stock Par Value $0.001
   
 
   
 
                     
 
 
    Number of          
Additional
   
Common stock
     Accumulated     Stockholders'     Non-controlling    
Total
 
   
Shares
   
Amount
   
paid-in Capital
   
to be Issued
   
Deficit
    Equity (Deficit)     Interest    
Equity (Deficit)
 
                                                 
 Balance, March 31, 2012
    58,354,775     $ 58,355     $ 1,474,751     $ -     $ (2,323,551 )   $ (790,445 )   $ -     $ (790,445 )
                                                                 
 Restricted common shares issued for farm management services to
                                                               
 a related party valued at $0.79 per share discounted at 69%
                                                               
 on July 5, 2012
    500,000       500       272,050                       272,550               272,550  
                                                                 
 Restricted common shares issued for technology rights
                                                               
 valued at $0.79 per share discounted at 69%
                                                               
 on July 5, 2012
    3,000,000       3,000       1,632,300                       1,635,300               1,635,300  
                                                                 
 Common shares issued for notes conversion
                                                               
 at $0.832143 per share on July 6, 2012
    600,858       601       499,399                       500,000               500,000  
                                                                 
 Common shares issued for conversion of accrued interest
                                                               
 at $0.832143 per share on July 6, 2012
    33,335       33       27,707                       27,740               27,740  
                                                                 
 Common shares and warrants issued to two investors for cash
                                                               
 at $0.46875 per unit on August 6, 2012
    1,066,667       1,067       498,933                       500,000               500,000  
                                                                 
 Warrants issued to investors in connection with the sale of
                                                               
 equity units on August 6, 2012 classified as derivative liability
                    (381,300 )                     (381,300 )             (381,300 )
                                                                 
 Commissions and legal fees paid in connection with the sale of
                                                               
 equity units on August 6, 2012
                    (52,500 )                     (52,500 )             (52,500 )
                                                                 
 Warrants issued to placement agent in connection with the sale of
                                                               
 equity units on August 6, 2012 classified as derivative liability
                    (30,504 )                     (30,504 )             (30,504 )
                                                                 
 Issuance of warrants in connection with
                                                               
 convertible note payable issued in February and March 2013
                    220,438                       220,438               220,438  
                                                                 
 Beneficial conversion feature in connection with
                                                               
 convertible note payable issued in February and March 2013
                    224,350                       224,350               224,350  
                                                                 
 Common shares issued for future director
                                                               
services on October 4, 2011 earned during the period
                    375,000                       375,000               375,000  
                                                                 
 Net loss
                                    (2,035,864 )     (2,035,864 )     (214,158 )     (2,250,022 )
 Balance, March 31, 2013
    63,555,635       63,556       4,760,624       -       (4,359,415 )     464,765       (214,158 )     250,607  
                                                                 
 Common shares issued for consulting services
                                                               
 valued at $0.20 per share on April 30, 2013
    500,000       500       99,500                       100,000               100,000  
                                                                 
 Exercise of warrant with exercise price adjusted
                                                               
 to $0.20 per share on May 6, 2013
    853,333       853       169,813                       170,666               170,666  
                                                                 
 Commissions and legal fees paid in connection with the exercise of
                                                               
 warrants on May 6, 2013
                    (18,653 )                     (18,653 )             (18,653 )
                                                                 
 Reclassification of derivative liability to additional paid-in capital
                                                               
 associated with the exercise of warrants
                    595,852                       595,852               595,852  
                                                                 
 Warrants issued to investors in connection with warrants
                                                               
 exercised on May 6, 2013 classified as derivative liability
                    (833,106 )                     (833,106 )             (833,106 )
                                                                 
 Make good shares released to officer for achieving
                                                               
 the second and third milestones on June 21, 2013
    3,000,000       3,000       597,000                       600,000               600,000  
                                                                 
 Common shares issued for future director
                                                               
 services on October 4, 2011 earned during the period endng June 30,2013
                    93,750                       93,750               93,750  
                                                                 
 Reclassification to derivative liability for warrants
                                                               
 that became derivatives
                    (167,949 )                     (167,949 )             (167,949 )
                                                                 
 Common shares issued for future director
                                                               
 services on October 4, 2011 earned during the period endng September 30, 2013
                    93,750                       93,750               93,750  
                                                                 
 Anti-dilution shares issued in accordance with the Security Purchase
                                                               
 Agreement dated August 1, 2012 on October 1, 2013
    286,666       286       (286 )                     -               -  
                                                                 
 Common shares issued for future director service
                                                               
  on December 4, 2013
    1,500,000       1,500       186,000                       187,500               187,500  
                                                                 
 Common shares issued for future director service
                                                               
  on December 4, 2013
                    (187,500 )                     (187,500 )             (187,500 )
                                                                 
 Common shares issued per debt settlement agreement
                                                               
 for past due accounts payable and related settlement costs
    13,000,000       13,000       1,416,715       279,222               1,708,937               1,708,937  
                                                                 
 Common shares issued for future director service on December 4, 2013
                                                               
 earned during the period endng December 31, 2013
                    7,811                       7,811               7,811  
                                                                 
 Net loss
                                    (2,017,484 )     (2,017,484 )     (131,788 )     (2,149,272 )
                                                                 
 Balance, December 31, 2013
    82,695,634     $ 82,695     $ 6,813,321     $ 279,222     $ (6,376,899 )   $ 798,339     $ (345,946 )   $ 452,393  
 
 
 See accompanying notes to the consolidated financial statements.

 
7

 
 
 Stevia Corp.
 Consolidated Statements of Cash Flows
 

   
For the Nine months
   
For the Nine Months
 
    Ended     Ended  
   
December 31, 2013
   
December 31, 2012
 
   
(Unaudited)
   
(Unaudited)
 
 Cash flows from operating activities:
           
 Net loss before non-controlling interest
  $ (2,149,272 )   $ (1,439,811 )
 Adjustments to reconcile net loss to net cash used in operating activities
               
 Depreciation expense
    3,100       762  
 Amortization expense - acquired technology
    81,765       54,510  
 Amortization expense - website development costs
    801       801  
 Amortization of discount of convertible notes payable
    626,446       -  
 Debt settlement loss
    561,077       -  
 Excess of fair value of warrants over notes, net of OID
    38,075       -  
 Change in fair value of derivative liability
    (675,949 )     (305,244 )
 Common shares issued for director services earned during the period
    195,312       281,250  
 Common shares issued for services-related party
    600,000       272,550  
 Common shares issued for outside services
    205,860       -  
 Changes in operating assets and liabilities:
               
 Accounts receivable
    (6,980 )     (120,659 )
 Seeds
    (765,000 )     -  
 Prepayments and other current assets
    (41,850 )     142,858  
 Accounts payable
    144,164       412,110  
 Accounts payable - president and CEO
    173,383       -  
 Accrued expenses
    (10,100 )     6,045  
 Accrued interest
    123,517       40,397  
 Net cash used in operating activities
    (895,651 )     (654,431 )
                 
 Cash flows from investing activities:
               
 Purchases of property, plant and equipment
    (16,475 )     (4,889 )
 Net cash used in investing activities
    (16,475 )     (4,889 )
                 
 Cash flows from financing activities:
               
 Advances from (repayments to) president and significant stockholder
    (10,495 )     2,100  
 Proceeds from issuance of convertible notes, net of costs
    431,500       200,000  
 Proceeds from sale of common stock, net of costs
    -       447,500  
 Proceeds from exercise of warrants, net of costs
    152,012       -  
 Net cash provided by financing activities
    573,017       649,600  
                 
 Net change in cash
    (339,109 )     (9,720 )
                 
 Cash at beginning of the period
    424,475       15,698  
                 
 Cash at end of the period
  $ 85,366     $ 5,978  
                 
 Supplemental disclosure of cash flows information:
               
 Interest paid
  $ -     $ -  
 Income tax paid
  $ -     $ -  
                 
 Non-cash investing and financing activities:
               
 Issuance of common stock for past due payables
  $ 1,042,000     $ -  
 Issuance of common stock for conversion of convertible notes
  $ -     $ 500,000  
 Issuance of common stock for conversion of accrued interest
  $ -     $ 27,739  
 
 
 
 See accompanying notes to the consolidated financial statements.
 
 
8

 
 
Stevia Corp.
December 31, 2013 and 2012
Notes to the Consolidated Financial Statements
(Unaudited)

Note 1 – Organization and Operations

Stevia Corp. (Formerly Interpro Management Corp.)

Interpro Management Corp (“Interpro”) was incorporated under the laws of the State of Nevada on May 21, 2007.   Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization’s efficiency through planning and monitoring the daily operations of a business.

On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. (“Stevia” or the “Company”) to reflect its intended acquisition of Stevia Ventures International Ltd.

The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011.

Stevia Ventures International Ltd.

Stevia Ventures International Ltd. (“Ventures”) was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands (“BVI”).  Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia.

Acquisition of Stevia Ventures International Ltd. Recognized as a Reverse Acquisition

On June 23, 2011 (the “Closing Date”), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the “Share Exchange Agreement”) by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the “Ventures Stockholder”).

Immediately prior to the consummation of the Share Exchange Agreement on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company’s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares were being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the “Milestones”), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures’ Stockholder (the “Escrow Agreement”).  Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock, immediately after the consummation of the Share Exchange Agreement, the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition.

As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification.  The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition.  The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost.  The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction.

 
9

 

Formation of Stevia Asia Limited

On March 19, 2012, the Company formed Stevia Asia Limited (“Stevia Asia”) under the laws of the Hong Kong Special Administrative Region (“HK SAR”) of the People’s Republic of China (“PRC”), as a wholly-owned subsidiary.

Formation of Stevia Technew Limited (Formerly Hero Tact Limited)/Cooperative Agreement

On April 28, 2012, Stevia Asia formed Hero Tact Limited, as a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited (“Stevia Technew”).  Stevia Technew intends to facilitate a joint venture relationship with the Company’s technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou’s affiliates Technew Technology Limited.  Prior to July 5, 2012, the date of entry into the Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities.

On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the issued shares and Technew legally and beneficially owns 30% of the issued shares. The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities. On March 1, 2013, the partners agreed to terminate the Cooperative Agreement specific to the investment in an agricultural project and no further obligation by either party related to the payment of $200,000.

The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.

Formation of SC Brands Pte Ltd

On October 1, 2013, the Company formed SC Brands Pte Ltd (“SC Brands”) under the laws of Singapore, with the Company owning 70% of the shares and 30% owned by a Singapore strategic partner that will provide the working capital funds via fixed convertible notes to the Company. As of December 31, 2013 SC Brands was inactive.

Note 2 – Summary of Significant Accounting Policies

The Management of the Company is responsible for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application.  Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial condition and results and require management’s most difficult, subjective, or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain. The Company’s significant and critical accounting policies and practices are disclosed below as required by generally accepted accounting principles.

Basis of Presentation – Unaudited Interim Financial Information

The unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Interim results are not necessarily indicative of the results for the full fiscal year.  These consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the fiscal year ended March 31, 2013 and notes thereto contained in the Company’s Annual Report on Form 10-K as filed with the SEC on July 16, 2013.

 
10

 

Fiscal Year End

The Company elected March 31st as its fiscal year end date upon its formation.

Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).

Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company’s critical accounting estimates and assumptions affecting the financial statements were:
 
 
(i)  
Assumption as a going concern: Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
 
(ii)  
Allowance for doubtful accounts: Management’s estimate of the allowance for doubtful accounts is based on historical sales, historical loss levels, and an analysis of the collectability of individual accounts; and general economic conditions that may affect a client’s ability to pay. The Company evaluated the key factors and assumptions used to develop the allowance in determining that it is reasonable in relation to the financial statements taken as a whole.
 
(iii)  
Inventory Obsolescence and Markdowns: The Company’s estimate of potentially excess and slow-moving inventories is based on evaluation of inventory levels and aging, review of inventory turns and historical sales experiences. The Company’s estimate of reserve for inventory shrinkage is based on the historical results of physical inventory cycle counts.
 
(iv)  
Fair value of long-lived assets: Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.
 
(v)  
Valuation allowance for deferred tax assets: Management assumes that the realization of the Company’s net deferred tax assets resulting from its net operating loss (“NOL”) carry–forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.
 
(vi)  
Estimates and assumptions used in valuation of equity instruments: Management estimates expected term of share options and similar instruments, expected volatility of the Company’s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.
 
 
11

 
 
Principles of Consolidation

The Company applies the guidance of Topic 810 “Consolidation” of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.  Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries—all entities in which a parent has a controlling financial interest—shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.  Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.  The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent’s power to control exists.

The Company's consolidated subsidiaries and/or entities are as follows:
 

Name of consolidated
subsidiary or entity
 
State or other jurisdiction
of incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable
interest
 
               
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
    100 %
                 
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
    100 %
                 
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
    70 %
                 
 SC Brands Pte Ltd    Singapore   October 1, 2013     70
 
The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.

All inter-company balances and transactions have been eliminated.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.

Fair Value of Financial Instruments

The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
 
Level 1
 
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2
 
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3
 
Pricing inputs that are generally observable inputs and not corroborated by market data.
 
 
 
12

 

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable,accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.

The Company’s convertible notes payable approximates the fair value of such instrument based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangements at December 31, 2013 and March 31, 2013.

The Company’s Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation and the derivative liability on the conversion feature.  The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.  These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities – Derivative Warrant Liabilities and Derivative Liability on Conversion Feature

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability and derivative liability on the conversion feature at every reporting period and recognizes gains or losses in the consolidated statements of operations that are attributable to the change in the fair value of the derivative liabilities.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount, net of an allowance for doubtful accounts.  The Company follows paragraph 310-10-50-9 of the FASB Accounting Standards Codification to estimate the allowance for doubtful accounts.  The Company performs on-going credit evaluations of its customers and adjusts credit limits based upon payment history and the customer’s current credit worthiness, as determined by the review of their current credit information; and determines the allowance for doubtful accounts based on historical write-off experience, customer specific facts and economic conditions.

Pursuant to paragraph 310-10-50-2 of the FASB Accounting Standards Codification account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.  The Company has adopted paragraph 310-10-50-6 of the FASB Accounting Standards Codification and determine when receivables are past due or delinquent based on how recently payments have been received.

Outstanding account balances are reviewed individually for collectability.  The allowance for doubtful accounts is the Company’s best estimate of the amount of probablecredit losses in the Company’s existing accounts receivable. Bad debt expense is included in general and administrative expenses, if any.

There was no allowance for doubtful accounts as December 31, 2013 or March 31, 2013.

The Company does not have any off-balance-sheet credit exposure to its customers.

 
13

 

Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company’s long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful livesagainst their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company’s stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

The key assumptions used in management’s estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.  These forecasts are typically based on historical trends and take into account recent developments as well as management’s plans and intentions.  Other factors, such as increased competition or a decrease in the desirability of the Company’s products or services, could lead to lower projected sales levels, which would adversely impact cash flows.  A significant change in cash flows in the future could result in an impairment of long lived assets.

The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.

Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
 
Inventories

Inventory Valuation

The Company values inventory, consisting of finished goods, at the lower of cost or market.  Cost is determined on the first-in and first-out (“FIFO”) method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value.  Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures.

Inventory Obsolescence and Markdowns

The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classify inventory markdowns in the income statement as a component of cost of goods sold pursuant to Paragraph 420-10-S99 of the FASB Accounting Standards Codification to adjust inventory to net realizable value. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations.

There was no inventory obsolescence for the interim period ended December 31, 2013 or 2012.

There was no lower of cost or market adjustments for the interim period ended December 31, 2013 or 2012.
 
Property and Equipment

Property and equipment is recorded at cost.  Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred.  Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.
 
 
14

 
 
Intangible Assets Other Than Goodwill

The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.  Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwillon a straight-line basis over the estimated useful lives of the respective assets as follows:

   
Estimated Useful Life (Years)
 
         
Acquired technology
   
15
 
Website development costs
   
5
 
 
Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:  a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Extinguishment Accounting

On July 25, 2013, the Supreme Court of the State of New York, County of New York (the  "Court"),  entered  an order (the  "Order")  approving the settlement  (the "Settlement Agreement")  between the Company and Hanover Holdings I, LLC, a New York limited  liability company  ("Hanover"),  Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the  "Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.

The Settlement  Agreement  provides that the Initial Settlement Shares will be  subject  to  adjustment  on  the  trading  day  immediately   following  the Calculation Period to reflect the  intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the  Settlement  Agreement be based upon a specified  discount to the trading volume  weighted  average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court's entry of the Order.

The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.  The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.

Derivative Instruments and Hedging Activities

The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification (“Paragraph 810-10-05-4”). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.  The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.  For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.
 
 
15

 
 
Derivative Liability

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.  The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.  In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.  Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.  Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.  Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification (“Section 815-40-15”)to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock.  Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions.   The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).

The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.  The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.  Therefore, the fair value may not be appropriately captured by simple models.  In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).  The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.  Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).  Projections were then made on the underlying factors which led to potential scenarios.  Probabilities were assigned to each scenario based on management projections.  This led to a cash flow projection and a probability associated with that cash flow.  A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.

Beneficial Conversion Feature

When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company's common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.
 
 
16

 
 
Commitment and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.  The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s consolidated financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.  Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

Non-controlling Interest

The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interests in its majority owned subsidiaries in the consolidated statements of balance sheets within the equity section, separately from the Company’s stockholders’ equity.  Non-controlling interests represents the non-controlling interest holder’s proportionate share of the equity of the Company’s majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holder’s proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

Revenue Recognition

The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv)collectability is reasonably assured.

Shipping and Handling Costs

The Company accounts for shipping and handling fees in accordance with paragraph 605-45-45-19 of the FASB Accounting Standards Codification.  While amounts charged to customers for shipping products are included in revenues, the related costs are classified in cost of goods sold as incurred.

Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 “Accounting for Research and Development Costs”) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 “Research and Development Arrangements”) for research and development costs.  Research and development costs are charged to expense as incurred.Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.
 
 
17

 
 
Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities

The research and development arrangements usually involve specific research and development projects.  Often times, the Company makes non-refundable advances upon signing of these arrangements.  The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 “Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities”) for those non-refundable advances.  Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.  Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.  The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.  If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.

Stock-Based Compensation for Obtaining Employee Services

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company’s most recent private placement memorandum ("PPM”), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.  Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees’ expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.  Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity’s shares and the method used to estimate it.  Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.  The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.
 
 
 
18

 
 
·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

The Company’s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.

Equity Instruments Issued to Parties other than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification (“Subtopic 505-50”).

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company’s most recent private placement memorandum ("PPM”), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder’s expected exercise behavior into the fair value (or calculated value) of the instruments.  The Company uses historical data to estimate holder’s expected exercise behavior.  If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity’s shares and the method used to estimate it.  An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.  A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.
 
 
 
19

 

 
·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.

Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.

Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9,an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.Deferred tax assets are reduced by a valuation allowance to the extent management concludes it ismore likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.  Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.
 
 
20

 
 
The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management’s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the reporting period ended December 31, 2013 or 2012.

Limitation on Utilization of NOLs due to Change in Control

Pursuant to the Internal Revenue Code Section 382 (“Section 382”), certain ownership changes may subject the NOL’s to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation’s ability to utilize NOLs if it experiences an “ownership change.”  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

Net Income (Loss)per Common Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:

   
Potentially Outstanding Dilutive Common Shares
     
For Interim
PeriodEnded
December 31, 2013
 
For Interim
Period Ended
December 31, 2012
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the “Milestones”).
   
-
 
3,000,000
           
Sub-total Make Good Escrow Shares
   
-
 
3,000,000
 
 
 
21

 
 
 
Convertible Note Shares
         
           
On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
881,752
 
426,667
           
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
1,739,130
 
426,667
           
On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.
   
            1,400,000
 
-
           
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
1,762,228
 
-
           
On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.
   
             2,353,573
 
            -
           
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
440,571
 
-
           
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.
   
            290,000
 
            -
           
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.
   
812,634
 
-
           
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
   
881,142
 
-
           
Sub-total Convertible Note Shares
   
10,561,070
 
853,334
 
 
 
22

 
 
 
Warrant Shares
         
           
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company’s common stock to investors (the “investor warrants”) and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.
   
956,481
 
1,152,000
           
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company’s common stock to two (2) note holders in connection with the issuance of convertible notes.
   
1,400,000
 
-
           
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company’s common stock to the note holder in connection with the issuance of the convertible note.
   
881,753
 
-
           
On May 6, 2013, the Company issued three (3) series of warrants:
 
Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company’s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.
   
2,027,520
 
-
           
 
Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company’s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.
   
1,151,999
 
-
           
 
Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company’s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.
   
2,534,399
 
-
           
On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company’s common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.
   
1,000,000
 
-
           
Sub-total Warrant Shares
   
9,952,152
 
1,152,000
           
Total potentially outstanding dilutive common shares
   
20,513,222
 
5,005,334

Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.  The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.
 
 
23

 

Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Recently Issued Accounting Pronouncements

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." The ASUadds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.

In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date."  This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05, "Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU 2013-07, “Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting.” The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity’s governing documents from the entity’s inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity’s inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity’s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.
 
 
24

 

Note 3 – Going Concern

The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the consolidated financial statements, the Company had an accumulated deficit at December 31, 2013, a net loss and net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

The Company is attempting to generate sufficient revenue; however, the Company’s cash position may not be sufficient to support its daily operations.While the Company believes in the viability of its strategy to generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect.  The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds.

The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Note 4 – Inventory - Seeds

Inventory – seeds consisted of the following:

   
December 31, 2013
   
March 31, 2013
 
                 
Seeds (*)
 
$
1,807,000
   
$
-
 
             
   
$
1,807,000
   
$
-
 
 
* The company acquired certain seeds in the amount of $1,807,000 in aggregate which was used for preparation of the fall planting for this spring harvest which will start from the second half of February, 2014 and last through April, 2014, $1,042,000 of which was in default. The vendor sold its accounts receivable of $1,042,000 to a third party, which sued the Company and settled the accounts payable and related legal costs and fees with the Company for the issuance of 15,538,882 common shares in aggregate.
 
Slow-Moving or Obsolescence Markdowns
 
The Company recorded no inventory obsolescence adjustments for the reporting period ended December 31, 2013 or 2012.
  
Note 5 – Property and Equipment

(i) Depreciation Expense

Depreciation expense was $3,100 and $762 for the interim period ended December 31, 2013 and 2012, respectively.

Note 6 – Acquired Technology

On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company's common stock.  These restricted shares were valued at $0.79 per share, discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market, for a total value of $1,635,300, which was recorded as acquired technology and is being amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years.

(i) Amortization Expense

Amortization expense was $81,765 and $54,510 for the interim period ended December 31, 2013 and 2012, respectively.

Note 7 – Website Development Costs

(i) Amortization expense

Amortization expense was $801 each for the interim period ended December 31, 2013 and 2012, respectively.
 
 
25

 
 
Note 8 – Related Party Transactions

Related parties

Related parties with whom the Company had transactions are:
 
Related Parties
 
Relationship
     
George Blankenbaker
 
President and significant stockholder of the Company
     
Leverage Investments LLC
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Technew Technology Limited
 
Non-controlling interest holder
 
Growers  Synergy Pte Ltd.
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Guangzhou Health Technology Development Company Limited
 
An entity owned and controlled by Non-controlling interest holder
 
Advances from Stockholder

From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.

Lease of Certain Office Space from Leverage Investments, LLC

The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011.  For the interim periods ended December 31, 2013 and 2012, the Company recorded $4,500 each in rent expense, respectively.

Farm Management and Off-Take Agreement with Growers Synergy Pte Ltd.

On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the “Management Agreement”) with Growers Synergy Pte Ltd. (“GSPL”), a Singapore corporation.  Under the terms of the Management Agreement,  the Company will engage GSPL to supervise the Company’s farm management operations, recommend quality farm management  programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization  targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services at $20,000 per month for a term of two (2) years from the date of signing expiring on November 1, 2013.  The Management Agreement may be terminated by the Company upon 30 day notice.  In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company’s GSPL supervised farms.

On October 31, 2013 ("Effective Date"), the Company extended the Management and Off-Take Agreement (the “Management Agreement”) with GSPL with the same terms and conditions for a period of two (2) years ("Term") from the Effective Date expiring October 31, 2015 and shall automatically be extended for subsequent period of one (1) year expiring October 31, 2016 ("Extended Term") unless earlier terminated in writing.

Farm management services provided by Growers Synergy Pte Ltd. were as follows:

   
For the interim
period ended
December 31, 2013
   
For the interim
period ended
December 31, 2012
 
                 
Farm management services – related parties
 
$
180,000
   
$
180,000
 
             
   
$
180,000
   
$
180,000
 

Future minimum payments required under this agreement were as follows:

Fiscal Year Ending March 31:
       
         
2014 (remainder of the fiscal year)
 
$
240,000
 
2015
   
240,000
 
2016
   
240,000
 
2017
   
140,000
 
       
   
$
860,000
 
 
 
 
26

 

Cash Commitment in Connection with the Operations of Stevia Technew

For the fiscal year ended March 31, 2013, Stevia Asia provided Stevia Technew $200,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related parties. On March 1, 2013, the partners agreed to terminate the Cooperative Agreement specific to the investment in an agricultural project and no further obligation by either party related to the payment of $200,000.

Note 9 – Convertible Notes Payable

(i) February 26, 2013 issuance of convertible notes with warrants

On February 26, 2013, the Company entered into two (2) 12% convertible notes payable of $350,000 in aggregate (“Convertible Notes”) with two investors (the “Payees”) maturing on September 30, 2013. The Payees have the option to convert the outstanding notes and interest due into the Company’s common shares at $0.25 per share at any time prior to September 30, 2013. In connection with the issuance of the Convertible Notes, the Company granted to the Payees a warrant to purchase 1,400,000 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance. The notes were currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.

The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
Expected volatility
   
74.53
%
Risk-free interest rate
   
0.37
%
Dividend yield
   
0.00
%

The relative fair value of these warrants granted, estimated on the date of grant, was $110,425, which was recorded as a discount to the convertible notes payable. After allocating the $110,425 portion of the proceeds to the warrants as a discount to the Convertible Notes, an additional $113,925 was allocated to a beneficial conversion feature by crediting $113,925 to additional paid-in capital and debiting the same amount to the beneficial conversion feature.  The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Notes. The amortization of the discount and beneficial conversion feature were fully amortized as of September 30, 2013.

(ii) March 15, 2013 issuance of convertible note with warrant

On March 15, 2013, the Company cancelled a prior convertible note and entered into a 12% convertible note payable of $220,438, which is the total amount of the prior note principal and accrued interest, with the existing investor (the “Payee”), maturing on September 30, 2013. The Payee has the option to convert the outstanding note into the Company’s common shares at $0.25 per share at any time prior to payment in full of the principal balance of the convertible note. In connection with the issuance of the convertible note, the Company granted the Payee a warrant to purchase 881,753 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.

The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
Expected volatility
   
75.11
%
Risk-free interest rate
   
0.40
%
Dividend yield
   
0.00
%

 
 
27

 

The relative fair value of these warrants was $98,095, which was recorded as a discount to the convertible note payable. After allocating the $98,095, portion of the proceeds to the warrants as a discount to the convertible note, the effective conversion price of the convertible notes payable was lower than the market price at the date of issuance and per calculation the remaining balance of the face amount was allocated to a beneficial conversion feature by crediting $122,343 to additional paid-in capital and debiting the same amount to the beneficial conversion feature. The Company amortizes the discount and beneficial conversion feature over the term of the convertible note and the amounts were fully amortized as of September 30, 2013.

(iii) October 15, 2013 issuance of convertible note with derivative warrant

General Terms

On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company. The restricted shares will be issued in the name of Black Mountain Equities, Inc. upon closing.

Events of Defaults

An “Event of Default”, wherever used herein, means any one of the following events: (i) An “Event of Default”, wherever used herein, means any one of the following events, (ii) A Conversion Failure; (iii) The Company or any subsidiary of the Company shall commence, or there shall be commenced against the Company or any subsidiary of the Company under any applicable bankruptcy or insolvency laws; (iv) (a) The Company or any subsidiary of the Company shall default in any of its obligations under any other indebtness in an amount exceeding $100,000, whether such indebtedness now exists or shall hereafter be created and (b) The Common Stock is suspended or delisted for trading on the Over the Counter Bulletin Board market (the “Primary Market”), (c) The Company loses its ability to deliver shares via “DWAC/FAST” electronic transfer, (d) The Company loses its status as “DTC Eligible.”, (e) The Company shall become late or delinquent in its filing requirements as a fully-reporting issuer registered with the Securities & Exchange Commission.

Piggyback Registration Rights

The Company shall include on the next registration statement the Company files with SEC (or on the subsequent registration statement if such registration statement is withdrawn) all shares issuable upon conversion of this Note. Failure to do so will result in liquidated damages of 25% of the outstanding principal balance of this Note, but not less than $25,000, being immediately due and payable to the Holder at its election in the form of cash payment or addition to the balance of this Note.

Warrants

In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.

Pursuant to Section 3 (b) Subsequent Equity Sales if the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to re-price, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock, at an effective price per share less than the then Exercise Price (such lower price, the “Base Share Price” and such issuances collectively, a “Dilutive Issuance”) (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share which is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced and only reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price prior to such adjustment.

 
28

 

Pursuant to Section 3 (c) Subsequent Rights Offerings if the Company, at any time while the Warrant is outstanding, shall issue rights, options or warrants to all holders of Common Stock (and not to Holders) entitling them to subscribe for or purchase shares of Common Stock at a price per share less than the VWAP at the record date, then the Exercise Price shall be multiplied by a fraction, of which the denominator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of shares which the aggregate offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise of such rights, options or warrants) would purchase at such VWAP.

The fair value of note derivative liability and the warrant liability were $11,428 and $76,647, respectively, or $88,075 in aggregate; $50,000 of which was recorded as a discount to the convertible note and the $38,075 remaining balance was recorded as other expense. The Company amortizes OID and the discount to the note over the term of the convertible note and marks to market the warrant value as of each quarter end.

Convertible notes payable consisted of the following:

   
December 31, 2013
   
March 31, 2013
 
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal of this note and any accrued and unpaid interest thereon, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
    200,000       200,000  
                 
February 26, 2013 convertible notes
    350,000       350,000  
                 
March 15, 2013 convertible note
    220,438       220,438  
                 
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    111,111       -  
                 
On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014.
    153,500       -  
                 
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    27,778       -  
                 
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company.  In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.
    58,000       -  
 
 
 
29

 
 
 
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014.
    53,000       -  
                 
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    55,556       -  
                 
Sub-total: convertible notes payable
    1,229,383       770,438  
                 
Discount representing (i) the relative fair value of the warrants issued, (ii) the beneficial conversion features and (iii) the derivative liability on conversion features
    (816,310 )     (444,788 )
                 
Accumulated amortization of discount on convertible notes payable
    658,496       32,050  
                 
Remaining discount
    (157,814 )     (412,738 )
                 
    $ 1,071,569     $ 357,770  

Note 10 – Derivative Instruments and the Fair Value of Financial Instruments

(i) Warrants Issued

Description of Warrants and Fair Value on Date of Grant

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company’s common stock to the investors (the “investors warrants”) and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants")with an exercise price of $0.6405 per share, subject to certain adjustments, pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance.

On February 26, 2013 and March 15, 2013 the Company issued warrants with an exercise price of $0.25 per share. Pursuant to Section 3(b), the previously issued warrants’ exercise price was reset to $0.25 per share and the number of warrant shares was increased to 2,732,801 and 218,623, respectively, for a total of 2,951,424.

On May 6, 2013, the Company issued warrants with an exercise price of $0.25 per share. Pursuant to Section 3(b), the previously issued warrants' exercise price was reset again to $0.20 per share and the number of warrant shares was increased to 3,416,001 and 273,279, respectively, for a total of 3,689,280. On May 6, 2013, investors exercised warrants to purchase 2,732,799 (out of 3,416,001) shares of the Company’s common stock at $0.20 per share.

On May 6, 2013, the Company issued (i) warrants to purchase 1,877,333 (Series A), 1,066,667 (Series B) and 2,346,666 (Series C), in aggregate 5,290,665 shares of the Company’s common stock to the investors (the “investor warrants”) and (ii) warrants to purchase 150,187 (Series A), 85,333 (Series B) and 187,733 (Series C) shares of the Company's  common  stock to the placement agent (the "agent warrants")with an exercise price of $0.20 (Series A) per share, $0.25 (Series B) per share and $0.25 (Series C) per share subject to certain adjustments, pursuant to Section 3(b), expiring five (5) years from the date of issuance.

On October 15, 2013, the Company issued a warrant to purchase 1,000,000 common shares with an exercise price at $0.25 per share with full ratchet reset features expiring five (5) years from the date of issuance in connection with the issuance of a convertible note.

Derivative Analysis

Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification (“Section 815-40-15”).
 
 
30

 

Valuation of Derivative Liability

(a) Valuation Methodology

The Company’s August 6, 2012 and May 6, 2013 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset.

Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections.

Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability.

(b) Valuation Assumptions

The Company’s 2013 derivative warrants were valued at each period ending date with the following assumptions:

·  
The stock price would fluctuate with the Company projected volatility.

·  
The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods.

·  
The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price.

·  
The Holder would exercise the warrant at maturity if the stock price was above the project reset prices.

·  
A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market

·  
The Warrants with an exercise price of $0.25 exercise price is projected to reset to $0.047 at maturity; the Warrants with an exercise price of  $0.20 per share  is projected to reset to $0.043at maturity

·  
The Company had no reset event during this quarter period ending 12/31/2013. Prior reset events occurred on 2/26/2013 to $0.25 and 5/6/2013 to $0.20.

·  
No warrants have expired. Warrants with full reset feature issued during this quarter period ending 12/31/2013

·  
The projected volatility curve for the valuation dates was:

     
1 Year
   
2 Year
   
3 Year
   
4 Year
   
5 Year
 
                                 
August 6, 2012
   
129%
   
178%
   
218%
   
252%
   
281%
 
September 30, 2012
   
127%
   
173%
   
211%
   
244%
   
272%
 
March 31, 2013
   
122%
   
167%
   
205%
   
236%
   
264%
 
December 31, 2013
   
111%
   
168%
   
202%
   
233%
   
261%
 

 
 
31

 
 
(c) Fair Value of Derivative Warrants

The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 (reset to 6,247,146 on May 1, 2013) shares of the Company’s common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).

 
Derivative warrants
Assets (Liability)
 
Total
       
Balance, September 30, 2012
 
$
(180,284
)
   
$
(180,284
)
Total gains or losses (realized/unrealized) included in:
                 
Net income (loss)
   
(305,829
)
     
(305,829
)
Other comprehensive income (loss)
   
-
       
-
 
Purchases, issuances and settlements
   
-
       
-
 
Transfers in and/or out of Level 3
   
-
       
-
 
                   
Balance, March 31, 2013
   
(486,113
)
     
(486,113
)
Total gains or losses (realized/unrealized) included in:
                 
Net income (loss)
   
675,949
       
675,949
 
Other comprehensive income (loss)
   
-
       
-
 
Purchases, issuances and settlements
   
(787,355
)
     
(787,355
)
Transfers in and/or out of Level 3
   
-
       
-
 
                   
Balance, December 31, 2013
 
$
(597,519
)
   
$
(597,519
)

(d) Warrants Outstanding

As of December 31, 2013, 853,333 warrants (2,732,799 warrants after the exercise price being reset to $0.20 per share) have been exercised and warrants to purchase 9,952,152 shares of Company common stock remain outstanding.

The table below summarizes the Company’s derivative warrant activity:

   
 
 
 
 
 
 
 
 
   
Warrant Activities
 
APIC
 
(Gain) Loss
 
   
Derivative
Shares
 
Non-derivative
Shares
 
Total Warrant
Shares
 
Fair Value of
Derivative
Warrants
 
Reclassification
of Derivative
Liability
 
Change in
Fair Value of
Derivative
Liability
 
                                       
Derivative warrant at August 6, 2012
   
1,152,000
   
-
   
1,152,000
   
(411,805
 
-
   
-
 
Mark to market
                     
231,521
         
(231,521
)
Derivative warrant at September 30, 2012
   
1,152,000
   
-
   
1,152,000
   
(180,284
)
           
Mark to market
                     
(73,723
)
       
(73,723
)
Derivative warrant at December 31, 2012
   
1,152,000
   
-
   
1,152,000
   
(106,561
)
           
 
 
 
32

 
 
 
Reset of warrant shares
   
1,799,424
                               
Mark to market
                     
(379,552
)
       
379,552
 
Derivative warrant at March 31, 2013
   
2,951,424
   
-
   
2,951,424
   
(486,113
)
           
Exercise of warrants  on May 6, 2013
   
(2,732,799
 
-
   
(2,732,799
 
-
   
-
   
-
 
Issuance of warrants  on May 6, 2013
   
5,713,918
   
-
   
5,713,918
   
(106,360
 
-
   
-
 
Reset of warrant shares
   
737,856
         
737,856
                   
Issuance of warrants on Oct 15, 2013
   
1,000,000
         
1,000,000
   
(76,647
)
           
Mark to market
                     
299,373
         
(299,373)
 
Derivative warrant at December 31, 2013
   
7,670,399
   
-
   
7,670,399
   
(369,747
)
           

(ii) Warrant Activities

The table below summarizes the Company’s warrant activities through December 31, 2013:

Summary of the Company’s Warrant Activities

The table below summarizes the Company’s warrant activities:

   
Number of
Warrant Shares
   
Exercise Price
Range
Per Share
   
Weighted
Average
Exercise Price
   
Fair Value
at Date
of Issuance
   
Aggregate
Intrinsic
Value
 
                               
Balance, March 31, 2013
    5,233,177     $ 0.20     $ 0.20     $ 620,325     $ -  
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales
    737,856       0.20       0.20               -  
Granted
    6,713,918       0.20 - 0.25       0.23       183,007       -  
Canceled
    -       -       -               -  
Exercised
    (2,732,799 )     0.20       -               -  
Expired
    -       -       -               -  
Balance, December 31, 2013
    9,952,152     $ 0.20 - 0.25     $ 0.23     $ 803,332     $ -  
Earned and exercisable, December 31, 2013
    9,952,152     $ 0.20 - 0.25     $ 0.23     $ 803,332     $ -  
                                         
Unvested, December 31, 2013
    -     $ -     $ -     $ -     $ -  

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2013:

   
Warrants Outstanding
 
Warrants Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Average
Remaining
Contractual
Life (in years)
 
Weighted
Average
Exercise Price
 
Number
Exercisable
 
Average
Remaining
Contractual
Life (in years)
 
Weighted
Average
Exercise Price
 
                               
$0.20 - 0.25
 
9,952,152
 
4.36
 
$
0.23
 
9,952,152
 
4.36
 
$
0.23
 
$0.20 - 0.25
 
9,952,152
 
4.36
 
$
0.23
 
9,952,152
 
4.36
 
$
0.23
 
 
 
 
33

 
 
Note 11 – Commitments and Contingencies

Supply Agreement – between Stevia Ventures International Ltd. and Asia Stevia Investment Development Company Ltd.

On April 12, 2011, Stevia Ventures International Ltd., a subsidiary of the Company entered into a Supply Agreement (the “Supply Agreement”) with Asia Stevia Investment Development Company Ltd. (“ASID”), a foreign-invested limited liability company incorporated in Vietnam.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID.

(ii) Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") expiring on April 1, 2014 and thereafter automatically renew on its anniversary for an additional period of one (1) year expiring on April 1, 2015 ("Extended Term").

(iii) Purchase Price

ASID and the Company shall review and agree, on or before September 30th of each year, on the quantity of the Products to be supplied by ASID to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Supply Agreement – between Stevia Ventures International Ltd. And Stevia Ventures Corporation

On April 12, 2011, Stevia Ventures International Ltd., a subsidiary of the Company also entered into a Supply Agreement (the “Supply Agreement”) with Stevia Ventures Corporation (“SVC”), a foreign-invested limited liability company incorporated in Vietnam.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC.

(ii) Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years expiring April 1, 2014 ("Term") and thereafter automatically renew on its anniversary for an additional period of one (1) year expiring April 1, 2015 ("Extended Term").

(iii) Purchase Price

SVC and the Company shall review and agree, on or before September 30th, of each Year on the quantity of the Products to be supplied by SVC to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

 
34

 

Engagement Agreement – Garden State Securities Inc.

On June 18, 2012, the Company entered into an engagement agreement (the “Agreement”) with Garden State Securities Inc. (“GSS”) for GSS to act as a selling/placement agent for the Company.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company on a “best efforts” Private Placement offering of debt or equity securities to fulfill the Company’s business plan, and contacts for the Company possible financing sources.

(ii) Term

GSS shall act as the Company’s exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the “Exclusive Period”). GSS shall act as the Company’s non-exclusive placement agent after the Exclusive Period until terminated.

(iii) Compensation

The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company’s common stock (the “Securities Financing”) during the Exclusive Period;(i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the “Warrants”) with “piggy back” registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investors’ warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors.  The Company will also pay, at closing, the expense of GSS’s legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company.  In addition, the Company shall cause, at its cost and expense, the “Blue sky filing” and Form D in due and proper form and substance and in a timely manner.

Consulting Agreement – Mountain Sky International Limited

On April 18, 2013, the Company entered into a consulting agreement (the “Consulting Agreement”) with Mountain Sky International Limited (“Mountain Sky”) to perform consulting certain services for the Company. In consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties hereto, the parties agree as follows.

(i) Scope of Services

The Consultant agrees to perform certain consulting, advisory and related services to the Company.

(ii) Term

This Agreement shall commence on April 18, 2013 (the "Commencement Date") and shall continue until April 30, 2015 unless terminated. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Services performed by Consultant through the date of termination.

(iii) Compensation

The Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation (“Mountain Sky”), in partial consideration for consulting services to be rendered by Mountain Sky.  500,000 of the 1,000,000 shares vested at the time of grant, and 500,000 will vest on the one (1) year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.

 
35

 

Note 12 – Equity

Shares Authorized

Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share.

On November 15, 2013, the Company approved an amendment to the Articles of Incorporations to increase the authorized number of shares to Two hundred and fifty million (250,000,000) shares, par value $0.001 per share.

Common Stock

Reverse Acquisition Transaction

Immediately prior to the Share Exchange Agreement on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company’s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company’s common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares were being held in escrow (“Escrow Shares”) pending the achievement by the Company of certain post-Closing business milestones (the “Milestones”), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures’ Stockholder (the “Escrow Agreement”).

 
*
On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned by and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.  These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as salary and compensation - officer.

 
**
On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned by and released to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as salary and compensation - officer.

Common Shares Issued for Obtaining Employee and Director Services

October 14, 2011 Issuance of Common Shares for Director Services

On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director’s continuous service to the Company as directors.  These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.

The Company recorded $375,000 and $187,500 in directors’ fees for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, respectively.

The Company recorded the remaining balance of $187,500 for the interim period ended December 31, 2013.

December 4, 2013 Issuance of Common Shares for Director Services

On December 4, 2013 the Company issued 1,500,000 shares to a newly appointed member of the board of directors as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director’s continuous service to the Company as a director.  These shares were valued at $0.125 per share or $187,500 on the date of grant and are being amortized over the vesting period of two (2) years or $7,811 per month.
 
 
36

 
 
The Company recorded $7,811 in director’s fees for the interim period ended December 31, 2013.

Common Shares Issued to Parties other than Employees for Acquiring Goods or Services

Common Shares Issued to a Related Party

On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party.

Common Shares Issued in Connection with Consulting Agreement

On April 18, 2013, the Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation (“Mountain Sky”), in partial consideration for consulting services rendered by Mountain Sky.  500,000 of the 1,000,000 shares vested at the time of grant, and 500,000 will vest on the one (1) year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.

Sale of Equity Units Including Common Stock and Warrants

Entry into Securities Purchase Agreement

On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667shares of the Company's common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company's common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000.

At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,(“GSS”), who served as placement agent for the Company in the offering, (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the  "agent warrants") to GSS  or its  designee.

The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for gross proceeds of $500,000.  In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500.

Per the terms of the SPA, from the date until one (1) year anniversary of the closing date, if the Company issues or sells any shares of the Company’s common stock at a price that is less than the per share purchase price, than immediately without any obligation of or notice to the Purchasers, the per share purchase price paid shall be reduced to be the discounted per share purchase price and the number of shares issuable under this agreement shall be deemed increased to the subscription amount paid by such Purchaser. On October 1, 2013,
The Company issued 286,666 common shares to the investor according to this anti-dilutive term.

Exercise of Warrants with Issuance of New Warrants per the Warrant Reset Offer

On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the "Reset Letter") with an investor (the "Investor") whereby the Company and the Investor agreed that the Investor would immediately exercise his warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share for cash in the aggregate of $170,667.  In  consideration  for the Investor's  immediate  exercise,  the Company agreed to issue to the Investor three (3) new warrants in the amounts of 1,877,333, 1,066,666  and  2,346,666,  with exercise  prices of $0.20,  $0.25 and $0.25 per share,
 
 
37

 
 
respectively (the "Series A Warrants",  "Series B Warrants" and "Series C Warrants",  respectively,  and collectively  the "New  Warrants").  The Series A Warrants are subject to the Company's call right, and the Series C Warrants are only exercisable upon the Investor's exercise in full of the Series A Warrants. In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") within ten (10) business days. The Company will use its best efforts to have  the  Registration  Statement declared effective by the SEC within thirty (30) days. The Company filed a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within ten (10) business days which was declared effective by the SEC within thirty (30) days.

Issuance of Common Stock per the Settlement Agreement

On July 25, 2013, the Supreme Court of the State of New York, County of New York (the  "Court"),  entered  an order (the  "Order")  approving the settlement  (the "Settlement Agreement")  between the Company and Hanover Holdings I, LLC, a New York limited  liability company  ("Hanover"),  Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the  "Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.

On July 26, 2013, the Company issued and delivered to Hanover 7,500,000 shares (the "Initial  Settlement  Shares") of the Company's common stock,  $0.001 par value (the "Common  Stock"),  pursuant to the terms of the Settlement Agreement approved by the Order.

The Settlement  Agreement  provides that the Initial Settlement Shares will be  subject  to  adjustment  on  the  trading  day  immediately   following  the Calculation Period to reflect the  intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the  Settlement  Agreement be based upon a specified  discount to the trading volume  weighted  average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court's entry of the Order.  Specifically,  the total number of shares of Common  Stock to be issued to Hanover pursuant to the Settlement Agreement shall be equal to the sum of: (i) the quotient obtained by dividing (A) $1,042,000 (representing the total amount of the Claim), by (B) 65% of  the  average  of  the  lowest  40  VWAPs  of  the  Common   Stock  over  the 120-consecutive  trading day period  (subject to extension  under the Settlement Agreement)  immediately following the date of issuance of the Initial Settlement Shares (or such shorter  trading-day  period as may be  determined by Hanover in its  sole  discretion  by  delivery  of  written  notice  to the  Company)  (the "Calculation  Period");  (ii) the  quotient  obtained by dividing  (A)  $22,500, representing  (1)  $25,000 of  Hanover's  legal fees and  expenses  incurred  in connection  with the Action  that the  Company has agreed to pay less (2) $2,500 heretofore paid by the Company, by (B) 100% of the VWAP of the Common Stock over the Calculation  Period;  and (iii) the quotient  obtained by dividing (A) agent fees  of  $83,360,  by (B)  100%  of the  VWAP  of the  Common  Stock  over  the Calculation  Period,  rounded up to the nearest whole share (the "VWAP Shares"). As a  result,  the  Company  ultimately  may be  required  to issue  to  Hanover substantially  more shares of Common Stock than the number of Initial Settlement Shares issued  (subject to the  limitations  described  below).  The  Settlement Agreement further provides that if, at any time and from time to time during the Calculation  Period,  Hanover  reasonably  believes  that the  total  number  of Settlement  Shares  previously  issued to  Hanover  shall be less than the total number of VWAP Shares to be issued to Hanover or its designee in connection with the Settlement  Agreement,  Hanover may, in its sole discretion,  deliver one or more written  notices to the  Company,  at any time and from time to time during the Calculation Period,  requesting that a specified number of additional shares of Common  Stock  promptly be issued and  delivered  to Hanover or its  designee (subject to the  limitations  described  below),  and the Company will upon such request  reserve  and issue  the  number of  additional  shares of Common  Stock requested to be so issued and  delivered  in the notice (all of such  additional shares of  Common  Stock,  "Additional  Settlement  Shares").  At the end of the Calculation  Period,  (i) if the  number of VWAP  Shares  exceeds  the number of Initial  Settlement  Shares and Additional  Settlement  Shares issued,  then the Company will issue to Hanover or its designee  additional shares of Common Stock equal to the  difference  between  the  number of VWAP  Shares and the number of Initial  Settlement  Shares and Additional  Settlement  Shares,  and (ii) if the number of VWAP Shares is less than the number of Initial  Settlement  Shares and Additional Settlement Shares issued, then Hanover or its designee will return to the Company for cancellation  that number of shares of Common Stock equal to the difference  between  the  number  of VWAP  Shares  and  the  number  of  Initial Settlement Shares and Additional Settlement Shares.  Hanover may sell the shares of Common Stock issued to it or its designee in connection with the Settlement Agreement at any time without restriction, even during the Calculation Period.

 
38

 

The  Settlement  Agreement  provides  that in no event  shall the number of shares of Common Stock issued to Hanover or its designee in connection  with the Settlement Agreement, when aggregated with all other shares of Common Stock then beneficially  owned by Hanover and its  affiliates  (as  calculated  pursuant to Section 13(d) of the Securities  Exchange Act of 1934, as amended (the "Exchange Act"),  and the  rules and  regulations  thereunder),  result in the  beneficial ownership by Hanover and its affiliates (as calculated pursuant to Section 13(d) of the Exchange  Act and the rules and  regulations  thereunder)  at any time of more than 9.99% of the Common Stock.

On September 30, 2013, the Company issued and delivered to Hanover 2,000,000 Additional Settlement Shares pursuant to the terms of the Settlement Agreement approved by the Order. Since the issuance of the Initial Settlement Shares and Additional Settlement Shares described above, Hanover demonstrated to the Company's satisfaction that it was entitled to receive another 3,500,000 Additional Settlement Shares, based on the adjustment formula described above, and that the issuance of such Additional Settlement Shares to Hanover would not result in Hanover exceeding the beneficial ownership limitation set forth above. On December 13, 2013, the Company issued and delivered to Hanover another 3,500,000 Additional Settlement Shares and on January 22, 2014, the Company issued and delivered to Hanover the final 2,538,882 Additional Settlement Shares pursuant to the terms of the Settlement Agreement approved by the Order.

The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.  The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.

Warrants

Issuances of Warrants in Connection with Securities Purchase Agreement

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company’s common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Issuance of Warrants to the Placement Agent as Compensation

Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS  or its  designee,  a warrant  to  purchase  85,333  shares  of  the  Company's  common  stock representing  8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Garden State Securities, Inc. (the "Placement Agent") served as the placement agent of the Company for the Warrant Reset Offering on May 6, 2013. In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,653, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company,  the  Placement  Agent will receive additional  warrants  equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the "Agent Warrants").


 
39

 

Note 13 – Research and Development

Lease of Agricultural Land

On December 14, 2011, the Company and Stevia Ventures Corporation (“Stevia Ventures”) entered into a Land Lease Agreement with Vinh Phuc Province People's Committee Tam Dao Agriculture & Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the “Leased Property”) for a term expiring five (5) years from the date of signing expiring December 14, 2016.

The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement.

Future minimum payments required under this agreement at December 31, 2013 were as follows:

Fiscal Year Ending March 31:
       
         
2014 (remainder of the year)
 
$
7,500
 
2015
   
30,000
 
2016
   
30,000
 
       
   
$
67,500
 

Supply and Cooperative Agreement – Guangzhou Health Technology Development Company Limited

Entry into Supply Agreement

On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People's Republic of China (the "Guangzhou Health").

Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years.

Entry into Cooperative Agreement

On February 21, 2012, the Company also entered into Cooperative Agreement (the “Cooperative Agreement”) with Guangzhou Health Technology Development Company Limited.

Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company's business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing.

Note 14 – Concentrations and Credit Risk

Credit Risk

Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents.
 
 
 
40

 
 
As of December 31, 2013, substantially all of the Company’s cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation (“FDIC”).  However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

Customers and Credit Concentrations

One (1) customer accounted for all of the sales for the interim period ended December 31, 2013 and the accounts receivable at December 31, 2013.  A reduction in sales from or loss of such customer would have a material adverse effect on the Company’s results of operations and financial condition.

Vendors and Accounts Payable Concentrations

Vendor purchase concentrations and accounts payable concentration are as follows:

 
Accounts Payable at
   
Net Purchases
 
 
December 31, 2013
   
March 31, 2013
   
For the Reporting
Period Ended
December 31, 2013
   
For the Reporting
Period Ended
December 31, 2012
 
                               
Growers Synergy Pte. Ltd. – related party
 
45.0
%
   
50.1
%
   
6.0
%
   
49.8
%
Stevia Ventures Corporation
 
19.3
%
   
16. 9
%
   
26.6
%
   
10.3
%
SG Agro Tech Pte Ltd
 
-
%
   
-
%
   
52.2
%
   
-
%
   
64.3
%
   
67.0
%
   
84.8
%
   
60.1
%

Note 15 – Subsequent Events

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.  The Management of the Company determined that there were certain reportable subsequent event(s) to be disclosed as follows:

On January 21, 2014 and February 4, 2014, a convertible note holder converted part of the accrued interest through the date of conversion of $23,400 and $26,325, respectively, at $0.0585 per share to 400,000 and 450, 000 shares of the Company’s common stock, respectively.

On February 7, 2014, the Company issued a convertible note in the principal amount of $80,000 convertible at $0.10 per share with interest at 8%, per annum, maturing one year from the date of issuance on February 7, 2015. In connection with the issuance of the convertible note,the Company issued the note holder a warrant to purchase 1,000,000 common shares at an exercise price of $0.10 per share with full reset features, expiring five (5) years from the date of issuance.

On February 13, 2014, one investor exercised warrants to purchase 1,877,333 shares of the Company’s common stock with an exercise price of $0.0585 per share for $109,824 in cash.

Entry into Service Agreement

On January 27, 2014, the Company entered into a Farm Management and Technology Agreement (the “Agreement”) with Ebbu LLC ("Ebbu"), that is developing proprietary marijuana farming and extraction technologies. Under the terms of the Agreement, Ebbu wishes to engage the Company to provide technical support for farm management operations and extraction for both cash and assignable warrants. The scope of work and exact compensation is still under negotiation and will be completed by the end of next week.

 
41

 

 

 

 

PART II - INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 13. Other Expenses of Issuance and Distribution

 

The following table sets forth the costs and expenses payable by us in connection with the issuance and distribution of the securities being registered hereunder. No expenses will be borne by the Selling Security Holders. All of the amounts shown are estimates, except for the SEC registration fee.

 

SEC registration fee  $1,145.53 
Accounting fees and expenses  $5,000.00 
Legal fees and expenses  $10,000.000 
Total  $16,145.53 

 

Item 14. Indemnification of Directors and Officers

 

Nevada Law

 

Section 78.7502 of the Nevada Revised Statutes permits a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him in connection with the action, suit or proceeding if he:

 

(a)is not liable pursuant to Nevada Revised Statute 78.138, or

 

(b)acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful.

 

In addition, Section 78.7502 permits a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys’ fees actually and reasonably incurred by him in connection with the defense or settlement of the action or suit if he:

 

(a)is not liable pursuant to Nevada Revised Statute 78.138; or

 

(b)acted in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation.

 

To the extent that a director, officer, employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to above, or in defense of any claim, issue or matter, the corporation is required to indemnify him against expenses, including attorneys’ fees, actually and reasonably incurred by him in connection with the defense.

 

Section 78.751 of the Nevada Revised Statutes provides that such indemnification may also include payment by the Company of expenses incurred in defending a civil or criminal action or proceeding in advance of the final disposition of such action or proceeding upon receipt of an undertaking by the person indemnified to repay such payment if he shall be ultimately found not to be entitled to indemnification under Section 78.751. Indemnification may be provided even though the person to be indemnified is no longer a director, officer, employee or agent of the Company or such other entities.

 

42
 

  

Section 78.752 of the Nevada Revised Statutes allows a corporation to purchase and maintain insurance or make other financial arrangements on behalf of any person who is or was a director, officer, employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise for any liability asserted against him and liability and expenses incurred by him in his capacity as a director, officer, employee or agent, or arising out of his status as such, whether or not the corporation has the authority to indemnify him against such liability and expenses.

 

Other financial arrangements made by the corporation pursuant to Section 78.752 may include the following:

 

(a)the creation of a trust fund;

 

(b)the establishment of a program of self-insurance;

 

(c)the securing of its obligation of indemnification by granting a security interest or other lien on any assets of the corporation; and

 

(d)the establishment of a letter of credit, guaranty or surety

 

No financial arrangement made pursuant to Section 78.752 may provide protection for a person adjudged by a court of competent jurisdiction, after exhaustion of all appeals, to be liable for intentional misconduct, fraud or a knowing violation of law, except with respect to the advancement of expenses or indemnification ordered by a court.

 

Any discretionary indemnification pursuant to NRS 78.7502, unless ordered by a court or advanced pursuant to an undertaking to repay the amount if it is determined by a court that the indemnified party is not entitled to be indemnified by the corporation, may be made by the corporation only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances. The determination must be made:

 

(a)by the stockholders;

 

(b)by the board of directors by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding;

 

(c)if a majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding so orders, by independent legal counsel in a written opinion, or

 

(d)if a quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained, by independent legal counsel in a written opinion.

 

Charter Provisions and Other Arrangements of the Registrant

 

Pursuant to the provisions of Nevada Revised Statutes, the Registrant has adopted the following indemnification provisions in its Bylaws for its directors and officers:

 

The Company shall indemnify, to the maximum extent permitted by the law, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the Company, by reason of the fact that such person is or was a director, officer, employee, or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee, or agent of another company, partnership, joint venture, trust, or other enterprise, against expenses, including attorneys’ fees, judgments, fines, and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit, or proceeding if such person acted in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe such person’s conduct was unlawful.  The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of no lo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Company, and that, with respect to any criminal action or proceeding, such person had reasonable cause to believe that his conduct was unlawful.

 

The Company shall indemnify, to the maximum extent permitted by the law, any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee, or agent of the Company, or is or was serving at the request of the Company as a director, officer, employee or agent of another company, partnership, joint venture, trust, or other enterprise against expenses, including attorneys’ fees, actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit if such person acted in good faith and in a manner which such person reasonably believed to be in or not opposed to the best interests of the Company, but no indemnification shall be made in respect of any claim, issue or matter as to which such person has been adjudged to be liable for negligence or misconduct in the performance of such person’s duty to the Company unless and only to the extent that the court in which such action or suit was brought determines upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.

 

43
 

  

To the extent that a director, officer, employee or agent of the Company has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in the prior two paragraphs, or in defense of any claim, issue or matter therein, such person shall be indemnified by the Company against expenses, including attorneys’ fees, actually and reasonably incurred by such person in connection with such defense.  Any indemnification under the prior two paragraphs, unless ordered by a court, shall be made by the Company only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances because such person has met the applicable standard of conduct set forth in the prior two paragraphs.  Such determination shall be made:

 

(i)by the stockholders;

 

(ii)by the board of directors by majority vote of a quorum consisting of directors who were not parties to such act, suit or proceeding;

 

(iii)if such a quorum of disinterested directors so orders, by independent legal counsel in a written opinion; or

 

(iv)if such a quorum of disinterested directors cannot be obtained, by independent legal counsel in a written opinion.

  

Expenses incurred in defending a civil or criminal action, suit or proceeding may be paid by the Company in advance of the final disposition of such action, suit or proceeding as authorized by the board of directors unless it is ultimately determined that such director, officer, employee or agent is not entitled to be indemnified by the Company as authorized in the Bylaws or as provided by law.

 

The indemnification provided by the Bylaws:

 

(i)does not exclude any other rights to which a person seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders, or disinterested directors or otherwise, both as to action in such person’s official capacity and as to action in another capacity while holding such office; and

 

(ii)shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors, and administrators of such a person.

 

The Company may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Company, or is or as serving at the request of the Company as a director, officer, employee, or agent of another company, partnership, joint venture, trust, or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the Company would have the power to indemnify such person against such liability under the provisions of the Bylaws.

 

Item 15.   Recent Sales of Unregistered Securities

 

Promissory Notes

 

On February 14, 2011 we issued a convertible promissory note in the principal amount of $250,000 to Vantage Associates SA (“Vantage”) and on June 23, 2011, we issued an additional convertible promissory note to Vantage in the principal amount of $100,000 (the “Original Notes”). The Original Notes were convertible into shares of the Company’s common stock upon the closing by the Company of an equity financing yielding aggregate gross proceeds of at least $100,000. The Original Notes convert at the price per share of the securities issued in such financing. The Original Notes were issued in reliance upon exemption from registration under the Securities Act pursuant to Regulation S thereof. The Original Notes were converted into common stock on October 4, 2011 and are no longer outstanding.

 

Share Exchange Transaction

 

In connection with the Share Exchange Transaction, on June 23, 2011 we issued a total of 12,000,000 shares of our common stock in exchange for 100% of the issued and outstanding common stock of BVI. The common stock was issued in reliance upon exemption from registration under the Securities Act pursuant to Rule 506 of Regulation D thereof, and comparable exemptions under state securities laws. The common stock was issued to “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act, based upon representations made by such investor.

 

Sale of Common Stock and Additional Promissory Notes

 

On October 6, 2011, we raised $100,000 through the sale of 400,000 shares of our common stock at a price of $0.25 per share (the “October Shares”).

 

On October 6, 2011, we raised $150,000 from the proceeds of a convertible note (the “October Note”). The October Note was based upon the Company’s standard form of promissory note, accrues interest at the rate of ten percent per annum, simple interest and the principal balance of the October Note and any accrued interest thereon is convertible into our common stock at a $0.25 per share conversion price. The October Note was converted into common stock on January 18, 2012 and is no longer outstanding.

 

44
 

  

On November 16, 2011, we raised $250,000 from the proceeds of a convertible note (the “November Note”). The November Note was based upon the Company’s standard form of promissory note, accrues interest at the rate of ten percent per annum, simple interest and the principal balance of the November Note and any accrued interest thereon is convertible into our common stock at the lower of (a) the price per share at which shares of capital stock are sold in our next equity financing, or (b) the closing price of our securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securities, in each case over the thirty (30) day period prior to the date of conversion; provided however, that if no active trading market for the securities exists at the time of the conversion, such conversion price shall be the fair market value of a share of our common stock as determined in good faith by our board of directors. The November Note was converted into common stock on July 6, 2012 and is no longer outstanding.

 

On January 16, 2012, March 7, 2012 and May 30, 2012, we raised $250,000, $200,000 and $200,000 respectively from the proceeds of convertible notes (the “Subsequent Notes”). The Subsequent Notes were based upon the Company’s standard form of promissory note, accrue interest at the rate of ten percent per annum, simple interest and the principal balance of the Subsequent Notes and any accrued interest thereon is convertible into our common stock at the lower of (a) the price per share at which shares of capital stock are sold in our next equity financing, or (b) the closing price of our securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securities, in each case over the thirty (30) day period prior to the date of conversion; provided however, that if no active trading market for the securities exists at the time of the conversion, such conversion price shall be the fair market value of a share of our common stock as determined in good faith by our board of directors. The Note issued on January 16, 2012 was converted into common stock on July 16, 2012 and is no longer outstanding. The other Subsequent Notes remain outstanding.

 

On January 26, 2012, we entered into an Equity Purchase Agreement (the “Southridge Agreement”) with Southridge Partners II, LP, a Delaware limited partnership (“Southridge”). Upon execution of the Southridge Agreement, we issued 35,000 shares of our common stock to Southridge as a commitment fee (the “Southridge Shares”).

 

On March 19, 2012, we issued 27,500 shares of our common stock to Empire Relations Group (“Empire”) as consideration for consulting services rendered by Empire to the Company (the “Empire Shares”).

 

On July 5, 2012, we entered into a Technology Acquisition Agreement (the “Technology Agreement”) with Technew, pursuant to which we acquired the rights to certain technology from Technew in exchange for 3,000,000 shares of our common stock (the “Technew Shares”).

 

On July 5, 2012, we issued 500,000 shares of our common stock (the “Growers Synergy Shares”) to Growers Synergy Pte Ltd., a corporation organized under the laws of Singapore (“Growers Synergy”), as consideration for services rendered by Growers Synergy to the Company. George Blankenbaker, our president, director and stockholder is the managing director of Growers Synergy. Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and Mr. Blankenbaker controls a 49% interest in Growers Fresh. owned and controlled by the president and major stockholder of the Company.

 

On February 26, 2013 we raised an aggregate of $350,000, from the proceeds of convertible notes. Additionally, on March 15, 2013, we issued a convertible promissory note in the aggregate principal amount of $220,438.36 in exchange for the cancellation of an outstanding promissory note in the principal amount of $200,000 issued March 7, 2012 (collectively, the "2013 Notes").

 

The 2013 Notes were each based upon our standard form of promissory note, accrue interest at the rate of twelve percent per annum simple interest, and the principal balance of each 2013 Note and any accrued interest thereon is convertible into our common stock at a price per share of $0.25.

 

In connection with the issuance of the Notes, we issued to each investor a warrant to purchase such number of shares of common stock as is equal to four times the principal amount of their 2013 Note (the “2013 Warrants”). The 2013 Warrants have a three year term and an exercise price of $0.25 per share.

 

The issuance of the October Shares, the Notes, the Technew Shares and the Growers Synergy Shares were conducted in reliance upon Regulation S of the Securities Act of 1933, as amended and the rules and regulations promulgated thereunder (the “Securities Act”), to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act, in offshore transactions (as defined in Rule 902 under Regulation S of the Securities Act), based upon representations made by such investors.

 

The issuance of the Southridge Shares and the Empire Shares were conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act, based upon representations made by such investors.

 

The issuances of the 2013 Notes and the 2013 Warrants were conducted in reliance upon Regulation D and Regulation S of the Securities Act of 1933, as amended and the rules and regulations promulgated thereunder (the "Securities Act"), to investors who are "accredited investors," as such term is defined in Rule 501(a) under the Securities Act or in offshore transactions (as defined in Rule 902 under Regulation S of the Securities Act), based upon representations made by such investors.

 

45
 

  

2012 Financing

 

On August 6, 2012, we raised $500,000 in a private placement financing (the “Offering”) through the sale of (i) an aggregate of 1,066,667 shares of common stock at a price per share of $0.46875 and (ii) warrants to purchase an equal number of shares of the Company’s common stock at an exercise price of $0.6405 with a term of 5 years (the “Financing Securities”). The Company intends to use the net proceeds from this offering to advance the Company’s ability to execute its growth strategy and to aid in the commercial development of the recently announced launch of the Company’s majority-owned subsidiary, Stevia Technew Limited.

 

Garden State Securities, Inc. (the “Placement Agent”) served as the placement agent of the Company for the Offering. In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $40,000, or 8.0% of the gross proceeds received in the Offering, and (ii) issue to the Placement Agent, or its designee, a Warrant to purchase up to 85,333 shares of the Company’s common stock (representing 8% of the Shares sold in the Offering) with an exercise price of$0.6405 per share and a term of 5 years (the “GSS Securities”).

 

The issuance of the Financing Securities and the GSS Securities were conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act, based upon representations made by such investors.

 

Reset Warrants

 

On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the “Reset Letter”) with an accredited investor (the “Investor”) whereby the Company and the Investor agreed that the Investor would immediately cash exercise its warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share. In consideration for the Investor’s immediate exercise, the Company agreed to issue to the Investor three new warrants in the amounts of 1,877,333, 1,066,666 and 2,346,666, with exercise prices of $0.20, $0.25 and $0.25 per share, respectively (the “Series A Warrants”, “Series B Warrants” and “Series C Warrants”, respectively, and collectively the “New Warrants”). With the exception of the different exercise prices, the Warrants all contain the same terms, except that the Series A Warrants are subject to the Company’s call right, and the Series C Warrants are only exercisable upon the Investor’s exercise in full of the Series A Warrants, pursuant to the terms of a Warrant Exercise Reset Offer Letter Agreement.

 

In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) within ten (10) business days. The Company will use its best efforts to have the Registration Statement declared effective by the SEC within thirty (30) days.

 

Garden State Securities, Inc. (the “Placement Agent”) served as the placement agent of the Company for the Offering. In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,600, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company, the Placement Agent will receive additional warrants equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the “Agent Warrants”).

 

The New Warrants and the Agent Warrants (including the shares of the Company’s common stock underlying the New Warrants and the Agent Warrants) were offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws.

 

Stock Issuance for Services

 

On April 30, 2013, the Company issued 1,000,000 shares of our common stock (the “Mountain Sky Shares”) to Mountain Sky International Limited, a Hong Kong corporation (“Mountain Sky”), in partial consideration for consulting services rendered by Mountain Sky. 500,000 of the shares vest at the time of grant, and 500,000 vest on the one year anniversary of the date of grant.

 

June 2013 Note

 

On July 16, 2013, the Company entered into a $400,000 Promissory Note (the “June 2013 Note”) with an accredited investor (the “Investor”) whereby the Investor agreed to loan to the Company up to $400,000 pursuant to the terms of the June 2013 Note. The June 2013 Note provides for the first $100,000 to be advanced upon closing and additional amounts will be advanced at the Investor’s sole discretion. Each advance is subject to a 10% original issue discount, such that the total amount which may actually be received by the Company pursuant to the June 2013 Note is only $360,000. The maturity date for each advance made under the June 2013 Note is one year from the date of such advance. If the Company repays the June 2013 Note on or before 90 days from the effective date, the interest rate shall be 0%, otherwise a one-time interest charge of l2% shall be applied to the principal sum.

 

The June 2013 Notes are convertible into common stock of the Company on a cashless basis at any time, at a conversion price equal to the lesser of $0.26 or 65% of the lowest trade price in the 25 trading days prior to the conversion. If the conversion shares are not deliverable by DWAC an additional 10% discount will apply, and if the shares are ineligible for deposit into the DTC system and only eligible for Xclearing deposit an additional 5% discount will apply. Unless otherwise agreed in writing by both parties, at no time will the Investor convert any amount of the June 2013 Note into common stock that would result in the Investor owning more than 4.99% of the common stock outstanding. The Company will reserve at least 3,000,000 shares of Common Stock for issuance upon conversion of the Preferred Stock.

 

46
 

  

The Company agreed to include all shares issuable upon conversion of the June 2013 Note in its next registration statement filed with the Securities and Exchange Commission.

 

So long as the June 2013 Note is outstanding, upon any issuance by the Company or any of its subsidiaries of any security with any term more favorable to the holder of such security or with a term in favor of the holder of such security that was not similarly provided to the Investor in the June 2013 Note, then the Company shall notify the Investor of such additional or more favorable term and such term, at the Investor's option, shall become a part of the transaction documents with the Company.

 

Garden State Securities, Inc. (the “Placement Agent”) served as the placement agent of the Company for the June 2013 Note. In consideration for services rendered as the Placement Agent, the Company and Investor agreed that eight percent (8%) of any amounts advanced under the June 2013 Note would be wired directly to the Placement Agent by the Investor as payment of the Placement Agent’s fee.

 

Settlement Shares

 

On July 25, 2013, we issued 7,500,000 shares of our common stock to Hanover Holdings I, LLC, a New York limited liability company (“Hanover”), in full and final settlement, subject to adjustment, of past-due accounts payable of the Company, which Hanover had purchased from a farming supplies vendor of the Company, plus fees and costs (the “Hanover Settlement”).

 

On September 30, 2013, pursuant to the adjustment provision included in the Hanover Settlement, an additional 2,000,000 shares of our common stock were issued to Hanover based upon the volume weighted average price of our common stock.

 

The issuance of shares of our common stock to Hanover was exempt from the registration requirements of the Securities Act pursuant to Section 3(a)(10) thereof, as an issuance of securities in exchange for bona fide outstanding claims, where the terms and conditions of such issuance are approved by a court after a hearing upon the fairness of such terms and conditions at which all persons to whom it is proposed to issue securities in such exchange shall have the right to appear.

 

Asher Note

 

On August 22, 2013, we issued the Asher Note, pursuant to the terms of a Securities Purchase Agreement. The Note matures on May 26, 2014, incurs interest at the rate of 8% per annum, and is convertible into shares of our common stock at a 35% discount to the average of the lowest three trading prices for our common stock during the 30 day trading period prior to the conversion date. The Asher Note was offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws.

 

Black Mountain Shares

 

On October 15, 2013, we issued a Convertible Debenture in the principal amount of $58,000 (the “Debenture”), to Black Mountain Equities, Inc. (“Black Mountain”). The Debenture matures on May 1, 2014, incurs a one-time interest charge of 10%, and is convertible into shares of our common stock at a conversion price of $0.20 per share. The Debenture is secured by 1,250,000 shares of our common stock. The Debenture provides that on the next registration statement the Company files, the Company will include the shares issuable upon conversion of the Debenture. Black Mountain also received a warrant to purchase 1,000,000 shares of our common stock, with an exercise price of $0.25 per share and a term of five years. The Debenture was offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws.

 

Note Issuances

 

On November 21, 2013, we issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014 and on December 9, 2013, we issued a convertible note in the principal amount of $55,556 with a 10% original issuance discount and 12% one time interest. The convertible notes were offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws.

 

Foster Debenture and Warrants

 

Effective February 7, 2014, we issued a Convertible Debenture to an investor in the principal amount of $80,000.  The Convertible Debenture matures on February 6, 2015, incurs interest at the rate of 8% per annum, and is convertible into shares of our common stock at a conversion price of $0.10 per share.  The Convertible Debenture requires that we reserve at least 2,000,000 shares for issuance upon its conversion and provides the holder with participation rights in future financings and piggyback registration rights on the next registration statement the Company files.  In connection with the issuance of the Convertible Debenture, the investor  also received a Common Stock Purchase Warrant to purchase 1,000,000 shares of our common stock, with an exercise price of $0.10 per share, subject to adjustment, and a term of five years.  The Convertible Debenture and Common Stock Purchase Warrant were offered and sold in reliance on the exemption from registration afforded by Section 4(2) and Regulation D (Rule 506) under the Securities Act and corresponding provisions of state securities laws.

 

47
 

  

Supplemental Warrant

 

On February 20, 2014, in consideration for Cranshire Capital Master Fund, Ltd.’s (“Cranshire”) immediate cash exercise of an outstanding warrant to purchase common stock of the Company, we agreed to issue Cranshire an additional warrant to purchase 683,202 shares of common stock (the “Supplemental Warrant”). The issuance of the Supplemental Warrant was conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act.

 

Restricted Stock Awards

 

On February 26, 2014, we issued an aggregate of 28,300,000 shares of common stock pursuant to restricted stock award agreements to employees and consultants of the Company for services rendered (the “Restricted Shares”). 20,000,000 of the Restricted Shares were issued to Blankenbaker Ventures (Asia) Pte. Ltd. on behalf of George Blankenbaker, the Company’s President and director; 4,000,000 of such shares vest at the time of issuance and the remainder vest over the following four years in equal annual installments. 3,000,000 of the shares were issued to Growers Synergy Pte Ltd., a corporation organized under the laws of Singapore (“Growers Synergy”), all of which were fully vested at the time of issuance. Mr. Blankenbaker is the managing director of Growers Synergy and Growers Fresh Pte Ltd (“Growers Fresh) owns a 51% interest in Growers Synergy and Mr. Blankenbaker controls a 49% interest in Growers Fresh. Thomas Ong, a director of the Company is a director of Growers Synergy and is also a 25% shareholder of Agriventure Pte Ltd., which is a 49% shareholder of Growers Synergy. The issuance of the Restricted Stock was conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act and Regulation S of the Securities Act, in offshore transactions (as defined in Rule 902 under Regulation S of the Securities Act).

 

Accounts Payable Conversion

 

On February 26, 2014, the Company agreed to convert an aggregate of approximately $893,579.93 of advances for working capital received from George Blankenbaker, the Company’s President and director, and entities affiliated with Mr. Blankenbaker, into an aggregate of 16,744,682 shares of common stock at a deemed fair market value of $0.053365 per share. The issuance was conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act.

 

Nomis Bay Transaction

 

On March 3, 2014, pursuant to a Securities Purchase Agreement (the “Purchase Agreement”) with Nomis Bay Ltd., a Bermuda company (“Nomis Bay”), we issued a senior convertible note with an initial principal amount of $500,000 (the “Initial Convertible Note”) for a purchase price of $340,000.  The Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, we shall have the right to require Nomis Bay to purchase from the Company on or prior to the 10th trading day after the effective date of a registration statement registering the shares issuable upon conversion of the Initial Convertible Note, an additional senior convertible note with an initial principal amount of $600,000 (the “Additional Convertible Note” and, together with the Initial Convertible Note, the “Convertible Notes”) for a purchase price of $600,000.

 

The Initial Convertible Note matures on December 27, 2014 (subject to extension as provided in the Initial Convertible Note) and, in addition to the 32% original issue discount, accrues interest at the rate of 8% per annum. If issued, the Additional Convertible Note will mature on the date that is the 10-month anniversary of the date of issuance of the Additional Convertible Note (subject to extension as provided in the Initial Convertible Note) and will accrue interest at the rate of 8% per annum. The Initial Convertible Note is convertible at any time, in whole or in part, at Nomis Bay’s option into shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price equal to the lesser of (i) the product of (x) the arithmetic average of the lowest three (3) volume weighted average prices of the Common Stock during the 10 consecutive trading days ending and including the trading day immediately preceding the applicable conversion date and (y) 40% (the “Variable Conversion Price”), and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). If issued, the Additional Convertible Note will be convertible at any time, in whole or in part, at Nomis Bay’s option into shares of Common Stock at a conversion price that will be equal to the lesser of (i) the Variable Conversion Price and (ii) $0.30 (as adjusted for stock splits, stock dividends, stock combinations or other similar transactions). At no time will Nomis Bay be entitled to convert any portion of the Convertible Notes to the extent that after such conversion, Nomis Bay (together with its affiliates) would beneficially own more than 4.99% of the outstanding shares of Common Stock as of such date.

 

The issuances were conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act.

 

Warrant Exercises

 

On August 1, 2012, the Company issued to Cranshire a warrant to purchase an aggregate of 213,334 shares of the Company’s common stock at an exercise price of $0.6405 with a term of 5 years (the “Cranshire Warrant”). On May 1, 2013, the Company issued to Anson Investments Master Fund LP (“Anson”), three warrants to purchase 1,877,333, 1,066,666 and 2,346,666 shares respectively, at exercise prices of $0.20, $0.25 and $0.25 respectively (the “Anson Warrants” and together with the Cranshire Warrants, the “Investor Warrants”). The Investor Warrants each contained certain adjustment provisions in the event the Company undertook subsequent stock issuances at a price per share less than the exercise price of the Investor Warrants. As of February 20, 2014, as a result of dilutive issuances, the Investor Warrants were each adjusted to an exercise price of $0.053365. As of February 20, 2014, the Cranshire Warrant is exercisable for an aggregate of 2,560,486 shares and the Anson Warrants are exercisable for an aggregate of 7,035,820, 4,997,029 and 10,993,469 shares respectively. As of February 28, 2014 Cranshire had exercised an aggregate of 683,202 shares pursuant to the Cranshire Warrant and Anson had exercised an aggregate of 3,540,659 shares pursuant to the Anson Warrants. The issuances were conducted in reliance upon Regulation D of the Securities Act to investors who are “accredited investors,” as such term is defined in Rule 501(a) under the Securities Act.

 

48
 

  

Item 16. Exhibit Index

 

The following exhibits are included as part of this registration statement by reference:

 

Number   Description
     
2.1   Share Exchange Agreement, dated June 23, 2011 (incorporated by reference to Exhibit 2.1 of the Registrant’s Current Report on Form 8-K filed on June 29, 2011)
     
3.1   Articles of Incorporation of the Registrant, dated May 18, 2007, including all amendments to date (Incorporated  by  reference  to the Quarterly Report on Form 10-Q filed on November 20, 2013)
     
3.2   Amended and Restated Bylaws of the Registrant, as amended, dated March 18, 2011 (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K filed on March 22, 2011)
     
4.1   Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant’s Registration Statement on Form S-1 filed on July 16, 2008)
     
5.1   Opinion of Greenberg Traurig, LLP*
     
10.1   Supply Agreement with Asia Stevia Investment Development Company Ltd, dated April 12, 2011 (incorporated by reference to the registrant’s Form 8-K filed on June 29, 2011)
     
10.2   Supply Agreement with Stevia Ventures Corporation, dated April 12, 2011 (incorporated by reference to the registrant’s Form 8-K filed on June 29, 2011)
     
10.3   Convertible Promissory Note, with Vantage Associates SA, dated February 14, 2011 (incorporated by reference to the registrant’s Form 8-K filed on June 29, 2011)
     
10.4   Convertible Promissory Note, with Vantage Associates SA, dated June 23, 2011 (incorporated by reference to the registrant’s Form 8-K filed on June 29, 2011)
     
10.5   Form of Convertible Promissory Note (incorporated by reference to the registrant’s Form 10-Q filed on November 21, 2011)
     
10.6   Stock Purchase Agreement (incorporated by reference to the registrant’s Form 10-Q filed on November 21, 2011)
     
10.7   Management and Off-Take Agreement with Growers Synergy Pte Ltd., effective November 1, 2011 (incorporated by reference to the registrant’s Form 8-K filed on October 31, 2011)

 

10.8   The Minutes for Land Transferring Agreement for New Crop Plants Variety, dated December 14, 2011 (incorporated by reference to the registrant’s Form 10-Q filed on February 17, 2012)
     
10.9   Supply Agreement with Guangzhou Health China Technology Development Company Limited, dated February 21, 2012 (incorporated by reference to the registrant’s Form 8-K filed on February 27, 2012)
     
10.10   Cooperative Agreement (incorporated by reference to the registrant’s Current Report on Form 8-K filed on July 11, 2012)
     
10.11   Technology Acquisition Agreement (incorporated by reference to the registrant’s Current Report on Form 8-K filed on July 11, 2012)
     
10.12   Securities Purchase Agreement (incorporated by reference to the Current Report on Form 8-K filed on August 7, 2012)
     

 

49
 

 

10.13   Registration Rights Agreement (incorporated by reference to the Current Report on Form 8-K filed on August 7, 2012)
     
10.14   Form of Warrant (incorporated by reference to the Current Report on Form 8-K filed on August 7, 2012)
     
10.15   Reset Letter with Anson Investments Master Fund LP, dated May 1, 2013 (incorporated by reference to the Current Report on Form 8-K filed on May 6, 2013)
     
10.16   Form of Warrant (incorporated by reference to the Current Report on Form 8-K filed on May 6, 2013)
     
10.17   Stipulation of Settlement with Hanover Holdings I, LLC, dated July 16, 2013 (incorporated by reference to the Current Report on Form 8-K filed on July 29, 2013)
     
10.18   $400,000 Promissory Note, dated July 16, 2013(incorporated by reference to the Quarterly Report on Form 10-Q filed August 19, 2013)
     
10.19   Form of Senior Convertible Note (incorporated by reference to the Current Report on Form 8-K filed March 4, 2014)
     
10.20   Securities Purchase Agreement, dated as of March 3, 2014, by and between Nomis Bay Ltd. and Stevia Corp. (incorporated by reference to the Current Report on Form 8-K filed March 4, 2014)
     
10.21   Registration Rights Agreement, dated as of March 3, 2014, by and between Nomis Bay Ltd. and Stevia Corp. (incorporated by reference to the Current Report on Form 8-K filed March 4, 2014)
     
10.22  

Note Purchase Agreement, dated as of April 2, 2014, by and between Stevia Corp. and YOPCP, LLC (incorporated by reference to the Current Report on Form 8-K filed on April 3, 2014)

     
10.23  

Form of Senior Secured Convertible Promissory Note (incorporated by reference to the Current Report on Form 8-K filed on April 3, 2014)

     
10.24  

Security Agreement, dated as of April 2, 2014, by and between Stevia Corp. and YOPCP, LLC (incorporated by reference to the Current Report on Form 8-K filed on April 3, 2014)

     
21   List of Subsidiaries *
     
23.1   Consent of Li and Company, PC*
     
23.2   Consent of Greenberg Traurig, LLP (filed as part of Exhibit 5.1)*
     
24   Power of Attorney (included on the signature page of this Registration Statement)*
     
101   Interactive Data File*

 

*Filed Herewith  

 

Item 17. Undertakings

 

The undersigned registrant hereby undertakes to:

 

(a) Rule 415 Offering :

 

1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

i. To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

 

ii. To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) (§ 230.424 of this chapter) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.

 

iii. To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

Provided, however, that:

 

(A) Paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if the registration statement is on Form S-8 (§ 239.16b of this chapter), and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) that are incorporated by reference in the registration statement; and

 

50
 

  

(B) Paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) of this section do not apply if the registration statement is on Form S-3 (§ 239.13 of this chapter) or Form F-3 (§ 239.33 of this chapter) and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) (§ 230.424(b) of this chapter) that is part of the registration statement.

 

(C) Provided further, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the registration statement is for an offering of asset-backed securities on Form S-1 (§ 239.11 of this chapter) or Form S-3 (§ 239.13 of this chapter), and the information required to be included in a post-effective amendment is provided pursuant to Item 1100(c) of Regulation AB (§ 229.1100(c)).

 

2. That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

3. To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

4. If the registrant is a foreign private issuer, to file a post-effective amendment to the registration statement to include any financial statements required by “Item 8.A. of Form 20-F (17 CFR 249.220f)” at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with respect to registration statements on Form F-3 (§239.33 of this chapter), a post-effective amendment need not be filed to include financial statements and information required by Section 10(a)(3) of the Act or §210.3-19 of this chapter if such financial statements and information are contained in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the Form F-3.

 

5. That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

 

i. If the registrant is relying on Rule 430B (§230.430B of this chapter):

 

(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) (§230.424(b)(3) of this chapter) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) (§230.424(b)(2), (b)(5), or (b)(7) of this chapter) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) (§230.415(a)(1)(i), (vii), or (x) of this chapter) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or 

 

ii. If the registrant is subject to Rule 430C (§230.430C of this chapter), each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A (§230.430A of this chapter), shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

6. That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:

 

The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

51
 

  

i. Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424 (§230.424 of this chapter);

 

ii. Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

iii. The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

iv. Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

52
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Indianapolis, State of Indiana, on April 8, 2014.

 

  STEVIA CORP.
  a Nevada corporation
   
Dated: April 8, 2014 /s/ George Blankenbaker
  By: George Blankenbaker
  Its: President, Secretary, Treasurer and Director
  (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)

 

SIGNATURES AND POWER OF ATTORNEY

 

Known All Persons By These Present, that each person whose signature appears below appoints Mr. George Blankenbaker as his true and lawful attorney-in-fact and agent, with full power of substitution, for him and in his name, place and stead, to sign any amendment (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he may do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or any of them, or of his/her substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated:

 

Dated: April 8, 2014 /s/ George Blankenbaker
  George Blankenbaker
  President, Secretary, Treasurer and Director (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
   
   
Dated: April 8, 2014 /s/ Pablo Erat
  Pablo Erat
  Director
   
   
Dated: April 8, 2014 /s/ Thomas Ong
  Thomas Ong
  Director

 

53

EX-5.1 2 v372818_ex5-1.htm EXHIBIT 5.1

  

Exhibit 5.1

 

April 8, 2014

 

Board of Directors

Stevia Corp.

7117 US 31 S,

Indianapolis, IN 46227

 

Re: Opinion of Counsel for Registration Statement on Form S-1

 

To Whom It May Concern:

 

We act as counsel to Stevia Corp., a Nevada corporation (the “Company”), in connection with the registration of 47,898,931 shares of the Company’s common stock (the “Shares”) under the Securities Act of 1933, as amended (the “Securities Act”), of which up to 20,296,139 Shares will be issued upon the exercise of warrants to purchase shares of common stock of the Company, up to 10,674,182 Shares are issuable upon the conversion of the principal amount of a Senior Convertible Note issued March 3, 2014 to Nomis Bay Ltd. (“Nomis Bay”), up to 508,905 Shares issuable upon the conversion of interest accrued under a Senior Convertible Note issued March 3, 2014 to Nomis Bay, up to 12,809,018 Shares are issuable upon the conversion of the principal amount of a Senior Convertible Note to be issued by the Company to Nomis Bay, up to 610,687 Shares are issuable upon the conversion of the interest to be accrued under a Senior Convertible Note to be issued to Nomis Bay, and 3,000,000 Shares issuable upon the conversion of a promissory note issued July 10, 2013 to JMJ Financial (the “Notes”), and all of which will be sold by the selling security holders of the Company as defined and further described in the Company’s registration statement on Form S-1 (the “Registration Statement”) filed under the Securities Act.

  

For the purpose of rendering this opinion, we examined originals or copies of such documents as deemed to be relevant. In conducting our examination, we assumed, without investigation, the genuineness of all signatures, the correctness of all certificates, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted as certified or photostatic copies, the authenticity of the originals of such copies, and the accuracy and completeness of all records made available to us by the Company. In addition, in rendering this opinion, we assumed that the Shares will be offered in the manner and on the terms identified or referred to in the Registration Statement, including all amendments thereto.

 

Our opinion is limited solely to matters set forth herein. The law covered by the opinions expressed herein is limited to the Federal Law of the United States and the laws applicable to the State of Nevada.

 

Based upon and subject to the foregoing, and assuming that (i) the Registration Statement becomes and remains effective, and the Prospectus which is a part of the Registration Statement (the “Prospectus”), and the Prospectus delivery requirements with respect thereto, fulfill all of the requirements of the Securities Act, throughout all periods relevant to the opinion; (ii) all offers and sales of the Shares will be made in compliance with the securities laws of the states having jurisdiction thereof; (iii) the Company receives, to the extent applicable, the consideration set forth in the warrants; and (iv) the Notes are converted into Shares pursuant to the terms of such applicable Notes; we are of the opinion that the Shares issued are legally issued, fully paid and nonassessable, and the Shares to be issued will be legally issued, fully paid and nonassessable.

 

We hereby consent in writing to the reference to this firm under the caption “Interests of Named Experts and Counsel” in the Prospectus included in the Registration Statement and the use of our opinion as an exhibit to the Registration Statement and any amendment thereto. By giving such consent, we do not thereby admit that we come within the category of persons where consent is required under Section 7 of the Securities Act or the rules and regulations of the Securities and Exchange Commission.

 

Very truly yours,

 

/s/ Greenberg Traurig, LLP

 

Greenberg Traurig, LLP

 

 

EX-21 3 v372818_ex21.htm EXHIBIT 21

   

Exhibit 21

 

List of Subsidiaries

 

1.Stevia Asia Limited, a company incorporated under the companies ordinance of Hong Kong

 

2.Stevia Technew Limited, a company incorporated under the companies ordinance of Hong Kong

 

3.Stevia Ventures International Ltd., a corporation organized under the laws of the British Virgin Islands

 

4.SC Brands Pte Ltd., a corporation organized under the laws of Singapore

 

5.Real Hemp LLC, an Indiana limited liability company

 

 

EX-23.1 4 v372818_ex23-1.htm EXHIBIT 23.1

   

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

Stevia Corp.

Indianapolis, Indiana

 

We hereby consent to the use in the Registration Statement on Form S-1 (the “Registration Statement”) of our report dated July 16, 2013, relating to the consolidated balance sheets of Stevia Corp. (the “Company”) as of March 31, 2013 and 2012, and the related consolidated statements of operations, equity (deficit) and cash flows for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012 , which report includes an explanatory paragraph as to an uncertainty with respect to the Company’s ability to continue as a going concern, appearing in such Registration Statement. We also consent to the reference to our firm under the Caption “Experts” in such Registration Statement.

 

/s/ Li and Company, PC  
Li and Company, PC  
   
Skillman, New Jersey  
April 8, 2014  

 

 

GRAPHIC 5 image_002.jpg GRAPHIC begin 644 image_002.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,# M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_ MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`&Q`R<#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HJJ-36)6,K1[4!)<':,* M<.QSPH!]SQ7R9\9_^"['[)_[/GC6]\-^+/CIX.M=9L':*[@L%N-2^QR`JI1V MMHI%CD!W9C8E@00<8-`'U[17P\W_``@\9Z:/J?O\`].WL?T]1 MD;_@Y'_8C7/_`!?O0>,]-'U/W_Z=O8_IZC(!]PT5\/-_PFCZG[_].WL?T]1D;_@Y'_8C7/\`Q?O0>,]-'U/W_P"G;V/Z>HR`?<-%?#S? M\'(_[$:Y_P"+]Z#QGIH^I^__`$[>Q_3U&1O^#D?]B-<_\7[T'C/31]3]_P#I MV]C^GJ,@'W#17P\W_!R/^Q&N?^+]Z#QGIH^I^_\`T[>Q_3U&1O\`@Y'_`&(U MS_Q?O0>,]-'U/W_Z=O8_IZC(!]PT5\/-_P`'(_[$:Y_XOWH/&>FCZG[_`/3M M[']/49&_X.1_V(US_P`7[T'C/31]3]_^G;V/Z>HR`?<-%?#S?\'(_P"Q&N?^ M+]Z#QGIH^I^__3M[']/49&_X.1_V(US_`,7[T'C/31]3]_\`IV]C^GJ,@'W# M17P\W_!R/^Q&N?\`B_>@\9Z:/J?O_P!.WL?T]1D;_@Y'_8C7/_%^]!XSTT?4 M_?\`Z=O8_IZC(!]PT5\/-_P@\9Z:/J?O_`-.WL?T]1D;_`(.1 M_P!B-<_\7[T'C/31]3]_^G;V/Z>HR`?<-%?%?A+_`(.'/V-?'/B6'2+'X^># M[>^GDVI]O@N[.W;`Z&XFB2!">Q,F/Y#[&\/^)=/\6:7!?Z3?6>J:?E`%ZBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`_(O\` MX+B_M$?$;]L;]N+X<_L)_!?7-1\*W7BZW&O?$/Q'9R_9Y-,TDL[M%N5D;:(H MVE9-RB7?`A+!V%?2G[+?_!OI^R3^RSX`L-&A^#/A'QOJ%JJ"\U?QII\>N7NH MOM)9R)T>)3U^2!%7Y1[Y^:?V5(8W_P"#P[]IQ9O]5;_"*S:+`?\.G?V6?^C:?V?\`_P`-YI'_`,CT M?\.G?V6?^C:?V?\`_P`-YI'_`,CU]`44`?/_`/PZ=_99_P"C:?V?_P#PWFD? M_(]'_#IW]EG_`*-I_9__`/#>:1_\CU]`44`?/_\`PZ=_99_Z-I_9_P#_``WF MD?\`R/1_PZ=_99_Z-I_9_P#_``WFD?\`R/7T!10!\_\`_#IW]EG_`*-I_9__ M`/#>:1_\CT?\.G?V6?\`HVG]G_\`\-YI'_R/7T!10!\__P##IW]EG_HVG]G_ M`/\`#>:1_P#(]'_#IW]EG_HVG]G_`/\`#>:1_P#(]?0%%`'S_P#\.G?V6?\` MHVG]G_\`\-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]?0%%`'S__`,.G?V6? M^C:?V?\`_P`-YI'_`,CT?\.G?V6?^C:?V?\`_P`-YI'_`,CU]`44`?/_`/PZ M=_99_P"C:?V?_P#PWFD?_(]'_#IW]EG_`*-I_9__`/#>:1_\CU]`44`?)_QC M_P""('[(_P`:_"-UHNI?L\_"_25O(VB6XT#P_!H=U%C.&6>S2-T/H<_@>E?G M[^Q#J?CK_@@U_P`%7M!_9@\4>,-:\6_L]?'*%3\.]2U:Y6:31+Y<"&T^7`1F M?$#QQC;*T]LZA"SU^V*(L:!54*JC``'`%?D;_P`'&<>/^"F/_!-&09W?\+:\ MHD?W7U3P^&4\="!@C/(['L`?KG1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`?D;^R6,?\'B_[3_'7X161Z=?W?ACV']?KV'ZY5^1O[)8Q_P>+_M/\=?A M%9'IU_=^&/8?U^O8?KE0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!7Y%_\'%RX_X*3?\`!,_Y67'Q<0?-\S#_`(FF@<$\_P`^??J/UTK\B_\` M@XN7'_!2;_@F?\K+CXN(/F^9A_Q--`X)Y_GS[]0`?KI1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`?D;^R6,?\'B_P"T_P`=?A%9'IU_=^&/8?U^O8?K ME7Y&_LEC'_!XO^T_QU^$5D>G7]WX8]A_7Z]A^N5`!1110`4444`<'9?''PC< M_$Z^\&P^+O#DWB[2UBN+W0O[8A_M"S69&EBWVY<3(KJ"ZLR$%8I```,5VD$S M/(2%;]X%8'=NC/3)4_CT.,XX[FO@L^,]&\'?\%';;0_#WB#PYK%YXT\37\UQ MX7U/3XXO%/@K4ETAX9O$>G2J=TNCS0VB0S)?4M1\6>(;"UF\4ZFEW$E]H4-O;:1$F2=O.+`'Z8^,/'&F>`O":A?:A=I!:VEO$K%II M969=L9P#O.5QR0.M=#!+]H59`WR\@`?=89X/3V[<<]^#7Y]_%OXL_&;X3_`' MXW?;?C'XC\/^)/@C9Z_JJ^)]:\/Z(VG:[9W41N-'8(ME%%*T4.],120XNH0T MPGB;R"?L\?\`!0^\^(O_``5&_P"$+MOBMIOB+P?X@T_5X;7P\]YH\#07]FFG MR1R6=K;Q/>F":%KR1)KF\8W86XE@M%MXH;F4`^S/BE\??`GP0?13XN\>>&O" M9\37G]FZ1'K>L06/]I7>-HMX/.96EF+8'EKO8D_=)Y'5:3K5KX@TF"ZT^\M[ MVSN(TD@G@F\Z*2-N8Y%9?OJWR\@[2,\\'/QWXY^*_P`._P!F+_@HC\2-6^-> ML>#_``KH/CKP5H^E^%M9\57L%KI^JVMM+>_VAIL3S$1F=9989'MT`:5)82=V MP;>+^(O[0>I?"#XM^&_`/P[\2-\,4T&R\+_\()\,+O1[..+QWIUQ=[=0'E2Q M/?[K.W$A6.SFB%KY&^.)?AQ\/?&GB']L+PCX>\'>* M_BWXH\">)];MM*T&'2=%M[3_`(2!K'['.[/Q?XAOKG57\/ZHS6EG?>+]$M+UHX=72VAVK+&8WM MU\^"%(9_,CF1%BG0*`?1E%%%`!1110`5^1?_``<7+C_@I-_P3/\`E9 M?Y\^_4`'ZZ4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'Y&_LEC'_!XO M^T_QU^$5D>G7]WX8]A_7Z]A^N5?D;^R6,?\`!XO^T_QU^$5D>G7]WX8]A_7Z M]A^N5`!1110`4444`%?/?QX^,_Q"U%O&F@_#:^\(Z9K'P]T.+6=4U3Q/HMUJ MEH]PPEEBL4M[>XM"7,40>2?S]J>9#MADWOY?T)7SI\4?@EXSOO&WCZW\)ZAI M=C:_%+0A97FJ7UC]O3PU>VZ>3&S6,,,)DDZUXPQP6TU MO$MS!+-#.'BNXGXV,E=OX0_X*'?"_P`>^(_#^DZ;J?B9=3\4:W+H%G;S>"]: MMY#?I9_;ECF#VJF`-9K]H268I%-"CM&TBJS*SQC^Q=9_$KQCH'C37M>%GXP7 MP_+X;\27N@VWV&R\46TEI-$'-O++.8V@DGN);0(Z2R*D<2EB0#T?PG_P4$^&?CKXAZ#X;LM8\46>K^*HW-D;OP3K6GVZNL5U M+Y<\]S:)#;W#PV4\T<,[K+)$L]0/9VC6:O>6^+0&.33H[J.6+?<"8*&6*+]H3_ M`()AWWQV_:7\,^,+;QYH%GX9\.M!!9:#?^'[J_O=*M5T^ZT^ZL]/NAJ,4-C' M<6]TS.5LWE,R0&5YX88X%YV\_P""97Q<\2F277?CWH&K-_PC^B^$DL4\!R:? MI&OV&FRW,@&M0QZK]IO1*;N2.2*WN+.!S(ZS03P,8"`>A>(=6L_VE_VCO@MK MY\7:M9^&8[>7Q]X`GTF&&V_MLBS6UN+35;6]LWN8V-OJ$K1-;O"S">=9(HI; M6"27ZJ=%D0JRAE88((X(KY9_9,_8\UWX'1?"WP[KE]INI>'_`(&>'I?#.CZC M'81Z>NN/+_`+3_`!U^$5D>G7]WX8]A_7Z]A^N5`!1110`4444`%-\E=V[:N[.[..^, M9_+CZ4ZB@`I`BARVT;B,$XY(_P`DTM%`#%MHT*D1H"H`7"]`,@8_,_F:5851 MLA5!&>0/4Y/YGFG44`($4.6VC<1@G')'^2:6BB@`HHHH`****`"OR+_X.+EQ M_P`%)O\`@F?\K+CXN(/F^9A_Q--`X)Y_GS[]1^NE?D7_`,'%RX_X*3?\$S_E M9P_K]>P_7*OQW^&NO0?`C_`(/# MOB0/$4R:.WQB^%T%IX-@(522=*NE"\Y>-QUP*_8B@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"OR+_X.+EQ_P4F_X)G_`"LN M/BX@^;YF'_$TT#@GG^?/OU'ZZ5^/7_!>OQ##\4O^"RO_``3N\`Z')_:7B;P[ MX^_X2?4+)5!FM+(:GI4@%?%7@?Q!#X"^.GPIO!J?A' MQ.0]O^]60.+6:2(B58WD2)HI5WF)D8@?.X;Y<^'G_!9S]NW]ES3E\"_&;]B/ MXE?%3Q3H^8)O%O@RVNS9:D$R%-U&"/W/'/[(10K"N$55'HHQ MVQ_(`?A2JBJ6(4`LW;KTY!XI5_X.)OVAF93_P[A_:97<_(-AJ7RC`'/_$IZ=^.G`%?K-10!^ M3(_X.)?VA2%W?\$X?VG%W%@=NGZB64''/_(*QQT'/;GUK,\:?\'*GQI^'G@[ M4M?U[_@G]^T/H.AZ/;M=76HZC;7]K9VJ+N\R6>9]/VPQIR?F#``=N*_7FOEW M_@M2,_\`!)O]HW1#ME59K?3F3Y./N\Y4@C))'4+_`,'$ MW[0FY<_\$X?VGL,06_XEVH_+\Q/'_$JYXP.V_X-)Y&/_!%[P:I7Y1K^ MM8(;./\`3&ZC/'4\8[>_/Z84`?DPO_!Q/^T,%!/_``3@_:>++@8_L_4<-P/QETGQ+?@Q66I^)[?4(M/LYL M8W2HUA#&T>>?FN4^HX->D_\`!(O_`()&_$OX-_M&:_\`M2?M0>)--\8_M$^. M;-;>*V#Q20>$+9H]LB(\8$33B(1PD0*L<:)(J22+*V?TUIIA5E8%5(D^\,?> MXQS^'%`#J***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`*^6_^"T:;O\`@DG^T=Y8_P":=ZKR\;%L"VDZDY_7D'DXSFOJ2OEO M_@M(%D_X)*?M&?*9F7X>:JPS]\?Z+*-Q4CY>_(`/7IB@#YQ_X-*`3_P1>\'J M!MSXAUD[E(.<7AX/7&>G3H/H3^F5?F;_`,&E`)_X(O>#U`VY\0ZR=RD'.+P\ M'KC/3IT'T)_3*@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M*^?_`-MG_@I%\%_^"=7A[1-4^,7CRU\%V_B)G@TX/:WE])=R1`,0(;=))L)Y MB;V\L??3)'2OH"OQO_X.9/"&D^.?^"D/_!-G0-;TO3M8T+6/B5<:??Z=?6R7 M%I?6TNJ>'(Y()8G!1XW1F5D8%64D$$&@#Z./_!T-^PB1_P`ET?D$?\B?XB[] M?^7'\O3MBE_XBB?V$]V[_A>C==W_`")WB'TQ_P`^/Z=,\]:^@?\`AT[^RS_T M;3^S_P#^&\TC_P"1Z/\`AT[^RS_T;3^S_P#^&\TC_P"1Z`/GT?\`!T-^PB!_ MR71^`!_R)_B+MT_Y^:#_P`'0W[")'_)='Y!'_(G^(N_7_EQ_+T[8KZ" M_P"'3O[+/_1M/[/_`/X;S2/_`)'H_P"'3O[+/_1M/[/_`/X;S2/_`)'H`^?O M^(HG]A/=N_X7HW7=_P`B=XA],?\`/C^G3//6D'_!T-^PB!_R71^`!_R)_B+M MT_Y^:^@O^'3O[+/_1M/[/\`_P"&\TC_`.1Z/^'3O[+/_1M/[/\`_P"& M\TC_`.1Z`/GT_P#!T-^PB1_R71^01_R)_B+OU_YC==W_(G>(?3'_/C^G3//6OH'_AT[^RS_P!&T_L__P#AO-(_^1Z/^'3O[+/_ M`$;3^S__`.&\TC_Y'H`^?1_P=#?L(@?\ET?@`?\`(G^(NW3_`)^:#_P M=#?L(D?\ET?D$?\`(G^(N_7_`)@#Y^_P"(HG]A/=N_X7HW7=_R)WB'TQ_S MX_ITSSUI!_P=#?L(@?\`)='X`'_(G^(NW3_EQ_/U[YKZ"_X=._LL_P#1M/[/ M_P#X;S2/_D>C_AT[^RS_`-&T_L__`/AO-(_^1Z`/GT_\'0W[")'_`"71^01_ MR)_B+OU_Y(?3'_`#X_ITSSUKZ!_P"' M3O[+/_1M/[/_`/X;S2/_`)'H_P"'3O[+/_1M/[/_`/X;S2/_`)'H`^?1_P`' M0W["('_)='X`'_(G^(NW3_EQ_/U[YH/_``=#?L(D?\ET?D$?\B?XB[]?^7'\ MO3MBOH+_`(=._LL_]&T_L_\`_AO-(_\`D>C_`(=._LL_]&T_L_\`_AO-(_\` MD>@#Y^_XBB?V$]V[_A>C==W_`")WB'TQ_P`^/Z=,\]:0?\'0W["('_)='X`' M_(G^(NW3_EQ_/U[YKZ"_X=._LL_]&T_L_P#_`(;S2/\`Y'H_X=._LL_]&T_L M_P#_`(;S2/\`Y'H`^?3_`,'0W[")'_)='Y!'_(G^(N_7_EQ_+T[8I?\`B*)_ M83W;O^%Z-UW?\B=XA],?\^/Z=,\]:^@?^'3O[+/_`$;3^S__`.&\TC_Y'H_X M=._LL_\`1M/[/_\`X;S2/_D>@#Y]'_!T-^PB!_R71^`!_P`B?XB[=/\`EQ_/ MU[YH/_!T-^PB1_R71^01_P`B?XB[]?\`EQ_+T[8KZ"_X=._LL_\`1M/[/_\` MX;S2/_D>C_AT[^RS_P!&T_L__P#AO-(_^1Z`/G[_`(BB?V$]V[_A>C==W_(G M>(?3'_/C^G3//6D'_!T-^PB!_P`ET?@`?\B?XB[=/^7'\_7OFOH+_AT[^RS_ M`-&T_L__`/AO-(_^1Z_+']E#]B+X+^(_^#L#]IKX&+CPK8RZ-IUPUOX:+30VC1&&.0F>:1_P#(]'_#IW]EG_HVG]G_`/\`#>:1_P#(]`'S MZ/\`@Z&_81`_Y+H_``_Y$_Q%VZ?\N/Y^O?-!_P"#H;]A$C_DNC\@C_D3_$7? MK_RX_EZ=L5]!?\.G?V6?^C:?V?\`_P`-YI'_`,CT?\.G?V6?^C:?V?\`_P`- MYI'_`,CT`?/W_$43^PGNW?\`"]&Z[O\`D3O$/IC_`)\?TZ9YZT@_X.AOV$0/ M^2Z/P`/^1/\`$7;I_P`N/Y^O?-?07_#IW]EG_HVG]G__`,-YI'_R/1_PZ=_9 M9_Z-I_9__P##>:1_\CT`?/I_X.AOV$2/^2Z/R"/^1/\`$7?K_P`N/Y>G;%+_ M`,11/[">[=_PO1NN[_D3O$/IC_GQ_3IGGK7T#_PZ=_99_P"C:?V?_P#PWFD? M_(]'_#IW]EG_`*-I_9__`/#>:1_\CT`?/H_X.AOV$0/^2Z/P`/\`D3_$7;I_ MRX_GZ]\T'_@Z&_81(_Y+H_((_P"1/\1=^O\`RX_EZ=L5]!?\.G?V6?\`HVG] MG_\`\-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]`'S]_Q%$_L)[MW_"]&Z[O M^1.\0^F/^?'].F>>M>"?\%.?^#A_]CW]H;_@G9\:/`_@WXP3:QXH\8>#]1TK M2+%O"FLP"XN)+8HD)DGM%C4EFSO9QCUX`/WY_P`.G?V6?^C:?V?_`/PWFD?_ M`"/1_P`.G?V6?^C:?V?_`/PWFD?_`"/0!^2__!O1_P`%P_V7/V%O^"8WA_X= M_%/XH-X3\9:?K&IW5Q8Q>']6OF5)+DR1,)+>UEA.Y3V?I@$5]S#_`(.AOV$1 MG_B^C\G/_(G^(O7/_/C_`)''2OH+_AT[^RS_`-&T_L__`/AO-(_^1Z/^'3O[ M+/\`T;3^S_\`^&\TC_Y'H`^?5_X.AOV$5*_\7T?Y0`,^#_$1Z9Z_Z#SU[^WH M*3_B*$_81V;?^%Z28_[%#Q%GICK]A_R>>O-?0?\`PZ=_99_Z-I_9_P#_``WF MD?\`R/1_PZ=_99_Z-I_9_P#_``WFD?\`R/0!\^M_P=#?L(L6_P"+Z/\`,"#C MP?XB'7'3_0>.G;W]30?^#H;]A$X_XOH_!S_R)_B+US_SX_Y''2OH+_AT[^RS M_P!&T_L__P#AO-(_^1Z/^'3O[+/_`$;3^S__`.&\TC_Y'H`^?1_P=#?L(C/_ M`!?1^3G_`)$_Q%ZY_P"?'_(XZ4+_`,'0W["*E?\`B^C_`"@`9\'^(CTSU_T' MGKW]O05]!?\`#IW]EG_HVG]G_P#\-YI'_P`CT?\`#IW]EG_HVG]G_P#\-YI' M_P`CT`?/G_$4)^PCLV_\+TDQ_P!BAXBSTQU^P_Y//7FE;_@Z&_818M_Q?1_F M!!QX/\1#KCI_H/'3M[^IKZ"_X=._LL_]&T_L_P#_`(;S2/\`Y'H_X=._LL_] M&T_L_P#_`(;S2/\`Y'H`^?3_`,'0W[")Q_Q?1^#G_D3_`!%ZY_Y\?\CCI0/^ M#H;]A$9_XOH_)S_R)_B+US_SX_Y''2OH+_AT[^RS_P!&T_L__P#AO-(_^1Z/ M^'3O[+/_`$;3^S__`.&\TC_Y'H`^?5_X.AOV$5*_\7T?Y0`,^#_$1Z9Z_P"@ M\]>_MZ"D_P"(H3]A'9M_X7I)C_L4/$6>F.OV'_)YZ\U\9?\`!:7]B+X,?"G_ M`(+%_L%^&O#/PA^&/AOPOXR\326VNZ5I?A6PL[#7$%]8KY=U"D2QSKMD9=L@ M;AR!UK]4/^'3O[+/_1M/[/\`_P"&\TC_`.1Z`/GUO^#H;]A%BW_%]'^8$''@ M_P`1#KCI_H/'3M[^IH/_``=#?L(G'_%]'X.?^1/\1>N?^?'_`"..E?07_#IW M]EG_`*-I_9__`/#>:1_\CT?\.G?V6?\`HVG]G_\`\-YI'_R/0!\^C_@Z&_81 M&?\`B^C\G/\`R)_B+US_`,^/^1QTH7_@Z&_814K_`,7T?Y0`,^#_`!$>F>O^ M@\]>_MZ"OH+_`(=._LL_]&T_L_\`_AO-(_\`D>C_`(=._LL_]&T_L_\`_AO- M(_\`D>@#Y\_XBA/V$=FW_A>DF/\`L4/$6>F.OV'_`">>O-*W_!T-^PBQ;_B^ MC_,"#CP?XB'7'3_0>.G;W]37T%_PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^ MC:?V?_\`PWFD?_(]`'SZ?^#H;]A$X_XOH_!S_P`B?XB]<_\`/C_D<=*!_P`' M0W["(S_Q?1^3G_D3_$7KG_GQ_P`CCI7T%_PZ=_99_P"C:?V?_P#PWFD?_(]' M_#IW]EG_`*-I_9__`/#>:1_\CT`?/J_\'0W["*E?^+Z/\H`&?!_B(],]?]!Y MZ]_;T%)_Q%"?L([-O_"]),?]BAXBSTQU^P_Y//7FOH/_`(=._LL_]&T_L_\` M_AO-(_\`D>C_`(=._LL_]&T_L_\`_AO-(_\`D>@#Y];_`(.AOV$6+?\`%]'^ M8$''@_Q$.N.G^@\=.WOZF@_\'0W[")Q_Q?1^#G_D3_$7KG_GQ_R..E?07_#I MW]EG_HVG]G__`,-YI'_R/1_PZ=_99_Z-I_9__P##>:1_\CT`?/H_X.AOV$1G M_B^C\G/_`")_B+US_P`^/^1QTH7_`(.AOV$5*_\`%]'^4`#/@_Q$>F>O^@\] M>_MZ"OH+_AT[^RS_`-&T_L__`/AO-(_^1Z/^'3O[+/\`T;3^S_\`^&\TC_Y' MH`^?/^(H3]A'9M_X7I)C_L4/$6>F.OV'_)YZ\TK?\'0W["+%O^+Z/\P(./!_ MB(=<=/\`0>.G;W]37T%_PZ=_99_Z-I_9_P#_``WFD?\`R/1_PZ=_99_Z-I_9 M_P#_``WFD?\`R/0!\^G_`(.AOV$3C_B^C\'/_(G^(O7/_/C_`)''2@?\'0W[ M"(S_`,7T?DY_Y$_Q%ZY_Y\?\CCI7T%_PZ=_99_Z-I_9__P##>:1_\CT?\.G? MV6?^C:?V?_\`PWFD?_(]`'SZO_!T-^PBI7_B^C_*`!GP?XB/3/7_`$'GKW]O M04G_`!%"?L([-O\`PO23'_8H>(L],=?L/^3SUYKZ#_X=._LL_P#1M/[/_P#X M;S2/_D>C_AT[^RS_`-&T_L__`/AO-(_^1Z`/GUO^#H;]A%BW_%]'^8$''@_Q M$.N.G^@\=.WOZF@_\'0W[")Q_P`7T?@Y_P"1/\1>N?\`GQ_R..E?07_#IW]E MG_HVG]G_`/\`#>:1_P#(]'_#IW]EG_HVG]G_`/\`#>:1_P#(]`')?L,7<$:OM+#(!(&5YX& M/JVOQ7^$OP8\&_L_?\'>D'AOP'X1\.>!?#L/PP>6+2]`TJ#3;'>]J6=Q#"B( M"S"?%$ZS:?MN_"*XM_%7B:'0;S3==@N]$CN532KIHX[:1 M+J91$'>1H![W17YTZ_\`&WQ?\/OAUI_C[3?%WB-M?^+^D^() M=6BNM9N=0LO#KP:C:6UG+:6LDAM;(62SM#(8XT#M('N/,*977^*'P/\`B9XH MO/$7@'X=_$K6-#\.?"GQ397[ZEX@^(FM0ZAI=O&OSXQ MS[5^@'PK_:A\-^)?C=JOAW4-%*_7ZOR!_8W_`.5R3]K'_LE5C_Z3>%*`/U^HHKYG\=>, M_$'P[_:_^(&IV?B#7]8L]/\`A7'JMCX8NIPVGVUU!=W?[R*.$!FDD8+'(TA9 MB%4*P4$4`?3%%?GRNN^(/`VJ>&?`4?Q`\:ZCH?Q:TKPOJ/B/6Y_$&H37EI=W M]Q=Q7DEC=F9FL$O_`"HXH8;)XHK=EW6ZQLX)N6/ASXFZSXQ\+^)]/^(6HQ_# MOX,^+-9T&\,GBS4Y=1NK.UU*2-+9[5%F37KFX@5-.#7TPG@EA\Z,R74K@@'W MU17A_P"SK^T'H_C;QKXH\+GQ%>ZEX^TN[:^UFR>RO8]/@8DPO::=<3HEM=); M^0L$IM781SI(TH221T/N%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`'X^_\`!=\D_P#!<'_@G/)\RJ_BN0`D%<_\3#3N.H]1Q[]#T/[! M5^/O_!=\.O\`P7!_X)SLPV[O%<@R#\N?[0T[(!XSU_7H>A_8*@`HKPK]HGPG MXUD^*W@W4O#OQ8\9^'4O]OZUK#_%KP_KVH>']&L]-L[IO!SZ=.GV=M."6 MXFO)GLS)(\=VTXEN4B5%2-VAH`^[Z*^(_AU^WAJ7PS^!7A^Z^)GB+Q9;&#Q) MJ-K>ZU>>%KC_`(2"^T]+VZFTR-](M[`2+>7.FP"XN4%K$UM!#-,T5J)80/M# M2KZ'6+.&ZM[J.\M[J-;B*:*3Y7C8[HRN."I!Z]P._8`N4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110!^/O^K_X/*?\`EI'O^%OX2?Z)^''' MOR/R_8*OQ]_U?_!Y3_RTCW_"W\)/]$_#CCWY'Y?L%0!@WGC#3M)\2:?HMQJE MK;ZQJLF^-M5TC7[&P\V2VAUB]@9+=HX[<$F62,M$YVID97D=17S/XE=_&G MPVB\%Z$)-8\_"^Y\#Z#XMC^*7P]G\*^,M232?#>N+XELFTW6[QI9HA;6TPD6*X MEWQR1^7&S/NC8;24R>[;5(QKMQIL=RDEY#%'/Y7G_O(E+M6?X:MXAL&TK4?!E[:3V_CDOIUEI]S8PM- M#(ACN'2TLU>VDCE$T#)',C+(3Z=\,?VH;_0/VW=5^$.K>'=*?Q+JVGMXAU'4 M5UP_V@SF..1)4LS;#&C6Z*MBE]Y@,EU`R-;[G:1@#ZRHHHH`****`"BBB@`H MHHH`****`"BBB@`HHJKN!C*NS1F-`S*TI&Q3N&2P[XSW/(Z]Z`"1O(3#?:/+ M(*G+#"*,#<6SGMGKGD^G#C+YA8!I';'SQ*RAH\C(SSD=..>I].GXL^/OVJOV MA/\`@X!_:L\:?"W]G3XA)\'?V:?AM=IIWB#X@:8\T>H^)6ZYM9(RI9&*L4CC M:%6B`>67$T<([C1/^#07X(KIZC7_`(W_`+2&J:E(F^6:TUZQME9F\YSG_F'?[1_,^M#?\`!GY^S^V< M_&']IX[LYSXKTWG.<_\`,._VC^9]:`/U:-U$CL3,G3&"PP,;L_R/_?)]Z\^\ M=?L]>%?'OQA\(^.M7CU^3Q%X),YTJ:V\1:C96UL9P!*L]I;2I:S@Q[1FX1^% M`[9K\YF_X,_/V?VSGXP_M/'=G.?%>F\YSG_F'?[1_,^M"?\`!GY^S_'Y>WXP M_M/+Y>=F/%>FC9GKC_B7<9H`_0G0_P!D?X?:)XQ\6:W'X?:^F\ MW5]8S0794W*6]K+(;:VCN6`EN!;QH)I!OD#M\U3^`_V9/!?PT^%A\)Z78:LV MFW&H#4KA=3UO4-3OM3G#QR%[JZNII+F]XC1=LTC_`+J-(_:;57QN4>*M-PV. MF?\`B74`?HV?V8/!:_'[_A97]DW'_"9-;M8F[%]=?8RC@!Y#9>9]D^T&%$A^ MU>49S&!'OV#;7Y@_\'&;M_P]-_X)E,"9E'Q3;:0>7_XFWAL^R\YZC`YQVKI& M_P"#/G]GYI%<_&#]IPNIR&/BO3<@YS_T#O7FJMY_P9O?LXZA=6\]Q\5/VDIY M[5S)!))XFTQFA8L'+*3IN5.X!LCN`>M`'ZTFX7?M4AGS@J",CIG\L@_C2+".!_S#NW;TH`_5Y;E7QM^;=@K@CYU MX^8<]!G_`#QD6Y5\;?FW8*X(^=>/F'/09_SQG\H1_P`&?/[/P.?^%P?M.9!! M'_%5Z;P1P/\`F'=NWI0/^#/G]GX'/_"X/VG,@@C_`(JO3>".!_S#NW;TH`_5 MY;E7QM^;=@K@CYUX^8<]!G_/&1;E7QM^;=@K@CYUX^8<]!G_`#QG\H1_P9\_ ML_`Y_P"%P?M.9!!'_%5Z;P1P/^8=V[>E`_X,^?V?@<_\+@_:F\$<#_F'=NWI3?\`B#\_9_\`FV?% M[]IS>A&,^*].49`^7G^S>V<9'2@#]6K=OM*>9YA9I`8U:/E1COC)7J"^-7P3\-Q[O%W@7QBT]S+I]K]TSJD9V; M(P?,::`0O&NUGCFA#"OUI_8P_:R\,?MR_LQ>$OBGX,O))-"\7:?'=)!)-NFL M9-Q2:V<\#S4E1HCTY3<#\W(![%1110`445SOCOQWI/PI\&ZYX@\0:E'I.AZ# M:3ZE?WMU*!';6T:&227)&`$`(QV')SD9`-9B]M"Q623S=GF.9EW+@9XX(0'Z M'_&K+S;7*JI=E7<0",^W?OSCMP:_#CP/J_[3'_!S%XUU[7=(^(FM?L\_LDZ% MJMQI>E)I8E76O%9C7!9_+=?/X95?=(8(Y&VHLLB%AZ];?\&?_P`!8]/6.^^, M'[2EQ+&QX1K%L`;F/!.,L.O%`'ZU;SNQL;KC/'IG/7\/7/MS2 M"5B/]6_0'&1QGKW[=_TS7Y0'_@SU_9X)_P"2L?M+=2G_,/[=OUS M0/\`@SU_9X!_Y*Q^TMU!Q_PE6G?[/.W'_"V?VE^F,_\`"4Z=ZYS_ M`,@[\/3'OS2G_@SU_9X)_P"2L?M+=2G_,/[=OUS0!^KXE8C_5OT M!QD<9Z]^W?\`3-!E8#_5OT)QD`?^2L?M+=0?[/.W'_"V?VE^F,_\`"4Z=ZYS_`,@[\/3'OS0!^L.\ M[L;&ZXSQZ9SU_#US[,_M6<[I)?A78HN?O#_`$7PH0Q!V]N2 M!SP:Z,_\&>W[/0.5^+7[3$9R?N^*M.Z'C'_(.Z?X]ZKQ_P#!G#^SG%JTFH+\ M5OVE%OI%5'N1XFTP3.J@!07_`+-R0`J@#/``]*`/UG%S&S[1(A;.,;N<\_X' M\CZ5Y['^SQX5A^/DGQ06'6E\5R:0FC-+_P`)+J7]F&V0F1$^P>=]BPK%F$OD M[PS$YR37YQ'_`(,^?V?F3:?C!^TX5QC'_"5Z;C''_4.]A^0]*'_X,^?V?I)3 M(WQ@_:<:1A@L?%>FY(QCK_9WIQ0!][:)^Q'\,_"7@#Q)X9M/#%TND^+"CW2) MK.HM=6RHP-NMI,TQGL8;9@&MXK1XULVP8%C)R.L\*?`[PKX-\+^'=#L;":'1 MO!MS]JL89=0N;I1<_,SS3NTC-=2%YGD+W1=O.7SN7`^_YG_(UZ;][^]_R#NOO3&_X,]OV?7*[OB]^TVVS.W/BK3?ER-IQ_Q+O[ MO'TXH`_1?P)^S)X%^%OQ4\5>,-%T6ZM/$/BP,NHRRZG?3VN993(XMX)':"V\ MZ4^9-]F1/,DP\F]L-7HS742ODS(NT$$;ACO_`"VM^1]./RC_`.(/?]GQ6FV_ M%W]IJ,3DEU7Q5IV&RVXY_P")=S\V#SW&>M.7_@S\_9_7&/C#^T\-N,8\5Z;Q MC&/^8=_LC\AZ4`?JT+F./&ZX4[`0V67GKR?^^6]N#Z<`N8X\;KA3L!#99>>O M)_[Y;VX/IQ^4J_\`!GY^S^N,?&']IX;<8QXKTWC&,?\`,._V1^0]*JW?_!H+ M\`VT\O9_&;]ICS,?NW/BC3Y4R,'HNG@_P@<'J!UP!0!^KVUI5;S9)$,9+ELF M/RU(R/57QT]/ZW*_"WXIZ/\`M-?\&R_BC2?%P^(>M?M`_LFZEK5OIVJV.K-+ M/J_A82G8#"7?;`VT.B,)5MW@>) MK!-2TV]@=MMU;2*A#@#HV".!SG/0D@`'64444`%%%%`!561O(3#?:/+(*G+# M"*,#<6SGMGKGD^G!N!C*NS1F-`S*TI&Q3N&2P[XSW/(Z]Z_%OQ]^U5^T)_P< M`_M6>-/A;^SI\0D^#O[-/PVNTT[Q!\0-,>:/4?$K=E`'ZM&YCDSMN%&\`+AEXZ MO(;F.3.VX4;P`N&7CIR/^^E]N1Z\_E*O_!GY^S^N,?&']IX;<8Q MXKTWC&,?\P[_`&1^0]*%_P"#/S]G]<8^,/[3PVXQCQ7IO&,8_P"8=_LC\AZ4 M`?JT;F.3.VX4;P`N&7CIR/\`OI?;D>O(;F.3.VX4;P`N&7CIR/\`OI?;D>O/ MY2K_`,&?G[/ZXQ\8?VGAMQC'BO3>,8Q_S#O]D?D/2A?^#/S]G]<8^,/[3PVX MQCQ7IO&,8_YAW^R/R'I0!^K1N8Y,[;A1O`"X9>.G(_[Z7VY'KR+=1,^1,C;@ M`!N&.W\]R_F/7G\I5_X,_/V?UQCXP_M/#;C&/%>F\8QC_F'?[(_(>E"_\&?G M[/ZXQ\8?VGAMQC'BO3>,8Q_S#O\`9'Y#TH`YG_@NS<*G_!;C_@G7+YA_Y&N5 M0[_NTV_;]-^;?@JV06X&.H'&:_85G5!EB%&0.3W/`K\EKC_@S@_9QO;RWGN/ MBG^TE<2VLIFA:7Q-IC-&Y96+*?[.RI+*I)!!RH/4"K`_X,]_V?$3:OQ=_::3 MC#;?%6G?-UZ_\2[T)'T_&@#]/M8\%V>L^,=$UR?[1(/#PF:RCW1_9HVFC$9F M`ZAECWH&'(6:0#AB#Y[\+?V3]!^$7Q4U3Q;8ZOXBU*+%ZNBZ1=2VK:;X32_N M?M=_]B"0K+_I$ZI*WVB:;RP%2+R(?W=?`3?\&>W[/KL2WQ>_:;8MG)/BK3>< MD$_\P[N5!_`>E*W_``9\_L_-(KGXP?M.%U.0Q\5Z;D'.?^@=Z\T`?='QF_8: MT'XR>`-+T&Z\2>--!U31[^;5K;Q1IDUH=<>[EM9K2ZE8RP2V^V>UN9H2@@"H MCJD2PB*!4]>\)^#[/P)X3TW1M+@-OINB6EO:V5NQDP8 MS_PM[]IK,3;T_P"*JTWY&Z9'_$NX/O0!^KWVJ)"VZ9.N<%A\N,Y_]!;KZ'TI MS7*IG=\NW);)'R+S\QYZ''^>Y_,T`?J^)LOMVG=GD M9&5'.">>AQ_GG$%NWVE/,\PLT@,:M'RHQWQDKU!.3["ORD;_`(,^?V?7A9%^ M+W[3;;.`K>*M."YY(_YAON>1ZGWKQKX]_L1?M/\`_!OEHNI?&#X"_%[7_C9\ M%?#L>_Q?X&\9-/._L8?M9>& M/VY?V8O"7Q3\&7DDFA>+M/CND@DFW36,FXI-;.>!YJ2HT1Z8R!CY@+YP.1@$*IZ=#@\^F:Q_'7CK2OA;X)UKQ+KNI+I/A_ M0;*?4M2O;MML=K`B&1I(->TGQ]KG[ M/G[(>AZO/I.FQ:2LB:SXL*C#&38RB?A@)-\C01NQ5$FD0L`#]R#<*KXR.#@G M(PIXP#[G(_SBD6Y4XS\O0-DCY&.,*>>IR/\`.*_)>T_X,_\`X#6VG1K>?&#] MI>::('S)XO$^FPQMD*#A6L6*KCMDG"GV%6C_`,&?/[/QQ_Q>#]IS@8'_`!5> MF\#&/^@=Z`#Z4`?J\MRIQGY>@;)'R,<84\]3D?YQ0MRIQGY>@;)'R,<84\]3 MD?YQ7Y0G_@SY_9^./^+P?M.<#`_XJO3>!C'_`$#O0`?2@_\`!GS^S\F\#&/\`H'>@`^E`'ZO+F\#&/^@=Z`#Z4`?J\MRIQGY>@;)'R,<84\]3D?YQ0M MRK,J_=9N""1\K8!VGGKCGCL*_*$_\&?/[/QQ_P`7@_:F\#&/^@=Z M`#Z4'_@SY_9^9-I^,'[3A7&,?\)7IN,/[H]J^=\*\ MC<6!Q]D&"5(7OQC)Z$\'I^OAF0./WPY;@9'/\./^^B/?/'M7Y+_\0;'[-_\` M;']H?\+2_:0_M#9Y?VG_`(272_.V[=NW?_9N<;>,9Z<5>7_@S\_9_7&/C#^T M\-N,8\5Z;QC&/^8=_LC\AZ4`?JT\L-W#)')Y;QR`*0Q#+(K<#CT/(YZT,\#- MEC"68@3SAD"XYX(!'_`01]!7Y2M_P`&?G[/[9S\8?VGCNSG/BO3 M>OX4&14RK7'*`;LE>-N"2>.X(S[$=*_*5O^#/S]G] MLY^,/[3QW9SGQ7IO..[.<^*]-YSG/_ M`##O]H_F?6@#]6FD7&/M&-VY1RO7('IV)Q^/.34+H\V7ED,:QG.03&8AC//) M5L<>W7Z5^4-__P`&@OP#FT]WM?C-^TPTC@[';Q1I\J$\DY"Z?GG+#KU;OG!\ M7^*>C_M-?\&R_BC2?%P^(>M?M`_LFZEK5OIVJV.K-+/J_A82G8#"7?;`VT.B M,)5MW'_$]BFHZ?>P2-MN; M615(<`#AL$#`P+3;F2,C:."C*K*5R05!'(R?;*\(_X*<1AO\` M@FK^T053"R?#'Q&0,'DG2[HGY<'U]"3GD<4`?+7_``:J>`]/\,?\$0?A=>6= MJLG6-UJMU<33R+#%!;P6D;SW$C,>$CC>3))'2@#NJ*XOX<_&CP[\4_#VG:GH. MO6>H6FK&Y-DZ2`?;6MK@P7(C5\,0DJ[<]!O';%=I0`45RX\7K>^+K_1[<:M] MMTZTBO)6FTZ=;5UE>8(([C:(9G0PNKQ1.70>7YNT31&3J*`"BN%^&7QQ\,_& M76/%VF>&];&I7?@?5FT#65C#;K&_$<4Y1@RJ3A)H\E MF6\CB=8I)=TSQHXAC*02KYLQ2/S/+3_`%LL2.`=116! MXI\70^$M#U#4+F+4F73K=YWALK6>^N&0D'*0PQR2ROUPL2/W%<=\,/VE_"GQ M;^`R?$C0KKQ5?>$KC3_[3@F?P[J%M?WMJ-Y$D=C+`EXYD"ED$<&904\H/QD` M]0HJ&VV2P_+Y@P1D,YW#&,9YR,C!P?7GJ:Y75?B/I^B:_<:??3:E8G3EM;B> M>6SGALI5N)C;PQ1W4J>3-*94*F&.3S?FC)CQ-'O`.PHHKB/AY\;O#'Q7USQ5 MI_AS7K?6+[P3JO\`8FKQV\GF?9+\0)+Y#C`^;RIHG(!V_-U&&-`';T444`9G MB3PG8>,?#5YHVJV=K?:9J5I)97=O)&&CGAD7:\90@@HRD@J<@C@@BOR@_P"# M-34[BX_X)<>.+6:ZFEM]'^*.J65JQD^2WA_LS2I.`W`&]W;@?>=B1DL3^N)1 M2X;:-P&`<<@?Y`K\C/\`@S0/E_\`!-7XE+E4_P"+OZJ-I&,_\2G2.!T_ET!X M'8`_72BBB@`KX7_X./O$5UX5_P"")OQ]O-/FN+%IM,LK1S!NC>5+C4[&&0,0 M`<-'(Z,.058@]P/NBO@G_@YH@6/_`((9_'=5C1?]'TCA1Q@:WIX';T`[<8ZC M&:`/5O\`@C)X%T_X;_\`!)[]G"PT^UM[>UN/AYHFJNRJL>ZXO+-+F9L`?>,L MS$GJQ/^"6W[,^%#2?\`"J?"^"1T']DV MF>?[X&1P0`=I117,Q^+5U#QA?:+;?VM]NT^UBNY6GT^:.T=97 MF"".YVB"9T:%P\4;[T'E^:5$L1<`Z:BN!^/'QS\-_LW?";7O&WBZ_P!3TOPM MX9M?[2U.YM[*XU"6VM4!$DC0V\%]5\2^#=&A; MQ0M_X[TB36]#BN?#6IVD2K*K#!`->&?\`!LKJ]UXC_P""&WP-O+V=[B=+?6H`TFZ0 MA8=XZ'CMSS\Z_P#!KJ,?\$*?@6V&8C^WQ@'U\0ZESCIQ^?6@#]`:***` M"BBB@#Q/_@HGKMYX._X)]?&[5M/FDL]0T;X?Z]J%A(C[9(9XM-N9(R-HX*,J MLI7)!4$(SV_XJ#4P2/P)H`_0&BBB@#D?'_Q3\-_!KP3 MJ'B3QAXDT?POX:TV,/=ZKK&HI9V5G&6"[Y)9&54#-@*6TTM'\X1;!<.RI]Y6`&>N=U>>?\%")M M`7]GE;G6O&%QX!:QU?3]1TCQ0EG#>6OA_4+:<7$-[>)*5A:S1XV^T_/&!!YS M&6'`FB^5?@?^T!X7\"_%GX-?%;XH-\._!7PSL]$\7Z#H?B;2IC:^"DUR35X) M)=2MKFX"I;0ZE;PW$ML6EE65#-''*^Y3,`?H!#\5/#\7A&X\12>(M'_X1S3( M);B\U<7\?V.V2)F$A>7<8U5-KHQ+$@J*K74YK55R"Y2&0D+N<#M[^)5L]'\N25Y[C4(\E8T@FE>282JRQ21N9DWM?#EB1??"Z*+2&)O_$,BWD_VBU1UBAE& M=-C::='1)66,VX!^QU%?DGJO_!2;QI\.O@5^S7XPOOVC3K&H^.M/\.>)O$0U M!O"^C:%J<-QJ.GV6JVD+-;?:;@VX^TL8;7RC;C[3-F?V-X@A@LKZVM8':\N%BT^6YD>)K MB7SHK>WVAI=]Q<`'Z::1XHTW6[G4K.QU"WO+S1YS!>);3F5K-]H(1\9Q)Y;* MVQN22#CG-<;\:_VL/AK^SG!93?$/XD>"/`-KK)=--G\2:]::5'?LH4ND+2NI ME95D1B$.<-'W+&OS1\*?M>:/\!O#7QLUCX:_M!>'?%FDVOQ1M=8U;Q;YWAO3 MY/%<`?B7I'Q9\+Z9XF\)Z]H_B3PWK2&?3]1TN\CO+/4(C@!XY(BZLF1C#U5?GC!\$M5_8B_:`^'.GVWQ$:\USQ!I_Q#\5R:';6ECI&E^,O$5Q!-4;XD?%GX9^-K MW4]&_'?A'Q'KW@^Y2SU[2],U:&\O=$EDW!4NX8W+Q$M%,P#JG MRQOC`1L]?/=%@QW,NU-[!2`<`GH2VT%3][J#Q]*^/O@_^WM\'/AQ^UQ\=/"N MK?%;X?V/BK5/B+IVF6.A'Q!;2:KJ5PVBZ78)##9^89Y9/M2"!D5`PDCN>&?&'[0P\/^&?$GQ9\9Z3XQ\2ZE#X=G'A7R;B\DM-(D6YLY M+2T%S'&C@ZA'*9%/EQLOVBVV`'Z+^&/&FG^./#EGJ>CW]GJVEZA"EQ9W]C<+ M)O"MCXU\.WVD:Q9VNH:;J=H]G=PRH&CN8I%*R1LAR"C+P5.002"".NE2%% M+AMHW`8!QR!_D"@#\C?^#-+49Y?^"6_CBUFNKB:WTCXHZK9VK-*2MO%_9NER MG`;@#>[M@#JY..6-?KG7Y%_\&:!\O_@FK\2ERJ?\7?U4;2,9_P")3I'`Z?RZ M`\#M^NE`!1110!\*_P#!R!XAN_"O_!$KX]WFG375I-)I=A8LT4CQM)%<:G8P M2ACC)W1NZ$'(*LP)P3CTK_@C)X$T_P"''_!)[]G"QT^WM[6UG^'FB:JY6-4W MW%[9IYKRG_@YHC6#_`((9_'?:J1_Z/I`PIP,?VWIX'IV` M&/PYZ'W+_@E&RI_P2U_9G/RJW_"JO"X#,O8Z3:9&??C\?7%`'T&B+&@55"JH MP`!P!2T44`%%%?._QF_X*+_"KX`?%+6O"?B;6/&NFW_A[3[?5-5GB\%ZY?:3 MI-C<;Q%>7&I0VLEI#;L8Y0TTDZ1Q^1+N>,QR9`/HBBJ<$_\`:=FDL+B2.8+F M17VJR]25ZXZD=C[\`UQ'C;X[^%_AKXV\'^&];\1)IOB'X@7\ECX>TZ8,SZO+ M#%)O#/PYOCXJ_X2CQ;; MRWFF1V_AO4KNQ\F`HLIFO889+6':7&[SI$/[V+)&^(M'\#/VH?"G[2,.K?\` M"*S>*O\`BF]2.CZC_;'A35M`*3@?/$O]H0P&5E/):+?MR/7D`]0HHHH`**\Q M\2?M(^&_#?QY\/\`PTN)_$K>*O%EG/J6GK;^'M1N+`P6^!)))?Q6SVD&&\L% M9I(^9TZ^;"'=H_[1WAW7?V@-9^&5FWB23Q=H>EP:[>1R:!J4>G):3N1`R7[0 M"SD9GWJ$CN"S?9Y1_P`LI0@!Z917B/Q4_;G^%OP)\::QHOB7Q7>V]QH=HNH: MO=6ND:AJ.G>'8/*>:,ZE=V\<'Z9Y.3UYH`M4444`($4.6VC<1@G')'^2:^>?\`@K7X(L/'W_!+ M_P#:&T_4+:WNH6^'.O3JDL:NOFQ:=<2POA@1F.54D4XRK(K#!`-?0]>#_P#! M3Z+=_P`$V/VA%VF5E^&7B/)8?]0J[&0-I&3R#@=#TZ`@'S__`,&RFM77B+_@ MAK\#+R]FDN[A8=9MP9"6RL6N7\4*YY(5$C15`X55```4`??%?G]_P:ZK_P`: M*?@6P568?V^,GL#XAU+//X?H*_0&@`HHHH`****`"BBB@`KPC_@IXI_X=K_M M#%E7=)\,?$:D*I;G^RKHX)P+4K40([R26\T6]HE23S$#((9B_D2^Y M4A12X;:-P&`<<@?Y`H`_/+P#I7Q%\6>,_@YXLUJR^(W_``E-GH?CO2-!U-=` MU3P]9ZI=O2"\1G M8V7F1&&V8I+*B?I5+"LRX=58>C#/;'\B1^->9_M*_$S4OAAX(TRST7:OB+Q= MK5IX?TVYE`\NSEF^_=,#D.(8DEEV.?G\K;R#0!\2_'CP=XR^#WBWQ9X+M]4_ M:.\4:)>:!X7V7=M>^+-2L-&F^W:I+?7%O?6$;ZC=`2S63/#:W*W31>3"]Q;V M:2>5]%_LI?&[Q%\//^"8O@+QAX\TGXD:EXJ\.^$[.WUJP?POK-WX@U*_AVVS M;K%DFOY)))E):0@[E;SF/E'?8KM*0# M@OA9#X\_9G^/>CW_`(KU34/&&F_%SPJ+..X\&_"C7M/;1+VVD>[@GU%7ENX( MKFYDU*Y#-<+9;7B0&,#=Y/F'PP\4?%+PGX'^':_:OVAM9M_#?C;4;-A!H/B2 M/_A+X3X=O-KW,&M6'O^"K_@KQ!8ZI MJ"^#?BIINDZ?INO:A9:E?^'4L%UE=&U&/3[JVMXII$GCD,\UL4%S'%&1'?''PSDCU+4O"K1:O-H]QJ-K>6TWV*:XB^ MSW-Y:?N[E)D590V]H"WEE'7S0#YY_P""5'CSQ;X/^&/Q@'C"V^*_]CZ-JMOK M6B1^)-(\8WU_]CETFS-Q;V\^M(;^^9+R"\BQ#!&[N?.2U@%RD(Y7PO\`M`ZM MKG_!*2Z^&WA;PW^TAX-^('AOX3LCZA8?#G6]'O[&^M[.(&&UFO;)4FNIIF$: M"V\R1?WSAH@@E'1?\$Y?C-XV_:XDTF&Z^.'C.75OA.Y@\76MYH>AV-[XRO+A MUD22:V&GK)#I20Q/'!<6QA-TS28E;[,))>^\>_\`!67P7\+;'Q7JVO>%OBE9 MZ#H^BZOKNBZC#HD5[!XRMM-D$5X+".WEDFBDAD>,'[;';[D=I>88Y)8@#YYO M_P#A(/&?QWNKS6?$_P"U[-H6L_$^2UB^S6'BG2K=?#$OA2.6:)([6VMDAMX] M3*QQW.T7(>+=Y[AB!$'AFB3T;X, M_%_7]7^*VM^&_$/V]%U+0[#Q;HJWD,,=]I=M=O+%<:9=-:R26LTUK/$`)87& M^.X1`96A:XF`/DKXHV/Q\TC]H?XP:YH'BOXKR_9=&U#^SO#6G^#M9DBGTGRH M/L]S9:A=WSZ.VH1JKB*""S2]DFD83JZ*9AZQ_P`$PM/M])\0_':RT/1?C38^ M#]6\8VNJZ%J/Q'@UJ*\U-9-%L89XHFUMDU*81R6DBL9DV*'C$G7N.M`'N7_!*/>W0YKZ"KY]_X)1[C_`,$LOV9_E++_`,*K\+9PV"#_ M`&3:?IUSSVZ'-?05`!1110!X;^W?X?L?%7P*FT_5;'QY?6,VHVC_`&[P3'.W MB#09(',\6I6H@1WDDMYHA(T2QR^8@*>3,7\B7YD\":7\1/%WC;X.^+=9L?B* MOBBTT/QYI.@ZDF@:KX>LM3NWNK=M,OM9TR`);VDE]$DTT@OTA1IU1A#!(T<< M?I.N_M2WW[*OQF^+6J^,/%WQ,^('AU?$?AWP]X9T#3_#UEJ#:1+JK(JA&L[. M*18/.G2,27D[EC`$!EF94EV_#/\`P467QKX\\"VL/P_\7:1H6O:;XGN_$4NL M/IQD\(OHMU':3BY"7C&3#,V[[)]IR)(2/ED:10#Y\^`WPR^,&G_#K2_'D?BO MXS>/]1^'_B^UUN3PK>V7BCP9)JEM+;"WU33A;:MJMU-J2PO)!>(SL;+S(C#; M,4EE1)/CSX-\9?!_Q7XM\%6NK?M'>)M%O=`\+^7>6]WXLU2PT:;[?JDM_<6] M[8(^I70$D]FSP6MTET\?D0/-_AWID_@7PQJ7[ MS5+[5-+AF!74$\F2"YENI[$6QE$30RO/:;HF0E36W\.O^"F^G_'#Q#\/Y/"? M@?Q9<>&_&&F^*;[5+RW_`+-U.XT*31;N."1,6=[<)>%YO,"BQ%VV9[?"C>V) M?!7_``4FT#3?A[\/;MO#_P`6O$6AZEI6@7&L>)KO3]-@;P\VK[([$:O!#)#( MDLDCQ&065H\<"L'D\N,D4`?)/BCPS\5H?A_#9CXF?M7>*-/L?AKXTOM&ET3P M?XJT!)M5^UZ?-HBR+,;K5C,CB\B2._NWFEBM$S'Y%P3>>M^,O">I:;XO^+7C M[3[7X_1ZP?B-X%\;(;%/$ZPZAHB1Z)'>QV^G0.(KH+;MJBS6:V\DBM"@FCD* MVX7V'X;_`/!43PW\7;[4%T/X=?&EBNFZW=Z,TOAZ.&7Q)-HVIQ:?=6-M#)<" M59OM$T(S?VVKS]J_X\_#76_#FL&S^&_B;PYXF2Z\/ MW4-A=7<6JZ9J]A9B:6_LKF>V9!ND$:V\CHPE#%Y1(OD`'S[\#H_B7\3_`(P^ M']-7_AJ31='M=-\=WGAJV\17.M6>FW]PNNVUYX>N;R[YN`C6HGA6VU:>(M': MF-K<).1/@VFG_%SPA^RM<:A)X^^//BB[L_$L>KIIK>`/'^BW1NH[5%GTU9UN MM1U4(TKQS).8;S1]XEC$$RAA%]M?LSZCXJO?CS\=+/6O''B#Q+I>A^*;?3M' MLKJUT];?1+-8F\WS[JT,CKY47 MSS0F0`^GM!ENKG0+5KF&XL9VMTE>%G,S0.#DJ7R2^>A`)X'7D5L5XS^PA\2M M<^,O[$GPE\8>*;R:^\1^*/"&EZSJEQ=6J6DDUW+:Q/+(8$;RXE#'=L7`&$?\%/%/_#M?]H8LJ[I/ACXC4A5+<_V5='!.#D>F1^!SBOG7 M_@UU&_\`X(4_`M<-C_B?G(.,8\0ZEQZ_TX-?17_!3I?^-;/[1"_*[?\`"L/$ M0)X+M_Q*[KJ,'W['J>/7YU_X-=BO_#B;X%[FVC.N\[L<_P#"0ZEC]>W>@#]` M:***`$**7#;1N`P#CD#_`"!2T44`-\E?.\S:OF8V[L?-CTS7R_\`M,_MF^*? M`GP]^('B?PVOA[2/#?@/5[70[[7-7TR\U>+3B\T'VW59;6UDA=K"SMY2SYD3 MY'D@BW?.SK_\`P5&^ M#7ACP'J7B>\\3:TVFZ/J4^EWUO:^%=9NKZ&:WL8;^6;[%%:-=BU%K-#/]I$9 MMS#-%('*2JQ\K\5?\$J/%6L_!BX\)Z7\3O!NDKJ/A[Q;H^I2)X#D^RO-XDNX M[J>>QMHM4C2VAB*&.&&0S-EG*_[ M>$F@_"?Q/K<%@T>CV^G-8W-MH>JKJ,B7,4;.7>5+5@D\5Q')YD&T`^B-3_X* MG?!?PI8^))O$7C#4?#-EX7T.7Q)J%_JWAK5;"VBM8UM7FBBGGLTAN+B(WMO& M]K$SW4)KJ'Q#K'VKPNMJUY8MX;U9-0NHYV9 M;:XLK%K<7%_!/(KK%-9)/'-M.QW`./D?]MK]@7XAZ5\/_B[\8+OQ.OBCQ1KO MP[\3:%;^'M*\!ZCKVN1R:O801)I5M(/B?H\GQ(C.D:AX5U"P\"W.A:9HBV=Q)=Q+=:7=7L]U,U MQ]IGBN!+Q42"9'D<`ZW0O\`@I9\%=;\0>%]*TWQN+S5_%\S:G%%!>1V=PUW:)")K#[-<,\4WVE$\E8)3*5$,A1+K]NK0_$NC6?BOPG?-J M'A/1-;M]!\66FHZ3J.CZSI[7P@6RNXK:[@21H3)<1.S M\(VR66GW$,@2>WAEN9+S4KDQM`\@,,(C+O'Y$D(CN0#[+I`BARVT;B,$XY(_ MR32T4`-,*G/RK\Q#'CJ1C!_0?E3J**`"BBB@#\B_^#-`^7_P35^)2Y5/^+OZ MJ-I&,_\`$ITC@=/Y=`>!V_72OR+_`.#-`^7_`,$U?B4N53_B[^JC:1C/_$IT MC@=/Y=`>!V_72@`HHHH`^"_^#FL>5_P0S^._"Q_N-)^Z>N=_?W+_ M`()1R[/^"67[,XW!2WPK\+TVYE0>78RSL?,N"&/S"*..6?:V0_E;2?F%`'R!\2_$GQ(\?\` M[4V@^,O`^L?&#PSX/T_23-X<\*VWPZ\0V:Z];1V]W%>6UQ)>W%MIFFS><"\1 MU73S,1':O;O(DGDCA_V)?%WC:U\;>$=,\2:5\:-1M=/^+UKK.GRZ[X=\:7W] ME:==>$KJS99+_6K=IWCBOFFA:61+1'=A,((([B-1[W>-/ M&7Q3^)/ARVU_PQX8T/1[7PQ974^G7&K%8T<"PL+8^7YLR1;YIFQY809E:-)< M7]K#_@IGK%G^QKXN\0_"WPGX\C^*5IH?B"X_LQ]"TS4)_!ATRZDM+VXO4>^A MMFV7$$B(MO\#E=!U[[1XH M\(>#/[1MK4W+V/E6EQ=76EWNGVZR+:S\2%)5,466`D42?-/C/_A8FN?L_:IH M.B^-OCOX=AC^(FL/K/B^_P#A1XHEUZ\$RNVFWBV&CPZ3+-"2L@;R(I;3S%A6 M>%UD.?HSXI_\%,?#?[-G@GXG>*]6T7XO>)M,\">(4TK6O-T[3--@T(?V7974 MLD,UU)9(UI(TT2(9':YN+FX(M4FB:/;UFC_\%+/"GB/XUW?@^W\)?%1CI/B. M\\*W&NGP_LT^/4(]&;6%A5"1>3+):(YB:"VD#E$S_K8C(`?+,>F^/-6^.]Q# MXV\7?M;7T4OQ/DTN^?2](\1:;9'0'\)Q?;(XQID'V6&!=9;$5Q$TD@$8^SWC M;IIFXOP%XZ\=?$1VTGQ?XH_:Y3XA7GP:\)WWAC1-#LM>T_\`L;Q.IUFVD:^5 M(!%;O)/:I(QUN=[>Z5R\H,<4:0_H!^R'^V?I'[8>A^,+RRT/Q#X5U#P%KS>' M-9TC7;K3+BZLKQ;>"8(_]GWES"KK]H"NCRK)%(DB.BE`1\H_#K]HCP[^RY\1 M?&'Q:^)NI?%KQ-X[ATGQB=>N_#^B7DGAO6-$T#Q-]FLUBL5EE@BELH966'[/ M(A6.XO9KSS&)G(![9\;_`(W#X._M8?!_4/%7A_XC7[:'X(UJVU:Z\*_#W7_$ M=E;7EW-I0C026%G<`'%G=$;N_'Q;#7OAW MX;>RM[7X5Z_?2-=I<:K=FW:2"T>"&:..ZM`R2R((W?;)L:*39V'AS_@I=I.N M_$9O#.H?#GXM>$YH=:GT"[N=0TFSECM[K^S!JT4:16MW+//)/9[GC$$4DB./ M*FCCE.P\O\._^"F.G:=X0;5=:TOQX/AWX?\`A)H7Q"N/%VN_V1873_;WNDBA MO8HI8EBFG6WZQV\=O&Z3[GA"K@`3X8^.+[]E;XS_`!C\-^*/A]\0?$$GQ2\4 M-XJT&;2O"=]K-CKL5Y86]N+&ZOK>&2ULY(9;?[.WVZ2"-81$YE\H';]*^`_' M^G^)]3UK1[9;JPO/"5Q%I]_&=,GLX(I##'*3;F:./SH/G'[V+S(B>-^4E1?C M7X^_\%>K/XA?L)>+?&'P'TOQ+KGC"XT+6=6_XEECIFO)X46PD$4MW=LNH)93 M)NV*B6L]RTN6ECBNHXI0?N;PCHECI.ES7UOINGVT^M2)J%\UI;)&U](@J[0%_Y! M5UQC!/IP0>W'6O=Z\)_X*(R`#P&_LJZSM(&[/;./3' M>@#YT_X-=AG_`((3?`OAFYUW[IQ_S,.I?Y^GK7Z`U^?W_!KL,_\`!";X%\,W M.N_=./\`F8=2_P`_3UK]`:`"BBB@`HHHH`****`"O"/^"FS*W_!-?]H155?+ M3X8^(F$>/O`Z5=#:5QD#Z<\8QQ@^[UX3_P`%.MS_`/!-;]H@-GW'/(!\Z?\&NS[/\`@A-\"_F5>==&6_[&'4N/QZ?6OT!K\_O^ M#79]G_!";X%_,J\ZZ,M_V,.I:_M&?"RZ^*OP\2&QU2 MWTCQ!HE]#KFC7=Q!)<6]MJ%O*)+99HD<-)$Q;9)&CH\BL54C(QZ54?V.$LQ\ MJ/+`J3M'()R1^)YH`^3?BQ\*/!_P)\$_%;Q!\4/C[JWP[T_XV&*WU:XUC5O# MEE8^';LVX@$-A8^#OPF^!7Q0\-MX\\/?M)- M\0?"O@W3[&V\;W-CXH\/3:+K2:;YDME)J\EK:HMO)!&_+V[6@FBAC6?S8U"U MZ3_P5!^*_AKX0_LFM?>*/$6B^%K%O%/AI!GPCR]-?BEXU MU+R?$T2Z5)<>'X6UN+Q%J$=_JK*7L(K9IB^][>.5X[5G9(IR8I)%KUK]BKX9 M:U\-OV6+/PC=1^*O!XMC-:Z/;:KI_ANVU?P_;-NCC_=:+`-'5TD+,B0QR*%: M,2[BS@?)GBG]L7XC>(=`^.GBCPQ\??!]_I7A7QQ8>'+":UN='T?1?"FE7EEI M]V+^\U![#5&29)'GM5GDB>W9IIV:$9C-OV?P)_:M\<>/OB+X'T'QY\>/#GAK MQA)I6G_V5H6@6%M?6'Q7M[FSE\[5[(SVL=W*D=PA=);98K=4MB\B-!A_%+XM:+XG^&=O>V%MXHA31&UC6-/NIEGDTZ]WZ68I M[59071?)1E?+`[B&#]?_`."6_A/Q-X!\7>%I/&WQ'L_#?BS3]4TO3;&.;3O( M\&VVIR^9J,6G"2Q)'VAF,8%U]H\J/*P>0#@_*?A#]J_7OAU^Q9\%]+T;]H6Z MT6]N/AU=ZIH>MWMGHFHV_C7Q3:RVZ)X9?;:[9"DKO#]EM!%J$A5AYOF0N6Z_ MQ-^UG\1-3\/?M":_=?M">%?"^I_#_P`:6.@KHT%UH>AV/AZTETW2+J2.2^N[ M._$=VLW]H0))>?N&F\]'$:^68`#KOVS?V$M4OM-+S2[SQ7?:?:>'T&ER,L%O;6K3LTF&`_?SO,\L@&!&GE1+N,!FFR?V2_ MC3:_&GPCI.N'QMJ.J:QK'A?2=4NO#\R:9'-IDF*`'4444`%%%%`!7Y%_\&:!\O_@FK\2E MRJ?\7?U4;2,9_P")3I'`Z?RZ`\#M^NE?D7_P9H'R_P#@FK\2ERJ?\7?U4;2, M9_XE.D<#I_+H#P.P!^NE%%%`!7P7_P`'-<>/^"&?QW&Q5_<:2<*,_P#,G7N.M`'N7_! M*,[O^"67[,Z@'/\`PJOPL>I48&DVF>1_+O\`3-?05?/O_!*/>W0YKZ"H`Y7Q[\2M!^#OA:;6O%?B+1_#NAVF# M<7FK:C#9V\!"AL--+(JK_$2&9AM4\XKD/@]^V;\'_P!I#7+K3?AY\6/AWXXU M2QC::[L_#WBJSU22VC&5:1DAE9E0,XY.W[HQT&>8^(GB2Q\._MB:=?>(KRUT M[0/#7P_O]?TZXNW2&TLY8YX8KR\>3'EJT=O)#'O()CCN9`A"RR@_GC^P;^U+ M;Z_:_LP:7IOQ9^"?CF7PQX-UHPV_ARP(O?A='#I+9O\`Q#*MY.+FU1TCAD&= M-C>6=)$24K&;<`^ZOB1^Q?I/B[XK:ZNH_&OX@Z7J_C_7M,\86^BB30(F@_L& MZM[B(6D$-(^(<&GR_$SQ9K6L>'9M M6>VN(H;02K:27MI(86#1S;[:5?/D5&4_(8_:F\?\` MC/\`9&\*S:I^T%IWB&\^+G[._B+Q>UK;:/I%M>)K5M9:2Q:U,,0<1P+]OV1F M*0K))=.\A6."&W[SXM_MKZUX0A\::3X9_:2\#W.DZ;X`\&:YH>MW6IZ'IMPM MO<7=W'>WC7\EG/8QSWD<%N8Y);1+,>=`@BMV?SV`/H#PS^R?I;_$'P=;W'QR M^)7BCQ+\(]3MO%-O97E[HLD]O;36=YIMO;7<$6GJ([1H)=059P%N9]TK-<2F MVB,7F?C;]A/X0WGC#1?A3XD^/7B3_A+O%&G^)YK/PCJ>J^'%U364UJ^_M+4) M18O8,]Q$D]KN""-[?RH)5E6:(R*WA%_A7 MJ/BJVO+'1(;GQ2;_`%K4K25[[;-+$JKIDL+(]O,"4-FR7;0_NY/MC]N&QO/A MM=>!/C%HNDWNOZA\,M2:VU:QTZV$U]J&@W\D-O?1(Q^;]PZVE\4W`2'30#SC M`!YO^S?\`/AGI?B[1XO`W[1GB+Q7XBTC5?%-Q'-;:OX:NY[R:_GMI=7M9HHK M$1J+:^^RW!CCB22"6X1&)B<0#H_!'_!+KPG\.K+PO9V_C;XE7^A^'=)TC2=3 MTJZDTXVWB^'3)7DTUK](K$2*\#&-=UK]F\Q((UF\Y8PM>+_\%"?VI/&G[$GA MK4+'P_\`%SP#X!U"7X2^+O%BV&H:;:/+<>(XKC3[J.ZC\YT$XE:YNH(@-L9E ME=Y!<,GEBM\1/VD/&NB?MM^#/AS9_M10VVC7FDP^)$OM0G\&1V>N64D6JW3M M-;2Q1WUU"9([..-],"Q+9PS^;<)<*TY`/3G_`."9W@;XW_">S6'XQ?$+QAX4 MUZUUI[>\@D\/7UEK46OWT&J3R#R],>&:'[1%"Z+L\DPLZ2+-`S(='P_^SC\/ M?^">_B'0_B1XZ^/>M:'INFWNMX?QUJGAS2-,N[G7;B"ZO4DFCL+8;VGM!<+' M%(OSEA_JPJCY6^&7_!2[QEXEMO#>O:K^T]X%EL-)\,_##4[^QM=-T2W74[O5 MM7ELM6CU"1I)V&4S-BT:W%NOV?A=LGG_`&U_P4]^*7AOX2_L=:[J/BKQ)H/A M73[K4--BAN=5O8K&WW_;X'*[I2`9"@=L$8&SMC=0!EW7[*MOX0\3>+OBA)^T M9\3O#_@_7M2A\9Z]9F[\.6>@M;V\,`P]V--%Y%8BVM(D9UO59XT=FE)=Y&N: MC^P%97^F6]UH_P`2?BAX:UBT\7:IXLTG5-(ETK[5H4FIBX:\LHEDL);>YM9) M+F5MMZEP\;LI293%'M^7OVROVJ[/QX_[2G@/Q=XT\&^+?!=Y\-=8UVPT>/4= M(U"TT>*UMHFMYKN!H8K^R>2>7?%,[7MK,_V9H9[9]L4OGG[27_!5[Q+X!^)? MQ8C\(?'[POI6GV/@+Q#D?]H/]JA:Z:">^NY( M[AGEF2SDMHHC*`?HY^S)^S1;_LH_#?1?".B^+?'&M>&?#FE6^F6=OXANX;MH MPKS,]UYWDBQ32&&W^SEIIW\\4?^"> M_P"UO>1+^R[X/L_B!INI>%M=^'FEZ/;^$[+^SX+VYN+>PE$]]+I5Y;Q:D;!E MM_W5_8SRP%6YM3'FYH`_2R"ZCU:S26WG,D`<= M,=-"O#?V&[,Z7\*]M?17_!3J/'_``39_:(7[[?\*P\1 M`DQ_,W_$KNNIP0?H`<>G.*^=?^#789_X(3?`OAFYUW[IQ_S,.I?Y^GK0!^@- M%%%`!1110!X1_P`%-F5O^":_[0BJJ^6GPQ\1,(\?>!TJZ&TKC('TYXQCC!^= M?^#79]G_``0F^!?S*O.NC+?]C#J7'X]/K7T7_P`%.MS_`/!-;]H@-GW'//SK_P:Y;O^'%?P+Y&W&OY&.<_\)#J7_UZ`/T`HKRG M]J+]I#3_`-E_X8/KNK07VK7VH:A9:#H^CV"/BU<>"_CAH/A'X8:U>>'+KQ7H^H:?XP;6-"U"QLY M$COMT]S::?)!-;&:T>1'B*&&X5ED)6X$8!]*45Y#XG_;6^$/AKX?3>--2^*W MPXT[P9;:J^BR:W<>*[2'38]15&$EE)<"7RTG3:W[LMNW*P*A@K%OQR_:JT/X M3_`RP\=:/)_PG%OXDN]/L/#5MHUW%/'KUSJ,T26*PS^8(1#+YT3RTAW/ M]WB@#V"OFC_@J1\+/"OQ9_91_L_Q=X7T/Q7IT/BGPZT=MK5A#>QJ[:Y9PR2* MLP\MZB53Y>^:/4^,'QS_9=_:(^&XL_'GBK]GC MQSX2BT^'Q6T/B'6-'U+3%TY+MK--4'GEH_LR3O);+/MV^A?#R<>&?'=IX"\.Z-I=D^HW]U M<7%CIU^EW.]YJ6F6^3%=2YLC+"0TL:B<^3_I?L'@SP3^S#X"M-6^"?A_0_@' MHZ^*)7;5OA]IECI-NNLR"V@>7S],C4&3;%):NQDC9MCQ9&&3/E'Q3?PK\$OB MYX_^%EC^S9\#;[PCXP\+PZS;6T=Q!!)\0-08R1VFF76F1:7(GRRVYW7+R3I! M;0M.0%CE6,`W/@5^U9\:OC%XATN+4;;X8^`YO"HT_2_&N@:Q/)'?A M3\+]3^$NK?$SP=\"/AW\4K&,^&?!EM:W%G<2:81&T*:=H][/:VMP4:!XT$,$ M$9Q)L",IYSX-(_98OKR]\)_8_P!GW4)O@K)[O27M]'W^`KHL]Q+J,L6T? M89F9&G>4I&RE7*`/,KS]K?]HGQ?H_Q>U;P_X?^'NGKX/\4VOAS0M`MM+F MU;6[F&:PT?46O9?.U#3XYYH8+Z[+Z?'Y;F3")/+Y/^F?1G[/_C[6OC!X'TGQ MA-JFE7>CZ_HUM/;6MGHEW97EI`_%OB(6WBC4]2DT9M)U[6X-[>7?S,#%+>1%6($S-( MK;A@'#'M+^Q'@OX=Z/KOP#\"_#/Q+>:QINF:?IW45\8>#/^"B'Q2TSX0^&?'OC+X->'-+\*^*/ M$>C:+%>Z1\1VU1=-2_U6/399[L7&FVFQ8-X95B\T2'[[1@F4>[7_`.U_\*=+ M\$^%]?D^*OP]AT'QQ,+#PUJ$WB6U-KKT['RXX[283[+E]^Y"$8LS]Q@"@#UF MBO*?&?[8GPG^'6OWFC:[\4?`N@ZMI*W%Q>66I^);*UN+9+>!9IVD2656$<,< MD+.RG"[QO(!8FU8_M3?#74/B5X=\%Q_$?P9<>*O%NG+K&A:1#KULVH:O:%&= M+FU@#^;/`8X9I?,"NFU6.XJ*`/3**X/X5?''PG\>O"@\0>#O%.B^*-!666,Z MCI&IQ7=HLD`"K8KO*`/R+_P"#-`^7_P`$U?B4N53_ M`(N_JHVD8S_Q*=(X'3^70'@=OUTK\B_^#-`^7_P35^)2Y5/^+OZJ-I&,_P#$ MITC@=/Y=`>!V_72@`HHHH`^"_P#@YK'E?\$,_COPL?[C2?NGKG7+#Z=?YGOW M]R_X)1R[/^"67[,XW!2WPK\+P\#^'=0U;5]1M]*TG387NKR\N[M88[:)=S%G9N$CQGY@<]/2O M/_C#X:TW]HCP9?:3X=\2:*OBCP/JMCJ-CBS:&G@O5S(VM1I):B06DB0DF M0@;S)A@5!P<$'_$DDGA9M&.@6<' MV)?#%G>6NGS3WJWZOY]Q+<,B1PS7EW."J"VMX)9(P#ZPF_8:LOB_XG\9:U=? M&3QX+[5O%>BZYK&CZ1=:#/9Z!J>CR6]U;6<4@TOSUC4I:C9,QF>((2078'AO M$W[&7PE^(_@?5+2S_:8\86*^*;34_MNJ:;XC\,O+J^C^*M1:5;7;)826YMY[ M\RBSF6,3A[B5(K@AVCKSCX(?M`V_AC]I'Q=8_#KXK^"-/_X33QI-KLO@:TM- M.O;`:1>^&[2_D\3W'D;+GR1<[)/M1NHK:X61D?=/,KCA?`7[;UC9G1?B):?& M#X8Z?X\\7>#/A1<^-=>6+28Y]=BDUZ^M-1,B>._`'PQU[Q[H/QT\5:QH?PI^,OB&Z^)_A2 MRTO1;R3^PVU:?S;<0QZ<]W"T,)2[\H,;B:"2.OA=^Q+XJ M\?7'B'7_`!!J>L2R^(+1]:TRVCG\)Z)=7,>W%K#;P"3[%8L9V2<&4M&RR,)M.O6A3PZK-! MKUU'=ZB,C2&/VI4U2WN=)UO4O!GCH M:)HD^G_$O6;>[1;?P^\L5J+6\*JZ6^-,CMYYW#+&XE@E0XNI?MD>.]:_:`U# M1-<_:=\-?#[=\46\$2:/IUCH<9T?3I/"<6ISY>Z%P[7UIJ$@@$TCM"'\T20N MSK%"`?4>H?\`!../4?B2OBB;XO?%=]63QA!XS!\G0_+%[#I']CI_S"^4^RMR MIZMDYX)IWA#_`()N:#X(\*:?HZ^.OB1?6=CX)M?!'^E3Z\'>"]6U3X3>&_%O@ M[P[INCZ7=77C37IY-6@NK+R)/-N=06XN+2%6M].CM[@&:**,PRK*9Z/[5G_! M4_Q]\+OBQ\8+2T^,GASPIJ%CX'\23V6B>))-#*^&]=TV/39[:*VL81]MD#Q2 MW9AFO+IQ=R>9*MG]DB1I0#[/^+G_``3BA^-?A(6.I_&3XT6>NZAH.H>']<\0 M6EQI2W_B/3+MHS+;SP2:8UE'Y93]TUK;021[G*L#/*6]T\&0:3X,T:T\(Z?J M5U:94FKUY=)UVPNO@OXRU;Q!KFO>)?$GCZZ;1Y=3TRRL+_`$SPY?V= MW-)I)$,%NRV\=O!;3R";=(9[6,DLT<(`!]?4444`%>$?\%.H\?\`!-G]HA?O MM_PK#Q$"3'\S?\2NZZG!!^@!QZO"/\`@IO&#_P33_:&VIB-OAAXB"K@ M_P#0*NN-N#C\B>V.*`/G7_@UV&?^"$WP+X9N==^ZM?H#7Y_? M\&NPS_P0F^!?#-SKOW3C_F8=2_S]/6OT!H`****`"BBB@`HHHH`*\(_X*>*1 M_P`$U_VAE^:1O^%8^(PQ;/(_LJZZ#!!.>H`_#H*]WKPC_@INH;_@FG^T,JJP MC_X5AXB"KM`7_D%77&,$^G!![<=:`/G7_@UV?9_P0F^!?S*O.NC+?]C#J7'X M]/K7Z`U^?_\`P:Y-_P`:*_@6-IZ:^<]A_P`5#J7^?PK[OOM1M]-TYKNZN%L[ M:UA\V22:;R_LR$#YI-QV\88DMTQWH`T:^2_B+^UG\0-:\3_%;5?">O\`PF\% M_#WX):J-%UF_\=F>*'Q'=?9;>\G1-1CNHHM)@C%S%;"ZDMKTB8R_N,0;9O:O M@Q^T_P##[]HS0KJ]^'OQ$\#^/+;3[D07%YX=UVVU.WBE(!$9,4C`%\G"ECCG MYLJ!7E/B+]CSQIX,^(OCS7?@_P#$3PKX+@^*$QU;Q5H'B3PA-XBM)]16WCM) M+ZR6VU&P>"26**%)M[2H[P1NBQ%I3*`;7PZ_;V\`^*H?`%I-XKL[C6O&VD6] MY%<:,)M4T`7,T;2-;#5XT>P\UFCF,<;3"5TA/EHP89SO^'IGP1TSP]<:E>_$ M!M*MK?4-.L$@U71=1L+S47U.5HK&6SM[BV6>\@G=)?)FMXW@E$,K+)LBD$?& M:Q_P2P\"Z-\4-)\17LNZ'3XI M(AF4+;R!B)'C>%I2:\\\+_!+2?B;\'/#>M:;^TW\'_&E];ZGX0T30_%=GHMO M/97-AHNN1SV4$J0:J!1B`?05C_P`%)/A'<>/5 M\.QZIXVMM2AT^6_F6;P)KT,"16]O#=2QO.]DL"3Q)<1*UOY@E5YXX?+\V1(Q MZ#X&^,^G?M!?"Z\UOX?ZH(Y9I;FRM)=7T6Z@DTC4$_=F.[L)1;W4;HY9G@E$ M;XSN:/((^,YOV6)_VA_VP_C'H>K6>I6MCXMCOK"[MM?^'.NKIVGVQ-FZW,%] M->MX>OH[J:SL3-;VUJEU<(["9P8)*^IOV=OV:;K]G/\`9VN/!^B2_#'1M79K MFXB_X1KP)'H'AFQN)R1%LT>*X:3R\;#*)+HR2DR;98@ZB(`^;?V"O^"C_P`0 M/VFIO!MFOCGX%_%;6?&7AR[U'5O#WA2RN-*O/A_>1VZR11:K(+[4S%#-+F#, ML4,LDZ);>'XM!U>P@;2FM?[3U5IM9N)OL,4$S2.D2VB2-Y;O M)MB45)\&O^"68FMXEN7W/)'@$+$\%PLF9X3;'T2?]OWX: M65MI[7U_XHTNVUG49=-AGU/PCK-I#!ND2-9[AYK;9;V;S2+''>3[+:1@5B=P M#CP+5/\`@D'XJ\1_"+0?A[K7Q2\"ZMX9T[PSX+\*7EG<>`;I1JEIX;U#[>B[ M1JP`6Y)V2``A%`V^@W+[_@E7?^(=1^']QXK\2_"KQQ/\.XVT+3K[Q'\*H-6U M"PT6.6![-;62:]>.WU6((P^VB)XY3)&SV9,?(!I?&+_@K)X%OO@3XVUCX2>) MO#OC3Q+X3TC5-:@_M*&^L]$N8=,NHH-2D6^,'D3/:^9YAC20`A[=V,4$R7*] MQXN_X*:?"+P;X#NO$&H:YXH%M9ZK+I%S9VG@_7+G6+26*U^V2S2Z:EL;R.U6 MU83FX:$1&*6%ED*O$S^)_&?]C1?@S\*+RZ^)GQX^&?@_PF;/QEH]WJ>J>'?[ M'MXI/$^IIJ$3":XU7RD%O&Y4O((M+TV*/38=9+I.DRQO:M=W=TAO)V80LPM8 M[8`^GOAG^V[*GQ,^(OA_QZMOI[:/X_G\->'I/#^GZEJENVFIH^E:@MY?SQPN MEH-VH%I)IA%;1*RH9)`JRR2/_P`%2O@KINGZ7]I\6:Q;:IK.IS:7IF@S^&]7 M37]2N4MC>8BTY[47DB/`0RND+1/YL(B9B\8;S?X>?\$O?%GA7XP^)/'ES\3/ M",^O?$&1-+\5_8?!-Q;IK6CC3+*R:SC#:M*+>=181SV]P"1$T\WF13^9Q=^! MW_!,/4/@/K/PWNO#^O\`P<\.P^"_%K>);NR\'_"B+PZGB*!=+O-+7S5AOC_I M;1ZC<&2Y;=%Q;^7;P!)//`/L>%EDMBRF3R2&!Y9F;'`*G.>0,\XZU]Z5\%_P#!S7'C_@AG\=QL5?W&DG"C/_,< ML#GI^/3KW'6@#W+_`()1[C_P2R_9G^4LO_"J_"V<-@@_V3:?IUSSVZ'-?05? M/O\`P2C.[_@EE^S.H!S_`,*K\+'J5&!I-IGD?R[_`$S7T%0!S/BOX8:+XROM M$N]0T^&2_P##E\-0TFZ)$=Q:7`B>!FC=1F/?`[QMLQNCD=2,$@]*R*Q4E02I MR,CH>E)'"L7W55>`O`QP.@_"O-=$_:G^''BGXKZMX#TOXC>"]1\;Z#&IUCP[ M;:Y;SZMI@\R.-GFM5830KF2,;V"KF6,X.]=P!Z6$4.6VC<1@G')'^2:^8/!/ M[6?C#Q+^W-XL^&UYJ'P_L-)T.Y6Y_L.YCN;'Q)#HQLEDCUR&6:;R=1LYKYOL MQ-O"J6SH8W>5]XC^H*^8_B=^PQK'QP^-&D7_`(J\'+/6;;Q+IFI:1)#H^JZM%9?VC:0SVT4ETC(9T@N$/V9G20^9,8FB M;UGX8?M1^"OC7XWU[PWH>HW%QK7AO#7:7NCW>GICIY] MJ\\?4;\G->$K_P`$\O'E[X&AMM4^+.@WGB_1X_#>G:3KLW@AUCCTK0]2BU&! M+V!=0!FO99X29+E)H82#F*WC^;,GP>^!/PO_`."6E]XH\:>*O%_P)^'7AGQ! MTOP7XF^!MU9?#O68(-+T+4?!VHP7>LQRV-M?K#+J":P5MB1<"$W`LY1 MN!D\DC]T/)?A_P#MN_"GQE\1[/XM^(/CSX@\,Z#XETOPCJVH?"AK"VNX8-=U M$7,=AYLRV\]W))(;)'2TLY%\L:>]S*&AE^7J-,TWQ'\5+GXD>/OAQ^UO\$8_ MA[\4/$5G;3ZKH/AF#4;[3)3':Z9;V%IJ1UM['[?*HAB1I;24-<2@B'!CB&[X MM_X)BZUH\NDZ7\-_'GA?PGX+T'3?"&F:=IVH^#[O6+Z(>&]9;58VDNTU&`2& M:;(?=%N;)^8DG(!ZW9?M^?#*[U>ZT^;7-8TJYM-&?7ITU?PYJFEQM:JD,27,0FB62V5O/A+_`#Q(1MK(\'_\%$?AY\0OB]X#T'P_#XJOE\=6VM7" MW4WAG5;-M(FTN6.&>*_BEM%DLW)E8`79A`"K@9EA#^7>,_\`@FCX.\5?M*>- M+J/7?A7HOBCQR+KQ-HUY#X%LO^$^M[B*6U\0W6GZ;KF@:_!IWA2;3['4[#4EM,Q62_ MVA));2*UA"YDFEO,F2X.(LQ>0`5HO^"IOP1T_P`/W.I7WCS^QX;>^TZQ,.I: M-J.GWFHR:E(8;"6SM[BU2>]@G>.00SVTZ M7I_B;3[5?)`_MG0;_19"\D<5PI$-Y##(?DN(M_'$@DA/[V&9$^5K[]@?Q4/" M_A;2=<^,_@U_'$%_X73H[6R:TDL+79'N6XDDFE$Q#K M,WFJ(4"LJ>7O3>0#IU14&%4*,D\#N>361XIT.W\3Z#>6%Q<7$5CJ-K+;R/#= MO;N5D'S,DJ,&5E4,05QC/!&.(_!WBO3O&OAG3]>TG5K'6M)U.WCN;2]L[I9[ M6XB8%UE61/D96C8$'&#\O/0UM1PK#NVJJ[CN;`QD^IH`S/#/AK2_!/ANSTG2 M+2STO3-(C$5K:PPK%#9PKD!$08"(%!5<#``[BM6BB@#PC_@IO&#_`,$T_P!H M;:F(V^&'B(*N#_T"KKC;@X_(GMCBOG7_`(-=AG_@A-\"^&;G7?NG'_,PZE_G MZ>M?17_!3Q3_`,.U_P!H8LJ[I/ACXC4A5+<_V5='!.#D>F1^!SBOG7_@UV&? M^"$WP+X9N==^Z$?\`!3Q2/^":_P"T,OS2 M-_PK'Q&&+9Y']E7708()SU`'X=!7SK_P:Z[7_P""%/P+5MI)_M]@I]O$.I<_ M@?M#_""'2=%O[70_%GA_6K/Q M7H%Q=+*UI_:5C.+FW2Y6-EDDMY"OE3+$V[9(P&>E?/'[7?[$'Q7_`&X?AEXZ MU+XA:'\(;37K?P+K'A+PCX8@UZ[U;1HKO43")=6O=1FTV!_,A^SQ>5;I9E(W MB:1I"95\C[L,*M)NVKN'1L%_BI^R/)IGBSPOX=\26, M7BOPX8K36;""]A,AUBTA+JDH$8)@ED5F'_+-Y5/RY%`'RA^W;\+-4^$?B75I MO$^H?!;X7Z=\0?$W.A7$22RK`%C@@A,\D M(9XY(&MN?L_]I3X.:E^T7^SSH3:;<0^%?&WAV]TSQ=HHU+-Q;V.I64\-REE> M,FYOLY*B"9E&X*YD7YT!KYB^+=CX/_X)X?M@3P_`FS\&_#];_P``:CJ'B_P[ MIFE71\,Z9<"]T^WT:_ETK357?>SRR7EO''$@GO?*,2LICWQT(_\`@I#^T1J_ MPS:6WT/X6:7KF@>%?B!KFJ7&K:=>1M-?>&=9@LUA%A;WY_';X.?&C]J+X.VNC^)_"OP?M;R/Q?X=U5_#DWB:^U+2[BRT[4 M[?4+B0WDVEQRO-)'!'`L`M5C7]X[ROYC1)YAX]_80^.&I^#=;M=`LOA-;ZQK MUC\1O#TL?$VL6^IQZAE--W37,#K*KVO[E9?,#?:LDL#XL?MC?"WX7^"-3\>:KXW9+**SAM;A]3M8/#NGW<4FI-=:AI227DBRK&) MDFE,5O:@)%=_9GDKV7]A46R_$#X[:O9VTT8U[QQ9ZW<1OJ;Z@18_"3]@GXH?#KXY+XA;PS\$5^T_%:+QMJNJZ5/= MZ3-J-J?#`T:ZF2U%G(4N)+F2XN?)>[=&$TJ&5MS2-M_M<_L/^/?VG?VJ;[QE MIS>#_#MSX-\+BU^'WBVP\236_B;P_P"(%9IBSP'3Y85L;B.4PSPM+,)8"=\3 M[D$6;9_\$Q_V>S^W7=6"_`_X9QI:>#+758;F/P[9K=+J(U25C>_:`GVC[1\L M;&7S?,(."3FN*7_@I3\:-7U[Q1::/IOPX\0VD>K^$/[!OI])U+1[+^R-;\1W M&D.X>2::>_*&"$)\1>!_$OQ+\,?#C M^VK*VCTO6].T+XG^)M-TBU6"[AO%U..&VMK8Z@?.5V^P7A2,&&`B[RS$!M8TOX0ZXVE>'/%7ASP/J.I:K="XUB+6[V.X\[4XS8N+: M6T:&*8-%]J$\\*R_Z,RJU?1GP1NV_;#_`&7M2T/XP:/X3\6J^NZMX9UFVLK& M6WTK61IVKSVH;[---,Z12?98V>*2:56,FTNR'GX_^+'[`GP5\*?L`_M8:_X< M^%O@SPIK^@Q^-;6TO_#>GKH-V8H;=Y$M3+9E2UN2D:BVD/EL.,#<<@%3]NKX M6:Q\)_$6J7'BC4/@K\*[3XB>(YKRQN[OX@CP[;SZ8/#>GZ1?:7)?W6B3V\$L MJP1,D,=J\TL`E9)(&MR3^C^CZMK5[\,8+[2M!M[?69M-CN;72=1OI+%$F\K, M<%Q*(I9(U#?(T@B9_EYC."M?'GQ0_;<_:$\#Q>(O"/AOPGX*\7?$JQ\62V6G MKHUG'%I]S81:/9:F8&34M7LE,H:[:`W$4[GR;=IQ:J:4-/-U;3:K'<.=1"K=R2M':6,(M%\4Z)JFIV#^*+NXTB MZTW3];M]4P)7TPRO)(;9(VA>'803^]/(KC]1_8)^+6I:/XDM6TWX/WVE^/;3 MQCX?UW3KS6+[R;32M26)[MH6=643>2 MCB.$LT8\5^&WQ"UWPW_P43F\5W7P]\:>'_"7Q:BO/#TWBC4KK29M)U::RVRZ M";40WLMW'&UNFJR_O[:/#WBK@%3D`Q?#7_!/KQU\//B^-5T/P/\`!B\\/P_% MJ'XAQW%UKTMK>R10>&4TA)9DCTF1?MAN#->96;&9F4R$R,3QOPU_X)L?M!^% MM0^#2ZI)\*;S3?AS#86]Y'#XRU&UMYQ%I-]I5VDEO%I:G4))?M,4BRW$Z+$D M(@A@MRTTT^E\4?\`@I[\6OA-\&)-5O-0^#>K>)_^$:^)$]E8W%A>Z'#K6H^& M-6:WBGMLWL[&&33E>[>SR\K%`5N(HF>6#ZD_9;^*?CCQQK_Q,T7XA-X3EUCP M;XDM],BD\.V\]O;O;RZ;97H4I<2/*[1/>-#YZ,JS&$.L,+%X@`8/[!_P"\9? M`'P1XBM_%TFEVMO-J\=QHMA;>)YO$S6,"V\-NJOJ=S86MW<%E78JW"SR1QB- M5N)%*)#](5']CAW2-Y4>Z3.\[1\^0`<^O``^@'I4E`'Y%_\`!F@?+_X)J_$I MX&DVF>/Q_45X;_P,O&/Q-_P"$XUCP1I>B?#:YU,Z]I<0N+3Q!X-\J=?L4=ZDT MA\^*:T22YCNDBCBG26,('*&2;8N_V[[7QAXR^&,G@:^T^;POK'C&[\,>-H_$ MUI?Z+K?AYH]&N]2AB-A=P6\\$K>1"V;D+N@=62*;SQ(G/>+_`/@G%K?Q8\6: ME?>+OBO7WB=M;\4S:=X.EL[75K;^Q[G21:6EO M]OD:VD6WN'?S9I;L^U?!']I?P?^T/I>H7GA74-1F.GW45G*3R_)E)^1VY(\]_9/_:4\7:YKOQ&\-_$ZZ\+ MG6/!E[->V&JZ+:S6.F:MH8N+BV%PT<\\[P7$,UC>0S1M,RKLB?(\T`6/V(?V M/K']BSP;J6CV$[6X2!"JR7,$W_8B\6>*]8\.ZEXV^(^EWVL^'=+5M%U!TN+G1[B. M>[O)/+:ZCM92\;J66U1"`)&)`.7^&O\`P4BF\`>`?$WC#XT7-KH^EMXEU+2_ M#VB^'?!NMWVJ6.GV0\R6XOA#]IDD98-DDLHMH(H&)5F((D/HUI_P4<^#]_\` M%6\\$VOCJSN-=TG5+G0KU!:7?V6QU"VLS>SVTM]Y1M5F2U\R18I75G%O.1DP MR[/FS]J+]@;Q!K/P&\2>'/BI^T5\)_#_`(;\>^)M1E>WU/P5-I6E:A>:NCQQ MPO!-K@6ZN8WP]HLKLB2J9##)/'!+;][X7_8(^(>HPKJD/QL\(^;J/BU/&0O] M#\#2P2C=X:70,6.]L+C2GU%+!+5C,]Q`D";&;,NPE*[ MOQ'_`,%-O@S\.M/UK4/%7BZ\\)VF@Z0=8OKC7/#^I:9;I;P^494CFGB19[J- MIXUDLXV:[B>9(Y($D#(?CKXT_P#!.CQ!^S;I*Z;K'BA-8TWQMKW]MWVH^&/A M#XNUR+[5%I$.F3PW\>DZU)JTPOHHXI9)KB[>*::&Y-R)6FBV^LZ[_P`$T[+X MRW'QBNM$\0?!;P[XM\>:+=Z-KU]9?#JSU#Q5X6U'4]/MUN+:XU..[626U6&X M$T%J4BE(DMCY\L(V2`'U-]1L;V_TW4-8_ ML>Y\,ZJNM6=EI]Y]BNY;G3_LYN[5(9PX=IX5.R.:4?NH)7C]%_:`\!:Y\1OV M8_$7AZ;QN?!?B*ZTKRIO$UA'/9Q6DJI%+/,BPW2W-O"VUP52[65(V8K,"JR# MXQ_9Q_8+;XG?";4]+^&O[1'P/\0>$M5\,^-/#]G_`,(9X*\_2K*'Q)>Q3W#0 MK!KXLF6-591MRC[Y,O0!Z7XJ^/%A\._^"K/AVS\)^*M:\3:M\4[FW\$ M^+M/O;-_[#\+VUAI.J:Q9165Y#IPA>_9IYIV@GOVE$%V&^SM&8Y(/4_$_P`> M/'GPV_;GTOPAJDWAV]^&?B[3DM]*G@L)H-6TG5F%R\4-S(T\D%91% M"4D$*'SBXKBH/V#?B#I?Q8\,7MO\9-*C\(Z'XR3X@3Z%!X("ZEUFN85N6CCN%'DE.S^/G[+WB[XZ:[XVL[WQUH.C^$=?TC3 M;70H[?PQ/#K&@:M87'VZQU);QKTQ3M;W0\_RA:1`[(U,G[M\@'F_Q\^*_B7X ML?M@ZMH-QXWA\+_`WX;^&9=5\56%OI"W5UXUN?->"2U=WCE>.SB8(NVWC:2> M5;B%B5"BM[Q;_P`%+/V+9+;Q1'H-Y_P#!*_Q) M!X472?#OC#X/^"K.Y\$>)/!SZ?X8^$[:3H\;ZW)8//=6UM!JB>6$33X&$
._\`@I9H.D>-?`5QH-Q)K7@G6-?O_#OB&<:-K4WB!+V' M2CJ%HFGZ5%:BXO$FC19C+"C1O`1)$KI*\D??/_P4$^%-K<:#YGC2&.T\46`U M6QU2>QNUT=(#!)2*\XD_8*^)6C?$+5?&FE_ M%+P1'XLN/%=GXHLYKCP)=W&FV\J:$-#G@EMUU>-IA*BI(A6:,Q,OSM-A6JMH M_P#P2@TOP;\4?#OBK0+KX>WVJ:#HUO:1:[XF^'UIKGB1+NVAD2&YM-1$L*VD M,CR!Y;>.$%B9?*E@W;@`>T?`K]L;P+^TMH6G:QX)O/%FK:/K5B=2TS4I?"VJ M6>GWT)6"3?%=7$$=N^5NHPH+GF.;`/D3[,G_`(*>KN_X)M_M%?*"6^&'B,?< MY/\`Q*[KO@Y^F#CT.:N_LK?!/Q1^SI\&?A[X)U#Q7X<\2:7X'\-QZ!.]GH$M ME=ZI)!%%':W$;?:YA;J((Y]\1$K222*ZRPJ#":7_``4]^;_@FW^T4O#'_A6' MB/C.X_\`(+NOX<'^1SZ<4`?.G_!KL,_\$)O@7PSV<>F.]>[5X1_P4ZCQ_P`$V?VB M%^^W_"L/$0),?S-_Q*[KJ<$'Z`''ISB@#YV_X-N?\%3/#=]XK_9=T^Z2RO-<\'Z/XMT#5?&5A;0-+O%WQJ_9Z^)7@QE\`_";Q M%'XJ\=Z8MOK'AI[L264FDZ=).K+;W6H+_IQ@@,[M;_;"TB;)T6;(_:3_`&_/ M&_PY\"^--!TW]I+0)M2T;QQ_9T/B:WG\):;/#'=^'+2^L%DDU$#35LDOI+G< M'S=R0P;(9)Y(Y&/ZH%%+AMHW`8!QR!_D"O*?CK\"=1^,&N:#J&F_$;XB?#O4 MM#^T)%<^&QILC7<4^TRQ317]G=0-M\I-K1H)E`;:^';(!Y!_P4!\..?V+/"L MFH76I>//".@>)/#&L^-;LVT=U)K^C07T$UY>316L21RQX5+F58%6()&^$\M? M+;R3]N+XM?`GXQ_#.+XC^!_%'PIO?$#>/_`5J_Q#LGL=2TR*^M_$-K]G1KI) M52XN[6VN+HLD<@,<%Q(9&CBF`K[^\/:!:^%-*L=/L8O)M;"`6UO!D%E12!G) M.2``O_US@#29%8J2H)4Y&1T/2@#\K/B'_P`%#/$OPX^%_B#5+[]IR3[/8^%_ MB-HFF:HT'AQ6O_$FAZW:_P!D)&JV)2749M/ED22`+YE`'Y:?%[_@H%\4O"7PR^+OB'0?C1 MH^GZ]X5\)^*[KQ+H&MZ-ITD/PGU.PN_)TN...*.*X"7B+(L']H&-QIT/B>UN/"6ESPI=^&[2^LDDDU` M#35L5OWNMP_+ M8SG])/#NAVWA/1;'2[&,P6.GVZ6MM;Y!*1IA1R3T"A<>@_`#19%8J2H)4Y&1 MT/2@#\Q-?_;U\67GPWATE?VA(]-U31Y/%]EH/B5=/T>^7XBZYIFJR0Z=H-U' M':^2;B6V>U8VMBEM>7@E;R`@0L35?VQO''B#]H/4-%U[]ISPWX!W?%)O!4FC M65IHD?\`9&G/X4BU.0%[I;E_MUI?NENLTC-")/.\R!F=8H/T[5%0850HR3P. MYY-+0!^3/PR_X*X>(O%_Q4_9YOI/C%IJ6OBO1=*@\1Z'J%UHEKIVH7%WH^H3 M+=PQ1PR:C=.VH06\4CP26UK%*\=I$ES.TR1?7G_!+W]H37OC[\'O$']N^.(? MB)J_AK5_[.N-;TS4=)U?3+JG7N.M?>E?!?\`PX_\$LOV9_E++_PJOPM MG#8(/]DVGZ=<\]NAS7T%7S[_`,$H]Q_X)9?LS_*67_A5?A;.&P0?[)M/TZYY M[=#FOH*@#G_'7]J:CX(UJ/P]-#%KDEI.FGS2.QBBN3$?)9N"-O*L>V?4G-?F MU\&_C1X0U#]E/]FCX0>&]3^&.E_&3P1XA\/PZU\.O&VEG5?%^C:Q%,HU'4H; M:*^L[N.X3S;V]DO0DD,]L\K8,,SE_P!0A;1@8\M,``#Y>@'(_+MZ4^@#\P_# M/[=/Q9C_`.%F7WB[XL>$=%\-P:U8:=JTFAZE;:OKGP@B?59;:6:]M9-)BATZ M,0M'\NHO>MB*>X\Z6W@D"]!\+_VK/B9X_P#COX$\)M^T!X<.GZEX9\7:]HDM MKI&G_P!I>/;?2]7LTTV^E9HY/-MKRT^T;CIUI"DT=O&K?XA^#=8T"\FO8[77;26RF:TN#;7-O%(AC&/V\/C!XV_9HC\6:)^TIX56'6O$*6PU_QGXP\&V6F^$Y8 MM+$L=M/(?!_@36KWQ'X/^S:CJZR1:7;WAUS3YV5K>5X)WCB2-Y'C_9XMS):!=/LK:'RU=Y<$PF4 M>=)\WRKCTZ@#\G9?V@O"?Q,N_BYXF\4>./A#\1;72?B!\,;J#XB^'A;V7A.> M^&J0K]CMT:2Y\F_MK/)OB/XXT;3?VB/" MMA;WWBGP>NE#Q-#HL]_I%M=^)YM-U:S2SMQ"UF8('MBT5Y/?3QPQJ9GMI[@K M%^O%%`'Y$>)/VV;/1_CYX)UL?%/0-;\5:?I7COP5XH^(5A=Z!#K^@Z%;>*]+ MBM-1GA2WDM+B6"WCDE96MTA$)OKA4B5)`_1_M"?\%!?BYX/M?C9JWA?X[?"B M/1O"/@G4-1T5-5U&VU;556"T@GT[64TVVTN"-(;TX3[9+?W%D\M[#Y,2-BT? M]5**`/RW\??''2-5^,.EWWBS]I'PCIJ_#7XE7&DQ?$UH_#MO?>'=,U+P@+HV M<=Q<1/;0QR7HE2(2I<-*D48D,TBK<"'6O^"ANM1_'/X/^'_B=\0--TOPWXBT MBTTWQQX3\26NBZ+I6HV5[HVIS)=O9WL,VHOYKI`LSF6TM8]R6Z17+*"0_2/[!_[0?Q+^ M.?[3FH>&_&?QT\&ZY_PB/P_\+Z])HO@VUMFL=4N;P:O#/<2W$T(NIX9$BL;L M/"MHNR>T9%2%]]W]XTU853;M55V#:N!]T<<#\A^5`#J***`/"/\`@ITO_&MG M]HA?E=O^%8>(@3P7;_B5W748/OV/4\>OSK_P:[#/_!";X%\,W.N_=./^9AU+ M_/T]:^BO^"FV)/\`@FO^T)'&J[5^&/B(B/:.0=*N@`5.,#\1TQQ7SK_P:[#/ M_!";X%\,W.N_=./^9AU+_/T]:`/T!HHHH`****`/"?\`@ISN/_!-K]H1CGS$ M^&7B-@`,A&_LJZY4[>3VZ'MQSS\Y_P#!KNRC_@A1\"PV57.O?-NVC/\`PD6I M8'7N?SKZ+_X*>*1_P37_`&AE^:1O^%8^(PQ;/(_LJZZ#!!.>H`_#H*^=O^#7 M1MO_``0G^!GREN=>&!_V,.I4`?H!7(_&#]GWP%^T+X470?'W@CPCXXT-9H[@ M:=X@T:WU.T$D881OY4R,FY0[@'&1O;'4UUU%`'S'\,K;]F?PEXF\3_`/PGX) M^'WAVW\07$MIJ_AC3O!*6NA:W<_95DG@;9;+97 M&/V"OV<;C0O.T?X'_!EM+U*QEBWVG@O3?)NK:9466(A8?F1TBB5D(PPC0$'; M@>)RVNOZ7_P4!CA\+Z5\4-)M?&6M7$?BW1K[1KFX\-?9DT^>&#Q-IFJF'R=/ MU(B*WMY+87"F:)Y&-HTCB\;PWP9\/_B1X;^#7[,NA^&=>^,_P]M?#NC0BXLY M_"'B[7KV77HKJ`WMG>R&^M(;>U8HT<4VJ";36BDD:/RTB61@#[YO?V$_@AJ7 MAS4M'N/@W\*KC2-9O8-2U"QD\)6#6U]=0(8X)Y8S%MDEC0E4=@6520"!79>$ M?@]X1^'_`(BU[6-!\*^'-$U;Q5<1W>MWMAIL-M<:Q-&NV.2YD10TSJO"LY)` MX&*^+/%/[/WQ4^&_PV^*FCZ5K7Q2:Z\!7FK:CX0UV[\6ZYK4GB&SU80R!/(% M[YUW-IUN+RWBMLAMZ6TD++/([UX3XI\-_%>'X?V]BOQ+_:L\4Z?8_#7QK?Z/ M/HG@_P`5>'Q)JOVO3YM$219FNM6:5'6]C1+^[::6*U3=$8+@M>`'WE\??^%* M_LJ^,(?C5XJ\!:7#XPNYH=$/BW0_`LVMZ_/),K0);O+86DUX8V(2,<;=S(N! MP*JZQ^P_^S[I/BW2;ZX^`_PLFUC7-7-RU[!\.+6ZF-X5:\^TSRI;9@7;V\K$2K'AT"<.5C/`_M!_M$WGQHOOAGK'@V/]I+PAX;TOQ?>Z M;JG]G?#O5[&ZNH7\.W8%S-:3V#7)A@N)K<1//&D,EQCY9A$"H!]:_#;X/>$? M@UH]SI_@_P`*^'/"FGWE[+J=Q;:/IL-C#/=R\RW#I$JAI7_B)/(-PNZOT5_:^TK3==_9?\`'UCJ5GK&HZ;=:)<[ M8-'T^[U#4-XB7R7M(K1'N/-278Z-`C.K*&!4@8`/.[/X(X+/6;;4/@]=+IEQJD%K(]M=3336*6]PL<"%5N@[1J)84613*@?FOV MJ-%_93\`_&27_A8_P1\/>)/&OC2TFOY[ZP^"5]XLNM3@2)(YI9KNTTVX$FU& M"$.Q.UD!`!K.\*W7B'2?`?[).I:>WQ6LY-3UQKGQ?8Q^&-0L?MUU>:1?BXNM M:ACLTDB`U2;SBMP;>VWS%RI*0-'I?MD:!JOQ#_;B^#7A[1/$GQB\!S+H>O>? MXH\(>$?[0@M?M3:>(;>YO+K3;VP@\P6EQS+Y9;!;X+$%N!)9QR+Y#AF2([< M#S(P_I^M?L;_``A\2_#KP_X/U+X5?#?4/"7A.=;K0]$N?#-E+IVC3+OVR6UN MT9CA<>8^&15(WMZFO@_XA?!&/]E[X]2:?X!A_:`T_0?AMHGPZTW1ET'2=+Q+.8LW`:6.- MR)2P+1JQY4$=-\.O@'X%^$&HZI>>$O!?A/PO=ZW)%-J,^D:1;V,E^\49BB:9 MHD4R,D9**6R54X&!Q7YGW?AWXA_"CQ7\1M3TWQ+^V%KTO@CXY>'++PE:WMOX MHO[-O#4W]FK?A%^S;=3LDAAU*.26Z6XVF"-UF\^Y^T7GZN4`%%%%`'Y%_P#! MF@?+_P"":OQ*7*I_Q=_51M(QG_B4Z1P.G\N@/`[?KI7Y%_\`!F@?+_X)J_$I MN=_?W+_@E&&/_!++]F?J5_X5 M7X6R!P<_V3:UGL=9$DL+0P7,<_E"5)(F25XEW-O\F;P M/2OVA?$7AZ^O_$_A/6!X)UJ?]GOP[JV@?#V[N;:.QTR+[3?+-=1/)I\E])#8 M1>66D*2(OG*9+=M\*K^EE%`'YX_"'XO_`!SU+P3X!\37/Q'_%7]L>"A MJ/@)]+\1:6-1N&/]B:Q-JC:1;+,D3F:VF>WMUM?M"PYC^6:%O+_VSO\`@H5X M\^!?@'XO>%=._:%LY_&'@7Q/+IVBWZP>'-):?R/#%G+]7!"HQ\J_*2PXZ$YR?U/YTZ@#Y&_;[UNS^+/[%'A+ MQ5%'_P`)-\/6\1^&?%GB<:=_I]O?:`+VWNIIR(Q)]IMXU$4[A1M-NC':4&PX M'QV_:O\`AO>>"_$WQ0^%'C'PY#'JU_H7A[QE\5/"KV6I6>AV)O&BWR7)26S: M6T25I#]I$BVJ7:O-MB*I)]K+"J-D*H(SR!ZG)_,\TI12X;:-P&`<<@?Y`H`_ M.3X2?M*_%;XG?M`^`_`J_M">'[&P\0^&O%VKZ!>QZ#ILMWXYATS6+)-,U5TS M^^M[NSDN2XL8[5)X[:YGMG1'ADAF_P""=?[<]Y\2-+^'_B[6/VB?#OQ,T74_ MAXOB#XFI':Z3:Z?\-K]+6V9&GN+14-D\C278DM]0DF+M;32QB"."1%^^/%]A M-XG\+:E9VNIWNF37MO-;I=67E&XLV90JM&)D:+S`2"%E4C)]`0><_9S^!5O^ MS)\"_"?@+3=6UK7--\%Z9!H]C>ZL\$EX]G;HL<2.8(8H]P15'RQ#(4#.<$`' M>QW*O"TC?NU7J6(XQUY![<@^X-!LX6=6,4>Y`O`QP.@_"FFSA9L^5'D'<#M'!R3G\R3^)J2B@!AMHR M,>6F""#\O4'D_GW]:\-_X*>@M_P39_:(&&*GX8^(P!@%3_Q*[KM@G]".G!YK MW6O!_P#@IN(V_P"":W[0ZI&@'_"K_$6`%^;']EW6`5P>/08/?CU`/G;_`(-= MAG_@A-\"^&;G7?NG'_,PZE_GZ>M?H#7Y_?\`!KL,_P#!";X%\,W.N_=./^9A MU+_/T]:_0&@`HHHH`****`"BBB@`KPG_`(*4:7+>_P#!.']H"UMHW>2X^&WB M*!8%!.<<#'/3BO=JS];T"Q\1Z1=Z=J-I#>6>H*\,\4\*R1W". MA#*RD%64J2A##!'!R#R`?`7_``:S:_;WW_!#CX/V\,@EETFXUZTNXU&7MY?[ M;U";:PSG)CEC.,9^8>M?H;7X2_"OXE?$'_@UI_:)\8^!_&'A'Q9XU_8U^(&N M'4/"_B2S3[1-X6FDCW&.0='D*QJDT,GEF1+9YX>1)"_W%I?_``? M;_'*SA\S(>&[\/ZS;,N>.]GGC'\/')/6@#[XIL<*Q?=55X"\#'`Z#\*^&_\` MB)1_8A_Z+UHO_@DU7_Y%H_XB4?V(?^B]:+_X)-5_^1:`/N5T61"K*&5A@@C@ MBEKX9_XB4?V(?^B]:+_X)-5_^1:/^(E']B'_`*+UHO\`X)-5_P#D6@#[FHKX M9_XB4?V(?^B]:+_X)-5_^1:/^(E']B'_`*+UHO\`X)-5_P#D6@#[FHKX9_XB M4?V(?^B]:+_X)-5_^1:/^(E']B'_`*+UHO\`X)-5_P#D6@#[FIL<*Q?=55X" M\#'`Z#\*^&_^(E']B'_HO6B_^"35?_D6C_B)1_8A_P"B]:+_`."35?\`Y%H` M^Y/)7R?+VKY>-NW'RX],4ZOAG_B)1_8A_P"B]:+_`."35?\`Y%H_XB4?V(?^ MB]:+_P""35?_`)%H`^YJ*^&?^(E']B'_`*+UHO\`X)-5_P#D6C_B)1_8A_Z+ MUHO_`()-5_\`D6@#[FHKX9_XB4?V(?\`HO6B_P#@DU7_`.1::/\`@Y*_8?`_ MY+UI/``_Y`VK]NG_`"[?GZ]\T`?;AU&&T@:229(U56>0R/B.,(W[QMQ'09[\ M8`Z"OR7_`.#,V0?\.Q_B',D5@.F=IX&#CA? MV_\`_@O'>?\`!1;3+W]F[]A_P_XL^)GB[Q_826>J>,8[*72[?1-/E$8G:-9H MHGC\Q2R/<3K$L18^7YA>,C](_P#@F#^PAI7_``37_8B\&_"?3Y8;VYT.V:[U MC45B")J>I3/YMS<8_A0.VU`6R(XU'.T&@#Z+HHHH`*^#?^#E;2[C4O\`@AY\ M>(;6W:1HK+3)2FW<"B:U8N[]-V55&;/3OD]:^\JX']H/X">'OVI_@+XL^&_B M^T^U>&?&VES:5?6ZD1R)!)$%+1G&0Z,0RM@%6`(P0*`/*_\`@D1K=MXE_P"" M57[-=Q93":)?AGX=LS)'(6"20Z7#%(,8(RLB.I![KZ@"OI*OPK_8E_X*%^/O M^#=?Q5)^S3^U9X?\577PCMM5NH_A[\1M/M9+BUDLV(;RA&NYI(?F\UEB:2>U M>3RS&R21E/N/2_\`@Y1_8EU>RCFC^/.FP^<24\S0]4A>,$YPRR6W7@]1P.,` MD`@'WC17PR/^#D7]B$)_R7S1\!0?^01JV<`\?\NVG;H#[TU?^#DS]B!-O_%^M'^4;1G1=6/IU_T7GIU/ M-`'W.Z+(A5E#*PP01P12U\+K_P`')G[$";?^+]:/\HVC.BZL?3K_`*+STZGF MA?\`@Y,_8@3;_P`7ZT?Y1M&=%U8^G7_1>>G4\T`?=%%?"Z_\')G[$";?^+]: M/\HVC.BZL?3K_HO/3J>:%_X.3/V($V_\7ZT?Y1M&=%U8^G7_`$7GIU/-`'W1 M17PNO_!R9^Q`FW_B_6C_`"C:,Z+JQ].O^B\].IYH7_@Y'_8@DVQ_\+[T?IL! M.CZL.N.I^S?J>1ZT`?=%%?#/_$21^Q#][_A?>B_W_P#D#ZK_`+O3[-^GXX[T M?\1(?[$*_+_POS1?E^7_`)!.JG[O/_/M^O\`%TYH`^YJ*^&?^(D/]B%OE_X7 MYHOS?+_R"=5'WN?^?;]?X>G%'_$21^Q#][_A?>B_W_\`D#ZK_N]/LWZ?CCO0 M!]S45\,_\1(?[$*_+_POS1?E^7_D$ZJ?N\_\^WZ_Q=.:BN?^#E#]B6S@DD/Q MZT4E"-Z)HFK2DGCA?]&Z<'D#'(/U`/:?^"IVL1Z-_P`$SOVAKR\DMX[>/X9^ M)`XDW*O.EW"[`_P#!L)8M;?\`!#/X&QLDWW=<.-Y1@K:_ MJ3(<9QRC[NN<8Z\5\5_MW_\`!2_QE_P<%:K-^R]^R/X?\5?\*[U;4K5OB!\1 M+ZP>TM8K'=YAAV.`Z1#RRQ1WCGN&@,2)Y>_?^QO[,G[.?AO]DG]GKP9\-/"L M1M=!\":5#IEJQVAF1(V!G89QO=R[,Q!+,S$YZT`>CT444`%%%%`'A7_!2329 MM0_X)R_'RSM89I9+KX<>(;=;>)#(7DDTR95"9[#.,`8YZ<8KYF_X-9?$%GJO M_!#3X-PV\OG2Z38Y8SCG[X..]??VMZ!8^(](N].U M&TAO+/4%>&>*>%9([A'0AE92"K*5)0AA@C@Y!Y_#3X5_$WQ]_P`&M/[17C/P M/XQ\(^*O&W[&WCS7!J/ACQ-9QBXG\*2S(#YTY[=!@]R>E:1_X.1?V M(8PW_%_-'_=E5/\`Q*-6.<9Q_P`NW/N>_?M0!]R>2HC5=J[5QA<<#'3\J/)7 M=NVKNSNSCOC&?RX^E?#9_P"#DK]B&&3_`)+UH^5)'_(&U9AR>?\`EVP?;].* M/^(E']B'_HO6B_\`@DU7_P"1:`/N:D"*'+;1N(P3CDC_`"37PU_Q$H_L0_\` M1>M%_P#!)JO_`,BT?\1*/[$/_1>M%_\`!)JO_P`BT`?`! M_P`@;5^W3_EV_/U[YKXY_;__`."\=Y_P46TR]_9N_8?\/^+/B9XN\?V$EGJG MC&.RETNWT33Y1&)VC6:*)X_,4LCW$ZQ+$6/E^87C(`.Z_P"#,V0?\.Q_B',D M5@.F=IX&#C]=*^=/^"8/["&E?\`!-?]B+P; M\)]/EAO;G0[9KO6-16((FIZE,_FW-QC^%`[;4!;(CC4<[0:^BZ`"BBB@#X/_ M`.#E;3;J]_X(??'B&UA:22.QTR5@H!#(NLV+R.<#.0BLQX`Y/6O7O^"1&MVW MB7_@E5^S7<64PFB7X9^';,R1R%@DD.EPQ2#&",K(CJ0>Z^H`KU3]H7X`>'_V MJ?@%XO\`AMXMLS/X9\;:5+I5_%&2KQPRQ;=T99<+(C#?\&['BJ3]FC]J[P[XHO?A#;ZK=1_#WXBV-H]U:2V;$-Y/E#<9(/F\UDB M:2>U>7RS&R21E0#]U**^#M(_X.4OV)];LXYE^/NDQ^<,+N\/ZM;/%U)W));? M[..1QGWJRO\`P:`/NBBOA=?^#DS] MB!-O_%^M'^4;1G1=6/IU_P!%YZ=3S0O_``:`/NBBOA=?^#DS]B!-O_%^M'^4;1G1=6/IU_T7GIU/-"_\')G[$";? M^+]:/\HVC.BZL?3K_HO/3J>:`/NBBOA=?^#DS]B!-O\`Q?K1_E&T9T75CZ=? M]%YZ=3S0O_!R9^Q`FW_B_6C_`"C:,Z+JQ].O^B\].IYH`^Z**^%U_P"#DS]B M!-O_`!?K1_E&T9T75CZ=?]%YZ=3S0O\`P:`/N:.%8ONJJ\!>!C@=!^%*J*I8A0"QR<#J>E?#3_\`!R?^Q"Z%3\>M M'PPQQHFK`_G]EH_XB2/V(?O?\+[T7^__`,@?5?\`=Z?9OT_''>@#[FHKX9_X MB0_V(5^7_A?FB_+\O_()U4_=Y_Y]OU_BZGV;]/QQWH_XB0_ MV(5^7_A?FB_+\O\`R"=5/W>?^?;]?XNG-`'W-7S[_P`%3M8CT;_@F=^T->7D MEO';Q_#/Q('$FY5YTNX7;D\,6.%_P!&Z<'D#'(/U^%OV[/^"EOC+_@X,UB7]EW]DC0/%"_#O5]2M3\0 M?B-?V#VEI!8[O,,.QP'2(>66*.R3W#0&)$\O?O`/M3_@V$L6MO\`@AG\#8V2 M;[NN'&\HP5M?U)D.,XY1]W7.,=>*_0"O.?V8?V=/#_[)7[//@WX:^$X9(=!\ M"Z;!I%F95W-*$CP92.C_AT[^RS_T;3^S_`/\`AO-(_P#D>OH"B@#Y_P#^'3O[+/\`T;3^S_\` M^&\TC_Y'H_X=._LL_P#1M/[/_P#X;S2/_D>OH"O$_C9\:OB=\-OB!H::/X%\ M'Z]X*O=5TW2K_4;OQ=G2Q3)'&XD/F7<1*JW``#.`9?\` MPZ=_99_Z-I_9_P#_``WFD?\`R/1_PZ=_99_Z-I_9_P#_``WFD?\`R/7$^,?^ M"E-YX%\&^(/$E]X1TN'PNUAJ>H^#=4E\2LL>N+I\Z07#:DWV4QZ;;DS"X69' MNP;.*>*+*;4M12+41=VFFVB/+"ES# M.L2FYM[F>(_9)62$7%N)9P`(BI`*G_#IW]EG_HVG]G__`,-YI'_R/7Y8_P#! M=']B;X,?"#_@J?\`\$^O#OA3X/\`PO\`"_A[QIX[DL_$&G:5X4L+*RUZ'^T= M&C\JZBCB5)U"RR+MDW#$K`#YB&_A`/T"_X=._LL_\`1M/[/_\`X;S2/_D>C_AT[^RS_P!& MT_L__P#AO-(_^1Z^@**`/G__`(=._LL_]&T_L_\`_AO-(_\`D>C_`(=._LL_ M]&T_L_\`_AO-(_\`D>OH"B@#Y_\`^'3O[+/_`$;3^S__`.&\TC_Y'H_X=._L ML_\`1M/[/_\`X;S2/_D>OH"B@#Y__P"'3O[+/_1M/[/_`/X;S2/_`)'H_P"' M3O[+/_1M/[/_`/X;S2/_`)'KZ`HH`Y'X0?L^^`OV>_#`?!'A'P/H]Q(9 MI;'P_HUOIEM*YSEFCA15+')R2,\UUGDKNW;5W9W9QWQC/Y&]`\5>';Y0ESI6L:?%?65 MPHZ!X959&`]"#7CW_#IW]EG_`*-I_9__`/#>:1_\CU]`44`?/_\`PZ=_99_Z M-I_9_P#_``WFD?\`R/1_PZ=_99_Z-I_9_P#_``WFD?\`R/7T!10!\_\`_#IW M]EG_`*-I_9__`/#>:1_\CT?\.G?V6?\`HVG]G_\`\-YI'_R/7T!10!\__P## MIW]EG_HVG]G_`/\`#>:1_P#(]'_#IW]EG_HVG]G_`/\`#>:1_P#(]?0%%`'S M_P#\.G?V6?\`HVG]G_\`\-YI'_R/1_PZ=_99_P"C:?V?_P#PWFD?_(]?0%%` M'S__`,.G?V6?^C:?V?\`_P`-YI'_`,CT?\.G?V6?^C:?V?\`_P`-YI'_`,CU M]`44`?/_`/PZ=_99_P"C:?V?_P#PWFD?_(]'_#IW]EG_`*-I_9__`/#>:1_\ MCU]`44`?/_\`PZ=_99_Z-I_9_P#_``WFD?\`R/1_PZ=_99_Z-I_9_P#_``WF MD?\`R/7T!10!\_\`_#IW]EG_`*-I_9__`/#>:1_\CT?\.G?V6?\`HVG]G_\` M\-YI'_R/7T!10!@?#GX5>%_@]X1M?#_A'PWH'A;0;(`6^FZ1I\5C9P```;(H ME5%P%4#`X"CTK<%M&!CRTP``/EZ`0+/;W"'JKHP*L/8@BKU%`'S_\` M\.G?V6?^C:?V?_\`PWFD?_(]'_#IW]EG_HVG]G__`,-YI'_R/7T!10!\_P#_ M``Z=_99_Z-I_9_\`_#>:1_\`(]'_``Z=_99_Z-I_9_\`_#>:1_\`(]?0%%`' MS_\`\.G?V6?^C:?V?_\`PWFD?_(]'_#IW]EG_HVG]G__`,-YI'_R/7T!10!\ M_P#_``Z=_99_Z-I_9_\`_#>:1_\`(]'_``Z=_99_Z-I_9_\`_#>:1_\`(]?0 M%%`'S_\`\.G?V6?^C:?V?_\`PWFD?_(]'_#IW]EG_HVG]G__`,-YI'_R/7T! M10!\_P#_``Z=_99_Z-I_9_\`_#>:1_\`(]'_``Z=_99_Z-I_9_\`_#>:1_\` M(]?0%%`'S_\`\.G?V6?^C:?V?_\`PWFD?_(]'_#IW]EG_HVG]G__`,-YI'_R M/7T!10!\_P#_``Z=_99_Z-I_9_\`_#>:1_\`(]'_``Z=_99_Z-I_9_\`_#>: M1_\`(]?0%%`'S_\`\.G?V6?^C:?V?_\`PWFD?_(]>I?"#]GWP%^SWX;FT;P# MX(\(^!]'N)#-+8^']&M],MI7.!W/)K!^(_PJ\+_&/P7=>&_%WAO0/%7AV^4) M&561@/0@UOT4`?/\`_P`.G?V6?^C:?V?_`/PWFD?_`"/1 M_P`.G?V6?^C:?V?_`/PWFD?_`"/7T!10!\__`/#IW]EG_HVG]G__`,-YI'_R M/1_PZ=_99_Z-I_9__P##>:1_\CU]`44`?/\`_P`.G?V6?^C:?V?_`/PWFD?_ M`"/1_P`.G?V6?^C:?V?_`/PWFD?_`"/7T!10!\__`/#IW]EG_HVG]G__`,-Y MI'_R/1_PZ=_99_Z-I_9__P##>:1_\CU]`44`?/\`_P`.G?V6?^C:?V?_`/PW MFD?_`"/1_P`.G?V6?^C:?V?_`/PWFD?_`"/7T!10!\__`/#IW]EG_HVG]G__ M`,-YI'_R/1_PZ=_99_Z-I_9__P##>:1_\CU]`44`?/\`_P`.G?V6?^C:?V?_ M`/PWFD?_`"/1_P`.G?V6?^C:?V?_`/PWFD?_`"/7T!10!\__`/#IW]EG_HVG M]G__`,-YI'_R/1_PZ=_99_Z-I_9__P##>:1_\CU]`44`?/\`_P`.G?V6?^C: M?V?_`/PWFD?_`"/7L/PY^%7A?X/>$;7P_P"$?#>@>%M!L@!;Z;I&GQ6-G``` M!LBB547`50,#@*/2M^B@!@MHP,>6F``!\O0#D?EV]*?110`4444`%%%%`!11 M10`4444`%%59&\A,-]H\L@JV>N>3Z<.$GF*ZAFD;'SQ[P'CR" M0.._0=>V<^H!8HJ%9D=UQ,#N(95!'((.,>W!/X'MQ31/&(]WVH;<`;MR\X&X M]NZ\GVY&*`+%<1XU\%W'BGXA^$;J2:WBT?P]=W6H3Q>8?.GN6A:V@7:HV^7M MN[AFSSE82<\X['SD23:TPW`D;21U)&/RR!^(Z\41RPE5`\M5CV^7R,8(P"/K MD@?C0!\W?`']F+Q9\/\`XN:2VN7'A\>#?AC'JEEX->POYIM2U2/4)U=AJ$30 M1Q0^1'$(4\N642L=[>6R^6H>'_&S:;KBZPVI^)Q;>*- M1T>TL9)!!Y4\#6L+&_BLHU:--/N?*MKL3-),R.N:^J$FM]L85H<+C8`1QP`, M?@P'_`AZTU;BWC#-&82S#.$*Y?N/S+#_`+Z]Z`+%?C[_`,'![?\`&X#_`()K MMG.?B)*N\'"G&JZ(-O4><].Q_8#>=V-C=<9X],YZ_AZY]N:_'W_@X&F` M_P""O/\`P38EW$_\7`=CEU#$'4=#R^[!7:,<@8Z'&,YH`_82BD=UC0LQ"JHR M23P!3&NXQGYE(7.\AA\@YY/X@CZ_C0!)14;7*IG=\NW);)'R+S\QYZ''^><# M7*IG=\NW);)'R+S\QYZ''^><`$E%1M_..0/0\B@":BH1,A.[SAM)#`9&"#P/P)Y'J?RH0AL*)RS8Q_ M#D[3\W;\#Z>U`$U%58`T@61Y#YDB^7\@.$/.>,LN1TSZCKSBK5`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`55W`QE79HS&@9E:4C8IW#)8=\9[GD=>]6J\ M1_X*(Z[=>#?^"??QPU73I;BSU#1?`&O:C8O'N#6\T6FW,D9#+G!1U#`K]TJN M.V0#\O\`Q[^U7^T+_P`'`'[5?CCX6?LY_$&'X._LU_#>YCT_7_B!IGF1ZEXF M<`D?99H]KF-B&*1QM"AB`DDD_?1PCN-$_P"#07X(KIZC7_C?^TAJFI2)OEFM M->L;967(Q^Z>SE?[V3]X_ACGUK_@U3\":;X7_P""(?PMO+6".&;Q5J.MZG?N M%"FXG75;NU4Y&#N$5I",G)`0`=!C]'*`/R?;_@S\_9_;.?C#^T\=V.[.<^*]-YSG/_,._P!H_F?6OU@HH`_) M]O\`@S\_9_;.?C#^T\=V.[.<^*]-YSG/_`##O]H_F?6OU@HH`_)T_\&>W M[/0.5^+7[3$9R?N^*M.Z'C'_`"#NG^/>JMW_`,&;?[.&H7L-S)=+9XFW;\J3IN0=WS9'?GK7ZV44`?DY_P`0>G[/:ME?BY^TRG&WY?%6 MF\\8/_,.[_UIY_X,_/V?V;/_``N']I[(.X'_`(2O3>#DG/\`R#O4D_B:_6"B M@#\G5_X,^?V?D"@?&#]IP!2"N/%>F\$9(Q_Q+O<_F:%_X,^?V?D"@?&#]IP! M2"N/%>F\$9(Q_P`2[W/YFOUBHH`_)U?^#/G]GY`H'Q@_:<`4@KCQ7IO!&2,? M\2[W/YF@_P#!GS^S\R;3\8/VG"N,8_X2O3<8X_ZAWL/R'I7ZQ44`?D^W_!GY M^S^V<_&']IX[LYSXKTWG.<_\P[_:/YGUJ-_^#/O]G]P8Q\8/VG.@R&\4Z<5( MXX_Y!V/X1],#VK]9*145!A5"C)/`[GDT`?AK\=_V'/VH/^#?/0[[XN?L_P#Q M!YHCC;;L0-O>6`0R1K@NDL08#]:/V,?VL? M#/["[UY-!\76$=T())=T]D^62:V<\`2I*C1'_<+`_-D^G^)_"& MG^-/#-YHNK6-GJ&EZE:/9W=O+$&BGB<;6C*$$%&&05.01P017Y1_\&:=[=/_ M`,$NO'%A+=7$D>D?%35;*T60LZQ1_P!F:7)M`/W5WR.V!M^9CW)R`?KA1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`5X1_P`%-E+?\$V?VA8PL8;_`(5GXC8Q MKAMQ;2[K((..">^1DYZ5[O7A'_!3P%O^":_[0T>[=M^&/B,GH6?.E70Y&T_H M.3V[$`^=?^#78?\`&BCX%G9N*G7L=./^*@U,9_(G\*_0&OS^_P"#789_X(3? M`OAFYUW[IQ_S,.I?Y^GK7Z`T`>1^+?VL?!7@/XUVW@75_$9M_$5^+*-(%L[H MVEI+=3F*"&6Z$30Q7$\F3##+('E2-BD817D/I6D:I;:W*T]G=PW,<,T]L?+F M+!61]DH8=V21"O\`L\CVKX[_`&J;K7O!G[7VBZ[X+T7XH6_BBXN=#TR[M;;P MW<:QX/\`&^E_;%><7:9%---!=R36X"(?\`A;/BF;Q!K"^'O&?B2]666YN)=,GL[:QOK:ZDM#$T3>;; M.^GF1E,T+,TGE`'Z=1G=]YMVXC+(S?>'7C^$?+TSUR#[XW@SQE;^-?#MCJEO M'JT%GJ%O%\-W^NWBB.^AE9S#90SR[5$;G)0`%3U.,^3_MYV MOQ)\;_'CX1WGA;Q=XZ\'^'?*BNK;^R?!'B#5AJ.HM>6[M;7T=I=VT%G#+!B, MG5DFMD5YP5@EC#,`?3/Q5^._AGX):5X?O?%6O0Z##XEURQ\.:6;I787VH7DZ M0P0+L&69Y&XP`H52_P`L22/7H-?F7\0-+\1>*_A'J-GK4?[3+?$K4?&W@Z/Q MCMT;6]1T;39K/Q3:74][HJO;2VZPK:Q3NLVGI]G$<,7GA)G0R\=X_/Q$UC1- M6TFQ\2?MD6^G>%?"'Q(31[*WTOQ*LDVHPZY!)X=W7PMA=WL_V8,J":ZG$L5I M@@K-/]H`/UEHK\Y;WX,_%;]I_P#:5^)&FWGQ.^+WA"'Q-I-TFGZ=8:)XIT.S ML+=[>TGTN\&K#4(;&*2&546>VLK:VOG::>*=9(@\E>@?LO?#7X@Z_P#%N/4O M%>F_%+PSI/C*33OB#]DO?'FL7+]#TFWUV]CGT#4([!+6=B(76_^SBRD9GW MJ$CN"3]GE'_+*4)U&C^)6UR]U:SADU&&ZT>]6TE-UI\]K'))Y<,I,,DB+'<1 M>7.B^;#OC\S>G$L,J#YF^(G[3>C_``'_`&[/'^J:UX0^,6K6LW@S0+&SET+X M8^(-:M-2O;>ZU6>2&&>VLW@#JEQ;_>E"[G7YMT;!?'/B6GBWQ!^U+JVCZMXB M_:@@\&W7Q1NFU2TTK1-3R MX0SKK:1JEMK*/BEX4\ M#:!;MJ'[5;7EQHOPTU[6YK_P[XCN[J_U./7)EUBR=7M"((5M!#)=+;_9Q<*@ MWAA):/\#/$.@^&/$'QN\#1M\5_%4FOZROAWQEXEO4EFN+B73) M[*VLKZWNI+0Q-$XEMG?3S*RF:%F,GE`'Z!>-?C/X=^'OC/PKX;UOQ%:Z;KWC MF]N+'P]8S2$2ZK-%`;B14``(VQ!F;<0!@!1EDQWU?F_JJ>+K[]M3X:7_`(PT M7]H?7/'_`(;^(JC9:6FJ6_@F#P_/X=N8!?95_P"Q(S%/=.T@DN'OPYGA1YE% MNC?I!0`A12X;:-P&`<<@?Y`K\B_^#--5_P"':?Q,C;8%;XO:JI1E^\/[)TGC M&!_+H#P.WZZU^1?_``9H'R_^":OQ*7*I_P`7?U4;2,9_XE.D<#I_+H#P.P!^ MNE%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!7A'_!39E;_@FO^T(JJOEI\,?$ M3"/'W@=*NAM*XR!].>,8XP?=Z\)_X*=;G_X)K?M$!L[C\,/$>4`W*#_9=UT. MWG\CVXYY`/G3_@UV&?\`@A-\"^&;G7?NG'_,PZE_GZ>M?H#7Y_?\&NPS_P`$ M)O@7PSE>8?M*_$J]^&_@72+/1Q&WB#Q9JMMX15>WT^6<[9+AE(" MMY,*3R[2/F\HKP&Q7J%>9_M&_"V;XL_#V.WL]6M]+UK1;^'7M%NI[.2YAMM0 MMI!-;"6%6626,YVR1(Z.ZDA2N>`#X]^)O[57B+X(>)_VE/#NM?%C]H36KKP_ M#"?"MSI'PK_MRUT+=IEO>%C=V&@S6HS)))&5O3)B$JYP2)CZYX5_;8LOV??! M7@W2?%3?$;X@-'9:*?%OCD66E_9=&GU2399_;DMFMV`DEE4#['9R"--CW!17 M,IC^+/PK\)?`CP9\6/$7Q,^/^K?#>Q^-QBMM7N=7U;P[96'AVZ-LMOY%A<7% MA"'=[:%85:[68E(=P`^%7P-^)7A__`(3OP]^TH_Q!\+>";"QM?&US M8>*O#T^B:TFF&6:S?5Y+6V18'AC*)$N/-B&V@#I/#_\`P5@\%:]: M:Q?)X/\`BUINCV-CK^HVNH:CH*V2ZR=%U)--NK>"*:5)TF\^6VV_:8HD(N%# MR!H;B*+U#]GWX[3?M7?"77M:C\-^-?AC-_:6H^%9$U>71I]2M[RUF^Q2W$?V M>YO+7]W4B9_LXEE[[QY_P5A\&_"C3_`!5JGB#PI\4K+0M%T/5M.2&1XP?ML=ON21IN8(WDBL>#?^"7.D^"--^'%YHOQ M4^+6C^*/AG;WNGVWBB&/0_[8UC3[J99Y-.O=VEF*>U60%D7R4=7RX8L=U/US M_@EKX1\1>!?&'AA_&7Q%L_#?BS3=4TG3;!)]/,/@RUU.4R:A%IWFV+-^_9R@ M%V;CRH\K!Y()!`*GCO\`X*JZ#\.?!'B#4;CX;_%*YU'P_JM]8WOA^.UTV#5W M@M=.CU22_037T4`A-E(DP02^&?$:7D<>I: M-I_BW2([RW@CO["TNVDBN=,NFM'DM9IK6:$*)8G^:.X1!YS0M<3_`#K^V?\` ML*:M>ZS'?PQ?%SXJ:;X@\3V_BC4AIJ>!)Y['5H-.MM/M)HK77+..Q:%XXAF0 MM)N4B(L:!54*JC``'`%+10`4444`%?D7_P9H'R_ M^":OQ*7*I_Q=_51M(QG_`(E.D<#I_+H#P.WZZ5^1?_!F@?+_`.":OQ*7*I_Q M=_51M(QG_B4Z1P.G\N@/`[`'ZZ4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M>$?\%/%(_P"":_[0R_-(W_"L?$88MGD?V5==!@@G/4`?AT%>[UX1_P`%-U#? M\$T_VAE56$?_``K#Q$%7:`O_`""KKC&"?3@@]N.M`'SK_P`&NPS_`,$)O@7P MSM?H#0 M`445\E_$7]K/X@:UXG^*VJ^$]?\`A-X+^'OP2U4:+K-_X[,\4/B.Z^RV]Y.B M:C'=11:3!&+F*V%U);7I$QE_<8@VS`'UI3'MHY'+-&C,R["2O)7T^GM7SW\. M?V]?`/B^'P#9S>++&XUCQMI,%TD^CK<:EH`N9X))&MUUB)'L/-9XY3%&9A*Z MP_NXV#5GQ_\`!4WX(V.@W&IZAX^;28;>]TW3_(U/1]1L+O4'U*1HK"6RMKBU M2:\@GD27R9[:.2&412L'V0OL`'_\%0OBIX8^$O[)KX=CU3QM;:E#I\M_,LW@37H8$BM[>&ZEC>=[)8$GB2XB5K?S!*KS MQP^7YLB1CT/P)\9-/_:$^%M[KGP^U+;)))#;_`$WPKXWT_P`.V4EI M>:+I.C>$M*O;+3[L7]YJ#6.JE)DE:XM1/)$]NSRW!:$'8;?M_@+^U3XX^(/Q M)\"Z'X\^.GAKPSXN?2K#^R]"T#3[:^L?BO;W%G+YVKV,EQ:174J)<(SJ]JL= MNB6P>5'@N(G$7[!G_!2+X@?M/3^#;5?&WP(^*FL>-/#EWJ6J^'/"5C?# MV\2W66*'5I/M^IF.*64FWS+%#)&Y&(IB&CC]4_9[_P""EWA'5OAK\.5^(/B" MWT7QOXN\*66O:M);:)J/_",Z9/)ITM_+&VHR(UM;L(;:X=+>>X6X,<8=HP6. M`#Y6\&?M8:Y\/?V+?@GIVD?M!3:/?3?#N[U;1-8OK30]2@\9>*K:2!$\,2;+ M;:[))(\'V2T$6HRX8>=YD3%NN\2?M9?$74O#W[0FOWG[0GA7POJ7P_\`&=CH M*Z-;W.AZ%8^'K273M)NI(Y+Z[M+\1W:R&^@22]_<-/\`:$<1*8_L_MWB'_@J M!H/Q3^'_`(#K/6O[;L=1TUAHNO:G%8K=V8EMXEN7+N\> M`0L3P3K)^^A:V/H5S^WY\-;.UTYKS4/%&EV^LZE)IT,^J>$-9M883[+:1LK&[@'`!)^R9\;+7XT^%-)UH^.-0U36M:\+Z3JMUX>F M33(YM-CE\\1ZB8+,3,!>`.`YN9[9Q9J;=MN^1_-NW'RX],5\= M_&/_`(*V>`;_`.!OCS5OA-XD\.^,?$WA+1]2UVV&H17]GH=Q!IMY%;ZE(M\T M'D3M:^:K^6D@R)K9V,,$R7`[CQ=_P4T^$7@WP'=>(-0USQ0+:SU672+FSM/! M^N7.L6DL5K]LEFETU+8WD=JMJPG-PT(B,4L++(5>)G`/HZBOF?X9_MNRI\3/ MB+X?\>K;Z>VC^/Y_#7AZ3P_I^I:I;MIJ:/I6H+>7\\<+I:#=J!:2:816T2LJ M&20*LLDC_P#!4KX*Z;I^E_:?%FL6VJ:SJU% MY(CP$,KI"T3^;"(F8O&&`/I2BJ\++);%E,GDD,#RS,V.`5.<\@9XY.0>O6Q0 M`5^1?_!F@?+_`.":OQ*7*I_Q=_51M(QG_B4Z1P.G\N@/`[?KI7Y%_P#!F@?+ M_P"":OQ*7*I_Q=_51M(QG_B4Z1P.G\N@/`[`'ZZ4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%>$_\%.=Q_X)M?M",<^8GPR\1L`!D(W]E77*G;R>W0]N.>?= MJ\(_X*>*1_P37_:&7YI&_P"%8^(PQ;/(_LJZZ#!!.>H`_#H*`/G7_@UUPO\` MP0I^!;'=_P`Q]>,GKXAU+M_7MS[U]WWNJ6VGZ?)=7-REK;V<7F2R2SB/[*I4 M?-)N.W@9)+=,=Z^$?^#7)O\`C17\"QM/37SGL/\`BH=2_P`_A7KG_!4[P[?> M+/V8--NH[*]UKP;HOBS0=5\9:;;1/=-JOAV#4X9+Y?(6*9KB-85\Z2)1F>&. M2,Y60JP!ZU\&/VG_`(??M&:%=7OP]^(G@?QY;:?:]\'?B%X7\%6_Q0F.J^*M#\2>#Y?$ MEG+J2V\=H][9K;ZC8O!+-%%$LP''NUDLI-)T^6=66WNM0'^FF"#SW:W^V%I( M]D\:S9'[2G[?OC;X=>!_&V@Z9^TEH$VHZ+XX&G0^);>;PEID]NEWX;M+ZQ22 M745&FK9)?27);=FZ>"$1Q2SRQ2,0#Z'US_@EGX&T?XF:3XDO)OA_-X=\.^%K M;1=1O_$?@NUOO%5M;6%F]IYMGK+R(;".2/F4"WD!Q(\;PM(6'GOAKX)Z3\4? M@_X?UK2?VF/@_P",[ZTU'PEHVA^*[;1(+FQN-/T?7(IK&&=;?55%U?W6HV\5 MN\T$D<3,WEQ6<+.['U;_`(*`^''/[%GA634+K4O'GA'0/$GAC6?&MV;:.ZDU M_1H+Z":\O)HK6)(Y8\*ES*L"K$$C?">6OEMY'^W'\7/@3\9?AM#\1?`_BCX5 M7WB!?'W@*V;XB6;6.I:7#>P^(;7R$:[254N+NVMIKDM''(&C@G$^&O`D>@>&;" MXN&Q'LTB*X:3R\",RB2[,DI\S;+$'41?#?Q"_P""AGB7X<_#+7-3OOVG)/L] MGX:^(N@Z9JC0>'`U_P")-$URU&D)$BV)274IM/FD1[<#RYUQ)':PL-P[7X0_ MMX^)O%/[7-K#J?QU\.S:!=?%9O"%IX+&C6FER?8[GPBFHQQ70F4ZC%>17S+& MQS#LF-S$\9S'#``3_#3]GNP^!7Q1^%GA/XB?M1_`J\U+]EOPSJ.IZ3HEMX?B MT'5["!M*:U_M/56FUFXF^PQ03-(Z1+:)(WEN\FV)14GP:_X)RZ[\0C\%_'O@ M_P#:&^'/CW2_AW8VD7AG5H_",^JV!-MI]WI1[BWC M9IFBAAMTC_;]^-ZZ#^WK>6V@ZGX3\46O@_P##J_Q,\#0:C;6WB#6_#\=W=42[C*1>;"LS"6]^T5_P`%&K[XL>/_`(5:I\"?C%\+6\`> M))89OMM_XCCAM/%-XUW#NT1(1I=_/<7IMG4?889K*Z$EQ%URT8`-;5/^"0?B MO7_A'HO@'6/B;X(UCPOIGA?P7X4N[*Y^'USC5K3PY?\`VY4R-7`1;IE".@&$ M"\<'G+/$WPJ\<77P]C;0]-OO$?PK@U;4+#0XI8'M%M7F MO7CM]5B"D?;1$\(_#_QJT73]?\`#'A/ MQ5=^)?#^N:+ITL7PFU*PNQ%I<<<4217`2]C$BP#4#.URQ@FA'EB6%H_VD/V^ M_&_P[\#>-=`TW]I306U+1_&_]G0>)[>X\)Z7-"EWX;M;ZP2634`-.2Q6^DN- MX?-W)!!LA>XDCD)`/6/C/^QPWP:^$5Y-\3/CU\,?!_A'[)XRTF[U+5O#O]CV MT4GB?4TU")A/<:H8XQ;W$2`(21<(&C_=.=]<#\1_A%X"_P""A/PW\7:3;_M? M?`KQAK7BR]2#QDNCP17WAJ5+V&/2M,B338-9+)<),B/;->7=TGVR*-9DLHP6@@*S:C))&B01,4,GF2(L M2*&8*%!Q7P/XL\>?#?XJ?\$L/@[XJTWQ=\-9-8T_XB^%+'0_$\LECJG]AWB^ M+;+(BD+8!CMS.S)YBL(R^6`SD`];^'__``2^\5>%OC)XF\>7'Q,\)S:Y\09% MTOQ4++P5<6ZZUHPTRRLFLXPVJRBWG46$<]O<`D1-/-YD4WF<7/@=_P`$P]0^ M`^L_#>Z\/Z_\'/#L/@OQ:WB6[LO!_P`*(O#J>(H%TN\TM?-6&^/^EM'J-P9+ MEMT7%OY=O`$D\_Q#7OV^/%4WPVCTU?VA+?2]6T=O&%AHGBA].T>]3XBZWIFJ MRP:;H5W'':&'SI;:2U?[+8I;7EX)6:`1[22[5?VQO''B#]H/4-%U[]ISPWX! MW?%)O!4FC65IHD?]D:<_A2+4Y`7NEN7^W6E^Z6ZS2,T(D\[S(&9UB@`/T\HK M\F?AE_P5P\1>+_BI^SS?2?&+34M?%>BZ5!XCT/4+K1+73M0N+O1]0F6[ABCA MDU&Z=M0@MXI'@DMK6*5X[2)+F=IDB^O/^"7O[0FO?'WX/>(/[=\<0_$35_#6 MK_V=<:WIFHZ3J^F74YABGD6TO],6""X@1F90LUK:W$:X21&.V:8`^JJ_(O\` MX,T#Y?\`P35^)2Y5/^+OZJ-I&,_\2G2.!T_ET!X';]=*_(O_`(,T#Y?_``35 M^)2Y5/\`B[^JC:1C/_$ITC@=/Y=`>!V`/UTHHHH`****`"BBB@`HHHH`**** M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB MB@`HHHH`*\(_X*;J&_X)I_M#*JL(_P#A6'B(*NT!?^05=<8P3Z<$'MQUKW>O M"_\`@I-I$^K_`/!.OX^6L,-Q)<77PY\111I&QD=I7TN=5V<$]20.F/2@#YS_ M`.#70L/^"$_P,V@$YU[J<!C@=!^%`&?X=T.V\):19:78QF&QTZW2UMH`0=L:!5&"3G"C`[8P>O%:5-\E M?)\O:OEXV[%456>1G)1$"'$C9.0`/3Z\\YK\EO^#,V=1_P3%^(MPJNL5U\5]2GAW* M$\Q6TO25&WH,;@R@\#*D<8(`!^NM%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M44`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!6=KWAK3_$6A7FFZC:VMQI]_&UO-!)$ICEC=?+9&4Y#!E)4@C!!VD$==&D1% MC0*JA548``X`H`_"7X5_$WX@?\&M/[17C/P/XP\)^+/&O[&OCW7!J/AGQ)9K M]HF\*2RH"$E&<-(0BQS0R>49%MGGAY$D+_<>D_\`!S+^Q'XDM!-;_'2P@:0A M3%=Z!K-HRC!&#NM/4YRN.W/'/W5XE\,Z;XST&ZTO6-/L=6TN^C,5S9WD"SV] MPAZJZ,"K#V((KPW_`(=._LL_]&T_L_\`_AO-(_\`D>@#QD_\'(O[$)3_`)+Y MH^"I/_((U;.">?\`EVSG/3N!TP*:1_\CT?\.G?V6?^C:?V?_\`PWFD?_(] M`'C)_P"#D7]B%$_Y+YH^%"#_`)!&K$^H_P"7;\_R-#?\')7[$,;[?^%]:/\` M(Q/&C:L1GGO]FY'/TZ>U>S?\.G?V6?\`HVG]G_\`\-YI'_R/1_PZ=_99_P"C M:?V?_P#PWFD?_(]`'BX_X.3/V(!C_B_6C_*2W_(%U;OG_IU]^G3\J=_Q$H_L M0_\`1>M%_P#!)JO_`,BU[-_PZ=_99_Z-I_9__P##>:1_\CT?\.G?V6?^C:?V M?_\`PWFD?_(]`'C/_$2C^Q#_`-%ZT7_P2:K_`/(M'_$2C^Q#_P!%ZT7_`,$F MJ_\`R+7LW_#IW]EG_HVG]G__`,-YI'_R/1_PZ=_99_Z-I_9__P##>:1_\CT` M>,_\1*/[$/\`T7K1?_!)JO\`\BT?\1*/[$/_`$7K1?\`P2:K_P#(M>S?\.G? MV6?^C:?V?_\`PWFD?_(]'_#IW]EG_HVG]G__`,-YI'_R/0!XR?\`@Y/_`&(2 MX;_A?6CY`Q_R!-6Q^7V6FK_P:]H_ MX=._LL_]&T_L_P#_`(;S2/\`Y'H_X=._LL_]&T_L_P#_`(;S2/\`Y'H`\77_ M`(.3/V($V_\`%^M'^4;1G1=6/IU_T7GIU/-"_P#!R9^Q`FW_`(OUH_RC:,Z+ MJQ].O^B\].IYKVC_`(=._LL_]&T_L_\`_AO-(_\`D>C_`(=._LL_]&T_L_\` M_AO-(_\`D>@#Q=?^#DS]B!-O_%^M'^4;1G1=6/IU_P!%YZ=3S0/^#DK]A\#_ M`)+UI/``_P"0-J_;I_R[?GZ]\U[1_P`.G?V6?^C:?V?_`/PWFD?_`"/1_P`. MG?V6?^C:?V?_`/PWFD?_`"/0!^:/[?\`_P`%X[S_`(*+:9>_LW?L/^'_`!9\ M3/%WC^PDL]4\8QV4NEV^B:?*(Q.T:S11/'YBED>XG6)8BQ\OS"\9'Z1_\$P? MV%=)_P"":G[$G@OX2Z=-#>7FAVSWFK:DB>6NIZC,WF75QMR,1AWVHI.1'&@_ MA!/KOP@_9]\!?L]^&YM&\`^"/"/@?1[B0S2V/A_1K?3+:5SG+-'"BJ6.3DD9 MYKK515+$*`6.3@=3TH`6BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** 1**`"BBB@`HHHH`****`/_]D_ ` end EX-101.INS 6 stev-20140408.xml XBRL INSTANCE DOCUMENT false 2013-12-31 S-1 0001439813 Smaller Reporting Company Stevia Corp 0.501 0.164 0.45 0.169 0.541 0.193 0 0 54284 38589 123517 40397 23400 26325 2821.92 0 0 15890.41 4356 2822 15890 15890.41 2821.92 81765 0 163530 -1869 801 32050 0 658496 32050 595233 1869 801 2670 1635300 0 1635300 1553535 0 1471770 113925 0 110425 0 1066667 1066667 45000 274000 0.02 274000 100000 20000 81765 81765 54510 81765 0 81765 54510 1068 801 801 801 93750 750000 3000000 286666 286 -286 1 1 0.7 0.7 1 1 5233177 0 9952152 0.25 0 0.25 0 0.23 0 0 0 620350 0 803332 -486113 -597519 -106561 -411805 -180284 -486113 -597519 -411805 -180284 0 0 -214082 0 0 0 -214082 0 224350 224350 224350 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Beneficial Conversion Feature</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company&#39;s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Beneficial Conversion Feature</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company&#39;s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 75.11</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.40</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 75.11</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.40</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div><br /> &nbsp;</div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 74.53</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.37</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 74.53</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.37</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 0 0 0 0 0 0 0 0 15698 424475 15698 424475 15698 85366 5978 0.08 13600 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Flows Reporting</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.&nbsp;&nbsp;The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Flows Reporting</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.&nbsp;&nbsp;The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.</div> <!--EndFragment--></div> </div> -0.34 -0.34 -52500 -52500 -52500 -18653 -18653 -18653 292218 500000 447500 1066667 1067 498933 500000 500000 250000000 250000000 100000000 100000000 0.001 0.001 3000000 500000 11288 63561 1000000 6000000 6000000 6000000 79800000 12000000 12000000 12000000 500000 500 99500 100000 100000 33335 33 27707 27740 27740 375000 93750 375000 93750 375000 93750 187500 7811 7811 187500 7811 93750 93750 93750 -187500 -187500 600858 601 499399 500000 500000 272550 0 600000 272550 13000000 13000 1416715 1708937 1708937 279222 1500000 0.79 0.79 85333 1066667 1066667 400000 33000000 85333 20000000 400000 1000000 63561 0.001 0.64 0.6405 3000000 0.47 0.46875 0.25 0.25 0.25 0.25 100000 0 220438 350000 0 1400000 0 881753 6000 4500 4500 4500 617425 3000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Fiscal Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period from</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> April 11, 2011 (inception)</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Farm management services - related parties</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Farm management services provided by Growers Synergy Pte Ltd. were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> period ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> period ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Farm management services - related parties</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 200000 2000000 20438 0 350000 100000 2500000 250000 2500000 0.0585 0.10 0.0585 8000000 220438 100000 2500000 2500000 55556 0 220438 220438 53000 0 58000 0 153500 0 350000 0 350000 350000 350000 0 250000 0 111111 0 220438 200000 220438 200000 0 200000 200000 200000 0 250000 0 27778 0 0 -214082 0 -214082 3000 881142 0 1234 3100 762 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Number&nbsp;of</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> Exercise&nbsp;Price&nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Weighted&nbsp;Average</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Fair Value at Date</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Aggregate</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant&nbsp;Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Range</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Per&nbsp;Share</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise&nbsp;Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Issuance</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Intrinsic</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Value</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,350</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Canceled</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expired</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,350</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Earned and exercisable, March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,350</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Unvested, March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s warrant activities:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number&nbsp;of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant&nbsp;Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise&nbsp;Price</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Range</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Per&nbsp;Share</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise&nbsp;Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> at Date</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Issuance</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Aggregate</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Intrinsic</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,325</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">737,856</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,713,918</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20 - 0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">183,007</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Canceled</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (2,732,799</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expired</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, December 31, 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,952,152</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20 - 0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">803,332</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Earned and exercisable, December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,952,152</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20 - 0.25</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.23</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">803,332</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Unvested, December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 2951424 7670399 1152000 1152000 1152000 0 0 0 0 0 2951424 7670399 1152000 1152000 1152000 -486113 -369747 -106561 -411805 -180284 0 0 0 0 0 0 0 0 0 0 -412738 0 626446 0 -444788 0 -816310 -444788 -645829 0 0 5233177 9952152 0.25 0.25 0.23 0 0 620350 803332 0.25 0.20 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">E</font><font style="TEXT-DECORATION: underline; DISPLAY: inline">quity Instruments Issued to Parties other than Employees for Acquiring Goods or Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder&#39;s expected exercise behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;The Company uses historical data to estimate holder&#39;s expected exercise behavior.&nbsp;&nbsp;If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.&nbsp;&nbsp;A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.&nbsp;The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">E</font><font style="TEXT-DECORATION: underline; DISPLAY: inline">quity Instruments Issued to Parties other than Employees for Acquiring Goods or Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder&#39;s expected exercise behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;The Company uses historical data to estimate holder&#39;s expected exercise behavior.&nbsp;&nbsp;If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.&nbsp;&nbsp;A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9,an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 3000000 3000000 3000000 3000000 0.20 0.25 0.20 38075 0 38075 0 0.25 0 0.25 0 -2732799 0 0.20 0 0 0 0 -2732799 0 -2732799 0 0 0 853333 853 169813 170666 170666 0.6405 0.20 0.10 0.0585 0.6405 3 3 0.7453 0.7511 0 0 0 0 0 0 0 0 140000 712550 180000 180000 652550 60000 60000 1789034 0 758809 0 0 0 2.64 2.61 2.81 2.72 18000 52500 52500 500000 30000 1.22 1.11 1.29 1.27 2.36 2.33 2.52 2.44 240000 30000 7500 240000 30000 30000 240000 30000 30000 140000 67500 5233177 6713918 0.25 0.25 0.23 0 0 620350 183007 0.25 0.20 40000 500000 500000 40000 500000 765000 0 0.12 0.1 0.1 0.1 0.12 0.1 0.1 0.1 0.1 27740 23068 0 27739 1042000 0 500000 500000 737856 0.20 0.20 0 0 220438 220438 220438 5713918 0 5713918 -106360 0 0 1000000 0 1000000 -76647 0 0 30000 -81765 0 -1234 0 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Limitation on Utilization of NOLs due to Change in Control</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL&#39;s to annual limitations which could reduce or defer the NOL.&nbsp;&nbsp;Section 382 imposes limitations on a corporation&#39;s ability to utilize NOLs if it experiences an "ownership change."&nbsp;&nbsp;In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.&nbsp;&nbsp;In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.&nbsp;&nbsp;The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Limitation on Utilization of NOLs due to Change in Control</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL&#39;s to annual limitations which could reduce or defer the NOL.&nbsp;&nbsp;Section 382 imposes limitations on a corporation&#39;s ability to utilize NOLs if it experiences an "ownership change."&nbsp;&nbsp;In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.&nbsp;&nbsp;In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.&nbsp;&nbsp;The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.</div> <!--EndFragment--></div> </div> 3000000 6000000 0 3000000 0 3000000 1635300 272550 0 0 0 0 0 0 0 0 299373 231521 -73723 -379552 0 0 0 0 -299373 -231521 -73723 379552 675949 -305829 231521 675949 231521 -305829 -2149272 -1439811 -2035864 -2035864 -214158 -2250022 -2017484 -2017484 -131788 -2149272 0.264 0.135 0.06 0.498 0.522 0 0.557 0.144 0.266 0.103 1553535 0 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-controlling Interest</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interest in Stevia Technew Limited, its majority owned subsidiary in the consolidated statements of balance sheets within the equity section, separately from the Company&#39;s stockholders&#39; equity.&nbsp;&nbsp;Non-controlling interest represents the non-controlling interest holder&#39;s proportionate share of the equity of the Company&#39;s majority-owned subsidiary, Stevia Technew Limited. Non-controlling interest is adjusted for the non-controlling interest holder&#39;s proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-controlling Interest</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interests in its majority owned subsidiaries in the consolidated statements of balance sheets within the equity section, separately from the Company&#39;s stockholders&#39; equity.&nbsp;&nbsp;Non-controlling interests represents the non-controlling interest holder&#39;s proportionate share of the equity of the Company&#39;s majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holder&#39;s proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The research and development arrangements usually involve specific research and development projects.&nbsp;&nbsp;Often times, the Company makes non-refundable advances upon signing of these arrangements.&nbsp;&nbsp;The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities"</font>) for those non-refundable advances.&nbsp;&nbsp;Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.&nbsp;&nbsp;Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.&nbsp;&nbsp;The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.&nbsp;&nbsp;If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The research and development arrangements usually involve specific research and development projects.&nbsp;&nbsp;Often times, the Company makes non-refundable advances upon signing of these arrangements.&nbsp;&nbsp;The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities"</font>) for those non-refundable advances.&nbsp;&nbsp;Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.&nbsp;&nbsp;Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.&nbsp;&nbsp;The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.&nbsp;&nbsp;If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 1000000 150000 100000 250000 1000000 812634 0 290000 0 1000000 0 2353573 0 2353573 0 2951424 0 956481 1152000 956481 1152000 1400000 0 1400000 0 1400000 0 1400000 0 1400000 0 1400000 0 1762228 0 1762228 0 881753 0 881753 0 881753 0 881752 0 881752 426667 881752 426667 426667 0 1739130 426667 1739130 426667 2027520 0 2027520 0 1151999 0 1151999 0 2534399 0 2534399 0 440571 0 0 0 0 0 0 0 0.25 0 0.25 0.08 0.02 0.08 0.204 0.08 0.7 0.7 0.3 0.3 0.25 0.25 0.20 0.20 <div> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 4 - Prepaid Expenses</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Prepaid expenses consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Prepaid research and development</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 25,546</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 128,445</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Prepaid rent</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6,667</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 21,250</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Retainer</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 451</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 15,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 432</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4,179</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 33,096</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 168,874</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 4 - Prepaid Expenses</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Prepaid expenses consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Prepaid research and development</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 25,546</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 128,445</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Prepaid rent</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6,667</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 21,250</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Retainer</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 451</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 15,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 432</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4,179</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 33,096</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 168,874</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> </div> 25546 128445 0 1807000 0.46875 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The projected volatility curve for the valuation dates was:</div> </td> </tr> </table> </div> <br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> &nbsp;</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2 Tear</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 3 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 4 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> August 6, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 129%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 178%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 218%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 252%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 281%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 127%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 173%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 211%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 244%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 272%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 122%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 167%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 205%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 236%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 264%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The projected volatility curve for the valuation dates was:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 3 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 4 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="28%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> August 6, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 129%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 178%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 218%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 252%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 281%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 127%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 173%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 211%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 244%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 272%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 122%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 167%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 205%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 236%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 264%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> December 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 111%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 168%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 202%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 233%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 261%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> &nbsp;</div> <!--EndFragment--></div> </div> 7925 3036 6691 3036 -787355 0 0 -787355 0 0 0.25 0.23 0.25 0.23 0.1 0.08 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2013, the FASB issued ASU No. 2013-01, "<font style="FONT-STYLE: italic; DISPLAY: inline">Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities</font>". This ASU clarifies that the scope of&nbsp;ASU No. 2011-11, "<font style="FONT-STYLE: italic; DISPLAY: inline">Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities.</font>" applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in FASB Accounting Standards Codification or subject to a master netting arrangement or similar agreement. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the FASB issued ASU No. 2013-02, "<font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.</font>" The ASU <font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; DISPLAY: inline; BACKGROUND-COLOR: rgb(255,255,255)"> &nbsp;</font> adds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "<font style="FONT-STYLE: italic; DISPLAY: inline">Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date</font>."&nbsp;&nbsp;This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU No. 2013-05, "<font style="FONT-STYLE: italic; DISPLAY: inline">Foreign Currency Matters (Topic 830): Parent&#39;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</font>." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU 2013-07,<font style="FONT-STYLE: italic; DISPLAY: inline">"Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting."</font> The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity&#39;s governing documents from the entity&#39;s inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity&#39;s inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity&#39;s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the FASB issued ASU No. 2013-02, "<font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.</font>" The ASUadds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "<font style="FONT-STYLE: italic; DISPLAY: inline">Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date</font>."&nbsp;&nbsp;This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU No. 2013-05, "<font style="FONT-STYLE: italic; DISPLAY: inline">Foreign Currency Matters (Topic 830): Parent&#39;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</font>." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU 2013-07, <font style="FONT-STYLE: italic; DISPLAY: inline">"Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting."</font> The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity&#39;s governing documents from the entity&#39;s inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity&#39;s inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity&#39;s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> -167949 -167949 -167949 595852 595852 595852 12500 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Related Parties</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Section 850-10-20 the related parties include a.&nbsp;affiliates of the Company; b.&nbsp;entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c.&nbsp;trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e.&nbsp;management of the Company; f.&nbsp;other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g.&nbsp;other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:&nbsp;&nbsp;a.&nbsp;the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c.&nbsp;the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Related Parties</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Section 850-10-20 the related parties include a.&nbsp;affiliates of the Company; b.&nbsp;entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c.&nbsp;trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e.&nbsp;management of the Company; f.&nbsp;other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g.&nbsp;other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:&nbsp;&nbsp;a.&nbsp;the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c.&nbsp;the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Related Parties</div> </td> <td style="PADDING-BOTTOM: 2px" valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &#12288;</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Relationship</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> George Blankenbaker</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> President and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Leverage Investments LLC</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Technew Technology Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Non-controlling interest holder</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Growers&nbsp;&nbsp;Synergy Pte Ltd.</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Guangzhou Health Technology Development Company Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by Non-controlling interest holder</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Related parties with whom the Company had transactions are:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Related Parties</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Relationship</div> </td> </tr> <tr> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> George Blankenbaker</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> President and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Leverage Investments LLC</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Technew Technology Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Non-controlling interest holder</div> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Growers&nbsp;&nbsp;Synergy Pte Ltd.</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Guangzhou Health Technology Development Company Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by Non-controlling interest holder</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <!--EndFragment--></div> </div> 240000 180000 180000 180000 15391 207782 0.27 0.18 -412738 0 -157814 -412738 -50596 737856 0 737856 0 0 0 3000000 3000 1632300 1635300 1635300 500000 500 272050 272550 272550 35000 35000 27500 27500 750000 451 15000 0.0037 0.004 0.7 1.67 1.68 1.78 1.73 18000 25000 45000 1877333 0.20 1066666 0.25 2346666 0.25 1.39 1.39 400000 450000 853333 1877333 600000 750000 600000 33000000 38225 38225 1.50 1.50 15000 15000 2000000 275000 0.25 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Name of consolidated</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> subsidiary or entity</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> State or other jurisdiction of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> incorporation or organization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Date of incorporation or formation</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (date of acquisition, if applicable)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Attributable interest</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Ventures International Ltd.</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Territory of the British&nbsp;Virgin&nbsp;Islands</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> April 11, 2011</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 100%</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Asia Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> March 19, 2012</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 100%</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Technew Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> April 28, 2012</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;70%</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated subsidiaries and/or entities are as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Name of consolidated</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> subsidiary or entity</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> State or other jurisdiction</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of incorporation or organization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Date of incorporation or formation</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (date of acquisition, if applicable)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Attributable</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> interest</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd.</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> The Territory of the British&nbsp;Virgin&nbsp;Islands</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> April 11, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Asia Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> March 19, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Technew Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> April 28, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">70</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="30%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; PADDING-LEFT: 0pt" valign="bottom" width="30%" align="left">&nbsp; <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> SC Brands Pte Ltd</font></td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt" valign="bottom" width="29%">&nbsp;Singapore</td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt" valign="bottom" width="29%">October 1, 2013</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">70</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> %&nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <!--EndFragment--></div> </div> 2708419 0 10561070 853334 10561070 853334 770438 700000 1229383 770438 3000000 6000000 0 3000000 0 3000000 5233177 0 9952152 1152000 9952152 1152000 1635300 0 P5Y 0 122343 110425 98095 2.05 2.02 2.18 2.11 0.67 0.705 0.643 357770 700000 1071569 357770 997842 2000000 230000 2000000 0 6000000 1500000 240000 180000 180000 180000 860000 500 1500 1500 0.821 0.279 0.848 0.601 190649 100213 786508 -247341 789266 -60785 10941596 6000000 20513222 5005334 20513222 5005334 33096 168874 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100000 170667 109824 600000 0.25 113925 0 1000000 -381300 -381300 -381300 -833106 -833106 -833106 -30504 -30504 -30504 3446 4514 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 7 - Website Development Costs</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Website development costs, stated at cost, less accumulated amortization consisted of the following:</div> <br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Website development costs</div> </td> <td valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 5</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,315</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,315</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Accumulated amortization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (1,869</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (801</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,446</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4,514</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Amortization expense</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Amortization expense was $1,068 and $801 for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through December 31, 2012, respectively.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note&nbsp;7 - Website Development Costs</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Amortization expense</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Amortization expense was $801 each for the interim period ended December 31, 2013 and 2012, respectively.</div> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</div> <!--EndFragment--></div> </div> 948073 237288 1092237 89193 20220 262576 158008 0 164988 19700 5400 9600 1234 0 4334 4760624 1474751 6813321 -750000 187500 -750000 186000 1500 187500 626446 0 63263 0 2194251 207122 3641781 615579 184572 2132300 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation - Unaudited Interim Financial Information</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission ("SEC") to Form 10-Q and Article 8 of Regulation S-X.&nbsp;&nbsp;Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. &nbsp;The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.&nbsp;&nbsp;Interim results are not necessarily indicative of the results for the full fiscal year.&nbsp;&nbsp;These consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the fiscal year ended March 31, 2013 and notes thereto contained in the Company&#39;s Annual Report on Form 10-K as filed with the SEC on July 16, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 5315 5315 5315 424475 15698 85366 0 3199 408777 15698 -339109 -9720 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Equivalents</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Equivalents</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Inventories</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Inventory Valuation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company values inventory, consisting of finished goods, at the lower of cost or market.&nbsp;&nbsp;Cost is determined on the first-in and first-out ("FIFO") method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value.&nbsp;&nbsp;Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Inventory Obsolescence and Markdowns</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classify inventory markdowns in the income statement as a component of cost of goods sold pursuant to Paragraph 420-10-S99 of the FASB Accounting Standards Codification to adjust inventory to net realizable value. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There was no inventory obsolescence for the interim period ended December 31, 2013 or 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There was no lower of cost or market adjustments for the interim period ended December 31, 2013 or 2012.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 14 - Commitments and Contingencies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Supply Agreement - between Stevia Ventures International Ltd. and Asia Stevia Investment Development Company Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 12, 2011, Stevia Ventures International Ltd, a subsidiary of the Company entered into a Supply Agreement (the "Supply Agreement") with Asia Stevia Investment Development Company Ltd ("ASID"), a foreign-invested limited liability company incorporated in Vietnam.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (I) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Purchase Price</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> ASID and the Company shall review and agree, on or before September 30th of each year, on the quantity of the Products to be supplied by ASID to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Supply Agreement - between Stevia Ventures International Ltd. And Stevia Ventures Corporation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 12, 2011, Stevia Ventures International Ltd, a subsidiary of the Company also entered into a Supply Agreement (the "Supply Agreement") with Stevia Ventures Corporation ("SVC"), a foreign-invested limited liability company incorporated in Vietnam.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Purchase Price</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> SVC and the Company shall review and agree, on or before September 30<font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; DISPLAY: inline">th</font><font style="TEXT-DECORATION: underline; DISPLAY: inline">,</font> of each Year on the quantity of the Products to be supplied by SVC to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Consulting Agreement - Dorian Banks</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Consulting Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 1, 2011 the Company entered into a consulting agreement (the "Consulting Agreement") with Dorian Banks ("Banks").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Consulting Agreement, the Company engaged the Consultant to provide advice in general business development, strategy, assistance with new business and land acquisition, introductions, and assistance with Public Relations ("PR") and Investor Relations ("IR").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continue until December 31, 2011. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Service performed by Consultant through the date of termination.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Compensation</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company shall pay the Consultant a fee of $3,000 per month.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Extension of the Consulting Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On December 30, 2011, the Consulting Agreement was extended with the same terms and conditions to expire on March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Expiration of the Consulting Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Consulting Agreement expired on March 31, 2013 with no further extension.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Summary of the Consulting Fees</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, the Company recorded $41,250 and $27,000 in consulting fees under the Consulting Agreement, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Financing Consulting Agreement - David Clifton</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Financial Consulting Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 1, 2011 the Company entered into a consulting agreement (the "Consulting Agreement") with David Clifton ( "Clifton").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Under the terms of the Consulting Agreement, the Company engaged Clifton to introduce interested investors to the Company, advise the Company on available financing options and provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continuing until December 31, 2011. This Agreement may be terminated by either the Company or Clifton at any time prior to the end of the consulting period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Clifton for all service performed by him through the date of termination.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On December 31, 2011, the financial consulting agreement expired.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Compensation</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company shall pay Clifton a fee of $3,000 per month.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Summary of the Consulting Fees</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the period from April 11, 2011 (inception) through December 31, 2011, the Company recorded $18,000 in financing cost under this Financing Consulting Agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Engagement Agreement - Garden State Securities Inc.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 18, 2012, the Company entered into an engagement agreement (the "Agreement") with Garden State Securities Inc. ("GSS") for GSS to act as a selling/placement agent for the Company.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; FONT-STYLE: italic; DISPLAY: inline"> Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company on a "best efforts" Private Placement offering of debt or equity securities to fulfill the Company&#39;s business plan, and contacts for the Company possible financing sources.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; FONT-STYLE: italic; DISPLAY: inline"> Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> GSS shall act as the Company&#39;s exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the "Exclusive Period"). GSS shall act as the Company&#39;s non-exclusive placement agent after the Exclusive Period until terminated.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) Compensation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company&#39;s common stock (the "Securities Financing") during the Exclusive Period; (i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the "Warrants") with "piggy back" registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investors&#39; warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors.&nbsp;&nbsp;The Company will also pay, at closing, the expense of GSS&#39;s legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company.&nbsp;&nbsp;In addition, the Company shall cause, at its cost and expense, the "Blue sky filing" and Form D in due and proper form and substance and in a timely manner.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 11 - Commitments and Contingencies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Supply Agreement - between Stevia Ventures International Ltd. and Asia Stevia Investment Development Company Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 12, 2011, Stevia Ventures International Ltd., a subsidiary of the Company entered into a Supply Agreement (the "Supply Agreement") with Asia Stevia Investment Development Company Ltd. ("ASID"), a foreign-invested limited liability company incorporated in Vietnam.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (ii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") expiring on April 1, 2014 and thereafter automatically renew on its anniversary for an additional period of one (1) year expiring on April 1, 2015 ("Extended Term").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Purchase Price</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> ASID and the Company shall review and agree, on or before September 30th of each year, on the quantity of the Products to be supplied by ASID to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Supply Agreement - between Stevia Ventures International Ltd. And Stevia Ventures Corporation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 12, 2011, Stevia Ventures International Ltd., a subsidiary of the Company also entered into a Supply Agreement (the "Supply Agreement") with Stevia Ventures Corporation ("SVC"), a foreign-invested limited liability company incorporated in Vietnam.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (ii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years expiring April 1, 2014 ("Term") and thereafter automatically renew on its anniversary for an additional period of one (1) year expiring April 1, 2015 ("Extended Term").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Purchase Price</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> SVC and the Company shall review and agree, on or before September 30<font style="FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; DISPLAY: inline">th</font>, of each Year on the quantity of the Products to be supplied by SVC to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Engagement Agreement - Garden State Securities Inc.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 18, 2012, the Company entered into an engagement agreement (the "Agreement") with Garden State Securities Inc. ("GSS") for GSS to act as a selling/placement agent for the Company.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company on a "best efforts" Private Placement offering of debt or equity securities to fulfill the Company&#39;s business plan, and contacts for the Company possible financing sources.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (ii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> GSS shall act as the Company&#39;s exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the "Exclusive Period"). GSS shall act as the Company&#39;s non-exclusive placement agent after the Exclusive Period until terminated.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Compensation</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company&#39;s common stock (the "Securities Financing") during the Exclusive Period;(i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the "Warrants") with "piggy back" registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investors&#39; warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors.&nbsp;&nbsp;The Company will also pay, at closing, the expense of GSS&#39;s legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company.&nbsp;&nbsp;In addition, the Company shall cause, at its cost and expense, the "Blue sky filing" and Form D in due and proper form and substance and in a timely manner.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Consulting Agreement -</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Mountain Sky International Limited</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 18, 2013, the Company entered into a consulting agreement (the "Consulting Agreement") with Mountain Sky International Limited ("Mountain Sky") to perform consulting certain services for the Company. In consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties hereto, the parties agree as follows.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Scope</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">of Services</font></font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Consultant agrees to perform certain consulting, advisory and related services to the Company.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (ii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> This Agreement shall commence on April 18, 2013 (the "Commencement Date") and shall continue until April 30, 2015 unless terminated. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Services performed by Consultant through the date of termination.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iii)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Compensation</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation ("Mountain Sky"), in partial consideration for consulting services to be rendered by Mountain Sky.&nbsp;&nbsp;500,000 of the 1,000,000 shares vested at the time of grant, and 500,000 will vest on the one (1) year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Commitment and Contingencies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.&nbsp;&nbsp;The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.&nbsp;&nbsp;In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#39;s consolidated financial statements.&nbsp;&nbsp;If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.&nbsp;&nbsp;Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company&#39;s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company&#39;s business, financial position, and results of operations or cash flows.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Commitment and Contingencies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.&nbsp;&nbsp;The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.&nbsp;&nbsp;In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#39;s consolidated financial statements.&nbsp;&nbsp;If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.&nbsp;&nbsp;Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company&#39;s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company&#39;s business, financial position, and results of operations or cash flows.</div> <!--EndFragment--></div> </div> 0.001 0.001 0.001 100000000 100000000 250000000 63555635 58354775 82695634 63555635 58354775 82695634 63556 58355 82695 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 15 - Concentrations and Credit Risk</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Credit Risk</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of March 31, 2013, substantially all of the Company&#39;s cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation ("FDIC").&nbsp;&nbsp;However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Customers and Credit Concentrations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> One (1) customer accounted for all of the sales for the fiscal year ended March 31, 2013 and the accounts receivable balance at March 31, 2013.&nbsp;&nbsp;A reduction in sales from or loss of such customer would have a material adverse effect on the Company&#39;s results of operations and financial condition.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Vendors and Accounts Payable Concentrations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Vendor purchase concentrations and accounts payable concentration are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> Accounts Payable at</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="7"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Net Purchases</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Growers Synergy Pte. Ltd. - related party</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 50.1</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 16.4</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 26.4</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 13.5</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Stevia Ventures Corporation</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 16. 9</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 54.1</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 55.7</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 14.4</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 67.0</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 70.5</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 82.1</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 27.9</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 14 - Concentrations and Credit Risk</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Credit Risk</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of December 31, 2013, substantially all of the Company&#39;s cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation ("FDIC").&nbsp;&nbsp;However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Customers and Credit Concentrations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> One (1) customer accounted for all of the sales for the interim period ended December 31, 2013 and the accounts receivable at December 31, 2013.&nbsp;&nbsp;A reduction in sales from or loss of such customer would have a material adverse effect on the Company&#39;s results of operations and financial condition.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Vendors and Accounts Payable Concentrations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Vendor purchase concentrations and accounts payable concentration are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> Accounts Payable at</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Net Purchases</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Reporting</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Reporting</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="38%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Growers Synergy Pte. Ltd. - related party</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 45.0</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 50.1</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6.0</div> </td> <td valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 49.8</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="38%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Stevia Ventures Corporation</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 19.3</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 16. 9</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 26.6</div> </td> <td valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 10.3</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="38%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> SG Agro Tech Pte Ltd</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 52.2</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 64.3</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 67.0</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 84.8</div> </td> <td valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 60.1</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Principles of Consolidation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company applies the guidance of Topic 810 <font style="FONT-STYLE: italic; DISPLAY: inline">"Consolidation"</font> of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.&nbsp;&nbsp;The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent&#39;s power to control exists.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated subsidiaries and/or entities are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Name of consolidated</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> subsidiary or entity</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> State or other jurisdiction of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> incorporation or organization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Date of incorporation or formation</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (date of acquisition, if applicable)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Attributable interest</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Ventures International Ltd.</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Territory of the British&nbsp;Virgin&nbsp;Islands</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> April 11, 2011</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 100%</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Asia Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> March 19, 2012</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 100%</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Technew Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> April 28, 2012</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;70%</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> All inter-company balances and transactions have been eliminated.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Principles of Consolidation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company applies the guidance of Topic 810 <font style="FONT-STYLE: italic; DISPLAY: inline">"Consolidation"</font> of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.&nbsp;&nbsp;The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent&#39;s power to control exists.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated subsidiaries and/or entities are as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Name of consolidated</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> subsidiary or entity</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> State or other jurisdiction</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of incorporation or organization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Date of incorporation or formation</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (date of acquisition, if applicable)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Attributable</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> interest</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd.</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> The Territory of the British&nbsp;Virgin&nbsp;Islands</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> April 11, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Asia Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> March 19, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Technew Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> April 28, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">70</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="30%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; PADDING-LEFT: 0pt" valign="bottom" width="30%" align="left">&nbsp; <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> SC Brands Pte Ltd</font></td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt" valign="bottom" width="29%">&nbsp;Singapore</td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt" valign="bottom" width="29%">October 1, 2013</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">70</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> %&nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> All inter-company balances and transactions have been eliminated.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 357700 700000 1071569 2617381 711246 1257043 740543 64925 132993 94547 523746 318234 66743 4925 66743 500000 500000 0 500000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 9 - Convertible Notes Payable</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 14, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,890.41 at $0.25 per share to 1,000,000 shares and 63,561 shares of the Company&#39;s common stock, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 23, 2011, the Company issued a convertible note in the amount of $100,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $100,000 and accrued interest through the date of conversion of $2,821.92 at $0.25 per share to 400,000 shares and 11,288 shares of the Company&#39;s common stock.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 4, 2011, the Company issued a convertible note in the amount of $150,000 with interest at 10% per annum due one (1) year from the date of issuance.&nbsp;&nbsp;On January 18, 2012, the note holder converted the entire principal of $150,000 and accrued interest through the date of conversion of $4,356 at $0.25 per share to 617,425 shares of the Company&#39;s common stock.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (i) February 26, 2013 issuance of convertible notes with warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 26, 2013, the Company entered into two (2) 12% convertible notes payable of $350,000 in aggregate ("Convertible Notes") with two investors (the "Payees") maturing on September 30, 2013. The Payees have the option to convert the outstanding notes and interest due into the Company&#39;s common shares at $0.25 per share at any time prior to September 30, 2013. In connection with the issuance of the Convertible Notes, the Company granted to the Payees a warrant to purchase 1,400,000 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 74.53</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.37</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The relative fair value of these warrants granted, estimated on the date of grant, was $110,425 in aggregate, which was recorded as a discount to the convertible notes payable. After allocating the $110,425 portion of the proceeds to the warrants as a discount to the Convertible Note, an additional $113,925 was allocated to a beneficial conversion feature by crediting additional $113,925 to additional paid-in capital and debiting the same amount to the beneficial conversion feature.&nbsp;&nbsp;The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Notes. The amortization of the discount and beneficial conversion feature amounted to $32,050 for the fiscal year ended March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (ii) March 15, 2013 issuance of convertible note with warrant</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 15, 2013, the Company cancelled a prior convertible note and entered into a 12% convertible note payable of $220,438, which is the total amount of the prior note principal and accrued interest, with the existing investor (the "Payee"), maturing on September 30, 2013. The Payee has the option to convert the outstanding note into the Company&#39;s common shares at $0.25 per share at any time prior to payment in full of the principal balance of the Convertible Note. In connection with the issuance of the Convertible Note, the Company granted the Payee a warrant to purchase 881,753 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 75.11</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.40</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The relative fair value of these warrants was $98,095, which was recorded as a discount to the convertible note payable. After allocating the $98,095, portion of the proceeds to the warrants as a discount to the Convertible Note, the effective conversion price of the convertible notes payable was lower than the market price at the date of issuance and per calculation the remaining balance of the face amount was allocated to a beneficial conversion feature by crediting $122,343 to additional paid-in capital and debiting the same amount to the beneficial conversion feature. The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Note and began to amortize the amount from April 1, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Convertible notes payable consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On November 16, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.&nbsp;&nbsp;On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,959 to 319,607 shares of the Company&#39;s common stock at $0.83 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 250,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On January 16, 2012, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.&nbsp;&nbsp;On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $11,781 to 314,586 shares of the Company&#39;s common stock at $0.83 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 250,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.&nbsp;On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price $0.25 per share</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 220,438</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 200,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 200,000</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company&#39;s common stock.</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 350,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total: convertible notes payable</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 770,438</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 700,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (444,788</div> </td> <td valign="bottom" width="2%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Accumulated amortization of discount on convertible notes payable</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 32,050</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Remaining discount</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (412,738</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 357,770</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 700,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note&nbsp;9 - Convertible Notes Payable</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (i) February 26, 2013 issuance of convertible notes with warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 26, 2013, the Company entered into two (2) 12% convertible notes payable of $350,000 in aggregate ("Convertible Notes") with two investors (the "Payees") maturing on September 30, 2013. The Payees have the option to convert the outstanding notes and interest due into the Company&#39;s common shares at $0.25 per share at any time prior to September 30, 2013. In connection with the issuance of the Convertible Notes, the Company granted to the Payees a warrant to purchase 1,400,000 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance. The notes were currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 74.53</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.37</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The relative fair value of these warrants granted, estimated on the date of grant, was $110,425, which was recorded as a discount to the convertible notes payable. After allocating the $110,425 portion of the proceeds to the warrants as a discount to the Convertible Notes, an additional $113,925 was allocated to a beneficial conversion feature by crediting $113,925 to additional paid-in capital and debiting the same amount to the beneficial conversion feature.&nbsp;&nbsp;The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Notes. The amortization of the discount and beneficial conversion feature were fully amortized as of September 30, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (ii) March 15, 2013 issuance of convertible note with warrant</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 15, 2013, the Company cancelled a prior convertible note and entered into a 12% convertible note payable of $220,438, which is the total amount of the prior note principal and accrued interest, with the existing investor (the "Payee"), maturing on September 30, 2013. The Payee has the option to convert the outstanding note into the Company&#39;s common shares at $0.25 per share at any time prior to payment in full of the principal balance of the convertible note. In connection with the issuance of the convertible note, the Company granted the Payee a warrant to purchase 881,753 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected option life (year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.00</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected volatility</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 75.11</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Risk-free interest rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.40</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Dividend yield</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.00</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div><br /> &nbsp;</div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The relative fair value of these warrants was $98,095, which was recorded as a discount to the convertible note payable. After allocating the $98,095, portion of the proceeds to the warrants as a discount to the convertible note, the effective conversion price of the convertible notes payable was lower than the market price at the date of issuance and per calculation the remaining balance of the face amount was allocated to a beneficial conversion feature by crediting $122,343 to additional paid-in capital and debiting the same amount to the beneficial conversion feature. The Company amortizes the discount and beneficial conversion feature over the term of the convertible note and the amounts were fully amortized as of September 30, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (iii) October 15, 2013 issuance of convertible note with derivative warrant</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> General Terms</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company. The restricted shares will be issued in the name of Black Mountain Equities, Inc. upon closing.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Events of Defaults</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> An "Event of Default", wherever used herein, means any one of the following events: (i) An "Event of Default", wherever used herein, means any one of the following events, (ii) A Conversion Failure; (iii) The Company or any subsidiary of the Company shall commence, or there shall be commenced against the Company or any subsidiary of the Company under any applicable bankruptcy or insolvency laws; (iv) (a) The Company or any subsidiary of the Company shall default in any of its obligations under any other indebtness in an amount exceeding $100,000, whether such indebtedness now exists or shall hereafter be created and (b) The Common Stock is suspended or delisted for trading on the Over the Counter Bulletin Board market (the "Primary Market"), (c) The Company loses its ability to deliver shares via "DWAC/FAST" electronic transfer, (d) The Company loses its status as "DTC Eligible.", (e) The Company shall become late or delinquent in its filing requirements as a fully-reporting issuer registered with the Securities &amp; Exchange Commission.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Piggyback Registration Rights</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company shall include on the next registration statement the Company files with SEC (or on the subsequent registration statement if such registration statement is withdrawn) all shares issuable upon conversion of this Note. Failure to do so will result in liquidated damages of 25% of the outstanding principal balance of this Note, but not less than $25,000, being immediately due and payable to the Holder at its election in the form of cash payment or addition to the balance of this Note.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Section 3 (b) Subsequent Equity Sales if the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to re-price, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock, at an effective price per share less than the then Exercise Price (such lower price, the "Base Share Price" and such issuances collectively, a "Dilutive Issuance") (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share which is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced and only reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price prior to such adjustment.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Section 3 (c) Subsequent Rights Offerings if the Company, at any time while the Warrant is outstanding, shall issue rights, options or warrants to all holders of Common Stock (and not to Holders) entitling them to subscribe for or purchase shares of Common Stock at a price per share less than the VWAP at the record date, then the Exercise Price shall be multiplied by a fraction, of which the denominator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of shares which the aggregate offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise of such rights, options or warrants) would purchase at such VWAP.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of note derivative liability and the warrant liability were $11,428 and $76,647, respectively, or $88,075 in aggregate; $50,000 of which was recorded as a discount to the convertible note and the $38,075 remaining balance was recorded as other expense. The Company amortizes OID and the discount to the note over the term of the convertible note and marks to market the warrant value as of each quarter end.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Convertible notes payable consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="12%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="12%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal of this note and any accrued and unpaid interest thereon, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company&#39;s securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company&#39;s common stock as determined in good faith by Company&#39;s Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">200,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">200,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> February 26, 2013 convertible notes</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">350,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">350,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> March 15, 2013 convertible note</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">220,438</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">220,438</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">111,111</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">153,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">27,778</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company.&nbsp;&nbsp;In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">58,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">53,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">55,556</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Sub-total: convertible notes payable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">1,229,383</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">770,438</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Discount representing (i) the relative fair value of the warrants issued, (ii) the beneficial conversion features and (iii) the derivative liability on conversion features</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (816,310</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (444,788</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Accumulated amortization of discount on convertible notes payable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">658,496</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">32,050</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Remaining discount</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (157,814</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (412,738</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">1,071,569</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">357,770</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Prepaid research and development</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 25,546</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 128,445</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Prepaid rent</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6,667</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 21,250</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Retainer</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 451</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 15,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 432</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4,179</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 33,096</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 168,874</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 0 0 1311552 790007 -1311552 -790007 15000 15000 15000 1234 0 3100 762 0 0 0 0 227772 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 10 - Derivative Instruments and the Fair Value of Financial Instruments</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">(i)</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Warrants Issued on August 6, 2012</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Description of Warrants and Fair Value on Date of Grant</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company&#39;s common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments, pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. The Company issued the warrants on February 26 and March 15, 2013 with an exercise price of $0.25 per share. Pursuant to Section 3(b) Subsequent Equity Sales of the SPA those warrants&#39; exercise price was reset to $0.25 per share and the number of warrant shares was increased to 2,732,801 and 218,623, respectively, for a total of 2,951,424.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Analysis</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The exercise price of the August 6, 2012 warrants and the number of shares issuable upon exercise is subject to reset adjustment in the event of stock splits, stock dividends, recapitalization, most favored nation status and similar corporate events.&nbsp;&nbsp;Pursuant to Section 3(b) Subsequent Equity Sales of the SPA, if the Company issues any common stock or securities other than the excepted issuances,&nbsp;&nbsp;to any person or entity at a purchase or exercise price per share less than the share purchase price of the August 6, 2012 Unit Offering without the consent of the subscriber holding purchased shares, warrants or warrant shares of the August 6, 2012 Unit Offering, then the subscriber shall have the right to apply the lowest such purchase price or exercise price of the offering or sale of such new securities to the purchase price of the purchased shares then held by the subscriber (and, if necessary, the Company will issue additional shares), the reset adjustments are also referred to as full reset adjustments.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification ("Section 815-40-15") (<font style="FONT-STYLE: italic; DISPLAY: inline">formerly FASB Emerging Issues Task Force ("EITF") Issue No. 07-5: Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity&#39;s Own Stock ("EITF 07-5")</font>). Section 815-40-15 became effective on January 1, 2009 and the Warrants issued in the August 6, 2012 Unit Offering have been measured at fair value using a Lattice model at each reporting period with gains and losses from the change in fair value of derivative liabilities recognized on the consolidated statement of income and comprehensive income.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Valuation of Derivative Liability</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (a)&nbsp;<font style="TEXT-DECORATION: underline; DISPLAY: inline">Valuation Methodology</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s August 6, 2012 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (b)&nbsp;<font style="TEXT-DECORATION: underline; DISPLAY: inline">Valuation Assumptions</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s 2012 derivative warrants were valued at each period ending date with the following assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The stock price would fluctuate with the Company projected volatility.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Holder would exercise the warrant at maturity if the stock price was above the project reset prices.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The 2,732,801 Investor Warrants with an exercise price of $0.25 per share (1,066,667 Investor Warrants with an exercise price&nbsp;&nbsp;of $0.6405 per share prior to the occurrence of the February 26, 2013 reset event) is projected to reset to $0.095 at maturity; and the 218,623 Placement Agent Warrants with an exercise price of&nbsp;&nbsp;$0.25 per share (85,333 Placement Agent Warrants with an exercise price of $0.6405 per share prior to the occurrence of the February 26, 2013 reset event) is projected to reset to $0.095 at maturity.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> No warrants have been exercised or expired.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The projected volatility curve for the valuation dates was:</div> </td> </tr> </table> </div> <br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> &nbsp;</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2 Tear</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 3 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 4 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> August 6, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 129%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 178%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 218%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 252%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 281%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 127%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 173%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 211%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 244%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 272%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="20%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 122%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 167%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 205%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 236%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 264%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (c) <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Fair Value of Derivative Warrants</font></font><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 shares of the Company&#39;s common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: center" valign="bottom" colspan="7">&nbsp;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Fair Value Measurement Using Level 3 Inputs</font></td> </tr> <tr> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> Derivative warrants&nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Assets (Liability)</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, August 6, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(411,805</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(411,805</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">231,521</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">231,521</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, August 6, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (180,284</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (180,284</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(305,829</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(305,829</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(486,113</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(486,113</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (d) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Warrants Outstanding</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of March 31, 2013 no warrants have been exercised and warrants to purchase 2,951,424shares of Company common stock remain outstanding.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s derivative warrant activity:</div> <br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="43%" colspan="11"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012 Warrant Activities</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> APIC</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Gain) Loss</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Non-derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total Warrant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Change in</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at August 6, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (411,805</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 231,521</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (231,521</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at September 30, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (231,521</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at December 31, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (106,561</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (305,244</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Reset of warrant shares</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,799,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (379,552</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 379,552</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at March 31, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 74,308</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (ii) Warrant Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s warrant activities through March 31, 2013:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Summary of the Company&#39;s Warrant Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s warrant activities:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Number&nbsp;of</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> Exercise&nbsp;Price&nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Weighted&nbsp;Average</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Fair Value at Date</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-ALIGN: center" valign="bottom" colspan="2">Aggregate</td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant&nbsp;Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Range</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Per&nbsp;Share</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise&nbsp;Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Issuance</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Intrinsic</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> Value</font></div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,350</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Canceled</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expired</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,350</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Earned and exercisable, March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.25</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,350</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Unvested, March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes information concerning outstanding and exercisable warrants as of <font style="FONT-SIZE: 11pt; DISPLAY: inline">March 31, 2013</font>:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="31%" colspan="8"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="8"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Range of Exercise Prices</div> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average Remaining</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual Life</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average Remaining Contractual Life</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note&nbsp;10 - Derivative Instruments and the Fair Value of Financial Instruments</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (i) Warrants Issued</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Description of Warrants and Fair Value on Date of Grant</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company&#39;s common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants")with an exercise price of $0.6405 per share, subject to certain adjustments, pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 26, 2013 and March 15, 2013 the Company issued warrants with an exercise price of $0.25 per share. Pursuant to Section 3(b), the previously issued warrants&#39; exercise price was reset to $0.25 per share and the number of warrant shares was increased to 2,732,801 and 218,623, respectively, for a total of 2,951,424.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 6, 2013, the Company issued warrants with an exercise price of $0.25 per share. Pursuant to Section 3(b), the previously issued warrants&#39; exercise price was reset again to $0.20 per share and the number of warrant shares was increased to 3,416,001 and 273,279, respectively, for a total of 3,689,280. On May 6, 2013, investors exercised warrants to purchase 2,732,799 (out of 3,416,001) shares of the Company&#39;s common stock at $0.20 per share.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 6, 2013, the Company issued (i) warrants to purchase 1,877,333 (Series A), 1,066,667 (Series B) and 2,346,666 (Series C), in aggregate 5,290,665 shares of the Company&#39;s common stock to the investors (the "investor warrants") and (ii) warrants to purchase 150,187 (Series A), 85,333 (Series B) and 187,733 (Series C) shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants")with an exercise price of $0.20 (Series A) per share, $0.25 (Series B) per share and $0.25 (Series C) per share subject to certain adjustments, pursuant to Section 3(b), expiring five (5) years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 15, 2013, the Company issued a warrant to purchase 1,000,000 common shares with an exercise price at $0.25 per share with full ratchet reset features expiring five (5) years from the date of issuance in connection with the issuance of a convertible note.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Analysis</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification ("Section 815-40-15").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Valuation of Derivative Liability</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (a)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Valuation Methodology</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s August 6, 2012 and May 6, 2013 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (b)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Valuation Assumptions</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s 2013 derivative warrants were valued at each period ending date with the following assumptions:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The stock price would fluctuate with the Company projected volatility.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Holder would exercise the warrant at maturity if the stock price was above the project reset prices.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Warrants with an exercise price of $0.25 exercise price is projected to reset to $0.047 at maturity; the Warrants with an exercise price of&nbsp;&nbsp;$0.20 per share&nbsp;&nbsp;is projected to reset to $0.043at maturity</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company had no reset event during this quarter period ending 12/31/2013. Prior reset events occurred on 2/26/2013 to $0.25 and 5/6/2013 to $0.20.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> No warrants have expired. Warrants with full reset feature issued during this quarter period ending 12/31/2013</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The projected volatility curve for the valuation dates was:</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 3 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 4 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5 Year</div> </td> <td style="PADDING-BOTTOM: 2px" valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="28%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> August 6, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 129%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 178%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 218%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 252%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 281%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 127%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 173%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 211%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 244%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 272%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 122%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 167%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 205%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 236%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 264%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="28%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> December 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 111%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 168%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 202%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 233%</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 261%</div> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> &nbsp;</div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (c)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Fair Value of Derivative Warrants</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 (reset to 6,247,146 on May 1, 2013) shares of the Company&#39;s common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative warrants</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Assets (Liability)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> </tr> <tr> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="12%" colspan="4"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="12%" colspan="4"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, September 30, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (305,829</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (305,829</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 675,949</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 675,949</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (787,355</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (787,355</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, December 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (597,519</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (597,519</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (d)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Warrants Outstanding</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As of December 31, 2013, 853,333 warrants (2,732,799 warrants after the exercise price being reset to $0.20 per share) have been exercised and warrants to purchase 9,952,152 shares of Company common stock remain outstanding.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s derivative warrant activity:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="43%" colspan="11"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <div>&nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="11"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant Activities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> APIC</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Gain) Loss</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Non-derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total Warrant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Change in</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at August 6, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (411,805</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 231,521</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (231,521</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at September 30, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at December 31, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (106,561</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Reset of warrant shares</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,799,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (379,552</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 379,552</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at March 31, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Exercise of warrants&nbsp;&nbsp;on May 6, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (2,732,799</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> (2,732,799</div> </td> <td valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Issuance of warrants&nbsp;&nbsp;on May 6, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,713,918</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 5,713,918</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (106,360</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Reset of warrant shares</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 737,856</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 737,856</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Issuance of warrants on Oct 15, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (76,647</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 299,373</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (299,373)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at December 31, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 7,670,399</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 7,670,399</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (369,747</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> (ii) Warrant Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s warrant activities through December 31, 2013:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Summary of the Company&#39;s Warrant Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s warrant activities:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number&nbsp;of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant&nbsp;Shares</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise&nbsp;Price</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Range</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Per&nbsp;Share</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise&nbsp;Price</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> at Date</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Issuance</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Aggregate</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Intrinsic</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Value</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">620,325</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">737,856</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Granted</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,713,918</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20 - 0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">183,007</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Canceled</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Exercised</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (2,732,799</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expired</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, December 31, 2013</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,952,152</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20 - 0.25</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.23</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">803,332</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Earned and exercisable, December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">9,952,152</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.20 - 0.25</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.23</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">803,332</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="40%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="40%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Unvested, December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes information concerning outstanding and exercisable warrants as of <font style="FONT-SIZE: 11pt; DISPLAY: inline">December 31, 2013</font>:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Range of Exercise Prices</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.20 - 0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.20 - 0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="10%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Liability</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.&nbsp;&nbsp;The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.&nbsp;&nbsp;In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.&nbsp;&nbsp;Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&nbsp;&nbsp;Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.&nbsp;&nbsp;Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")<font style="FONT-STYLE: italic; DISPLAY: inline">&nbsp;</font> to determine whether an instrument (or an embedded feature) is indexed to the Company&#39;s own stock.&nbsp;&nbsp;Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument&#39;s contingent exercise and settlement provisions.&nbsp;&nbsp; The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.&nbsp;&nbsp;The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.&nbsp;&nbsp;Therefore, the fair value may not be appropriately captured by simple models.&nbsp;&nbsp;In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).&nbsp;&nbsp;The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.&nbsp;&nbsp;Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).&nbsp;&nbsp;Projections were then made on the underlying factors which led to potential scenarios.&nbsp;&nbsp;Probabilities were assigned to each scenario based on management projections.&nbsp;&nbsp;This led to a cash flow projection and a probability associated with that cash flow.&nbsp;&nbsp;A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Liability</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.&nbsp;&nbsp;The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.&nbsp;&nbsp;In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.&nbsp;&nbsp;Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&nbsp;&nbsp;Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.&nbsp;&nbsp;Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")to determine whether an instrument (or an embedded feature) is indexed to the Company&#39;s own stock.&nbsp;&nbsp;Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument&#39;s contingent exercise and settlement provisions.&nbsp;&nbsp; The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.&nbsp;&nbsp;The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.&nbsp;&nbsp;Therefore, the fair value may not be appropriately captured by simple models.&nbsp;&nbsp;In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).&nbsp;&nbsp;The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.&nbsp;&nbsp;Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).&nbsp;&nbsp;Projections were then made on the underlying factors which led to potential scenarios.&nbsp;&nbsp;Probabilities were assigned to each scenario based on management projections.&nbsp;&nbsp;This led to a cash flow projection and a probability associated with that cash flow.&nbsp;&nbsp;A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Instruments and Hedging Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.&nbsp;&nbsp;The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.&nbsp;&nbsp;For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.</div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> From time to time, the Company may employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates.&nbsp;&nbsp;The Company does not use derivatives for speculation or trading purposes.&nbsp;&nbsp;Changes in the fair value of derivatives are recorded each period in current earnings or through other comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and the type of hedge transaction.&nbsp;&nbsp;The ineffective portion of all hedges is recognized in current earnings.&nbsp;&nbsp;The Company has sales and purchase commitments denominated in foreign currencies.&nbsp;&nbsp;Foreign currency forward contracts are used to hedge against the risk of change in the fair value of these commitments attributable to fluctuations in exchange rates ("Fair Value Hedges").&nbsp;&nbsp;Changes in the fair value of the derivative instrument are generally offset in the income statement by changes in the fair value of the item being hedged.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company did not employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates for the fiscal year ended March 31, 2013 or 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Instruments and Hedging Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.&nbsp;&nbsp;The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.&nbsp;&nbsp;For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.</div> <!--EndFragment--></div> </div> 21238 19138 10743 -0.03 -0.05 -0.03 -0.02 -0.01 -0.01 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Net Income (Loss) per Common Share</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification.&nbsp;&nbsp;&nbsp;Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.&nbsp;&nbsp;Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" width="10%" colspan="7"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Potentially Outstanding Dilutive</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Common Shares</font></div> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Fiscal Year Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> from April 11, 2011</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (inception) through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March&nbsp;31, 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Make Good Escrow Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Convertible Note Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">881,752</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at&nbsp;&nbsp;$0.46875 per share with gross proceeds of at least $100,000.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">426,667</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,400,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Convertible Note Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,708,419</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Warrant Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the <font style="FONT-SIZE: 11pt; DISPLAY: inline">new warrants issued</font> triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,951,424</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company&#39;s common stock to two notes holders in connection with the issuance of convertible notes.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,400,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company&#39;s common stock to the note holder in connection with the issuance of the convertible note.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">881,753</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Warrant Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Total potentially outstanding dilutive common shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,941,596</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Net Income (Loss)per Common Share</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.&nbsp;&nbsp;Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Potentially Outstanding Dilutive Common Shares</div> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> PeriodEnded</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,000,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Make Good Escrow Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,000,000</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Convertible Note Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,752</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 426,667</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company&#39;s securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company&#39;s common stock as determined in good faith by Company&#39;s Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,739,130</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 426,667</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,400,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,762,228</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,353,573</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 440,571</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;290,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 812,634</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,142</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Convertible Note Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 10,561,070</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 853,334</div> </td> </tr> </table> </div> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Warrant Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to investors (the "investor warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 956,481</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company&#39;s common stock to two (2) note holders in connection with the issuance of convertible notes.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,400,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company&#39;s common stock to the note holder in connection with the issuance of the convertible note.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,753</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 6, 2013, the Company issued three (3) series of warrants:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,027,520</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,151,999</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,534,399</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company&#39;s common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Warrant Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Total potentially outstanding dilutive common shares</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 20,513,222</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,005,334</div> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 0 0 0.34 0.34 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Level 3 Financial Liabilities - Derivative Warrant Liabilities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability at every reporting period and recognizes gains or losses in the consolidated statements of operations and comprehensive income (loss) that are attributable to the change in the fair value of the derivative warrant liability.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Level 3 Financial Liabilities - Derivative Warrant Liabilities and Derivative Liability on Conversion Feature</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability and derivative liability on the conversion feature at every reporting period and recognizes gains or losses in the consolidated statements of operations that are attributable to the change in the fair value of the derivative liabilities.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.&nbsp;&nbsp;The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 1</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 2</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 3</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs that are generally observable inputs and not corroborated by market data.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.&nbsp;&nbsp;If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The carrying amounts of the Company&#39;s financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable, accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s convertible notes payable approximates the fair value of such instrument based upon management&#39;s best estimate of interest rates that would be available to the Company for similar financial arrangements at March 31, 2013 and March 31, 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.&nbsp;&nbsp;The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.&nbsp;&nbsp;These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> It is not, however, practical to determine the fair value of advances from president and significant stockholder, if any, due to their related party nature.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.&nbsp;&nbsp;The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 1</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 2</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 3</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs that are generally observable inputs and not corroborated by market data.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.&nbsp;&nbsp;If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The carrying amounts of the Company&#39;s financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable,accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s convertible notes payable approximates the fair value of such instrument based upon management&#39;s best estimate of interest rates that would be available to the Company for similar financial arrangements at December 31, 2013 and March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation and the derivative liability on the conversion feature.&nbsp;&nbsp;The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.&nbsp;&nbsp;These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.</div> </div> <!--EndFragment--></div> </div> 3446 4514 2645 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fiscal Year End</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company elected March 31 as its fiscal year ending date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fiscal Year End</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company elected March 31st as its fiscal year end date upon its formation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 1316 0 0 1316 0 1 74308 0 -675949 -305244 -40105 -73723 561077 0 561077 0 412409 113742 387040 204616 133641 69302 -449288 -709946 636822 -619604 323821 -124851 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Carrying Value, Recoverability and Impairment of Long-Lived Assets</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company&#39;s long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.&nbsp;&nbsp;Fair value is generally determined using the asset&#39;s expected future discounted cash flows or market value, if readily determinable.&nbsp;&nbsp;If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&nbsp;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&nbsp;significant changes in the manner or use of assets or in the Company&#39;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#39;s overall business strategy; (iii)&nbsp;significant negative industry or economic trends; (iv)&nbsp;increased competitive pressures; (v)&nbsp;a significant decline in the Company&#39;s stock price for a sustained period of time; and (vi)&nbsp;regulatory changes.&nbsp;&nbsp;The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The key assumptions used in management&#39;s estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.&nbsp;&nbsp;These forecasts are typically based on historical trends and take into account recent developments as well as management&#39;s plans and intentions.&nbsp;&nbsp;Other factors, such as increased competition or a decrease in the desirability of the Company&#39;s products or services, could lead to lower projected sales levels, which would adversely impact cash flows.&nbsp;&nbsp;A significant change in cash flows in the future could result in an impairment of long lived assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Carrying Value, Recoverability and Impairment of Long-Lived Assets</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company&#39;s long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful livesagainst their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.&nbsp;&nbsp;Fair value is generally determined using the asset&#39;s expected future discounted cash flows or market value, if readily determinable.If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&nbsp;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&nbsp;significant changes in the manner or use of assets or in the Company&#39;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#39;s overall business strategy; (iii)&nbsp;significant negative industry or economic trends; (iv)&nbsp;increased competitive pressures; (v)&nbsp;a significant decline in the Company&#39;s stock price for a sustained period of time; and (vi)&nbsp;regulatory changes.&nbsp;&nbsp;The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The key assumptions used in management&#39;s estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.&nbsp;&nbsp;These forecasts are typically based on historical trends and take into account recent developments as well as management&#39;s plans and intentions.&nbsp;&nbsp;Other factors, such as increased competition or a decrease in the desirability of the Company&#39;s products or services, could lead to lower projected sales levels, which would adversely impact cash flows.&nbsp;&nbsp;A significant change in cash flows in the future could result in an impairment of long lived assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> -2250022 -2323551 -2149272 -1439811 -857342 -409579 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 14 - Income Tax Provision</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> United States Income Tax</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Stevia Corp is the parent Company which incorporated in the State of Nevada and is subjected to United States of America tax law.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Hong Kong SAR Income Tax</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Stevia Asia Limited, a wholly-owned subsidiary of the Company, is registered in the Hong Kong Special Administrative Region ("HK SAR") of the People&#39;s Republic of China ("PRC") and is subject to HK SAR tax law.&nbsp;&nbsp;Armco HK&#39;s statutory income tax rate is 16.5% and there were no significant differences between income reported for financial reporting purposes and income reported for income tax purposes for the year ended March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Stevia Technew Limited, a majority owned subsidiary of the Company, is registered in the Hong Kong Special Administrative Region ("HK SAR") of the People&#39;s Republic of China ("PRC") and is subject to HK SAR tax law.&nbsp;&nbsp;Armco HK&#39;s statutory income tax rate is 16.5% and there were no significant differences between income reported for financial reporting purposes and income reported for income tax purposes for the year ended March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Deferred Tax Assets</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At March 31, 2013, the Company has available for federal income tax purposes net operating loss ("NOL") carry-forwards of $3,857,505 that may be used to offset future taxable income through the fiscal year ending March 31, 2033.&nbsp;&nbsp;No tax benefit has been reported with respect to these net operating loss carry-forwards in the accompanying financial statements since the Company believes that the realization of its net deferred tax asset of approximately $1,317,552 was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are fully offset by the full valuation allowance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Deferred tax&nbsp;assets consist primarily of the tax effect of NOL carry-forwards.&nbsp;&nbsp;The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability.&nbsp;&nbsp;The valuation allowance increased approximately $521,545 and $790,007 for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Components of deferred tax assets are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net deferred tax assets - Non-current:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected income tax benefit from NOL carry-forwards</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,311,552</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 790,007</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Less valuation allowance</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (1,311,552</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (790,007</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Deferred tax assets, net of valuation allowance</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Limitation on Utilization of NOLs due to Change in Control</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company had ownership changes as defined by the Internal Revenue Code Section 382 ("Section 382"), which may subject the NOL&#39;s to annual limitations which could reduce or defer the NOL.&nbsp;&nbsp;Section 382 imposes limitations on a corporation&#39;s ability to utilize NOLs if it experiences an "ownership change."&nbsp;&nbsp;In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.&nbsp;&nbsp;In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.&nbsp;&nbsp;The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Tax Provision in the Consolidated Statement of Operations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income taxes is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Fiscal Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period from</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> April 11, 2011 (inception)</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Federal statutory income tax rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 18pt"> 34.0</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 34.0</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Change in valuation allowance on net operating loss carry-forwards</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 18pt"> (34.0</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (34.0</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Effective income tax rate</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 18pt"> 0.0</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td style="PADDING-BOTTOM: 4px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.0</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 0 0 0 0 0 0 0 0 0 0 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Tax Provision</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.&nbsp;&nbsp;Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&nbsp;&nbsp;Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.&nbsp;&nbsp;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&nbsp;&nbsp;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.&nbsp;&nbsp;Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&nbsp;&nbsp;The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.&nbsp;&nbsp;Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management&#39;s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Tax Provision</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.&nbsp;&nbsp;Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.Deferred tax assets are reduced by a valuation allowance to the extent management concludes it ismore likely than not that the assets will not be realized.&nbsp;&nbsp;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&nbsp;&nbsp;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.&nbsp;&nbsp;Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&nbsp;&nbsp;The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.&nbsp;&nbsp;Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management&#39;s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Uncertain Tax Positions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the fiscal year ended March 31, 2013 or for the period from April 11, 2011 (Inception) through December 31, 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Uncertain Tax Positions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the reporting period ended December 31, 2013 or 2012.</div> <!--EndFragment--></div> </div> 68973 20220 173383 0 710785 141530 144164 412110 158008 0 6980 120659 14300 -1290 -10100 6045 -135778 168874 41850 -142858 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 6 - Acquired Technology</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company&#39;s common stock.&nbsp;&nbsp;These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market for a total value of $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology&#39;s estimated useful life of fifteen (15) years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Technology right</div> </td> <td valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 15</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,635,300</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Less accumulated amortization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (81,765</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (-</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,553,535</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Amortization Expense</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Amortization expense for the fiscal year ended March 31, 2013 was $81,765.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note&nbsp;6 - Acquired Technology</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company&#39;s common stock.&nbsp;&nbsp;These restricted shares were valued at $0.79 per share, discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market, for a total value of $1,635,300, which was recorded as acquired technology and is being amortized on a straight-line basis over the acquired technology&#39;s estimated useful life of fifteen (15) years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Amortization Expense</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Amortization expense was $81,765 and $54,510 for the interim period ended December 31, 2013 and 2012, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Intangible Assets Other Than Goodwill</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.&nbsp;&nbsp;Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill inclusive of acquired technology and website development costs on a straight-line basis over their relevant estimated useful lives of fifteen (15) and five (5) years, respectively.&nbsp;&nbsp;Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Intangible Assets Other Than Goodwill</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.&nbsp;&nbsp;Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwillon a straight-line basis over the estimated useful lives of the respective assets as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Acquired technology</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 15</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Website development costs</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 86400 29757 123516 40462 75613 10130 0 0 0 0 21627 15521 145144 1807000 1807000 1042000 0 -44 0 90725 205860 0 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Extinguishment Accounting</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 25, 2013, the Supreme Court of the State of New York, County of New York (the&nbsp;&nbsp;"Court"),&nbsp;&nbsp;entered&nbsp;&nbsp;an order (the&nbsp;&nbsp;"Order")&nbsp;&nbsp;approving the settlement&nbsp;&nbsp;(the "Settlement Agreement")&nbsp;&nbsp;between the Company and Hanover Holdings I, LLC, a New York limited&nbsp;&nbsp;liability company&nbsp;&nbsp;("Hanover"),&nbsp;&nbsp;Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the&nbsp;&nbsp;"Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Settlement&nbsp;&nbsp;Agreement&nbsp;&nbsp;provides that the Initial Settlement Shares will be&nbsp;&nbsp;subject&nbsp;&nbsp;to&nbsp;&nbsp;adjustment&nbsp;&nbsp;on&nbsp;&nbsp;the&nbsp;&nbsp;trading&nbsp;&nbsp;day&nbsp;&nbsp;immediately&nbsp;&nbsp;&nbsp;following&nbsp;&nbsp;the Calculation Period to reflect the&nbsp;&nbsp;intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the&nbsp;&nbsp;Settlement&nbsp;&nbsp;Agreement be based upon a specified&nbsp;&nbsp;discount to the trading volume&nbsp;&nbsp;weighted&nbsp;&nbsp;average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court&#39;s entry of the Order.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.&nbsp;&nbsp;The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.</div> <!--EndFragment--></div> </div> 1943644 997567 3189388 2194251 207122 3641781 1457531 997567 2591869 486113 0 597519 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 3 - Going Concern</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As reflected in the accompanying consolidated financial statements, the Company had an accumulated deficit at March 31, 2013, a net loss and net cash used in operating activities for the fiscal year then ended. These factors raise substantial doubt about the Company&#39;s ability to continue as a going concern.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> While the Company is attempting to generate sufficient revenues, the Company&#39;s cash position may not be sufficient enough to support the Company&#39;s daily operations.&nbsp;&nbsp;Management intends to raise additional funds by way of a public or private offering.&nbsp;&nbsp;Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues provide the opportunity for the Company to continue as a going concern.&nbsp;&nbsp;While the Company believes in the viability of its strategy to generate sufficient revenues and in its ability to raise additional funds, there can be no assurances to that effect.&nbsp;&nbsp;The ability of the Company to continue as a going concern is dependent upon the Company&#39;s ability to further implement its business plan and generate sufficient revenues.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 3 - Going Concern</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As reflected in the consolidated financial statements, the Company had an accumulated deficit at December 31, 2013, a net loss and net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the Company&#39;s ability to continue as a going concern.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company is attempting to generate sufficient revenue; however, the Company&#39;s cash position may not be sufficient to support its daily operations.While the Company believes in the viability of its strategy to generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect.&nbsp;&nbsp;The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Accounts Receivable and Allowance for Doubtful Accounts</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Accounts receivable are recorded at the invoiced amount, net of an allowance for doubtful accounts.&nbsp;&nbsp;The Company follows paragraph 310-10-50-9 of the FASB Accounting Standards Codification to estimate the allowance for doubtful accounts.&nbsp;&nbsp;The Company performs on-going credit evaluations of its customers and adjusts credit limits based upon payment history and the customer&#39;s current credit worthiness, as determined by the review of their current credit information; and determines the allowance for doubtful accounts based on historical write-off experience, customer specific facts and economic conditions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to paragraph 310-10-50-2 of the FASB Accounting Standards Codification account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.&nbsp;&nbsp;The Company has adopted paragraph 310-10-50-6 of the FASB Accounting Standards Codification and determine when receivables are past due or delinquent based on how recently payments have been received.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Outstanding account balances are reviewed individually for collectability.&nbsp;&nbsp;The allowance for doubtful accounts is the Company&#39;s best estimate of the amount of probablecredit losses in the Company&#39;s existing accounts receivable. Bad debt expense is included in general and administrative expenses, if any.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There was no allowance for doubtful accounts as December 31, 2013 or March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company does not have any off-balance-sheet credit exposure to its customers.</div> <!--EndFragment--></div> </div> -214158 0 -345946 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 12 - Non-controlling Interest</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Non-controlling interest consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contributed</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> and</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> additional</font></div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> paid-in</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> capital</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Earnings</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> and losses</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Other</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Comprehensive</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Income</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> non-controlling</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> interest</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance at March 31, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Current period earnings and losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (214,082</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (214,082</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance at March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(214,082</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(214,082</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 1444389 1300200 573017 649600 -4889 -5152 -16475 -4889 -1030723 -1279350 -895651 -654431 -2035864 -2323551 -2017484 -1342473 -831410 -364601 -214158 0 -131788 -97338 -25932 -44978 -214158 -345946 375000 187500 195313 281250 7813 93750 83343 0 83343 0 1610085 1513392 1999586 1067548 391897 345513 -2059373 -2223338 -1362764 -1687152 -68076 -470364 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> Note 1 - Organization and Operations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stevia Corp. (Formerly Interpro Management Corp.)</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Interpro Management Corp ("Interpro") was incorporated under the laws of the State of Nevada on May 21, 2007.&nbsp;&nbsp;&nbsp;Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization&#39;s efficiency through planning and monitoring the daily operations of a business. The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. ("Stevia" or the "Company") and effectuated a 35 for 1 (1:35) forward stock split of all of its issued and outstanding shares of common stock (the "Stock Split").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> All shares and per share amounts in the consolidated financial statements have been adjusted to give retroactive effect to the Stock Split.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd. ("Ventures") was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands ("BVI").&nbsp;&nbsp;Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Acquisition of Stevia Ventures International Ltd. Recognized as a Reverse Acquisition</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 23, 2011 (the "Closing Date"), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the "Share Exchange Agreement") by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company&#39;s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company&#39;s common stock to the Company for cancellation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares were being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures&#39; Stockholder (the "Escrow Agreement").&nbsp;&nbsp;Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock immediately after the consummation of the Share Exchange Agreement the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification.&nbsp;&nbsp;The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition.&nbsp;&nbsp;The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost.&nbsp;&nbsp;The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Formation of Stevia Asia Limited</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 19, 2012, the Company formed Stevia Asia Limited ("Stevia Asia") under the laws of the Hong Kong Special Administrative Region ("HK SAR") of the People&#39;s Republic of China ("PRC"), a wholly-owned subsidiary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Formation of Stevia Technew Limited (Formerly Hero Tact Limited)/Cooperative Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 28, 2012, Stevia Asia formed Hero Tact Limited, a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited ("Stevia Technew").&nbsp;&nbsp;Stevia Technew intends to facilitate a joint venture relationship with the Company&#39;s technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou&#39;s affiliates Technew Technology Limited.&nbsp;&nbsp;Prior to July 5, 2012, the date of entry into the Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% of the shares (representing 30% of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia&#39;s financial capabilities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 1 - Organization and Operations</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stevia Corp. (Formerly Interpro Management Corp.)</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Interpro Management Corp ("Interpro") was incorporated under the laws of the State of Nevada on May 21, 2007.&nbsp;&nbsp;&nbsp;Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization&#39;s efficiency through planning and monitoring the daily operations of a business.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. ("Stevia" or the "Company") to reflect its intended acquisition of Stevia Ventures International Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd. ("Ventures") was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands ("BVI").&nbsp;&nbsp;Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia<font style="FONT-FAMILY: Times New Roman; DISPLAY: inline">.</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Acquisition of Stevia Ventures International Ltd. Recognized as a Reverse Acquisition</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 23, 2011 (the "Closing Date"), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the "Share Exchange Agreement") by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Immediately prior to the consummation of the Share Exchange Agreement on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company&#39;s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company&#39;s common stock to the Company for cancellation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares were being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures&#39; Stockholder (the "Escrow Agreement").&nbsp;&nbsp;Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock, immediately after the consummation of the Share Exchange Agreement, the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification.&nbsp;&nbsp;The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition.&nbsp;&nbsp;The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost.&nbsp;&nbsp;The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Formation of Stevia Asia Limited</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 19, 2012, the Company formed Stevia Asia Limited ("Stevia Asia") under the laws of the Hong Kong Special Administrative Region ("HK SAR") of the People&#39;s Republic of China ("PRC"), as a wholly-owned subsidiary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Formation of Stevia Technew Limited (Formerly Hero Tact Limited)/Cooperative Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 28, 2012, Stevia Asia formed Hero Tact Limited, as a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited ("Stevia Technew").&nbsp;&nbsp;Stevia Technew intends to facilitate a joint venture relationship with the Company&#39;s technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou&#39;s affiliates Technew Technology Limited.&nbsp;&nbsp;Prior to July 5, 2012, the date of entry into the Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the issued shares and Technew legally and beneficially owns 30% of the issued shares. The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia&#39;s financial capabilities. On March 1, 2013, the partners agreed to terminate the Cooperative Agreement specific to the investment in an agricultural project and no further obligation by either party related to the payment of $200,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Formation of SC Brands Pte Ltd</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 1, 2013, the Company formed SC Brands Pte Ltd ("SC Brands") under the laws of Singapore, with the Company owning 70% of the shares and 30% owned by a Singapore strategic partner that will provide the working capital funds via fixed convertible notes to the Company. As of December 31, 2013 SC Brands was inactive.</div> <!--EndFragment--></div> </div> 21250 7500 0 21250 0 6250 28625 70500 30000 16125 8000 2807 432 4179 4889 3036 16475 4889 0 5315 0.001 0.001 0.001 1000000 1000000 1000000 0 0 0 0 0 0 0 0 0 33096 168874 74946 6667 21250 550000 1200000 431500 200000 892289 100000 0 447500 152012 0 2100 200 -10495 2100 454958 255959 487867 352031 178135 123356 -2250022 -2323551 -2149272 -1439811 -857342 -409579 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 5 - Property and Equipment</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment, stated at cost, less accumulated depreciation consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Property and equipment</div> </td> <td valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 5</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 7,925</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,036</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Less accumulated depreciation</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (1,234</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (-</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6,691</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,036</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Depreciation Expense</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company acquired furniture and fixture near the end of February 2012 and started to depreciate as of April 1, 2012. Depreciation expense for the fiscal year ended March 31, 2013 was $1,234.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note&nbsp;5 - Property and Equipment</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt"><font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)</font><font style="COLOR: black; LETTER-SPACING: 9pt">&nbsp;</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Depreciation Expense</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Depreciation expense was $3,100 and $762 for the interim period ended December 31, 2013 and 2012, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 7925 3036 24400 6691 3036 20066 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment is recorded at cost.&nbsp;&nbsp;Expenditures for major additions and betterments are capitalized.&nbsp;&nbsp;Maintenance and repairs are charged to operations as incurred.&nbsp;&nbsp;Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.&nbsp;&nbsp;Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment is recorded at cost.&nbsp;&nbsp;Expenditures for major additions and betterments are capitalized.&nbsp;&nbsp;Maintenance and repairs are charged to operations as incurred.&nbsp;&nbsp;Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.&nbsp;&nbsp;Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Property and equipment</div> </td> <td valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 5</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 7,925</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,036</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Less accumulated depreciation</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (1,234</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (-</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6,691</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,036</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.&nbsp;&nbsp;&nbsp;These reclassifications had no effect on reported losses.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.&nbsp;&nbsp;&nbsp;These reclassifications had no effect on reported losses.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 8 - Related Party Transactions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Related parties</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Related parties with whom the Company had transactions are:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Related Parties</div> </td> <td style="PADDING-BOTTOM: 2px" valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &#12288;</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Relationship</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> George Blankenbaker</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> President and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Leverage Investments LLC</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Technew Technology Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Non-controlling interest holder</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Growers&nbsp;&nbsp;Synergy Pte Ltd.</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Guangzhou Health Technology Development Company Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by Non-controlling interest holder</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Advances from</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Stockholder</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Lease of Certain Office Space from</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Leverage Investments, LLC</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011.&nbsp;&nbsp;For the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through December 31, 2012, the Company recorded $6,000 and $4,500 in rent expenses due Leverage Investment LLC, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Farm Management and Off-Take Agreement with Growers Synergy Pte Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the period from July 1, 2011 through October 31, 2011, the Company engaged Growers Synergy Pte Ltd. to provide farm management services on a month-to-month basis, at $20,000 per month.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a Singapore corporation owned and controlled by the president and major stockholder of the Company.&nbsp;&nbsp;Under the terms of the Management Agreement,&nbsp;&nbsp;the Company will engage GSPL to supervise the Company&#39;s farm management operations, recommend quality farm management&nbsp;&nbsp;programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization&nbsp;&nbsp;targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services for a term of two (2) years from the date of signing, at $20,000 per month.&nbsp;&nbsp;The Management Agreement may be terminated by the Company upon 30 day notice.&nbsp;&nbsp;In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company&#39;s GSPL supervised farms.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Farm management services provided by Growers Synergy Pte Ltd. is as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Fiscal Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period from</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> April 11, 2011 (inception)</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Farm management services - related parties</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future minimum payments required under this agreement were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 140,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 140,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Commitment in Connection with the Operations of Stevia Technew</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, Stevia Asia, entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% shares (representing 30% of the of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to provide $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia&#39;s financial capabilities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the fiscal year ended March 31, 2013, Stevia Asia provided Stevia Technew $230,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related parties.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-WEIGHT: bold; DISPLAY: inline"> Note&nbsp;8 - Related Party Transactions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Related parties</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Related parties with whom the Company had transactions are:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Related Parties</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="top" width="60%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> Relationship</div> </td> </tr> <tr> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> George Blankenbaker</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> President and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Leverage Investments LLC</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Technew Technology Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Non-controlling interest holder</div> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Growers&nbsp;&nbsp;Synergy Pte Ltd.</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by the president and significant stockholder of the Company</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Guangzhou Health Technology Development Company Limited</div> </td> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="60%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> An entity owned and controlled by Non-controlling interest holder</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Advances from</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Stockholder</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Lease of Certain Office Space from</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Leverage Investments, LLC</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011.&nbsp;&nbsp;For the interim periods ended December 31, 2013 and 2012, the Company recorded $4,500 each in rent expense, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Farm Management and Off-Take Agreement with Growers Synergy Pte Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a Singapore corporation.&nbsp;&nbsp;Under the terms of the Management Agreement,&nbsp;&nbsp;the Company will engage GSPL to supervise the Company&#39;s farm management operations, recommend quality farm management&nbsp;&nbsp;programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization&nbsp;&nbsp;targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services at $20,000 per month for a term of two (2) years from the date of signing expiring on November 1, 2013.&nbsp;&nbsp;The Management Agreement may be terminated by the Company upon 30 day notice.&nbsp;&nbsp;In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company&#39;s GSPL supervised farms.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 31, 2013 ("Effective Date"), the Company extended the Management and Off-Take Agreement (the "Management Agreement") with GSPL with the same terms and conditions for a period of two (2) years ("Term") from the Effective Date expiring October 31, 2015 and shall automatically be extended for subsequent period of one (1) year expiring October 31, 2016 ("Extended Term") unless earlier terminated in writing.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Farm management services provided by Growers Synergy Pte Ltd. were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> period ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> period ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Farm management services - related parties</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 180,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future minimum payments required under this agreement were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2014 (remainder of the fiscal year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2015</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2016</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2017</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 140,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 860,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Commitment in Connection with the Operations of Stevia Technew</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the fiscal year ended March 31, 2013, Stevia Asia provided Stevia Technew $200,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related parties. On March 1, 2013, the partners agreed to terminate the Cooperative Agreement specific to the investment in an agricultural project and no further obligation by either party related to the payment of $200,000.</div> <!--EndFragment--></div> </div> 177169 206191 262810 118669 71930 0 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and Development</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Research and Development Costs"</font>) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 <font style="FONT-STYLE: italic; DISPLAY: inline">"Research and Development Arrangements"</font>) for research and development costs.&nbsp;&nbsp;Research and development costs are charged to expense as incurred.&nbsp;&nbsp;Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and Development</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Research and Development Costs"</font>) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 <font style="FONT-STYLE: italic; DISPLAY: inline">"Research and Development Arrangements"</font>) for research and development costs.&nbsp;&nbsp;Research and development costs are charged to expense as incurred.Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 13 - Research and Development</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Agribusiness Development Agreement - Agro Genesis Pte Ltd.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Agribusiness Development Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 16, 2011, the Company entered into an Agribusiness Development Agreement (the "Agribusiness Development Agreement") with Agro Genesis Pte Ltd. ("AGPL"), a corporation organized under the laws of the Republic of Singapore expiring two (2) years from the date of signing.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Agreement, the Company engaged AGPL to be the Company&#39;s technology provider consultant for stevia propagation and cultivation in Vietnam, and potentially other countries for a period of two (2) years. AGPL will be tasked with developing stevia propagation and cultivation technology in Vietnam, recommend quality agronomic programs for stevia cultivation, harvest and post harvest, alert findings on stevia propagation and cultivation that may impact profitability and develop a successful model in Vietnam that can be replicated elsewhere (the "Project"). The Project will be on-site at stevia fields in Vietnam and will have a term of at least two (2) years. For its services, AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated at $274,000 as specified in Appendix A to the Agribusiness Development Agreement. Additionally, the Company will be AGPL&#39;s exclusive distributor</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> for AGPL&#39;s g&#39;farm system (a novel crop production system) for stevia growing resulting from the Project. AGPL will receive a commission of no less than 2% of the price paid for crops other than stevia, from cropping systems that utilize the g&#39;farm system resulting from the Project. All technology-related patents resulting from the Project will be jointly owned by AGPL and the Company, with the Company holding a right of first offer for the use and distribution rights to registered patents resulting from the Project.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Addendum to Agribusiness Development Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 26, 2011, in accordance with Appendix A , 3(a), the Company and AGPL have mutually agreed to add to the current Project budget $100,000 per annum for one, on-site resident AGPL expert for 2 (two) years effective September 1, 2011, or $200,000 in aggregate for the term of the contract as specified in Appendix C.&nbsp;&nbsp;In-country accommodation for the resident expert will be born separately by the Company and is excluded from the above amount.&nbsp;&nbsp;The expert, Dr. Cho, Young-Cheol, Director, Life Sciences has been appointed and commenced on September 1, 2011.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Termination of Agribusiness Development Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 31, 2012, the Company and AGPL mutually agreed to terminate the Agribusiness Development Agreement, effective immediately.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Lease of Agricultural Land</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On December 14, 2011, the Company and Stevia Ventures Corporation ("Stevia Ventures") entered into a Land Lease Agreement with Vinh Phuc Province People&#39;s Committee Tam Dao Agriculture &amp; Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the "Leased Property") for a term expiring five (5) years from the date of signing.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future minimum payments required under this agreement at March 31, 2013 were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2014</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2015</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2016</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 90,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Supply and Cooperative Agreement - Guangzhou Health Technology Development Company Limited</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Supply Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People&#39;s Republic of China (the "Guangzhou Health").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Cooperative Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 21, 2012, the Company also entered into Cooperative Agreement (the "Cooperative Agreement") with Guangzhou Health Technology Development Company Limited.</div> <div><br /> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company&#39;s business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 13 - Research and Development</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Lease of Agricultural Land</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On December 14, 2011, the Company and Stevia Ventures Corporation ("Stevia Ventures") entered into a Land Lease Agreement with Vinh Phuc Province People&#39;s Committee Tam Dao Agriculture &amp; Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the "Leased Property") for a term expiring five (5) years from the date of signing expiring December 14, 2016.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future minimum payments required under this agreement at December 31, 2013 were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2014 (remainder of the year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 7,500</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2015</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2016</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 67,500</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Supply and Cooperative Agreement - Guangzhou Health Technology Development Company Limited</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Supply Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People&#39;s Republic of China (the "Guangzhou Health").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Cooperative Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 21, 2012, the Company also entered into Cooperative Agreement (the "Cooperative Agreement") with Guangzhou Health Technology Development Company Limited.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company&#39;s business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 375000 187500 195312 381250 -4359415 -2323551 -6376899 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.&nbsp;&nbsp;The Company recognizes revenue when it is realized or realizable and earned.&nbsp;&nbsp;The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.&nbsp;&nbsp;The Company recognizes revenue when it is realized or realizable and earned.&nbsp;&nbsp;The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv)collectability is reasonably assured.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 2168093 1300 1893865 120939 388746 8142 190549 0 66556 110982 378 59105 0 750000 600000 0 0 0 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" width="10%" colspan="7"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Potentially Outstanding Dilutive</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Common Shares</font></div> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Fiscal Year Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> from April 11, 2011</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (inception) through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March&nbsp;31, 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Make Good Escrow Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Convertible Note Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">881,752</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at&nbsp;&nbsp;$0.46875 per share with gross proceeds of at least $100,000.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">426,667</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,400,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Convertible Note Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,708,419</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Warrant Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the <font style="FONT-SIZE: 11pt; DISPLAY: inline">new warrants issued</font> triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,951,424</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company&#39;s common stock to two notes holders in connection with the issuance of convertible notes.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,400,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company&#39;s common stock to the note holder in connection with the issuance of the convertible note.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">881,753</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Warrant Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Total potentially outstanding dilutive common shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,941,596</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Potentially Outstanding Dilutive Common Shares</div> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> PeriodEnded</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,000,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Make Good Escrow Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,000,000</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Convertible Note Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,752</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 426,667</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company&#39;s securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company&#39;s common stock as determined in good faith by Company&#39;s Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,739,130</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 426,667</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,400,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,762,228</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,353,573</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 440,571</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;290,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 812,634</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,142</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Convertible Note Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 10,561,070</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 853,334</div> </td> </tr> </table> </div> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Warrant Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to investors (the "investor warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 956,481</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company&#39;s common stock to two (2) note holders in connection with the issuance of convertible notes.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,400,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company&#39;s common stock to the note holder in connection with the issuance of the convertible note.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,753</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 6, 2013, the Company issued three (3) series of warrants:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,027,520</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,151,999</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,534,399</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company&#39;s common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Warrant Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Total potentially outstanding dilutive common shares</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 20,513,222</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,005,334</div> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: center" valign="bottom" width="61%">&nbsp; <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Milestones</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Completion Date</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Escrow</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Shares</font></div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="61%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> I.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (1)Enter into exclusive international license agreement for all Agro Genesis intellectual property and products as it applies to stevia</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (2)Enter into cooperative agreements to work with Vietnam Institutes (a) Medical Plant Institute in Hanoi; (b) Agricultural Science Institute of Northern Central Vietnam</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (3)Enter into farm management agreements with local growers including the Provincial and National projects;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (4)Take over management of three existing nurseries</div> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Within 180 days</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of the Closing Date</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 3,000,000 shares</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> only if and when ALL four (4) milestones reached (*)</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> II.&nbsp;&nbsp;&nbsp;Achieve 100 Ha field trials and first test shipment of dry leaf</div> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Within two (2) years</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of the Closing Date</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1,500,000 shares (**)</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> III.&nbsp;&nbsp;Test shipment of dry leaf to achieve minimum specs for contracted base price (currently $2.00 per kilogram)</div> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Within two (2) years</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of the Closing Date</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1,500,000 shares (**)</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> *</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; text-align: justify"> On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.&nbsp;&nbsp;These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> **</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; text-align: justify"> On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.&nbsp;&nbsp;These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.</div> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On November 16, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.&nbsp;&nbsp;On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,959 to 319,607 shares of the Company&#39;s common stock at $0.83 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 250,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On January 16, 2012, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.&nbsp;&nbsp;On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $11,781 to 314,586 shares of the Company&#39;s common stock at $0.83 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 250,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.&nbsp;On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price $0.25 per share</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 220,438</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 200,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 200,000</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company&#39;s common stock.</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 350,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total: convertible notes payable</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 770,438</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 700,000</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (444,788</div> </td> <td valign="bottom" width="2%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Accumulated amortization of discount on convertible notes payable</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 32,050</div> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Remaining discount</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (412,738</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" colspan="2" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 357,770</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" colspan="2" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 700,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Convertible notes payable consisted of the following:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="12%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="12%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal of this note and any accrued and unpaid interest thereon, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company&#39;s securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company&#39;s common stock as determined in good faith by Company&#39;s Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">200,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">200,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> February 26, 2013 convertible notes</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">350,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">350,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> March 15, 2013 convertible note</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">220,438</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">220,438</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">111,111</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">153,500</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">27,778</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company.&nbsp;&nbsp;In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">58,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014.</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">53,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">55,556</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Sub-total: convertible notes payable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">1,229,383</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">770,438</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Discount representing (i) the relative fair value of the warrants issued, (ii) the beneficial conversion features and (iii) the derivative liability on conversion features</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (816,310</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (444,788</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Accumulated amortization of discount on convertible notes payable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">658,496</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">32,050</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Remaining discount</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (157,814</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (412,738</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">1,071,569</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="11%">357,770</td> <td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net deferred tax assets - Non-current:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Expected income tax benefit from NOL carry-forwards</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,311,552</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 790,007</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Less valuation allowance</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (1,311,552</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (790,007</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Deferred tax assets, net of valuation allowance</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: center" valign="bottom" colspan="7">&nbsp;<font style="FONT-WEIGHT: bold; DISPLAY: inline">Fair Value Measurement Using Level 3 Inputs</font></td> </tr> <tr> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold"> Derivative warrants&nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Assets (Liability)</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, August 6, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(411,805</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(411,805</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">231,521</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">231,521</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, August 6, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (180,284</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> (180,284</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(305,829</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(305,829</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(486,113</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">(486,113</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 (reset to 6,247,146 on May 1, 2013) shares of the Company&#39;s common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative warrants</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Assets (Liability)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> </tr> <tr> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="12%" colspan="4"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="12%" colspan="4"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, September 30, 2012</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (305,829</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (305,829</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Total gains or losses (realized/unrealized) included in:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Net income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 675,949</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 675,949</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Other comprehensive income (loss)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Purchases, issuances and settlements</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (787,355</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (787,355</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Transfers in and/or out of Level 3</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Balance, December 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (597,519</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (597,519</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--><br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="43%" colspan="11"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012 Warrant Activities</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> APIC</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Gain) Loss</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Non-derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total Warrant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Change in</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at August 6, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (411,805</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 231,521</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (231,521</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at September 30, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (231,521</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at December 31, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (106,561</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (305,244</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Reset of warrant shares</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,799,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (379,552</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 379,552</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at March 31, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 74,308</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The table below summarizes the Company&#39;s derivative warrant activity:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="43%" colspan="11"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <div>&nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="11"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrant Activities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> APIC</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Gain) Loss</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Non-derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total Warrant</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Change in</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Derivative</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Liability</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at August 6, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (411,805</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 231,521</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (231,521</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at September 30, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (180,284</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (73,723</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at December 31, 2012</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (106,561</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Reset of warrant shares</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,799,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (379,552</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 379,552</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at March 31, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 2,951,424</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (486,113</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Exercise of warrants&nbsp;&nbsp;on May 6, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (2,732,799</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> (2,732,799</div> </td> <td valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Issuance of warrants&nbsp;&nbsp;on May 6, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,713,918</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 5,713,918</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (106,360</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )&nbsp;</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Reset of warrant shares</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 737,856</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 737,856</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Issuance of warrants on Oct 15, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (76,647</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Mark to market</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 299,373</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (299,373)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="26%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Derivative warrant at December 31, 2013</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 7,670,399</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 1.75pt; text-align: right; TEXT-INDENT: 0pt"> 7,670,399</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (369,747</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Fiscal Year</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> &nbsp;March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period from</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> April 11, 2011 (inception)</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Federal statutory income tax rate</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 18pt"> 34.0</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 34.0</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Change in valuation allowance on net operating loss carry-forwards</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 18pt"> (34.0</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (34.0</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Effective income tax rate</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 18pt"> 0.0</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td style="PADDING-BOTTOM: 4px" valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.0</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--><br /> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Website development costs</div> </td> <td valign="bottom" width="20%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> 5</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,315</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,315</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="56%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Accumulated amortization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (1,869</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> (801</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> )</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="56%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="20%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> $&nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,446</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4,514</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2014</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2015</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2016</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 90,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future minimum payments required under this agreement at December 31, 2013 were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2014 (remainder of the year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 7,500</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2015</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> 2016</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 30,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 67,500</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Inventory - seeds consisted of the following:</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> <br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="11%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Seeds (*)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,807,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="12%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="12%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="11%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,807,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="11%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> * The company acquired certain seeds in the amount of $1,807,000 in aggregate which was used for preparation of the fall planting for this spring harvest which will start from the second half of February, 2014 and last through April, 2014, $1,042,000 of which was in default. The vendor sold its accounts receivable of $1,042,000 to a third party, which sued the Company and settled the accounts payable and related legal costs and fees with the Company for the issuance of 15,538,882 common shares in aggregate.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="31%" colspan="8"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="8"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Range of Exercise Prices</div> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average Remaining</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual Life</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average Remaining Contractual Life</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted Average Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="middle" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,233,177</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3.73</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes information concerning outstanding and exercisable warrants as of <font style="FONT-SIZE: 11pt; DISPLAY: inline">December 31, 2013</font>:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Warrants Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Range of Exercise Prices</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Outstanding</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercisable</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Remaining</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Contractual</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Life (in years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="8%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Weighted</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Average</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Exercise Price</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="25%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="7%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.20 - 0.25</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="25%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $0.20 - 0.25</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="10%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 4.36</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="7%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 0.23</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> Accounts Payable at</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="7"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Net Purchases</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: center" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2012</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Growers Synergy Pte. Ltd. - related party</div> </td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 50.1</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 16.4</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 26.4</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 13.5</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Stevia Ventures Corporation</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 16. 9</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 54.1</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 55.7</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 14.4</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 67.0</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 70.5</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 82.1</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> 27.9</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Vendor purchase concentrations and accounts payable concentration are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: -18pt"> Accounts Payable at</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Net Purchases</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="11%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Reporting</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Reporting</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="38%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Growers Synergy Pte. Ltd. - related party</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 45.0</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 50.1</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 6.0</div> </td> <td valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 49.8</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="38%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> Stevia Ventures Corporation</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 19.3</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 16. 9</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 26.6</div> </td> <td valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 10.3</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="38%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> SG Agro Tech Pte Ltd</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 52.2</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="38%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 64.3</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: -18pt"> 67.0</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: -18pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 84.8</div> </td> <td valign="bottom" width="2%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 60.1</div> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> %</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stock-Based Compensation for Obtaining Employee Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.&nbsp;&nbsp;Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees&#39; expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the <font style="FONT-STYLE: italic; DISPLAY: inline">simplified method</font>, <font style="FONT-STYLE: italic; DISPLAY: inline">i.e.,</font> <font style="FONT-STYLE: italic; DISPLAY: inline">expected term = ((vesting term + original contractual term) / 2)</font>, if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.&nbsp;&nbsp;The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stock-Based Compensation for Obtaining Employee Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.&nbsp;&nbsp;Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees&#39; expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the <font style="FONT-STYLE: italic; DISPLAY: inline">simplified method</font>, <font style="FONT-STYLE: italic; DISPLAY: inline">i.e.,</font> <font style="FONT-STYLE: italic; DISPLAY: inline">expected term = ((vesting term + original contractual term) / 2)</font>, if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.&nbsp;&nbsp;The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> 5233177 9952152 5233177 9952152 P3Y8M23D P4Y4M10D P3Y8M23D P4Y4M10D 63555635 58354775 82695634 6000000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Shipping and Handling Costs</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for shipping and handling fees in accordance with paragraph 605-45-45-19 of the FASB Accounting Standards Codification.&nbsp;&nbsp;While amounts charged to customers for shipping products are included in revenues, the related costs are classified in cost of goods sold as incurred.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 2 - Summary of Significant Accounting Policies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Principles of Consolidation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company applies the guidance of Topic 810 <font style="FONT-STYLE: italic; DISPLAY: inline">"Consolidation"</font> of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.&nbsp;&nbsp;The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent&#39;s power to control exists.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated subsidiaries and/or entities are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Name of consolidated</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> subsidiary or entity</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> State or other jurisdiction of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> incorporation or organization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Date of incorporation or formation</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (date of acquisition, if applicable)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="18%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Attributable interest</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Ventures International Ltd.</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The Territory of the British&nbsp;Virgin&nbsp;Islands</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> April 11, 2011</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 100%</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Asia Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> March 19, 2012</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 100%</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Stevia Technew Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="24%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> April 28, 2012</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="18%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;70%</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> All inter-company balances and transactions have been eliminated.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.&nbsp;&nbsp;&nbsp;These reclassifications had no effect on reported losses.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates and Assumptions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s significant estimates and assumptions include the fair value of financial instruments; the carrying value, recoverability and impairment of long-lived assets, including the values assigned to and the estimated useful lives of website development costs; interest rate; revenue recognized or recognizable; sales returns and allowances; foreign currency exchange rate; income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; expected term of share options and similar instruments, expected volatility of the entity&#39;s shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s); and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Actual results could differ from those estimates.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.&nbsp;&nbsp;The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 1</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 2</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 3</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs that are generally observable inputs and not corroborated by market data.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.&nbsp;&nbsp;If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The carrying amounts of the Company&#39;s financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable, accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s convertible notes payable approximates the fair value of such instrument based upon management&#39;s best estimate of interest rates that would be available to the Company for similar financial arrangements at March 31, 2013 and March 31, 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.&nbsp;&nbsp;The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.&nbsp;&nbsp;These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> It is not, however, practical to determine the fair value of advances from president and significant stockholder, if any, due to their related party nature.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Level 3 Financial Liabilities - Derivative Warrant Liabilities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability at every reporting period and recognizes gains or losses in the consolidated statements of operations and comprehensive income (loss) that are attributable to the change in the fair value of the derivative warrant liability.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Carrying Value, Recoverability and Impairment of Long-Lived Assets</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company&#39;s long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.&nbsp;&nbsp;Fair value is generally determined using the asset&#39;s expected future discounted cash flows or market value, if readily determinable.&nbsp;&nbsp;If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&nbsp;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&nbsp;significant changes in the manner or use of assets or in the Company&#39;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#39;s overall business strategy; (iii)&nbsp;significant negative industry or economic trends; (iv)&nbsp;increased competitive pressures; (v)&nbsp;a significant decline in the Company&#39;s stock price for a sustained period of time; and (vi)&nbsp;regulatory changes.&nbsp;&nbsp;The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The key assumptions used in management&#39;s estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.&nbsp;&nbsp;These forecasts are typically based on historical trends and take into account recent developments as well as management&#39;s plans and intentions.&nbsp;&nbsp;Other factors, such as increased competition or a decrease in the desirability of the Company&#39;s products or services, could lead to lower projected sales levels, which would adversely impact cash flows.&nbsp;&nbsp;A significant change in cash flows in the future could result in an impairment of long lived assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fiscal Year End</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company elected March 31 as its fiscal year ending date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Equivalents</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment is recorded at cost.&nbsp;&nbsp;Expenditures for major additions and betterments are capitalized.&nbsp;&nbsp;Maintenance and repairs are charged to operations as incurred.&nbsp;&nbsp;Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.&nbsp;&nbsp;Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Intangible Assets Other Than Goodwill</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.&nbsp;&nbsp;Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill inclusive of acquired technology and website development costs on a straight-line basis over their relevant estimated useful lives of fifteen (15) and five (5) years, respectively.&nbsp;&nbsp;Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Related Parties</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Section 850-10-20 the related parties include a.&nbsp;affiliates of the Company; b.&nbsp;entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c.&nbsp;trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e.&nbsp;management of the Company; f.&nbsp;other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g.&nbsp;other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:&nbsp;&nbsp;a.&nbsp;the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c.&nbsp;the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Instruments and Hedging Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.&nbsp;&nbsp;The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.&nbsp;&nbsp;For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> From time to time, the Company may employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates.&nbsp;&nbsp;The Company does not use derivatives for speculation or trading purposes.&nbsp;&nbsp;Changes in the fair value of derivatives are recorded each period in current earnings or through other comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and the type of hedge transaction.&nbsp;&nbsp;The ineffective portion of all hedges is recognized in current earnings.&nbsp;&nbsp;The Company has sales and purchase commitments denominated in foreign currencies.&nbsp;&nbsp;Foreign currency forward contracts are used to hedge against the risk of change in the fair value of these commitments attributable to fluctuations in exchange rates ("Fair Value Hedges").&nbsp;&nbsp;Changes in the fair value of the derivative instrument are generally offset in the income statement by changes in the fair value of the item being hedged.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company did not employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates for the fiscal year ended March 31, 2013 or 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Liability</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.&nbsp;&nbsp;The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.&nbsp;&nbsp;In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.&nbsp;&nbsp;Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&nbsp;&nbsp;Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.&nbsp;&nbsp;Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")<font style="FONT-STYLE: italic; DISPLAY: inline">&nbsp;</font> to determine whether an instrument (or an embedded feature) is indexed to the Company&#39;s own stock.&nbsp;&nbsp;Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument&#39;s contingent exercise and settlement provisions.&nbsp;&nbsp; The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.&nbsp;&nbsp;The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.&nbsp;&nbsp;Therefore, the fair value may not be appropriately captured by simple models.&nbsp;&nbsp;In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).&nbsp;&nbsp;The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.&nbsp;&nbsp;Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).&nbsp;&nbsp;Projections were then made on the underlying factors which led to potential scenarios.&nbsp;&nbsp;Probabilities were assigned to each scenario based on management projections.&nbsp;&nbsp;This led to a cash flow projection and a probability associated with that cash flow.&nbsp;&nbsp;A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Beneficial Conversion Feature</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company&#39;s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Commitment and Contingencies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.&nbsp;&nbsp;The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.&nbsp;&nbsp;In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#39;s consolidated financial statements.&nbsp;&nbsp;If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.&nbsp;&nbsp;Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company&#39;s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company&#39;s business, financial position, and results of operations or cash flows.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-controlling Interest</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interest in Stevia Technew Limited, its majority owned subsidiary in the consolidated statements of balance sheets within the equity section, separately from the Company&#39;s stockholders&#39; equity.&nbsp;&nbsp;Non-controlling interest represents the non-controlling interest holder&#39;s proportionate share of the equity of the Company&#39;s majority-owned subsidiary, Stevia Technew Limited. Non-controlling interest is adjusted for the non-controlling interest holder&#39;s proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.&nbsp;&nbsp;The Company recognizes revenue when it is realized or realizable and earned.&nbsp;&nbsp;The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and Development</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Research and Development Costs"</font>) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 <font style="FONT-STYLE: italic; DISPLAY: inline">"Research and Development Arrangements"</font>) for research and development costs.&nbsp;&nbsp;Research and development costs are charged to expense as incurred.&nbsp;&nbsp;Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The research and development arrangements usually involve specific research and development projects.&nbsp;&nbsp;Often times, the Company makes non-refundable advances upon signing of these arrangements.&nbsp;&nbsp;The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities"</font>) for those non-refundable advances.&nbsp;&nbsp;Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.&nbsp;&nbsp;Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.&nbsp;&nbsp;The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.&nbsp;&nbsp;If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stock-Based Compensation for Obtaining Employee Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.&nbsp;&nbsp;Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees&#39; expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the <font style="FONT-STYLE: italic; DISPLAY: inline">simplified method</font>, <font style="FONT-STYLE: italic; DISPLAY: inline">i.e.,</font> <font style="FONT-STYLE: italic; DISPLAY: inline">expected term = ((vesting term + original contractual term) / 2)</font>, if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.&nbsp;&nbsp;The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">E</font><font style="TEXT-DECORATION: underline; DISPLAY: inline">quity Instruments Issued to Parties other than Employees for Acquiring Goods or Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder&#39;s expected exercise behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;The Company uses historical data to estimate holder&#39;s expected exercise behavior.&nbsp;&nbsp;If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.&nbsp;&nbsp;A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.&nbsp;The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 36pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Tax Provision</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.&nbsp;&nbsp;Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.&nbsp;&nbsp;Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.&nbsp;&nbsp;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&nbsp;&nbsp;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.&nbsp;&nbsp;Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&nbsp;&nbsp;The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.&nbsp;&nbsp;Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management&#39;s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Uncertain Tax Positions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the fiscal year ended March 31, 2013 or for the period from April 11, 2011 (Inception) through December 31, 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Limitation on Utilization of NOLs due to Change in Control</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL&#39;s to annual limitations which could reduce or defer the NOL.&nbsp;&nbsp;Section 382 imposes limitations on a corporation&#39;s ability to utilize NOLs if it experiences an "ownership change."&nbsp;&nbsp;In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.&nbsp;&nbsp;In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.&nbsp;&nbsp;The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Net Income (Loss) per Common Share</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification.&nbsp;&nbsp;&nbsp;Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.&nbsp;&nbsp;Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center" valign="bottom" width="10%" colspan="7"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Potentially Outstanding Dilutive</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Common Shares</font></div> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Fiscal Year Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="12%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For the Period</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> from April 11, 2011</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (inception) through</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> March&nbsp;31, 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="3"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Make Good Escrow Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">3,000,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Convertible Note Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">881,752</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at&nbsp;&nbsp;$0.46875 per share with gross proceeds of at least $100,000.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">426,667</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,400,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Convertible Note Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,708,419</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> <div>&nbsp;</div> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Warrant Shares</div> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the <font style="FONT-SIZE: 11pt; DISPLAY: inline">new warrants issued</font> triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">2,951,424</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company&#39;s common stock to two notes holders in connection with the issuance of convertible notes.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,400,000</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company&#39;s common stock to the note holder in connection with the issuance of the convertible note.</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">881,753</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Warrant Shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">5,233,177</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="50%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="6%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="50%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Total potentially outstanding dilutive common shares</div> </td> <td valign="bottom" width="6%" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">10,941,596</td> <td valign="bottom" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">6,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Flows Reporting</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.&nbsp;&nbsp;The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Subsequent Events</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the&nbsp;financial statements are issued.&nbsp;&nbsp;Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In January 2013, the FASB issued ASU No. 2013-01, "<font style="FONT-STYLE: italic; DISPLAY: inline">Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities</font>". This ASU clarifies that the scope of&nbsp;ASU No. 2011-11, "<font style="FONT-STYLE: italic; DISPLAY: inline">Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities.</font>" applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in FASB Accounting Standards Codification or subject to a master netting arrangement or similar agreement. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the FASB issued ASU No. 2013-02, "<font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.</font>" The ASU <font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> &nbsp;</font> adds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "<font style="FONT-STYLE: italic; DISPLAY: inline">Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date</font>."&nbsp;&nbsp;This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU No. 2013-05, "<font style="FONT-STYLE: italic; DISPLAY: inline">Foreign Currency Matters (Topic 830): Parent&#39;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</font>." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU 2013-07, <font style="FONT-STYLE: italic; DISPLAY: inline">"Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting."</font> The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity&#39;s governing documents from the entity&#39;s inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity&#39;s inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity&#39;s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 2 - Summary of Significant Accounting Policies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="BACKGROUND-COLOR: #ffffff; DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Management of the Company is responsible for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application.&nbsp;&nbsp;Critical accounting policies and practices are those that are both most important to the portrayal of the Company&#39;s financial condition and results and require management&#39;s most difficult, subjective, or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain. The Company&#39;s significant and critical accounting policies and practices are disclosed below as required by generally accepted accounting principles.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation - Unaudited Interim Financial Information</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission ("SEC") to Form 10-Q and Article 8 of Regulation S-X.&nbsp;&nbsp;Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. &nbsp;The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.&nbsp;&nbsp;Interim results are not necessarily indicative of the results for the full fiscal year.&nbsp;&nbsp;These consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the fiscal year ended March 31, 2013 and notes thereto contained in the Company&#39;s Annual Report on Form 10-K as filed with the SEC on July 16, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fiscal Year End</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company elected March 31st as its fiscal year end date upon its formation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="BACKGROUND-COLOR: #ffffff; DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company&#39;s critical accounting estimates and assumptions affecting the financial statements were:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Assumption as a going concern</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business<font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">.</font></div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (ii)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Allowance for doubtful accounts</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Management&#39;s <font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">estimate of the allowance for doubtful accounts is based on historical sales, historical loss levels, and an analysis of the collectability of individual accounts;</font> and general economic conditions that may affect a client&#39;s ability to pay<font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">. The Company evaluated the key factors and assumptions used to develop the allowance in determining that it is reasonable in relation to the financial statements taken as a whole.</font></div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iii)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline">Inventory Obsolescence and Markdowns</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> The Company&#39;s estimate of potentially excess and slow-moving inventories is based on evaluation of inventory levels and aging, review of inventory turns and historical sales experiences. The Company&#39;s estimate of reserve for inventory shrinkage is based on the historical results of physical inventory cycle counts.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iv)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Fair value of long-lived assets</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Fair value is generally determined using the asset&#39;s expected future discounted cash flows or market value, if readily determinable.&nbsp;&nbsp;If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&nbsp;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&nbsp;significant changes in the manner or use of assets or in the Company&#39;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#39;s overall business strategy; (iii)&nbsp;significant negative industry or economic trends; (iv)&nbsp;increased competitive pressures; (v)&nbsp;a significant decline in the Company&#39;s stock price for a sustained period of time; and (vi)&nbsp;regulatory changes.&nbsp;&nbsp;The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (v)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Valuation allowance for deferred tax assets</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Management assumes that the realization of the Company&#39;s net deferred tax assets resulting from its net operating loss ("NOL") carry-forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (vi)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Estimates and assumptions used in valuation of equity instruments</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">: Management estimates</font> expected term of share options and similar instruments, expected volatility of the Company&#39;s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> <font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</font></div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Actual results could differ from those estimates.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Principles of Consolidation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company applies the guidance of Topic 810 <font style="FONT-STYLE: italic; DISPLAY: inline">"Consolidation"</font> of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.&nbsp;&nbsp;Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.&nbsp;&nbsp;The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent&#39;s power to control exists.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s consolidated subsidiaries and/or entities are as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Name of consolidated</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> subsidiary or entity</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> State or other jurisdiction</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of incorporation or organization</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Date of incorporation or formation</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (date of acquisition, if applicable)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Attributable</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> interest</div> </td> <td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; FONT-WEIGHT: bold; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Ventures International Ltd.</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> The Territory of the British&nbsp;Virgin&nbsp;Islands</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> April 11, 2011</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Asia Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> March 19, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">100</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="30%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Stevia Technew Limited</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Hong Kong SAR</div> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: center; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="29%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt"> April 28, 2012</div> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">70</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">%</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="30%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="29%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 9pt; PADDING-LEFT: 0pt" valign="bottom" width="30%" align="left">&nbsp; <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> SC Brands Pte Ltd</font></td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt" valign="bottom" width="29%">&nbsp;Singapore</td> <td valign="bottom" width="2%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center; TEXT-INDENT: 0pt" valign="bottom" width="29%">October 1, 2013</td> <td valign="bottom" width="1%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: right" valign="bottom" width="9%">70</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> %&nbsp;</font> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> All inter-company balances and transactions have been eliminated.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reclassification</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.&nbsp;&nbsp;&nbsp;These reclassifications had no effect on reported losses.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Instruments</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.&nbsp;&nbsp;The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 1</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 2</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</div> </td> </tr> <tr bgcolor="white"> <td valign="top" width="6%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="top" width="6%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Level 3</div> </td> <td valign="middle" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="top" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Pricing inputs that are generally observable inputs and not corroborated by market data.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.&nbsp;&nbsp;If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The carrying amounts of the Company&#39;s financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable,accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s convertible notes payable approximates the fair value of such instrument based upon management&#39;s best estimate of interest rates that would be available to the Company for similar financial arrangements at December 31, 2013 and March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation and the derivative liability on the conversion feature.&nbsp;&nbsp;The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.&nbsp;&nbsp;These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Level 3 Financial Liabilities - Derivative Warrant Liabilities and Derivative Liability on Conversion Feature</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability and derivative liability on the conversion feature at every reporting period and recognizes gains or losses in the consolidated statements of operations that are attributable to the change in the fair value of the derivative liabilities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Accounts Receivable and Allowance for Doubtful Accounts</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Accounts receivable are recorded at the invoiced amount, net of an allowance for doubtful accounts.&nbsp;&nbsp;The Company follows paragraph 310-10-50-9 of the FASB Accounting Standards Codification to estimate the allowance for doubtful accounts.&nbsp;&nbsp;The Company performs on-going credit evaluations of its customers and adjusts credit limits based upon payment history and the customer&#39;s current credit worthiness, as determined by the review of their current credit information; and determines the allowance for doubtful accounts based on historical write-off experience, customer specific facts and economic conditions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to paragraph 310-10-50-2 of the FASB Accounting Standards Codification account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.&nbsp;&nbsp;The Company has adopted paragraph 310-10-50-6 of the FASB Accounting Standards Codification and determine when receivables are past due or delinquent based on how recently payments have been received.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Outstanding account balances are reviewed individually for collectability.&nbsp;&nbsp;The allowance for doubtful accounts is the Company&#39;s best estimate of the amount of probablecredit losses in the Company&#39;s existing accounts receivable. Bad debt expense is included in general and administrative expenses, if any.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There was no allowance for doubtful accounts as December 31, 2013 or March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company does not have any off-balance-sheet credit exposure to its customers.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Carrying Value, Recoverability and Impairment of Long-Lived Assets</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company&#39;s long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful livesagainst their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.&nbsp;&nbsp;Fair value is generally determined using the asset&#39;s expected future discounted cash flows or market value, if readily determinable.If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&nbsp;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&nbsp;significant changes in the manner or use of assets or in the Company&#39;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#39;s overall business strategy; (iii)&nbsp;significant negative industry or economic trends; (iv)&nbsp;increased competitive pressures; (v)&nbsp;a significant decline in the Company&#39;s stock price for a sustained period of time; and (vi)&nbsp;regulatory changes.&nbsp;&nbsp;The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The key assumptions used in management&#39;s estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.&nbsp;&nbsp;These forecasts are typically based on historical trends and take into account recent developments as well as management&#39;s plans and intentions.&nbsp;&nbsp;Other factors, such as increased competition or a decrease in the desirability of the Company&#39;s products or services, could lead to lower projected sales levels, which would adversely impact cash flows.&nbsp;&nbsp;A significant change in cash flows in the future could result in an impairment of long lived assets.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Equivalents</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Inventories</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Inventory Valuation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company values inventory, consisting of finished goods, at the lower of cost or market.&nbsp;&nbsp;Cost is determined on the first-in and first-out ("FIFO") method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value.&nbsp;&nbsp;Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Inventory Obsolescence and Markdowns</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classify inventory markdowns in the income statement as a component of cost of goods sold pursuant to Paragraph 420-10-S99 of the FASB Accounting Standards Codification to adjust inventory to net realizable value. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There was no inventory obsolescence for the interim period ended December 31, 2013 or 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There was no lower of cost or market adjustments for the interim period ended December 31, 2013 or 2012.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-INDENT: 0pt"> &nbsp;</div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Property and Equipment</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Property and equipment is recorded at cost.&nbsp;&nbsp;Expenditures for major additions and betterments are capitalized.&nbsp;&nbsp;Maintenance and repairs are charged to operations as incurred.&nbsp;&nbsp;Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.&nbsp;&nbsp;Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Intangible Assets Other Than Goodwill</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.&nbsp;&nbsp;Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwillon a straight-line basis over the estimated useful lives of the respective assets as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Estimated Useful Life (Years)</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Acquired technology</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 15</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt" valign="bottom" width="88%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Website development costs</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 5</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Related Parties</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Section 850-10-20 the related parties include a.&nbsp;affiliates of the Company; b.&nbsp;entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c.&nbsp;trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e.&nbsp;management of the Company; f.&nbsp;other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g.&nbsp;other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:&nbsp;&nbsp;a.&nbsp;the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c.&nbsp;the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Extinguishment Accounting</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 25, 2013, the Supreme Court of the State of New York, County of New York (the&nbsp;&nbsp;"Court"),&nbsp;&nbsp;entered&nbsp;&nbsp;an order (the&nbsp;&nbsp;"Order")&nbsp;&nbsp;approving the settlement&nbsp;&nbsp;(the "Settlement Agreement")&nbsp;&nbsp;between the Company and Hanover Holdings I, LLC, a New York limited&nbsp;&nbsp;liability company&nbsp;&nbsp;("Hanover"),&nbsp;&nbsp;Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the&nbsp;&nbsp;"Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Settlement&nbsp;&nbsp;Agreement&nbsp;&nbsp;provides that the Initial Settlement Shares will be&nbsp;&nbsp;subject&nbsp;&nbsp;to&nbsp;&nbsp;adjustment&nbsp;&nbsp;on&nbsp;&nbsp;the&nbsp;&nbsp;trading&nbsp;&nbsp;day&nbsp;&nbsp;immediately&nbsp;&nbsp;&nbsp;following&nbsp;&nbsp;the Calculation Period to reflect the&nbsp;&nbsp;intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the&nbsp;&nbsp;Settlement&nbsp;&nbsp;Agreement be based upon a specified&nbsp;&nbsp;discount to the trading volume&nbsp;&nbsp;weighted&nbsp;&nbsp;average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court&#39;s entry of the Order.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.&nbsp;&nbsp;The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Instruments and Hedging Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.&nbsp;&nbsp;The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.&nbsp;&nbsp;For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Derivative Liability</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.&nbsp;&nbsp;The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.&nbsp;&nbsp;In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.&nbsp;&nbsp;Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.&nbsp;&nbsp;Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.&nbsp;&nbsp;Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")to determine whether an instrument (or an embedded feature) is indexed to the Company&#39;s own stock.&nbsp;&nbsp;Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument&#39;s contingent exercise and settlement provisions.&nbsp;&nbsp; The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.&nbsp;&nbsp;The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.&nbsp;&nbsp;Therefore, the fair value may not be appropriately captured by simple models.&nbsp;&nbsp;In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).&nbsp;&nbsp;The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.&nbsp;&nbsp;Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).&nbsp;&nbsp;Projections were then made on the underlying factors which led to potential scenarios.&nbsp;&nbsp;Probabilities were assigned to each scenario based on management projections.&nbsp;&nbsp;This led to a cash flow projection and a probability associated with that cash flow.&nbsp;&nbsp;A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Beneficial Conversion Feature</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company&#39;s common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Commitment and Contingencies</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.&nbsp;&nbsp;The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.&nbsp;&nbsp;In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company&#39;s consolidated financial statements.&nbsp;&nbsp;If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.&nbsp;&nbsp;Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company&#39;s consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company&#39;s business, financial position, and results of operations or cash flows.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-controlling Interest</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interests in its majority owned subsidiaries in the consolidated statements of balance sheets within the equity section, separately from the Company&#39;s stockholders&#39; equity.&nbsp;&nbsp;Non-controlling interests represents the non-controlling interest holder&#39;s proportionate share of the equity of the Company&#39;s majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holder&#39;s proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Revenue Recognition</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.&nbsp;&nbsp;The Company recognizes revenue when it is realized or realizable and earned.&nbsp;&nbsp;The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv)collectability is reasonably assured.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Shipping and Handling Costs</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for shipping and handling fees in accordance with paragraph 605-45-45-19 of the FASB Accounting Standards Codification.&nbsp;&nbsp;While amounts charged to customers for shipping products are included in revenues, the related costs are classified in cost of goods sold as incurred.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Research and Development</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Research and Development Costs"</font>) and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 <font style="FONT-STYLE: italic; DISPLAY: inline">"Research and Development Arrangements"</font>) for research and development costs.&nbsp;&nbsp;Research and development costs are charged to expense as incurred.Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The research and development arrangements usually involve specific research and development projects.&nbsp;&nbsp;Often times, the Company makes non-refundable advances upon signing of these arrangements.&nbsp;&nbsp;The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 <font style="FONT-STYLE: italic; DISPLAY: inline">"Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities"</font>) for those non-refundable advances.&nbsp;&nbsp;Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.&nbsp;&nbsp;Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.&nbsp;&nbsp;The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.&nbsp;&nbsp;If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Stock-Based Compensation for Obtaining Employee Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.&nbsp;&nbsp;Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees&#39; expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the <font style="FONT-STYLE: italic; DISPLAY: inline">simplified method</font>, <font style="FONT-STYLE: italic; DISPLAY: inline">i.e.,</font> <font style="FONT-STYLE: italic; DISPLAY: inline">expected term = ((vesting term + original contractual term) / 2)</font>, if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.&nbsp;&nbsp;The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">E</font><font style="TEXT-DECORATION: underline; DISPLAY: inline">quity Instruments Issued to Parties other than Employees for Acquiring Goods or Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.&nbsp;&nbsp;The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.&nbsp;&nbsp;If shares of the Company are thinly traded the use of share prices established in the Company&#39;s most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.&nbsp;&nbsp;The ranges of assumptions for inputs are as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder&#39;s expected exercise behavior into the fair value (or calculated value) of the instruments.&nbsp;&nbsp;The Company uses historical data to estimate holder&#39;s expected exercise behavior.&nbsp;&nbsp;If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected volatility of the entity&#39;s shares and the method used to estimate it.&nbsp;&nbsp;An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.&nbsp;&nbsp;A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.&nbsp;&nbsp;If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Expected annual rate of quarterly dividends.&nbsp;&nbsp;An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.&nbsp;&nbsp;The expected dividend yield is based on the Company&#39;s current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 54pt" align="right"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-SIZE: 11pt"> &middot;&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.&nbsp;&nbsp;The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9,an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Tax Provision</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.&nbsp;&nbsp;Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.Deferred tax assets are reduced by a valuation allowance to the extent management concludes it ismore likely than not that the assets will not be realized.&nbsp;&nbsp;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.&nbsp;&nbsp;The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.&nbsp;&nbsp;Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.&nbsp;&nbsp;The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.&nbsp;&nbsp;Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management&#39;s opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Uncertain Tax Positions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the reporting period ended December 31, 2013 or 2012.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Limitation on Utilization of NOLs due to Change in Control</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL&#39;s to annual limitations which could reduce or defer the NOL.&nbsp;&nbsp;Section 382 imposes limitations on a corporation&#39;s ability to utilize NOLs if it experiences an "ownership change."&nbsp;&nbsp;In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.&nbsp;&nbsp;In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.&nbsp;&nbsp;The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Net Income (Loss)per Common Share</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.&nbsp;&nbsp;Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="20%" colspan="4"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Potentially Outstanding Dilutive Common Shares</div> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> PeriodEnded</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2013</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> For Interim</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Period Ended</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Make Good Escrow Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,000,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Make Good Escrow Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 3,000,000</div> </td> </tr> </table> </div> <div>&nbsp;</div> <div style="text-align: left"> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Convertible Note Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,752</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 426,667</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company&#39;s securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company&#39;s common stock as determined in good faith by Company&#39;s Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,739,130</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 426,667</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,400,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,762,228</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,353,573</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 440,571</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;290,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 812,634</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,142</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Convertible Note Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 10,561,070</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 853,334</div> </td> </tr> </table> </div> <div>&nbsp;</div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Warrant Shares</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to investors (the "investor warrants") and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 956,481</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company&#39;s common stock to two (2) note holders in connection with the issuance of convertible notes.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,400,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company&#39;s common stock to the note holder in connection with the issuance of the convertible note.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 881,753</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On May 6, 2013, the Company issued three (3) series of warrants:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,027,520</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,151,999</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company&#39;s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 2,534,399</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 7.75pt; text-align: justify; TEXT-INDENT: -9pt"> On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company&#39;s common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,000,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> -</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Sub-total Warrant Shares</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 9,952,152</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 1,152,000</div> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 7.75pt; text-align: left; TEXT-INDENT: -9pt"> Total potentially outstanding dilutive common shares</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 20,513,222</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 5,005,334</div> </td> </tr> </table> </div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Cash Flows Reporting</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.&nbsp;&nbsp;The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline"> Subsequent Events</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the&nbsp;financial statements are issued.&nbsp;&nbsp;Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Pronouncements</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the FASB issued ASU No. 2013-02, "<font style="FONT-STYLE: italic; DISPLAY: inline">Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.</font>" The ASUadds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "<font style="FONT-STYLE: italic; DISPLAY: inline">Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date</font>."&nbsp;&nbsp;This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU No. 2013-05, "<font style="FONT-STYLE: italic; DISPLAY: inline">Foreign Currency Matters (Topic 830): Parent&#39;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity</font>." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In March 2013, the FASB issued ASU 2013-07, <font style="FONT-STYLE: italic; DISPLAY: inline">"Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting."</font> The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity&#39;s governing documents from the entity&#39;s inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity&#39;s inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity&#39;s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.</div> </div> <!--EndFragment--></div> </div> 464765 -790445 798339 100 63556 58355 82695 6000 4760624 1474751 6813321 -5900 -4359415 -2323551 -6376899 -214158 -345946 464765 -790445 798339 279222 250607 -790445 452393 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 11 - Equity</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Shares Authorized</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Stock</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reverse Acquisition Transaction</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company&#39;s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company&#39;s common stock to the Company for cancellation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares are being held in escrow ("Escrow Shares") pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures&#39; Stockholder (the "Escrow Agreement").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <br /> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Make Good Agreement Shares</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Duration of Escrow Agreement</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Make Good Escrow Agreement shall terminate on the sooner of (i) the distribution of all escrow shares, or (ii) December 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Disbursement of Make Good Shares</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Upon achievement of any Milestone on or before the date associated with such Milestone on Exhibit A, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such achievement (each a "COMPLETION NOTICE"). Upon the passage of any Milestone date set forth on Exhibit A for which the Company has not achieved the associated Milestone, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such failure to achieve the milestone (each a "NON-COMPLETION NOTICE").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Exhibit A - Schedule of Milestones</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; TEXT-ALIGN: center" valign="bottom" width="61%">&nbsp; <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Milestones</font></td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Completion Date</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Number of</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Escrow</font> <font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> Shares</font></div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="61%" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> I.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (1)Enter into exclusive international license agreement for all Agro Genesis intellectual property and products as it applies to stevia</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (2)Enter into cooperative agreements to work with Vietnam Institutes (a) Medical Plant Institute in Hanoi; (b) Agricultural Science Institute of Northern Central Vietnam</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (3)Enter into farm management agreements with local growers including the Provincial and National projects;</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> (4)Take over management of three existing nurseries</div> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Within 180 days</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of the Closing Date</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 3,000,000 shares</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> only if and when ALL four (4) milestones reached (*)</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> II.&nbsp;&nbsp;&nbsp;Achieve 100 Ha field trials and first test shipment of dry leaf</div> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Within two (2) years</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of the Closing Date</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1,500,000 shares (**)</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="61%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="61%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -18pt"> III.&nbsp;&nbsp;Test shipment of dry leaf to achieve minimum specs for contracted base price (currently $2.00 per kilogram)</div> </td> <td valign="bottom" width="3%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Within two (2) years</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> of the Closing Date</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" colspan="2"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 1,500,000 shares (**)</div> </td> <td valign="bottom" width="1%" colspan="2"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> *</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; text-align: justify"> On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.&nbsp;&nbsp;These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> **</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; text-align: justify"> On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.&nbsp;&nbsp;These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Surrendered for Cancellation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 4, 2011, a significant stockholder of the Company, Mohanad Shurrab, surrendered another 3,000,000 shares of the Company&#39;s common stock to the Company for cancellation.&nbsp;&nbsp;The Company recorded this transaction by debiting common stock at par of $3,000 and crediting additional paid-in capital of the same.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued for Cash</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 4, 2011 the Company sold 400,000 shares of its common stock to one investor at $0.25 per share or $100,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued for Obtaining Employee and Director Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director&#39;s continuous service to the Company as directors.&nbsp;&nbsp;These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.&nbsp;&nbsp;The Company recorded $187,500 in directors&#39; fees for the period from April 11, 2011 (inception) through March 31, 2012.&nbsp;&nbsp;The Company recorded $375,000 in directors&#39; fees for the fiscal year ended March 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Common Shares Issued</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">to Parties other than Employees for Acquiring Goods or Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Equity Purchase Agreement and Related Registration Rights Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Equity Purchase Agreement</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On January 26, 2012, the Company entered into an equity purchase agreement ("Equity Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership (The "Investor"). Upon the terms and subject to the conditions contained in the agreement, the Company shall issue and sell to the Investor, and the Investor shall purchase, up to Twenty Million Dollars ($20,000,000) of its common stock, par value $0.001 per share.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At any time and from time to time during the Commitment Period, the period commencing on the effective date, and ending on the earlier of (i) the date on which investor shall have purchased put shares pursuant to this agreement for an aggregate purchase price of the maximum commitment amount, or (ii) the date occurring thirty six (36) months from the date of commencement of the commitment period. the Company may exercise a put by the delivery of a put notice, the number of put shares that investor shall purchase pursuant to such put shall be determined by dividing the investment amount specified in the put notice by the purchase price with respect to such put notice. However, that the investment amount identified in the applicable put notice shall not be greater than the maximum put amount and, when taken together with any prior put notices, shall not exceed the maximum commitment The purchase price shall mean 93% of the market price on such date on which the purchase price is calculated in accordance with the terms and conditions of this Agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Registration Rights Agreement</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In connection with the Equity Purchase Agreement, on January 26, 2012, the Company entered into a registration rights agreement ("Registration Rights Agreement") with Southridge Partners II, LP, a Delaware limited partnership (the "Investor"). To induce the investor to execute and deliver the equity purchase agreement which the Company has agreed to issue and sell to the investor shares (the "put shares") of its common stock, par value $0.001 per share (the "common stock") from time to time for an aggregate investment price of up to twenty million dollars ($20,000,000) (the "registrable securities"), the Company has agreed to provide certain registration rights under the securities act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, "securities act"), and applicable state securities laws with respect to the registrable securities.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Common Shares Issued Upon Signing</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a condition for the execution of this agreement by the investor, the company issued to the investor 35,000 shares of restricted common stock (the "restricted shares") upon the signing of this agreement. The restricted shares shall have no registration rights.&nbsp;&nbsp;These shares were valued at $1.50 per share or $52,500 on the date of issuance and recorded as financing cost.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Marketing Service Agreement - Empire Relations Group, Inc.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On March 14, 2012 the Company entered into a consulting agreement (the "Consulting Agreement") with Empire Relations Group, Inc. ("Empire").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (i) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Scope of Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Under the terms of the Consulting Agreement, the Company engaged Empire to introduce interested investors to the Company, advise the Company on available financing options, provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (ii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Term</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> The term of this agreement were consummated from the date hereof, and automatically terminated on May 30, 20 12.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> (iii) <font style="TEXT-DECORATION: underline; DISPLAY: inline">Compensation</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> For the term of this agreement, the consultant shall be paid an upfront, non-refundable, non-cancellable retainer fee of 27,500 restricted shares. For the purposes of this agreement, these shares shall be considered to be fully earned by March 31, 2012. These shares were valued at $1.39 per share or $38,225 on March 31, 2012, the date when they were earned.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued in Connection with Entry into Technology Acquisition Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, the Company entered into a Technology Acquisition Agreement (the "Technology Acquisition Agreement") with Technew Technology Limited ("Technew"), pursuant to which the Company acquired the rights to certain technology from Technew in exchange for 3,000,000 restricted shares of the Company&#39;s common stock. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market or $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology&#39;s estimated useful life of fifteen (15) years.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued to a Related Party</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party in the consolidated statements of operations.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Sale of Equity Unit Inclusive of Common Stock and Warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Securities Purchase Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667<font style="FONT-WEIGHT: bold; DISPLAY: inline">&nbsp;</font> shares of the Company&#39;s common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company&#39;s common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,("GSS"), who served as placement agent for the Company in the offering, (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company&#39;s common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the&nbsp;&nbsp;"agent warrants") to GSS&nbsp;&nbsp;or its&nbsp;&nbsp;designee.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for gross proceeds of $500,000.&nbsp;&nbsp;In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company intended to use the net&nbsp;&nbsp;proceeds&nbsp;&nbsp;from the Offering to advance the Company&#39;s&nbsp;&nbsp;ability to execute its growth&nbsp;&nbsp;strategy and to aid in the commercial&nbsp;&nbsp;development&nbsp;&nbsp;of the&nbsp;&nbsp;recently&nbsp;&nbsp;announced&nbsp;&nbsp;launch&nbsp;&nbsp;of&nbsp;&nbsp;the&nbsp;&nbsp;Company&#39;s majority-owned subsidiary, Stevia Technew Limited.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Registration Rights Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In connection with the equity financing on August 1, 2012, the Company also entered into a registration rights agreement with the Purchasers (the "rights agreement").&nbsp;&nbsp;The Rights Agreement requires the Company to file a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company&#39;s entrance into the rights agreement (the "filing date") for the resale by the Purchasers of all of the Shares and all of the shares of common stock issuable upon exercise of the Warrants (the "registrable securities"). The Company filed the Registration Statement with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company&#39;s entrance into the rights agreement.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The registration statement must be declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments.&nbsp;&nbsp;If the&nbsp;&nbsp;registration statement is not filed prior to the filing date, the Company will be required to pay certain liquidated damages, not to exceed in the aggregate 6% of the purchase price paid by the Purchasers pursuant to the SPA. The Registration Statement was declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Issuances of Warrants in Connection with Entry into Securities Purchase Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company&#39;s common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Issuance of Warrants to the Placement Agent as Compensation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS&nbsp;&nbsp;or its&nbsp;&nbsp;designee,&nbsp;&nbsp;a warrant&nbsp;&nbsp;to&nbsp;&nbsp;purchase&nbsp;&nbsp;85,333&nbsp;&nbsp;shares&nbsp;&nbsp;of&nbsp;&nbsp;the&nbsp;&nbsp;Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock representing&nbsp;&nbsp;8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 12 - Equity</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Shares Authorized</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On November 15, 2013, the Company approved an amendment to the Articles of Incorporations to increase the authorized number of shares to Two hundred and fifty million (250,000,000) shares, par value $0.001 per share.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Stock</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Reverse Acquisition Transaction</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Immediately prior to the Share Exchange Agreement on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company&#39;s former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company&#39;s common stock to the Company for cancellation.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares were being held in escrow ("Escrow Shares") pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures&#39; Stockholder (the "Escrow Agreement").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> *</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; text-align: justify"> On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned by and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.&nbsp;&nbsp;These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as salary and compensation - officer.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%" align="center" border="0"> <tr valign="top"> <td style="WIDTH: 27pt"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> &nbsp;</div> </td> <td style="WIDTH: 27pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> **</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; text-align: justify"> On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned by and released to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.&nbsp;&nbsp;These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as salary and compensation - officer.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued for Obtaining Employee and Director Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> October 14, 2011 Issuance of Common Shares for Director Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director&#39;s continuous service to the Company as directors.&nbsp;&nbsp;These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recorded $375,000 and $187,500 in directors&#39; fees for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recorded the remaining balance of $187,500 for the interim period ended December 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> December 4, 2013 Issuance of Common Shares for Director Services</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On December 4, 2013 the Company issued 1,500,000 shares to a newly appointed member of the board of directors as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director&#39;s continuous service to the Company as a director.&nbsp;&nbsp;These shares were valued at $0.125 per share or $187,500 on the date of grant and are being amortized over the vesting period of two (2) years or $7,811 per month.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company recorded $7,811 in director&#39;s fees for the interim period ended December 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="TEXT-DECORATION: underline; DISPLAY: inline">Common Shares Issued</font> <font style="TEXT-DECORATION: underline; DISPLAY: inline">to Parties other than Employees for Acquiring Goods or Services</font></div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued to a Related Party</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Common Shares Issued in Connection with Consulting Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 18, 2013, the Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation ("Mountain Sky"), in partial consideration for consulting services rendered by Mountain Sky.&nbsp;&nbsp;500,000 of the 1,000,000 shares vested at the time of grant, and 500,000 will vest on the one (1) year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Sale of Equity Units Including Common Stock and Warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Securities Purchase Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667shares of the Company&#39;s common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company&#39;s common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,("GSS"), who served as placement agent for the Company in the offering, (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company&#39;s common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the&nbsp;&nbsp;"agent warrants") to GSS&nbsp;&nbsp;or its&nbsp;&nbsp;designee.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for gross proceeds of $500,000.&nbsp;&nbsp;In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Per the terms of the SPA, from the date until one (1) year anniversary of the closing date, if the Company issues or sells any shares of the Company&#39;s common stock at a price that is less than the per share purchase price, than immediately without any obligation of or notice to the Purchasers, the per share purchase price paid shall be reduced to be the discounted per share purchase price and the number of shares issuable under this agreement shall be deemed increased to the subscription amount paid by such Purchaser. On October 1, 2013,</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company issued 286,666 common shares to the investor according to this anti-dilutive term.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Exercise of Warrants with Issuance of New Warrants per the Warrant Reset Offer</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the "Reset Letter") with an investor (the "Investor") whereby the Company and the Investor agreed that the Investor would immediately exercise his warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share for cash in the aggregate of $170,667.&nbsp;&nbsp;In&nbsp;&nbsp;consideration&nbsp;&nbsp;for the Investor&#39;s&nbsp;&nbsp;immediate&nbsp;&nbsp;exercise,&nbsp;&nbsp;the Company agreed to issue to the Investor three (3) new warrants in the amounts of 1,877,333, 1,066,666&nbsp;&nbsp;and&nbsp;&nbsp;2,346,666,&nbsp;&nbsp;with exercise&nbsp;&nbsp;prices of $0.20,&nbsp;&nbsp;$0.25 and $0.25 per share,</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> respectively (the "Series A Warrants",&nbsp;&nbsp;"Series B Warrants" and "Series C Warrants",&nbsp;&nbsp;respectively,&nbsp;&nbsp;and collectively&nbsp;&nbsp;the "New&nbsp;&nbsp;Warrants").&nbsp;&nbsp;The Series A Warrants are subject to the Company&#39;s call right, and the Series C Warrants are only exercisable upon the Investor&#39;s exercise in full of the Series A Warrants. In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") within ten (10) business days. The Company will use its best efforts to have&nbsp;&nbsp;the&nbsp;&nbsp;Registration&nbsp;&nbsp;Statement declared effective by the SEC within thirty (30) days. The Company filed a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within ten (10) business days which was declared effective by the SEC within thirty (30) days.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Issuance of Common Stock per the Settlement Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 25, 2013, the Supreme Court of the State of New York, County of New York (the&nbsp;&nbsp;"Court"),&nbsp;&nbsp;entered&nbsp;&nbsp;an order (the&nbsp;&nbsp;"Order")&nbsp;&nbsp;approving the settlement&nbsp;&nbsp;(the "Settlement Agreement")&nbsp;&nbsp;between the Company and Hanover Holdings I, LLC, a New York limited&nbsp;&nbsp;liability company&nbsp;&nbsp;("Hanover"),&nbsp;&nbsp;Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the&nbsp;&nbsp;"Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 26, 2013, the Company issued and delivered to Hanover 7,500,000 shares (the "Initial&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares") of the Company&#39;s common stock,&nbsp;&nbsp;$0.001 par value (the "Common&nbsp;&nbsp;Stock"),&nbsp;&nbsp;pursuant to the terms of the Settlement Agreement approved by the Order.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Settlement&nbsp;&nbsp;Agreement&nbsp;&nbsp;provides that the Initial Settlement Shares will be&nbsp;&nbsp;subject&nbsp;&nbsp;to&nbsp;&nbsp;adjustment&nbsp;&nbsp;on&nbsp;&nbsp;the&nbsp;&nbsp;trading&nbsp;&nbsp;day&nbsp;&nbsp;immediately&nbsp;&nbsp;&nbsp;following&nbsp;&nbsp;the Calculation Period to reflect the&nbsp;&nbsp;intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the&nbsp;&nbsp;Settlement&nbsp;&nbsp;Agreement be based upon a specified&nbsp;&nbsp;discount to the trading volume&nbsp;&nbsp;weighted&nbsp;&nbsp;average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court&#39;s entry of the Order.&nbsp;&nbsp;Specifically,&nbsp;&nbsp;the total number of shares of Common&nbsp;&nbsp;Stock to be issued to Hanover pursuant to the Settlement Agreement shall be equal to the sum of: (i) the quotient obtained by dividing (A) $1,042,000 (representing the total amount of the Claim), by (B) 65% of&nbsp;&nbsp;the&nbsp;&nbsp;average&nbsp;&nbsp;of&nbsp;&nbsp;the&nbsp;&nbsp;lowest&nbsp;&nbsp;40&nbsp;&nbsp;VWAPs&nbsp;&nbsp;of&nbsp;&nbsp;the&nbsp;&nbsp;Common&nbsp;&nbsp;&nbsp;Stock&nbsp;&nbsp;over&nbsp;&nbsp;the 120-consecutive&nbsp;&nbsp;trading day period&nbsp;&nbsp;(subject to extension&nbsp;&nbsp;under the Settlement Agreement)&nbsp;&nbsp;immediately following the date of issuance of the Initial Settlement Shares (or such shorter&nbsp;&nbsp;trading-day&nbsp;&nbsp;period as may be&nbsp;&nbsp;determined by Hanover in its&nbsp;&nbsp;sole&nbsp;&nbsp;discretion&nbsp;&nbsp;by&nbsp;&nbsp;delivery&nbsp;&nbsp;of&nbsp;&nbsp;written&nbsp;&nbsp;notice&nbsp;&nbsp;to the&nbsp;&nbsp;Company)&nbsp;&nbsp;(the "Calculation&nbsp;&nbsp;Period");&nbsp;&nbsp;(ii) the&nbsp;&nbsp;quotient&nbsp;&nbsp;obtained by dividing&nbsp;&nbsp;(A)&nbsp;&nbsp;$22,500, representing&nbsp;&nbsp;(1)&nbsp;&nbsp;$25,000 of&nbsp;&nbsp;Hanover&#39;s&nbsp;&nbsp;legal fees and&nbsp;&nbsp;expenses&nbsp;&nbsp;incurred&nbsp;&nbsp;in connection&nbsp;&nbsp;with the Action&nbsp;&nbsp;that the&nbsp;&nbsp;Company has agreed to pay less (2) $2,500 heretofore paid by the Company, by (B) 100% of the VWAP of the Common Stock over the Calculation&nbsp;&nbsp;Period;&nbsp;&nbsp;and (iii) the quotient&nbsp;&nbsp;obtained by dividing (A) agent fees&nbsp;&nbsp;of&nbsp;&nbsp;$83,360,&nbsp;&nbsp;by (B)&nbsp;&nbsp;100%&nbsp;&nbsp;of the&nbsp;&nbsp;VWAP&nbsp;&nbsp;of the&nbsp;&nbsp;Common&nbsp;&nbsp;Stock&nbsp;&nbsp;over&nbsp;&nbsp;the Calculation&nbsp;&nbsp;Period,&nbsp;&nbsp;rounded up to the nearest whole share (the "VWAP Shares"). As a&nbsp;&nbsp;result,&nbsp;&nbsp;the&nbsp;&nbsp;Company&nbsp;&nbsp;ultimately&nbsp;&nbsp;may be&nbsp;&nbsp;required&nbsp;&nbsp;to issue&nbsp;&nbsp;to&nbsp;&nbsp;Hanover substantially&nbsp;&nbsp;more shares of Common Stock than the number of Initial Settlement Shares issued&nbsp;&nbsp;(subject to the&nbsp;&nbsp;limitations&nbsp;&nbsp;described&nbsp;&nbsp;below).&nbsp;&nbsp;The&nbsp;&nbsp;Settlement Agreement further provides that if, at any time and from time to time during the Calculation&nbsp;&nbsp;Period,&nbsp;&nbsp;Hanover&nbsp;&nbsp;reasonably&nbsp;&nbsp;believes&nbsp;&nbsp;that the&nbsp;&nbsp;total&nbsp;&nbsp;number&nbsp;&nbsp;of Settlement&nbsp;&nbsp;Shares&nbsp;&nbsp;previously&nbsp;&nbsp;issued to&nbsp;&nbsp;Hanover&nbsp;&nbsp;shall be less than the total number of VWAP Shares to be issued to Hanover or its designee in connection with the Settlement&nbsp;&nbsp;Agreement,&nbsp;&nbsp;Hanover may, in its sole discretion,&nbsp;&nbsp;deliver one or more written&nbsp;&nbsp;notices to the&nbsp;&nbsp;Company,&nbsp;&nbsp;at any time and from time to time during the Calculation Period,&nbsp;&nbsp;requesting that a specified number of additional shares of Common&nbsp;&nbsp;Stock&nbsp;&nbsp;promptly be issued and&nbsp;&nbsp;delivered&nbsp;&nbsp;to Hanover or its&nbsp;&nbsp;designee (subject to the&nbsp;&nbsp;limitations&nbsp;&nbsp;described&nbsp;&nbsp;below),&nbsp;&nbsp;and the Company will upon such request&nbsp;&nbsp;reserve&nbsp;&nbsp;and issue&nbsp;&nbsp;the&nbsp;&nbsp;number of&nbsp;&nbsp;additional&nbsp;&nbsp;shares of Common&nbsp;&nbsp;Stock requested to be so issued and&nbsp;&nbsp;delivered&nbsp;&nbsp;in the notice (all of such&nbsp;&nbsp;additional shares of&nbsp;&nbsp;Common&nbsp;&nbsp;Stock,&nbsp;&nbsp;"Additional&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares").&nbsp;&nbsp;At the end of the Calculation&nbsp;&nbsp;Period,&nbsp;&nbsp;(i) if the&nbsp;&nbsp;number of VWAP&nbsp;&nbsp;Shares&nbsp;&nbsp;exceeds&nbsp;&nbsp;the number of Initial&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares and Additional&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares issued,&nbsp;&nbsp;then the Company will issue to Hanover or its designee&nbsp;&nbsp;additional shares of Common Stock equal to the&nbsp;&nbsp;difference&nbsp;&nbsp;between&nbsp;&nbsp;the&nbsp;&nbsp;number of VWAP&nbsp;&nbsp;Shares and the number of Initial&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares and Additional&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares,&nbsp;&nbsp;and (ii) if the number of VWAP Shares is less than the number of Initial&nbsp;&nbsp;Settlement&nbsp;&nbsp;Shares and Additional Settlement Shares issued, then Hanover or its designee will return to the Company for cancellation&nbsp;&nbsp;that number of shares of Common Stock equal to the difference&nbsp;&nbsp;between&nbsp;&nbsp;the&nbsp;&nbsp;number&nbsp;&nbsp;of VWAP&nbsp;&nbsp;Shares&nbsp;&nbsp;and&nbsp;&nbsp;the&nbsp;&nbsp;number&nbsp;&nbsp;of&nbsp;&nbsp;Initial Settlement Shares and Additional Settlement Shares.&nbsp;&nbsp;Hanover may sell the shares of Common Stock issued to it or its designee in connection with the Settlement Agreement at any time without restriction, even during the Calculation Period.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The&nbsp;&nbsp;Settlement&nbsp;&nbsp;Agreement&nbsp;&nbsp;provides&nbsp;&nbsp;that in no event&nbsp;&nbsp;shall the number of shares of Common Stock issued to Hanover or its designee in connection&nbsp;&nbsp;with the Settlement Agreement, when aggregated with all other shares of Common Stock then beneficially&nbsp;&nbsp;owned by Hanover and its&nbsp;&nbsp;affiliates&nbsp;&nbsp;(as&nbsp;&nbsp;calculated&nbsp;&nbsp;pursuant to Section 13(d) of the Securities&nbsp;&nbsp;Exchange Act of 1934, as amended (the "Exchange Act"),&nbsp;&nbsp;and the&nbsp;&nbsp;rules and&nbsp;&nbsp;regulations&nbsp;&nbsp;thereunder),&nbsp;&nbsp;result in the&nbsp;&nbsp;beneficial ownership by Hanover and its affiliates (as calculated pursuant to Section 13(d) of the Exchange&nbsp;&nbsp;Act and the rules and&nbsp;&nbsp;regulations&nbsp;&nbsp;thereunder)&nbsp;&nbsp;at any time of more than 9.99% of the Common Stock.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On September 30, 2013, the Company issued and delivered to Hanover 2,000,000 Additional Settlement Shares pursuant to the terms of the Settlement Agreement approved by the Order. Since the issuance of the Initial Settlement Shares and Additional Settlement Shares described above, Hanover demonstrated to the Company&#39;s satisfaction that it was entitled to receive another 3,500,000 Additional Settlement Shares, based on the adjustment formula described above, and that the issuance of such Additional Settlement Shares to Hanover would not result in Hanover exceeding the beneficial ownership limitation set forth above. On December 13, 2013, the Company issued and delivered to Hanover another 3,500,000 Additional Settlement Shares and on January 22, 2014, the Company issued and delivered to Hanover the final 2,538,882 Additional Settlement Shares pursuant to the terms of the Settlement Agreement approved by the Order.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.&nbsp;&nbsp;The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Warrants</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Issuances of Warrants in Connection with Securities Purchase Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company&#39;s common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Issuance of Warrants to the Placement Agent as Compensation</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS&nbsp;&nbsp;or its&nbsp;&nbsp;designee,&nbsp;&nbsp;a warrant&nbsp;&nbsp;to&nbsp;&nbsp;purchase&nbsp;&nbsp;85,333&nbsp;&nbsp;shares&nbsp;&nbsp;of&nbsp;&nbsp;the&nbsp;&nbsp;Company&#39;s&nbsp;&nbsp;common&nbsp;&nbsp;stock representing&nbsp;&nbsp;8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Garden State Securities, Inc. (the "Placement Agent") served as the placement agent of the Company for the Warrant Reset Offering on May 6, 2013. In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,653, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company,&nbsp;&nbsp;the&nbsp;&nbsp;Placement&nbsp;&nbsp;Agent will receive additional&nbsp;&nbsp;warrants&nbsp;&nbsp;equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the "Agent Warrants").</div> <!--EndFragment--></div> </div> -118288 79800 79800000 -198088 350000 1400000 1400 348600 100000 400 400000 99600 18713 15538882 74850 75 18638 750000 3000000 1500000 3000 747000 750000 600000 3000 3000 3000000 3000000 747000 597000 600000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Subsequent Events</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the&nbsp;financial statements are issued.&nbsp;&nbsp;Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Subsequent Events</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the&nbsp;financial statements are issued.&nbsp;&nbsp;Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 16 - Subsequent Events</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.&nbsp;&nbsp;The Management of the Company determined that there were certain reportable subsequent events to be disclosed as follows:</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On April 30, 2013, the Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation ("Mountain Sky"), in partial consideration for consulting services rendered by Mountain Sky.&nbsp;&nbsp;500,000 of the shares vested at the time of grant, and 500,000 will vest on the one year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the "Reset Letter") with an investor (the&nbsp;&nbsp;"Investor")&nbsp;&nbsp;whereby the Company and the Investor agreed that the Investor would immediately exercise his warrant to purchase 853,333&nbsp;&nbsp;shares of common stock of the Company at an exercise price of $0.20 per share for the aggregate of $170,667.&nbsp;&nbsp;In&nbsp;&nbsp;consideration&nbsp;&nbsp;for the Investor&#39;s&nbsp;&nbsp;immediate&nbsp;&nbsp;exercise,&nbsp;&nbsp;the Company agreed to issue to the Investor three new warrants in the amounts of 1,877,333, 1,066,666&nbsp;&nbsp;and&nbsp;&nbsp;2,346,666,&nbsp;&nbsp;with exercise&nbsp;&nbsp;prices of $0.20,&nbsp;&nbsp;$0.25 and $0.25 per share, respectively (the "Series A Warrants",&nbsp;&nbsp;"Series B Warrants" and "Series C Warrants",&nbsp;&nbsp;respectively,&nbsp;&nbsp;and collectively&nbsp;&nbsp;the "New&nbsp;&nbsp;Warrants").&nbsp;&nbsp;The Series A Warrants are subject to the Company&#39;s call right, and the Series C Warrants are only exercisable upon the Investor&#39;s exercise in full of the Series A Warrants. In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the "Registration Statement") with the Securities&nbsp;&nbsp;and Exchange&nbsp;&nbsp;Commission&nbsp;&nbsp;(the "SEC") within ten (10) business days. The Company will&nbsp;&nbsp;use its best&nbsp;&nbsp;efforts&nbsp;&nbsp;to have&nbsp;&nbsp;the&nbsp;&nbsp;Registration&nbsp;&nbsp;Statement declared effective by the SEC within thirty (30) days. The Company filed a registration statement (the "Registration Statement") with the Securities&nbsp;&nbsp;and Exchange&nbsp;&nbsp;Commission&nbsp;&nbsp;(the "SEC") within ten (10) business days which was declared effective by the SEC within thirty (30) days.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Garden State Securities, Inc. (the "Placement&nbsp;&nbsp;Agent")&nbsp;&nbsp;served&nbsp;&nbsp;as the placement agent of the Company for the Offering.&nbsp;&nbsp;In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,600, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company,&nbsp;&nbsp;the&nbsp;&nbsp;Placement&nbsp;&nbsp;Agent will receive additional&nbsp;&nbsp;warrants&nbsp;&nbsp;equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the "Agent Warrants").</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned by Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.&nbsp;&nbsp;These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.</div> <br /> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Note 15 - Subsequent Events</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.&nbsp;&nbsp;The Management of the Company determined that there were certain reportable subsequent event(s) to be disclosed as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On January 21, 2014 and February 4, 2014, a convertible note holder converted part of the accrued interest through the date of conversion of $23,400 and $26,325, respectively, at $0.0585 per share to 400,000 and 450, 000 shares of the Company&#39;s common stock, respectively.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 7, 2014, the Company issued a convertible note in the principal amount of $80,000 convertible at $0.10 per share with interest at 8%, per annum, maturing one year from the date of issuance on February 7, 2015. In connection with the issuance of the convertible note,the Company issued the note holder a warrant to purchase 1,000,000 common shares at an exercise price of $0.10 per share with full reset features, expiring five (5) years from the date of issuance.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 13, 2014, one investor exercised warrants to purchase 1,877,333 shares of the Company&#39;s common stock with an exercise price of $0.0585 per share for $109,824 in cash.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Entry into Service Agreement</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On January 27, 2014, the Company entered into a Farm Management and Technology Agreement (the "Agreement") with Ebbu LLC ("Ebbu"), that is developing proprietary marijuana farming and extraction technologies. Under the terms of the Agreement, Ebbu wishes to engage the Company to provide technical support for farm management operations and extraction for both cash and assignable warrants. The scope of work and exact compensation is still under negotiation and will be completed by the end of next week.</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2014</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 140,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 140,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Future minimum payments required under this agreement were as follows:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="text-align: left"> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> Fiscal Year Ending March&nbsp;31:</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2014 (remainder of the fiscal year)</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2015</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2016</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 240,000</div> </td> <td valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="88%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: -9pt"> 2017</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 140,000</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="bottom" colspan="2" align="right"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td valign="middle" align="left"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="88%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> $</div> </td> <td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> 860,000</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"><font style="FONT-SIZE: 11pt; FONT-FAMILY: times new roman; DISPLAY: inline"> &nbsp;</font> </td> </tr> </table> </div> <div>&nbsp;</div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates and Assumptions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The Company&#39;s significant estimates and assumptions include the fair value of financial instruments; the carrying value, recoverability and impairment of long-lived assets, including the values assigned to and the estimated useful lives of website development costs; interest rate; revenue recognized or recognizable; sales returns and allowances; foreign currency exchange rate; income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; expected term of share options and similar instruments, expected volatility of the entity&#39;s shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s); and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Actual results could differ from those estimates.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-STYLE: italic; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="BACKGROUND-COLOR: #ffffff; DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company&#39;s critical accounting estimates and assumptions affecting the financial statements were:</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt">&nbsp;</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (i)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Assumption as a going concern</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business<font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">.</font></div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (ii)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Allowance for doubtful accounts</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Management&#39;s <font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">estimate of the allowance for doubtful accounts is based on historical sales, historical loss levels, and an analysis of the collectability of individual accounts;</font> and general economic conditions that may affect a client&#39;s ability to pay<font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">. The Company evaluated the key factors and assumptions used to develop the allowance in determining that it is reasonable in relation to the financial statements taken as a whole.</font></div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iii)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline">Inventory Obsolescence and Markdowns</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> The Company&#39;s estimate of potentially excess and slow-moving inventories is based on evaluation of inventory levels and aging, review of inventory turns and historical sales experiences. The Company&#39;s estimate of reserve for inventory shrinkage is based on the historical results of physical inventory cycle counts.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (iv)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Fair value of long-lived assets</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Fair value is generally determined using the asset&#39;s expected future discounted cash flows or market value, if readily determinable.&nbsp;&nbsp;If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&nbsp;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&nbsp;significant changes in the manner or use of assets or in the Company&#39;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#39;s overall business strategy; (iii)&nbsp;significant negative industry or economic trends; (iv)&nbsp;increased competitive pressures; (v)&nbsp;a significant decline in the Company&#39;s stock price for a sustained period of time; and (vi)&nbsp;regulatory changes.&nbsp;&nbsp;The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (v)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Valuation allowance for deferred tax assets</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">:</font> Management assumes that the realization of the Company&#39;s net deferred tax assets resulting from its net operating loss ("NOL") carry-forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.</div> </td> </tr> </table> </div> <div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt">&nbsp;</td> <td style="WIDTH: 36pt" align="right"> <div style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; FONT-STYLE: italic; DISPLAY: inline"> (vi)&nbsp;&nbsp;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="FONT-STYLE: italic; DISPLAY: inline; BACKGROUND-COLOR: #ffffff"> Estimates and assumptions used in valuation of equity instruments</font><font style="DISPLAY: inline; BACKGROUND-COLOR: #ffffff">: Management estimates</font> expected term of share options and similar instruments, expected volatility of the Company&#39;s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> <font style="FONT-SIZE: 11pt; FONT-FAMILY: Times New Roman; DISPLAY: inline"> These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</font></div> </div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.</div> <div style="DISPLAY: block; TEXT-INDENT: 0pt"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Actual results could differ from those estimates.</div> <!--EndFragment--></div> </div> 486113 0 369747 62092487 45093271 72842975 61613572 79632959 63225253 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares 0001439813 2013-10-01 2013-12-31 0001439813 us-gaap:CapitalUnitsMember 2013-04-01 2013-12-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2013-04-01 2013-12-31 0001439813 stev:TotalWarrantSharesMember 2013-04-01 2013-12-31 0001439813 stev:StockholdersEquityDeficitMember 2013-04-01 2013-12-31 0001439813 stev:NonDerivativeSharesMember 2013-04-01 2013-12-31 0001439813 us-gaap:RetainedEarningsMember 2013-04-01 2013-12-31 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2013-04-01 2013-12-31 0001439813 stev:FairValueOfDerivativeWarrantsMember 2013-04-01 2013-12-31 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2013-04-01 2013-12-31 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2013-04-01 2013-12-31 0001439813 stev:WarrantsOutstandingAverageRemainingContractualLifeInYearsMember 2013-04-01 2013-12-31 0001439813 stev:WarrantsExercisableAverageRemainingContractualLifeInYearsMember 2013-04-01 2013-12-31 0001439813 stev:NumberOfWarrantSharesMember 2013-04-01 2013-12-31 0001439813 stev:FairValueAtDateOfIssuanceMember 2013-04-01 2013-12-31 0001439813 stev:ExercisePriceRangePerShareMember 2013-04-01 2013-12-31 0001439813 stev:AverageExercisePriceMember 2013-04-01 2013-12-31 0001439813 stev:AggregateIntrinsicValueMember 2013-04-01 2013-12-31 0001439813 us-gaap:ReceivablesFromStockholderMember 2013-04-01 2013-12-31 0001439813 us-gaap:NoncontrollingInterestMember 2013-04-01 2013-12-31 0001439813 us-gaap:CommonStockMember 2013-04-01 2013-12-31 0001439813 2013-04-01 2013-12-31 0001439813 stev:TotalWarrantSharesMember 2013-01-01 2013-03-31 0001439813 stev:NonDerivativeSharesMember 2013-01-01 2013-03-31 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2013-01-01 2013-03-31 0001439813 stev:FairValueOfDerivativeWarrantsMember 2013-01-01 2013-03-31 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2013-01-01 2013-03-31 0001439813 stev:TotalWarrantSharesMember 2012-10-01 2013-03-31 0001439813 stev:NonDerivativeSharesMember 2012-10-01 2013-03-31 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2012-10-01 2013-03-31 0001439813 stev:FairValueOfDerivativeWarrantsMember 2012-10-01 2013-03-31 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2012-10-01 2013-03-31 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2012-10-01 2013-03-31 0001439813 2012-10-01 2013-03-31 0001439813 2012-10-01 2012-12-31 0001439813 stev:TotalWarrantSharesMember 2012-08-07 2012-09-30 0001439813 stev:NonDerivativeSharesMember 2012-08-07 2012-09-30 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2012-08-07 2012-09-30 0001439813 stev:FairValueOfDerivativeWarrantsMember 2012-08-07 2012-09-30 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2012-08-07 2012-09-30 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2012-08-07 2012-09-30 0001439813 2012-08-07 2012-09-30 0001439813 us-gaap:CapitalUnitsMember 2012-04-01 2013-03-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2012-04-01 2013-03-31 0001439813 stev:StockholdersEquityDeficitMember 2012-04-01 2013-03-31 0001439813 us-gaap:RetainedEarningsMember 2012-04-01 2013-03-31 0001439813 stev:WarrantsOutstandingAverageRemainingContractualLifeInYearsMember 2012-04-01 2013-03-31 0001439813 stev:WarrantsExercisableAverageRemainingContractualLifeInYearsMember 2012-04-01 2013-03-31 0001439813 stev:TotalNonControllingInterestMember 2012-04-01 2013-03-31 0001439813 stev:OtherComprehensiveIncome1Member 2012-04-01 2013-03-31 0001439813 stev:NumberOfWarrantSharesMember 2012-04-01 2013-03-31 0001439813 stev:FairValueAtDateOfIssuanceMember 2012-04-01 2013-03-31 0001439813 stev:ExercisePriceRangePerShareMember 2012-04-01 2013-03-31 0001439813 stev:EarningsAndLossesMember 2012-04-01 2013-03-31 0001439813 stev:ContributedAndAdditionalPaidInCapitalMember 2012-04-01 2013-03-31 0001439813 stev:AverageExercisePriceMember 2012-04-01 2013-03-31 0001439813 stev:AggregateIntrinsicValueMember 2012-04-01 2013-03-31 0001439813 us-gaap:NoncontrollingInterestMember 2012-04-01 2013-03-31 0001439813 us-gaap:CommonStockMember 2012-04-01 2013-03-31 0001439813 2012-04-01 2013-03-31 0001439813 2012-04-01 2012-12-31 0001439813 us-gaap:CapitalUnitsMember 2011-04-12 2012-03-31 0001439813 us-gaap:AdditionalPaidInCapitalMember 2011-04-12 2012-03-31 0001439813 us-gaap:RetainedEarningsMember 2011-04-12 2012-03-31 0001439813 us-gaap:NoncontrollingInterestMember 2011-04-12 2012-03-31 0001439813 us-gaap:CommonStockMember 2011-04-12 2012-03-31 0001439813 2011-04-12 2012-03-31 0001439813 2014-02-13 0001439813 2014-02-07 0001439813 2014-02-04 0001439813 2014-01-21 0001439813 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001439813 stev:TotalWarrantSharesMember 2013-12-31 0001439813 stev:StockholdersEquityDeficitMember 2013-12-31 0001439813 stev:NonDerivativeSharesMember 2013-12-31 0001439813 us-gaap:RetainedEarningsMember 2013-12-31 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2013-12-31 0001439813 stev:FairValueOfDerivativeWarrantsMember 2013-12-31 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2013-12-31 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2013-12-31 0001439813 stev:WarrantsOutstandingWeightedAverageExercisePriceMember 2013-12-31 0001439813 stev:WarrantsOutstandingNumberOutstandingMember 2013-12-31 0001439813 stev:WarrantsExercisableWeightedAverageExercisePriceMember 2013-12-31 0001439813 stev:WarrantsExercisableNumberExercisableMember 2013-12-31 0001439813 stev:NumberOfWarrantSharesMember 2013-12-31 0001439813 stev:FairValueAtDateOfIssuanceMember 2013-12-31 0001439813 stev:ExercisePriceRangePerShareMember 2013-12-31 0001439813 stev:AverageExercisePriceMember 2013-12-31 0001439813 stev:AggregateIntrinsicValueMember 2013-12-31 0001439813 us-gaap:ReceivablesFromStockholderMember 2013-12-31 0001439813 us-gaap:NoncontrollingInterestMember 2013-12-31 0001439813 us-gaap:CommonStockMember 2013-12-31 0001439813 2013-12-31 0001439813 2013-11-15 0001439813 2013-10-15 0001439813 2013-06-23 0001439813 2013-05-03 0001439813 2013-04-30 0001439813 us-gaap:AdditionalPaidInCapitalMember 2013-03-31 0001439813 stev:TotalWarrantSharesMember 2013-03-31 0001439813 stev:StockholdersEquityDeficitMember 2013-03-31 0001439813 stev:NonDerivativeSharesMember 2013-03-31 0001439813 us-gaap:RetainedEarningsMember 2013-03-31 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2013-03-31 0001439813 stev:FairValueOfDerivativeWarrantsMember 2013-03-31 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2013-03-31 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2013-03-31 0001439813 stev:WarrantsOutstandingWeightedAverageExercisePriceMember 2013-03-31 0001439813 stev:WarrantsOutstandingNumberOutstandingMember 2013-03-31 0001439813 stev:WarrantsExercisableWeightedAverageExercisePriceMember 2013-03-31 0001439813 stev:WarrantsExercisableNumberExercisableMember 2013-03-31 0001439813 stev:TotalNonControllingInterestMember 2013-03-31 0001439813 stev:OtherComprehensiveIncome1Member 2013-03-31 0001439813 stev:NumberOfWarrantSharesMember 2013-03-31 0001439813 stev:FairValueAtDateOfIssuanceMember 2013-03-31 0001439813 stev:ExercisePriceRangePerShareMember 2013-03-31 0001439813 stev:EarningsAndLossesMember 2013-03-31 0001439813 stev:ContributedAndAdditionalPaidInCapitalMember 2013-03-31 0001439813 stev:AverageExercisePriceMember 2013-03-31 0001439813 stev:AggregateIntrinsicValueMember 2013-03-31 0001439813 us-gaap:NoncontrollingInterestMember 2013-03-31 0001439813 us-gaap:CommonStockMember 2013-03-31 0001439813 2013-03-31 0001439813 2013-03-15 0001439813 2013-02-26 0001439813 stev:TotalWarrantSharesMember 2012-12-31 0001439813 stev:NonDerivativeSharesMember 2012-12-31 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2012-12-31 0001439813 stev:FairValueOfDerivativeWarrantsMember 2012-12-31 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2012-12-31 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2012-12-31 0001439813 2012-12-31 0001439813 stev:TotalWarrantSharesMember 2012-09-30 0001439813 stev:NonDerivativeSharesMember 2012-09-30 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2012-09-30 0001439813 stev:FairValueOfDerivativeWarrantsMember 2012-09-30 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2012-09-30 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2012-09-30 0001439813 2012-09-30 0001439813 stev:TotalWarrantSharesMember 2012-08-06 0001439813 stev:NonDerivativeSharesMember 2012-08-06 0001439813 stev:GainLossChangeInFairValueOfDerivativeLiabilityMember 2012-08-06 0001439813 stev:FairValueOfDerivativeWarrantsMember 2012-08-06 0001439813 stev:DerivativeWarrantsAssetsLiabilityMember 2012-08-06 0001439813 stev:ApicReclassificationDerivativeLiabilityMember 2012-08-06 0001439813 2012-08-06 0001439813 2012-08-01 0001439813 2012-07-06 0001439813 2012-07-05 0001439813 2012-06-18 0001439813 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0001439813 stev:StockholdersEquityDeficitMember 2012-03-31 0001439813 us-gaap:RetainedEarningsMember 2012-03-31 0001439813 stev:TotalNonControllingInterestMember 2012-03-31 0001439813 stev:OtherComprehensiveIncome1Member 2012-03-31 0001439813 stev:NumberOfWarrantSharesMember 2012-03-31 0001439813 stev:FairValueAtDateOfIssuanceMember 2012-03-31 0001439813 stev:ExercisePriceRangePerShareMember 2012-03-31 0001439813 stev:EarningsAndLossesMember 2012-03-31 0001439813 stev:ContributedAndAdditionalPaidInCapitalMember 2012-03-31 0001439813 stev:AverageExercisePriceMember 2012-03-31 0001439813 stev:AggregateIntrinsicValueMember 2012-03-31 0001439813 us-gaap:NoncontrollingInterestMember 2012-03-31 0001439813 us-gaap:CommonStockMember 2012-03-31 0001439813 2012-03-31 0001439813 2012-01-26 0001439813 2012-01-18 0001439813 2011-12-23 0001439813 2011-12-14 0001439813 2011-10-14 0001439813 2011-10-04 0001439813 2011-08-26 0001439813 2011-07-16 0001439813 2011-06-23 0001439813 us-gaap:AdditionalPaidInCapitalMember 2011-04-11 0001439813 us-gaap:RetainedEarningsMember 2011-04-11 0001439813 us-gaap:NoncontrollingInterestMember 2011-04-11 0001439813 us-gaap:CommonStockMember 2011-04-11 0001439813 2011-04-11 0001439813 2011-02-14 EX-101.SCH 7 stev-20140408.xsd XBRL TAXONOMY EXTENSION SCHEMA 000420 - Disclosure - AMORTIZATION AND DEPRECIATION EXPENSE (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000120 - Disclosure - ACQUIRED TECHNOLOGY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000280 - Disclosure - ACQUIRED TECHNOLOGY (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000311 - Disclosure - Black-Scholes option-pricing model - weighted-average assumptions(TABLE) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000460 - Disclosure - Black-Scholes option-pricing model with the following weighted-average assumptions: (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000210 - Disclosure - COMMITMENTS AND CONTINGENCIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000522 - Disclosure - COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000220 - Disclosure - CONCENTRATIONS AND CREDIT RISK link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000550 - Disclosure - CONCENTRATIONS AND CREDIT RISK DURATION (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000560 - Disclosure - CONCENTRATIONS AND CREDIT RISK INSTANT (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000370 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000020 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000030 - Statement - Consolidated Balance Sheets Parentheticals link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000150 - Disclosure - CONVERTIBLE NOTES PAYABLE link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000312 - Disclosure - Convertible Notes Payable - Amortized (TABLE) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000440 - Disclosure - CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000441 - Disclosure - CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES QUARTERLY (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000450 - Disclosure - CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000451 - Disclosure - CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES QUARTERLY (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000310 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000480 - Disclosure - COMMON SHARES ISSUED FOR SERVICES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000060 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000040 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000050 - Statement - Consolidated Statement of Stock Holders Equity (Deficit) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000010 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000160 - Disclosure - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000320 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000410 - Disclosure - ENTITY'S ASSETS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000472 - Disclosure - ENTRY INTO SECURITIES AND TECHNOLOGY PURCHASE AGREEMENT (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000471 - Disclosure - EXHIBIT A - SCHEDULE OF MILESTONES PARENTHETICALS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000556 - Disclosure - FUTURE MINIMUM PAYMENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000540 - Disclosure - Federal statutory income tax rate (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000452 - Disclosure - Fair Value of Derivative Warrants (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000090 - Disclosure - GOING CONCERN link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000473 - Disclosure - GARDEN STATE SECURTIES INC (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000454 - Disclosure - Issuance of Convertible Notes with Warrants (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000481 - Disclosure - ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000105 - Disclosure - Inventory - Seeds link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000405 - Disclosure - Inventory - Seeds (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000265 - Disclosure - Inventory - Seeds (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000200 - Disclosure - INCOME TAX PROVISION link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000360 - Disclosure - INCOME TAX (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000530 - Disclosure - Net deferred tax assets (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000180 - Disclosure - NON-CONTROLLING INTEREST link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000510 - Disclosure - NON-CONTROLLING INTEREST (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000340 - Disclosure - NON-CONTROLLING INTEREST (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000500 - Disclosure - OUTSTANDING AND EXERCISABLE WARRANTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000070 - Disclosure - ORGANIZATION AND OPERATIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000380 - Disclosure - ORGANIZATION AND OPERATIONS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000425 - Disclosure - Office space with Leverage Investments, LLC (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000110 - Disclosure - PROPERTY AND EQUIPMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000270 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000100 - Disclosure - PREPAID EXPENSES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000400 - Disclosure - PREPAID EXPENSE. (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000260 - Disclosure - PREPAID EXPENSES. (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000455 - Disclosure - Projected volatality curve (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000190 - Disclosure - RESEARCH AND DEVELOPMENT link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000520 - Disclosure - RESEARCH AND DEVELOPMENT PAYMENTS (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000521 - Disclosure - RESEARCH AND DEVELOPMENT PAYMENTS QUARTERLY (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000350 - Disclosure - RESEARCH AND DEVELOPMENT (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000430 - Disclosure - Related party payments and services (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000140 - Disclosure - RELATED PARTY TRANSACTIONS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000435 - Disclosure - RELATED PARTY TRANSACTIONS CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000300 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000470 - Disclosure - SHARES AUTHORIZED AND TRANSACTION (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000170 - Disclosure - STOCKHOLDERS' EQUITY link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000230 - Disclosure - SUBSEQUENT EVENTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000330 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000570 - Disclosure - Subsequent Event Transactions (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000490 - Disclosure - SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000391 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ATTRIBUTABLE INTEREST (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000390 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000250 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000130 - Disclosure - WEBSITE DEVELOPMENT COSTS link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000290 - Disclosure - WEBSITE DEVELOPMENT COSTS (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 000453 - Disclosure - Warrants Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 stev-20140408_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 stev-20140408_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 stev-20140408_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amortization Expenses On Websited Development Costs Amortizaion expenses on acquired technology Amortizaion expenses on acquired technology AMORTIZATION AND DEPRECIATION EXPENSE Amortization expenses on websited development costs Depreciaton expenses on Property and equipment Depreciaton expenses on Property and equipment Goodwill and Intangible Assets Disclosure [Abstract] ACQUIRED TECHNOLOGY {1} ACQUIRED TECHNOLOGY ACQUIRED TECHNOLOGY (Tables) Company Acquired The Rights to Technology Tabular disclosure of amortizable intangibles assets, in total and by major class, including the gross carrying amount and accumulated amortization. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Black Scholes Option Pricing Model Weighted Average Assumptions Other Issuance [Table Text Block] Black Scholes Option Pricing Model Weighted Average Assumptions [Table Text Block] Black-Scholes option-pricing model - weighted-average assumptions(TABLE): Dividend yield The Dividend yield rate assumption that is used in valuing an option on its own shares. Expected option life (year) Expected option life in years Expected volatility The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period Risk-free interest rate The risk-free interest rate assumption that is used in valuing an option on its own shares. Weighted -average assumptions COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES {1} COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES COMPENSATION Consultants fees per month Gross proceeds to the Company Financing cost recorded under the Financing Consulting Agreement. Financing cost recorded under the Financing Consulting Agreement. Gross proceeds The gross proceeds received from the asset(s) sold in connection with the transaction involving the sale of property to another party and the lease back to the seller. Gross proceeds to the Company Gross proceeds to the Company Percentage of stock issued Percentage of stock issued Securities financing Securities financing Securities for financing Securities for financing CONCENTRATIONS AND CREDIT RISK {1} CONCENTRATIONS AND CREDIT RISK CONCENTRATIONS AND CREDIT RISK Net Purchases SGAgro Tech Pte Ltd Net Purchases SG Agro Tech Pte Ltd CONCENTRATIONS AND CREDIT RISK DURATION Net Purchases Growers Synergy Pte. Ltd. - related party Net Purchases Growers Synergy Pte. Ltd. - related party Net Purchases Stevia Ventures Corporation Net Purchases Stevia Ventures Corporation Total Net Purchases Total Net Purchases Accounts Payable To SGAgro Tech Pte Ltd 1 Total Accounts to payable concentration Accounts Payable at Growers Synergy Pte. Ltd. - related party Accounts Payable at Growers Synergy Pte. Ltd. - related party Accounts Payable at Stevia Ventures Corporation Accounts Payable at Stevia Ventures Corporation CONCENTRATIONS AND CREDIT RISK INSTANT Total Accounts Payable Total Accounts Payable CONCENTRATIONS AND CREDIT RISK (Tables) Vendor purchase concentrations Accumulatd Amortization Acquired Technology Accumulatd amortization Acquired Technology Accumulated Amortization Website Development Costs Accumulated amortization Website development costs Accumulated depreciation Acquired Technology Acquired technology, net Total assets Capitalized Computer Software, Gross Website development costs Derivative note liabilities Website development costs, net Accrued interest Total liabilities Total Liabilities and Equity (Deficit) Total current liabilities Noncontrolling interest - retained earnings in consolidated subsidiaries Prepaid Seeds Prepaid payments for seeds. Seeds Property and equipment, net The cumulative amount of amortization (related to Acquired technology) that has been recognized in the income statement. The cumulative amount of amortization (related to Website development costs) that has been recognized in the income statement. Sum of the gross carrying amounts before accumulated amortization as of the balance sheet date of all intangible assets having statutory or estimated useful lives. The aggregate gross carrying amount (including any previously recognized impairment charges) of a major finite-lived intangible asset class. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Acquired technology, net The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Total Stevia Corp stockholders' equity (deficit) Total Equity (Deficit) Accounts payable Accounts payable - president and CEO Accounts receivable Accrued expenses Accumulated depreciation Additional paid-in capital Total assets Assets {1} Total current assets Current assets: Non-current assets: Cash Common stock at $0.001 par value Convertible notes payable - net of discount Security deposit Derivative Liabilities Current portion of derivative liability Advances from president and significant stockholder Website development costs, net Interest Payable Current Total liabilities Total Liabilities and Equity (Deficit) Liabilities and equity (deficit) Total current liabilities Current liabilities: Total non-current liabilities Non-Current liabilities: Non-controlling interest in subsidiary Preferred stock at $0.001 par value: 1,000,000 shares authorized;none issued or outstanding Prepayments and other current assets Property and equipment Property and equipment, net Accumulated deficit Total Stevia Corp stockholders' equity (deficit) Stevia Corp stockholders' equity (deficit): Total Equity (Deficit) Equity (Deficit) Derivative warrant liabilities Common Stock, par or stated value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Preferred Stock, par or stated value Preferred Stock, shares authorized Preferred Stock, shares issued Preferred Stock, shares outstanding Stockholders equity number of shares par value and other disclosures CONVERTIBLE NOTES PAYABLE CONVERTIBLE NOTES PAYABLE {1} CONVERTIBLE NOTES PAYABLE Convertible Notes Payable - Amortized (TABLE) Convertible Notes Payable - Amortized (TABLE): Accrued interest through conversions Carrying value as of the date of interest through conversions Accrued interests through conversions Accrued interest through the date of conversion Convertible notes issued Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES Interest rates on convertible note Interest rate on convertible notes Value per common share Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Accumulated Amortization Of Discount On Convertible Notes Payable 1 Convertible Notes Issued December 9, 2013 On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . Convertible Notes Issued December 9 2013 Convertible Notes Issued March 15, 2013 March 15, 2013 convertible note Convertible Notes Issued March 15 2013 Convertible Notes Issued November 21, 2013 On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014. Convertible Notes Issued November 21 2013 Convertible Notes Issued October 15, 2013 Note issuance Convertible Notes Issued October 15 2013 On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014. Convertible Notes Issued On August 27 2013 1 On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company?s common stock. Convertible Notes Issued On February 26 2013 1 Note issuance Convertible Notes Issued On January 16 2012 1 On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . Convertible Notes Issued On July 16 2013 1 Issuance of notes Convertible Notes Issued On March 7 2012 1 Issuance of notes Convertible Notes Issued On May 30 2012 1 Note issuance Convertible Notes Issued On November 16 2011 1 Convertible Notes Issued On September 26 2013 On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . Convertible Notes Issued On September 26, 2013 CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATE [Abstract] Discount Representing IThe Relative Fair Value Of The Warrants Issued And Ii The Beneficial Conversion Features 1 Remaining Discount 1 Accumulated amortization of discount on convertible notes payable Convertible notes issued On August 27, 2013 Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Convertible notes issued On January 16, 2012 Convertible notes issued On july 16, 2013 Convertible notes issued On March 7, 2012 Convertible notes issued On May 30, 2012 Convertible notes issued On November 16, 2011 Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features Remaining discount on the liability component of convertible debt which may be settled in cash upon conversion. convertible notes payable Total amt outstanding for notes after conversion Sub Total Convertible Notes Payable 1 Total Amt Outstanding For Notes 1 Accumulated amortization of discount on convertible notes payable Accumulated amortization of discount on convertible notes payable Convertible notes issued On February 26, 2013 Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Convertible notes issued On January 16, 2012 Convertible notes issued On January 16, 2012 Convertible notes issued On March 7, 2012 Convertible notes issued On March 7, 2012 Convertible notes issued On May 30, 2012 Convertible notes issued On May 30, 2012 Convertible notes issued On November 16, 2011 Convertible notes issued On November 16, 2011 CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features Remaining discount Remaining discount on the liability component of convertible debt which may be settled in cash upon conversion. Total amt outstanding for notes Total amt outstanding for notes after conversion Total of convertible notes on various dates Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder. Accrued Interest Through The Date Of Conversion 1 Accrued Interest Through The Date Of Conversion 2 Accrued Interest Through The Date Of Conversion 3 Common Shares For Convertible Notes 1 Commons Shares For Conversion Of Principal 1 Common Stocks Per Share 1 Company Issued AConvertible Note In The Amount 1 Company SCommon Stock Shares 1 Convertible Note Amount 1 Interest Rate On Convertible Notes 1 Note Holder Converted The Entire Principal Amount 1 Note Holder Converted The Entire Principal Of 1 Per Share Value 1 Per Share Value 3 Shares For Convertible Notes 1 Shares Of The Company SCommon Stock 1 Accrued interest through the date of conversion accrued interest through the date of conversion, Accrued interest through the date of conversion' Common shares for convertible notes Commons shares for conversion of principal Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Company issued a convertible note in the amount Company's common stock shares Convertible note amount Company's common stock shares [Abstract] CONVERTIBLE NOTES PAYABLE {2} Interest rate on convertible notes Note holder converted the entire principal amount Note holder converted the entire principal of Per share value per share value , Shares for convertible notes Shares of the Company's common stock CONVERTIBLE NOTES PAYABLE (Tables) CONVERTIBLE NOTES PAYABLE. Amortized value over per quarter Amortized value over per quarter Amortized value over the vesting period Amortized value over the vesting period COMMON SHARES ISSUED FOR OBTAINING EMPLOYEE AND DIRECTOR SERVICES Common shares issued to two new members of BOD Common shares issued to two new members of BOD COMMON SHARES ISSUED UPON SIGNING AND COMPENSATION Common shares value to issue and sell Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Commons shares par value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Common stock in aggregate as compensation for future services Common stock in aggregate as compensation for future services EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT Financing costs The cash outflow for loan and debt issuance costs. Restricted common stock issued Restricted common stock issued Restricted shares for non cancellable retainer fee Restricted shares for non cancellable retainer fee Restricted stock shares Restricted stock shares Share par value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Shares value Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Share value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Stock price value Stock price value Accrued Interest Amortization Expense Acquired Technology Net change in cash Cash At Beginning Of The Fiscal Year Cash At End Of The Fiscal Year Common Shares Issued For Compensation Common Shares Issued For Services Related Party Converstion Of Accrued Interest To Convertible Notes Discount Of Convertible Notes Payable Excess of fair value of warrants over notes, net of OID Excess Of Fair Value Of Warrants Over Notes, Net Change in fair value of derivative liability Debt settlement loss Debt settlement loss Accounts receivable Prepayments and other current assets Increase Decrease In Prepaid Seeds Seeds The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the prepayment of seeds. Issuance Of Common Stock For Conversion Of Accrued Interest Issuance Of Common Stock For Past Due Payables Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital. Issuance of common stock for past due payables Net cash provided by financing activities Net cash used in investing activities Net cash provided by (used in) operating activities Net Loss Before Non Controlling Interest This element represents the income or loss from continuing operations (before interest income and interest expense) attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before interest income, interest expense, income taxes, extraordinary items, and noncontrolling interest Net loss before non-controlling interest Net Loss For The Period Purchase of property, plant and equipment Website development costs Proceeds from exercise of warrants, net of cost The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. The reporting period amortization expense on acquired technology Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Common shares issued for compensation Common shares issued for services rendered by a related party. Converstion of accrued interest to convertible notes under non cash activity. Discount of convertible notes payable Issuance of common stock for conversion of accrued interest The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities Cash received from reverse acquisition Net change in cash Issuance of common stock for conversion of convertible notes Depreciation expense Change in fair value of derivative liability Income tax paid Accounts payable - President and CEO; Accounts payables; Accounts receivable; Accrued expenses; Changes in operating assets and liabilities: Prepaid expenses; Interest paid Common shares issued for outside services Net cash provided by financing activities Cash flows from financing activities: Net cash used in investing activities Cash flows from investing activities: Net cash used in operating activities CASH FLOWS FROM OPERATING ACTIVITIES: Non-cash investing and financing activities: Purchases of property, plant and equipment Websites development costs, Proceeds from issuance of convertible notes, net of costs Proceeds from sale of common stock, net of costs Advances from (repayments to) president and stockholder Common shares issued for director services earned during the period Supplemental disclosure of cash flows information: Debt discount Total cost of revenues Derivative Expense Derivative Expense Derivative expense Farm Management Services Related Parties Farm Produce Gross margin Loss before income tax provision and non-controlling interest Net income (loss) attributable to Stevia Corp. Total operating expenses Income (Loss) from operations Net loss before non-controlling interest Cost of services of Farm management services - related parties Cost for Farm produce Total Other Income Expense Total Other Income Expense Total other (income) expense Total cost of revenues Cost of revenues Farm expenses Net loss per common share - Basic and diluted Foreign currency transaction gain (loss) General and administrative expenses Gross margin Loss before income tax provision and non-controlling interest INCOME STATEMENT Income tax provisions Interest expense Interest income Net loss attributable to Stevia Corp. Net loss attributable to the non-controlling interest Directors' fees Other (income) expense Other (income) expense: Total operating expenses Operating expenses: Income (Loss) from operations Farm field lease Financing cost Professional fees Net loss before non-controlling interest Research and development Revenues Salary and compensation - others Salary and compensation - officer Weighted average common shares outstanding - basic and diluted Anti-dilution shares issued in accordance with the Security Purchase Agreement dated August 1, 2012 on October 1, 2013 Antidilution Shares Issued In Accordance With Security Purchase Agreement, Shares. Beneficial Conversion Feature In Connection With Convertible Note Payable Issued In February And March 2013 Commissions And Legal Fees In Connection With The Stock Sales Commissions And Legal Fees Paid In Connection With The Sale Of Equity Units On May 62013 Commissions and legal fees paid in connection with the sale of equity units on May 6, 2013 Commissions and legal fees paid in connection with the sale of equity units on May 6, 2013 Common Shares And Warrants Issued For Cash To Two Investors Common Shares Cancelled By Significant Stockholder Common Shares Cancelled In Reverse Acquisition Common Shares Issued For Consulting Services At $1.39 Per Share On March 31, 2012 Common Shares Issued For Consulting Services Valued At 020Per Share On April 302013 Common shares issued for consulting services valued at $0.20 per share on April 30, 2013 Common shares issued for consulting services valued at $0.20 per share on April 30, 2013 Common Shares Issued For Conversion Of Accrued Interest Common Shares Issued For Conversion Of Accrued Interest At $0.25 Per Share On January 18, 2012 Common Shares Issued For Financing Services Upon Agreement At $1.50 Per Share On January 26, 2012 Common Shares Issued For Future Director Services on October 4, 2011 During the Period Common Shares Issued For Future Director Services Earned During The Period Common Shares Issued For Future Director Services On October 42011Earned During The Period Ending September 302013 Common shares issued for future director services on October 4, 2011 earned during the period ending September 30,2013 Common shares issued for future director services on October 4, 2011 earned during the period ending September 30,2013 Common shares issued for future director service on December 4, 2013 Common Shares Issued For Future Director Service Subscribed Common Shares Issued For Notes Conversion Common shares issued per debt settlement agreement for past due accounts payable and related settlement costs Common Shares Issued Per Debt Settlement Agreement For Past Due Accounts Payable And Related Settlement Costs Exercise Of Warrant With Exercise Price Adjusted To 020Per Share On May 62013 Exercise of warrant with exercise price adjusted to $0.20 per share on May 6, 2013 Exercise of warrant with exercise price adjusted to $0.20 per share on May 6, 2013 Initial Settlement Shares Of 75mmIssued On July 262013And Additional Shares Of 2mmIssued On September 302013In Accordance With The Settlement Agreement For Past Due Accounts Payables Initial Settlement shares of 7.5mm issued on July 26, 2013 and additional shares of 2mm issued on September 30, 2013 in accordance with the settlement agreement for past due accounts payables Initial settlement shares of 7.5mm issued on July 26, 2013 and additional shares of 2mm issued on September 30, 2013 in accordance with the settlement agreement for past due accounts payables Issuance Of Warrants In Connection Withconvertible Note Payable Issued In February And March 2013 Net Loss for 2012 Net Loss for 2013 Net Loss For December Nine Months Ended Common stock to be Issued [Member] Reclassification Of Derivative Liability To Additional Paid In Capital Associated With Reclassification Of Warrants Reclassification of derivative liability to additional paid-in capital associated with reclassification of warrants. Reclassification Of Derivative Liability To Additional Paid In Capital Associated With The Exercise Of Warrants Reclassification of derivative liability to additional paid-in capital associated with the exercise of warrants Restriced Common Shares Issued For Technology Rights Valued Restricted Common Shares Issued For Farm Management Services To ARelated Party Beneficial conversion feature in connection with convertible note payable issued in February and March 2013 Commissions and legal fees in connection with the stock sales on August 6, 2012 Common shares and warrants issued for cash to two investors at $0.46875 per unit on August 6, 2012 Number of shares of stock cancelled during the period by a significant stockholder. Number of shares of stock cancelled during the period pursuant to acquisitions. Number of shares issued in lieu of cash for consulting services contributed to the entity. Number of shares includes, but is not limited to, shares issued for consulting services contributed by vendors and founders. Common shares issued for conversion of accrued interest at $0.832143 per share on July 6, 2012 Number of shares issued during the period as a result of the second conversion of convertible securities. Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. Common shares issued for future director services on October 4, 2011 earned during the period Changes in additional paid in capital related to exercise of share-based payments awards (such as stock options) and the amount of recognized equity-based compensation during the period (such as nonvested shares). Common shares issued for notes conversion at $0.832143 per share on July 6, 2012 Issuance of warrants in connection withconvertible note payable issued in February and March 2013 The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Restriced common shares issued for technology rights valued at $0.79 per share discounted 69% on July 5, 2012 Restricted common shares issued for farm management services to a related party valued at $0.79 per share discounted at 69% on July 5, 2012 Number of shares issued during the period as a result of the second conversion of convertible securities. Total Equity (Deficit) Warrants issued to investors in connection with the sale of equity units on August 6, 2012 Warrants issued to placement agent in connection with the sale of equity units on August 6, 2012 Balance Balance Stockholders Equity Deficit [Member] Stock Issued During Period Shares Second Conversion Of Convertible Securities Total Equity Deficit [Member] Additional paid-in Capital [Member] Common shares issued for future director services Common Stock, $0.001 Par Value Number of Shares [Member] Common Stock, $0.001 Par Value Amount [Member] Equity Component [Domain] Non- controlling Interest [Member] Accumulated Deficit [Member] Balance Balance, shares Balance, shares Statement, Equity Components [Axis] Statement [Line Items] Statement Consolidated Statement of Equity (Deficit) Statement [Table] Common shares deemed issued in reverse acquisition Common shares issued for notes conversion at $0.25 per share on October 4, 2011 Common shares issued for cash at $0.25 per share on October 04, 2011 Common shares issued for conversion of accrued interest at $0.25 per share on October 4, 2011 Stock Issued During Period Shares Restricted Stock Award Gross Make good shares released to officer Warrants Issued To Investors In Connection With The Sale Of Equity Units On August 6, 2012 Warrants Issued To Investors In Connection With The Warrant Exercisd On May 62013Classified As Derivative Liability Warrants issued to investors in connection with the warrant exercised on May 6, 2013 classified as derivative liability Warrants issued to investors in connection with warrants exercised on May 6, 2013 classified as derivative liability Warrants Issued To Placement Agent In Connection With The Sale Of Equity Units On August 6, 2012 Net Loss For September Nine Months Ended Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Voluntary Filers Entity Well-known Seasoned Issuer Document and Entity Information Derivative Instruments And Hedging Activities [Abstract] DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS {1} DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS Projected Volatility Curve Projected Volatility Curve [Table Text Block] Fair Value of Warrants Summary Of The Warrant Activities DERIVATIVE INSTRUMENTS Schedule Of Derivative Instruments Included In Trading Activities [Text Block] Warrant Activities Warrants Outstanding Accumulated amortization. The aggregate expense charged against earnings to allocate the cost of acquired intangible assets. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method. ACQUIRED TECHNOLOGY RIGHTS GROSS, NET Less accumulated amortization Accumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations. Less accumulated depreciation The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement. Net technology right estimated useful life 15 years Net technology right estimated useful life 15 years PROPERTY AND EQUIPMENT {3} Property and equipment estimated useful life 5 years Gross amount, at the balance sheet date, of long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. Property and equipment net Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. Technology right estimated useful life 15 years Technology right estimated useful life 15 years WEBSITE DEVELOPMENT COSTS Website development costs Net The aggregate sum of gross carrying value of a major finite-lived intangible asset class, less accumulated amortization and any impairment charges. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company. Website Development Costs [Abstract] Aggregate common shares Aggregate common shares Common shares exchanged under technology agreement Common shares exchanged under technology agreement Common shares par value under technology agreement Common shares par value under technology agreement Common shares purchased under Securities agreement Common shares purchased under Securities agreement Common stock exercise price under Securities agreement Common stock exercise price under Securities agreement Common stock per share under Securities agreement Common stock per share under Securities agreement ENTRY INTO SECURITIES AND TECHNOLOGY PURCHASE AGREEMENT Financing for private placement Financing for private placement Issuance of gross proceeds Issuance of gross proceeds under Securities agreement Market total value under technology agreement Market total value under technology agreement Escrow Shares earned and released to Ventures stockholder Escrow Shares earned and released to Ventures stockholder Escrow shares par value Par value of Escrow shares Shares earned and released to Ventures stockholder EXHIBIT A - SCHEDULE OF MILESTONES PARENTHETICALS Shares on the date of release and recorded as compensation Shares on the date of release and recorded as compensation Total escrow shares Total escrow shares Future Minimum Payment [Abstract] Future Minimum Payments For The Fiscal Year 2014 1 Future Minimum Payments For The Fiscal Year 2015 1 Future Minimum Payments For The Fiscal Year 2016 1 Future Minimum Payments Total 1 Stevia Ventures Corporation Entered into lease with Vinh Phuc Province People's Committee Tam Dao Agriculture &amp; Industry Co., Ltd. [Abstract] Amount of minimum lease payments maturing in the remainder of the fiscal year following the latest fiscal year ended for capital leases. Amount of minimum lease payments maturing in the remainder of the fiscal year following the latest fiscal year ended for capital leases. Amount of minimum lease payments maturing in the remainder of the fiscal year following the latest fiscal year ended for capital leases. Amount of minimum lease payments for capital leases. Change in valuation allowance on net operating loss carry-forwards Change in valuation allowance on net operating loss carry-forwards Federal statutory income tax rate Effective income tax rate Federal statutory income tax rate {1} Federal statutory income tax rate BalanceFair Value of Derivative Warrants BalanceFair Value of Derivative Warrants BalanceFair Value of Derivative Warrants BalanceFair Value of Derivative Warrants, BalanceFair Value of Derivative Warrants, BalanceFair Value of Derivative Warrants BalanceFair Value of Derivative Warrants; BalanceFair Value of Derivative Warrants; BalanceFair Value of Derivative Warrants BalanceFair Value of Derivative Warrants: BalanceFair Value of Derivative Warrants: BalanceFair Value of Derivative Warrants Derivative warrants Assets (Liability) [Member] Fair Value Measurement Using Level 3 Inputs Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Net income (loss), The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Net income (loss): The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Other comprehensive income (loss) Tax effect of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest. Other comprehensive income (loss), Tax effect of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest. Other comprehensive income (loss): Tax effect of other comprehensive income (loss) attributable to both parent entity and noncontrolling interest. Purchases, issuances and settlements Purchases, issuances and settlements Purchases, issuances and settlements, Purchases, issuances and settlements Purchases, issuances and settlements: Purchases, issuances and settlements Total gains or losses (realized/unrealized). included in: Total gains or losses (realized/unrealized), included in: Total gains or losses (realized/unrealized) included in: Transfers in and/or out of Level 3: Transfers in and/or out of Level 3: Transfers in and/or out of Level 3, Transfers in and/or out of Level 3: Transfers in and/or out of Level 3 Transfers in and/or out of Level 3: Going Concern [Abstract] GOING CONCERN {1} GOING CONCERN Common share for a net proceed Common share for net proceeds Common share for gross proceeds Common share for gross proceeds Common share for net proceeds Common share for net proceeds Common shares purchased Common shares purchased Exercise price per security issued Exercise price per security issued GARDEN STATE SECURTIES INC Gross proceeds received in the equity financing Gross proceeds received in the equity financing Percentage cash commission Percentage cash commission Price per unit of security issued Price per unit of security issued Reimbursed legal fees Reimbursed legal fees Relative fair value of the common stock and warrants Relative fair value of the common stock and warrants Relative fair value Per common share Relative fair value Per common share Relative fair value Per warrant Relative fair value Per warrant additional paid-in capital and debit amt additional paid-in capital and debit amt After allocation of proceeds The relative fair value of these warrants granted, estimated on the date of grant Company cancelled a prior convertible note and entered into a 12% convertible note payable of Company cancelled a prior convertible note and entered into a 12% convertible note payable of Company entered into two (2) 12% convertible notes payable Company entered into two (2) 12% convertible notes payable Company granted to the Payees a warrant to purchase common shares Company granted to the Payees a warrant to purchase common shares exercisable per share exercisable per share Accrued interest through the date of conversion' [Abstract] Issuance of Convertible Notes with Warrants Payees have the option to convert the outstanding notes and interest due into the Company's common shares Payees have the option to convert the outstanding notes and interest due into the Company's common shares The amortization of the discount and beneficial conversion feature amounted The amortization of the discount and beneficial conversion feature amounted The relative fair value of these warrants granted, estimated on the date of grant The relative fair value of these warrants granted, estimated on the date of grant warrants as a discount to the Convertible Note warrants as a discount to the Convertible Note Cash commission percentage Cash commission percentage Common shares to purchase warrants Common shares to purchase warrants Exercise price of warrant for agent Exercise price of warrant for agent Gross proceed received Gross proceed received Gross proceeds of the offering Gross proceeds of the offering ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION Percentage of common shares sold Percentage of common shares sold Relative fair value of the agent warrants using the Black-Scholes Option Pricing Model Relative fair value of the agent warrants using the Black-Scholes Option Pricing Model INCOME TAX PROVISION [Abstract] INCOME TAX PROVISION INCOME TAX: Deferred Tax Assets and Liabilities Effective Income Tax Rate Reconciliation Deferred tax assets, net of valuation allowance Net deferred tax assets - Non-current: Expected income tax benefit from NOL carry-forwards Less valuation allowance NON-CONTROLLING INTEREST {1} NON-CONTROLLING INTEREST NON-CONTROLLING INTEREST Balance 0f non controlling interest Balance 0f non controlling interest Balance NON-CONTROLLING INTEREST Balance 0f non controlling interests Contributed and additional paid-in capital [Member] Current period earnings and losses Current period earnings and losses Earnings and losses [Member] NON-CONTROLLING INTEREST {3} Other Comprehensive Income [Member] Total non-controlling interest [Member] Non-controlling interest consists Tabular disclosure of Non-controlling interest. NON-CONTROLLING INTEREST (Tables) Range Of Exercise Prices 025 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Ending Balance Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term OUTSTANDING AND EXERCISABLE WARRANTS Range of Exercise Prices 0.25, warrants excercisable Range of Exercise Prices 0.25 Range of Exercise Prices 0.25., Warrants Exercisable Average Remaining Contractual Life (in years) [Member] Warrants Exercisable Number Exercisable [Member] Warrants Exercisable Weighted Average Exercise Price [Member] Warrants Outstanding Average Remaining Contractual Life (in years) [Member] Warrants Outstanding Number Outstanding [Member] Warrants Outstanding Weighted Average Exercise Price [Member] ORGANIZATION AND OPERATIONS ORGANIZATION AND OPERATIONS {1} ORGANIZATION AND OPERATIONS Common shares held in escrow Common shares held in escrow Common shares issued and outstanding Common shares issued and outstanding. Common shares issued for acquisition of 100% of issued and outstanding Common shares issued for acquisition of 100% of issued and outstanding Common shares surrendered for cancelletion Common shares surrendered for cancelletion Contribution per month Contribution per month Percentage of shares represented of the issued and outnstanding Percentage of shares represented of the issued and outnstanding Percentage owned by Stevia Asia Percentage owned by Stevia Asia Percentage owned by Technew Percentage owned by Technew Total contribution Total contribution Farm management services - future payments 2014 (remainder of the fiscal year) [Abstract] Company leases certain office space rent details Company leases certain office space with Leverage Investments, LLC per month Company leases certain office space with Leverage Investments, LLC Stevia Asia provided Stevia Technew the amount, all of which has been paid to Guangzhou Health Stevia Asia provided Stevia Technew the amount, all of which has been paid to Guangzhou Health Total lease Company leases certain office space with Leverage Investments, LLC Net long-term land leases which are capitalized as part of real property. Property Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT {1} PROPERTY AND EQUIPMENT Property And Equipment Tables [Abstract] Property and equipment Property Plant and Equipment [Text Block] PREPAID EXPENSES [Text Block] PREPAID EXPENSES [Abstract] PREPAID EXPENSES Text block that explains the prepayments of the entity. Prepaid expenses consisted of the following Prepaid research and development, The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Retainer, Carrying amount for a unclassified balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. Total Prepaid Expenses Carrying amount for a unclassified balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. For a classified balance sheet, represents the noncurrent portion of prepaid expenses (the current portion has a separate concept). Other Prepaid rent Going Concern Tables [Abstract] Prepaid expenses consists Fifth year projection Fifth year projection volatality First year projection First year projection volatality Fourth year projection Fourth year projection volatality Projected volatality curve Second year projection Second year projection volatality Third year projection Third year projection volatality RESEARCH AND DEVELOPMENT [Abstract] RESEARCH AND DEVELOPMENT {1} RESEARCH AND DEVELOPMENT Aggregate security deposit Aggregate security deposit AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated ENTRY INTO AGRIBUSINESS DEVELOPMENT AGREEMENT First year lease payment First year lease payment. LEASE OF AGRICULTURAL LAND Percentage of commission not less than [Abstract] Percentage of commission not less than Percentage of commission not less than Six month lease payment Six month lease payment Agpl receives commission Agpl receives commission AGPl related expenses AGPl related expenses AGPL 's Current project budget per annum AGPL 's Current project budget per annum Lease payment to Vinh Phuc PPCTDA Lease payment to Vinh Phuc PPCTDA Security Deposit to Vinh Phuc PPCTDA Security Deposit to Vinh Phuc PPCTDA six month lease payment To Vinh Phuc PPCTDA Six month lease payment To Vinh Phuc PPCTDA stevia entered with Agro Genesis pte ltd (AGPL) and details of Agpl Stevia Ventures Corporation Entered into lease with Vinh Phuc Province People's Committee Tam Dao Agriculture & Industry Co., Ltd. stevia will receive fee from AGPL in singapore dollars Stevia will receive fee from AGPL in singapore dollars RESEARCH AND DEVELOPMENT (Tables) Future minimum payments {1} Future minimum payments 2014 (remainder of the fiscal year) 2015 2016 Future Minimum Payments For The Fiscal Year 2017 2017 Future Minimum Payments For The Fiscal Year 2017 Agreement amount with Growers Synergy Agreement amount with Growers Synergy Farm management services Farm management services - future payments Farm management services - future payments Future Minimum payments for the fiscal year 2014 Future Minimum payments for the fiscal year 2014 Future Minimum payments for the fiscal year 2015 Future Minimum payments for the fiscal year 2015 Future Minimum payments for the fiscal year 2016 Future Minimum payments for the fiscal year 2016 Related party Farm management services Related party Farm management services Total Farm management services amt Total Farm management services amt Total Future minimum payments Total Future minimum payments RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS {1} RELATED PARTY TRANSACTIONS Percentage Owned By Stevia Asia 1 Percentage Owned By Technew 1 Company leases certain office space with Leverage Investments, LLC Company leases certain office space with Leverage Investments, LLC Contribution per month related party Contribution per month related party Percentage owned by Stevia Asia Percentage owned by Technew Stevia Asia provided Stevia Technew the amount, all of which has been paid to Guangzhou Health [Abstract] RELATED PARTY TRANSACTIONS CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW Total contribution related party Total contribution related party Consulting services Tabular disclosure of Consulting services. Related parties with whom the Company had transactions Tabular disclosure of Consulting services. RELATED PARTY TRANSACTIONS (Tables) Future minimum payments Unrecorded Unconditional Purchase Obligations Disclosure [Text Block] Common Shares Authorized Shares After Amendment To The Articles Of Incorporations To Increase The Authorized Number Of Shares To Common shares authorized shares after amendment to the Articles of Incorporations to increase the authorized number of shares to Common shares authorized shares after amendment to the Articles of Incorporations to increase the authorized number of shares to Another shares surrendered Another shares surrendered Common shares authorized to issue The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Common shares authorized to issue par value Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Common shares held in escrow. Common shares held in escrow. Common shares issued for acquisition of 100% of issued and outstanding. Common shares issued for acquisition of 100% of issued and outstanding. Common shares sold to one investor Common shares sold to one investor COMMON SHARES SURRENDERED FOR CANCELLATION AND COMMON SHARES ISSUED FOR CASH Common stock price Common stock price Common stock value Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Debiting common stock at par Debiting common stock at par SHARE EXCHANGE AGREEMENT Shares surrendered for cancellation [Abstract] SHARES AUTHORIZED AND REVERSE ACQUISITION TRANSACTION Shares surrendered for cancellation Shares surrendered for cancellation STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY {1} STOCKHOLDERS' EQUITY SUBSEQUENT EVENTS SUBSEQUENT EVENTS {1} SUBSEQUENT EVENTS STOCKHOLDERS' EQUITY (Tables) Schedule of Milestones Accrued Interest Converted By Convertible Note Holder Cash Commissions Exercise Price Of Warrants Accrued Interest Converted By Convertible Note Holder Cash Commissions Convertible Note Conversion Rate Convertible Note Principal Face Value Debenture Security Issued In The Form Of Restricted Common Shares To The Note Holder Debenture security issued in the form of restricted common shares to the note holder Exercise Price Of Warrants Rate Of Interest Per Annum Rate of interest per annum. Series A Warrants Granted Series A Warrants Granted Exercise Price Series B Warrants Granted Series B Warrants Granted Exercise Price Series C Warrants Granted Series C Warrants Granted Exercise Price Shares Issued For Accrued Interest Converted By Convertible Note Holder Shares Issued For Warrants Exercised By Investor Escrow Shares earned by Ventures stockholder Escrow Shares earned by Ventures stockholder No of shares issued for services No of common shares issued for services Per share value of shares Per share value of shares issued for services Subsequent Event Transactions Value of consultation fee considered Value of consultation fee considered in shares issued for services Value of stockissued Value of stockissued for services Term Of Warrants Granted With Convertible Note Value Of Shares Issued For Warrants Exercised By Investor Warrants Granted With Convertible Note Series A Warrants Granted Series A Warrants Granted Exercise Price Series B Warrants Granted Series B Warrants Granted Exercise Price Series C Warrants Granted Series C Warrants Granted Exercise Price Shares Issued For Accrued Interest Converted By Convertible Note Holder Shares Issued For Warrants Exercised By Investor Term Of Warrants Granted With Convertible Note Warrants Granted With Convertible Note Earned And Exercisable With Maximum Exercise Price Range Warrants Earned and exercisable with maximum exercise price range Earned And Exercisable With Minimum Exercise Price Range Warrants Earned and exercisable with minimum exercise price range Granted With Maximum Exercise Price Range Warrants Granted with maximum exercise price range Granted with maximum exercise price range Granted With Minimum Exercise Price Range Warrants Granted with minimum exercise price range Granted with minimum exercise price range Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales Issuance Of Warrant Shares, Subsequent Equity Sales Aggregate Intrinsic Value [Member] Average Exercise Price [Member] Balance {1} Balance Outstanding warrants balance Canceled Warrants Cancelled during the period. Earned and exercisable Earned and exercisable Warrants Earned and exercisable as of the date. Exercised Warrants exercised during the period. Exercise Price Range Per Share [Member] Expired Warrants expired during the period. Fair Value at Date of Issuance [Member] Granted Warrants granted during the period. Number of Warrant Shares [Member] SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES Unvested Unvested Warrants unvested as of the date. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES {1} SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Attributable interest of Steiva Asia Limited - Hong Kong SAR Attributable interest of Steiva Ventures International Ltd - BVI Attributable interest of Steiva Technew Limited - Hong Kong SAR Attributable interest of Steiva Technew Limited - Hong Kong SAR Attributable interest of Steiva Ventures International Ltd - BVI Attributable interest of Steiva Ventures International Ltd - BVI SC Brands Pte Ltd - Singapore SC Brands Pte Ltd - Singapore On August 27, 2013, the Company issued a convertible notes in the amount of $153,000 convertible at 65% multiplied by the arket price, with interest at 8% per annum due on May 26, 2014. [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ATTRIBUTABLE INTEREST December 92013Convertible Note Issuance On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . December 9, 2013 Convertible Note Issuance November 212013Convertible Note Issuance On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014. November 21, 2013 Convertible Note Issuance October 152013Convertible Note Issuance On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014. October 15, 2013 Convertible Note Issuance October 15, 2013 Warrant Issuance On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company?s common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note. October 15, 2013 Warrant Issuance On August 272013The Company Issued AConvertible Notes In The Amount Of 153000Convertible At 65Multiplied By The Arket Price With Interest At 8Per Annum Due On May 262014 On August 27, 2013, the Company issued a convertible notes in the amount of $153,000 convertible at 65% multiplied by the arket price, with interest at 8% per annum due on May 26, 2014. On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014. Note issuance On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company?s common stock to two (2) note holders in connection with the issuance of convertible notes. On July 162013The Company Issued AConvertible Note For 400000With Consideration Of 360000And A40000Original Issue Discount On July 16, 2013, the Company issued a convertible note for $400,000, with consideration of $360,000 and a $40,000 original issue discount. On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date. On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company?s common stock to the note holder in connection with the issuance of the convertible note. Issuance of notes Issuance of notes On May 62013The Company Issued Three 3Series Of Warrants Of Series A On May 6, 2013, the Company issued three (3) series of warrants of Series A On May 6, 2013 the Company issued three (3) series of warrants: Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company?s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance. On May 62013The Company Issued Three 3Series Of Warrants Series B On May 6, 2013, the Company issued three (3) series of warrants. Series B On May 6, 2013 the Company issued three (3) series of warrants: Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company?s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. On May 62013The Company Issued Three 3Series Of Warrants Series C On May 6, 2013, the Company issued three (3) series of warrants. Series C On May 6, 2013 the Company issued three (3) series of warrants: Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company?s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised. On September 262013Convertible Note Issuance On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date. September 26, 2013 Convertible Note Issuance Convertible Note Shares Make Good Escrow Agreement shares issued and held with the escrow agent Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"). On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum. On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum Sub-total Convertible Note Shares Total of Convertible Note Shares Sub-total Make Good Escrow Shares Sub-total Make Good Escrow Shares Sub-total Warrant Shares Total of Warrant Shares SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE Total potentially outstanding dilutive common shares Total potentially outstanding dilutive common shares Warrant Shares Beneficial Conversion Feature [Policy Text Block] Policy text block for Beneficial Conversion Feature BENEFICIAL CONVERSION FEATURE Cash Flows Reporting Policy [Policy Text Block] CASH FLOWS REPORTING DERIVATIVE LIABILITY Equity Instruments Issued To Parties Other Than Employees [Policy Text Block] EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS Legal Costs, Policy [Policy Text Block] EXTINGUISHMENT ACCOUNTING Limitation On Utilization Of Nols Due To Change In Control [Policy Text Block] LIMITATION OF UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS Non Controlling Interest [Policy Text Block] Non Refundable Advance Payments For Goods Or Services To Be Used In Future Research And Development Activities [Policy Text Block] Policy text block for Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities NON-REFUNDABLE ADVANCE PAYMENTS FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES Recently Issued Accounting Pronouncements [Policy Text Block] RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Related Parties [Policy Text Block] RELATED PARTIES SHIPPING AND HANDLING COSTS Disclosure of accounting policy Cash Flows Reporting. Disclosure of accounting policy for Equity instruments issued to parties other than employees for acquiring goods or services Disclosure of accounting policy for limitation on utilization of nols due to change in control NON-CONTROLLING INTEREST Disclosure of accounting policy for Non Contolling Interest. Disclosure of accounting policy for recently issued accounting pronouncements. Disclosure of accounting policy for Related Parties. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) BASIS OF PRESENTATION CASH EQUIVALENTS COMMITMENT AND CONTINGENCIES PRINCIPLES OF CONSOLIDATION Derivatives Policy [Text Block] DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES NET INCOME (LOSS) PER COMMON SHARE FAIR VALUE OF FINANCIAL INSTRUMENTS FISCAL YEAR END CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS INCOME TAX PROVISION {1} INCOME TAX PROVISION UNCERTAIN TAX POSITIONS INTANGIBLE ASSETS OTHER THAN GOODWILL PROPERTY AND EQUIPMENT {2} PROPERTY AND EQUIPMENT RECLASSIFICATION RESEARCH AND DEVELOPMENT {2} RESEARCH AND DEVELOPMENT REVENUE RECOGNITION STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES SUBSEQUENT EVENTS {2} SUBSEQUENT EVENTS USE OF ESTIMATES AND ASSUMPTIONS Tabular disclosure of subsidiaries of the Company. Subsidiaries Of The Company [Table Text Block] Subsidiaries of the Company Summary Of Significant Accounting Policies Tables [Abstract] Potentially Outstanding Dilutive Common Shares WEBSITE DEVELOPMENT COSTS The entire disclosure for all or part of the information related to website development costs. Website Development Costs [Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] Website development costs, stated at cost WEBSITE DEVELOPMENT COSTS (Tables) Issuance of warrants on Oct 15, 2013 Issuance Of Warrants On October 15 2013 APIC Reclassification Derivative Liability [Member] Derivative warrant Balance Derivative warrant Balance Derivative warrant Balance Derivative warrant Balance. Derivative warrant Balance. Derivative warrant Balance Derivative warrant Balance.. Derivative warrant Balance.. Derivative warrant Balance Derivative warrant Balance; Derivative warrant Balance; Derivative warrant Balance Derivative warrant Balance: Derivative warrant Balance: Derivative warrant Balance Exercise of warrants on May 6, 2013 Exercise of warrants on May 6, 2013 Fair Value of Derivative Warrants [Member] (Gain) Loss Change in Fair Value of Derivative Liability [Member] Issuance of warrants on May 6, 2013 Issuance of warrants on May 6, 2013 Mark to market Mark to market value of Derivative warrants Mark to market, Mark to market value of Derivative warrants Mark to market. Mark to market value of Derivative warrants Mark to market; Mark to market value of Derivative warrants Non-derivative Shares [Member] Reset of warrant shares, Reset of warrant shares Reset of warrant shares. Reset of warrant shares Total Warrant Shares [Member] Warrants Outstanding {1} Inventory - Seeds [Abstract] Inventory Disclosure [Text Block] Inventory - Seeds Schedule of Inventory, Current [Table Text Block] Schedule of Inventory - Seeds Seeds Inventory, Net Inventory, net Inventory, Raw Materials and Supplies, Gross Inventory Write-down Write down for obsolete inventories Shares issued, other EX-101.PRE 11 stev-20140408_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE            
Make Good Escrow Agreement shares issued and held with the escrow agent 0 3,000,000 0 3,000,000 3,000,000 6,000,000
Sub-total Make Good Escrow Shares 0 3,000,000 0 3,000,000 3,000,000 6,000,000
Issuance of notes 881,752 426,667 881,752 426,667 881,752 0
Issuance of notes 1,739,130 426,667 1,739,130 426,667 426,667 0
On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum. 1,400,000 0 1,400,000 0 1,400,000 0
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date. $ 1,762,228 $ 0 $ 1,762,228 $ 0    
On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014. 2,353,573 0 2,353,573 0    
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.     440,571 0    
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.     290000 0    
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.     812,634 0    
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .     881,142 0    
Sub-total Convertible Note Shares 10,561,070 853,334 10,561,070 853,334 2,708,419 0
Note issuance 956,481 1,152,000 956,481 1,152,000 2,951,424 0
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company?s common stock to two (2) note holders in connection with the issuance of convertible notes. 1,400,000 0 1,400,000 0 1,400,000 0
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company?s common stock to the note holder in connection with the issuance of the convertible note. 881,753 0 881,753 0 881,753 0
On May 6, 2013 the Company issued three (3) series of warrants: Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company?s common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance. 2,027,520 0 2,027,520 0    
On May 6, 2013 the Company issued three (3) series of warrants: Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company?s common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. 1,151,999 0 1,151,999 0    
On May 6, 2013 the Company issued three (3) series of warrants: Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company?s common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's common stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised. 2,534,399 0 2,534,399 0    
On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company?s common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.     $ 1,000,000 $ 0    
Sub-total Warrant Shares 9,952,152 1,152,000 9,952,152 1,152,000 5,233,177 0
Total potentially outstanding dilutive common shares 20,513,222 5,005,334 20,513,222 5,005,334 10,941,596 6,000,000
XML 13 R54.htm IDEA: XBRL DOCUMENT v2.4.0.8
Projected volatality curve (Details)
Dec. 31, 2013
Mar. 31, 2013
Sep. 30, 2012
Aug. 06, 2012
Projected volatality curve        
First year projection 111.00% 122.00% 127.00% 129.00%
Second year projection 168.00% 167.00% 173.00% 178.00%
Third year projection 202.00% 205.00% 211.00% 218.00%
Fourth year projection 233.00% 236.00% 244.00% 252.00%
Fifth year projection 261.00% 264.00% 272.00% 281.00%
XML 14 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES (Details) (USD $)
Mar. 15, 2013
Oct. 04, 2011
Jun. 23, 2011
Apr. 11, 2011
CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES        
Convertible notes issued $ 220,438 $ 2,500,000 $ 100,000 $ 2,500,000
Interest rates on convertible note 12.00% 10.00% 10.00% 10.00%
Accrued interests through conversions   15,890.41 0 0
Accrued interest through conversions   $ 2,821.92    
Value per common share   $ 0.25    
EXCEL 15 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`UFZOG5P(``!`K```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,VM]NVC`4!O#[27N'R+<3 M,;83TTU`+_;GTU50Q*E2D?C<@2'S.1Y!^5]_\ M>M>UV3WYT#B[8"*?LHQLY>K&KA?LU^VWR17+0C2V-JVSM&!["NQZ^?[=_';? M4\C2:1L6;!-C_XGS4&VH,R%W/=ET9>5\9V+ZZ->\-]76K(G+Z53SRME(-D[B M,(,MYU]H9>[:F'W=I:\/23RU@66?#S<.NQ;,]'W;5":FI/S>UL^V3!XVY.GD M>$_8-'WXD&(P?G3#<.7_"Q[._4B/QCD)Y*'W9.JP(8I=FX_O>6<:^YC[Q/[QYL#'-W'A(,/O&P>? MF4."Y%`@.0J0'"5(#@V28P:2XPHDQT>0'&**$@1%5(%"JD`Q5:"@*E!4%2BL M"A17!0JL`D56B2*K1)%5HL@J4625*+)*%%DEBJP215:)(JM$D56AR*I09%4H MLBH4616*K`I%5H4BJT*15:'(JE!D+5!D+5!D+5!D+5!D+5!D+5!D+5!D+5!D M+5!D+5!D+5%D+5%D+5%D+5%D+5%D+5%D+5%D+5%D+5%D+5%DU2BR:A19-8JL M&D56C2*K1I%5H\BJ4635*+)J%%EG*++.4&2=H<@Z>RM98^H;$A]?7_^GC&-> M*+R%N&\I7+BDX-_9IW*DWN*-=WU(#4Y/YS^%QXKF M<'K2IT'D8T-/)GC:G]>?["9VU+&OJE-=5'=O.QS[K\"P``__\#`%!+ M`P04``8`"````"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@ M``(````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4 M'L`D[A^UC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIX MK9]6#Z!B(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QR MI9$P4P>J/OH\^;*W-$UO>"_F?6*7 M3HQ`GA,[RW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;',@H@0!**```0`````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````````"\ MFLMNVS`01?<%^@\"][7,US`I(F=3%,BV33]`L.@'8DN"R#[\]R7<5'&`]F9C MW(T!23`]("_/&_S\X495*;=] MUQZ&/C;J%).Z7[U_=_ND9-#YT153V>QO+3;P\^;#;[ M=?PTK+\?8Y__\1OUSV%Z2KL8KS%2.+4K.J_U..9I>C43G. MD,MQ!I83V.4$5(Y8H''9T8'(T>YMKO,UOR4ME;M%2:39U M-*2.<>S9<6AV+#O)%D;9LB%H(01=43J5.FZ)%LMY=CD>E>/9BO!0$9ZM"`\5 M(6PJ"Z1RN"IW=[!PT]9=B>,M!3ANTI`SUEV9ZRT%.6O<\MW.B.[2D'/>78GG+04Y[M M*0\])6SN".2.L*DLD,KLZ.#DL`7JH4`#6Q$!*H(-'<@=&L_6IH3X- MVU<&^LK2HP.S8]G0L9`ZCNTK!WWEV8+P4!#"WEF"=Q:[,36P,75L8SEH+,_N M=3SN==B2$"B)P,Y.@-D)5Y5$RJ=#^3MP?H+RYQ@];6-'%R:7S6"(8'W5E9F? M2[PLSGSJ[Z,*J&_#UK>!^C9L?1NH;\N.CH79<6Q].ZAOS]:WA_K6;`1KB&#+ M9J"%$'1L?3NH;\_6MX?Z%G9V!&9'V)(0*(G`ED2`DJ`G&74Z;"1#(FOV0FFX M4)IM-5.,.W:*79?\U3>OKR\K[H\ MC:##;KQ@WQ78C4Z8&YWZU&PO=V]R:V)O;VLN>&ULE)C;)^AS-) MIB:9I)OJR_Z;S^]>K/ M/[Z\I-G/'VGZLP:!)+^L+XMB_;G1R.=+O5+YIW2M$WSSF&8K56"9/37R=:;5 M(E]J7:SB1KO9[#=6*DKJ6X7/V>]HI(^/T5P/TOEFI9-B*Y+I6!4P/U]&Z[Q^ M]>4QBO5LZU%-K=>>6L'NU[A>BU5>L$54Z,5EO8=E^J+W/L@VZ^M-%./;BTZS M4V]<[9R<9+6%?E2;N`CAWKLZXM7NMMM]\TL3BEFD7_*/3699>[V+DD7Z8GZ* MT+[M5AT8\%)^=1$8E, M29844?$F>;*-?I0BA2;J')ZUZK7LD2E>Y)6W8J1D04 MZ9RH(.Z[H/1^3Z6TQ54T+GVB4C)!/?*#6\?CWYV0^YYTO('T)RPH5X(843\9LWUS4F%W\6Q:5 MCHL]`1O(D+E#SQ_YMP_4Z@NZV>+QCET+'C(Y8#,V\LLGPW414OO/<3(_GF_! M&+"1$^+Q$\K!: M%H<#%O`9B)DQR3T1!E,315$&-1SNZ72H.Q:)(O3=;T-_!#TA33I"&LYS2F#+ M0M`#-;X7!OYH9"#B7L@")BA[YY2]E@4??LV2[?8_J<,MFVF"Q/#^*P/<&E M,RX0Y:$,N/A&S:%XMBT\Q?1:(`?(I`2@R"?9>D&Q;%M8GJX&P+$L/Z;F7U`V MVQ:;IX4`Y8<0);1M$5HM$3)4/V+T"T2`HKF].&F1Y,DSRGR:O4FA]2(_L)_2 MV;;H!`\'*LT!&KQPF&$J`YEMG.`V2/%P[*'0MNQ MH+V.U?RGF"]3)$6F:],SK;-HCE9/KM(%M8="V[&@/5*)K&RCI2&5J&,3;%M)J6W8]%[K*!LE8A3K2:E%_U7I3*0NG+`$PINQZJII\L!/8NM)D6X8R%\ MHD^0`TWSEVF+X]*&&-[M#W=E+M@7Q:2$XLQ/JTFQC48EOI3K`FT)%,:T. M79II+"H"U>IP0(!FN&MQB_J*RPY7IA`,-^>!_33+78M79^SC"B<]W(#!*9=O MFSH:"9KCKH6L7PXQ,E\KM-RBT6%F)-",V)0CZ*+147G1D69G*EXH\WP,-!9](R)\UG+.Y5EBNI0 M@GL6P>7/S1SC;XIRJ#:EU\:P90;!74/:LSCF>;XI1S,8@Y$-Z!01+EKII04* M.S6'\MRS>)YDZ3]Z;@AZ3D&2BLW4.-]D<`Q&41W*<\_B^?2]0O/5VW/,`EH, M'91SZ4S#H1_P[^BYS:3TWG%3@RC0/0MH=C_DU^C%'"G<(1M,T71C9AKS$5K5 MO6:Q1X'&HI)W%`R,6VAR?2F8.PUXB"9Q:Q-&$6H/!;IG`7WK!`/F21%BCM@J ME4*X<:J!ICSW#O`\'N,H_0H3%V**$-WX`32#&2?V]"G/6%3\,CL=C'\F*G=. M@(D&Y1!.8HZ0DQ'5H3SW+9[)W6"VHB^?.!X*[%:3ZM#"W+>`]J!R8>8C:%$="G3?`OK(=/+KB%$="G3?`OIH3X&A; MC#X%&HM*PA#9XU,+/?%]"C06%1U/%Q(OLG26X=`7ZE6J/,?+G0,!HD#W+:!O M]`+W52Q1Q(I-V;!'>&FXTJ4FO7GZ%&@L*O:<[IL`S:ZY.*-$8U$1NIF&TX#A MB'M\/!V;X7H[XFV+*]6A1)]91)\V"/1]&$21/K.0%IL?N?YW@W%&,C/4R#!3 M2:[FY8M*FK$SBC06<*Q1/@1O^.8JGN/5H_ECYKC2Z\;[B]>K_P```/__`P!0 M2P,$%``&``@````A`!$)9\P1"@``YRX``!@```!X;"]W;W)K_K[WQZ^ZL/WXWM5G680 M87]\G+^?3A_WR^5Q_5[M5L>[^J/:0\EK?=BM3O#/P]OR^'&H5B]-I=UVR8-` M+G>KS7YN(]P?IL2H7U\WZRJKUY^[:G^R00[5=G6"]A_?-Q_'<[3=>DJXW>KP M_?-CL:YW'Q#B>;/=G'XU0>>SW?K^][=]?5@];Z'?/UFX6I]C-__HA=]MUH?Z M6+^>[B# MWV?']_JK/&Q>_MCL*U`;QLF,P'-=?S?H[R_F)ZB\[-4NFA'XUV'V4KVN/K>G M?]=?_Z@V;^\G&.X(>F0Z=O_R*ZN.:U`4PMSQR$1:UUMH`/PYVVU,:H`BJY_- M_[\V+Z?WQ[F0=Y$*!`-\]EP=3\7&A)S/UI_'4[W[KX68"V6#4,.??8P*;'YP(W4I`GIOV M"25PT[(^0H+D?8(&*?H(D_@YY05$M0@21=PBBH%A@G@:J+`-VPQI8I'00X@& MZ2B1C1+Y*%&,$N40@22"SDS/&P,_SD'_-DU41"2RB&JFD=!:A63T4A_0+"0I MDOG%3,="2_*$'!$\B$6,FU#X`&=2`X*)TB>8"+K9CJ2!!6^Z-`8FV4-ZGE@$ MGMVJ1]J5CA+9*)&/$L4H40X12")8-*=+9&"2/=V\M1/,(F&3/=VH-&7I0%EF MR[1=O",-0XY'/!^H7/B5F=)Q(,B\+R_71DK`]C-="0,3)31N<&(1VZ,PYF02 MI'ZQE"HDF93YY8)I3KN4^\"%`(5?'H=12$:J],LC+OQYCG0Q5M3;HH?W)0,3 M7K)828R7G"Z/=9Y('C*Z";OL3JUI'BK,7*$55IIMOR?-0.QB M*':)8C>SKHN-!3%.(8UE.RJN48":2*0I*I!48D"P)- M$XC<9ZX;&QMI;T9IQ3AQC)]("SED4Z6.*B1`.GB7Q"!E&F)!< M428GC-2*15TOF\84F.%!!'Z"^(V2,!QV4]%ICM**WV2P&QJ?_GC#X-2R)GS( M-[HP`T@VCN3C2#&.E(,(E@IFDS\#I[W5E]Z@#:K*;-&:[-9>B]1#5$/E2]:`N[ER7R^'(0P4ED[.7D99Q;,XJ6<;(R M)HYQVSPLGHHNXXZX(HY]Q/7J^5#UHBT<$,<^`?YL7S8[_;`XQ%)/G&%]:QV3 M!3HQ'_!::RU@!29]4QU34^T8 MVVH52>H&4P2P`+XXX8',,,!%1'N>(R($3]WS/[YOUS*DZ5:B"#Q649>P6)^; M##7O&VJPJ;A[B8,N3^-FIJ?C2#:.Y.-(T2+F.S]I:(D*%YX+0`J9(_OI>U5# MX^D$*4`4I`RY.N&RL=CY4NV@+KZ_#@PC6YB;?+/H'TXR^<"8. M*D%?C0N$L#B0U$F6F`@"[BT% M6*;_RS.+OF=F0><9FIF4.,C*M=`1=(2L%2E&X.4[4F1-RS#"&9S"TZLH.698 M*&+-2&(7F.'P82V@WP1*PL#'!WBC;B<(UNTF"RWL\;%O$QG]W)`XZ.+,2H<* MLZ'"?*BP&"HLKQ1B'8QW].SR-$L=YCN$YCQ.,>*H)Z98WUG#FU<[F=T292%[26BA!321 M[,2I0`@<&TFZ9V88X0%3H28OR#EF&"R%L+#CUA28@8\C<%9'XI2$&4PQ8K8G MZM8_UV9TCTJ$A>+FFLLBN*.2I&-`U@.(&'D/($E<]``2H>P!W0*#\XOX\(DZ M]?TXG+_C$4W@2F[W5JMB"9_TO:]5UG`B!@@.MQI(5S+$**Y#8YOQLW+$P$DW M?,&C&V6!&;BR!M_.R9PPUXB[-H<1W%GCBFZ"]IZPO0&[JPYO55IMM\?9NOXT M=X#-;&Y_;>\G?^/FEB?Y/6'W:7/)E_R>L7NXE-KG"[CGW/R^;"O`->./U5OU MS]7A;;,_SK;5*S0AN%.PQAWL167[CU/]T=S3?:Y/<,&X^>L[7"BOX(9L<`?P M:UV?SO\P=UK;*^I/_P,``/__`P!02P,$%``&``@````A`'R]TT^/`P``N0P` M`!D```!X;"]W;W)K&ULE%?;;J,P$'U?:?\!\=Z` MN>2F)%53U-V5=J75:B_/#CB)5<`(NTW[]SOV$!I,2IH^A%"?.9PY,\:3Q>U+ MD3O/K)91BI89S47)ENXKD^[MZO.GQ4'4 MCW+/F'*`H91+=Z]4-?<\F>Y90>5(5*R$E:VH"ZK@MMYYLJH9S4Q0D7N![X^] M@O+2189Y_1$.L=WRE"4B?2I8J9"D9CE5H%_N>26/;$7Z$;J"UH]/U4TJB@HH M-CSGZM60NDZ1SK_M2E'330YYOY"(ID=N<].C+WA:"RFV:@1T'@KMYSSS9AXP MK189APRT[4[-MDOWCLP3$KC>:F$,^LO909Y\=^1>'+[4//O.2P9N0YUT!39" M/&KHMTS_"X*]7O2#J<#/VLG8EC[EZI$R10>*;V2S<94$!+Z(SG%0DBLO">H9QI`UKW M04$7<=]'$#*==4')&5#@3UN0!WFTR4"5KD]&!T'2KG.:C"5UC2`PJ`6%K03C MR?U%1#*$Z*0!6JY/0P[:=_2#UNOU MZZ">_MC2CZ`9N@NOK>[R_?!R@LMV;3K6C_O2+V]G'=23/NYJ6R,(C261+OZ; M>[@#3A'3*9G$5OV+I1M"[E@\O)[@\:+F>-ZPW MZ.5NUT$]Z5:KKA$TU.V(P*+,IO[,:JCD=)T0/SKIN([MLVX.P[9K<$^[]=I> M(VA(^Q'1W8BX27&M:;8!W02.*MO\R_UNHNP,8JN=UPUJ*(46#Q"7VQ_FQGX/Q?:A MVZ`&DT`BW*`D"$+[R-,CJG[4^2V,PR<.1!7=L1^TWO%2.CG;0A[^:`*OW!I' M3[Q1HC*#ST8H&!G-USW\1&`P%?DC`&^%4,<;/=RV/SI6_P$``/__`P!02P,$ M%``&``@````A`+H-J^48`P``/@H``!D```!X;"]W;W)K&ULG)9=;]HP%(;O)^T_1+YOOB`$$%`50K=*FS1-^[@VB4,LDCBR36G_ M_8YC(,3N5A@7.(8GK\][SDGLV?U+53K/A`O*ZCD*7!\YI$Y91NOM'/W\\7@W M1HZ0N,YPR6HR1Z]$H/O%QP^S`^,[41`B'5"HQ1P54C93SQ-I02HL7-:0&O[) M&:^PA"G?>J+A!&?M357IA;X_\BI,:Z05IOP:#9;G-"4)2_<5J:46X:3$$N(7 M!6W$2:U*KY&K,-_MF[N450U(;&A)Y6LKBIPJG3YM:\;QI@3?+\$0IR?M=F+) M5S3E3+!E>2%;]UE1PU-(JX5$%QJ-*\!\J@Z,*C)U*%/N#X(90AD<1 M&#N1FPV!]38M,'8JPS"*QU?$XNDR#@MM;(/L"^NIY`4L/9MXS=$-ZA)8V%/:)E4T$HSZ2O($$DTD?6K\!A8/@ M#'E@\>P3VN!ZGPJ&KD/.I<_A6;A-QE)#4-,S9&1B]2Z1O$NL_T7T#$*TUQM4 M\!R!]CEV*&1D&-10$$6ZTFX0^)>?+M%M/E8F'AIE3RP@[B^XMH"NX#VKD//K MK2K8LFJTVU)#G=71N!_:R@*,V!,3B(UF6%M`MT3/'#R$UYM3L&7."&VIH9.Y MT/6-PJPL8#BY_'2!MH5.3#PP.F%M`>/+OKE8OF=\=(MQ!5O&C4"7&NJ,#XR: MK"S`Z(O$!(;&2V!M`E&7VYZY^!9S"K;,=<^"?OUHJ#,W,JJPL@`C]L0$XB[V M=@DX(Z@XNB7&W1+:G#X"Z/VDP5OR%?,MK853DAQ>++X;0R=P?0#0$\F:=O_8 M,`G[=GM9P#F-P.;BNP#GC,G31!TQSB>_Q1\```#__P,`4$L#!!0`!@`(```` M(0!GI[1GI@(``$T'```9````>&PO=V]R:W-H965TGG..;1:WSW6%GKC20C89)D&$$6^8S$6SS?#/'P\W4XRTH4U.*]GP M#+]PC6^7[]\M]E(]ZI)S@\"AT1DNC6GG8:A9R6NJ`]GR!IX44M74P%1M0]TJ M3G,75%=A'$5I6%/18.\P5]=XR*(0C-]+MJMY8[R)XA4UP*]+T>JC6\VNL:NI M>MRU-TS6+5AL1"7,BS/%J&;SS]M&*KJI(.]G,J;LZ.TF9_:U8$IJ69@`[$(/ M>I[S+)R%X+1]VY1[J4^X]*Y%]$PZ'8 MT";;@(V4CU;Z.;=_07!X%OW@&O!-H9P7=%>9[W+_B8MM::#;"21D\YKG+_=< M,R@HV`1Q8IV8K```?E$M[,J`@M!G-^Y%;LH,C](@F40C`G*TX=H\"&N)$=MI M(^O?7D0.5MXD/IC`>#`A\9M-1@<3&%]-XFE"DO3_**%/RU7IGAJZ7"BY1[#R M`%RWU*YC,@=G6Y[Q7\L#=;$Q=S;(A8):0TN?EB1.HT7X!(U@!]'J@HA,9WW1 M^H(HCJ8G40B4)U2H7A?U<@>/B%8,O<*HBTA.QBZ/E1>-.Z)17['^EZ('!V^Z M'LZ*,PS>)[ADDO3?O/*:L:OND.KRLQX/)'4]CQ4/>=(!C]>0)'%$43!)2#3K M7GW]^DP_3N*N_-6_QPUK[WIN*QYR3_H<*Z\YTBW_2M56-!I5O(!5 M9_N'D?+GH9\8V;H]O9$&SC%W6\)GB\.&CP(0%U*:X\2>N*)?6>5JRFN[<3\K=;_N??]I>6?O*+Y1V#B34?.=>NJ[9>![/ M+K1*^80UM(9O3JRMT@X.V[/'FY:FN6Q4E9X_G09>E1:UBPF;]I$,=CH5&8U8 M]E;1NL.0EI9I!_WGEZ+A7VE5]DAVH.D_38O8`1"N]/2T\[] M3C8)F;O>?BL%_5/0*[_Y[/`+N_[2%OEO14W!-M1)5.#(V*M`?^3B7]#8&[5. M9`7^:)V@5&(F?@+D92Q$CH`?YVJ M$%,#C*0?\OU:Y-UEY\Z"R6(YG1'`G2/E75*(2-?)WGC'JG\1(GT4AOA]"+SW M(<2?^*L%601/I,SZE/EMRK-=@4[+\00W(;9Q>.A$*H[2+MUO6W9U8-["J'F3 MBJN`;"!0N)U!A>Z[!:FBS7?12#8%FL.$>-\3/_"WWCM4,>NA<`QIQ&%,0,Q, MC8GN0(&*Q'<0LIZJ4'(/(NL!\L#'(`6*_+P4T0CDN`]6(K(2L95(3(2B`L9SJ\(\+P2\8 MV'JFQ$0H&J"[MQH>NTQ$HY$.;?*&")ET(+%&'?&+-F$B\]>Q-3\Q$8H$6'AT M"8%UK1"-1A*6:C5#A+#B_N)NQ0\/,!$R,*!A`FJV8BN1F`A%!RR7N@[[TBD: M:3J(KZU5(4*&81RL1&0E8BN1((%E6:Y7LBY#Y1072]6%>9D0L.;`#U9#,*Z4 M")D<6(G(2L16(D$"'PI<8_@A)C+":&+,)U'%2'V78^+P%V:)D+?61/37DZN;P<[$MF1N$=P/R8> M.74-IHZH&J!J3V@0]&B!T,X>PH.XH(SSP8I$]I2X1_"R('?G@^D\*`*?^?&! MM$G/]/>T/160=/ZO+C!7Z9H?!4.IT` M?&*L^SH0ORD,O_7L_P,``/__`P!02P,$%``&``@````A`(1_T]#(`@``,0@` M`!D```!X;"]W;W)K&ULE%7;;N(P%'Q?:?_!\GMS MHPD7$:I"U-U*6VFUVLNS<1QB-8DCVY3V[_?8AC0!1"D/),9SAIDY1_;\[K6N MT`N3BHLFQ:$78,0:*G+>;%+\Y_?#S00CI4F3DTHT+,5O3.&[Q=\K6K*:*$^TK(&=0LB::%C*C:]:R4ANB^K*CX(@\6O"&^P8 M9O(:#E$4G+),T&W-&NU()*N(!OVJY*TZL-7T&KJ:R.=M>T-%W0+%FE=]PT0I)U!;Y?PUM"#]QV<4)?<[!@8D= M25:D^#Z<90GV%W.;SU_.=JKWCE0I=M\DSW_PAD'8T";3@+40SP;ZF)N?H-@_ MJ7ZP#?@I4.Y+E,\2KQX'(Q"@*,U4_J!&TJ,Z%9I4?]SH'!/Y4BB/0D\]R0A MO%Y9/-H7P[,K]J))',;))R3<[EG@V;%\),%W6=AH,Z+)8B[%#L&X@EO5$C/\ MX0P(3:8CZ,SY3"%,4W-OBFPIH!7,P:\7D_I@A\8]3W\_X'UO32@2"C#C3J)%C$ZD-$=@DQL`%: M^C8NM\.`4PS3-&)@7`H;^E`SL#HG+S5AXCL$F)@`PZ$OHW+^1OPB?SH2+X#35UVWM'N MZF@W'A9G1]O=[D!S,M1\7?2FZ$3[T6`O'^.YI:LF%/1&YXHU#%"ICJP!M#!-*=^6ZA16N/H+70<%;;UQ*N9@;G M4^`!N!!"'Q;F5NDN^\5_````__\#`%!+`P04``8`"````"$`WP&F7Y0#``!M M#0``&0```'AL+W=OU^_/'PZ>YZS".Z@*5M,9K]Q4S]_/F MSS]69]H^LA/&W`&%FJW=$^?-TO=9?L(58AYM<`U/#K2M$(?;]NBSIL6HD$%5 MZ4=!,/,K1&I7*2S;>S3HX4!RG-'\J<(U5R(M+A&'\;,3:=A5KE[X"Q^4-JN"@`.1=J?%A[7[)5SNPM#U-RN9H%\$GUGON\-.]/Q72XIOI,:0 M;:B3J,">TD>!?BW$OR#8'T0_R`K\TSH%/J"GDO]+SW]CK^,J73%.&.-JL M6GIV8.[!R%F#Q$P.EZ`L\C-]-S^0&!'S103)4*`9%/5Y$T;SZ@N:Q#F4WH9D.[6Y`83CO(!_\=J:A(*;I"4RMVY/B:EH$0?E=IV\Z MZ5X@,Y,J"$K501.=V(X2V2BQLQ&:41AMWZC=H(#7+FAW8X>JOF50&520S:`B M$CDMXD!<>@:R48F=C=#\P3CN]R?@@;^%/KA407,UJ8,97$:)MZ-$I@CX[!)I M3(*=C=`,PE+L&Q3+%/3I?%X-D_,5:D(FTL;H;F< M?<2E"!JX-/:75$&V&L^#J:+ MWF7LI9FB;8YMA.98-%*]\\6^`PEXX-18.ZF"5$EO[2_;,2!3@,V>C=#L+71[ M]ZU/$32P:50L59!ED-M1(E/$^ZG:]8&)W*O?M@G-9PC'8[^.]QF540.GQD:2 M7BB;U7$DNR#7%9`8&_ON_>>Z4=%']";LG495]Z&?G0MC6:70Z(K"6XV.(ME% M11VP41+%\5O-Y!DM&FKQ'D6$LTD,I>VV"^56-G'-I<^?4$/VLPM(.!!_"!4GZ]$0UY]T-I\Q\```#_ M_P,`4$L#!!0`!@`(````(0">G$KD*@,```@*```9````>&PO=V]R:W-H965T M@MB_NWLG!>F51<5$N7>('KL"H3.:^V M2_?/[^>[U'64IE5."U&QI?O.E'N_^OQI<1#R1>T8TPXP5&KI[K2NY[ZOLATK MJ?)$S2IXLA&RI!INY=97M60TMXO*P@^#8.J7E%Q+9OF25 M1A+)"JK!O]KQ6AW9RNP:NI+*EWU]EXFR!HHU+[A^MZ2N4V;S;]M*2+HN(.XW M$M'LR&UO1O0ESZ108J,]H//1Z#CFF3_S@6FUR#E$8-+N2+99N@]D_D@BUU\M M;(+^Z!C1534T/DCDPF\@FD)^/(X.0S)H'L\@N!;2"FD#7KK`W9>>M<0HC:"DR4LD#0T=("BU^E$`G_;YP,!T:.!RN0UX)!RVQ"B,(!1.X\GD M3+&36X0->"3<$:,P@F9-QJ=1$,UZGVEKFCVLT4G,%:NC]JB1]I=/E&[034-%R5G-QLY MF7.74V[1(_'1@,,)A^+A+`S)F?U&3L;;=1O.KAJ9Z"2:#."@PVD3!DF2=EMC MT'/DID%GT2/QTTG7H(YM%W89&DK?-.K@(!]W'>DF21,WHH[2H]3C68Y'74VW M[`>56UXIIV`;F-V!E\"HDGB2XXT6M3W2UD+#"6PO=_#&Q>"\"SP`;X30QQOS MKM"^PZW^`P``__\#`%!+`P04``8`"````"$`'C]-S)$'``#J*@``&0```'AL M+W=O9[G.Z(8J:UB`=G9^^U/8].&'NQ%;I+8ZV/Q]_"O--BO__VYG%._;<]WW&LU MK65RZ91]W;L'Y_I132\7K9=2.N4'UO5@G=VK74W_M?WT?V___O/ZY7J__)-M M!RFI7TZ<@N%6R67]_LB^6GW%O]A5'CJYWL0+\T?O(^C?/M@[WBR[GK)[+ M%;,7R[FF28:*ER2'>SPZ>[OA[C\O]C4@23S[;`58OW]R;C[-=MDG27>QO%^? MMY>]>[GA%._.V0G^WI.F4Y=]I?MQ=3WK_8S[_4?+6WN:^_Y!2']Q]I[KN\<@ M@]-EB5"QS^5L.8LSO;T>'-R#<-A3GGVLII%60A^@E6-_^;&_4_[) M_6I[SF'@7&T\VGB>PAEX=]U?(=H]A$WXXJQP=>L^`Q,O=;"/UN_#=O?XQ'%:3)Z(;3]H.6'.=&K_Z0?N94TH+F*HJ9@IDS$HQKEDSU?>4TK,!Z>_7A!-4WI0TJ?3,1XO7-1434MY!`K+XE):B^%6U0Z5N+$*]O(R*B MOJT$8O7M*$'UH<@+N/U[F0L+$$G,P"M$#SLPF;@EB!X>B5&L1A1W31;[^V%R M7(%^8/*0#DU.NUJC#=]WUMD[UT&B(1*FP29IBHBFE!>KWE.$5S'EAF^H\PT-OJ')-[3XAC9IB'<"[URX MKG:20-TD4"\)U$\"#:005SJ'2:!1$FB3RFFB.2Y(J(N M'B%=3>.2&=N$&=S6J4:@TOUY12\7M+S.+<-ZG#"+^)&*WWZQ MIPD2+9!H$R)_5\KE[RAB746LIXCU%;$!B9%1D_9X"!(CD!C'">G<3.*$=&ZF M<>(EKVFE'.?6&4-HN6*AR&T9YRQ1RNDE;HTL&")?*FH:5X67#&$4RV:>6XDK M0DCG=ZV(;12QK2*V4\004@4CSTB5HL@N\F#D%'DP,@D?9`H`?B7"["+4!2"D MV0)0+'.S7R,,[NZC2'`S5P>)!D@T0:(%$FU"F%+_*V)=1:RGB/5)3#$R`\75 M0T5LI(B-%;$)B2D43>-7XT>_@LY9>18'7@RS7"AP^[PY0YB&J7/K81$']#)^ M3\BR8FE'6N#)3)X1B`!H@T02)%DBT0:(# M$EV0Z%%",E%]&GNZH`8@,02)$4B,":&8LPF88PH2,Y"8@\2"$%&UPX\K1I&K MRTLPQPHDUB"Q`8DM)23SOJ.QI_..$(Q$3E/X",%60P^O270BIE$C^ M96E(\X4DSTUDC4!DJO%NJE3@7K'4":#H?P,DFB#1`HDV2'1`H@L2/4I(YJE/ M8T_7TP`DAB`Q`HDQ(9Y/V01,,06)&4C,06)!"MC3\ M4E)X+UDGA*+_#9#`AY9")8H<+9!H@T0')+H@T2,$&0^NUO;!JP<@,02)$4B, M":&8LPF88PH2,Y"8@\2"$-&CO%DL\B\TEV"*%4BL06(#$EM"2*=]!UZ-$(Q$ M1E-8`,%.0Y'5I#K#HX'/74;*"#GZ1PYP76SOPZ[;Y[.?VKN?X;&^(GYO^&C] M/G)HA"1_.U4^=[2.6G,N$1^`\O02Z1INX3..$BI@:I<`F1`ZF+N(''^FC2JL9Q MVC8J6/HCY3]!(W-F]:[=@3^K+44'^)SWOQ%+M]Q=CPU,-PN M.&+&%NEGB&D"&049PW:94D)RZ`!\:D7&I@9D)/YH_UZRM#FM=,DZKF,UDM`#E/C_PF#3#&15Z:RTJ$] MY(+"*+^OD6V[2_,=AB;IH`V'X',,>2*TG81\$0HG()&(>H*-*.OA;O2#"=8' M_S`V8__3\Z*WR6!FLU?=\!]`^VH)S>=B7[83D.0ZO$5L421Z2.QN"=\91`3/ MCNB9C;D#*TOMG35:Z?"2JU7;#H87M%G><"AH9\#+#*'`DB;!5B`@;@ALY>-814`/+\\#-83('GR1G@C-]FP':0 M:R/1WG8,O#B6&]A2Y\,QX?GN?"8!$0?@<\(=G^TJ0O`/1>5Y_PR6_/N6:&_# MF5GK7XIM%;%0$8OZV'V_*D+P"R7J>;\,EOU*P[GAS+1?12SDL6ZE^('ON-)* MB?K6]UVK",&U_RNN&2R[EJK1AC/3KA6Q4!&+^MA]ORI"\,M.;]*F]KC`L4:B M;]C#I*6WX9!BZ6T?$N%#(GI([%2$D(KY_TD%:W23"KG2<4A5ZP5BLM8+Q&2M M%XC)6B\0R/)<[[I&A50@V./&TT*]W[6TF(3;:M]!71*FJOE60*9VA%`@)@M^ M1RBFW4Z)B&E@1Z'1ZGB0!GYP&N_[WDW11QSBNYY<]57!4!6,NJ#2-G_S-"+: M9N>CYVWSTY1H^SJO^&D'<6BZ#*J"81=4E?^A_?UZJ$1$\^Q`]+QY?GP2SLCWN(\IUI"SNRNA^!T,OPZ MW$-?[?8F.03@&EC%1_Q'7!^SDFHY/D!3R_#AK%'SBR1_:$C57J/VI($+8/OU M!!=^#+<.RP#X0$C3/["KZO`OA/5/````__\#`%!+`P04``8`"````"$`[(L, M[+\$``"Z%0``&0```'AL+W=OZOJQLNTI/-$\JBUUH`6\.K,R3&KZ6 M1[NZE#39-XWRL^TZSLS.DZPP46%5CM%@AT.6TH"E;SDM:A0IZ3FI8?S5*;M4 M-[4\'2.7)^7KV^5;RO(+2+QDYZS^;$1-(T]7/X\%*Y.7,\S[@TR3]*;=?!G( MYUE:LHH=:@OD;!SH<,Y+>VF#TG:]SV`&W':CI(>-^8.L8N*9]G;=&/1O1J]5 M[[-1G=@U+K/][UE!P6U8)[X"+XR]DK=S_1>[ M_D:SXZF&Y?9@1GQBJ_UG0*L4'`49RVV&D;(S#`!^&WG&0P,<23Z:YS7;UZ>- M.9E9WMR9$,"-%UK54<8E32-]JVJ6_X<0X8/J1-Q6!)ZM"'$M=^$1;_8%E4FK M`L^;"K$6GC>=+>;CQS)M5:#%306&-7(BL[8Q/+O&%IDZ7YG&O-6`YUUCK!DV M+D^SVD%2)]MUR:X&I!`L0'5)>$*2%2CS99X^7698&M[F!V_4-`6Z@MA\WQ+7 MF:_M=PBHM(7\A]!"A'8/H:4(!0\@LG1$*'P$$4DI>@0MB:@4/X!<+PQ@3M;O[$):YH@8_0O`F]B>?`CPCL$%"X&/0EW$9"T@C[!.%]2$#4!QY* MQ$.B&Z?@$`QTO$,<'C@D!8F/$/&\QB/'DBW<(0"_.Y\EB6`@T8V]V05"S?M( M\SY^_E[P!G:COC=\AYK`<:9.-=YHX-%4G("/$`SCF04[+1$@`0<2;H/>8NE8 M4RFG0X06#>(N7"F:(VTO<5^`\#ZZF0A6P?'R=:MXHX%57M=!L]8^0BJKM$2` M!+J`^72?!D:40!!W(9T6D;:/N*\PFWBS^TH(1L%)]W6C>*.!43/)*(141FF) M``DT2IP$VM1_/WVT,6F[B/L2\EH(3O%ZOE:8D`"56Z#0DQF"-M)W%? M`H_`3D*PBL".W8^C<5XUK09F246=WU(JM_1(T"*WG1RV:6(MI9TZU.M$>B16 M(J)MO!8=G7X$*U>Q=G*E3=9O*:5=**1`@E;E:0KJ>XGT2*Q$1*=X-=IS:F2` M80TK.78_-/#P(T@I[-BU2)MM#RK20"\2ZI%(C\1*1/2,EZ=?]PR+6LDS*5-\ M@I32LWYU/(7#NMLZ&ML#O42H1R(]$BL1T3&83]\Q]7%(."UO7ZY49OLMI70* MA9XE6Z"7"/5(I$=B)2(ZQ4O67FQIG,("5XHIN5[G]T_@I]*I?J4\(_.I7!L$ M>I%0CT1ZA-_./1\M>H6W;W@?&ULG)=;;YLP%,??)^T[(-X;<`CDHB15*>HV:9.F:9=G!TQB%3#";M-^^QUS MR,6D==A>FE!^_O,_%WRU+63C/K)%<5"N7C'S7854J,EYM5^ZOGP\W,]>1 MBE89+43%5NXKD^[M^N.'Y5XTCW+'F')`H9(K=Z=4O?`\F>Y82>5(U*R".[EH M2JK@LMEZLFX8S=I%9>&-?3_R2LHK%Q46S1`-D><\98E(GTI6*11I6$$5^)<[ M7LN#6ID.D2MI\_A4WZ2BK$%BPPNN7EM1URG3Q9=M)1JZ*2#N%S*AZ4&[O;B0 M+WG:""ER-0(Y#XU>QCSWYAXHK9<9APATVIV&Y2OWCBP2$KC>>MDFZ#=G>WGV MW9$[L?_4\.PKKQAD&^JD*[`1XE&C7S+]+UCL7:Q^:"OPO7$REM.G0OT0^\^, M;W<*RAU"1#JP1?::,)E"1D%F-`ZU4BH*,`!_G9+KUH",T)?V<\\SM5NY030* MIWY``'#2>A22,_D$EZ%0FYRH# MK7@85INEA"JZ7C9B[T#K@7%94]W(9`'";Z<%\J'9.PVW2R!B";5\7A,23I?> M,Q0@[:#X$AJ;Q/TE02(32=Y`3L_QP/LQ`,CI\``T#!5TG?,`9N:S8X0@&4]:.7",XX.H0YSTV2,D"T,)*9M(:?S<6@* M).>W`S\XE<@(`!YP'H#=N(9-XY/YJ:YMD\7(V'PC,6M]WY!Q,.D9/RCH!O6/ M]PS7\.X.=ZUATS4AT4D8;2-DLXT$VHZB.3DZ:P62\]OOISLRC0_K%[VHW_91 M[_DQ0K8`KA*)C3#R/_V?,/2BBSKT-I<8(5L82&`=2!2$@=^K97+0L#20/A\, MWCF[6'MHQ>9]J'_>WMBC)#-/Q)= MWL,0$M\/X*!A"8#`YC@\\2UM=G[8GS5Q!]FL7T<2*V+T/M'#;7#OM+29_:#_ MZG8,IC8,2"^O]U?N)^_?-XWKJ3;<.,Y`3;8F,XN>I7P^K>&*.3R6F,XK;?2>`4GH3DE"!T MCR=;/+/5=,N^T6;+*^D4+(?I[X^F,#<:/-?BA1)U>T;;"`7GT?;K#GY_,#C` M^2.`68!JD2EM)J%YF_?SW>S$Q#2%REN&`5B=/BP/C MSR(G1!K`4(G(S*6LY[8MDIR46%BL)A5$,L9++&'(=[:H.<%IDU06MNLX@5UB M6IF:8YA&[[($CIFJ=O,1$)&`HTENLKIH05 M4``\C9*JG0&&X-?F]T!3F4>F%UA^Z'@(X,:6"/E(%:5I)'LA6?E7@]"12I.X M1Q(/JC_&76"TNQM:S&I1A+O%QP=C!@YT'AHL9J'Z,Y M$+?V:#&=8?_S"XQ2)`^*)3(#TP`K!/3X98E0$"SL%^A,<@2MSH"&B'6+4&U0 MO'$[<>(-W6'.IH6H30":.F'@>5_8^7ZW]2NPJK]=>*4G@+L3-%IW/46$WK"T M>`I!(T\V9R!AQS+0`WNGKT0PR$0B'7"U5)D0EN=AI`Z*QS4@O5H+#9GQYRG&%XW0^'P:C?<3^* M7.]VF+S187AV!9Q,',B#E^QZ>2II(N]N6,)*@V:-O!D*`W\87_?C_JV/1OKC M?OQ,_D;'+Y`(Y\#U$E722&(P,GFE,;J!,P>-]+T;C?M1Y(SW!EQ!:ODIM>Z= MOE[TP5D2OB-K4A3"2-A>71T>6-[-=K?:@ZN.D]'\"LWAE)O.QW`+-O-VEP"W M4(UWY#OF.UH)HR`9+.58(;2!ZWM,#R2KFV-\RR3&PO=V]R:W-H965T0"+0JI MFI#N5MJ55JN]/#M@@E7`R'::]N]WC`/ADB;=/J3!/G,\9\[@R>+^M;6XRD(F5"^7GS\M#EP\RXQ2A8"A ME"'.E*H"VY9Q1@LB+5[1$G92+@JBX%'L;%D)2I(ZJ,CMB>-X=D%8B0U#(#[" MP=.4Q33B\;Z@I3(D@N9$0?XR8Y5LV(KX(W0%$<_[ZB;F10446Y8S]5:38E3$ MP=.NY()L<]#]ZLY(W'#7#R/Z@L6"2YXJ"^ALD^A8\YU]9P/30O$54QE!0H+$F<\T4\QP2@$]4,-T9 M4!#R6O\_L$1E(9YZUMQWIB[`T99*]<@T)4;Q7BI>_#4@]TAE2"9'DBED?]R? M6)/;N3OW_H-E=F2!5"\`."SH/$945T'[L!$#?E,6+: M@KU7+RB4)GG0+"'V,()22/#X9>FZOK.P7\"9^`A:G0'U$>L&H6W0O%&S<.+U M)_V830/130":6F%0\ZZP\WXW^6NPSK\Y>&46@+L5-#AW/4;XTWYJT1CB>GW( MY@S$;R$]/=`[73W:J"F\#9=UZ2#`=62`+VY[0%WDE0%!=[5:!T+65Q'15<3F M$J(G%!(9"IV]^\(V!NJ@$$,U6PT@= RH#\NC]GGFO.Z9#AK)FPV:TX"@N*VQIQ3J]EU?140&87R'Z:O_^J?``-*IG#_%"#4# MQER=!14[NJ9Y+E',]WIX3*&`[6H[UQXF^D(9K*_<`.ZY\7H$<[!>M]L`F$,5 MV='O1.Q8*5%.4SC*L7RP19A)9AX4K^J+?,L53*#Z:P8_."C?S:[SD'?%A_?-^^/?YR]+UY&*%@G->,$V[CN3[M?M[[^MKUR\R#-C MR@&%0F[L@+N'+G(J8)+S3X\9C&+.3Q)6>%TB*"953!_N4Y+66CEL?WR.54O%S*+S'/2Y`XI%FJ MWBM1U\GCU;=3P04]9.#[C3S0N-&N+@;R>1H++OE134#.TQL=>G[T'CU0VJZ3 M%!Q@V!W!CAOWB:PB$KC>=ET%Z&?*KK+SVY%G?OU#I,GWM&`0;<@39N#`^0NB MWQ(<@LG>8/9SE8&_A9.P([UDZA]^_9.EI[."=,_`$1I;)>\ADS%$%&0FP0R5 M8I[!!N"ODZ=8&A`1^E;]OZ:).F_P?8=Q_L_!.#X!V:ZBW[GY( M+*;FUL(A0N8F$MU`%BUB^(':N=\/PE"IG>U#/GIK[S0$5=5Z[!G8CQ+A*!'9 M",,@;*1K$"MQ"H^[/7$X:>-"%%L/8/0C@E45[31D,SI*A)I85+4-KW#?;[-4 MK1'9%`R;\)!]WB9.&MA^R9TY#%W!@0=H&;YKJ`S=S"-'=?H>*DOLEEKXAV&K(5ZB@1:J(. MU*TXV?L(8SV M\&@+?-)WIF];G&G`YFR4B&R$X8S`:_/^S%5TQUO_F*CO6\S5A,W=.!)9$=,? MGOEW5R;1'4*;N_[I4-__]1.SKPFK/[V(!8FL*J8_[`KN]Z=["/,,7)+>^Q-Z M;*Q@?8`MY\-W^[XF+!;"<01[>5SGMHIVJ7MUW87F3)S8GF69=&)^P3Y\"L]8 M.]I^(SQ5GPB]\1U90&ULE)5+C]HP%(7WE?H?+.\G)D"`0831`*(=J96JJH^U<1QB$<>1 M;1[S[WMM0W@6,2Q(#,>?SSW7<48O.UFB#==&J"K%<=3"B%=,9:):IOCWK_G3 M`"-C:9714E4\Q>_4@O^32%J MH`&GO(7#=0^+VAR&=/02N!T@<==M)?_"`%1+*\BG-J*7C MD59;!#L/C)N:NGT<#X'LXNE!R+?C@5SB"\7T MGN+,)*QT:O)^BDZ<8F"?FNM>F`NB>^:"(DX2WXA6U&\(9]8`\;@U)[ZREC3@ MD%L0W;,6%$=KQUS/K$$;'[?FQ%?6+C;6)(CN60N*OL\,3F3W:"=Q.%I;D4@SI6RAX$[3INWW/@?````__\#`%!+`P04 M``8`"````"$`NA&G1`<#``#6"0``&0```'AL+W=OV6]I_ MOV,;*/D8'[T@I'G\YKSGM768W;^5A?-*A62\FB/L^LBA5<)35FWGZ/>OQ[L) MJ<2W2\^?YKMN'B6.:7*`85*SE&N5#WU/)GDM"32Y36MX$G& M14D4W(JM)VM!26H6E847^/[(*PFKD%68BFLT>):QA,8\>2EII:R(H`514+_, M62T/:F5RC5Q)Q/-+?9?PL@:)#2N8>C>BR"F3Z=.VXH)L"O#]AH+;3K.?(B#Y06LY2!`]UV1]!LCA[P=#U&WF)F^O.'T9T\^>[( MG.^^")9^8Q6%9D-,.H`-Y\\:?4KUOV"QUUG]:`+X(9R49N2E4#_Y[BMEVUQ! MVB$8TKZFZ7M,90(-!1DW"+52P@LH`#Z=DNF=`0TA;^:Z8ZG*YV@P@JSL[@'SZ.PLMU6L>]"*S%&@) MN^%U@?%D,O->(<-D#RU[H:@)K?J@R&]"<1^$6TKK/BC"1R4/_!Y-0X2WF]:+ MH#G(.3$=!<<7F,XL+03I'J%!DUA=).*+Q/HGH8[]H;-VI86 MPF%H#/HN;@6\Z@!-@?C"\_7_GS>Z+#2>2[PX\39#9X?)#1A[X5[+K_6B<+TM$=LM.`NRV M3VU\46-]CF@8'-]B4,,=@^.600N=,V@):U!/P*9`?%$`1K>NH_\5UIT=S79R MU&1+OQ.Q995T"IK!?O+=,60O[&"V-XK79D)LN(*!:K[F\/N)POCP78`SSM7A M1H_^XR^RQ3\```#__P,`4$L#!!0`!@`(````(0!+?!;;7@4``$T7```9```` M>&PO=V]R:W-H965T,(=A0.^U%TY3'P\SKF6'P^MM[<='> MLKK)JW*CDX6I:UF95H>\/&WT?_Z.GWQ=:]JD/"27JLPV^D?6Z-^VO_ZROE7U M2W/.LE8#"V6ST<]M>UT91I.>LR)I%M4U*^'*L:J+I(6O]ZFAA53]BHSH>\S0+J_2UR,H6C=39)6G!_^:<7YO>6I$^8JY(ZI?7 MZU-:%5''"*@LFMU=MSHW\DJ)H%N;->=0/_FV:T9_:TUY^KV6YT? M?N9E!FK#/M$=>*ZJ%XK^.-!_P6)CLCKN=N#/6CMDQ^3UTOY5W7[/\M.YA>UV M(2(:V.KP$69-"HJ"F87E4DMI=0$'X+=6Y#0U0)'DO?N\Y8?VO-'MY<+U3)L` MKCUG31OGU*2NI:]-6Q7_(428*31B,2/PR8P0:V'Y+G&77[!B,ROP>;?R55<< M9@2=,5`A;L-"Y,VV:[KZJ9!%8"&S36A-4568)CNE//I M3L$6T37?Z:)N*=`-I-?;EI#`7QMOD!,I@W93R.*)_90@2QX)IXAG\T@T1<"9 M@(?B&<@;$`.T&`2!=!$%L:$`YE.W%X0N@B35M;L@T'*&&W2J[1""7!@@(92] MD@B51*0D8AG!20'QC*602T#AC0ZVA^@(L5U!`H1D$B#A=4DE"!@J5T>2U?'X MFN6:\#,XQT4-WCT>-86542,DB[HG:"G=W>K2)NROW845TB;JB9G5,5[S.SUE M44/-/QXUA2=1"]6]0PCN/R2$X/<>">:;93JVT$)"I8E(92+F`+KI=WFY78?> M]WC\%%;&CQ"+CK]SM[%[%1"J@$@%Q`@X0C5Q@7M\X/0!8!%EPZ.K!`4LDPP% MA0T/(53`YBL.%5`!H0J(5$",@%0!.G6.'H'R-D=A/G!7?-CLD/D\K_<(2$HC M5)F(E"9B&<%E0,#'C\.:,@/H*EZ(Y:BV,`&002%(]\-GR!X!F1`],=/;HO[: MIQTFEA&".QI+N,B]3K8RG" M*T$GI9$2BES`N6HLP,P$1)!"!5Q__#S"GL@`J0)HXQ,%^HN27)`AO`)T:!HI M\&A9X*P%MQF>_4O3X9-^1Q!B2M@S2B`@5:)'9JNBOWCW0IA`8N;#_"UX)8"9 M*.$JNR2AR\0&(4[%#&)*N*XKO`7M&3#O9I2-;'P_HYL7@EZ$@U MR@E%5>``-DX%8DW[PGA,(Y85V+ZP57MZ?@!*HDB>-S,M*HF($5(=N-OP8QLO M`YVM1C+0TGC@S1DG,D$.(=8=&0]V3SY9VF3RR.`0QW$\7^BE(6]E#HEX9.FX MOC5Y<\8;B*$GIG='O+G6@`>B>+YV34[9'TE]RLM&NV1'Z`[F MPH/F4N-Q*'YIJVMWCO92`6?'&E=)AS>UB>?76J29+)16?CCT6CFETE>N9BPJH=DT.,Q M3TE$T^>25!Q#:E(D'/K/SOF%W=+*=$A'E)87B#CD1<[?9*CKE.GJ MZZFB=7(HP/LUF"3I+5N^Z<27>5I31H_<@S@?.]IU7OI+'Y*VZRP'`S'L3DV. M&_=+L(J#F>MOUW*`?N7DRN[^=MB97O^N\^Q;7A$8;:B3J,"!TB>!?LW$OZ"Q MWVG]*"OPHW8R"_XOO?Y#\M.90[FG8"3$5ME;1%@*(PHQWG@JDE):0`?@ MMU/F8FK`B"2O\O6:9_R\<<.9-YV/P@!PYT`8?\Q%I.NDSXS3\C="@8K"D+$* M":'WZO/QAT,F*@1>;R&!MYA.)[/%?'A7@)0^\'I+@=Z9/7P<$SG$4<*3[;JF M5P?F+5BS2R+N@F`%@6)L0ZA0_]C"H(HV7T0CV11H!A/B91N$0;#V7Z"*J8)V M/="LC>Q[D'D;B7H0J%L;BGNAL(%\<&V$8:ATX0F(FX5%(Q@8U[D7GC07D*.R M0PAJVT#O79#$WDI$5B(V$2U1Z*TN:J^L:+1QX1J-`U1VJHDB9!*U$I&5B)%8 MX/2:CL1/TX^6*'3DXZ*B44=4FY\[A$RB5B*R$C$2*!I*SS^(PC2]%S5/60%W M!+6[:X>02=!*1%8B1@(%Y[*2_86M:-2Q7#870$N$3)96(K(2,1)S:6FJHMAVW:THYEDJ8-UO M_#[]T0\ADY^5B*Q$C`3.TF4(ALTHM\JX_(B>@#MZ^D*)D$G/2D1(8.=A>RI_ MFO[+48Q-(2W#`-;_X164=,=16Z%WBC))VI%((7BG!?&#MK[&QHBVH]@R#)ZE M`6XPVLOB6+OZ3E'J02Z><^T*[!5@&(3(EA$;,]J*8J M3=Q1:-74-S?BC`@#<9NLH;9L[BV?1^ISHR!>HA]I"XI-PG!!W%)H@OKN!@[= M0A"7Y'`QOMMYJ/O1`D0JH;__JH:8T8^@(I[<\5AY24[D>U*?\HHY!3G",6+D MB;-MC>=V?,/I11X?#Y3#>5O^>8;O5PB<+4<>P$=*^>V-^&:@^<9F^S\```#_ M_P,`4$L#!!0`!@`(````(0`<4Z#![@(``!$)```9````>&PO=V]R:W-H965T MZ/L3KZ:\(>@PEY=XB*+@&;L7V5/-&HTF MDE54`[\J>:N.;G5VB5U-Y>-3>Y.)N@6++:^X?K6FQ*FS^9==(R3=5A#W2Q#3 M[.AM!P/[FF=2*%%H%^P\!!W&G'JI!TZK1Z"^28EWFIA\_.; ML[TZNW94*?:?),^_\H9!LJ%,I@!;(1Z-]$MN_H+)WF#V@RW`=^GDK*!/E?XA M]I\9WY4:JIU`0":N>?YZSU0&"04;-TR,4R8J`(!?I^:F,R`A],6>]SS7Y9)$ M$S>9^E$`,]0B>P@6@]%85^Q&2H"R$HG\@"QXX3<7<]I)D'%B'/&&?G= M`VPP:Q3%9Z*HK]B,*7J0\*1SR/>;[)A$(UX2\#Z'"_J/7J-H#`X509+8.OBN M/^LL>FS@<3F;$0_8WI1OC:(Q-E1,+5GLP_$^&O3;Y6A&/$![4[$UBL;04#&S M:+,DBDX.O:Q-KD$SX@%:W,6,[8:B,314_+^BTVO8C'C`=GK7D`U%8VRH2`^] M-HG].#T[)EVLO22:O?3J-<9,&@"?'H#`*,(J!DF4OGE]-GC__8!ZB&D?(!VK2+'=%0A+V?F-X_-;\5P*YG7,;8<%?#Y;JE._:-RAUOE%.Q`M8,WYU" M$TO586-LR M)&6S^^\[U)!<<4A34B]QG'D:OS<E\MV?RHO1;NH;^45(L>ZN10=O&U>E^VM*8M#?]'EO(Q7JX?EI:BN(69X M;*;DJ(_':E_R>O]V*:\=)FG*<]$!__94W5J5[;*?DNY2-)_?;A_V]>4&*5ZJ M<]5]ZY.&P67_^.OKM6Z*ES/H_AHEQ5[E[M]8Z2_5OJG;^M@M(-T2B=J:M\OM M$C(]/QTJ4"#*'C3E<1=^C!YYL@F7ST]]@?ZIRO=V\'O0GNKWGYOJ\%MU+:': ML$YB!5[J^K.`_GH0?X*+E];5G_H5^*,)#N6Q>#MW?];OOY35ZZF#Y5Z#(B'L M\?"-E^T>*@II%O%:9-K79R``/X-+)5H#*E)\[5_?JT-WVH7L8;%.5RP">/!2 MMMVG2J0,@_U;V]67?Q$4R528))9)X%4FB=:+)%ZGFSE9F,P"KRK+P_PLB3*+H"+.B*IA'\,_S#D!KYW-Q&1`^$F@.2:HA!%OI@.ED!WH60_'O9&-OJ MQ"@`0;"`&L1,1#Z*X#Z$01\^9DA?]`R#[>VON;C(E)'&5`5B-GT#I2S=K$F) MP%F+(G_9TA)NE+3Y3EGAA7,=>*&(S3.8P%F#(F#9TA!NO] M(4Y9G&Y)/^4(<8KB*C9*7)PG!A/2WR@"3(DGI%$0XV25>V)-N0-SD M)63"SHR$0TWNEQYM:2#%S22*UJZ?&;DOR'5PM&DB85\#WM.F>G^5Q9]N58ER M5T^J0/?T0+@WB]E'PLKF:T$#'#JM;5&1.XP0A4;[!HR'NK<#- MN%X4H\/C6>[;HRWJ]`0A45[J>%NJIQ'9Y=R;PA0`RS]LF6DV'(NK+"'D[BF3 MJ'LLA>P&V@PQX=RL9=$%.'L-7) M>S@6:&LAZ-"4*,F?LL<4SB#75X[S%O8VG3>:X7#V0-W)#6PFOCCK3=?UZ;+V MHQ#NS6+6_G\9;VP;KWV.DZ"[+>3S5+D5?!!3QBS;C5VV2V_()$C3)_Z6T[@U MD)1MNU;2)"_<;GH?H3<.^\@^,\3*0%UG!E^0Z^`X;>%VTVFC-YJT24VS6!FH MD[8GR/65H[3%]VC3:?=H<]JDC)X8),@Y3W)?D.O@..U9MLO0+8?5=IP8).IN MB],X;7$SKH>LT=P,.,PHMT";Y0;>]+C0YQS0KOTRBW-5#BQJ'<"_$7`-B MLQ.UV'9K6Q135NJH=JZ#KFJC07DAI@CBLR.-Y/!7ZXL&AB#\VBW:L-6*'.)R M`_$0K]B:F!R7"/=:F@)F.2RS'=8U?Q"%"C8KQNB];R[S(,*M0-FLN80F]UD& MRVR#= M3:<_[=E,HMQ5P_DS#N%>B*F!..^T^9/8#FS/'PER5CG705>5RB&=8T0%[_/&1Y_P<9Q+V;R6>7D^M\&^?A./-47POWC]5_W(U<>X M?VA*!^")IUOQ6OY>-*_5M0W.Y1$N72U2:/\&GYG"-UU]ZQ_V>:D[>-:I__4$ MS[:5\/3+:@'@8UUWZHUXMD8_+??\'P```/__`P!02P,$%``&``@````A`,5% M(`36`@``DP@``!D```!X;"]W;W)K&ULE)9=;YLP M%(;O)^T_6+XOX`3(AT*J)JA;I4V:IGU<.V""%<#(=IKVW^\8IQ"@ZI)3CO.0<[J_N7LD#/3"HNJ@@3Q\.(58E(>;6/\.]?CW=SC)2F54H+4;$(OS*% M[]>?/ZU.0AY4SIA&0*A4A'.MZZ7KJB1G)56.J%D%=S(A2ZKA4NY=54M&TR:H M+-R)YX5N27F%+6$IKV&(+.,)BT5R+%FE+42R@FK(7^6\5F^T,KD&5U)Y.-9W MB2AK0.QXP?5K`\6H3)9/^TI(NBO`]POQ:?+&;BY&^)(G4BB1:0=PKDUT['GA M+EP@K5F[$BR+,(/9!F'V%VOFOK\X>RD+LZ1RL7IB^3I-UXQ*#:TR31@ M)\3!2)]2\Q,$NZ/HQZ8!/R1*64:/A?XI3E\9W^<:NAV`(>-KF;[&3"504,`X MD\"0$E%``O"-2FXF`PI"7YKCB:8= M4=B7;,>2V8`2CR5DUE)<,-$Z@0[=[L0$@6.,+IWX[0,:NQLK@NJTHD&6V_\J MXH\4/1N0R^TV3%"$X1EMAM"08&##BD@0-!WSG,`C?<5VJ/`'B'@H(*'O77XZ M8,\3E.YV3R9HY&DP01LKZCR1<'&9S\CA2+\8M#(>*@*?](C==/BMJ+0Y:]N'=V-X%2^U<='9[Z8?]]#]^_8UXE/:\G]C&BMJTG7#@ M:SL2^-->H2=](.PTYJD=<.;YB\M/-QK6F=U7[&)7TSW[3N6>5PH5+(-J>,X, MBB/MKF(OM*B;16TG-.P&S6D.FS^#%0]>%HPR(?3;A=FWVK\3ZW\```#__P,` M4$L#!!0`!@`(````(0#OFA.3>`8```\G```9````>&PO=V]R:W-H965T&P2;U"=N'`N7G@WU\/=2/7[\?]M9[43=E=5S:;#2QK>*XKC;E M\65I__U7_&5N6TV;'S?YOCH62_M'T=A?GW[]Y?&CJE^;75&T%BDO;ZNS=O?B1OY0KNNJJ;;MB.3&HJ*W;5Z,%V-2 M>GK.X/^*8N/YNJYU>RJCZ0N-[^5QX+*D"_K4/)AP8YDG_O'C_*3;M;VNYTY,\F+B/<>BZ:-BZY MI&VMWYJV.OPK(":EA(@C13RJO7S?&3ESG_G3.U3H\[JJT.-9A8WFON]-Y[/A M=9E*E=E/%:K>P(;0K.BJ0(^R"HO[V[&0(O1X;H2^[-%;Z>YFZEY?YQ@MU18EN:&B^/S&/+1['[S2> MUA(*^B!GHD*K7HBI4-@+.2H4]4*N"L6]D*="20_DS&8JE$K(GW7-]YB[T(BL M1\9S_(O,F#K@T@LTD*Y[P>P^AZF7;.O*?6=Z$>ZZ*!`0S9L+I'FQ@D0(B0@2 M,2022*20R$R$8C2Y-MQH#B]MTKYXR#Q'Z^9`0":C(1%"(H)$#(D$$BDD,D', MQ9R?=#^7@:<8388,-YK#-T;/+\)B1`O(9#0D0DA$D(@AD0ABT9E$NZ/:CA26 MSSXKKQA,&]=P@SE\8["^8`N(/OPRW/4E`Q(A)")(Q)!(()%"(A.$6+Z982#3 MMC_<9P[K/KO:GA<(R.0S)$)(1)"((9$(0LSVJ>I1-R=3*)&9"&4\T[%JN,\< MOO%9.S8$`C+Y#(D0$A$D8D@DD$@%(=?=^6SFNMK&E;M9U/4TR01F-ATB(52*,Q!A))")<=;7@+<[B6"4S M(JKU/!X-'^LB3&EC7<^7_-MCZABCY0)AOB_#\T3KMQ"+1!B))?+S<[3LD&"- M%".9$5']YCGIRN^!0UVD*]5W3YMP`3-EL&[LK#`22D0>V*;NU5>9G4:D`JZG M3_P8?TB"D10CF1%1;>>IZ7[;1=;2;->&4,!,B4S:#I%0J@C;/9_/?'4]C52B M)Z7'N"8)1E*,9$9$-9ZGJ/N-%]E+,UZ/HTS)<'UA>241PU(48B3"2(R1!".I M1,0@F/L4_K5DF!E%5.=YK+K?>1'&-.>U6@3L.M2QR6+N:'%J)0FC\:;<)Y<: MB,3X@Q*,I&J#9I/I5#O`9481Q7A'2ZGFXV-'ZZ<83[,SD)3!SI5$Q!>=\[Z3 M0XA5(HS$&$DPDF(D,R*JY5I"!9;W)5-/RVF!`V/G2B+GR*%M#*'RMD__B!:= M(G^[T1=M08ON+1#C.B8823&2&1&U*VCIN'_9<7BIFUF@AU9)&6>!$!(KJ/BZ M7]M'0ZP2823&2(*1%".9$5&MORNW.GVYU=.6O4!28H@/&,,KIL11F*,)!A),<*O/'W>;N&^N-(D;KF<\I?B][Q^*8^-M2^V])_-R8C?^:G% MA2;QHJU.W6V6YZJEBTC=TQU=/"OHJLMD1/"VJMKS"WYEZG*5[>D_````__\# M`%!+`P04``8`"````"$`^V*E;90&``"G&P``$P```'AL+W1H96UE+W1H96UE M,2YX;6SL64]OVS84OP_8=R!T;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-)) M?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\ M_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ( M[]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\! MW8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6 M-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1 M+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P M]?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS) MBZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F> M"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8 M>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20 M$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3 M>H<] M,9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$45*&'=`X+&(_ MD%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G? MP9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW M"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8T MO;>$#6C\S210*:D M`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5- MX*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY M"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:+T5';:S76&A[R M<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]3 M1>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_ M((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/994FRE)")J(*X,K%B MC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL M,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q; MK:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$# M47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;, M9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TP MP:&PO^]P^<=DT/.D$.-%FB-9B5*O'/F MW/<,1=Y^^^RYVD]V&#F!OQI-+LCOWXR+Q8C+8HM?V>Y@6^O M1B]V-/KV[M>_NHWB%]?^^&3;L08B_&@U>HKCPXVN1]LGV[.BR^!@^_#)/@@] M*X:WX:,>'4+;VD7D),_5I^/QE>Y9CC]*)=QX6QXAGA5^/AXNMH%WL&)GX[A. M_)+(&FG>]N;=HQ^$UL8%J,\3P]KFLI,W%?&>LPV#*-C'ER!.#_9[9VM742[U MI0Z2[F[]HV=Z<:1M@Z,?KT;3XI"6?O)NMQI=C;1TRNM@!R!^]^]C$'_SF_2? MK_[PU5?C?WW]S3^^MW?__.'WU<]^^'JDY\,@F:"#9IF7XT:Q\'$J6<]F<'>[ M#WPTD6N@B;!U\]D/?O9-\AD8`TR/?.WN-OI%^\ERXYX":R$$]'>&TXVP(FGQ."P*# MFM.,',%S\F!*%CG8/"?KQYHY46/-V\?JPQ\U5C*+YGE)&ZMJ%Q4.^XQ5Z`J- M$SYN5B/3A!@R&8\)K5AA`PVV7(]AO),-=C4_VB,#SDR9 M5+8,:+ZY?GLR.N4/QII=%H9/Y0'$X>2RZ(#K-OCWM4G^3F$G)TYH4C768AV) M^Y7Q\9/CV9'VP?Y9^S[P+)^0BQ-;\FTJ+Q,='1EZJJ=->(@Z$Y`M.J&H_6=S4AW#D;M;:$-B._1->*-EKS^]'*`V]J%C(M/4T^^U M?/LQM%XFTZ1"Y#LA"EQG1U`\KI.*/-/:^NK!7#\DXR)DO"@80DUS?3V`T(?[ MY5H^TO5R*5OHU(0_R4+?S,F?9*$F_&\MC=,LV!BR0!;RM-@A'?3X\GJY7"XF M5XO%8FG,)H:1D+S)+-KQ=_:S39IJ:315$+^60Y->#_2;0?'H%L3NU]#!UIZ#P^D7_CX`#_W01Q#-M?=[<[QWH,?,N%EWI^ M1OYOPYFP00A[@:M1_.1L/\-@5%N?_;..7K5V15CU]HET$BX;9\XXM`O!LG,H5P#U8D6,O5QGI&H.M$TYPE@$[E) M<)XA8X[E?@#O'-$9?'-$)W#.$9W!.T=PG3KGRIG>(SA7B2\4W[J?D+UF?J)EIRQG5>;:<4#/+ MEC-XYTC;3:Y=2GBQ=$'"WSWMT10EI%F'@_ORX>AM[-!,KOU)ADB.DB7R\MU] M4J>4[]^XSJ/OVR!7865K`1MV$1R8"6%W($8`25"`@5XUE M'(!YJD``75N.``RT1`!P&JRBCQ],4#0#&RB'A/&'&A)B3#Y+:L@!9\D*OS!^ MPRQ-*OSVHAG%6S#TDF9XTP"@UY"L$*LJQ""U@Z>5%,";!@I,R+IR4MZ$%?.5 M$8*"+F`H&8$PT,2(/*M$,1?&+`$T,W(OL0Y!1D%"D6H(`$<)!*2(B:+\.\$8 M%&5@;`V*4C"&0.7@$_H$U@25(15A`#Q*O**L$R94QC@A#0B"J@B)K&&J*D1B M#*IB9*F*J:H0B2"HBI!8$ZI"),:@*D8B5:@*D0@",*(D0F)-J`J1&(.J&%FJ M8J8J1"((JB(DTL1LX!"IXV73=!$5K9].YHM."ZC:\[YU)77"ZII`\?GI:?N4 MMHZ@C*290KTT^:&>E2^>:D]!Z/P"72;YP=X65E/M<$1^X!D[6WSDY]`Z?+*? MH1=-]YV>]^S%7D"2+W"\MD8:(1-3.3ZLX8\TD<&E\],#2W\B6F>>=/6M*_.O M+(->W6ZUD%809)X9!NGT2S)/XC6J:2*+8*HQ0)94C@&;"\&3+3K#8:J(H&.% M"%5[AV'_ZX+8DS]HA8L707PLK+RS@I@,BZ=%,H MOL^6PX5"$@\9!KX`T<60F>Q9"#"6`A"I?')O.!!VN M3@7(JZ]/:2_L0&E?HQN:U"SFBGBM`*F]Z1-WD=<+=!)#NZ+T M,QL875_+&AB>N&6=//AJY+>E:0<"E[GI35E">FH7L7GI@V,C[Q)`F8#.IJY@ M(FPI?)C]!:9,V+1AT/Y=L(C%X!1"#0YW[Y)3^'5%,W2^36-VGPX"=8-#@#TG MXCIC&2!W]%'9D$UST95V)8OR/QGAITO$9@>$%D1*.L&A2Z>^#`X1%W""Z8N/ M,KFSR$44$0USK&Z[1<4\W?;)7!L78T.[3K5G*ZK\ M]!=B354^CI)#`RTLHFM>H0&V>3F]M-))];P-)]H28Q-:Q M>Q;P)0GK'SCT-]AO>J^>BOURT5T!*LXV5VO$:R/GQVYZSYQN[)+KFVD[$*=W M4)<\(=VMX>S_]LI_[4Y?=QJ@3^,,5H+)5AU0QJ5/K+JKI341]WNNL-J0%1CX MR14/=>FKF>BS@8\"%GE9US54*PCN$-H:H]#P5/':S)Z&4%TV:@ M`ZFY9[0"TC?)OG/V,W0ZH]+D[4NV,]#T23L[L8 MD.5=<)S3EW%1UDE-MW,UT.AD+=Y'/LA902UDG#51/8FOA]5&,5W8NDA-M`2%=GS1Y M%K.^Q=Q4/:EH@--[B%;69S%+Y'76$[U*"Q6G:D+*;89R6#Q!@.I@ M+KAD3,5M.;@;4+8V,("`$7R$L'5RGVK8;(/+=.\6L`(JQ]'QC'2,PTZ5MP*H M8+JAC+$M1-)>Q*UQ3&B;?JDNA`8W3"YLIE4([@!K:!A=AV1(L4G!.\]ZD>G= M;9;);8N84/X(S]BK(J$SZ^.8R.7%I1Y!GHE.#:_GY%7\1B"8YBEW:[$".K`* MY*H>-D'%!BK2#@46YX$B7PFR2@%MLUZ:UAXQ`B.O-5Z`E4<"-J]5N%_(NM2I M2?\2,EVK2:#DP#:)4[A:#X.ME%Q?AL$"JYMB0[[J=1W[_JX:'P8-+F2Z=OFL M)5%Z$:IBH^)&()#1,,M%DF`T-6=UK5"N!#R!6M<[2]2BA033=*A<\>69CA+X MO4U'*6I1TP&CR&LE=E\BZ^>>=6&RU4,10BIU#US2=[H``@,$W&7>J_@>G?8Z MAN3:B,;BBS+++VR[8!CZBHS68T5!6D&#?:-A1;$=ZHEML""1418PS!$.R_6. MGFV*,CSHMGM8Y1 M.!CTRA)?D^%R0Y<3J-6T#&W&RUKZH()E=7^59]6,FU^9E4,+;MH>AD7(1RWX M'IV_SXK:$V>OVF1*`M(^VYDF+[G*U'H6F4FUU<4AF"O'@`V*_V[P]4S0CL#D MI8X#/+D!/0>7?@IN\9P'S;<\>&;]=/Q;[4)[LR5"BP4S\H.+ MS=%Q8\E9/)(D_-*7$9<'-^45QP2B:+YG[.R;U1IT?2 MFB-<9,H\N+"L4H^DL"KG.(,IB\HJ]0B*P[)@RJ*R2CT"0B3+@$%$995Z!"U@ M66!NHK(*/1HT]W-.[J]J]4C;*GD8#`\N+*O4(VVK,TY;Q;)*/=*V2J8LBJO4 M(TC%W,,'HK)*/=)QPN",$WB.I1YI[N>(8Y(5\;# M42JEU!IMY3-.*T^EE/JB[=O@M.]42JDID(=F9,`'_#,J=#2CV34XV;VW=GG4 MI0V&Y!D>&&O+W1Y=BSR?/1=$BG8T(?+;3BY)3_;VL[:&9]<7@FA_(&F41]## M\\&U?"L.PA>-/-^H$$,_:L!+FN!H&R85 ME8B8PA=H>LC33D7$P-DI&MK^2.$M(@;.3L7009743SQBWOF'8Z$A.I:2U,TC MXKWC?[9WM.70#$\!)(^D#_8Q#JW"_FB7FG(2\R$(O5(&'2+&Y'D$KVO&#T%L MYR222AOY#NE`>(#_Y1@C&LE92`AYB`"/D$].[)9`*!$$%I>(`)XY5LSE543A ME/$W*_2)MU"N^\I&&3,J'^$&U?_N>5_4_0GOL;5Q[8_QBVNCX]K.WEM'-_Y4 M?+@:E:__;.^G($Y$K$;EZ_?.XU,,7@RZA7#S/HJ3?[5CZ*Q& M_WFXOUZ^?3"G%XOQ_>+"F-GSB^7\_NW%W%C?OWUK+L?3\?J_0)GG^M'-\\18 MC9[B^'"CZ]'VR?:LZ-)SMF$0!?OXK#?.UM;CPXA!)7HR;9CS]6GX_%2 M7^J>Y?CD(743XR9RX5MA-MD,_,?RV&J$WJ3PDR=E`'RX$WH^"3TB9'TD@]S] M#P``__\#`%!+`P04``8`"````"$``0#/%00`%````'AL+W-H87)E M9%-T&UL[)WK>_;\2^0P?"#H$1``62HJW["0@D)-@D@4-` MTOIL[(?&3`,8:3`SGIX!23^-GD5/MK]_9E5U]64`4$>6=\]1A"T)T]5UR5VO"MZ=U5]L7:U6BT\__+`>75779?UPOJAF/+F8 M+Z_+%7\N+S^L%\NJ'-=75;6ZGG[X>&_O3Q]>EY/95C&:KV>K+[:>/GK"..O9 MY._KZL!_>O31T[VM+S^O)U]^OOKRV7RTOJYFJX*)%,]GJ\GJ77$T\Q&8^.:?%"_GL]553=-Q->X^?5:-'A9/'NT4C_<>/>D^_*#[0QCM=74Y MJ5?+DCF\*J^K;JL/3E?5S:0L#N;+1?=9FOS9N\7`B[N/-KYP4BTG%D6BV+`^9U.5_VWS^]+J=J\+I:S)3 M,1V-BZ_*:3D;5<6I6*4NMK\]?5;\X4%W8=S!\^[KYYL%XN67I1UC7] M?]I[7-97W=_V1\:D=;&L1M7DICR?]HAZ6E7CNOO>R;):E.^T/;6Q[7QU!3E& MK0ETWSF;K]B4V]N\FL]VVRUZRSA9(H-+9$3B4OU]/5EH&MW!6-CZ>CTUNH\K M)'0T*5<#TC33Z60UJ?KLFU@5QAOBT^[S8K=@V^O)V$0" M7CEX?MP=EW>6:^A3O46MU]40#>WY9+:JZ*NWIOWQC22Z+BZ6\^O.O5?/3CU7PZKI;=*:`AL%"K"9)7S.8K^@KK8_XP83&_*,:3VJ2T]VJ@ MFNF@^[5_">)^=>=8,JA6DD0>ZS)J^*9=F M<6Z9@,]TENF$.QO?TB"S8OF&U!^8%H%QM\<5^S59/1C0.=5%A7(=^XM%N2K^ ML/<0(\)F+8N;[6!6]/^BOBKAEJ)8C>RJQCO4:Q MC2?EF\#HS]'KVISGX7-[<[9U_RBT3SNA]WQ%F*[T;"?L/MX M:-4*X9]NM/.GC4ZH(P?.UM?GV%%D/K!08J_,RDH=3.?U&A;KK@6S'/C4>M\Q M]H3?8#8Y(,:H=[[3X][[ON'\?=_6=\O`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`-_9N]/`H,1'XKG?D&TC;V.;,`'')J6J:E;NW_?;O/.D:@R@`^I"CI]L5L&,R8)G+A,Q`8 M+,L)]A!H-4@/W@:J:"05X8WW,5GCPGR@>U/[8KTBX,"`NN=3U,$?V]!!&#H( MQR';=>@=1->I<>B>$Q`RM3#U,Y2N3[_;\\ORQZJXG+,NVV=!EN8YCB6(&_RA MC-=O14X'V/K6]AE)`R\-+%BN\9`'>S8O]G,OMA>WAMXARL;.&PBR>"WU7[OJ M[!F'C1V\,DY'VP=.[U)[XXO-*\7Q!<"F`VA1Z]S>S3XHW/<.^]219<4;!Q)E MR'+V9@YH?P._XEMWN^J^2/O4EO^"5K,97KFD]OO)BO[@)/SA2M,,UNK;V01* M'<^*_?7EF@CA3Z8>>L&2UHZBH:>ZT)1?5)?XR(=X^AO',8.@T>XS[9-I.7(_ M<_]2X.2O.GF)G&496'9#LAYY7!4Y["A>*$X<58W;PIP.J_/E6O&':(`X$*\, M)96^(H80F`2),MXXK$I3&`-K\U:_QM`;F72CLLF,0]"G4?'(VQM6//+MS)V5 MU1FD0,CKH+]SK?&DR\%W:)E>^["\H.YRTP=GKJ<6?D4][-@.3J`;K+VV0<30 M3Z;%D[WAM.#SM]5R-,$,8Y0P#8;*OI$(5?$!KY.W*L<_(#6H)10N3MOCSB`O MRW=!H@97$B5*:9NI291"8P,M`Q88Q=?&UG[4$E\FI2P/$!XI5,27+;QEI-?5 M:$J.P8!WTP6(008Z1YCOG=1-Y@">`)V:'`8'<+^NY\H8L=BD3!*9,LGJ;G&2 MN+!;4&H2%=K0*@.Y`0`#J8&'6^LKXG*825G?*]+])Y%@J-NXW"X9-G+N)C^.U;4)*/0%J,) M$2BYS^78=&7BN)3$.EFC[\"EBOW+I;Q6U+0G<8/I<*?Y<3[O#4GW]Z6%N@3+ M\Y4Y+0;EJ;F,B+"V=T*C)-4DH\:>,X;/7!Q.+ M21_*=*>9O@+=OQ6?S'RQ'*KLK6U`2][:'G/2(/$I8C6@QOR*P^G\S4;$]6#_ M])OB\,7Q]Z?%X>OCE\7QR?/7^V='K[XN]@_.CKX[.CMZ?MJ#H?9-#SJNBX#C M$9/VH&#`\G46Q_/K#*MA(B$1*9>J:\7KZ$%T7]K(_[U8PG)#0Q*_ MHRAEUH9[(T--GGHDF;C4X/FQI#_G&198-H']^):$[,+$S/+@[O% MDXIN.+U'CZ1@L>\,C?):O2-?187,RF@IFS]8V6&C(7.4JS!9&_`>,$):9A3' MH4EV=Z2[L(N$W=ZRL'9-P'96*+.:/^C6"#0YP.[8)!%&JKSQ%$J"[)N^JQ6M" MA3/]I"G6Z[%Y%#OS<[N3R7%M'-#N8V%[-DS&JTQ[B'C]<5L,DY44M/R`4&K2 M4_1'M[WM_&?PV!`W=E?AAJ*.SG@7,9`CWK,EW3[2?-BRH+T=RI(+$@:0C\?C M;O_=KHY??[W_ZN@_,/+'KXK]5\^BR3]^==IM^DIQ\2-0\^/E93F+M5QRE8Y1 M5Y[*[;Z3P_S%-M.[KI93U7.NJB42D`-"*J=\.)S)&6A9;&_%3K8>$*;)"N&_ M4OMC3MN:6L>EI2RF)>X.&R.'V=PA_?&JNBG'98PM'INKNO?GAX)X?_XI]EM< M4(DJ;P5*AJRD*7$6#+Z&[XV$O:G.E42@43V_6!&^D"JY(NC4A,88JTNY[+@_ M(.,E/L^,.A#\]N7\!Z`9$JXIG[N:SZ>%#4;C:H:<*\#DC8S4'Q`6*<\YH6B7 M3-C5-R`K&#;19\P]++XGQ=,XNZ[N5=CA5J M"=<((<=.LT^4P:J\ME#$N8^R'0'MJ#>)K!,=?MLQ2T6<0%;2F\YX3\MOL\&6 M_[FETA]-7E`MRD;2EIJ-J:BCH2;PB8V;(>(:-O3W'7&(ZCY\GC-C0333 MB]6XMS;IP3",IST)ALCP^S39Q=W.+D8B%>L%VZ]9OO<4Q#=_6;/?CY\X[MZ; MU/LOX^XW$(Q(EB'!8$Z.?L0\!S#"D*B<4=\E5H)]7':^XL\).OZ[B:H$P,5P M33#'VUM??7>T]-4+!V0M7#*&'-._8T54",'%$I($^Y( M>J=KBV/C>X(M+F>6?:S>\K!6%=\BQJ%H77+!(WA$?(^D9,UKF2GJ!%*P%T,Y MN,N'[NV$5:1ZQN5^_$7AQ6A.12/5;`(B2OX6=$R`O#EW@WRU^*'8=NXG1A)A MGJ&YMA[L&+-%5E5EDT8H;N93(E3!CQ:X$PVYG+4RXA:WIUV`5O*25A*JTK,? M!5E[]R&:.-XG<6KYU?YC>`@'V&B,'738GH2V2;V53DN_OS)SL>A;'&499Y11?@`V@EI_R:'_+`XG5!7S:&) M:KZNF5N"3K1SVM4[IK2C.8D-#C(NV`$Y8)N8SND51:WE.9K5]]WIHUGP4[)K M[7>M-]>HF`P<'&QN$1--.TT0M5.<<5)#A7-+6Q9@C\H2E\0=_$C-'GJ!%3]Y MTBWD#$L*;,`8D5(Q#YS-0./C'&+.IL`I[%%O9_PXX\>ISF M%^?AZ56-K/8=Q?UH;^^/<:#A38W86,:L#^5+J;.-HX6N_I0F4_LLWD!$S+]8 MX4KE76C$JAXMYV^`[QRX\SE>35`@!JPA;_DRF454B122KW;C9B<+=0W6@HQA MTH-">9E^D#K)U8#Z757+Z\0YED7\6EG$YSZII!=VF/3J354%[G1^VBF^!OZ; M`3)>PCPE4.3E3O'BQ8DQ8U@6-13M!`T@W/-Y[^-%=VQO91!/"\F2:I;R`.D;] M]U$KMZLY1B-HLLGAY?WH=5%2(V;"*`UF#5KF^5QI:'8[`D%NVC(GD6=J>.![ MX9Y)QMSWD:R1:W^8,(P>U2@=S])FY7NU8Q(<@BRSA;E23>^%L@F1(@"W$BYK'U59 M3J9;FU>9^Y./>%U1JVZ[D0T!U?17#I+7(<7Z\=[3W4=[NT^?1LURN'_ZE8(O M05B:'J$'Y^J6>$P''+C#BW=EJ'CCC(4,0#98'$((JQ`IT:!6P]ZR]N(A+530 M*MY/A2\$AR0RF8QELX\$>E`H2AF1V)K`>2A)HA:+47*BVEHKOV>:I3;/O M""")*#K$Q[BJ*$%4K^^T7"NM9G?I7A%12PF;KWC6_DTQD=43DIR8XE35]E)< M-04;^(D8JDC=*`*1!&'Y^C,#'5OD>',U(;+1T@50+Q7,I&E?4>=)U"201)A1 MFF!(M'7DCGW1BK*7FG:)^EC2Y=Q@,6DEE)7$QL@!S"?5''V) M5_&Z6JS/IU3[\>#@"JR1QB>O#V33S.-^@S,T?;=+L,%,FV,/]R+-F4Z556\B M=3)HXIL*6.*,G8O/'GQX,`\A-`%(LH]=!Q6">F#U^.-(T(Q.[H:-BU[OMZ]E M9X"Z3J^=PAE:ZX;]D$38S+7[8.C=6W#<)38PF^XVUV[^FJR:!S@(*-LY"H=X=,!C!4UUO@11":7_[B:KR%) M.26Y[CML`]M9PD[ZQ0""N"4XS8XXP5X-^R$>)"L,"-K'43'U,%)C#G^LH;03^,62RS'H@D\"C4(SR",!R:# M7+,312H.Y\B5*PK3L`I"9@1L0:$OJJTO"K^P/T`=D90V7H`AM45*F_AB,7*#DA# MES\T$1Z6,.']"E//#4@-$DF!8P&J9/_R]Z&A[\L("/?F3_.\2SX/@=[W$2$9H6`1$ M"URLE\::<^S@I4,])3"]6.B=FJ91+.%Z M^R`VCY(W>4F>Q3GQ`[Y=<)K\[+T3QR4*AVTV)ZV+`SDV*60EBDNIV'C1P?'(&'!4@/1'X6 MBWGBM1Q%6G'(X[@U[.W`T8:D$32+CV2R4#4;[,_OJ:"-J2!3]V&C_M_)CR1% M_*]+2$D1DW4CS%\C);@GQ9.GAH@\*K8???KD*6?Y0@1-",DIF'J!DRPVER+E M7Y;%&H2.(ZY%(QRCYI"[8V.&EA$[T=L`&KY/YYELRWC:G[K98JU"-C2<9!:9 M;(K!&G.7,)S:?15#8?)RUDOE6K(0-I`@2G0VN;Z49G!:"Z@_;6<8@`_32;YY M)S'2UI6_*BP?T5.H+@)U)I6B.TQ3`#Y_A^5_A^5_A^6!*7]36/Y70.5-ODTI MAZ09(I_@.86B_QI0/MFT_S^!-X+4^Z%NK/,7XF&;AO@=#//KK:*;%N`I3-7O M8)@N#H3C?@?#VD7K'=14SNQ_`S`L>,:J-?8L<2:-G@ M&)O0M`?_G>&T+C1R^NW+E_NO_U8<'Q:G1U^_.CH\.MA_=<8!DX/C;U_969.3 MXQ='!YPTZ;[Y2@6HCRE`/57!#U@[%OTTNU8N2[>><,LDA9*]2MXS?/[L$'*( M`J)&!2CJ(IP*$FI.5OM)6K$*59H6WZGL@`"'J#!/0R_"P,95>MG*$[R=BB[M MU28MW&U.#I47F'N3'CY0X9U2DUDNM_7:0G5P=AE0N1140R:>?P+AZ,]SX#"` M50XZ3:Z!C)43360H8V,SBE2L=HJK1WJ@%0"@=I_GPII[KF5THN5+U'9.V]BT*: MS2R'S\F?6H4'S6`'V;Y3HSN: M0(M^%:YN.+%%G;CRP@;?G__!%A/V88X^0;(R(X:D%)A#Q,FNERK0MD7<;EF M&22;K7NQ5GO,<,A1>2FU3S60<$HX]RY4]CF)9TF.<.""4H]_M\:A%KKX6#,G MI1U&*DYW_Y>E#?>-.MB?*55U#,UUH)R%`XSV>E?4@\-$FE6V&.O[8CY?.>5S MODI$,9*,0AR3Y3(:<.=A\;,5E_R2[2?SP.U75^Q,K%?03!TC,LDMM@4N43@A MX\KB9\J\3&D-S&X%Z#`"Y^6GW';E*#P,HS)?$]WY@KNU0%AXKU$?.C>C&A!I M=@@-KJQ;K=)RU%ADBCI('.%D8T+&A()%AO^K-!SI$O M,L^9Z62IU!6DI;NU-'`[2);V'/)'%)FE;*BL$M4Z!\!@*>B&S=WXCIMME4ML MHQ4"-P_22MV++2%K;T8JE=/=C*8CX[5\^;%X?TE[Z"J!P7H\F78\VX*,4"B) MYB\I&E=AVR4F@&F1\B67&%<06ZI@+^4D=:P<05/K*1/FWE/6&_+5.NWL.?WH M!R5UY)K/N=`$_(K3$[D3HQ',U0G:KU[7\BXF=D^T><26Q(RM).M>\BF2;I_[ M_'$%5>`4=B#-'TEN=@->#8X?(S4(`R05"UN./5MOU[<:\J7B.+YS.2-2AB,' MFQT3O9HY9-*C,NK>J;[MR0,54+8E]KI?R?\ MH_Z'"A;Y),*CK0^__'Q$_9&9EFN^@6"_+`]A;F]R-KF&]51:])H<^4SM+THJ ML-^%'O3#A];IZLM/\U##ULNK)G1:9E3CEFB50M9YI('9QDHO-:E`+@Y%ID'`8)6 MV:<7MB>;Z3_%)38FD?2,Y^OS%38T>L`A+/MM=X#H)')@Y'QMBHYW\%Y)$=9!S)[7J.KCN]%UPY;7?L)7"2*\SL6V3WT%Z7>8VJ*'Z M,]-J(78H=)/"_)K,//]V80S\HZ()%QIX>S3E1."*Y<6N$7I.LK9$LN#`X]0S MF)K+CSBB%/3I7BD;,!=&XEN4[SP>>321;`@%HXPI9E?=B\LK`1<)3R@%X]5< M\:K;(FD4:P*C$AP4ZA7V*<1^@I6K35RVD]Q#.6'#?]UE?X^#_J>LU\KF*M;)SHX4]]W<&^K@?[LMSR8"(9J8/\H(4])I6S=LIHM%7FXI M&ZW8GIB)]T[77*!C[XIX2(H:?,PYX++7CM4 M,/PGMJ1O9-IBD)%NYM6;'/$)4`JET%FOM%WR=1^7\*@S#?B2#A>A82G\'P(; MW$692M0=G`L;.H<'9YLS:N((G4\XU\D76T<*PC?-=T$(Z5=-V0W"WL-[3J_% MT-*>NL?$\"$QLK2^[8D1I-:]S-7;4@E!FUP#E(7`4%K2S+;4+G='7NIX"TN6 M&S6A3A[?P&7OT\(\DAQ8LO+DW=QK8E]E+GPL-\^\CEE7_,D>)>[()(EW0F5@ MPS6-3Q;D[#-&EZ;,AW?GSX(/$1*/!52*O4HH9BHS#AY`$P@:EZC.Q.O#0LC" M6&+>J-9['6J4<&(D2J.&Z\RC/TIT--)PMIKN( M*$G3BU(<("PR21(J0!*^/F`OPEU$0/R#9FI%B6*&((^Y+DTG]'O$L#PR>Z!" M06E"7F-\#Z$]RC"?`N?0+?CVC::^=$!(]BD0(`('R?N+=AF)BA_%"3RA89+= MR'DMXTJ,KR[]).2RJ!T9EJKG9B-FJ9@0UN0W"Y.U,7-NW]7!3A:!3K9`0<'4 M)OV[4?U^9[Z$3%+C&)B?%S^WH*NI?1F_G2I^V82^#+V6FYY\[8Y3+%HT+"C] MQ*=.*BB#DDPS1R@%=DM1^#4^H!!JVLB=>7W;6Z^.7P`-VM&G7:B@XU1V[)8; M(U$Z9O/@0&1;%WZ'DW*-/D$EQFL`LV#,V5OJZYQIBK6H,R8 MJ^WS=/*C3AB9#M9ST,(((JKI31B=BA*\@="UAO<8;= MU]X>/3"(*'-_EZ7N;RR;;\%XL2K:57<#"-@2:C3N7H_!*M^@XB%+R4[YV2-I M7MVF;Z0`8I2G!3X"5WBA<7"CAST8TP*#`>KS%B#5D*KV6T!00`VAF4\X82;^ M6,+:B.R_1+"B,Y#Y,')$1+':ROOF&:I6<_*,#S:@3-.D=QKKQH4&J'+*&XW> M;8F$X:T>TD]0BZ/U/)S)C/%)G`M;F77KBK!02;-F]?W=C* MG<>8R%.OUQ@:0[W"ER8"!9HO,68*6%&SX[;9+%HQM+P#5'=W0_-). M='#D.HE;?:4=RF8>;6?_Y:D%\"`3#8X,V('\X*E$KX,](A:*9Z,7*0^OK5/R MNYF_6"?5-4L6=>Z,7%R/BONJ[U;VRO/;A&-D;)3'QENV3>CTW.O@)"5TI78. M4E((0]G>,4`O^YCJI_6":Z^_V%HPI@+LK2_/V*IH%ZT(P#P8+GD7:!=\MC,R M9Z/BXT=[14__3T`>_TE`YE9K/5N]H?\YP^J3LWTJB;QBZOL=L)?B2B$P*+Z? M]),07I&RY^$H[12<,G-10_(P2^:JGP"$QCMT]CFGUW^0`R\ZAU(1COOXB;K>"@AB-3B+&9$=>)&8F['XS25]-F*!BZSI#<< MO8N!I1>47S9E?:I1\#]G$91F!4P+G0"Y,A+K$4OK,$\X*N0#NHZ+$]9APFI) M//08/\J)&^8E)X[S4'.N\MD=@RLC#.HI1$>`%@LSLLZ4GWP$'2!LG`$O1]_4 MXFR!U]S.MGS'2$_PEQ/AY4O*OR2@!@.K5Q90XP(L=)3TMO'^)%XH6>5LMWF3 M#^/YF_Y3Y?C(??;Q8^.K-?NM:P!B]D.:'HSUUKT1"&9$M!/0-JE$W!M.EZ$_ MXS::]37ZDU>W8UR>G_!JD4)E"UE7D$5?2FPR6LZ:.^&.$+0QLU,\B.N,;E8U MC4<%%@X\M1O)@413JB>[N8@;I6QBYK>YA6JQO]9DZW;@F1"")6@E*R!S+HQH M[5\*:Q=S$C5!KL3,&$EV=EH+UJ!6P!FQ)&C%&N)9<]$ZLQ.,R,03!?W*D0#) M`%(1/8O\6)4="W>8>NLANO(?5O'.1W._ MFN^%E\L!9_;NCMS/OCG5[2_*8_=W[_'ZM0-7?S\4W:$MGO,[%VVI&J;GJNTS7=O^9"K._8L5[K.B:.+!M/QX'`&(G_7N=_BZ M\Y&%+H$//$Y+917!?H(KL("PO,;@$X?$KV0V%7?H]_`=!X^!(*=$19I6%`C> M>>S,?$KTJE7$^*6F9Q::-MUX@:D6:`?-O992M3Q.3$9Q#*9'/,^F,%NO%(O!JPBT$4K M8>0%1;%X,L,GC*WRJ?FM3IK@>TY-O-D4R,!9%AO>$9&7ZO)D MG"^6:'H=R_9PU.)SR4@V"JR601!P7*@ZS5)5//?RU,"6[>)(Q#D59*;20]W` M@_P1P_$O<+3F"[S]=89=,,P*`ZP/@#@N;_8)GP`X6LZ?P_1L9ZAD83;9.O)> MK+%E3.#2;&RN-ASD!L6#.=4:5N#./1S2T15NIEV]81*)DQ[OGYK,%ESU*"%K MP+B5;D.AD((=B$A49+1LON@72:;P)3F[^-#(F1<")5^I>=Q4"&5=-),#G+9: M/=R9#2M4G,MUPU3=G$,3P)+YFUZQS`N5(16]C[_]^YK<-%BRIQJA`"!#*\:' M@2QSXBT<^B";AC-H1>DI@92C&G@GP0XTNEF:NZ=-?%*]3TZ=,`WWFFT#W`$Q MG_;O/MTP3V/OUNR"3;(RR[#B6$`C(H6+):+#W':?BSEW*2UO#-MXSQ4\Z>J\ MS@H2S-.DB+/!`I])"&8&\2^7\_-PDS6;'O8&`I8]`C8*.`),K%+&5@E/]M5I M\,2#0S0A%;4-C['1QCC"<(W#/%`QNJJ M)AEQM%V$>S,!T8)2BDJ!3)YKL]XSM,_W@OU6Y+&>->3IK5GVI%D$%0=1BG5L M75D?52%4L3X,A;=VQ\OG3 MN[C8Y/[(O:.PX5T%HLX:1R!N**/DLG4A=RN$Q98!,KD0=:P.;HW(5Z MQ=Q7EU`B%(9!X538E*W`.[#)\98J>^K6EIE.:]$^T\M1XAMS.KAQ"1K-BDPU MA>`P$@C=10&=*M%5?H1,<".F"%P/[E0%DKZ"(?'EUE,4CU^%`Y-#05/#)D`[:Y$$@>[LW]<_JD=E?XS.IO(\"@ACN:`:Q;9IJ12[5P7 MQAR"=!ZY.1@Q%V1\X+NULS2U4ZR$8[L M.-H%>^D3%JHBVPWZ_T.5S^TND2T*>4).BK7PHI"=SUCE14F"W,3+W?I=YI0^ MC8"`W-BWK>4HR9P`^Y"E4@6%J?[L`B/$$4W:[!X1"Q(6#=!GW:/#$?84[1, M)&-6`P(]`B(EL%#F$S,9!1P:MI*+/**7-UR`K7^SUE2`'X("_Q1L8.79)>V; MY*@KH'"#P7E%1*B@D7XB;Z/8]=]B:".@1,FOPPJ?8218(+\_Z'T=RA7^KA_+ M[3>YJA<3=\C%Y"\]`X@RQ5P6KU.V_BNEQ+H.4)30PQ0AYEWMH@224'X?A#)O MH&5D3>(C8_N#AN7#=S6[@Y\UVE->>IW^/OF<6WF>,`Y#?[LOZ;.?H&)]2N14H?9B+5 M@!.5C=@K4(_:(@E_'[=XX@F@IWN[GT1AO"=L`:,E4VM*^3WGPN:C_W2)^VPW M'&S`U:<*NZD5-OT@F(,OV'"9GVH?Q2ON\?*KMQ>D11MW! M7N&$*FC3SJN/III0YE/"8EH%+P=K%@-&*G\!!'K\;RG*,>4]]#>T>,O%:9![ MRH#FE';:HU,F%'0"S`HI%BILU#DJ)DL@.IE9/6.VX61P]8[5."9GOR&`]S<` M`!\3C*8**=>+QRT;].+Y9:R5>0AT,/B*R"GL3Z`JEJ+F>(-Y9X-LM?*(@08 M%(,.=(#@XK)2AAS>0*1)")/MZLG"F?G'7I-XERZ5M_*,??)OTX;K,+6I]_?X MFW2V;:\2PP@(WVPRR2$U+A%N]N4`[\FBLZ#D@ MD&+1HZ;$FVUYH1+[%Q#(CI!2SM,U3)`E;K(G]?L2\Z>(=C]Z7[1;_*<%]0KG M6WE--'2O043`PNZ+O;`AX0RB2@L7"@/1W[$$V3`@` M!1(+V6VYIKC:[PPI.Y=Y2><9>AN<;X=>U/],$--+J0!QD+">0&9!*OMT%>J? M;F.M1$4-+*8*V@2-F8\?/Y=MZ6DM)P+6W!_#>=>9 MC,Q<6&LKU)/3=9!5BV20YX'39H M.P,TZ&?2_;_!`1E`MSYA96&R2:`LVLST7_APS&U:*WH"+B?N]1KS_WY6QKE: M\MHSQ&8V\,C,@%:77K:$P/Y^5@9J_=<\*].&:E5B"W\D9,>0?=BD0:>PRS'H ML^`,&ZR[Z[$DR7"@CTK*D!0`X&Z:Y<"B@B7+T**'[=QQR"*:UX;=X-PQN"0G M[US=8O'0O\U;TG*K=]2,XJ%RS[H=AU*4@*M'-D`)/#\T9=WI."Z\C2J,H0F# M8[ESLR_CEK"LUNKTK6J>XC0).R8]2$QA#O(Q]D-9IY&.&S?@/#U'C!4%*?D33_0OD[93`%T*F$E]-15C.N%(U. MG,Y4`;P.3XC@)>\NOL9$X6KX2H+OX6`&<5:3_A)Y:D! M/K5LHGP.YL MN[..C]X9'&JX?;<)HI5\^PCVA0ZI!C2[2?X$/Y$M!&Q4F[ES( M<_G.8G5/*1A?'=@=;?KDURIF8X,C=C%94OYKG(.+;7_H"K3MK<.CPV-*71SF M;@4!F!Y$0G!DG*'YYB+>6&5,U/5+UB[\Q(M`_]91MR!1RH>G0_6D@WH8?YA."=$3(K&P_RF1!#HJ#!3 M>8+1W@[2.;Z#,= MJVV4%`YU3)`OH)M"S7[ZKN&GXXR&IAV)>O.+"=IV)&BUB.0%0#E"9IZ?9=N: M;8W^FA@OT^JNWT1'3WP&[:L)X-A&,V#']!K0$"[V(C-T7^(;;:K=H\!O)GU0 M3J<9D\*005"A,-7=,QF+Q-X7W+JB"[G@(3"CK)#^)(%G'WEQT^DGOP!"=2PS MFRF1W(US2$DOK#;G`@6[+.<7V,0 MP_D0U`MQF!2?M&]@E@'T,(,;Q\9*$G<1R0XB(WSYX1*IZ1$*V$SF@-YAO@%J M:?8EE\TDW):UY7J_D!ZP^L=A[$7YSIZ"1,4U0VU05JT[X!3P2^K^D^.>Y'B$ M;(LA#%U"M%I)SSL.05BI<#Y^T4\:Q33$H.*23R.0576G0Z'NJJ"+I&YM M/\46X>,F^JRS=?*2C`K.3,JLJ:H`#6RPAYMA@9 M^S&(*ZDY43\PS2^EHXOLN;3R6`^@BDS(FD?A$(+9@MG MKX`48N;(7@7_4ZY+,["#R\8#]MEXW@EZ*BDH4^O-#O6X_HA*V=FE?=-JW_RO MPCW6,UUKH6_CZH:F+C.>L:0#]Z4V(7UDAI[L[3ZFKE6T$0WNB8T;C-9,*L:= M]"!I8U+2JYJ4,=BWZ?OMH;3`N-G+?N(,R7^1-XQEC0;SA8^=:SN,0/!2I,+F M`=EYHKD68V),H'Z$J88X2359@0`PHC2=F"H,@KB$U%JO8/%Y*$<9%]_6E6X> M>3&!*;?_)D[LU_KWHNO*4&->HFH[[V.:[^WBO1=$X7/2[2G@W^_IBX(_`KY\5 MYSQ&*7MQC>3!C;3,GQ\0BU$6*D^F`"P[J\9)A4I!(MC=DM).G!/1)-WF'`;- ML]EV?#T[&FSPY7=6(7'LST[UP4U?*>^G12/F=AH0/C*D+.@KJ3!F'U1ZF&G0 MY>%'7Y-8TA;,\;@1B^>8OP0S&MAP98.VAV-TT_F[2C%NK(-3>D?F1;H1'7PQ ML=."#EI[/RFY[R&[&1GF!8CM\#+;S'ATJD]X,D@3V5/G\U`.KPK'L2!^2$M- M1,JT7TH8-N_T'E_PV!W1R`<6\J5:J]@1X^IR(\;!N5))HYJ'XU]SW:&(#X7^ M:SMH9)`IO=`!64TIGP61"O8(@86XZ"K#@=>(TC1J:)-;7 MZT%6A*'OUV"B5@4YH8V14E M_>U8,$F"C9J.X+W8274%(\0EP%$B6+PBZ6'Q#6@6*)579N,`X>(:13-5[7MM MD4XZN!3[AG6-*X-'VL*!)&'SZW.K!A^D&<9^9L>*+1(*WI:2/@U='8K(R=DB M]*K#DF$H#ZI<)T=S!*WR ME1'X2UN?)ZEM4P:A5AY.RF>]&LM3;4 MOGX;VJM@27@ZYJ@HEXRDM:.]/5TS._CL`%5@^(JH MO#A`5-)"P,+MD_4:IBF/E'J%I6SLK=!+6$_LDR;05_5^(A"0C?E$ MX58M_10G@LSXE>6/G1_;!81%R0>YE5_R5XL]8>,_#K$L. M'$S7,#`>E"W3PZI$U(-I.;GF.X[VFU1_&#*A@UAWP M[".^W2`+V;SD'U04H@_@?VX<12"C1)=Z6,WU3P?N8J_SF3UQ[D,K:<'ZA:_S MZE^3YG.2^O/GGU)*6G\83&:_\O>N>[F<5SI^E8((<&6L$5%I$1)CC,&%!TR M&O@@6/3X]\>#9(XIDN#!EG(UC'#$8LHI*1)+: M9T)$%>$7;WV4G_=E@B;[PDJ*R2L@C6NL%V[\]_>^,&.@SV'SDO/=]RI,J$>5 M4E%;-BX*@*JOFW"4N?35]KFD26N6>(J_*BB=G'C6:$K@W%-)FLU_\2N`34@K MC&Q3'`)HHK*>EZB-F3A4MX^E:7*FQ)3^61-^!/-MX#'L"?F!U&M0G>%I?:6L MO6[3PLB#<^XM*Y?2'",*@]BX[@*[VO*.[?]AZ@.AY^)!J(/HXRJH4_J^Y MTZ70C^8C<.R54.NS/QB?=&DHJ0Q>EMXH5/"_M=6PD73&H2HL.KX&9J?0C(S(\VK M2CW$JC)/@G((95J3X\R[[M;Z_=+=EPQC#?J3A]6D1IX.;M\:PV"IDX6 M1[)=;,YD?;_KX6B&O]Q/"RG:.3HM3[6"S:.Y1G_$YAXII7MT^>BJQ M2I`A/[LGU7FLU>+=:[)@`F\T[!)+&=ZVQ)F^T2L!;;S5K>[LB^KU@H`Q(+9# M5OR5'%-KQ_7CBH_D/X0;9<.&B)G)7`$E]`=6'WQJ5_4RCOPR*>C]98PWS)IS MM6W7J2A)CXML?PWG+'MAD"V5049/(-\HW;#!C77GZ%G+@"L(%)AJ#^I=%1+O M2;H(W,XYIH$O+W1X,DC(Z!H0;8Y"`5=<1B'@L,993^1^95D@*FW1/Z:`W5>H M_WH2HK$)SW@^=HI"\U46;:`Y)*-2(@([BJ'(P1M_$8ZGHV"S6^/[>&XHY"#C[OW0 M4"%9!/'N//U+*;1D34SK5`2M1L1E=+_%4:+H^$P&-+$`.>O M14=1%N_#.#?`AU3[@]>@D`VSJ>3X\2`!KUVZ]R*RLUKJQ:D&D3`@0&*\.V-: MSP8\RUWILT(0B!;,\_4R5+J%`WBC03$1@1U\.G'0[6?$=;VLD""`83&4DL;K)+6D(EO>J:T#T!+K; MB/.:UP,`,LXV_^D^:%5*VT<4WMI$L/*Z47^FUCZ\8M&&S0SW5X_+8. M03=%B[@/I9*R+9UHKJS(/20KHBR\VR<1U,'#=+)$'K91./DP'BZ1J!9\T/+* M#I+U"\X@7@B[GO]\O$X6ZR2F(BATRW?*/FDFJ%XVH:NRXD3YL&TD<(ME_Z(/:U_W. M2CND1!`XF#%W>.TZ]LZL2DINJYK).,V7_4P&S@<@LKI59RVIZ:BR?C$'NR8, MF9KOQL7HJJI`U8KY01HN%'$@K8NNZD9`Z#?(PIDA$-2_OK6(V.81%8FG.JBS M4>HN4N"/XX,A>WPVB(N0/9F)!;I1SZ&/E'3&:J`8Z5Q7\DXDE[6KEDQ)9ESH MYUF[0E:WUV/H*>J0!=_%IQ=K?SU<[/ZX_FI7=UV=&[4R$0/%A!JC*SW-S1;=1UR#N/#R.A'W!TJW%1Q9O8D\ZCSQCP,+_@"SU!` M6:.M6X7+HR=:O<'X'/.?$CD;TA0:4$*U1L^?U#5=:Q18L\VZ M&:OMU"04:4(2A^^I$G2T0J[&Z4D.[')1GK`1`ZXRNQQ2N$N/\KI(FA9C,'M59_LRD+M?M?`/^]3J2FF^.Z'C0D"Z8^TSAJJOMM/A=4S,8EVPH)@% MYE_<5U?EQLER69^!A>,Q>P%UCI9;CW(=[UO5N'9RZ*O[)_OW@FZ>MF1 MC'?%N47=1&93_'1`J+/'675=+O`<*$M7U.FF@\`U*]/H+7EIS6@/"4GX1E?S M"@VR8>J-H6Z[JW'IJ#E9`$F7'R4@U>)#PW.FV+&D1O@N]:L"MO:NUWW<2_$F MV1>PJO(/[=FA$+!XJG:/U8V#$KPO+<_I!D-2=&2M$S&0634S46E_I;N8RC8E MH)X,0N-YL-*R@?Q]DE6S&:I[0:%'$A+82.G)G,54)Q7A`@6@&1*IG$_VS2&< MMS`A\0Q1T&P%K@SVG/FQ_);.[!"`_[%B#[M*Z>Z?*@)*4;XP^\:=7%KL@-+E M(*[J@XEZ,"Q)K"89QS>?^#'[YT\1_YK;B:9K8.MD+48-;6?Z1,[`"^8&D?LZ`3]:SNXAR+R4.L,^<]N;V&$IJQ>@2UZFLM3 M9'H-6G1W3%#SIT[9JF./LRYL!8[9W=_'G%753H0QP/TER(I80Q0E-#HNPI!] M4URM-3ZXGTR"BT_T_'C9:^]MPCP=94BBPD#AE.PBAY9Y9YOO)]Y`N(;5:#A6 MEJ?>I]R36L_$SA53(QPJ`A#+?@I8'_9Q9ZTF)_-K*OFMLF5MQ"QYA?0"YXV- M>&ZPG0>W;BA-LO8,_Z0:/[1@!F!1&YG^2JC7J75/8LASAPZ.CS"DL!AYS>5) MH;1<.I?U;=48$KK9JDLB!GXX%$;]BV:RU%>O8N;%QZ2UG>]K7Q,!<+!#Q^W8JB5.,0./ MIZ4A8T$Y'BW0#1YH=,)A+XX<@?*-X@1\#BCPL4@=`]Q'27K6\L%%!9)RWL-T M(6>A$3%(/28:V?DFS8$Q/]WC_.>AF!K#)IZ:6V[,:\#A8)]:@.,+57U*1[A3 M)\0N!)!_X"6R*D<3)DN1%*`VHD"$+U5((E>C%2/U@77")J[2!1P>_Q+P6F!I MH`.DYXRJEC/#M(R+T\HF&@N)P7>36!HF?"&X)%(BAG$YGP65!7=VQU\Z+59(L[C'9QS(T6KOB%JL!A0Q(P([G#_* MR-ZS"M+58S]!$7\:/ M$5&VC?O0M$"=#[%3X,T*R9D)15\J!=\V8Y;DI_&()HNR8:"&SM@6A/?<,`O6 M1&(NHN0>(;+.6!/>85U>(3_8R!W^.K=!>5=?M8&APSB>G;B7JWH*78O45SD. MDT)MB(,;6>*B/_^,\R/`0-T9E(WBY`8LNK7D#)9=4-;V!PD1C%A=5&V#-467 M+8),FLEZUM73FI%%02H456NG*P*\6M:H%01)=O]R]_.O^BOX;]:\6ET9L,Y22@^6:-?B;$T=GY\G/;`PLW M-8YA.:YS>$`?0Q'XM96Y3NLH>;>;5OBN@(!D=EVNX@+TI9M.4M"(UJ<9/T-E M%`L7T3ADK@\/YKL,!4(767H/:EH7V4`X]@)CK.;9_\EW+;26H3GL'XL%L*:S MO?J@W"PEKQLIB1@B**#=(+^CS*E`FYM-^V785@%GYN:9.VNKMB:"C1`MBDG1 MWLOP<+7M+4YUO3L0;[,D19T1&MK%A%^99N6I2[\>0NU"^B[Z9'+8)#L7<9RI MZDY`DJ;C(44(H@Q`?E8^"T`;HT`Q*D*1'TCV98D3"G=XSAX4-E'0WVI]JCN_ M)7+Q1@FNZ=4VVY=RS0/J@BCMH8'YVFPC1+F'A._+SK@4\R"#C,>@Z_5[L`PFN3AADI7!:D/X"0. M)ZJJZ1[=E$.L7IB-1])BKR&/7I6DAU]C4H6X4362L`H]M[%DKZ-#R^OFZ%W$ M*/'!=@_%R-*P4IA1V*^T4=O",``UH7N6Q$_47'F9&,XL3?04^+"U!CF&6,,E MQ:)RUS;.5:B)!N_[/QO7;*,W;7S_PP$QX*JECSB`P5F@7-I=(@F1`Z>VZ"8[ M3.I,"[YU+-=TI>G]7N14S[ M7+%\V$'Y/:11%S96$U^1^!65WTW8&&<$)>."_#+RGS?]_CBJ"H17GCC:\^W0 M7Q_?6=O\M%*1:AV0/,8.@R*$G4^'G@>//BU^ M5B+D<3<]_U/AY8M;MB-D[C0BF5FW90B',"K)[EG'2.T@V[C[[ MY8+M&>K'%>TO5'9QMK:]X&;SY\=$RM;\&]R&.VMW'S*%(G0E.-!_7O+_/N:5 MP4OZ!JKKP/J1B>X3B\FH45Y!.2:+)9Y+JD+%O9?!$&(C#"&8KUFYCCM4K=J% MD\)R&=+@%9]FF'DEY7=-#K+`\).XVA(6EN!:'G7SRI?J9$NEGFZ.!\]G.)F( MKZ@^HK$EEF+CL?XAT5E]@+W)\JY'VI'T%,X!>Z?YM7%,E\\<^8<5_97_P7*Q M9CK+&8KU9V('X5!J4GC;0_MN_*U@YP]G<+;[=BO#B"CO+UHZPM<=;!43LH!- M9*]0B;.BVBUGZU$/H&.W]G+A_IL=E6I)]3S+B1#4H\?TP[%1'-=Y%MCD1Y!3 M#)JSR^TT9E1)R+5O'T'.1\Y#F*S7C_U5'//Z9@,QC]M[9RJW2+6.2X'_<)TF M2B>QV'F\IL;,.MI^1M77-87E;PZ%+?V+"/:Z8H8'27M*ZZT]W'@D8_[>-9-2 M=.5<#)=]=T*[EEM_<#W?`)<2CWET_@;2*;.+,P3H](O>ZF%1PS1^`]Y`'N MIV,`51W(E;DQL#RE6Q8!FY(]VP1V#Y0W=$=? M1,DXL_;I5R(^`6-AL<85G[:TND6(*+Z5TRR:H'@4+OE)<47FKC);7[]YR]`L MN&WOXBVUNR]??D5[M$[U\_[^CS*;E9IDG";_C%!(WK!G2S%C_D,Z84?U2Y!D M5SP&>`G@:$.Y[SVRF;.+H2`<+D]8('"H*F)%]=Q&Q0;O:6P+^Z>FG@`8B"?S MJA($]-\)`2D]?\[.XX,[!Z&S,&UXP1?Y22,QWY6".H$PO01!0?"55(37M-;K6S,Z>C1X=O7`=*5CQO4.P-FFP?#QQTC[PZ^QHSF(&Y@,I;=>49^"0?$N$HB MLT:P#C32$G!.*7!E/XH@JE#0-$!BZGQ=X[;TO7C:4D:+$MVRJFT7DA%ICSJ5 MCJ?4!\"$:3?G0S&N[VJHZ+8S0>9$]SJ\3GV]\FTNO!A)I6/+(YWQ4SHXKHQ5 MBRJQ!(S3X[W)Q\_^KC/_QXV-C1M_^N(OA)5#J;[=YU?ZS>ES4!6/;,L=]0", M;X\Q2/77UXNWDJZQ@G[Q)[MLYVOOWA[^^>P$F?\?-\Q:IS_MW_CB]B<]N^HH M;_^FY_VDQVW\87[ZCYO%%/[Q_Z)8#_"_J8C>&3ZES\6#5L2U)?7D?:D6DA>'_.^)Q<8/SL0OAA)GT>R:'A2./1 M;[MNQ0C#3]BP#NWRB-:DH:$=SM*FU"#NYYH$1#>074Q3NU*0HU=MS?@I+;X2 M>I).5`[HLA'LF%\)R,]EL9$:&V%4M3_\.B#N'&J@EMI"65:R1-21B?@_%4$F M>#"%M.\J/PCC[!,?)^K(RXW$@@RL3<2H2+!IC4$UF==0<2:8M!DN4:*QN&S[ MWXH/9AWZ9Z5IJ9R8XL.0'8[D:$P#Z"!I>VZ1)"E-P(H++N` M\#T%E&LFL';H,XR#L!%Q#5$? MN&PN5^H`TDF"#J/A"P1_:1_-SJ]3-]A6_?S\.LVBT^0:@R\(6A6:P\#=@EBO M?5X3+FB!4K0M`F..E(;JO&KT'[<-Y&5^ZH>C!7RRN^]"\)PT;_:DY8% M\1SONRF2+34:JO64LD%XE4"KYI'U(O[I"XUA)G]:>W^@#B4DRRBNE8R%]'1% M+%JP/IXO0-\BC1V$S2!PV&RFAMC>T@LBBC!;QD5FQ2"ECZ8A M:&..\P2J"?#`3QG7EE%?K0?"[$*'V8->R@DXVV7BS@45-(@8-S5W0_NA4;[> M1+6G5%"8V@J9DL(TA&V8))[+>U>LMMF.Y@,+`-X;:#:?`[ M\@*,?=NKV/:KZB_9HKIIZYJA?(TN&+_/T*WE8_;A(UE.U50?'R1]\'O\_O?X M?4J3M4LMG;"P;)G^'K__%XO?(]I;2/G?(93?#+TR,(*X/A!F__,H=XDRR*+^ MS@?\/08^C8&W2OUF9[9HV#\OLMT9)3*$1^&CBKDU'_@*.RJ'3`9#B2>L#(W[ M^QF[!56KN>(UD$">CWR^-LVV?VU>JDVL?2PXO74E2I2Y%>9^6-P-LM>BYRHQ MJ?/]%H',B<'06+-S,!,TOS!X\TOL_?9QF7N_VD<;K79%-ZV]\]ZD^!CB4&+[ M]XC2F6:TB)RA[8T64C'PHI_9/`V4<(FDU]MI8!`MI1'CGG&E<_ M*1ZD[(+*B-`!KQG'[9#]3-!$9E?,H*B!EZXETO$<*5,XBE"3_TUX$.."F(XK M+`CK8-G'E0S6---0RDT2D*TDOB]5PS!K8U(9S=>^QA<(WW"1HP;_12GS=,]4 MDO'"$7W>.=B^#)^\7,AF9@QC.":!^R;*0[`]]1F%ALK]ZN`-`(T*K&LA@WCM]UU9,@8WA4XGBA829'-<458YF=>ZP<*1<=5/ M"[]$GG65J$JK-0!,M3)]D3-3;L@V#6-?=['?R:)1/>698S$0BTRL:S-= M;&%`>,P?&"8PU;Y_!>?IU5_`?5">AF0#D`^SX9VU*-,O4`;)*\NZ0WG_P1G% MH.^!%>F.D(%%(#W#`[WBW@@I][58KO(C-WQT1JM`]<"*.EUI*;SM'[]N55PS MW#7LJ!N!,.K:KWW6+DP4*@^`7UH(F']7]0A@\8:419:%#;RB!F7FZ_9H<_?9 M%=R%Q(>`-&OLOX.I=#N5R&DB1P%TEI.W>'`5='2[3`%7-^Z(=5DU7(H*H^NPW[A9OJ(CJ3^Z_@H@R46,7U MQ(4VS[334V1 M'-0E=6+[_B\4\.E*,*74XXP)]A\H:K;(C]$CH@;./*$\R4)[XG[L='^':@\G MZ`&F&]E5P"A"OC.3!A2^:E3T'!5YBRPG$ MNG9B"F0;%[Z^(>3QQ5&:?"+I3*O)4CBY8'*HPH)@5,/!`%1V=;7-2:CEQO=T MR1.JZP`318]VHML?E":`U&M24'ZR+4T]*68JELL3GF'/4.8A`XY8B4^TN43H ML"0/%_FFIIS(LU1WK$$>>#!5]*KN?)C(K!=Q(&512ER6@'W+UQB_H]ZGY;^W6G?[,L%1KEN.;8;B$851CM11_ MLTAGRRW*F:C3*T*#0;S+@ZRG42/85D;?4._(N0XOE$]."3(,!J(/A`M!_8Y$ M!2N&^1,%'M]E)Q5*(JHZU..,RK;26[UAD=*H4-;KI57B>ACY/CQSU8"LB2,+5J`54M^Q.Q2U[2#*Z-!55#PECM?:O*L MI1-WIO0^@A#KESW5I_NWH243)M;NO-K25RQ[&)O#^TG7M).)T9D M\P?%(+']174H@[B8D9 M3F#9$!N-D5MPS@7=\Z<16N`8->PL;$0,"+-;=)JMY#+AFPB><(#ENYTG[>^SJ[.TS M&J$-JF(B>][B$A>PZ/X+K'GL"RL*X@L+OBE%00RDT]X$"8:1.+"OWSIXFP9U M:).FDWE1E680?!8:7_"!62[FN]F?U^G@D%WA7\P*PU[E&=%1L8404Z1BJMK" M%$.J2K.E[-%Q7`\;@9].HHW<7@@00[C-'X6H.1H^"6F%T]/W=$WKX@*+._^, M::%ZA;-QW7S(.9$MVH"!2P?[/Z=Q#6(0X>6QK[!?RC8S3B1->OD[WFT@L6Y= M4?/6DC9ELQKFUW2H+K2FX)OF5-]G/4'25\.C,6JC)M)ZH53-)@:$/;9/AA1+ ML!PN?%*,T;?V(R3QY*+MX\*C0D^@,L3-XD(0#2CB1+4.")9GU9\.CB]+HM(0?,_5,N>,$1J.S86%,.^1H_[LP,DJ6(]/J&S7T,,*36DQ%==OF4QA]'9,U0W#U@ MX+O:)O!<;%2@BH;9:F\ZR&WG]/U6L)I\18OE5W&4"#=APB+-FF*7,<#N%&_1 ML(0U&4``C+)+;S4M?->TPC8[>)G3.B\=E;9'K-1F&&-:0/#[%9HE6$BN-E[, M<&\-3'+L"O*Q2-3C[W19HTP@!ZVF@K,<@)BHK5].C0*HI@( M*Z0YN0-5<-N\N[$YX9`O=>]U$O[1VG?J#_E[XX.OO_E2^7[TT?':DV9?/8E) MF\MN5.\TZP@O))G5HO:MO!`6><+M*^TH]QYM=D8+/ZEQO-0V%S/A[C/>KO&2 ML-LHF\79&20K&H_:=,?MO&^XQ1<^1$4]T@[S7*>W(6FCAW=':DA;X5(2.\3] M.N)NI%5AE8*AOVPT=(:&3BQN3R< M2[Z+O0\LV2,R3:7A?C++U@R+4`0,.N<#I%*ZS7^]_"61FOT+M.$#?I."2EU=WZJ^VXCZ>N3=!? M*IVG?P^@2_]!`HK?R_7)]B%UUJU#RF\EN=8)&M$K;_\B@GH71PZ<3>BP!)(T MK1IVHR*;1CTDZVG*29'#-E\S]7D2J#9,:4L&HAM?Z@P][2'-M4M#$%H\?OU: M"9W!".E%;C#"[D*J22^5+3=U/#J6]"D3J=[,EZI]FQ90NF%/&'>T*DW,*1\LX:GP`)Y&587 M,K5ZF7R6@?G-!X[[W-\*1%VUO9_+N3'R=O-V7+[0[@B]=`<0HUM$!*6X6+=_ M-4FU>EM:*<[B7-:MA!8KMY%;\"#J`V"@R.X(]3(;N8M:V8K)">-ZQ>.VA&Y;O9F4BG;9$ MY2HJCL1<_B4XQ"EHB!GOEP!SA/I"B<#^?A#JO@)JL?@]2$'`B7AZ7I"$H7*P M7E^<3`9YV6WQFX[4GAK0;/%)QZ,3^^LYXL"FP\';9?Y]:1/GF2R<^3^MS?[M M*UEO?Y.?^NQL]Y2>2@N'R85LDA8`C8P5T_W6R&S>=@`Q^\&=<=CXE"C$2]SF* M[@&!U@1>2!/^_YA*Q,#ZLP0I!@FQ%-\X_O^O4_5-;9"RNCCJIBN#F>3SX/^Z\# M!&[XN)`3GPS*;WWO7ND6@B.QBV*4^,2&X][R"721H$K;AFY431-6'/D><>0] M"`RP*6C!,O`IPG0&\I_S5P^'0>D">S:A[0!E-JYPB_?NG8OQ8_):R_6-#HUL M0(@&&GL?,"A`4ATS;1A(*C:-:@SMRC.FPT3-"!-N]OZB*$P[$\3 MK)!@`$;E%UH0ZP$]/B#OK\>:^\9B3Q%+NXR4.%/5Q(U&"#>4OJ,82?LI.LA/ M$PXS-:PBNO$.2W]RL2TB)>L(,JD`$+N"H;6HJ=$7]Z06XPT[F\2CF8POJ:TH M?)=.+3'$&31'4M?T'CQLZ*"T?>/F5UBCT\&#KC\$T#,)"6L+=ENE+ M@AJ2B5]W,GAG'S$>MFS'@&+Z":*`>YJ2FV&WSS/!=2&_=>_V%HA>)O'N2(X_ MUL&8SQEY"8;NZC02'0(L%OFJDTRYXU%GL%'-$B:93)]D[_N3P\]1:/QN\_8] M'>'AO64Z7?7*Q,T"L(,Y>*F`N29LP=/#AVFP+FS[_;.(^M^;C+]!R\KT'KLB M2\+\FK#>>C2XGT2R_Q`_7A'>4_&-`&I.ZX0W)/X=KP]#9$3!&_8FKD[`FY]9 M^RP3+S3Y-3K>'LIFK/E/87=8!2]]]Q_HKR63K M]M;6@U^@9Z1)%+@8:9I_'S9D=7SU3&ERP(=::%I M:&6%8.5Y$.Q'6>.K;-R^^^#![0$,\D"8CS-VQ-8W;M=O; M^ZS&/2$*MU$>%]&V^KE],FT&WT(VNXU'6[?OW;N7>YA\4!HEOJE_\27JH=-] MHALC1W-'.#(V$/^N+_'U"*2HC"GKHIM#B4QY_)806S6?&[]BS:/EZYFCSA]^KE8Y>`'WCHUVM\!2J,(AJ7Y4S-[^`- M(4Y!(8>R9LSP.EPBF#W7MP,RX+8>X;;N-TS+5'")I("\F=A1]\@R8%ACR=9N M89?TN7ABA\ADQ*DB6ZGMUSTE-VQ(^9:O\3F>)Q89M`ZW=2L:I?"K1[MQ\\^NSVYJ.[5P):\1V'2CJ/R%]# M"CMLG+]Y^^$]_OO99[7TS4+RDE+Y]2!UDLLH5A3; M+"-]FM`R)2O(_P$K*P$QDL:/'FWQ6//&Y/L%-GZCQ-N5X;@6+C]J.'#R]3 M"K/`*`XP':U6-QN$'C8>E<[[U/JFMV'A5,H$Y,Q=62'\92DND,#]Z[6`&UK_ M07%0BK3DU1D5+[*Y(G!_4UW>AX?^>;!]<@W8XA??ET7U46`+T2*V5PJ(CVPH M_4K@.@34F%T)@%133OH/-@3B*>I#Q9A3T=&].-,"A?B]DIO;]M'KQ$$/I<+^ M(%]D+LQ_6GA-D.UO[ M=O]$5VX?O5E^9KO3]M.;^3;C`EB:XS$!$Z[/'[_Z*S<9.O$B&?BJ7=]*]:2G MK;NJ0!F7Z.CT!EH5*.YTUL<3=L]>3H+P)TI\$%1N=[\U2U,:IO5\_+!/D27) MR*@XS*OKC][(`Y([PWZ<,1H2!4Z^1+;)RT>B1ND.GG$]F_-?F0@ZWW]S?$KG MGQZE&"WR&`S-=K)#56"J%"=32VFT#YF3@V_>>%'/Q&_D.^4WL.#)H)RT>0,= M2+>N"5(`$6!T94P#[A(L(M\41^;+8*DZ`BB,`>7V=)YBB0[F)% M*9BNET#Y1N6CHB$JJY^=$FZ(NA3C`%VO.R6:;[=FGBP"A;MP<0*!7,_ORK?*DUPY2]'.@)LFD4G_GQW?=.8Y&94PD. MS*00,!<4#']N&,6CC^8W&WZ174?N[D9]L\5"U--:AH_ MW;\=_X;R^;K>RER)0S'];?O`-E^`(T(0?J*^1.,KFJQ!3[HPK)Q5X[E-@-7.^% M9KE>*(TJ95&L1+@.[,2?9`X\W41.GJ4ROEV]^\"^CW0U*?_5O)#KL>^<*BCW M_YF;8"^3S5%N%Y0U3(-0,)Z\&VA\M,6&[EY_)+#$M`AIZ"/2J;K(A%WM3`45 MF;O;K-U".7F8!:/RT`LK)XO\=@7V/_XW<;0X1(SSEVCD-6ME!_O&K M[Q1=N+M^][/K@7L/97=OVN49_IO7"9( M_3PDPZ^@JU/'*)873^A^_%N%;M@N!KJT`*F[Z^>>@;)-+VA;#!9*")DS'$O2 MBR.CZ]JQ8B++[@AFZ"M58J/']7MBZJB.%.X'HN)^N%()>_JR"1?&FQ%T%Q4H M:N8N<\4PM:G^OWN-5EC6#/:ICL)SN70IT.*H8(D`[3_5&/2+R-+6E$Q MG5B^(_'!>'1EB8TWT2\&7;+#B(#O?V("_I*+.F%B%RO=#+HE[@S=?M.F> M20>'XA\81[5?H3D^/ME'>Y!'$HFF('Y4:]G)T/Q^'J:BR^Q^*A%UD[@;7I^1)&NF)=YXD M=>%LH^4/HGF3-?^&7CZQ\?DX^I@3&0M=#&];_!EEJ;I\RO636`PO[%;Z4R!M M^;E/QW:H&P3XE.?0'RJ`M/!)H*5"$="@_@:T(1L6UAAI&4-^C8F,4J<,YZ5= MU;]%,U&"CO,$*&4>A6\]``'T&%C@+8%%E6/>[J:@BI8Q[]$BXITUR=^JC@Q, M&8Y&CP%.[N?BQ#HQ$7.NR7FYO1K0A.#A+>,VIHR4]P)&.Z`97=+9YD:>J=VR? MZEFT.:(0V.L8@"&+IV4)%"9/)+2HG=7^$^O\SZ"]`<:079GH[8\O=N;OVGQ1 MC1*K99'^LGZ7@JP)XWQ$(_3&2Q0+I)J=BJ_1HV6(8'V4"Y(R:=/:_$%=<2$R&H+N3,7HQ[F\,N^Z=8W%??_01OPGM:'$_^#'V! M-(M_Q9@"_ZDFH/#@,279M%^%]Q9K#[R6QO:'3O&.TG7K)D2FOZP=UE"6G4.* M'V)789B`F1@!PDV6BE.M/-#.ON1G='[[5/$^8HYQ$FLW^5\".PMEVAT!/3Z\ M@,Y/N0MXY[)NR\P,V8_X*Z6"1)XKY>A-&`$13R&_4#.X*S=XR( M!%/8K)K@,GH*Z4=[B-3R>#ONPMW?6_?<9F,9)X,&^N'E$JHYPPE\]>B;;B>)8:8[-3M=_8I4^$8"&E>!UD"A':\4"8S;#<;/$CVJR%6VO"' M#A=,*TD%DQP27>$?TXA78W+VUH*C"+ACBH,4K3L:?Z1@.0TZ#35-W),[@'_V^/'+]'ZVC%XRG$&FLPK'3N8,JT]U7%X5NGML6H0V25@)U$`WF/IE`6L0[:CT4(R3T M4C&;?NNZPA;]B)BC"H,_X`F,M7M$9G6@6@#L89P=W:'/-'>6ILO`9:/PQ)(M M4>RMJFL?J<,VFU,PHA?^SQ:Z8]%Y(TD`3LH^F-9!E&8F.'#^13?LIMU=LH-V MP!J+S[E35&<0!4!8XG<'`G"2P/L1P=SW!#<&)(S,ICYA(+P[,* M/+;1;G,?Z<;6P`_2X3(UO;G3N`8NZN(&_9R-&G3/UM0.X6178CG>U>&^PS'G M)UL\8T"5YO&6%X1' M6Q/<<(!N,*Q*"2FK(G#D@2Q^6*U,HX%A.B7F%ZO)_A'%>=;*(=XU"+`&E>55 MH2BMZ(78W9EVS5/HIH)5(=G)94:UHR;4?,:J/^_C"@/Q/2!W>'SBCVE8_MGG MK!ZLX8$NG[/!&%74:4CT6_TD9OH\!R*'.9UPJF&?+`AQC_..H]R@/B@Q[R%8 MRO/Y?/4+U,5/!]&'N&KLI,VNH>%M@3^L$22MEXK3Z_>9JL<0,$H*%5@1W7*EEY/X9ZX1#OVK M2V&QA??A1AYEVO7G#<<#10;GZMLI_L,A4&1$K<^137U#E-/]A$1$T=K;'IO< MTWLG?6K/4`SQF4Y$[#`'QX?WO@!$YGK5+`3Y:0NZP:!M2,XB_VU#*&W!$)SS MU1'QAJE3\@.UZWA?!LW*V+"VKV99);K&T-VXJV#(8@= MN#D8T*#O#+HA$2?KEC?=8 MS)WX)=4"%O7;XE5^>P*KO+-(%_R11F[/3>&P,[XN!!.-JT`0_TA(11]-R;98 MVU7DL[`:F14X:S',X@@'&T,L=MQO)++'PS[,<.HF'J1B3D%V6'704@!]!S0W MV:L7ZZCF@+1_VZ2LQ4\+[E+W$)KJF(XI(+*9BZ,[/';!>R4X(J9]+UMYC-_1 MKZ8SXK8'+F.S7TJ*KMWK**4C#YM@Y&\3S`@FEZ#K$6/=4W!(A"AY\P^WV]*U3B&=5B_(D/:%;;`$XF..B.SE6R*K3#2`OR)<$H-,NW%,QWH^"Y9P9143VKI=G>) M6HB1K$ALEVRR7LB"Z&P7UR'U#4!APT5KH_&D?FXB*E[@*XM6`6B;3Y`Q9J@" MP5P4*2=,JJ*WG19[1"(46K#SC]A4W40F.'LB-=CB`.%Z'5%'-R@@EB2J@;(L MA#.7^.)TVKA;K/N\!6DK>RHO>YTD=./6*J#L'ECV$K8Y3BE?-/\@&1*LW5&Y M)H.9X+L_1$`P-=44'/I-)S%ZN2*48)U!R'Q(>9/NN9(L]3P.&N(4;E2HXR1* M,].'-Z.5/<=*;Q:(9[$^0RUT!*22-@%E#HXDW%"!;$Z6I6L\X+6PYD`;%3AG MDG%IW>5T.0LE*6I8U@4MO=!.89`?[&!51#G@8G*^"1'VJ)!Z]5ET$!T50-3L M0!$YL)N8V54#0>($(:,7D3P:(PM%(;JRW9T?5/S@L%66PIV='9/0U6/VYN*3 M08G+'Q&46QIJ^8_@@&WJRZ;EMZ!%.RGS9\FF7QAM,KGB\4K8#`Y'VC?$9YM_ M,3`._$H`E#UG;`(3'8B5-%BRD=K&EE@WQMV'+6.Y^'S@;#Z0(SX)%C3^UR$* MO'X/9=JBC"G`.E!W8`9RJ0'-`#X)(ZJ9P#8L+]KR/HA(3Z%K(11L&B\#2$HF:M9:J0X^SYZP)I_]TK5TYUMUU M535NK=\K`GM^]1IO[$!&"![(U@M*2U,:R1)C9)0%,=:_\WC4X#]GK&Q]+]7I MT?)WSLS:T.R+79[#+Y:ZMC>L_5WI@Q)SA]`R`H]7O(X":9YN+TL!^8NT7NEU MB^UTB<_I0D.UR6'0S)P)B5X&9)2^49#"S".W7C/I]RE]O+E!TZB^.&X8&D]. M"2!1Y!6!5F$TKG-#4A@HV&>]]/)E>EH4[Z,5D>6SZ8!#]B[6YN@MR#7'Z.=_QVCYBTA80;+'A[[,NUQ!`$[#0U`*6]6W(`^+.-HE48Z\VIYG('\,BE'JRXJQXT M?8#CQ63A9AK.IF_+M/4:X],:MR$*T M:*!#])N98$GHC-!"):A_,,O`0][SBKM4CIFYHQMK4*%Y(S&/87] MT;I7,42(JH;/C0UY['FZL>02LLN0?[Y,+#RW1&A"!ACGN,<)AT[UAHG.<3Y@ MRD`Q_>:6C:'7AQ=R`00;D\<2R=Z\8<7ZW[+\UOY3N#@CE*[`]:4D)?P,9`5@ MR]DW@0W:.416MF9V2P%01N-B<<^_=?A M]O*K$:`CM0?>2S%&%[JXFS*3Y0B!ZU)[:5%JL-7/;VRMZV*;+1&_0'9%%7CS MQF2%&[?"#>G*,3]B>$@2SDZ`$"IC""3/2!,BR_G_"$Y6A@"O5TN*5AI82 M(,+P\_$Z[6(G$073L#^VVQH7FIAE;Q@:Y^^EZ%6H,42FED[QH2/(,&L;=^`\ M!\;E-\6`YL<&'$XJI&SJ6;`+ MN$`VU;YV((6HX2(5P54@V_$4_3$]N82K]H9I/6S,<1&,R%:!F<@,4>_N[=3[ M-@EW"#])@W@R*E4Y)>=;Z9^\^LBRR=RB5`C$*G:TI!\6[3_&;45@!&YZ9<0*;&_OQ/S`H[`9 MHX+A88WZK_'?XK]L/]]S3N;-F_<6%$C8S)/G_;2PFJZ#YQKS MO<&WS-9=RTBQ[^0#D[=`2=*2POC9U+.0#1:$8S:2/VW91Y8QXVPZA15$O*B2I+[:M[J,ZUM'W0$?#;@S7F604%+WR9AWEU:X5V3 MO6^8?#I2@H(']D=$;Q3_$O'^3_1X`4[)W6EOW>:@YBT0;MJ!\]L$>`[FICQ; M/:/US9GX@I)5>#RQ!A0$(I"F[Y6J05)6..S-2.^PX464:)RF@D%IO`V\[23% MZFWM.#$5O=02SZRQY#'.25SZ=OU*;>ANL??MX$OR(XY;39^[!T&H!11.AT3/ MU.\=G5!986J_X7R5ZX\O^)$EA]SF)DMD@W;)W-F#BY\&JU1?\=_RO2O>A#]! M/-JN1L#K\O`J6UIPCB"`S'O7I/X<#/8U?8QBFE<:^:(QHX+=VX/_PEQ77(0) M),>BYY0US`^U<(N6"@H","WOJ'.:^)%S?'GIQ42)&459(QZ!;"HUTJCP;E[] M6T@+P\^=<8?BX#)Z1%2W'MY=IH@!4.O"]6\4_!0(C9BF2:?$0YI=)<@\JR$S M,P:@SRD&&W<)T*%Q=4`L`?'AFRXLH'!=RBH9;P0-PB>9;)>Q^.(<()I'@]U) M76?GPI>KU/`VWBK6YEF#4A3"SRG!Z;1M&KTL+0*5I)2-?6N@4L=LW@<#$R_I M$L_RK-5EVBC>=($3JI:ZA2K:+U3M,./"5YP>-R[/80 M9:.2J"5#I3R$R`G-BD*-M%R>F3=N#1]W+BZ(=`YIZCA8E`7B?/&.58Q5 MHN##.HA^*-8!%N!Q94`*B4&2,<[$Q^P67>7DQ'Q_'D70#X3VBF9<,RA47#$E MFOC*8Q:2,G,A_=K"TV*W9[80B2`R+>%8T,[M>RETSK'0+7AS6&TWHZR`%\'\ ML0O(G#Z]MDJ)U(2M;D-AE>+".<:%4Z,AGQB^`HA,Y M`Q"LPK#FYL*[2JZ2V29-7%X61I&V*,4C%90BU)AE:_WW(\72H^=D&'@[[:R" MYZ-H-=Z/\Y8[%J](<[&>'2@`RL^ZOWGOA^#Q4XH?GLEQ[>(./:6LX"Z/IZ4I MXS:'-P];0"Z=N&_'!+OEV'Q'[-MU!CG_4H*``CM"8BV:U!Q$:8IYV.<]VQ:Z M-LJ8B58WF"PQBK^EY.+\01H3`Y<6SCO,&<2*7`H;,2]RA+_\MYIYJYUJ/]0K M2G4'N>UYF#(Y)[CX8Y644/$NK50`A*(ZWF9#CO/=,#@S(I]ZN9Q2`'Z_.+,A MCH"0[JI_E9`"1TKX)J8-\.R?(]U]CA!F>)4(984R\?-082,-4J?%(/*S):\: M6`RO@JKS8LU9#&<(LMHR;GS&-M!/,(<=F2P*(O;'H3B=;NS=A/)FN1.WS6+A8U)M>A?C$'I_L_>, MN6*&?B?^X]8>#`.4N!-'I':2L22R!4`#*?+HHF#SZ,2]`Y&'HM0D.+["08I- M\_PU)_:-TJO=Z/+@2A[`_[ZQ)#H1*LUJ?Q9LN"NE+\%,N42;%H5;5^V%S=^T;I8KQ+F5G`_8W[S-@X!J;R6+6/8)IS^A MWL70*^S8QE%9N#W*5FTXWP1H6Y*\57,,>;=_`IVY!BP"64)#!0*CUDJ\SM#( M\#_/'$,;E^YNY(@XQ@4AQX,YBL>6-5Z8*.5;^0XI'V-1=D]* MIOB5W)W6Z,*PVSE;]Q:!0'DJ.:B0[B)VDNGMY]6+'!9BW08/)(I$C8I@W(]. M6I!I),8N=2AH1JGE\"F$HYBM/J2-+!XD,?CDD>.55)B%85;E'D@T.C5DVG.Y!/:\-R<*1E7;V=CI9X\<[O\ MPC.9Y5EFG>$$U=QGD3FWX2-R62\S#%M,^M(`+ M`^%2]R7.;%$[CV`T.?W?W"-1*"6NJYNR8728*+*:8U.):(8# M162<#_B:;SR3BCM(QN^OYS(R9QH'M!(`47J'H[X]:3QPQ[OM%.!4[CT!6[R! MJN6]#;3!^8`OL#/V9$U-["C[7$M3X#8)EH'M-&ZP6++AM7#7^)IY.*S#1F0` MZ,I%*+F2#4NF2$`,JA<62_L9EWP8YP^98W<4=.6\R%#1H@;'K-Z1KSI@TDA3 MR/KZDQV#/DG@.M%70,3\T.MH8&<#1OXHK#TWF-Y&4!HC?PI6D[7-@-<\^R$R MYNO@]_6+'9+:^*&J>'P.L7)-!3R-`-N3O_2O58-B_2*N\?<>1.PU?U]_GD8< M*ENR$K/E<>?T9!'>!0HL*HWIP:2?0Z`>`D--D#2'UD&'9@)<8>4F>ORS3"/> M@O%M>5K(/U!#^R?LZB%QK5V<(^>=V;P]E%83Q#344!%>_8AEHOSV:Z+"^NO7 MJ4$*#5"4HM(.($:,?/PDGR;:]WE^K"05P6;<`4PY^#P_5E9Z=WZLPC%">13R ML<-C29&Q1M,EVIRKPU&[9)LT=#D.8G0][=".@1U822CE`W(GGP M6-?R&#&X?/@1**)LF M1-2#H'#TF;^?H)N[3\:/YOA#IT>T)T$I/41507)A'$4;P"9;C2R+&P6>Y<,[ MSYZ("0=!R:B]Y]@/C4CJX+2CM-)<$H!3@AP)<+U#GV+R>'X\.6*"K7*4"M?< MYA<_Y#B,OR,!HY$1*_Y`')PUYZL':,0=*IEB\):_-NW,&>#.K M02KJK3.#/M;`H)$YVU&DUL$V] M252AE*F7?,!AZM@.^2H["!]S0]W-]QY](ZIW0_:/ECZD4_7Y.Z&2"+_X@F$( MEIE9>/7+`(8W]6HJ()PU&6Z;T(XX`G7N*L$1MJ$(7/ M_E*5I(;]1=C;'HU87#ZNT!/VB:IIQ/W M"$:=9A6/W20F%*T2&J3)2=$@T.=&\84+TMU@#:`>FW<9;H@Q_?8K$I8HTN=F M\4W5T3>OMW>^&6R\WMG8?+-3JQK?6&N<#?S[M,89_,?Z(:%O8A/_63^W@X2G MV<>S0>L']5,B47A#X[+N"964>8.@#)$QV`@A@QLJU2+/0#(S:3H611"_&=/. M)X6J](B23,R7'L]'8DM3JB].:]F9*9#EH0IG$&47/F1U&1H*BV>D&*I:?*#? MFCP_5&2"K/O`]`;FZ\KK/(FJXOCUG8!IFV$*DBI5LZ@[);Y@Z;/8/;4[>H$S MB)=Z^K[XG?ZPP*F%4-E#,VQ'S3GH\"R9D;SAGD*N&TB>24T3@=F2HR7JXKSJ M;J11MM3K\IZ.?.L4HD;@W7*''?`)CQ("P.+))^9J M34RPD"=%*'W[1GV/3A6KBB3:+YO>&^U]&""H0O4R9X7]1Q[#+=9@Z:N;BPO2 MPRWE(Q(B`(>G9#S_X2>FFI@#(FWMT+LJFL:K]Y%=;Y,,+)W*$G,@)L9=F<"_ M9=LAG^RU:05VXX"&G]FN@?,)5L6580F6Q!'(@4.$[C@B'I(8%*;D5Z:R>4PJ MAZC2HJ!U`186/XMPH7.F,VCS*,"UU M0#1#`VGQ>LC*DHU[-"T"W?GM;A'@U/O;DJO83;VU7`!=)(VSKJYD[$0ST?*F M^)[Z&64Z`?;[4I+T.>L,)?*^&V)-`/[B7XD]WP]*]^'5[>+9#V34A6(K6O[C M>'27'=Z'4SL;2TP>23$)AZ:<7:%82"`QZH)&6*/#LN4]_?9@1-9GU,41KD,[ M9(%^'J/4B'<(!XB<;MXWS)\YDAF`8]UF:Z=^7,97BW6S',CFLB0L>A"_1'): M(9X7ABMT3NK41V&=5LUDN6&"PKE)KALZT%H!Z#WXO)VF>YOY4*&^/%2X.2=D MD4IX]-_`'RG=VLB49,!'NJR.^-I]L[F[OOURL/E_=S=W]C;W:EVZ_OXNY7P1 MY7Q7#)L/C5U-86$]WY?U-?X,_;0OM2)M974QN8)8>7I_KTY(`T9&O6]]74O#ZX.OH) M_N7/822=7^K#+\P9>/WBPUH3//2U_656_34S-SK"/WW[#O]2]9]J#:7P9R!]OHKLG;E^T7HND!]& M3Z1T88;(MB''DY5E;S\I,F@[B]P.ZMI<]CO/,H`J5`R,.^\L5?<=@',A#/) M7"ZU,#.2ZPXIAEP&E@[C7]^`9;W9?#G8W]SXV\[K5Z^_^4<-EV](A3;'A_:\ MW33_6O<00>/IOI.1+M>G+O]V4I/O86R+=YVR!*S2$KXGN1_"A0+LS`"?5_`^B'P)PEQ3;) M4WI?7+TTQ"*5*EFV."*ZO[1`FQ7D&+$0MEM9LUP\6YEDX*:/(;2TO/879%?]$5G2'\F) M*)-IQ)')JEK4=32;V*Y13_WPM!-&_7&+D,;H+:UG$K'=3W_PEU>\]OK%#YM? M[VWO;PY>;GZ_^>JU&3^$=_;V.R;D#S'PHE/A?Z?:L(+:,/;7;6A\YOV?#N\/ M-/,+XF(*$Z@7'9WWS\YY@\V$G(_`\>^!3^#WN#DM-!!2"YJ]=!+M.^8MN?.H-..MVC>;K];W,6-VU^6+V7^SOK.WOK&__7JG MPX=VL']_^W45GO(F.HE1JHO"O-],"NC,DDI/JG*20&4-N>IKSX=^]U,,3DSV MHF*HJ.%I'`'6\N6PX]BRI>2MILWY)#^^$^& M`M/O]>",(6&%:&^+-)][$E9F_<:[@7:O(YB\6R\'-O@+^5S_*47O\9(./Q&_ MVYYZAI;WRZ$+6;/5;7)-,XCTBXH6",>FX1<*;RLX4E"*,;-WYY=FGQ\=7%"0 M3_M![RBMQ`25<>8%E`9V@U^;C+A4Q6^R#,,6(]F'&HADHJSBF([VHQKM.,GU MBU<4O9CENQ'9S:1IJF'FWL4!_RN&^J]WYWT\:J9A4FT,V&\\-U9!A$SHS:;5HAM#0-NE9=; M!Y=O<1/F:*0P$;QZMJ]RVO64]ND@"2XYN(M%XK?;(6'!:H/BT.W(--LC[=RR M'TD4F>#UTR*^J6*;>6=4*-AUC=L;4RZ_V=M]-<7\X8/!'OZT`W)IE`^6IU7: M?7R7,^/96=/QHN^-,Y(2)3,PG^B0E9')>E>$@M4OXJJ5FH,WZT3@AL!3\+>= M!29G(AA`#Q("+PJ9MI_6B^F\04L-=BA]BAB9>F?2_`8?OYF*G-)&+JPC3Z+1`[NQI3L:1;TI=^]@VQTZ; M.J3ORK.@2'U^R6A<>NPQ-)%!3UU,K8A$74.:U>>WE*_$Z9*PXE M`^;5>_X">H#G>[X>';R=P95]3%O<*S4JU"90"W/U+""\Y/0W-']"W7ONUVOW MG?::3J``"-69YC9N^()VAP]##:.D:[T['TS//[4F"ER@R2/N2"7N^MJT-"X+ M>RENK4-'"\G%7-),I@40BP'@H!SO8XB2;))0OI+J:?E2]-W0D-_1N49UV8+; M-OJT4QO1B_V&(:'_#KA,.NX*X8VDW5=-"AB7]\P+\AL.`BB';,)`(@%Y0'/=EJX((3&U8&%---?(0AO29-\)#+S*/E MIJAU4K=[%F>FJ?VX7K9?1I'Z/!GNK$[D@`C>AP7:)K%(ZP/>L:VVVL*W5LT#]';[]7=C-_8,+J4T7QA(OVVX M=6/10`CS].W-6W4$$J]2."5"*#MS+7KGW"@0 MBX-I'YET#"T$N17F>R.B4MUED7:\X7WUY8+A+$&8AWILEM8BWS!/[4,=M$=>:9$HWK MCZQ,"=SC\*]SS<]5Z.<;CTH,9R/"`@S)N$MCD1GU@\^$[&=04.Y53QJ^Z34)W,]-LL_.D\A1J?XGH&C?A6V&`DF9"`Y@++;NPC*9 MCTIWER"0$>O)LJD'NJU0V+G34E=7RTF\#EV_BRR:.QQ?B:F5>R_-#M#)>\94 M<@&L+3?K>NSQ8"QS!7.2[C.62D`\2JE((_JI,H>@TAXUJ8-RD-2?R("([O2Z M5L3XK6XO:]N.0CK.[?#9%I$$`\4^VR)"IX?:(N)C]S4[QI"F+#VQ\T(#;J35 M9WM#++!K;XS5$K,6(T/(?2B5\&9-3VPVF(TH;^=PX/^M_Y'-"B=*PV2E9[4 M420WZ,\<\TL\W^PE\KMI7=^*`D!D+/G_U&AO\/?3`_X M14B?7H$F[U705O]$,].:O-UERT==,%Q.EX3FEY<:V5)&OJD72KT@G+*S7JV( M8R_"KB!*3,'P',[1G:C[)JPXJ\(3BC'2UXP,68L_0O+F>IV>ZIPT,5.M7/_R@ MK!!V$X@-@[8^A=[*1J;#[//Y):,Q8R"R)E0[:1VK\?=*-*JY3]VMB4G;_1Y. M<:-T@]I\!TSM._%FUF[,\[3#"0J/6];+LS^SZ6+3/D5NDTW99,^)LO,7$4NS M[NF%L>[BM'>_AL`Y4"8-HH5-7]#-PDQ*PT4\!!A?Q^BQ[ M*23?^M8<>\9F%F#9:@$\06.#F;/BCTD]B]M2.,H95RC!W!7LW]K-WZ M,OIAL[I\A\]@I"G"+Y9U/#STW^B4WO/OK>)#"5"-5M3SUAR]"1:G*FU+CP<> M+)=*`"KUJF>A9J"$G(H)N!UP.6LH,\?2H_=XE7G3JW'D,E"DF70Y;8W?UCHN M_*->QW&[W'0J#K2H%WN=7:VQ5)L]TWS@:,B`+I1V?%22!C7:&F0K.Z1/ILH] MGT7JO+?%3,2">:;+JKMGZC-_Z4@.4_Z9^G*"-YRXG$X`FU]96 M9V;7/D"L);H?)]72^A\DU?JQV)NC2$_R[XOFN6/(AKAX<"F=G8G'B&%J_5V1 M>GMP^3/9&]`@1B3:FWA*4JZ2YFC<4"H="14V,DJ"6@]ZB%!,J:)=Q M[N*7].M:D'Z#[T8!Q'VTATX6,U*V?FF;T88/9WS#\H;S!ZZ`P4^6H$URU$J@ MA?WCF711!VF"$21^XH^_IEP&]\;98!O-?6B]*DW=FIYZO?T2$[5E1LI*P1N4 MK926[/R6G!,1AKB:`EYHDD(.FI,&`D1CE/L%(?YR.T#"&)*,# M25J,:#RX.^H:(XH?D*C@TUL__KHQXW4];&]C>UO,#+NY''ZI\:^0P#Y02Q2L MR`8;+49!M^]"#DB@KNO2(!\;EP34H4/_@NM(WZ&6_0CDL6YU+1._P/W'VH1U MSSPR/?&05/S+FXOK(V"H.70TFP-J_'5V\.Y*YV!X[/3!@XY"?S5=,8OZ%?ET MO2;&K_E,4+Q_J:/R)%8*V0<4XMN/$L>FRMGGH^?.^881]AN;<>X_'![;3T?G M[TB0(-].[O&`G@#I[2<%1_XM.U,D.'V8SR:/C:5B2^VYNB&C0>$(K7%,9[(K M_4+QJ52('"+GM;#2[P&"X-]?HTD.L2<'7Y\SGQ9*-GD6NK$-W7ROO`N$G)3D MZ:/\_@M=#82#FZ!J[J+WZS5!GDJ=G'KYP_K&%UOK>_M3`QLK>'D^HKV.E6>< MV*C@XW$+J^KG!K*Y8I']C<$F.1=R)C^'S*:'[1\EU`/SAF"$TOT<&B.-F[*K MU59/F'J)S(V,($\/DEWK(N09+G59BS(5Q`LU(EKID%S)<6-.[#6=5__7P=N+ M+VE`<>1S?4#PM_P0&=_A)[LTGWZOK,O!&UO27_I+XIZEO[.1ABUM*EXV,SB\T>QQ#;6`8$V!>X)K M1CT($!YVW?"R8XW-Q'J0IU0$EU0_=BB8_NW\S'@`N`0B^8!,@`GYZ%M%$[0S M;V<5UAK@3KZ.[+R(YM$M8-2ZPP_1&[[^?'LR%VLI_SDU'+K$B=*&T[>T3O2# M)4U&6RU\K*E3@W@ZYXU;3CI$U2V=8U4.Y%;H)=4"E)WXRB@;I&6NK%N;QNMN MF@?A2GL-+CL]*;T>!6WTH^&,#A_>#J*79CZ'SLY"=AQ(B6;<:/*,7!3URC&? MO<0G,ABFE^YV$M>WM5N$#_-^C8T7&]XD-1%O\9[--8R)D)68A="3C7]MXI(Q_?%TTW3='A!<9+C?G@V$89DX$C M34B7Q&8X^DQL0@2C;SK[T#YM^5@:!^&YV`X/B^F"ERX/>:SUM\!+LPUI5PJ. MGUX;^]?/=LD<%"_$'>D=-A)F@\+E$@'61#[, MD<9<,@ZGC9&Z^6B_=HJ<8@S7T">$^8-3'`B4U.A5XZ)`2A$:I'1T&%(0>>HE MFIL:#IF^+G\@`K"GQJ]!?T]EQ+(5:7>410 MDTTX,)%J>70M@J+]R=FY^ZX;B:")FP$G[BTWB+'E3"/*"&5H*+[,=04IH\4[ MFMB3AI!8Z_E2W.NNPK`X&'R:-[<2\%N`EB0(%$'D&&H?#07E8'@56CB(;L$* MWP"4UT:/-F:(.1:7'83)1H[5"]ZV85TYSZE2MC&64NMN6U#BW99,C@BA9`=A M/`_?!5=[0\T.4'EL:*0PTGK7IP\`#8H#YJ*6KC'8$%A?-&/4$A/:\Q"C(;8R M`L3*7*UV=L2IT7)0>#59U<[0=%7,8=9JMTE$Y[4@$(N5E(U]\`Q[^(!M'0_] M#4ELM]=+G%&8X$=TT=^$>=O/BQ5P(4#$]MM(M:[ZUR\+[A!>;7D0G"ABL8G- M#^_@\H;^`Z>/%LDD.C(6",T[ZS")6?(_;"HP`$5!S[D.=(5TS+R4RW[K$#B\ M8DX`H!..\E]F#[<0T!V\]/L?UG>39\V#9^9@,^YY._:^5;V6!B]8&0/JO9J; M(S*`0$JZ$982%CRW.A[VF[&PC;[-[O5Y"S*%3$UJ=2([PW().EYGN!$,BO=D MN%^<8=NT7Y:T1:BK>6_[G1*:G$I`E@X/R%U8%A`'442TY4$A1Y4/?"+'C+,Y MBQ0$&@(SI4`:N0L5#J'O/1+4\)18`+%ESP./:0L[ZX<@RA"8U'59\/\4.7'O M!8E)Z/.>PY_XB)DLPRR46G?72SR41MIP](SL2$Z[;Z%NAPOLIK7&AVBS-@="#7MVF+VH?Z.7^1ML`J6"OS6 M@:Q%'8[F?7R)I6WB3)^[7LP;Y+W3!T[ZC2['D9Q5-#PQY0M8GG^AXNGG6YZK M!RN0^H>;\#A)^_R-$8<<:GH^7,!MCA.H28;45>/ND3RFN1_L!C6+5GO--TEY MM85YS"8MR)F0G@=MG_&R9S$7W@V``SY527/:P2$M?/WP8N_:F[]BSIS6<### M55P,W&BF`^J/,2"G%V:?(AQ)2/+D8Y;1$DXY%>2_Y"58NCK'3X2T6$G;`, MU7-#1*`J/5&$J6>::S@*]X,*.X14QT/H%=G-(0#,CS3.U()$_#%3FE^Y9Y/% M7M((\TAC+(@[#J8R(DR%9U[O2K<0KY9=JFV,0[KV#A.*G9Q>XNU&>[3B\HR) MH$%J1I,T5-YH!.B_D/\!$+-_YH/]`G%PJ$8^QH%V2KK"LY#243F_MPP$+).^:%VV<71M-\\ECQ\]DB7-01B9T4S=AK,7?RK]7T M;%S2V$PY6.=G:YZO'X?S>I%6Y)0ZZ26(AG5XST#;'-*7_W//ZH%%Q%I1-$MX M?!GM1G$Z-8&T`_'B9T8KF5<>@?%P`2Y1B3)NP*Q9!3G86M[00UAY\#V5>F!#T%E,1 M1;+AKMB;6UJP3ASEO;?/Y'F=<3)XJFI[*4N?S2R-`ZE[ZMBC="3J:H'"J8N, MQ/F\X]1BW]F;S*UX:M+C)U;2>WI`N;*R^AB(]R='M<_Q=(O]%R'R)#'=[](6 M5[?UI"AM5Y.+E?[;IN+/X005B5L*$&JP*R^/$DZ`G>:*W?E6(?R'R3+8J07" M'H^?1BIFEG=PZY*ATM[&3)0L+9:L^*.7J;[$N+>F1VM>(-+&Q8<)\Z6EF:6E MY<\L]?I%VN1I9"H[6JE36>5FF:*GO$1\8G&28G!X)?8??C M2%C1CVY-]E9&#:X?RV#1P[V.%$RU0E6)Y/1.R)V&O\LS"W.S]9&F%Q<79U96 M5^O/Q_4-E1:7'1?YU8UVFC,*ZP7?T)3.^T2EG]=/3,\MKZ,BCAU\#+M0*"%'-0IKHTMQ/\3^W0%FCHQP8F3NE)HX&$)9(@E1_6S/ZGZ? M8'NLKLT^7YR3U57%NV5S-Y.XPWC4BY916Y?G"G-2+PC6711BR;YM>_+ZE,N_ MWY!&-H]&2<.9#[@B9J"8UO#I75':V4.O:'YF=7[N^=K\F!M:C(,7]P,DW32[AYZ+XLS"\C: M?K)9GEM1R=2#KR#SKGZ#"U9@H1,H';?8YW)/I&>7>_&17+OFH(!IN@^Q,64I M2!;+69BXGF2C,!XDD*[:&ENV'MQ1N6MEL6.*2GZ_.T%;VR. MZ<5Y[E)[U@L6 MD=#/I8/1!*)40U*1I0L.!_"3!;H?+#437.[J0M`GQMK.U3:Q?B[^\WA]DYX6 MNJ9IFF4V@`E5ES.]2IZ[9"9EOX0;+;,7-I%"V-(=&YVVE?2:`FU-SX4',^OV M]6=>S;N-48_AT[]7\=_#N;18TY-4:/90=IN,X$R^4M2!0P\C>8&_,U:^LWG+%]1M^>1F?QH_BK7K#??JX0%9%["_ MB&$7=C0OTDAZM9FQ^O1J-3O9!*%3\X[+8M)H1(?KPZRE!-*'6DLX&M:6UJ0\ M+O[K0Y,/VB?IL#[9.^!"3-1WS,^9\.IA#`?[JG&,.DPM6 MES\FYKB2Z$'=((P'H)0&P2::Z!P]D)WWF@"6H>-:(%*G"*L#+2;FKN?!3.&7$ M0-C0DJT/G&G&?*"\.66F1%B2W>-JX'_;\7[CFV0,"=::;8?NH`5[C1 MHJ6([R,[=X&)7Q[I/('I/J51_A,']Q7.ZO)8@"? M!'WT7/L=#LB@C.1ZK,DBI[V4*%!$*IZ$3[P='8C!PH4'R4(4J4E=5R27Z)]# MKUW\CZ!MK_;FG*5L$S>QB=DY=-O&3"!"/21?V)@,C>^L0%$J74J&1B'*&=>] MP9:V?[^&&(:T<924$BV(-=[%B`D$9PK!5D5H.OK4QPI]FEU@'9VTP]NCGS4& MOMQ\L_W]^O[V]YN#[9V]_3???;NYL[\W6-]Y.=C_V^9@:WW[S>#[]5??;0Y> M;PVVMG?6=S:VUU^5SW96;#+3MZGBOZ2*0)5TZS#ZOPV/Z1KQ(T/&J46C'`^5 M^S_6#U6/?'3]G_4Z.WA^?_N5X<+/Z)20D]W+)<7I=6+*@B\'WQ^<*2.`0>ZY M[6;Q;+VXXLL_1,6L][#H-'E[.2P*)4Z:I_76\HVC@3*3]>9O2-B\KM]TAV@. MY-5^LD.XPM1E,O67)]3B^:D@DII67477JN;O]!+J_W00PYKTF32_3"*K3!A? M6!BG`2H\A%9!I:#^Y1G5\>[&$"--F2IZ[PW@_TYOFGIJ/`9#-A=.(,>]]`5) MN;PX6Z@?2@<^M($*O*&G&GA&F\Y-=W/5K%*U509+7JVVL5D6S0:=[NVN*^,U MYOH\N&B7*^YP<8-N6Q.RFZETW@204'W&P*/--7?'G-:YX@6=1$[/;ZZP0I-6 M%7C^;S6P/5R@+&(`6RDHMG^A4E-`$WM-**%?-\5WK*"$`D*H3"`59LW/K73!)ZU*TD@+)KF/`"$"S.+^&1F M$PA7%F;F5\A:NA6$"S/+JVN$H6=CYDD!LX;L$YG1DB)Q/6XL$[M?WALP&2S/S:[,\,EGH6-=[&V/-8+V3KRH8 M/K>ZDC>FQ6/RXWG9_,6UFEPGLJE9X)E%+O.WQGJ M.T=)7[/[YNN',O2/Q*U3WD6J!^CE+G=ICB[^$G6,D6==K= M7I[JTY.#MZ>(>OOYO#ZX`J5H9V0?4.IT?JD/O[#77+_X[=>)W@VKBI&H MX3^OBBOP^ZVUQK(*1Y7\MAE/#,N$7@X&KPZN-0FA;I1U7:JW`V5TO"02" M9P%/R(.ESBT.L@Y$=-MXY^]360?1$N_?S3_R2D'$A%&D MCZOK32*K7YB8C-;9S,91]QA8I,9S"IZ9N]E1K!R9<:MG[_^ITZ(NHDG&[%<^ MR%'PV($WLG)C+VDR:47[M0B[RU([]*K.$P81GH=_I3W9+;]_&S'>"P'UE'C2^,BWM0@*]0>BOHAJ5;*@&)'^6\MS.@DXX-F;AC3<,#X M$3,L]#OC8&?OQ9V&\'6Z#1Q1IVB5B*R+2#D=G8`*<%'4.4O\\:OG2+%E+S"W M_5HO%O-=O/?&EV>G/UN1*77PZA"B7!R'K.K`Q0%M4*E.Q)M\H4-9E-&W1)J> M-FG97M.GSRG+=O//##@)Z&C/$G\WK=CY[OKH^=/G]*UIT,[9Q MC9D/Y/$Y()%WO>9F\V^!89B[$->1-CY:A20$O!%;<<=&"X M`'I1!WU`)B.FPBG5V;16$!>T6M%`4MBVS8_5Y[>-C=B'B@O&%)P,OGETC[$ MRJTQXW23/]1J[NA)%=(&`-PB*@/3):F=U1#MI.IG`>/#AE7JGF1$Z]=SJUZ_ MW/XU!CT"QX::2S"'Y3!O\L>Y_$^P)HS2@$T#8C>K[#?J:U(@0^^U3@">Z^A< M3.^$:+-4+&HWZ'%.P33V$<:=[[SSWG7*P&<)+6:YH`YWR#;?N@GSAG,'D$]R M@X!6%Q+APD+,,`=B`2H:_EV>_X\FCXA>UA;^HO5==CG%-F/FA")98QECSO)C MM^KS#3IX6_>()//]\P^>GEUG`)O.68#Z^4?-'\)\WI,XN;2XT-__%PMP7GLF^:['GXO?09NJWAM8P M_\7\LCTIL>X0DY:U]$7[T]D.0NPTO>I\=I.IB\/CY]75%,9VRNH-;^]]SM$' MHH9^,N=A)HNQJ"Z[$6.&@1]TI_;,#?X!N=3Y=Z/G5]X.BS M/O#'Z`-E,*SE!DE$[EC`+56ZP;7WZ&8JXSNQ0'674<`6G<+,KV#H=&BYE#O# MHWMBK;>IBEG8'%E[Y1P?GV05Q$G+)QZA"JQG5LF%:J=IZ-1=9:2HBQJ\G-!35-85_.$+6#A6,_V`J`=%D).)J&:2 M65&B(?S5C1JYP>7*\\C"IU,-W1[%P5`B8&$^HDNVA3FU\!S=C,X)AEW^8D`_ M'5W<$)2=UE#KL\%"U[7ULOO^FIC1_H:V1O)V!0$V(N5K;US,Y,)Z(M%\O=@T MTI\@1J=0=5_EQ`-K""\A3@-Q=1#G1G"!X3OXXF:4_ODTH`M\3D>=*6([P%L^ M!M2::2W2V2O-D*C0G%^K-_8:C-/$HK<7ET/,U"O=R*T+$9X#]]@EUYV=G>+^ M0.OZS*RWCE]UOQ\3A`AQ0_6V,FB_M;/HETJG+A2`[TO>N:6E?KVU#6:PR'. MGO1#=_[EE4O^NT9H>'YF;FD^A5C8<=+?2JX*ZU,5?-FMNJ-62;+MMU)RZ=N3HL)8!=9+/4U+2^N[U1?S;]#9M].G@%#ZJ_:GAN_ M%?_4G^XP:['9J3>[+(J_.O=O3&%@WL(R@@2J!^;7B`[8&FILVS_;FZ7%)O) M)F_>>B6#*Q2=R,/H[""SA_J;[2+XF.A[@O7F`,C"E1M]JTL&(Y.:N;O4. MIKW%:?UQ/W#JJ^K<\/3"\MK,RN)*O9QE4-W-"B;F0.G&+7;D.7*INT1GCQV6 MM-=6G1N^]J@;[&QCYT;]=L"=DQI:L8_??NWG:`D)?_L5`_NH,Y7U#0/:.Q_N MZDVV7.=EX;2N/U\G`YY\M/KCAB?6W\"NE.-7?PRE)+RLOUI/::+U%]LC1E>A M11[57\BKVGE#6E[2.B'&E1>"CLL"&Y?S5K_/DA6'G:Q'\[@\&VB@<_V+#<7M MB3+4GZ=+Z_F"S+J>YP\N%?"02AQJ@$R2F:XZ4K_H.QJ$:E#1!(^*W$ZRG]A% M?R'T":!IDKO-#2'"1E+A2*83QE?2FNKM)?!CH/;K3ATB"%2_ZNIBC>S*SP0, M!8CZU(;T0H`$9Y_[T-$>G.CJ7W<4P>;EN7M0_9L-G+A*R<6#77_UZO0$`PIM M2_.7NT94>XOUCV\YI*N*_7BWHT8]CY('C%)\_8*<,]]HI:8_3O3D$\F%R(@G M#@,Q(DK[%+*VU?"Z?JB=OG#J2]V2PY>R]8*%@=,8UTFIK[+EI=+IVR:'T1.) MF[^#(5[=F7+WR*G,M^?N?N*YS*WRY;A!@3T!5YA1)#<;6W1%,B7/W7[\R5*7 MQPDML3WMAD1M_G]-!TK[^G,E,^]SAF%2L#UD$B=K4UT^GL%9)V_2KX-H=$?F MPFO/'<#E5Z3(N0G>I.%!109'CRCQ:H];73'MXAH_E?]U'#/O^0!OXL'%*9ZW MTW^:D&08Y3EQNY.#7^CD2^C$):?FQ]T@$.7;.B4-[4!^LLN+<_(:4R:*U;;> M5U4I;AT?6HM)>$Z[WDE0HG"M6H"O::WN

>*8 M41"ZAUT1ZLB5ZA4"/[A4E:&@3EM)D[24M+/H',IU):+07N/?A=-$:%2A6>OU MQL4=4,7;.`Q%E);9J07R]"Z-$/,DS6B6;*,KTIX\[M@#LSA.'M7!3G.S=(TS M4LUGD2<7S+]>UG$A?9H`(+B-/,$J\D>+O@C%$BET/\]R()X1)Q;\U9KXFOCL:;UO&OG4D[ MF/X=5:X7TO6'EV"MY?YN\F^K0MN6OG(UV#^X^GFP=7YYA&([M;F]OX4^85_1 M)^/Y8';EV=*_8YID/6<1 M<_PYS1F=I\DZ16Z#`I]0FK-CVN$?BFGW30R<[PF\/&9B8%.JN&T^);21S-#N M2GUJM+_IIOYLTF7,`VY)5&V[4'H3FPBU)U*)4%23&EB88-[7*;0,4^B)?%MK MHT@08Y$R!#>[MM3.OQ+7$GN+"LW!;NZL3,W<;#+;PJ`B'I MRO.&BECQ/JA2QDX_Y4P=5]L3T33AC])4_/-DX1@G[U$8#A\OM[O`D&\]V\AJ MZKZ[DN8;J2BHM$H>ZL.5`J62PI#VW_B=17M0"M58>DB:D5Z?H91LJG7!)"AU$Z*^+-C]$-.^W7^^, MWTG>=0-V1DY%")&_]=^X`DP.]H&5$OV,O\OU'Y&>=ZO@:(FN!H\J'OFO`),B MTEJ"X_I%9DPM5.UD5VR.B5^V?M7)'VB"E[<_)W'[J)'+]NL[=!C$-9@D.CA0 M.+#-MQ5/&Q<=3!0\2.](-.\1S7JA]%3>"7PF!R;_/WOGNM36E>W[5U%1S@GN MPNX8?$EV=KN*QB2AVL$<0]*GZ]3Y($`V[`B)+8DX[J?9S[*?[/S^XS+77&M) M@-UVTIWM?(B1M-:\C#GNM[ETZL.C%SM_^>[%,-,WH#N`S]U@/9MY41&>&<HW)FVUO:%6+_(SMN><).\]*N]4J]K M5ES$;K9%M:M>!(-GCZBR/8O=R1QY=?X*OSLA!-]G]`;5-2/OM4_DD9*N M#W4O2O?X7F(RS0@D;9_0?&!.@@T/6OJM$FZFD^[C>Q<7H]-S7#^X#ULVFN$) M,?D3]S)MOYZ-PCVD'K`K;UI1Y0E)6U]&F[[$#T>Z\*4)(E4J`JZZ<]U-/IR, MO*]/4[J&R\OR%B)*IE&6+(F$ M.DV>/JM3Y[!-QK?>M6_P?!$_P9GI#M9R7^H&]#S23=D3?%9]OJ`K-ZJ>@V5>[TMD#/W M?5EMLJ?S6N$Z(ZL=&H4:N*O]#QM5P?=+3E%8Z'`X.X?`C&NT>WF(:9!GLQ@R MU"7!Q'N)C,?R^A*9$?F3WL-5I]FU#+X77ZP1B2'J4YI\:2J`=&&L2!^^'_XT M&GRK"WUC=84>-U"W%V^D<>NYP)@->K7Q%5&UUR)^2K]>;PR>/S\PA(^->LS-/YW+E*T(BG)'2G7-(IY`]=O@(K+NE\S9U,#1DH'!@(U!Q2"_*U+>$: M"0#7N-R[`6$CZR(O\:V4R$(7?ZU\M`8G>>1$_+8&1RR0L\ ML=78-L%G15^(PQ%:5`,'00-Z!4'G[@&_QTMT.!C->ASB#\M.J-YM"$JWM83N MS5E]Y&.!9T[92&(BK3GH5E/`B9N42F:.*5N$6F:6@%.O/N_[NNFLFF%O=4Q5 M<:9BOG<>)S=IR\"M#W!`4*[)=.=/>YYK)/;[XE@\12>R2Q_WZ=L1W!APY>7= MB)S9SRH;[E'@R6*JL'I>6E=R.06[]FR:YN;Q+!NY/63%0A=A,DF!V_TAK0:0>CFW;BEC1%0G M5VH]$\O6>FJXL]%\?GXKI*Y:3QI2Y^8ZO,>69J@FK/%/[QIZ-&>,'U@M/=V7KRR)02(?P= M]8L#MQ2*+1O^G"8WR--44VZZW<>VDP_'BNL[);S*[($R0)51@[Y\ETW.IE>O MSZ+M=Y2+T>$]T(.S';^]W79T:@U_/?;B04&L;"V7)LJ@24\"56HD%)_WO&;) M6F_6\L3#"**(C62'M/J%6M8C>3!TJ(R7)71N"`(SNE;5;6WK>='#M>4$ZV]5%"KKJ:;0]\)L\^2U M\=<%I,N\RJFG7(./DU)R6V?G1\YV@+0.AO!@F%Z5!)B:@7-",_VM5EH6`P_. M.DI"VRVX#+`2,D-\9&-3=37CVYY^$7?!N)\%AKB$,Z0J4$M+5W`Z\MN_9-)O ML<$0EH/#MQ.,E[>#`Q1AF8BRWC/Y4BZ-Z8QK@BR9!3=+B*+Q\$U1(UZ.+J^. MQS3[8J)#Y-/PDLQ.C+ORMTRNZ9LLU$`#7#/X^'D)ZPH M;"_:B&E[EVPD[/ZD7Y>0)(@VE>BF$(0M(GE8B;;UM`5:.G/M.'MIF[+0ODR53%8Z^&LPN>G6"RFN5=8',/Z#B* MXB5<],7P4M1FT)V.%X'/ZJ2F+1?#>@F^;^,A&V,ONG1=BO&]SOL!KY,ZF1>@ M?J^&;/(5'/[TMNL1(=<8Q5@8_]V4%?U%_ZMQ?WVM?EL8Q#@"P#G^E/9I"9/T M36RN`*Y&JGHPDT9)M8&[O2UYE9)016=HC?)X-%19J6HY@.6>FD(=<@KG!U[> MNU9=PTFG8FQ=@3162RTV="YCA>H='T9>ONK=YEHH7K?6,10+][*A6-$Q M@_@"0,BJGJ0['([-&(\.Z\HMEA,K.UTDCIGC3KO/8&H7@79A,316$DEA\N*3 M,2Y^D'G8UR+>U>LKS!)73SNL%K(R'Z,-/+Q^Z&A63[D!?BUWLX:RKIMD<`3+ M(*-\CS3Q*VF_X%-3C^+.H%SO3*XQMC(;GF-"WY4]\+VA>:I-,#8E_`O^*(:92R M3GW;K/W?4/'O\G1E,(+")=^IL?.JPY>05K#ZUH$R0QJ=06,@ MT:7[FEN,`A)CC?W*BLPH>N?>_F8I#:%5RO,YING):"0%`1,D#K"'_=LT373@ MM_D=EQI='..R!.B"4:*)33#F#K^QZWT:&K$>"K&"PL9*'YE4&<_.TEW?3OKXR M"\Y

S=447TKDRX-8=XI#X$ MV7-(ENLWDQM&?]';2(T^^^SS"!!?&<\T+<0V`EZ#P@WIZ'>77.Y,D)Q(X&C_ M!F>=5>9?<(27R3A3J+1>$'YT#K;&+Q1A*BYL` M$N\O^J$Q#D45)XJC7(-Q259@?D5O0DC0"''F&"P[7-WR*DI_2(LGZ+%'Z0?! M@^'%3>#!KA`I*>*$^.K5>L/D7'M^-LSMFR&2;ST7A, M\(HRI=OR7!,O9(YZI^!YIT9)/B8;J<$/I-$)2[!JJ?,JW"GJ41A"DT^Q%5Z[ M\@V:`.[)U-I3]P2',\%5L]C]JYH?1^*QG#VG5VIBS"A\$@`J37OE&"G#>H%E MN5N\-"Y,'H772URVS'JJ0*V8!1)]&'$2S1U%0^;6(O@M!=37BV%AL;$B'DU( METL$0MOMJC-'W?/D3A2:,>E2BIH2K>F8IB\2`E6#0(:XG$%7FP"C[GE+8M+' MA'\]Y"RI%!Q/*EBNP<@3D#XN-7@MOPK`FCB^P)I5ES-CGMV]O/!N9UO+%/N. M?I6CE055PY)!N)`F4U2YT+?\$?\Q%2_D>H&(:U9[D:JM)RC`&7$L6G[23*)% M/N9'+^D;BGCYP3N@UJA>-`AU?WSCI2V"?N&AV1>I(<(\0U-K`7IK*:O5DI;2 M;=:'&BF'=&Z\\^+%#Y[H?I(G9G+L3<216[:+OD@IGUO[W$1-V9D>R:UYQ6,- M+U&&T9[H!K1R'3"'8D/\/EC?NFNU>0&4>5FJT8>I1C3J\;M9F@M9'FMF#D3_ ME+M8;`4FDG--^MFXCZM8ZCUA#R'[\.CI0/VOP@HVNH@)*U<,PIS,J;RC\.+] MV4Z\GJ_9F%SH8-__N?G>9LCO=YKO[?EZ9/M"R^%JAG%.I\7KT-<@*OT=B(_\ M3Y%4\1R0MR9 M]38E=,&D#G=W2IR6^"T*$ZFV=['GNPL1V%#H_U&X?4A(1=X:75[?E4V(C*KJ#()+LJNW-ZVX($Y:M][MGM*S2"NT!B9X$M=-AE]^G;IJWQU M85O)6Q4T*#Q&3:DP1=#&@XW]^-?M@Q;.-:0BR4^^GE_9`39`.AE>II6_Z;)8 M9@`J9]^97LT6D@KF90O0.?+8#N/R#T306\-,<=^;`&DO9D+>;6!9HU<#Q:*9 M%_>#)J?&@!-V1Y0^_^<5)H7^!*@936_WQW\/B1O`K:%"]49Z(_6]][YP-]_?`+_5_G MY,WRZK<;BI>,@.9M'(Y9_VI)#S:_N">5#JDF#<:^#O\_)!-'JF_7*Y6!>[O5 MA=9IK8GM-!C:L$Q*0%M4A^\I",X@DLYD44`:"%K6'C)7GO)JR&`%ZR!=9`DB MYF,CON)[0>2!A\B*"[9P;)LJMWX8TTHR0S*':P27AS]'F(7LT-C;L7&)X-[V MMY_!&QS#@$![FY@1:G`SY55_`?5++%;;>W#>AJOH`6_UH>\-5=_)X+I M[V4X9L]OV\!W-LUEIR2'!LWL]P?QN^=E^(ICQZZ@?/$RHGN'.DZ>)]1;\UY:%BUB$S,0%T!=%0J^!IG$W)4O5-G)/^5%2%-G1D MR.A30S$S>=4"#1!3)J/TA$O=I"`Y+,@*%['&`#I16Y,95*US`E/ MG[_"[G%_DP7-A#?N6I-(DWVJ?\L%!RU]05,YRAFH`T3Z5DX>(C7'#B(6J+17 M6WE-/";J]+B#1W\A))K%ZPOG@OH+HH]+=O6IJ!#Z4,W,2;B?R^BO'$!7JAII M^=C:Y%(Y"N.5D95.9)ET#6]P/X^PL[W>`N\:).++%A#5>.*\YG-SMFO/!<[9&$+^2)JS$ZK5G`9YAZ<>Z$)0=3%> MBRJ$#HIQ11'F<@-7\$J/%,-`'P!\DI7#VI]PG_W@O:C``0(.ZV0"2*Y-F[9H M@C3VJLFDKG"!@_X4XC*)O7IY7['\3P;OL``#H6!;(N@X%L9;$X M=^VN"WFA`:VS/6<#<'WO7$9_&!._UI.[)^M)H@6)ZMME@Z]LF-'4'^YK4' M$&U1C.]@:YVP05G4W$:J0L":\AH,#GNXUH?U!A>4$L[5Q7_Z%'4-^I-%Z)]5 M(#%'U\<`A$%`,#,]RL]FT%Y%FI$X5MMLL'GLW0ZE8G+-V&IB:1ZJR2J(.^7! MYZYFG)?[.O/(9$QQP2/=;=WX=)#"RYHU=FELR0G!2&]S/!H<3.PC;9!DZRS] M8?U_M;!NXVP?/.:.3#R4CJ&8DE'=BDT5>8;,4:SGW21/8W^TA'E&DZ0]*3$< M+9\+(;EAE'2FQ4V$(G+.(N?/ZIDC--R[A&:6Z:\`:?CT61$\4K1]CP[#TTX MUR9$").*:RO/:6ZU<$5G?6BL$/^RN5?-#3SSX:HLL:ID:^&Q/D3!N;-6/A8]+RPJDGEW!`\2--"*NX7#V)*.> MC8*\X1;]#SS?XM,7$V/SN_E.G2V;ZN[(R]#]BXO.JQ:X5SBK=MZ99S M]9I.^XRE#VZY;KU6:T"`R=0G4_V^NO\5B8,!6Q>:SD1Z*(YKLW<1`:$WG4ER MK$:*+_=O-O6*C33K`Q/D#>(&'C.+(XN%$_8T MX:U2EG/=DC"-AXH8XWS4G(W[4VD]U.B2MI[64*[940BLT`LZM@2.Z7_735:K M#QZR9*VH=+(G11:)]Z[LI)]K*94T)AO,GSZN>&_.?($6RBY%#`^61GAO0K9W M@Z$1%0#,SH*X4F@MJ"JLZA@K-74Y@NM9I1R-!YL;C[:^W/CRR\WKD:FF?;W\ MOJC^[W]G[W7*P5]O`\4E-/ M(I',E'R/_)7HJ#O<1::-.I`I`*$@66*6[#.H..]S;`"@5YN&0>.0/9!+,;3E)9VTW5A(M)%E*O1+SR7RA MPH/PL9E[,I],H+92!SL!(_$.L%7_%+#HP[;U$[4$@J)OMQR#N2L]?(N--0(Z MMA.:Z6]VPJTS2]*7@6LJ&-R2H/7EZ>*P/" MG^W4"'_$)K3/KB+A#Y*)SBEE^64M54_-(\1@L]/N&S)"Y,W#<8$UJ*XPKI7, MIR3@&QU6_I>K\E8IZ>19Y?DXE&I>J5$06,^@44K*7# MMH)Z)^O69V0X6-MY\?W!\]VCO1?[@_T71WL[NXK+V\:UG4NV@I)GJ-#:N.VS M4=>`0]F2:7YOSLZYL$1#A!IM&1<3?#.Q"DP(?JP@5>#S:X+DU?!\?*6CHU+= M>SW9LBZRJ=:@P&G_Q?Z]9;"Z/1=1;D>A7;&27^%>@^90[@T.3\XH)?$RU`+L MI7C_W__5H'BO)9#.[F<8L0V8Q=-`UYK:FG;'>SV]@@K?716E M8D%Q.+COQK1`LVO%^;(T?J,X7VE!506+U`)Q+=@E!B+1`%WTSAC0!?Y[5>Y! M52B$V-RB&3Y07H.)@;8,/>KB'NO'2]F@=9SK[H($H6I9)U,-19H'"QNFC6)A M_S=3+MPU8^7'\]%B,KP@JCJWBE@,;JZX&'Q/H2Q>=S66AWS+CS(8Y;,\_WH@ M/Q"[., M4LQ_T8/1BX_0TT]G1@^'4JB6*N/_L(9^^*B*%[/'3X%[W>MNRZ5LTTFJH8\6 MH^XW4(0;OQ-\\6O_[CKS70MI!*2EH'NRS&'5P56RR2\(]A2*+@US1EDP2:2' M>`\>8!*[;M459DFKVGDU=1-^RF:FZ)KXT=)S(:F.:MNIU1`[J'4X;:#.`2E% M7/$Z5!A=U^BVB!R<#6DJZ5%SO"&G(U1>L7G`)PC-S9-*U(_B!*WCCN&@,4CO M(Z%GA\478FFX]Q3$\&L7<^ER,/;0O7T("@?`LAW^\[.;X=[:-0F`IX.'[8:$ M+%<9'ZV=`"P5-)_G;3GLK%.:9S78T4&DM^3J]$N[Q1KXZ1`I0=@XP4^]$;-N MW!I:>5Y&YNW_C^V-*&_A465^%^T0$2I5:',^W4U7,T42BO& M:Z:^J?MBCVQV/8!VD)T<4)FCR;C4@I?1VJFN1QQTHPIM?G"=X^(WL.!6;<\7 MS6(K-Y"$_'!RI;:^4?)W;9\?NL+XZ!D7:XP8M;!>-3,A!C,2#FE\<#8[/\4_ M<$#C*%Q)M#3:HT>T6D33:9)6:G)F6EX%W%U..GB_,>C@PBO7=!_5*-F$O2H@B;+7!IN)6[-$W3NRW?F(XP_YMNP3# M8>@>G2+<$#Y8V7953P**([Z206-Z!5^6-#)3!LH1F1@F`MI$8'*`,"C"FKL8 M_F+VA_81N_3*M,8'J4TYIS^1$:*-,)=L^_GY+U0//\9R`U7.,%_(<#<8I&`( MZ'@ON)BQFLEA>+^E!R@MM$1\Z"#"9B/&$UGR;\U/9C],+#_NNW@1B!^SX[AH%?275J4;J7WGJ7L81D057U/]"-,5O#24 MKRY7WTQK]IS1=A5B+0OPM^[34.X->:+6S3!3MDSEJ:>U!H?G&+X-BT%EE4]?^U6SMFS1#E8I$&WF MF-,:V9!5LW@>F`$B!Z]._Q3@9?;7V6.F?T''0#6*JLKF=V MU)I$*;C#NC46*G&5:,EY>!<32W:SY>N=AO]5#,\0E->+<.N(P>MDUF_@=KR% MM&T+KKWEI3HK11`LX-U$W?(,A*(JK*]=N^0/(?%TMBV)=Z3K8-3;Q["Q,%8D M#4R&:E<7`,%:[)G5TGJYN]U8KG)U/%.P)P++G""Y;$%/]1#E^!=L>XF=Q.[I4K'K*\\LDV-5 M'98V&.H#)^#ON(G;+?WT*O]R[4:.8:G>D:EB"=U MMGF+92`47FK:AP#@1(8ZZ3P=YMIH*"'6DSX*"D)R9K7 M4FS:^I*^81>0F/0.CD@-GTOGVN:`G5_L-#\5P9JL_KKUR#BRY?;R8:Z3P[^^ M[7AX0GA*2!0`7QKL^T')GP9`USP,Y\0M"]@*;-I\=&39J'08\I.3E"$\H'": MJ$)G0`A-Q^`ZKH7%A$=Q3O"NTY_5]K7Z3J@V_)F8K*F)#3Y-K=\[A_8V-("Y449_F91*W1--4]>42*E>+ M*<\H1DE@1^-9ZHB5=2@CT'LFTY[C78#T&T!)V-9.[6Y+AV_B_)=#+#F_T8(" MM3!'-\*L)P1&P=4EVHWN<)M,)_?HP@/R"'G]<_K*)62IJI3+@@MDZ!@'D6WZ M120]7GY_D$O"+N,2L/31UV+`EM6P\K(H':VZK'.RX#$6E5J:8;26JZ^<;>;] M(R9-FF'Z$F&K;O`.H.Y01+))USFHK3V2P\DDA`5/H:BWCFT^=P=)%D\YEKXD MQR*"[;2N9MNU3CS&RH]&)V>3*6'%M_3VP#<5]Q(6[N2TT$1CD1+6_.J1A5*N M=80-;AH[A/9-CZ7PL.=H(UD]_]P;LB,ZXD=I;YQP<9+T57C+;+2SA$!#%>58 M3Z*`9-'`PQ3LG!0H8N5B0N.7$W=K(GL]7',645AR)_J3Z-%_K8LI7]Q_[ZL` MY"VK)O@P]P`\V'B,.K9%R*;JRU:K*@UH&R`:UVON)D(2F9R0U+A'3I5UL8(( M2R^7)6.H=129#,Y;K^9P@S'NSU=&[[J^4S?LK3]XY+WKYSVBN!9C0^V,%MLU MS$QALTA>[7ITDPY\09&R+(Y/MV'T"E[0\[O0`6"5.O"KD`#"X*-0P>8'N`T# M]H"7/5.YV'>*`8\$HW9DIGF; MF4OS>@IU1+G?IRL,.(Z(A;CD+?4:'_8*@Z)><@"6KO@1;V'/R^PUU6]QXWS# M12OZ[TC$W_5U#4"]"B7*B@A+S:PY:U\`'QS0@P+'',^GO%!=4SN'">NF$D>9YFAJ))FR%&Q':FBD%42.= M$HT83RV+3A_=@-5?2'R8E/>THKL\? M]X]0$S&"+'8E\Z'?1)S:5NAU/=97*:XOZPZ^U\>>%T_WEGO"P_5;F<37K4UD+U'*:W'*^'@"@,Z>X&M03-''VN%J(Z MX@_3Z?BP.'7-1MU--5=B!/U(SCQ?,JV$0QC":UC!#U24N>@8F8UX3,]LOFWXSDGE-?4KUG1/Y76%H54I"FF%5 M';^1Q9XE(#G[J3IW-\O&AI@0B?33(-@A)'*DJ[#+Q7HRX&@OG-1EUKTJKW,- M?E6:Z6:GPPL*-G"5:0[CK>+/R3B;F/OCSW)S&*%8B[!U#[S4S2XK5.:I8JH: MBAQL.W:MPB4W:?7]JQQ,6YV$R]ZV(47%QBNB2+@T'NSN!(VRZJ6S'?=# M&'.W[DUA)?P">SE`HD>>Z18XTM54`J4:[VO$QR5LD9SEN!F%),7./3_7H_FG M=A7T(OV@[2J\N&C_Z.6+Y\_W]K\=[.T?[;[4%Z,_K3W0-[-O&'+`17M_6CLBTVD^4.'T2_S-$_WZ:D@\ M]*W_;(__T6R/%>69_9JJCW-WZ],F$[GLM]*7Q39)3FX#:/$T78 M>G4NDDP4L>#T[;XA,I^-*$Q1%53W1VSJZ47O6WFD*QSIOO3GN#N:')ZV,[?[ MX([ED9.F[5FA\NAJ[29&ER]V?9,,YB^^W.R.M&K*K>Z#(/_N]LN=[P;;^\\& MSW9_W'W^XN#[W?T>0:QZ;O!_MVG[JUJ5_]<=>M]H:`L:>DFK`PLC"NK/&B.B M^\9S%9:(3'`U-]58SPOBMUS.S[`Y+HYQ\V<.=UN2:ZJP($H5Q-U\0#7Q,+BEQ7X^X_GD_.!@=G5R>#`Z_1(C%S-*5:#^$`_I!% MAP=R<$0QVK/AM-K-:/"_AA>77\-$3E&I9F]Y^#YIG-R8N\1#W5F?I5-$ZIC2$A; MZ3&I&.0]-X>M<[4&!8X*7!OI9BFFA.1M9^&&\RA+Z$HC4Y2R<-HKNNP>,P,& MV:YO+9N%X>\0*R-!U-[-7NJ6H&BYB:KXDC2NGG\0%]:K(0IYC;*23T>$@LX) M,\%)[SSTWS%MBCK@9D("B$E=60CTZ('EFRM*"KDZ-TJ\8G)YXLU\._48*(/4 M42=Y/PK$L^K;HSR*_EO?_'E/>JAMF:X:N"#Z16@JQ8U`U2L..[PB2=`-_IVJ MM+)!\WN#;\D]>/UW[EP;?#<:CNG0=M1X\"L:+KZ+L,^[-%WK=3YIF:3[**K< M-Z/CV95E5=_*]=@9,&W2SM=AH/9WM'-&J/66^R)8*S.4/B<3I$]<;)L9US2W M#"<+XN'2%VEC&)6W"I*3#[U2XN[Y-D&BS;87;XO00W5493TP%"N)!471LM_3A7 M!@PPC>?"N2H)%U19G($,6IFV[['^Y;/QNMUHR.X8K&S?D^$?;%F=I[75L>W` M&SQ#UZW"2#L^L>)@/S0W+WDXEVA@-4<54VEOZAJ)GXXB;3&!]@U_,"MXUG!< M>:P"C'&UC<_;A/'Q8G0(#I\*5C>EVG[P:1!YK^+^"@9BOD9S23995N<3`Z_E"C*/ M?/!E:2B#P$%@%O#J&9IC"I9'DGW3XU([`(BOO`J`HX,W<2I0N*7V!>$NQ9]5 M2S>R0'E$B34`Q;0Z?S`!O4(+1ROCY..L%4FXI[M9T9OX2F0-$RL9-22$V:V( M*'K:G)@1W%`J4%Z%P9]VR4*/O6NOIJ@(5S6#\AWI9LDX5)E0CXK*;8*%/0N1 M'/?*"6HE0B@PM$=JB$K:[X"\NHVFUF>*#,5PX>^FM\4!";]2U;N<9K?)G+EY MT.[+Z#R6._/`O5=H/3K2A+D!'*A`AU`-@8B;%^V:Q,T/)NM:ND4$_O:W!\\M M[QF8-U;3=/9Z.#G_.TO"PPLN:+&6^1R85FLVAX!]B+VE#&!23HU-Q/WU+A=* M&$M>?K&?T*I[$%[!%EFZ&V5=H*EY)]VD3T) MCVR?Y3<: M&R6&BK`@HV((4!F'_%(SL^FLR]^$^?'\Z\^M&<[\+;"^H#4/@1/"R0-ZGET* M#\2_%5?TWSWF%ZNED:/M0BH$)^`*@K.9]BZO73%*2$.RI+3Z M(5]RU$KX6?UJP5]3T,1NWJA"EZBHL3Q1475L9.:EHI=B1>W*M`G<,4JZ,\WO M?`8N3W5EB#%`#:`,!"/)/%X=3\1K02@/%EH.[,UK[O%TT`SDI.L-(]V,EEVT M0FQ&BE*47R,XP?ANF5]%`1N#+;I!M1%:FS.0&6V[V2.#2'(%&"JGPOX1,%3V MRKG(IK(&X\=7E&-#?-%DPD(U,JDN#'S$VO`@!7OA)$T_\[D0AL8XP;5-V-2; M:20I5D7#S7T+[@7A_SQ-^;.[M[31UZP1P>2)IUI?\B5;J^((8J\K.<*.1U#E MMI:,T MYIK#CG7+,VF>&`&R4YA&T[JHDZ.`;?3@V,/"HTBWUZ9A$>^%B&V?_@H,6X)< M.C'O$BE0WSPU%]1`GC!)Y%!U>VUO3]#<^^\8_M&^^!_;T]O2W\V;K1S;NW M3W?$W<'1]O\9'+Q\\>/>(1TEN^QQV3,W1FH>8O!X?(O(Q2]B=&Y&=@=OWX+> MO-%][M#5005=Q`V$Y#`,\=#D$]GI("T,J!;>I@?QZKE)L#_Z>7@Z--)FC+!\ M>0[FW%Z'J)=4-11!-.A?9)3T3NB[*3+O+_K?X?;+:JLK%KX]QTL:7FW47;MD M<]Q/5$L](C:%')+L5D**B<;84#6W5#3<:]NG"@HH=F84_9)78$+K:]_]1T$QTGTHIC%%PCX780J?:@J^+N4.7^"[PA6)RSV=M[#/"&NTK,\40K MM2\?J<#L$>2"*2#;%LL2U=EX%`JU]>[U*"#36+UE8O@9E;>OW0?[BMNF64_B MMPBE1O"M+5/8]C'C6.JQW;TF6SQTH$(_INJCM56W-J#$+]E19R?!I:0_6_Q* M\S?$*WX190@XS$[%+;#_ZS[@BR:7I6P\`YZ--NR-K0FJ=/#-1:F?7EXW/?Y+*:;:9?A<;*2&, M-%F+,Z:&EQV8%JC5V+EVH(!TBD*^.#=,*CVOXCYER5SYGHB:3-\HB[7'=`JJ MLD42KPU7?0,85QB:%\.9$FZ"LPL.KM+I&S"L@U\E^3=![?%P*\QESRN7)=57 MR^X#7.AR,I1=%TM0HO9,Y9+XC650S,PNU(G%(;IGIJQD"1!$0W+E@O"=LWRT M2:_4AX_LA.X\^4K&RY-B6G00OL?0[:UD^^$Y,SMB&SB.!^K8J+Z--%1G"U:U M?)=-.T'5E,.U!NS%/="X&][VSDS`Q5R+&IME,!-:0&FKXN[[2W%[CC9EN6-N M-_:B];N8@2>2D\D,*KJV??;QH:NG/)?K>LF)=)];%U%Q%(]Z:4+K<2K=-VH\ M=E*=D^?J!'N+"8]`O@9G,<7P3W@[,O)?J9:$&RMG%0;#_H/&]A1;T`UJ+TD9 MF7!!U0[1&BPX=PIM<:$:&3O-)[FF77T4QRV:#Q,#-_EXY2]7@).R0"(91K@$ M?JQ9>OKB%-V186UG;A3#NX;JU43R5%IM<#T.!*9^!\4OSH3IPV3B=`[CYJ(`:/QA(5AW33_ ME.?2B%'\6RR@>1F"SS":=8OQEO7FZM2#]IWQXWI?.ISFSDAO6Z%(M#K5F]4- M2Z5!%<"P_M+W3'PYL1HJYK5N<,$:&]`YTB:BPN2RO=88 M6^*>3DI2YA[YOMSM37!J,<(=2?^2JXFI`?T%AY(@Z:.4`2]TQ3O)FS./F1>& M:]AGS?B<9:.@-X@H1J\]U+@';R\0!!>O54"<$%P@Z*6D6=Y3TOL/]P_OXZ@^ M[6A*H#!:N'6O,R$,AEMI(XP,2O(4V= M%L2)=F%>DCR\U'TXI3)$CZ?ON5EQ!$\M9JS6XINL"BS-SLSTL1=@KC.*+C_< M9DGH(U015V5.VZZ9AGC_B^Z7NXUC MJPV=[H.X/K[?.U*"ZJ%EK.Z\V#\BCWMW?V=O][#[\'ZY,0G$CLZ&8K^G(#JI M$0@B3K2?`-S+9KF'UN0V;AB5F3**#P&*+7U8E0R:I M+0LHO\"Y[4H.NHLWI[YY8GDH5IJRW$ME]USXV>OC/ZU]\PW1,?[K),3O8*4< MS\Z[B?";^F+.S0.8P"#]G]9@/].9OHSL^*?_6`'M^TZ[_,ZD?E+^.2O]B!Y>]K'="*3L)7YDQ\C M3`FO@K-&8)[D:SPTYRA+V>$JW!C#`5$I\`PC]$JMJ?*ZAC4D12WU]' M+F2W7#BS6;57)O@LI[=L.4*#3W1`G'VT]O17IX,C M$*"PH*H\Y4B9W,VISZV-T8G\:1C9E.=.$?2)1*6`J]%1EHFEVHO^BC[*.[,P*LB+XT'Z1Z+X4F=BMU)0S:)2.OAF5 M5!N=V062P'0T4\J*>#+I]#")""<`C5<8K=70"H<_[E<6;HKJ)#O(^[V\F#=5 M]J<;#D:FU)!R+U&XPS)[B$%"+MK$CY`SN[\0+)Y@D8^$%XL"T7GF:(06).6(OK>;X#74E8*GJ MA'6+#TYB%0B8J7EZ%:VT/54Z7$QIZEBFMFC>?0CR_LG1QA>V?'.[(HP8$`]# ML9:O)N9C%J^Y&E/HC),;$Y$]X/G#"_GS='RE0L"KR-^#6SG[Z-#.XFE/27PG M/7@;/;BKM2H4&/57C@NM@JX/K?/V\[M18CL:[@T5(]=L0.ZH'W<^DHZ[LLZC M8N@UMF6'2%;T28%R!TA;@0(P/?S^O4GJ(J!K(4E%6`KPT#<_NIBNI[^EC!;> M=M7A=Q8"1;S()M25CUF>_.3^$YEO'ZHZ^NDB[C6ZP?:$0/_!.NRG"+(0:W]3 MX%N<'QGS#E(M&$+-*ZX3:GK\=RC3.*A*0]^U=KKF]"OLE&#-MP2_D-+F$53< M`=&\4#4+OL0>ZWBAK'UTU`=?FB:*FZ:&,,[N2/U`"*/B.G>V"8=I`8?@*0M( M5\MUJX"4OST\Y$GI[/PE5A]9?OA^J&E!J0$50IVQ*+@E%8^3#)ORA2I,.8(F'T!=)?8%B![A# MY]QJ2<2G!W-!S\DLCJ\]:Y-8O>HP&TM);WK<8/J*FTSI^_OX"[HFO65]>1&+ M-_V*#$<]KX-F_M%H\;7@42JEM?"Q_9K&9AJH>JN"5[-#]QON9DDHR4JZSTKY M]C?L42T35N_3#4G-VAT:O95P45GDJ%N.`ZDOGK*C3R;?;V3RB="O:P-]Q*$6 M9B!NZ(XVPDU0H9`&<\8,.4NZ`#T)?U!L!BL#-[-E%$Q*-E10_6;??8'K($98WNEMHKOC&/6;YNW1A@8BX4;G!!%0`1[J#0\Y@T3^0:B ML4N@8-"57==%X*]%HP2/AW,2?YK(K16$A&B."WC8Y)>?)?^,[S#B5$!2HN8) MR;3F+&*>DJNLZ&OC7$;G)"XQ*>S+U__7^)CB9^WR_#5MGX^'7">"L5FUU?*\ M?W*0542DLVK6Y@")3DNQATJ`EF6XZ8LCB6!7TQ>I#"A@ERY*GY/_8ROM/A[R M:>GXG*@&P>R6C\T%V=(',:C):"RP4()'+)^-E364(&Q"V=+?O3YR2&T,F!H( MZ4)207[=DHF]S9\2)"0;[H3X-[/;M$$9JT31Y4P2I@_@\:#/\D,:+O M551"4MG@$+!W8J3>G;W`I-++4:K#='2M>JM]Y$B`2JL6I\]BL*Y2O>P8DL'= MO#2T[/HA7H0<0`W#C&K6=+[/H]"OJQ#>9^>V2B4OMK(&HK_""7D?B`PP-_#/ M*ZJ9PNXO.*7%#Z%3$`_\\[C5ZREWA>JC!>.E:VH]97R'EXD(\E#TW/Q*5?3* M.[*DP\BW1_MF9%)[X/*3Z1MZ5:I<-O*PLE!?CRPHQC&&JA8;"&H#=)5_L(P& M/D5FA1"_143*(K.%L.25'V$B"@+,PNAM\5CAP@63U?Y%5$QI99TN5QH8D@V>\`4T6>(:1B/ MD7`$$"-NY^:/\TF_&>;!(VPB%[`1)L0HHAUM*PP9&6>R_&3;.;F/J`M%Y(G" M4ZXBW/UC`S!QD@A7>#PCMD_<+76LBN&Z`2AF\IKK,A&$"[\F='TKN[]VPB%2 MTV)5F*CT\[GBNJF)ATIBU8RD.K]J(::$L"H/AT2%*VM7U,7:1"@>*B`T.S/= M35EML=BL]%>3H<2?9/,.GNK!3"P6;(I-7*W:$:^)9M03AV+Y0-J3:5#H+BA' M@IUK+951`6AKV;-<=H*>W`P*:*V4J44]= MXS:!,8*V""T'0[T@4\HJO5'PZ&TL>F-Q7OHY4RKC?G"A=`Y@1Z*GT[&I#K4E M[(N6Q;G/YNH&)B2I0&]C^?'F6`'4F+L069!(5-59XB<2U*^+M[Y*\L.@_8,[ MI9+7:1ZX*JY,S*T"$S<*]?V25XZ^7^. M'"]0;?OCIG@M5V77]_Y)+W?K\-NP3WX':1^B!FCO':-&)11OC.96:1ZW2>98 M@11R]_WJ"4`WYS9\>!+_%PYIFX'\+Q_G^XB)E1M%>TW5_5?U$2!BC6@_!1HQ MJ]'#WBMYAI.K3(]0(#ONH,$SXEYPQ#\/)S_U"EEWFUYBR][NZIEP&.\>YGGB MIB2E*O]A_"7U8A'ZMNC;MR5=MH>N5\<#BE+OXFEIYAP`#CG+JI(MAMV$)INU M424J%[VB9#*1X*A*^M%K^64)Q(7OSM*PE(!8WI$\LW[)=JN<7VTH/=DO5%6* MY9P1>*@[RL'5,74_E*<1;M-30.-`9?IZUI/\42+K7_?XM:,GU*MA#MUF`CHV;>5\OU@B MLH=2T?B4]0HOS_L[T)LLITU("U<,:7['([VUEIGTV>__(`&:W M4RZSM"+13#7]]MF3G:?$9(H'D`/.Z`8NR;X$K1Z:JH&>[0NX(3BZ]MTEJY+X M-LAO#Y.N^KR]>7M]E2]552+::>Z@=]]+]<+<10[@Y82*`,?[!;W?+ M_OEK77'B4K_")1?V)[4P=IDZD]/EEOITQ]+IX-@YO96O>;7]N"1\.>9Q:W3\(D_P[(1(,^R1*9@7#: M;=.)-^1_#P#'4'*_(W!^1^!L@6*)Z)G?$3C@7Q/9Q.-7?T,(G-L?2`;0)S/` MK+<@):+/#S`;[`\7U6PX_]=5(BO61%:,2$5`**8S\24&B?5(_FE"?80,^HA22\$`ZD!W3`@D_`Q M<`CGAM[B$TH9H-#,`4(60K=`H2^958D^[IGO,;_R=BWR5&83>0L9I1RCWN_F M[T%!(-5X6R\N32"H-0.26(J]<$4B"V@YEJ0)L)>*H75RC3[X>7BN28H1KV%X)(6S` M;X^)/8`5H%.'/C1"3V(1-.:&@.H,&,5JD]_C_-IG!^@%BIR>?+')K5]U5U58 MSS-+'-`XR,YP$E<,.Y"UV"A3R1T-(79E&RO&J8(L@H0\LSR= M:%1Y[4.2K2LUPOP+*$>PP%.E,[+4)@]95HR?D(,P!5_RBFN")?.BY!BM_IC_ M.#\4:O*Z6I"R4[VJT[S,V)CV4(60HS+Y,*4 MV?V9<:KXS.$S]Z.`/=P",73E2FS.9>@+OWNN&T0R+I&;.WX+9D0F4R>3#28< MUV1P%GS[='?GF7\=\UN>3=@EJ$`7I?)0@K12ZE2'C'K\_-5S\T!@B6%MD%BH M9N9E7:#/GN-`D(_"OMH5J]U.9,0D3*;907'1LCYQ*5Z&I4A:"U$9+:N#^*"" MR,`$W7Q"QJRC9KY]Y4:;KJB;V9,4\V4.@KA^%'CU!]Y;P5.@A'T_[2#=\2"7 M<[J%]`PAI"XLL&C3!$T$N&PBSP/^^\HGK8Q^E+J2<^"DP]3&[[0L@'Y*B8)L MY#X\AMV)PD8-Q3OS>^"@ALQ-8:A_;<3=<"YXC[Q<$8N[@BP0(MX3+H*DO2+J M)^1@L6?]'CP/V6%BD&&^(FNW^@G*ALZ"\G3($B[4'@)@&""/'X4HI>;L7KU\ MN;.[N[L5Y3G_3]>T,Q*70`S^[X\[KYX^8SRFYA0S&-2^^;D#'-=1'CF/30]^ M*V'#;>$[=GX)XJT.3G`))TQ+!TURT!4O>B.#U1X7%[85_PYA#8/3T[MJ-.JC MY>B_2DOA$H,HGQ5G^_J3"%DQ+B@VO)BI*):;Y7]"O'@>Z5M?U2=.,CT<@IZ& MI\]W#_+_$+4+>K8S&FX0;69(E:+&+?I7 MV;R(WC6=1"-)E:I,=$\&IPT[)2BB5DCEKO_@4I\$ZG$(T=49S8AM?KZ^^>@G MJ;!;CDBTD2JM(AHJ=YJSXUY=?`"![+R46I;P[HGJ7'*!Q&@)%`4U?<70N$,N M/A9$,S:!]04"Z^^7[:VHX1Z7K='1/:[:!BH>%M/"1VL.6=]>OT$4]GWPUWXB M7X>ZML2]_U,0US#7(]P5[A+)]CGCJV_]+3D(=]_,+K:)O7,UNB`O$\^393D9 M7!'W,?!7[I%X38D%*UOS-P'U\\WW^M/>G3L-R`YGU1/O$!6&DBZ"JI8\ZP_. MS)$\ZQ-O0Z5*"!>B9+%XV[]ZOJO;4'W7Q!PN?LMJG(F^:\2`IZE@).:J4=>/ M3$E6>/+R\J5<$ESKX3#^$BF&ZWZWT:YR4_@AW_([^2`_HB7:! ME<%'CE!E4F=CY9!O0<@(RA78NRYJ&^9/SF3(()_L>!%A1V$)+UXPX!?JB'W0 M/T]W=I_9;]:["61A//K,W:C\W)KLXT=/'ULA_>^YW1KN?Y(/;;6;DFW((R6[ M(>G_*D]WJV^L$1*7V^][]>_69/B]7_]NY1&Y:J'Z M^R1I(:%RF@O+JCUR@?Q.UBU&U2DEIZ>PR0*54\GHK]]1A/]E^G(^&G_=7PG M';E^CH-'U".5FZ1*ZCM2"5&=\T$_CBL+R&J.2$N'2ON;7#N?OE_HM%\VTUQ* M/VQ/^;,#6SY[Y.ED&G+):*E[2JGCV/U*49[&51B.R"7/U9(QW\`;[>I!W/9\ M5.I]S41-"E;+QHBB%.![B$/ARF(<':?B3^;?-HRA.^19-23,:Y&P0+D=J@>O_O!]-$?$]PA1G4_AD7TJ!%429 M.=P.CM$XP(+QD%`R-`ISBXPQ$+(_.<8F675M2IQ?W"$GKSN'!(P@/FBJ`F%6 M^O\6$RNF8[<3SQ^+Z:T=\(.48;N]^L;V+@V11P%/]0P7><+\JQJX(DQ[=PE+O#7)QGUR M]N,2K=`<5YY,87;@.2/K)YSIAB>V8`9HYCR1'9E'^MBM]BD=+18N'80^9C&- M=1\[GE#4USQW)I4I&D#J9H.]#C[NJ<4,<>OC]$2ALC^Q`6GONS;X"-7AS$#C M4<,K%+/Y\=%1;_:NFAQ4\^'A>'@P[/;86LWSG'.9Z8SG^(;3$2U1$B?UG(;W6XO.!OU1 M;SZWP<56]ZHV.K=C`< M]QA);U0-Q_/%[-C2Z&];A5X&"]?A:-C;&XZ&"ZW-T:`W/\;)7DW&B#V,_WC& M=`\K6YF\;;^X3.8N4&]LQ:'1U.FK@EJO4:3\>'#T?`-PW33R`=V,)SW699W M`]X%'(SW\\_]WOQUA4V=(8_:+.I#=GY\.+3IN&6:+%X/9M7B=6]<'4XF^V^' MHU'>Z&PP8@OWJVEOII7,/P_^K(<-CH?SUS:+FB[S@ON#&>-:,+MT6VT57@_V M#[5.O3Z?;;_65`Z[^BXOLS<8#S@=HAN(EX76BY/5P:"W8./SPO4##3:"M>\S MS.2?@#2U?YS`-H*?OQY.IS8%")W5W!_IC_YDWN+6F(P?S@8'Q^-]1U?[;XRB MIKUW[KD(D9;V@E,XJ^:#V9MA'_I=3*J]0<6YVF?UJH-CS8D!S:&$_FN;PCZC M'$VF?A>Z%G*^F/3_]2%43T.LP70PGML)-XJ>["UZP[%&/CB:CB;O!H,X@'S] M1&6+=XV=''*^:961>E*I$NH*#1;T<\QQFJG;REX*G+T2/`\F=MEE]TZ(;M+5ZY$`DB6_<;-7X&"6^_0?DE]HP:U/ M<,C5N20*@2\8+78^C";\O>1I.9DM\*HAJKADU!$D'+4RXA1,:)``<9G,]C3, MUJ,F)%B8TS`MQ'I@9.`UL:M;H`I)[>2#J^6:YP'!Y8_*I<-W9"N9:(,O,(S8 M++YDP+GCH6MSDJX-T7G%%F)??BKRALEFBUDZ4P;<:];B<&]F)N,M[6446%S$3#:B6CC(L3I.;V] MY=BUNM+]\4-QV?J8N4,K3L4AN<3USW^65VPQCE$QHI-3I5J)A]RL/OY-0QB< M2WVJ/6PL(HXG4M@[OZI(F7&I!U$5J@)/N\H'K0G7[ER;?G@MT0"(>)%XF"W9Y=P[C<4]0^`XC\PV]8HU9@CN`?O2NZKEA]BC[\Y*G8*`&Z14? MKI9_@RR=B\@>1SOL]:;8=S1BADU-00>5'):U\PQ">7GS5>"4F,4'!!PF:*7M M99'<(VXZA)YV`I[ M*]$A'S0>^!.Q0WHO],.21"S:'@-V[`<@X!/``^Y>U38&T `+NG+&:/JD$8 M67'*_'WA+@_VMC9^UDELL9VY*36HB4W16P8U\Q_P,!W0U?/K3T:BS)2)D)0% M_=-K@,T0[?MH@0M9.TL=,$0/3LA#A0<2UF5/9->W26=J7J"SYEQ[9%>5I_H]\7O.S M'X&(8K]E^D6]O'!:8&5#\(/EF/KEB`;K<6) MRZC*\EE20]>1OYQJ-L73Q:^0)&69X%OM.W%)]\34.?,.>PM?X<:-+$@,[KT` M5;H3C!7J)),X2Y>A(5`P\EB>)-^6'-5(3O*:!T3*RMEO2!;&(U?O(QC%X2S, M,G)Y@I$\H(3,51I`&(S\\;.GSJ:"F]S>2-5XF09/HYX0Q.48#]L-+):LUMR1 MK[[:N<5K\FRO9;,U]G/TATK3$4H M&J@R:&6RMDA!<\I@%[5/+9,H@ER/,0\0A3^9H6WCP7L[V$-)&U2IPFF:;N>Y M>GL!NT!X3?(@,"^6!6BK/!J(,L(YK`J$<&I[>%<1,8&VBHU`41-=LYHET%]Q M)UOOSS\"W4[W43%[V/P_/H0378M=N[ODH;R#8J0_\2[Q)2SO MLUG#$2@QO=Z<\"`NDL0=#\#*I/Y@H9$4C.7OU6[!RJSA*@QXXBZ_J1_PD0WX MK1]NU?/#[=7#K?YBQ`GB"!C+GI2#@BU_;0\3J.2F&@:\W.8..\Q:79O;7CPG MFH.3Y4WU)CS_^]:CS/)2'&#_&,&;ZTNX]*6TLOX=+#@OF=S]"UB-;Q#-'$"E MZ1=%!9F)7D]&#'?^G?$2V$K7G-*KL+:9YTUV&JNZFO5&&IF%-A2/QJ2HFFJC-Y!V:ZM>*KNGD]#NR:>*[.P>/WT#45 M<1+J`D'%AW?EG4QFA[UQL'F)P8O7FP4,7K@/5FYY">;WP?%\O_JV.-#D8GE4 M/7:25S.9(YZE`&,^]U MK"%3?B<3@C$ZB-*8HP;$84Y@WFR\#=C[*XQPA;3PW=,_(DX7KT5_5_PRE@E/ M8]`9R+N9)-AL8.^)7Y4#]4DBOA_]YW;4,2,PV5BG(0#A(P'7NBI@YAM01UD) M#H3(.JH#]J*3?O%]_XOTJV8&V%OO8]62^"``D\7A8VNQY'QO!!"4D9^LA(MK MJ97W9"AA&=JQY:]>/=EY^7PW'%U_7-?,@CDF,Y`RL6D"&DL^B4(VLSE\J?P^ M-H1/OXT.*:873!$QO2(=MO9/:*H>HA5^8F3.0*2'.>*/,GZ%&+Z(*KO7Y)3O)PWN;O=])ZM)5V^+>V#C'7`/8:>W6,R&>\>FC^.>7@Q0EQ:U.)7+"E_; M[]8)D[;1,=9,NWNK8/DJ8K2&B@=R3WR?7"KR&0O#WIOA?=N3\(LJAL4; MF?AADB9^WIO=MRTO(&_;W+Q?[6'YP0SL8[=E%D:+.2&\IY#),NLUQNM-JM:T MPRQ=JP[1TIM/-%25KG%"7+[I68G-S'O_ZZ,TD]I']'OQP8G]H;V!MY#G_:56 M:6]DWC2[6&4'B'LA*+^],2O?]6?G9+X^Q01+%)+=9;+`(^3D8YA[NZ8IE@B= ML)>;O`S`"K`FWP'JO%_/J<`849:=" MQ%B?7` MCX`+_F_F$RADWDX[;\4H\GGUCH2D\2`>&33V!YPVX%NR[P9WT>;SME4S>=^D M8,$7`-SS6E*G]Q_Q__:MS&OW_!I(\TYK1P],O=YY55#5$FU7GQ",G6EZ!,#5 MS+(Z6JM;LR'ON!#)38?1*S4\WW9B_B_O]^$MT;H/3"^WV-W-/)0/9IOZ=F%V MCW&#X<%&EG>;V#]"G&5\@CWP1\\@HNM_PP^;[0S0X1)?^ M\#<`$=7KBY/+\.1QRB,=X9I?!^^.L](;:PV6_*?58?'$1MEMTY5A\U\!8O.+`=99]2.B+$-AQ=?(1^KZV4[ MW4V"2A],!'D6(A0@.+ZKC5\SZ# M+.KF]B9O0,K+F6@+"ZZPP,N=9H:@AJ4JK\'%V$ANH0`;E]W"J086MK*ITC9U MG"M(S#:8620VY2W?9Y&J?SL&SSV8@5C=N*?SBT^/*O]"4>$]N$>G:P`EDVUM MG\'HF.M>9GFL;PU=&*1"K`VBX=6D9CCDCGG?T0>CW=,J[OJ*QKVC-H2/^LG3 M/]@Q])DW]"8G9,+Z@,B20AN>9D/V`O860F MKD)N!$Y4.;8%PXLG;JP95E.??*S@%_LDME%`+]BZL+)">]0>:&89MVX'.+5,4`4K$XB(3F MC:&K.#@(^QYSFL4`JMA`T:U;J-Y/M]6D=L%5!QCUW8(5%=:>T#>]V7!R#'K> MV/L]F`)I9/`:>COJ__GGVQ_2%T5()@0O=\^C%AS#:BJI"K"\>PSVOY\6VEN^ MLA7;((HH6HVLW;RYK7M2U`G,/=9=>-XN"MN75YA]3@BEF"?$+]>IUW"U0?EX M5^5(726RVCF]N*YEQ$B/H"5\(J%BQ*%#Q=1S<.!'UDK9B0@%F\NE4J7X,:': M:5X#<%T(@G4G]%CT<]^5V1X$QQM=Q%V&=26>LIPN M='VZC&);5YEQ2=]*6@BC61F/*Z2!M.F28YI,YO<3).\F&\D]&LNG&,XW%I0Z M!5:0/R4)GB7"RI4)*QX%VM52@+Y@1L/RL>1&R)LPNT2CPQ,3.HMROB>6,^\, M@4G/J5BDM81&#S''5.(;,5$R@>\X3(/U'&5=2;;\463?2-%`><=AO>S54^X3 M7]N/IUW^/%O7H/<'FT]"NH_12]ZK;BW3;\5+WTO>^SG@YIC]"BM;D/C\N$@2 M%PVHT+B6B(@U=O.3!\@9UVW(Z ML:+JJ`43YB/^-Y1RB0`V%#H@V(=<;)M*\4;0QD);0&2-4XF\HL-G+1:7?!B! MF>7K%#&Q;1C>O+"%L.(K.5Z\GLR&_XZW0<;U!#M=]],%%QQ?_]QMQ&EO7S'2 MLSEA\G)QN!C>M,]\D%YDM1;`9D3ANK_/QS)UHWX&+ M-,DAK])<+EL@%Z%Q+UQD<=,VFVT"(XO"O2L7@^E7+1E^/MI],2I!T`-WET(B MB#];E)=M#L%"-B"!--UF5PUKU$PJ:TO8;9"7&/SY]7"/]Q9Z\OWV23]P3(8' M;,U'0[)?+"9C0^G/!F.LT0OR;1!='L]FUYE)4;2%JK!_<=8-L;WW8/+9.!G7 M(QC=]N1%/![2DY[/O:)K@:M39&P'+SKYR:5R]M$E8NEHR!-!YYGS'67WJ^_, M;C/\;\G+Y74"E*)#@OB59X#0?I)#'<]<.@]C:;43=7I,%H2>V,_A;&!Q]ILW MS"D9SMY<*!D.,-VA@4`7OV1(^<<;I(`>:K=YYVKAM_CHSSMAK=V$JB; MZC;='_9F^X,QGBZ,<([*+6<-`1";R;B[;KZQLXOE3Z=WO$;!:R$7'Q`J%8^6 M%\+JH2`$X=\MA%FTQGW3(I?AU4SV!$:BV#K:]O9A@2F0%7V0]Z8@@4AF^7BB M:FJ1EI?K:^0DH\=Q>VIS8H#]-B*-*TP M<+2Z>#[T:+1%T]SI^MQP7S-3=AM(*X3M30Z;TE>8Z@2`#?]13*X8C;)PN!%^J;;P.TJ\=2:B`K+FP)Q=\`$L)#AMSX2S ML2O80U/S/N>.MQN=MXHW/:<,THS7A?&IF*`JA(D$,TX'4?-YNZW5=)#^ZXZ@ MV!*7E1Z\JR.]VQRNG0-Z)JT3$L+]?`J_-RR5K$4C7K;%M4%[:Y(UV\;^^ M9BWD-*^9]..'I(VZXJAX:XV9'\BP8D@[\(`_-9,V+3QC'U%X_D4^RR.Q.FI[6\-\UG#?9LA" MDIND:09H"VC-!]98H)@\`Y3BF MNGSK;&&;[.!=9F*7LE%J0V*:RWL[-AQ;:4J*.^(NZ!FP+1Q-3;:9M, MOA!KV_%1X]NT$P*AL[)="Y8X,5"YS5$)]4=INJM:K5[@\(045R3U>F.6U*X: MD^,%$NMX7^@@W;2#/P]F_>'<8MLC,XM<*E\=3XJKAA?;4VKJ+.KJW:CF(NURIK1. M+.QA[>#O"Z!%]H$[!/&1T,4/D!YDF22*]__'G%MG&@V/Z\>_('=-OK_?/7.S MJ9ZYR%1\W8\QM'\I-([O=GW!5Z'@T]W6@JT+6XPPV]&NI73LAX/1++^JE$?] M40&HCWW[XL81/)FD/W5UUUI__:)N2Q2M3?_291F3G!*\B/(F6@;+,A*ER_YE M]*QX9,ZC;H@USHRN1?+73O588;:&OKN](9F\!-;@F,JI;(LJ!<&)+].FR\FB MQQSQEG4-R:6#$'^YN>`)L)6<3#(&DQR@JXJSQC&!A_A9B@ET5NM,CQ`3@T96 MVK4%B5T*.QC11/,AEDRP/6EFT&`@RU>R=S@=(5U*@;[[)*/X MTY?/+?(J!LM4Y^P.#(O7J"[OE%W'(:TC)#[ZV?*^2F'.F1CDB<0V@5F!/&57 M>:W$6V0VRP!7SLO-EW]UG,0!X[N*U1=>M`^<7WPB)71A$=N\-??`39DIN$NY M-9ND5XL+!(G9))\XFV3Q<>4PQ\%U;-(2:'3P\?C]E(@3B&)U2;C6`VTTJ1,Y MHCXL0#O<^_"IT-1\DS[#I%EWC"`LEY.1"S>6LO19Y%0@AGPW*,B##1EI%(7H M/I"="R5NMSE9K\1/]BVGA)E=Y#4DM=WY!YE5D"8-FIFW/S)7#3YS&3Q%RV^6 M5[S=^>/=636=]A?[O;S"JIV&0"ENK.IMFU_`^!@U;=-=C8EWF:O%@A&K!F3! MQA4AJ3_FZ=W(!6-$[(!>44CJA39#=4@@)40LFL3)DI&DQ$%TZ3X4WZ-)%7<*W MJCLJ!G\4KC/%8)&A[()$*#A:2"H#2DCY:#;N97@R6EFR[BR%'7Y'73YJ1##U MNHEBNNN3TNP?N^0Q7]U`WJ_F.O49"585>_S+'NEM-N,C*J*#*GDO>WW_\T-C M@@LL^"'<,Z_@[NM&?WD1GV[[B-S81\='2N#E4G5OWC\7,G/DM3V@,,:`NK,* M^J1B6865P7L%\S@`TH'"\`X]0?#99R4X\YXM//_J%EYLWX);ZN+N@MNMRY^D M1P#TY$%<[7Q[MJN?UP(@*LQ+C3!'6_[%Y-K6V#V(MJC./=-"NN5*NQ7-J^=3 MS9_TJQ983$+JNWI=N^1*!]C>=6D8\[;M(_DDC1S;/SJH][/\HX'$PW.S^4?G M`_"Y6_./%BH48BWRCVLGFQ<>@S6(:9[<=69NFBX+/;>@LUP'RWJHG#?L3">T MC1)@UXX!0B5/ZX?EN1"%G77L=NVZ7'U:F*CV>3M7WM@<>R*77/V4%\1MEK2. M@LGK6>L+)B]U!1-;4X?NZ*`<2:9[=]0K![:AGAFK$0+"NT%YNZU8"%*,Q]O% MEK\=_N#B!P0($B84\)H(HJ=W>/->.),6&Q9+(BDHM`4)@!!!_\=2>37&-1H_ M;\2,7"LSWE'O`,OUK]1LI*:PE39*%Y)\78!V''%/R`[A#/!#YS33^.[74+$, MV(9]=,.!(J2MHWQ1BDKN!\,S:G_R\G%(@5S-DINWDM<*"Z%8"$;"9$,[>4E9 MO]+OX:!56_7S71&W_\^KU>T/_T\`````__\#`%!+`P04``8`"````"$`Q?"N MRQ8#``"]"@``&````'AL+W=O[$7*$Q$V.*]:0&7HC`MW/ M/W^:;AE_%B4AT@&%1LQ0*64[\3R1E:3&PF4M:6"D8+S&$F[YVA,M)SC7D^K* M"WT_\6I,&V04)OP:#584-",IRS8U::01X:3"$OR+DK9BKU9GU\C5F#]OVKN, MU2U(K&A%Y9L614Z=39[6#>-X54'NUV"`L[VVOCF1KVG&F6"%=$'.,T9/,X^] ML0=*\VE.(8$JN\-),4,/P20-?.3-I[I`?RG9BJ-K1Y1L^Y73_#MM"%0;UDFM MP(JQ9X4^Y>HOF.R=S'[4*_"3.SDI\*:2O]CV&Z'K4L)RQY!(!9OD;RD1&504 M9-PP5DH9J\``?#LU5:T!%<&O^G=+F!< MM%@U"(I\OCQ0%S7G04W24X$6L*8O\\2?>B^P#-D.69PB89=8GA)! MTD72,\CP@'B0X!`#*GM[##4)XB+G/49PD-=)%P:!PAR0J$LL/R32/J(3`IP< MA^A?`P7/$&@?G"56A1<&&>L%"K[?S\Y7"S;G8'"/%4;^ON>Q]TN=BM[WY[V3?'\FD+>7\3NES_ MB-V_&(7?U>MCTS;/W2V$6Z'0<<[9*EM!I,?[30T9N+(OCM7SP_*CN+-:+5>/ M]WV!_JVKMS;X>]&^-F^_'.O-[_6^@FK#/+D9>&J:SP[];>/^!1>O1E=_ZF?@ MS^-B4SV77[;=7\W;KU7]\MK!=!O(R"5VM_ENJW8-%84PM]*X2.MF"P+@YV)7 MN]:`BI3?^M]O]:9[?5BJ^-8DD1*`+YZJMOM4NY#+Q?I+VS6[_Q`2/A0&D3X( M_/9!A+R5J1$FOB**\E%T&&6FE!6FU5?)EEWY>']LWA;0>B"\/92ND<4=!#Y? M%JB'8S\ZN+\$,FYA+K\^"G._^@KE7WLD'R.2$L68$#%%[!DD.2$K4'Z2#Q6= M+]_!,'_+Q2`_/87M,\P1@4*<$$6)XB)AIP@B'I3,%^_@AR7$/BD3&966(Y+T M$Y,:%;.R%N&XEEHG;/)L"$!O9D-UB&XHSWS=#J:Z9<1T(Y)B0\4Z2X?W[6>E M((!)HX@!%@'=1QBB$]&P6N>+=C`3+9AH1+SH-$JB:'AC5(T$%]6/V1]CPVP. M?49DQ]?(=C"3S59?C@C*3G2F>8^$XTI%&1NWX;B(TS31I[H0W`>SNK,M(4?$UUWK4=7#\223['(;#JM(#=U$1`NP]?DE M[VDF>PB,-?<,ZK[12K%)*2@@)`>L!_CRI;J=4.ED:4LRTX%\B@,!$K,UZAEQ'KD>FJ.YL* MM+LCG8(.NG!V07,C.;`=(A?(^*[!)$[;6S]!!452D<2\Y3TQG8(SK""%"]+1 MWD+IBIE-+I#QY=>)2!*&%!0Q!J9HI!VC3&MWWC5?.SH=TJ\*Q`^LV_0\4@"@W'X51NZXHV,QZ4G@$ACUGE6(("%OTFC MH40T!>=A00H7^@8=CTAGUI.+T!5EK%E'%&1<:7Y>L&1<&S'LLU2X,[#YPM'N MB/`AL*\Y,K[AS?CX)2X`=@*@VIV)S=>.ED>TLZ+F@MABK$62#A/N]YD0D2+3 MTC#$DB@R2H0<^I(D(*^RUYZF1YK`M['XGH'=XMTSS67$3B(T@ZN,5HZ-5G&C M]8QOGRB3DB,%03(-9WRV>"PA((`,[ERH?FB'^2TD'4T/.(K;K6=0OX3'"`D_ M*1`BS40V4H]OXT-$,K@OH^*9WTYO.G+LLXKM=KEG\)VS>'2H).,B@WLKZL*6 M`"8\E5+ESLYFKUR)YA>N7,W>./>,;QNWW[%]J2"$%#$_XED"P'V*'-8U%<]\ M=IY=N>=)K'?T\`9^]89^*Z)$L\XH?!#?&7`X9MUG"2`R$0`T!V=KP03,S`'- MD$S$L+7Y'$)'A1SJ^Q6CNV6MW7N&=\2)AN?80J""+B_AJ,.<:85GZ5R:JQR6JV M_>6>\347:::"TXGO%PR#")PQ5T#LV6<--5H4. MFLHX8S:/ M3RQE)#P[-^\FP6QWYB)&WPSWT6">^UKG"AE,)LE2Q6\*"D+H&.9CZ)4^AB7$ M39)%.G!Y,AF:F>^\//JKJ`GSALX]XR=%:2@XZ_F"(E+`C#!7L1XYOZ713*[R M8CWV8L.]V#.3&6`8CYS/`!&^E5'MSO=FN[%&ER1=Q.J6>P:%:2,5OZDM""%- M%$&PO=V]R:W-H965T+Z25;HD6LC5)WA)(HQXC53N:BW&?[S^^YBAI&QM,YII6J>X6=N\/7RZY?% M0>F=*3FW"!AJD^'2VF9.B&$EE]1$JN$U1`JE);6PU%MB&LUI[I-D149QG!)) M18T#PUR?PJ&*0C!^J]A>\MH&$LTK:D&_*45C7M@D.X5.4KW;-Q=,R08H-J(2 M]MF38B39_'Y;*TTW%=3]E%Q2]L+M%P-Z*9A61A4V`CH2A`YKOB)7!)B6BUQ` M!1VS+#XS2:3.-Q`G"TX<;>"4>)$=L;J^2_`$J.5(%D="2! M^Y$D&46CV229I&>PC(\L<']E.5$*"65YEVZII(GCAX4U?<:1:ZI`S#.[HBK_H2 M5@$T]0Y/)W'<#Z^[X7$,OS;>TP=%GJ_/);W5E[R^()@80#.OKR_`Q]$]@VA?X^?@Y\$#8F]%?!5#H;/I.:T,<_&O' MXW4\@[1PXH6]W-`M?Z!Z*VJ#*EY`3AQ-H38=SKNPL*KQ>W:C+)Q3_K&$SQ*' M#1U'`"Z4LB\+=Z*V'[KE?P```/__`P!02P,$%``&``@````A`+.6$F-F`P`` MDPH``!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/^` M>"^?(2112%5"NDW:I&G:Q[,#)E@%C&RG:?_]KG$@8-JTY2$!,2,$UI'IFLYIH'KE&:D/D3FG]_W-PO3X`+5&2IIC2/S&7/S=O/YT_I$ MV0,O,!8&,-0\,@LAFI5M\[3`%>(6;7`-;W+**B3@D1ULWC",LG925=J>X\SM M"I':5`PK]AX.FNS@V-RFM&J#8 MDY*(YY;4-*IT]>U04X;V)>A^6DO;6#: MK#,""J3M!L-Y9-ZYJUUHVIMUZ\]?@D]\<&_P@IZ^,))])S4&LR%-,@%[2A\D M]%LFAV"R/9E]WR;@)S,RG*-C*7[1TU=,#H6`;`<@2.I:9<\)YBD8"C26%TBF ME)80`/P:%9&5`8:@I_;_1#)11*8_MX+0\5V`&WO,Q3V1E*:1'KF@U3\%C*@\B!PWB!9 MQ^X*B#M[E)C>L-?\`J,DR9UDB[BU^"9?S=PK$:`.Y>D+;N=HH( M_7%HR13BSL>0W0N0L(>,]$#M#/7(1/FP&Z[KDI,`-Y`!>=&4Q`H$U=5KU81L MWT0D;R)VUQ`CH1#(QX7*29$);O8:0*@F(U8@-PC:"G4L1\O&5@?,EHL^&:H@ M=80WGSG#2ZOYG8YW_6`('^R1D0>P$S_N@9PT\6`V%A`KT,4#;SY_):!6\%;' MNXZW'%UC_D3'!_"!&E[!&+_3\>[,']$O>_S((/C4#`VZO@LD>&*,%DBL0!=C M`@\:]>#2=LU6P_=AJCI1;R'[?3UJQ;B[AAA)#3\B58(G4K4RCQ7H(G4Q"T>> M:T6_U?%0,=?PB8Y?>&.\9CVT?QGT)1XO7`Z,=P;[6!FCFKUJ8Q5F![S%9C_1GCSI,?=VT\=E?0RK@--#>%G#XP]#-'`O`.:6B>Y`MJS].;OX#``#_ M_P,`4$L#!!0`!@`(````(0"5PGH%L`(``!D'```9````>&PO=V]R:W-H965T M<6@4-M4EQ:VRP(,:SDDII` M-;R&E5QI22T,=4%,HSG-VDVR(G$83HFDHL;>8:%O\5!Y+AA_4&PO>6V]B>85 MM4'Z>]@W%B!^/*X.C6?@*\W^FF9R_^0#+K)0,42-+M M*$X,M3YY\SR9]+Z>SFLF)YKQ4+&YIABP@J"U$;5/$<+,-@!IG2OK?Y@55-VR"VRD)/:A]+ M^`1QN%-A`.)<*=L-W(WM/VJK?P```/__`P!02P,$%``&``@````A`(M0-C:/ M`P``90P``!D```!X;"]W;W)K&ULG)==;YLP%(;O M)^T_(-\WQ!#RI9"J2=6MTB9-TSZN'3#!*F!D.TW[[W>,"0&3D&HW:0CO>7G. M.3[&7=V_Y9GS2H5DO`@1'HV10XN(QZS8A^CWKZ>[.7*D(D5,,E[0$+U3B>[7 MGS^MCER\R)12Y8!#(4.4*E4N75=&*!)PB+ZR*-#3@ME3`3-B`)^F;)2GMSRZ"-V.1$OA_(N MXGD)%CN6,?5>F2(GCY;/^X(+LLL@[S<\(=')N[KHV>F_/A%L/@;*RA4&_JD M.[#C_$5+GV/]$P2[O>BGJ@,_A!/3A!PR]9,?OU*V3Q6T.X",=&++^/V1R@@J M"C8C+]!.$<\``#Z=G.FE`14A;]7?(XM5&B)_.@IF8Q^#W-E1J9Z8MD1.=)"* MYW^-"-=6QL2K37R@-_<]?S3Q@MG\`RZN(:H2?"2*K%>"'QU8-?!,61*]!O$2 MG$^9&8XFUVNI0H[:Y$&[A&B*',A"0G]>U]@/\,I]A:)&M6AC1/!Y%G45V[YB MYC42%X@;;"A&&_MR(TYT6JSI=&,T[L;\T"8Y/Z92;/L*/+U,`D5KD^@"^K#` MAHET4(C@(>=2^('%L#&B24OD-PB&8V)#3FY`ZJ`=I(6R,:%[U?+$( M/&RGL6TK`L_W\6S6I-&!A%&P(2=7A^S46QW4@YPT#S#]-B(`:LY MI.C44[\B6_O/\-AH<0]N8<$9T:1:D;`?VV36[7,7.EB++M;'IEH'V7C3L85G M1$.U&U)T(#&,<+MXFO+V6%=1-F9@E6E3JX8&NR,9G&RL-_96ES7H[=&NHFS0 M:>^M8EX:0P6MC2Y+NA75^[X%>GN\L7E;6-OY>6693:A6M2DN#/AEU94)Q__U M\JFB>G6UWSZUJHUKK9'MH*1;5[!IUW5XS.$HUQ^DP)[S6G5UT.W[YWX8-'/: M,X>AG(H]W=(LDT[$#_HDAV'_:'YM3ID/7G5.;&[`(:\D>_J=B#TKI)/1!$+' M([UDA#DFF@O%R^JHM>,*CG?5UQ2.\Q0.(^,1B!/.U>E"'T2;?Q#6_P```/__ M`P!02P,$%``&``@````A`%-:8916`P``$`P``!D```!X;"]W;W)K&ULE%9=;YLP%'V?M/^`_%[`^4X44K6KNE7:I&G:Q[,#)E@% MC&RG:?_]KNV$\)%2YR4)<#C']Q[[Y*YO7XO<>Z%",EY&"/LA\F@9\X25NPC] M^?UXLT">5*1,2,Y+&J$W*M'MYO.G]8&+9YE1JCQ@*&6$,J6J51#(.*,%D3ZO M:`E/4BX*HN!2[`)9"4H2\U*1!Z,PG`4%826R#"OAPL'3E,7T@]]5-S(L**+8L9^K-D"*OB%=/NY(+LLVA[E<\(?&) MVUSTZ`L6"RYYJGR@"^Q"^S4O@V4`3)MUPJ`"W79/T#1"=WAUCQI"-WY[,^.&K8,EW5E+H-OBD'=AR_JRA3XF^!2\'O;&M`1\FJ^#RQ1683& M,W\Z#\<8X-Z62O7(-"7RXKU4O/AG0?A(94E&1Q+X/I+@F3\93><+!Y;`KL@4 M^$`4V:P%/WBP:T!35D3O0;P"YE-E=AUUK>^5"C5JDCO-$J$9\J`*"?Z\;/!X M-EX'+]#4^`BZMR#XK$'S40T)8#WUHF`AS45=;O-)6X.UMFZ[7LR]O='4P;/+ M.N.VCBY^#)MC6$^_%"$0JU@%V#!4T:H',W6J4"Q+U4#>Y)3SO2%C0W M+H3ULY8H;#IW40WNB9X;:NNUH,F0*.P.=U$-;HLNPW,'K:;%#&K.K]'4X+8F M&#NO.VA%+:Y]&*^UT,7AG"J[]8#X=W(C'3U`YC'*K*C M/XC8L5)Z.4WAU="?@^'"3G3V0O'*3$5;KF`2,S\SF+PI3!:A#^"4&ULE%5;;YLP%'Z?M/]@^;T8DA#:**1J566K MM$G5M,NS8TRPBC&RG=N_W[&=.\F6O@1,OO-=SC%F_+B6-5IR;81JG$\))**!@>&D;Z%0Y6E8/Q%L87D MC0TDFM?4@G]3B=;LV"2[A4Y2_;YH[YB2+5#,1"WLQI-B)-GH==XH36":654:2.@(\%H-_,#>2#`-!D7`A*XMB/-RQP_):/G#)/)V/?G MM^`K'?2U<(^@F'2JIWX`;QH5O*2+VOY0 MJZ]X/ MHS2+^PG`T8P;.Q6.$B.V,%;)/P&4;*D"26]+`M[:X,KRC%H M'%OH[06"A0#*?)=ZV2".#WTZ<0`FSQW\?Q"NJ./@$#$X"*`D3;V'.(H/%D\< M0-YC!__>`@[<41Z<90^@>Z_;A^17H@\_(NS`'>'T3#B`@G"27A7./B+LP!WA MPXX.O0Z@,.W!!>%PPH0WL*5S_IWJN6@,JGD)FRB.,FB9#N=+6%C5^C=MIBR< M"_ZV@L\`A]"[3\LD[\```#__P,`4$L#!!0`!@`(````(0"Z M4^L-&0,``)`*```9````>&PO=V]R:W-H965T-X6T+N%V^"TZ-V>S&2KVC*F6"YM$'.T4;' MF6?.S`&EU2*CD$"5W>(D7Z(';Y[,D+-:M/7Y2\E!G)U;HF"'+YQFWVE-H-C0 M)M6`+6-/"OV6J;]@L#,:_=@VX">W,I+C?2E_L<-70G>%A&Z'$$CEFF>O"1$I M%!1D;#]42BDKP0#\6A55,P,*@E_:XX%FLEBB8&J'D1MX@%M;(N0C59+(2O=" MLNJ?AKQ.2HOXG0@<.Q'/M_TX],+I!U2"3@6.;RH3/XSBCWB9="IP/*IX]JTJ MCJY.6^P$2[Q:<':P8`)#?M%@M1R\.2BK*D_>K3*45XUY4(/:H4`+F!G/*R^( MHH7S#/U,.VA]$8K[T.8B-.M#R24H=D^0`U%.>:!3PSP!S+W+L^:81PV"^8&L MLSRQ=WI`&WJM(:C1"0KZQ.8JD9B(7@SP\O$8:M`2P3-.#KT@]OLFUQHRQ;A* M))J(VL[[4>BZ[S0#GG*>PMP$!8_<#TJ\UI#)_54BT43WN%3QR M/QG47D,F]U>)Y$BH5>?:[EM[>_-GVO>NEO7U9:`&C3*$@PP:,F70A*ZO!]4] MFQWM2DI,$KT443^%>?XH>.1^.G"O(>TM&%O;Z/N&=(F)Z)E7^Y#!F_5Z"]2@ M48CAFU5#78%[JZ^M[T;?-X4P$;T0LWX(..O-:3?'9,+YO5]DWD3 MH,R>.%VK2<]I*K_P```/__`P!02P,$%``&``@````A`#E5H>^@`@`` M@0<``!D```!X;"]W;W)K&ULE)7=;J,P$(7O5]IW ML'Q?#$E)0A12M:JZ6VE7JE;[<^T8$ZP"1K;3M&^_8T]"T])$Z4W`Y,SY9L9F M6%P]-S5YDL8JW>8TB6)*9"MTH=IU3O_\OKN846(=;PM>ZU;F]$5:>K7\^F6Q MU>;15E(Z`@ZMS6GE7#=GS(I*-MQ&NI,M_%-JTW`'2[-FMC.2%R&HJ=DHCB>L MX:JEZ#`WYWCHLE1"WFJQ:63KT,3(FCO(WU:JLWNW1IQCUW#SN.DNA&XZL%BI M6KF78$I)(^;WZU8;OJJA[N?DDHN]=U@,[!LEC+:Z=!'8,4QT6'/&,@9.RT6A MH`+?=F)DF=/K9'Z34;94M*Q,8ZW?Q#4;*S0I/1 MS@2N.Y,$;D\',TPDU'7+'5\NC-X2."N`LAWW)R^9@XLO:`QM^;@@J,3'7/N@ M$`IJ"YOPM$S&LVS!GJ!U8B>Z^4B4Q;V(00)]%D#^?!8^"+*EY""++.D!(=4; M%%T>B,:]XDT*X'.8PND&>'%.P?L0/>J-$8VB)$U#A^(HGO6"-V1([GRR%P_( MKR4A&46SP!VE<7RDZW#DS@=[\0!\V5>$8!1-`]ASCY$GGR%[\8"!3)V'DQ!&(2ZW=?N&G=/_Q7/X'``#__P,`4$L#!!0`!@`(````(0#O M`D/J;`(``$(&```9````>&PO=V]R:W-H965TGHWC$(LXCFQSV7_?L0TH7(IX`4S. MG'QSQO;D]2`KM./:"%5G.(EBC'C-5"[J=89__UIV7C`REM8YK53-,_S!#7Z= M?OXTV2N],27G%H%#;3)<6MN,"3&LY)*:2#6\AB>%TI):6.HU,8WF-/=%LB+= M.!X0246-@\-8/^.ABD(POE!L*WEM@XGF%;7`;TK1F).;9,_82:HWVZ;#E&S` M8B4J83^\*4:2C=_7M=)T54'?AZ1'V41&!)RF MDUQ`!RYVI'F1X;=D/.]C,IWX?/X(OC>MW\B4:O]%B_R;J#F$#6-R`U@IM7'2 M]]S]!<7DIGKI!_!#HYP7=%O9GVK_E8MU:6':?6C(]37./Q;<,`@4;**NQV"J M`@#X1%*XG0&!T(/_WHO$X,;6!TQAOU M>F=?W\(L:'HM37JIF#]27+#!B]ILST7HBC(,[V@Q]B\)9D$S/`:<)/U^]U(Q M;RN&HSB._Q,?]-E&?!R?$U^C74UN%C0O'JV3I/?8+B2/X.`$M.&>R\\574-> M[\"@"?G%5\G=?Q;F&JZ!<$P:NN;?J5Z+VJ"*%S"M.!I"L0Z70%A8U?CCL%(6 M#J__6<)=S>&LQ!&("Z7L:>&NF?/M/_T'``#__P,`4$L#!!0`!@`(````(0`B M*1=WQ@(``,`'```8````>&PO=V]R:W-H965T&ULE)7);MLP M$(;O!?H.!._1XC4V+`=)@[0!6J#H>J:ID45$%%62CI.W[U"T:2EQ4>5BB^*O M_^,L&JVNGF1%'D$;H>J,IE%""=19O3GC[N+2TJ,977.*E5#1I_!T*OU M^W>KO=(/I@2P!!UJD]'2VF89QX:7()F)5`,U[A1*2V9QJ;>Q:32PO'U(5O$H M26:Q9**FWF&IAWBHHA`<;A7?2:BM-]%0,8OG-Z5HS-%-\B%VDNF'77/!E6S0 M8B,J89];4THD7]YO:Z79IL*XG]()XT?O=O'*7@JNE5&%C=`N]@=]'?,B7L3H MM%[E`B-P:2<:BHQ>I\N;!8W7JS8_OP3L3>>:F%+M/VJ1?Q8U8+*Q3)9MOD,% MW$*.A:/$%62CU(-[]!YO)<@PK<`QS)\CY7KD*''`=*^/R+NV:E\UR:%@N\I^ M4_M/(+:E1=(4L^"2LD!R?O,3IXX/_>[X]FT72>C-/_F\3^/&VH MM\RR]4JK/<$^0Z1IF.O:=(G&Y^/!0)SVVHDS.L.,9]1@4A_7R2I^Q+3Q@^+& M*_`W*-*@B!$9N,@:SG5BQW5Y=0>Y\3>ZF-%YS/@M&"?&PG0._S(\KYAT%./S M7)0,#\^),XHQA:1-@JN/URNZW&E0]-**W32JY7=+GSH.AQL2>& MZA7=:--3`_3`[E,P^*UQ MXCXX/;T4GNPE/?(_&GKQ%K(3OR"?^M63O:1'/C6?C]D/2#\U).@M?("J,H2K MG1MX*18IW`T#_#!:PP;.PH9MX0O36U$;4D&!CR;1'!M,^VGJ%U8U[4S:*(MC ML+TL\4L)^-(G$8H+I>QQX69W^/:N_P(``/__`P!02P,$%``&``@````A`-LP M82S[`@``!0D``!D```!X;"]W;W)K&ULE)9?;YLP M%,7?)^T[6'XO8!("C4*J-E&W2JLT3?OS[(`)5@$CVVG:;[]K3$B!+J,O$.#' MR;GG7C"KFY>R0,],*BZJ&!/'PXA5B4AYM8_QKY_W5Q%&2M,JI86H6(Q?F<(W MZ\^?5DMW!+RBML%99RBH;(,IZPK4@.):NT%9&LH!K\JYS7ZJ16)E/D2BJ?#O55 M(LH:)':\X/JU$<6H3)8/^TI(NBN@[ABCT#W'\RO@^U]#M``HR=2W3URU3"00* M,HX?&*5$%&``MJCD9C(@$/K2[(\\U7F,9W.'S+T%T&C'E+[G1A&CY*"T*/]8 MAK1*5L-O-6#?:I#`F?M!&)$/J,Q:%=B?5!8?5YFW*K`_J?A.$'JS"59H3ZQ&1.AWT>V)\3,!SCM[$(?IMLUL+%K1L/XO[,GWEH;_.]F3)!P M8.T=9-$A/;/0[NEF#0P3^C8V+YIWPK8`"T&?NFP'Z6_^2VPO$3W[\#?3[1LX MQI!-Y\PG`_,6">W<1%[H>5Z?V%@"MIW(H+SMF"#^6:5G'Q[RZ?8-W+CE M'W[$OH%']L^/E9U^"[7Y!\$LBJ+A\]M#HI`,Y\=>?[\^Z]XN1_8=63*Y9QM6 M%`HEXF"6&@+-[\YVJ^"MWRQDW058A6JZ9X]4[GFE4,$RN-5S0FB^M.N8/="B M;M[`.Z%A`6I^YO"YP>!=Y3D`9T+HTX%Y$W8?,.N_````__\#`%!+`P04``8` M"````"$`ZF:5GXH"```N!P``&0```'AL+W=OOL4JP;]_+1Z>,#*6EBDM M5,D3_,X-?IE\_A3OE%Z;G'.+P*$T"]8J8 M2G.:UD&R(/U>;T0D%27V#F-]BX?*,L'X7+&-Y*7U)IH7U`*_R45ECFZ2W6(G MJ5YOJ@>F9`462U$(^UZ;8B39^&U5*DV7!>2]#X>4';WKAY:]%$PKHS(;@!WQ MH.VV1RM?NB1?I-E!R* M#6UR#5@JM7;2M]3]!<&D%;VH&_!#HY1G=%/8GVKWE8M5;J';$23D\AJG[W-N M&!04;()^Y)R8*@``?I$4;C*@('1?7WNP-0I"C)3=V(9PE1FQC MK))_O2@\6'F3_L$$K@>3L!_TGZ(P&MWA,CBXP/7LQ5CL$ MDP?@IJ)NCL,Q&+OR##O+`W5Q,:\NJ`X%M8&6;B=A..S'9`N-8`?1M"VZ4LS: MBG!T,B$`>**$PMU/Z8*@71A=4@Y.&]2I3+UH>"&Z4LP^4C0@8:=KR`',Z_\G M[5A*%Y1@V.,2?'M]>+CG"]X+$)/^M>;P".FH`?M]2)6V!7&T^]J!O,KT/U3G-Q MGDN/YH\\_S)7=,6_4[T2I4$%SR`&4H7&[Q.&- M[@4@SI2RQP=WI)Z^=)-_````__\#`%!+`P04``8`"````"$`9.Q*[\43```3 M<```&0```'AL+W=OWY^/+T;G9]O'V]WGN\>O[\__YS_1OZ[.S_;/ M-X^?;^YWC]OWYW]O]^?__O#?__7NY^[IC_VW[?;YC#0\[M^??WM^_KZZO-S? M?ML^W.PO=M^WCU3R9??TKG__K2]^7RH]'!_.1F-%I/YU+# MZNDU.G9?OMS=;H/=[8^'[>.S5/*TO;]Y)OOWW^Z^[[6VA]O7J'NX>?KCQ_=_ MW>X>OI.*3W?W=\]_'Y2>GSW<[N@+1[6=/VR_OSS^.5_UB='[YX=VA@_[W M;OMS;_U]MO^V^QD_W7TN[AZWU-OD)^&!3[O='T(T_2P05;Z$VM'!`\W3V>?M MEYL?]\_=[F>RO?OZ[9GV^OQWL-W?4H^2FHO)7&BZW=V3`?3_LX<[ M$1K4(S=_'3Y_WGU^_O;^?')],9O,EU=CDC_[M-T_1W="Y_G9[8_]\^[A_Z34 M6.F26B9*"WTJ+=/%Q7PYFIZB9*J4T*=2,IY?+,>CZ^F2+#G2^DQ5I,^WMTY- M'#J"/G7K$W,)1UI?J(I+4_%U9M,0/+1(G]KLB\G5?#Q?B)X_TN*UJDB?IYDZ MIO"2WA9QIASY.F/'0Z#0']KVX'6> M%N-*=A_Y7%=]9?=1=,BJ)DQFUC@[XNVQCA/QAVYU>7$UG\\65R^,C+$.%?&' MKGO4XDLY/QRFF^#F^>;#NZ?=SS.:P\GM^^\WXHXP7@EM>J*1E@]3SZ]F'IIR MA):/0LW[<^H_FE/V-%W^^6$^N7IW^2=-<;=*9HTR8RZQT1)B/A-J`Q>$+HA< M$+L@<4'J@LP%N0;F:I83;FJA1;2II0LJ%]0N:%S0NJ!S06^!2_+@X$8:=K_# MC4*-<*.^JK4&IB>;].?W_R-"3,DN*GD%HRCMG,XCHW@F` MA$`B(#&0!$@*)`.2#^27)A>#B#:Y!%(!J8$T0%H@'9#>)LRO=`/Z'7X5:FA6 MIH_!9SBG2J&CCAU$="\%0$(@$9`82`(D!9(!R0=BKLN)Q6(0T2:70"H@-9`& M2`ND`]+;A#F6U@G,L?[%N+XE"NF#__1%K"69TGQ@>?3:&8>#D*X6``F!1$!B M(`F0%$@&))=$+$B,T7/GUEX,0MKH$D@%I`;2`&F!=$!ZFS"'T7KD!(<):>XP M26ATZ#D#:Z!%(! MJ8$T0%H@'9#>)LR3M%UAGCP^"PII[C!)[$$%)``2`HF`Q$`2("F0#$@.I`!2 M`JF`U$`:("V0#DAO$^8*VJ\Q5[QQ4`DUW$>2+&DT6X/*W:T-0CH^`R`AD`A( M#"0!D@+)@.0#.6)T,0AIHTL@%9`:2`.D!=(!Z6W"/"E2.,R5QT?509R[3*'E ME;E9(0H0A8@B1#&B!%&**$.4:V3NJP6B$E&%J$;4(&H1=8AZAKA[Q+X;TR07 MAV71M[O;/]8[&B@DY'';E-(A*DDB=^^TI-?!MQ;Y-QI[U[2$&4;:=.PLKS9: MRFS,`XWLBO.ILSG/E=1X1+/YK_47@Y@)GG)@%+-#5;L%WD%BDWNL@_ZS^_ZK M#J*TZ-!#DBBZ^70:1N19!2=9E"`*-?H>JA8("H9XIR2Y#HFN9QJR>=3<]&Y#_%51E[`X6FO.*,+VYR)346X?MK_842FYE1 M5PXU*0JMFJ8!WB%B8V1WR`L=(?=1K",DLDS84+&X:@L%B'*%K+XI$)4,<=/% M%L$V7=PI9P1?N`11S9EF)7)\.>GH+Y28U6OE M4)/[TC3`.T0LU.T.>:$CY+J>.MC,7!)9)FS&@`)$N4+,E[*BA4HFQ4T7*],3 M3)<+66:Z1(X/EZX/E90]'B5R?.C,UOE8M>B,1T=_H<2L#BR'FMR'I@'>$6)= M>$)'R&4DZPB)V)H!4"`>4%`P6U(AH@A1C"A!E"+*$.4*62%2("H9XITEEEYV M9[UR!I`K-M9I$CG1XZ9QQ+,4=P:0R(D>,T`/BX1<571G`$=_H<18]"A;Q9W; MFLU-`ZQ#)J>M.`_B?"I4R#)A@RA`E"MD^Q)1R1`WG2X0?/GRG7DBJCF7(!'W MY'E.L6^4S@ZB^4F-61Y5"3^=)J@'>(N_HZ/IM/<)6E MD#7&-X@"1"&B"%&,*$&4(LH0Y1J9=4R!J$14(:H1-8A:1!VBGB'N'M]*4MRO M3WS(.L&EI4(\_35SM@$;(Z5OWP&B$%&$*$:4($H198AR@ZP)R[6^,%+:^A)1 MA:A&U"!J$76(>H:X=T];%D]P6:R0G1)#%"`*$46(8D0)HA11ABA'5"`J$56( M:D0-HA91AZAGB+M'K+O=&_];!I]H:X=\7.P?;N"W<^N=%@ M3I2(#3Y`P010B"A"%"-*$*6(,D0YH@)1B:A"5"-J$+6(.D0]0]P]8BMDN^>- M&>J)VE)9^T^%G#N?25T<5M,;(Z7#-T`4(HH0Q8@21"FB#%%ND#WX'.L+(Z6M M+Q%5B&I$#:(648>H9XA[5VP,;>^^,/CD/I(-/K6U-&NYS010@"A$%"&*$26( M4D09HAQ1@:A$5"&J$36(6D0=HIXA[AZQ'[3=(P:?V":=NNQ4^TI[\$G$'Q#- MG"S59C)(Z?`-$(6((D0QH@11BBA#E!MD#;ZYN\,V4MKZ$E&%J$;4(&H1=8AZ MAIAWA2.9=X\/OH,XW_PJ9-_Y$`6(0D01HAA1@BA%E"'*$16(2D05HAI1@ZA% MU"'J&>+N\>4HWK#LG&+20B'GSF?2//+.9Z1T^`:(0D01HAA1@BA%E"'*#;(& MW\RQOC!2VOH2486H1M0@:A%UB'J&N'=/2[B((U].YDDA-OBDE(4"E`H118AB M1`FB%%&&*$=4("H158AJ1`VB%E&'J&>(N\>;?6YR3W-T9* MQV^`*$04(8H1)8A21!FBW"!K]"VH9XN[Q9ES> M,OHPY3+UIES,`S)U[QND=/P&IJ)&(:((48PH090BRA#E!MFCSWEJ4!@I;6J) MJ$)4(VH0M8@Z1#U#W+TB%6)O*UY8>,K,B;WKFT(R98,H0!0BBA#%B!)$*:(, M48ZH0%0BJA#5B!I$+:(.4<\0=\]O2KE,,>6BD'/K<_9-&R.EPS=`%"**$,6( M$D0IH@Q1;I`]^)Q')861TM:7B"I$-:(&48NH0]0SQ+U[6LI%/)]T%YXJOV*. M-6R4U-*@`%&(*$(4(TH0I8@R1#FB`E&)J$)4(VH0M8@Z1#U#W#V^E,M;=GV8 M.J$!4&EU6BPLG65X9 M*=UBC;H:1*VI:*MW,A*=D=+J>Z:+QX`_^W/B>6$Z$.+.W@JQ")!2%@J4U-7U MX9O8L_%BZMRD0R.AKR9"U3&BQ%047_*>C2=+QP^ID="J,]23(RH0E0HM1^I" MINAU>?4DH5NK44^#J%6(CY*%LX_OC)16WS-=W.MN5N@P\NG7%&@R%H?$]1GH MPS]>=6)\AHDCA2CVM$4;1`&B$%&$*$:4($H198ARA:S(+!"5"BTGPP55B&JL MV"!J%=*!/[J^=@*_,Q*Z^WJFASO4ET>:CO^)0S&A-)-H01_6+=M9EVZ4%#V, MTW8'"HU'=,,9:LZNG)M7J,2N%HO:2U]N+T/EN4)6 M6!>(2D05HAI1@ZA%U"'J&>+!X6:A#H_7_E%P8*)J)A&=+=-NWR`*%%I.!ZD0 M48058T2)0M=F?DD190I9[LH5.A['A9*RXKA4Z(4XKI28BN/)#..X1N4-HO9U M[76\/=^XZ9ER'APB`V4G2?[YK4#FM.P\BO@"`^WNK+[<(`H4NJ+]_+%90NJZ MNCHR2ZCFS)>$8FPN>55SJ9;Z=7,9ZLXU,J.A0%0J9(V&"E&-%1M$K4+6:.@0 M]0K)T<#CP$V6_?,XP'S:#/-IB`)$(:((48PH090BRA#E"EDA6R`J%3H>LI66 MDC'DGQ!DS]`9"3U]-MA%)N[FR0-T9*=T2`*$04(8H1)8A21!FB7"-S`*A`5"*J$-6(&D0MH@Y1SQ#W MI)N!.XQHFAI//%4SP]2<0E8>;H,H0!0BBA#%B!)$*:(,4:X1C:_AIC)WHZXP M4CKJ2D05HAI1@ZA%U"'J&>*N=+-U+PP^3,K-%!K1+M3J!V=+O-%B9AH*$(6( M(D2Y0E:0%(A*1!6B&E&#J$74(>H98MT\=Q-BQ[OY(,[S7@I9J\T-H@!1B"A" ME"LT/N[%0HL9+Y:(*D0U0[QK1/;"7B:^T#4RV6&O`><275.BP`I`9P^X45+6 M;3?0B*:AH2)N'I74XM?WV$@K,CO37"'+7P6B$E&%J&:(=YXWW4(_@TB3\>M3 M+'-,L6@TFAP6PY/1&/I35K(N,%"5+!0J-)<[;]\")<):N4+D49%AH\:=V:10 M`I8S2X5>VD(I,9T*\&VAF'+>W;YDB/@I5]W=KUO"S#$#HI"Y8B?WNE$"UA4' MB$*%CL:J;-Q2E&M%UIY"(UU)J@>VQH&:Z>0>+ MS:D]D\IEVH:8>^AU#GA3$YG=$P??00]?0BCDY.CW^_/;G<_Q.LSQB/Q\VP#ER_WH.!=B4`A'6[)8J3?^^&6 MS*Y6(M7DJ3,C;90=\93,Y]3.X?4=KK;Y@DH.5P$E2RHYS,]00A;0[.-I9SI= MB>/TOI(9E1R^V.=JFY)M=`C85X=LD\_TH0[91F<7?77(-CHVYRF94!VY?7"U M3:B.7'5#"?4H?3/.HVU*_J$O9?E*Z(TM](4>7\F$2@[;/[>=,6FCWV[QU)E0 M'?E0UJTSH;ZF'XOPU:&^IM\I\)507]-WW'TEU-?T]6HL6<^7*['H\95<48FO MK]<4UV*N]M2AN!9#'TMR,MIKLPA=GSP9[+,W)S?[K,W)R3Y;?C'V>JC-RC79)H*2)0OS0*5[:>DRJZ%?)L(1.D-+(\CF$'F"OQ!-KK$./ MHU?B^3.64()J)3)26$)OJOKH:V5-T>4+KISF21]?B_CQZ,_%3.CA:Q&)'DX' MPI(:O%>55?R9A*?%;3.3DJ\;6S MGE$8TP-+U+:F18EX>H"['CI:2R4^J^D$_4J?IZ][@_N]]^H37GZ)"4 M?)(O=9/_>%:_COMI]TSO8J-E*;V(B5Z^MZ5W((W$:<,ON]VS_H=H8'B=WX?_ M%P```/__`P!02P,$%``&``@````A`)M\I^R)(0``+KT``!D```!X;"]W;W)K M&ULK)U;O?[P;1(-!X89W*N8B2!XT&!HUN8'IFP/?_^^]O7]_\ MZ_KN_N;V^X>3Q=O3DS?7WS_>?KKY_N>'DWE*_N?\Y,W]P]7W3U=?;[]??SCY MS_7]R?_^]M__]?Z?V[N_[K]<7S^\(0W?[S^H^/V M\^>;C]?1[<>_OUU_?]!*[JZ_7CU0_^^_W/RX-]J^?7R.NF]7=W_]_>-_/MY^ M^T$J_KCY>O/PGX/2DS??/E[F?WZ_O;OZXRM=][\79U[#_X#Z;S@AOW-W?7G#R>_+R[G\_.3=[^]/PS0 M_[NY_N?>^>\W]U]N_TGO;CY5-]^O:;3)3LH"?]S>_J5$\T\*4>5W4#LY6*"[ M>_/I^O/5WU\?AMM_LNN;/[\\D+G7=$7JPBX__2>ZOO]((TIJWB[72M/'VZ_4 M`?KWFV\W:FK0B%S]^_#WGYM/#U\^G"S/WR[.3C:/Z_N'Y$9I/'GS\>_[ MA]MO_U_++%B3UK%D'?27=:PV;]?;T]7B!4I6K(3^8D<>:?R,Z]%?KKJ;?E>O37M&A' M^I%ZY*F'GM+?EUS@!5>COZ:Y]7,&9D%34,\(-1>UN=?/&YG%<3+1?W#55\R$ MA9E/ZC]8S?9973=S:.%,HO6SC+,PTTC]![>YV+P]7Z_/-N=/&%:YFQXQ.YG( M6(^8=&'FD/H/;FWYS(Z::;2P\^AY@V/FT=(:Y_$VW^E0<8@\T=7#U6_O[V[_ M>4/AG!3<_[A2B\/B4FDS,4=?\3$*_2P(4?116GY7:CZ"#T0>3#V8'O",;'PU-_ON#S@>]#P8?C#Z8 M?#`[0%B5@N.OL*I2\^&$_OV(^VJ9+R`!D M!#(!F5TBC$_;$V'\\#V"69Z5],'&YD)WFJC=D&-U?ST^"IEJ$9`82`(D!9(! MR8$40,HCL9W>+,YD$*J.0J;3-9`&2`ND`](#&8",0"8@LTN$46G_]`*C*FEI M5$W(2\VE[X%$0&(@"9`42`8D!U(`*8%40&H@#9`62`>D!S(`&8%,0&:7"'/1 MKEV82^V=5W2G]<*]LU(C[:C)EOXXSNEOJXY"QM@1D!A(`B0%D@')@11`2B8T M6L=.;Q9KSSF/0J;3-9`&2`ND`](#&8",0"8@LTN$M>F>2UC[\8BKI*51-7&= M$T@$)`:2`$F!9$!R(`60$D@%I`;2`&F!=$!Z(`.0$<@$9':),!?E2H2YE'-N M7NZ<2HVTHR9;=YZOM][.8G\4,O,\`A(#28"D0#(@.9`"2'DDKG/Z=S]'(=/I M&D@#I`72`>F!#$!&(!.0V27"VBK3)Q*59&;G^B2A"%"-*$*6(,D0Y MH@)1B:A"5"-J$+6(.D0]H@'1B&A"-`LDC:AR%WXRZA4+JLI=>D[+R/-:;^NX MMU+&`R)$,:($48HH0Y0C*A"5%KGNN_765BME>E\C:A"UB#I$/:(!T8AH0C0+ M).>`RG2X<^`)1]:)$;I[-=>\4YEFLO[VXHCVB")$,:($48HH0Y0C*A"5!MD- M>X6H1M0@:A%UB'I$`Z(1T81H%D@:4>4L7".^-JNLHHV3T^,Z\LE)F4M:(&D0MH@Y1CVA` M-"*:$,T"21NJU(-KPR<<469N./=50EEINC^X:(8H-NCA8:GOV M=@W68CVT(3S.B^7&DRI9C[/*5XAJ1`VB%E&'J$=QWNJSYYK"XW1-!\4LQ1YW^G;EJ4F,@#MI`F;4FL5R MOEF<^POB4NOMM"LK9:9IC:A!U"+J$/6(!D0CH@G1+)`TN$H^^`9_ M18YAH9,8PN`:B0"WWE[(`+?GBD[HBA#%B!)$*:(,48ZH0%0:9+?@%:(:48.H M1=0AZA$-B$9$$Z)9(&EPE7]P#?Y$+-;I"F%7SF"XC@PH6@"*$26(4D09HAQ1 M@:@TR#4B]\NB&J4:1"VB#E&/:$`T(IH0S0()(R[]5-$KP_1!C\PA,9*W!^?> M*KFW4B;V18AB1`FB%%&&*$=4("H9+;R-GG=K5;&8LZNK$36,PK=6K:@@K>/G M@!YW,?7*DK=?9>0LC'M$$:(848(H190ARA$5B$I&S@:K0E0C:A"U`LDA50D1 M-VJI"?^*96JI]'@37B.Y3)W[CY&YHKM,(8H1)8A21!FB'%&!J&3D3WCO#K5B M,3'A]74[J&$IGO"!.]362%#=X\[(O;611E/9"M=H3_@!IT6<;?]2(^$'@"*4 MBA$EB%)$&:(<48&H9"3\0'?5035*-8A:@>20J@R!.Z2O#?PZT^`NZTN-/#_P MG]A:*1OXCQ4-BE$J090BRA#EB`I$)2/?#[Q;\XK%G$E?(VH8_?0.OS4"SW,# M=;_NVNP)-]"W]\(T?,=O]RQ[ZMOAULFB"%&,*$&4(LH0Y8@*1"4C9\Y7B&I$ M#:)6(.D&ZE[[!4.J;\W%D#)Z?*.P7VHQ9[Y$B&)&U-]0#A8KE(S\V>KE,RJL M62-J&''KWDZM-:7/FZK^[?\34Q7O\LGP:EYZB1IO.=JSE#-+(D2Q09PPI<\% MO%4Y,1*/)VNLE`E0%:*:T>)4?Y:BWMUN`JP55>6L].^EGQ@]O&5>,O)FI1?% M]BPF9J6NZ:"8I.OE+Q)3_K.9<7CD4+*4LP17B&I$#:(648>H1S0@&A%- MB&:!I+'4?:`;0M1*^HIL\U+?3XK8HI'G`YYS[[DB32,' MMV-L0K[EI5AVE-HLO$1,Q;J<'6Z-J$'4(NH0]8@&1".B"=$LD+"J>M(NK/JX M"Q[$Y>T`(V>^[Q%%B&)$":(4488H1U0@*A%5B&I$#:(648>H1S0@&A%-B&:! MI!']^^=7;G)7>&/-2%A72SDH0JD848(H190ARA$5B$J#:$$]>NW:3\145LI$ MD1I1@ZA%U"'J$0V(1D03HED@:7!:@E[BM4K<\UJ-'"/N5X`B1#&B!%&**$.4 M(RH0E8@J1#6B!E&+J$/4(QH0C8@F1+-`THCJ;M=?4%^1HEGINV9W067DW9IZ MS\7W5LJX0H0H1I0@2A%EB')$!:+2(NO(FZ6W3Z^LE.E]C:A!U"+J$/6(!D0C MH@G1+)"<`WYZXHGE%[,0*TXF.`\7$$6(8D0)HA11ABA'5"`J$56(:D0-HA91 MAZA'-"`:$4V(9H&D$?U\Q6N77TQDK#AK(=MS+T-662G3^QI1@ZA%U"'J$0V(1D03HED@.0=4WL,-YD\XLDZ3 MB)BMD5B1`44K0#&B!%&**$.4(RH0E0;97%J%J$;4(&H1=8AZ1`.B$=&$:!9( M&E'E8EPCOM:1=4Y'6%($,6($D0IH@Q1CJA`5#+RTV]> M]RL6?/'R/4#1!&B&%&"*$64(S*2/$,6($D0IH@Q1CJA`5#+R_<#K?L5B-,"F^S6BAM'/ M\NNM*7^>%ZALQ?-7@S.=W'"79$;""[24@R*4BA$EB%)$&:(<48&H9"2\0'?5 M035*-8A:@:07A!(2%Q1M7O@^^1DF)!AYJX&?X;=29AI%B&)$":(4488H1U0@ M*AGY7N!UOV(QX05Z*!S4L)3Q`OEV9VM*R;K'!EV8,SS!XP9FC:A!U"+J$/6(!D0CH@G1+)`TN+K+_A4&UW?KPN!\`^^.XOK"2UWO MSXY29A0C1#&B!%&**$.4(RH0E0:Y'LY=M:A&J091BZA#U",:$(V()D2S0-+@ M?N;@E7F=,TPI,'+<>8\H0A0C2A"EB#)$.:("46F0G)O^+:V5,G.S1M0@:A%U MB'I$`Z(1T81H%D@:/)374)_;O70GBWF-,TY/D%\RME1C%"%"-* M$*6(,D0YH@)1:9!UYPI1C:A!U"+J$/6(!D0CH@G1+)`P^/IE.9&#N+Q/9^0Z M,J((48PH090BRA#EB`I$)2/Z9,E,KHK1QF;D:T0-(TJ`FXHMHHZ1H[Y'70.B M$75-B&9&%X=4AS1B*`NC]FW@M0]?;C[^M;LE!Z0J@33PBMXK/;S*]?M:IU_< M-9J1O!>]\)Y*[:V4&:L(48PH090BRA#EB`I$)2/'.A6BFM&Y?@ON;+':>,\, M&RMAKJ]EY$R/#E'/R.G`8'6IUWG/3B\NO'N:T4J8UB94/0LDIX;*=OA;M@6= MN$RSXS`9IML?/YL,ASMMG@TZ:2)F@T;"[P%%:T`QH@11BBA#E",J$)6,G)&O M$-6,Z#F*&>H&46N0#04=HIZ1T^)@I*SZ$=%DD%4_"R2-&\H[+==DVH!KN];$ M/--:(\^W_1=?K)09H@A1C"A!E"+*$.6("D0E(YEGVBR]T%2QF$IG'[<@9Q?> M1JYFJ0T%P*/4ZMQSS,9*F:%H&:WM6M(AZAD]WHG!J#\]O.B_7)_2/S+C-5H1 MTX,)FYL%DK/G94FP-2;!&(D0H*4<%*%4C"A!E"+*$.6("D0E(R?K6R&J347[ MZ+-!U"+J$/6,G!8'E!H138AF@:01R=DAOC\G!*AZWD9.(R\$>,O?7D47JDA2 M9M9%B&)$":(4488H1U0@*AGY(<"+8!6+.7GEFM%3_JZOFZ3,=;=<4?B[EG)0 MCRT.IL7'G)N;LP^&)FQN%DC."Y5`<]?])U8$)>Y-!XT<3]ZO`46(8D0)HA11 MABA'5"`J$56(:D0-HA91AZA'-"`:$4V(9H&D$54.R37B*Q.L:YV+$KLW3D^1 M18^+W/K">R]ESQ6%LQ\K&C^(42I!E"+*$.6("D2E0=89*T0UH@91BZA#U",: M$(V()D2S0-+@H7S;2MW)/>&^F%];:R3<%U"$4C&B!%&**$.4(RH0E8S\T.VM M/!6+B="MKXC>_5;W3\OEZ=G*>[;8<"T2,?.U9>0$Z0Y1C\T-5M>A.;4G@TW9 ML4>FN0EUSP+)&?"+$G!T<1#0.0$G7=[;_>ZYHG#Y8T5S33%*)8A21!FB'%&! MJ&3D;*I1_8!2(Z()T2R0,+CZ;@%B_))NUIYP^4,] MN6(SS4#M;;Q!ED,YY[ M1O2^A.EKQ.B8]-JLO+O=V$J82@DC.DG%H!159[;B(<.%^;3<2A@]!:HN#;+9 MDPI1S6AK?;U!U"+J$/6,G(`SH-2(:$(T"R0MK_)CON4I$?A616F5K#7YN>=G M;M77P/XTT$AEDIS=GO(J4%6=V:0 MU9T_K;LPM:SNDI$?3+R5K3)BIW;FUX;1UEA=S2J09VD<&3,N+3,13WB,;8CI M34VGQ<$P]5#M:`M(+XV.F&ETPD9G@>3$"N4&W9!B)M;C.\L-I@H9.8ZQ1Q09 M9"-/;)`=H801?:%KKC(U4M;3,X.LKMP@JZM`7:61LKHJ1#6C!1U6:7K1!%C+ MS(DN':*>D3,\0T#9&&`3:IL%D@;VTW>O?#:_P;P>(R]<>#OK/4N)<*%UT=E- M9B!CHTN'BY"#)4:1'?[4(#=<@.[\:=V%461UEXR\<'$*X4*WYVP&:JY)Z[@* M%MMMX';#BI@1:!F)6*%U.ZAG*:>YP>HZ-!>ZW;`BIKD)FYL%DI-(I9G>) M:*#$O4VG1LYTWV\`1099#XX-LAZ<,!+1`'1EIJ+5E1MD=16HJS12;C0`]35+ M.5[>(&H1=8AZ1L[@#"@U(IH0S0))(ZJTG&M$DR9ZPIBJFF=,C3S']S:#^XV6 M$H[/R'5\UL7[A,"]>6(46>=,#7(='W3G+&7V(`'=A5%D=9>,/,=?>MN@BL4< M3ZP9J6W<<G'KCTE@IXXSML4G*FAUKGOE/>3M'S%3MF3G=&&P#5EE@ZZ#' MBSIK=$U.$D8@) MH#XS%:VNW""KJT!=I9%R8P*HKUE*Q`0MY:`6I3I$/;8XH-2(:$(T"R2-J/)0 MKA'U[H"2#4]84^>OA#4U$D%AXR>^]ALM)8("(SQF..0-2/>$*R6IVNO4F,EC#.VC!QG M[!#UC)S6!J/+C4(!]]AK")]VV'?^WE61NF@1FX1&'G1P'^-DZ7<:&"0$PV, M+HX&:W5WX$4#4\NZ:VJ0$PT,LKIS@VB#=UQXP5D*(V75EXS\:.!=867$G'O[ MVC!Q;[]9>,^@&T?L&!2.C):58W]QH^"(F:J]84Y/!L-$3^#R1T?,J)N8.>%I M%DC.LZ<2E\_+,M!3*G\KRLCQDSVBR"#K^+%!UO$31FX0,5+6\3.#K*[<(*NK M0%VED;*Z*D0U(Y%E"+"6F1-L.D0](V=XAH"R,<`FU#8+)`VLLEKN:L#[B)<& M$IT<)+>?+Z,]QPF].O5>V]BPE`HFNZ"89C"Z^U]ANMUZR(C%ZK*.G!KEQ M!%3G5LIV$QRI,%)6?VS!S/[1#UIN;CG1B,&'=B&\H^.#*F$Q.V.`LD9]>O25)N,4G)R/&//:+( M(.ORL4'6Y1-&(GSH%AWUF:EH=>4&65T%ZBH9D0^:0:P0U8@:1"VB#E&/:$`T M(IH0S0))XZHDEQ\Z5J=/WH)0Y(/%@/-E,E9XZ^J>*XI8H2N*6,&Z=*R@H1#8A&1!.B62`Y!52RRYT"3_BQSHV)W9Y&SH*Y5U_SJP2`W39'!MDU M-#;(KJ$)([$>@Z[,5+2ZD0#HA'1A&@6 M2!I198%<([YR*Z^32<*XG%^2R[.WK=UOM91P:]9%/ZQJ]CXQB]$K[VKSNZ9_ MO"=SB5%D'2\UR/5KU)T;W;1[>\RQN:-6?\D5G0E0(:H1-8A:1!VB'M&`:$0T M(9H%DG-");MP3MB[NV?>O^N@?5*-4@:A%UB'I$`Z(1T81H%D@8]SR8!'QI#O"@1>8` M&7G+N.>F>Y9R_=WH2,^#7ING-,US%R%O,]HL@@ZZ*Q M0=9%$T:NNQLINU?(#+*Z6LRME-4%#^L+(_5HBR5+.1.C0E0C:A"UB#I$/:(!T8AH M0C0+).>*GWA[8HY@@NT<,F![1)%!UDEC@ZR3)HR$PX/ZS%2TNG*#K*X"=96, MA!&U>@?5*-4@:A%UB'I$`Z(1T81H%D@:4:6(?(=?G=K-V[.>\9WK1)/P?XVD M__O/P_=<4?@_ZQ+K.RO3Z_MF?0Y?7"=&DUV!4X-<5T?E.8OQS4+@`7QA%%G= M)2/'^!6B&E&#J$74(>H1#8A&1!.B62`Y'U1JR9\/+W_E]URI\39\&HG5'5#$ M%=TG^@99!TT8"6<'79FIZ#H[2UE=!>HJ&0GCZHH.JE&J0=0BZA#UB`9$(Z() MT2R0-*[*-CUFW.XG2[6&^\%V@3H]VNU:E![C[@ M60WFLL'5&A^B%T:Y;:]DY,R("E&-J$'4(NH0]8@&1".B"=$LD)XD[^Z_7%\_ M1%2,2@Y3!$K65'*P$I1LJ.0PQ%"RI9+#+3V4G%/)P@#ROQ>GY$V.F(@4.>, MZM!IL*$2NAXZ-C140E:@\R5#)60%.H@P4+(B*^BH[_=M15:@7_,+U2$KT$_$ MA4IH1.F'PT(E-*+T:U2A$AH#^HVB0,F"QD!_&.;W;4%CL`B.P8+&0!_]!75H M#!;!,5A2';US]NLLJ0[]#FFH;S1NB^#L7="X+8+CMJ!QHQ_]#6FC<=,;*[\' M"QHWO>A#"8T;O6,8T$95@B--%8+R-,S!F:;7 M=VB.L'XM%O16`?CTVY%8QV, M3SN*Z^J7Q@)]6]%8Z\,,_;XMJ6\Z1PLEU+=E<.XLJ6_+X#Q84M_TAM#71G%= M_9IPJ&\TUL&XOJ/X5`3CTX[B;1&,MSN*MT4PWNX6-`^"\7:WI+XM@WU;4M_T MJ0;>]91J80E]GE[\'-RL[Y3N!"COE;2%.M@R:DJX\&*#HNH/3GZXZ./D7 M=-'!!6-'"T817##H;=1+];8I&I'>-[U4+YAB";T\>CD&2^CU4(KGH3J_+RY_ M#_&=ZEB@C5*M<`&^4W,[P$MJ.,1WRAL#\O0R/UUW:(*T5-(%2^BU>[KN4!UZ MJYZN.U1"[X53.Z$KH3?!J9U0";WJ3>V$2NCE;FHG5$+?*EVJKY'06O1!TJ7Z M`@E+Z(NCRS%8,E&)^H8(Z]#',M1.:/;1!S+43JB$OH"A=D(E]-4+M1,JH6\R MJ9V0M]!'E]1.J(0^H*1V0B7TA22U$RJA;_^HG9#WT?=^U$ZHA#[HHW9")?01 M'[43*J&/RZF=4+2@#\BIG5`)?2%.[81*Z"MP:B=40M\W4SNAZ$/?-%,[H1+Z M:)G:"970A\K43JB$CM:@=D(>1X=G4#NA$CH<@]H)E=#9%]1.J(1.;Z!V0AY, MYS50.Z$2.I"!V@F5T!$,U$ZHI*:-G3I9"&<\'2Y$[81*Z/0@:B=40L<#43NA M$CK#AMH)>3"=6T/MA$KH8!IJ)U1"A]%0.Z&2>DWQ(+BYI?/1+M6!:'BE=`#: MY1@LH4/.:%\?JD-'K4IW0C*<# M5:E.J(2._J2^A68OG>U)?0N5T.&=U$ZHA`[HI'9")73V,]4)S5XZ[YGJA$KH M&&+J6V@FTCG#U+=0"9T:3.V$2NAD8&HG5$)'U%^J,^G1VG0L_:4ZAQY+Z)1T MZEMH5M%1Z-2W4`F==4Y]"Y70@>;4MU`)'4QUJ8Z>PA[0N5*7ZN0H+*F7%*]U M[MG;OM%/7%TVP5L9^A6`2W7L/VJCD_\OU5'_6$+'A=,8A"Q'1X33&(1*Z'QA MJA.:B72F,-4YE+P[=OO^M_<_KOZ\KJ_N_KSY?O_FZ_5GRMCIQ[MW-W^JMS?Y M62\?X?['[GZ3@G0LZ_/M[&ULK-U9DQLWLK#A^R_B^P\*W1])O;%;#MLGT%R+ M^[[=:61YK!C+"2F:@J5)'\\7___>'W M9W^]^_3Y_<<_?GI^]>+5\V?O_GC[\9?W?_S]I^>;=>]_'IX_^_SES1^_O/G] MXQ_O?GK^GW>?G__OS_____WXKX^?_O'YMW?OOCR3$?[X_-/SW[Y\^?.'ER\_ MO_WMW8<_/[U[\\MIHP^_O[Q^]:KU M\L.;]W\\KT?XX=-3QOCXZZ_OW[[K?'S[SP_O_OA2#_+IW>]OOLCS__S;^S\_ MZV@?WCYEN`]O/OWCGW_^S]N/'_Z4(?[V_O?W7_YS&O3YLP]O?ZC^_L?'3V_^ M]KN\[G]?W;YYJV.?_@>&__#^[:>/GS_^^N6%#/>R?J)\S:]?OGXI(_W\XR_O MY17XM_W9IW>__O3<7?W@%E=WK>)*-7V+KWBD'\T_/?GGWZYM__OYE^?%?@W?O M__[;%TGXG;PF_])^^.4_G7>?W\I[*L.\N+[S([W]^+L\`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`!208:0$60,F4"FD!ED M#EE`EI`59`W90+:0792OIF(?0S05!\@1XARIR;N.Y)AGQT0[9MHQU8ZY=DRV M8[8=T^V8;\>$.V;<,>6..7=,NDNRGO2AG*F@#[]C)^>'D>-2^21W)M M1C'5CKEV3+9CMAW3[9AOQX0[9MPQY8XY=TRZ8]8=T^Z2O"<=)VLBW]!Q/CKM MN%ID_Z;O>AO2@70A/4@?,H!4D"%D!!E#)I`I9`:90Q:0)60%64,VD"UD!]E# M#I`CQ#G2(XEI=RB-,FXO\N.,?8Q2)-Q@!PASI$>26T24^V8:\=D M.V;;,=V.^79,N&/&'5/NF'/'I#MFW3'M+LE[THIR?29IQ?,'DCXZ[;A:[&X- MTH%T(3U('S*`5)`A9`090R:0*60&F4,6D"5D!5E#-I`M9`?90PZ0(\0YTB.I M36)>'1/KF%G'U#KFUC&YCMEU3*]C?AT3[)AAQQ0[YM@E24YZ2:Y7)KWTG;LU M/TS:9+5DN[7\ND`,TIFT`^E">I`^9`"I($/("#*&3"!3R`PRARP@2\@*LH9L M(%O(+DJS6VO=9,G8QR!-Q@%RA#A'>B2U24RU8ZX=D^V8;<=T.^;;,>&.&7=, MN6/.'9/NF'7'M+LD[TDK^KN>DEX\OU\[A:<]%\CNV4@=4I?4(_5)`U)%&I)& MI#%I0IJ29J0Y:4%:DE:D-6E#VI)VI#WI0#J2Y**WKXZ?GIO>O ME_\W[D.IK[O+-0.=0!^O:KJ74VYS;*-VP0^J2>J0^:4"J2$/2B#0F M34A3THPT)RU(2]**M"9M2%O2KJ$F0_=WV>GWOHG2#!U(1Y*T;:P`W5+:EE:H M`;ECA7&%*I"[5AA7J`.YH![F3A7%I M1:1MZ^]4L&U[87=9W]B0=&=-9DIM7X$ZI"ZI1^J3!J2*-"2-2&/2A#0ES4AS MTH*T)*U(:]*&M"7M2'O2@70D2=\AD=)WM$+"I>\85TBY]!WC"DF7OF-<(>W2 M=XPK)%[ZCG&%U$O?,:Z0?.D[QJ7I3_O.WZI@^^X[3QG]1Q6R<\9`V>[R-KO$ MUT3IE-HA=4D]4I\T(%6D(6E$&I,FI"EI1IJ3%J0E:45:DS:D+6FG)*N4YH`F MN]MVWT1IA@ZD(TG:-MP'V"Q2(PV\8J,!;+P%BL`V.Q$(S%2C`6 M2\%8K`5CL1B,Q6HP%LO!6*P'8[$@C,6*.%G:MOX.!=NV%W:7]0T-R>X2]SBT MY3]G)R4=4I?4(_5)`U)%&I)&I#%I0IJ29J0Y:4%:DE:D-6E#VI)VI#WI0#J2 MI.^02.D[6B'ALKMD7"'ELKMD7"'ILKMD7"'MLKMD7"'QLKMD7"'ULKMD7"'Y MLKMD7)K^M._\?0JV[[[W4P[U_0[RX#JG/OK;VOR20'IV>9?O+F.4;MAI-E3J MDGJD/FE`JDA#TH@T)DU(4]*,-"?)1X#U_=*7O22M2&O2AK0E[1IJ=I?W=_G" M:Q.ES^M`.I*D;?&*I&UI[8(5BD`6A;AMH0QD48AQA4*012'&%4I!%H485R@& M611B7*$<9%&(<86"D$4A&Y>VK;]+PK;MA=UE?5-%TITU)6>7H([_U&NZK-X0MZE[QA7R+ST'>,*N9>^8UPA^])W-B[M.W__ M@^V[[]U=UO=1)`T9;JV0QS;G+MEG9MK^,^7U3E4GXPZI2^J1^J0!J2(-22/2 MF#0A34DSTIRT("U)*]*:M"%M2;N&F@S=WV7+Y?LF2C-T(!U)TK;(K;0MK5`# MYC"M4@ASE,JY0"W*4R[A"-,*R1=^HYQA;1+ MWS&ND'CI.\854B]]Q[A"\J7O&)>F/^T[?U^%[;OO78RM[\](&C+S9):E#ZI)ZI#YI0*I(0]*(-"9-2%/2C#0G+4A+THJT)FU(6]*.M"<=2$>2 M?`3?WJI2?\?)8\':!2MD7#Z*S_$*.9>/XS.ND'7Y2#[C"GF7C^4SKI!Y^6@^ MXPJYEX_G,ZZ0??F(OHU+^\[?8?!?V%U>UWJ0^:4"J2$/2B#0F34A3THPT)RU(2]**M"9M2%O2+M"#5$?<7=[?95>7]TV4 M9NA`.I*D;>NBD/%U2_=8,*T!&Z=%8$VKP)J6@36M`VM:"-:T$JQI*5C36K"F MQ6!-J\&:EH,UK0=K6A#6M")J2]O6WZ!@V_;"[K*^GR'I3MSBT/;?JY>=79*Z MI!ZI3QJ0*M*0-"*-21/2E#0CS4D+TI*T(JU)&]*6M"/M20?2D21]AT1*W]$* M"9?OK6%<(>7RW36,*R1=OK^&<86TRW?8,*Z0>/D>&\854B_?9<.X0O+E^VP8 MEZ8_[;O_TJT^U[S5)U!V[3+[`'F[B=(IM4/JDGJD/FE`JDA#TH@T)DU(4]*, M-",*Z1=^HYQA<1+WS&N MD'KI.\85DB]]Q[@T_6G?^;L);-]]Y[5+_[W+TFI)0X8;%:D!6E)6I'6I`UI2]J1]J0#Z4B2OD/69'=):Q>LD'%9 MC.6VA9S+8BSC"EF7Q5C&%?(NB[&,*V1>%F,95\B]+,8RKI!]68RU<6G?^3L, M;-]]Y[5+_WL!>4,&\M\"']?Z6K?9Q_K:NJ6$Z73<*5BW8+V"]0LV*%A5L&'! M1@4;%VQ2L&G!9@6;%VQ1L&7!5@5;%VQ3L&W!=L'218%;K-#6R94H3=JAV5#I M2))>QI;2RS2M"_,(U(>]*!="1)WR%KTG>T0L*E[QA7 M2+F<URRLFX0N+EE)-QA=3+*2?C"LF74T[&I>E/^\[?HF'[ M[GOWH?6M'DE#QMMX["XT^^Q"V_]NCN_19C+ND+JD'JE/&I`JTI`T(HU)$]*4 M-"/-20O2DK0BK4D;TI:T"R07S)H,W=]E-S3OFRC=-QY(1Y*T;9U;>Y'NL6!: M`S9.B\":5H$U+0-K6@?6M!"L:258TU*PIK5@38O!FE:#-2T':UH/UK0@K&E% MU):TK?]A@*1MS^\N3^'I*6<@>\I)ZI"ZI!ZI3QJ0*M*0-"*-21/2E#0CS4D+ MTI*T(JU)&]*6M"/M20?2D22_!6#O7PE+/05K%ZR0M_[29*)^,.J4OJD?JD`:DB#4DCTI@T(4U),]*,*R1?^HYQ:?K3OO.W'=B^TPN:%_JOOELAZ;]X`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`U)%&I)&I#%I0IJ29J0Y:4%:DE:D-6E#VI)V M@2[-VW4ZLGF[^>A$6C_^E/^\Y?.[5]Y^?MV\O3 M=GW)->F_FLY/"NV;$"7_%$_,3P=<.XV2EQ*C"B?YI;',KZ`E+_367VRQ+_3\ M!',*3R]E!K*7,DD=4I?4(_5)`U)%&I)&I#%I0IJ29J0Y:4%:DE:D-6E#VI)V MI#WI0#J2Y,>3[:6X<"FS8.V"%3(N/Z#,\0HYEY]09EPAZ_(CRHPKY%U^1IEQ MATD_[:^\&(GF$`7)AB-2B>8 MYFRQGF`TZOP$HU')6.9'-](7ZI>L[0N],,'4*]S)"\2B=_L6U"%U23U2GS0@ M5:0A:40:DR:D*6E&FI,6I"5I15J3-J0M:4?:DPZD(TDF&"32/1:LD'!7R+A, M,!ROD'.98!A7R+I,,(PKY%TF&,85,B\3#.,*N9<)AG&%[,L$8^/2OBM=_+GV M/Z-TH0%Y]>>VIDLS3(A*9H7\-\5W3QIKKU%VK/N[9K9*7ZE?7?V&&:9>C$UF M&*S/MF]!'5*7U"/U20-211J21J0Q:4*:DF:D.6E!6I)6I#5I0]J2=J0]Z4`Z MDF2&02)EAJ$5$BXS#.,**7>%G,L,PVT+69<9AG&%O,L,P[A"YF6&85PA]S+# M,*Z0?9EA;%S:=WX!VO;=T\Z1_%F4O]I@O@D_T*4)IMXP73@QYS7A$"9$73B$ M*8QU?_>519A;O^1G7^B%&;1>(4Q>(!8-VZ=!DQ\$[)"ZI!ZI3QJ0*M*0-"*- M21/2E#0CS4D+TI*T(JU)&]*6M"/M20?2D203#'(K$PRMD'"98!A72+E,,(PK M)-T5LBX3#+^(Y4KW` MFO1?6',].RFT;TLKL^:\)DPP3QEK7QZKN?*:OE!Y7LD+O3#!^/!L!JTI680! M=?P$FUZPZY)ZI#YI0*I(0]*(-"9-2%/2C#0G+4A+THJT)FU(6]).Z77\C..> M="`=23+!A*PU@\D$0VL7+&;<;!M3;BSFW%A,NK&8=6,Q[<9BWHW%Q!N+F3<6 M4V\LYMY83+ZQF'UC,?TG2_M.SB^2OO,3S+T<&ESH/[]9UG\U^11\?66V[0]= M9,/L"";[3-8N1-TWKV%/.I".)"F>^B'-8%(\-'UJ-JY3B.L6K%>P?L$&!:L* M-BS8J&#C@DT*-BW8K&#S@BT22XKGSJ_MY7NGJ[L7OGZ^_/;^[3\>/THIR'I= MH9ANGO_\8[V<>AHEK:5`=BXG=4A=4H_4)PU(%6E(&I'&I`EI2IJ1YJ0%:4E: MD=:D#6E+V@6ZDGLG]2,%>[6'2(=`_G0IS@"M_--\1V[HG)I\#[<^@'LL#7?? MRKX+ZS6_DONNO)[>=./ZXY]?ZT;Y;I[8CEQ?/XTL MD_;YJ5VC9&IM7D#^VR<[C6J^8W9/.I".)*F;^KG*-8:8Y\>"M0O6*5BW8+V" M]0LV*%A5L&'!1L%>F_(?)Y9.NW[%TTZ[A>G5)K1>(+4G`W=VS?14J6U2A]0E M]4A]TH!4D8:D$6E,FI"FI!EI3EJ0EJ05:4W:D+:D7:`K^:[EGW_\Z^?;JZOK MYH;T4WKV(42^PT,K_1"WNCYM=?7B.IM]CMQ(6J9.O1E(9MI0(?+=JO[QKU[< MY].BEH?=3.O#FA;(51CJ^L75PRO[?]F1GM/RL8-H_5C3`FH&SG^$T&E!V3M3INO=%'A\FT1=[RF$.C2K%JZII!_ MJF&G8S43X9YT(!U)4B+A(9O!I$1H[8)U"M8M6*]@_8(-"E85;%BP4;!T5JU? M1VUI8OTJ[S?,JO6B<#*KVG7B,*N".G>@+JE'ZI,&I(HT)(U(8]*$-"7-2'/2 M@K0DK4AKTH:T)>T"F5GU(9M]]B'$S`Z'N)7.A?E4?.1&TC)U4LU`TC*UZ8PE MLVKV78IR[,K-M#[L4%H@.I3,JOF,I05C-].*L:8ETPR5?X9-YE$^*ZTA.Y06 M43./WF?OK\RC]5"E>=1??K#MYA<>_`?9+QS,U%',TW+X#=4A=4H_4)PU(%6E(&I'&I`EI2IJ1YJ0% M:4E:D=:D#6E+V@5JYM&;5OZ%=B'$S`Z'N%6<1[/)X9*9K"%VOG%H&4(J]>"P@ZL3HI9.=V'*$,'TI$DW8C!I!MI6@GF M$60)CG%:"C9.$V]-,V]-,V]-\VQ-$VU-$VU-TVI-\VI-\VI-LVA-TVA-TUA; M>K+A+UZ=Z],GKM75U\"21JW)+(FU[T`=4I?4(_5)`U)%&I)&I#%I0IJ29J0Y M:1'(',DL2;M`_L/`S4KF?2L[Y-Z;L&9-)B1$-E4[%N*DM1@HO55`S9[]:+)T M5R%2,YA$:@X3U"PFJ'E,4#.9H.8R02='0<7SM?&IJF!6$>0=J9<5H2-DZ+P)I6@34M`VN:>&N: M>6N:>FN:7FN:7VN:8&N:4FN:4VN:U-J2!O9?_)`T\/DSRE-X>CU927X-)2RP MYTM![1!B]IL=4C<.Y*^7^97R?'6HQXWZI`'&R=>&*FXT)(VR<;@P-.9&$](4 MX^2K0C-N-"+PDM0X39!>]T(_E\HK;.OF"'@AT+YEP)'TNH6;\R M#^TT[PG&S-M(3782J>E.,";<;JXY3B(URPG&/-O--;5)I"8WP9A>N[EF-(G4 MG"88LUIOGO9FZ:)S..&\T*:\SMP*%'>G6&EHAQ"[.R5UXT!?6WSH<:,^:8!Q M\J6'BAL-2:-LG.L7Y]<=QAQB0IIBU'S18<:-YJ1%'$=WI_F*PS)$V-UIW*A9 MI=MK6'.;R"%02W9P\::`^U:V$'YLHG0"D":NBT&VC/98,*T(&]OHJ M.P?I<=0^:8!16]DB1\6-AJ11-HZ4<7;X-.9&$](4X]QD!3'C1G/2(HZC>YO\ M'&T9(I*]C>:J*:R]CFT+MP[S7Q=G"C=;^#R&#T29U2%U2C]0G M#4@5:4@:D<:D"6E*FI'FI`5I25J1UJ0-:4O:!;J2;Z_76MD'DT\**AT"^6]; MBU7;RJ?S8Q.E&TK5UB605FUMY@&<%D'R"%>X'*F%8>M=*Z-4Q?XRX;DJ?MIR M6*N^VIB4<4U)&8,Z84,3U27U2'W2@%21AJ01:4R:D*:D&6E.6I"6I!5I3=J0 MMJ1=(%GFT,K;*S63X"'0Z^8J[)$D)5LG4GZ?2P=SCVK-:%*R=9P93H[Q:9KR M>KQTEO57.[4^_3<_U[/L-R\AM>JKIDF!!DH6&UOYCJRM6YJ%Q4[!N@7K%:Q? ML$'!JH(-"S8JV+A@DX)-"S8KV+Q@BX(M"[8JV+I@FX)M"[8+YO?6<:*];V6W M$^Q#E)FT#TJR@!LWO'W(-CQJE#UL;KW.CI*D`^KB\;=--(.]S@X]I2GJ,/,T MI"F"G7T>TB=QT^81^$2T[+[Z1-)N\I%C'[;R MM>5VV-"L>G9(75*/U"<-2!5I2!J1QJ0):4J:D>:D!6E)6I'6I`UI2]H%2N;K M5KZ:LP]19G7IH-2L31Z5FD-QF8GK"I`)T!R+U&9&DZH-U@PG51O,C*=54(^7 MSI[^TI^MV@NS9[A2V)QX/K9J,A]T:Y,ZI"ZI1^J3!J2*-"2-2&/2A#0ES4AS MTH*T)*U(:]*&M"7M`IG);4\Z!#+3W5')S'9.+9D]ZWR;!Y`ZK,T,)W48S(RG M*2_-GOZ:U3?487V)*YDU:Y*OD]6>:?MU0OEX:++JTLJ7"SM-E&[8)?5(?:7F M]&.@)*>Z<>K&^6S51.DC#DDCTBY0-N]DRV_[$&4.T`Y*S41QU+$>ZFLK-U=W MU]EZH,Q#X0U,YJ':S.B2_V#-\)+_VJ0,3A^+*(T?W^?3^,F\=&^OTC7G2,W' MSY[T8=#3*.G%NT"V3)3D)"XF#78::IX\SIZ[I:A6*[_E5*/LDY#;@7]\ M^9=\Y.MM^#AL/T299AV0*AU+SI9CWO"\AJ4H/*^11IU]7CL^B3WIT(RE!7!4 M,DWOU)))I,Z;>>$RB=1FYB291(*9\6("3N.E>PF_I&R+YVGG7/?U2K0]>@B4 MMEU^1-\.4>88O$/JDGJD/FE`JDA#THBT"Y2^H/ML#[_7#9N3A8-2T^5'I4OS M2/VVIO-(;6:BDKP':QY!\A[CFI+G5*5O;>%$YMXOP=I2.'\B</P>]*A&:N9(>IG;^9=YS0LF2'P*J52PK;)80;'B^]V88;P*XZV M+/+#C*<=1_I1LFJI*>NO;#_=]M]=(ALF$P:HJU%G^ZNG4VT$M["5\VYQ#&$/F\$M[%YA&D M6O@0,K'4>.$Q-`6EB<6O`IZKH"<>J-:+B1S=%M6^$Y?"][''#/FE`JDC#0. M;`0SX\7WL3"5^(6UDTS=@(]-`?#7:6S+=7C M6'W2@%3I\,TC#I7./N*(8^T")2^;%[UTPZ;1#TK-\<-1RZN8QI7Z"-0\JD MS&HRAQ'M>U"'U"7U2'W2@%21AJ01:4?:DPZ!3)!QP@+H:)?\E[GA; M]]GM:#V-DA<QVJ>ZD&I M:>NCDNE^%ZP^/#A]`D1F";RO4C#!FN&D8(*9\30!]7A)_S^4%CXO%\QIL[1@ ME-+#B_Q-:8D0R#3M4M^J0!J2(-`YUYN!&WVNE6]IP4I^)[W;#IK(-2TX!'I62>R4_% MG0MAOM6^/MNYQV8T/<.5$JG3DRR,JIU_5,W&5Q\UG1OD[8@[DR<4D@_/"BE0 M.B?DR\OMASHLF1-`W1!U_@2@Q['ZI`&I(@T#G7_$$3?@[C2"_=BP/ M&ZNZA5/,$)7,'&%!KME7=C4J*>G[[&:SGD:=W6'W-:H9?D"J2$.ELT]BI%%G MG\0N1&5O3K:&L]>Q["P3WAP[RP2RSPOGWS++U&'UCE]K)VYJIA0\@M1.C&MR MR8?0--4/DR=$CB5\7.5<+3SC+]JEJ^AZG)3"7M$&6H0^J2>J0^:4"J M2$/2B+0+E,T(^543W=#.".%EVQDAT*49H0Y+9X2XJ9D1\`B2]!AWIE._;/%\W^ZD7D1+:JHFN;=`7VG[`=0A=4D]4I\T M(%6D(6E$&I,FI"EI1IJ3%J0E:45:DS:D+6D7*)L4LYW[/D29*[V'0/*ATYC( M8S`_<\7NPLY=CI/J?*>S8FWF$:2*:[,/(=-BC1<>0ZNE-"W*<>/9RG[B[M$/ MDYV`!4H_H)-_KTK[H0G3%N@4K%NP7L'Z!1L4K"K8L&"C@HT+-BG8M&"S@LT+ MMBC8LF"K@JT+MBG8MF"[8&;WM2<=`IDI]:AD9E2GELS0=<+-`TAMUV:&D](. M9L;3(B@=YLFQQ]DZ?M(EJP<_2E;&-24S-*@3-C1175*/U"<-2!5I2!J1QJ0) M:4J:D>:D!6E)6I'6I`UI2]H%RF;H[`->^Q!EYL]#(#]AQMD8QSK'$/5:3C%B M%"X7R)Q=5X#,ITT8#L)D!:T.,T]#2KVV\\]#JK\.N_!$M,B^^D22DV+Y(.?Y M'GG:7'\:)FV20/[*LWG;LGN`VDU4G.E)75*/U"<-2!5I2!J1QJ0):4J:D>:D M!6E)6I'6I`UI2]HI-0>:>]*!="0Y5[#'@L6$-P_J.H6XF'(3%W-N+";=6,RZ ML9AV8S'OQF+BC<7,&XNI-Q9S;RPFWUC,OK&8_I.E+9I?0*E/-+[Y`].OZW5Z M>ZH1R.RBVJ0.J4OJD?JD`:DB#4DCTI@T(4U),]*])!]*1)#T:$MD,)CU*BPDW<3'CQF+*C<6<&XM)-Q:S;BRFW5C,N[&8 M>&,Q\\9BZHW%W!N+R3<6LV\LIO]D:8_Z"TC_C1ZM+T0E^]&:DOTHJ/,:U"7U M2'W2@%21AJ01:4R:D*:D&6E.6I"6I!5I3=J0MJ2=DCWUN,]O_=DW43IE'DA' MDO1H2*1=PBA8NV"Q",RVL0J,Q3(P%NO`6"P$8[$2C,52,!9KP5@L!F.Q&HS% M_3\%1E_*ISO+@,UEZ+:&M50)Y#YKKDNJ4?J MDP:DBC0DC4ACTH0T):D!6E)6I'6I`UI2]HIV1UA*S]WV#=1S8XP)*V9M8^,DAY%F/0H+=9` M,YPL^C`N5H&)BV5@+-:!L5@(QF(E&(NE8"S6@K%8#,9B-1B+Y6`LUH.Q6!#& M8D6<+.U1?RW:]NB%':$/S\X;:TI:$=1Y#>J2>J0^:4"J2$/2B#0F34A3THPT M)RU(2]**M"9M2%O2CK0G'4A'DO0=LB9]1VL7K)!Q5TBY*^3<%9+N"EEWA;2[ M0MY=(?&ND'E72+TKY-X5DN\*V7=I^M.^\Q?/;=]]UUT=\BM2:,=`S4%H6Z,: MZ@1*OA&VE?^D;K>)T@F[1^J3!J2*-"2-2&/2A#0ES0(EAZK_Q]JY-4>6V]CZ MKSC\?MI*W5*I\.D(J>[WN^KRUL>GW':,/3W1W9[Y^_,A20+87-!.5;O]4+87 M08";:P'D9C)3;7*FQY[N6+Q17V_5U[NPBD/4\XOIT\#W836F\(/Z^MBA5$,_ M*?19H2\*D;3M(9,SDE:Q(8ML-W21L:&"C`T99&SH(&-#"!D;2LC8D$+&AA8R M-L20L:&&C`TY9&SH(6.OBWD9]#>[9=+:M8"UI+WCAYCM=L%B/]N@_'M).X'N M=XB_-)X.[L\OIF^4/4AF0W0/A[>X"?XHF64%3W<*'R>SX>V)>GN:S+*WZ0KA MLV0VO#U7;R^26?8V?1?G93(;WEX-;['_>9W,PMOQ_&=.WB2SX>VM>GN7S,+; M^6ZZOOH^F0UO']3;QV$6Q?F30I]'1PZ$TBC*@\/5T0*N^GH75\/5\0.'KQ8"6 MOJ92]S*LAJ]7`PI?KP>T]#5=$7D35L/7VP&%KW<#6OJ:,O%]6`U?'P84OCXJ M]$FASP-:1IQFXDM8C8CDODB'W"^U,Q7]JWMAYNY<=O$$E(/2W53UV>2[F;MS MY25W26NO^0NJ2W<2>&G:*@[E^#>W:)H MV*7:;ZD:S7[Y#CZP7#<*[/[`TA[H08$]'%CR]VA@J>_C`GLRL-3WZ\+Q[+^S^;E]F4R&Q)[Y5B0^-JQ[.Y\-WW._2:9#7=O'0MW[QQ;N)NW M9.^3V7#WP;%P]['`/A789\>68:>R_269C;!75PY&W*MK!U<=7MU+=N[1995H MNW)=K:]25Z&UM`-PL66/KK;)XU0)KT*!R:-+,'MT#4X>IY7A*G29/(8PTSQF M&:8:<3%7L)!F\AC:W'NS11;+P*#7=TE@]NG*R1Y?.TN-ELJ:R63GMR::FLW9WX;.G,9]"I3X]SY=QG2R<_@\Y^ M[N[T9TOG/X,N@-S=%;`\SIUKKR5I?_+X/;4KET7S."4IQ7PU2>]VSF???9^/ MYP>V_!+);CJ"AL'6-7^;N\#@K]GU'W[9\//R_.W)Y<\APV=W%@<@T"D!8+-C MO+_X*9-\:Q!^Q1WTBCO8;=C:V&!;.D*V8'#=L3PV^:-&4-W-.+?Q1SC?35M$ MR)<(U(0B@CP]9<(CC'2E3(@[RL1=W%$YI"N5HV&I:E,Y!*-R"$;E$,PJAX)4 M#@5==RFT50ZU=.5E2U=:!EUJ&72M9="5E4&75@9=6QET+670Q91!5U,&73L9 M=*4T<"H3=DLHK^6'MN3]REB4(4CHV/*+_;OI10Y>FET:&[0(!BN"08I@<"(8 ME`@&(X)!B&#P(1AT"`8;@D%&P\[Z7X0M_H8%W$@_J!&,)!:,C!6,C!6,C&W8 MXJ<2SG?3T1@9V\U85+S$R!?P2.)FME[HR>ON+3Z8(:\%(Z^[N_:'/LI";XG> M>T:EMRV"N+/W^`[F>BK5SG)?/;K*TNID[_'-GR#,>99 M*OZ5RY'?!A2H%PSFN[L5&:*$WC%4"._B#-H[ MEAF6R4<(X@[2Q1T$-VQ-@!`N'2%7,+CM6!Z;_.HL;'>S+#XI!I`M$2A5@E&J M!*-4"4:I$HRZ)!A%J&%IV:#B"$;%$8R*(Y@5&`4I,`JZHE)HJR9JZ9K*EJZA M#+J(,N@JRJ!K)H,NF@RZ:C+H*LF@RR2#KI,,NBHRZ!IHX)3P=J-(]G>O2WV M%X*1[8)9MBM(MBM(MBOHLDJ+BAT>JJ4+*UNZLC+HTLJ@:ZM7_N-B!VG[!`WL M:LON7&X9=+UE,`07LVO'#3W08NF8]Y%V`M'M;EL[IAIA5[ARC;CKIJ!=_5K6 MBH9-VID^]H#49I8>&4X%@]+N;GU3T#LN-@7B#(([EF>OVA2(.Q@6=Q#0L"Z&:W$;O_14KXEPC4%\&H+X)17P2CO@A&,1&,RM&P MM`)0)@1C4R`894(P*Q,*4B84=$6ET+8I4$O75+:D3*@E94)!5U'N3IE02Q=- MMG359)"RH-U=)MG2=9)!5T4&70,-G!(>^?RFA+=^\_V`AO$CZ>/0"BX$@PK! M8$(PB!`,'@2#!L%@03!($`P.!(,"P6!`,`@0C/D7C.D7C!04C!04C!04C!04 MC!04[*;`2,MF-Q7EZ4V-3&UFJ2B3J8*1J=W=2E&VU.T]HRK;@8&XLP.##N;: M)W79LED]NH;2H.W`H%FNE68[,-#!N*ZR/Q?6XLU;7MEL(^`CC`,#>6>S`P.- M[`K,D5V"&70-9M!%N!QCM3G\P^[E$=&SQ_K`]FJZUHH-F ME\H8G`L&Y0WKIWJ;[6YW>CP=RB`!Z0CA@L&W8-`M&-0*!HV"P:)@D"@8'`H& MA8)11P2CC@A&'1&,.B(8=40PZHA@U`S!*!""42`$HT`(9O5`0>J!@I4.+/G5 MTI60%&/)KY85]?89HUI6Y%MBJV5%OUT$4,M*`%>5`FR'K]TG#2SS<_.-5_SV M]E-^=FQ:'J;WO7N;;I:JSOT">U!@#POL48$]+K`G!?:TP)X5V/,">U%@+QUC M]OWD?7LT?7;ZRLTHH6XF]?VUF\6[VYL">UM@[PKL_<#ZB/Y"\N0U_H80U^WC7$J$78U*;_>'UC"-^TJ MT^*U?F#3$CY]JP&.6]]4D*%8,!ANV/A@;G>V*9;P;I1^/Q7"Q1E\-VQQ^B7[ M1Q30S>(V#&R+.YAMV-K88%HZ0K1@\-RPQ=CDIS=AOINMGLQ!O$1X4V`4%K&C ML`A&81&,0B(8A40PJH9@5`W!J!J"6=50D*JA8*4HJQIJZ9I*VK.JH9:5B*QJ MJ*5K)ONL1&/U0+M7*KFJ9&+U0+N[*G+T20-3IB.?1:;?\2#/LGK>M'=LL79L MCZ9M-O2TKFGM@!W!(*=CN;1MCZ8]!G1ULUS9Y)(-!$H$^"LB5%7`(XSS"@@5 M=_!9N),!PW`SVZQ_1@SI$@+.BQ`R8E30S>)%&A&(NS>.Y2D6=]0&<4=M$'?4 MAHZMNJ-<2%?*1<,6VCG?38?`5!#I2@41C`K2W:V?-XR>,4VV$1%WG#<,(.ML4= MS#9L;6PP+1TA6C!X;MABL[(]FLX)8;Z;Y>F5(@WQ$H$:5420IZ=&>811I*E1 MXHX:=1=WU"CI2HT2C((D&`5),`J28+:E49#ZHV"E.RLV:NG*RQL`5UH&61&U MNVLM6[JR,EA)RZJ&^JRT9%5#+5U-.9!K)X.34J9Z8%>_OJ4>M*MBRWK0KX]E MO1;'C_2Q75"JA[`B&*1T=VTYVIYL+\ZFT@)'T@^*!(,AP2!(,/@1#'H:UA>= M:ARP)?T@2S"X$@RJ!(,IPAL*S4PJ<3A66E%[[-5%A6BK&,UG%6 M&K&,5LM*)9Q8%I:33J:,MHM:WY+1[6(78<9:``D=FU;X:5&&EV:7J@VT"`8K M#>NK*-]$M?_,WW70CI`DSN!(,"@2#(8$@Z"&K0T$PJ0C?`D&70V;EO-I&PZ! MW2R7Q[Q!ZW<*-`*I+U%)?<%(?<%(?<%(?<%(?<'(<\'(<\'(<\$LK15T126E MV(N"6E;ZL;162]):P4HQ=O:@EI5F;,>OEJZ://A*)9;6VMUUDKN[*C)(6N?N M4UK;E:-O2>MV16F9U@U;5/ES_<;"IM]NBM<16!$,4@2#$\&@1#`8$0Q"!(,/ MP:!#,-@0##($@XN&]47]>+<[V4Z'K%`C_6!&,+)3,+)3,+)3,+*S87T<_Z<: M".DJ'4G7WC%7$^&0#):N9+!@9+!@EL$*DL$*DL$*5EJQ#%;+2BVV,*MEI1=; MF+OEXA5Y_E3)DKK;W?:*W/[.<"4L^\Q!AU-)R\X8U=+%U(FN/EOB/N&BYY3W M=G4IY_U=SQS;E:=E_G=LN:QOII485N6Z%*0*!J<-ZZLIOY]^=#*?0L%Q,UJ^ MN(LS&.YVE,#5%W=Q![_B#BX;MC8VN)6.4"L8S#9LN=)OI@L6<-W-1K*=M[IC-W4E;:\@WEQE:-$RV+UZ!I*@[;/"INE[[V*#Z5M M^=?!N*ZR/Q?6\D;>=OH(S99_'V&L+%*6+?DULBLP1W8)9M`UF$$787_F[>G) MT?02;:M_CCO5`F9_40ML];>WA+_\ZY=??_KGXZ]__W&/'/R"X<8!<,"@7#((%@U_!H%KQ/^UGS>.YKRN6.+15^Q^QO%'A38PP)[5&"/"^Q)@3TML&<% M]KS`7A38RP)[56"O"^Q-@;TML'<%]K[`/A3838%]=&RUYGY*9J/F?BZP+P5& M/@]^X_R&<_4"O%>!(8_4/?21P!!(`D,A"0R))#`TDL`020)#)0D,F20P=)+` M$$H"0RD)#*DD,+2R!Z=\MFM%\]OY;UF?C]O]I,7K>L<6?]>1#\>7&T1(;%TQ M&UJ!0\&@4#`8%`P"!8,_P:!/,-@3#/($@SO!H$XPF!,,X@2#-\&@33!27#!2 M7#!27#!27#!27#!2O&.Q)I#/@I'/@I'/@ED^*T@^*QA2B-"LSX5EB"%9AAH2 M&')(8.@A@2&(!(8B$AB22&!H(H$AB@2&*A(8LDA@Z"*!(8P]..4S1S>_3SZ; MHWE];MAR?18,P@2#+\&@2S#8$@RR!(,KP:!*,)@2#*($@R?!H$DP6!(,D@2# M(\%(7L%(7L%(7L%(7L%(7L%(WHYQE!OO1-OIA)1\=K-1<\EGP+VP#($DRU!(`D,B"0R-)#!$DL!020)#)@D,G20PA)+`4$H" M0RH)#*WLP2F?[>+,[[(^MQLXR_6Y8=/[\W3^`(EN-K0"AX)!H6`P*!@$"@9_ M@D&?8+`G&.0)!G>"09U@,"<8Q`D&;X)!FV"DN&"DN&"DN&"DN&"DN&"D>,=B M32"?!2.?!2.?!;-\5I!\5C"D$*%M?5;+$$.R##4D,.20P-!#`D,0"0Q%)#`D MD<#01`)#%`D,520P9)'`T$4"0QA[<,IGNS;SN^1SNW^SS.>&+==GP2!,,/@2 M#+H$@RW!($LPN!(,J@2#*<$@2C!X$@R:!(,EP2!),#@2C.05C.05C.05C.05 MC.05C.3MV/+]>:JYY+.;C9I+/@M&/@MF^:P@^:P@^:Q@R".]0X8^$A@"26`H M)($AD02&1A(8(DE@J"2!(9,$ADX2&$))8"@E@2&5!(96]N"4SW;AY7?)YW9S M9IG/#9O>GZ?OQ$"BFPVMP*%@4"@8#`H&@8+!GV#0)QCL"09Y@L&=8%`G&,P) M!G&"P9M@T"88*2X8*2X8*2X8*2X8*2X8*=ZQ6!/(9\'(9\'(9\$LGQ4DGQ4, M*41H6Y_5,L20+$,-"0PY)##TD,`01`)#$0D,220P-)'`$$4"0Q4)#%DD,'21 MP!#&'ISRV:[`_"[YW.[2+/.Y88N?PCD6#,($@R_!H$LPV!(,L@2#*\&@2C"8 M$@RB!(,GP:!),%@2#)($@R/!2%[!2%[!2%[!2%[!2%[!2-Z.\5_Q_KR9:B[Y M[&:CYI+/@I'/@ED^*T@^*T@^*QCR2.^0H8\$AD`2&`I)8$@D@:&1!(9($A@J M26#()(&ADP2&4!(82DE@2"6!H94]..6S75/)^7S@+@H??NNQ5\/2'P"`F([% M=\7AI6.\#B7I3%_]@"DW&]*!J(Z=^1$X/$D(:/*^.<3TB3S$N=D(`6\2`MHD M!*QYWQ3B>+HJ!H]N-D)`HX2`10D!B=XWAY@^%X!6-QLA*`$2@A(@(2@!WC>' MF+B@*KC9"$%5D!!4A8:ERDT)$(P2(!@E0#`K`0I2`A1TI:70MJ2KI0LK6[JR M,NC2RJ!K*X.NI`RZE#+H6LJ@BRF#+IT,NG8RZ.+)H*LG@ZZ5!DXEP&ZG?$L) M:+=9EBMWPY8EH&.+$M"Q90F8OB`)4VXV9`=1'5N4``D!3=XW*7LS?6D#XMQL MA(`W"0%M$@+6O&\*<3S=JX%'-QLAH%%"P**$@$3OFT-,K\'0ZF8C!"5`0E`" M)`0EP/OF$!,7E``W&R$H`1*"$M"P#;>UAB$UH(&G\3>8J`'N,,7=3*6'LN!F MPYV5A0;RB9>#E`4)PNVVZ)ZB;*8PH<)%WLQ?;.`N>Q'&=9C#N!!SF%#B(LSQ1`T7VHHPKL469BHQ M=H,HEYAV*^:[+6]>O_[M[W_YC^N?V!'P@6>Q^SCYX_=_;O?W35JZ^6C8LO)T M;%%Y&I;^=!$T"P;+O>^BS(@_".T8!T2QF3F>/D>"8C<;O,.PA(!@"0&9WC>% MF+\X#[UN-D+`KH2`7`D!D=XWA3B>=O-0ZV8C!&5&0E!F)`1EQOOF$-.6C#+C M9B,$949"4&8:9O\]#"DS#4QBILRXPQ1W,Y4WRHR;#7=69AJ8,X8R(T&LS'CW M%$6NJ%)FW,[#N/YR&!=@>A8K,]X]A9FE8&7&[3R,:S"'<1'F,*'"I:@G.5B9 MT3"NPQS&A9C#A!(78;9SF*Q.?QK78@NS+#/V=SA6R\P=_SC8WL_TV?[`XE[U MO8UB]P=V$@>D#PKLX<#2;#T:&->%Q_,^'ECR]Z3`G@XL^7LVL.3O^<"2OQ<% M]G)@R=^K@25_KP>6_+TIL+<#2_[>#2SY>S^PY.]#@=T,+/G[Z%C4_4^.13W_ M/+#=D<_SEP*C#G2".648A'#1;H#AD3K0P>22O44!NABRSU!#\NERR#Y=#QET M062?H8CDTR61N[LF,NBBR#Y#%=\A:AV`IP4.M[ M@9-V/6KQ%C*PQ=??SN=M$F2UOK@;M,)5QT([4-6P_A6SL^.3D\UV6D"@KG<, MC<":3P0I-XE'C1[US(> ME$L\&/=.(QZ$WR4>$FAF?4[/CX].YNT&M4)"4BLD)+7B+B$I']XU9EZ^Z$)% MD:A4E(8MO\*SG3;$%)G>-?8D%)F.13&GR+C=RDBL[C0[ZL>87ZL[WMG!D#)O M,;X-%559*?+.82=SP#6C(G)(/!Z/+HD5WX^9E#["ERJ'T] MF1/@1PY9)\BA^[7(TEP[5Q7:C;%D7 M&[94\?%T)(*6FAF;NR$P=-.Q4#$:Z>[6?K^GVZ0Y13'B'W6(?Y3@=F5)0A7- M(#E'%-YI#!X!B'/(=KO2.<2+2.U0N"4'E:ECZ4BIE2C#*5`\1ZQYEJF.Q/EI-ZF"LPRJC?H,[<0P>=LI?(9ZTCA=,6DV^#K@Z)Y\AF;2LX=HDD\72O892DD^ M0RK)9VAE[W/*?+$!#I74?:P:.$@$:WZ[D_?:0" MI^(=2KW7\`ZCXAU"&]9G:'-QYXJ]AOM><(+LK\#"'!F"8K)AK!1=B_'&R; MW;,I`?FA@>(I0H@I1B@QN.`L=@0^N-?(DS75&[OEEO<:A^J-V<_UIF&3Q*:W M%ZAN9LL]1L?BL:#6[5;$#MG-+/$#U]YU"`"J)03^ZV')("*J.AQA#H(Y862TK&T1%)!.ABUWBJ(>+0*(BZM@JC/$%;RZ3)*([>:H3Y# M2&F>4R+E0V)8F7#+=?"N#QSF!!C/(M5$@T3VEM?MUV/.4QH,%8' MVX)HF%!A&I#+,/L,T25+5QT?^/JTA>S6A^Y2;&&F>F,7][ZEWK2+?LMZT[!) M7M,="4AN9LLM1\?BL>#3[59XA^%FEN8.@KWKF"7XE1!PZ78K(6!70D"N=QTA MX%9"0*W;K82`;`D!U[UKB`JJ)02T>H@Q%"J,^*/"B!T51OQ18=QN9`BH:EA_A]_MSHXW\U\*@[K>,>8) MYB0`Q'F`T+6:P2$][L$ M1`G-K$_MQ=')RE8K"W4&K=;&8EM79I=6EQLZ^*=QZ1;^9$H5G[<T4JP[&.FC%2CQ:L1*75JS4IRMV^D1(?89$8YCV MB9#ZI`QU,(V3,J0^0W_)IPLP[1WLT%9]4H;49R@L^72)99^NI_)V#*56:L[F M_#N3@=V?'1?;ON$R[8FYG.M/PY)$X$XPJ&M8D@C,=2PDPI+2L9AY>!-_T";^ M8$W\09KX@S/Q!V7B#\;$'X2)/_@2?]`E_F!+_+%_$7]DN_@CV\4?F2W^V)F( M/]*X8=,:,;WUDMF]:RR>9';#^/,<.;4;>+%:46QKTNS2,F'9+E$LVS6,I?N= MXKB.Y=3J>C8),/I9M2]33=;;%6&NR3#!\-PG;:' MPRQ-\*.!I1B/!V;3&[N08K/2Q[(>]NEPE\(^&U@*^WQ@!\*^&';K85\.LQ3V MUMB;89;"?AP8-(TL^U1@ MGP>65J0OCJ4,O7(PEB3*6%=!BD(9ZV!R214;8/+IVEUN6@J?(=6T&7"MYLW` M$P^4QNDRS.,,'2:?+L3LTU67Q^D:RSY#9,FGJRS[=$E5FY93NW.8#WCF;_V, M7Q2>=FEBH+Z=RQ M>'>]\RS415U0.ZI)*S\6>93CC3<%? MCF59XD5FV*W<3>DF.:CK+@=UX=FW]E:"NAC7KZL485V>.:SK\T!8URR=8WCR M3GOE.FX//&UZ[,Z@EIIO_QG]TW;Y<''(W+'ESPR=3%\$0$^MZ^)G>A5#+&*' M5@1#*H(A"\$H/X(A`\%0@6`P+ACE1S#X%0QZ!8-*P:!-,,J/8)0?P2@_@E%^ M!*/\"$;Y:5A:V*@U@E%K&I;6>6I-Q](R?^5@6I(I+>+12HNXM#JB/ET,>4EV M-:216^50GZZ'O"2[(+)/5T3VZ9)(C\YG0R-0>G871?;IJL@^71;9I^LBC].% M46X=[++:G,_??L;*UP[EC*-C:9<`7\TN8=`E&&P)!EF"P95@4"483`D&48+! MDV#0)!@L"09)@L&18%`D&`P)1NH*1NH*1NH*1NH*1NH*1NHV;+%SV,Y?O2*; MFUE:=U967H[KT7FWSM>/6T7\)8;B8[%KA8I=2Q^(0/5-,SN M\/E^;7LR?66>:N1F0^D(1S!T(Q@2$0Q-"(8D&F;?^!Y!D(0;YO%-WR="$&XV MNE*A!(-^P6!?,(@6#%(;EL='^6A@6I>H%8)1*QJ6EBI*1:\^G<"\HCJ#V:=3F'TZA>G1+8-UG,Y8]NF499_. M6?;II.5Q.FOERL\Y].^=BN9R/C_HF'V+,7+L=+J=#Y_-CJ\*#0U#9^^;WU>V MI],W52"X=XVS9/BMNLZ_'`3CTA7">U?[::L8\?S#8V@@[,:0T4!W&`)&`MUP M]3$01>\:CX$FJJ[S8Z`2Z8I(>M?UQT`W83<>`]UTA_$8)'O#IKW"5"S)_V:6 MZACYW["+>#3ROV$[4L%G65]&*0G-+B]D;!8DB)4$CQ(>R[W"G2*'KF*#PY_> M*R*[C'B^M<@NK0//[-+*S^S22A/+?8Z[/;.+ZT!D%UR.[/+*D5U?!Y[9]74@ M,^@L9]!ISJ#SG$%G-8-.:P:=Q`PZBQET MSC+HI#5P2F6[%J:I_!O.#]O]LF4N=VR9RPU.-FQYE+N=WEQ(6S<;[DA;P4A;P2QM%21M%21M%21M%709I+-E M6_/5TEG/EDY[!IWD##K+&72:,^A$9]"9SJ#SFD$G-H-.8P:=QP9.:6L7KC1M M8P6^V^\*GK9[6\ND[5A*4`AK8,+@JV'GD:'0U>T"@ZV&V9]I3&O<=+<3_J0K M]#4L_78A[`D&>=(7[AJ6A@=U8@=S#5L?'EQ*5ZAL6!H>3`H&D=*7A.QVL"09E@,"88A`D&7X)!EV"P)1@I)A@I)A@IUK#U M4T>RSLW&VFA9IR!9IR!9IZ!31VCWZ=QET,G+8+"7WP2=O^EYIK7>,E%'Y*3F M.,YJ!IW6##JO&71B,^C,9C"H;0^TS+JSW_]^W][EE'4=F\['IF.5>YMNEH[W M[@_L[/3V;QT\&$;I!/'AP,[L)W__^_O3[T[.C_)_II>Z1\,^'3@^'MAFDW>, MV_UVWM$&93D0_#3N^03AR]?/`]C^[G_I.1Z)?LMWH3/$84HMC M.*[L#$TNSPDOIN%PO)8,W:=KD*_[..B:FX9Y,3'/SKKRZ7)+3\Y%G62:]W73 MHU-FDJ$/R466Q^DJF\?\[*$R)M['Z9IJSSX5)+L? M)9OP?VL;<-:N7"TVY!T[6)#Z;:WX_`8Q-.RLW1PKOP:%.)I1REITT,?!N>,= M*U*/'A\7H)#NY"@?*5<5:1FL+$GB'K$T;.WA$$HS2@^'3);Q#I5;)"3144MW MLOYPZ&<93!^.HB3N*4JC6^Q)J4`-3'E(!>I8KOK;T^D8E`+D9JYMZH_XL_KC MEBFM+^:TIORXG7MTP:41\FM5A:4KC!]Q\NX4&AV0R\A^[BF5V.F,U.J,#H@R MHQY=.4N/%].<6951CZZ>_(BND/PT+I$,NA[*>F(7G7[G>M+N3BWK2Q%D M"@:7@D&E8#`I&$0*!H^"P9E@4"88C`D&.X)!CF!P(QC4"`8S@I&:@KTML'<% M]K[`/A3838&1_BVN_5+C2`_2OX%)>:1_'V#8D>N"V5Y#.ENN=S`7Z*TD@LLC M[]5='VDXENON<8S;=A4*ND1R]]!(/(XE=NN>CEFN7"6Y>\@D=0^=)-"%DKN[ M4O)CNE0RZ%IIW:==`75*L_C;/QQC%RLG`AU;IFZS2QC4"`8S@D&,8/`B&+0( M!BN"08I@<"(8E`@&(X)!B&#P(1AT"$;J"D;J"D;J"D;J"D;J"D;J"D;J-BSM M.,A1M!UKGFZ[8ZO>;/T5=_9>W\%V M=?;DN_G/./`)]W`6)\.6TZW?H7NCKJ?;;\FZO/*OG[F^TL/;XGR'IW?)I;GD MKLSH&I-I>^Y#3^\:S,Y>WI5Y^].[4-O33V7#[BJME8T[7GTY:W>>EAOS MABWKAF"P+QCD"P;/@D&L8/`J&+0*!HF"P:%@4"@8G`D&98+!CF#0(1AU0S#J MAF#4#<&H&X)1-P2C;@A&W6A86F8H%()1*`2C4`AFJ[N"U`4%J0L*NA;2>*P2 MJ*6K(5NZ'#+H>LB@"R*#KH@,NB0RZ)K(H(LB@ZZ*#+HL,NBZ:."4IG8%:"U- M[[BZMYM$RRR5VT50(QC,"`8Q@L&+8-`B&*P(!BF"P8E@4"(8C`@&(8+!AV#0 M(1AL"$:6"D:6"D:6"D:6"D:6"D:6"D:6-FQU=6\F:1$A:1NVBS,IDK9A%^M? MONU6R9NM[N+.5O<.ML^(ZM6]F>3%UZ5SX'JGRXGKG?6^AFOU8[!I]^#R2L]N MB_L='MX5EQ_>)9?]N>;ZX(J'=PEF9Z[!`P_ONKS]X5VF>6W_TR]_^_KUU_L_ M_/K#]W_^Y]>??_QZ[^L__O'+'_[RT[_^DP/'$SXL2O@??O[ZU__[1_X['ONJ9E[[LSKKG2Z,Y^[VN5F9RZY M@U;%.SZR1BZ_E(V;?>/^"'H>S.;X>-^X/U69&W?FM?T%-&DRG[O2Y&I-^SVD-)U9T_X#D;GIU.:9VS'%8Y_:?/'9>-%T9M-\5D[SF3GD MLXBJESD\*QV>VT2=E[-_8FRW`Z9Y\"<6B]_<*F*=FL.V(LZ]3FUZ^8YKUS<6R*:I_YBT.;J/;%'FDRV=Q2*JS7ILSI MS;Y.E&+;V,RWOQXYQVK97HIMG^MUJA_;S+<_*2D.C:]-*='-OCZ4N;QIU:%2 MU,9FGEL*A=@V-O-MMR7#L)G?5+G,0GMRR3Z@\DC;J;559-)V9FVW^#RWMI*8 M?;)4P[\XL;M/'C M%LH';_,^G%N7[6AT)MZ.6*<1[25$J7-QEEJE#:+5R8Z M;3;.,M-I,W64J7[-:G13+D;7.QR6:]'U#@K*]>::M?NF7+JO-T<7C.&H(OMZ M0Z(S5V7;.4W\8$DQPQ?;RQNV2E4+?=C)5BV03D'I\0IE[IK=FTW MY4IWS6[AIMPL7)\Q.UQ&*6;44J#.`"M)=44ZX4GY8P:%-W8#-^5FX/J$)VTW M7N8Y8)MP4^X2KMDEW)2;A&M+^#K?6=)ORA7]FA7]IES0KT]02+F>7Y\0IUS. MKT]02/O(7)Z'>2O7^6M+\3K#+<'K_+9R65=+*Y9UK633?U.NX]?LA6[*K=`U MR_C-IE3B/KG+;-R7R#(;K4#6]='*8UT=K3C>4ANMI-:5GS[\MGRA1)9O?I^S M;&&NR\6;E9:64M<;YKK<_ES3I>Q!AVHIO6::RUFVDE>-%CF7,[QAALOM#K]2 M2;;;O]6\7+$7JO!KF^(B_L?]WJEHN#:V"ORC[:BJAFM+F*J#[;.JABLV,/76 MYAH&JQ)LG[?SZ/Q;#<".\FGE];XJA-;*L]):38.U\F"TEIXY#\`S_Y:M'`S0 MRFM_V8KJ\,R)2]G*`1U]^;=LY;R%UH>WM'*$0BO_EGTY2Z&5PY-R-FAE-F@M M9X-6QDQKY=ENJMN@RG=3^^DT6O?WJC5K.1([NN2?RNTG:^.?JNVSM7$(5CT* M;1MKJQZ$MF-KJWSN+[Y>MBLI.E([-V/ZH*V*::U,'ZUU5!:I+_TG,:;5@S[V M4GK_EM9'^];'M[0^V[<^OZ7UU;[U==W*CP_;#);K(V.RMV%^(KA\5G[HEU9^ MV+=LY0>@:>7G>,M6?F>75GY7MVQ]O6,J7F^.*GH^;UC+F,2J:-HD\F;")):M M3"*M3&+9RB32RB26K4PBK4QBU6=1'MS0^ML8G]9`>[X?TY)8A MT;JOA/60:-U7PGI(3RWJTUN&Q"O5OD;4CFG%\;U;^MXWQ_=O:7Q@C0_K9WVP M?]:'MSPKK0R)UG+Z:65(M);3_VQG:;.K\@)!T/:J;/O(8#_6+C_1]*EN^DS3 ME_()/]L#?JF?CS9;"LJGH\V6@OK9K@C'2E`W7EOCO7(P'!*=7?)/-2F?SYGJ M!^?53'\^9RC\8$J1(/=HNKI?MGWFI?5+^=)Z=8\F>E6[K,^\T'XI7VCI1<&Z M7[9]-D*?E(2R]EG10;E5AO/-K;-+_JEFA.]JG5WNOSJI#\ZWL\XN]U^6U#8V M$V>7?"FKVH?3=FYMU5Z1[:=46E"^AG5J_JHVS MJ+-+_JE\\L6[L\O]=U[U^?BJW=GE_ENNVL:7Z\XN^:?RR5;KS,99S0MMY]96 MS0MM6VNKYH6V"VNKXO$F9B^1Y=NW;1YXAG*=MZT#/LLVVSA<\KO]E99LVT!V ME6W\#8>C2_YH0]V/<=[RH9BM[-96/9]MG:QM5R3F6WMV_JG:WED;_U1M[ZWM M`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```#_ M_P,`4$L#!!0`!@`(````(0`KLYIWYR8``$'P```9````>&PO=V]R:W-H965T MO[C^_?_CUP^???WK]?__K^!^[UZ\>G]Y]_O7=QX?/ M]S^]_M?]X^O__/E__Z\?_WKX\O?'/^[OGUYIA,^//[W^X^GISQ_>OGU\_\?] MIW>/;Q[^O/^LEM\>OGQZ]Z3__/+[V\<_O]R_^_74Z=/'M^NKJYNWG]Y]^/QZ M&N&'+__.&`^__?;A_7WV\/X?G^X_/TV#?+G_^.Y)U__XQX<_'_UHG][_.\-] M>O?E[__X\S_>/WSZ4T/\[&__3A_9>'QX??GMYHN+?3A?*>[][>O=5(/__XZP?=@9/]U9?[WWYZ M_' MO[O0ZE>'U/DM>A]/%HQ?7OUZ_]N[?WQ\^C\/?Y7W'W[_XTE^;W5+[LY^^/5? MV?WC>TFJ8=ZLMVZD]P\?=0'ZWU>?/KAG0Y*\^^?IW[\^_/KTQT^OU^LWMZNK MN\VM1OG;_>/3\8,;\O6K]_]X?'KX]/^GH-4\U#3(>AY$_\Z#K#9O=MOM]UZ_6>^VJ^V-KO9;':_GCC?GCIN;-]O;J\W*=?PWK_O6WWQP MX=LWJ^NKYUY]Y:][I>OPNJW>7*^WM[O3!7SCEIT[D^3+M:^^]:IO)\M.3T#V M[NG=SS]^>?CKE>:53'G\\YV;I:L?5AK,>S^]^/EI^-K#H*?`C?*+&^:GU^HO MGQ_U"/_WS[>[[8]O_UM/W?LY9L^851QQ\!'N$7/#9BG(/0A>9QT/RHZS)WJ2OH`[R`Q4@)4@%4H,T("U(!]*##"!C2"+IM0^_0'H7'4L_ M$3WQ7HP#2`:2@QQ!"I`2I`*I01J0%J0#Z4$&D#$DD:A*]")1+\R4W#"QVA.Y MU3_!@WZ;;`+G(&])!I*?R3<&.IZ#_$`%2`E2@=0@#4@+TH'T(`/(&)+($U>" MAMGKM]<8%QU+/Y'P00?)0'*0(T@!4H)4(#5(`]*"="`]R``RAB02]2X1U3WH MUUIK7E@2N&%BM2=RJQD6/.B[Y$$_!_GG,P/)S^0;`QW/07Z@`J0$J4!JD`:D M!>E`>I`!9`Q)Y,E*1?T+GO13>"S^C,)GG2@CRHF.1`512501U40-44O4$?5$ M`]$8H5AE5Y&%ZXE[]&\D_0L?_=54V2FO],_>?D;)PW^7//Q+E.^8$>4>:5E< M)M+=53S6<8GR8Q5$)5%%5!,U1"U11]03#41CA&*37-46FO3M17\U%7F1%Q.* MI@)0-G<,HG*B(U%!5!)51#510]02=40]T4`T1BA6V95>HN M/C;)%5^A2<],A:E6BZ9"6+Z=SMP.KAJ68\%SGQ'E1$>B@J@DJHAJHH:H)>J( M>J*!:(Q0K+*KLT*5W5387+`K3/6:7L@_A7MWCNNTCE?RY/$]+%&^8T:4>Q2F M5^LU=H7Y%9=CP6+IZ(FPE3F15Y, M*'CN#^Y`/)T*0#FCCD0%44E4$=5$#5%+U!'U1`/1&*%895>)A2J?=H7U!7-A M*NDB_2<49TAWZ0GUZASE']:,*%_0LBWL-LE8QR7*CU40E40544W4$+5$'5%/ M-!"-$8I=RH*H)*J(:J*&J"7JB'JB@6B,4.R(55&OW"3Y]IJT9@4]H[M3 M&CRM20M:M+V]NXX+X6R.NM9L.3MP>Y>\.YW/48'!1Z*"J"2JB&JBAJ@EZHAZ MHH%HC%!L2EI!7UC;K5E:SRA0\4"4$>4SVFD>W:;1(KCTO4,DVFBU!'CTI& M540U44/4$G5$/=%`-$8H=L2LMO^-:<+J>CVA:)J%=R*#6C MI!)/WYQ8HKRP&5'N49!Q$15$)5%%5!,U1"U11]03#41CA&)'7#F<.N*J]!?F MP.NIK`YSX!D%*\V!*"/*9Y1L)F0CMR9*Z]PU3V]BY]#V-]CO+"9D2Y1^$2L+HI*H(JJ)&J*6J"/JB0:B,4*Q(U;I?L&; MX1N6\C.*CGIW5^G;'DN4%S8CRCT*Y@A10502540U44/4$G5$/=%`-$8H=N0[ MU>WZ6Y(T_9U1-$>FJ`!EC,IG=!,>KNPV24YPG*,VRW)7$)7F6-?)TEDM4?ZQ MJ#E60]02=/_W_8-*.TT: MXX1LHS^M.!U]_;)AY3^C9%8E;WHE-$7\1G8]:AN^) M!H^6X<<(Q?)_IS)_PS)_1E&9O[M*3N,/2Y2_S8PH]\.[#]$LAS'7R6#'.6R[ M&%<0E7ZP3;207B?)1A6$^4NK.5I#U!)UP6#!#6R3!;$FCI2=ZA/Q!E1/F,=/KG[^DXH\BH:?@`E7/4*C$JV?&J(,R_ M0,T7:(A:HBX8+#0*^]2LCR[-O^;`T<8(Q4:Y"AQUD3,6.]4S3DVE?%@7:?TY M.:5K7";+57+`?UBB_!UD1/F,MKJP9:SK9*RCCUK4*(C*&>D/-L^B50:KV;4A M:HDZ8[#>8`.[CA&*G;+.%.Z44CSC"X\0-CQ"(,J(\ADE)J1'T3XJ-&%ZQ6A2 M^>L*32"K.5I#U!)U,PI=[@TVL.L8H=@$5^JGT\552,^8,)T01)-C0DGJEFAY M<$N.^SC2LHEF1/F,$E_2XT\?%?HR#1_YXB\U](6LYF@-44O4S2CVA2\PL.L8 MH<@7367ZXO:;;_MRZA8?'J\E1#E,]+IK8\Z$A5$ MI1]K^31G1503-43MC(*+Z!C5$PU$8X1B1[[3\<$UCP]F%,T3'A\P*C^/)9>7 MK7R;%'3'.2Q8F@JBT@_F5H9@L"0AKX(P[WG-T1JBEJ@+!@M?,\E%^B#,O^;` MT<8(Q>999P@7O-%VS7.#&273*5FK#DN4OX&,*#\/'QS'S2PR;[J*`)6^9VS> M=9I7!V'^.FJ^0$/4$G7&8+W!!G8=(Q0[E1X>/+/K\)#@FH<$1!E1/J-@'3D2 M%42E'RM7GX>,%+DGMCG-8,"$*HM(/%L^1+1:X^984YB^MYF@-44O4 M?>4UL<#Q-0>.-D8H-M05KVDR?]4F6Y9FF6E>F,H@>/E2FC,&HDJ@BJHD: MHI:H(^J)!J(Q0K$C:5GI/HU^02*V9;TYHT"R`U%&E'NDC#58=I,,[KA$>2L+ MHI*H(JJ)&J*6J"/JB0:B,4*Q(V8)>L$?`+I3XJ0$G5&2L22%WF&)\LIF1+E' MX2297C%PO&!42501U40-44O4$?5$`]$8H=@25SLAB=3-OC"'W,YU65!$SBB0 M[$"4$>4>11O)39)\'IY21+GXQ+EK2R(2J**J"9JB%JBCJ@G&HC& M",6.N,H3D^3J@G5K*F'#MY9U*C57M<$>O4K.'P]+E%:"`:(Q19XM[&IR4O=^0T3KQLS2C<28@RHMPCK4OG=.OV+BU) MEBAO94%4$E5$-5%#U!)U1#W10#1&*';$*MM7%^PD-ZS;9Y3L),DIPV&)\LIF M1+E'P20A*HA*HHJH)FJ(6J*.J"<:B,8(Q998=;L[XG]ANG7#NGU&B2/+B<[T M!0!+U.+(7-TOVWV^1"WS9G>35)S')3ZCY,`D6?8/2Y1_?#.B?$'!5+A*%KKC$N7'*HA*HHJH)FJ(6J*.J"<:B,8( MQ29I:8HV]6>F@@M/]NX)15,!*'-G`.Z=A&4+R(F.1`512501U40-44O4$?5$ M`]$8H5AELPAW\2_=%EB%WTPHV1:2$Z?#$N6?WXPH]RA,IW8WR1G+<8GR8Q5$ M)5%%5!,U1"U11]03#41CA&*77'4;UAS/S(6I&`XKBYL)!87U@2@CRCU:IL>1 MJ"`JB2JBFJ@A:HDZHIYH(!HC%*O\G6KM&];:,XKDG\OO)??)&)7/*/ZSUIOD MV.2X1"W/_32\.GI4,JHBJHD:HI:H(^J)!J(Q0K$C5JV]=I]C?>GJQ%K;_16D M6_>C4XST*S@/2Y27,2/*/0HGR3S\@@I&E40544W4$+5$'5%/-!"-$8HLN;5J M[0O>VCB-$^_7,PIVX@-11I1[%%EYDQR;')FVO]8$H(\H]BN=(6DPL47[X@J@DJHAJ MHH:H)>J(>J*!:(Q0[$A:5U_Z_9^WK+AG%&TDFW62FAZ6**]L1I1[M-A[)"J( M2J**J"9JB%JBCJ@G&HC&",666$7X!9\AO641/J-HDDQ1`V(PH]RB<(],K!NX6C"J)*J*:J"%JB3JBGF@@&B,4.^(JZ-21 M2S82-TZ2;$THD.S@W(E/0C*BW",%G]_8V-TD)US')'HD*HI*H(JJ)&J*6J"/JB0:B,4*1)>Y)Q%YR0>%^&B?>2V84 M3A*BC"CW*++R-OVXU1+EK2R(2J**J"9JB%JBCJ@G&HC&",6.6(7[):=;.U;N M,THF27(DY1,$F("J*2J"*JB1JBEJ@CZHD&HC%"L256Y7Y!4;)C MY3ZC:)),40'*&)5[I,U[6>]NDT.8XQ+EK2R(2J**J"9JB%JBCJ@G&HC&",6. MF)6[^QN2%Z9;.U;N,XHFR6:-23)U5)17-ELZ>I1[%$Z2N>.""D:51!513=00 MM40=44\T$(T1BBWY3I7[CI7[C((9<2#*B'*/XITD*3"/2Y3WK2`JB2JBFJ@A M:HDZHIYH(!HC%#MB5>Z7+%NLW'=S:1VN/MN[9/4Y+%%>V(PH]VB9$$>B@J@D MJHAJHH:H)>J(>J*!:(Q0[(@>1&1;ESCBQDFRK0E%?D$%HTJBBJ@F:HA:HHZH)QJ(Q@C%CEAE^R6.L&S? MH48_$&5$^8Q6[LM=%B]OD^KR&(1Y,PN#E0:K#%8;K#%8:[#.8+W!!H.-,8O= M,4OX"S["NV,)/Z,H\=JMDW/VPQ+E-))LDA/WPQ+E ME>Z",43G1D:@@*HDJHIJH(6J).J*>:"`:(Q2IO+JR2NT+ M_EIV&BBNM3T+'3!89K#\S*)5?Y=LX,<@[/SX&ZPT6&6PVF"-P5J#=0;K#388 M;(Q98E%:>W][)JRN6&-[%CLQQ05,3H#)"3#)#E883+(C3K*#278PR0XFV<$D M.YAD!Y/L8)(]9(GLWZG`7EVQPO8LT/Y@,/F!NEM^S"S:%Z[2HB$("V;&N:MG ML@A,%H')(C!9!":+P&01F"P"DT5@LBADB45IE?WKBPZA_E9((O`9!&8+`*316"R"$P6@N6^ZB?^F+2<`),38'("3+*#278PR0XFV<$D.YAD!Y/L8)(= M3+*#278PR1ZR1'97]H;%VNG/;Q3_PE._U94;*,VF)A;O&6#R`TQ^S"S:,W;I MQT:"L&!FG+MZ)HO`9!&8+`*316"R"$P6@3[&"2/62)[-^I MP%Y=L<+V+/8#9;?\`),?,].E+U7VBC/C'.9G@2P"DT5@L@A,%H')(C!9!":+ MP&01F"P"DT4A2RQZ6<6]NF+)[5GL!(MN(TY.($XS`TRR@TEV,,D.)MG!)#N8 M9`>3[&"2'4RR@TGVD,6RK[Y7!7X:*%FI9A;Y09:MR/(STUJZS(Q=^C&J(&R9 M&7ZXY:.DI1%7&:PV6&.PUF"=P7J##08;8Y98Y*K$%^P9JZFJ#$^_5S.+G0BK MS].7A\D),#D!=C1883#)CKZ2'4RR@TEV,,D.)MG!)#N89`>3["%+9'>57RB[ MRZ8N^-#!ROT8;KJ'SRSV8RXUEW=UY`>8_)A9-#-6Z6>G@K!@9IR[>B:+P&01 MF"P"DT5@L@A,%H')(C!9!":+0I98Y*K$T*)GLJG55%7&,R.L-*>OT%O-<8$[ M<@)Q<@),,P-,,P-,LH-)=C#)#B;9P20[F&0'D^Q@DAU,LH&6Z@-)N:6+`J M:6:`R0\P^3$S_1-D4]PSSF'^,9!%8+((3!:!R2(P600FB\!D$9@L`I-%8+(H M9(E%KDH,+7IN9DQ593PSPDK3[QE@<@),3H!I9H!)=C#)#B;9P20[F&0'D^Q@ MDAU,LH-)=C#)'K)$=E?YA;)?>C:UFDK(V(^YK(SV###Y`28_9J9+#V8&]XQS M6#`SP&01F"P"DT5@L@A,%H')(C!9!":+P&11R!*+7)486O3092NR_,RTE@8S(_TX;1"VS`P_7%B!DU5&W]I@C<%: M@W4&ZPTV&&R,66*1JQ)?,#/64U49S8R9Q4Z$U>=<@3-.3B#N:+#"8*7!)#O& MD^Q@DAU,LH-)=C#)#B;9P21[R!+97>47RG[QS)A*R-B/N:P,]XPUF&8&F/R8 M63PS\![X$A;,C'-7SV01F"P"DT5@L@A,%H')(C!9!":+P&11R!*+7)486O3, MGK&>JLK8B;#2G/>,.2Z8+7("<7("3#,#3#,#3+*#278PR0XFV<$D.YAD!Y/L M8)(=3+*'+)'=57ZA[)=F4^NIA(S]F,O*:&:`R0\P^3&S,)O"WS'+HG.8GP6R M"$P6@3[&"2'4RRARR1W55^H>P7SXRI MA(S]F%BP*AU6:S#Y`28_9A;.C-TN_1QY$!;,C'-7SV01F"P"DT5@L@A,%H') M(C!9!":+P&11R!*+7)486O33 M[&"2'4RR@TEV,,D.)MG!)'O($ME=Y1?*[F;&)>]GK*<2,IX9>NGLDB,%D$)HO`9!&8+`*316"R"$P6@R7[AFG@9*5:F;12D66K'^X\?'U^]?_C' MY].^OGD=\%=?[G_[Z;5;X'\XK82Z\W,?W[:Y4IN6"+-MY=I.1K'?VK6MS7[K MC7N]C=UV[=I.;SABS/76M6WM?C>N[72RR'ZWKNVT#K)MY]IVYI@KUT_O7ECW MOG+]=&QNMCD]=;9KM:V=GCKT--NUV2Y<.1?T M1R/FF,X%_66#V>9U^K1>+K M;U2M%DFOOY4T6G;JHZ^>LEK41]][9+5(=7W[CM%R)]'U+3!6BR37MY%8+1)< M7X5AM.S41]]!:K6HC[X+TVJ1UOI*1JM%6NNK`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`85S!1GTVYERX5A_]<+'1YUI:7YOKSK6T MUA=16WVD];7Y7%]+ZVLS2]JHS\;LLU&?C=U'6NLKGXTKV$CKC:GU1EIOS'5G M(ZTWIM8N$;/S,)>&V5F82Y;-&FSO4F4[4W:)LITGNS39S)+WIZ3-]-2E;';& MYI(R.R=S::R=Q;HDULYA70K[E0Q6GGXE3]/K?"5+T^M\)4?3ZWPE0Y,_7\EW MY8^9[?YR_<,O=MVQ=X^H]4SIPLQG39=E/FFZ*/,YTR693YD>&-/'4\IGSLTI M@;:N]90^6W.SU?K4FJM0IY;>;!G4,IHMOZQ^^,5ZE;T>9&O-R%7X6GSO'DCC M/G)WC&#PO5LL#)ZKX#6Y[B`W[^"HEJ/94JBE,%M*M53F&E]JC:_,/K7Z-%]I M6:O%NNI6*VQKMG1JZ3ZG[J6WFP9U#*:+;FN(#>OX*B6 MH]E2J*4P6TJU5&9+K9;&;&G5TDXM;\]O6#S^_..?[WZ_[]Y]^?W#Y\=7'^]_ MTQOI5V_<[P9_^?"[^^3#]!]/#W_J,SZO7_WMX>GIX=/I__YQ_^[7^R\N0,&_ M/3P\^?]02O?VKX&PO=V]R:W-H965T>W6M"G(0:P"E,)C/_?EN69%EZ-1RRE9N8 M/.I^]=%N69)]^^>/P[[V/3WEN^QX5W<:K7HM/6ZSI]WQY:[^O[_\/P;U6G[> M')\V^^R8WM5_IGG]S_O??[O]R$[?\MOVR MM_1()<_9Z;`YT[^GEV;^=DHW3X738=]LMUJ]YF&S.]:Y@G>Z1B-[?MYMTW&V M?3^DQS,7.:7[S9G:G[_NWG*I=MA>(W?8G+Z]O_VQS0YO)/&XV^_./PO1>NVP M]<*78W;:/.ZIWS^<[F8KM8M_0/ZPVYZR/'L^-TBNR1N*?7:;;I.4[F^?=M0# M-NRU4_I\5W]PO,09U)OWM\4`_;U+/_+*[UK^FGU,3[NG:'=,:;0I3BP"CUGV MC9F&3PR1VH`_:T==NS6H!'9_"BN'[NG\^M=O=UO#&YNNKU!GV0>T_SL[YAF MO;9]S\_9X1]NY0@MKM(6*G05*IU.P^FV>E3GM1I=H4%7H=%K=-LW_8'#1"Y4 M3J5%%^@J'&\:-_U6Y__Y40H4?G05?M3\*SOL"E^Z"M_!9_OK4*SYT+.@BU%M M])V6V_G$R#MRZ-D/H=*_;MRF'['7K M.E<9,,JGTO7:`6OR^[Y(H_'FO+F_/64?-9J;Z,;.WS9LIG,\)BP3B-]P94K] M*J,HE9C*`Y.YJ]-H4*[D-`U\OQ^XK=OF=TK=K;`9HDV_K9N,I`E+5*8[-L'$ M!+X)IB8(3!":8&:"N0DB$RQ,L#3!R@2Q"=8F2"J@2?$I@T3W]E<$B_%]*&V_3IWBB-.D:02I,R2D`F0'P@4R`!D!#(#,@<2`1D M`60)9`4D!K(&DE2)%C1ZM'Y%T)@,39=T*0."DQTWNABUTJ2,&I`)$!_(%$@` M)`0R`S('$@%9`%D"60&)@:R!)%6B18W6-5K4[$L[^2!BUD5PY*`..6%KBDJX M'".#2B/I-@8R`>(#F0()@(1`9D#F0"(@"R!+("L@,9`UD*1*M%C0`_X3L6#6 M>BPXH:R0PSP",@8R`>(#F0()@(1`9D#F0"(@"R!+("L@,9`UD*1*M(&GU:(V M\/]QF<9D](APTJ>**]EA+LM*(QFV,9`)$!_(%$@`)`0R`S('$@%9`%D"60&) M@:R!)%6B!8F6SUJ0+L]4S%J/!2=]5V4'D#&0"1`?R!1(`"0$,@,R!Q(!60!9 M`ED!B8&L@215H@T\;4.U@?^/V<%D](APTE%+YA&0,2<]NE0RR%BA34HCF4$^ M)TZW4T9[RE&EMJ!TJVKW]6=76!I)[1EJST$[*MV4=GM#9?O@K#B?XOII6[++6H<.1%G1`8V%E!/U&'[2)LI+ROD!ZT$$_ M$&:5]5"(:&81FPM6:7\DD-98MV4:H(MWL08=Y+:H74 M3W1]/<)L?XT1;A2K]=?=]MLPHTF5)"V/T@X=,XG#)[Y+U^++465\1NR$D*;W M"AH+U*4G>F7N-HY`)LI*=LD72(\OZ`?"K-\N!R-$-+.(S06K-#9"SP6BI45L MA6(Q>JX1);J8'CFVR[X4N;^RMU]%C@ZTR]#QS;H6.HZZQ<%_$>`1.ZJET%70 M6*"^>GQ.$/D"M=4#?(I:`3J&B&:H-4>M"!T7B):HM4*M&!W7B!)-2X\1VU-7 M8V3)HFHL^!9-HJY\<2T9*M=.P.8.8L'9559V`\ ME'RAU5$WQ%3*JQH#B2[6&$HK6FF4[8(:9UCC7#G*22"2Z&*-"VEUL<8EUKA2 MCK+&6**+-:ZEU<4:$ZU&_;9AV_]/W#;\M(#T9#N'[`V@WX@K)R*?FC3=UO&XGNF]%4KNJXQF\R%566RBBQ5+FQ5PD2Q M5%7*>W^%^K%%?VW3ARXE2M_>)?U>80<3E^Z5*Q_)_'Q#NUDXJB3)B+W(U%-\ M+)"6S]R*'C)R?'QII?)FBEJ!M%)Y$TJDM&82*:TY:D722FDM)%):2XF4U@JU M8FFEM-82*:U$(DL^T]1],4;7+7B9BK&+Y,U\YFA`D2ISU_*D MYE8N/;!+*T@'7\AK&0XU!L+JY2N!*K-,?%6-:UN-T&WV20V+(PVTO=M\7N!?S?#7_8?T])*.TOT^KVVS M=_9%3,>E57B)^>BE@(7W/#JSMO"^1\>D%C[PZ!0/>>+2 M9T)%3AD5TSK?8PM[=*%5N\>6Z5A":W"/+;JQA%;4'EM"8PE]I_1@JW_(OE^R MV`_;'KT;1IUAQZ/WC\@?NMX#!0T+EJ[']FQ8L'(]MG'#@MCUZ.C,PIT6=:YX M*AN#2%MW*K%U@_:!5&*K9>9Z;&.*U-8E/7FUH+`M>C(U)TH",WNH%L[:)S&2JQM8MV]%1BJW[H M>D-KP; MT\ONF-?VZ3-E?:M8.I[XEW+\G[/8J3]F9_K`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`?#GESEH&08G.3YZC?@4M4%'A>Q#_-$51$HBBHCNR;`_T9Q5?8C?5$VD(=*&1`@) MS820Q_/.1'=Z^8W/+3&7QD#!ZRC/^B#?K2!2$E%$=$^.;*SJ@_S&:B(-D38D M0B"4[Q,$,M%2($N0/7YW%D0*(B411403J8C41!HB;4C$H<,GB$-_YV70#",U ML>0*'T'2W$1)TP=YX0HB)1%%1/762K/LAOK";2$&E#(I0S]S*A@3A^ M5IEH*9`E8=(0*8B41!013:0B4A-IB+0A$8<.IR<.W23-)2YH)U9F,XS4Q)(K M9.N0--DX2IH^R,]C0:0DHHAH1S#!P\;RR&U4?9#?6$VD(=*&1"AGO*^0[GC6 M=.%2(H?"O&%4,"H9*4::4<6H9M0P:@62,AA;&9X\)H.FJ,\G9I`Q[E$*.13E M4%0+%D.4G]>"464+1B4CQ4@/*,RFJ:R!U1#EMU@S:ABU`DD9C7\,97PEFZS=%&(Y!WK3 M)]C"V&ZOC!@W28V MY&=H;FY>NFH%4?I+#I:=Y-PN?-AUW[-@5#)2C+1#LAKF,[G%:HCR^UHS:ABU M`DD9C>,,97PEFZQ!%6I9-.U6(KM5D45&J&!4,E*,M$-!Z:L8U8P:1JU`4@9C M'T,9NMKTCM)D;:C0QR.,UF?3319==Q:9#/C;T]T2^Z51,CYV_;EY_) MB8E.'/ M9H,\;\JVG.V^0T$N+1@5#EVCRARI>#[*5KS+1,GCH;5#4J(@JDS%BIU[GK)D6 M`EDDS706F>E%WD?YN2T8E8P4(SV@()NR:/&V&J+\%FM&#:-6("&C,09"QN/9 MU(5+F^Y06)H8%8Q*1HJ19E0QJADUC%J!I`QIFWYR,DW8J#L47>,"H8E8P4(^U0L!I1,:H9-8Q: M@:0,20O^CJ<\IDODP1V2Z91')F8Q1`WIY$SRX*1*CE*,M$,9GGF:=4(L-T:W MCY6+@`'R6ZL]@DGI4Y#6;1L7Y=9M$RN0K1^G&UJ*;,ST";EFO;?(-8O$99!0 M,2%4,E*,M$,BU^Q8`:HYJF'4"B1EB!WZ*Z<<&_&),^+!72^C@E')2#'2#@7I M$]TP5BY"I(_=IP`U+NI8KH2=I$C&*Y^0*]9:BUPAM[V8$"H8E8P4(^U0D!@5 MHYI1PZ@52,J0-."GKFQ.V'T[),XD9[6'K"HXJF2D&&F'@A2*ENDK%Q'D2^U0 ML$S?>/339?I6C".TP]3(%'K?$F8WC'3C#H7B,2H8E8P4(^T05A]]<:X.K\DW M/LJNR=_P\[16#"WUBWWX.].+_?F4_3FC@E')2#'2C"I&-:.&42N0E"?ES\T3 M_1-7#J;LSQT*LFG!J&!4,E*,M$>X-O5&Z(8B0(S%E%#!J&2D&&F/ M,`M!S8D]TQ`U9([;B>$>L>&H5B`IV6D^>\H^VR&A#/MLCBH9*4::4<6H9M0P M:@62,B1]]CL6NJ=LM1T2`K'5YJB2D6*D/9*I$ZVC5T/4D#IN)\+4(=2*CD*S M6>ROC]_'=N'21SL4*L.H8%0R4HPTHXI1S:AAU`HD94C[Z).+SHR=M$-"'W;2 M'%4R4HRT1R@A0=&)%LVK(:K/'$8-HU8@*5ELG5_)'+;(,[;(C`I&)2/%2#.J M&-6,&D:M0%*&E$4VCT].O%S-V"([)#+'N=/@]IZC2D:*D?9(UIQHA;P:HH;, M<3L1U!R.:@62DIUFD6=LD1T2RK!%YJB2D6*D&56,:D8-HU8@*8/QBZ'1>>4$ MLO8R]#-X$S5VPHP*1B4CQ4@SJAC5C!I&K4!2!F-:0QFZ6W"S`'WJ&60&BJY- M%HD\(53@3=Q(QI*18J0]0O^A]L8/!:HA:CB#W!;#,XB0^7F.;K^Z**N9_;D- M^RL%3^O=U_5B_?BX/UMMOYN?TLC&8SPKZ+G]H0],(W[IH_N)#6JY]+\!$K=, M;VZ-:<`.QRVS,?IT*UC48GY1I"M,U)*CI5L(HY8)6B;)[4S1TKWK&_>9H@_N MOQ/[-D4?W)*F6J`![B%2+=``-R.IEBNT=#=SM`?7:.F>W\4M.5KP)D9BM!R* MXN6"1,L$BN*"D6J!HGB&G&J!HGBLFFB9H@4+.HF6'"UV"9'V&HKB!;]4'RB* M=]Y2+5`4[W&E6J`H7FU*M4!1N^07[T&&/OB*1*)/ACYXJ3_5`JWQ*GNJ!5KC M/>Q$2PZM<4.0:H'6>),VT9*A#[ZGF&I!'WSW+M4"K?%UM%0+M,8WK%(MT-I6 M=U('6F/5C?O,9Y-;J!J?:I/I=H2FQ$W$:_-12'!YT:D!-?FLIS@US?PR6.NZ>#._N3;/:/@_OFT9?M`3^E M!B.)'[O"3^>M\3M3XPLX\?OM]N#_@$*C_L?X/OT?``#__P,`4$L#!!0`!@`( M````(0!X#:73@`P``*Y"```9````>&PO=V]R:W-H965T>QTG,3:.`]O[]>\[ M%$F)PY?KQ,'>')]].!QZAB/R%27GYL\?N^?>M\WAN-V_W/:SJV&_MWE9[^^W M+X^W_?_\)?Z8]GO'T^KE?O6\?]G<]G]NCOT_[_[^MYOO^\.7X]-F<^J1AY?C M;?_I='J=#P;']=-FMSI>[5\W+]3RL#_L5B?ZY^%Q<'P];%;W3:?=\V`T'%X/ M=JOM2]]ZF!_>XV/_\+!=;\K]^NMN\W*R3@Z;Y]6)OO_Q:?MZ]-YVZ_>XVZT. M7[Z^_K'>[U[)Q>?M\_;TLW':[^W6<_7XLC^L/C]3W#^R8K7VOIM_@/O==GW8 M'_#68#\G1W<[^E"$S:>X?-PVW_4S;7XU%_<'?3).B_V\WW M8_#_O>/3_GM]V-[_8_NRH6S3/)D9^+S??S&FZMX@ZCR`WJ*9@7\=>O>;A]77 MY]._]]_E9OOX=*+I'E-$)K#Y_<]R'$]B:USV>^NOQ]-^]S]KE#E7ULG(.:%/ M[^3Z8B>Y=N([T>5&$=*TV7Y4^+XEPYKK1IQ]N_+XO MFE$9VJHP]6AG_'R,`UM63966J]/J[N:P_]ZC2Y\*Y_BZ,@M)-C=N?7W:_+85 M^ZN"I4HU7CX9-[=]RCC5XI&NLF]WLWQT,_A&5\;:V2S09A*9++V)N0Z,WS(& M50Q$#.H8R!BH&.@`#"@O;7+H>OD=R3%N3')\5`L/NFQEUSQ92V_B^Y0QJ&(@ M8E#'0,9`Q4`'@&6"+OK?D0GCAE8P5B8YCWQA;28T)VTM12;+UJ3-#I`*B`!2 M`Y%`%!`=$I8D6N%^1Y*,&[HI*?@1;1LC7RW$D@%1`"I@4@@"H@."8N= M%L@+8C?6/'9+:-9]6$L@)9`*B`!2`Y%`%!`=$A8H;:$LT`]N*\8-SX`E$_H( M9G\.ENC=O:!5$`$D!J(!**`Z)"P MI!AUQ;)R?OH;RZ^A1A4@@JA%) M1`J19HCGQPBM,#]OU(0QC_8.BX("6&:`2D05(H&H1B01*42:(1ZST5%AS!_= M.ZP>8S712K1@[RB&<4VT5KX`R@Q0A4@@JA%)1`J19HCGQ\BO,#]OU(15:RP- MH8!SZP2@,@-4(1*(:D02D4*D&>(Q&W45QOS1=<*J-):,5KB%-9'%-=%:=34! MJ,H`"40U(HE((=(,L?R,+M.8C3E?)QP*UPE$):(*D4!4(Y*(%"+-$(\YI3%S M2L2%>F*$&M,AOG<4\:%E9]76!*(*D4!4(Y*(%"+-$,^/T7[A-7-^G1A9J1A> M&@ZQF@!!6:)5A4@@JA%)1`J19HC';,1;&/,']XZ1%8$L&:TN#->)^(32=:3* MZ6JB[>A1A58"48U((E*(-$,\/Y=IS!%J3(=D72RJ-ID`IGU:'264UG MS=.1(LNOHS/+JK/P!2+0=8U(=AW-@Y=B.)M%\E9U%MZU9GYXHF*Q:2Z>?-@E MZJ_]ZZ\215[;3*$('3ED;@Z[F_8B2L32F17-DU7['`A1A4@@JA%)1`J19HCG MQXC`<'%)%$R8!ZL9V1IBT6@25`R@DII-J056%2*!J$8D$2E$FB$>LQ&!8&O`;B(]R1-6,U`*AR5N/KYJ+*\BP;CZ/M6:"G&I%$I+CS MR6PX'$;'2YKUX@DS$C!,V!M%8A4C2Y1%-"?^FEV.`)6(*D0"48U((E*(-$,L M9B.Z6,QVU^T6CG>ML(T7+DH]BFHF/OAU9F'-M#WS-HN58V/:CX-%*)I:X:R, MQFBMBGAAK7%(F1A2I8>,#J;T6T/R9*=D;[B=O6^5SE'U.A06'J+2=Z0;>%^? M58()[%HCDHF>*L$TZ\KS811I>,'%N];[BL]XB8K/HC%MZ6TAS(IHAUWFUHK5 MGO,U)/74]BRFT4I7N9Z9F?W6+)]&`P@JSVKB<-G+G4P.GG$B*A%5B`2B&I%$I!!IAG@N8C%ME[V+;T!S5-D. ML<>=^21:-Y:=E;\22T05(H&H1B01*42:(9Z?6'B?WPIS5-@.A3>@B$I$%2*! MJ$8D$2E$FB$>%E9]75A/45W)-6:"40U8@D(H5( M,\3S8[1MN'Z\41-6"K-UPB)6$X#*'%"%2""J$4E$"I%FB,=L].L%,3NA'#S+ MR"UB,0,JT:I")!#5B"0BA4@SQ&..9?!'UT;4Q[E%;&V,#V\ZJNP[:CAY5 M:"40U8@D(H5(,\3R0WKADIIHS+D\<2BL"40EH@J10%0CDH@4(LT0CSFM7"_> M+PN4K@Y%:V-T1[CLK'P!E(@J1`)1C4@B4H@T0SP_1C>^?YTHG,P,U@F'PL,Y M1"6B"I%`5".2B!0BS1"/.:TG+Z\)%)2%1;07^=E>(BH=NJ:UH17AX^OH6+?J MK+PO@;YJ1++K&+J/;@549^7=:^:+I^PWRK'Q,`GW5B&3*_?@Z.ME0G95WKYDOGK*4D`UO]-YU6UV@C'6()B\ND;8'2UB%SH-JNO[-QM)@LO55W M)EHBJCRRCUKRR(GPS>%0HWBIK[U5-Y1$I#Q*#Z5]\Z^&XDDTNC0LJ//W1(65 ML:QP+&*%`ZAT'0.K"I%`5".2B!0BS1"+>1SK7W,1A<^:WK6\-%ZX+'8HJJ=H MPUUZJVZ22X>FG9RJ/*)E.:C-:"<2WE.E^7]6A\*9?DC:/ M[,(9F8VC#7CIK;H:*!V:!8\I/"J:9UO1^8[P/L*1)4M]*SE[J;%]I>WBV(X-W>) MM,=!"_THE^Z/4BTC:FG$0-PG+^;F##+1)Q]32_/;6NAS32W-?0&T3*BER1JT M3*FE>:X/+3-J:31;W#*B2.D%IL1W&U&D].I.JH4BM0?OX"VGEF;ZH(5R0"]` M)+SEU(=.L!,M&?6Q>TCL+:.\T2NIJ3Z4-_OZ37\5`OEF=Y'2+50SN@U;6RAFS*JPE3= MT*_)/Z5]D:N$IX69Y!0WTY7@GXKY)[H>\2LM:!:3$T]SF)Q"FL%4``N:O]3T MT6WNW,AL')GN=N=&;6,+W?3.S2UMJJ6@EM3WI5L8:DE]8Y+OU)(:AUZMF9N7 M9Q+C4(MY]P5;Z/'EW#RNQ!9Z%#DWCQZQ94'Q+)+?@`X4YLMD"YTKS,VI`7JC MVV=J2>6`[A*I)?FM*0?F_H>\#=HKC_Y:P.OJ%Q^W+L/6\>:,&U;^L< M[-\;<*_NN+=V/N]/]'<"2"W1C[WI[T)LZ&?6PRL2&@_[_&PO=V]R:W-H M965TE^ M:(PFPT%VVA3;_/1R/_S[B_=I,1Q4=7K:IH?BE-T/?V35\//#[[_=O17EUVJ? M9?6`(IRJ^^&^KL^K\;C:[+-C6HV**<1S?LCK'TW0X>"X684OIZ),GP_4[^^&E6Y$[.8'A#_FF[*HBET] MHG!C_J#8Y^5X.:9(#W?;G'K`9!^4V>Y^^&BL$G,R'#_<-0+]DV=OE?3WH-H7 M;WZ9;Y/\E)':-$YL!)Z+XBLS#;<,D?,8O+UF!/XL!]MLE[X>ZK^*MR#+7_8U M#;=-/6(=6VU_.%FU(44IS,BT6:1-<:`'H'\'QYRE!BF2?F^N;_FVWM\/I[.1 MN;`->T;V@^>LJKV@JVJ'QNN)`DZQY,+JV M#N9H;DR6T_GUYUNV?G05#5UW,.@Y^#"R!&K'41K&*\]H=!E`?[2NB]'"MJW9 MXB>/:8AA9W_8 ML/G$6G9UX.G`UT&@@U`'D0YB'202&).4G9XDX:_0DX5A>HIN/G%`K7;B:"P,K::25K8Q5_/H MB=O0@M?I.54MUMQB+DNNF3B=225[4PZ98%X0'P@`9`02`0D!I+(1%&6=@=0UERR'?^= M0D"LF,RQT5+T\*DEM(]T.6D;"RTKN1';'GHC4UM'G$!\(`&0$$@$ M)`:2R$11CS8,1;W+M9.0C%FKDG%B=FDO-*V&*[>4(1,MC;B1K!,0%X@'Q`<2``F!1$!B M((E,%)U8)0]"&?:H66OW^>;K4T$=IUET0;@IE;QM(*H"I-X5Q7^4IS?4Y@VU$YB%D:3F"-IPK+#%1E9S1F^&1H'D8O( M0^0C"A"%B")$,:)$0:I@K%"^?1UCYS==&(YD83B9T47*,S5CG#82+1/-44Z] MZ[9WS7F7O5Z/^JC64CL!^JW5;,'#0GH'?1B13B&B2"!:\KHN6`MMJL0_:RSI MPU!CJNZLD/Z`[KSNIKI8//433?8F_3JR%D1.R-:H1RY:>2VR^[W'1Q2@8X@H M0L<84:(XJL*P.E@6AA36MZ,51K^":G3(HF9=RGMJF=I1P6BLI%5U$ M7HL6?7A?(-H(NQRR36WE#$0L)=/T13`45OU\B$3XOL58(+5%+6L3$>N]%M7A M8(7UM>&X<4%E8;0%E:/^\=?LQ9Z^H`)RTD95G-7HUQ2_,45YJ:]( MSI$L.2?RZ<\`Y"+R$/F(`D0AH@A1C"A1D"H8*^11,/&V^_8WLBR.-JDYDA7C M9*$NLEHJ.49G)?+=1>0A\A$%B$)$$:(84:(@5416YZF@O8EU>JLNNQ!YB'Q$`:(0480H1L2^';()1$]/S\5%Y-\"^?>38U:^ M9.OL<*@&F^*5?>_@,``/__`P!0 M2P,$%``&``@````A``I_1_1#!P``$A\``!D```!X;"]W;W)K&ULK)E=C^HV$(;O*_4_(.X/$"!`T$*U"^2[4E6=MM=9"$NT0%"2 MW3WGWW<3GK?Y M+CN_++I_?76_S+J=LDK.N^28G]-%]WM:=G];_OK+PT=>O):'-*TZ%.%<+KJ' MJKK,^_UR>TA/2=G++^F9KNSSXI14]+5XZ9>7(DUVM=/IV!\.!I/^*DPJNO_RD%U*&>VTO2?<*2E>WRY?MOGI0B&> MLV-6?:^#=CNG[3QX.>=%\GRD>7^SQLE6QJZ_0/A3MBWR,M]7/0K7YS>*<\?V6FP8XA>U;6>6G?[B1)4+Q(",19'PUR`U'&J(>G3[%Z$.[-YS9ECUAP]_P MG`A/^A2>=F\\M*>S^KYO.$Z%(WW*(%2B0+P1/5;7ZZ3,/>9%%5&1QAZ,]9D_<1LJ?8U\1G:NN,54 M5=@P63$!](`"0$$@&)5:+I2/,$'=G[YI,/-0M#=4%5#9]J;J3: M&+*MN,5-91N31ED@+A`/B`\D`!("B8#$*M&4)1$U96]G)K.N!933>A*$$!](`"0$$@&)5:))1B^%3TC&K'7) M.!DWI7#%`>63G/D:R`:("\0#X@,)@(1`(B"Q2C0MJ)_1M&!OVR%KHF[G$7/3 M11&$"JF2(D:Y7W&C*=U-:V0-C#QJC*2:&R`N$`^(#R0`$@*)@,0JT;1CFR&U M4[DM&;/6)>-$R2,.IG7?7_<2:R`;("X0#X@/)``2`HF`Q"K1M*`V5=."=VV] MNF0 MC2RCJ&W`S>5DYM3MXM@:38R7MM<8R-3T(4@`)&R\6!PKUL)JS%;D?0FI*2X/ITU* MNQ+1$]CD]'AFY+0G1Y_QN).1/1H8]=67D=K@`:)0HIOC1=**\K6YJ]',R.]8 M6M5/J+XZK/&^OX:R_:"Y*ARI:2N(FK:`-B+4N+5R!;+;^NLA\M$Q0!2B8X0H MUAQU85@KK0KSOPJJQ1MR:IAE97D2J"4K01S2J%E#VS(VS4`;2JDW=4(9O1XPDTD8T'X-8QOK1B/IRL/[[UG+< M679Y&Z^M!T?M[:_8]H:27,G,-:(-(E>@Z:A9;0^1CXX!HA`=(T2QYJ@+QKKO M6X+=U1"P+:+YO'.DZL6)DIEKX:>@#2)7H!DU>$UF7BFI//Q,E%3;IIIJE%T? M@P>(PKO&BX250UG0W-65DBHF?:6DLE[_EO)WIBK?,M`*MZ6#HY:L+$[4G0^B M#2(7D8?(1Q0@"A%%B&(-Z:G*&GP4[-,_3EA\HZ`IQI&J&"=3^FA6U[:,/G,M M0I&5%'^#R$7D(?(1!8A"1!&B6$.ZB%1&-1&O-/IJ_\G,C?Z3(U4K3K3L`K2Q M`+F(/$0^H@!1B"A"%&M(%X:U\C\CN\26H-7GB0Z(ZA=%DR0K08P-ME&MUJU5 MFUT\%#E*Y**5A\A'%"`*$46(V($7FP^_"2XB/\#BYP.GM'A)5^GQ6':V^1L[ MG!H.J,UM,#\YHYI$1V?U/.#*E*[4CQ1Q!E7Z(3N<?T:^`5;L_I)Z\KG/2X*@>I<54, MTN*:%*XSI_TOQ@^=.6U@D5,[/6?],UZAYGC.NF&\0BT,^5R;'34DY%-?Z3>* MTXGD)7E)?T^*E^Q<=H[IGI)B4/_H4/`S3?ZE$GOBY[RBL\AZ>WR@L^>43FL& M/7J1[O.\DE_HIOK-:?;R7P```/__`P!02P,$%``&``@````A`'=)+T-2!P`` MTQX``!D```!X;"]W;W)K&ULK)G?]FT57U>:^;4T";EN:AWU?EEK?WY+?BRTB9MEY]W^;$^EVOM M1]EJ7S>__O+P43>O[:$LNPEX.+=K[=!U%U?7V^)0GO)V6E_*,]S9U\TI[^!G M\Z*WEZ;,=WVCTU&?&<92/^756:,>W.8>'_5^7Q6E5Q=OI_+<42=->/[V M4%U:[NU4W./NE#>O;Y^FX$ZG#XK'[.B.#IXV#[L*1D!DGS3E?JT]FFYF.IJ^>>@% M^JLJ/UKA_TE[J#_"IMIEU;D$M6&>R`P\U_4K,8UW!$%C';4.^AGXO9GLRGW^ M=NS^J#^BLGHY=##="Q@1&9B[^^&5;0&*@IOI;$$\%?41'@#^3DX5"0U0)/^^ MUF;0<;7K#FMMOIPN;&-N@OGDN6R[H"(NM4GQUG;UZ6]J9#)7U,F<.;&N.KG1 M$+KH>X/>Z,EF#>'*>S*FMFDX=\#^8=W<=^@3#Y[Y!_6U+FS*4PX[568 M^6L#TVG`]/'GY5V^>6CJCPDL:NBRO>0D19BN"4YXY%%MAEC\62A"#!(OC\3- M6@.)(,I:6#_O&VOE/.CO$/,%LWFB-O!WL#%EBRWV8L]D$X^;D#5`>O95$*@@ M5$&D@E@%B0I2%60"T$'*04^0\/_0D[@A>O)A/E$`O0[B*9/1PEPJXG$3 M[M570:""4`61"F(5)"I(59`)0!(/UB02;P[KZ7H:Y+%'6D'"$Z2Q'$,>^1.U M@7+;;4PA855DR\P630#Y$`D1"1")$8D021%)%,))*.,$ZD(WF=?')1 M$S>0%T35\*JF1J*-(MN66MQ4=C`9E$4D0"1$)$(D1B1!)$4D$XFD+(@H*7L[ M,HEU+R`?UA,C$--#(%J.F@:I$7FC"4:6'*_>8,1]^X@$B(2(1(C$B"2(I(AD M(I$D@Y?")R0CUK)DE%A#*MQ2`/'$1^XAXB,2(!(B$B$2(Y(@DB*2B432`NH6 M28O_^+8E;F21*''$[&4YZAN"&MGP=$)<+92X&HRXNCXB`2(A(A$B,2()(BDB MF4@D+1ZQ<;B]%8BU+1HD05Q38?9G?UQ8>(CXB`2(A(A$B,2()(BDBF4@D M+:!,E;0@<;6$RA@697>HBM>G&@`$QQ6-YE"MT1J..)$E8@1>UT+`J.F=&:W& MY4B)!4ET:#8WE3CS4;.`DI5#RT=SOE127C@8\-",D),8D61HU5>EAN,H=6DZ M&'"WF>A$TID4]TAH'(2;]SI/&(D8]1@%&( M4811C%&"48I1)B%9,`@Z2;`K$2@*0\P582@2A:%D*8;E3`DOC^REP)-%1'_? M*'=]=G=F#T$;C&B,6LM1*NB062U7O5O;4?N-1C<\FF*,$HY@00]+Q%HI3YG* MG@&.I-U)R7V_=F1[/Q4W2D2=:=D-AM$\U@[:XQ1GR'!*F!H,6;6 M$*,(-XPQ2AA:CF__%*-,:B@+0XIF41CZ"AY7\%VITJ2E-Y3&?):?&!K)EA$' M9!LGV;&5]RVS$D+1QRA@:#6Z#SDB.7[8=#LKV7W$?4F1IJ;`F%N-ZR'A[L<> M4X[$'A>&LM7*N*^?]2A/!ZFT;TW'G0F5%NS2?%`T/OZ6;&0@R(7(]!B2XA=9 M!I4C4BQ(A,CVR MB202CG'B8Q0PY,`B$2)325XALUK15+I!B,?HP"C$*,(HQBC M!*,4HTQ"LF"D9,>"??KS@TE+?TDQBD3%*+'A,DS_PE!VU!YS!59&LJ_VF"NP&J-K:,A1 M@*U"C"*,8HP2C%*,R(E5GTWZYZ(BTA,H>@)P*IN7C^VDJ-_(Z=+,@+)V MP/3H"W(2G'WU+M`=&^[T2PK=6<&=/I6B.PX_25/NP!';8U]9*GQ+CMZ(L"J? MN?`=^0J?N_!A%/-'RWT$0?"-K>7"][XK?.'"1ZTK'/2X*@>H<54,T.*:%('C MPHX6^T\<%[:DF$,9[9*Z&=^!HM@E53"^`Z4+M+DV.BA$H$U_1Q^4A2/%2_Y2 M_I8W+]6YG1S+/00%_8S0T$-)]DV![7*?ZPX.$R'MP+D1'!Z7HHMVL8D64>R[BSNCC7^3/$L62%-_] M\6/_.ON^/1QW_=O]W+M9S6?;MTW_N'M[OI__Y]_U(IW/CJ?UV^/ZM7_;WL]_ M;H_S/Q[^_K>[C_[P]?BRW9YFH/!VO)^_G$[OM\OEE\?WPW;].#3:OR[]U2I>[M>[MSDJW!ZF:/1/3[O-MNPWW_;;MQ.* M'+:OZQ/T__BR>S^>U?:;*7+[]>'KM_?%IM^_@\27W>ON]',0G<_VF]ON^:T_ MK+^\PKA_>.%Z<]8>?K'D][O-H3_V3Z<;D%MB1^TQ9\ML"4H/=X\[&(&R?7;8 M/MW/__1NNS">+Q_N!H/^N]M^'(U_SXXO_4=SV#W^M7O;@MLP3VH&OO3]5X5V MC^I_0>.EU;H>9N"?A]GC]FG][?7TK_ZCW>Z>7TXPW1&,2`WL]O%GN3UNP%&0 MN?$CI;3I7Z$#\'.VWZG4`$?6/X;/C]WCZ>5^'L0W4;(*/,!G7[;'4[U3DO/9 MYMOQU.__AY"GI5#$UR+PJ46\U8T7KN(K-`*M$5XT?J,CT.5A-/!Y'@WH31Q% MK!O#Y[EQ=+45B1:!3RWB9Y-[`"?ET'WX_-6#*WV$:(,&?)XU@HESL<3<&%*M M7)_6#W>'_F,&YR_,_O%]K58#[Q9T58X%D*ERCD%RJ39_JD9#4Z"/<&)\?_"\ MU=WR.R3S1C.YQ'B4*23&ITPI,0%E*HD)*5-+3$291F)BRK02DU"FDYCTPBS! M^HO_<%Z9_H_[KN#[.?PT?,\NNL/.U,T!C$Y[/NMG:#.MF9Q.F"K$8EI_I%BN86>RSM,V1&3&Q:F?_CJ9AJ0O M3"+)4L'.TD+H>5.9QQ<>:/`@-1+P\[-SI[$),RF'KK8VPU/;)DP58CE<#*^W M7#7BEK,^Y,B@Y9Y@9V$"H0"4"(1#@@/`W#:;9QF<`/1X?6[]N=:79ER9-#K(%)>4C,*$X`M@TV4G*`"E7DX M"%/;;@3&4MLF3*/0;IOA=MN$J4+LAEW6]7:K1MQN=I'/D=&IG28>ZV-A'D_" M-&*S4>)Q3.R$B5=F8R^-`[90U>?&G^>U39@6H=$VPP;1V82I0HQ6Y>+5.T#5 MB!O-=DHY,FAT(N6U"01#6G.O.<'RVCROWT,K[CP[J7,-7984R'6:J(4F3.O94$H!,<8&Q M$#IQ%3DN+C&:&)G:1D!,HW"1$2#+<+3%#&7J4,-5@33=<"RGB.$!2^+<0^B\ MPF2K,&27OT(C9@_9($JB$J5!Q#0J`G@AF!ZQ`JQVAVF(RL(/?`C$9%K*),*` M.B'2YY:K2FFZY5A74H+P*_%D)V/C4"8F:H7EQ<@^D<,M1U5349B3ZMTE>WKBW7V6AR#:'K M7AQ$L&S3);D@R">K.H9"%850B8I(0!3?BE)K!'R[7()87QL!$9PWNR(.J'/H M4.M5!76]]5AWT;6&EZ$>0GJ5&+;CU+:"$%!$IA';"96:P(2/5VPYJXA`F&5! MQB[J]45@Q/;Q(E(GO&LPG1#)G#WJNBJGKG<=BS#J.KO:Y1Y"YV4F"5FN%@0( MX#^F4&H`/0]8DE:DN9\D*U8VU)?F(XZ/5Y/:<<=`.B'0YX:K@NIZP[$,HX;S MJM1#:"S-3<);Q?`?,ZTD(H"PXQ4Y'F9IQN>EUL3H^H+],!'3,&V[V5GI(M0) MD4P9FNBJH&*^3[B>8AE&?6>6Y!Y"Z/LB2#UKS2TT,CK@<@I4N8/5@@X[=QH! M,9W3$^`<5^?0(3/@"V6J^X';'SO<`?*&&#=FF+]?0V?P0 M'G&P?:4F3&?98E`*B&5)Y8Q4"S(L4B,@5J36&:ESR%#S8>2_D?FJ%<]\7L7Z M"*'YP7!7F)N/!/R\%#K6>$LM,PI5SEBU(&/9/Z$[K3-2)T0R1T7M9^7L^+U) M]=Z393L;1:XAO3+ZZE+KLZDI-&-ZRF1*`3%'H==[[)"I8T&UH,2"-:S/JR!* M8W:-:B"SIR"XS9!W,?;/N"^,PB5FY5&C"M(LY M41(1N`<1L1JB(@#$@+?A6$=J=YB&J"Q@7+>4R3WJW M\T,KMIWQ^4T$#6E;4[6?H>M$H8F1N2FIB"51T>/J;1D6I!:"6)?<9@K4LECV M@#J'#'7^M^K70*A??7[S0$/H?))Z;)=?Z..COD^I7AUQ:B&.8/V$2*TC4N>( M1(U7M>'5ZWR@6K&4#]D:GFL(C<_4%IYG/*J,.F\CEFF5*U"M`3.0I=),@5I7 MJ,ZA0KT72E?W/82T[8FZ`\]SWB322#T6H409((&V`T$/ M5_JP#A%G<#N:$O5%8-3W5F`?.M%!!KE:@T]'FD>HI,,P5JG;$ZAPRUG]6LTVZ4!5+MRF\1 M:PA-B;(HC=BUH-#$J/T8R40$^\TJ68I4"Y$LF68*U#I'U3EDJ/VLAIUHOU#+ M\NMH'B"D$0B.FN5;ZVQ6Q95SE#E4+H2R=9@K4NH-U#ATZ`ZI@ M-+8ZXS=M`BPO8?]Q63#L-_DTA,ZK[3;?$D-_YL!`Z=Q4Y'F7"R\*:,&=7 ML-RNERVH);&D`76.6-1QH9)UWYL/A$J6OP&7:^B\#L=)%K)5J="(Z8J5\W8] M;'E2N4/50BA+IYD"M>Y@G4.'S$`H5+3N&1A:L;T.7])S#>$,2-M[#8SY+R"6 M;Y4K4#U%I9D"M:Y0G4.%>B_4M!.\%VI:OIO)PPEE8J$AG"`_56^#T)6EO,BH M/X0%@AZNR.&%=;R^'#>72%;D-5.@=@K4.2#JO:H;C;5>76W5_8CQ-3_$:I.L M^1&[/YYKZ+SR2+=R-#*:^1C*1(3,1V@D5"V$LG2:*5`[!>H<$)T#H;R=D/]" M>0[3?R'_5BJ_[;%7(0X1T4L)CFPQ>`*:^%9HQA\POO0)B)6XU M!:JG0(V&SKU>>?`'3^?P#2G*[1$O"S=2:@03;[`[ M#ECB56Z9VHTT;J1U(^I[83X?-5J.W_N"7\;QOG[>_F-]>-Z]'6>OVR>XS*YN M$IC[`W[K"_YRZM^'+]WXTI_@VUJ&?[[`M_-LX1LY5C<`/_7]Z?R+^EZ9R_?] M//P?``#__P,`4$L#!!0`!@`(````(0!\0MS&20D``&`L```8````>&PO=V]R M:W-H965T&ULG%I=;^.Z$7TOT/]@^-VQ*%)?09*+E<1M+W`+ M%$7O[;-C*XFQMA58RF;WWW>HH23.2);LW8=L;!Z.>.:+APH??OMQ/"R^%^=J M7YX>E^+.6RZ*T[;<[4^OC\L___MU%2\75;TY[3:'\E0\+G\6U?*WI[__[>&S M/'^KWHJB7H"%4_6X?*OK]_OUNMJ^%<=-=5>^%R<8>2G/QTT-'\^OZ^K]7&QV MS:3C8>U[7K@^;O:G)5JX/U]CHWQYV6^+O-Q^'(M3C4;.Q6%3P_JKM_U[U5H[ M;J\Q=]R?-\P%X_Q!JLVUM-Q\& MYH_[[;FLRI?Z#LRM<:%#SLDZ68.EIX?='A@8MR_.Q&@?] MM2\^*^?W1?56?O[CO-_]L3\5X&V(DXG`S/[:1.#?Y\6N M>-E\'.K_E)__+/:O;S6$.P!&AMC][F=>5%OP*)BY\P-C:5L>8`'P5A_A\!L+28=P5!$UB),%(S9 MO/VB-QOY=(YN(28'@%+'"USN\AH/=[M\`S;+;Q^9A+@'!HB]#K[C8]3Q$!N=509CVP6D<\B M]!2"\(2%W,[33'I<@C,[#L(+&$_$1$URKGRA$I_G4D8@0LDD%H):R1$"/[LG M,6_I*01A"M5V.U,SB4>4K3%%S,0:LUE$/HO04PC"$[J"RW,Z8PV813)DI9#-=D,4AJ%83"B_K=J%EY9B'CM+K!R]UQ$D+I MF9W]YEP4J`?31-E` M2/)F(A!C$S0*$L7T6$80T@M\Q8HV)XA5I*3'T]0BN*'N@&2K=.%(F0%EXI6 M7/0@5K79/"2?A^A)",U8HPDV_E0AUV:L`S0 MDQ`:.Z,1KJ>'BH+08\TR%4R7Q+R%9`0A%+S"8#6<4X0,HH@A-$&L1!C'4;_Q M$(;^30JG05.%(R(6@=2"[(ZAE`C[9V,?)0C09F*@LPDB`I$4][T$FPU!""4" MV:^#,F0B9[K^_*&X$1'/40NR#",I8Y9BF46,-U$R/8P3_E9#$X#O^4X'H-0@ MU:Y/3]^@>?!X?EH04EL);WCV(XC04RPP.1F'$S[?134!K(2?7`JOL]B@;/2`6'WG6' M7!\%!J7)EI!:D`UBG`1AP%(XHY`P4$HR2$XAPI.PH[,\UPSC1XET&AKERT3- M3!VBT""[/3]$I.;%+F3T1*_/YB'Y/$1/0BC+7](V/LH6&E6NQ"VH+97F=M7I+M.@V;O>J'=<4S2I!4W%;AZ2 MST/T)(2R9)KFNKU#CF@;?G9(+:@-IJ?X*ZR,(/R!0,AGQK4=1VT$?ZH=/R1* MHU9NWAZ;64SCQ&QC2RT(*<*^Y[YL0(%*$+#$P1DD)PAX#S!`:(*`,QB!T&@R MH7-E-$<$3]Q7A07(HB#AKILUF=W&6GVN"KKX!:&O!W;"@_UPH2Z,:G#8[$T/4/V0DI ME:X0B0/)7REG!!`D7$_D9%R-^$@3!'4!#2`3.U=6(XH1Z([=*R01]REB`XD@ MU\FL+V5R%I+/0_0DA+!5-VF?!LU;*RNVU()&&VH+@Y0-TSC3F:E& MM(WS8@%C9D$7V*"%T<%\:J:^,$C9_)*<4686TZ<)ES,6-)6)\Y!\'J(G(92M M419.5[FN[A3J$=)=$JYH+,BV1T\98=6UMB;,F85S-^]*]O8$,\>(F7DD\%N?7(BL.AVJQ+3_,I4P) MMWBZ;[L+HU]\\(8H?ZO*]N2#Y7-9PL[/Y]0UN\A9P-=&[`_!+6=;M!W/_L+L; M_/1_````__\#`%!+`P04``8`"````"$`W"2'TLP%``#O&0``&````'AL+W=O M\1P?CX]==_'MLSQ$[Z)N"EDM M8S8:QY&H$C\=W29D5 M5:Q'F-?7C"&WVR(73S)_*T75ZD%J<$?M]@")*3(/M9K<"?=;01V^SMT/XE/WX7Q6[?PG)/848XL?GF MYY-H1R]B*9]+G"H.,K? MFE:6_^E?,C.$3@:D2DZ!M4F^&TWOQRF#6@.#))J(FM=3UF:K12T_(F@6*-D< M,VP]-H>!^R<",T#L`X*7\5T<`=<&U']?L=G=(GD'Q7*#>=08^&HQ%+$.$??\ M!$F`UXD)+:,0ZQ#!['0($Y#F>B8(AI5U)0ADTIB) M@TE/&FAREQ"$&PQR/3<$PUJ[A<,UU"`7XY.[A"#DH#-=5I.$X$]:SMK=N^)9D!4>PLBU*"/76J76Q_!E(^.3$[]MG8"I,X]K8,2I#"+ MR_4PB=8S$;>?V>RK-_\!$.&%A]+56Q_!E(^../-W`J3.C-91GCD;;`#,H@5- M!#:MTP`S3X`>$&=G&H#!*ERO@$)31B;D:.!&B`@,7<]16ZDP'E1!I7E%C7^Z M.L`UP-.A2R0H9MN%DD,C=,A=;DV&:(^3#KE".!%:"WW-J85"W`UN!Z;=$'SK MY`=="`J=^H&/F:^#220H9KN&KZ M6L;8W/F;D&L(?.P?<7@[P<4ZAZ*<;K)$%GJB"5F6:S=":_78(DN![8#HH3$R M$R)+//9/K"$4)7>3-[+0'$W(%>*?YP,ZQ#ZHQHH6.J)OR%,(FT(BR(Z M\)L<4J&I,9B0HX,;H;70UYP-H1QRN"$XIGE%38@VQ-03HDL\AZ+D`.62N]RD M'-$>)QURA7`BM%:/0[+A`Y.'%MF%H))CD?:*:V[!?1;)[8%"R=UDD3RT2!-R MA3AGD7A+=$7'CDB'SPJ5YJEO7)`*8:\%1H@^%+:D"N$!JD( MK=7CE>EL\-#DH5=V(2J$O188(7H=U:(HN9N\DH=>:4*N$.>\DGM>.;`-0X]4 M`T!O4/>SUP$S?YT8+@3>V]V.O%Q?H6DCFI`SUPYTCA'1.D5G\SQRN`]4EL>C MSR*9W?-:!Y/8HP-ZU^T\,,OCH4.N'@8$WZQG<7NMH7KT6.7PV9F&3MF%R"HP MN_6-'CJQ1P_/%=&IKN`1NF/J>*&I:4#GF%$]>AR33R$XT*C&^.PR/.+!BVM% MEH'993#D-*I'$,\=49!KB(0VF3JF:(H:$*'&[7V/*M)CG9/Q;#2L26B>:9\M M,EO8T-.H'DT\HU3'V?TPD=`Q4\U4C11T MB2UKR)VSTXEGIU<246G41TS(-O"Z`Q%%F*5&NF3B^>IE(13:JV_\E.Y2_\II M$L/6F`!+UT\'ZB/:JZ]#[OR=")UKCV>RZ>#JP[-Z4-2$H)*U:N<%5:^^270F MK9_7]3-T*>J=6(O#H8ER^89/YQP>ED_1T[/^`\>__/WX9/Z@G_N3TV_@N?V8 M[<2/K-X551,=Q!;&'(]PG]7ZP5Y_:.41)(1W<]G"@[OZ<0__6!'P&PO=V]R:W-H965T&ULK-U=D]M&FJ;A\XW8_Z#0^5C% M(JND&!/$!T%\LG?W6"VKVXJV+(>D=G?_^WV2R`3RS1M6N1@Z&?5<3E`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`'6)[IYCYI%H:$I]JDT*;0I="G,*0PIG".P#336P^FWE9O9>NGB##3 MW%8Z&7QQIDUC7NI@F:?CUNZ+_3PD[(P,0` MR2$%I(14D".DGF5Y7)J'A*?<0%I(!^DA`V2$G&,Q8=70A/WRO'2C+_W" MB_AQ$G<=$!5-WI/V\Z"P608Y0')(`2DA%>0(J6?YPI,^S8/"DVX@+:2#])`! M,D+.L9A@NOQX0C`WV@:;1+,KO*P])(,<(#FD@)20"G*$U)`3I(&TD`[20P;( M"#G'8E+HPM2D<)>5.X5[XINB>QC;:)*7^HNC2?4R.;G-@T+(#'*`Y)`"4D(J MR!%2>]$?\Y/>W29/^C0/"D^Z@;20#M)#!L@(.<=B2KH5B?@&X0`R2$%I(14D".DAIP@#:2%=)`>,D!&R#D6DT*W9R;%E?=J[F%LHTE> MZAB8C\_;VU?)I)H'A>,S@QP@.:2`E)`*(N6<8Y+:/"LV](+:DC]:2!-)+.AFQ==T,>UWUD\DWW[[HS"Z_F MQ\U$9O*!,HXZD')202I)%>E(JDDG4D-J21VI)PVDD70V9/.X.^TXS[63;[IC M-]W\3;PY?+2;1X7@F5LFUD36&3+0@923"E))JDA'4ATH/N/=WB7K<:=E M5'BJ#:DE=:2>-)!&TMF0K>MNM^.ZCTR^Z>[<1(QOV"_+Q'O]YTN>YE`RDD%J215I".I7BBZ1KY+5[*64>'9-Z26U)%ZTD`:26=# MMJ[VO:G[R.1SPY/+SHG,F0^4;4`'4DXJ2"6I(AU)->E$:D@MJ2/UI($TDLZ& M;!YW$_XU)I][G*3;1/86;YN<._;N\T1[FLM(!U).*D@EJ2(=2;4G]_GD&PZ!=,$P/]5=]"YG@[M; M?0;_YK)F_/.[-__X\8,>1#<1*_-TJT]9_6>OTX*!WM3#F\Z/FW@-P9\C01E' M'4@YJ2"5I(IT)-6>;G5W->^PV[ODL^.3'V7:3B_(;+A++^9:;MBM_XW)0=%S MPR'094?;D.Y./PWI/LO##>-GE_4O'W[[HZSZCL3<=5H^,%WG%85H9VV3L]#> MS1,WC>-S*.C`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`RDG%:225)&.I#K0#*S,RO]/7Z<< M*_U20)QRHF@*[K>@C'0@Y:2"5)(JTI%4!XK/E;OTDZ;3,BH<=0VI)76DGC20 M1I)^CGLZ;5V^G&53ZCWEJZ1TCY-X[OYMN9S/2`=23BI( M):DB'4EUH&4*GD@-J25UI)XTD$;2V9!-J0,1*:]Y@W6/DZ2HE<[[Y_;]/O)^^T\*NR?C'0@Y:2"5)(JTI%4!XIGI7^J"S4< MU9(Z4D\:2"/I;,BF=,L5:+5'D]F5G*UAZ,.I)Q4D$I2 M13J2ZD!V5B8K?J=E5#CJ&E)+ZD@]:2"-I+,ADU*?EC'E%3_S<'D<^P;K*3E7 M)LOV^V54V#\9Z4#*206I)%6D(ZD.M$S!$ZDAM:2.U),&TD@Z&[(IUU9[KCA7 M[KC:XRF>E:2,="#EI()4DBK2D50'BF?E[2Y9S3@MH\)1UY!:4D?J20-I))T- MV91KJSU7W(SLN-KC*9F5R7WW?AD5]D]&.I!R4D$J217I2*H#Q;/2+U\MU'!4 M2^I(/6D@C:2S(9MR;;7GFEG)U9Z=7]I9OK&U)V6D`RDG%:225)&.I#J0G97) M:L9I&16.NH;4DCI23QI((^ELR*9T*QCQ9<^75\UWTX)'?'7CZ>7#_!V[/2DC M'4@YJ2"5I(IT)-6!EFEU(C6DEM21>M)`&DEG0S:/6Q"(\USY0RSN%Q8D]XJ! M="4:W6`DGY+O_2BM_(;#-UO?,/F\]\`-\_4-D]-8P0W+0'IO6)[J?;)"42VC MPE,]!EH^TZX])>>*Y+%.RZCP6`VI)76DGC201M+9D#TL])ZS3K_"OO<;FH-B=2^%;O,B/0[\?O=/"KL MCFRA:,/T._&'9538,`\4OK6+[\078<1R_BA)52#_1=Z;Y.WX&/Z[INGRRNZ3 M"_S:CXJF[(G4D%I21^I)`VDDG0W9]FN+3O=/_P1\QT4G3_KJ6*BU)V6D`RDG M%:0RT/*64`5:K@V/GG2`A^=5>[*GY)?IHM,R*FS8D%I21^I)`VDDG0V9E.X[ M=V8:?WGZ7H;;GK1\73E]206E)'ZDD#:22=#=GF:ZM3[JKMD?9Y7T:%YYDM%+W`>TRG^>'#AGG8\`]_+J`( M(^+IA,>IPJAI.J5?23Z&__S(;)H>5^MQX?F=PH;+$=5XFD;9`&MK/.[4]$@( M+NG<362.;5#&40=23BI():D*%!_;TY,PQ[8G>VPG=Z@G_UCFV%[=<+F+L;OV M:6LN=UQS\>2^6K?,P?ME*DT_)^U':0:$0R!;*-XP>8&'9538,`\4CNV[=/FY M"".6OZTD58'^Z-B>7JO[^8+HA2W[\?+":O\@YMCV&\;']D1KQ_;:JLJ?>-_F M(LK=1+IT"7MJ3\I(!U).*D@EJ2(=2;4G]PGHLFM?)5?:)S_*'-O3:TPV7&ZT M[;&M9E1,ELW)Y M=_"GHGE4V#^9?ZQHHAY(.:D@E:2*="35@98I>"(UI);4D7K20!I)9T,VY=J2 M@5LN>N*7YN^X9.#)S,II5$091QU(.:D@E:2*="35@>RL3!:$3LNH<-0UI);4 MD7K20!I)9T,FI;N:_AJS\O(X=E9Z2E9&DW>M_3(J[)^,="#EI()4DBK2D50' MBF8EJ2&UI([4DP;22#H;LBG75@*NF)7W7!KP%$W!/2DC'4@YJ2"5I(IT)-6! MXEFYVR:WW*=E5#CJ&E)+ZD@]:2"-I+,AF]+=.'^%L_**+\W? MN\=)KF`G2LZ5R2K\WF\8W41FI`,I)Q6DDE21CJ0ZT'+4G4@-J25UI)XTD$;2 MV9!-^956>^ZYVN/)S,II5$091QU(.:D@E:2*="35@>RL3-:?3\NH95;Z%[0L M!+<-)!&TMF0W;5KJR_77(9P]>5^HNA#C;VGZ#L<&4?5GNSU2_KK M\T[+J.68]8L[RR5-RU$=J2<-I)%T-F1VK/L-43B3N(N"+W_<>-G,GC@\)<=L M-)!&TMF0W;5K:Q-7'+-ZR>E)VE-\ MS'J*CUF.JCV98W:7_G*YTS)J/F9)+:DC]:2!-)+.ANR.75LI>/Q]]B47!CS9 M8S;];&[O1YEC=GJL9,-D];WV&^J5A/UX(C6DEM21>M)`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`KMM(P*1UU#:DD=J2<-I)%T-F12OEI;F[AB5EX>QRY6>$IF M9;K*O8P*^R(JFX)Z4D0ZDG%202E)%.I+J0/&LO'U(5KI.RZAPU#6DEM21>M)`&DEG M0S;EVNK+-2FY'/-JHF16)E?X^V54V#\9Z4#*206I)%6D(ZD.%,]*_X(6:CBJ M)76DGC201M+9D$VYMMKC%M*>^(GP*Z[V>#*S%9NTQ^%/2VCPE'7D%I21^I)`VDDG0W9E&NK/5(JF MX)Z4D0ZDG%202E)%.I+J0'96)BOLIV54..H:4DOJ2#UI((VDLR&;4L\>2P37 MS$KW.,D5[$3)K$P_;GLUCPK[)R,=2#FI()6DBG0DU8'B6>F?ZD(-1[6DCM23 M!M)(.ANR*=WZ2[S:\^4/2%]-RS7QHHXG,_FXJ,-1!U).*D@EJ2(=237I1&I( M+:DC]:2!-)+.AFR>K[2"\XHK.)Z2J]+DJGV_C%IFVKST$^C`43FI()6DBG0D MU8',V3O]-VY/RZCP5!M22^I(/6D@C:2S(5LW7=1Y9/)Q[>85UVY(&>E`RDD% MJ215I".I)IU(#:DE=:2>-)!&TMF0R>-^QZMY;[SRAT\OCV-/XA_>'3 M950X?#/2@923"E))JDA'4AU(I[;YTGFW2SZ2.2VCPK-O2"VI(_6D@322SH9L MW73MYLN3[X%+-)[B,Q\I(QU(.:D@E:2*="35I!.I(;6DCM23!M)(.ANR>=;6 M8ZZXB7_@>HPG>^9[2*[!]\NH;7&)Y]LVP8J"5UI)XTD$;2V9"MFZ[$/#+YN.#B_N%F^ZG]GI21 M#J2<5)!*4D4ZDFK2B=206E)'ZDD#:22=#=D\;L4@OB6_\M^Q>YA6'N)[=4_) MY$L.W_TR*ARK&>E`RDD%J215I".I#F3.?)ODO'U:1H5GWY!:4D?J20-I))T- MV;IN;22N^\CD<\.3>X>)S&4G*'L`'4@YJ2"5I(IT)-6D$ZDAM:2.U),&TD@Z M&[)YUA9'PS4@'4DXJ2"6I(AU)]4++L]]N MDO/V:1D5GGU#:DD=J2<-I)%T-F3K/FW!Y8$++I[,Y,,:3,91!U).*D@EJ2(= M237I1&I(+:DC]:2!-)+.ADR>S$0SE;LL&+Y MBA4K5JY8M6+'%:MGT_O[O/BRW23G\%,T++R,9L7:%>M6K%^Q8<7&%3M;2XH_ M;15F<\-EF&#QG%PQ59RVC<:I(DP58:H(4T68*L)4$::*,"6#*1E,R6!*!E,R MF)+!E`RF9+$ER;[2RLSFADLSP9*%T?2[,M&P<'0K[_1PVC28\L*4%Z:\,.6% M*2],>6'*Z\VND";G>A6?AX6GK.(P%8>I.$S%82H.4W&8BL>6%'_::LWFALLU MP:+)MU\Q5<2ZCBK"5!&FBC!5A*DB3!5AJ@A3,IB2P90,IF0P)8,I&4S)8$H6 M6Y)L;07GBB^9;FZXA!,L.9.F7YV)AH6C6WFQ-**\,.6%*2],>6'*"U->F/)Z MLV?2Y+L&*CX/"R]#Q6$J#E-QF(K#5!RFXC`5CRTI_K15G:&2SW!DDF:'-UZ#YXVU;!P="LO3'EAR@M37ICRPI07IKPPY9TMOMQ-OJ:@ MXO.P\#)4'*;B,!6'J3A,Q6$J#E/QV)+B;E7FSZ_^;&ZF59QX#2^8G:33N,A4 M$::*,%6$J2),%6&J"%-%F"K"E`RF9#`E@RD93,E@2@93,IB2Q98D6UL1*,%6$J2),%6&J"%-%F)+!E`RF9#`E@RD93,E@2@93LMALLLW:PM$UD_3R M0,G"D3,*9=#,M:)@SJ3FO##EA2DO3'EAR@M37ICR>M/UR+*Z>YNL M?ZGX/"R\#!6'J3A,Q6$J#E-QF(K#5#RVI+A;H(B+?_G#SLUF6M"P8>-%CNG7 M_X=QT<1518Q319@JPE01IHHP582I(DP584H&4S*8DL&4#*9D,"6#*1E,R6)+ MDKD5ACB9FZ37W),J8OK)]<:;6=W%=]-5CDMRY84I+TQY8=AT22%J3A,Q6$J#E-QF(K#5#RVI+A;H(B+/S9)IP4- M/6)X63]NW`__)%\(6C%5Q#A5A*DB3!5AJ@A319@JPE01IF0P35*8DL&4#*9D M,"6#*1E,R6)+DKD5ACB9FZ177>Y.2Q6VY;Q\$1W=Z7?<-$GG8>$P4%Z8\L*4 M%Z:\,.6%*2],>6'*.]OR,G:[Y.->%9^'A9>AXC`5AZDX3,5A*@Y3<9B*QY84 M=PL4JBK"5!&FBC!5A*DB3!5AJ@A319@J3A:=Z94, MIF0P)8,I&4S)8$H&4S*8DL66)',K#'&RJR]WIZ4*VW(R]ZLIEE/03?(!H_+. MPT)RY84I+TQY8@_689%H[N;,4.*Y:O6+%BY8I5*W9\UM\DF2 M)ND\+!RY*@Y3<9B*PU0I>&Q)<;=`$1=_Y$QZ.RUHV$GJ%SF6":F* M,$U2F"K"5!&FBC!5A*DB3!5AJNC-3%*8DL&4#*9D,"6#*1E,R6!*%EN2S*TP MQ,G<)+WF&T>WTU*%;3E9=AX4A67ICRPI07IKPPY84I M+TQY86'*"U->F/+.MKR,W2ZY(-`DG8>%EZ'B,!6'J3A,Q6$J#E-QF(K'EA1W"Q1Q M\<7NY8&2A2-O]CIQDWR?;K]9AH6C.UNQPXKE*U:L M6+EBU8H=5ZR.;)FDVRU^5(TOHXDV#2^M7;%NQ?H5&U9L7+&SM:2X6Z!XPB3= M3@L:9I)Z,Q_!T%1QVC8:IXHP582I(DP58:H(4T68*DYF/H*A*1G&*1E,R6!* M!E,RF)+!E"RV))E;88B3N4EZ61Q\ZO+N=EJKL#']^H7.Y,OR;OK["#1+YV'A M4%9?F/K"U!>FOC#UA:DO3'UAZNM-UY#+R]@F'R6=HF'A92CYO&DP)86)'FO##EA2DO3'EAR@M37ICR>HNOE&C*BW'*"U->F/+" ME!>FO##EC2W)ZY8CTKS7?,2VG=8U;-YXK2-,59A:PM02II8PM82I)4PM86H) M4\O)W"^PC]YPDX\%-7OG8>&05%Z8\L*4%Z:\,.6%*2],>6-+\KJUAZ^2=UK$ ML'G]PH8]Q297D)J]\["PJU0I.$S%82H.4W&8BGLSLQ>FO##EA2DO M3'EAR@M37ICRQI;D=>L4:=YKO@^ZG18\;-[)HI.J6L+4$J:6,+6$J25,+6%J M"5-+F%IZTRZ+9F_R>:%F[SPL')+*"U->F/+"E!>FO##EA2EO;$E>MRB1YG4W M9$^^0)Y6-VS>><4CVE6;Y,I2Q>=A85>I.$S%82H.4W&8BL-4'*;B,!7W9F8O M3'EAR@M37ICRPI07IKPPY8TMR>L6,-*\5YU[IY40F]>OCCQ$WX+8PM02II8P MM82I)4PM86H)4TN86GK3C(AF+]8-EV'AD%3>>=-@R@M37ICRPI07IKPPY8W- MYM6_W;R6]QOW5>#//[][\X\?/^A5ZOYXY29H^_R'[RX73/^SN3Q,L@05+%Y. MI&5AVYW9H9OD8N80#0L[+P^F+]0%JX-%9X33BC4KUJY8MV+]B@TK-J[8V5H2 MPZU#I'-M]4QY2?.7#[_]41I]@+>TF58WS,33/Y#N/GQ3CK#C]AN:VF"<0L`4 M`J80DYDER-TN^3!/;>9AX:FH#4QM8&H#4QN8VL#4!J8VL25MW()!W&9E0IB] M/BTPV+T^F5O&7]XZ-LF)7R'\L.77$"D$3"$FTX>O/WSW^P_IC%$4;*,HD]G9 M`5,!F`K`5`"F`C`5@*D`3`5B2PJX^_^XP+4W^;MI(<&FF2M3&&PB<),9F;+=IM\JJ;9,@^+9@M,K6!J M!5,KF%K!U`JF5K$EK=S-?-SJL=DRW?S;)/&"@+\QW\$4`*8`,.UU6+%BY8I5 M*W9<,57$WZ%D,$TOF)+!E`RF9#`E@RD93,EB2Y*Y&_0XV=73:[K3MRTGLT?W M)KEHTOR:AX6C6WEAR@M37ICRPI07IKPPY84I[VS1N\0N^51-Q>=AX66H.$S% M82H.4W&8BL-4'*;BL27%W3U[7/RQ23K=X]NP\7U_F*0P582I(DP58:H(4T68 M*L)4$::*,"6#*1E,R6!*!E,RF)+!E`RF9+$ER=Q]>)SL\G&4$C_U9MM=;:?? MOO)FOZ6_22[8-$FG3:/?DJB\,.6%*2],>6'*"U->F/+"E'>V>)+BVU?+L&B2 MSIL&4W&8BL-4'*;B,!6'J7AL27%W:QX7?VR23K?R=I+&M_=ADL)4$::*,%6$ MJ2),%6&J"%-%F"K"-$EAFJ0P)8,I&4S)8$H&4S*8DL66)'.WVW$R-TE7;^,> M:SG=M]N6_EY>[Q'1A6IRG:A).@\+1[+RPI07IKPPY84I+TQY8Q MVR4O0\7G8>%EJ#A,Q6$J#E-QF(K#5!RFXK'9XG?I*LHC82_CD^42;]&=V7Y# MRU;LL&+YBA4K5JY8M6+'%:M7[+1BS8JU*]:M6+]BPXJ-*W:VEB1SM_KI)'7_ MUM=3SZ1WTYJ!F:3>[.5N^MO,E#=>;KB\+RLO3'EAR@M37ICRPI07IKPPY?6F ML]/R7H-_I2T:MDS29=-@*CX_7#`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`$1=_;))."QHV;+S($28I3!5AJ@A319@JPE01IHHP582I(DS)8$H&4S*8 MDL&4#*9D,"6#*5EL23*WPA`G`_^9YT6JJP+>?EB^7HWM[BJU1W\[!P M="LO3'EAR@M37ICRPI07IKPPY?46?Y6*IKP8I[PPY84I+TQY8LGDUO8M'Z`A8!PU-> MO@_11)N&P[1=L6[%^A4;5FQO@:L_=^6L,PL]=;\QLS[Z?U#ILW7@/Q)UH_+IK1:HEQ:@E32YA:PM02II8PM82I MI3==="ZSEPL/R[!P2"KOO&DPY84I+TQY8J]Z)@WNO1W6'*&UN2UZU??)6\TT*(S1LOCH39"U-+F%K"U!*FEC"UA*DE3"UA M:NG-')*\V5F&A4-2>>=-@RDO3'EAR@M37ICRPI0WMB2O6ZQ(\[KKAJ=>.=]/ MJQXVKU\),6]TM_CRDM_4W-[25'Q^N+#[5!RFXC`5AZDX3,5A*N[-S%Z8\L*4 M%Z:\,.6%*2],>6'*&UN2URULI'FO^1S@?EHAL7DGBWY27N_$,,U>F%K"U!*F MEC"UA*DE3"UA:CF9O1R\2Y9%3]&P<*@I[[QI,.6%*2],>6'*"U->F/+&EN1U MJQAIWJO.O>Z!TANCR>RWFM+?/:KB\["P6U0I.$S%82H.4W&8BGLS MLQ>FO##EA2DO3'EAR@M37ICRQI;D=2L>7R7OM'1B9V^\G!+.O3"UA*DE3"UA M:@E32YA:PM02II;>-".B*^=DO52S=QX6#DGEA2DO3'EAR@M37ICRPI0WMB2O M6_%(\UYU8S0MG=B\?CG%[*KTEY)J]L[#PJY2<9B*PU0I.$S%82KN MSF/+"E!>FO##EA2DO3'EARAN;S?O_63O7'4>2(\V^RD`/(&62S*K,A4;` M*NM^O^P+#(3>F<'.K!:29IY_C]/<(]SL>#H_#9QTCZRTXU]$N#%(/E]U MK4XW#[_G6D['G4V[VL=;LQ<+]G+!7BW8ZP5[LV!O%^S=@KT?K#WR M-^6UM$X_;,.HY31L[]&4NK960XW-->^;I92ZZ'66[P_JQX12^-[NV%M#%%Z, MPHM1>#$*+T;AQ2B\&(47H_"=S;$Q^[@8]VG!/B_8EP7[NF#?%NQ[9D5O:S54 MO:?V5;Z70A,]BG06?-[[%GL=<">&.S'%.#'=BN!/#G1CNQ'`7[&)H^K`< MFOT]<:6J;8>OJE+4I^[SGD>K(%>YMP_2M:9^;">%WX;MUQHS"J]Q%%Z,PHM1 M>#$*+T;AQ2A\9_MBX=0D1FC$"(T8H1$C-&*$1HS0B!&:F16];8=?]=ZVKRBY M%)IH#62=O5VPUP%W8H1&#'=BN!/#G1CNQ'`GACLQW`6[&)H^+(=F[TB4JK:- M=:WJ-=E2M-V8E2^)B:FB-F%%[C*+P8A1>C\&(47HS"BU'XSO;% M0FC$"(T8H1$C-&*$1HS0B!$:,4(SLZ*W;:RKWO-'U%T*39M8;\^"<9$=)S?< MB1$:,=R)X4X,=V*X$\.=&.[$U-I:IM/UNK>M7M66R,\ZFI M;Y;Y%^UWBO5C+2G\-FS(H/!B%%Z,PHM1>#$*+T;AQ2B\&(47(S1BA$:,T(@1 M&C%"(T9HQ`B-&*&96=';]K-5[S4M)[[!Q2'JF^44(C%MO7)/WE MO_[^C[_^YYM?_OU?SX^I7KZS:$>J)\E@[;PSQ;?L!XGO-FS4!>5B*!=#N1C* MQ5`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`GACLQW(GA3@QW8K@3 MPUVP2[W>,8P.PA3JO4-3JMH:#;6JU[SOZCXZ%KG*O8M!9O=_2OU@1PJ_#9M" M(T;AQ2B\&(47H_!B%%Z,PHM1^,[VQ<(=C1BA$2,T8H1&C-"($1HQ0B-&:&:6 M];8'1:WWAYY@.4\M%[G.TD7.[,6MV[5@KQ?LS8*]7;!W"_9^L$NQZ?_D M]DE'VUH]38^5EKJV'?[/B,U#M`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`NAG$QC(MA MO+,47S'TBJ%7#+UBZ!5#KQAZQ=`[LZ*W[,?2*H5<,O6+H%4.O&'IGEO0>;E;=D2L>=(P#9;V#S=?>!7NQ M8"\7[-6"O5ZP-POV=L'>+=C[CZXVE_QU.D=QHV2H7QWAC9GT3" MN!C&Q3`NAG$QC(MA7`SCG4WI73#T:AQZQ=`KAEXQ](JA5PR],RMZ6_/AI^B- M+D;6&RRG5PR78K@4PZ48+L5P*89+,5R*X;*SM"2?EQ;(AVG86)+HW:8.AEXQ M](JA5PR]8N@50^_,BM[6::AZKSHY1\LBZ^UMC'2B.^V-JY'>;=@H"\;%,"Z& M<3&,BV%<#.-B&!?#>&VM'D_< M]QYNHIV2]0;+Z17#I1@NQ7`IADLQ7(KA4@R78KCL;%Z2I[MR.TAZMV%C2:)7 M#+UBZ!5#KQAZQ=`KAMZ9%;VMY5'U7G7M;0>JMU;!RK5W[Z"-]&[#1JDP+H9Q M,8R+85P,XV(8%\.X&,8[2^D50Z\8>L70*X9>,?2*H5<,O3,K>EFETGO%OO=P MTPY4]0;+Z17#I1@NQ7`IADLQ7(KA4@R78KCLC/_MMX//Z[YW&C:6)'JWJ8.A M5PR]8N@50Z\8>L70.[.BMW4\:GJOTANMDWQR#E;VO:7!]WBXV8:-LF!<#.-B M&!?#N!C&Q3`NAG$QC'>6TBN&7C'TBJ%7#+UBZ!5#KQAZ9U;TMHY'U7O5K56T M3K+>WD[9ZX)+,5R*X5(,EV*X%,.E&"[%<"F&R\Y(Q)1>7WNW86-)HE<,O6+H M%4.O&'K%T"N&WID5O:WC4?5>=>V-UDG6V]LIK*Z]5/7;JS"^#1NEPK@8QL4P M+H9Q,8R+85P,XV(8[VQ?I=Q:B:%7#+UBZ!5#KQAZQ=`KAMZ99;VWJZ[5%4W) MP_E`Y=K;6;KVFKT8UO&HZ;UF8W0;K9.4WL[RM;=^<.WC81\V2H7Q MWHG9^]`8%\.X&,;%,"Z&<3&,BV&\LSF]9NC5./2*H5<,O6+H%4.O&'IG5O2V MCD?5>\W)^39:)UEO;Z?L=<&E&"[%<"F&2S%,?2*H5<,O6+H%4.O&'K%T#NSHK=U M/*K>:^Z<\:I];V?3-167O<6RUPJ78K@4PZ48+L5P*89+,5R*X;*S^=I[NO.U M=QLVEB1ZQ=`KAEXQ](JA5PR]8NB=6=';.AY5;WLR^*E-R79"KVV-SLJUMSYL M==B'C5)AO'=BTK57#.-B&!?#N!C&Q3`NAO'.]A5)>L70*X9>,?2*H5<,O6+H M%4/OS(K>UO&H>MOX)^MM!ZIWSL%R>L5P*49ZQ7`IADLQ7(KA4@R78KCL+%U0 MGI=6#'JW86-)HE<,O6+H%4.O&'K%T"N&WID5O?P9/T=O.U#5&ZRDMS3X.%]O MPT:I,"Z&<3&,BV%<#.-B&!?#N!C&.TOI%4.O&'K%T"N&7C'TBJ%7#+TS*WI; MQZ.F]ZJ-4;1.N`X,1W\^W/9VREX77(KA4@R78K@4PZ48+L5P*89+,5QV1B+V M5LSS^KE%T[#QYZ)WFSH8>L70*X9>,?2*H5<,O3,K>EO'H^K]H0_;/=Q&LR0+ M#?;;#V/CN`_C?WL-Z_T+I8YAT\F=LZ(8=16CKF+458RZBE%7,>HJ1EUGENO: M'L!77:^YZ)T/5,Z*G4UU>3R8O5BPEPOV:L%>+]B;!7N[8.\6[/W&.--LRD]W MVG"./V-_2N?C-'6/C<=]7HS[LF!?%^S;@GW/K.AMK0;'AIN:WW[7Q>$0/8H4 MFLXNA68,8]%M%3S6"E+HN0MR?DWVPX)158W[M&!45>.HJAA5%:.J8E1U9J6J M;8>OJEYQIWB(5D&N:/FX*$J'1.$(C1FC$"(T8H1$C-&*$1@R7G%]V_.C=ADVA$4.O M&'K%T"N&7C'TBJ%W9D4O)JVW7?XN76G:Q'KC$.QB:/JP')JR0:70,8Q/Q1P5 MI*IBA$:,JHI153&J*D95Q:BJ&%6=6:EJV\_^E-"T`]4J!YM.)H^'@QBA$2,T M8H1&C-"($1HQ0B-&:,1P&8R=PN12#)?!VM=W[#L70*X9> M,?2*H7=F16_;S_X4O;$QSN?$OEGFU^\EJ!]W22]8A@/EHR?[LK)`./;L/'G8ER'P_@V;J_>J5:/1;`-&X=C M$8BQ"&96%D';]?Z411#;Y[P(^I8Z71C%,"Z&<3&,BV%<#.-B&!?#N!C&@V7C M8ACO?3K?'9^69'&QO0X8>;.M0V`Z6%T_]E%AL;\/&X;`MANV9 M%=ND8/EA]]K7\&D=^&C3^#!2#&`A!C`8BQ`,18`&(L`#$6@!@+ M(%A>`&(L@#YW7]P8%\.XYF(\6#%>W@Z!\6W8*!7&Q3`^LVR\O0"X,/[[UIS\ MQ[_]^U_^SY__ROF9W>;B1NG(TC[OC?_GX7R8XKNS=`4W>S'F3N->+MBK!7N] M8&\6[.V"O5NP]X,EN?W?/+&/8QS?EC,J_VG!/@\VS?TRV(F3[G;I.]4/GOPZ M#1N_XMN"?<^LR&U=`I^\=[G_ZZ__[]?D.O0/@V=3"$BR%<#.%B"!=#N!C"Q1`>[+1_L70*X9>,?0&RR$-M@QI:TI4 MO;='KJZ7TAK=C*RS=SA26L5P)X8[,=R)X4X,=V*X$\.=&.Z"/2,!4UK+SH>T MQC#N5,821&=G^W::M/;#W9]OJX\WY__^^(?__M,?__"7?KW";Y^X1Q^_.AA^ MT\&>K0Z&\!B4\SS_@I+GUB^1<.!3']1H:Z3>0G>67\E_5AH'Y#FF,FP4DS4A MQIH08TV(L2;$6!-BK`DQUH08:R)8SK,8"T",!1",#OGXV_#=V?[WXEOC\-W9 MW387O9K+Z3K8,L^M7S+KO13C-K[>&`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`2Y5(`@Q]34AS1C56@V%.YF($68P@BV%RG(L9W/00Z6@RQ& MD,50)H8R,92)H4P,96(H$T-99TF9&,K$4":&,C&4B:%,#&5B*)M944;`D[)S M2_&:2VL[4+VT!LN)K!]_2R*W8=.E50R]8N@50Z\8>L70*X9>,?0&RY=6,?2* MH3=8OK1VEBZM&H?>SM*E57/1&VQU:;VKW9L+B3R/+Q8[2XDT>W$P>[E@KQ;L M]8*]6;"W"_9NP=X/EGJ;IYO23_@PAJ7>9O\S)O9I&[=?;C\/-EWZO@PV-7R^ M;FP_.7P;;)K[?;!51^:NM17F\VH+Z35O.3L?J.J-GD5^`JY^RNWCH4]EV!Y2 M,XQOAQOC,"Z&<3&,BV%<#.-B&`^60FKV<3$.O3$WA72P.:2#[2_SH;?/G4,Z MV#X7O?._+Y^#[UH/H>KE5>2+6]KSQ*HS&A(YK6*D50QW8K@3PYT8[L1P)X8[ M,=P%RS?"T]=>]>U,'Y9NA`?;DXG.?KA^(_QP=WLZE#X3\8U!4\R);V?[P?#; M&>?8O8'I&^$^+"=Z_A5%>6MP5.77/&!S%YV2=`O56;GLEBXSB8ZIZ4;8C%6A M<:P*,5:%&*M"C%4AQJH08U4$RXD6(]%B+(%@.=&=[:G$N,9AO+.4:,TET<&6 ME]W6S*AZS]]"=.GZ&UV0K#-83K08B1;#G1CNQ'`GACLQW(GA3@QWP4JB2X.6 MZV\,RXGN;`\A.OOA?K-)-0ZV7Z'PJX/A=_NEOYWH&)83W:O<%;%-G5[S4I[%L*OCAR.6X]C6J7@4]N,-]%SE)X-1>]P9;A;?V/6>^ET$:_)%OL/93Y,=<[,92)H4P,96(H$T.9&,K$ M4":&LF`YM+=J,/=A.;0Q==K)8K$?+D)[QU/'M\_+)9W4]HDIM3H86CN[=%\= MP_)5>/X5),PWED*LN82Y&"K(+>7"J2W MG:[M@[Q;L_6`ET&IK]7]R"O1@ M\U6XL_XLTNW-P^GV[J$<[?/XI6FG[*-]'>/ZT7[EB=<^,>5Y'&QQ5_VL=4UJ MGJ_I?)T/5%=`M&1*YZO\_8^'/C5UOLQ8%-OAQ@6<12'&HA!C48BQ*,18%&(L MBL[V*].'!?NX8)\6#-\ZWI<%P[?&?5NP[YGETW5;R#]';[1:TA7[?'!V0WM= M\V;"PU](JA5PR] M8N@50Z\8>L70.[.BMW5(?DIZH]62]08K5^-2*HQOPT:I,"Z&<3&,BV%<#.-B M&!?#N!C&.]M7*7K%T"N&7C'TBJ%7#+UBZ!5#[\R*WM8-J7JO^73?9]%6R7J# M34G%I1@NQ7`IADLQ7(KA4@R78K@4PV5G\T[O=%L>)4+O-FPL2?2*H5<,O6+H M%4.O&'K%T#NSHK=U0ZK>JZZ]T5;)>H.5:V\I%<:W8:-4&!?#N!C&Q3`NAG$Q MC(MA7`SCG:7TBJ%7#+UBZ!5#KQAZQ=`KAMZ9%;VM'?)3]$9?)>L-EM,KADLQ M7(KA4@R78K@4PZ48+L5PV5F^]JK%M0\;2Q*]V]3!T"N&7C'TBJ%7#+UBZ)U9 MT=O:(57O52?GZ*MDO<'*M;>4BO1NPT99,"Z&<3&,BV%<#.-B&!?#N!C&.TOI M%4.O&'K%T"N&7C'TBJ%7#+TS*WI;#Z3J;<]8/K71P79-C8[.J:V\T4W)Z@^5K[WTI%>G=AHVR8%P,XV(8%\.X&,;%,"Z&<3&, M=Y;2*X9>,?2*H5<,O6+H%4.O&'IGEO4^7_6QKM%[/E!I:W0V)?61AX'/*9_8 MBP5[N6"O%NSU@KU9L+<+]F[!WF^,$]Z47KT7=?P9>W/YXS1U+--/"_9YP;XL MV-<%^[9@WS,K>EMGI*:W=;F>>G+&ET[.G>5K[WTI%<9[=V;ORF)<#.-B&!?# MN!C&Q3`NAG$QC'E=3SJ\?RQF78K@4PZ48+L5P*89+,5R*X5(,EYVE:^^SLIG[,`T;?QIZMZF# MH5<,O6+H%4.O&'K%T#NSHK=U/*K>JT[.T3K)>GL[92Z5/L(8X]NP41:,BV%< M#.-B&!?#N!C&Q3`NAO'.]E6*7C'TBJ%7#+UBZ!5#KQAZQ=`[LZ*W=3RJWFM> MZW\>K9.LM[=3]N<.<"F&2S%<#N4I**QNP\8?@54QK(IA50RK8E@5PZH85F=6 MK+96Q1R["Z_(M\VG?`7+OL3P)8:O8,57>38#7YJ*K^74\C(POF)8CIP82((4<,.6+(F5F1TQH-LYQ??=OE$SY=ER\'L,%@V:`8!L4P&(RWW\1G M4S\[EDL0]C0->V4:UX;\R7N8BR%M]4Y)*\-(VC9L2IH8,L60*89,,62*(5,, MF3,K,EM;HL:,]D2^?0G6WJNR54J?8LI)-(9-3Q"A5`RE8C@4PZ$8 MTH+EN(D1-S$,B6%(#$-B&!+#D!B&9I8-W2^[.]=\7L'Y2*6]T]GT.,[CP>S% M@KUZ\4W3SY/O$^V@0I19VUMP1-*2K;8:3%U)0B,Z3%N/9VD^EP.CEZ*A[[U-.O M?S`I8F-02IK9Q\4X+&HN%L6P*(9%,2R*87%FQ6+;QW/TR0Z7&H5(,E6*H%$.E&"K% M4#FSHK)MS&>5%_9I][&1S\J"Y;O$^L&A!"^&Y>")85$,BV)8%,-$L!PJ,4R( M84(,$V*8$,.$&";$,#&S8J)MII]B(C;?V42P?(T2(SQBE%V,LHM1=C'*'BR7 M78RRBU%V,C[#,K96_;Y+GLYP\\:2_.74I"[*]S_8/E.[T' MO=/Z/H;E)(BAI!_NV?EV;?79H"C2/!2E>2<>"_)'_O4Q65G,FQC*Q%`FAC(Q ME(FA3`QE8BB;65'6-L.SLDNF8O.<307+21$C*6)H$4.#&!K$2$JPJ<3QMASN7_?Q>JIN'WW-.NV0@-L?90+"2E=+O M?#S_\=$_NX M&/=IP3XOV)<%^[I@WQ;L>V:E[&V36L/R(U^I\A"[VQ25SDI42L/R\="'I:B8 MH21^1?O2U'UG\U`Z-UB*8=/AL+2:6C=%B(MADZ0/"X8XC4.<&.+$$">&.#'$ MB2%N9D5PG!RM[2T*^.E\L?V,Y<_6`F+WC?W$,-R6,0P$BRO^0?'15.1M)Q: M&MMXBV'9FQC>Q/`FACC[&*478RRBU%V,'&);S(H:2?KBXN)Q.-W?ULQ91I'DH"I9SMKBVQ+!L30QK M8E@3PYH8UL2P)H8U,:S-K%AK6]'9VJ6PQ-8URPJ6PR)&6,0P(X8),4R($99@ MN>QBE%V,LHM1=C'*+D;9Q2B[&&6?62E[VTO.93^'Y0>^4.$A-J&Y_L%*6/1P M>I^:PQ)3)X:28&G1GVY*?PU+FHJEQ=3C@R\N,2R+$T.<&.+$$">&.#'$B2%. M#'$S2^+.'Q":Q/UV7F)\WND/-N=EP5XLV,L%>[5@KQ?L_6!SV1?LXX)]6K#/ M"_9EP;XNV+<%^YY9*7O;2UZ1E^--;$+GO`Q6\E*;8F/8E`V4Q.$FAI)@?-)9 M>X;J_I9W[Y>N`8HT#T7!4LZ.NKB,8=E:3)T8UL2P)H8U,:R)84T,:V)8FUFQ MUK:BL[5+88FM:Y85+(=%##-BF!'#A!@FQ`A+L*G$'Q:,LFL<91>C[&*478RR MBU%V,& MH7ZX>!&?%U_XU.!\DXQ0<@R(5$R=XH,@,00% MXP-WV^6(SS]^=GM3O_X!99J)LC3S_NYXK!NK&(#7!6%BP]4*-O MJ\!B#,NQ$\.B&!;%L"B&B6`Y5&*8$,.$&";$,"&&"3%,B&%B9L5$V^,^Q43L MB;.)8/ER)$9XQ"B[&&47H^QBE#U8+KL891>C[&*478RRBU%V, M=JASV=LMW@]]\?+Q)C:WV4"PS'F3N->+MBK!7N]8.\'2V7OOW=B'Q?C/BW8YP7[LF!?%^S;@GW/ MK)2][5!K6'[@BR&.M[&U35'IK$2EO/3R.*9.L4!)'&YB*`G6FP?+;P+%D2;B M*-BE[D$?-BGZ,*9.#&UQN(FA30QM8F@30YL8VL30-K.BK>UP9VT7+O*WL2/. MMH)-*4"-&&K$4".&"3%,B)&68%,Y*;L891>C[&*478RRBU%V, M]J1SV=NEI;VU^%+Y8R^;RQ^LA*7T@S$2PZ9@8$0,(_UPO=/6OL:]=.TPI'D8 M"G8Q*S$L2Q-#FAC2Q)`FAC0QI(DA30QI,RO2VLYUEG9)5NQTLZQ@.2MBF!'# MC!@FQ#`A1E:"Y;*+478QRBY&V<4HNQAE%Z/L8I1]9J7L;;YO&@F$DQO&,=6L#'&[X=(#ZP6PHTL%0U"=R M8OZMUEH?EJW%U(EA30QK8E@3PYH8UL2P)H:UF15K;6,Y6[L4EMB(L@Y&R?]\ MO`UVW#6@)EA6(X::8*@9Q\.$QF&BC]LWZ(0EV%1B+BQBE%V,LHM1=C'*+D;9 MQ2B[&&6?62E[VT7.9>]MZH\L>S5.RLGJ?("U^-Q#-NO)2\6[.5@Z23EN:^W+1AEU[CW@TWE_+!@E#WF3N,HNQAE%Z/L8I1=C+*+4?:9E;*W+>)3 MRAY;RESV8.DDQ=<8M7O?=)(RH^PQKI^D^.+/DYXDPH,.AH<^D3_MMVY@^["I MY*B)J1-#C1AJQ%`CAAHQU(BA1@PU,RMJVD9P5G,^2;6/G;]P_3[$#C(["E9. M4F5?S4FJ#TLG*3&T!^L!$&/MO1AJ5EEAI'X%:.S MRRL9>C$#13%H.AB*@K7__>;Y*X9E:V)8$\.:&-;$L":&-3&LB6%M9L5:VR3. MUBZ%)3:5.2S!SGR\;T2-&//19&R9V=8/D9EOJEEYS-8MBTW!$DAJ!^N'B&Y>'A M[L!K@?F%0(QI(L;2Q%]Y!;$/R@ICXL10*(9",12*H5`,A6(H%$/AS(K"MJG\ M+84_^%087S%JA\'X[:,MA3`QA(DA3`P_8O@1(U'!IM)SU1=#AQ@ZQ-`AA@XQ M=(BA0PP=,RLZVD:RZGCZ4V%\9Z1M!&M?L+M=!4ZW]>V5QSXU)RJF3@Q!_7#Q M-;*'F[M;;C`=*M72^'5SP6=CY.:0!T-I7E\6CV8L%>+MBK!7N]8&\6[.V"O5NP]POV8<$^ M+MBG!?N\8%\6[.N"?5NP[YD5E6TW6^/87@AXXE=`'(^Q+4XW')VU3WR=`JEG M9/9AXRR*WK[+WL^LZ!5#KQAZQ=`KAEXQ](JAM[-]WX5>,?2*H5<,O6+H%4.O M&'K%T#NSHK?MB&>]%VX;C[&#SA;G7?5?_NEO__P[$BF&,C&4B:%,#&5B*!-# MF1C*Q%`FAC(QE(FA3`QE8B@30YD8RL10-K.BK.V89V7G6\[VD.Z3(QE[[RRS M[\>YY9TBJ6=QCMNP*9)B^!7#KQA^Q?`KAE\Q_(KAM[,423'\BN%7#+]B^!7# MKQA^Q;YG5ORVK?GL]U(D8RN?+<[;^Q%),2(IAC(QE(FA3`QE8B@30YD8RL2( MI!C*Q%`FAC(QE(FA3`QE8BB;65'6]N5/41;[^*PL6+ZO$4.9&,K$4":&,C&4 MB:%,#&5B*!-#F1C*Q%`FAC(QE(FA3`QE8BB;65'6]O2SLMBX7W$2C>9`=AFL M?1+I=!+5,UI\O'S;HS!L.HF*H5<,O6+H%4.O&'K%T"N&WF#3DD2O&'K%T"N& M7C'TBJ%7#+UBZ)U9T=OV^[/>2R?1Z`]DB\&F/__Q>!0CD6(H$T.9&,K$4":& M,C&4B:%,#&5B*!-#F1C*Q%`FAC(QE(FA;&9%6>L)S,I:(I??IW+)9307LLO> M<&#%[(FL#V^A=QLV)5(,O6+H%4.O&'K%T"N&7C'T=I9N:\30*X9>,?2*H5<, MO6+H%4/OS(K>UBZ8]5ZR&.V%;'%N.8S;&C$2*88R,92)H4P,96(H$T.9&,K$ M2*08RL10)H8R,92)H4P,96(HFUE61KY" M]+O6MJ\AN5-*42:&,C&4B:%,#&5B*!-#F1C*Q$BD&,K$4":&,C&4B:%,#&5B M*)M94=:Z`K.RELCV9KNGML=/[4#UKC58^5*C\MKMX[%/S=?(;>I(*7K%T"N& M7C'TBJ%7#+UBZ.TL)5(,O6+H%4.O&'K%T"N&7C'TSJSH;1V$6>^E1$;'(2=R M[D*,1(J12#&4B:%,#&5B*!-#F1C*Q%`F1B+%4":&,C&4B:%,#&5B*!-#V6S-3:T6?]G+9A(W[X%<.O&'[%\"N&7S'\ MBN%7#+^=I4B*X5<,OV+X%<.O&'[%\"N&WYD5OZV%,/N]%,EH.62+T#ZI.R MS5POV>L'>+-C;!7NW8.\W-B=R_%MV M]G$Q[M."?5ZP+POV=<&^+=CWS$+O'_[^;[_\\H\7__*/?_G3'__SE[_]ZR^/ MO_S'?_S]G_[RU__ZOYP;G_$1!1/_I[_]\K__^7?M9N!_G*^X6-CF;#][WGYV M?LC&/[MO/SM_8;Q_]M!^=GYC@WYV=\//*.3R][6?T3];_NRV_>Q<>1WS=&@_ M.ZSG'=O/SB^R>=ZI_>S\+F3_[*[][&YYS&.;QRO"JW_GL(IO];-C\\!C=/M.;\A>S;MM\WAG\/)GS0-O7UW^K'G@_9.KGQV:!]Y4 MN/Q9\\"[S?X_76>WX\9QA-%7$?(`]G9S.?Q!8$"S5B11DBW!3Z`@LF+8R1JR M@+Q^SADBN?`>WC2L_5S#9G\S78=5Y$QIPSCN)92:<=PD)C5]8)M(31^X849J M^G!-Z$_73!_XRF#%W1G'/2)3,X[O-:6F#]S-+C5]X/YJJ>D#-P%+31^XU51H MW'?\_),W'T^-..]O'1KW7_:8[<.=/G"KWXS3!^Y'FYH^<)O3T'A2C7/)N'DB MCJ'C\,$'=^0Q\<&'0Z2&#S[!(#5\\#[YI1V-X^F&J1G'8_12TP>>]9::/O!$ ML=).^.!CKU+#!Y^L5-K1.![[G9IQ/-0Y-7W@<<*IZEKX=%'Y;V83J7SHUS.I?.C7,ZE\Z-\][7:^:;]_K7S#<7?5CZ>C`W MSLZ-$YT;ISF1H9C<.._TX49NE#5FLP8W MP3C_Q)`>F1NY&V5K^M"YD?LNJ;5_=_IP(S?*&K-98YQX/8::RS!O,K2&#Z-S MXSCA`T/'XMOY=I@[ M&/*8!]]?YXYA[F#(.'/QZ%P\COK7N7@<.5\8\ICNK:/WUF&N8N@XY]FY:IB/ M&#+.G#,ZYW#G/;7<"X9[*T,>TUPU.E<-:OJP;Q_V^G"][\6?<_]8/%^N-TUXHMT;U_4)'M[H M,7-?XK8^:NW#7A_XJ7N^!WW8MP][?>#>\A5W;US7+L:]<5V[&/?ZT+6+8;V' MH5]/'SKW#W,_0\;MC.O:Q=@9U[6+L=.'KEUPXU9?KWVXUX>N!?&X"[7V86=< MUR[X]:;:C3A]Z-K%L!;$T.NB#UT+&CM]Z%K0D,\8\IC3N*Y=C*D/7;L8UH(8 M^ICZT+6@82V((>/DL]%\-N0SAHR3ST;SV9#/&#I.'YIWA[S+D''RV6@^X_DH M:C?B]*'Y;,AG#/UZ^M"\.^1=AHR3SWBV1&O&-9\-^8PAX^2S<8//Y-W1O#OD M788\IK6+T7PVY#.&CM.'YK,AGS%TG#XT[PYYEZ'B3H0UG0EGS68G+&@R$\R: MR\3-QT;"&GV=@R3E=Q!+GF M.#&N*4XH;B86B9N(!>+FX86U;AH6?)I[Q,BF2"&R&5(,;@K>L];-P'MFT`0L M[#3KB(Y-CH)C MG*SU#1IDK6^Q!$I_,F+=;G`$ZW:#RCA';S`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`HO5^)I]U1Y?WH`_-NW9TT9)?[-!=ND.WTNQ4Z^M= M=NN.)W'.LS]KV]'E/71>D7>[H\LQ?7_-9S0[U6Z\/\^7YC.:G6I]OLB[W?%D M+LZS>=<.W:4[=*L=3[2^WN6S[G@2IP_-9W8\T?I\D7>[X[G:H;MTAP[-N.QX M,A=]:#:EV:G6/LBMW?'DF/J0'4_F8ESS)\U.M?9/_NR.)\?4A^9/.YYH?;W+ MG]WQ7.W07;I#AV9<\R?-3K7V3_[LCB?O01^:/VEVJK4/\F?WZIBG<K^6/[OCR3'UH?F39J=:7@_B9].G\-GL*7HV>0J>S9UB9U.GT-G,*7(V<0J< MS9OB9M.FL)G=SE74;-(4-)LSQ9(,;(I4HALAA2_ MFKZ$KZZ-B5Y-7H)7 MFMVV'YB MW8KCN=]OI?'.!&Q>MK4W[W_F-RS.\-[>3Z^\J%7L=Y0[.T_KYR^==\ M?K1"R?NH57NOQF\=RALTV[])QV@V@+,:S-K0`N[78TV'M<4RFV"N)=E2K,QWMI%9G M.ZMUAY;./>S8!!G*<1X7,\\,I?%4DGEF*(W'Q\PS0VD\DV2>&4I[RTJ_S96F M"L5)7^^;6B!*O6LJJQ96XTJA-HQ2Y\?#CHV2HU8C-9_4 MS6JDQE-9]ZQ&:DSCI#/U#IC&26=*\Q&Q.E.:3X;5F=)\0JS.E/:*8LGKK)5\ M[[>G7_2WI[_GQX#GE_V+P)4?`YX9RM,'-8;2..9R9BCM;VH,I:V6D+J"9`&I M^Z66X[);^D"1Y"'[?B]07J3R$N5E*J]07F>'\14%K-<9-OSS[ M^^/7KX__VO[SGY\^_N,33]2X^X;_^>?'QZ__^P=?X_CV/X]??MUN^/#=?P$` M`/__`P!02P,$%``&``@````A`.1[[Q`[`P``@`H``!@```!X;"]W;W)K0+2D&$"JBZ3=JD:=K'LTD< M8C6)(]N4]M_O.@[&!D3S$LC-\;GGGNNOQ>-;7:%7*B3C38JC48@1;3*>LV:7 MXC^_G^\>,)**-#FI>$-3_$XE?EQ^_K0XV>IL"%U-Q,N^OD&-79_-NNX8)L*ZC[+1J3 M[,C=O5S0URP37/)"C8`N,$(O:YX%LP"8EHN<007:=B1HD>)5--]$"0Z6B\Z@ MOXP>I/,?R9(?O@B6?V<-!;>A3[H#6\Y?-/1;KD,P.+@8_=QUX*=`.2W(OE*_ M^.$K9;M20;LG4)$N;)Z_/U&9@:-`,XHGFBGC%0B`)ZJ9GAK@"'GK?@\L5V6* MXV0TF89)!'"TI5(],TV)4;:7BM?_#"CJJ0Q)W),DH-Y\3^Z'D@1&4%??$U%D MN1#\@$K9$CT%HSD07R\(*M'8E0:G^!XCT"JA"Z_+\31?B;B$\<3"] MAXO3X$Z<[6$?@07K>'G>Q@]`GAZ8O,/U:+"OQT3&=I)MG("79^KGZ3:,$(3> M7F!ZE)^PC\!,=0PX[\95T-3.)T^8/I(&+W@-]O68B&.`$_#RS/P\G0$Q]/&V M`7J4G["/^`:,;6UFK5P%/5B0)RP"$<,=Z-"^HC[D>.!&_%QZKW/4JQ/H9\'R:V1./#==3,HGQQ>OMSQ-WN3*319T:8T$GEI@=U$3^7WLV< M7`/7`YSI%TG[D&_$:=ONC?@`9<29\]Z\]8 MQ7KQG\?'\Y6Y?P3V"YS_+=G1'T3L6"-110O@#$=3V`2$N4&8%\5;L!5N`5S! MR=_]+>&F1^$("T<`+CA7QQ?('-B[X_(_````__\#`%!+`P04``8`"````"$` M""9W(J@(```P*P``&0```'AL+W=O@_];B??K\IUL7][ZO[GK_B/ M:;=3G9;[]7);[O.G[J^\ZO[Y_/>_/7Z4Q^_5)L]/'5+85T_=S>ET"'J]:K7) M=\OJH3SD>SKR6AYWRQ/]>7SK58=COES7@W;;GM_OCWN[9;'O*H7@>(M&^?I: MK/*P7+WO\OU)B1SS[?)$W[_:%(?*J.U6M\CMEL?O[X<_5N7N0!(OQ;8X_:I% MNYW=*DC?]N5Q^;*EO']ZP^7*:-=_@/RN6!W+JGP]/9!<3WU1S'G6F_5(Z?EQ M75`&LNR=8_[ZU/WF!=E@V.T]/]8%^F^1?U36_SO5IOQ(CL7Z'\4^IVK3.LD5 M>"G+[S(T74M$@WLP.JY7X%_'SCI_7;YO3_\N/T1>O&U.M-PCRD@F%JQ_A7FU MHHJ2S(,_DDJK5I+J?A:A3ZURF#PX$]'WFA\A\I0J]"G^2Z6R)7IZ8O6 M2="G'FCG<&4@G07U0/HT,U[-7IY@4=K;E9-233K>&D9:?VDRCD;N,YKDK0JMNTEH`"8%$0&(@"1`! M)`62V80E.G$2_'YH@4Z802`0D!I(`$4!2()E-6%&D MT[7OM=<[7T;SW!69S-K5!Q("B8#$0!(@`D@*)+,)2Y1,"4M4K?Y#?4F+1Q?X,P48D'E0ED**\/PUF;;Y`PD5F5A3GUJ&%TBC86W4ZRHN$(6( M(D0QH@210)0BRACBM9#6Z_9SPE-.C>Z-ILQSC<;D7*PK@K/J"QWE3YJ!H4'4 MQ=;`$5_7R,A/ZX;R1Z.AX]1BH]-*)XB$05=G2_ELGC\=#ITOE!FA>CI>2VG> M[JBE\GJLE@JQ_@$4>H`B1#&B!)%`E"+*&.(Y2S-V1\[*N[&<%7+ZQUGDA:>B M6/\`BG346#7+>#R>\&Z*429!)!"E7-FG)V+GZ2IC@WB-I!6[HT;*N;$:*<3Z M`E!((^05VXJ*$,6($D0"48HH8XCG+"W8'3DKQT9Z[75%(:R+I%#9RV MG1?IJ*F\U=,^RL!YMHE1)4$DC$HKG!HTUN9HXIB8C,GPPDFO=ZUP-WH691E9 MY13R_>;46WB`0HUFK;.)$,4:60V9H);`@2FBC`WDM9#.[EHM;K*WGO:'[?K, M-;+:8X$HU&A*C7/-MVA#JFY%@T%_YMS28I1.$(F;9DM-E)K-&T^G$\>!94R; MU=/_&C]P5ME+GXAX@B1#&B!)%`E"+*&.+EN<\B^VB1-;*W#1"% MB")$,:($D4"4(LH8XCE+BXFGF-G9OGE;FJXJ[D.D1I_L(+11;4\H+1IH4(11 M,:($D4"4(LH8XO61WM.NSYDG:>M1T5=6U;[L:F1O)B`*$46(8D0)(H$H190Q MQ'.6]M+.^;?NW;XRJ:P4&EG["B:J1:%&5W86V@C3(#'J)(A$._#2[D(;8:0S MIL,+)2W?M4+==J^6/YCA`)`RZ.EO*9SN[OV"$<'^!DN-] M]S7L^Y#N?>5".G+]S]!1UE]P6BR*!+^POF>-M= M"2*!*-7HROX"&\1+=)]O':!OU,[G?>N=OWP, MT+5JY'2+N[^@HUBW*"U[?T%'7=Q?0)4$D3`J[?-K:M#%_04FPPOG&EK7W-WF M609H=#4B+VVNK`M$H4;V_@*B6".K(1/4$C@P192Q@;P67V)TZ54OU[YI9+7' M`E&HT2?["R;J\OX"2B>(A-$A&W#9):4FZLK^`M-6]52OJJG7G7;Y\2U?Y-MM MU5F5[_(U-.J(Y\<&JW?DYI.`?KZE1G'Y-*!?.\]POQ_(1_=S1^AU.WK`/7?$ MIR-U.[JS^`,Z,C@SAOHSB*AC4(VZ+9#MA4?H?;]O9V>A+W;^>]'D9W3F]*7. MZ@^#;U1TG'@^#.CMCS-\%-";$6?X.*`7"9"'LX!^K44N9@']W(J<-@D#N2N( M1VC++Y![?'B$'NN"B!ZE\`@]E06I.M)KUHG>5SPLW_)_+H]OQ;[J;/-7:J1^ M?7D_JC<>U1\G_0ON2WFB%Q7K'W,W]&9J3J^T]1_HN>JU+$_F#YJZU[SK^OQ_ M````__\#`%!+`P04``8`"````"$`T'X-(;X"``!B!P``&0```'AL+W=ONH\L3`>HC40G94PU)N?35(1BN[J6O],`A2OZ.\Q\YA+B_Q$'7-2W8KREW' M>NU,)&NI!G[5\$$=W;KR$KN.RH?=<%6*;@"+#6^Y?K:F&'7E_'[;"TDW+>3] M1&):'KWMXI5]QTLIE*BU!W:^`WV=\\R?^>"T7%0<,C!E1Y+5!;XA\W6&_>7" MUND:J$?LODE??>,^@V-`FTX"-$`]&>E^9GV"S_VKWG6W`#XDJ5M-= MJW^*_5?&MXV&;B>0D,EK7CW?,E5"0<'&"Q/C5(H6`.`3==S<#"@(?;+?>U[I MIL!1ZB59$!&0HPU3^HX;2XS*G=*B^^M$Y&#E3,*#203TAWAXJ8GO@&Q^MU33 MY4**/8([`T>J@9H;2.9@_'9"D(G1WABQW0*L"IKPN"0DSA?^(Y2N/(A6;XC2 MJ63]AB0[27P@.^%!SF,\4_<(NO<^IMD$.HS&F+/3`3:7E1/%(U$T5:S?4TP@ MX:0QY/MP1EQ@\![!)<'TZ)439;;$89+$YP4.4UNP=(T?>F:+>IZ'`[A;K_D-<&".W\YEA%/L0A)R"E?UTTGBBU7?!Y= MNZBC)DD0_`RLQS!'C8F+DS3/L_@$[LC\5:ED-ESKP M,JBW=$/2+;08[-C8"`W#S3XV\"YC,%,"#\2U$/JX,&/X]'9<_@,``/__`P!0 M2P,$%``&``@````A`/8_D*-W"@``V#D``!D```!X;"]W;W)K&ULE)M;;]O(#L??%SC?P?#[QI9ODH(DB\9%SRZP"QPV8?\SO`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`ABE3D79?(F)!_ MPV,B6KILGS-K"#X0,S+)1G`I4B`A5>&F%AE<$A,S'XIDXHW0A\5,<3'2 M=#X/S09>(SC64?YVH6B$LG#W39$_8GEXC@NMY*D1(5;J) M2@:7A,B9I9]H4@9$\L\LTI="9.2"\,DXLR9UB]"S`JD$&8KOQ#FUL3S9Q;I*T#&`;/"W$=C M:P)/C@BY?G@(JOIFA7D2&HU:-0(#H6U$$OEHG"LT1HKN$]%L$)T52"4:H7=6 MF"<1T:A5_HQ_E#^SR$901!PX*\Q]-+8FV0@:C4%5Z=I%!I>$QKF/1C+Q*Z(/ MC?,`&A$?D88@P#D/SV8C.`\Q*S#XTX'00J$J7;5$'19)9#1JV1!DV6&11$JC5H5@7"3_S"(+$2!EAC>X2"%\5"[()%+,]7,VJ51']!0" M/^\8C@BCEH4@$[LTN$448AE`959&"V&6*:<6G[(C`E8MI>1 MBCY<+A%?;(A'7,;'"+-*E1\W`I.X,>;Z2;M=**I5]M4AB99+"T)^VR`3KT,? M+9>I5L7[(9M.7=O(X)!L[*J-%`+5JA#6Q`O!+-)7")914JY\4I)) M-L1*CQ'M0@BGXRD4PO6-#"X)E2L?E63BA>A#)7XBS8N.J)SAUWR1ZA,8G8MG MLQ,<",^Q+-Q#A+TT6I5J"=":3 M;`EOCF@7\G)!2[AZR>"28+GR84DF%^::6Z2O`"RS^%UCY=.R-?$!C1!HV1^2X2OFT)NZ31/`7)T+/0)U#!7D@ MMR].HU8!X`;BF9M$)B29=`"->$.)^/31F%L33YI$O!^@YWN&YSP)@T:MDF;0 ML_0A42!IA<%(LC[]<`!T6?P9.O=) M1R:>-(GPRPK>USW#<)Z$-:-6:7LS((D"1ZRP%CEBGV:Y-?%LR2*/N.<:1H(. MOX:-6N9*)N:?6\01%T@7!:X!"#?+E%./7*V()PT7<<^47X",1W*[ZD:M`L`- M!+E(Y)]P$2!7_+'/K%(^/7*U(I5TSTA?))'+J%4`'KE(%$@ZB5R%3RXR\;8* MDJOG$BZ2R&74*E?&*4LN$@5R#9!KP`'[X"JLB>?<@DMP*^MY5"F2N&74*FF/ M6R0*))W$K<+G%IEXLHQD@ALX[PZ_6HU:YD4FYJL5J4&G9^#'H3DA``LG_F!J M-A"XX!:9K$(33G=X&[^-J-+R2/CT$-6*)"ZRGN>]4G$K$@`-4:[&SV8#F30C MF$Q:H6G82%M:'HFD/42U(GG26=]))W$+/]!5,S697!G6W"*35HS"I+$O(X6V M8!))>ZPJ2<1/NLQ[GEU*Q:^(?Y];9@-YT(QD,N9#SYDGTGI@X\"679U&=9:Q,Q6%DH>86SV('[ M',NF'LA:DVAR:,2>#Z2R:1++K%R?.&-7>^+,I(JL>(:7^*"OM_#5.;_A/;AU M,G[FD+]&N7V+SKYD=JPNK]6Z.AR:T;9^QS?D9O#:6&?M7M_[-,/?[]?VQ?TG M>JUOTOT7O%9WWKQ6?VTNK_M3,SI4+[#I]`['DHM],<_^<*W/4$QXMZZ^POMT MYI]O\`9E!2^&3?$;OY>ZOK8_@.M)]T[FT]\```#__P,`4$L#!!0`!@`(```` M(0"'\IT9JP,``)$,```9````>&PO=V]R:W-H965T[BT-BAPBR MEY0*1*2\V*W\W[^>;FY]3VE:I#03 M!5OY'TSY=^O/GY9'(5_5GC'M@8="K?R]UN4B"%2R9SE5(U&R`K[9"IE3#:]R M%ZA2,II6A_(LB,)P&N24%[[QL)!#?(CMEB?L422'G!7:.)$LHQKXJSTOUBAO$I&7X.*%9UQ_5$Y]+T\6S[M"2/J20=[O)*;)R7?U,%`;ZH05>!'B%:'/*9K@<'!V^JFJP`_II6Q+#YG^*8Y?&=_M-91[ M`AEA8HOTXY&I!!0%-Z-H@IX2D0$!>'HYQ]8`1>A[]??(4[U?^1$@;R=D,@6\ M]\*4?N+HT_>2@](B_VM0I/9EO$2UES'0-]^/IZ/)+!R3ZTX"PZA*\)%JNEY* M!F\@79)#7HP('BV M(!>Q.4?,H@82`+&&':0\G!V"D1WJCW0?C,%FTH:I$)MS!)GV,P%MAC-!\,J' M9RO!N4X&%%N@<1/:L+N$<&0")\/)(1BJ;0?NJ:)!V:`NNTL(AQUT^'!V"*[8 M-56L+7!I;34G':UZ47%;;X<1=/!P1@AV&1E+W#3:QC(X<69NG&ILC('IY5N& MI]R`M06ZU9:@[533+KVHN"V;0PU_F@;?>P2[C(S%DL`R.''F;IQ*@OE5"?"4 M&["V="28=;J@%Q6W$\JA1J"EAFM0H5U.MPN1J9@.I31TIYETI>F%Q>X%<>CC9+'I76)DYZ+`ZC<83SPU.6]"K M1PJ<6U:LZGY,KDN!QSKZUR;[YXZ$<=B5HH:YBL7M17*E^*])2)Y'V$[=NWQXMXLI$'S#2R$)=VQ[U3N>*&\C&W!9SB:08;2K)3F18L2 M*@M;H="P"58?][#Z,]AH0IP76R'TZ04B!\T_$^M_````__\#`%!+`P04``8` M"````"$`NO*?01U'```AA@$`&0```'AL+W=ORAN]/U?D/+M^O+9(2*:62G!KQ^_M;0_+.ZSB):V,K93O)[K\_ M#:)?H(%W-**VDHN5]G&C`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`;HKYSG^X7-&W% M@-;TV0@ZDE^T:5.\U#6!>AI&/I>-$Y)I1,TT+XM'`YIQO[SP(T(U+KVTZ?5E M$6E`/^X7]'KUIG%]]9S$&Q"0^P4MFQ?V"@DUC!(N5)^+W5D*[A?T>YD4FI"" M^T6;-M_C5S)\1\\1OGV(E4V$63W M"P;?N*R2-1%F]PO:7M8K@MPTA>*R*MA$H7"_:*>WEP6J!7FX7[3IW66J;$$> M[A=\U.L+NX4^6D8?MQ?V"WVX^4W[O;XD!5LH&>Z7.."+2G$+:G*_:%M[B2^< M9UN0EOM%W32-LBYU`Y6UC,HZ%UT#J*QE5'996EQ#*NX7'?N%*7T-J;A?\+%E M`#63RC44XGY!DZH6;_TZZ+RLZKW[]N['[[\\_O5*5JO2U=??W[FU;^.[:Y$* M%E2^T[#$>FJ%):LCYZ5P;GYX+>&21=1761C^^6.C<=7Z_NV?LI9[KT;W%4:I M11<6;M7E_/9RT,_!(`?#'(QR,,[!)`?3',QR,,_!(@?+'*QRL,[!)@?;'.QR ML,_!0PY*@!B:3C.][`>8X+(?!<<\((C7G#("XYYP4$ODJ@GF2DW$W]'9CHWLE25'R'I9*%YDZ6FMZI-S6"" M*/:(](D,B`R)C(B,B4R(3(G,B,R)+(@LB:R(K(ELB&R)[(CLB3P0*0.)`ZX$@7'.J"8UUPL`N.=L'A+CC>!0>\X(@7'/*" M8UYPT(LDZDEJRKTZI:;;Z'CA+:!SDXZ]*VRW\U5I,$*S'I$^D0&1 M(9$1D3&1"9$ID1F1.9$%D261%9$UD0V1+9$=D3V1!R*E)PW9T<"%/C`Z,CHQ M*HH*IM&V'13="CL-;V*G`4Z8ACAA&N2$:9@3IH%.F(8Z81KLA&FX$Z8!3YB& M/&$:](1IV!.F@5>6)*,D"R6CVX%_83(Z-VDR>M*Y"^'O$ND1Z1,9$!D2&1$9 M$YD0F1*9$9D361!9$ED161/9$-D2V1'9$WD@4GK2D&WGD'D>R7X;R-&3MFQ- MAX5-IYW-E*=@A&9%P>B>D89:O(>&&FN+--@>):*4_=-$E-5/6[$7Z*Q3[7DB MN[GHOJM$EM?AX[;SC]L+1FC6)S(@,E32#)V-@DWLK-%HI&O&<3!"9Q,B4R*E M)TEL/;*Q#WKU[=>/[_]U_RA!DOO)"'VR(8X-*OY9*=@A$]6 M%!XE(2;G13%`2$^KHR=WY<,I9[RS;=$!K.P@KN_NTJH\5"MYF(9!C!B-XJTLRMQ@*\X[QZ!)*6?'NH)5B*?8-6^RY8# M\@S&:4$V*N5',*-K*`]FO)E9@!0ANK7CD."D#\YD%3![M%(_LS1 M-7U&R?Z)BNS]0`KW#8^2*+3;G51#7;62LP9HV&/49S1@-&0T8C1F-&$T950J M,G(_,#JB8:Q8)Z"8K*(.?W5\#?&3-*Z8Z4"DH';1G<1=F?$7KE!%39(T^&\B MZIIEM4E15IMN\Y!Z,_,Q>JZ%.#.HKT@JF!%O.RLQ`UA)^Z>3:,CN1XS&C"9P M7SN(*:QJ!U&J5;W>#_`5]7X$BK/G"2C6)E&,OX:2B\@4*1Z>F>P1Q2B+[D0Q MRHP_!,#[2VN`VUBW->"9W/?[\$GN>Y1>B\Y5+A1O94;?,1HSF@#5]CB%571?*C(R/S`ZHF%,Z1.0R>@"S*Y8V)O$6S]Y M="?Q5F;\A>M842'I9

C:\ANQ\Q&L-]['$"5-OCE'V5BI)2X<=ET!$-8VZ? M@$QJ%V!)J2!O4BKTDT=W(@MEQA^N8]4-CMN_LJ4BE\%E]Z;N['&N`X_,I^^J ME4$]1GU&`T9#1B-&8T831E-&I:),Q=F$=U`KDZI'H)BI)Z#:Z4=J@;]@:2WP MS'0@05<6>Y"@![M8KBE1Y/B7[2)=(KB]+NC`G9Y]9HF@6V,Q<^[=(7*10';% MLKNHKEJ97.TQZ@/9*];N9'M7`U@E=U5\4^O'97H,)D"U@YC"JG80 MI5H9Y1\8'>$KIO,)R&1S`994!_\I30*JZ_Z@1!J:?.TQZBO2Q4^[H[ZB9^XJN.&0T8C1F-%$47V/4VY8*DJ% MGR^)#W!O[BH4-:[B'L%)V:TL\\*=646M4+.D5G`/0A2+Z'+EI5G-YF&_%Y9=BVSLMO5AK:(,.H#27:$2RFE)-W5&,!**F.P MHGW?(:SBFF+$:,QH`E0[B"FL:@=1JI7)G`.C(WS%"G$",@6B`+,%A[V)@G3W M,KH3`2DS_L+5YF6&/`VJ5\ME!+EH3PI$!/3ITC(-Y4_,T3H1$+*ZGM%4)[L-;G+ M:;IM-'N7D\]L%Y8EOQN7*$TWZ&+Z=\^=I0L91GU&`T9#1B-&8T831E-&I2*3 M``=&1S2,B7X",GE>@"5UPU\>TX$$72]9="=!5V;\A2M443?<#E@>3J>$^J5I MTV^<)>%3E!6*[#%J5UN:C]%3E"P*Z&EHO\JJWG0U@)`!OF*B'(%B]I^`XEI(ZHN/D5]MZ!,V MV$5OHBMOEQ839<8?8N+]I67";:%973VC)[_CENC)(SD4CX+6=0J1^QJ#>HSZ MC`:,AHQ&C,:,)HRFC&:,YHP6C):,5HS6C#:,MHQVC/:,'AB5BDS>'A@=%15-V)NN^X%.O2[>XD./3*BZTH_ MI$-"?;8:,!HR&C$:,YHPFC*:,9HS6C!:,EHQ6C/:,-HRVC':,WI@5"K*2F3^ M>$FMS`KI"&1+I`^:6,7)HIT_;Y>JZ7!^AD`9OT+X(6%GL5`0<[.IZA7R> M[#4MMVY/\@4R]UN8BII*N!/J,!HR&C$:,QHPFC*:, M9HSFC!:,EHQ6C-:,-HRVC':,]HP>&)6*TG*;;S<>U"HIMSY"\B^HAJ=H%0L? MW?Q+N?4MTT6J>C.+SR[T8[1D],"H5F3IW8'14 M9"K?"<@4O@(L*:0^;*8#*:2>&7,>HSZ MC`:,AHQ&C,:,)HRFC&:,YHP6C):,5HS6C#:,MHQVC/:,'AB5BK)"FFVZ']1* M=(&J>02*9>X$)(H*FQP5A53-Y`><%?>Q:6!=L-B#O`[`/[YP`JWI`EKQ720K M`7<`XB4"]KO==B5P]I#<[7<9]1CU&0T8#1F-&(T931A-&U*S9Q[>%FKFJY_N M`G`/HF+N0BJLA\_T`;5455BWT8][+?G;/GT57OPSR,N>Q+CW+69+6$5&M%U& M/49]1@-&0T8C1F-&$T931C-&7U5K)C&B;[`F9)Y25OHEEM&W=R1;+L#R&OJKSN@4&=/B^KO/ZQ0[(P M\"B1)Z&>>QUH=H?%:,!HR&C$:,QHPFC*:,9HSFC!:,EHQ6C-:,-HRVC':,_H M@5&I**N\V:G5@UHEE=='Z%9VF,(:DYZOG;3AG1@'*SK(*B^^\L[7UTQESU[OW5MN M?4I$LRQ.W6B#FM%CU&QJT3U#[WE31.T M\O+HVMYVMV^RXW2E-GS2*AV'R747TY?V1UB[-._YP\*RW<[^C&VC9G?Q%%6IR-3(`Z,CHQ,CR5,? M8>-,\I09E&#M(`7+(`7+$'C+$'G+$'G+$&?+$&C+$&C+$%;+$%?+$%?+$$7+ M$$;+$$;/TCQUSV4H3^6;223>[F526(%?_F:IEO.8;19Z9.[7NVIE4(]1G]&` MT9#1B-&8T831E-&,T9S1@M&2T8K16M%=K%0;1J6BAFQ"H*`=P&(.'Q75U[@3 M-Y04T["9[)<66[40KX$ M!E>]!(I/'@^,CHQ.C.2]R4Y2R5^O%O<5#-&7?\(X"H3?,L3?,D3<,H3<,L3< M,D39,H39,L39E#EYA;+_;)ZEB62?G[K=_?K;-KGZ^9P#)(>Y-6%N,PETU<0, ML\>H'QRY%^G)%^6\R1-OP(V&C$;DIY-M/HVYT831-/,C"9-)%?/%3!Y53D[@5YL9U$P<)S7,'EY.;N" M9*RKJ)FGRICDHG(SN:B/^\Q?T;FONW)+PC!YM?+WJ7;5 MQ(RZQZ@?'"%LS2RG!]QHR&A$?O+W"(RYT831-//3?',EF^[FOVQ*G+&+.:,% M>6UE-ZE+;K1BM`Y^$/7\JF_4P@?]_`BW!(KSR('1D=&)D:2>#[RIL))ZS!!] M:X?P6X;X6X:(6X:06X:86X8H6X8P6X8XFPHF">,_1]7DY1X4OB!A_'-%N\GA M9KQSPF#R:K>R55I73XSZP1$F+WDN8O_+IHX!NQ@R&I'7_!T,8VXT833- M_$CZ9.D\XT9S1@ORT\JFUB4W6C%:!S^8RMK9]=FHA1%"&1J%J2Q?:!S4Q!2W M8V@5*EFVG#]Q(\DGKPOC2/()6H&G?%TA4QDW@UBLJZ@6S#CYTD(F+W8%A5A7 M42)PE:\N9/)B5Q")=155@C*6+S`D%[VKJLE+[C5?DHO./+OS\L@^;W>WUV)E M4(]1G]&`T9#1B-&8T831E-&,T9S1@M&2T8K1FM&&T9;1CM&>T0.C4I&I>P=& M1T8G1I)//I#&F>03LVX%0\1M6X3<,L3<,@3=,D3=,H3=,L3=,@3>E"7)"?\Y MJN8G]WCO!?.3?QJ8S$_T@+![3:C'J,]HP&C(:,1HS&C":,IHQFC.:,%HR6C% M:,UHPVC+:,=HS^B!4:FH9GU]4!-36(^A%2:.?#%]XD:2,C[.QI&DC"HDW$WE MRVF9@K@9]&%=02`-=?71=`WY3 M*%]72_)Y5U434OZT_)F[*7Y*?NV1F7VZC'J,^HP&C(:,1HS&C":,IHQFC.:, M%HR6C%:,UHPVC+:,=HSVC!X8E8P.C(Z,3HPDNRBVDEW,*@(NFQ-L5Q%RR1BV MJPBZ?%D:VU6$7;XNC>TJ`B\YP785H9>O3&.[BN#+EZ:Q71K^=!?#/:JVDYY_ M(/WBKVJZ]H^\938T#T3S7>%[M9(HSVC`:,AHQ&C,:,)H MRFC&:,YHP6C):,5HS6C#:,MHQVC/Z(%1&=&3\3E$&\3GR.C$2+)8CT7$9P*2 MQA!T8+1DM&*T9K1AM&6T8[1G],"H!(II=6!T9'1B)#FJ@8S.)$>9A8`; MNQ!QPT+(#0LQ-RP$W;`0=<-"V`T+<3NX`:+H+TVD MH@^D.=HBJ!%$8-P9%5A59P\_ MB@IE%$$:QIW1AG67/7NR"NL[LTA=V3^LOGUQO_8-]NWRJR\RNC'J,^HP&C(:,1HS&C":,IHQFC M.:,%HR6C%:,UHPVC+:,=HSVC!T:E(O/5JP=&1Z`T#[,_CCE%*Y/57@'&OV2U MLEIODM7!++B#+JP["".;J[+!25:S.ZC%NH-<,G=9!9.L9G?0D'4'$67NLB?J M!81ETQ#*LNX@KO/NTJQVQPE>D-7^]$&2U1XE64VH=T.HSVC` M:,AHQ&C,:,)HRFC&:,YHP6C):,5HS6C#:,MHQVC/Z(%1J<@HY\#HR`U/C(J" M6TH*4R0E7YDAXF8@147()3FY+8)NVR+JB?QO:%*#$JS\(07K#EI(W+7OLGT7 M24X_.NL.`K'NH)#4W6U>.J`:ZPZR\>[2Y)0RF23G?_773.XE[-GA`B"[F%:K MB'IJY?ZV.MQ:M?,]YWZT0JT>,!HR&C$:,YHPFC*:,9HS6C!:*DK6U_Y*9!\[ M.R*T9E\;]K6-5O829C=3NVB%2[AG7R6LXDKOP.BHJ!-?(7%B))FM'S(ZD\SV MS#25S&86=&':0@6V+61@6="!:0LA6#LHP;(@!=,66K!V$(-E00VFK9&#"0Z5 M`$A$](#H%*OD\J4YZ\X_V`DUSUG\:5/]]M2-/T:13+0>F;+352N#>F@HCX[- MI\HK4=^8X5,-X"V>6!X:,^LMNPT;&3-X&[.WB3&SWK*[L*DQ@[<9>YL;,^LM M6Q`MC!F\+>$MJF%ES*(WN@=;&S-XV["WK3&+WN@6;&?,X&W/WDI%YNS-@=&1 MT8F19+Z7D7$FF<\,VK)V$)=E4))E4))ED))ET(UET(UE$(YE4(EE4(EED(EE MT(1ET(1E$(5G:9J[DQ8VS9])9W\P(TEGCTSN=F\(]8"D#)LY.+O#Z4&6RG1L$QJ^UA`ZM.ZC.C%96\]Z= M?K]=]=@@1-L0LK,,NDO>A]F^RU9/LJ,6/FK\".V[3#\%Q&A[@!J3'OC30Z'V MTT./UAT$^8P[B-0W3.5O"U`8J^MD")KWR= MM8M6\+4'BKY*16;N.3`Z,CHQDLSWL37.)/.9=2L8=&';0AB601F601J601N6 M01R601V601Z601^602"600Z600^601">I9GH#HB\(!/]>9(D$STRV=.](=13 ME&2BMS)HP`V'W'#$:,P-)VPU933CAG.V6C!:M M8H[1A2[5*IN!LY740:U,53\R.C&2M/-=FI:2=LR@`6L'$5C6KV@+&5@[Z,`R M",$R*$%GYF9+E@WY$R%(P[:#-BR#."R#.BR#/"R#/I(YLGV7W5'*';9>.CD; M$]8E]M6":;*Z$S0O2%9_X"9)5H],<>C>$.HQZC,:,!HR&C$:,YHPFC*:,9HS M6C!:,EHQ6C/:,-HRVC':,RH9'1@=&9T821I2U"0-F55$5QXLBW``S<\,CK!5_V-L`Q1'G_8>[=[]B4WPFI7^XFD1K`[Z-*H M5VJ$MZM3A1PM46?Q^DC18!:$*/\40T[?9!O$:95AYTS_MG0(U@ZW0J!26G@D M0:)FQ$&0R>@J9G1U]]3HD@+4?MF!L;-Y>F`,*/UJU+MLP==5,S/Q]QCU&0T8 M#1F-&(T931A-&4MNM6*T9K1AM&6T4^2^,S*J-=?# M'E;R@#58D5A+=G]@=&1T8E04%>R^@E5HHJ@015&ABJ)"%D6%+HH*8105RB@J MI%%4:*.H$$=1H8X"\C!Z+RKT4*2"2%/3'7]Y^=J@[4_-V+6!HOJYH*M6IESU M&/7AJV8N&*!9G-J&0+&>C8!L.:-I<@RKZ&L"%'U-%=7-`C-N-F>T`+*C:N=3 MP!)63]78\PRP@E4"^I2EH/6UI4)_1@-&0 MT8C1F-&$T931C-&UA53NNDMT? M&!T9G1A)\I,")/F9=2M8A51D6N>V%6*1Y&>["KG(M,YV%8*1M&:["LE(6K,= M1&,D+],ZVZ6"2!-6-EF3A+WLEK_MFF4K;X]<]V%EU[[+GL%VM:$IL3U&?45U M$^@`S>)4/`2*56X$9(MG=9U['&@:S2,:,-HRVC':,^H5%0?Z0,W/#(ZP5?-`DY2G<(CJ4X?NPCB MLI>5@BU3/[N#XHPN95'O[>KB+>6`QQ%$%Z^_E`.ULV.CD,M:((PM9A'='TG1 MX%XKI"=%@^V"^,SH@M22T='7LZ_@[BE%IJ7%'2]ZP5K`GT9*[A0\,F\7[[8) M]1CU&0T8#1F-&(T931A-&,D3>,H3> M,L3>,@3?,D3?LS3'W"&8D&.2[,^LM_V9F23'%"7K[S$SD#;C9D-&(T9C1A-&4T8S1GM&"T9+1BM&:T8;1EM&.T9U0J M2F9;BL]!K3@69J9[NS-"S+3']5),M.C)/!MWLGV M5F94O3:A/J,!HR&C$:,QHPFC*:,9HSFC!5"R%,G?U;J$U5,K$5T;TY58HV%< M_6P8;1GM%.EJL-6YN\E?D;WG5J4B4S')S=U-HV+.])[,%\X.V=-(4;)50[<_8UC% M/Q6:L*^IHKI1S;C9G-%"43(J^E+1):SL[@'=]ZS8_9K1AM&6T8[1GE&IJ+X( M']3*%.$CHQ,C26F-;"Q'DM+,H"73@]S'LAW49.T&%7:0C[4+^C%C"6JIK<9R MVZI#J2W'5K%AJU@5>MK MSPU+1=ELD*T*#W`?R\.1T0F^_)UZLVI5*)7`1\P\MI!*H"RZEWUQ9?+C:4G( M>H+=09=V)H8.)<_/9XTJQS:$,S..($W#@A#MV&AY*`N,,+;X$6A]*`L,-3,] M0*#V(T"AE@6)FK80I'[4SG7K*DM*65_8+I,2TTE.LSV[.7T:E(O,G/`=&1T8G1D51P>XK6+>"(?QF(`7B;]F@HBTB;NT0Z_,2G]P]X!-QLR&C$:,YHPFBJJ&\*,F\T9+10E=_N=J^P4 MP!)6=IZG:KYB]VM&&T9;1CM&>T:E(OF!ORD[,#HR.C&2!/:ZD1]P5MQ7,*C$ MVD$FED$GED$7ED$8ED$9ED$:ED$;ED$"]2H8!&#]00&600*600.60026006600:600>600B600F6(?26(?:6(?B> MI8GICIO8F?6RTV0=?TK%;K$#I3-L(WOA15?-DAG6.S.HKU8ZO77:G:M6?C!M MH#;VYIJ=CV!5>V\XAE6\SYRPKZFBNE'-N-FWA)4H/=P%5DRZ M=/G6W..&T9;1CM&>4:G(2.S`Z,CHQ$ARVP_?.)/<9@;A6+M>A1VD8^T@%2/"LJ%%!42$!N?ME?A0B*"A44%3(H*G105`BAJ%!"42&% MHD(+1848B@HU%!5R*%(]I&DL&?NWI+'SDRVJ/>K(B80PP70:V6.A;B=8(8P] M1GU&`T9#1B-&8T831E-&,T9S1@M&2T8K1FM&&T9;1CM&>T8/C$J@NW!+>F!T M9'1B)#FJ@8S.9*IE%@)N[$+$#0LA-RS$W+`0=,-"U`T+83L!!\PT+T#0OA/[,T1]V9'CO5UI_J=`F7IZ)']N2T6AG48]1G-&`T M9#1B-&8T831E-&,T9[1@M&2T8K1FM&&T9;1CM&?TP*A4U)#7WZ#H'93)MTD# M'14EKY/N-+('BJ=HA8:2BS[>S62OR3/3@,/ MM"1WRQ[9EXZI52O>@_:`Y';(S,_99^I'*\1^`'03I#H$BNY'0*G[;$]\'*W@ M?@(4W4^!HOL94.(^?YG5/%K!_0(HNE\"1?:'4:V7W6*5JA2ZDFWIE-DGMEI@.I M)BJ[I(=.=AA)JDDP"UU`9;8+R,QV$726=)&?C)!JPEU`:;8+2,UV$;26=-', MEJU23;@+J,UV`;G9+H+>DBXZ>1=!@^:=XU"<[R*M)N[,3UTUN>R=XQU_="@I M)QXEY411E'1/&Z8E,M=7/UHA^`.@*.DA4'0_`DHRII$]21I'*[B?`$7W4Z#H M?@:4N,^_E'P>K>!^`13=+X&B^Q50ZCY+C76T@OL-4'2_!8KN=T"I^RRW]]$* M[A^`HOM2D=GY/`!%JZ.BNZLP!YP82>GP.FG&UYS*38&RZ$U*AV?&G=0)9I"/ M]0?]R'8G/I;E^V>+!GU9)LMVC)-L51<7UY+[!W63(\P]<]#ZC@:)6#,T0*#8< M`27EL)GM[8^C%7J<`$7W4Z#H?@:4N,_GC'FT@OL%4'2_!(KN5T")^WR^6$EDJXZ#6IF;DR-0/`][`A(= MA-4C';&3`J#2B75""H!GI@,I`,HD;X.[Z]M\2H3LDO>&C@!9M MKQ!CX5`G^DU*-3T"HG:7J'19WJ%;I_I-0C7]`KEVEXAW6=ZA9R?Z37H M^=QK4IAN\V-N^5W-9>N0LYMT0Q$HJK#+J*>H%<_M]1D-%)FEVI!]C;CAF-&$ M?4W9UXP;SADMV->2?:VXX9K1AGUMV=>.&^X9/;"O4I%YLGI@=$3#6-).0+$R M%06872BPMP(!-ZN3`A&W$RQ";B=BQ-P,N$#0K3]$W?I#V*T_Q-WZ0^"M/T3> M^D/HK3_$WOI#\*T_1-_Z0_@K%@JW[MR172A4[":(*VPGG,VSO/,GEQK)P_=V M?E2DJRW-L'I`,?A]1?J8^Z;9:C4ZV4)U@&91#$.@J)D14/(`.Y\RQK!RG_#/ M'Z_>9#M/$_Q[[&L*%/N:`=7V-8?5$WTM\.^QKR50[&L%5-O76JWT.K:;5ZU\ MS;&!H]C=%BAVMP.J[6X/*[+21/O`ZQBCZ6B=,W1RA9W!S2,&Z)' MH%CM3_#ESRQ7:DKG?OOX2NZETKB[>QI^:#7.X@E7X!`OM9[D*OQ'O0: M1U\$P3[I'6*UWH-`C?>@4.,=$M6C5$X0-]E5+B!0ZS^(TO@/JC3^@RSK%WS0 MI>\B71B(PI)"Y!8&UR*H9PJ2:Y85)(]2336SO8#NK;4/Q._,LCQ4E"XM./CET;[U9LK!0%$?? M5RM,B)5_,@=/\>(,@>)G'@%%YV,@._UU6MF#L@FLHOLI4'0_`XKNYT!AX9`] M:%C`('I>`D7/*Z#H>:U(KTKCMG65'ZW:H%7TO06*OG=`T?<>R%Z4BC6!ABJZ M+[5A6K];VQ%AV!8I4Y`=56&2D#?A2FADL9T)'%#J0,*(L]2!D(=C5K MGP("M%T,_I^TJUUN*\>QKY*:!^BV8SNV5;-==27K^]NR++RP%=*]9]VYP`$0.(0Y-6EQ-)4RSDJ`[LPRG7W0FGH71CI2F%O MC'6N%T8[UUOEG;=G5'-ZQC5GS\C6';(2,+EHUP]\I/4C]4/4J_J1H&X>#>Z2 M5FL?D*'2GV'1ZDCR*&NY`1N7AIKBB4+%_%2ASM&:L?EY::CF%PH5\TN%.LVO MV/Q:&Q;V;!0JYK<*%4X\LJT=:STI5&P]*]09Z@N;WV?(K6*O#!W4?*E3;PJ5 M:H9ZD!E0JA+J0<*<`]2#K%?,H1YDS-DS^CA[2A9OS]CB[!E=G#WCB[.G[/#V MC![.GO'#V3.".'M*!V_/^.#L&2&K5M,Y0M2VHUL3! M75)K;0LR5*(?%JTRK^G'*4:JA?,;]GA+A^''JE4&8J)0\3A5R!;S>M>?@RRI MF)J5>+>*E1Z]ZA0L;53J&@]*51L/2N$ M3MAX4J@OJE7,[S-4E?0J]:_:L-2C@T*ETKPIU%EI4`K22+N:CE*01[\X0"G( M6/&`4F!Z'?W$UH!=&.6<"R.8*.K0'W8J&8"T7)YNT9 MM9R>-:9A;MT\JHUVS/4VC%\ MJM]L#W++UHXAM73O5X99*S\RW]_CBLSZIQU':JF,V5BA,A03A?!1D*V"]'IY MJEHHS*85?+:0`RT>YZ5AF?_6G6*+/"Y+P_Q.I%I?5ZI0G*T5*MW;*-39O6W6 MRL-Y=W%U53_I/ZJAXFZG4''WI%"GNV?5\J,9[#QH-/>Y8?>*\:KF2[D[9.CR MHKR!?\N8+*R64XH"I2:%X=8,E)H<6O&`4I,P[P*U)H$G?"B=O0^CK_.A_&WY M4`:?\*$4]CYFVH^R?&#S$?1C4?JA-,:+BJ3H#1HI7=#*RE;0RLL302LQDX]V MG9+38W6=NKK\2;(IY[+U!,/YA[3OTGFT5LU*4,6WZH73(#=L[5"R+<>W85;# M\B,S^IV:E=JY,1VS]8E&"NN%NE1"INK0$SPH6N1RSBX7Y[E<%I?O52WRMF9O MF_.\;=5;&M&X;)&_'?M[.L_?L_KS`TH5XR5KN1SN,^26ZE>&#AERZ]R;0J7$ MHB"E+OFW&WVVAH*4]=Q>X$$Q9T]YZ>V-`GM&1&=/F>A6ZT9IY^W-`GO&,F=/ M:>;M*:>\O55@SWCD["F1O#UE3;+7KBG8U%)-N71?]M"BE7/=)">ZCD="Y5!:><&G,A%4;>ZKN MC;(U=;15/G`JO+M\G/7H=+32KAX9:M'U]JHZ$SS(6HY/#VK+;T,RUKWS&F4M ME\XQVY\X^V7,B*_3LUS.V.6<72[.<[D\R^6*7:[9Y>8\E]NS7#ZRRQV[?#K/ MY?-9+E_8Y3Y#;CUZ9>B0(;<>O2E4ZFO3*%8*;--G:XT1M)3K1AGJ%^AA8$_Y MZ`)NC)#.GC+2VU/Z^0V$DLW;,[8Y>THW;T^YY>TID[P]HY*SIUSR]I0XP8;D MOCX7*A_&_*F'G*/%JKJD0W;NASL&6[N3P*-2Q_4(,SQ9.N51"?6^1^67 M[Z,2S'M4AIWRJ+3+`QN?Y`QZJ43T/I6)IWPJ/;M7[D8I&VU0Y+Q;_9G)CS_? MW(N9JH8DR!6,0=9RT`-#0X9&#(T9FC`T96C&T)RA!4-+AE8,K1G:,+1EZ)&A M'4-/##TS],+0/D-N-7IEZ)"AUO*>\NB7IT;56LM[TG,.L+SGMFZYTXQ[>YIR MOWQJSKT]3;H+K]&L>WN:=F]/\^[M:>*]/I]_8T]]Z>)M_;T^Q[>YK^ M:'F74V9=\_&\!X9T5LU_;GF?(#?W!@P],#1D:,30F*$)0U.&9@S-&5HPM&1H MQ=":H0U#6X8>&=HQ],30,T,O#.TS5"WIU?=#7[.66QH.&<(G[?JQ^UN&[G&^ MJ>,IMU7^N&YA73_+JY+JA%J3/->E6HG^JKT.^%5*>F]*B>]5R7E":]*U!->E;S):_O3!SGQUE5,SOOP M4@)(BWLAQ.U5Q=5^UD*!*5K5"\I!T5'R/C`T9&C$T)BA"4-3AF8,S1E:,+1D M:,70FJ$-0UN&'AG:,?3$T#-#+PSM"_1N?EZ+CN;GP-`;0WC@3QQQRPL>&!@+ M&(!*PGH!!YJ`!"@;W#:@01/PH`F(T`1,:`(J-`$7FH`,3<"&)J`#=NB^'^U) MC%=+P23^X5]LO1<[U18]0?+S5U;I<:5(^^#C(#>$EI+B@:$A0R.&Q@Q-&)HR M-&-HSM""H25#*X;6#&T8VC+TR-".H2>&GAEZ86BO4/E%N%>&#@R],80YFM-= MC&&.,F8)=WJ6<8=9RAUF.7>8)=UAEG6'6=H=9GEWF"7>899YAUGJ'6:Y=Y@E MWV&6?8=9^H]8>X[*^;&NA?:\77LZA=;:M2?(E=7!/4$/#`T9&C$T9FC"T)2A M&4-SAA8,+1E:,;1F:,/0EJ%'AG8,/3'TS-`+0_L,799W?:\,'3)TA9+NRFJU M7WHK6EI6,4-3;M'2L'Z`*0>\GI+`8\H"CRD-/*8\\+]%AP=K"\9WH_JZ+E96 M4[.8E1[>A_+#8TH0CRE#/*84\9ARQ&-*DMR/]A25HTDT13_]B<-!]_E45$E6 M7Z'"CX%"Y0="'S*$R/W`5OP8%BT=UQ%#8X8F#$T9FF7(IWQ>U'Q@5<8714L# M6S*T8FC-T(:A;89\8'O%KOS#Q>UU]47Y5[56=BH';8EKU5R?KJNO@+XY->T4 M9F-*L/M)&JR7.>EM>W=5)'B(+GIFT!)?GMT;3?-E9;!ZA:ALL)W65E11U@=RLD6JMPAKKI-\@M_8^UJC%_@."V9M]0&Y9^CL*&]0\;CKGA M1!NV^53_PNK4J>G8SM1:8=-T@._VFEMC0RNK;*A_>N>U]43'FH!NPC8@*=CTW/C=%>-$RJ! MJ5ET2@@_4)9^UPO-O^^9)CNU;<]Y.>_3->?/VWB+E>K1.$...(/[A+7F=U;# MG_>),]2&)3.C#%VV&U8E<,P-)PJUR%5/K&G1T@S,%"I!S#-4!5&Q8\$-EW'# M*OH5-UPKU!G]IFAI]%N%2O3[#%VZ?+RRVB%#[B/&@6`EYJ)#K[DBQ:D94 M6YVQJKFF$\-:U+ZN3N1-G9IR>V98X=YD]C.7=!-I9T#UJ*/6@Y M]J!EU(.64@^6G+J0+*M>T]+J04NB!RV+'K2<);":C7)^YD^OF)<7^1A.X2=R MDS$W\9";!#H,J4G8IT(?9";K%0R)2=A'?[CH]KHZ9XQ445-D*F&NOB%1A"%/ MU!9I2I@+#UDB/20I8=WA(6W4%%E+F`L/22,,$XW:8J(E[!*3.3Y,A7F75-R# M$^9=PO`K&#J/,>\REBR]5)JC"#',F:[ M2'[C;JQYO_=&HM3[:N;+89RNF7_N.IP.]?@'Y,N+C+D/O@(,V2<]))\PY)DP M))8PY)4PI)4P))$PY)`PI)`PY(PPI(PP9(=#RY4%+ MF`0UNR\'.=#5A-V>8F_ M[Q;*.*9^M=RWCN5E9+5`!$H;C4FX93QB^`2EY?'<9)VNRC),Y6<8SF$8] M7L:SL5+PI4`D\,2Y)N,=SCS$&YBF4,W9-ZZYOC=&K,[.%W*5H6R,7=Z>L2D' M%W3>R.6W!,:@$YTW5KW?>2-4N(C+.1%:Q/_,:ZS+"S%95Z.$G:Q&2:U=C1)V MD\@8?J<=3$E*;LJ"%0F[Q$&V,\M1]MXJ1]F(&.LL1VUG/&E!&3(/QB2LJW-@ M4%)RG0-EVO[.*$CD'=3)1N3O^YT#?]K.N'.H2&0>%2EA[K`!-B&$H001]A9@ ML@DA1:DX#*+B,(AUC4%CC@M2GN!9$R6$0900!E%"&+3T>T>6?P]:OCUH"?<@ M:@0[LJQZ34NA!RUI":QV)G*.A^K"#[_\NKQ(YX':FWLZ(X2$$89\$89T$89L M$89D$89<$894$89,$89$$88\$88T$88L$88D$88<$884$?888+L`>PJPYP![ M"3#,7?*+N4L8YBYAF+N$R=QE$'.7P8@*\IC/FA$99.ZR9D2')N*#+/_SA*W#N>6(U$-R**?(&CTDQJ8-!.W*51"H2W M5Y#='G>\59BX8KXG7VS@1KAHOBBX MC:Y%MQ?BZOAA-(DN113U=W_[4411A_=7$GNZ-:XV>"41IF,E))((K\((KS]! M=!WQLY$NAY3H0_(2CD4?8_$2#D7_^AZ2XQ=;J^CZ-TC\3300_1LD_B8:AT;& M(8RZ#\E+.$!]#-!+.#[]:Z3].DI[_QK6)(@ZO=6L)'OA?M2=O;`GZLU>IG\TCQJ8"GWT9;JI>]#^B2?K^'DF0R?1H2!+P+SW4D03\2U\1JB3R M]K:'$Q41-_$M!$P">6W+#,"W$2"35[6!#(>H>O@:0BC#Q(\XW0'0NL(G#-B*+"IF\OQ=99!/'EGI8%:,QQ$EBB3)BIAS/ M[2&_D0S')7MR.H)CQ`G)GIR18`D.2O;D%&0DN8,DZA6.5D`269.SD[WCF0JV M)V1+QPZZF'W%HT%#A7UL%V+1#A'U,/^+!+A.%%/C@]Q&)@:D$3!8U=W MT<,N+BJ2D%V*+/(E/,46.1+AK%R,(Q%.=/6P%8Y$PK68:L*T MF&C80%_TL&&.^@79I<@B7[@TN">W!/,8R@7`F&*Q#)?Y]G"E=]@.%_.BJ,4R M7+*+XA3*9$;+N56.!(=4D>G*??22Y@R3R@QMK(8FLK6!-+J5E:T($N9J6 M)2-(Y-)>E@CIY.I>EH")O6D8->H')%'4N-T7DLC:#-;D`E_VTZQN\,BSOHDX M`AFV,NMPJP\9=BWK>+._NL'V='T3;ETVXF\3ROJ(4JY4YBAEXLK%RBS!;.X- MPW%"#88D&B?8>Y#BZ^0O(:2`R1O8<\.Z-A;V*\#NO46 M]NJ`3KV%?II&QK")97V1#<(H=C?7O2>\Y.9YL;NY@21ZL-O=?((D6JEW-[>0 M1)7R&7Z>0\E!!GP:#G@C'Q0@\&@#!1F2/PB'"3(D?Q`/QH,,QD,H6R/(=1CD M!I)M.$P;#-,V'*8-AFD;#M,&P[0-_3S"SV,HF4$R#R.8(8)Y&,$,$1DM(DD?VXC($H(:13'!]2C2'V-S M%N$3S+X(1T"C*)[)?6]^Q'^V3[+^^.6O__K\VY?EYV^__?V??WSX_+UQ M\1,^Y/[P[>^_R>]7IG]\__HO'$/XRX?__/K]^]=_'/_W;U\^__>7;Z(`Y5^_ M?OVN_\`B\//_??WV/\=7*+_\OP````#__P,`4$L#!!0`!@`(````(0!P%B/6 MO0@``!,H```9````>&PO=V]R:W-H965T+(ES@1D@S:UOT"+!:S,\^.HR1&VU9@N3O=_WX/15$B>3B=[D%> MIBC MYKPY/F[V];&Z&W^OFO'O]__^U^U;??K00/Q^9N_'(^O_J32;-]J0Z; MYJ)^K8XH>:I/A\T9?YZ>)\WKJ=H\MI4.^\GT\O)JVV4M\/V9]P=-J?/7UY_V]:'5[AXV.UWY^^M MT_'HL/73YV-]VCSL,>YOWGRS5;[;/\C]8;<]U4W]=+Z`NXGL*(_Y9G(S@:?[ MV\<=1B!D'YVJI[OQ)\\OI_/QY/ZV%>C/7?76:/\_:E[JM_BT>RQVQPIJ8Y[$ M##S4]6=AFCX*A,H3JAVU,_"?T^BQ>MI\V9__6[\EU>[YY8SI7F!$8F#^X_>@ M:K90%&XNI@OA:5OOT0'\=W38B:4!13;?VG_?=H_GE[OQ[/)BL;R<>3`?/53- M.=H)E^/1]DMSK@]_22.OVI?AMAO<%!\[H1J]?S/71*B2)=]#+]G4J01WCY)-SY?7MY"OF8]L9K=AH.35-ULI$J"\P06B#R`:Q#1(;I#;(;)#; MH+!!J0%#/"S`CQ!/N,'N_/%JE$9+S&._9F>6H+U)KRB1D$A$)":2$$F)9$1R M(@614B>&MO./T5:X0;#`/[ULV.HWIG(K:?5#<7N37EPB(9&(2$PD(9(2R8CD M1`HBI4X,<7$`&`O7?::H:"FL6PW5T%>20"]%UD0"(B&1B$A,)"&2$LF(Y$0* M(J5.#'EP,!CR_,-31K@Q=9/DZD9;C=NZ9C>6]D6JL($>E3@S!ET[!+Y:8H?/+;OMY5]4AX,97LR/1FD+)#UST)B(22S(8)B(C$'1F6>T(D ME<0;VLK(3TZD(#^E3@S=L",=NJFK\4_?*X4;4[B.>+A"]`?0]=P^N:758E`W M(!)VGF;X5_-D75JCP4HMGYA<)412(MG@2&MN8868?+!2S17DJM2)H;I(##Y" M]M:/J7N'IK-^>:X[I*O,*%2^+)VM(!UI9FKD,7M+&*6,,LV9+K8=8C4SU6;! MWDH#F7J++,`.#R+(.N(JDD056#V9/.`2I9I==6@A`K1*H:[G<_-,6"LK;5TS M"GOW;3[2!BEC#)'`[F#%5RU-)"II<@";"VOWM=2 M)@^&EA)96MJ9IW@Y@$K:Z`-&88>\N:ZE:G)@,5=-&*6,,D<#N8,57+4TD*FE MN/3;6L[>UU+F"H:6$EE:+NUUV5GIZY)0"+^\+IG%G9TV,PFCE%'F:"!WL(*K ME@8RM109@J[E.WM;F%O'D$33X0:T%F]XL-)0P"CLT'*(N1&CF%'"*.V0UF+& M5CFC@E%I(%,L<;O7Q?J'69,GLP3,RG#:**2_?EPOK)OSNJNI+9Z`4:C\FP?\ MPKJ219J9ZD?,WA)&*:-,Y@Q5O7 MQ1+A0)Q#O_I4WZ48>CA0R`P'=&/2\X[N>9Y0Z'7.S-7)X6`P4PLJ[JIJRS]A ME#+*_J9-"@?<9L'>2@,9#L+6&4,LH#)F`V3MQK==[]\Y4JBQ`ZY1$QE02"O`<(8*]9A4RBAC%C!)&*:.,41%[_VI5/=]336)K*D<)JF-VFM\91>J65,Y)"*R=_)#NOQ: M?*A.S]6ZVN^;T;;^(CZ27XGGC![++_BKJ?B$WP8P*IFAI'T[LDH0SGT181"3 MK!)$=5\$%2Y!T(8W5PE^0_!IZJBQ0L?<_8(CESVZZ^KMISG\MR>GU=G5W,?7 M(>[J:N'CLXB#8P@KYQ#6*%D[2P*4B`.`O>'0]2,<6XZ2Z:4?.>O@M/5%M.U<)+F'H=?L&;:F)BQ=ZX"K!S0KM MN$IPFT([SA*L%GEIM)I!4H@.N*8'B2`ZX"I!IH<.N$J0W:$=5\D*$JR<$B#% M\M?.$F1:?N`L0<*%7K?/^S2>)4I<4L>8:Z<$*7:?LR##YG,M*+RM8ORN98-G M092X=AD>N5#BVF=XLD&):Z?A`0(EKBVUQOYP%@38'LZ"$+O#-1:\34,OUUCP MAHH2UUCP(H@2UUCPOH42UUCP6H,2UU@R[!K73&9+']^M')L)>\G%0^PDU]*/ ML8]\C%5UC`KG;76+XN'F#QNGB(I>OB,2*.BZ>(-RV?]$L=/\EZ MW3Q7Y>;TO#LVHWWUA-/HLOTB=Y(_ZI)_G+LO&PO=V]R:W-H965T3X@)N:%-CC;QX.FQ\S@_V? MP8S]\/.]/&JO>=T4U6FED]%8U_)35FV+TWZE__/+_['0M:9-3]OT6)WRE?Z1 M-_K/]>^_/;Q5]7-SR/-6@PBG9J4?VO9L&T:3'?(R;4;5.3_!G5U5EVD+/^N] MT9SK/-UV3N71,,?CF5&FQ4EG$>SZ*S&JW:[(8]SNQTDS$[GZ@ M\&61U553[=H1A#/80/&"O6MOFN_3EV/Y= MO85YL3^TD.XIS(A.S-Y^N'F3@:(09F1.::2L.L(`X'^M+&AI@"+I>W=]*[;M M8:5/9J/I?#PA8*X]Y4WK%S2DKF4O35N5_S$CPD.Q("8/`M6.9TONL??\+2X)URYISF:D_%R,H=AW_"#N]U\X,FCP%7,]\N^!*J*)9F6%TO@3)+Y]A`,5C%=`;II MFZX?ZNI-@[<::J(YIW2-(#:!'Z+TF/I],7Y6BU"$-,HC#;/205H-%N^0S\:ANHG1K01X#*+P20<82%(CTC0DT\? M%?8FXE$1(C$BB4P4(6&]_`XA:1AX[^'2:P2+[Z``-LSJII*]B9B>BXB'B(]( MT)/+@`9)"WL3\:@(D1B11":*DK!V(R4GL,#>N?S1,)V28E0;1N;RBK@DPU>X M-Q)N+B(>(CXB`2?+?OD($8D0B1%)9*+(!--09+K>F(B/`;56U6!D?AF@@XB+ MB(>(CTC`"+$@PWT1PV=9?=5#;K7H!8H0B1%)9*+(`5W`'7)0:U4.06X.VN%6 MET&[B'B(^(@$C%A="]I]54-$(D1B1!*9*'+0;8C<0]RN#FJMRL&(-$`'$1<1 M#Q$?D8`18DV[EL0,J M6D'K=X=6U%K52A!X5?OQ+2+,[+.<^]@IX$@JP,'# M0VXAI2K"*.;H1L$I3JJ"M'657T_6XH_HOJ4]%-GSIH)*`J,KK^T$)LL;?-8` MLUUPAS9TN]!59Z_LH'5PN(4T.9>C1;>;[N)X`MU0ECU)BA-P)REI(4811C%& MB8)4[6@KB[2#O367[E=U[J2[0T?6'"LZ,F2:_2+D$(:DV;D<+2_+N(>1SY$4 M*^!(JL%!FD+A)*V"'$EIB@7Z-$V)$D?5D;:RWZLC:XX5'1F2JL0A"+D<+>!K MUB^@:('WA!5;X6=7UD(<.A#HDLB0(RF1$4=2(F.,$B66JB5M9K]72]8>*UHR M!%V_:$T=N$U?=PFY&'D8^1@%'$FI"C&*.+J=JEA8L50MKWR,E=!,2W84QTY" MRKS>YTY^/#9:5KW08S9":[S'[`QP8]FP8P$UAGQJ0T=^A<]L:%>O<`*!8$3X M3F#9L%&YPJ<.)Y3O?YGVF]+TZ-=LQW MD*IQ]QVKV9DI^]'R1?FI:N&LLUN?#W"VG<-YTIBNW+NJ:L4/>++1GY:O_P<` M`/__`P!02P,$%``&``@````A`-\E)A_H!P``@",``!D```!X;"]W;W)K&ULK)K?C^(V$,??*_5_0+P?D)``B1:J#?FM5JJJ:_N< MA;!$"P0EV=N[_[[CV$X\GAS+7;8QY^^WH^C;[D55V4E_78 MF,S&H_RR*_?%Y7D]_OMS^&DU'M5-=MEGI_*2K\??\GK\V^;77Q[>RNJE/N9Y M,P(/EWH]/C;-U9U.Z]TQ/V?UI+SF%V@YE-4Y:^#/ZGE:7ZL\V[>=SJ>I.9LM MIN>LN(RY![>ZQT=Y.!2[W"]WK^?\TG`G57[*&GC^^EA<:^GMO+O'W3FK7EZO MGW;E^0HNGHI3T7QKG8Y'YYV;/%_**GLZ0=Y?#2O;2=_M'\3]N=A595T>F@FX MF_('I3D[4V<*GC8/^P(R8+*/JORP'C\:;FK:X^GFH17HGR)_JY5_C^IC^195 MQ?[WXI*#VC!.;`2>RO*%F29[AJ#SE/0.VQ'XLQKM\T/V>FK^*M_BO'@^-C#< M-F3$$G/WW_R\WH&BX&;"'V-7GN`!X/^C<\&F!BB2?5V/30A<[)OC>CQ?3.SE M;&Z`^>@IKYNP8"['H]UKW93G?[F1P1ZJV M82]8U!N1%J(G?(J>YF1EV]9BM;S_<6'NM^'A4SBY,[HC.L*G?&[P<>-Q#1C/ M-A3[QP\_\)2/53OT?M9DFX>J?!O!^P2C45\S]G8:+O,L!YT_23<-OC<+8.28 MET?F9CT&*6&`:YBZ7S8&_/,/&JT-+')5IJP*<$<^SH(=!#J(-)! MK(-$!ZD"IB!,IPY,Y8]0A[EAZLBL/`D4N1::$M)$]O%U$.@@U$&D@U@'B0Y2 M!2`EYA^C!',#ZP*>)]HD\+C1$@:EFTUS39W.I).'D("0D)"(D)B0A)!4)4@E M6+4^8KXP-_!"PDM[HI4V?2R41(0$A(2$1(3$A"2*H2)!.LKTBF MX1U&KBW,NE5#)N%QLG2Z%VI+B$](0$A(2$1(3$A"2*H2E"@LB"A1OKI.V`;3 M'(O=BU?R#7%`@#FLHGQM94YP_H*L^OP)\3E9.>UB;!GSA85?H:`SD+*&Q$E$ M2-SU8FN\-7,UL.\8'D$,6`MZ]X? MQ]+RWW(KJZV)^%Y#2$!(2$A$2$Q(0DBJ$B0*JZ;5#7E@:D!A(^<&L\;).E:A^D$JO)D$RWY6G- ML3X"J3."(I^B@**0HHBBF**$HA0AG#,KQ]1WX*>638,7=;"+RI7(DTB;*WKI M)`L%LJ`:4948;V5!8F>KTM/15,Z(AXX&0R7#(E3:9W@N)Q685 MWRVQ[UN%V6*KO9@"H8G'K13DRXY&7QX'`RRDWB**XH&>R0!+45>L!RON=#W4 M7>FN/=O@)2*:?!S9;.^7AR3'TK;/K>B(YI[P-8-ZJNMIK;05+I`AV1K:FJ;(IRB@**0HHBBF**$H10CGS"I(->>?_9)"5**J&!S-^\5G"PL1TT=!OD`+ MV*6[-\M>:.>QH+>26H?45T11W'=4W6OO=]);2?I'2,8K7B09 M1T@R@GR#(R298Y-9UEG)G$+147$?410/N;<76KF2]%;2?8I\8 MMNLE['U55>L&E_,"*07"EB*?HH"BD**(HIBBA*(4(:R%7L[?WK),6K<+9,+4 M[]9?Q]86DZVTZH^^/D6!1/R+D;GF))3-:BA37^HC:=6'BBE*)!H.E=;1PID9*;D=A] M-$L3Y:1&XLKR*V=^[WC.J^=\FY].]6A7OK+K9$AU\]!A?M<-IQ27G0A`/*T% MBEYH:;_ZUUK@?ORQ+04T[L&]>7O)K',3[M,'(GAS%VYX:.1'RWV$DRQM\"P7 M[CH&..0PE,*C`9Y`N8$>T,(.?[0%CA(N*V5H"YPH7%;1T!8X6+CLV##4LH26 M=N`U4:!,A);V9H&T.-`R%,=?N'";,!`%P@]Q^,['9=_Q#/2`%O9]#6WQ(!=O M,#H6H?RAW(26-LZTDP9^_W#-GO,_LNJY MN-2C4WZ`"3>`=.I1E(_^` M1*;=;V@W+#```SSL``!D```!X M;"]W;W)K&ULK)M9]L>'O9O3W?QV;3^OV(\=CIOWAXV+X>WW5W\G]TI_M?] M?__SY>?A^.WTO-N=8Z3A[707?SZ?W_UD\K1]WKUN3HG#^^Z-[CP>CJ^;,_UY M?$J>WH^[S4-0Z/4EF4ZE\LG7S?XMKC3XQUMT'!X?]]M=];#]_KI[.RLEQ]W+ MYDSU/SWOWT^L[75[B[K7S?';]_?_;0^O[Z3BZ_YE?_XG4!J/O6[]UM/;X;CY M^D+M_MO+;K:L._@#U+_NM\?#Z?!X3I"ZI*HHMKF4+"5)T_V7ASVU0'9[[+A[ MO(L+SQ=-+Q=/WG\)>FB^W_T\6=>QT_/A9^.X?^CNWW;4W>0HZ8*OA\,W*=IZ MD(@*)Z%T/7#!\!A[V#UNOK^?S=W^Z?E,_LY1DV3+_(=_JKO3EKJ4U"32 M036VAQ>J`/T?>]W+V*`NV?Q]%T^3X?W#^?DNGLDGJI0IW-Z8DM9!O[]?$8_[55YH-5XJX653>=FO5_K2(T\$;9`7%RIPK6B& MB]*%+II.%'.Y;+[XB0Z0X:-J8'QQ8]WS7)(N/EGW`A>EBS^H.T>`9T+@-P(Z MS>Z3%V%#V'LW9D6:/2DO?K]),EX"=\@+KLO-J9EFE\B+/Z@$9T7:2HN;*Y&A M82UH@KSX_4ID.+[EQ:=[(L.CE+SX="62:MP,AN'JYKRY_W(\_(S1Y$8!*B-"](0%W"O"G`(<*\*@` ME]*:1,<;V4I2)(?A3$/5OQ'.4HT,9VY*F8'QC..8"DMPD:H+:BZHNZ#A@J8+ M6BYHNZ#C@JX+>B[HNV#@@J$+1BX8,S`=Y.6=T&41[J&I"V8NF+M@X8*E"U8N M6+M`"""A>[EJ`MPIP)\"'"K`HP)<*FR?1D*7)@4(73GA7%X*\\`K2]&B]_K` MJX0*E#3A\)R).J<2BG`75('4@-2!-(`T@;2`M(%T@'2!](#T@0R`#(&,@(Q# M\F&'34(1[K`ID!F0.9`%D"60%9`U$"$0E1&AGP4Z6J"G!;I:H*]%Q-F1Z*:E M!42W7*E_*=6U16I!!9:J?2CK3<+I5C3',@"R!+("LA:D;3Q MH1"A4*1*SFZ`*(=B7">AW4^-"9'VOXUT`-A(1X"-=`C82,>`JFLDOJGW,+YI M(UF']_3P3H'[F5B7"J.QKHGQ9441JF"DFQS/54,I[I(:D#J0!I`FD)8B5G2U M@73"4I$Z.J[LAE)@>&F*!8I3I5(IFF@K(\&*UZ!8"-`LRJ;@!W46.F`\:A;K M%CH\K%H+C@]+2@>(+/E!O86.F(AR'3,7\H5VIS%?D9UGE*X18^T]KU]EIEHHD[: MY`;L5)%2<(H73.,S('-=RFA>@)XEE%H!68,>(4"1*$,YH8/$JJ3049$V=1(Z M*BC^N+E"AX5=4,>%C70@*%V1:8,.$R`-?KUE(TM%PUX1.^P5*9ANKP*I0:DZ MD`:4:@)I0:DVD(XB>?H)8SI3=$,Z%.(.[H&B/I!!6.J*ZF$HQ*I'H&BL99R\ M*T0'Z(F2HG,@UC35Q,S,LU!&#@TY.O>,ZIBK^]+386^D\\XCV")4PH:68&@5 MRDA#7CZ1H0G%^A@U9M" M!V':=*?044A203,S"6?]('10?F@LDG0>=3MDG6=-/C<]C`1:HEFHD9V&&A5- MM%01U;!@'5$#"S81M;!@&U''%)0]FO5@5NP:"0Z#'NKI(QJ8@DIUNN"$QM!( ML.H1ZAEKE#5#V`315"-K#IHQ,N/TG)$9S1>H:\E29CY;,3*ZUHR,+CK+DB%U M%[?J2J=9BEDU$Q5F1AV=:&DY2Q\'A*V/(\+6QR%A3TD<$Q=F&_DN!@;^GSRE M!!J=)%`G:]:*N\)2)J.KB&J(ZH@:B)J(6HC:B#J(NHAZB/J(!HB&B$:(QAKE MG5FG&!VZ)UK,&BBGK"QE,F2F65$^>(8'Z:FTL^2=:[$/Q\M@H;9`F\L+-E?& MIDSX7-:=[=8W6:,D4I%C-9&22$>3U4;*(@6ID8%!&KFCG44YI22NMX^.CM%B M&'.V18XZ;='+PFS'0?BAQ>@,)`\0W9_*B.%%_6[+)F*:.+\E:)6;%$>:N+&FV4MJ".$E4S2Q\'FJV/ MHRHZ^:$^CJM+DY\\RW1S[O.K/G4B2N>'W.-E3Z%?#.`5+98V#^=5C3S:P9,# MF5=*.(\`M4NZ(0?JJ+J!J&E9,PGEP=S0NLEF&PUT$'49J84[/25`ZJG.H\6^ MJ1,TL,]J3-\-$`T9Z:>$E-N;(Q:X:FS,4L;8A)%9Q4\U*AJIF4:E;.#-O#/D MSO7M#V<(/>?J#C&FEFAJ%3552+D/1.N;C%'J@C5*7<6LEE'J*J:;5DR[4SPE MLI*XWCJ:<=$@AZ]MD.-7&TP7$LX*AE[@^H7!Z(0K3W$A^?]HY:O.A2,#@49R M3`MG+"^52457)Q4J$TS;*;/!6F66M6,S4W1:76.QB`G(E[H6LT;0!I>TC#:9 M73?:8K'K1MMHM,,E+:-=S?1.9'&LIZ[1Q@FB*:(9HCFB!:(EHA6B-B!);Q9A55TIL9!R+MAS'HLTX\&S& M468S#C.;<9@I%DU+>6C][Z:EU.@\D"ID)4-%OC<42)E1MLHLEU+#=]:=/FHL M<3T/ZEK,LM?@DEEC3WX4$]2![3G318OO7[?61FL=+FE9ZS*C\5DN-8I9=UW: MTQ*_2COHS`&KMLP-F6ES>=@!'=UD;JREK'":()HBFB&:(UH@6B):(5HCHI13 M76/5E5(.&0>?+G767W\G** M;0_?Y==167FP%V+U[58YYX^"QPB7YWUZU8#6OPX?9^E;KV!A[-[(T8U+FFA( ME9^'72SCR4+4?VB'3EU\0<NA0P5N'1#4,LOMJZ<]4>7.F14I#8$.SV.B6G>I[[]_P$``/__`P!02P,$%``&``@````A`"T%H,L?`P``9@H``!D```!X M;"]W;W)K&ULE)9=;YLP%(;O)^T_(-\7<,BWDE1- MJFZ5-FF:]G'M@`E6`2/;;=I_OV.?A`3(4,)%@/">E^><8VPO[M^+W'OC2@M9 M+@GU0^+Q,I:)*'=+\OO7T]V4>-JP,F&Y+/F2?'!-[E>?/RWV4KWHC'/C@4.I MER0SIIH'@8XS7C#MRXJ7\"25JF`&;M4NT)7B+'%!11X,PG`<%$R4!!WFZAH/ MF:8BYH\R?BUX:=!$\9P9X->9J/31K8BOL2N8>GFM[F)95&"Q%;DP'\Z4>$4\ M?]Z54K%M#GF_TR&+C][NIF-?B%A)+5/C@UV`H-V<9\$L`*?5(A&0@2V[IWBZ M)`]TOJ&4!*N%*]`?P??Z[-K3F=Q_42+Y)DH.U88^V0YLI7RQTN?$_@7!02?Z MR77@A_(2GK+7W/R4^Z]<[#(#[1Y!1C:Q>?+QR'4,%04;?S"R3K',`0!^O4+8 MH0$58>_NO!>)R98D&ONC21A1D'M;KLV3L);$BU^UD<5?%+F,:I/!P03.!Q-* M_>%@-)G>XA(=7.!\=`'#?H0`TW'5>62&K19*[CT8<@"L*V8',)V#H2U+!,6] M7!:HAXUYL$$N%-0:>OFVHI1.%L$;-"`^B-871=.F:'-1-*M%`5#6J)#D.6H_ MHA5#*L0[(<[&M:]+8XV:X9DF:BHV?8H&&[SHG.VZ,MJ@)8%WG!CI(&PBK%'4 M!XF*J>O#9#8-[5&;-"C!Y79*&]2AI/4+L)0HZJ-$!5)&D8/\#R5\3[=3VJ`. MY:!%B:(^2E0@)?3"';5)HY;C)F7_:+3B#EUKL*U1U$>'"J0;]\%-FG#7#4<; MU($EIQ!W54&R,JBDX@ MK0EJ@\\OI])`F]V"9L4=M/;,@Z(36FLH;/#Y%6@4YNKKR^;4';A67=8'U<3U M#[^!9F4W!\4U?*WUI;^ML`&X4+S6FK$^J,[Y3C.):[W=25BC/D#<*>!:6+$= M_\[43I3:RWD*TW'H3V`J4+A/P!LC*[?F;:6!]=U=9K"?X[`@ACZ(4RG-\<;N M1.H=XNH?````__\#`%!+`P04``8`"````"$`N3G-3\8&``!R'P``&0```'AL M+W=O]%VX#DO]NO#\1G\]/%;U87-M;=;"^5[WU\?GGGY[> MVNY+?ZFJ804*M_Y@78;AOM]L^O)2-46_;N_5#>ZU<5QS&H MN6X!B735M1A@_/VEOO>36E,^(M<4 MW9?7^X>R;>X@\5)?Z^'[*&JMFG+_^7QKN^+E"O/^1KRBG+3''Q;R35UV;=^> MAC7(;=A`EW,.-^$&E)Z?CC7,@-J^ZJK3P?I$]KGC69OGI]&@O^OJK1?^O^HO M[5O>U<=?ZUL%;L,ZT15X:=LO%/U\I)<@>+.(SL85^+U;':M3\7H=_FC??JGJ M\V6`Y?9A1G1B^^/WI.I+7!H6S8M$:7DF(HGI^Z]FT%J0<#[^\%362R!V%JCP?#9).9#7O/+S"*BGRB M*@<+!@CA/2SRUV="G/!I\Q56IN10M(0"(B/QA-!UH,+)=$$0ED/2B9A"LNG" MCY#`D6/R":&)`S[,9L`ZB6:H%<$+0EQ[?L"XN!&#/`%";L1& M(C$2J9'(C$2N(R2S8#)B!E&S7*A9>K-HT,&"%9D3!\Q"KT;$(&]\N9"1,;NW M&^^Y]OA'MCK11*?&Z,Q(Y"*Q12.0#(+:(AJD-X;"LC%NB.8>,4;M"[NG\T43 MG1JC,R.1BX36%ZB=C_M"8=D72!A4)R(&LX,A8W.,(@Y0P(W7%2F6"14$TM$0"F1BH1* M(C,!.0.TWM`N%>W>Q(6>8J2$C,"#X]ECC$ZU41G MQNA<'2VE3:BPQC>68AJ%K4%;9\28@+4YP=9QG)UL7BP2J%XEXCVBBDY%`D5G M[!Y4VWFK0%MFKB,D@PB8L4@>VY@\8QBV"%6.B$,L?1S7=WW>/.3[5 MQ6?SS?=]TB*R4;1=Q&^9.94(ZS+%;1W>(SE3(@YI%C0V(PE'F-V>9_NXL4YG M$=J;HT%D\TV-6VPRZG'*;M'.$KOU0%JQAE1V"_=`A$'J48R5)S8CB0*![1.] M1ZF:0F4R4U!(*-(AUJP M='Z.TBWC$_(YWNP6[42%W-)W"/0+R<(D']<(WC#D7.*]J./N\2Z5_'%@T*RL$EL@D-_ MZ^U068N)2!#BPR="Y&,B(2J15"*4(IF$.*$/^8@2/^>(WB3:F`HFC9_4'JCP MK)]%;N'FBHAM,5$VGAS!8V2=ISD^U<5GYOC\G7@YD6B'BCP*S+T5ZVN118OF M2NR/Q]^J4+&/B;H_Y@Z9PE-=>,9OSD4M\-'3\W?"97]HFXK\(5NS0:R[10:A M]CLBC&)#=&P'?O5%[U/,D7=RR!B?ZN*S^::J*H^+D&L1R2E'U::;G1K#Y&T. M:A.JB1&G>`DG/@E#A,0<43MECD]U\=E\\WVGM(CLE*)/=VB;K]_KG&6?#CLU M2IB(4SRG?-=SETY-/;)B,T_,\2E'E$YG\TV-4]/S58CL%+Q`^.T+S4;1*)Q2 M'MK,(H=1FKXH-B,)1_@OV>B#XO@*I1*"EBLS/R+7(K)=M&T5BI4AGUB3*]8H MC^"FP&$02Z7V*I80Y8:>2(A2)940I4HF(;[CNB1`6T[.$9R:LDNT M715<>NS;-YS]X:3R\&%%Q*&IH/OPL=-9V,6$&./;-G2)J+E)'I!))48IDTD( ML4-8W1"U,?1(DTZ+C4;]X9<=6;+#N*;JSE5<7:_]JFQ?Z7$DM7J^.A^5?G+H M<1.Z'I$]')PMKR=D#Z=CR^L9'+F.US>S$)QXWHMS]5O1G>M;O[I6)QB"O:8= M2\?.3-D/0WL?CPQ?V@'..L?_7N!LNX*C.GL-\*EMA^D'>/!F/BU__A<``/__ M`P!02P,$%``&``@````A`#O7H_I5$P``.&@``!D```!X;"]W;W)K&ULK)W9;Y?OOQX?GS^^/9M/Z?J^.CU[>[YX]WC]OGS?OC?S:OQ__]\+__\^[[ M]N7/UR^;S=N1:'A^?7_\Y>WMZ\WIZ>O]E\W3W>O)]NOF64H^;5^>[M[DGR^? M3U^_OFSN/NXJ/3V>%L_.+DZ?[AZ>CZV&FY=#=&P_?7JXWU2W]]^>-L]O5LG+ MYO'N3?K_^N7AZZMJ>[H_1-W3W?WDY$W:GM**_Y^O3Z5#1]>/?Q M0:[`#/O1R^;3^^.D<),TB]?'IQ_>[49H_K#Y_NI\/WK]LOW>>'GXV'UXWLAP MBZ&,"?[8;O\THJV/!DGE4]2N[TPP?#GZN/ET]^WQ;;S]WMP\?/[R)O8^ETLR M5W;S\9_JYO5>AE34G!3/C:;[[:-T0/Y_]/1@?$.&Y.[OW>?WAX]O7]X?ETHG MY>+YY55!Y(_^V+R^U1^,SN.C^V^O;]NGA94JI+JLEF*J13Y5R\7)^>59Z5>4 ME%(E\IDJ*99.KL[/RQ=7E]*5/Y-DA+5ZG]>3SEWI:$(^R!A8+:HL' M#FM!S6J^:*MBG3T#4U`CFB]IE4O'G_9552L:]_W5GJI!"O+EP)Z*[>S`Y$8\ MM*=JQ$)NQ=*O^WM!;5HT46_#ZE`W*FK M:@=W68/-Q%;6Y;W>5%2SFB^_V%,U;S&WT<$]S0SC1-M^OR]IF)DOO];3DIJR ME)OCT)Z6U![FRV%C6M(P,U\.ZNFI73)V*U#U[NWNP[N7[?EXZ]?[\PN MH7!CM.G:8X,\6XU^M!C)*F2T)$;-^V.QL"PSK[*$_O6A<%8X?W?ZERQ[]ZG0 M;43(EZBHA%GCC-YJ"&HAJ(>@$8)F"%HA:(>@$X)N"'HAZ(=@$()A"$8A&"O( M1_&RZ(_01$5TA*8AF(5@'H)%")8A6(5@'8(DL[AV),G,FQ&8,X$]$Q@T@443 MF#1Q;7HJGIRYLX3?O^'.1HUQ9[V46P6Y90+#5%1"JU1#4`M!/02-$#1#T`I! M.P2=$'1#T`M!/P2#$`Q#,`K!6$$^0(6+P'551$=H&H)9".8A6(1@&8)5"-8A M2!*0S+S:M03F3&#/!`9-8-$$)I5?$KEO>:XKL_^_X;I&C?P`V#\36Z%+B>IL MOB[YUJID(CHF59`:2!VD`=($:8&T03H@79`>2!]D`#($&8&,,_+#`9MD(CI@ M4Y`9R!QD`;($68&L09*$Z):(=DYHZ(263FCJA+9./&-[[BY[C7_#W8T:V;O( M1^;)D9V'E=KK[YF(FJ\*4@.I@S1`FB`MD#9(!Z0+T@/I@PQ`AB`CD'%&\F$- M)HA))J(#-@69@WN.+#_R?L&1C;3OR);(7*R74@&I@M1`ZB`-D"9("Z0-T@'I M@O1`^B`#D"'("&0,,@&9@LQ`YB`+D"7("F0-DB1$MT0T:T*[)C1L0LLF-&WB MV=9S4+EKY#GH;][2,&I\S[7D4C[<*?C2GTXJF93Z=Q6D!E(':8`T05H@;9`. M2!>D!]('&8`,048@XXSL&[-))J5C-@69@/;V/-SD9#T7WS\'[\1]5TZ1.PL358EJ1'6B!E&3J$74)NH0=8EZ1'VB M`=&0:$0T)IH038EF1'.B!=&2:$6T)I+DB/&.]\>.;24]0E:)L(C%)4G"NA&; M2Z*$2G[^:_+/9(;D)IW/';<&B<**^#B;J7$QK5HEJ1'6B M!E&3J$74)NH0=8EZ1'VB`=&0:$0TSI$[<9>"Q-,D%],QG!+-B.9$"Z(ET8IH M321!D/F`=DR"@*P281$OD"!@W8@?2!!0SO<$/PA,/L8-@I],Y#9]X_FZ14ZP M5\QA&S_^JT0UHCI1@ZA)U")J$W6(ND0]HC[1@&A(-"(:$TV(ID0SHCG1@FA) MM"):$XD/PY#BPV01@TNNFW(1DTN^FW(1HTO.VY7S?=CD=5P?_LW]MCGP%6RX M4Q3<]"B>A1-YFEFZS):`:EY3P[]&5"=J$#6)6D1MH@Y1EZA'U"<:$`V)1D3C M'+D3>3B&DUQ,!VQ*-".:$RV(ED0KHC61!`&,*T%`5HFPB!?(1,ZZ$3^0B9QR MOB?X06`R.VX0_&0BMXD@;R)';J@BQ9C(@6J4JA,UB)I$+:(V48>H2]0CZA,- MB(9$(Z(QT81H2C0CFA,MB)9$*Z(UD?@PK"8^3!8QN$SDE(N87"9RRD6,+A.Y M*^?[L$G]N#[\NQ.Y32%)0SJ5W)H3N69+XM\Z*0;)L$HNIC6K1#6B.E&#J$G4 M(FH3=8BZ1#VB/M&`:$@T(AKGR)W(2V%F/!?3,9P2S8CF1`NB)=&*:$TD09#Y M@'9,@H`LX@02!)2+N($$`>4BCB!!X,KY06!R26X0_&0BMZDGS](ZD0-HB91BZA-U"'J$O6(^D0#HB'1B&A,-"&:$LV(YD0+HB71BFA- M)#X,JXD/DU4B+&)QV8RP;L3FLAFAG&]UWX=-MLCUX=^=R&W6R7/N+!'E3D+% MX+9`I9")::Q7B6I$=:(&49.H1=0FZA!UB7I$?:(!T9!H1#3.T;XQG.1B.H93 MHAG1G&A!M"1:$:V))`A@7`D"LH@3R$1.N8@;R$1.N8@CR$3NROE!8-)/;A#\ M9"*WV2K/UY'`JICG=?Q9NTI4(ZH3-8B:1"VB-E&'J$O4(^H3#8B&1".B,=&$ M:$HT(YH3+8B61"NB-9'X,`PI/DP6,;CX,.4B)A6N_(FH6`W63&/F-F-NTY"5:(:49VH0=0D:A&UB3I$7:(>49]H M0#0D&A&-<[1O#">YF([AE&A&-"=:$"V)5D1K(@D"&%>"@"SB!!($E(NX@00! MY2*.($'@RGE!8!YN]()@_T2^$_>3G2ER=^1$5:(:49VH0=0D:A&UB3I$7:(> M49]H0#0D&A&-%>V>.M\]"C46OK\&SF]U<3)7UB/I$`Z(AT2A%3E_'1!.B::[+ZWXPU+-<3+L_)UH0 M+8E61.L4R8>JE["PKA(Z03"P$BJ97%;7<:",1;Q%GD!CW8B_R%-HE%./D2)I MPP\5DVA"J,C#\>+.)E*FVZ^[2-G]X["PL:DK+VPL*N4/65;,L^RRTRF<%W9/ M$)<+%Z7@P$#5$=&1J:6LE.>>ZD0-IZ9Y/+E<*%T$3M)T1%1Y2S7EW6P3=;*: M<@5NQ`>/9W0=.6VAI^KR[O>)!D[-?2T,'3EM8:3J\FL8JU@^-TQ25"YE/CQ5 MJ7,S`4;';.:(:'OSE%G/VLV;"RI?.C5WRL^NKP-KKQP15;ZF<@DUZSA.UR6L MU)E^V'=YR#.74?WRG*>%3N\ESMB`^EA!!X?]E[B+-*!N%@L\D_!"X)WG:Y1& M7F2-DCWK, M.PRF*;K.1W5&-->*>9`N%.6ZEJRX(EIKQ5R7Q(@=,'$3[:O$B&5.SR0FR*I: MU]&GCN'J4\]P]:EKN$Q]H[C3YR\])C461D#I+(^`PY8;FV#S`L`BQX\KYOTG MXNU7N0M5B6HI+Q7EC:T4V<8*%R?D`&U2_E(Z9!@NEDW#[ MJ6[ZPP;]\#1)NS`\"[^^0-G?*+RH1HFB)G@9HIRM>!N:)\>E]0UU*E\L5NI2C7 MM5:4ZY+HL(9T^BK189G3,XF.E.7J)!Y2YNA3D[OZU.:N/C6ZJ,B"1*T>6WI, M@B_T[5]?>FR:T'/M%)GS>]G\Q=FR(GTR_NY<5C5%A?*%W8`'T5O3(FJHL;8P3<4LE]C?7INX.43=%8ATS-07[NYZ6NF.&"^M3[8!HJ+IL2^7K MD^!YH9$*[&ULG$J%BUZ@;*+*\FW%-$6%LSQ:9RF[$O]VG2+X"31/Q7XX/:<_ MKZSK..O/,M+F*F_3#/FYO"8Q7.ZLGOVM24"C.0EHR]QKE(BV4"YRUZ`L%'Z# M$M\'M:B.[ER@K'>1%M6OTQ8+9:RPZN8_O$9_P3/)S7!2^(T%S^9(O5G!HI]X M4Z5HQ>1#Y[!JB@IR9VFWJ%^?!%NA6BKAZ4;PU*FZ0=1T6MOGJ*V#VFRS@0Y1 M5Y'=M<@V";-#.BJ2MLN"!Q?85S7YV`V(AHK2+=)9.)HC%=C;V#B56+Z$Q1ODK-%>6+WH*ZEBJ5ZUHIRG6M%>6Z)'[M\#E]E?A-AS37)N&;LER= M!&S*''WJ;ZZ^S+L1;^,%L?U)B$,EJ34,:522A;EE[:53%<^B6PK<3^JY-?GFQ0W=BY/KGUZ358 MO#P)0D1>A/>3!OW)P"2G,1G\OW(2-MWM30P6.>%8$3/NYH!R[CE59>=GUD_* MX9)14XG]D5A/Q9SV&EK3:<^\>WS7!VTO\,N6EN]OKTT-U26-G>!VS^C@YH;IU+."8,)T91H1C0G6A`MB59$ M:R()6CLT3E\E:,G4^5PY=3Z7J;NY3'W+9>I<+E/GLLR&G'U1O7U-\-/FY?.F MLGE\?#VZWWXS+Z$7R0_O,FQ?D2\GB.4=^7)$5M9P%%V:HMTLBZ(K4[2[OX.B M:U.T"[JPJ'@F17*8(-)6T=22D8P4%4PM>3XZ5F1>\"]/C<:*BJ9HMX<)NU$H MF:+=U@!%95.T>_@"1>>F:+-.:O*7LBQ."F)#9.<%9*2V/7*"8P; M<["$VL:F<]&^F:[%>C8VQHW:UI@VUN.Q,6RLPV-CH&A_"P6YDI@-Y'E+*8F9 M0!Y"DY*8!>31'BF)7:0\[R`EL:N44^12$KO,6ZD2K2$5HO)BR-BHW(H98X-R M*T:,CXG8,.JR\N-7O,_D5FA?\^M)*EOZ%"N1@R`WYF1&9#SD)(89JUB99+AO3`J; MM20]+?IB)3)5RP"8W#%KB5VDS*1]629Y0&DK-@R2U9.V8B72EHR=R'X]>MQ\DA75 MIC=?[!]^27.=Z1&;/[9O\O=:=J=MOLA?Z-E(/EE^*AP??=INW_0?TO1I]C=_ M/OR?`````/__`P!02P,$%``&``@````A`$!?C$QL"```"2<``!D```!X;"]W M;W)K&ULK)K;;MLX$(;O%]AW,'Q?VY*/,9(4L<[2 M+K!8[.%:L>5$J&T9DM*T;[]#D91)_HIK%7M3-Q^'0_+GD)Z1=?_YV_$P^)J5 M55Z<'H;6:#(<9*=MLTYK^+%_&U;G,TEW3 MZ7@8VY/)8GQ,\].0>UB7M_@H]OM\F[G%]NV8G6KNI,P.:4WSKU[SW MN#NFY9>W\Z=M<3R3B^?\D-??&Z?#P7&[CEY.19D^'VC=WZQ9NI6^FS_`_3'? MED55[.L1N1OSB>*:[\9W8_+T>+_+:05,]D&9[1^&3]8ZL1?#\>-](]`_>?9> M*?\?5*_%>U#FN]_R4T9JTSZQ'7@NBB_,--HQ1)W'T-MO=N"/`^S_.6UINV>TXK8PM:[[VY6;4E1+T7PYF5ID/GC.JMK/F'DRL=IZ+C MK.UHDX\K'6A.S73I4XQDS48S>[Y<-?.]TG,A>M*GZ+D8K>;SV6*U)&=7.BY% M1_KLMS@Z8LU<[]J./UB<1;O/-X.%@1#ZQN59[4;2?VY:X)A'0A-8;EJGC_=E M\3Z@TTH.JG/*SKZU9FYE2'&-VB#[*,8HN)B7)^;F84AR4_A4=#"^/EJ3N[O[ M\5>*YJTPVG08Z1:.M&"AR_RZ)O!,X)L@D.`RE:6M#Q-*$SE,9(+8!(D"QB1= MJQ]%\/^A'W/#]),SVDAP686Q"$=:R"ZN"3P3^"8()+B,8BT,K:2)'"8R06R" M1`&:5G0!@%8S.H_=UY<,+=:++BHUM*S)1)_EAALM:9?:`)SJ)DYK(E?B`O&` M^$""EGPX5-B:R*$B(#&01"6:;G1A@F[LVN]Y1ID;.N;TT6ID61-+EVG#K:XJ MV9K(Y;E`/"`^D*`EEPD9FQ:V)G*H"$@,)%&)IB2)!DI.Z?[MJ21STR@I9[7A M9*E>@//E3)?6:8UD-Q>(!\0'$K3DHAL,%K9&HR('>-,,O9:&Z*(PSHH]T">V$8!=S(NKY1(;=2 M-BH"$G/2O5&):J[)2;EC#SF9M2ZG(,;\ET:@<2ME_BX0CQ,Q_\EH:OCP1;NZ M<2BG,+IL7`@D`A(#252BZ<52Z!Z"->:Z8@(9$;@R%!-6:@@B\B3B06@D*+YL MID@\C`TUE-!C7#%3(`@4!K0"![U8X8(HH$LB;\&1U[T!%WL$3KJD<02U95(7[VL0U/ M>MDFM*>7:D+C41Y;>JBM>K`HNGPYI8'"F%BR.L%.0B\A#YB`)$(:((48PHT9`N M`TM;>\C`LUQ-!H'85^PE:*!PM+B9<@N[B#R!NDL2'SL$`IG?`4;9&F+/"%$L M4/?HB=9!$]'NE^$WYGJR)9"1X1L)M2.LE"]Y%Y$GD2@SYR/+>'CF2XOK6;ZT M4BHC1!&B&%&B(5V[?OFZC?FZ1$8`&IFD(\S4`$3D"233@)'Q<,R7[6JP8TTI MK,RH-/8SQ/$C1+$<4A1(N)^)M/AH4KK@9-7CQ+/?AXS*0"`C6(VTRQ%66K!R M7PKRI%5W.2I;?Q"HX#:4'2^Q&R&*$24:TG7K5Q786!4(I-1*#B(7D8?(1Q0( M9`:=<0Y"8::<@PA1+-!'YR"1[21]>^FKYT"7CJ7SMW_)V#S[5[]D!-*D@QK! M12L/D8\H$$@)S!!1A"A&E&A(EX$EYSUDX+F\)@.D]P[MD%$$N(@\1#ZB0"`S M@HR3'0HS+8+X+!04"ROZ8(^!C0=-B6R]+7[,.N)ZKD;O-L"5U98&,H%TA)42 M4BXB#Y&/*!!(+:@010)I!54'8^]FL/ES;SR"^+L6_"?Q8U:^9$YV.%2#;?'& MWJ.83DGC%O.7/*@Z6;,B@M8++4MJ:6Y&:%E12U,5&BU/Y.V)YH7>J.I:L^*H MJV5)+5WC;*P5M72-L[&G:W:W=7BS9]32U,C&W#;VG%J:(A5::&X?S)J\\9-E M]K'(&Y6T.(-@MJ:?[#KX?$T_2'5PVH`N70*2OU,5FE*7_PU-J,O_AA;7Y7]C M6;2"YM$!K,VF%KMCKO3$BEJZ=*?'`&M6]N/Z*)[7<:>Z](+14_ M2.KB&YINEY_`IA>8.OQL:!%=:PBF:_K9&E?P-%L_\:6-6Z7H1:1S^I+]GI8O M^:D:'+(]';#)B+V04_)7F?@?=7&F%)Y>1RIJ>@6I^>\KO7*6T5.2R8B,]T51 MRS]HY''[$MOC?P```/__`P!02P,$%``&``@````A`(`W;;<3#@``,T@``!D` M``!X;"]W;W)K&ULK)Q9'V[J__DG^>NZ7CL%ROCS72\'RXJ3\>CR]!HW%8/:ZWR\/5[F7]3"7W MN_UV>:1_[A\:AY?]>GEWJK1]:K2:S6YCN]P\U[F&8'^)CMW]_6:UCG:K;]OU M\Y$KV:^?ED?J_^%Q\W*0VK:K2]1ME_NOWU[^6NVV+Z3BR^9I<_QU4EJO;5?! M^.%YMU]^>:)Q__3:RY74??H'J-]N5OO=87=_O")U#=Y1''._T6^0IL^?[C8T M`F;VVGY]?U._]8)%NUEO?/YT,M!_-^L?!^WWVN%Q]V.XW]QEF^F.YK=^O[Y;>GXWSW8[3>/#P>R=T=&A$;6'#W*UH? M5F114G/5ZC!-J]T3=8#^7]MN6&B0198_;^HM:GAS=WR\J?O=JTZOZ7LD7ONR M/AR3#5-9KZV^'8Z[[?^XD"=4<25MH81^OE\)-7?J"?T42GI7[5:G=_V6GE!8 MGY303Z&D==7SFGV_1VK/C*`OZM%/4<]K:JV?J>E)"[)?WC]ZSQ<]8+_\@1KI M"D_YXAUF]'JR-_2+Z$W[(D-ZT@/L%VG*GHHHM&2#1^0IP*/E.08&=I<117LOXMU"G*FY9:IN:EWZS4*XP,]H-\_LWCXU/A. M3]5*"`T<0J9$*"78(\3T1C:(;9#88&B#D0W&-IC8()5`#:?7,KN:21'9U=P& MA0U*&TQM,+/!W`8+#33(A94?:6KY"#\R-K42DF2(@,9`$R!#(",@8R`1(6A$U,"L8LTI$=CD'4@`I@4R!S(#,@2QT M8GB6G/@1GF5J3IZ5HQMPTM,7S([OF:X.*R%9+0(2`TF`#(&,@(R!3("D@O"T ME"W/&9`<2`&D!#(%,@,R![+0B>$V,JO#;5;3LF6I^2%Y[2 M,"6FTSCI75>K8P@D`A(#28`,@8R`C(%,@*2<>$U***LYQ/>NS;C*I)0:2"X1 M98!5Q8ZOEGK#O*0=S4L;&F'=?W8O9+>WF)HI-$W-29^IE`DEC",40BI;B1S5 M]%&<')L*H7[EQ@Q(KA-C[)1PP]C]I@HM.7A':-%>3\86TV(.F)-^K^I4""0" MD@H]'B4-E9TZOCVYFYS64_/#SJ^6FJ,(5-,.(;\6IK":IE#Y*1/;?^^ MKZ$04LZ)./'-:JJKW*=0+0.2Z\08(#,?C+!-L7?>B:=JYA`%TDP=(HH0I5(7 M^ZE9IV,]N5@SKVJ:OE2IKSE4DGK/4%DU:Z@<6>ZT.ARR_3I5[&O^%,ARJ.HO M=RA6S!#E!C('RI)N?6/[BB]YCD[)EUQK!QY'AB\!12B5"N19ONS9O@1E>563 MK*9%@9J_S2&RA/0-0^3YJS%$CBP?6AT-V6&)[4..+!^J?@H?0L4,=>4&,@?( M\C)]@.QPXH+GDJ=SQD!%AJ=6O)"*V:BTU3Q"%"-*$`T1C1"-$4T0I0+9T=.W MHX=W7XO.O*II1H]ZLDSCTOSV'N.R:M9,P)$515:'0[8ALJ.((RN*5']%%$'% M#'7E!C('RG(;.XI>WV9[(B729P2.-)N'0DI#$:)4ZC)GA';3]BGHSZN:AD_; M:J=@#I6E+>\8*L]V*'[4Y"<2(&/5M3L6("D0EHBFB&:(YHH6!3-.RE$DW[2OK"1.W'A..M`DG9,>W)*6A"%&,*$$T M1#1"-$8T091*I+M'=%6A'*4*1"6B*:(9HCFBA8%,][#D3G?/>\^Q>9+(IM)J M`:9#&"NM&;"3QL!7CCB=M)C_F4"F2>S+3MQ4Q)2?M$B&)$ M":(AHA&B,:()HE0BE6YGB')$!:(2T131#-$&+M.[;(_S`=-RB^^5]`Q%(,UD(:)((--D'2OQBI64 M'%."NH:(1JJB9C);_5A)2?43U)4BRA#E2I?68M1S)275+PQ=9@RP7>!'Q`#?31HQ(+:AZK$)6X`B@:P84"GT*26-E90<4X*Z MAHA&JJ)FLHZE?JRDI/H)ZDH198AR@7K-TXOVMN>C_[D52$*V5J*>*:*90*:M MNM:)P%Q)2?4+0Y?I?[931?^K(].+3N-;?+]K>)\C8P8`%(F*UWUAK*YO+>:Q MDI"C20325`\1C51%=N&A[;5ZUG,X5A)2]03UI(@R1+E`O5;ETP)1B16GB&8" M2:,T^WW+*',E(7N^,/28+F9;]',NONQ4G%V&LM=PCOCEKM.#&@HI#46(8D0) MHB&B$:(QH@FB%%&&*$=4("H131'-$,T1+0QDNLU],O+6)Q,/2EH<=6D64HE* M1[U-$H[D4BWUSB,2%;VF?@S>OK9RD%B(77=/S[1WW:3_S+.41(AHRH>(1I>U M-WZ]O0DJ3P4Z;X4,*^8"O6*%0H@)*[3::(42E4\1S2YK;VZVY[+ZPE!NQAH[ M\?F`*8(?'!G+`$>4@,B9*B2OLXE$0Y%`/;^2BA$E6'&(:"107ZVN8T03@;1Y M*D5=&:)<(*VK!:(2*TX1S032NCI'M!"(=]5T&SOV.>>VRQ9O?GAD>(TC:EEY M#5#4XNB:_%E-)([I0$A=GYD.A&[U`F`H=&L]&%W4W%A*_;ZY">I.$66((*WIZ$=A1BII8(X&\IGKM$CM8(JNJC",52+-LABA'5"`J$4T1 MS1#-$2T,9!K[M>WK9?-[M7N5VY*!SY$6U"&B2""O28ONN162*^OP*?:ZBT>! M"2I/!3*\P15I*$>I`E&):(IHAFB.:&$@PQMDK8\(_9,:+O>/ZS# M]=/3H;;:?6-?RW?9!Q$5YI_R4U`&+`#H.;%+VDWYE;]5N@$E??Z-T_ ME;C:H4M)`;N:@#V@NTG!V-D.W5BA$E<[=*.!2ES:Z,(2.=150F_6`O8JS=6# M'FESE0Q(V\"IC>YP!:&SA*YR43LNN]$%'RIQC83[4GM;WM$CQ;_OV_(^^B`_]Q`>.7W9'^F,ME$?0G\V@ M/\ZSIB]BF^PKR/O=[BC_P1JH_MS/Y_\#``#__P,`4$L#!!0`!@`(````(0!1 MPDU5"'```'"]`@`9````>&PO=V]R:W-H965T?_Q;S\]_S]_R?[K]?-G7[Z^^?C+F]\_?7SWT_/_O/OR_+]__M__Z\=_??K\ M]R^_O7OW]9GV\/'+3\]_^_KUCQ]>OOSR]K=W']Y\>?'ICW//^X_-E#S]\_C/[^/3KK^_?ODL^ MO?W'AW[MP]O_\SN/KSY_/=__/%?;S]]^$.[ M^.O[W]]__<]YI\^??7C[0_FWCY\^O_GK[SKO?^\.;][:?9__#W;_X?W;SY^^ M?/KUZPOM[N5RH#SGNY=W+[6GGW_\Y;W.8![V9Y_?_?K3\__9_3!=W[Q^_O+G M'\\C]'_?O_O7%^^?GWWY[=._\L_O?ZG??WRGX590:LAU6Y> M[&_F/;W]]+L.0/_[[,/[>6YH2-[\^Z?G!_W@][]\_>VGY]>W+VY>75WO5/[L MK^^^?,W>S[M\_NSM/[Y\_?3A_RU%.[.K92>J/.]$?YJ=[&Y?'/8WKUZ?]_+` MEK=F2_UI?_SUG]ORE=E2?]J?N7^Q?WVSN[F=C_R!GWEGMM2?9DN=_`/U.X5R M/KWY'^Q1_KF#W-GAW5V[39\^OCL=X'($+J:[%Z]O;@ZWKU\]?++S7%@V=>%< M_\DAWMDQGO_!G/C^ZL$S?[E,K_-L3=Y\??/SCY\__>N9/@,T$%_^>#-_HNQ^ MV&GD[3Q=QGV=N=^:N)JQ\U[^9][-3\\U6S0GOVBY_?/GW=7A]8\O_ZDE\M84 MW6\4A15'6S&OAWF_20QI#%D,>0Q%#&4,IQ@J"^YT7NW#0ZUMB3W4)H8VABZ& M/H8AAC&&R8.7BG#-@AN):"".ML)NDL20QI#%D,=0Q%#& M<(JALN".='<;969+[*$V,;0Q=#'T,0PQC#%,'@29Z;,':^]:GV7;UPB[U.:M M=#5X>*DM1:\T6]8%>1T.QG$ML:.10%)(!LDA!:2$G"#5*M\\Y'HML8?<0%I( M!^DA`V2$3+X$.>K#'SG.G^]/_`R==Z./8?VQ9J8/T;LPMONEZL%DUQ([3`DD MA620'%)`2L@)4JWB3BR:C/5:8@^Y@;20#M)#!L@(F7P)DE6(WR/9>3?G9.W9 MW2_R2M?O->O]/KI>'MB^Q!-Y`6 MTD%ZR``9(9,O09*Z-0F2?/@S=JX.`UM$R\Z>UA&20%)(!LDA!:2$G"`5I(8T MD!;207K(`!DADR]!%)KT013S+>>=+GM/_+B<=Q-FM,@K_6!O446?G\>UR`:9 M0%)(!LDA!:2$G"#5*NZ@#_$G0;T6V8-N("VD@_20`3)")E^").=NQ7=X>)AW M@PO?S57XP7*_5#UXX5M+[#`ED!2207)(`2DA)TBUBLLVOO"M)?:0&T@+Z2`] M9(",D,F7(%D]"7Z/9.?=A&MTD?#"=[,+HSZN1790$D@*R2`YI("4D!.D6L7E MN(\/NEZ+[$$WD!;207K(`!DADR]!DG-S)(CRX2O?N3R,S)!_[2,EI)24D7)2 M02I))U)%JDD-J25UI)XTD$;2%%`8S_Q`'W^&7G`UG#M:T5(S%%X/;^+'=U=E MYVU"2DD9*2<5I))T(E6._$47'7WMJNS1-Z26U)%ZTD`:25-`8;KSH[^?[B.+ M;^D4Z!'0GLW];J%@\8$25J6DC)23"E)).I$J4DUJ2"VI(_6D@322IH#">.9' M>C^>2[N?2VL@R,UT"X*;T9OHZG^;37_NQD MNY][;//JN5OI2$I(*2DCY:2"5)).I,K0_`V+>S:].83WO;6INMZO)]1L;7C8 M1P^U+3?LMC;ZN':W:*'(GPM796=OR=+R_>_\_==E:&];MK7P=_?W,3S!*?=;&UXN(X. MHK4_T4VP;FO#_4TTP7IN.%@Z+\AP4LP-`TP*?;UJYL1?/OUQGA-/F"!+"R*8 M(`L]/%+'^1M2?40$$V1SPZB-F7+#S%#T$Z.1RKEA84F7#A?JK5M1YT50NBHW M0!5A7 M_]*%",(UY*ZRQQTH(:6DC)23"D/7K]:/WI)T,K1W5]G*T*UNREVX5WA.68Y^ M[TZHL1N&'QO1AJW]B6[#SFYX.'_/?KBZ/437D9X;#7:C>=CUY?SZ@1(&.G<1 M&.CFI[1@NDMOMR MNV_LAN%RC*Z\+3?L[(9VXMV]CJXE/3<:[$8/+D=]S#PI.+:`SGLX+S!_LD:C M<715=A@31_Z&T6BDKLINF%GZYFCDML);AJ32TK>6H?WW#R]#4^4O0U)#:DD= MJ2<-`87+<&[;^!^NCRS#I[7*KNJ$D?^AEB.V#"S&WYS5');X2]' M[*>T5IFUV="CAM22.E)/&D@C:0HHC'SN]CQAS2[- MH6#-+A2L65"R!Z6DC)23"E)IR5^SRT\,UNQ"7A:UV="CAM22.E)/&D@C:0HH MC&=N`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`PG3G!LCW2'=II"A=-QBZD+JVXOD&_OYZ[;>X,N2]UM@12]QFEE)2 M1LI)!:DDG4B5HV\>>^UJ[($VI);4D7K20!I)4T!AVG,CY'NDO314@K6\4'@A M]=K*Y_R/UVN5'9^$E)(R4DXJ2"7I1*HU\`-T-H$<=-W'T_? MH]G0[_V04E)&RDD%J22=2)4C=_2'Z^@;V]I5N<6WGK:EEE4=J2<-I)$T!12F M^[3>SS5[/X:\E78D):24E)%R4D$J22=21:I)#:DE=:2>-)!&TA10&,]6[\?] MOI(__4L_KMG[,13V?N+I>W15=JXFI)24D7)202I))U+ER%]\T=>LM:NR1]^0 M6E)'ZDD#:21-`07IZF6'\*/UX2O?N3S\UL.0O_A("2DE9:2<5)!*THE4D6I2 M0VI)':DG#:21-`44QK/9O[G2C(J^C&9S8*ETRW+/F M=?0>0F6JPK4#\&X36U9UI)XTD$;2 M%%`XW',O(+YG/ES=S>_5/S+@2Q?!?[HY&/('W%`PX(?H>YO$;A@.>-3;J$Q5 M,)F7W7O4L*HE=:2>-)!&TA10.+KSHV0\NOM7CT_F>;OH^FG('UM#X=A&S]3) MP52%8QO=_%>F*IS,\:]+J%V5F\S+[H/)#.JX84\:2"-I"B@<;HT$AGMW\_AP MS]M%PVW('VY#^L-=X`ZX#)JJ<+AQ&5RJO'E;'T`-J25UI)XTD$;2%%`XMCJA M8&P?^728RZ,A7<@[Y^,!E)!24D;*206I))U(%:DF-:26U)%ZTD`:25-`83SQ MT_&%O8\#'YL-S7T7;]Y']R-'5V4_&A)22LI(.:D@E:03J3+DS;J:U)!:4D?J M20-I)$T!A5'&3]*/K#0^,!\6\L[Y2$I(*2DCY:2"5)).I(I4DQI22^I(/6D@ MC:0IH"">^7(2?!!>N-+.^PD_(0V%%^'XX>CHJM:51DI)&2DG%:22=")5EEQO MNR8UI);4D7K20!I)4T!AE/%C\\,K[89/RX;\E49*2"DI(^6D@E223J2*5),: M4DOJ2#UI((VD*:`PGJW'[`OZ^3=\[#84K;3HV>WHJMQ*6_;EW>ZFK,I(.:D@ ME:03J;+DKS1S7(X:5K6DCM23!M)(F@(*HYP?>?T'H4=6FGE,]U[X$ MCZ2$E)(R4DXJ2"7I1*I(-:DAM:2.U),&TDB:`@KCF1^C_7C.#2T]QCWQF[,; M\[3OYV:>T(.[Q_C!\F@V])950DI)&2DG%:22=")5EMRLJTD-J25UI)XTD$;2 M%%`8Y?SP_3VB7![BX_=-HN["_8UYUM>E<7TXB&J.KL9]C*Z;64I9E9%R4D$J M22=2Y>B;QUZ[&GN@#:DE=:2>-)!&TA10F/;<-/@>:2_-![^9=[-0^+[)JZAO M='15=GP24DK*2#FI()6D$ZERY++=QT=?NRI[]`VI)76DGC201M(44)CNTWHN M-^RY&`KN3]ES855*RD@YJ2"5I!.I(M6DAM22.E)/&D@C:0HHC&>KYW+!5][Z M3\;$O3)#X?WIJZC7>'15=OHFI)24D7)202I))U+ER%]\T='7KLH>?4-J21VI M)PVDD30%%*;[M#;,#=LPAH+%A\Y,PJJ4E)%R4D$J22=21:I)#:DE=:2>-)!& MTA10$,_M5AMF_FK@X2>+\V9AU\70_&K+>@NS?Q5U[(^F2M_!V]F:;&\8-4:K M[:IH]S5WWVQOZ'8?#L?36AFW;&48TK?>]@2/AO3W\2PEK*I(-3=L@JKPT+<> M\^>3?R1)/M7/OQE"7SI$24;?B1]-59#DYH91.Z#Z4[NON?MF>T.W^W`XGO:H M//]2B^B+%D-!DDM5D.1"7E7%#6M#WH9-4!4>^M9CY)]8DWQJO%TH3/)U]`W\ MT50%26YN&'W?7/VIW=?B?Q[\%L\)AU)"2DE M9:2<5)!*THE4D6I20VI)':DG#:21-`44QK/U['1!>_&6STZ&PMNWU]'[#$=7 MY3Y>S4.7^]V]*:LR4DXJ2"7I1*H<>1?$^.AK5V6/OB&UI([4DP;22)H""M-] MVK/3+9^=#/FW;Z2$E)(R4DXJ2"7I1*I(-:DAM:2.U),&TDB:`@KCV7IVNF3Q M\=GI=J%H\<5-*5=EIV]"2DD9*2<5I))T(E6._,47'7WMJNS1-Z26U)%ZTD`: M25-`8;I/>W:ZY;.3H6#Q\=F)52DI(^6D@E223J2*5),:4DOJ2#UI((VD*:`@ MGOD%M.#&Y,*OL,_["1^F#$6++^X:NBH[?1-22LI(.:D@E:03J7+D%M\A?H>Y M=E7VZ!M22^I(/6D@C:0IH##=IST*:HG%#Q"&_,5'2D@I*2/EI()4DDZDBE23 M&E)+ZD@]:2"-I"F@,)ZMQ]T+KGRO^/QK*%I\4=_MZ*KL]$U(*2DCY:2"5)). MI,J1O_AE$JASYBR]JG=6NRAY]0VI)':DG#:21-`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`PGN_4K'G-9HVA^1[+6WS1?>#15=GIFY!2 M4D;*206I))U(E2-W](?X[W77KLH>?4-J21VI)PVDD30%%*8;-VLNO(M]O79Q MW&#H+C9JO-V;L@?O8EV-';&$E)(R4DXJ2"7I1*HZOU<V!/[+*^7IH@_AM1AL*KYIU[`6OY+9BN MRJTT-%125F6DG%202M*)5%GR5YHY+D<-JUI21^I)`VDD30&%4<:-GH??87N] M]G/LP-\;"E;:4N51PJJ4E)%R4D$J22=21:I)#:DE=:2>-)!&TA10&,]69^:2 ME<;.S&O3F='\=/>G=_$[;*[*!IZ04E)&RDD%J22=2)4EMZQJ4D-J21VI)PVD MD30%%$;YM#;,:[9A#'G+ZDA*2"DI(^6D@E223J2*5),:4DOJ2#UI((VD*:`@ MGKNM-LP%7]N?]Q.V80Q%U[3H[OKHJM:51DI)&2DG%:22=")5EKR51FI(+:DC M]:2!-)*F@,(HG]9SN6//Q9"_TD@)*25EI)Q4D$K2B521:E)#:DD=J2<-I)$T M!13&L]5SN>`Y[8X]%T/12HN^;3JZ*K?2EGUI0TLIJS)23BI()>E$JBSY*\T< MEZ.&52VI(_6D@322IH#"*.,&R\-WCW=K'\6.\KVA8*4M51XEK$I)&2DG%:22 M=")5I)K4D%I21^I)`VDD30&%\7RGCL@=.R*&HI46=<2.KLH&GI!24D;*206I M))U(E26WK&I20VI)':DG#:21-`441AEW1"YL9E$JAQ]\]AK5V,/M"&UI([4DP;22)H""M.>FP9Q M@^622^32?/`;+'>F'Q%\)W@7Y7]T579\$E)*RD@YJ2"5I!.I_0-J25UI)XTD$;2%%"8[M-Z+G?LN1CR+I%'4D)*21DI)Q6DDG0B5:2:U)!: M4D?J20-I)$T!A?%L]5PN>1)DS^5NL^<2O0)]=%5V^B:DE)21NRAY]0VI)':DG#:21-`44IONT-LP=VS"&@L6W5'F4L"HE9:2<5)!* MTHE4D6I20VI)':DG#:21-`44Q+.[VNK#7/`&][*CL!%C+;IKC5^(\#A$K=O:*[.GT6Q8NV'=AO4;-FS8N&%3:%'B M3VO7[*[8K['F+<#CABG%95NO3BG"E"),*<*4(DPIPI0B3"G"%!E,D<$4&4R1 MP1093)'!%!E,D?D61;;5PKEHD;*'L[M:>S%N=N_OXA=GO#([NQ7ONJDUQ0M3 MO##%"U.\,,4+4[PPQ;O:`Z>AQ-\A*'*;$84HG97;/58\Q:?%BF;/1NF%%&G%&%*$:8484H1IA1A2A&FR&"*#*;(8(H,ILA@ MB@RFR&"*S+ZNV/ZQ%EQ)KZ_B-V*\,CN[M4B7W?F]U@U3O*A3 MO##%"U.\,,4+4[RKN46*TU#B:YD]#24.4^(P)0Y3XC`E#E/B,"7N6Y1XW"1Z MN!VK5]AL,\B>UKVU<)&RT[-1IT6*.J4(4XHPI0A3BC"E"%.*,$4&4V0P1093 M9#!%!E-D,$4&4V2^19%]IT[/[HJM'FO1(HU?IO'*[#30(C5M(N\+D0U3O*A3 MO##%"U.\,,4+4[RK^8LT.@TEOI;9TU#B,"4.4^(P)0Y3XC`E#E/BOD6)Q]V? M"SNYNZNU+^2&15,M>A[7BE[JM*)=7=S+]8KLX&D.K!M:TQ*':0[`-`=@F@,P MS0&8Y@!,>_C MTU#B:YD]9"4.4^(P)0Y3XC`E#E/B,"7N6Y3XTYI.NRMVG:R%%V;VG3;JE"+J ME"),*<*4(DPIPI0B3"G"%!E,D<$4&4R1P1093)'!%!E,D?D61K;;ZD-=LDC/ M.XKZ4,:""_/^.KJB'7>NS,[N9,/2#QK-AK4;UFU8OV'#AHT;-H46)3[W.[[#EVZ[W=(XT;=N;EAT88[:C/>V[N$+ ML]F9M^PU!_S.S/F-:,T!F.8`3',`ICD`TQR`:0[`-`=63,`IAD` MTPR`:0;`A@W3#$"=9H!OT0R8^Q_?908LC13_>]?=SC17=%^POF][?14U;;7F MUS([5,H;IKQARANFO&'*&Z:\8^`TM.;7,GL:6O,P)0Y3XC`E#E/B M,"4.4^*^18G/[1,_\4>>F'=+NR4,UF_!+'\_86?JPE6+.J4(4XHPI0A3BC"E M"%.*,*4(4V0P10939#!%!E-D,$4&4V0P1>9;%-G<__`CN_3Y:?Y\CG[-R,Y8 M<&&^OHH^S[1(_1[,.7(M4ICBA2E>F.*%*5Z8XH4I7ICB7[6G=[^8[-X6MOZAM32G" ME"),*<*4(DPIPI0B3"G"E"),*2[F?8@H,I@6*4R1P1093)'!%!E,D<$4F6]1 M9'/_PX_LXD6Z-%+"+!>;_]*]=R6-W_+=[=8R&[GBA2E>F.*%*5Z8XH4I7ICB MA2G>Q<)X88H7IGAABA>F>&&*%Z9X88K7MRC>N;GAQ_O8BER:(6&*ID'RVE^1 M,$4&4V0P10939#!%!E-D,$4&4V3&O/=&-TR1H4Z1P1093)'!%!E,D<$4F6]1 M9'-WPH_LXA6YM#G"+!>;?\^"MR+CMX%WN[7,6Y$PQ0M3O##%"U.\,,4+4[PP MQ;M8N")ABA>F>&&*%Z9X88H7IGAABM>W*-ZYD^''^]B*7#H?88JF&Q*L2)A6 M)$R1P1093)'!%!E,D<$4&4R1&0M6)$R1P1093)'!%!E,D<$4&4R1^19&MM_J M,%WR_>QY1U&'R5AT(QN_YKMS96Y%TM*-NFS#\@TK-JSHW<+QV',,O%HFMD]&V=XEW+;.2*%Z9X88H7IGAABA>F>&&*%Z9X%PNND33% MBSK%"U.\,,4+4[PPQ0M3O+Y%\1ZZ1^Z4)$:9H&A-N52DRF"*#*3*8 M(H,I,I@B@RDRF"*#*3)CP8J$*3*8(H,I,I@B@RDRF"*#*3+?HLCFKH`?V;PB M+[I&+NV%,,NUY>#?M49M>L6[EGDK$J9X88H7IGAABA>F>&&*%Z9XC07QPA0O M3/'"%"],\<(4+TSQPA2O;U&\Q%;ET',(431F>&&*UU@0+TSQPA0O3/'" M%"],\<(4+TSQ^A;%.W<0_'@?6Y%+QR%,T70A@A4)TXJ$*3*8(H,I,I@B@RDR MF"*#*3)C060P10939#!%!E-D,$4&4V0P1>9;%-G<%?`CNWA%+NV%,$O3)]FN9MR)ABA>F>&&*%Z9X88H7IGAABM=8$"],\<(4+TSQPA0O3/'" M%"],\?H6Q3MW$/QX'UN12\OR"U1MZ&U=*,NV[!\PXH-*S?LM&&59]\\B=HKL@?<;%B[ M8=V&]1LV;-BX85-HT028>PS^FKUX`BS-BF`Q7YL&AJX(WD:^[LW7*&Z:\8&&*%Z9X88H7IGAABA>F>%?S%VET&DI\+;.'K,1A M2ARFQ&%*'*;$84H2VR@ZA&;`6F1/0C,`IAD` MTPR`:0;`-`-@F@$PS0#?HADP-S:^RPQ8.B3AFC==D_#"S+S7,CM4RANFO&'* M&Z:\8F.*%*5Z8XEW-+=+#(3H-);Z6V=-0XC`E#E/B,"4.4^(P)0Y3 MXKY%B<_M#S_QQQ;ITBX)@S4ME+OU5DJ+%*8484H1IA1A2A&F%&%*$:8484K1 MF-^6HBDRU"DRF"*#*3*8(H,I,I@B\RV*;&Y_^)$MC[@OYO\\Y-??WK_]^_TG MW4[K@6DCRNOG/_]X?K[YG]WUTD4)DS3F]X]MG3,EN=0=-*^\!^'HK3.%NY;9 M-:!P\2,4QF+>I[S6#TQAP!0&3&'`%`9,8<`4!DQA^!:&<=AN.+DP_O+ICV^% MH>]ZUC3.^XG>)#*F/^SP'7>T9,/2#U;)G_=W9I&O5E=WJ4_?G' M?_Z\BQ:$$C`_SNU'"2SFC7:]84H`=4H`I@1@2@"F!&!*`*8$?(L2F!_QGY+` MTA(($UAL?GG$2^#'E__\^<>7;\WRT+1?JKREH&D/4P#&;L\!?S6#;ZWEO"BF]DT:'W1%.^Z.WO]4;PPQ0M3O##%"U.\,,5K MS$U)Q0M3O##%"U.\,,4+4[PPQ0M3O+Y%\8`HA&;`6 MV9/0#(!I!L`T`V":`3#-`)AF`$PSP+=H!LQ/U]]E!BR/Z>$"-X_NX7TWWIL[ MK&5VJ)0W3'G#E#=,><.4-TQYPY0W3'FOYN6]BTY#B:]E]C24.$R)PY0X3(G# ME#A,B<.4N&]1XO/3M9_XOW>'-V]_^.4_R;LO;]]]U"?QU8O@/G1Y&@^#7%Y1U%OQ5C8C-Y'MU?'G2NSLSO9L'3#L@W+-ZS8 ML'+#3AM6>>8MTO@T:J_,GD:S8>V&=1O6;]BP8>.&3:%%B<^MAB[QO=;.6V=FM>&&*%Z9X88H7 MIGAABA>F>&&*=S5_D4:GH<37,GL:2ARFQ&%*'*;$84H"W8>P2AVD.P#0'8)H#,,T! MF.8`3'-@-7>RT7.Z9L!:9$]",P"F&0#3#(!I!L`T`V":`3#-`-^B&3#W/[[+ M#%@:*>&:7RSX+9K7^^B]I^/N9BVS0Z6\85KS,.4-4]XPY0U3WC#E#5/>QOP> M%DWQHD[QPA0O3/'"%"],\<(4KV]1O'-SPX_WD5OEFZ49$J;H-TC,K;*I\Z[, MB@QUB@RFR&"*#*;(8(H,ILA@B@RF%0E39#!%!E-D,$4&4V0P10939+Y%D?*N\M#G"+!>+;I6C#R^MR+7,6Y$PQ0M3O##%"U.\,,4+4[PP MQ6LL6)$PQ0M3O##%"U.\,,4+4[PPQ>M;%._0M"+7,F]%PA0O3/'"%"],\<(4+TSQPA2OL6!% MPA0O3/'"%"],\<(4+TSQPA2O;U&\<]O"C_>Q%;FT.<(4_=:'79$PK4B8(H,I M,I@B@RDRF"*#*3*8(H-I1<(4&4R1P1093)'!%!E,D<$4F6]A9/-_)"F([-(5 M>=Y1U$XR%ETCH_RT9U=[179D]`,6#>TIAD`TPR` M:0;`-`-@F@$PS0#?HADP]RR^RPQ8FA_!A_6M:8CHBN^^U-GC13%79H,.4-4]XPY0U3WJL]9;%-G<=_`CFS^FYTO,4Y]4;Y<&1IBE:6KH M2$G_M@B7=H<8;!^Z\,N4I@^:F%*$:8484H1 MIA1A2A&F%&%*$:;(8(H,ILA@B@RFR&"*#*;(8(K,MRBRN17A1S8OTOFO%SQY MD2X]C3!+O\]ALX0I2YBRA"E+F+*$*4N8LH0I2YBR-*8_U@^6PR&ZO5>\:YFW M(F&*%Z9X88H7IGAABA>F>'V+XIW;%GZ\CZW(I&&* M%Z9X88H7IGAABM>W*-ZY;?%=XEWZ'XK7#8L>7J-'NOO=[=HG<751T=$KLH.G M.;!N:$US`*8Y`-,<@&D.P#0'8)H#,,V!U;YY$IH!:Y$]8"UPF&8`3#,`IAD` MTPR`:0;`-`-\"V?`JZWNU"7MB_..HNZ4L>@[U>A]V^/.E=FA2C8LW;!LP_(- M*S:LW+#3AE6>>7GOH].HO3)[&LV&M1O6;5B_8<.&C1LVA18E/GY&TB,']EWV`<9254G=`@8#N-7W>TO[!H.%;1C&+&#O//\> M%B\9C$,I)4'?GP\X"&:+/!')9%2JU%@XJ&(Q=DC.=W,LBF%1#(MB6!3#HA@6 MQ;`HAD4QE(FA3`QE8B@30YD8RL10)H:RR)*RTHJ(RE[Z7/RF]C2F7;BQU$+6 M:\-;6,]N]+86R?9=-N@50Z\8>L70*X9>,?2*H7>P6*1I&A@?87T:&!?#N!C& MQ3`NAG$QC(MA/+)DO'0RHO&](JV=CUEL[(:TQZLW8E@4PZ(8%L6P*(9%,2R* M85$,BV(H$T.9&,K$4":&,C&4B:%,#&61)66E%1&5E2(M7[?W]__WW__SC__Z M_'_^X]_.#\_+WX^/OZ?QIO8T9I>CSQ&R._]Q7.[!(ZQG-WK%T"N&7C'TBJ%7 M#+UBZ!5#[V"/3`/C(ZQ/`^-B&!?#N!C&Q3`NAG$QC$>6C)=.1C2^5Z2U\S&+ MC=V07J1B6!3#HA@6Q;`HAD4Q+(IA40R+8B@30YD8RL10)H8R,92)H4P,99$E M9:4[$965DGS)"TMEN]13T6A]Q.Q.[Y52I".L9S=ZQ=`KAEXQ](JA5PR]8N@5 M0^]@CTP#XR.L3P/C8A@7P[@8QL4P+H9Q,8Q'EHR7YD8TOE>DM1DR%VELD/0B M%<.B&!;%L"B&13$LBF%1#(MB6!1#F1C*Q%`FAC(QE(FA3`QE8BB++"DK#8NH MK!3I2SZKX:_HN$A'-R1F=_J4G2(=83V[T2N&7C'TBJ%7#+UBZ!5#KQAZ!]NF M<3JECYPP/L+Z-#`NAG$QC(MA7`SC8A@7PWADR7AI4$3C>T5:&QISD<8F1R]2 M,2R*85$,BV)8%,.B&!;%L"B&13&4B:%,#&5B*!-#F1C*Q%`FAK+(9F7E;W%. MRE[ZN'N^4&H<-59NZZ/+>CRJ4;B%]>Q^?VGV8<$^+MBG!?N\8%\6[.N"?0OL MD6E\#V%]&C\6[.>"_5JPWPOV9\'N%NQ^9LEX:5`\HTC+W[W*CTB-T>OH4[V] M-,-B;(:.W]CZZ'[%\"N&7S'\BN%7 M#+]B^!TL5FF:!LI'6)\&RL50+H9R,92+H5P,Y6(HCRPI+QT**>=$]&SCM=6! M\6U9^$@GKC);+%^4X]@OKBD0-BU+@8.2!&#HB1`V+D@!@Y($8.#/;@ M),B`$=0G00:(D0%B9(`8&2!&!HB1`6)D0&0I`TK'XE4RH+8^YIJOK"1@V)G3 M&PG7 M%"C2$=:S&[UBZ!5#KQAZQ=`KAEXQ](JA=[!'IH'Q$=:G@7$QC(MA7`SC8A@7 MP[@8QB-+QDO#(QK?*]+:()G%5L89IT\5BV)8%,.B&!;%L"B&13$LBF%1#(N5 MA9L(RL10)H8R,92)H4P,96(H$T-99$E9Z5A$9>?'9XKZV<]2M?6!RRV3>99* MV^:[R[>M1<(3_;:[YN\DW8)Z$B!\#.P,X6((%T.X&,+%$"Z&<#&$#_;@),B` M$=1_8#)`C`P0(P/$R``Q,D",#!`C`R)+&5`:(*^2`;63,E=SZZZ0@)OM8^KA M4>`CK"\5OL7P+89O,7R+X5L,WV+X%L/W8(],`^,CK$\#XV(8%\.X&,;%,"Z& M<3&,1S8;+]\A,QG?N4V?XU/[JK%PR[N]-'N_8!\6[.."?5JPSPOV9<&^+MBW M!?N^8#\6[.>"_5JPWPOV9\'N%NQ^9DE9:8#D(GW)YP4WM9,R%6ECJF4IH'Q$;85J1G&%8=Q,8R+ M85P,XV(8CRP9+_V/:'RO2&N_9!;;>BBQ%7DCAD4Q+(IA40R+8E@4PZ(8%L6P M*(8R,8I4#&5B*!-#F1C*Q%`FAK+(DK+2L(C*RK/42SYYOZF=C]EEZX;P]!UV MTO3R%T4ZPGIVHU<,O6+H%4.O&'K%T"N&7C'T#O;(-#`^POHT,"Z&<3&,BV%< M#.-B&!?#>&3)>&E81.-[15H;'+/8RN:=5`R+8E@4PZ(8%L6P*(9%,2R*85$, M96(H$T.9&,K$4":&,C&4B:$LLJ2L-"RBLA<7:>U\S"Y;-V0JTI.^^O)FA/7L M1J\8>L70*X9>,?2*H5<,O6+H'2P4:9X&QD=8GP;&Q3`NAG$QC(MA7`SC8AB/ M+!DO#8ML_"7O_]_4S@?&MV5Y>Y/LOKML813T%J9/"[:@OG:D0+U^N!.0`F*D M@!@I($8*B)$"8J2`&"DPV(.3(`%&4)\$"2!&`HB1`&(D@!@)($8"B)$`D:4$ M*.V/5TF`VD>92[[U5J83[DEOQ-V,L+Y4^!;#MQB^Q?`MAF\Q?(OA6PS?@P7? M>1H8'V%]&A@7P[@8QL4P+H9Q,8R+83RR9+RT.Z+QO7VYMD=FL;%ETCXMN!'# MHA@6Q;`HAD4Q+(IA40R+8E@40YD8RL10)H8R,92)H4P,96(HBRPI*_V*J.RE MGQ;J%S?VI; M%EK/Z<.@=SWNT8TY!/7%>[]@'Q;LXX)]6K#/"_9EP;XNV+?`MLFFIXOO(:A/ MXL>"_5RP7POV>\'^+-C=@MW/+&5`:7_DFG_!D]GAHO918LUW5E["#36?ENHV MA/6EPG=KRVQ_2P[?8O@6P[<8OL7P+89O,7P/]L@T,#["^C0P+H9Q,8R+85P, MXV(8%\-X9,EXZ9Y$XX]OS(>+VFV9Q<8.3-V8>UQX=,:BXK`HAD4Q+(IA40R+ M8E@4PZ(8RL10)H8R,92)H4P,96(H$T-99$E9:7]$92\\,!\N:A]E=CEZ*S&[ MTPM8%.D(Z]F-7C'TBJ%7#+UBZ!5#KQAZQ=`[V#:-TU4Z&6)\A/5I8%P,XV(8 M%\.X&,;%,"Z&\B-+>DNO).K=VX5K;V6V&/LM?1<6 M0YD8RL10)H8R,92)H4P,96(H$T.9&,K$4":&,C&4B:%,#&5B*(LL*2O-CJBL M[,(O^-7KPT7MFLPN*YL_`#ZE\Q,5.<)"18JA5PR]8N@50Z\8>L70*X;>QJ:* M%$.O&'K%T"N&7C'TBJ%7#+V1);VE,9+UOFC+K1V6:I[!/5)D`!B)(`8"2!&`HB1`&(D M@!@)$%E*@-(G>94$J`V7N;Y;$X;\"T?A]!B&[Q'6EXK;MQB^Q?`MAF\Q?(OA M6PS?8O@>[)%I8'R$]6E@7`SC8A@7P[@8QL4P+H;QR&;CE[G]M;,)G^/GM[`. MC85C[^V"O5^P#POV<<$^+=CG!?NR8%\7[-N"?5^P'POV<\%^+=CO!?NS8'<+ M=C^SI*PT-G*1ON`MK,-E[9!,1=I8VH33ZTOH;,/0J#KUBZ!5#KQAZ MQ=`KAM[!MB(]7:7/PS`^PK8B-<.XXC`NAG$QC(MA7`SCD27CI2\2C>\5:>VC MS&)C;Z4]*5^*4:1B6!3#HA@6Q;`HAD4Q+(IA40QE8A2I&,K$4":&,C&4B:%, M#&61)66EL1&5O?1CAI>A>I(I\=VAQCW[PAO+9CM>17A8@@7 M0[@8PL40+H9P,80/MI6MNA=;4)\$&3`&=D8&B)$!8F2`&!D@1@:(D0&1I0PH MC8U7R8#:(9FKN75-YF>I]!D63)>>AW1^-YMNO9&N&*?`F4<^R7] M-BV&13$LBF%1#(MB6!3#HA@6Q;`HQFU:#&5B*!-#F1C*Q%`FAC(QE$66E)5> M1U16;M/E:ZV>^8M'A\O:-)E=MD8*_]L./+D?3Y&.L)X&Z!5#KQAZQ=`KAEXQ M](JA5PR]@STR#8R/L#X-C(MA7`SC8A@7P[@8QL4P'EDR7MH?V7C)D&<;KWV4 MW>\7[,."?5RP3POV><&^+-C7!?L66"S2-(WO(:Q/X\>"_5RP7POV M>\'^+-C=@MW/+!DO_8]G%.FA]DNF(FULZD2:8;'U6K9BQJ(8%L6P*(9%,2R* M85$,BV(H$T.9&,K$4":&,C&4B:%,#&61)66E_Q&5O;3)<:B-E-EE:Z[P*!=V MTO30<7MH0^/;L@N&WG&Y7@7H%4.O&'K%T"N&7C'T#O;(-#`^POJ/AW$QC(MA M7`SC8A@7NULPC,>X9+ST.Z+QG9WT4/LCL]C8,VE'W!87"IGBYB^<>?;L MU5[';*^R$T];H2SUKMRAA;'#A[#T>@WK^I2KL=0[5TLS+N?]...]:9;X_(A0 M64A(;C5B)*D822I&DHJ1I&(DJ1A)*D:2BK&88JR<&$DJ1I**D:1B)*D822I& MDHJ1I)$E9>7`'I75)&7`GKMZTI]3M++=%&UAN5J:;SF> MQOGN3;,>9^=IQB-NOX^*D:)BI*@8*2I&BHJ1HF*DJ!@I*L9BBK%R8J2H&"DJ M1HJ*D:)BI*@8*2I&BD:6E)7S951V?M@IWX*[YZX>3&=WE>VF:`N;4S2],L&J M/N5J+/3.U=)\R^$LSG=OFB4^WT4KF^^B8J2H&"DJ1HJ*D:)BI*@8*2I&BHJQ MF&*LG!@I*D:*BI&B8J2H&"DJ1HJ*D:*1SK(WQ[:T.G(:(;><;E^)D.O&'K%T"N& M7C'TBJ&WL:T[@5XQ](JA5PR]8N@50Z\8>L70&UG26\XAKZ*W'FAFO?&0TQYX MCF*4JA@NQ7`IADLQ7(KA4@R78KALC*?#<-]+*8G>$=93#;UBZ!5#KQAZQ=`K MAEXQ]$:6])9SV*OHK0DX/X]POI2X5L,WV+X%L.W&+[%\"V&;S%\ M#Q9\YVE@?(3U:6!<#.-B&!?#N!C&Q3`NAO'(DO%RL(W&]YXEZT%X%EO9_)`E MAD4Q+(IA40R+8E@4PZ(8%L6P*(8R,92)H4P,96(H$T.9&,K$4!994E9.L5'9 MBQ^RZG%X=MF.R/SSVXYVG5ZMI4A'6,]N](JA5PR]8N@50Z\8>L70*X;>P1Z9 M!L9'6)\&QL4P+H9Q,8R+85P,XV(8CRP9+T?[:'RO2&LK8!9;V5RD8E@4PZ(8 M%L6P*(9%,2R*85$,BV(H$T.9&,K$4":&,C&4B:%,#&61)67E'!^5E2)]R:MG MQ]H0F%U6-G_"?9T^&J9(1UC/;O2*H5<,O6+H%4.O&'K%T"N&WL%BD:9I8'R$ M]6E@7`SC8A@7P[@8QL4P+H;QR&;CI]R>V2G2VWO4POC;A^>@E,_FU5]RM58Z)VKI?F6XWF<[]XTZW%^GF8\XO<4 M%2-%Q4A1,5)4C!05(T7%2%$Q4E2,Q11CY<1(43%25(P4%2-%Q4A1,5)4C!2- M+"DKY^NHK*3HTU["*%_=G3]7:VPW2>O0TYRD>@GC25=CJ1=7.X6W)M.,R_$T MSG@O2>MQ=D[2>,3M22I&DHJ1I&(DJ1A)*D:2BI&D8B2I&$DJQLJ)D:1B)*D8 M22I&DHJ1I&(DJ1A)&EE25LZ74=FY;?"$3[A/]6`ZNZML-T5;V)RB>@FC_0N/ M7XV%WKE:FF\YG,7Y[J5H/VA#TUU4+V'TL$>OQD*W?Y3_;?]H^#*R>;Y7SSPRGN/3D;&QZYGEI25 ML\4R19_[$?=5/:5,]YO&TIDQO6YQ>]C"^F$+O_'0<[Y5X5<,OV+X%<.O&'[% M\"N&W\%B%:1IH'R$]6F@7`SE8B@70[D8RL50+H;RR)+R MYF:Q\837BU0,BV)8%,.B&!;%L"B&13$LBF%1C"(50YD8RL10)H8R,92)H4P, M99$E9:M3(,?5797*3Y#12*=(3U3$:O&'K%T"N&7C'TBJ%7#+UB MZ!UL*])CG@;&1UB?!L;%,"Z&<3&,BV%<#.-B&(\L&2^GTUBDY^=[XI]MO!YS MJ=YM66Z.Z9.C=X>K<1K>PM(-CA0807WM2`$Q4D",%!`C!<1(`3%20(P4$",% M!GMP$B3`".J3(`'$2``Q$D",!!`C`<1(`#$2(+*4`.4$_RH)4%L!\^V[LOG] MHC=Z=>%JA/6EPK<8OL7P+89O,7R+X5L,WV+X'BSXSM/`^`CKT\"X&,;%,"Z& M<3&,BV%<#..1)>/EM!^-[^W+M3LPBZTL/"A3M6)8%,.B&!;%L"B&13$LBF%1 M#(MB*!-#F1C*Q%`FAC(QE(FA3`QED25EI8<1E96[]$M>7;BJS9#9965I7TYW M;O2.L)[=Z!5#KQAZQ=`KAEXQ](JA5PR]@VU%>LK-)8R/L#X-C(MA7`SC8A@7 MP[@8QL4P'MELO)R,)N,[17J.3WVHQJ8B-7M_,/NP8!\7[-."?5ZP+POV=<&^ M+=CW!?NQ8#\7[->"_5ZP/PMVMV#W,TO*2K_B-8KTNC8^IB)M+!6IGIRVL)[= MZ(U]E-:&,D.OXM`KAEXQ](JA5PR]@VU%>GR3IH'Q$=:G@7$QC(MA7`SC8A@7 MP[@8QB-+QDN[(QK?*]+:'IG%QI9).^%>BV%1C"(5PZ(8%L6P*(9%,2R*85$, M96(H$T.9&,K$4":&,C&4B:$LLJ2L]"NBLK*3ON2$>UT;'[/+T0R)V:W/-]I0 M:KEG-WK'T,[0*X9>,?2*H5<,O6+H%4/O8(],`^,CK/_(&!?#N!C&Q3`NAG$Q MC(MA/+)DO+0[HO&](JWMD5EL;)GT(A7#HA@6Q;`HAD4Q+(IA40R+8E@40YD8 MRL10)H8R,92)H4P,96(HBRPI*_V*J*P4:7D;XKE-B>O:^)A=5I9VTO2.QNVA M#9V+=`SM&8]>,?2*H5<,O6+H%4.O&'H'BT6:IH'Q$=9_9(R+85P,XV(8%\.X M&,;%,!Y9,EX:%-GX2U[[O*Z=#HQOR\+ON:66P[M#B^/9>(M+CR'D0&R;G,N> M$A16_MDLQZ8^>D;\]BN!3# MI1@NQ7`IADLQ7(KA4@R7C;%D;&[__;_^]M=__NV84Y+J'6$])=$KAEXQ](JA M5PR]8N@50V]D26_I9+R*WMH2F?6.-DEC7GIJ.E\HM:D:F]I4 M9N\/9A\6[.."?5JPSPOV9<&^+MBWP=C/1O6>KO3TU7_D[:3W(PSM:?ISP7XM MV.\%^[-@=PMV/[.DM[0X7J-ZR^-4?>EO6Q:>OE(O^=VAQ3W^]+4%]84B!UHS M9JLA@/@DR8`SLC`P0(P/$R``Q M,D",#!`C`R)+&5`Z)J^2`;7U,MV_W[1VS+S5I7?/;@];6%\6?(^AG>%;#-]B M^!;#MQB^Q?`MAN_!@N\W:1H8'V']1\:X&,;%,"Z&<3&,BV%<#..1)>.E8Q*- M[[1%WM0.RRRV=5VV:L2B&!;%L"B&13$LBF%1#(MB6!3#HAC*Q%`FAC(QE(FA M3`QE8B@30UED25GIF$1E91=^R5=TOZFME]EE:\?$'>WX1J_0M:%36\0,O>-R MO0K0*X9>,?2*H5<,O6+H'2P6:9H&QD=8__$P+H9Q,8R+85P,XV(8%\-X9,EX MZ9ADXR]IBY3/BA<;<]JNWAU:7-DIQG--"J+$6Q]G*WM*7(P<$",'Q,@!,7)` MC!P0(P?$R('!'IP$&3""0@:(D0%B9(`8&2!&!HB1`6)D0&0I`TK'Y%4RH+9> MYIJO;'X]YZV^_J>T2DD>POI2X5L,WV+X%L.W&+[%\"V&;S%\#[;Y/EVE[@[& M1UB?!C4OAG$QC(MA7`SC8A@7PWADR7AIHD3C>QMS;;K,8BNCC/M4J5HQ+(IA M40R+8E@4PZ(8%L6P*(9%,92)H4P,96(H$T.9&,K$4":&LLB2LM(8B MJGCNYQ5O:H=E=MFZ+F3,=DM^FQK:Z!UA73EZQ=`KAEXQ](JA5PR]8N@50^]@ MVS1.5ZF)@_$1UJ>!<3&,BV%<#.-B&!?#N!C&(TO&2Z\D&M\KTMI;F<7&?DOK M6KX1PZ(8%L6P*(9%,2R*85$,BV)8%$.9&,K$4":&,C&4B:%,#&5B*(ML5E9^ MK7925HKT)<]2YPNE'E9CY;8>BC3U/6X/6UC/[O<+]F'!/B[8IP7[O&!?%NSK M@GT+[)%I?`]A?1H_%NSG@OU:L-\+]F?![A;L?F;)>.EW/*-(W];^R%2DC9%7 M?:I8;'V4C6%1#(MB6!3#HA@6Q;`HAD4Q+#;V=OS,*!-#F1C*Q%`FAC(QE(FA M3`QED25EI6$1E=4B_4MY0OZ??_^/O__GNW^4JEU^TP>NEM+*1I*-*>,A2/;>CVT^%1#(^531Y/5ZESB,<1 MUB>+1UT.CR-NF]CI*O4X4#O"^N50*X;:R)+:TIJPVN<_V+ZM/8[9;66S6S'< MBN&VLN0V??Z"6PW%[7)H.BWB5D-Q*X;;ROBDIWR">[H\7J<,P^L(Z2+PJDOA MM;(Y3?+7V.)UA/7+X54,KY$EKZ7A8*_/OLW6OL5LM;+9JAA6Q;!:&=^+4-?R M^IB2&J,:AM$TC([:7__EGW_[Z[_\O=U;L*EAV!3#9F7AX(P^,?1I+/HJ2_K2 M00U](RSH$T-?9$E?Z1Y(WW7Y`U/G3;+?<)^S8]:&Q*RRLO)[^.$&FHYLW(]K M&%^`V">$73'LBJ%3#)UB^*LL9!7^Q/!7&9][])\%?V+XTUC\539M_*?\%9[X M&V']GZ#\Q/`76?)76@GR=[657Q>XAH[+Z\R4= MY9PO'1?!QQ.?.FN_8-916?EBA%!#:>O'4`T+JX;Z_'B_)_NDS6HO,@5KI]*'K$U+"098BOCTXR^Z(@50ZP88L40*X;8RGA? MO_\;B*VL_BQ);.D&2&SP^M0ZJUV%66QE80FP*(9%,2R*46=B*!.CSBH+F8(. M,714-M>9&#K$T"&&#C%T5#;7666K.BL?55K',?AX6IV=KY,:,(V5WW3?$O=& M'V6TL+!Z[P]F'SHKWVZQ7>ZMZLQ#/XVAC]99&UA^425H>K[_ M&&P[//[LC!?TSJ\1KFK[5P\*&?M[L.UB?SIK%[M>7>RN!TV5V":UJL2;K;^V$;9%N#RTNM&WPK#@\BWU<,*0J[O."?5FPKPOVK;.0A\BN_T9@ MR!9#=F7\T=B>%+AM;-OQ<*LXW#9V-<:B4F/O.UM6<>D$1)4[#RDWM7,PW3P; MFY\L;]*C,A;KT+`B6!3#HA@6Q;`HAHG*YDK,-P[DU+"Y$AO;B@?HJ]V!65]EX4Z"*S%%*#%=B MN!+#564A'Q`C1M6((:9=;ZJ:QJ:J41P>&INJ1F.IFLJ655,.XW'92V/S*5^9 M?%-/\?/Z5S8_5-[HTX8V-"P72NK0P%#2+G=]WCW>OKU\$[YD]MQ119'&H6@: M=^*W.\+7*I['H:S&S`^4N=*Q6,-"1F%1#(N-;27'O:^R4`!4D^*PV-BV3W#O MTU@LMKAS=:;B*6?R:''OWE?/\+.\RL)4*1XQ3(EA2@PS8I@1PT1EP3S++L:R MB['L[7I3\30V%8_B6/;&IN+16):]LF7QE*-T7/92/$_[,N>;>@J?#526RB=U M^)'2#O#;80,I8DAIEZOE<_GF>'-Y3`^>6-)`+$T#'ZB?&C-M3Z?K]+,BLH;- MVU-C6ZT@LEVN;D^K4J>>VKAI=]*U$-L8#_SA&38](U-B-2R4)Z[C/Y%*K)S3 MH^N]$JOG^EEP97.)B6%3#)MBR!-#GA@E5ME<8F*4F!AFVO6F$FML*C'%8:*Q MJ<0TEF6O;%EBY10=E[V4V*'\`?&]]:_'[WG]*TL%EIJR%%@-"\N%$C&45%9^ MF"W1;M3L]U`LK8;FM-5=;85&6*PT1C4Y5I+%56V:+*:+JE9:\?;T,?7_\Z<#[W=I:J M+'V0==O#PG*]7[`/G?%5<:6'%%+T]V#;Q?X,AKGM#I.G<-?#8I%U5O^)JU5V/UT!SO<<>+RE*-I7XX M1FI86!F,B&&DLKE4;EQE&HJDY=#TM(6W&C97V86KK%TM[&1]Z&$K#%2VR]6= MC-\A?'NZ3/\F5=8NMN4H5=;8=C'_\JF,N../G\ZA9(:-I>9&$K:Y>I6=CI=7.4O`$&1QJ&H MLKD\\S:`-0W%FAC6Q+#6_HGMGH>UQK;[&]84A[7&IGNCQF*MLN6]L1RRH[6] M8JF'\EE696%3Q8P8Q2*&&3%,B&%"C&6O;&HEG2[2\PXF-!038IAH;+M#8:*R M<.O!A.(PT=AV^Z1^-!83+>Y\7TGU4X[`T<2Y?LJ`/27U[#PKJ2S53^ZG'R]J MV%P_8EBJ;*J#TT7J+R).0Q&W&'J\25L&+C44<6*($T-<^R>F$FIL*B'%(:ZQ MJ80T%G&5+4NH'**SN/-CX)ZX>OJ>Q;53^K3QB%%+8E@20XD82L18_\KFQX1K MUU(;NN4Y2AK;Z@8E[7+M,>'FZO)T2*=GBJL-W.9*<>EB.&IL[V&\AH5:15O\ M)U*]E<-PUG;YE'JKI^A96V6IWE)7CKMB#9OK30R3[7*M`7_)U]FEU<.LQF&V MLJE.CXO]2D,I-C',BF&V_1-3L34V%9OB$-G85&P:B[7*EL56SM(OLE8/X;.U MRN:-2XQB$T.1&$K$4")&L566BBT=(E#2AD[%UMA4;.URM=@>.OFV@5.QZ6(X M:HS_/7KRK6%SL;6AB\WM/:;'L?S==*)N+%4>ZE>;OO0J?;:T,`^]#C^ M*$9I>]`1Y]8U/W=^[#%AW*?.'G]#Y%L/"T._+]B/!?O9V72.;E,(K]S\7L3] M&2S6GL?>][CZ\\UWS,MR%,^U=W/QW+<4C^?K9(EJ.6!,[/V"84QQ&!+#D!@Z M*IM+\2(]GF"H#8VEV%DLQ7ZY6HKGCU/2)O!K7"M68K_6QC#6_LWM^G>#;3\' MQFI<+<5DK)R2L[%C,/:D]ZN.E_6P/=T[&YO>K^)<-5<*#NO0D.XX%,-A9:WJ MV(:O^9J@=-[#JD9B=1KY]NIXS'LEEC4.I6(4G1A%5]E<=(W%#<]Q*&QQ4]%I M+`HK6Q9=.7%GA9?A%;FGO;)XO*PG]]EA/,W77SCM<:$#@3#%(4P,/6+H$?N\ M8%\6[.N"H;)>;R[8RY1WV*UA4]>XLZV@L-LN5POVZG`\7KY)&S$5VRZV52?W MV,:VBZ%[_*./[ITM;-H[^]#5WEE.[S$#=HX5*,Y_://8V/1^E8[*5&ML%)P3 M`OEBR!=#OACRQ1`HABTQ:E$,6Y7-M=C85(N*0TYC4RUJ++58V;(6R^D]FBA' M=#3NG=#++Q6G/WUZ;&QZ]C1C^6/'X*R$Y1=C^<58?C&6O[)4/SKH]:';1H.1 M=KDMY3'2+M>>/2]N3I=7-^EJ%)!^$`I(5\/1=+7U^VT]:"Z?^`^D/;"75P<^[YHW7US7H/#+2Y2:&&+%$"N&1C$TBJ%1C"<7,4HMLF2M'-RCM;V; M7CWHSZKBX;]O;V*4F!A>Q/`@A@=G%6'8QEEV,91=CV<58=C&678QE MCRPM>SEYQV5_:A.27UWV+:ZR5"KIPRU*)9[V>ZF(H:1=KGT>O?J`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`,28]DK:WL#Y^S+F_SR`AXT$`]MX-[>4,-F-6*H$4.-&&K$4".& M&C'4B*$FLJ2F'".CFB??I.KY;H^43GD:F+6)H:VR^2:E."RU MN.DF5=FL1`PE8B@10XD82L10(H82,91$EI24(V)4LG>3JD?*V41E_"M]RV79 MQ;A)B;'L8A2'&,LNQDVJLGG9Q5AV,99=C&478]G%6'8QEEV,98\L+7LY(CYG MV>N1F,WEBZ2:4/>&^//2P^29E] MZ''33I%A?8^Z,9RZZQ'Q>,95?*N$)OP5QK*?#Z6;56"H$O7+3PD*#"2/U.]3PYVZAL?G$FO\!PRTLLY[M>J!,$B2&H M7:Z^KG9S=:Q&$-FAV*X5`,AV(X%,.A&`[%<"B& MP\B2PW+RS`Y?\"[:L9Y@N2UNPGC=+RW5NV.+8ZFV.#]MQ^-P^_AX&]C/L&A5 M''4GAD2QSPOV9<&^+AB^Q_4>G`1%/(+Z#TP"B)$`8B2`&`D@1@*(D0!B)$!D M*0'*&=@)\.RO?SX>ZV%ZWAC;`9M_/I2QWJQI0_GK*WVIN,^.H9WA6PS?8O@6 MP[<8OL7P+8;OP1Z9!L9'6/^1,2Z&<3&,BV%<#.-B&!?#>&3)>#E:1^-[SY_U M*#Z+C/Y2NGDW=CTATU.EWJI9POKZ?V^ M7XZAG7U8L(\+]FG!/B_8EP7[NF#?`HM5FJ;Q/83U'_G'@OU3=K"^E+A>PSM#-]B^!;#MQB^Q?`MAF\Q M?%=6_F[;P]/`^`CK/S+&Q3`NAG$QC(MA7`SC8AB/+!DO'8UH?&=G+G\:(Y]C M&PN[\"V?'9SC`L.B&!;%L"B&13$LBF%1#(MB6!1#F1C*Q%`FAC(QE(FA3`QE M8BB++"DKW8JHK-RF3R_9F&O;8R[2U@KA^+9E=WZ/";TCK&L70*X9>,?2* MH5<,O6+H%4/O8(],`^,CK$\#XV(8%\.X&,;%,"Z&<3&,1Y:,EX9(-EY^R^'9 MCV+E0N='L6U9.#*GWWMZ=RS95)^KMSAOS".H+QXY($8.B)$#8N2`&#D@1@Z( MD0-BY,!@#TZ"#!A!?1)D@!@9($8&B)$!8F2`&!D@1@9$EC*@M%->)0-J7V:N M^=:KF7:T@U[M.HVPOE3X%L.W&+[%\"V&;S%\B^%;#-^#;;Y/>1H8'V%]&A@7 MP[@8QL4P+H9Q,8R+83RR9+ST3Z+QO8VYQ.=35F5A$^;.+89%,2R*85$,BV)8 M%,.B&!;%L"B&,C&4B:%,#&5B*!-#F1C*Q%`665)6&B!16=F8^5S^^;?IVDF9 MB[1U5\B8L#&GAC)Z1UC/;O2*H5<,O6+H%4.O&'K%T"N&WL'"-*Y]8AYA?1H8 M%\.X&,;%,"Z&<3&,BV$\LF2\]$^B\;TBK?V666SLP;2^UDD,BV)8%,.B&!;% ML"B&13$LBF%1C"(50YD8RL10)H8R,92)H4P,99'-RO@K<+.RESX]GR^4;KB- MS6VM@YZW>^/9A\6[.."?5JPSPOV9<&^+MBWP&*1II/Z]Q#6I_%CP7XN MV*\%^[U@?Q;L;L'N9Y:,EW[',XJT_'I[WDD;FW92,RS&WLJYF+$HAD4Q+(IA M40R+8E@4PZ(8RL10)H8R,92)H4P,96(H$T-99$E9:5A$9:5(RZ_$/??`4]XM MDLO6#9EWTO2QX>VQ#0U]9O2.H3WCT?O_*3O#'3F**PJ_BL4#!'>OO9Y=$:0I M0X!I0D!^`B=9#`I@9!SE]?-]L_8RGOI&B#\E^YZMKJI[SJWI/M/3/<6@=XI! M[Q2#WBD&O5,,>J<8]#[$3HKT?*^!\8<_>S]E&)]B,#[%8'R*P?@4@_$I!N-3 M#,9/8V>,ZW><,OX'GZ0^(&DB]M0S>?=)^N[O3@H7%J>_@\4I!HM3#!:G&"Q. M,5B<8K`XQ6!QBD'9%(.R*09E4PS*IAB433$HFV)0-L6@[#1V1IF&Q2EE%NGB MS1M_NDKOK8\/3HMXAH\$GWV4GCD55.G#G[V7-_Q.,?B=8O`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`FXDG[$]])BSRJ:66^)EF8O+' M[_<*6^W'F7]B]N/!.XG).X]W24S>>09)8O+.PS`2DW=^<1?8NF,N-(7QZACZ M\?Z8Z,>#`,%X&F!B\L`CZQ*3!YZ+EI@\\/"NP'C`#_/$E4R,N:SWWN$Y[^LS MYD+3_9C+^BSGLCYC+C39;P>WZZZXW3M/"J;R,L0.O08P]N1>`Q@UUFL`H\9Z M#6#46*]A,'VP7`,8^V!K8O!6<3!>-S[S,'B8+G7+8W%GC+RP[Z[/2I_,TV/> M>Q1G_(&Q[]+$,<$8CZ8Q]MT>;W,\N*TU@%%_/1X8]=#C@5%_/1[S--?/2B\; M+URFWW7I!4SM\JZ<.9]@:I5Z8BWFY[KQ09OCF9?K MXH%YFI?KXAW,FN:'_?,Q]^8%O=0\A]BA8+V@B9V#JI:\MUJ?JI:\1UJ?JY?Z1%6?U M!T?JY?YY!Q/&^37]6A->5_%8BYZGFLCS:]:@)O+\>N_:$4;I98@=.B]@:B+S M`J8F,B]@:B+S`D?6](6\<*[X8LUSQ6WE?!"LZ\'KL37/R^DG?WGN3<[DJ,^O M5Z^K:(('UJ<&DP>]-D7KP^:AZ&/(#5ODO.U$3R`.8>>EZ]]7KYZ[DT3/,"M'/7Y M]>KU$4WW<^_)ZZ.]VF4CZ3T$C)Q5;9)/ZR%U#:9>4M=@[CVI:S#SF6L`D_=< MP[8NYK//K]?%6NGSZW4QUQ?.K[U>6?MZ95WEH:]7^)FU6/.PRD-?KZRK^T1> MDPR/>>AC@IF7/":8'%TZICRD!NEGK:0&X<%ZN*!!SG?)9W_&+>Z1]\;P]+FY MN'9N*9_/>^#6/3*OJ_;RCH!KO"%V:$V`N4^D)L!<>VJ"O+A/I";`S,L%33Q6 M@[P1K-;W6`WRQJK"%C7(&XX24X.\-RT'R M!Z;.DC\P]X(<;T]*G$O-3IJ8>>%7JXF9%U[)F)C:S?$VQT,O-1>F^-AY=CV`<F-K-\<#<7WJ\Y88]A";FN5]N.$_FH9>! M#;$#36/PL-Q4KNF'/FFZ'_KL\3;'8YXU'AB?8ST>&'M(CP?&'M+C,4\XHNEY MHMWE)K5K/L$JG]NRZ+*3HUUQQ-KYS.F\L#[UR<]R8W^1([#BB'[J M,SD"LZ:3(S!K.CEB?6HIY[(M^EDT,4\P]=)>[(*/"=9ZT8OE75U]3&NLO=A% M+Y8F^@VZL+[L!Z:6+O33_VS>R9E:2M[!U%+ROBUX2"]H8I[D3)VEGP6FSMJ/ M7/0C:?J8\I?^Y]ZYH,'J-\0./4]R9EYRGF#F)><)9EYRGF!J/N<)IN939V!J M/G4&IN939V!J/G7&VM5+>H#P)P_I\X')0_I\8/*0/A^8=90^'YAUE'X6F'74 MOO"B+TR3FM`7[O6Q=KEMSVK1KVL,+>'=7SRFFLB<,9Z:R)R!J8G,&9B:R)R! MJ8G,&9B:R)R!J8D+.=,CXS'AF4\]3A[/%]C>G)&7^GP?8@>:Z`?F^MIW6_3= M:+J?ZTOOEV.ZOO8X%SU.FCZF>T%[G(O?Z=-T/[747A>I%*M\,D\UD?G<%N]5 MH8GQP*R']D87[ED`ZWK0-UW2K^.8[M>YOHVE@>7ZZ">6_AF86DK_#$PMI7\& M9OWE/01@[B'IK>W-&4(L?0XQ^*M\@JFES">86LI\@JFE"_G4%U[2/]L6?6&: MY%9?>$G_C'YRF_X9F-RV+[SH"]/$>'NF2,XRGT/LT&L`,Y^Y!C#SF6L`,Y^Y M!C#SF6L@U^XAJ0DPYYEKV!8]59I>.]?,2WM("_S_3!EO3!6(,UW3XF M0XG5/@A_UE&.!V8=Y7A@UE&.!V8=71A//W))[Y"\NZ>6Q!G/=7MZBOTN3Q\1? M8KS:YYF+_=)?`I.']-W`Y"%]-S!Y2-\-3![2=QMR>VANP:SIY!;,FDYNP:SI MY!;,FDYNP?Q,S=H%!GZ4?ND0I[SZ6U.\_4$FMWGJDE,.>96@*3]]02F+RGEL#D_8*6]-DOU:9> MY9+>Z,;KT<5Z#WFL=M,;W?/#"'*6^1QB!YJH33"UE!X\F%I*_EB[6LKQ6(/[ M4HX'YKYT:3SSF>O;M#'3)=HT#MLWU#9,EW+3-$R/4F:O8=FX7G5N: MR##]W.':N5UT;FFB']DWPSD>F%60XX%9!3D>F%5P:3RK(%5)/ZL@53DTS=*# M'%JL[;!B0![27]VTFA+9HP!47H;1T)--<0Q=[!3'0!R'%,?0P4YQ#,1Q2''L M=?)RVD,?+ZVSH8O7)IX>7EMX.GAMX.G?I7TW=%'3E!YZJ&VAZJ"F(3WT3]N. MUK5+,V7#>WN1UMNF8Y?&VZ;?VG:K;FN:;IM>:UI9>^:V3V3H`>6LAXYASGKH M%^:LAVYASGKH%>:LATYASFW3[TL;;=/M2Q-M\][#M-`VG=HTT#9]VK3/-EW: M-,\V/:FT5S8=J317-OVHME9TH]ILTRMMJU2GM`U(/<;,SM!AS.P,_<7,SM!= MS.P,O<7.CG>GI3FS>5]>6C.;=^6E,;-Y3U[:,IMWY+4IH\>5+`P=KF1AZ'DF M"T,G.%D8^L`76$#QK5Z]LK0B-MW%-,,VO+`7:87MR?4^61AZ9,G"\"[`9&'H MCR4+0W_W>!!6;05:)/E;;*IDN5ILJF1]66B@Y5&U3Z4VU/Z6:F^;;I M6[5MI6O5II6>55M6.E9I3FSZ56U-Z/"E(<6/8;CW/[]NTCE*TV73-TK+9=,U M2L-ETS-*NV73,4K#:.B#)@O#._Z2A:$'FBP,'="LDJ%GG%4R=(R[2O2R$ADZ M69G1H8^5&1VZ6)G1H8>5&1TZ6)G1X3V(%S)*WE*)0^\QJV3H/':5'.\A+-MC MC\.T3S-HZ'6E]31TNM)X&OI<:3L-7:X<9]/CRG$V':XJ"0R45A,>Z#G__GC17!/F>IH+K)HP#@M( MD8R?"E(3QO4%*<+X7@6DW`7N5.>FI2)L<+`\EI^ND?SAF4?%J=BDW4^!^/O- M\:V_M+I.@SI"KBFYJ+^(#`.LZ&$BL^ MW"/B.)LU'?$].WNMF[59G7DA"69]YJ4D^7IFOBX<\YGY*HQ^._M513#>SGZ% MT<],]"70RO7SUO/\6HRFM,`QKVZ_H8E\@3T1*\V!/14KW8%=B]5X+/O*M1?& MVF&NYP+FWIIS>7Y%2=)4KGE'[_4M36&^V?KV^)[D^=XA7VA]2U/]?+'U[?&] MR7,_IG'#7/(#BFG<,)?$?($MPS]?)%ZX7?)%[=TA1_ MS\5H"N.85[6H,/*RRE%AY(6U-_8E7PM\ ME=\*?,VN_W7ZU-^`?)/(MR#?)O(=R'>)?.:WJ9_WMZG\NI%ML'0'72"U,PQ$ MP(](HX;9$BR;0)YCRC_/[\0^!_D\D2]`ODCD2Y"O6KN[^_?//JQU]^>_33W?<\:N3Q7_`5'KWY\97/E;G_S]O7 MO_*\MH\>_?/UV[>O?S[^\X>[E_^^>^,?\,??OW[]]OU_*-./__?ZS7^.CS/Y M]/\"````__\#`%!+`P04``8`"````"$`W*ANWHX:``!#C0``&0```'AL+W=O MC^)0!F`8D\4*7B^W_^>?_] MY/?MP^/=[L>'T_&[T>G)]L?M[O/=CZ\?3O_G7_D_SD]/'I]N?GR^^;[[L?UP M^N_MX^D_/_[W?[W_8_?PZ^.W[?;IA"S\>/QP^NWIZ>?Z[.SQ]MOV_N;QW>[G M]@>U?-D]W-\\T7\^?#U[_/FPO?F\5[K_?C89C19G]S=W/TZMA?7#:VSLOGRY MN]VFN]O?[K<_GJR1A^WWFR?J_^.WNY^/8NW^]C7F[F\>?OWMYS]N=_<_R<0O M=]_OGOZ]-WIZD?F MSFQ'\9I79ZLSLO3Q_><[N@+C]I.'[9YS=?=C2]ZF.)D(_++;_6I$KSX;1,IGH)WO(]`]G'S>?KGY[?O3 M9O?'Y?;NZ[GW;W_V>%QFS* M&IFQ$?K\ZT;HZ_8]H4\V,EZ\FTWFR_.W=&7!5NA3NC)]NY4E6Z%/Z1\ M/IXOWN"6%5NA3[9"#GJE2\K63SVPJ[3,S MO7FZ^?C^8??'"4UWY.K'GS=F\AROQQ1\R4F;08XDASXM\11V/&Q%&NZD*` M\T3@B$0D1"4-01:"/`1%""Y#LKO;!"2QHMAX2<:I'D("+>2(%D M0'(@!9!+(%=`KH&4!_)LEZN#B'2Y!M(`:8%T0'H@&R"#3U0<:8&`.)IY_XUS MJ#%#TS!]'&)&D^A*A^W"2KT8V8.(N"D%D@')@11`+H%<`;D&4AZ(N[!@,%8' M$>ER#:0!T@+I@/1`-D`&GZC(4A#_CL@:,_O(RM5=6$*;;>>2R3QP2G(0$K44 M2`8D!U(`N01R!>0:2,G$[J?-\EP!J8$T0%H@'9`>R`;(X!,5-G*K"MO+$ZJ1 MUM&Q9'E^6`83("F0#$@.I`!R">0*R#60TA*S83O,%9/Y3$\5E16:3@Z744?4 M9I-@AFE`K8VH3>;!DM.!6L^$YLU#)V?3\:&3*F2TJU4AL_O0=V:G_?3M[O;7 MBQW9H.4L$LHI[3?M+M08T9&T9+DZN"`!D@+)@.1`"B"70*Z`7`,I+9G0LG]P MTF0^/SAI?V&5%?(C&5&;34=:K0&U-J(VF0<#H`.UGLG,N%&%S91F\/C@PO:O MW<_GPD:'4XF;L:+CQN3%\9U8(<\K:50MV`5FH)9'U8+Q78#:)1-_?$\600RN M#D(RB5\SL14.,XV6ELSVU1,;<"`UD`9("Z0#TOM$A9)\#:&$"S=3[6-R=1`Z1)*)%TE+ M%K3C=X9&P8FILD(3M[S4K*9'4J#6@%K+:K/]@7LV6LR"%:`#E9Y53.[1&?TP M7ZB18,HX,!3&S-Z,`AREYX@2A%EB')$!:)+1M/E806X0G3-:.*V M-B4C/RD1U8@:1"VB#E&OD`Z(.?6'T^SQDZ*IHP79R&CRX@!-G)0,]=0A;V0O M@B&:.2E1S`4].T@+D7#[E$M$5X)XY(Z">?9:VFG3X5)O$6RI2Y;2";H(TJ82 M6VZ8UJ*H4S18IQM4;$51KG]U'LQB'2KUHO1RFIJZ@C\J(GLC;Y$=VS($G2\E M-A>,)BXY$D0IH@Q1CJA`="G(>?9*D-NC73.B$2Y=+1FI=+07Y*$:I1I$+:(. M4:^03D<:!&]QO!$/YD&+=!J&PS`QE6Q2)"EQ0^J0/\J#89@Y*5',!3T[#`N1 M<-]VB>A*T+-IR'T^DH96*DC#8*-6R7>YP5(S6I"^E^7!]3>HV(HB7_]X-($T MY)Z[;^M%R?^VV=1->GI4F"K"&]+1%AU4.EKD;0P24PTR0\!E:(HH0Y0C*A!= M"G+7?"7(3T?;"96.%E$92D98Q8H>JA$UB%I$':(>T0;1H)`.CZD6O"$\MKA` M]N0"+TQ)SZ:C/_:"09LX*5%,'?(5@T&;.2E1S`4].V@+D?"3]M!-L7,E4C9I ME[!TLL:1G+527GPKMNNA&E&#J$74(>H1;1`-"NF0FP+$&T)NQ(-YVB*5D8#2 M,:`,48ZH0'2)Z$J0GY'V&U5&6N3%HF)%#]6(&D0MH@Y1CVB#:%!(A\=4%=X0 M'EN$4!G)=0G_-L=D$4SLB;EC&BZC!^1G9'#BSU`Q%R09.9\%2H5(^!EY^#:7 MD8R>RTANIIAZRUQPCBWYJ[SX5HAJ1`VB%E&'J$>T030HI$-NJ@]O"+DM5JB0 M6V0?4]F?RY,QH!11ABA'5""Z1'2%Z!I1*D0;1(-" M.CRF.N"'YZ\^#6"K#&8Q/@S?Z7EP%KLPU6O*2QJ^GM2A(L&Q/D0;1(-"*MBF)/=W!'MO1R^; MC-3MK>FYVS?;V#HI\4^**$.4(RH072*Z0G2-J!3D-L45HAI1@ZA%U"'J$6T0 M#0KI4,;J0V9?],8[T%3_"G=`C/P[*(A21!FB'%&!Z!+1%:)K1"4CFMYD/%6( M:D8+FEB>GYL:)R6V6D0=HA[1!M&@D`YE6-3Y2S?"3&$AV,H*-X[F9,2[^2("D0EHZE[P*A"5#-2(9J%]QL;)R6=:-%6YZ35#IS%&Q>)5B M*8I^)&WOO:[6++4 M5,9H+N-^,0W.;CDJ%:'29!ED:XE*%:*:T=*=0!M$+2IVC-3D/POO\?1.2D*S M030HI*-E"A4O1>MU=QXY2=A M*;]PC2A#E",J$)6,%GJ?$E1^*E2L&2U=7;=!U"+J$/6(-HR\PMS`B#XH%MKQ MIAK@.WZ_UQMY-]I?-W'9HH+*!(OFM`WTMG%!J2JALJ:)I,H$0!E+S?5&`N8S M4"Q$T=;*IJ/]__3YOL0N5(AJL>1G"U^A0RU*=8AZ1!M&*EO\R]%!,Q4)"-K4 M"]HKYR];V5!1L\B.%#XC`THG@#)$.:("4;G@?CI!)%Y^M:D#M--&+K M?+_7BX:[%34W472"G*5>6UK$!LZ&952B^8Y1,2,IC-F;GVW:6]&%#D9SVA2X M/%L%]U<2EO+S#%$FME[.,U0L1/&E/$.U"E&-J&%$1Q]925I!;G'I!#FI7I![ M.&HCR"D.C"*KTC1>TW";NM>EV=Y,$#1;Y?!+&BSEH111ABA'5""Z1'2%Z!I1 MR4CG9SB^*I:BE)`8U8)<5C5BZZ7\%#4O/P4Y2[VV%,]/EJ'X2I\&L80+(3WX MI_/SY1W(7CR(J2UXZ*W?*CAH)*RH$M$J>BA#J1Q1@:A$5"&J$36,5)+9?GEK M4H=2O2`_R4!Q4-^H)T9S9/<7LR..MR=\?\V:6N2O68A21!FB'%&!J&2DMWYA MJ"M4K!$U@MS@;AEY`[=#J5Z02[D-*@XB%1GQYGSK.]YL_:8+6J>.1,">BU4$ M+-)[O558;)]:*6^RDJ-1CYZP\C/S5`<5#?J%/#'/0A0C.B1R)D"P0J0A:I'`&43@%EB')$ M!:*2D5HW9N'#D)4HND%<"W()T8@MNV[$QD0K6OZRP5?C#/4B1=LTMUDZ#PX2 M&Y;R\F\0Q4@:Q6H)L]'J'7W[D3!A^8`*..8X%"12<-";!EU5HJ$;4,%*99&VI3&+D9Q(C/Y-`<5#?J#,IK"^8 MN6YB"D1'0H2%!GJ,VX1(91*@%*4R1#FB`E')*,BDH#!7B:*?2=POEP"-V+*9 M%(MN*X;\3`)#O4@=R22KJ#+)=Y8.DCGPAM/=V&3>D2#9@[*:[OAH3AL1E^>K MP&7)U#]A[P^[*:*,D1DLGJVP_(V*150QG&Q*5*P0U8@:,>_2I!7D3C>=("?5 M"_*3R7K"R\*!I>R,HN-D#KD0I]'Q.-G#L8J312J9`*530!FB'%&!J&04)%,0 MS4H4_63B3OC)9-'")M-X%JDNM6+)SR:PU(L4M;@Q%@Z5#4NI;&);N"Y1X")1 MHML!1[)IKZ=/-HR"52FXCY.P%'W(<2M%E(DM6946D\DD*/;DJ%8PTDD8.JA$ MQ0I1C:@1\RY+6D%>+@ER4KT@+Y<$.<6!$7V0:U0NS<(2P\M3W5X\"(XM)?@I MQ%(>2A%EB')$!:*2D4ZA49A"HNBED"`OA<263:')S$EMN>JH1-8+W:#B(%*128SV92IN M1U88(QZL,!:I[`"4FK*$/A=EB')$!:*2D1?Z"E&-J!%;;MRW@MP@[P0YJ5Z0 MGQU\04YQ8*E8=IC3:)@==`/JZ&[+GF)5=E@49$6BF20 MV8XI+^\SR'\RY%6/\^S-:.\S"A(JR(.$I3R/I8@RL66?%J!R/DWU>E.5HU8A M6K1I?;Y&4K*43JA1L'!5+.4O28)<&C1BR[OM$,P@K6AY^82H%^1L;P2YE!X8 MV7Q2)QQS3QG#^N;G??9F@K!B]8"EO#Q+$66(W%OL'&8X>O>;V=._O&AF9J>`PIN#`G["4YZ$4488H1U0@*AD%Z18> MJEA*I9N]()5N7,'@.Q2CU6P\7P6F6C'EYQN8ZJ5;UE3\B2N64=G&EB+99L[7 M?MA>WA&:63*D0;1(-" M.CG,,=?WLDF.5SV>0.<=<+A%9@;U\B,XK22LJ/+#*GHH8RD^5:WFB]EY4./( MT5"AM<;C.?U^1K#*E2RC@F2_WT,U2C6(6D0=HA[1!M&@D`Z2.27[03J2"O90 MK68NJ"4DT0;1H)#VLCF<^EY^97EA M;@^URMT6!8D0W(-)6-$;]2FBC!&-COW[$&-WD7-4*Q@=J2^PE(J2[;N':I1J M$+6(.D0]H@VB02$=)7/>]:-T)!?L\5@%AT_,;CU+Z(^H1;1`-"BDOF\<\E9=-+I@W';_L[;V:/D$R"E(A.'`G M+.6G`J),;'G/?@8'[ARU"D9',H&E_!@AJA$UB%I$':(>T0;1H)".47CJ/Q(; M>Y3W,V&!IWM$*:(,48ZH0%0R4EZVG?!0C5(-HA91AZA'M$$T**2];(Z6_GSS MNM.#V9X'VU%&.A/&P>XD$2EW%$P198QH<)A%84*O"J2=CBX,Y*A6B!JY_+!! MPZ(S2WD1J1#5B!I$+:(.48]H@VA02`#CM)@M`*:(,48ZH0%0R\EQ:(:H1-8A: M1!VB'M$&T:"0]K(Y#;[!R_;PJ+QLD9I-+%)C&5"VL(CG=3J_CE?A7?6<93Q+ MA:@=F=>M<14)0#7;\J0:1"VB#E&/:(-H4$A'(CSX[H]DQQ_Y-H_DA*NO1<&, M$]Q72EC1\VV**&.D9APV[^:E0J3\&<=*>;ZM6,I#-:(&48NH0]0CVB`:%-(1 M"`_%1V8;@;)4@2A%EB')$!:*2D>?2"E&-J$'4(NH0]8@VB`:%M)?- M8?,-,XX]FZH9QR(UXUBDQC*@S+SXAE*%9QSZA:<9/,>3LXQGJ1"U(S..-:XB M`:AF6YY4@ZA%U"'J$6T0#0JI2-![H'0D]C..62M>'OA[/7WR913,.,&!-1$I M-W&DB#)&_HR#4H5(>3,.(\^W%:(:48.H1=0AZA%M$`T*Z0B8\^#KH1;1`-"FDOQXZUQY]=ISA(A8>ER"=JRE-RY!<"Q2J0`H945/*D.4(RH0E8P\EU:(:D0-HA91AZA' MM$$T**2];(Z!_H2SG_*]IV=>]4P4O:X)G,^G4%H\#M46NL&JRS0)*ZK,L(H> MREB*[J":@L]J-9_0O2UM*4=+A5:+WP]C&14QVP$/U2C5(&H1=8AZ1!M$@T(Z M8N;$^E+$7O?B%5//#DX)C+Q,2!"EB#)$.:("4!PA844O.5)$&2.ZCV0+I//QE/Z2 M,$P8^X6>J4+KS4N(I6,M*EE$ALY8\5*-4@ZA%U"'J$6T0#0K9D)UY/Z=^ MOWWXNDVVW[\_GMSN?OM!+A[3'R!\?'_@)P_;+_13?\O)VJQ)M$A"RY1:]J_U M@Y89M>Q?6`+);4LK]Q!SKGU+)_@!): M5M2RWUZ'+DT>I>)UK(4\2@77 M6`MYE`J!L1;R*!U((BTS^A[Z.[A(RYQTZ"&06`OYFO9;L1;R->5BK(5\39D5 M:R%?VV-BX)U/X]7Z4S3:])+]M7E_/5J[F(S6YNWGL98QM<1\?3&E%GJ-4T1G M/EV;!]JPI2171SUMG!:3'Y."/7P'5UF.287>:A[YCC'YF7YH)-9"?J;?H\"6 M3[/U)_NJ\.!K+F9K^@UK5+B8TQ7&^&)-/]`;D5^NZ>=>(WQ\3B&)!?C3>/TI M-L`NR.LQIY>4$S%^,:'X1;ZYI!$NC;O)L5KH]>3KLW[ M2+&%7KQ).C%_T)LU22?60N]]))V8I^C%CJ03:Z%W%:_-RXEC/9A32RR"]-YP M^IY8"[T^G%P6\QF]DII:8MZAEQY32ZP']()=:HE]3[)8K4VQ`GN=4HNI66`+ M%9?6IG2!+5126N?1%JHLK4TA`W7HO?C4M]AHHI>VK\V;AU&'WMV^-B\@QA9Z MA3OY.N8W>B4XM<3\1O=/U^9&$EI+:,DRQ6-L2:G%U)"QA8K]:U-*QA8J\:_S M:`M5^JD',9T+ZO5%]$KI;>SK)-I"+V5?FW=#1WI`+>8%T-A"-ZCI2F,^H/O4 M=*6Q%KI=35<::Z&;U'2EL1;Z6=2U^1U4[$&U6-.O32-O%FOZ.6GDW6)-OQ>- MO*>)(,;I%P;6YIFLUA.TZ^M4$ML$:/?ZJ!1&[N.Y'R=Q#2R\W46 MX\7YNHCQR_,U_80S]O9RM:8?!$9^39/[GI\=EI7'C^]_WGS=UC6'NZ_F/,R_LLR_E?W+[NEI=T\;R-.3;]N;SUOZA>B1>:'5E]WN M2?Z#OOCLC]W#K_L=Z,?_"````/__`P!02P,$%``&``@````A`*R>+LS!$0`` M\U0``!D```!X;"]W;W)K&ULK)S;7[L44=;562K5A'BJ(H4N3NM6(KB6ILRR4IDYFW7[0:8!_^'MG>32YB^VLT MP&8#8#=X^/"O/Y\>+_[8[`_;W?/'R^BJ<7FQ>;[?/6R?OWV\K,KQ;S>7%X?C M^OEA_;A[WGR\_&MSN/S7IW_^X\//W?[WP_?-YGA!&IX/'R^_'X\O_>OKP_WW MS=/Z<+5[V3Q3R]?=_FE]I#_WWZX/+_O-^N'4Z>GQNMEH=*^?UMOG2ZVAOW^+ MCMW7K]O[S7!W_^-I\WS42O:;Q_61CO_P??MR$&U/]V]1][3>__[CY;?[W=,+ MJ?BR?=P>_SHIO;QXNN_'WYYW^_671QKWGU%[?2^Z3W^`^J?M_7YWV'T]7I&Z M:WV@..;;Z]MKTO3IP\.61J!.^\5^\_7CY>>H7[7:E]>?/IQ.T+^WFY\'Z_>+ MP_?=S\E^^S#?/F_H;-,\J1GXLMO]KD3C!X6H\S7T'I]F8+F_>-A\7?]X/!:[ MG]/-]MOW(TUWAT:D!M9_^&NX.=S3&24U5\V.TG2_>Z0#H/\OGK;*->B,K/\\ M_?RY?3A^_WC9ZEY>?-DY-[^T'0.,]*:&?K"2ZZD6- MV]8[=%`XG730SW@7UM+J MOGM"(W$+]8N4&9B`9V>%FKO!;U MF_2'A(MV\CJ`_BY^*'"4EL]*S<=+K,J(G*HJ0\6/LA\L/1![H/"!RL?E#ZH+.#,:NO7S*I2 M0U>Z\_&KA7KD8'64M]SS-ZA%Y`0.@8R`C(%,@$R!Q$!F0)*:_.TASVL1.>04 MR`)(!F0))`=2`%D!*8%4-G$FGU8(OR*DE1K*__2CGE?*WC?NU-YIJ;.S7XO( MJ1P"&0$9`YD`F0*)@F=KPYD467TK:G4%->K?U57H` M9`AD!&0,9`)D"B0&,@.2:!+=U$FB!;DS77H1?:6V2\?OV_O?[W9ZYQB8QA8MEO426BEQ9Y&) M.4<#3=JM>OQ#36YN3VON=M1MW;II>U0+R"D;:T*+?2$34#NM>ZFE?#MJ==NN MVK@6$"4S4)MH8LW$'$A:Z_D;0XM:0`QEFEA.L`22:V*9+FH])T.-VUOO1*UJ M`3%4@MK*)HX'J.J1OXUJ-VZOR&5.'E#N7FAN7]M%*2VN"VC2H=5??6GN^/NJ M@1:BW;$<^9!)LR8C5M0]^0F5I.B?.Z-C[F-B:P)ZIZ`W?E7O#/0FFEB3,P>2 M:M(ZQ=HI/A9`,B;FB)=`Y'MK\@%+V:$OR(I]T:6#OQ48 M[5AZF5B:"#)I92K(Z(Y?USV37D9W(L@X^QQ1RJAWJA;K)(`H0[1$E#.RPJM` MJ16B$E'E('?>5?'%OPZ\(1NH0J.7#AA9!SQ`-!1D901!)DC&C.R<(%)F!J:" MC*Y8D-$U0UT)(S\Q^%LM%J/(E)!*&;V2!XR4=,P8V9D`4<[(LEB(KC.1;T3$ M7(FZ*P>Y3J!J-;83O!+\NK1#VV\Q=Z>ARPE!/\NF/3!.A(=/&5 MO]EHM[PL,A9%)D`G@NS@!]WQZ[IGHLCH3AA1)4$&/$>4(EH@RA`M$>6("D0K M1"6BRD'NO*LZC3WO:AO0:K^Z%(AT?<=Q`(V@.:*4 MD;,$T`=AH0REEHAR5%^@U`I1B:ARD.L#JJCC^T"39N@U'U#]O#6@1DX6`#14 M-[>5#YC('0DRD3MFY&0!T#65CD97+,CHFJ&NA)&?!3JNF\U9S,D"^B@D"P1V MI@ON12(2EADC*^27B'(T5XBNLSN/E9$2BR6JKQSD.H$J%?E.$#5HJ*\D`EUB M(N\2NW>11EXBB-P3.V`I)Q'HCLY:@'5Q(NBHK8"K:"R*3*1.!-F)`'3'1NIL M(N".1GTB'>U$P%(&I2QE1?T"489HB2AG9,55@5(K1"6BRD&N#ZABD>\#S:CQ MSK)@I&M.CDMH9!W_@*4L-!1D8GDDR,3RF)&3%T#]5#H:7;$@HVN&NA)&?E[P M;B;,1:QA*INI,!JYNF"'MJT+2T8")F/FI`8](@OETM.R6`A3<5W7+N!BMK+$ MQ&B)1BL'N9ZABDF^9]`RP7C&V\J%5-6"2X9&7K;P2C0#[NAD"]W1R1:LBW<. MO5X/-@[B911GP@RF6&.*&4447#*#"T"+&-F)94E MHIR1%5M%0-DJP$K45CG(=0M53D*WD`?.WOXLCBY+.1E#(VL(@PC04)")\I$@ M$^5C1D[&`%U3Z6ATQ8*,KAGJ2AAY&:,!&4.;=%82&O%*HM?#G>Z"E3LK"=W+ MR@U+EK)0SL@R5QA=*CWU`@N7E1$1-RQ1=^4@QR.:?AGQM*-LO+J?./5SUY*, MO,3@E6@&+&4G!D$F>D>B2R>&S@W>2Y!.)OXF@JQ5A""C.A9T/C&(E%&?"+(2 M`Z*4D17P"T09HB6BG)$54P5*K1"5B"H'N2X0JBB^7E.@NWO^I8&1?5,8T1#1 M"-$8T031%%&,:(8H8>3E@*;W/.&6F'3-F5F'41@#1ADN)(R4Z"H96:FG,UW<9=)$'Y]#( M2P]>$6?`'9WT`%7!$4MU.#VT`NF!.YGXG:#JJ2`[/7#'5](#J$]$EYT>6,J@ ME*6<]*"E+)2AU!)1CA8+E%HA*A%5#G)=0)6^?!>@2_,K^\RFKIC92P1&5CH; M(!H*,I?UD2!S61\SLI<((F7.]E20T14+,KIFJ"MAY*6'R-O*SEG,BLN4$2\1 M6LU&Q^NT,!(2DQDC*R:7B')&EK5"=)VO-1@IL5BB^LI!K@NH>ICO`LYNXDV/ MGS1U6@FKZYS-Z3;&>I/!!FOG"-*&5DY8($H0[1$E#.RPJQ`J16B$E'E(-IZ36S3R]FL]1%?H'`_1R!K,@'Y7 M2V?,XH:=`6KKTGM&^_B MF8H8585TD9.J;+`DX7-#,A+0&?>S`GJ)*!?MYP^B$#$^B&`IPY*1@RC18N4@ MUV=4K=#WF5[GO35/NLT%UR&N4])*O3[3W8:W61QP1TI[\6)2!F+4T'&8BS(M>CM6&'O!@_Z+*7$J),;U.ZG1MX=G4LFJR5A"`K MU`/*8U=Y8/LY$T5&=\+(FOPYHA31`E&&:(DH1U0@6B$J$54."3(".&=$P)'%,1,KDDJD@HRL69'3-4%?"R)EIN5F2@[:S)A*I4(C)S,`&G)'6H]( MS(\$F6@>,W(R`^B:2D>C*Q9D=,U05\+(F5RMWD(I2BT098B6B')$!:(5HA)1 MY2!W)/!V#78ZN`^<";*C;V$D>41+NYW/]0G>Z*&FH^:ZP\*T8*Y MKY:=%*M^2ZM!WQHZ7;FA17V%Z/0`.K0TJ>6T/X.6%K6<*MK0TJ:6DRM""S4$ MCNQSN_\YV.&NW:?WV'$H=YT^O?,D/H>.[(X&'QP[S7J(WS7I9`6.*:&AA_A=JT_?FL`Q4+&8QATZBU0+IG&' M6JBL2^,.M5#5ELR'6JAL2'9"\TZ%0K(3:J%*(-D)M5#MC^R$6NA^&=D)C91N MBI&=4`O=]2([H1:ZK45V0BUTAX7LA+R2[JJ0G5`+W38A.Z$6NE5"=D(M]'@` MV0EY`-W_)SNA%KJ73W9"+72SGNR$6NA&,MD)>0[=/"8[H1:Z.TQV0BUT1YCL MA%K2Z+:OGFE"3\RH13W'A"WTW%)?/9B$+?1L$H5'J(6>FZ'QA!(I/2M#XPFU MT,,P-)Y0"ST`0^,)M=`SGS2>4*334YTTGE`+/;5)XPFUT$.9-)Y0"ST@2'9" MF8L>"20[H19ZYH_LA%KH*3^R$VI)(\H'=+L&SS4]P$YV0BWTA#K9";70(^AD M)]1"3T>3G5`$TQ/19"?40H\\DYU0"SWF3'9"+?3*#MD)13"]ED-V0BWTW@W9 M";70NS5D)]1"KWV0G5`$TZL>9"?40N]RD)U0"[V_079"+?2&*=D)>2*]54IV M0BT%M:CW1'%.Z551LA-JH?<GSXX M@7S>[=-'0I`ONGWZ,`CRO-LO0GS5[=/G/E`^I704LIM1,@KQ@E)1B)>4B$[\ MNEX.T2&PO=V]R:W-H965TTV)DZ"&.`+:SOS[.<8VQ3YM MIEWUIC1/CE]S7A_,B5=?O]=GXXDT;44O:].>3$V#7$JZKR['M?G/M_B+;QIM M5USVQ9E>R-K\05KSZ^;WWU;/M'EH3X1T!BA2)UT4[HE5S@ MFP-MZJ*#C\W1:J\-*?;]H/IL.=.I9]5%=3&Y0M"\1X,>#E5)0EH^UN32<9&& MG(L.[K\]5==6JM7E>^3JHGEXO'XI:7T%B?OJ7'4_>E'3J,L@.UYH4]R?(>_O MMEN44KO_@.3KJFQH2P_=!.0L?J,XYZ6UM$!IL]I7D`&SW6C(86W>V4%N>Z:U M6?4&_5N1YW;TO]&>Z'/25/L_J@L!MV&=V`K<4_K`0K,]0S#80J/C?@7^:HP] M.12/Y^YO^IR2ZGCJ8+GGD!%++-C_"$E;@J,@,W'F3*FD9[@!^&O4%2L-<*3X MWE^?JWUW6ILSN(=[TG9QQ:1,HWQL.UK_Q[^TA00?[(C!<)6#9Q/'G]MS#R9[ MKXHK5.`J5)R1R(WI88K^WN$J!BXFKC-?^#:;_<9`*/Y^(%SEC#?CER(>KL-$ M"WNZG"U>GZKLP`:;Y6+Q6QV6[ZW5@V5C M*G=,9FUZI@$+U$+)/6WLJ3]=64]0)Z4(VN*@A:.&[&0(JPHF'.H@TD&L@T0' MJ0XR'>0C8($Q@SM019_A#I-A[LBLMA*,[/(T)V2('!/J(-)!K(-$!ZD.,AWD M(Z`X,?L<)Y@,/,]JG=AJZEL>M(!%&:IIIH;LAI#!'D0B1&)$$D121#)$\C%1 M7(+]XC/JAS=D$EM.%LOA@=HA$B(2(1(CDB"2(I(ADH^)DBALB$JB?'>= ML#VZ.U7EPY;R%]HK!LQ@%^5[*Q-1\Q?$?\D?D9`3?]EOQJX]\USU$8J&`&EK MC$021-)A%-OCW>ERN51ELR%`RN9C$<6=Q2_<^4:OD/>O7CU,1;6'$[?O4GH+ M=XB$B$2(Q(@DB*2(9(CD8Z(8P#K>\DV"48I2IR@YTS5H3F2N#5(]8%_?^ MQ\GF31^\9>5.M15H7`\8A1A%&,48)1BE&&48Y0I27+,^%^\I,R?NQ2D^9(=N1\;HV2/K)3,-C<-ZL! M\R.Z[3R`'Q7P7M)XZ`70MV.>>@$TWIA#/06L@/`W4!T!*P?\#1P/WO5%JLV] M9<>&K\1OG0!.#;#.=A;`#V7,[]S@#DS"7VS=`'XR`K>&F>%8\%HKXV6YT&YOD'Q9Y!6MZ;X9@)S%!XKG'%B! M!4KSZ:Z`&3#;C8KL9^:#$VZ=H6G-IZU!?Q?D6O?^-^HCO:ZK8O=;<2;@-JP3 M6X%'2I]8:+IC"!I;J'7V^NUV#7'F>GZ@]'8=AT(-QY)W<0%DS2- M_+EN:/D/#W(Z*2XR[$3@*D2&@[%C!^[X\R)N)P+73F0X'CB>[7]A(-!;.QNX M"HW!9#3R_`D;R)T9^%U#N'8-_<\U''<-X=HU=+X\\Z#3@*L0[GJ\,]7AVWQ#&H3,U0PG=.!&I"(? MB$S.CW(3DI*I/#"9F0D+`6E7PP/U,G?L23"U7N`IR+N@!0X:#]60I0AA.<^$ M5SJ(=!#K8*V#1`>I#C8ZV/:`!4Y)N^!A^3_L8C+,+C'-A0`]_WS-&A$BVJQT M$.D@UL%:!XD.4AUL=+#M`<4:*`'(&A=R_/VB)A*'M8+RI21.8*M37_"@,2R* M3"]7#5G*$&D/(A$B,2)K1!)$4D0VB&S[1+')>\4[+J?52RZ=4=,:\').)"/ MW!*1%2(1(C$B:T021%)$-HAL^T29.E159>J\1`_8YM@_XXE+I1B M7J"9B.I(1R8W1SCQ8`UD3KF.EE0KU"SB9!*T9=]S7-]3\S"6`6(UUD@D0225 MK=ANXME!H&TG&QD@9+=]$<5"V.CO6OB#7L"VU/B\162$2 M(1(CLD8D021%9(/(MD\42]B[1'_C?R=[X`PGTH=%JU/GQ(?=0":+7H"6/,9C M,B]S/9'XC\.QS+](DIND%VC;8-SU.VDUQX'>YUJ*B*Q($$D[`AD6N[VD"V4@0Z4IR%$^$7G&71JK.<#-OW#YY4G/32;(5B(DY&MP(7([)& MK1)$4DY\_J[`CF`;1+;]5LK4V>%6F?M_JE6MBNI)AX)^NGG!6"TTRRZJEU,K MC*(.33R9>;%`K*2*`ZP73%3YM=!2\D8O2XF(NB5V*N1O/6X$ZO.GI:H_P1WE@H9V!!NG:&B)Z(^K'I"N3TV<'_Y9P[^5EF2ZD"6Y'2J MC9P^LT\8#CN#2"R_KSRTY4WC"_;=A:6*SH1J$4$8QAPS!8+L]"5;\*Q*_:;KCS"-MX.L/K`&\U\/7 M/@+5W!Y`Q=E3VH@;UH'\?CC_"0``__\#`%!+`P04``8`"````"$`-8N)/FD% M``"&%```&0```'AL+W=OK/9/(S? MV*_'$\>S[^_%T7@C9973T]RT>WW3(*>,;O/3?F[^]2/X-C6-JDY/V_1(3V1N M?I#*_+[X]9?9A98OU8&0V@"%4S4W#W5]]BRKR@ZD2*L>/9,3_+*C99'6<%ON MK>ITAOY7A_Q< M";4B>T2N2,N7U_.WC!9GD'C.CWG]T8B:1I%Y\?Y$R_3Y".-^MYTT$]K-#9(O M\JRD%=W5/9"S>$?QF%W+M4!I,=OF,`)FNU&2W=Q\LKW$'IC68M88]'=.+E7G M?Z,ZT$M8YMO?\A,!MV&>V`P\4_K"0N,M0]#80JV#9@;^*(TMV:6OQ_I/>HE( MOC_4,-TC&!$;F+?]6),J`T=!IC<8,:6,'J$#\-:](Q.[[P[9 M`Q^TSVTUX"I[+:?@3J=MR!8^>2QM^,1<+;O74,XZ_//5;EL\@YJ$7*=UNIB5 M]&+`*@>MZIRRFF%[-MR(5.0=D3 M87:)82X%Z/@WUJP1(:+-6@>^#@(=A#J(=!#K8*.#I`,4:Z`$(&N&D..WBYI( M'-8*RM?]Q.%!$Y@4F5Y#S1T9(NU!Q$(C$B`2(A(A$B.R023I$L4X\$C)K_MY MQ:(;?\2PEIQ,7+GH5HBL$?$1"1`)$8D0B1'9())TB3)TJ*O*T'F1[K&W57W( MLYSAV MU":!#!"S$2*1")%8MF+O$Z?ONJXJNY$!0C;IBB@6PJO^KH4_Z!G,^;=JQ514 M#SEQFOU>X_,*D34B/B(!(B$B$2(Q(AM$DBY1+&%?$]U7_XWL@5V<2!\6K0Z= MDS&\#SK)HL[0BLAL>ZN,_3_5JD9%]:1%;C?=1@-]&]!&=7)JC9'?HJDC M,R\0B)54L84=#;0Z%@HM)6_TLA2)J&MBQT+^^L2-0.H3M1Q,A-9G3U3-9]O6 M[I+6S7^LRK'O`"TC6]1-28S6&/DMF@P[5G/Y#@K;J$'SS=V4T0AKQ5AK@U&B M-%3M85O7>_8\]!Z%@P'D#D>=K%NU41VTQLAOD0N[19EUN."U45->B(:.HU7$ M$"M'&,5"!EX(UX>AHB>B^,.EX ML,6\P4<>[+\P]\<>[%XPC\<>;#\P]UT/RB[FL>M!&<4<%H@70,KB7R#=/9;? M\(LEW8!3H'.Z)[^GY3X_5<:1[,#@?K,3+/DY$K^IV^W,,ZWA_`?F`+[LX;R/ MP"=UOP<59T=I+6[8`^0)XN(G````__\#`%!+`P04``8`"````"$`S/L4[UT% M```_%0``&0```'AL+W=O^_K6ZT?*[.A-0*>"BJM7JNZZNC:55Z)GE23>B5%/#D2,L\J>%K>=*J M:TF20S,HOVA375]H>9(5*O?@E(_XH,=CEA*7IB\Y*6KNI"27I(;Y5^?L6G7> M\O01=WE2/K]86L^;]FA/J_5J36Q MYW-S85O@9D^JVL^83U5)7ZJ:YO]Q*Z/UQ;U,6R\SF#Y_/EM,YI8^,^"E]P:: M[4#X;`?:$W,ZM^Q?#02WS;PM,?#!-T+A-P/A\W-O7+8#X;,=:$T,4U_\(D(# M4LH59KE]1!R-IZC)N)O4R695TIL"RPAR4%T3MB@-A[GM(CXB`2(A(A$B<9](,L$V M*\DT?JQT.PNS;M3H@MARPDZ2OCX+69^=L.K&N8AXB/B(!(B$B$2(Q'TB!0]; MY">"9]9R\"V9-\=_LT?N,'(Q\C#R,0HP"C&*,(HE)$4,IZD4,3]A)DW^SEGZ MO*601ECM(V4P@Y.$GR_,B2Q$2VRQJ^X0<3FQE\V!9!J+V5(N$D\8=$7B(RRQ"WJUQA&;HNLF=#8P\C'`P.,0CPPPBB6!LI:L$;O MWFI[J-@,WB[R7V#-VMJVJ%=(.XS<%MFP&8A,XMKJK.P[Q86=!QB%G:>[[XM: MJR6>?9&1]VG6[N"/-&F#_" M@A$6CK!HA,4RD[5B#6)?JY$&H'?$L7YXL,>W2*H/;M5#+K;R,/(Q"C`*,8HP M8G!2Y7-BN!^27/=NY`%PD)'/*% M`\W6"#>F<"LT'7TR@R?-_COT99C=3=+@B6LYT!SAMX26`]T-YK#-.VQ?QT]@ MTW;8+HV?P#76T_A\85(C]EL(<-0>PAN+[LETGB`5^,5;B+KAFH@:KJ^NR8G\ MF92GK*B4"SE"6O2F#2OY!1C_4K?MV)[6<&\%F8,;$[BH)'!7H;-5?J2T[K[` MBS5Q];GY'P``__\#`%!+`P04``8`"````"$`-M@1.C,!``!``@``$0`(`61O M8U!R;W!S+V-O&UL(*($`2B@``$````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````G)%?3\,@%,7?3?P.#>\M9?-/0UJ6J-F32TR^1;P+,^OL(;`)0\<]\#43D0T(J68D/;#U0-`"@PU:##!8Y(1 M_.T-X+3_+\K\6^ME&)(1X4#'D`F\3UZ2'=4GN>W M=^LE8K.<7*1Y/,6:7--Y02_):XF/KG&>34`]!O@W\0A@0^Z??\Z^````__\# M`%!+`P04``8`"````"$`D-&R$4T%``#*$```$``(`61O8U!R;W!S+V%P<"YX M;6P@H@0!**```0`````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````````"<6,%R MVS80O7>F_Z#1/9%C9YJ.AU:&IB`+$XE4"5"V<\'`%&2QH4F6@%2[7]\',K:E M!&33W$1R'_;M8K'[(._CXT,^V*M:9V5Q,7SW]F0X4$5:KK/B_F*8\.F;WX<# M;62QEGE9J(OAD]+#C^-??_&6=5FIVF1*#[!$H2^&6V.J\]%(IUOU(/5;?"[P M95/6#]+@L;X?E9M-EJI)F>X>5&%&IR=759ZETB#*\2)+ZU*7&S,@CZG*O='A1P_LF$IW=6:>QB?> MZ/#18ZG,58"%QQN9:^6-7E]X,R5MTI8RJ_78VYOSO4I-60]T]@_2=CH##,4>>F5SI:+.4M7%0_G!VR+EAT3)N"3WOHD!M"%(8Y$O0HMWM MK#QD_A)#4!:ZS+.U-&HM+F4NBU0)]EVD/V(OEO*_73`#3[;2M"@W(JJP82]K MV]2W@1RQ>H%8!#-E^C\@C9=`'NW:BY M5T30D/$XL<&Q)E8^AU5?_;[["U#K.2%^RNLJ_Q3@Y'1R"'A[]]>PNNY[6+";NF='? MG<^<`?1CWCLQWU0WZ!B9Y3]6W7VV.+;H8FA[C!%TOSY3?Q&AN1X,K@D!JX"V MD\S).FIDGM"5Q'S_.S-;,5>0F/)>02'LG9!8Y8TJJ*!%GD0EG]JQ;;6%5K4; MTCDF1."[FU+WZ<%0GCJ]]$/[;2:KUKI%<\`#1@QTQ&7JE"$N#SN"D!1'])V0LY-J^ MQ`;)W*H\B&,0@RH)\<7JY\N,)"07C$"0M MJ,&@%W7&;V$6=7JR1#]5F([CV8P@>G$FPA"`1R[D3 M[Z1A`NSNM_MI!`@EB MA9#@M2RT3*TB.#[_1Y?&;ZZ)\ZSXHI.*EQ,T[.=[\/%+CVTEDHP;XO/WUQ?> M#%?@.K>+!%M9W*OUL\WW'^RM?=7^-3%^]_[MR=D)+N0'[[S1ZY\0XW\!``#_ M_P,`4$L!`BT`%``&``@````A`#6;J^=7`@``$"L``!,````````````````` M`````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$`M54P(_4` M``!,`@``"P````````````````"0!```7W)E;',O+G)E;'-02P$"+0`4``8` M"````"$`HT(4#K\"``#E*@``&@````````````````"V!P``>&PO7W)E;',O M=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`KW(CK+\&``"\%0`` M#P````````````````"U"P``>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@` M```A`!$)9\P1"@``YRX``!@`````````````````H1(``'AL+W=O&PO=V]R:W-H965TG$KD*@,```@*```9`````````````````.\Q``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`!X_3&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%_LD?*7`P``%@T``!D````````````````` M=D8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`,N_A_7&`P``4PX``!D`````````````````Z5```'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&YE.`U*!P``&PO=V]R M:W-H965T`8```\G M```9`````````````````)QR``!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,`````````````````2WD` M`'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8`"````"$`<(O1NL,/```F MJ```#0`````````````````0@```>&PO&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`,(`KU&8`@``+0<``!D` M````````````````+[H!`'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(M0-C:/`P``90P``!D````````````````` M@L,!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`+I3ZPT9`P``D`H``!D`````````````````B\T!`'AL+W=O&UL4$L!`BT`%``&``@````A M`.IFE9^*`@``+@<``!D`````````````````@]P!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!&D$I$58P``M#L" M`!D``````````````````!4"`'AL+W=O`(` M>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`&&EJ/OZ#@``T4\``!D````````````` M````L:@"`'AL+W=O`VETX`,``"N0@``&0````````````````#BMP(`>&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A``I_1_1#!P``$A\``!D`````````````````3LP"`'AL+W=O M&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-PDA]+,!0``[QD``!@````````````` M````&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A``@F=R*H"```,"L``!D`````````````````Q&8#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(?RG1FK M`P``D0P``!D`````````````````1GT#`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'FTD7#=!0``&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`"T%H,L?`P``9@H``!D`````````````````I>P# M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`$!?C$QL"```"2<``!D`````````````````A`H$`'AL+W=O&UL4$L!`BT`%``&``@````A`-RH;MZ.&@`` M0XT``!D`````````````````L)$$`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%I3=FQX!0``A!0``!D````````` M````````4,0$`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`#;8$3HS`0``0`(``!$`````````````````,]4$`&1O M8U!R;W!S+V-O&UL4$L!`BT`%``&``@````A`)#1LA%-!0``RA```!`` M````````````````G=<$`&1O8U!R;W!S+V%P<"YX;6Q02P4&`````%(`4@!P )%@``(-X$```` ` end XML 16 R70.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONCENTRATIONS AND CREDIT RISK DURATION (Details)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
CONCENTRATIONS AND CREDIT RISK DURATION        
Net Purchases Growers Synergy Pte. Ltd. - related party 6.00% 49.80% 26.40% 13.50%
Net Purchases Stevia Ventures Corporation 26.60% 10.30% 55.70% 14.40%
Net Purchases SGAgro Tech Pte Ltd 52.20% 0.00%    
Total Net Purchases 84.80% 60.10% 82.10% 27.90%

XML 17 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Black-Scholes option-pricing model with the following weighted-average assumptions: (Details)
Mar. 15, 2013
Feb. 26, 2013
Weighted -average assumptions    
Expected option life (year) 3 3
Expected volatility 75.11% 74.53%
Risk-free interest rate 0.40% 0.37%
Dividend yield 0.00% 0.00%
XML 18 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related party payments and services (Details) (USD $)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Farm management services        
Agreement amount with Growers Synergy     $ 20,000  
Related party Farm management services 180,000 180,000 240,000 180,000
Total Farm management services amt 180,000 180,000 240,000 180,000
Farm management services - future payments     140,000  
2014 (remainder of the fiscal year) 240,000      
2015 240,000      
2016 240,000      
2017 140,000      
Total Future minimum payments $ 860,000      
XML 19 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE INSTRUMENTS (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
DERIVATIVE INSTRUMENTS    
Fair Value of Warrants
The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 (reset to 6,247,146 on May 1, 2013) shares of the Company's common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).

 
Derivative warrants
Assets (Liability)
 
Total
       
Balance, September 30, 2012
 
$
(180,284
)
   
$
(180,284
)
Total gains or losses (realized/unrealized) included in:
                 
Net income (loss)
   
(305,829
)
     
(305,829
)
Other comprehensive income (loss)
   
-
       
-
 
Purchases, issuances and settlements
   
-
       
-
 
Transfers in and/or out of Level 3
   
-
       
-
 
                   
Balance, March 31, 2013
   
(486,113
)
     
(486,113
)
Total gains or losses (realized/unrealized) included in:
                 
Net income (loss)
   
675,949
       
675,949
 
Other comprehensive income (loss)
   
-
       
-
 
Purchases, issuances and settlements
   
(787,355
)
     
(787,355
)
Transfers in and/or out of Level 3
   
-
       
-
 
                   
Balance, December 31, 2013
 
$
(597,519
)
   
$
(597,519
)

 
     Fair Value Measurement Using Level 3 Inputs
    Derivative warrants         
   
Assets (Liability)
   
Total
 
             
Balance, August 6, 2012
  $ (411,805 )   $ (411,805 )
                 
Total gains or losses (realized/unrealized) included in:
               
                 
Net income (loss)
    231,521       231,521  
                 
Other comprehensive income (loss)
    -       -  
                 
Purchases, issuances and settlements
    -       -  
                 
Transfers in and/or out of Level 3
    -       -  
                 
Balance, August 6, 2012
    (180,284 )     (180,284 )
                 
Total gains or losses (realized/unrealized) included in:
               
                 
Net income (loss)
    (305,829 )     (305,829 )
                 
Other comprehensive income (loss)
    -       -  
                 
Purchases, issuances and settlements
    -       -  
                 
Transfers in and/or out of Level 3
    -       -  
                 
Balance, March 31, 2013
  $ (486,113 )   $ (486,113 )

Projected Volatility Curve
The projected volatility curve for the valuation dates was:

     
1 Year
   
2 Year
   
3 Year
   
4 Year
   
5 Year
 
                                 
August 6, 2012
   
129%
   
178%
   
218%
   
252%
   
281%
 
September 30, 2012
   
127%
   
173%
   
211%
   
244%
   
272%
 
March 31, 2013
   
122%
   
167%
   
205%
   
236%
   
264%
 
December 31, 2013
   
111%
   
168%
   
202%
   
233%
   
261%
 

 
The projected volatility curve for the valuation dates was:


 
 
1 Year
   
2 Tear
   
3 Year
   
4 Year
   
5 Year
 
                               
August 6, 2012
 
129%
   
178%
   
218%
   
252%
   
281%
 
                               
September 30, 2012
 
127%
   
173%
   
211%
   
244%
   
272%
 
                               
March 31, 2013
 
122%
   
167%
   
205%
   
236%
   
264%
 
 
Warrant Activities
The table below summarizes the Company's derivative warrant activity:

   
 
 
 
 
 
 
 
 
   
Warrant Activities
 
APIC
 
(Gain) Loss
 
   
Derivative
Shares
 
Non-derivative
Shares
 
Total Warrant
Shares
 
Fair Value of
Derivative
Warrants
 
Reclassification
of Derivative
Liability
 
Change in
Fair Value of
Derivative
Liability
 
                                       
Derivative warrant at August 6, 2012
   
1,152,000
   
-
   
1,152,000
   
(411,805
 
-
   
-
 
Mark to market
                     
231,521
         
(231,521
)
Derivative warrant at September 30, 2012
   
1,152,000
   
-
   
1,152,000
   
(180,284
)
           
Mark to market
                     
(73,723
)
       
(73,723
)
Derivative warrant at December 31, 2012
   
1,152,000
   
-
   
1,152,000
   
(106,561
)
           
 
Reset of warrant shares
   
1,799,424
                               
Mark to market
                     
(379,552
)
       
379,552
 
Derivative warrant at March 31, 2013
   
2,951,424
   
-
   
2,951,424
   
(486,113
)
           
Exercise of warrants  on May 6, 2013
   
(2,732,799
 
-
   
(2,732,799
 
-
   
-
   
-
 
Issuance of warrants  on May 6, 2013
   
5,713,918
   
-
   
5,713,918
   
(106,360
 
-
   
-
 
Reset of warrant shares
   
737,856
         
737,856
                   
Issuance of warrants on Oct 15, 2013
   
1,000,000
         
1,000,000
   
(76,647
)
           
Mark to market
                     
299,373
         
(299,373)
 
Derivative warrant at December 31, 2013
   
7,670,399
   
-
   
7,670,399
   
(369,747
)
           



   
2012 Warrant Activities
 
APIC
 
(Gain) Loss
 
   
Derivative
Shares
 
Non-derivative
Shares
 
Total Warrant
Shares
 
Fair Value of
Derivative
Warrants
 
Reclassification
of Derivative
Liability
 
Change in
Fair Value of
Derivative
Liability
 
                                       
Derivative warrant at August 6, 2012
   
1,152,000
   
-
   
1,152,000
   
(411,805
 
-
   
-
 
                                       
Mark to market
                     
231,521
         
(231,521
)
                                       
Derivative warrant at September 30, 2012
   
1,152,000
   
-
   
1,152,000
   
(180,284
)
       
(231,521
)
                                       
Mark to market
                     
(73,723
)
       
(73,723
)
                                       
Derivative warrant at December 31, 2012
   
1,152,000
   
-
   
1,152,000
   
(106,561
)
       
(305,244
)
                                       
Reset of warrant shares
   
1,799,424
                               
                                       
Mark to market
                     
(379,552
)
       
379,552
 
                                       
Derivative warrant at March 31, 2013
   
2,951,424
   
-
   
2,951,424
   
(486,113
)
       
74,308
 

Summary Of The Warrant Activities
The table below summarizes the Company's warrant activities:

   
Number of
Warrant Shares
   
Exercise Price
Range
Per Share
   
Weighted
Average
Exercise Price
   
Fair Value
at Date
of Issuance
   
Aggregate
Intrinsic
Value
 
                               
Balance, March 31, 2013
    5,233,177     $ 0.20     $ 0.20     $ 620,325     $ -  
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales
    737,856       0.20       0.20               -  
Granted
    6,713,918       0.20 - 0.25       0.23       183,007       -  
Canceled
    -       -       -               -  
Exercised
    (2,732,799 )     0.20       -               -  
Expired
    -       -       -               -  
Balance, December 31, 2013
    9,952,152     $ 0.20 - 0.25     $ 0.23     $ 803,332     $ -  
Earned and exercisable, December 31, 2013
    9,952,152     $ 0.20 - 0.25     $ 0.23     $ 803,332     $ -  
                                         
Unvested, December 31, 2013
    -     $ -     $ -     $ -     $ -  


    Number of     Exercise Price      Weighted Average     Fair Value at Date     Aggregate  
   
Warrant Shares
   
Range Per Share
   
Exercise Price
   
of Issuance
   
Intrinsic Value
 
                               
Balance, March 31, 2012
    -     $ -     $ -     $ -     $ -  
                                         
Granted
    5,233,177       0.25       0.25       620,350       -  
                                         
Canceled
    -       -       -               -  
                                         
Exercised
    -       -       -               -  
                                         
Expired
    -       -       -               -  
                                         
Balance, March 31, 2013
    5,233,177     $ 0.25     $ 0.25     $ 620,350     $ -  
                                         
Earned and exercisable, March 31, 2013
    5,233,177     $ 0.25     $ 0.25     $ 620,350     $ -  
                                         
Unvested, March 31, 2013
    -     $ -     $ -     $ -     $ -  

Warrants Outstanding
The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2013:

   
Warrants Outstanding
 
Warrants Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Average
Remaining
Contractual
Life (in years)
 
Weighted
Average
Exercise Price
 
Number
Exercisable
 
Average
Remaining
Contractual
Life (in years)
 
Weighted
Average
Exercise Price
 
                               
$0.20 - 0.25
 
9,952,152
 
4.36
 
$
0.23
 
9,952,152
 
4.36
 
$
0.23
 
$0.20 - 0.25
 
9,952,152
 
4.36
 
$
0.23
 
9,952,152
 
4.36
 
$
0.23
 
 

   
Warrants Outstanding
 
Warrants Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Average Remaining
Contractual Life
(in years)
 
Weighted Average Exercise Price
 
Number
Exercisable
 
Average Remaining Contractual Life
(in years)
 
Weighted Average Exercise Price
 
                                       
$0.25
   
5,233,177
   
3.73
 
$
0.25
   
5,233,177
   
3.73
 
$
0.25
 
                                       
$0.25
   
5,233,177
   
3.73
 
$
0.25
   
5,233,177
   
3.73
 
$
0.25
 

XML 20 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 21 R73.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Event Transactions (Details) (USD $)
Feb. 13, 2014
Feb. 07, 2014
Feb. 04, 2014
Jan. 21, 2014
Oct. 15, 2013
Jun. 23, 2013
May 03, 2013
Apr. 30, 2013
Subsequent Event Transactions                
No of shares issued for services               1,000,000
Per share value of shares           $ 0.20   $ 0.20
Value of consultation fee considered               $ 100,000
Value of stockissued           600,000    
Series A Warrants Granted             1,877,333  
Series B Warrants Granted             1,066,666  
Series C Warrants Granted             2,346,666  
Series A Warrants Granted Exercise Price             $ 0.20  
Series B Warrants Granted Exercise Price             $ 0.25  
Series C Warrants Granted Exercise Price             $ 0.25  
Cash Commissions             13,600  
Escrow Shares earned by Ventures stockholder           3,000,000    
Rate Of Interest Per Annum   8.00%     10.00%      
Accrued Interest Converted By Convertible Note Holder     26,325 23,400        
Shares Issued For Accrued Interest Converted By Convertible Note Holder     450,000 400,000        
Shares Issued For Warrants Exercised By Investor 1,877,333           853,333  
Value Of Shares Issued For Warrants Exercised By Investor 109,824           170,667  
Convertible Note Principal Face Value   $ 8,000,000            
Convertible Note Conversion Rate   $ 0.10 $ 0.0585 $ 0.0585        
Warrants Granted With Convertible Note   1,000,000            
Exercise Price Of Warrants $ 0.0585 $ 0.10         $ 0.20  
Term Of Warrants Granted With Convertible Note   5 years            
XML 22 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
EXHIBIT A - SCHEDULE OF MILESTONES PARENTHETICALS (Details) (USD $)
Jun. 23, 2013
Dec. 23, 2011
Jun. 23, 2011
EXHIBIT A - SCHEDULE OF MILESTONES PARENTHETICALS      
Total escrow shares 1,500,000 6,000,000 0
Escrow Shares earned and released to Ventures stockholder 3,000,000 3,000,000 3,000,000
Escrow shares par value $ 0.20 $ 0.25 $ 0.20
Shares on the date of release and recorded as compensation 600,000 750,000 600,000
XML 23 R71.htm IDEA: XBRL DOCUMENT v2.4.0.8
FUTURE MINIMUM PAYMENTS (Details) (USD $)
Dec. 31, 2013
Mar. 31, 2013
Future Minimum Payment [Abstract]    
Future Minimum Payments For The Fiscal Year 2014 1 $ 7,500 $ 30,000
Future Minimum Payments For The Fiscal Year 2015 1 30,000 30,000
Future Minimum Payments For The Fiscal Year 2016 1 30,000 30,000
Future Minimum Payments Total 1 $ 67,500  
XML 24 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Summary Of Significant Accounting Policies Tables [Abstract]    
Subsidiaries of the Company
The Company's consolidated subsidiaries and/or entities are as follows:
 

Name of consolidated
subsidiary or entity
 
State or other jurisdiction
of incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable
interest
 
               
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
    100 %
                 
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
    100 %
                 
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
    70 %
                 
  SC Brands Pte Ltd    Singapore   October 1, 2013     70
 

Name of consolidated
subsidiary or entity
 
State or other jurisdiction of
incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable interest
             
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
 
100%
             
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
 
100%
             
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
 
   70%


Potentially Outstanding Dilutive Common Shares
The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:

   
Potentially Outstanding Dilutive Common Shares
     
For Interim
PeriodEnded
December 31, 2013
 
For Interim
Period Ended
December 31, 2012
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").
   
-
 
3,000,000
           
Sub-total Make Good Escrow Shares
   
-
 
3,000,000
 
Convertible Note Shares
         
           
On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
881,752
 
426,667
           
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
1,739,130
 
426,667
           
On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.
   
            1,400,000
 
-
           
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
1,762,228
 
-
           
On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.
   
             2,353,573
 
            -
           
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
440,571
 
-
           
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.
   
            290,000
 
            -
           
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.
   
812,634
 
-
           
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
   
881,142
 
-
           
Sub-total Convertible Note Shares
   
10,561,070
 
853,334
 
Warrant Shares
         
           
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to investors (the "investor warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.
   
956,481
 
1,152,000
           
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company's common stock to two (2) note holders in connection with the issuance of convertible notes.
   
1,400,000
 
-
           
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock to the note holder in connection with the issuance of the convertible note.
   
881,753
 
-
           
On May 6, 2013, the Company issued three (3) series of warrants:
 
Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company's common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.
   
2,027,520
 
-
           
 
Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company's common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.
   
1,151,999
 
-
           
 
Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company's common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.
   
2,534,399
 
-
           
On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company's common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.
   
1,000,000
 
-
           
Sub-total Warrant Shares
   
9,952,152
 
1,152,000
           
Total potentially outstanding dilutive common shares
   
20,513,222
 
5,005,334

 
   
Potentially Outstanding Dilutive Common Shares
   
For Fiscal Year Ended
March 31, 2013
 
For the Period
from April 11, 2011
(inception) through
March 31, 2012
           
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").
    3,000,000     6,000,000    
                 
Sub-total Make Good Escrow Shares
    3,000,000     6,000,000    
                 
Convertible Note Shares
               
                 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.
    881,752     -    
                 
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at  $0.46875 per share with gross proceeds of at least $100,000.
    426,667     -    
                 
On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share
    1,400,000     -    
                 
Sub-total Convertible Note Shares
    2,708,419     -    
 
                 
Warrant Shares
               
                 
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the new warrants issued triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.
    2,951,424     -    
                 
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company's common stock to two notes holders in connection with the issuance of convertible notes.
    1,400,000     -    
                 
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock to the note holder in connection with the issuance of the convertible note.
    881,753          
                 
Sub-total Warrant Shares
    5,233,177     -    
                 
Total potentially outstanding dilutive common shares
    10,941,596     6,000,000    

XML 25 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES QUARTERLY (Details) (USD $)
Feb. 26, 2013
Jan. 18, 2012
Oct. 04, 2011
Jun. 23, 2011
Apr. 11, 2011
Feb. 14, 2011
CONVERTIBLE NOTES PAYABLE {2}            
Convertible Note Amount 1 $ 350,000   $ 2,500,000 $ 100,000 $ 2,500,000 $ 250,000
Interest Rate On Convertible Notes 1 12.00%   10.00% 10.00% 10.00% 10.00%
Accrued Interest Through The Date Of Conversion 2     15,890.41 2,822   15,890
Common Shares For Convertible Notes 1     1,000,000 11,288   63,561
Commons Shares For Conversion Of Principal 1     63,561 400,000   1,000,000
Common Stocks Per Share 1     $ 0.25 $ 0.25   $ 0.25
Note Holder Converted The Entire Principal Of 1     1,000,000 100,000   250,000
Accrued Interest Through The Date Of Conversion 3     2,821.92      
Per Share Value 1     $ 0.25      
Note Holder Converted The Entire Principal Amount 1   150,000        
Accrued Interest Through The Date Of Conversion 1   $ 4,356        
Per Share Value 3   $ 0.25        
Company SCommon Stock Shares 1   617,425        
XML 26 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory - Seeds (Details) (USD $)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Inventory - Seeds [Abstract]      
Seeds $ 1,807,000     
Inventory, net 1,807,000     
Write down for obsolete inventories $ 1,042,000    
Shares issued, other 15,538,882 18,713  
XML 27 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONCENTRATIONS AND CREDIT RISK (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
CONCENTRATIONS AND CREDIT RISK (Tables)    
Vendor purchase concentrations
Vendor purchase concentrations and accounts payable concentration are as follows:

 
Accounts Payable at
   
Net Purchases
 
 
December 31, 2013
   
March 31, 2013
   
For the Reporting
Period Ended
December 31, 2013
   
For the Reporting
Period Ended
December 31, 2012
 
                               
Growers Synergy Pte. Ltd. - related party
 
45.0
%
   
50.1
%
   
6.0
%
   
49.8
%
Stevia Ventures Corporation
 
19.3
%
   
16. 9
%
   
26.6
%
   
10.3
%
SG Agro Tech Pte Ltd
 
-
%
   
-
%
   
52.2
%
   
-
%
   
64.3
%
   
67.0
%
   
84.8
%
   
60.1
%


   
Accounts Payable at
 
Net Purchases
 
   
March 31, 2013
   
March 31, 2012
   
March 31, 2013
   
March 31, 2012
 
                         
Growers Synergy Pte. Ltd. - related party
    50.1 %     16.4 %     26.4 %     13.5 %
                                 
Stevia Ventures Corporation
    16. 9 %     54.1 %     55.7 %     14.4 %
                                 
      67.0 %     70.5 %     82.1 %     27.9 %

XML 28 R52.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants Outstanding (Details) (USD $)
9 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Dec. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Aug. 06, 2012
Sep. 30, 2012
Non-derivative Shares [Member]
Mar. 31, 2013
Non-derivative Shares [Member]
Mar. 31, 2013
Non-derivative Shares [Member]
Dec. 31, 2013
Non-derivative Shares [Member]
Dec. 31, 2013
Non-derivative Shares [Member]
Sep. 30, 2012
Total Warrant Shares [Member]
Mar. 31, 2013
Total Warrant Shares [Member]
Mar. 31, 2013
Total Warrant Shares [Member]
Dec. 31, 2013
Total Warrant Shares [Member]
Dec. 31, 2013
Total Warrant Shares [Member]
Sep. 30, 2012
Fair Value of Derivative Warrants [Member]
Mar. 31, 2013
Fair Value of Derivative Warrants [Member]
Mar. 31, 2013
Fair Value of Derivative Warrants [Member]
Dec. 31, 2013
Fair Value of Derivative Warrants [Member]
Dec. 31, 2013
Fair Value of Derivative Warrants [Member]
Sep. 30, 2012
APIC Reclassification Derivative Liability [Member]
Mar. 31, 2013
APIC Reclassification Derivative Liability [Member]
Mar. 31, 2013
APIC Reclassification Derivative Liability [Member]
Dec. 31, 2013
APIC Reclassification Derivative Liability [Member]
Dec. 31, 2013
APIC Reclassification Derivative Liability [Member]
Sep. 30, 2012
(Gain) Loss Change in Fair Value of Derivative Liability [Member]
Mar. 31, 2013
(Gain) Loss Change in Fair Value of Derivative Liability [Member]
Mar. 31, 2013
(Gain) Loss Change in Fair Value of Derivative Liability [Member]
Dec. 31, 2013
(Gain) Loss Change in Fair Value of Derivative Liability [Member]
Dec. 31, 2013
(Gain) Loss Change in Fair Value of Derivative Liability [Member]
Derivative warrant Balance 2,951,424 7,670,399 1,152,000 1,152,000 1,152,000 0 0 0 0 0 1,152,000 1,152,000 1,152,000 2,951,424 7,670,399 (411,805) (106,561) (180,284) (486,113) (369,747) 0 0 0 0 0 0 0 0 0 0
Mark to market           $ 0 $ 0 $ 0 $ 0   $ 0 $ 0 $ 0 $ 0   $ 231,521 $ (379,552) $ (73,723) $ 299,373   $ 0 $ 0 $ 0 $ 0   $ (231,521) $ 379,552 $ (73,723) $ (299,373)  
Exercise of warrants on May 6, 2013 (2,732,799)               0         (2,732,799)         0         0         0  
Issuance of warrants on May 6, 2013 5,713,918               0         5,713,918         (106,360)         0         0  
Reset of warrant shares. 737,856               0         737,856         0         0         0  
Issuance of warrants on Oct 15, 2013 $ 1,000,000               $ 0         $ 1,000,000         $ (76,647)         $ 0         $ 0  
XML 29 R67.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) (USD $)
Jun. 18, 2012
COMMITMENTS AND CONTINGENCIES COMPENSATION  
Percentage of stock issued 8.00%
Securities for financing 25,000
Gross proceeds $ 500,000
Securities financing 18,000
Gross proceeds to the Company 500,000
Consultants fees per month 3,000
Financing cost recorded under the Financing Consulting Agreement. $ 18,000
XML 30 R61.htm IDEA: XBRL DOCUMENT v2.4.0.8
ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION (Details) (USD $)
Dec. 31, 2013
Aug. 01, 2012
ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION    
Cash commission percentage   8.00%
Gross proceed received   $ 40,000
Common shares to purchase warrants   85,333
Percentage of common shares sold   8.00%
Exercise price of warrant for agent   $ 0.6405
Relative fair value of the agent warrants using the Black-Scholes Option Pricing Model 15,391  
Gross proceeds of the offering $ 500,000  
XML 31 R47.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW (Details) (USD $)
Mar. 31, 2013
Jul. 05, 2012
RELATED PARTY TRANSACTIONS CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW    
Percentage Owned By Stevia Asia 1   70.00%
Percentage Owned By Technew 1   30.00%
Contribution per month related party   $ 2,000,000
Total contribution related party $ 230,000 $ 2,000,000
XML 32 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOING CONCERN
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Going Concern [Abstract]    
GOING CONCERN
Note 3 - Going Concern

The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the consolidated financial statements, the Company had an accumulated deficit at December 31, 2013, a net loss and net cash used in operating activities for the reporting period then ended. These factors raise substantial doubt about the Company's ability to continue as a going concern.

The Company is attempting to generate sufficient revenue; however, the Company's cash position may not be sufficient to support its daily operations.While the Company believes in the viability of its strategy to generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect.  The ability of the Company to continue as a going concern is dependent upon its ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds.

The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Note 3 - Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

As reflected in the accompanying consolidated financial statements, the Company had an accumulated deficit at March 31, 2013, a net loss and net cash used in operating activities for the fiscal year then ended. These factors raise substantial doubt about the Company's ability to continue as a going concern.

While the Company is attempting to generate sufficient revenues, the Company's cash position may not be sufficient enough to support the Company's daily operations.  Management intends to raise additional funds by way of a public or private offering.  Management believes that the actions presently being taken to further implement its business plan and generate sufficient revenues provide the opportunity for the Company to continue as a going concern.  While the Company believes in the viability of its strategy to generate sufficient revenues and in its ability to raise additional funds, there can be no assurances to that effect.  The ability of the Company to continue as a going concern is dependent upon the Company's ability to further implement its business plan and generate sufficient revenues.

The consolidated financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

XML 33 R62.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Mar. 31, 2012
Number of Warrant Shares [Member]
     
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales 737,856    
Granted 6,713,918 5,233,177  
Canceled 0 0  
Exercised (2,732,799) 0  
Expired 0 0  
Balance 9,952,152 5,233,177 0
Earned and exercisable 9,952,152 5,233,177  
Unvested 0 0  
Exercise Price Range Per Share [Member]
     
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales 0.20    
Granted   0.25  
Granted with minimum exercise price range 0.20    
Granted with maximum exercise price range 0.25    
Canceled 0 0  
Exercised 0.20 0  
Expired 0 0  
Balance   0.25 0
Earned and exercisable   0.25  
Earned And Exercisable With Maximum Exercise Price Range 0.25    
Earned And Exercisable With Minimum Exercise Price Range 0.20    
Unvested 0 0  
Average Exercise Price [Member]
     
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales 0.20    
Granted 0.23 0.25  
Canceled 0 0  
Exercised 0 0  
Expired 0 0  
Balance 0.23 0.25 0
Earned and exercisable 0.23 0.25  
Unvested 0 0  
Fair Value at Date of Issuance [Member]
     
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales 0    
Granted 183,007 620,350  
Balance 803,332 620,350 0
Earned and exercisable 803,332 620,350  
Unvested 0 0  
Aggregate Intrinsic Value [Member]
     
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales 0    
Granted 0 0  
Canceled 0 0  
Exercised 0 0  
Expired 0 0  
Balance 0 0 0
Earned and exercisable 0 0  
Unvested 0 0  
EXCEL 34 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX M,V$X-V5B,F0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E!215!!241?15A014Y315,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E=%0E-)5$5?1$5614Q/4$U%3E1?0T]35%,\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E9%4E1)0DQ%7TY/5$537U!!64%"3$4\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D-/34U)5$U%3E137T%.1%]#3TY4 M24Y'14Y#2453/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E M;%=O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!2 M15!!241?15A014Y315-?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!23U!%4E197T%.1%]% M455)4$U%3E1?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E)%4T5!4D-(7T%.1%]$159%3$]0345.5%]486)L93PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D]21T%.25I!5$E/3E]!3D1? M3U!%4D%424].4U]$93PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-534U!4EE?3T9?4TE'3DE&24-!3E1?04-#3U5.5#,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D5.5$E465-?05-315137T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I7 M;W)K6UE;G1S7V%N M9%]S97(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/DES#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!R;VIE8W1E9%]V;VQA M=&%L:71Y7V-U#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D)L86-K4V-H;VQE#I7;W)K#I7;W)K#I7;W)K#I7;W)K M#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O%]A#I%>&-E;%=O%]R/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D-%3E12051)3TY37T%.1%]#4D5$251?4DE3 M2S,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7 M;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T&-E;"!84"!O3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C M-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA2!);F9O2!296=I'0^)U,M,3QS<&%N/CPO2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S`P,#$T M,SDX,3,\2!&:6QE3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O;7!A;GD\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO6UE;G1S(&%N9"!O=&AE'0^)SQS<&%N/CPO2P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XQ+#0W,2PW-S`\'0^)SQS M<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D.VYO;F4@:7-S M=65D(&]R(&]U='-T86YD:6YG/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W M85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A M.#=E8C)D+U=O'0O:'1M;#L@8VAA2!N=6UB97(@;V8@'0^)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XR-3`L,#`P+#`P,#QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T M,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y M.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'!E;G-E M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A;F0@8V]M<&5N'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&-E2!T'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO"!P M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y M7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2`H1&5F:6-I M="D@*%531"`D*3QB'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2!2:6=H=',@5F%L=65D/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ+#8S-2PS,#`\'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO2!5;FET'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO6%B;&4@ M27-S=65D($EN($9E8G)U87)Y($%N9"!-87)C:"`R,#$S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XR,C`L-#,X/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO&5R M8VES92!O9B!W87)R86YT('=I=&@@97AE2`V+"`R,#$S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XQ-S`L-C8V/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO M&5R8VES960@;VX@36%Y(#8L M(#(P,3,@8VQA3PO=&0^ M#0H@("`@("`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`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#$P,#QS<&%N M/CPOF%T:6]N($5X<&5N3PO=&0^#0H@("`@("`@(#QT9"!C;&%SF%T:6]N($5X<&5N'0^)SQS<&%N/CPO3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G1S(&%N9"!O=&AE6%B;&5S.SPO M=&0^#0H@("`@("`@(#QT9"!C;&%S2`H=7-E9"!I;BD@;W!E'0^)SQS<&%N/CPO2P@<&QA M;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!P86ED/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6%B;&5S/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`T,BPP,#`\'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y M7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A3L@5$585"U)3D1%3E0Z(#!P="<^ M($YO=&4@,2`M($]R9V%N:7IA=&EO;B!A;F0@3W!E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/ M4D%424]..B!U;F1E3L@5$585"U)3D1%3E0Z(#!P="<^($EN=&5R M<')O($UA;F%G96UE;G0@0V]R<"`H(DEN=&5R<')O(BD@=V%S(&EN8V]R<&]R M871E9"!U;F1E2`R,2P@,C`P-RXF;F)S<#LF;F)S<#LF;F)S<#M);G1E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@ M36%R8V@@-"P@,C`Q,2P@26YT97)P3L@ M5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&1I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IUF5D(&%S(&$@4F5V97)S92!!8W%U:7-I=&EO M;CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!C;&]S960@82!V;VQU;G1A&-H86YG92!!9W)E96UE;G0B M*2!B>2!A;F0@86UO;F<@=&AE($-O;7!A;GDL(%9E;G1U6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26UM961I871E;'D@<')I;W(@ M=&\@=&AE(&-O;G-U;6UA=&EO;B!O9B!T:&4@4VAA28C,SD[2!F;W(@8V%N8V5L;&%T:6]N+CPO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!I2!T:&4@0V]M<&%N>2!O9B!C97)T86EN('!O2P@1W)E96YB97)G(%1R875R:62!R97!R97-E;G1E9"!A M<'!R;WAI;6%T96QY(#(P+C0E(&]F('1H92!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2`H=&AE(&QE9V%L(&%C M<75I2D@870@=&AE:7(@8V%R M2!R97-T871E9"!T;R!R969L96-T('1H M92!N=6UB97(@;V8@2!T:&4@0V]M<&%N>2!I;B!T M:&4@=')A;G-A8W1I;VXN/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^ M($]N($UA2!F;W)M960@4W1E=FEA M($%S:6$@3&EM:71E9"`H(E-T979I82!!2X\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1% M3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`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`E(&]F('1H M92!I6UE;G0@;V8@)#(P,"PP,#`N/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;V]P97)A=&EV92!! M9W)E96UE;G0@2!T97)M:6YA=&4@=7!O;B!E M:71H97(@4W1E=FEA($%S:6$@;W(@5&5C:&YE=R!C96%S:6YG('1O(&)E(&$@ M2!B92!T97)M M:6YA=&5D(&)Y(&5I=&AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU2!O=VYI;F<@-S`E(&]F('1H92!S:&%R97,@86YD M(#,P)2!O=VYE9"!B>2!A(%-I;F=A<&]R92!S=')A=&5G:6,@<&%R=&YE2X@07,@ M;V8@1&5C96UB97(@,S$L(#(P,3,@4T,@0G)A;F1S('=A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU2!);G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU2!T:')O=6=H('!L86YN:6YG(&%N9"!M;VYI=&]R M:6YG('1H92!D86EL>2!O<&5R871I;VYS(&]F(&$@8G5S:6YE6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@36%R8V@@ M-"P@,C`Q,2P@26YT97)P6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@4W1E=FEA(%9E;G1U&-L=7-I=F4@<'5R8VAA2!A9W)E96UE;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@2G5N92`R M,RP@,C`Q,2`H=&AE(")#;&]S:6YG($1A=&4B*2P@=&AE($-O;7!A;GD@8VQO M&-H86YG92!!9W)E M96UE;G0@*'1H92`B4VAA3L@ M5$585"U)3D1%3E0Z(#!P="<^($EM;65D:6%T96QY('!R:6]R('1O('1H92!3 M:&%R92!%>&-H86YG92!42!H860@-SDL.#`P+#`P,"!C;VUM;VX@28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@07,@82!R97-U;'0@;V8@=&AE(%-H87)E($5X8VAA M;F=E($%G3L@5$585"U)3D1% M3E0Z(#!P="<^($%S(&$@2!D965M960@=&AE(&%C8V]U;G1I;F<@86-Q=6ER964@=6YD97(@=&AE(&%C M<75I2!O9B!696YT=7)E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@36%R8V@@,3DL(#(P,3(L('1H M92!#;VUP86YY(&9O2UO=VYE9"!S=6)S:61I87)Y+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2UO=VYE9"!S=6)S M:61I87)Y+"!U;F1E2!C:&%N9V5D(&ET2!P87)T;F5R+"!'=6%N9WIH;W4@2&5A;'1H($-H:6YA(%1E8VAN;VQO9WD@ M1&5V96QO<&UE;G0@0V]M<&%N>2!,:6UI=&5D+"!O<&5R871I;F<@=6YD97(@ M=&AE('1R861E(&YA;64@5&5C:"U.97<@0FEO+51E8VAN;VQO9WD@86YD($=U M86YG>FAO=28C,SD[2!, M:6UI=&5D+B9N8G-P.R9N8G-P.U!R:6]R('1O($IU;'D@-2P@,C`Q,BP@=&AE M(&1A=&4@;V8@96YT3L@5$58 M5"U)3D1%3E0Z(#!P="<^($]N($IU;'D@-2P@,C`Q,BP@4W1E=FEA($%S:6$@ M96YT97)E9"!I;G1O(&$@0V]O<&5R871I=F4@06=R965M96YT("AT:&4@(D-O M;W!E2!I;F-O2!O=VYS(#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!-86YA9V5M96YT M(&]F('1H92!#;VUP86YY(&ES(')E28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z M(#!P="<^(%1H92!U;F%U9&ET960@:6YT97)I;2!C;VYS;VQI9&%T960@9FEN M86YC:6%L('-T871E;65N=',@86YD(')E;&%T960@;F]T97,@:&%V92!B965N M('!R97!A2!5+E,N($=!05`@9F]R(&-O M;7!L971E(&9I;F%N8VEA;"!S=&%T96UE;G1S+B`F;F)S<#M4:&4@=6YA=61I M=&5D(&EN=&5R:6T@8V]N2!T;R!A(&9A M:7(@65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@96QE8W1E9"!-87)C M:"`S,7-T(&%S(&ET65A6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE('!R97!A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!O9B!S=6-H(&UA='1E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX@/&1I=CX@/'1A8FQE('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9 M.B!I;FQI;F4G/B`H:2DF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z M(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!"04-+1U)/54Y$+4-/3$]2.B`C M9F9F9F9F)SX@07-S=6UP=&EO;B!A6QE/3-$)U=)1%1(.B`Q.'!T)SXF;F)S<#L\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58 M5"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1$E34$Q!63H@:6YL:6YE.R!"04-+1U)/54Y$+4-/3$]2.B`C9F9F M9F9F)SX@06QL;W=A;F-E(&9O3QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^ M+B!4:&4@0V]M<&%N>2!E=F%L=6%T960@=&AE(&ME>2!F86-T;W)S(&%N9"!A M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$ M)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U35%E,13H@:71A;&EC.R!$25-03$%9.B!I;FQI;F4G/B`H:6EI*29N M8G-P.R9N8G-P.SPO9&EV/B`\+W1D/B`\=&0^(#QD:78@2!/8G-O;&5S8V5N8V4@86YD($UA2!T=7)N'!E7-I8V%L(&EN=F5N=&]R>2!C>6-L92!C;W5N=',N/"]D:78^ M(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1( M.B`Q.'!T)SXF;F)S<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!"04-+ M1U)/54Y$+4-/3$]2.B`C9F9F9F9F)SX@1F%I2!D971E2!E2!D971E2!C;VYS:61E2!W:71H(')E2!A;F0@;6]R92!F6QE/3-$)U=)1%1(.B`Q.'!T)SXF;F)S<#L\+W1D/B`\=&0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@0D%#2T=23U5. M1"U#3TQ/4CH@(V9F9F9F9B<^.CPO9F]N=#X@36%N86=E;65N="!AF%T:6]N(&]F('1H92!#;VUP86YY)B,S.3MS(&YE M="!D969E2UF;W)W87)D"!B96YE9FET2!A(&9U;&P@=F%L=6%T:6]N(&%L;&]W M86YC92X@36%N86=E;65N="!M861E('1H:7,@87-S=6UP=&EO;B!B87-E9"!O M;B`H82D@=&AE($-O;7!A;GD@:&%S(&EN8W5R2!O9B!A('!U8FQI8R!O M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T M:#TS1#$P,"4^(#QT6QE/3-$)U=)1%1(.B`S-G!T M)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U35%E,13H@ M:71A;&EC.R!$25-03$%9.B!I;FQI;F4G/B`H=FDI)FYB'0M M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@0D%#2T=2 M3U5.1"U#3TQ/4CH@(V9F9F9F9B<^.B!-86YA9V5M96YT(&5S=&EM871E'!E8W1E9"!V;VQA=&EL:71Y(&]F('1H92!# M;VUP86YY)B,S.3MS(&-O;6UO;B!S:&%R97,@86YD('1H92!M971H;V0@=7-E M9"!T;R!E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@36%N86=E;65N="!B87-E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!E=F%L=6%T97,@=&AE(&ME M>2!F86-T;W)S(&%N9"!A'!E3L@5$585"U)3D1%3E0Z(#!P="<^ M($%C='5A;"!R97-U;'1S(&-O=6QD(&1I9F9E3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GDF M(S,Y.W,@8V]N6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`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`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`E(&-O;'-P86X] M,T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@071T M#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4 M15A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4W1E=FEA(%9E M;G1U6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`P/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0R.24^(#QD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,3`P/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^)3PO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5. M5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S,"4^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!4 M15A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!!<')I;"`R M."P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`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`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0G/B!,979E;"`Q/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1M:61D;&4@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!1=6]T960@;6%R:V5T('!R:6-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@3&5V96P@,CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M;6ED9&QE('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M1FEN86YC:6%L(&%S3L@5$585"U)3D1%3E0Z(#!P="<^ M(%1H92!F86ER('9A;'5E(&AI97)A2!G:79E2!T;R!Q=6]T960@<')I8V5S("AU;F%D:G5S=&5D*2!I;B!A8W1I M=F4@;6%R:V5T2!T;R!U;F]BF%T:6]N(&ES(&)A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&-A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!U2!O;B!T M:&4@8V]N=F5R6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U M;F1E2!P97)F;W)M M2!T:&4@'!E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R6UE;G1S(&AA=F4@8F5E;B!R96-E:79E9"X\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T28C,SD[2X\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1% M3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY M(&1O97,@;F]T(&AA=F4@86YY(&]F9BUB86QA;F-E+7-H965T(&-R961I="!E M>'!O6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E M6EN9R!686QU92P@4F5C M;W9E6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE($-O;7!A;GD@:&%S(&%D;W!T960@<&%R86=R87!H(#,V,"TQ,"TS-2TQ M-R!O9B!T:&4@1D%30B!!8V-O=6YT:6YG(%-T86YD87)D2!N;W0@8F4@3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&%S2!O9B!I=',@;&]N9RUL:79E9"!A6EN9R!A;6]U;G0@;W9E3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&-O;G-I9&5R'!E8W1E9"!H:7-T;W)I8V%L M(&]R('!R;VIE8W1E9"!F=71U28C,SD[3L@*&EI:2DF;F)S<#MS M:6=N:69I8V%N="!N96=A=&EV92!I;F1U2!O2!E=F%L=6%T97,@86-Q=6ER960@87-S971S M(&9O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE(&ME>2!A2!B87-E9"!O;B!H:7-T;W)I8V%L('1R96YD M2!I;7!A8W0@8V%S:"!F;&]W3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!I;7!A:7)M96YT(&-H87)G97,L(&EF(&%N M>2P@:7,@:6YC;'5D960@:6X@;W!E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU2!C;VYS:61E2!L:7%U:60@:6YV97-T;65N=',@=VET:"!M871U3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE2!O8G-O;&5S8V5N8V4@9F]R('1H92!I M;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@5$585"U)3D1%3E0Z(#!P="<^ M("9N8G-P.SPO9&EV/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%!R M;W!E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@4')O<&5R='D@86YD(&5Q=6EP;65N="!I65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1% M3E0Z(#!P="<^($EN=&%N9VEB;&4@07-S971S($]T:&5R(%1H86X@1V]O9'=I M;&P\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U) M3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE($-O;7!A;GD@:&%S(&%D;W!T960@<&%R86=R87!H(#,U,"TS,"TR-2TS M(&]F('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%, M24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5V5B6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B`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`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`R,#$S('1O(')E8V]V97(@)#$L,#0R+#`P,"!O9B!P87-T M+61U92!A8V-O=6YT3L@5$585"U)3D1%3E0Z(#!P="<^(%1H M92!3971T;&5M96YT)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@8V]N M'1I;F=U:7-H;65N="!O9B!D96)T(&%N9"!A<'!L:65D M(&5X=&EN9W5I6%B;&4@86YD(')E;&%T960@2!A<'!L M:65D(&5X=&EN9W5I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`X,34M-#`M,34@;V8@=&AE($9! M4T(@06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N("@B4V5C=&EO M;B`X,34M-#`M,34B*71O(&1E=&5R;6EN92!W:&5T:&5R(&%N(&EN2UL:6YK960@9FEN86YC:6%L(&EN6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!M87)K6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!U=&EL:7IE2!P:6-K"!T:&%T(&$@ M0FQA8VLM4V-H;VQE2!N;W0@8F4@87!P2!C87!T=7)E9"!B>2!S:6UP;&4@;6]D96QS+B9N8G-P.R9N8G-P.TEN M(&]T:&5R('=O2!E M=F5N=',@=&AA="!C86X@;V-C=7([('1H92!(;VQD97(@97AE6EN M9R!F86-T;W)S('=H:6-H(&QE9"!T;R!P;W1E;G1I86P@2!A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!415A4+4E.1$5. M5#H@,'!T)SX@0F5N969I8VEA;"!#;VYV97)S:6]N($9E871U6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5VAE;B!T:&4@ M0V]M<&%N>2!I2`H0V]M;6ET;65N="!$871E*2P@82!B96YE9FEC:6%L(&-O M;G9E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U19 M3$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@3&]S2!I;G9O;'9E M(&=U87)A;G1E97,L(&EN('=H:6-H(&-A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^ M(%1H92!#;VUP86YY(&9O;&QO=W,@<&%R86=R87!H(#@Q,"TQ,"TV-2TQ(&]F M('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A2XF;F)S<#LF;F)S<#M.;VXM M8V]N=')O;&QI;F<@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!F;VQL;W=S('!AF5D(&]R(')E86QI>F%B;&4@86YD(&5A2!C;VYS:61E&ES=',L("AI:2D@=&AE('!R;V1U8W0@:&%S(&)E96X@ M&5D M(&]R(&1E=&5R;6EN86)L92P@86YD("AI=BEC;VQL96-T86)I;&ET>2!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!A8V-O=6YT3L@5$585"U$14-/4D%424]. M.B!U;F1E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W2!3=&%T96UE;G0@;V8@1FEN86YC:6%L($%C8V]U M;G1I;F<@4W1A;F1A6QE/3-$)T9/3E0M4U19 M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SXB06-C;W5N=&EN9R!F;W(@ M4F5S96%R8V@@86YD($1E=F5L;W!M96YT($-O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(')E6UE;G1S(&9OF5D(&%S(&%N(&5X<&5N3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!#;VUP86YY(&%C8V]U;G1S(&9O2!I;G-T2!M96%S=7)A8FQE+B9N8G-P.R9N8G-P.U1H92!M96%S M=7)E;65N="!D871E('5S960@=&\@9&5T97)M:6YE('1H92!F86ER('9A;'5E M(&]F('1H92!E<75I='D@:6YS=')U;65N="!I2!T2!P6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE(&9A:7(@=F%L=64@;V8@;F]N+61E6QE/3-$)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT/B`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`\+W1D/B`\+W1R M/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV/B`\=&%B M;&4@6QE/3-$ M)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT/B`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`Q M,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^(%)I6EE;&0@8W5R=F4@:6X@969F96-T(&%T('1H92!T:6UE(&]F(&=R86YT(&9O M3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY)B,S.3MS('!O;&EC>2!IF4@8V]M<&5N2!);G-T65E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!A8V-O=6YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!I;G-T2!A28C,SD[2!O2!I M;F9L871E9"!D=64@=&\@82!L87)G97(@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P M,"4^(#QT6UB;VPL('-E'!E8W1E9"!T97)M(&]F('-H87)E M(&]P=&EO;G,@86YD('-I;6EL87(@:6YS=')U;65N=',@'!E8W1E9"!E>&5R8VES92!B96AA=FEO2!I2!T M'!E8W1E9"!T M97)M+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R M("\^(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I M9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI M;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU'!E8W1E9"!V;VQA=&EL:71Y(&]F('1H92!E;G1I='DF(S,Y.W,@ M7,@9&EF9F5R96YT('9O;&%T:6QI=&EE'!E8W1E9"!V;VQA=&EL:71Y+B9N8G-P.R9N8G-P.T$@=&AI;FQY+71R M861E9"!O"P@86YD(&AO=R!I="!H87,@8V%L M8W5L871E9"!H:7-T;W)I8V%L('9O;&%T:6QI='D@=7-I;F<@=&AA="!I;F1E M>"Y4:&4@0V]M<&%N>2!U2!O9B!T:&4@8V]M<&%R86)L92!C;VUP86YI97,@;W9E2!T2!P M2!C86QC=6QA=&EO;B!U2!O8G-E2!I;F9L871E9"!D=64@=&\@82!L87)G97(@6QE/3-$ M)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ M(&IU'!E8W1E9"!A;FYU86P@ M2!T:&%T('5S97,@82!M971H;V0@=&AA="!E;7!L;WES(&1I9F9E'!E8W1E9"!D:79I M9&5N9',N)FYB6EE;&0@87,@=&AE(&)E3H@4WEM8F]L+"!S97)I9CL@1D].5"U325I%.B`Q,7!T)SX@)FUI M9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1% M3E0Z(#!P="<^(%)I6EE;&0@8W5R M=F4@:6X@969F96-T(&%T('1H92!T:6UE(&]F(&=R86YT(&9O6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@4'5R2!T M:&4@9W)A;G1E92!T;R!R971A:6X@=&AO2!T;R!E M87)N('1H92!E<75I='D@:6YS=')U;65N=',L(&$@;65A2!C;VYC;'5D92!T:&%T(&%N(&%S M2!T:&4@9W)A M;G1E92!I;B!O65D(&%S M(&-O;G1R82UE<75I='D@8GD@=&AE(&=R86YT;W(@;V8@=&AE(&5Q=6ET>2!I M;G-T2`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`P<'0[('1E>'0M86QI9VXZ M(&IU"!06QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R2!R97-U;'0@9G)O;2!T M65AF%T:6]N(&]F('1H92!.3TQS('=O M=6QD(&)E('-U8FIE8W0@=&\@86X@86YN=6%L(&QI;6ET871I;VX@=6YD97(@ M4V5C=&EO;B`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`E(&-O;'-P86X],T0T/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T M)SX@1F]R($EN=&5R:6T\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`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`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@,RPP,#`L,#`P/"]D:78^(#PO=&0^(#PO M='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM4DE'2%0Z(#6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,RPP,#`L,#`P/"]D:78^(#PO=&0^ M(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV/B9N8G-P.SPO9&EV/B`\9&EV M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\9&EV('-T>6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!-87)C:"`W+"`R,#$R+"!T M:&4@0V]M<&%N>2!I2!C;VUP;&5T97,@82!P'0@<')I=F%T M92!P;&%C96UE;G0@870@)#`N-#8X-S4@<&5R('-H87)E('=I=&@@9W)O2!P87-T(&1U92!W:71H(&YO M('!E;F%L='D@86YD('1H92!#;VUP86YY(&-O;G1I;G5E6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-#(V M+#8V-SPO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!- M05)'24XM4DE'2%0Z(#3L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!/;B!-87D@,S`L(#(P,3(L('1H92!#;VUP86YY M(&ES2!T28C,SD[ M2!A;F0@=&AE($-O M;7!A;GD@8V]N=&EN=65S('1O(&%C8W)U92!T:&4@:6YT97)E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L-S,Y+#$S,#PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#0R-BPV-C<\+V1I=CX@/"]T9#X@ M/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&IU2!C;VYT:6YU97,@=&\@86-C'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB M'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!*=6QY(#$V+"`R,#$S M+"!T:&4@0V]M<&%N>2!I6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^(#$L-S8R+#(R.#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`\+W1D/B`\+W1R/B`\ M='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#2!I6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.S(Y,"PP,#`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`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`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO M9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,S9P=#L@34%21TE.+5)) M1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@4W5B+71O=&%L($-O;G9E6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$P+#4V,2PP-S`\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#@U,RPS,S0\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE. M+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`M.7!T)SX@5V%R6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB2!I2`X+"`R,#$S M+"!T:&4@0V]M<&%N>2!C;VUP;&5T960@82!P2`X+"`R,#$S+"!I;G9E M'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@.34V+#0X,3PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P,#PO9&EV/B`\+W1D M/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G M/B!/;B!&96)R=6%R>2`R-BP@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D('=A M'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,2PT,#`L,#`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M+3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)' M24XM4DE'2%0Z(#3L@5$585"U) M3D1%3E0Z("TY<'0G/B!/;B!-87)C:"`Q-2P@,C`Q,RP@=&AE($-O;7!A;GD@ M:7-S=65D(&$@=V%R28C,SD[6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\ M+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/ M;B!-87D@-BP@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D('1H6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T M.R!-05)'24XM4DE'2%0Z(#3L@ M5$585"U)3D1%3E0Z("TY<'0G/B!397)I97,@02!W87)R86YT&5R8VES92!P65A6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(L,#(W M+#4R,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`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`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^(#$L,#`P+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P M,#PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@-#5P=#L@34%21TE. M+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`M.7!T)SX@5&]T86P@<&]T96YT:6%L;'D@;W5T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@,C`L-3$S+#(R,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#4L,#`U+#,S-#PO9&EV/B`\+W1D M/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%1H M92!#;VUP86YY(&%D;W!T960@<&%R86=R87!H(#(S,"TQ,"TT-2TR-"!O9B!T M:&4@1D%30B!!8V-O=6YT:6YG(%-T86YD87)D6UE;G1S(&%C8V]R9&EN9R!T;R!W:&5T:&5R('1H97D@2P@86YD('5S97,@=&AE(&EN9&ER96-T(&]R(')E8V]N8VEL:6%T:6]N M(&UE=&AO9"`H(DEN9&ER96-T(&UE=&AO9"(I(&%S(&1E9FEN960@8GD@<&%R M86=R87!H(#(S,"TQ,"TT-2TR-2!O9B!T:&4@1D%30B!!8V-O=6YT:6YG(%-T M86YD87)D2!A9&IU6UE;G1S(&%N9"!A;&P@86-C2!P6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[(%1%6%0M M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX@4W5B3L@5$585"U)3D1%3E0Z(#!P="<^ M(%1H92!#;VUP86YY(&9O;&QO=W,@=&AE(&=U:61A;F-E(&EN(%-E8W1I;VX@ M.#4U+3$P+34P(&]F('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A2!A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@1F5B6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY#;VUP M6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU2`R,#$S+"!T:&4@1FEN86YC M:6%L($%C8V]U;G1I;F<@4W1A;F1A&5D(&%T('1H M92!297!O65A3L@5$585"U)3D1%3E0Z(#!P="<^ M($EN($UA2!-871T97)S("A4;W!I8R`X M,S`I.B!087)E;G0F(S,Y.W,@06-C;W5N=&EN9R!F;W(@=&AE($-U;75L871I M=F4@5')A;G-L871I;VX@061J=7-T;65N="!U<&]N($1E2!O2!&05-"('1O(&5L:6UI;F%T92!S;VUE(&1I2!I;B!C=7)R96YT(&%C8V]U;G1I;F<@<')A8W1I8V4N(%1H:7,@05-5(&ES M(&5F9F5C=&EV92!P65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN($UA2!T:&4@<&5R2!O=&AE2DN($EF(&$@<&QA;B!F;W(@;&EQ=6ED871I;VX@=V%S('-P96-I9FEE M9"!I;B!T:&4@96YT:71Y)B,S.3MS(&=O=F5R;FEN9R!D;V-U;65N=',@9G)O M;2!T:&4@96YT:71Y)B,S.3MS(&EN8V5P=&EO;B`H9F]R(&5X86UP;&4L(&QI M;6ET960M;&EF92!E;G1I=&EE2!M96%S=7)I M;F<@86YD('!R97-E;G1I;F<@87-S971S(&%T('1H92!A;6]U;G0@;V8@=&AE M(&5X<&5C=&5D(&-A2!S:&]U;&0@:6YC;'5D92!I;B!I=',@<')E2!T:&%T(&QI<75I9&%T:6]N(&)E8V]M M97,@:6UM:6YE;G0N($5A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@36%N86=E M;65N="!D;V5S(&YO="!B96QI979E('1H870@86YY(&]T:&5R(')E8V5N=&QY M(&ES6EN9R!F:6YA;F-I86P@&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF M>3L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@,B`M(%-U;6UA6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U M;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE($-O;7!A;GDF(S,Y.W,@8V]N2!A8V-E<'1E9"!I M;B!T:&4@56YI=&5D(%-T871E'0M86QI9VXZ(&IU M2!A<'!L:65S M('1H92!G=6ED86YC92!O9B!4;W!I8R`X,3`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`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@071T M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@5&5R6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,3`P)3PO9&EV/B`\+W1D M/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M("TY<'0G/B!3=&5V:6$@07-I82!,:6UI=&5D/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@2&]N9R!+;VYG(%-!4CPO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@,3`P)3PO9&EV M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!3=&5V:6$@5&5C:&YE=R!,:6UI=&5D/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)2!A;&EG;CTS1&QE M9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@2&]N9R!+;VYG(%-!4CPO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@36%N86=E;65N="!B87-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!E=F%L=6%T97,@=&AE(&ME>2!F86-T M;W)S(&%N9"!A'!E3L@5$585"U)3D1%3E0Z(#!P="<^($%C='5A M;"!R97-U;'1S(&-O=6QD(&1I9F9E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@ M9F]L;&]W2!087)A9W)A<&@@.#(P+3$P M+3,U+3,W(&%R92!D97-C6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!,979E;"`R/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1M:61D;&4@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!02!O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&5V96P@,SPO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@4')I8VEN9R!I;G!U=',@=&AA="!A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1FEN86YC:6%L M(&%S2!T M;R!Q=6]T960@<')I8V5S("AU;F%D:G5S=&5D*2!I;B!A8W1I=F4@;6%R:V5T M2!T;R!U;F]BF%T:6]N(&ES(&)A'0M86QI9VXZ(&IU28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GDF M(S,Y.W,@8V]N=F5R=&EB;&4@;F]T97,@<&%Y86)L92!A<'!R;WAI;6%T97,@ M=&AE(&9A:7(@=F%L=64@;V8@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU28C,SD[2P@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@270@:7,@;F]T+"!H;W=E=F5R+"!P2!N871U6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A M;GD@=7-E2!T M;R!M96%S=7)E('1H92!F86ER('9A;'5E(&]F('1H92!D97)I=F%T:79E(&QI M86)I;&ET:65S(&%N9"!R979A;'5E2!A="!E=F5R>2!R97!OF5S(&=A:6YS(&]R(&QO6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6EN9R!686QU92P@4F5C;W9E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@96QE8W1E9"!- M87)C:"`S,2!A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@5&AE($-O;7!A;GD@8V]N3L@5$585"U$14-/4D%424]..B!U;F1E2!A;F0@17%U:7!M96YT/"]D:78^(#QD M:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%!R;W!E2!T:&4@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!H87,@861O<'1E9"!P87)A9W)A<&@@ M,S4P+3,P+3(U+3,@;V8@=&AE($9!4T(@06-C;W5N=&EN9R!3=&%N9&%R9',@ M0V]D:69I8V%T:6]N(&9O65A2XF;F)S M<#LF;F)S<#M5<&]N(&)E8V]M:6YG(&9U;&QY(&%M;W)T:7IE9"P@=&AE(')E M;&%T960@8V]S="!A;F0@86-C=6UU;&%T960@86UOF%T:6]N(&%R92!R M96UO=F5D(&9R;VT@=&AE(&%C8V]U;G1S+CPO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O M;7!A;GD@9F]L;&]W6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2!M971H;V0@8GD@=&AE(&EN M=F5S=&EN9R!E;G1I='D[(&,N)FYB3L@9BXF;F)S<#MO=&AE3L@5$585"U)3D1%3E0Z M(#!P="<^(%1H92!F:6YA;F-I86P@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY M(&%C8V]U;G1S(&9OF4@86QL(&1E2!A'!O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`P<'0[('1E M>'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!F;VQL;W=S('-U8G1O<&EC(#0U,"TR,"!O9B!T:&4@ M1D%30B!!8V-O=6YT:6YG(%-T86YD87)D2!B=70@=VAI8V@@ M=VEL;"!O;FQY(&)E(')E3L@5$585"U) M3D1%3E0Z(#!P="<^($EF('1H92!A2!C86X@8F4@97-T:6UA=&5D+"!T:&5N('1H92!E2P@86YD(&%N(&5S=&EM871E M(&]F('1H92!R86YG92!O9B!P;W-S:6)L92!L;W-S97,L(&EF(&1E=&5R;6EN M86)L92!A;F0@;6%T97)I86PL('=O=6QD(&)E(&1I6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3&]S2!I;G9O;'9E(&=U87)A;G1E97,L(&EN M('=H:6-H(&-A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU M3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&9O M;&QO=W,@<&%R86=R87!H(#@Q,"TQ,"TV-2TQ(&]F('1H92!&05-"($%C8V]U M;G1I;F<@4W1A;F1A2!I;B!T:&4@8V]N M2XF;F)S<#LF;F)S M<#M.;VXM8V]N=')O;&QI;F<@:6YT97)E2P@4W1E=FEA(%1E8VAN97<@3&EM M:71E9"X@3F]N+6-O;G1R;VQL:6YG(&EN=&5R97-T(&ES(&%D:G5S=&5D(&9O M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O M;7!A;GD@86-C;W5N=',@9F]R(&ET2!I;G-T2!A28C,SD[2!O2!I;F9L871E9"!D=64@=&\@82!L87)G97(@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE3H@4WEM8F]L+"!S97)I9CL@1D].5"U3 M25I%.B`Q,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@ M/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`Q M,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`Q,7!T)SX@)FUI M9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`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`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^/&)R("\^(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG M;CTS1')I9VAT/B`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`S-G!T)R!A;&EG;CTS1')I9VAT/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O M;"P@'0M86QI9VXZ(&IU'!E M8W1E9"!A;FYU86P@2!T:&%T('5S97,@82!M971H;V0@=&AA="!E;7!L M;WES(&1I9F9E'!E8W1E9"!D:79I9&5N9',N)FYB6EE;&0@87,@=&AE(&)E6QE/3-$)U=)1%1( M.B`S-G!T)R!A;&EG;CTS1')I9VAT/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R2!R97-U;'0@9G)O;2!T65AF%T:6]N(&]F('1H92!.3TQS('=O=6QD M(&)E('-U8FIE8W0@=&\@86X@86YN=6%L(&QI;6ET871I;VX@=6YD97(@4V5C M=&EO;B`S.#(@9&5T97)M:6YE9"!B>2!M=6QT:7!L>6EN9R!T:&4@=F%L=64@ M;V8@:71S('-T;V-K(&%T('1H92!T:6UE(&]F('1H92!O=VYE2!U;G5S960@86YN=6%L(&QI;6ET871I;VX@;6%Y(&)E(&-A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@3F5T(&EN8V]M92`H;&]S2!D:79I9&EN9R!N970@:6YC;VUE("AL M;W-S*2!B>2!T:&4@=V5I9VAT960@879E3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!F;VQL;W=I;F<@=&%B;&4@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@0V]M;6]N(%-H M87)E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-3`E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E(&-O;'-P86X],T0T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@=&AE(%!E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`M M.7!T)SX@36%K92!';V]D($5S8W)O=R!!9W)E96UE;G0@&-H86YG92!!9W)E96UE;G0@8V]N6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,RPP,#`L,#`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`Q,7!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BPP,#`L,#`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`M.7!T)SX@3VX@36%R8V@@-RP@,C`Q,BP@=&AE($-O M;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T92!I;B!T:&4@86UO=6YT M(&]F("0R,#`L,#`P('=I=&@@:6YT97)E2!C;VUP;&5T97,@82!P M'0@<')I=F%T92!P;&%C96UE;G0@870@ M)#`N-#8X-S4@<&5R('-H87)E('=I=&@@9W)O6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB2`S M,"P@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T M92!I;B!T:&4@86UO=6YT(&]F("0R,#`L,#`P('=I=&@@:6YT97)E2!C;VUP;&5T97,@82!P'0@<')I=F%T M92!P;&%C96UE;G0@870F;F)S<#LF;F)S<#LD,"XT-C@W-2!P97(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`M.7!T)SX@3VX@1F5B2!I6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`W M+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!- M05)'24XM4DE'2%0Z(#28C,SD[&5R8VES92!P M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`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`Q,7!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,3`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`P<'0[('1E>'0M M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A M;GD@861O<'1E9"!P87)A9W)A<&@@,C,P+3$P+30U+3(T(&]F('1H92!&05-" M($%C8V]U;G1I;F<@4W1A;F1A2!S=&5M(&9R;VT@ M;W!E2!P87)A9W)A<&@@ M,C,P+3$P+30U+3(U(&]F('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A6UE;G1S(&%N9"`H M8BD@86QL(&ET96US('1H870@87)E(&EN8VQU9&5D(&EN(&YE="!I;F-O;64@ M=&AA="!D;R!N;W0@869F96-T(&]P97)A=&EN9R!C87-H(')E8V5I<'1S(&%N M9"!P87EM96YT2!R97!O6UE;G1S(&EN('1H92!P97)I;V0@ M<'5R3L@5$585"U)3D1%3E0Z M(#!P="<^(%1H92!#;VUP86YY(&9O;&QO=W,@=&AE(&=U:61A;F-E(&EN(%-E M8W1I;VX@.#4U+3$P+34P(&]F('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A M2!A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@2F%N=6%R>2`R M,#$S+"!T:&4@1D%30B!I65A2`Q M+"`R,#$S+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2`R,#$S+"!T:&4@1D%30B!I'0M86QI9VXZ(&IU M2`R,#$S+"!T M:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A&5D(&%T('1H92!297!O65A3L@5$585"U)3D1% M3E0Z(#!P="<^($EN($UA2!-871T97)S M("A4;W!I8R`X,S`I.B!087)E;G0F(S,Y.W,@06-C;W5N=&EN9R!F;W(@=&AE M($-U;75L871I=F4@5')A;G-L871I;VX@061J=7-T;65N="!U<&]N($1E2!O2!&05-"('1O(&5L:6UI;F%T92!S;VUE M(&1I2!I;B!C=7)R96YT(&%C8V]U;G1I;F<@<')A8W1I8V4N(%1H M:7,@05-5(&ES(&5F9F5C=&EV92!P65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN($UA2!T:&4@<&5R2!O=&AE2DN($EF(&$@<&QA;B!F;W(@;&EQ=6ED871I;VX@=V%S M('-P96-I9FEE9"!I;B!T:&4@96YT:71Y)B,S.3MS(&=O=F5R;FEN9R!D;V-U M;65N=',@9G)O;2!T:&4@96YT:71Y)B,S.3MS(&EN8V5P=&EO;B`H9F]R(&5X M86UP;&4L(&QI;6ET960M;&EF92!E;G1I=&EE2!M96%S=7)I;F<@86YD('!R97-E;G1I;F<@87-S971S(&%T('1H92!A;6]U M;G0@;V8@=&AE(&5X<&5C=&5D(&-A2!S:&]U;&0@:6YC;'5D92!I;B!I=',@<')E2!T:&%T(&QI<75I9&%T M:6]N(&)E8V]M97,@:6UM:6YE;G0N($5A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@36%N86=E;65N="!D;V5S(&YO="!B96QI979E('1H870@86YY(&]T:&5R M(')E8V5N=&QY(&ES6EN9R!F:6YA;F-I M86P@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#!P="<^($YO=&4@,R`M($=O:6YG($-O;F-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&-O;G-O;&ED M871E9"!F:6YA;F-I86P@2!W:6QL(&-O;G1I;G5E(&%S(&$@ M9V]I;F<@8V]N8V5R;BP@=VAI8V@@8V]N=&5M<&QA=&5S(&-O;G1I;G5I='D@ M;V8@;W!E3L@5$585"U)3D1% M3E0Z(#!P="<^($%S(')E9FQE8W1E9"!I;B!T:&4@8V]N2!H860@86X@86-C=6UU M;&%T960@9&5F:6-I="!A="!$96-E;6)E28C,SD[6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE($-O;7!A;GD@:7,@871T96UP=&EN9R!T;R!G96YE6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@5&AE(&-O;G-O;&ED871E9"!F:6YA;F-I86P@2!B92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN M9R!C;VYC97)N+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@,R`M M($=O:6YG($-O;F-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5VAI M;&4@=&AE($-O;7!A;GD@:7,@871T96UP=&EN9R!T;R!G96YE28C,SD[2!N;W0@8F4@28C,SD[2!O<&5R871I;VYS+B9N8G-P.R9N8G-P M.TUA;F%G96UE;G0@:6YT96YD2!O9B!A('!U8FQI8R!O2!B96QI979E2!T;R!F=7)T:&5R(&EM<&QE;65N="!I=',@ M8G5S:6YE6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE(&-O;G-O;&ED871E9"!F:6YA;F-I86P@2!B92!U;F%B;&4@=&\@8V]N=&EN=64@87,@82!G;VEN9R!C M;VYC97)N+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@-"`M(%!R M97!A:60@17AP96YS97,\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@4')E<&%I9"!E>'!E;G-E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`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`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#,S+#`Y-CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N M/3-$'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,38X+#@W-#PO9&EV/B`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&'!E;G-E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4')E<&%I M9"!R97-E87)C:"!A;F0@9&5V96QO<&UE;G0\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`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`M.7!T)SX@4F5T M86EN97(\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#0U,3PO9&EV/B`\+W1D/B`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`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@ M3W1H97(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#0L,36QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO M9&EV/B`\+W1D/B`\=&0@3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B M,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B M9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO2!A;F0@17%U:7!M96YT M/"]D:78^(#QD:78@6QE/3-$)T-/3$]2.B!B;&%C:SL@3$545$52+5-004-) M3D'!E;G-E/"]F;VYT/CPO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\(2TM M16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT;6P@ M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]% M3B(@(FAT='`Z+R]W=W&AT;6PQ+71R M86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&IU2!A;F0@17%U:7!M96YT/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%!R;W!E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI M9VXZ(&-E;G1E6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T M)SX@4')O<&5R='D@86YD(&5Q=6EP;65N=#PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`M,3AP="<^ M(#4\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,RPP,S8\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#$L,C,T/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B`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`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@,RPP,S8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D3L@5$585"U)3D1%3E0Z M(#!P="<^(%1H92!#;VUP86YY(&%C<75I'!E;G-E(&9O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M3VX@2G5L>2`U+"`R,#$R+"!T:&4@0V]M<&%N>2!A8W%U:7)E9"!T:&4@2!F2!,:6UI=&5D(&EN(&5X8VAA;F=E(&9O28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`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`M($%C<75I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@2G5L>2`U+"`R,#$R+"!T:&4@0V]M M<&%N>2!A8W%U:7)E9"!T:&4@2!F2!,:6UI=&5D(&EN(&5X8VAA;F=E M(&9O6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV M/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`M.7!T)SX@5&5C:&YO;&]G>2!R:6=H=#PO9&EV/B`\+W1D/B`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`M M,3AP="<^(#$U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@,2PV,S4L,S`P/"]D:78^(#PO=&0^(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#@Q+#"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^("@M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^(#PO M='(^(#QT6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D3L@5$585"U) M3D1%3E0Z(#!P="<^($%M;W)T:7IA=&EO;B!E>'!E;G-E(&9O'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPO'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7 M,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W M=W&AT;6PQ+71R86YS:71I;VYA;"YD M=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU6QE/3-$)TU!4D=)3BU,1494.B`P<'0[(%1%6%0M24Y$ M14Y4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U35%E,13H@:71A;&EC M.R!$25-03$%9.B!I;FQI;F4G/B`H:2D\+V9O;G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-4 M64Q%.B!I=&%L:6,[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX@06UO MF%T:6]N(&5X<&5N3L@5$585"U)3D1%3E0Z(#!P="<^($%M;W)T:7IA=&EO;B!E>'!E;G-E('=A M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN M;&EN92<^("9N8G-P.SPO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@ M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!8 M2%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD M:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1% M3E0Z(#!P="<^(%=E8G-I=&4@9&5V96QO<&UE;G0@8V]S=',L('-T871E9"!A M="!C;W-T+"!L97-S(&%C8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B!C;VYS:7-T M960@;V8@=&AE(&9O;&QO=VEN9SH\+V1I=CX@/&)R("\^(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W M:61T:#TS1#$P,"4^(#QT6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`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`P<'0G M/B`D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#4L,S$U/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q+#@V.3PO9&EV/B`\ M+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE M(&%L:6=N/3-$'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-"PU,30\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D3L@5$585"U)3D1%3E0Z(#!P="<^($%M;W)T:7IA=&EO;B!E M>'!E;G-E('=A65A M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4F5L871E9"!P87)T:65S M('=I=&@@=VAO;2!T:&4@0V]M<&%N>2!H860@=')A;G-A8W1I;VYS(&%R93H\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1T;W`@=VED=&@],T0V M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1T;W`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`Q.'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!, M979E6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB2!O=VYE9"!A;F0@8V]N=')O;&QE9"!B>2!T:&4@<')E3PO M9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!.;VXM8V]N=')O;&QI;F<@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z("TY<'0G/B!'2!0=&4@3'1D+CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H M/3-$-B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06X@96YT:71Y(&]W;F5D M(&%N9"!C;VYT'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@1W5A;F=Z:&]U($AE86QT:"!496-H;F]L;V=Y($1E=F5L;W!M96YT M($-O;7!A;GD@3&EM:71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P M('=I9'1H/3-$-B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06X@96YT:71Y M(&]W;F5D(&%N9"!C;VYT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@1G)O;2!T:6UE('1O('1I;64L('-T;V-K:&]L9&5R(&]F('1H M92!#;VUP86YY(&%D=F%N8V5S(&9U;F1S('1O('1H92!#;VUP86YY(&9O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@ M;&5A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]. M.B!U;F1E'0M86QI9VXZ(&IU2!E;G1E M2!0=&4@3'1D+B`H(D=34$PB*2P@82!3:6YG87!O'!I2!T:&4@0V]M<&%N>2!U<&]N(#,P(&1A>2!N;W1I M8V4N)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M3VX@3V-T;V)E'!I3L@5$585"U)3D1% M3E0Z(#!P="<^($9A2!'6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B!$96-E;6)E"<@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ(&-E M;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!P97)I;V0@96YD960\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0G/B!&87)M(&UA;F%G M96UE;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@ M'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@,3@P+#`P,#PO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$X M,"PP,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M,3@P+#`P,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$X,"PP,#`\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@1G5T=7)E(&UI;FEM=6T@<&%Y;65N=',@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,3AP M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`M.7!T)SX@1FES8V%L(%EE87(@16YD:6YG($UA6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`R-W!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TY<'0G/B`R,#$T("AR96UA:6YD97(@;V8@=&AE(&9I'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#(T,"PP,#`\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B`R,#$U/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#(T,"PP,#`\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`R M-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TY<'0G/B`R,#$W/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@,30P+#`P,#PO9&EV/B`\+W1D/B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L M:6=N/3-$'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@.#8P+#`P,#PO9&EV/B`\ M+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU2!R M96QA=&5D('1O('1H92!P87EM96YT(&]F("0R,#`L,#`P+CPO9&EV/B`\(2TM M16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT;6P@ M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]% M3B(@(FAT='`Z+R]W=W&AT;6PQ+71R M86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%4 M24]..B!U;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@4F5L871E9"!P87)T:65S('=I=&@@=VAO;2!T:&4@0V]M<&%N>2!H860@ M=')A;G-A8W1I;VYS(&%R93H\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV M/B`\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@.7!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^(%)E;&%T960@4&%R=&EE"<@=F%L:6=N/3-$=&]P('=I9'1H M/3-$-B4@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^("8C,3(R.#@[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T M)SX@1V5O6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4')E M3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@06X@96YT:71Y(&]W;F5D(&%N9"!C M;VYT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@ M5&5C:&YE=R!496-H;F]L;V=Y($QI;6ET960\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1'1O<"!W:61T:#TS1#8E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M("TY<'0G/B!'2!0=&4@3'1D+CPO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-B4^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@06X@96YT:71Y(&]W;F5D(&%N9"!C;VYT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1W5A;F=Z M:&]U($AE86QT:"!496-H;F]L;V=Y($1E=F5L;W!M96YT($-O;7!A;GD@3&EM M:71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-B4^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`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`Q+"`R,#$Q M+B9N8G-P.R9N8G-P.T9O2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$58 M5"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R('1H92!P97)I;V0@9G)O M;2!*=6QY(#$L(#(P,3$@=&AR;W5G:"!/8W1O8F5R(#,Q+"`R,#$Q+"!T:&4@ M0V]M<&%N>2!E;F=A9V5D($=R;W=E2!0=&4@3'1D+B!T;R!P M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@3F]V96UB97(@ M,2P@,C`Q,2P@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@36%N86=E;65N M="!A;F0@3V9F+51A:V4@06=R965M96YT("AT:&4@(DUA;F%G96UE;G0@06=R M965M96YT(BD@=VET:"!'65EF%T:6]N)FYB2!O=&AE2!T M:&4@0V]M<&%N>2!U<&]N(#,P(&1A>2!N;W1I8V4N)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV M/B`\+W1D/B`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`Q,7!T.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M($9A"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,3@P+#`P,#PO9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@,3@P+#`P,#PO9&EV/B`\+W1D/B`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M,30P+#`P,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,30P+#`P,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E M3L@5$585"U)3D1%3E0Z(#!P="<^ M($]N($IU;'D@-2P@,C`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`T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T M-E]D,SDX,V$X-V5B,F0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2`R M-BP@,C`Q,R!I3L@5$585"U)3D1%3E0Z(#!P M="<^($]N($9E8G)U87)Y(#(V+"`R,#$S+"!T:&4@0V]M<&%N>2!E;G1E2!G'!I65A2!A;F0@=&AE($-O;7!A;GD@8V]N=&EN=65S('1O M(&%C8W)U92!T:&4@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A M;GD@97-T:6UA=&5D('1H92!R96QA=&EV92!F86ER('9A;'5E(&]F('1H97-E M('=A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B`\=&%B;&4@'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`M.7!T)SX@17AP96-T960@;W!T:6]N(&QI9F4@*'EE87(I M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO M='(^(#QT6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$ M:79I9&5N9"!Y:65L9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XP,#PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\+W1D/B`\+W1R/B`\ M+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@5&AE(')E;&%T:79E(&9A:7(@=F%L=64@;V8@=&AEF5D(&%S(&]F(%-E<'1E;6)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU65E(BDL(&UA='5R:6YG(&]N(%-E<'1E;6)E65E(&AA2!G'!I65A2!A;F0@=&AE($-O;7!A;GD@8V]N=&EN=65S('1O M(&%C8W)U92!T:&4@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A M;GD@97-T:6UA=&5D('1H92!R96QA=&EV92!F86ER('9A;'5E(&]F('1H97-E M('=A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!%>'!E8W1E9"!O<'1I;VX@;&EF92`H>65A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#,N,#`\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@17AP96-T960@ M=F]L871I;&ET>3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-S4N,3$\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@/"]T'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4FES:RUF M6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N-#`\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@/"]T M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#PO M=&%B;&4^(#PO9&EV/B`\9&EV/CQB'0M86QI9VXZ(&IU2!A;6]R=&EZ97,@=&AE(&1I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%4 M24]..B!U;F1E3L@5$585"U)3D1%3E0Z(#!P="<^ M($]N($]C=&]B97(@,34L(#(P,3,L('1H92!#;VUP86YY(&ES2`Q+#(U,"PP,#`@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$58 M5"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@06X@(D5V96YT(&]F($1E9F%U;'0B+"!W:&5R979E M2!O;F4@;V8@=&AE(&9O;&QO=VEN9R!E M=F5N=',L("AI:2D@02!#;VYV97)S:6]N($9A:6QU2!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY('-H86QL M(&-O;6UE;F-E+"!O2!O=&AE2!L;W-E&-H86YG92!#;VUM:7-S:6]N+CPO9&EV/B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@5&AE(&9A:7(@=F%L=64@;V8@;F]T92!D97)I=F%T:79E(&QI M86)I;&ET>2!A;F0@=&AE('=A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@0V]N=F5R=&EB;&4@;F]T97,@<&%Y M86)L92!C;VYS:7-T960@;V8@=&AE(&9O;&QO=VEN9SH\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R M("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\ M9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`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`Q.'!T.R!-05)'24XM M4DE'2%0Z(#3L@5$585"U)3D1% M3E0Z("TY<'0G/B!/;B!-87D@,S`L(#(P,3(L('1H92!#;VUP86YY(&ES2`H,S`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E/C(P,"PP,#`\+W1D/B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#2`R-BP@,C`Q,R!C;VYV97)T:6)L92!N;W1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,24^/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,24^/&9O;G0@'0M86QI M9VXZ(&IU2`Q-BP@ M,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T92!I M;B!T:&4@<')I;F-I<&%L(&%M;W5N="!O9B`D,3$Q+#$Q,2!W:71H(&$@,3`E M($]R:6=I;F%L($ES2!P M97)I;V0@8F5F;W)E('1H92!C;VYV97)S:6]N(&1A=&4@+CPO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,24^/&9O;G0@'0M86QI9VXZ(&IU2!I7,@8F5F;W)E M('1H92!C;VYV97)S:6]N(&1A=&4@=VET:"!I;G1E2`R-BP@,C`Q-"X\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3$E/C$U,RPU,#`\+W1D/B`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`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3$E/BT\+W1D/B`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`Q M.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!/8W1O8F5R(#$U+"`R,#$S+"!T M:&4@0V]M<&%N>2!I2XF;F)S<#LF;F)S<#M);B!C;VYN96-T:6]N('=I=&@@ M=&AE(&ES2!G&5R8VES M92!P6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E/C4X+#`P,#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE2!I6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB65A6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-S(E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`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`Q.'!T.R!- M05)'24XM4DE'2%0Z(#3L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!$:7-C;W5N="!R97!R97-E;G1I;F<@*&DI('1H M92!R96QA=&EV92!F86ER('9A;'5E(&]F('1H92!W87)R86YT6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,24^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!- M05)'24XM4DE'2%0Z(#3L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!!8V-U;75L871E9"!A;6]R=&EZ871I;VX@;V8@ M9&ES8V]U;G0@;VX@8V]N=F5R=&EB;&4@;F]T97,@<&%Y86)L93PO9&EV/B`\ M+W1D/B`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`Q M,7!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3$E/C,U-RPW-S`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU2`Q M-"P@,C`Q,2P@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T M92!I;B!T:&4@86UO=6YT(&]F("0R-3`L,#`P('=I=&@@:6YT97)E28C,SD[2X\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@2G5N92`R M,RP@,C`Q,2P@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T M92!I;B!T:&4@86UO=6YT(&]F("0Q,#`L,#`P('=I=&@@:6YT97)E28C,SD[3L@ M5$585"U)3D1%3E0Z(#!P="<^($]N($]C=&]B97(@-"P@,C`Q,2P@=&AE($-O M;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T92!I;B!T:&4@86UO=6YT M(&]F("0Q-3`L,#`P('=I=&@@:6YT97)E2`Q."P@,C`Q,BP@=&AE(&YO=&4@:&]L9&5R M(&-O;G9E28C,SD[2`R-BP@,C`Q,R!I3L@5$58 M5"U)3D1%3E0Z(#!P="<^($]N($9E8G)U87)Y(#(V+"`R,#$S+"!T:&4@0V]M M<&%N>2!E;G1E28C,SD[2!G'!I65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@97-T:6UA=&5D('1H M92!R96QA=&EV92!F86ER('9A;'5E(&]F('1H97-E('=A6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W M:61T:#TS1#$P,"4^(#QT'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@,RXP,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@17AP96-T M960@=F]L871I;&ET>3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-S0N-3,\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY M<'0G/B!2:7-K+69R964@:6YT97)E'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@,"XS-SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E M/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3L@5$585"U) M3D1%3E0Z(#!P="<^(%1H92!R96QA=&EV92!F86ER('9A;'5E(&]F('1H97-E M('=A6%B;&4N($%F=&5R(&%L;&]C871I;F<@=&AE("0Q,3`L-#(U('!O65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU65E(BDL(&UA='5R:6YG(&]N(%-E<'1E;6)E65E(&AA2!G'!I65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@97-T:6UA=&5D('1H92!R96QA=&EV M92!F86ER('9A;'5E(&]F('1H97-E('=A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!%>'!E8W1E M9"!O<'1I;VX@;&EF92`H>65A6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#,N M,#`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4FES:RUF6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N-#`\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G M/B!$:79I9&5N9"!Y:65L9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XP,#PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\+W1D/B`\+W1R M/B`\='(@8F=C;VQO6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!A;6]R=&EZ97,@=&AE(&1I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@0V]N=F5R=&EB;&4@;F]T97,@<&%Y86)L92!C;VYS:7-T M960@;V8@=&AE(&9O;&QO=VEN9SH\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\ M9&EV/B`\=&%B;&4@6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@8V]L6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`M.7!T)SX@3VX@3F]V96UB97(@,38L(#(P,3$L('1H M92!#;VUP86YY(&ES65A2`V+"`R,#$R+"!T:&4@;F]T92!H M;VQD97(@8V]N=F5R=&5D('1H92!E;G1I6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`M.7!T)SX@3VX@2F%N=6%R M>2`Q-BP@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@ M;F]T92!I;B!T:&4@86UO=6YT(&]F("0R-3`L,#`P('=I=&@@:6YT97)E6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D M:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT65A'0@<')I=F%T92!P;&%C96UE;G0@<')I8V4@;VX@82!P97(@2!C;VUP;&5T97,@82!P'0@<')I=F%T92!P;&%C96UE;G0@870@)#`N M-#8X-S4@<&5R('-H87)E('=I=&@@9W)O6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(R,"PT,S@\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E(&-O M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#(P,"PP,#`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!-87D@,S`L M(#(P,3(L('1H92!#;VUP86YY(&ES65A'0@<')I=F%T92!P;&%C96UE;G0@<')I8V4@;VX@ M82!P97(@2!C M;VUP;&5T97,@82!P'0@<')I=F%T92!P M;&%C96UE;G0@870@)#`N-#8X-S4@<&5R('-H87)E('=I=&@@9W)O'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@,C`P+#`P,#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@8V]L'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`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`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!$:7-C;W5N="!R97!R97-E;G1I;F<@*&DI('1H92!R M96QA=&EV92!F86ER('9A;'5E(&]F('1H92!W87)R86YT6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@T-#0L-S@X/"]D M:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)2!C;VQS M<&%N/3-$,B!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D M/B`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`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@4F5M86EN:6YG(&1I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("@T,3(L-S,X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R M)2!C;VQS<&%N/3-$,B!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R<'@@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)2!C;VQS<&%N/3-$,B!A;&EG;CTS1')I9VAT/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#,U-RPW-S`\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO M9&EV/B`\+W1D/B`\=&0@7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4F M;F)S<#LQ,"`M($1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]. M.B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@3VX@075G=7-T(#8L(#(P,3(L('1H92!#;VUP86YY M(&ES28C,SD[&5R8VES92!P65A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@3VX@1F5B2!I&5R8VES92!P6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@36%Y(#8L(#(P,3,L('1H92!#;VUP M86YY(&ES2!I&5R8VES92!P M&5R8VES960@=V%R6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@36%Y(#8L(#(P,3,L('1H M92!#;VUP86YY(&ES&5R8VES92!P'!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@0F5C875S92!T:&5S92!W87)R86YT2!S96-U6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T-/3$]2.B!B;&%C:SL@3$545$52+5-004-)3D3PO9F]N=#X\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GDF M(S,Y.W,@075G=7-T(#8L(#(P,3(@86YD($UA>2`V+"`R,#$S('=A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@0F%S M960@;VX@=&AE2!E M=F5N=',@=&AA="!C86X@;V-C=7([('1H92!(;VQD97(@97AE&5R8VES M92!P2P@971C+BDN(%!R;VIE8W1I;VYS('=E3L@5$585"U)3D1%3E0Z(#!P="<^(%!R;V)A8FEL:71I M97,@=V5R92!A2X\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R M("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`P<'0[(%1% M6%0M24Y$14Y4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U35%E,13H@ M:71A;&EC.R!$25-03$%9.B!I;FQI;F4G/B`H8BD\+V9O;G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!& M3TY4+5-464Q%.B!I=&%L:6,[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE M)SX@5F%L=6%T:6]N($%S6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU28C,SD[ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE3H@4WEM8F]L+"!S97)I9CL@1D].5"U3 M25I%.B`Q,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@ M/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!S=&]C:R!P6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6UB;VPL('-E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M1D%-24Q9.B!T:6UE3H@4WEM8F]L M+"!S97)I9CL@1D].5"U325I%.B`Q,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S M<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`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`U-'!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ M(%-Y;6)O;"P@'0M86QI9VXZ(&IU6QE/3-$)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ M(%-Y;6)O;"P@'0M86QI9VXZ(&IU2!H860@;F\@6QE/3-$)U=)1%1(.B`U-'!T M)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU6QE/3-$)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@ M'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C@E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`U(%EE M87(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B`R,3@E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B`Q,C6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B`R-#0E/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI M9VXZ(&-E;G1E6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@36%R M8V@@,S$L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`Q-C6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R-C0E/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1&5C M96UB97(@,S$L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`Q-C@E/"]D M:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R-C$E/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1T;W`@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T-/3$]2.B!B M;&%C:SL@3$545$52+5-004-)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE('1A8FQE(&)E;&]W('!R M;W9I9&5S(&$@2!O9B!T:&4@9F%I2!A;F0@=&AE(&-H86YG97,@:6X@ M=&AE(&9A:7(@=F%L=64@;V8@=&AE(&1E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@ M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1) M4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X],T0T/B`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`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\+W1R M/B`\='(@8F=C;VQO'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5&]T M86P@9V%I;G,@;W(@;&]SF5D*2!I;F-L M=61E9"!I;CH\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@3F5T(&EN8V]M92`H M;&]S6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@S,#4L.#(Y/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE M9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@S,#4L M.#(Y/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^ M(#PO='(^(#QT6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G M/B!/=&AE6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4'5R M8VAA6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TY<'0G/B!46QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@0F%L86YC92P@36%R8V@@,S$L(#(P,3,\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^("@T.#8L,3$S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^("@T.#8L,3$S/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^(#PO='(^(#QT6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!.970@:6YC;VUE("AL;W-S*3PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@-C6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#8W-2PY-#D\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M("TY<'0G/B!/=&AE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`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`Q,7!T.R!-05)'24XM3$5& M5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`M.7!T)SX@5')A;G-F97)S(&EN(&%N9"]O"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV M/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV M/B`\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494.B`P<'0[(%1%6%0M24Y$14Y4 M.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U35%E,13H@:71A;&EC.R!$ M25-03$%9.B!I;FQI;F4G/B`H9"D\+V9O;G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q% M.B!I=&%L:6,[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX@5V%R3L@ M5$585"U)3D1%3E0Z(#!P="<^($%S(&]F($1E8V5M8F5R(#,Q+"`R,#$S+"`X M-3,L,S,S('=A3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!T86)L92!B96QO=R!S=6UM87)I>F5S('1H M92!#;VUP86YY)B,S.3MS(&1E3H\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1% M3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV/B`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`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`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`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$97)I=F%T:79E('=A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P M,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^("@T,3$L.#`U/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`I)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M+3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY M<'0G/B!-87)K('1O(&UA6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@,C,Q+#4R,3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#(S,2PU,C$\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("D\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#$L,34R+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q.#`L,C@T/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0G/B`I/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO M'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1&5R:79A=&EV92!W87)R M86YT(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1M:61D;&4@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PQ M-3(L,#`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`M.7!T)SX@4F5S970@;V8@=V%R6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#$L-SDY+#0R-#PO9&EV/B`\+W1D/B`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`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^("D\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@17AE'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@*#(L-S,R+#6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M*29N8G-P.SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`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`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!) M2`V+"`R,#$S M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1M:61D;&4@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@-2PW,3,L.3$X/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*29N M8G-P.SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@27-S=6%N M8V4@;V8@=V%R6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XW-7!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,#`P+#`P,#PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@*#6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#(Y.2PS-S,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^("@R.3DL,S'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@-RPV-S`L,SDY/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,2XW-7!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^(#'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#,V.2PW M-#<\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("D\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$58 M5"U$14-/4D%424]..B!U;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU2!O9B!T:&4@0V]M<&%N>28C M,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`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`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5V5I9VAT960\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE M/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E' M2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1F%I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@870@1&%T93PO9&EV M/B`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`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`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-C(P+#,R-3PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XR,#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BPW,3,L.3$X/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,"XR,"`M(#`N,C4\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3@S+#`P-SPO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`M.7!T)SX@0V%N8V5L960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q.'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TY<'0G/B!"86QA;F-E+"!$96-E;6)E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XR,"`M(#`N,C4\+W1D/B`\ M=&0@6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XR,SPO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-#`E(&%L:6=N/3-$;&5F=#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`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`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`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`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`\+W1D/B`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`P<'0G/B`D,"XR,"`M(#`N,C4\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@.2PY-3(L,34R/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&%L:6=N/3-$'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-"XS-CPO9&EV/B`\ M+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XR,SPO M9&EV/B`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#DL.34R+#$U,CPO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-"XS-CPO9&EV M/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XR M,SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#`N,C`@ M+2`P+C(U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@-"XS-CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#DL.34R+#$U M,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#0N,S8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@,"XR,SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^ M/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($YO=&4@,3`@+2!$97)I=F%T:79E M($EN6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@=6YD M97)L:6YE.R!$25-03$%9.B!I;FQI;F4G/E=A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU&5R8VES92!P2`R-B!A;F0@36%R8V@@,34L(#(P M,3,@=VET:"!A;B!E>&5R8VES92!P2!3 M86QE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@4')O8F%B:6QI=&EE6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^("AB*29N8G-P.SQF;VYT M('-T>6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!$25-03$%9 M.B!I;FQI;F4G/E9A;'5A=&EO;B!!6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A M;GDF(S,Y.W,@,C`Q,B!D97)I=F%T:79E('=A6QE M/3-$)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI M9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE3H@4WEM8F]L+"!S97)I9CL@1D].5"U325I%.B`Q,7!T)SX@ M)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#!P="<^(%1H92!S=&]C:R!P2X@5&AE('!R;VIE8W1E9"!V;VQA M=&EL:71Y(&-U2!F;W(@=&AE('9A;'5A=&EO;B!P97)I;V1S M+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^ M(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ M(%-Y;6)O;"P@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!T:6UE3H@4WEM8F]L+"!S97)I9CL@1D].5"U325I%.B`Q,7!T)SX@)FUI9&1O=#LF M;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!(;VQD97(@=V]U;&0@97AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE3H@4WEM8F]L+"!S97)I9CL@1D].5"U325I%.B`Q M,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^($$@,3`P)2!P2!O9B!A(')E M6QE/3-$)T9/3E0M4TE: M13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P M86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6UB;VPL('-E&5R8VES92!P2`R-BP@,C`Q,R!R M97-E="!E=F5N="D@:7,@<')O:F5C=&5D('1O(')E6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT M6UB;VPL('-E'!I6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG M;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N M="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU6QE/3-$)T9/ M3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@ M8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^ M(#QT6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B`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`M M.7!T)SX@075G=7-T(#8L(#(P,3(\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B`Q-S,E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ M(&-E;G1E6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`R-S(E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`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`M.7!T)SX@36%R8V@@,S$L(#(P,3,\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[(%1%6%0M M24Y$14Y4.B`P<'0G/B`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`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`M.7!T)SX@0F%L86YC92P@075G=7-T(#8L(#(P,3(\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z("TY<'0G/B!.970@:6YC;VUE("AL;W-S*3PO9&EV/B`\ M+W1D/B`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,C,Q+#4R,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!0=7)C:&%S M97,L(&ES6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`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`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`M.7!T)SX@3F5T(&EN8V]M92`H M;&]S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#,P-2PX M,CD\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#,P-2PX M,CD\+W1D/B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!"86QA M;F-E+"!-87)C:"`S,2P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#0X-BPQ,3,\+W1D/B`\ M=&0@6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!0041$24Y'+4)/5%1/33H@ M-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#PO=&%B;&4^(#PO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$58 M5"U)3D1%3E0Z(#!P="<^("AD*2`\9F]N="!S='EL93TS1"=415A4+41%0T]2 M051)3TXZ('5N9&5R;&EN93L@1$E34$Q!63H@:6YL:6YE)SY787)R86YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@07,@;V8@36%R8V@@,S$L(#(P,3,@;F\@=V%R6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@5&AE('1A8FQE(&)E;&]W('-U;6UA6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M,C`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`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@1&5R:79A=&EV93PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4 M15A4+4E.1$5.5#H@,'!T)SX@4VAA6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&-O;'-P86X],T0R/B`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`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`M.7!T)SX@1&5R:79A=&EV92!W87)R86YT(&%T($%U9W5S="`V M+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1M:61D;&4@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PQ-3(L,#`P/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@*29N8G-P.SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!-87)K('1O(&UA M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,C,Q+#4R,3PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@*#(S,2PU,C$\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`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`Q.'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TY<'0G/B!$97)I=F%T:79E('=A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PQ-3(L,#`P/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^("@R,S$L-3(Q/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@ M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`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`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^("@W,RPW,C,\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^("D\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`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`M.7!T)SX@1&5R:79A=&EV92!W87)R M86YT(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1M:61D;&4@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PQ M-3(L,#`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@S,#4L,C0T M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`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`M.7!T)SX@4F5S970@ M;V8@=V%R6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L-SDY M+#0R-#PO9&EV/B`\+W1D/B`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`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`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@S-SDL M-34R/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`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`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&IU2!O9B!T:&4@0V]M<&%N M>28C,SD[6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE('1A8FQE(&)E;&]W('-U;6UA M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@ M0F%L86YC92P@36%R8V@@,S$L(#(P,3(\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`Q,7!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^-C(P+#,U,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`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`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!%>&5R8VES960\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`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`M.7!T)SX@0F%L86YC92P@36%R M8V@@,S$L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M-2PR,S,L,36QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XR M-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B0\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/B0\+W1D/B`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`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&9O;&QO M=VEN9R!T86)L92!S=6UM87)I>F5S(&EN9F]R;6%T:6]N(&-O;F-E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1$E34$Q!63H@:6YL:6YE M)SY-87)C:"`S,2P@,C`Q,SPO9F]N=#XZ/"]D:78^(#QD:78@6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB&5R8VES86)L93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@8V]L'0M M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/B`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`P<'0G/B`D,"XR M-3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,B4^/&9O;G0@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#4L,C,S+#$W-SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#,N-S,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#`N,C4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-2PR,S,L,36QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,RXW M,SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#,N M-S,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@,"XR-3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#4L,C,S+#$W-SPO9&EV/B`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,RXW,SPO9&EV M/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N,C4\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E# M("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT M='`Z+R]W=W&AT;6PQ+71R86YS:71I M;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^(%5P;VX@9F]R;6%T:6]N('1H92!T M;W1A;"!N=6UB97(@;V8@2!IF5D('1O(&ES6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!M:6QL:6]N M("@R-3`L,#`P+#`P,"D@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@26UM961I871E;'D@<')I;W(@=&\@=&AE(%-H87)E($5X8VAA;F=E($%G M2!H860@-SDL M.#`P+#`P,"!C;VUM;VX@28C,SD[6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@07,@ M82!R97-U;'0@;V8@=&AE(%-H87)E($5X8VAA;F=E($%G&-H86YG92!!9W)E M96UE;G0L(#8L,#`P+#`P,"!O9B!S=6-H('-H87)E6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&IU2!A;F0@ M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y)SX@3VX@2G5N92`R,RP@,C`Q,RP@=&AE(')E;6%I M;FEN9R`S+#`P,"PP,#`@17-C6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU M6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!R96-O2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@5&AE($-O;7!A;GD@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@1&5C M96UB97(@-"P@,C`Q,R!T:&4@0V]M<&%N>2!I2!AF5D(&]V97(@=&AE('9E65A'0M86QI M9VXZ(&IU2!R M96-O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U) M3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@ M=6YD97)L:6YE.R!$25-03$%9.B!I;FQI;F4G/D-O;6UO;B!3:&%R97,@27-S M=65D/"]F;VYT/B`\9F]N="!S='EL93TS1"=415A4+41%0T]2051)3TXZ('5N M9&5R;&EN93L@1$E34$Q!63H@:6YL:6YE)SYT;R!087)T:65S(&]T:&5R('1H M86X@16UP;&]Y965S(&9O3PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!0=&4@3'1D+BP@82!C;W)P;W)A=&EO;B!O2!'96]R9V4@ M0FQA;FME;F)A:V5R+"!T:&4@<')E2`H(D=R;W=E M2(I+"!A2!'2X\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^ M(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($]N M($%P2!I2!) M;G1E2!-;W5N=&%I;B!3 M:WDN)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@3VX@075G=7-T(#$L(#(P,3(L('1H92!#;VUP86YY(&5N=&5R960@ M:6YT;R!A(%-E8W5R:71I97,@4'5R8VAA&5R8VES92!P3L@5$585"U)3D1%3E0Z(#!P M="<^($%T(&-L;W-I;F28C,SD[&5R8VES92!P'!I6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@5&AE('5N:71S('=E2!U;FET(&]F9F5R:6YG M('1H92!#;VUP86YY('!A:60@*&DI($=34R!C87-H(&-O;6UI3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%!E2!S:&%R97,@;V8@=&AE($-O;7!A;GDF(S,Y.W,@8V]M;6]N('-T M;V-K(&%T(&$@<')I8V4@=&AA="!I2!W:71H;W5T(&%N M>2!O8FQI9V%T:6]N(&]F(&]R(&YO=&EC92!T;R!T:&4@4'5R8VAA3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!#;VUP86YY(&ES6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU M3L@5$585"U)3D1%3E0Z(#!P="<^($]N($UA M>2`S+"`R,#$S+"!T:&4@0V]M<&%N>2!E;G1E&5R8VES92PF;F)S M<#LF;F)S<#MT:&4@0V]M<&%N>2!A9W)E960@=&\@:7-S=64@=&\@=&AE($EN M=F5S=&]R('1H&5R8VES929N8G-P M.R9N8G-P.W!R:6-E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB M'0M86QI9VXZ M(&IU3L@5$58 M5"U)3D1%3E0Z(#!P="<^(')E2`H=&AE(")397)I97,@02!7 M87)R86YT29N8G-P.R9N8G-P.W1H92`B M3F5W)FYB2!E>&5R8VES86)L92!U<&]N('1H92!);G9E&5R M8VES92!I;B!F=6QL(&]F('1H92!397)I97,@02!787)R86YT&-H M86YG92!#;VUM:7-S:6]N("AT:&4@(E-%0R(I('=I=&AI;B!T96X@*#$P*2!B M=7-I;F5S2!W:6QL('5S92!I=',@8F5S="!E M9F9O2`H,S`I(&1A>7,N(%1H92!# M;VUP86YY(&9I;&5D(&$@2`H,S`I(&1A>7,N/"]D:78^ M(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^ M($]N($IU;'D@,C4L(#(P,3,L('1H92!3=7!R96UE($-O=7)T(&]F('1H92!3 M=&%T92!O9B!.97<@66]R:RP@0V]U;G1Y(&]F($YE=R!9;W)K("AT:&4F;F)S M<#LF;F)S<#LB0V]U2!O;B!*=6QY(#$R M+"`R,#$S('1O(')E8V]V97(@)#$L,#0R+#`P,"!O9B!P87-T+61U92!A8V-O M=6YT3L@5$585"U)3D1%3E0Z(#!P="<^($]N($IU;'D@,C8L M(#(P,3,L('1H92!#;VUP86YY(&ES2!T:&4@3W)D97(N/"]D:78^(#QD:78@ M3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!3971T;&5M96YT M)FYB2!(86YO=F5R(&EN(&ET29N8G-P.R9N8G-P.V]F)FYB2!T:&4@0V]M<&%N>2P@8GD@*$(I(#$P,"4@;V8@=&AE(%9705`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@3VX@075G=7-T(#8L(#(P,3(L('1H92!#;VUP86YY(&ES28C,SD[65A2P@9'5E('1O('1H92!O8V-U2`R-BP@,C`Q,R!R97-E="!E=F5N="X\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@1V%R9&5N(%-T871E(%-E8W5R:71I97,L($EN8RX@*'1H92`B M1U-3(BD@2!'4U,@8V%S:"!C;VUM:7-S M:6]N28C,SD[&5R M8VES92!P2!386QE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU2!F;W(@ M=&AE(%=A2!T;R!T:&4@4&QA8V5M96YT($%G96YT(&-A2!T:&4@26YV97-T;W(L(&%N9"`H:6EI*2!U<&]N(&5X M97)C:7-E(&]F('1H92!.97<@5V%R&5R8VES92!O M9B!T:&4@3F5W(%=A3PO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/ M4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26UM M961I871E;'D@<')I;W(@=&\@=&AE(%-H87)E($5X8VAA;F=E(%1R86YS86-T M:6]N(&]N($IU;F4@,C,L(#(P,3$L('1H92!#;VUP86YY(&AA9"`W.2PX,#`L M,#`P(&-O;6UO;B!S:&%R97,@:7-S=65D(&%N9"!O=71S=&%N9&EN9RX@4VEM M=6QT86YE;W5S;'D@=VET:"!T:&4@0VQO28C,SD[2!F;W(@8V%N8V5L;&%T:6]N+CPO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!I2!T:&4@0V]M<&%N>2!O9B!C97)T86EN('!O3L@5$58 M5"U$14-/4D%424]..B!U;F1E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^("AI M*2`\9F]N="!S='EL93TS1"=415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@ M1$E34$Q!63H@:6YL:6YE)SY$=7)A=&EO;B!O9B!%6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@57!O;B!A8VAI979E M;65N="!O9B!A;GD@36EL97-T;VYE(&]N(&]R(&)E9F]R92!T:&4@9&%T92!A M2!S:&%L;"!P2!P6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU&AI8FET($$@ M+2!38VAE9'5L92!O9B!-:6QE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^($DN/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`S-G!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z("TQ.'!T)SX@*#$I16YT97(@:6YT;R!E>&-L=7-I=F4@ M:6YT97)N871I;VYA;"!L:6-E;G-E(&%G6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!O9B!T:&4@ M0VQO6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E2!I9B!A;F0@=VAE;B!!3$P@9F]U6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^($E)+B9N8G-P.R9N8G-P.R9N M8G-P.T%C:&EE=F4@,3`P($AA(&9I96QD('1R:6%L6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!7 M:71H:6X@='=O("@R*2!Y96%R6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!O M9B!T:&4@0VQO6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M,3AP="<^($E)22XF;F)S<#LF;F)S<#M497-T('-H:7!M96YT(&]F(&1R>2!L M96%F('1O(&%C:&EE=F4@;6EN:6UU;2!S<&5C6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!7:71H:6X@='=O("@R*2!Y96%R6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!O9B!T:&4@0VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E M;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&IU6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@5$585"U)3D1%3E0Z(#!P="<^("HJ/"]D:78^(#PO=&0^(#QT9#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE2<^($]N($IU;F4@,C,L(#(P,3,L('1H92!R96UA:6YI;F<@,RPP M,#`L,#`P($5S8W)O=R!3:&%R97,@:&%V92!B965N(&5A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($]N($]C=&]B97(@-"P@,C`Q M,2P@82!S:6=N:69I8V%N="!S=&]C:VAO;&1E2P@ M36]H86YA9"!3:'5R2!D96)I=&EN M9R!C;VUM;VX@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$ M14-/4D%424]..B!U;F1E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@3V-T;V)E2!IF5D(&]V97(@=&AE('9E65A2!R96-O2!R96-O6QE/3-$)U1% M6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!$25-03$%9.B!I;FQI;F4G/G1O M(%!A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@ M5$585"U)3D1%3E0Z(#!P="<^("AI*2`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`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@ M=6YD97)L:6YE.R!$25-03$%9.B!I;FQI;F4G/E)E9VES=')A=&EO;B!2:6=H M=',@06=R965M96YT/"]F;VYT/CPO9&EV/B`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`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@07,@82!C;VYD:71I;VX@9F]R('1H92!E>&5C=71I;VX@;V8@ M=&AI2!I M6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M3VX@36%R8V@@,30L(#(P,3(@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@ M8V]N6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4:&4@=&5R;2!O9B!T:&ES M(&%G2!T97)M:6YA=&5D(&]N($UA>2`S,"P@ M,C`@,3(N/"]D:78^(#QD:78@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU2!E87)N960@8GD@36%R8V@@,S$L(#(P,3(N M(%1H97-E('-H87)E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!A;F0@86UOF5D M(&]N(&$@65A3PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!0=&4@3'1D+BP@82!C;W)P;W)A=&EO;B!O M2!'96]R9V4@0FQA;FME;F)A:V5R+"!T:&4@<')E2`H(D=R;W=E2(I+"!A2!'2!I;B!T:&4@ M8V]N6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E2!I;G1O(%-E8W5R:71I97,@4'5R8VAA3L@5$585"U)3D1%3E0Z(#!P="<^ M($]N($%U9W5S="`Q+"`R,#$R+"!T:&4@0V]M<&%N>2!E;G1E2!I&5R8VES92!P3L@ M5$585"U)3D1%3E0Z(#!P="<^($%T(&-L;W-I;F28C,SD[&5R8VES M92!P'!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE('5N:71S('=E2!U;FET(&]F9F5R:6YG('1H92!#;VUP86YY('!A:60@*&DI($=34R!C87-H M(&-O;6UI3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&EN M=&5N9&5D('1O('5S92!T:&4@;F5T)FYB2!T;R!E>&5C=71E(&ET2!A;F0@=&\@86ED(&EN('1H92!C M;VUM97)C:6%L)FYB29N8G-P.R9N8G-P.V%N;F]U;F-E M9"9N8G-P.R9N8G-P.VQA=6YC:"9N8G-P.R9N8G-P.V]F)FYB28C,SD[2UO=VYE9"!S M=6)S:61I87)Y+"!3=&5V:6$@5&5C:&YE=R!,:6UI=&5D+CPO9&EV/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%4 M24]..B!U;F1E2!I;G1O M(%)E9VES=')A=&EO;B!2:6=H=',@06=R965M96YT/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($EN(&-O;FYE8W1I;VX@=VET M:"!T:&4@97%U:71Y(&9I;F%N8VEN9R!O;B!!=6=U28C,SD[2`H,S`I(&1A>7,@;V8@=&AE($-O M;7!A;GDF(S,Y.W,@96YT6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&AE(')E9VES=')A=&EO;B!S=&%T96UE;G0@;75S="!B92!D96-L87)E9"!E M9F9E8W1I=F4@8GD@=&AE(%-%0R!W:71H:6X@;VYE(&AU;F1R960@86YD('1W M96YT>2`H,3(P*2!D87ES(&]F('1H92!C;&]S:6YG(&1A=&4@;V8@=&AE($]F M9F5R:6YG('-U8FIE8W0@=&\@8V5R=&%I;B!A9&IU2!T:&4@4T5#('=I=&AI M;B!O;F4@:'5N9')E9"!A;F0@='=E;G1Y("@Q,C`I(&1A>7,@;V8@=&AE(&-L M;W-I;F<@9&%T92!O9B!T:&4@3V9F97)I;F<@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@3VX@075G=7-T(#8L(#(P,3(L('1H92!#;VUP86YY(&ES M&5R8VES92!P M2!386QE&5R8VES92!P3L@5$585"U)3D1%3E0Z(#!P="<^($=A2!A9W)E960@=&\Z("AI M*2!P87D@1U-3(&-A2!F:6YA M;F-I;F2P@9'5E M('1O('1H92!O8V-U2`R-BP@,C`Q,R!R M97-E="!E=F5N="X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\(2TM16YD1G)A M9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX M,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X M-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($YO;BUC;VYT6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B M;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!P86ED+6EN/"]D:78^(#QD M:78@'0M86QI9VXZ(&-E;G1E6QE M/3-$)U!!1$1)3D#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!/ M=&AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!#;VUP'0M86QI9VXZ(&-E;G1E M#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!4;W1A;#PO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B!N;VXM8V]N=')O;&QI;F<\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@:6YT M97)E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!"86QA;F-E(&%T($UA M6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#(Q-"PP.#(\+W1D/B`\=&0@ M6QE/3-$)U!!1$1) M3D"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M*#(Q-"PP.#(\+W1D/B`\=&0@7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@1&5C96UB97(@ M,30L(#(P,3$L('1H92!#;VUP86YY(&%N9"!3=&5V:6$@5F5N='5R97,@0V]R M<&]R871I;VX@*")3=&5V:6$@5F5N='5R97,B*2!E;G1E'!I3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&AA65A"!M;VYT:"!L M96%S92!P87EM96YT(&]F("0Q-2PP,#`@87,@3L@5$585"U)3D1%3E0Z M(#!P="<^($9U='5R92!M:6YI;75M('!A>6UE;G1S(')E<75I6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-RPU,#`\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TQ.'!T M)SX@,C`Q-3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,S`L,#`P/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1) M3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,S`L,#`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU2!,:6UI=&5D/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2`R,2P@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O(&$@ M4W5P<&QY($%G2!,:6UI=&5D+"!A(&9O3L@5$585"U)3D1%3E0Z(#!P M="<^(%5N9&5R('1H92!T97)M2!S=&5V:6$@<&QA;G0@;6%T97)I M86QS+"!I;F-L=61I;F<@&-L=7-I=F5L>2!T;R!'=6%N9WIH;W4@2&5A;'1H+B!&;W(@=&AE(&9I2!O9B!02!A8V-O65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@3VX@1F5BFAO=2!( M96%L=&@@5&5C:&YO;&]G>2!$979E;&]P;65N="!#;VUP86YY($QI;6ET960N M/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%5N M9&5R('1H92!T97)M'!L;W)E('!O=&5N=&EA;"!T96-H;F]L M;V=Y('!A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E'0M M86QI9VXZ(&IU2!E;G1EF5D('5N9&5R M('1H92!L87=S(&]F('1H92!297!U8FQI8R!O9B!3:6YG87!O3L@5$585"U)3D1%3E0Z(#!P="<^(%5N9&5R M('1H92!T97)M2!E;F=A M9V5D($%'4$P@=&\@8F4@=&AE($-O;7!A;GDF(S,Y.W,@=&5C:&YO;&]G>2!P M2!O=&AE M65A2!I;B!6:65T;F%M M+"!R96-O;6UE;F0@<75A;&ET>2!A9W)O;F]M:6,@<')O9W)A;7,@9F]R('-T M979I82!C=6QT:79A=&EO;BP@:&%R=F5S="!A;F0@<&]S="!H87)V97-T+"!A M;&5R="!F:6YD:6YG2!W:6QL(&)E($%'4$PF(S,Y.W,@97AC;'5S:79E(&1I'0M86QI9VXZ(&IU3L@5$585"U)3D1% M3E0Z(#!P="<^(&9O7-T96TI(&9OF4@=&AE(&2UR96QA=&5D('!A=&5N=',@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@3VX@075G=7-T(#(V+"`R,#$Q+"!I;B!A8V-O"!#+B9N8G-P.R9N8G-P.TEN+6-O=6YT2!B>2!T:&4@0V]M<&%N>2!A;F0@:7,@97AC;'5D960@9G)O;2!T:&4@ M86)O=F4@86UO=6YT+B9N8G-P.R9N8G-P.U1H92!E>'!E6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@ M5$585"U$14-/4D%424]..B!U;F1E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@:&%S(&)E M9W5N(&1E=F5L;W!M96YT(&]F(&$@2!A;F0@:&%S('!R97!A:60@*&DI('1H92!F:7)S M="!Y96%R(&QE87-E('!A>6UE;G0@;V8@)#,P+#`P,"!A;F0@*&EI*2!T:&4@ M6UE;G0@;V8@)#$U+#`P,"!A2!D97!O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@1G5T=7)E(&UI;FEM=6T@<&%Y;65N=',@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^ M($9I6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^(#(P M,30\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`L,#`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI M8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&IU2!,:6UI=&5D/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2`R,2P@,C`Q,BP@=&AE($-O;7!A;GD@96YT97)E9"!I;G1O M(&$@4W5P<&QY($%G2!,:6UI=&5D+"!A(&9O3L@5$585"U)3D1%3E0Z M(#!P="<^(%5N9&5R('1H92!T97)M2!S=&5V:6$@<&QA;G0@;6%T M97)I86QS+"!I;F-L=61I;F<@&-L=7-I=F5L>2!T;R!'=6%N9WIH;W4@2&5A;'1H+B!&;W(@=&AE(&9I M2!O9B!02!A8V-O65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@3VX@1F5BFAO M=2!(96%L=&@@5&5C:&YO;&]G>2!$979E;&]P;65N="!#;VUP86YY($QI;6ET M960N/"]D:78^(#QD:78^/&)R("\^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@56YD97(@=&AE('1EFEN9R!A(&IO:6YT('9E;G1U2!O9B!H87)V M97-TFAO=2!(96%L=&@@=VEL;"!S:&%R92!A;&P@879A:6QA8FQE(&EN9F]R M;6%T:6]N(&]F(&ET2!R97%U97-T960@8GD@=&AE($-O;7!A;GDL('-U<'!L>2!W:71H M;W5T(&-O3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T M-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,V)E-#,X-V%?,F)B9E\T.3`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`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@4W1E=FEA($-O"!L87'0M86QI9VXZ(&IU2UO=VYE9"!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY+"!I"!L8765A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@4W1E=FEA(%1E8VAN97<@3&EM:71E9"P@82!M M86IO2!O=VYE9"!S=6)S:61I87)Y(&]F('1H92!#;VUP86YY+"!I"!L8765A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U19 M3$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU&%B;&4@:6YC;VUE M('1H2!T:&%N(&YO="!A;F0@86-C;W)D:6YG;'DL('1H92!P;W1E M;G1I86P@=&%X(&)E;F5F:71S(&]F('1H92!N970@;&]S2UF;W)W M87)D3L@5$585"U)3D1%3E0Z M(#!P="<^($1E9F5R"9N8G-P.V%S2!O9B!T:&4@=&%X(&5F9F5C="!O9B!.3TP@8V%R2XF;F)S<#LF;F)S<#M4:&4@=F%L=6%T:6]N(&%L;&]W86YC M92!I;F-R96%S960@87!P2`D-3(Q+#4T-2!A;F0@)#65A3L@5$585"U)3D1%3E0Z(#!P="<^($-O;7!O M;F5N=',@;V8@9&5F97)R960@=&%X(&%S6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(&-E;G1E M6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`R-W!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY M<'0G/B!%>'!E8W1E9"!I;F-O;64@=&%X(&)E;F5F:70@9G)O;2!.3TP@8V%R M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,S$Q+#4U,CPO M9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q+#,Q,2PU M-3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV M/B`\+W1D/B`\+W1R/B`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`S-G!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$969E"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T M<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS M1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@ M:&%D(&]W;F5R2!S=6)J96-T('1H92!.3TPF(S,Y.W,@=&\@86YN=6%L(&QI M;6ET871I;VYS('=H:6-H(&-O=6QD(')E9'5C92!OF4@3D], M'!E2!M;W)E('1H86X@-3`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`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B!&;W(@=&AE($9I'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!!<')I;"`Q,2P@,C`Q,2`H:6YC97!T:6]N*3PO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!T:')O=6=H/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,3AP="<^ M($9E9&5R86P@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,3AP="<^(#,T+C`\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("4\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&UI9&1L92!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#,T+C`\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q M.'!T)SX@0VAA;F=E(&EN('9A;'5A=&EO;B!A;&QO=V%N8V4@;VX@;F5T(&]P M97)A=&EN9R!L;W-S(&-A6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,3AP="<^("@S-"XP/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B`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`Q.'!T)SX@169F96-T:79E(&EN8V]M92!T87@@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,3AP="<^(#`N M,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@,"XP/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO M=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA M+2U%;F1&'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO M2!,=&0N M/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($]N M($%P6QE/3-$)T-/3$]2.B!B;&%C:SL@3$545$52+5-004-) M3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!P=7)C:&%S92!T:&4@ M4')O9'5C=',@9G)O;2!!4TE$+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I M=&%L:6,[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX@5&5R;3PO9F]N M=#X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U) M3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@3VX@07!R:6P@,3(L(#(P,3$L(%-T979I82!696YT=7)E2!O9B!T:&4@0V]M<&%N>2!A M;'-O(&5N=&5R960@:6YT;R!A(%-U<'!L>2!!9W)E96UE;G0@*'1H92`B4W5P M<&QY($%G2!C;VUP86YY(&EN8V]R<&]R871E9"!I;B!6:65T;F%M+CPO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@56YD97(@=&AE('1E2!P=7)C:&%S92!T:&4@4')O9'5C=',@ M9G)O;2!35D,N/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU65A2!F;W(@86X@861D:71I;VYA;"!P97)I;V0@;V8@;VYE M("@Q*2!Y96%R(&5X<&ER:6YG($%P'1E;F1E9"!4 M97)M(BDN/"]D:78^(#QD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[(%1%6%0M M1$5#3U)!5$E/3CH@=6YD97)L:6YE)SX@4'5R8VAA3L@5$585"U)3D1%3E0Z(#!P="<^(%-6 M0R!A;F0@=&AE($-O;7!A;GD@6QE/3-$)T9/3E0M4TE: M13H@-S`E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`[($1)4U!,05DZ(&EN M;&EN92<^=&@\+V9O;G0^+"!O9B!E86-H(%EE87(@;VX@=&AE('%U86YT:71Y M(&]F('1H92!02!35D,@=&\@=&AE M($-O;7!A;GD@:6X@=&AE(&9O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2!E;G1E6QE/3-$)T-/3$]2.B!B;&%C:SL@3$545$52+5-004-)3D6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2!A;F0@:71S(&AI6QE/3-$)TU!4D=)3BU,1494.B`P<'0[(%1%6%0M24Y$ M14Y4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U35%E,13H@:71A;&EC M.R!$25-03$%9.B!I;FQI;F4G/B`H:6DI/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)T-/3$]2.B!B;&%C:SL@3$545$52+5-004-)3D3L@5$585"U)3D1%3E0Z M(#!P="<^($=34R!S:&%L;"!A8W0@87,@=&AE($-O;7!A;GDF(S,Y.W,@97AC M;'5S:79E('!L86-E;65N="!A9V5N="!F;W(@=&AE('!E&-L=7-I=F4@<&QA8V5M96YT(&%G96YT(&%F=&5R('1H92!% M>&-L=7-I=F4@4&5R:6]D('5N=&EL('1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`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`Q,7!T.R!& M3TY4+5-464Q%.B!I=&%L:6,[(%1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE M)SX@0V]M<&5N6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU2!I2!);G1E2!- M;W5N=&%I;B!3:WDN)FYB2!,=&0N/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z M(#!P="<^($]N($%P2!O9B!T:&4@0V]M<&%N>2!E M;G1E2!! M9W)E96UE;G0B*2!W:71H($%S:6$@4W1E=FEA($EN=F5S=&UE;G0@1&5V96QO M<&UE;G0@0V]M<&%N>2!,=&0@*")!4TE$(BDL(&$@9F]R96EG;BUI;G9E2!C;VUP86YY(&EN8V]R<&]R871E9"!I;B!6 M:65T;F%M+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^("A)*2`\9F]N="!S='EL93TS1"=4 M15A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@1$E34$Q!63H@:6YL:6YE)SY3 M8V]P92!O9B!397)V:6-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@56YD97(@=&AE('1E2!I6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)U1%6%0M M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!$25-03$%9.B!I;FQI;F4G/E1E3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H:7,@06=R965M96YT('-H86QL(&-O;64@:6YT;R!F;W)C92!O;B!T M:&4@9&%T92!O9B!S:6=N:6YG(&%N9"P@2!E86-H('EE87(@9F]R(&%N(&%D9&ET:6]N86P@<&5R:6]D(&]F(&]N M92`H,2D@>65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@05-) M1"!A;F0@=&AE($-O;7!A;GD@65A2!! M4TE$('1O('1H92!#;VUP86YY(&EN('1H92!F;W)T:&-O;6EN9R!Y96%R(&%N M9"!!4TE$('-H86QL('!R;W9I9&4@=&AE($-O;7!A;GD@=VET:"!P6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($]N($%P2!O9B!T:&4@0V]M<&%N>2!A;'-O(&5N=&5R960@:6YT;R!A M(%-U<'!L>2!!9W)E96UE;G0@*'1H92`B4W5P<&QY($%G2!C;VUP86YY(&EN8V]R M<&]R871E9"!I;B!6:65T;F%M+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@56YD97(@=&AE('1E M2!P=7)C:&%S92!T:&4@4')O9'5C M=',@9G)O;2!35D,N/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU65A2!R96YE=R!O;B!I M=',@86YN:79E'1E;F1E9"!497)M(BDN/"]D:78^ M(#QD:78@3L@5$585"U)3D1%3E0Z M(#!P="<^(%-60R!A;F0@=&AE($-O;7!A;GD@6QE/3-$ M)T9/3E0M4TE:13H@-S`E.R!615)424-!3"U!3$E'3CH@=&5X="UT;W`[($1) M4U!,05DZ(&EN;&EN92<^=&@\+V9O;G0^/&9O;G0@2!O9B!T:&4@4')O9'5C M=',@=&\@8F4@2!W:71H('!R:6]R('=R:71T96X@;F]T:6-E(&%T(&%N>2!T:6UE M(&1U65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$58 M5"U$14-/4D%424]..B!U;F1E2!I;G1O($-O;G-U;'1I;F<@06=R965M96YT/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($]N($IU;'D@,2P@,C`Q,2!T M:&4@0V]M<&%N>2!E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^(%5N9&5R('1H92!T97)M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!E:71H97(@=&AE($-O;7!A;GD@;W(@=&AE($-O;G-U M;'1A;G0@870@86YY('1I;64@<')I;W(@=&\@=&AE(&5N9"!O9B!T:&4@0V]N M2`H,S`I(&1A>7,@=W)I M='1E;B!N;W1I8V4@;V8@=&5R;6EN871I;VXN(%-U8V@@;F]T:6-E(&UA>2!B M92!G:79E;B!A="!A;GD@=&EM92!F;W(@86YY(')E87-O;BP@=VET:"!O2!W:6QL('!A>2!#;VYS=6QT86YT M(&9O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^ M("AI:6DI(#QF;VYT('-T>6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@=6YD97)L M:6YE.R!$25-03$%9.B!I;FQI;F4G/D-O;7!E;G-A=&EO;CPO9F]N=#X\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O M;7!A;GD@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@3VX@1&5C96UB97(@,S`L(#(P,3$L('1H92!#;VYS=6QT:6YG($%G'!I3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VYS=6QT:6YG($%G M'!I'1E;G-I;VXN/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$ M14-/4D%424]..B!U;F1E6QE/3-$)U1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE M.R!$25-03$%9.B!I;FQI;F4G/E-C;W!E(&]F(%-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!5;F1E2!E;F=A9V5D($-L:69T;VX@=&\@:6YT6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE M/3-$)U1%6%0M1$5#3U)!5$E/3CH@=6YD97)L:6YE.R!$25-03$%9.B!I;FQI M;F4G/E1E3L@5$585"U) M3D1%3E0Z(#!P="<^(%1H92!T97)M(&]F('1H:7,@06=R965M96YT('-H86QL M(&)E('-I>"`H-BD@;6]N=&AS+"!C;VUM96YC:6YG(&]N($IU;'D@,2P@,C`Q M,2!A;F0@8V]N=&EN=6EN9R!U;G1I;"!$96-E;6)E2`H M,S`I(&1A>7,@=W)I='1E;B!N;W1I8V4@;V8@=&5R;6EN871I;VXN(%-U8V@@ M;F]T:6-E(&UA>2!B92!G:79E;B!A="!A;GD@=&EM92!F;W(@86YY(')E87-O M;BP@=VET:"!O2!W:6QL('!A M>2!#;&EF=&]N(&9O3L@5$585"U)3D1%3E0Z(#!P="<^($]N($1E8V5M8F5R(#,Q+"`R M,#$Q+"!T:&4@9FEN86YC:6%L(&-O;G-U;'1I;F<@86=R965M96YT(&5X<&ER M960N/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!S:&%L;"!P87D@0VQI9G1O;B!A M(&9E92!O9B`D,RPP,#`@<&5R(&UO;G1H+CPO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@)FYB M3L@5$585"U$14-/4D%424]. M.B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@1F]R('1H92!P97)I;V0@9G)O;2!!<')I;"`Q,2P@ M,C`Q,2`H:6YC97!T:6]N*2!T:')O=6=H($1E8V5M8F5R(#,Q+"`R,#$Q+"!T M:&4@0V]M<&%N>2!R96-O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$58 M5"U$14-/4D%424]..B!U;F1E2!I;G1O($5N9V%G96UE;G0@06=R965M96YT("T@1V%R9&5N(%-T871E M(%-E8W5R:71I97,@26YC+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!E M;G1E3L@ M5$585"U)3D1%3E0Z(#!P="<^("AI*2`\9F]N="!S='EL93TS1"=415A4+41% M0T]2051)3TXZ('5N9&5R;&EN93L@1D].5"U35%E,13H@:71A;&EC.R!$25-0 M3$%9.B!I;FQI;F4G/B!38V]P92!O9B!397)V:6-E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@56YD97(@=&AE M('1E3L@5$585"U)3D1%3E0Z(#!P="<^("AI:2D@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1U-3('-H M86QL(&%C="!A28C,SD[&-L=7-I=F4@<&QA8V5M M96YT(&%G96YT(&9O7,@9G)O;2!T:&4@97AE8W5T:6]N(&]F('1H92!T97)M('-H965T M.R!O&-L=7-I=F4@4&5R:6]D(BDN M($=34R!S:&%L;"!A8W0@87,@=&AE($-O;7!A;GDF(S,Y.W,@;F]N+65X8VQU M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@*&EI:2D@0V]M<&5N3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY M(&%G2!E<75I='D@9FEN86YC:6YG+"!C;VYV97)T M:6)L92!D96)T(&9I;F%N8VEN9RP@9&5B="!C;VYV97)S:6]N(&]R(&%N>2!I M;G-T&-L=7-I=F4@4&5R:6]D.R`H:2D@82!C87-H('1R86YS86-T M:6]N(&9E92!I;B!T:&4@86UO=6YT(&]F(#@E(&]F('1H92!A;6]U;G0@'!E;G-E(&]F($=34R8C,SD[2!S:&%L;"!C875S92P@ M870@:71S(&-O6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#PA+2U%;F1&'0O:F%V87-C3X- M"B`@("`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`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VYE("@Q*2!C=7-T;VUE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z M(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU6%B;&4@8V]N8V5N=')A=&EO;B!A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI M9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E(&-O;'-P M86X],T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C M96YT97([(%1%6%0M24Y$14Y4.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!$96-E;6)E M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O M;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@=&AE(%)E<&]R=&EN M9SPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C M96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!097)I;V0@16YD960\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@ M;&5F=#L@5$585"U)3D1%3E0Z("TQ.'!T)SX@)3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#0Y+C@\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@ M/"]T9#X@/"]T6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@+3$X<'0G/B`Q.2XS/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^("4\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(V+C8\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#$P+C,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@ M/"]T9#X@/"]T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,S@E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^(%-'($%G M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U) M3D1%3E0Z("TQ.'!T)SX@)3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z("TQ.'!T)SX@)3PO M9&EV/B`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#4R M+C(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^ M(#PO='(^(#QT6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$X<'0G/B`V-"XS/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^("4\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F M=#L@5$585"U)3D1%3E0Z("TQ.'!T)SX@)3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@.#0N M.#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@ M86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\+W1D/B`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@-C`N,3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\ M+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\ M(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z M(#!P="<^($9I;F%N8VEA;"!I;G-T2!O9B!C87-H M(&%N9"!C87-H(&5Q=6EV86QE;G1S+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU2!A;&P@;V8@=&AE($-O;7!A;GDF(S,Y.W,@8V%S:"!A;F0@ M8V%S:"!E<75I=F%L96YT6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B!-87)C:"`S,2P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@-3`N,3PO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@-'!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)3PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@ M,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&'1087)T M7S-B930S.#=A7S)B8F9?-#DP.5]B8S0V7V0S.3@S83@W96(R9`T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T M-E]D,SDX,V$X-V5B,F0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!M=7-T(&)E(')E<&]R=&5D+B9N8G-P.R9N8G-P M.U1H92!-86YA9V5M96YT(&]F('1H92!#;VUP86YY(&1E=&5R;6EN960@=&AA M="!T:&5R92!W97)E(&-E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU2`T+"`R,#$T+"!A(&-O;G9E28C,SD[2X\+V1I=CX@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P M="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@1F5B2!I&5R M8VES92!P'!I6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2`Q,RP@,C`Q-"P@;VYE(&EN=F5S M=&]R(&5X97)C:7-E9"!W87)R86YT6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M3L@5$585"U$14-/4D%424]..B!U;F1E2!I;G1O(%-E3L@5$585"U)3D1%3E0Z(#!P="<^($]N M($IA;G5A2!!9W)E96UE;G0@*'1H M92`B06=R965M96YT(BD@=VET:"!%8F)U($Q,0R`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@36%Y(#,L M(#(P,3,L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A(%=A&5R8VES92PF;F)S<#LF;F)S<#MT:&4@0V]M<&%N>2!A9W)E M960@=&\@:7-S=64@=&\@=&AE($EN=F5S=&]R('1H2`H=&AE(")397)I97,@02!787)R86YT29N8G-P.R9N8G-P.W1H92`B3F5W)FYB2!E>&5R8VES86)L92!U<&]N('1H92!) M;G9E&5R8VES92!I;B!F=6QL(&]F('1H92!397)I97,@ M02!787)R86YT&-H86YG929N8G-P.R9N8G-P.T-O;6UI'0M86QI9VXZ(&IU2!T;R!T:&4@4&QA M8V5M96YT($%G96YT(&-A2!T:&4@26YV97-T;W(L(&%N9"`H:6EI*2!U<&]N(&5X97)C:7-E(&]F('1H M92!.97<@5V%R&5R8VES92!O9B!T:&4@3F5W(%=A M6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@ M2G5N92`R,RP@,C`Q,RP@=&AE(')E;6%I;FEN9R`S+#`P,"PP,#`@17-C65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F M7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D M+U=O'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!U;F%U9&ET960@ M:6YT97)I;2!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@86YD M(')E;&%T960@;F]T97,@:&%V92!B965N('!R97!A2!5+E,N($=!05`@9F]R(&-O;7!L971E(&9I;F%N8VEA;"!S=&%T M96UE;G1S+B`F;F)S<#M4:&4@=6YA=61I=&5D(&EN=&5R:6T@8V]N2!T;R!A(&9A:7(@65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY)B,S.3MS(&-O;G-O;&ED871E M9"!F:6YA;F-I86P@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1& M'0^)SPA+2U$ M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41% M0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%!R:6YC M:7!L97,@;V8@0V]N6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU2!A<'!L:65S('1H92!G M=6ED86YC92!O9B!4;W!I8R`X,3`@/&9O;G0@3L@*#,I(&-O;G-O;&ED871I;VX@8GD@86X@:6YV97-T M;65N="!C;VUP86YY('=I=&AI;B!T:&4@2!I;G9E2!O;F4@2P@9&ER96-T;'D@;W(@:6YD M:7)E8W1L>2P@;V8@;6]R92!T:&%N(#4P('!E2!C;W5R="!D96-R964N(%1H92!#;VUP86YY M(&-O;G-O;&ED871E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU28C,SD['0M86QI M9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&-E;G1E M3PO9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0S,"4^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!415A4+4%,24=..B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@4W1E=FEA($%S:6$@3&EM:71E9#PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($U!4D=)3BU, M1494.B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!415A4+4E.1$5.5#H@,'!T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0R.24^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-S`\+W1D/B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,CDE/B9N8G-P.U-I;F=A<&]R M93PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)2!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^-S`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($%L;"!I;G1E3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M($-O;7!A;GDF(S,Y.W,@8V]N6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,C0E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E. M1$5.5#H@,'!T)SX@3F%M92!O9B!C;VYS;VQI9&%T960\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`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`Q.'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY M<'0G/B!3=&5V:6$@5F5N='5R97,@26YT97)N871I;VYA;"!,=&0N/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)2!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(%1E2!O9B!T:&4@0G)I=&ES:"9N8G-P.U9I'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!<')I;"`Q,2P@ M,C`Q,3PO9&EV/B`\+W1D/B`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`M.7!T)SX@4W1E=FEA($%S:6$@3&EM:71E9#PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!-87)C M:"`Q.2P@,C`Q,CPO9&EV/B`\+W1D/B`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`M.7!T)SX@4W1E=FEA(%1E8VAN97<@3&EM M:71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!!<')I;"`R."P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!C;VYS;VQI9&%T960@9FEN86YC M:6%L('-T871E;65N=',@:6YC;'5D92!A;&P@86-C;W5N=',@;V8@=&AE($-O M;7!A;GD@86YD('1H92!C;VYS;VQI9&%T960@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@ M06QL(&EN=&5R+6-O;7!A;GD@8F%L86YC97,@86YD('1R86YS86-T:6]N&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^($-E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU'!E;G-E3L@5$585"U)3D1%3E0Z(#!P="<^($-R:71I8V%L(&%C8V]U;G1I M;F<@97-T:6UA=&5S(&%R92!E2!T;R!A8V-O=6YT(&9O6QE/3-$)U=)1%1(.B`Q.'!T)SXF;F)S<#L\+W1D/B`\=&0@2!O9B!O<&5R871I;VYS+"!R96%L:7IA=&EO M;B!O9B!A6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^ M+CPO9F]N=#X\+V1I=CX@/"]T9#X@/"]T6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@0D%#2T=23U5.1"U#3TQ/4CH@(V9F9F9F9B<^ M.CPO9F]N=#X@36%N86=E;65N="8C,SD[7-I6QE/3-$)U=)1%1( M.B`Q.'!T)SXF;F)S<#L\+W1D/B`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`Q.'!T)SXF;F)S M<#L\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF M>3L@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4U19 M3$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE.R!"04-+1U)/54Y$+4-/3$]2 M.B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@06-T=6%L(')E'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4 M+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ M('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%5S92!O9B!%3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!P2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@06-T=6%L(')E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET M86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W2!087)A9W)A<&@@.#(P+3$P+3,U+3,W(&%R92!D97-C6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@3&5V96P@,3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$;6ED9&QE('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`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`P<'0G/B!,979E;"`S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1M:61D M;&4@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!06QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@5&AE($-O;7!A;GDF(S,Y.W,@3&5V96P@,R!F:6YA;F-I86P@;&EA M8FEL:71I97,@8V]N2!S=&]C:R!P M3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!F;VQL;W=S('!A2!A8V-E<'1E9"!I;B!T:&4@56YI=&5D(%-T871E2!W:&EC M:"!P2!D969I;F5D(&)Y(%!A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&5V96P@,3PO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0G/B!,979E;"`S/"]D M:78^(#PO=&0^(#QT9"!V86QI9VX],T1M:61D;&4@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!06QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM M/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J M=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1% M3E0Z(#!P="<^($9A:7(@5F%L=64@;V8@1FEN86YC:6%L($%S6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!U2!O;B!T:&4@8V]N=F5R'0^)SPA+2U$ M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41% M0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($9A:7(@ M5F%L=64@;V8@1FEN86YC:6%L($%S6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U19 M3$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M($-O;7!A;GD@=7-E2!T;R!M96%S=7)E('1H92!F86ER('9A;'5E(&]F('1H92!D97)I=F%T M:79E(&QI86)I;&ET:65S(&%N9"!R979A;'5E2!A="!E=F5R>2!R97!OF5S(&=A:6YS(&]R(&QO6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U% M;F1&3L@5$585"U$14-/4D%424]..B!U;F1E M3L@5$585"U)3D1%3E0Z(#!P="<^($%C8V]U;G1S(')E M8V5I=F%B;&4@87)E(')E8V]R9&5D(&%T('1H92!I;G9O:6-E9"!A;6]U;G0L M(&YE="!O9B!A;B!A;&QO=V%N8V4@9F]R(&1O=6)T9G5L(&%C8V]U;G1S+B9N M8G-P.R9N8G-P.U1H92!#;VUP86YY(&9O;&QO=W,@<&%R86=R87!H(#,Q,"TQ M,"TU,"TY(&]F('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A2!P97)F;W)M2!T:&4@'!E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R6UE;G1S(&AA=F4@8F5E;B!R96-E:79E9"X\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T28C,SD[2X\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`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`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`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4 M+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ M('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($9I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E. M1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!E;&5C=&5D($UA'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($9I M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!E;&5C=&5D($UA65A&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!C;VYS:61E2!L M:7%U:60@:6YV97-T;65N=',@=VET:"!M871U3L@5$58 M5"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE2!O8G-O;&5S8V5N8V4@9F]R('1H92!I;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M4U193$4Z(&ET86QI8SL@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO M9&EV/B`\+V1I=CX@/"$M+45N9$9R86=M96YT+2T^/"]D:78^(#PO9&EV/CQS M<&%N/CPO3L@5$58 M5"U$14-/4D%424]..B!U;F1E3L@5$585"U) M3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&-O;G-I9&5R&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!A;F0@97%U:7!M96YT(&ES(')E8V]R M9&5D(&%T(&-O'1U&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!A;F0@97%U:7!M96YT(&ES(')E8V]R M9&5D(&%T(&-O'1U'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($EN M=&%N9VEB;&4@07-S971S($]T:&5R(%1H86X@1V]O9'=I;&P\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@ M:&%S(&%D;W!T960@<&%R86=R87!H(#,U,"TS,"TR-2TS(&]F('1H92!&05-" M($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`U/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE3L@5$585"U)3D1% M3E0Z(#!P="<^(%1H92!#;VUP86YY(&AAF5S('1H92!A8W%U:7-I=&EO;B!C;W-TF5D+"!T:&4@&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z M(#!P="<^(%1H92!#;VUP86YY(&9O;&QO=W,@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`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`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`P<'0[('1E>'0M86QI9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2`Q,BP@,C`Q,R!T;R!R96-O=F5R("0Q M+#`T,BPP,#`@;V8@<&%S="UD=64@86-C;W5N=',@<&%Y86)L92!O9B!T:&4@ M0V]M<&%N>2P@<&QU&5C=71I;VX@;V8@=&AE($]R9&5R(&)Y('1H92!#;W5R="!O M;B!*=6QY(#(U+"`R,#$S+CPO9&EV/B`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`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494 M.B`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`P<'0[('1E>'0M86QI9VXZ(&IUF4@86QL(&1E2!A'!O'0M86QI9VXZ(&IU2!F;W)E:6=N(&-U&5D(&9O2!C:&%N9V5S(&EN M('1H92!F86ER('9A;'5E(&]F('1H92!I=&5M(&)E:6YG(&AE9&=E9"X\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z M(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O M;7!A;GD@9&ED(&YO="!E;7!L;WD@9F]R96EG;B!C=7)R96YC>2!F;W)W87)D M(&-O;G1R86-T2!E>&-H86YG92!R871E'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`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`X,34M-#`M,34@;V8@ M=&AE($9!4T(@06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T:6]N("@B M4V5C=&EO;B`X,34M-#`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`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU2!E=F%L M=6%T97,@:71S(&-O;G9E2!A8V-O=6YT960@9F]R(&EN(&%C8V]R9&%N8V4@=VET:"!P87)A M9W)A<&@@.#$P+3$P+3`U+30@86YD(%-E8W1I;VX@.#$U+30P+3(U(&]F('1H M92!&05-"($%C8V]U;G1I;F<@4W1A;F1A&5R8VES92!O2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@26X@8VER8W5M6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU2!A="!T:&4@9F%I'0M86QI9VXZ(&IU2!A9&]P=&5D(%-E8W1I;VX@ M.#$U+30P+3$U(&]F('1H92!&05-"($%C8V]U;G1I;F<@4W1A;F1A&5D('1O('1H92!#;VUP M86YY)B,S.3MS(&]W;B!S=&]C:RXF;F)S<#LF;F)S<#M396-T:6]N(#@Q-2TT M,"TQ-2!P2!S:&]U;&0@=7-E(&$@='=O M+7-T97`@87!P&5D('1O(&ET&5R8VES92!P2!F;W)E:6=N('-U8G-I9&EA2X\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^ M/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@ M;6%R:W,@=&\@;6%R:V5T('1H92!F86ER('9A;'5E(&]F('1H92!E;6)E9&1E M9"!D97)I=F%T:79E('=A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M1$5# M3U)!5$E/3CH@=6YD97)L:6YE.R!415A4+4E.1$5.5#H@,'!T)SX@0F5N969I M8VEA;"!#;VYV97)S:6]N($9E871U6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@5VAE;B!T:&4@0V]M<&%N>2!I6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!S96-U2!T:&%T(&ES(&-O;G9E2!S96-U2!C;W5N=&5R<&%R='D@:7,@;&5G86QL>2!C;VUM:71T960@ M=&\@<'5R8VAA'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($-O M;6UI=&UE;G0@86YD($-O;G1I;F=E;F-I97,\+V1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@3&]S2!I;G9O;'9E(&=U87)A;G1E97,L(&EN('=H:6-H(&-A3L@5$585"U$14-/4D%424]..B!U;F1E M3L@5$585"U)3D1%3E0Z M(#!P="<^(%1H92!#;VUP86YY(&9O;&QO=W,@2!E>&ES="!A2!R97-U;'0@:6X@82!L;W-S('1O('1H92!#;VUP86YY(&)U="!W M:&EC:"!W:6QL(&]N;'D@8F4@2!O2!R97-U;'0@:6X@2!L96=A;"!P'!E8W1E9"!T M;R!B92!S;W5G:'0@=&AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@268@=&AE(&%S2!I;F1I8V%T97,@=&AA="!I="!I2!I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!N;W0@9&ES8VQO2!A9F9E8W0@=&AE($-O;7!A;GDF(S,Y.W,@8G5S:6YE6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M($-O;7!A;GD@9F]L;&]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`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`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@9F]L;&]W2!3=&%T96UE;G0@;V8@ M1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SXB M06-C;W5N=&EN9R!F;W(@4F5S96%R8V@@86YD($1E=F5L;W!M96YT($-O'0^)SPA+2U$ M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`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`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@ M/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!8 M2%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD M:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU, M1494.B`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`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@5&AE($-O;7!A;GD@86-C;W5N=',@9F]R(&ET2!I;G-T2!A28C M,SD[2!O2!I;F9L871E9"!D=64@=&\@ M82!L87)G97(@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD M:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%- M24Q9.B!T:6UE3H@4WEM8F]L+"!S M97)I9CL@1D].5"U325I%.B`Q,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\ M+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`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`Q,7!T)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@ M/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($5X<&5C=&5D('9O;&%T M:6QI='D@;V8@=&AE(&5N=&ET>28C,SD[2UT2!T:&%T('5S97,@=&AE(&-A M;&-U;&%T960@=F%L=64@;65T:&]D('-H86QL(&1I2!I="!I'!E8W1E9"!V;VQA=&EL:71Y(&]F(&ET"!T:&%T(&ET(&AA2!B92!M;W)E(&%P<')O<')I871E('1H86X@=&AE('5S92!O9B!D86EL M>2!P6QE/3-$)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT/B`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GDF(S,Y.W,@<&]L:6-Y(&ES M('1O(')E8V]G;FEZ92!C;VUP96YS871I;VX@8V]S="!F;W(@87=A2!S97)V:6-E(&-O;F1I=&EO;G,@86YD(&$@9W)A9&5D('9E'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@5$585"U) M3D1%3E0Z(#!P="<^(%-T;V-K+4)A65E(%-E3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&%C8V]U;G1S(&9O M2!I;G-T2!M96%S=7)A8FQE+B9N M8G-P.R9N8G-P.U1H92!M96%S=7)E;65N="!D871E('5S960@=&\@9&5T97)M M:6YE('1H92!F86ER('9A;'5E(&]F('1H92!E<75I='D@:6YS=')U;65N="!I M2!T2!P6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5&AE(&9A:7(@=F%L=64@;V8@;F]N+61E6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG;CTS M1')I9VAT/B`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`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^ M(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ M(%-Y;6)O;"P@'0M86QI9VXZ(&IU'!E8W1E9"!V;VQA=&EL:71Y(&]F('1H92!E;G1I='DF(S,Y.W,@2!T;R!E2!O9B!I=',@2!S96-T;W(@:6YD97@@=&AA="!I="!H87,@2!U'!E8W1E9"!C;VYT M2!A2!O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE3H@4WEM8F]L+"!S97)I9CL@1D].5"U325I%.B`Q,7!T M)SX@)FUI9&1O=#LF;F)S<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$58 M5"U)3D1%3E0Z(#!P="<^($5X<&5C=&5D(&%N;G5A;"!R871E(&]F('%U87)T M97)L>2!D:79I9&5N9',N)FYB7,@9&EF9F5R96YT(&1I=FED96YD(')A M=&5S(&1U6EE;&0@:7,@8F%S960@;VX@ M=&AE($-O;7!A;GDF(S,Y.W,@8W5R6QE/3-$)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@ M'0M86QI9VXZ(&IU7,@9&EF9F5R96YT(')I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@)FYB'0M86QI9VXZ(&IU28C,SD[6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#PA+2U%;F1&'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!&3TY4+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`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`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV M/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`U-'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O M;"P@'0M86QI9VXZ(&IU'!E M8W1E9"!V;VQA=&EL:71Y(&]F('1H92!E;G1I='DF(S,Y.W,@7,@9&EF M9F5R96YT('9O;&%T:6QI=&EE'!E8W1E M9"!V;VQA=&EL:71Y+B9N8G-P.R9N8G-P.T$@=&AI;FQY+71R861E9"!O"P@86YD(&AO=R!I="!H87,@8V%L8W5L871E9"!H M:7-T;W)I8V%L('9O;&%T:6QI='D@=7-I;F<@=&AA="!I;F1E>"Y4:&4@0V]M M<&%N>2!U2!O M9B!T:&4@8V]M<&%R86)L92!C;VUP86YI97,@;W9E2!T M2!P2!C86QC=6QA=&EO;B!U2!O8G-E2!I M;F9L871E9"!D=64@=&\@82!L87)G97(@6QE/3-$)U=)1%1(.B`U M-'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU'!E8W1E9"!A;FYU86P@2!T:&%T M('5S97,@82!M971H;V0@=&AA="!E;7!L;WES(&1I9F9E'!E8W1E9"!D:79I9&5N9',N)FYB M6EE;&0@ M87,@=&AE(&)E3H@ M4WEM8F]L+"!S97)I9CL@1D].5"U325I%.B`Q,7!T)SX@)FUI9&1O=#LF;F)S M<#LF;F)S<#L\+V1I=CX@/"]T9#X@/'1D/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^ M(%)I6EE;&0@8W5R=F4@:6X@969F M96-T(&%T('1H92!T:6UE(&]F(&=R86YT(&9O6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R2!T:&4@9W)A;G1E M92!T;R!R971A:6X@=&AO2!T;R!E87)N('1H92!E M<75I='D@:6YS=')U;65N=',L(&$@;65A2!C;VYC;'5D92!T:&%T(&%N(&%S2!T:&4@9W)A;G1E92!I;B!O M65D(&%S(&-O;G1R82UE M<75I='D@8GD@=&AE(&=R86YT;W(@;V8@=&AE(&5Q=6ET>2!I;G-T2`H;W(@;&%C:R!T:&5R96]F*2!O9B!T M:&4@97%U:71Y(&EN2!O9B!T:&4@87-S970N(%1H:7,@9W5I9&%N M8V4@:7,@;&EM:71E9"!T;R!T65E&-H86YG92!F;W(@9V]O9',@;W(@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!I;G-T&5R M8VES86)L92!B>2!T:&4@9W)A;G1E92!O;FQY(&%F=&5R(&$@2!M96%S=7)E9"!C;W-T(&]F('1H92!TF5D(&EN('1H92!S86UE('!E3L@5$585"U)3D1% M3E0Z(#!P="<^(%!U2!R96-E:79E2P@=&AE'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O M+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B M("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L:6,[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@/&9O;G0@2!);G-T65E6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2!A8V-O=6YT M6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M'0M86QI9VXZ(&IU2!I M;G-T2!A28C,SD[2!O2!I;F9L871E9"!D=64@=&\@82!L87)G97(@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#$P,"4^(#QT6UB;VPL('-E'!E8W1E9"!T M97)M(&]F('-H87)E(&]P=&EO;G,@86YD('-I;6EL87(@:6YS=')U;65N=',@ M'!E8W1E9"!E>&5R8VES92!B M96AA=FEO2!I2!T'!E8W1E9"!T97)M+CPO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1% M3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$)U=)1%1(.B`S-G!T M)R!A;&EG;CTS1')I9VAT/B`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`S-G!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF86UI;'DZ M(%-Y;6)O;"P@'0M86QI9VXZ(&IU'!E8W1E9"!A;FYU86P@2!T:&%T('5S97,@82!M971H;V0@=&AA M="!E;7!L;WES(&1I9F9E'!E8W1E9"!D:79I9&5N9',N)FYB6EE;&0@87,@=&AE(&)E6QE/3-$ M)U=)1%1(.B`S-G!T)R!A;&EG;CTS1')I9VAT/B`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`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`H M-3`I('!E&5S+"!A8V-O=6YT:6YG(&EN(&EN=&5R:6T@<&5R:6]D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU"!C2!P97)I M;V1I8V%L;'D@2X\+V1I=CX@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R M("\^(#PO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@36%N86=E;65N="!M86ME M2X\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@5$585"U) M3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\ M+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^)SPA+2U$3T-465!%(&AT;6P@4%5" M3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@ M(FAT='`Z+R]W=W&AT;6PQ+71R86YS M:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q% M.B!I=&%L:6,[($U!4D=)3BU,1494.B`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`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L M:6,[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@ M5$585"U)3D1%3E0Z(#!P="<^($QI;6ET871I;VX@;VX@571I;&EZ871I;VX@ M;V8@3D],6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4'5R2!R97-U;'0@9G)O;2!T M65AF%T:6]N(&]F('1H92!.3TQS('=O M=6QD(&)E('-U8FIE8W0@=&\@86X@86YN=6%L(&QI;6ET871I;VX@=6YD97(@ M4V5C=&EO;B`S.#(@9&5T97)M:6YE9"!B>2!M=6QT:7!L>6EN9R!T:&4@=F%L M=64@;V8@:71S('-T;V-K(&%T('1H92!T:6UE(&]F('1H92!O=VYE2!U;G5S960@86YN=6%L(&QI;6ET871I;VX@;6%Y(&)E(&-A M&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T M9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&IU6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@'0M86QI9VXZ(&IU M2!T;R!U=&EL:7IE($Y/3',@:68@:70@97AP97)I96YC97,@86X@ M(F]W;F5R"UE>&5M<'0@2!T;R!U2!T;R!P87D@52Y3+B!F961E&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M4U193$4Z(&ET86QI8SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&IU2!D:79I M9&EN9R!N970@:6YC;VUE("AL;W-S*2!B>2!T:&4@=V5I9VAT960@879E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!4 M15A4+4E.1$5.5#H@,'!T)SX@1F]R($EN=&5R:6T\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5. M5#H@,'!T)SX@4&5R:6]D16YD960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M1&5C96UB97(@,S$L(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@26YT97)I;3PO M9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT M97([(%1%6%0M24Y$14Y4.B`P<'0G/B!097)I;V0@16YD960\+V1I=CX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4 M+4E.1$5.5#H@,'!T)SX@1&5C96UB97(@,S$L(#(P,3(\+V1I=CX@/"]T9#X@ M/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!-86ME($=O;V0@17-C"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#@X,2PW-3(\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB2`S,"P@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R M=&EB;&4@;F]T92!I;B!T:&4@<')I;F-I<&%L(&%M;W5N="!O9B`D,C`P+#`P M,"!W:71H(&EN=&5R97-T(&%T(#$P)2!P97(@86YN=6T@9'5E(&]N92`H,2D@ M>65A2!A8V-R=65D(&%N9"!U;G!A:60@:6YT97)E M28C,SD[&ES=',@870@=&AE('1I;64@;V8@=&AE(&-O;G9E28C,SD[2!F:6YA;F-I;F<@ M=')A;G-A8W1I;VX@869T97(@=&AE(&1A=&4@9FER2!R96-E:79E2!C;VYT:6YU97,@ M=&\@86-C'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@,2PW,SDL,3,P/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@-#(V+#8V-SPO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!&96)R=6%R>2`R-BP@ M,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D('1W;R`H,BD@8V]N=F5R=&EB;&4@ M;F]T97,@:6X@=&AE('!R:6YC:7!A;"!A;6]U;G0@;V8@)#(U,"PP,#`@86YD M("0Q,#`L,#`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`\+W1D/B`\+W1R M/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!! M=6=U2`R M-BP@,C`Q-"X\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.S(L,S4S+#4W,SPO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#0T,"PU-S$\+V1I=CX@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB2`Q+"`R,#$T+CPO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.RT\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&IU'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@.#$R+#8S-#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M("T\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&IU2!P97)I;V0@8F5F;W)E M('1H92!C;VYV97)S:6]N(&1A=&4@+CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX] M,T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`S-G!T.R!-05)'24XM4DE'2%0Z(#6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@,3`L-38Q+#`W,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@.#4S+#,S-#PO9&EV/B`\ M+W1D/B`\+W1R/B`\+W1A8FQE/B`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`R-BP@,C`Q,RP@=V%R2X@3VX@36%Y(#@L(#(P,3,L('1H92!#;VUP86YY(&-O M;7!L971E9"!A('!R:79A=&4@<&QA8V5M96YT(&%T("0P+C(P('!E2X@3VX@36%Y(#@L(#(P,3,L(&EN=F5S=&]R&5R8VES960@ M=&AE('=A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,2PQ-3(L,#`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#@X,2PW-3,\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB2`V+"`R,#$S+"!T M:&4@0V]M<&%N>2!I'!I M'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,BPP,C'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SXF;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`W+C'0M86QI9VXZ(&IU28C,SD[&5R8VES92!P65A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#$L,34Q+#DY.3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#(L-3,T+#,Y.3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M("T\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ(&IU&5R8VES92!P'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PP,#`L,#`P M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\+W1R M/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,S9P=#L@34%21TE.+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4W5B+71O=&%L M(%=A6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#DL.34R+#$U,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@,2PQ-3(L,#`P/"]D:78^(#PO=&0^(#PO M='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`T-7!T.R!-05)'24XM4DE'2%0Z(#2!O=71S=&%N9&EN9R!D:6QU=&EV92!C;VUM;VX@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@-2PP,#4L,S,T/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^ M(#PO9&EV/B`\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\(2TM16YD1G)A9VUE M;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L M:6,[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@ M5$585"U)3D1%3E0Z(#!P="<^($YE="!);F-O;64@*$QO6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@3F5T(&EN8V]M92`H;&]S2!D:79I9&EN9R!N970@:6YC;VUE("AL M;W-S*2!B>2!T:&4@=V5I9VAT960@879E3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!F;VQL;W=I;F<@=&%B;&4@6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@0V]M;6]N(%-H M87)E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-3`E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3(E(&-O;'-P86X],T0T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@=&AE(%!E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`M M.7!T)SX@36%K92!';V]D($5S8W)O=R!!9W)E96UE;G0@&-H86YG92!!9W)E96UE;G0@8V]N6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,RPP,#`L,#`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`Q,7!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BPP,#`L,#`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`M.7!T)SX@3VX@36%R8V@@-RP@,C`Q,BP@=&AE($-O M;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T92!I;B!T:&4@86UO=6YT M(&]F("0R,#`L,#`P('=I=&@@:6YT97)E2!C;VUP;&5T97,@82!P M'0@<')I=F%T92!P;&%C96UE;G0@870@ M)#`N-#8X-S4@<&5R('-H87)E('=I=&@@9W)O6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB2`S M,"P@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T M92!I;B!T:&4@86UO=6YT(&]F("0R,#`L,#`P('=I=&@@:6YT97)E2!C;VUP;&5T97,@82!P'0@<')I=F%T M92!P;&%C96UE;G0@870F;F)S<#LF;F)S<#LD,"XT-C@W-2!P97(@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`M.7!T)SX@3VX@1F5B2!I6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`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`W+C'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#28C,SD[&5R8VES92!P6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`L.30Q M+#4Y-CPO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z M+R]W=W&AT;6PQ+71R86YS:71I;VYA M;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5-464Q%.B!I=&%L M:6,[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN93L@ M5$585"U)3D1%3E0Z(#!P="<^($-A6UE;G1S(&%C8V]R9&EN9R!T;R!W:&5T:&5R('1H97D@2P@ M86YD('5S97,@=&AE(&EN9&ER96-T(&]R(')E8V]N8VEL:6%T:6]N(&UE=&AO M9"`H(DEN9&ER96-T(&UE=&AO9"(I(&%S(&1E9FEN960@8GD@<&%R86=R87!H M(#(S,"TQ,"TT-2TR-2!O9B!T:&4@1D%30B!!8V-O=6YT:6YG(%-T86YD87)D M2!A9&IU6UE;G1S(&%N9"!A;&P@86-C2!P'0^)SPA+2U$3T-465!%(&AT M;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L M+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ M+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A M9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4 M+5-464Q%.B!I=&%L:6,[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+41%0T]2051)3TXZ M('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^($-A3L@5$585"U)3D1%3E0Z(#!P M="<^(%1H92!#;VUP86YY(&%D;W!T960@<&%R86=R87!H(#(S,"TQ,"TT-2TR M-"!O9B!T:&4@1D%30B!!8V-O=6YT:6YG(%-T86YD87)D6UE;G1S(&%C8V]R9&EN9R!T;R!W:&5T:&5R('1H M97D@2P@86YD('5S97,@=&AE(&EN9&ER96-T(&]R(')E8V]N8VEL M:6%T:6]N(&UE=&AO9"`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`R,#$S+"!T:&4@1D%30B!I2!C;VUP;VYE;G0@ M86YD('1H96ER(&-O3L@5$585"U)3D1%3E0Z(#!P="<^ M($EN($9E8G)U87)Y(#(P,3,L('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3 M=&%N9&%R9',@0F]A2!!65A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@36%R8V@@,C`Q,RP@ M=&AE($9!4T(@:7-S=65D($%352!.;RX@,C`Q,RTP-2P@(CQF;VYT('-T>6QE M/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE)SY&;W)E M:6=N($-U3PO9F]N=#XN(B!4:&ES($%352!A9&1R97-S97,@=&AE(&%C8V]U;G1I;F<@ M9F]R('1H92!C=6UU;&%T:79E('1R86YS;&%T:6]N(&%D:G5S=&UE;G0@=VAE M;B!A('!A65A6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5. M5#H@,'!T)SX@26X@36%R8V@@,C`Q,RP@=&AE($9!4T(@:7-S=65D($%352`R M,#$S+3`W+"`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`P<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@26X@2F%N M=6%R>2`R,#$S+"!T:&4@1D%30B!I2`Q+"`R,#$S+CPO9&EV/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2`R,#$S+"!T:&4@1D%30B!I'0M86QI9VXZ(&IU2`R,#$S+"!T:&4@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A M&5D(&%T('1H92!297!O65A3L@5$585"U)3D1%3E0Z(#!P="<^($EN($UA2!-871T97)S("A4;W!I8R`X,S`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SPA+2U$3T-465!%(&AT;6P@ M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]% M3B(@(FAT='`Z+R]W=W&AT;6PQ+71R M86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY)B,S.3MS(&-O M;G-O;&ED871E9"!S=6)S:61I87)I97,@86YD+V]R(&5N=&ET:65S(&%R92!A M6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^(#QD:78@6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S`E/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@3F%M92!O9B!C;VYS;VQI9&%T960\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0[('1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!, M05DZ(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,CDE/B`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`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`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`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M4W1E=FEA(%1E8VAN97<@3&EM:71E9#PO9&EV/B`\+W1D/B`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`Q,7!T.R!-05)'24XM3$5&5#H@.7!T.R!0041$24Y'+4Q%1E0Z(#!P M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S`E(&%L:6=N/3-$;&5F=#XF M;F)S<#L@/&9O;G0@6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R M.R!415A4+4E.1$5.5#H@,'!T)SX@3F%M92!O9B!C;VYS;VQI9&%T960\+V1I M=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=( M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)U!! M1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ M(&EN;&EN92<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,C0E/B`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`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!3=&5V:6$@5F5N='5R97,@26YT97)N871I;VYA;"!, M=&0N/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R M)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE M(%1E2!O9B!T:&4@0G)I=&ES:"9N8G-P.U9I'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!! M<')I;"`Q,2P@,C`Q,3PO9&EV/B`\+W1D/B`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`M.7!T)SX@4W1E=FEA($%S:6$@3&EM M:71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!-87)C:"`Q.2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4W1E=FEA(%1E M8VAN97<@3&EM:71E9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!!<')I;"`R."P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T M1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!F;VQL;W=I;F<@ M=&%B;&4@6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@ M/"]D:78^(#QD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C`E(&-O M;'-P86X],T0T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1F]R($EN=&5R:6T\ M+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`S-G!T.R!-05)'24XM4DE'2%0Z(#6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M+3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,RPP,#`L,#`P/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^ M(#PO9&EV/B`\9&EV/B9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B`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`Q.'!T.R!-05)'24XM M4DE'2%0Z(#3L@5$585"U)3D1% M3E0Z("TY<'0G/B!/;B!-87)C:"`W+"`R,#$R+"!T:&4@0V]M<&%N>2!I2!C;VUP;&5T97,@82!P M'0@<')I=F%T92!P;&%C96UE;G0@870@ M)#`N-#8X-S4@<&5R('-H87)E('=I=&@@9W)O2!P87-T(&1U92!W:71H(&YO('!E;F%L='D@86YD('1H M92!#;VUP86YY(&-O;G1I;G5E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-#(V+#8V-SPO9&EV/B`\+W1D M/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G M/B!/;B!-87D@,S`L(#(P,3(L('1H92!#;VUP86YY(&ES2!T28C,SD[2!A;F0@=&AE($-O;7!A;GD@8V]N=&EN=65S M('1O(&%C8W)U92!T:&4@:6YT97)E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#$L-S,Y+#$S,#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#0R-BPV-C<\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ M(&IU2!C M;VYT:6YU97,@=&\@86-C'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M+3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)' M24XM4DE'2%0Z(#3L@5$585"U) M3D1%3E0Z("TY<'0G/B!/;B!*=6QY(#$V+"`R,#$S+"!T:&4@0V]M<&%N>2!I M7,N(%1H92!N;W1E(&ES(&1U92!O;F4@ M*#$I('EE87(@9G)O;2!T:&4@9&%T92!O9B!I6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L-S8R+#(R M.#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!/8W1O8F5R(#$U+"`R,#$S+"!T M:&4@0V]M<&%N>2!I6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^("9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.S(Y,"PP,#`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`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`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\+W1R M/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,S9P=#L@34%21TE.+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4W5B+71O=&%L M($-O;G9E6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#$P+#4V,2PP-S`\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#@U,RPS,S0\+V1I=CX@ M/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5V%R6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB2!I65A2`X+"`R,#$S+"!T:&4@0V]M<&%N>2!C M;VUP;&5T960@82!P2`X+"`R,#$S+"!I;G9E'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@.34V+#0X,3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#$L,34R+#`P,#PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C M;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!&96)R=6%R>2`R M-BP@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D('=A'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PT,#`L M,#`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\ M+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/ M;B!-87)C:"`Q-2P@,C`Q,RP@=&AE($-O;7!A;GD@:7-S=65D(&$@=V%R6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#3L@5$585"U)3D1%3E0Z("TY<'0G/B!/;B!-87D@-BP@,C`Q,RP@ M=&AE($-O;7!A;GD@:7-S=65D('1H6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z M(#3L@5$585"U)3D1%3E0Z("TY M<'0G/B!397)I97,@02!W87)R86YT&5R8VES92!P65A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(L,#(W+#4R,#PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,#`P+#`P M,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P,#PO9&EV/B`\+W1D/B`\ M+W1R/B`\='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!-05)'24XM3$5&5#H@-#5P=#L@34%21TE.+5))1TA4.B`W+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5&]T86P@ M<&]T96YT:6%L;'D@;W5T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,C`L-3$S+#(R M,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#4L,#`U+#,S-#PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE M/B`\+V1I=CX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB2!/=71S M=&%N9&EN9R!$:6QU=&EV93PO9F]N=#X@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,3`E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@1FES8V%L M(%EE87(@16YD960\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@36%R8V@@,S$L M(#(P,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!-87)C:"9N8G-P.S,Q+"`R,#$R/"]D:78^(#PO=&0^(#PO='(^(#QT M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`W M+C'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^-BPP,#`L,#`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`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`W+C'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`M.7!T)SX@0V]N=F5R=&EB;&4@3F]T92!3:&%R97,\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#8E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#8E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#2!I2!C;VUP;&5T960@=&AE('9E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`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`M.7!T)SX@3VX@36%Y(#,P+"`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`Q.'!T.R!-05)' M24XM4DE'2%0Z(#2`R-BP@,C`Q,R`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`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`M M.7!T)SX@3VX@1F5B2P@,2PT,#`L,#`P('-H87)E28C,SD[6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^,2PT,#`L,#`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`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`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`M.7!T)SX@5&]T86P@<&]T96YT:6%L;'D@;W5T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#PA+2U%;F1&'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'!E;G-E'0^)SPA+2U$ M3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A M;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`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`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#,S+#`Y-CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N M/3-$'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,38X+#@W-#PO9&EV/B`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5. M5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&'10 M87)T7S-B930S.#=A7S)B8F9?-#DP.5]B8S0V7V0S.3@S83@W96(R9`T*0V]N M=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S8F4T,S@W85\R8F)F7S0Y,#E? M8F,T-E]D,SDX,V$X-V5B,F0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7 M,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`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`Q,7!T.R!- M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4V5E9',@*"HI/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3$E(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`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`P<'0G/B`D/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U M8FQE)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,24@86QI9VX],T1R:6=H M=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q,24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@2!A8W%U:7)E9"!C97)T86EN('-E961S(&EN M('1H92!A;6]U;G0@;V8@)#$L.#`W+#`P,"!I;B!A9V=R96=A=&4@=VAI8V@@ M=V%S('5S960@9F]R('!R97!A2P@=VAI8V@@ M2!A;F0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)T9/3E0M4TE:13H@ M,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#,L,#,V/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!,97-S(&%C8W5M M=6QA=&5D(&1E<')E8VEA=&EO;CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,C`E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M("@Q+#(S-#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^("@M/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0G/B`D/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@ M9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I M9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#,L,#,V/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&'1087)T7S-B930S.#=A7S)B8F9?-#DP.5]B8S0V7V0S.3@S83@W96(R M9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\S8F4T,S@W85\R8F)F M7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1- M3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^ M(#QD:78^/"$M+5-T87)T1G)A9VUE;G0M+3X\8G(@+SX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO M9&EV/B`\9&EV('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@ M"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E M6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5V5B6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-2PS,34\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-38E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@06-C=6UU;&%T960@86UOF%T M:6]N/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R,"4^/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#$L.#8Y/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B`I/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\+W1R/B`\ M='(@8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-38E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,C`E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#,L-#0V/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@)#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D M,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E M-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO2!H860@ M=')A;G-A8W1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I M=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@4F5L M871E9"!P87)T:65S('=I=&@@=VAO;2!T:&4@0V]M<&%N>2!H860@=')A;G-A M8W1I;VYS(&%R93H\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&IU'0M86QI9VXZ(&IU#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1T M;W`@=VED=&@],T0V)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V M86QI9VX],T1T;W`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`Q.'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TY<'0G/B!,979E6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB2!,:6UI=&5D/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED M=&@],T0V)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.;VXM8V]N=')O;&QI M;F<@:6YT97)E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!'2!0=&4@3'1D+CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$=&]P('=I9'1H/3-$-B4^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06X@ M96YT:71Y(&]W;F5D(&%N9"!C;VYT'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`M.7!T)SX@1W5A;F=Z:&]U($AE86QT:"!496-H;F]L;V=Y M($1E=F5L;W!M96YT($-O;7!A;GD@3&EM:71E9#PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$=&]P('=I9'1H/3-$-B4^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@06X@96YT:71Y(&]W;F5D(&%N9"!C;VYT'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV/B`\=&%B;&4@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@.7!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M(%)E;&%T960@4&%R=&EE"<@=F%L:6=N/3-$=&]P('=I9'1H/3-$-B4@86QI M9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("8C,3(R.#@[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R<'@@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1V5O6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4')E3PO9&EV M/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@06X@96YT:71Y(&]W;F5D(&%N9"!C;VYT6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@5&5C:&YE=R!4 M96-H;F]L;V=Y($QI;6ET960\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1'1O M<"!W:61T:#TS1#8E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!' M2!0=&4@3'1D+CPO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@06X@96YT:71Y(&]W;F5D(&%N9"!C;VYT6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1W5A;F=Z:&]U($AE86QT M:"!496-H;F]L;V=Y($1E=F5L;W!M96YT($-O;7!A;GD@3&EM:71E9#PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$-B4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@06X@96YT:71Y(&]W;F5D(&%N9"!C;VYT'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($9A2!'6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`P<'0G/B!&87)M(&UA;F%G96UE;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M,3@P+#`P,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#$X,"PP,#`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$ M'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,3@P+#`P,#PO9&EV/B`\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#$X,"PP,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0^)SPA M+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@ M5')A;G-I=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^ M/"$M+5-T87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@=&AE(%!E M'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!&87)M(&UA;F%G96UE;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R<'@@'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,C0P+#`P,#PO9&EV M/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#$X,"PP,#`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`Q,7!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@,C0P+#`P,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#$X,"PP,#`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`P,#PO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(T,"PP,#`\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T M)SX@,C`Q-CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,C0P+#`P,#PO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@&AT;6PQ+T141"]X:'1M;#$M M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!- M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1FES8V%L(%EE87(@16YD M:6YG($UA6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`R-W!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TY<'0G/B`R,#$T/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P M="<^(#$T,"PP,#`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV M('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#$T,"PP,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R M8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E M8C)D+U=O'0O:'1M;#L@8VAA'0^)SPA+2U$3T-465!%(&AT;6P@ M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]% M3B(@(FAT='`Z+R]W=W&AT;6PQ+71R M86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($-O;G9E6%B;&4@8V]N6QE M/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS M1#$P,"4^(#QT6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3$E/C,U,"PP,#`\+W1D/B`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`Q,7!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E/C(R,"PT,S@\ M+W1D/B`\=&0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB65A6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E/C$Q,2PQ,3$\+W1D/B`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`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E M/BT\+W1D/B`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`Q.'!T.R!-05)'24XM4DE' M2%0Z(#3L@5$585"U)3D1%3E0Z M("TY<'0G/B!/;B!397!T96UB97(@,C8L(#(P,3,L('1H92!#;VUP86YY(&ES M65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`\=&%B;&4@ M6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q,7!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E/BT\+W1D/B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`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`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`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`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`Q.'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G M/B!/;B!.;W9E;6)E6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)"9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&-O;'-P86X],T0R(&%L:6=N/3-$ M'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@8V]L6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(U,"PP,#`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`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!/;B!*86YU87)Y(#$V+"`R,#$R+"!T:&4@0V]M M<&%N>2!I2!C;VUP;&5T97,@82!P6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E(&-O;'-P86X] M,T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(U,"PP M,#`\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@3VX@36%R8V@@-RP@,C`Q,BP@ M=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB;&4@;F]T92!I;B!T:&4@ M86UO=6YT(&]F("0R,#`L,#`P('=I=&@@:6YT97)E2!C;VUP;&5T960@=&AE('9E'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M,C(P+#0S.#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,B4@8V]L'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@,C`P+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@8V]L6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB2`S,"P@,C`Q,BP@=&AE($-O;7!A;GD@:7-S=65D(&$@8V]N=F5R=&EB M;&4@;F]T92!I;B!T:&4@86UO=6YT(&]F("0R,#`L,#`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`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@3VX@1F5B28C,SD[6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#,U,"PP M,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@8V]L6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4W5B+71O M=&%L.B!C;VYV97)T:6)L92!N;W1E'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-S'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@-S`P+#`P,#PO9&EV M/B`\+W1D/B`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`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`M.7!T)SX@06-C=6UU;&%T960@86UOF%T M:6]N(&]F(&1I6%B;&4\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!296UA:6YI;F<@9&ES8V]U;G0\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV M/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@8V]L6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&-O;'-P86X],T0R(&%L:6=N/3-$ M'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,S4W+#"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,B4@8V]L6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0M86QI9VXZ(&IU2!E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!4 M15A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!%>'!E8W1E9"!O M<'1I;VX@;&EF92`H>65A6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#,N,#`\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`M.7!T)SX@17AP96-T960@=F]L871I;&ET>3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M,'!T)SX@-S0N-3,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I M=CX@/"]T9#X@/"]T'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`M.7!T)SX@4FES:RUF6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#`N,S<\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("4\+V1I=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D M:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D M:78^(#PA+2U%;F1&&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE($-O;7!A;GD@ M97-T:6UA=&5D('1H92!R96QA=&EV92!F86ER('9A;'5E(&]F('1H97-E('=A M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,RXP,#PO9&EV/B`\+W1D/B`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@17AP96-T960@=F]L871I;&ET>3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@-S0N-3,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I=CX@ M/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q M.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TY<'0G/B!2:7-K+69R964@:6YT97)E'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@,"XS-SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0^)SPA+2U$3T-465!% M(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO M;F%L+R]%3B(@(FAT='`Z+R]W=W&AT M;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T M1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&5S M=&EM871E9"!T:&4@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B M;&4@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`M.7!T)SX@17AP96-T960@;W!T:6]N(&QI9F4@*'EE87(I/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT M6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$:79I9&5N M9"!Y:65L9#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XP,#PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE M/B`\+V1I=CX@/&1I=CX\8G(@+SX@)FYB'0^)SPA+2U$3T-465!%(&AT;6P@ M4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]% M3B(@(FAT='`Z+R]W=W&AT;6PQ+71R M86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T87)T1G)A9VUE M;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S M=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!#;VUP86YY(&5S=&EM871E M9"!T:&4@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!%>'!E8W1E9"!V M;VQA=&EL:71Y/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@ M8F=C;VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO M=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`M.7!T)SX@1&EV:61E;F0@>6EE;&0\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^(#`N,#`\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("4\+V1I M=CX@/"]T9#X@/"]T6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX M,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X M-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)SQS<&%N/CPO'0M M86QI9VXZ(&IU'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@0F%L86YC92P@4V5P=&5M M8F5R(#,P+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q.#`L M,C@T/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q M.#`L,C@T/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO M=&0^(#PO='(^(#QT6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!.970@ M:6YC;VUE("AL;W-S*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#,P-2PX,CD\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("D\+V1I M=CX@/"]T9#X@/"]T'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY M<'0G/B!0=7)C:&%S97,L(&ES6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`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`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`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`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!"86QA;F-E+"!-87)C:"`S,2P@,C`Q,SPO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@*#0X-BPQ,3,\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`Q,7!T.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^("D\+V1I=CX@/"]T9#X@/"]T'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`M.7!T)SX@4'5R8VAA6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!46QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M'0M86QI9VXZ(')I9VAT.R!4 M15A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX] M,T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`M.7!T)SX@0F%L86YC92P@1&5C96UB97(@,S$L(#(P,3,\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z M(#!P="<^("@U.3'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("@U.3'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B`I/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`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`M M.7!T)SX@0F%L86YC92P@075G=7-T(#8L(#(P,3(\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`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`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!.970@:6YC;VUE("AL;W-S*3PO9&EV/B`\+W1D/B`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`Q,7!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,C,Q+#4R,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!0=7)C:&%S97,L(&ES M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`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`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`M.7!T)SX@3F5T(&EN8V]M92`H;&]S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#,P-2PX,CD\+W1D M/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#,P-2PX,CD\+W1D M/B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TY<'0G/B!/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!"86QA;F-E+"!- M87)C:"`S,2P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#0X-BPQ,3,\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!0041$24Y'+4)/5%1/33H@-'!X.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@ M5$585"U)3D1%3E0Z(#!P="<^(%1H92!P2!C M=7)V92!F;W(@=&AE('9A;'5A=&EO;B!D871E6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`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`M.7!T)SX@075G=7-T(#8L(#(P,3(\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B`Q-S@E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ M(&-E;G1E6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`R.#$E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`M.7!T)SX@4V5P=&5M8F5R(#,P+"`R,#$R/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,3$E/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TY<'0G/B!-87)C:"`S,2P@,C`Q,SPO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B`Q,C(E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R M,S8E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`R-W!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$96-E;6)E6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B`Q,3$E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B`R,S,E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0^)SPA+2U$3T-465!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T14 M1"!82%1-3"`Q+C`@5')A;G-I=&EO;F%L+R]%3B(@(FAT='`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$ M14Y4.B`P<'0G/B`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`M M.7!T)SX@075G=7-T(#8L(#(P,3(\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B`Q-S,E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ M(&-E;G1E6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B`R-S(E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1T;W`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`M.7!T)SX@36%R8V@@,S$L(#(P,3,\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`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`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`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,C8E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@05!)0SPO9&EV/B`\+W1D/B`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`P/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1&QE9G0^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XW-7!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P,#PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@*#0Q,2PX,#4\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^("DF;F)S<#L\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1&5R:79A=&EV92!W87)R86YT(&%T M(%-E<'1E;6)E'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PQ M-3(L,#`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XW-7!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P M,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#$X,"PR.#0\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("D\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("@W,RPW,C,\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("D\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`I/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$97)I=F%T:79E('=A6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L,34R M+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q,#8L-38Q/"]D:78^(#PO=&0^(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD M:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#,W.2PU-3(\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!$97)I M=F%T:79E('=A6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#(L.34Q+#0R-#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@T.#8L,3$S M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z("TY<'0G/B!%>&5R8VES92!O9B!W87)R86YT2`V+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1M:61D;&4@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I)FYB'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,2XW-7!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^("@R+#6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@ M,'!T)SX@*29N8G-P.SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("T\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$;&5F=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#4L-S$S+#DQ.#PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@Q M,#8L,S8P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^("T\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@4F5S970@;V8@=V%R6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!)6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#$L,#`P+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I M9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,2PP,#`L,#`P/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B`I/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!-87)K('1O M(&UA6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,CDY+#,W M,SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@*#(Y.2PS-S,I/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@1&5R:79A=&EV92!W M87)R86YT(&%T($1E8V5M8F5R(#,Q+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1M:61D;&4@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M-RPV-S`L,SDY/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`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`\+W1D/B`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`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`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XW M-7!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L M,34R+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#0Q,2PX,#4\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^("DF;F)S<#L\+V1I=CX@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@+3PO9&EV/B`\+W1D/B`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`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`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^(#(S,2PU,C$\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@R,S$L-3(Q/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE M9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`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`M.7!T)SX@1&5R:79A=&EV92!W87)R M86YT(&%T(%-E<'1E;6)E'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@,2PQ-3(L,#`P/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XW M-7!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#$L M,34R+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#$X,"PR.#0\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\ M+W1R/B`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`P<'0G/B`I/"]D:78^(#PO=&0^ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@*#6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV M/B`\+W1D/B`\+W1R/B`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`P/"]D:78^(#PO=&0^(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O M;G0@'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,2XW-7!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#$L,34R+#`P,#PO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T M)SX@*#$P-BPU-C$\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`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`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@*3PO9&EV/B`\+W1D/B`\+W1R/B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`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`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,2XW M-7!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#(L M.34Q+#0R-#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI M9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@*#0X-BPQ,3,\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`M.7!T)SX@0F%L86YC92P@36%R8V@@,S$L(#(P,3,\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^-2PR,S,L,36QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^,"XR,#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`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`Q,7!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XR M,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`M.7!T)SX@1W)A;G1E9#PO9&EV/B`\+W1D/B`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`Q,7!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G/B!#86YC M96QE9#PO9&EV/B`\+W1D/B`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@*#(L-S,R+#6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`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`M.7!T)SX@17AP:7)E9#PO9&EV/B`\ M+W1D/B`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`Q,7!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`],T1N;W=R87`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`E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E M>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@56YV97-T960L M($1E8V5M8F5R(#,Q+"`R,#$S/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3XM/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[(%1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@ M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI M9VX],T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX] M,T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1B;W1T;VT@8V]L M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E' M3CH@8V5N=&5R)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R)R!V86QI M9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB#L@5$58 M5"U!3$E'3CH@8V5N=&5R)R!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B`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`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B`\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U714E'2%0Z(&)O;&0[($1)4U!,05DZ(&EN;&EN92<^(%9A;'5E/"]F M;VYT/CPO9&EV/B`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U) M3D1%3E0Z("TY<'0G/B!"86QA;F-E+"!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\ M+W1D/B`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`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`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`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-2PR,S,L,36QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^,"XR-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`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`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`M.7!T)SX@0V%N8V5L960\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`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`Q M,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`Q,7!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`E(&%L:6=N/3-$;&5F=#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`M.7!T)SX@17AP:7)E9#PO9&EV/B`\+W1D/B`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`Q.'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z("TY<'0G M/B!"86QA;F-E+"!-87)C:"`S,2P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,"XR-3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`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`E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M M.7!T)SX@56YV97-T960L($UA6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)U!!1$1) M3D6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,7!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@-'!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5V%R6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,C@E(&-O;'-P86X],T0V/B`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`\+W1D/B`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`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`Y<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@)#`N,C`@+2`P+C(U/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#DL M.34R+#$U,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#0N,S8\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N,C,\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#0N,S8\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N,C,\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C4E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@.7!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^("0P+C(P("T@,"XR-3PO9&EV/B`\+W1D M/B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#0N,S8\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,"XR,SPO M9&EV/B`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#`N,C,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0^)SPA+2U$3T-4 M65!%(&AT;6P@4%5"3$E#("(M+R]7,T,O+T141"!82%1-3"`Q+C`@5')A;G-I M=&EO;F%L+R]%3B(@(FAT='`Z+R]W=W&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/CQD:78^(#QD:78^/"$M+5-T M87)T1G)A9VUE;G0M+3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO9&EV/B`\9&EV/B`\=&%B;&4@ M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C4E/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$;6ED M9&QE('=I9'1H/3-$,B4^/&9O;G0@'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,C4E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,7!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#EP=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`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`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@*&EN M('EE87)S*3PO9&EV/B`\+W1D/B`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`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@079E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@*&EN('EE87)S*3PO9&EV M/B`\+W1D/B`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`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`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@ M,"XR-3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@86QI9VX],T1R:6=H=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@86QI9VX] M,T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV/B`\ M+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#`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`Y<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@)#`N,C4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$58 M5"U)3D1%3E0Z(#!P="<^(#4L,C,S+#$W-SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N M/3-$'0M86QI9VXZ M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@,RXW,SPO9&EV/B`\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@)#PO9&EV/B`\+W1D/B`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`Q,7!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#'0M86QI9VXZ(')I9VAT.R!415A4 M+4E.1$5.5#H@,'!T)SX@,"XR-3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^($DN/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`S M-G!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z("TQ.'!T)SX@*#$I16YT97(@:6YT;R!E>&-L=7-I=F4@:6YT M97)N871I;VYA;"!L:6-E;G-E(&%G6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`S-G!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TQ.'!T)SX@*#0I5&%K92!O=F5R(&UA;F%G96UE;G0@;V8@=&AR964@ M97AI6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!O9B!T:&4@0VQO M6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E2!I M9B!A;F0@=VAE;B!!3$P@9F]U6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^($E)+B9N8G-P.R9N8G-P.R9N8G-P M.T%C:&EE=F4@,3`P($AA(&9I96QD('1R:6%L6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!7:71H M:6X@='=O("@R*2!Y96%R6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!O9B!T M:&4@0VQO6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP M="<^($E)22XF;F)S<#LF;F)S<#M497-T('-H:7!M96YT(&]F(&1R>2!L96%F M('1O(&%C:&EE=F4@;6EN:6UU;2!S<&5C6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B!7:71H:6X@='=O("@R*2!Y96%R6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M M24Y$14Y4.B`P<'0G/B!O9B!T:&4@0VQO6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&-E;G1E M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T)SX\ M8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@5$585"U)3D1%3E0Z(#!P="<^("HJ/"]D:78^(#PO=&0^(#QT9#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M2<^($]N($IU;F4@,C,L(#(P,3,L('1H92!R96UA:6YI;F<@,RPP,#`L M,#`P($5S8W)O=R!3:&%R97,@:&%V92!B965N(&5A7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO M6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@1G5T=7)E(&UI;FEM=6T@<&%Y;65N=',@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4 M+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^($9I6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^(#(P,30@*')E;6%I;F1E M65A6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX] M,T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#@E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,S9P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^(#(P,38\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`P<'0G/B`D/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)2!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#8W+#4P M,#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#PA+2U%;F1&&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!415A4+4E.1$5.5#H@,'!T M)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`M,3AP="<^($9I6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@ M,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@ M:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`M,3AP="<^(#(P,30\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@)#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`L,#`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`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)#PO9&EV M/B`\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S M8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9? M9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA"!!&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!415A4+4E.1$5.5#H@,'!T)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G M/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM M3$5&5#H@,C=P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`M.7!T)SX@3&5S6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!R:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^("@W.3`L,#`W/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B`I/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)U!!1$1)3D"!A6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\ M+W1D/B`\=&0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("0\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@+3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M"!2871E(%)E8V]N8VEL:6%T:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/"$M+41/0U194$4@:'1M;"!0 M54),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A M;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!%;F1E9#PO9&EV/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B`F;F)S<#M-87)C:"`S,2P@,C`Q,SPO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB"<@=F%L M:6=N/3-$;6ED9&QE/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE M)SX@)FYB'0M86QI9VXZ(&-E M;G1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#$X<'0G/B`S-"XP/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1M:61D;&4@=VED M=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,3AP="<^($-H86YG92!I;B!V86QU871I;VX@86QL;W=A;F-E(&]N M(&YE="!O<&5R871I;F<@;&]S2UF;W)W87)D"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!R:6=H=#L@5$585"U)3D1%3E0Z(#$X<'0G/B`H,S0N,#PO9&EV M/B`\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T M>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5. M5#H@,'!T)SX@*3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$;6ED9&QE('=I9'1H/3-$,24^/&9O;G0@ M6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U)3D1% M3E0Z(#!P="<^("@S-"XP/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`I/"]D:78^(#PO=&0^(#PO M='(^(#QT6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$ M)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R M:6=H=#L@5$585"U)3D1%3E0Z(#!P="<^(#`N,#PO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@)3PO M9&EV/B`\+W1D/B`\+W1R/B`\+W1A8FQE/B`\+V1I=CX@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@5$585"U)3D1%3E0Z(#!P="<^/&)R("\^(#PO M9&EV/B`\(2TM16YD1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F M7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D M+U=O'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$Q M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5F5N9&]R('!U M6QE/3-$)T9/3E0M4TE:13H@,3!P=#L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;B<@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,C0E(&-O;'-P86X],T0V/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`M,3AP M="<^($%C8V]U;G1S(%!A>6%B;&4@870\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q! M63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,3$E(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!$96-E M;6)E6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E M(&-O;'-P86X],T0R/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!-87)C:"`S,2P@,C`Q M,SPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([ M(%1%6%0M24Y$14Y4.B`P<'0G/B!&;W(@=&AE(%)E<&]R=&EN9SPO9&EV/B`\ M9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1% M6%0M24Y$14Y4.B`P<'0G/B!097)I;V0@16YD960\+V1I=CX@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`Q.'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z("TQ.'!T)SX@1W)O=V5R6YE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$X<'0G/B`T-2XP/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P M<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^("4\ M+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U! M4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E' M3CH@;&5F=#L@5$585"U)3D1%3E0Z("TQ.'!T)SX@)3PO9&EV/B`\+W1D/B`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5. M5#H@,'!T)SX@-BXP/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0R)2!A;&EG;CTS1&QE9G0^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D M:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU, M1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z("TQ.'!T)SX@4W1E=FEA(%9E;G1U6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(')I9VAT M.R!415A4+4E.1$5.5#H@+3$X<'0G/B`Q-BX@.3PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)T9/3E0M M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E3 M4$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D M:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B`E/"]D:78^(#PO=&0^(#PO='(^(#QT6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@ M+3$X<'0G/B`M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!- M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q) M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^("4\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M4TE:13H@,3%P M=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL M:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@ M86QI9VX],T1R:6=H=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$X<'0G/B`M/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@ M34%21TE.+5))1TA4.B`P<'0[(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`M,3AP="<^("4\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`E/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$Q M<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T)SX@+3PO9&EV/B`\+W1D M/B`\=&0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@)3PO9&EV/B`\+W1D/B`\+W1R/B`\='(@8F=C;VQO6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#DE(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M'0M M86QI9VXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$X<'0G/B`V-RXP/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,7!T.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0[ M(%1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP="<^("4\+V1I M=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@5$585"U) M3D1%3E0Z(#!P="<^(#@T+C@\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M("4\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$Q<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#8P+C$\+V1I=CX@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,7!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z M(#!P="<^("4\+V1I=CX@/"]T9#X@/"]T6QE/3-$ M)T9/3E0M4TE:13H@,3!P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;B<@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#$P M,"4^(#QT6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0V/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$Q<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`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`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4 M.B`P<'0G/B!-87)C:"`S,2P@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#$Q<'0[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB M6QE M/3-$)T9/3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@)FYB6QE/3-$)T9/ M3E0M4TE:13H@,3%P=#L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1$E34$Q!63H@:6YL:6YE)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`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`Q,7!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`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`Q,7!T.R!0041$24Y'+4)/5%1/33H@-'!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^)3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3%P=#L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1$E34$Q!63H@:6YL:6YE)SX@ M)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!3=&5V:6$@07-I83PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO2!496-H M;F5W/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,"XP,"4\'0^)SQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!C;VYT M:6YU97,@=&\@86-C2!I'0^)SQS<&%N/CPO M2!I7,@8F5F;W)E('1H92!C;VYV97)S:6]N(&1A=&4@ M=VET:"!I;G1E65A M'0^)SQS<&%N M/CPO2!I'0^)S(Y,#`P,#QS<&%N/CPO'0^)SQS<&%N/CPO2!I'0^)SQS<&%N/CPO2!P97)I;V0@8F5F;W)E('1H92!C;VYV97)S M:6]N(&1A=&4@+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO2!I2`V+"`R,#$S('1H92!#;VUP86YY(&ES2=S(&-O;6UO;B!S=&]C:R!T;R!T:&4@<&QA8V5M96YT(&%G M96YT("AT:&4@(F%G96YT('=A&5R8VES92!P M65A M'0^)SQS<&%N/CPO M2`V+"`R,#$S('1H92!#;VUP86YY(&ES'!I'0^)SQS<&%N/CPO'!I'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2`M(%-E961S("A$971A:6QS*2`H55-$("0I/&)R/CPO2`M(%-E961S(%M!8G-T'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO2P@;F5T/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XQ+#@P-RPP,#`\'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO2!A;F0@97%U:7!M96YT(&5S M=&EM871E9"!U'0^)SQS<&%N/CPO M2!R:6=H="!E65A'0^)SQS<&%N/CPO2!R:6=H="!E M65A'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T M.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO'!E M;G-E'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!L96%S97,@8V5R=&%I M;B!O9F9I8V4@'0^)SQS<&%N/CPOFAO=2!( M96%L=&@\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C M-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA2!P87EM96YT'0^)SQS<&%N M/CPO6UE M;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T M,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y M.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!I2!I M'0^)SQS<&%N M/CPO65A'0^)SQS<&%N/CPO2!P97)I;V0@8F5F;W)E('1H92!C;VYV97)S:6]N(&1A=&4@ M+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R M8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E M8C)D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO2D@6TUE;6)E M'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!;365M8F5R73QB2!;365M8F5R73QB M2!;365M8F5R73QB2!;365M8F5R73QB2!;365M8F5R73QB2!;365M8F5R73QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T M.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6%B;&4\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2=S(&-O M;6UO;B!S:&%R97,\+W1D/@T*("`@("`@("`\=&0@8VQA2!G&5R M8VES86)L92!P97(@'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X M-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%? M,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^)SQS<&%N/CPO65A65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D('1O(&ES'0^)SQS<&%N/CPOF5D('-H87)EF5D(&YU;6)E'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M&-H86YG960@=6YD97(@=&5C:&YO;&]G>2!A9W)E96UE;G0\ M+W1D/@T*("`@("`@("`\=&0@8VQA2!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA2!A9W)E96UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!I2!I3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D M,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E M-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPOF5D('9A;'5E(&]V97(@=&AE('9E M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&EM=6T@97AE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO&5R8VES86)L92!7:71H($UA>&EM=6T@17AE'0^ M)SQS<&%N/CPO&5R8VES86)L92!7:71H($UI;FEM=6T@17AE'0^)SQS<&%N/CPO2!386QE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA MF5D('5N9&5R(%-T;V-K($]P=&EO;B!0;&%NF5D('5N9&5R(%-T;V-K M($]P=&EO;B!0;&%N7,\'0^)SQS<&%N/CPO&5R8VES86)L92!;365M8F5R73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!0'0^)S0@>65A7,\&5R8VES92!07!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA65A"!M M;VYT:"!L96%S92!P87EM96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XQ-2PP,#`\2!D97!O7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@5&\@5FEN:"!0:'5C(%!0 M0U1$03PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO M3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E? M8F,T-E]D,SDX,V$X-V5B,F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,V)E-#,X-V%?,F)B9E\T.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@ M8VAA"!A'0^)SQS<&%N/CPO"!B96YE9FET(&9R M;VT@3D],(&-A"!A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!I;F-O;64@=&%X(')A=&4@*$1E=&%I;',I/&)R/CPO"!R871E/"]S=')O;F<^/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO"!R871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XS-"XP,"4\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO2!0=&4N($QT9"X@+2!R96QA=&5D('!A'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\S8F4T,S@W85\R8F)F7S0Y,#E?8F,T-E]D,SDX,V$X-V5B,F0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,V)E-#,X-V%?,F)B9E\T M.3`Y7V)C-#9?9#,Y.#-A.#=E8C)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6%B;&4@870@1W)O=V5R6YE'0O:F%V87-C3X-"B`@("`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htm IDEA: XBRL DOCUMENT v2.4.0.8
ENTITY'S ASSETS (Details) (USD $)
Dec. 31, 2013
Mar. 31, 2013
Mar. 31, 2012
PROPERTY AND EQUIPMENT {3}      
Property and equipment estimated useful life 5 years   $ 7,925 $ 3,036
Less accumulated depreciation   (1,234) 0
Property and equipment net   6,691 3,036
ACQUIRED TECHNOLOGY RIGHTS GROSS, NET      
Technology right estimated useful life 15 years   1,635,300 0
Less accumulated amortization   (81,765) 0
Net technology right estimated useful life 15 years   1,553,535 0
WEBSITE DEVELOPMENT COSTS      
Website development costs 5,315 5,315 5,315
Accumulated amortization.   (1,869) 801
Website development costs Net   $ 3,446 $ 4,514
XML 36 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
WEBSITE DEVELOPMENT COSTS (Tables)
12 Months Ended
Mar. 31, 2013
WEBSITE DEVELOPMENT COSTS (Tables)  
Website development costs, stated at cost


 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Website development costs
5
 
5,315
   
$
5,315
 
               
Accumulated amortization
     
(1,869
)
   
(801
)
               
     
3,446
   
$
4,514
 

XML 37 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
PROPERTY AND EQUIPMENT (Tables)
12 Months Ended
Mar. 31, 2013
Property And Equipment Tables [Abstract]  
Property and equipment

 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Property and equipment
5
 
7,925
   
$
3,036
 
               
Less accumulated depreciation
     
(1,234
)
   
(-
)
               
     
6,691
   
$
3,036
 

XML 38 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
SHARES AUTHORIZED AND TRANSACTION (Details) (USD $)
Dec. 31, 2013
Nov. 15, 2013
Mar. 31, 2013
Oct. 04, 2011
Jun. 23, 2011
SHARES AUTHORIZED AND REVERSE ACQUISITION TRANSACTION          
Common shares authorized to issue   100,000,000 100,000,000    
Common shares authorized to issue par value   $ 0.001 $ 0.001    
Common shares authorized shares after amendment to the Articles of Incorporations to increase the authorized number of shares to 250,000,000 250,000,000      
Common shares issued and outstanding         79,800,000
Shares surrendered for cancellation         33,000,000
Common shares issued for acquisition of 100% of issued and outstanding.     12,000,000   12,000,000
Common shares held in escrow.     6,000,000   6,000,000
Another shares surrendered       3,000,000  
Debiting common stock at par       $ 3,000  
Common shares sold to one investor       400,000  
Common stock price       $ 0.25  
Common stock value       $ 100,000  
XML 39 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
AMORTIZATION AND DEPRECIATION EXPENSE (Details) (USD $)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
AMORTIZATION AND DEPRECIATION EXPENSE        
Depreciaton expenses on Property and equipment $ 3,100 $ 762 $ 1,234  
Amortizaion expenses on acquired technology 81,765 54,510 81,765  
Amortization Expenses On Websited Development Costs $ 801 $ 801 $ 1,068 $ 801
XML 40 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
RELATED PARTY TRANSACTIONS (Tables)    
Related parties with whom the Company had transactions
Related parties with whom the Company had transactions are:
 
Related Parties
 
Relationship
     
George Blankenbaker
 
President and significant stockholder of the Company
     
Leverage Investments LLC
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Technew Technology Limited
 
Non-controlling interest holder
 
Growers  Synergy Pte Ltd.
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Guangzhou Health Technology Development Company Limited
 
An entity owned and controlled by Non-controlling interest holder
 

Related Parties
 
Relationship
     
George Blankenbaker
 
President and significant stockholder of the Company
     
Leverage Investments LLC
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Technew Technology Limited
 
Non-controlling interest holder
     
Growers  Synergy Pte Ltd.
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Guangzhou Health Technology Development Company Limited
 
An entity owned and controlled by Non-controlling interest holder

Consulting services
Farm management services provided by Growers Synergy Pte Ltd. were as follows:

   
For the interim
period ended
December 31, 2013
   
For the interim
period ended
December 31, 2012
 
                 
Farm management services - related parties
 
$
180,000
   
$
180,000
 
             
   
$
180,000
   
$
180,000
 


   
For the Fiscal Year
Ended
March 31, 2013
   
For the Period from
April 11, 2011 (inception)
through
March 31, 2012
 
                 
Farm management services - related parties
 
$
240,000
   
$
180,000
 
             
   
$
240,000
   
$
180,000
 
Future minimum payments
Future minimum payments required under this agreement were as follows:

Fiscal Year Ending March 31:
       
         
2014 (remainder of the fiscal year)
 
$
240,000
 
2015
   
240,000
 
2016
   
240,000
 
2017
   
140,000
 
       
   
$
860,000
 
 

Fiscal Year Ending March 31:
       
         
2014
 
$
140,000
 
       
   
$
140,000
 

XML 41 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE NOTES PAYABLE (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
CONVERTIBLE NOTES PAYABLE (Tables)    
CONVERTIBLE NOTES PAYABLE.
Convertible notes payable consisted of the following:

   
December 31, 2013
   
March 31, 2013
 
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal of this note and any accrued and unpaid interest thereon, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
    200,000       200,000  
                 
February 26, 2013 convertible notes
    350,000       350,000  
                 
March 15, 2013 convertible note
    220,438       220,438  
                 
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    111,111       -  
                 
On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014.
    153,500       -  
                 
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    27,778       -  
                 
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company.  In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.
    58,000       -  
 
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014.
    53,000       -  
                 
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    55,556       -  
                 
Sub-total: convertible notes payable
    1,229,383       770,438  
                 
Discount representing (i) the relative fair value of the warrants issued, (ii) the beneficial conversion features and (iii) the derivative liability on conversion features
    (816,310 )     (444,788 )
                 
Accumulated amortization of discount on convertible notes payable
    658,496       32,050  
                 
Remaining discount
    (157,814 )     (412,738 )
                 
    $ 1,071,569     $ 357,770  


 
 
   
 
   
   
March 31, 2013
   
March 31, 2012
 
             
On November 16, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.  On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,959 to 319,607 shares of the Company's common stock at $0.83 per share.
-
 
250,000
 
             
On January 16, 2012, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.  On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $11,781 to 314,586 shares of the Company's common stock at $0.83 per share.
 
-
   
250,000
 
 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price $0.25 per share
 
220,438
   
200,000
 
             
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.
 
200,000
   
-
 
             
On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company's common stock.
 
350,000
   
-
 
             
Sub-total: convertible notes payable
 
770,438
   
700,000
 
             
Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features
 
(444,788
)
 
-
 
             
Accumulated amortization of discount on convertible notes payable
 
32,050
   
-
 
             
Remaining discount
 
(412,738
)
 
-
 
             
 
$
357,770
 
$
700,000
 
XML 42 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Note 2 - Summary of Significant Accounting Policies

The Management of the Company is responsible for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application.  Critical accounting policies and practices are those that are both most important to the portrayal of the Company's financial condition and results and require management's most difficult, subjective, or complex judgments, often as a result of the need to make estimates about the effects of matters that are inherently uncertain. The Company's significant and critical accounting policies and practices are disclosed below as required by generally accepted accounting principles.

Basis of Presentation - Unaudited Interim Financial Information

The unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission ("SEC") to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Interim results are not necessarily indicative of the results for the full fiscal year.  These consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the fiscal year ended March 31, 2013 and notes thereto contained in the Company's Annual Report on Form 10-K as filed with the SEC on July 16, 2013.

Fiscal Year End

The Company elected March 31st as its fiscal year end date upon its formation.

Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).

Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company's critical accounting estimates and assumptions affecting the financial statements were:
 
 
(i)  
Assumption as a going concern: Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
 
(ii)  
Allowance for doubtful accounts: Management's estimate of the allowance for doubtful accounts is based on historical sales, historical loss levels, and an analysis of the collectability of individual accounts; and general economic conditions that may affect a client's ability to pay. The Company evaluated the key factors and assumptions used to develop the allowance in determining that it is reasonable in relation to the financial statements taken as a whole.
 
(iii)  
Inventory Obsolescence and Markdowns: The Company's estimate of potentially excess and slow-moving inventories is based on evaluation of inventory levels and aging, review of inventory turns and historical sales experiences. The Company's estimate of reserve for inventory shrinkage is based on the historical results of physical inventory cycle counts.
 
(iv)  
Fair value of long-lived assets: Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.
 
(v)  
Valuation allowance for deferred tax assets: Management assumes that the realization of the Company's net deferred tax assets resulting from its net operating loss ("NOL") carry-forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.
 
(vi)  
Estimates and assumptions used in valuation of equity instruments: Management estimates expected term of share options and similar instruments, expected volatility of the Company's common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.
 
Principles of Consolidation

The Company applies the guidance of Topic 810 "Consolidation" of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.  Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.  Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.  The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent's power to control exists.

The Company's consolidated subsidiaries and/or entities are as follows:
 

Name of consolidated
subsidiary or entity
 
State or other jurisdiction
of incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable
interest
 
               
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
    100 %
                 
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
    100 %
                 
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
    70 %
                 
  SC Brands Pte Ltd    Singapore   October 1, 2013     70
 
The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.

All inter-company balances and transactions have been eliminated.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.

Fair Value of Financial Instruments

The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
 
Level 1
 
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2
 
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3
 
Pricing inputs that are generally observable inputs and not corroborated by market data.
 
Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable,accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.

The Company's convertible notes payable approximates the fair value of such instrument based upon management's best estimate of interest rates that would be available to the Company for similar financial arrangements at December 31, 2013 and March 31, 2013.

The Company's Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation and the derivative liability on the conversion feature.  The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.  These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities - Derivative Warrant Liabilities and Derivative Liability on Conversion Feature

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability and derivative liability on the conversion feature at every reporting period and recognizes gains or losses in the consolidated statements of operations that are attributable to the change in the fair value of the derivative liabilities.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount, net of an allowance for doubtful accounts.  The Company follows paragraph 310-10-50-9 of the FASB Accounting Standards Codification to estimate the allowance for doubtful accounts.  The Company performs on-going credit evaluations of its customers and adjusts credit limits based upon payment history and the customer's current credit worthiness, as determined by the review of their current credit information; and determines the allowance for doubtful accounts based on historical write-off experience, customer specific facts and economic conditions.

Pursuant to paragraph 310-10-50-2 of the FASB Accounting Standards Codification account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.  The Company has adopted paragraph 310-10-50-6 of the FASB Accounting Standards Codification and determine when receivables are past due or delinquent based on how recently payments have been received.

Outstanding account balances are reviewed individually for collectability.  The allowance for doubtful accounts is the Company's best estimate of the amount of probablecredit losses in the Company's existing accounts receivable. Bad debt expense is included in general and administrative expenses, if any.

There was no allowance for doubtful accounts as December 31, 2013 or March 31, 2013.

The Company does not have any off-balance-sheet credit exposure to its customers.

Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company's long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful livesagainst their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable.If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

The key assumptions used in management's estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.  These forecasts are typically based on historical trends and take into account recent developments as well as management's plans and intentions.  Other factors, such as increased competition or a decrease in the desirability of the Company's products or services, could lead to lower projected sales levels, which would adversely impact cash flows.  A significant change in cash flows in the future could result in an impairment of long lived assets.

The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.

Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
 
Inventories

Inventory Valuation

The Company values inventory, consisting of finished goods, at the lower of cost or market.  Cost is determined on the first-in and first-out ("FIFO") method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value.  Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures.

Inventory Obsolescence and Markdowns

The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classify inventory markdowns in the income statement as a component of cost of goods sold pursuant to Paragraph 420-10-S99 of the FASB Accounting Standards Codification to adjust inventory to net realizable value. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations.

There was no inventory obsolescence for the interim period ended December 31, 2013 or 2012.

There was no lower of cost or market adjustments for the interim period ended December 31, 2013 or 2012.
 
Property and Equipment

Property and equipment is recorded at cost.  Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred.  Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.
 
Intangible Assets Other Than Goodwill

The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.  Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwillon a straight-line basis over the estimated useful lives of the respective assets as follows:

   
Estimated Useful Life (Years)
 
         
Acquired technology
   
15
 
Website development costs
   
5
 
 
Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:  a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Extinguishment Accounting

On July 25, 2013, the Supreme Court of the State of New York, County of New York (the  "Court"),  entered  an order (the  "Order")  approving the settlement  (the "Settlement Agreement")  between the Company and Hanover Holdings I, LLC, a New York limited  liability company  ("Hanover"),  Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the  "Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.

The Settlement  Agreement  provides that the Initial Settlement Shares will be  subject  to  adjustment  on  the  trading  day  immediately   following  the Calculation Period to reflect the  intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the  Settlement  Agreement be based upon a specified  discount to the trading volume  weighted  average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court's entry of the Order.

The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.  The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.

Derivative Instruments and Hedging Activities

The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.  The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.  For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.
 
Derivative Liability

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.  The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.  In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.  Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.  Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.  Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock.  Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.   The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).

The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.  The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.  Therefore, the fair value may not be appropriately captured by simple models.  In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).  The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.  Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).  Projections were then made on the underlying factors which led to potential scenarios.  Probabilities were assigned to each scenario based on management projections.  This led to a cash flow projection and a probability associated with that cash flow.  A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.

Beneficial Conversion Feature

When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company's common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.
 
Commitment and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.  The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's consolidated financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.  Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company's business, financial position, and results of operations or cash flows.

Non-controlling Interest

The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interests in its majority owned subsidiaries in the consolidated statements of balance sheets within the equity section, separately from the Company's stockholders' equity.  Non-controlling interests represents the non-controlling interest holder's proportionate share of the equity of the Company's majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holder's proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

Revenue Recognition

The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv)collectability is reasonably assured.

Shipping and Handling Costs

The Company accounts for shipping and handling fees in accordance with paragraph 605-45-45-19 of the FASB Accounting Standards Codification.  While amounts charged to customers for shipping products are included in revenues, the related costs are classified in cost of goods sold as incurred.

Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 "Accounting for Research and Development Costs") and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 "Research and Development Arrangements") for research and development costs.  Research and development costs are charged to expense as incurred.Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.
 
Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities

The research and development arrangements usually involve specific research and development projects.  Often times, the Company makes non-refundable advances upon signing of these arrangements.  The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 "Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities") for those non-refundable advances.  Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.  Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.  The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.  If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.

Stock-Based Compensation for Obtaining Employee Services

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.  Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.  Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.  The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.
 
·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

The Company's policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.

Equity Instruments Issued to Parties other than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments.  The Company uses historical data to estimate holder's expected exercise behavior.  If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.  A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.
 
·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.

Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.

Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9,an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.Deferred tax assets are reduced by a valuation allowance to the extent management concludes it ismore likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.  Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.
 
The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management's opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the reporting period ended December 31, 2013 or 2012.

Limitation on Utilization of NOLs due to Change in Control

Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL's to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation's ability to utilize NOLs if it experiences an "ownership change."  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

Net Income (Loss)per Common Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:

   
Potentially Outstanding Dilutive Common Shares
     
For Interim
PeriodEnded
December 31, 2013
 
For Interim
Period Ended
December 31, 2012
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").
   
-
 
3,000,000
           
Sub-total Make Good Escrow Shares
   
-
 
3,000,000
 
Convertible Note Shares
         
           
On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
881,752
 
426,667
           
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
1,739,130
 
426,667
           
On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.
   
            1,400,000
 
-
           
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
1,762,228
 
-
           
On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.
   
             2,353,573
 
            -
           
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
440,571
 
-
           
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.
   
            290,000
 
            -
           
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.
   
812,634
 
-
           
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
   
881,142
 
-
           
Sub-total Convertible Note Shares
   
10,561,070
 
853,334
 
Warrant Shares
         
           
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to investors (the "investor warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.
   
956,481
 
1,152,000
           
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company's common stock to two (2) note holders in connection with the issuance of convertible notes.
   
1,400,000
 
-
           
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock to the note holder in connection with the issuance of the convertible note.
   
881,753
 
-
           
On May 6, 2013, the Company issued three (3) series of warrants:
 
Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company's common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.
   
2,027,520
 
-
           
 
Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company's common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.
   
1,151,999
 
-
           
 
Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company's common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.
   
2,534,399
 
-
           
On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company's common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.
   
1,000,000
 
-
           
Sub-total Warrant Shares
   
9,952,152
 
1,152,000
           
Total potentially outstanding dilutive common shares
   
20,513,222
 
5,005,334

Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.  The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.
 

Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Recently Issued Accounting Pronouncements

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." The ASUadds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.

In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date."  This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05, "Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU 2013-07, "Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting." The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity's governing documents from the entity's inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity's inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity's expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.
Note 2 - Summary of Significant Accounting Policies

Basis of Presentation

The Company's consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

Principles of Consolidation

The Company applies the guidance of Topic 810 "Consolidation" of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.  Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.  Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.  The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent's power to control exists.

The Company's consolidated subsidiaries and/or entities are as follows:

Name of consolidated
subsidiary or entity
 
State or other jurisdiction of
incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable interest
             
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
 
100%
             
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
 
100%
             
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
 
   70%


The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.

All inter-company balances and transactions have been eliminated.

Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.

Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

The Company's significant estimates and assumptions include the fair value of financial instruments; the carrying value, recoverability and impairment of long-lived assets, including the values assigned to and the estimated useful lives of website development costs; interest rate; revenue recognized or recognizable; sales returns and allowances; foreign currency exchange rate; income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; expected term of share options and similar instruments, expected volatility of the entity's shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s); and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.

Fair Value of Financial Instruments

The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1
 
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2
 
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3
 
Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
 
The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable, accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.

The Company's convertible notes payable approximates the fair value of such instrument based upon management's best estimate of interest rates that would be available to the Company for similar financial arrangements at March 31, 2013 and March 31, 2012.

The Company's Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.  The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.  These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

It is not, however, practical to determine the fair value of advances from president and significant stockholder, if any, due to their related party nature.

Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities - Derivative Warrant Liabilities

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability at every reporting period and recognizes gains or losses in the consolidated statements of operations and comprehensive income (loss) that are attributable to the change in the fair value of the derivative warrant liability.

Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company's long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

The key assumptions used in management's estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.  These forecasts are typically based on historical trends and take into account recent developments as well as management's plans and intentions.  Other factors, such as increased competition or a decrease in the desirability of the Company's products or services, could lead to lower projected sales levels, which would adversely impact cash flows.  A significant change in cash flows in the future could result in an impairment of long lived assets.

The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.


Fiscal Year End

The Company elected March 31 as its fiscal year ending date.

Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.

Property and Equipment

Property and equipment is recorded at cost.  Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred.  Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

Intangible Assets Other Than Goodwill

The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.  Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill inclusive of acquired technology and website development costs on a straight-line basis over their relevant estimated useful lives of fifteen (15) and five (5) years, respectively.  Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:  a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Derivative Instruments and Hedging Activities

The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.  The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.  For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.

From time to time, the Company may employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates.  The Company does not use derivatives for speculation or trading purposes.  Changes in the fair value of derivatives are recorded each period in current earnings or through other comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and the type of hedge transaction.  The ineffective portion of all hedges is recognized in current earnings.  The Company has sales and purchase commitments denominated in foreign currencies.  Foreign currency forward contracts are used to hedge against the risk of change in the fair value of these commitments attributable to fluctuations in exchange rates ("Fair Value Hedges").  Changes in the fair value of the derivative instrument are generally offset in the income statement by changes in the fair value of the item being hedged.

The Company did not employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates for the fiscal year ended March 31, 2013 or 2012.

Derivative Liability

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.  The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.  In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.  Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.  Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.  Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")  to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock.  Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.   The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).

The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.  The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.  Therefore, the fair value may not be appropriately captured by simple models.  In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).  The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.  Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).  Projections were then made on the underlying factors which led to potential scenarios.  Probabilities were assigned to each scenario based on management projections.  This led to a cash flow projection and a probability associated with that cash flow.  A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.


Beneficial Conversion Feature

When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company's common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.

Commitment and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.  The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's consolidated financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.  Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company's business, financial position, and results of operations or cash flows.

Non-controlling Interest

The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interest in Stevia Technew Limited, its majority owned subsidiary in the consolidated statements of balance sheets within the equity section, separately from the Company's stockholders' equity.  Non-controlling interest represents the non-controlling interest holder's proportionate share of the equity of the Company's majority-owned subsidiary, Stevia Technew Limited. Non-controlling interest is adjusted for the non-controlling interest holder's proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

Revenue Recognition

The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.

Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 "Accounting for Research and Development Costs") and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 "Research and Development Arrangements") for research and development costs.  Research and development costs are charged to expense as incurred.  Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.


Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities

The research and development arrangements usually involve specific research and development projects.  Often times, the Company makes non-refundable advances upon signing of these arrangements.  The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 "Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities") for those non-refundable advances.  Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.  Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.  The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.  If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.

Stock-Based Compensation for Obtaining Employee Services

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.  Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.  Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.  The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.
 
The Company's policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.

Equity Instruments Issued to Parties other than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments.  The Company uses historical data to estimate holder's expected exercise behavior.  If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.  A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.

Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.
 
Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.  Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management's opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the fiscal year ended March 31, 2013 or for the period from April 11, 2011 (Inception) through December 31, 2012.

Limitation on Utilization of NOLs due to Change in Control

Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL's to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation's ability to utilize NOLs if it experiences an "ownership change."  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

Net Income (Loss) per Common Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification.   Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:
 
   
Potentially Outstanding Dilutive Common Shares
   
For Fiscal Year Ended
March 31, 2013
 
For the Period
from April 11, 2011
(inception) through
March 31, 2012
           
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").
    3,000,000     6,000,000    
                 
Sub-total Make Good Escrow Shares
    3,000,000     6,000,000    
                 
Convertible Note Shares
               
                 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.
    881,752     -    
                 
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at  $0.46875 per share with gross proceeds of at least $100,000.
    426,667     -    
                 
On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share
    1,400,000     -    
                 
Sub-total Convertible Note Shares
    2,708,419     -    
 
 
                 
Warrant Shares
               
                 
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the new warrants issued triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.
    2,951,424     -    
                 
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company's common stock to two notes holders in connection with the issuance of convertible notes.
    1,400,000     -    
                 
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock to the note holder in connection with the issuance of the convertible note.
    881,753          
                 
Sub-total Warrant Shares
    5,233,177     -    
                 
Total potentially outstanding dilutive common shares
    10,941,596     6,000,000    

Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.  The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.

Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Recently Issued Accounting Pronouncements

In January 2013, the FASB issued ASU No. 2013-01, "Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities". This ASU clarifies that the scope of ASU No. 2011-11, "Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities." applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in FASB Accounting Standards Codification or subject to a master netting arrangement or similar agreement. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013.

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." The ASU   adds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.
 
In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date."  This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05, "Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU 2013-07, "Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting." The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity's governing documents from the entity's inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity's inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity's expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.
XML 43 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Black-Scholes option-pricing model - weighted-average assumptions(TABLE)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Black-Scholes option-pricing model - weighted-average assumptions(TABLE):    
Black Scholes Option Pricing Model Weighted Average Assumptions [Table Text Block]
The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
Expected volatility
   
74.53
%
Risk-free interest rate
   
0.37
%
Dividend yield
   
0.00
%

The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:


Expected option life (year)
   
3.00
 
         
Expected volatility
   
74.53
%
         
Risk-free interest rate
   
0.37
%
         
Dividend yield
   
0.00
%
       

Black Scholes Option Pricing Model Weighted Average Assumptions Other Issuance [Table Text Block]
The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
Expected volatility
   
75.11
%
Risk-free interest rate
   
0.40
%
Dividend yield
   
0.00
%

 

The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
         
Expected volatility
   
75.11
%
         
Risk-free interest rate
   
0.40
%
         
Dividend yield
   
0.00
%
       

XML 44 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ATTRIBUTABLE INTEREST (Details)
Dec. 31, 2013
Mar. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ATTRIBUTABLE INTEREST    
Attributable interest of Steiva Ventures International Ltd - BVI 100.00% 100.00%
Attributable interest of Steiva Asia Limited - Hong Kong SAR 100.00% 100.00%
Attributable interest of Steiva Technew Limited - Hong Kong SAR 70.00% 70.00%
SC Brands Pte Ltd - Singapore 70.00%  
XML 45 R53.htm IDEA: XBRL DOCUMENT v2.4.0.8
Issuance of Convertible Notes with Warrants (Details) (USD $)
Dec. 31, 2013
Mar. 15, 2013
Feb. 26, 2013
Issuance of Convertible Notes with Warrants      
Company entered into two (2) 12% convertible notes payable   $ 0 $ 350,000
Company cancelled a prior convertible note and entered into a 12% convertible note payable of   220,438 0
Payees have the option to convert the outstanding notes and interest due into the Company's common shares $ 0.25 $ 0.25 $ 0
Company granted to the Payees a warrant to purchase common shares 1,400,000 881,753 0
exercisable per share $ 0.25 $ 0.25 $ 0
The relative fair value of these warrants granted, estimated on the date of grant   98,095 110,425
After allocation of proceeds   0 110,425
warrants as a discount to the Convertible Note   0 113,925
additional paid-in capital and debit amt   0 113,925
The amortization of the discount and beneficial conversion feature amounted   $ 122,343 $ 0
XML 46 R72.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONCENTRATIONS AND CREDIT RISK INSTANT (Details)
Mar. 31, 2013
Dec. 31, 2012
Mar. 31, 2012
CONCENTRATIONS AND CREDIT RISK INSTANT      
Accounts Payable at Growers Synergy Pte. Ltd. - related party 50.10% 45.00% 16.40%
Accounts Payable at Stevia Ventures Corporation 16.90% 19.30% 54.10%
Accounts Payable To SGAgro Tech Pte Ltd 1 0.00% 0.00%  
Total Accounts Payable 67.00% 64.30% 70.50%
XML 47 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
Dec. 31, 2013
Mar. 31, 2013
Mar. 31, 2012
Current assets:      
Cash $ 85,366 $ 424,475 $ 15,698
Accounts receivable 164,988 158,008 0
Seeds 1,807,000 0  
Prepayments and other current assets 74,946 33,096 168,874
Total current assets 2,132,300 615,579 184,572
Non-current assets:      
Property and equipment 24,400 7,925 3,036
Accumulated depreciation (4,334) (1,234) 0
Property and equipment, net 20,066 6,691 3,036
Acquired Technology 1,635,300 1,635,300 0
Accumulatd amortization Acquired Technology (163,530) (81,765) 0
Acquired technology, net 1,471,770 1,553,535 0
Website development costs 5,315 5,315 5,315
Accumulated amortization Website development costs (2,670) (1,869) (801)
Website development costs, net 2,645 3,446 4,514
Security deposit 15,000 15,000 15,000
Total assets 3,641,781 2,194,251 207,122
Current liabilities:      
Accounts payable 1,092,237 948,073 237,288
Accounts payable - president and CEO 262,576 89,193 20,220
Accrued expenses 9,600 19,700 5,400
Accrued interest 145,144 21,627 15,521
Advances from president and significant stockholder 10,743 21,238 19,138
Convertible notes payable - net of discount 1,071,569 357,700 700,000
Current portion of derivative liability 0 0 0
Total current liabilities 2,591,869 1,457,531 997,567
Non-Current liabilities:      
Derivative note liabilities 227,772 0  
Derivative warrant liabilities 369,747 486,113 0
Total non-current liabilities 597,519 486,113 0
Total liabilities 3,189,388 1,943,644 997,567
Stevia Corp stockholders' equity (deficit):      
Preferred stock at $0.001 par value: 1,000,000 shares authorized;none issued or outstanding 0 0 0
Common stock at $0.001 par value 82,695 63,556 58,355
Additional paid-in capital 6,813,321 4,760,624 1,474,751
Accumulated deficit (6,376,899) (4,359,415) (2,323,551)
Total Stevia Corp stockholders' equity (deficit) 798,339 464,765 (790,445)
Noncontrolling interest - retained earnings in consolidated subsidiaries (345,946) (214,158)  
Non-controlling interest in subsidiary (345,946) (214,158) 0
Total Equity (Deficit) 452,393 250,607 (790,445)
Total Liabilities and Equity (Deficit) $ 3,641,781 $ 2,194,251 $ 207,122
XML 48 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
Office space with Leverage Investments, LLC (Details) (USD $)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Company leases certain office space rent details        
Company leases certain office space with Leverage Investments, LLC per month $ 4,500 $ 4,500 $ 6,000 $ 4,500
Total lease 1,500 1,500 500  
Stevia Asia provided Stevia Technew the amount, all of which has been paid to Guangzhou Health     $ 2,000,000  
XML 49 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss before non-controlling interest $ (2,149,272) $ (1,439,811)    
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation expense 3,100 762 1,234 0
Amortization Expense Acquired Technology 81,765 54,510 81,765 0
Amortization Expenses On Websited Development Costs 801 801 1,068 801
Discount Of Convertible Notes Payable 626,446 0 (412,738) 0
Debt settlement loss (561,077) 0    
Excess of fair value of warrants over notes, net of OID 38,075 0    
Change in fair value of derivative liability 675,949 305,244 (74,308) 0
Common shares issued for director services earned during the period 195,312 381,250 375,000 187,500
Common Shares Issued For Services Related Party 600,000 272,550 272,550 0
Common shares issued for outside services 205,860 0 0 90,725
Changes in operating assets and liabilities:        
Accounts receivable (6,980) (120,659) (158,008) 0
Seeds (765,000) 0    
Prepayments and other current assets (41,850) 142,858 135,778 (168,874)
Accounts payables; 144,164 412,110 710,785 141,530
Accounts payable - President and CEO; 173,383 0 68,973 20,220
Accrued expenses; (10,100) 6,045 14,300 (1,290)
Accrued Interest 123,517 40,397 54,284 38,589
Net cash provided by (used in) operating activities (895,651) (654,431) (1,030,723) (1,279,350)
Cash flows from investing activities:        
Purchase of property, plant and equipment (16,475) (4,889) (4,889) (3,036)
Website development costs     0 (5,315)
Cash received from reverse acquisition     0 3,199
Net cash used in investing activities (16,475) (4,889) (4,889) (5,152)
Cash flows from financing activities:        
Advances from (repayments to) president and stockholder (10,495) 2,100 2,100 200
Proceeds from issuance of convertible notes, net of costs 431,500 200,000 550,000 1,200,000
Proceeds from sale of common stock, net of costs 0 447,500 892,289 100,000
Proceeds from exercise of warrants, net of cost 152,012 0    
Net cash provided by financing activities 573,017 649,600 1,444,389 1,300,200
Net change in cash (339,109) (9,720) 408,777 15,698
Cash At Beginning Of The Fiscal Year 424,475 15,698 15,698   
Cash At End Of The Fiscal Year 85,366 5,978 424,475 15,698
Supplemental disclosure of cash flows information:        
Interest paid 0 0 0 0
Income tax paid 0 0 0 0
Non-cash investing and financing activities:        
Issuance of common stock for past due payables 1,042,000 0    
Issuance of common stock for conversion of convertible notes 0 500,000 500,000 500,000
Converstion Of Accrued Interest To Convertible Notes     20,438 0
Issuance Of Common Stock For Conversion Of Accrued Interest $ 0 $ 27,739 $ 27,740 $ 23,068
XML 50 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
GARDEN STATE SECURTIES INC (Details) (USD $)
Aug. 01, 2012
GARDEN STATE SECURTIES INC  
Reimbursed legal fees $ 12,500
Percentage cash commission 8.00%
Gross proceeds received in the equity financing 40,000
Common shares purchased 85,333
Exercise price per security issued $ 0.6405
Price per unit of security issued $ 0.46875
Common share for gross proceeds 500,000
Common share for net proceeds 447,500
Common share for a net proceed 292,218
Relative fair value of the common stock and warrants $ 207,782
Relative fair value Per common share $ 0.27
Relative fair value Per warrant $ 0.18
XML 51 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESEARCH AND DEVELOPMENT (Tables)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
RESEARCH AND DEVELOPMENT (Tables)    
Future minimum payments
Future minimum payments required under this agreement at December 31, 2013 were as follows:

Fiscal Year Ending March 31:
       
         
2014 (remainder of the year)
 
$
7,500
 
2015
   
30,000
 
2016
   
30,000
 
       
   
$
67,500
 


Fiscal Year Ending March 31:
       
         
2014
 
$
30,000
 
         
2015
   
30,000
 
         
2016
   
30,000
 
       
   
$
90,000
 

XML 52 R65.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESEARCH AND DEVELOPMENT PAYMENTS (Details) (USD $)
Mar. 31, 2013
ENTRY INTO AGRIBUSINESS DEVELOPMENT AGREEMENT  
AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated $ 274,000
Percentage of commission not less than 2.00%
First year lease payment 30,000
Six month lease payment 15,000
Aggregate security deposit $ 45,000
XML 53 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONCENTRATIONS AND CREDIT RISK
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
CONCENTRATIONS AND CREDIT RISK    
CONCENTRATIONS AND CREDIT RISK
Note 14 - Concentrations and Credit Risk

Credit Risk

Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents.
 
As of December 31, 2013, substantially all of the Company's cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation ("FDIC").  However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

Customers and Credit Concentrations

One (1) customer accounted for all of the sales for the interim period ended December 31, 2013 and the accounts receivable at December 31, 2013.  A reduction in sales from or loss of such customer would have a material adverse effect on the Company's results of operations and financial condition.

Vendors and Accounts Payable Concentrations

Vendor purchase concentrations and accounts payable concentration are as follows:

 
Accounts Payable at
   
Net Purchases
 
 
December 31, 2013
   
March 31, 2013
   
For the Reporting
Period Ended
December 31, 2013
   
For the Reporting
Period Ended
December 31, 2012
 
                               
Growers Synergy Pte. Ltd. - related party
 
45.0
%
   
50.1
%
   
6.0
%
   
49.8
%
Stevia Ventures Corporation
 
19.3
%
   
16. 9
%
   
26.6
%
   
10.3
%
SG Agro Tech Pte Ltd
 
-
%
   
-
%
   
52.2
%
   
-
%
   
64.3
%
   
67.0
%
   
84.8
%
   
60.1
%

Note 15 - Concentrations and Credit Risk

Credit Risk

Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents.

As of March 31, 2013, substantially all of the Company's cash and cash equivalents were held by major financial institutions, and the balance at certain accounts exceeded the maximum amount insured by the Federal Deposits Insurance Corporation ("FDIC").  However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

Customers and Credit Concentrations

One (1) customer accounted for all of the sales for the fiscal year ended March 31, 2013 and the accounts receivable balance at March 31, 2013.  A reduction in sales from or loss of such customer would have a material adverse effect on the Company's results of operations and financial condition.

Vendors and Accounts Payable Concentrations

Vendor purchase concentrations and accounts payable concentration are as follows:

   
Accounts Payable at
 
Net Purchases
 
   
March 31, 2013
   
March 31, 2012
   
March 31, 2013
   
March 31, 2012
 
                         
Growers Synergy Pte. Ltd. - related party
    50.1 %     16.4 %     26.4 %     13.5 %
                                 
Stevia Ventures Corporation
    16. 9 %     54.1 %     55.7 %     14.4 %
                                 
      67.0 %     70.5 %     82.1 %     27.9 %

XML 54 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAX (Tables)
12 Months Ended
Mar. 31, 2013
INCOME TAX:  
Deferred Tax Assets and Liabilities

   
March 31, 2013
   
March 31, 2012
 
Net deferred tax assets - Non-current:
               
                 
Expected income tax benefit from NOL carry-forwards
   
1,311,552
     
790,007
 
                 
Less valuation allowance
   
(1,311,552
)
   
(790,007
)
             
Deferred tax assets, net of valuation allowance
 
$
-
   
$
-
 

Effective Income Tax Rate Reconciliation

   
For the Fiscal Year
Ended
 March 31, 2013
   
For the Period from
April 11, 2011 (inception)
through
March 31, 2012
 
                 
Federal statutory income tax rate
   
34.0
%
   
34.0
%
                 
Change in valuation allowance on net operating loss carry-forwards
   
(34.0
)
   
(34.0
)
                 
Effective income tax rate
   
0.0
%
   
0.0
%

XML 55 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)    
BASIS OF PRESENTATION
Basis of Presentation - Unaudited Interim Financial Information

The unaudited interim consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information, and with the rules and regulations of the United States Securities and Exchange Commission ("SEC") to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim consolidated financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Interim results are not necessarily indicative of the results for the full fiscal year.  These consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company for the fiscal year ended March 31, 2013 and notes thereto contained in the Company's Annual Report on Form 10-K as filed with the SEC on July 16, 2013.

Basis of Presentation

The Company's consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

PRINCIPLES OF CONSOLIDATION
Principles of Consolidation

The Company applies the guidance of Topic 810 "Consolidation" of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.  Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.  Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.  The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent's power to control exists.

The Company's consolidated subsidiaries and/or entities are as follows:
 

Name of consolidated
subsidiary or entity
 
State or other jurisdiction
of incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable
interest
 
               
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
    100 %
                 
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
    100 %
                 
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
    70 %
                 
  SC Brands Pte Ltd    Singapore   October 1, 2013     70
 
The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.

All inter-company balances and transactions have been eliminated.

Principles of Consolidation

The Company applies the guidance of Topic 810 "Consolidation" of the FASB Accounting Standards Codification to determine whether and how to consolidate another entity.  Pursuant to ASC Paragraph 810-10-15-10 all majority-owned subsidiaries-all entities in which a parent has a controlling financial interest-shall be consolidated except (1) when control does not rest with the parent, the majority owner; (2) if the parent is a broker-dealer within the scope of Topic 940 and control is likely to be temporary; (3) consolidation by an investment company within the scope of Topic 946 of a non-investment-company investee.  Pursuant to ASC Paragraph 810-10-15-8 the usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, of more than 50 percent of the outstanding voting shares of another entity is a condition pointing toward consolidation.  The power to control may also exist with a lesser percentage of ownership, for example, by contract, lease, agreement with other stockholders, or by court decree. The Company consolidates all less-than-majority-owned subsidiaries, if any, in which the parent's power to control exists.

The Company's consolidated subsidiaries and/or entities are as follows:

Name of consolidated
subsidiary or entity
 
State or other jurisdiction of
incorporation or organization
 
Date of incorporation or formation
(date of acquisition, if applicable)
 
Attributable interest
             
Stevia Ventures International Ltd.
 
The Territory of the British Virgin Islands
 
April 11, 2011
 
100%
             
Stevia Asia Limited
 
Hong Kong SAR
 
March 19, 2012
 
100%
             
Stevia Technew Limited
 
Hong Kong SAR
 
April 28, 2012
 
   70%


The consolidated financial statements include all accounts of the Company and the consolidated subsidiaries and/or entities as of reporting period ending date(s) and for the reporting period(s) then ended.

All inter-company balances and transactions have been eliminated.

RECLASSIFICATION
Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.
Reclassification

Certain amounts in the prior period financial statements have been reclassified to conform to the current period presentation.   These reclassifications had no effect on reported losses.

USE OF ESTIMATES AND ASSUMPTIONS
Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).

Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company's critical accounting estimates and assumptions affecting the financial statements were:
 
 
(i)  
Assumption as a going concern: Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.
 
(ii)  
Allowance for doubtful accounts: Management's estimate of the allowance for doubtful accounts is based on historical sales, historical loss levels, and an analysis of the collectability of individual accounts; and general economic conditions that may affect a client's ability to pay. The Company evaluated the key factors and assumptions used to develop the allowance in determining that it is reasonable in relation to the financial statements taken as a whole.
 
(iii)  
Inventory Obsolescence and Markdowns: The Company's estimate of potentially excess and slow-moving inventories is based on evaluation of inventory levels and aging, review of inventory turns and historical sales experiences. The Company's estimate of reserve for inventory shrinkage is based on the historical results of physical inventory cycle counts.
 
(iv)  
Fair value of long-lived assets: Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.
 
(v)  
Valuation allowance for deferred tax assets: Management assumes that the realization of the Company's net deferred tax assets resulting from its net operating loss ("NOL") carry-forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors.
 
(vi)  
Estimates and assumptions used in valuation of equity instruments: Management estimates expected term of share options and similar instruments, expected volatility of the Company's common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.
Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.

The Company's significant estimates and assumptions include the fair value of financial instruments; the carrying value, recoverability and impairment of long-lived assets, including the values assigned to and the estimated useful lives of website development costs; interest rate; revenue recognized or recognizable; sales returns and allowances; foreign currency exchange rate; income tax rate, income tax provision, deferred tax assets and valuation allowance of deferred tax assets; expected term of share options and similar instruments, expected volatility of the entity's shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s); and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.

Actual results could differ from those estimates.

FAIR VALUE OF FINANCIAL INSTRUMENTS
Fair Value of Financial Instruments

The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
 
Level 1
 
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2
 
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3
 
Pricing inputs that are generally observable inputs and not corroborated by market data.
 
Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable,accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.

The Company's convertible notes payable approximates the fair value of such instrument based upon management's best estimate of interest rates that would be available to the Company for similar financial arrangements at December 31, 2013 and March 31, 2013.

The Company's Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation and the derivative liability on the conversion feature.  The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.  These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.
Fair Value of Financial Instruments

The Company follows paragraph 820-10-35-37 of the FASB Accounting Standards Codification ("Paragraph 820-10-35-37") to measure the fair value of its financial instruments and paragraph 825-10-50-10 of the FASB Accounting Standards Codification for disclosures about fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in accounting principles generally accepted in the United States of America (U.S. GAAP), and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels.  The three (3) levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:

Level 1
 
Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2
 
Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3
 
Pricing inputs that are generally observable inputs and not corroborated by market data.

Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable.

The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.  If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.
 
The carrying amounts of the Company's financial assets and liabilities, such as cash, accounts receivable, prepayments and other current assets, accounts payable, accrued expenses, and accrued interest, approximate their fair values because of the short maturity of these instruments.

The Company's convertible notes payable approximates the fair value of such instrument based upon management's best estimate of interest rates that would be available to the Company for similar financial arrangements at March 31, 2013 and March 31, 2012.

The Company's Level 3 financial liabilities consist of the derivative warrant issued in August 2012 for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.  The Company valued the automatic conditional conversion, re-pricing/down-round, change of control; default and follow-on offering provisions using a lattice model, with the assistance of a third party valuation specialist, for which management understands the methodologies.  These models incorporate transaction details such as Company stock price, contractual terms, maturity, risk free rates, as well as assumptions about future financings, volatility, and holder behavior as of the date of issuance and each balance sheet date.

It is not, however, practical to determine the fair value of advances from president and significant stockholder, if any, due to their related party nature.
FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES MEASURED ON A RECURRING BASIS
Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities - Derivative Warrant Liabilities and Derivative Liability on Conversion Feature

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability and derivative liability on the conversion feature at every reporting period and recognizes gains or losses in the consolidated statements of operations that are attributable to the change in the fair value of the derivative liabilities.
Fair Value of Financial Assets and Liabilities Measured on a Recurring Basis

Level 3 Financial Liabilities - Derivative Warrant Liabilities

The Company uses Level 3 of the fair value hierarchy to measure the fair value of the derivative liabilities and revalues its derivative warrant liability at every reporting period and recognizes gains or losses in the consolidated statements of operations and comprehensive income (loss) that are attributable to the change in the fair value of the derivative warrant liability.

ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are recorded at the invoiced amount, net of an allowance for doubtful accounts.  The Company follows paragraph 310-10-50-9 of the FASB Accounting Standards Codification to estimate the allowance for doubtful accounts.  The Company performs on-going credit evaluations of its customers and adjusts credit limits based upon payment history and the customer's current credit worthiness, as determined by the review of their current credit information; and determines the allowance for doubtful accounts based on historical write-off experience, customer specific facts and economic conditions.

Pursuant to paragraph 310-10-50-2 of the FASB Accounting Standards Codification account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.  The Company has adopted paragraph 310-10-50-6 of the FASB Accounting Standards Codification and determine when receivables are past due or delinquent based on how recently payments have been received.

Outstanding account balances are reviewed individually for collectability.  The allowance for doubtful accounts is the Company's best estimate of the amount of probablecredit losses in the Company's existing accounts receivable. Bad debt expense is included in general and administrative expenses, if any.

There was no allowance for doubtful accounts as December 31, 2013 or March 31, 2013.

The Company does not have any off-balance-sheet credit exposure to its customers.
 
CARRYING VALUE, RECOVERABILITY AND IMPAIRMENT OF LONG-LIVED ASSETS
Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company's long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful livesagainst their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable.If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

The key assumptions used in management's estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.  These forecasts are typically based on historical trends and take into account recent developments as well as management's plans and intentions.  Other factors, such as increased competition or a decrease in the desirability of the Company's products or services, could lead to lower projected sales levels, which would adversely impact cash flows.  A significant change in cash flows in the future could result in an impairment of long lived assets.

The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.

Carrying Value, Recoverability and Impairment of Long-Lived Assets

The Company has adopted paragraph 360-10-35-17 of the FASB Accounting Standards Codification for its long-lived assets. The Company's long-lived assets, which include property and equipment, acquired technology, and website development costs are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset's expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i) significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in the Company's overall strategy with respect to the manner or use of the acquired assets or changes in the Company's overall business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant decline in the Company's stock price for a sustained period of time; and (vi) regulatory changes.  The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

The key assumptions used in management's estimates of projected cash flow deal largely with forecasts of sales levels and gross margins.  These forecasts are typically based on historical trends and take into account recent developments as well as management's plans and intentions.  Other factors, such as increased competition or a decrease in the desirability of the Company's products or services, could lead to lower projected sales levels, which would adversely impact cash flows.  A significant change in cash flows in the future could result in an impairment of long lived assets.

The impairment charges, if any, is included in operating expenses in the accompanying consolidated statements of operations.


FISCAL YEAR END
Fiscal Year End

The Company elected March 31st as its fiscal year end date upon its formation.

Fiscal Year End

The Company elected March 31 as its fiscal year ending date.

CASH EQUIVALENTS
Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
 
Inventories

Inventory Valuation

The Company values inventory, consisting of finished goods, at the lower of cost or market.  Cost is determined on the first-in and first-out ("FIFO") method. The Company reduces inventory for the diminution of value, resulting from product obsolescence, damage or other issues affecting marketability, equal to the difference between the cost of the inventory and its estimated market value.  Factors utilized in the determination of estimated market value include (i) estimates of future demand, and (ii) competitive pricing pressures.

Inventory Obsolescence and Markdowns

The Company evaluates its current level of inventory considering historical sales and other factors and, based on this evaluation, classify inventory markdowns in the income statement as a component of cost of goods sold pursuant to Paragraph 420-10-S99 of the FASB Accounting Standards Codification to adjust inventory to net realizable value. These markdowns are estimates, which could vary significantly from actual requirements if future economic conditions, customer demand or competition differ from expectations.

There was no inventory obsolescence for the interim period ended December 31, 2013 or 2012.

There was no lower of cost or market adjustments for the interim period ended December 31, 2013 or 2012.
 
Cash Equivalents

The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.

PROPERTY AND EQUIPMENT
Property and Equipment

Property and equipment is recorded at cost.  Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred.  Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.
Property and Equipment

Property and equipment is recorded at cost.  Expenditures for major additions and betterments are capitalized.  Maintenance and repairs are charged to operations as incurred.  Depreciation of furniture and fixture is computed by the straight-line method (after taking into account their respective estimated residual values) over the assets estimated useful life of five (5) years.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.

INTANGIBLE ASSETS OTHER THAN GOODWILL
Intangible Assets Other Than Goodwill

The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.  Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwillon a straight-line basis over the estimated useful lives of the respective assets as follows:

   
Estimated Useful Life (Years)
 
         
Acquired technology
   
15
 
Website development costs
   
5
 
 
Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

Intangible Assets Other Than Goodwill

The Company has adopted paragraph 350-30-25-3 of the FASB Accounting Standards Codification for intangible assets other than goodwill.  Under the requirements, the Company amortizes the acquisition costs of intangible assets other than goodwill inclusive of acquired technology and website development costs on a straight-line basis over their relevant estimated useful lives of fifteen (15) and five (5) years, respectively.  Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

RELATED PARTIES
Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:  a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Related Parties

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include:  a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

EXTINGUISHMENT ACCOUNTING
Extinguishment Accounting

On July 25, 2013, the Supreme Court of the State of New York, County of New York (the  "Court"),  entered  an order (the  "Order")  approving the settlement  (the "Settlement Agreement")  between the Company and Hanover Holdings I, LLC, a New York limited  liability company  ("Hanover"),  Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the  "Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.

The Settlement  Agreement  provides that the Initial Settlement Shares will be  subject  to  adjustment  on  the  trading  day  immediately   following  the Calculation Period to reflect the  intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the  Settlement  Agreement be based upon a specified  discount to the trading volume  weighted  average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court's entry of the Order.

The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.  The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.
 
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Derivative Instruments and Hedging Activities

The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.  The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.  For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.
Derivative Instruments and Hedging Activities

The Company accounts for derivative instruments and hedging activities in accordance with paragraph 810-10-05-4 of the FASB Accounting Standards Codification ("Paragraph 810-10-05-4"). Paragraph 810-10-05-4 requires companies to recognize all derivative instruments as either assets or liabilities in the balance sheet at fair value.  The accounting for changes in the fair value of a derivative instrument depends upon: (i) whether the derivative has been designated and qualifies as part of a hedging relationship, and (ii) the type of hedging relationship.  For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument based upon the exposure being hedged as either a fair value hedge, cash flow hedge or hedge of a net investment in a foreign operation.

From time to time, the Company may employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates.  The Company does not use derivatives for speculation or trading purposes.  Changes in the fair value of derivatives are recorded each period in current earnings or through other comprehensive income, depending on whether a derivative is designated as part of a hedge transaction and the type of hedge transaction.  The ineffective portion of all hedges is recognized in current earnings.  The Company has sales and purchase commitments denominated in foreign currencies.  Foreign currency forward contracts are used to hedge against the risk of change in the fair value of these commitments attributable to fluctuations in exchange rates ("Fair Value Hedges").  Changes in the fair value of the derivative instrument are generally offset in the income statement by changes in the fair value of the item being hedged.

The Company did not employ foreign currency forward contracts to convert unforeseeable foreign currency exchange rates to fixed foreign currency exchange rates for the fiscal year ended March 31, 2013 or 2012.

DERIVATIVE LIABILITY
Derivative Liability

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.  The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.  In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.  Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.  Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.  Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock.  Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.   The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).

The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.  The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.  Therefore, the fair value may not be appropriately captured by simple models.  In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).  The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.  Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).  Projections were then made on the underlying factors which led to potential scenarios.  Probabilities were assigned to each scenario based on management projections.  This led to a cash flow projection and a probability associated with that cash flow.  A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.
Derivative Liability

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification.  The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.  In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations and comprehensive income (loss) as other income or expense.  Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.  Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the fair value of the instrument on the reclassification date.  Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification ("Section 815-40-15")  to determine whether an instrument (or an embedded feature) is indexed to the Company's own stock.  Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument's contingent exercise and settlement provisions.   The adoption of Section 815-40-15 has affected the accounting for (i) certain freestanding warrants that contain exercise price adjustment features and (ii) convertible bonds issued by foreign subsidiaries with a strike price denominated in a foreign currency.

The Company marks to market the fair value of the embedded derivative warrants at each balance sheet date and records the change in the fair value of the embedded derivative warrants as other income or expense in the consolidated statements of operations and comprehensive income (loss).

The Company utilizes the Lattice model that values the liability of the derivative warrants based on a probability weighted discounted cash flow model with the assistance of the third party valuation firm.  The reason the Company picks the Lattice model is that in many cases there may be multiple embedded features or the features of the bifurcated derivatives may be so complex that a Black-Scholes valuation does not consider all of the terms of the instrument.  Therefore, the fair value may not be appropriately captured by simple models.  In other words, simple models such as Black-Scholes may not be appropriate in many situations given complex features and terms of conversion option (e.g., combined embedded derivatives).  The Lattice model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise and full reset features.  Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The Lattice model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.).  Projections were then made on the underlying factors which led to potential scenarios.  Probabilities were assigned to each scenario based on management projections.  This led to a cash flow projection and a probability associated with that cash flow.  A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrants.


BENEFICIAL CONVERSION FEATURE
Beneficial Conversion Feature

When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company's common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.
 
Beneficial Conversion Feature

When the Company issues an debt or equity security that is convertible into common stock at a discount from the fair value of the common stock at the date the debt or equity security counterparty is legally committed to purchase such a security (Commitment Date), a beneficial conversion charge is measured and recorded on the Commitment Date for the difference between the fair value of the Company's common stock and the effective conversion price of the debt or equity security. If the intrinsic value of the beneficial conversion feature is greater than the proceeds allocated to the debt or equity security, the amount of the discount assigned to the beneficial conversion feature is limited to the amount of the proceeds allocated to the debt or equity security.

COMMITMENT AND CONTINGENCIES
Commitment and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.  The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's consolidated financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.  Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company's business, financial position, and results of operations or cash flows.
Commitment and Contingencies

The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur.  The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.  In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's consolidated financial statements.  If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.  Management does not believe, based upon information available at this time, that these matters will have a material adverse effect on the Company's consolidated financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company's business, financial position, and results of operations or cash flows.
NON-CONTROLLING INTEREST
Non-controlling Interest

The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interests in its majority owned subsidiaries in the consolidated statements of balance sheets within the equity section, separately from the Company's stockholders' equity.  Non-controlling interests represents the non-controlling interest holder's proportionate share of the equity of the Company's majority-owned subsidiaries. Non-controlling interest is adjusted for the non-controlling interest holder's proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

Non-controlling Interest

The Company follows paragraph 810-10-65-1 of the FASB Accounting Standards Codification to report the non-controlling interest in Stevia Technew Limited, its majority owned subsidiary in the consolidated statements of balance sheets within the equity section, separately from the Company's stockholders' equity.  Non-controlling interest represents the non-controlling interest holder's proportionate share of the equity of the Company's majority-owned subsidiary, Stevia Technew Limited. Non-controlling interest is adjusted for the non-controlling interest holder's proportionate share of the earnings or losses and other comprehensive income (loss) and the non-controlling interest continues to be attributed its share of losses even if that attribution results in a deficit non-controlling interest balance.

REVENUE RECOGNITION
Revenue Recognition

The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv)collectability is reasonably assured.

Revenue Recognition

The Company follows paragraph 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition.  The Company recognizes revenue when it is realized or realizable and earned.  The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured.

SHIPPING AND HANDLING COSTS
Shipping and Handling Costs

The Company accounts for shipping and handling fees in accordance with paragraph 605-45-45-19 of the FASB Accounting Standards Codification.  While amounts charged to customers for shipping products are included in revenues, the related costs are classified in cost of goods sold as incurred.
 
RESEARCH AND DEVELOPMENT
Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 "Accounting for Research and Development Costs") and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 "Research and Development Arrangements") for research and development costs.  Research and development costs are charged to expense as incurred.Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.
 
Research and Development

The Company follows paragraph 730-10-25-1 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 2 "Accounting for Research and Development Costs") and paragraph 730-20-25-11 of the FASB Accounting Standards Codification (formerly Statement of Financial Accounting Standards No. 68 "Research and Development Arrangements") for research and development costs.  Research and development costs are charged to expense as incurred.  Research and development costs consist primarily of remuneration for research and development staff, depreciation and maintenance expenses of research and development equipment, material and testing costs for research and development as well as research and development arrangements with unrelated third party research and development institutions.


NON-REFUNDABLE ADVANCE PAYMENTS FOR GOODS OR SERVICES TO BE USED IN FUTURE RESEARCH AND DEVELOPMENT ACTIVITIES
Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities

The research and development arrangements usually involve specific research and development projects.  Often times, the Company makes non-refundable advances upon signing of these arrangements.  The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 "Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities") for those non-refundable advances.  Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.  Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.  The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.  If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.

Non-refundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities

The research and development arrangements usually involve specific research and development projects.  Often times, the Company makes non-refundable advances upon signing of these arrangements.  The Company adopted paragraph 730-20-25-13 and 730-20-35-1 of the FASB Accounting Standards Codification (formerly Emerging Issues Task Force Issue No. 07-3 "Accounting for Nonrefundable Advance Payments for Goods or Services to be Used in Future Research and Development Activities") for those non-refundable advances.  Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are deferred and capitalized.  Such amounts are recognized as an expense as the related goods are delivered or the related services are performed.  The management continues to evaluate whether the Company expect the goods to be delivered or services to be rendered.  If the management does not expect the goods to be delivered or services to be rendered, the capitalized advance payment are charged to expense.

STOCK-BASED COMPENSATION FOR OBTAINING EMPLOYEE SERVICES
Stock-Based Compensation for Obtaining Employee Services

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.  Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.  Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.  The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.
 
·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

The Company's policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.

Stock-Based Compensation for Obtaining Employee Services

The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding.  Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments.  Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the simplified method to calculate expected term of share options and similar instruments as the company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.  The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments.

 
The Company's policy is to recognize compensation cost for awards with only service conditions and a graded vesting schedule on a straight-line basis over the requisite service period for the entire award.

EQUITY INSTRUMENTS ISSUED TO PARTIES OTHER THAN EMPLOYEES
Equity Instruments Issued to Parties other than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments.  The Company uses historical data to estimate holder's expected exercise behavior.  If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.  A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index.The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.
 
·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.

Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.

Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9,an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

Equity Instruments Issued to Parties other than Employees for Acquiring Goods or Services

The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Subtopic 505-50 of the FASB Accounting Standards Codification ("Subtopic 505-50").

Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  If shares of the Company are thinly traded the use of share prices established in the Company's most recent private placement memorandum ("PPM"), or weekly or monthly price observations would generally be more appropriate than the use of daily price observations as such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

The fair value of non-derivative option or warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  The ranges of assumptions for inputs are as follows:

·  
Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2 of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments.  The Company uses historical data to estimate holder's expected exercise behavior.  If the Company is a newly formed corporation or shares of the Company are thinly traded the contractual term of the share options and similar instruments is used as the expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

·  
Expected volatility of the entity's shares and the method used to estimate it.  An entity that uses a method that employs different volatilities during the contractual term shall disclose the range of expected volatilities used and the weighted-average expected volatility.  A thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses the average historical volatility of the comparable companies over the expected contractual life of the share options or similar instruments as its expected volatility.  If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market.

·  
Expected annual rate of quarterly dividends.  An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends.  The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected contractual life of the option and similar instruments.

·  
Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used.  The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option and similar instruments.

Pursuant to Paragraphs 505-50-25-8, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic.
 
Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a stock option that the counterparty has the right to exercise expires unexercised.

Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.

INCOME TAX PROVISION
Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.Deferred tax assets are reduced by a valuation allowance to the extent management concludes it ismore likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.  Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.
 
The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management's opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

Income Tax Provision

The Company accounts for income taxes under Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the consolidated statements of income and comprehensive income (loss) in the period that includes the enactment date.

The Company adopted section 740-10-25 of the FASB Accounting Standards Codification ("Section 740-10-25"). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty (50) percent likelihood of being realized upon ultimate settlement.  Section 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures.

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying consolidated balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its consolidated balance sheets and provides valuation allowances as management deems necessary.

Management makes judgments as to the interpretation of the tax laws that might be challenged upon an audit and cause changes to previous estimates of tax liability. In addition, the Company operates within multiple taxing jurisdictions and is subject to audit in these jurisdictions. In management's opinion, adequate provisions for income taxes have been made for all years. If actual taxable income by tax jurisdiction varies from estimates, additional allowances or reversals of reserves may be necessary.

UNCERTAIN TAX POSITIONS
Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the reporting period ended December 31, 2013 or 2012.

Uncertain Tax Positions

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the provisions of Section 740-10-25 for the fiscal year ended March 31, 2013 or for the period from April 11, 2011 (Inception) through December 31, 2012.


LIMITATION OF UTILIZATION OF NOLS DUE TO CHANGE IN CONTROL
Limitation on Utilization of NOLs due to Change in Control

Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL's to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation's ability to utilize NOLs if it experiences an "ownership change."  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.
Limitation on Utilization of NOLs due to Change in Control

Pursuant to the Internal Revenue Code Section 382 ("Section 382"), certain ownership changes may subject the NOL's to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation's ability to utilize NOLs if it experiences an "ownership change."  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

NET INCOME (LOSS) PER COMMON SHARE
Net Income (Loss)per Common Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:

   
Potentially Outstanding Dilutive Common Shares
     
For Interim
PeriodEnded
December 31, 2013
 
For Interim
Period Ended
December 31, 2012
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").
   
-
 
3,000,000
           
Sub-total Make Good Escrow Shares
   
-
 
3,000,000
 
Convertible Note Shares
         
           
On March 7, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and the entire accrued unpaid interest for the total amount of $220,438 with interest at 12% per annum convertible at $0.25 per share due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
881,752
 
426,667
           
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal and any accrued and unpaid interest thereon convertible, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
   
1,739,130
 
426,667
           
On February 26, 2013, the Company issued two (2) convertible notes in the principal amount of $250,000 and $100,000, respectively, convertible at $0.25 per share, with interest at 12% per annum due on September 30, 2013. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.
   
            1,400,000
 
-
           
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
1,762,228
 
-
           
On August 27, 2013, the Company issued a convertible note in the principal amount of $153,500, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on May 26, 2014.
   
             2,353,573
 
            -
           
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date.
   
440,571
 
-
           
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 with an $8,000 Original Issuance Discount ("OID") and with interest at 10% per annum, convertible at $0.20 per share, due on May 1, 2014.
   
            290,000
 
            -
           
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum, due on August 25, 2014.
   
812,634
 
-
           
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and 12% one time interest. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
   
881,142
 
-
           
Sub-total Convertible Note Shares
   
10,561,070
 
853,334
 
Warrant Shares
         
           
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to investors (the "investor warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. On February 26, 2013, warrantsissued subsequent to these warrantstriggered a reset of these warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted to 2,951,424 shares accordingly. On May 8, 2013, the Company completed a private placement at $0.20 per share with gross proceeds more than $100,000; this event triggered the reset of the conversion price of the convertible note to $0.20 per share and the shares to be issued under the warrants were adjusted to 3,689,280 shares accordingly. On May 8, 2013, investors exercised the warrants to purchase 2,732,799 shares (853,333 original shares) at $0.20 per share.
   
956,481
 
1,152,000
           
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, or 1,400,000 shares in the aggregate, of the Company's common stock to two (2) note holders in connection with the issuance of convertible notes.
   
1,400,000
 
-
           
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock to the note holder in connection with the issuance of the convertible note.
   
881,753
 
-
           
On May 6, 2013, the Company issued three (3) series of warrants:
 
Series A warrants include (i) warrants to purchase 1,877,333 shares of the Company's common stock to the investor and (ii) warrants to purchase 150,187 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.20 per share expiring five (5) years from the date of issuance.
   
2,027,520
 
-
           
 
Series B warrants include (i) warrants to purchase 1,066,666 shares of the Company's common stock to the investor and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance.
   
1,151,999
 
-
           
 
Series C warrants include (i) warrants to purchase 2,346,666 shares of the Company's common stock to the investor and (ii) warrants to purchase 187,733 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.25 per share expiring five (5) years from the date of issuance. The warrants are exercisable under the condition of Series A warrants are exercised.
   
2,534,399
 
-
           
On October 15, 2013, the Company issued warrants to purchase 1,000,000 shares of the Company's common stock to a note holder with an exercise price of $0.25 per share in connection with the issuance of convertible note.
   
1,000,000
 
-
           
Sub-total Warrant Shares
   
9,952,152
 
1,152,000
           
Total potentially outstanding dilutive common shares
   
20,513,222
 
5,005,334

Net Income (Loss) per Common Share

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification.   Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent shares issuance arrangement, stock options or warrants.

The following table shows the potentially outstanding dilutive common shares excluded from the diluted net income (loss) per common share calculation as they were anti-dilutive:
 
   
Potentially Outstanding Dilutive Common Shares
   
For Fiscal Year Ended
March 31, 2013
 
For the Period
from April 11, 2011
(inception) through
March 31, 2012
           
Make Good Escrow Shares
         
           
Make Good Escrow Agreement shares issued and held with the escrow agent in connection with the Share Exchange Agreement consummated on June 23, 2011 pending the achievement by the Company of certain post-Closing business milestones (the "Milestones").
    3,000,000     6,000,000    
                 
Sub-total Make Good Escrow Shares
    3,000,000     6,000,000    
                 
Convertible Note Shares
               
                 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price is $0.25 per share.
    881,752     -    
                 
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis, provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at  $0.46875 per share with gross proceeds of at least $100,000.
    426,667     -    
                 
On February 26, 2013 , the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, with interest at 12% per annum due on September 30, 2013 with the conversion price at $0.25 per share
    1,400,000     -    
                 
Sub-total Convertible Note Shares
    2,708,419     -    
 
                 
Warrant Shares
               
                 
On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance. On February 26, 2013, the new warrants issued triggered a reset of the above warrants exercise price to $0.25 per share and the shares to be issued under the warrants were adjusted accordingly.
    2,951,424     -    
                 
On February 26, 2013, the Company issued warrants to purchase 1,000,000 and 400,000 shares respectively, 1,400,000 shares in the aggregate, of the Company's common stock to two notes holders in connection with the issuance of convertible notes.
    1,400,000     -    
                 
On March 15, 2013, the Company issued a warrant to purchase 881,753 shares of the Company's common stock to the note holder in connection with the issuance of the convertible note.
    881,753          
                 
Sub-total Warrant Shares
    5,233,177     -    
                 
Total potentially outstanding dilutive common shares
    10,941,596     6,000,000    

CASH FLOWS REPORTING
Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.  The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.
Cash Flows Reporting

The Company adopted paragraph 230-10-45-24 of the FASB Accounting Standards Codification for cash flows reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method ("Indirect method") as defined by paragraph 230-10-45-25 of the FASB Accounting Standards Codification to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.  The Company reports the reporting currency equivalent of foreign currency cash flows, using the current exchange rate at the time of the cash flows and the effect of exchange rate changes on cash held in foreign currencies is reported as a separate item in the reconciliation of beginning and ending balances of cash and cash equivalents and separately provides information about investing and financing activities not resulting in cash receipts or payments in the period pursuant to paragraph 830-230-45-1 of the FASB Accounting Standards Codification.

SUBSEQUENT EVENTS
Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

Subsequent Events

The Company follows the guidance in Section 855-10-50 of the FASB Accounting Standards Codification for the disclosure of subsequent events. The Company will evaluate subsequent events through the date when the financial statements are issued.  Pursuant to ASU 2010-09 of the FASB Accounting Standards Codification, the Company as an SEC filer considers its financial statements issued when they are widely distributed to users, such as through filing them on EDGAR.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS
Recently Issued Accounting Pronouncements

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." The ASUadds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.

In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date."  This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05, "Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU 2013-07, "Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting." The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity's governing documents from the entity's inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity's inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity's expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Recently Issued Accounting Pronouncements

In January 2013, the FASB issued ASU No. 2013-01, "Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities". This ASU clarifies that the scope of ASU No. 2011-11, "Balance Sheet (Topic 210): Disclosures about Offsetting Assets and Liabilities." applies only to derivatives, repurchase agreements and reverse purchase agreements, and securities borrowing and securities lending transactions that are either offset in accordance with specific criteria contained in FASB Accounting Standards Codification or subject to a master netting arrangement or similar agreement. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013.

In February 2013, the FASB issued ASU No. 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income." The ASU   adds new disclosure requirements for items reclassified out of accumulated other comprehensive income by component and their corresponding effect on net income. The ASU is effective for public entities for fiscal years beginning after December 15, 2013.
 
In February 2013, the Financial Accounting Standards Board, or FASB, issued ASU No. 2013-04, "Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for which the Total Amount of the Obligation Is Fixed at the Reporting Date."  This ASU addresses the recognition, measurement, and disclosure of certain obligations resulting from joint and several arrangements including debt arrangements, other contractual obligations, and settled litigation and judicial rulings. The ASU is effective for public entities for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU No. 2013-05, "Foreign Currency Matters (Topic 830): Parent's Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity." This ASU addresses the accounting for the cumulative translation adjustment when a parent either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. The guidance outlines the events when cumulative translation adjustments should be released into net income and is intended by FASB to eliminate some disparity in current accounting practice. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013.

In March 2013, the FASB issued ASU 2013-07,"Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting." The amendments require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent. Liquidation is imminent when the likelihood is remote that the entity will return from liquidation and either (a) a plan for liquidation is approved by the person or persons with the authority to make such a plan effective and the likelihood is remote that the execution of the plan will be blocked by other parties or (b) a plan for liquidation is being imposed by other forces (for example, involuntary bankruptcy). If a plan for liquidation was specified in the entity's governing documents from the entity's inception (for example, limited-life entities), the entity should apply the liquidation basis of accounting only if the approved plan for liquidation differs from the plan for liquidation that was specified at the entity's inception. The amendments require financial statements prepared using the liquidation basis of accounting to present relevant information about an entity's expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The entity should include in its presentation of assets any items it had not previously recognized under U.S. GAAP but that it expects to either sell in liquidation or use in settling liabilities (for example, trademarks). The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. Entities should apply the requirements prospectively from the day that liquidation becomes imminent. Early adoption is permitted.

Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

XML 56 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net deferred tax assets (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Net deferred tax assets - Non-current:    
Expected income tax benefit from NOL carry-forwards $ 1,311,552 $ 790,007
Less valuation allowance (1,311,552) (790,007)
Deferred tax assets, net of valuation allowance $ 0 $ 0
XML 57 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 58 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND OPERATIONS
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
ORGANIZATION AND OPERATIONS    
ORGANIZATION AND OPERATIONS
Note 1 - Organization and Operations

Stevia Corp. (Formerly Interpro Management Corp.)

Interpro Management Corp ("Interpro") was incorporated under the laws of the State of Nevada on May 21, 2007.   Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization's efficiency through planning and monitoring the daily operations of a business.

On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. ("Stevia" or the "Company") to reflect its intended acquisition of Stevia Ventures International Ltd.

The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011.

Stevia Ventures International Ltd.

Stevia Ventures International Ltd. ("Ventures") was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands ("BVI").  Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia.

Acquisition of Stevia Ventures International Ltd. Recognized as a Reverse Acquisition

On June 23, 2011 (the "Closing Date"), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the "Share Exchange Agreement") by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder").

Immediately prior to the consummation of the Share Exchange Agreement on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company's former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares were being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement").  Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock, immediately after the consummation of the Share Exchange Agreement, the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition.

As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification.  The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition.  The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost.  The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction.

Formation of Stevia Asia Limited

On March 19, 2012, the Company formed Stevia Asia Limited ("Stevia Asia") under the laws of the Hong Kong Special Administrative Region ("HK SAR") of the People's Republic of China ("PRC"), as a wholly-owned subsidiary.

Formation of Stevia Technew Limited (Formerly Hero Tact Limited)/Cooperative Agreement

On April 28, 2012, Stevia Asia formed Hero Tact Limited, as a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited ("Stevia Technew").  Stevia Technew intends to facilitate a joint venture relationship with the Company's technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou's affiliates Technew Technology Limited.  Prior to July 5, 2012, the date of entry into the Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities.

On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the issued shares and Technew legally and beneficially owns 30% of the issued shares. The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities. On March 1, 2013, the partners agreed to terminate the Cooperative Agreement specific to the investment in an agricultural project and no further obligation by either party related to the payment of $200,000.

The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.

Formation of SC Brands Pte Ltd

On October 1, 2013, the Company formed SC Brands Pte Ltd ("SC Brands") under the laws of Singapore, with the Company owning 70% of the shares and 30% owned by a Singapore strategic partner that will provide the working capital funds via fixed convertible notes to the Company. As of December 31, 2013 SC Brands was inactive.
Note 1 - Organization and Operations

Stevia Corp. (Formerly Interpro Management Corp.)

Interpro Management Corp ("Interpro") was incorporated under the laws of the State of Nevada on May 21, 2007.   Interpro focused on developing and offering web based software that was designed to be an online project management tool used to enhance an organization's efficiency through planning and monitoring the daily operations of a business. The Company discontinued its web-based software business upon the acquisition of Stevia Ventures International Ltd. on June 23, 2011.

On March 4, 2011, Interpro amended its Articles of Incorporation, and changed its name to Stevia Corp. ("Stevia" or the "Company") and effectuated a 35 for 1 (1:35) forward stock split of all of its issued and outstanding shares of common stock (the "Stock Split").

All shares and per share amounts in the consolidated financial statements have been adjusted to give retroactive effect to the Stock Split.

Stevia Ventures International Ltd.

Stevia Ventures International Ltd. ("Ventures") was incorporated on April 11, 2011 under the laws of the Territory of the British Virgin Islands ("BVI").  Ventures owns certain rights relating to stevia production, including certain assignable exclusive purchase contracts and an assignable supply agreement related to stevia.

Acquisition of Stevia Ventures International Ltd. Recognized as a Reverse Acquisition

On June 23, 2011 (the "Closing Date"), the Company closed a voluntary share exchange transaction with Ventures pursuant to a Share Exchange Agreement (the "Share Exchange Agreement") by and among the Company, Ventures and George Blankenbaker, the stockholder of Ventures (the "Ventures Stockholder").

Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company's former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Ventures. Of the 12,000,000 common shares issued 6,000,000 shares were being held in escrow pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement").  Even though the shares issued only represented approximately 20.4% of the issued and outstanding common stock immediately after the consummation of the Share Exchange Agreement the stockholder of Ventures completely took over and controlled the board of directors and management of the Company upon acquisition.

As a result of the change in control to the then Ventures Stockholder, for financial statement reporting purposes, the merger between the Company and Ventures has been treated as a reverse acquisition with Ventures deemed the accounting acquirer and the Company deemed the accounting acquiree under the acquisition method of accounting in accordance with section 805-10-55 of the FASB Accounting Standards Codification.  The reverse acquisition is deemed a capital transaction and the net assets of Ventures (the accounting acquirer) are carried forward to the Company (the legal acquirer and the reporting entity) at their carrying value before the acquisition.  The acquisition process utilizes the capital structure of the Company and the assets and liabilities of Ventures which are recorded at their historical cost.  The equity of the Company is the historical equity of Ventures retroactively restated to reflect the number of shares issued by the Company in the transaction.
 

Formation of Stevia Asia Limited

On March 19, 2012, the Company formed Stevia Asia Limited ("Stevia Asia") under the laws of the Hong Kong Special Administrative Region ("HK SAR") of the People's Republic of China ("PRC"), a wholly-owned subsidiary.

Formation of Stevia Technew Limited (Formerly Hero Tact Limited)/Cooperative Agreement

On April 28, 2012, Stevia Asia formed Hero Tact Limited, a wholly-owned subsidiary, under the laws of HK SAR, which subsequently changed its name to Stevia Technew Limited ("Stevia Technew").  Stevia Technew intends to facilitate a joint venture relationship with the Company's technology partner, Guangzhou Health China Technology Development Company Limited, operating under the trade name Tech-New Bio-Technology and Guangzhou's affiliates Technew Technology Limited.  Prior to July 5, 2012, the date of entry into the Cooperative Agreement, Stevia Technew was inactive and had no assets or liabilities.

On July 5, 2012, Stevia Asia entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% of the shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% of the shares (representing 30% of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to contribute $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities.

The Cooperative Agreement shall automatically terminate upon either Stevia Asia or Technew ceasing to be a shareholder in Stevia Technew, or may be terminated by either Stevia Asia or Technew upon a material breach by the other party which is not cured within 30 days of notice of such breach.
XML 59 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets Parentheticals (USD $)
Dec. 31, 2013
Mar. 31, 2013
Mar. 31, 2012
Stockholders equity number of shares par value and other disclosures      
Preferred Stock, par or stated value $ 0.001 $ 0.001 $ 0.001
Preferred Stock, shares authorized 1,000,000 1,000,000 1,000,000
Preferred Stock, shares issued 0 0 0
Preferred Stock, shares outstanding 0 0 0
Common Stock, par or stated value $ 0.001 $ 0.001 $ 0.001
Common Stock, shares authorized 250,000,000 100,000,000 100,000,000
Common Stock, shares issued 82,695,634 63,555,635 58,354,775
Common Stock, shares outstanding 82,695,634 63,555,635 58,354,775
XML 60 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
STOCKHOLDERS' EQUITY    
STOCKHOLDERS' EQUITY
Note 12 - Equity

Shares Authorized

Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share.

On November 15, 2013, the Company approved an amendment to the Articles of Incorporations to increase the authorized number of shares to Two hundred and fifty million (250,000,000) shares, par value $0.001 per share.

Common Stock

Reverse Acquisition Transaction

Immediately prior to the Share Exchange Agreement on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company's former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares were being held in escrow ("Escrow Shares") pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement").

 
*
On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned by and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.  These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as salary and compensation - officer.

 
**
On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned by and released to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as salary and compensation - officer.

Common Shares Issued for Obtaining Employee and Director Services

October 14, 2011 Issuance of Common Shares for Director Services

On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director's continuous service to the Company as directors.  These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.

The Company recorded $375,000 and $187,500 in directors' fees for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, respectively.

The Company recorded the remaining balance of $187,500 for the interim period ended December 31, 2013.

December 4, 2013 Issuance of Common Shares for Director Services

On December 4, 2013 the Company issued 1,500,000 shares to a newly appointed member of the board of directors as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director's continuous service to the Company as a director.  These shares were valued at $0.125 per share or $187,500 on the date of grant and are being amortized over the vesting period of two (2) years or $7,811 per month.
 
The Company recorded $7,811 in director's fees for the interim period ended December 31, 2013.

Common Shares Issued to Parties other than Employees for Acquiring Goods or Services

Common Shares Issued to a Related Party

On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party.

Common Shares Issued in Connection with Consulting Agreement

On April 18, 2013, the Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation ("Mountain Sky"), in partial consideration for consulting services rendered by Mountain Sky.  500,000 of the 1,000,000 shares vested at the time of grant, and 500,000 will vest on the one (1) year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.

Sale of Equity Units Including Common Stock and Warrants

Entry into Securities Purchase Agreement

On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667shares of the Company's common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company's common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000.

At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,("GSS"), who served as placement agent for the Company in the offering, (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the  "agent warrants") to GSS  or its  designee.

The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for gross proceeds of $500,000.  In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500.

Per the terms of the SPA, from the date until one (1) year anniversary of the closing date, if the Company issues or sells any shares of the Company's common stock at a price that is less than the per share purchase price, than immediately without any obligation of or notice to the Purchasers, the per share purchase price paid shall be reduced to be the discounted per share purchase price and the number of shares issuable under this agreement shall be deemed increased to the subscription amount paid by such Purchaser. On October 1, 2013,
The Company issued 286,666 common shares to the investor according to this anti-dilutive term.

Exercise of Warrants with Issuance of New Warrants per the Warrant Reset Offer

On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the "Reset Letter") with an investor (the "Investor") whereby the Company and the Investor agreed that the Investor would immediately exercise his warrant to purchase 853,333 shares of common stock of the Company at an exercise price of $0.20 per share for cash in the aggregate of $170,667.  In  consideration  for the Investor's  immediate  exercise,  the Company agreed to issue to the Investor three (3) new warrants in the amounts of 1,877,333, 1,066,666  and  2,346,666,  with exercise  prices of $0.20,  $0.25 and $0.25 per share,
 
 
respectively (the "Series A Warrants",  "Series B Warrants" and "Series C Warrants",  respectively,  and collectively  the "New  Warrants").  The Series A Warrants are subject to the Company's call right, and the Series C Warrants are only exercisable upon the Investor's exercise in full of the Series A Warrants. In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the "Registration Statement") with the United States Securities and Exchange Commission (the "SEC") within ten (10) business days. The Company will use its best efforts to have  the  Registration  Statement declared effective by the SEC within thirty (30) days. The Company filed a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within ten (10) business days which was declared effective by the SEC within thirty (30) days.

Issuance of Common Stock per the Settlement Agreement

On July 25, 2013, the Supreme Court of the State of New York, County of New York (the  "Court"),  entered  an order (the  "Order")  approving the settlement  (the "Settlement Agreement")  between the Company and Hanover Holdings I, LLC, a New York limited  liability company  ("Hanover"),  Hanover commenced the action against the Company on July 12, 2013 to recover $1,042,000 of past-due accounts payable of the Company, plus fees and costs (the  "Claim"). The Settlement Agreement became effective and binding upon the Company and Hanover upon execution of the Order by the Court on July 25, 2013.

On July 26, 2013, the Company issued and delivered to Hanover 7,500,000 shares (the "Initial  Settlement  Shares") of the Company's common stock,  $0.001 par value (the "Common  Stock"),  pursuant to the terms of the Settlement Agreement approved by the Order.

The Settlement  Agreement  provides that the Initial Settlement Shares will be  subject  to  adjustment  on  the  trading  day  immediately   following  the Calculation Period to reflect the  intention of the parties that the total number of shares of Common Stock to be issued to Hanover pursuant to the  Settlement  Agreement be based upon a specified  discount to the trading volume  weighted  average price (the "VWAP") of the Common Stock for a specified period of time subsequent to the Court's entry of the Order.  Specifically,  the total number of shares of Common  Stock to be issued to Hanover pursuant to the Settlement Agreement shall be equal to the sum of: (i) the quotient obtained by dividing (A) $1,042,000 (representing the total amount of the Claim), by (B) 65% of  the  average  of  the  lowest  40  VWAPs  of  the  Common   Stock  over  the 120-consecutive  trading day period  (subject to extension  under the Settlement Agreement)  immediately following the date of issuance of the Initial Settlement Shares (or such shorter  trading-day  period as may be  determined by Hanover in its  sole  discretion  by  delivery  of  written  notice  to the  Company)  (the "Calculation  Period");  (ii) the  quotient  obtained by dividing  (A)  $22,500, representing  (1)  $25,000 of  Hanover's  legal fees and  expenses  incurred  in connection  with the Action  that the  Company has agreed to pay less (2) $2,500 heretofore paid by the Company, by (B) 100% of the VWAP of the Common Stock over the Calculation  Period;  and (iii) the quotient  obtained by dividing (A) agent fees  of  $83,360,  by (B)  100%  of the  VWAP  of the  Common  Stock  over  the Calculation  Period,  rounded up to the nearest whole share (the "VWAP Shares"). As a  result,  the  Company  ultimately  may be  required  to issue  to  Hanover substantially  more shares of Common Stock than the number of Initial Settlement Shares issued  (subject to the  limitations  described  below).  The  Settlement Agreement further provides that if, at any time and from time to time during the Calculation  Period,  Hanover  reasonably  believes  that the  total  number  of Settlement  Shares  previously  issued to  Hanover  shall be less than the total number of VWAP Shares to be issued to Hanover or its designee in connection with the Settlement  Agreement,  Hanover may, in its sole discretion,  deliver one or more written  notices to the  Company,  at any time and from time to time during the Calculation Period,  requesting that a specified number of additional shares of Common  Stock  promptly be issued and  delivered  to Hanover or its  designee (subject to the  limitations  described  below),  and the Company will upon such request  reserve  and issue  the  number of  additional  shares of Common  Stock requested to be so issued and  delivered  in the notice (all of such  additional shares of  Common  Stock,  "Additional  Settlement  Shares").  At the end of the Calculation  Period,  (i) if the  number of VWAP  Shares  exceeds  the number of Initial  Settlement  Shares and Additional  Settlement  Shares issued,  then the Company will issue to Hanover or its designee  additional shares of Common Stock equal to the  difference  between  the  number of VWAP  Shares and the number of Initial  Settlement  Shares and Additional  Settlement  Shares,  and (ii) if the number of VWAP Shares is less than the number of Initial  Settlement  Shares and Additional Settlement Shares issued, then Hanover or its designee will return to the Company for cancellation  that number of shares of Common Stock equal to the difference  between  the  number  of VWAP  Shares  and  the  number  of  Initial Settlement Shares and Additional Settlement Shares.  Hanover may sell the shares of Common Stock issued to it or its designee in connection with the Settlement Agreement at any time without restriction, even during the Calculation Period.

The  Settlement  Agreement  provides  that in no event  shall the number of shares of Common Stock issued to Hanover or its designee in connection  with the Settlement Agreement, when aggregated with all other shares of Common Stock then beneficially  owned by Hanover and its  affiliates  (as  calculated  pursuant to Section 13(d) of the Securities  Exchange Act of 1934, as amended (the "Exchange Act"),  and the  rules and  regulations  thereunder),  result in the  beneficial ownership by Hanover and its affiliates (as calculated pursuant to Section 13(d) of the Exchange  Act and the rules and  regulations  thereunder)  at any time of more than 9.99% of the Common Stock.

On September 30, 2013, the Company issued and delivered to Hanover 2,000,000 Additional Settlement Shares pursuant to the terms of the Settlement Agreement approved by the Order. Since the issuance of the Initial Settlement Shares and Additional Settlement Shares described above, Hanover demonstrated to the Company's satisfaction that it was entitled to receive another 3,500,000 Additional Settlement Shares, based on the adjustment formula described above, and that the issuance of such Additional Settlement Shares to Hanover would not result in Hanover exceeding the beneficial ownership limitation set forth above. On December 13, 2013, the Company issued and delivered to Hanover another 3,500,000 Additional Settlement Shares and on January 22, 2014, the Company issued and delivered to Hanover the final 2,538,882 Additional Settlement Shares pursuant to the terms of the Settlement Agreement approved by the Order.

The Company considered the settlement of debt with common shares as an extinguishment of debt and applied extinguishment accounting accordingly.  The Company compared the trade accounts payable and related settlement costs with the fair value of common shares issued. Because the fair value of common shares issued was $561,077 greater than trade accounts payable and related settlement costs, the Company applied extinguishment accounting, resulting in a loss on extinguishment of debt of $561,077, for the reporting period ended December 31, 2013.

Warrants

Issuances of Warrants in Connection with Securities Purchase Agreement

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company's common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Issuance of Warrants to the Placement Agent as Compensation

Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS  or its  designee,  a warrant  to  purchase  85,333  shares  of  the  Company's  common  stock representing  8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Garden State Securities, Inc. (the "Placement Agent") served as the placement agent of the Company for the Warrant Reset Offering on May 6, 2013. In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,653, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company,  the  Placement  Agent will receive additional  warrants  equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the "Agent Warrants").
Note 11 - Equity

Shares Authorized

Upon formation the total number of shares of common stock which the Company is authorized to issue is One Hundred Million (100,000,000) shares, par value $0.001 per share.

Common Stock

Reverse Acquisition Transaction

Immediately prior to the Share Exchange Transaction on June 23, 2011, the Company had 79,800,000 common shares issued and outstanding. Simultaneously with the Closing of the Share Exchange Agreement, on the Closing Date, Mohanad Shurrab, a shareholder and, as of the Closing Date, the Company's former Director, President, Treasurer and Secretary, surrendered 33,000,000 shares of the Company's common stock to the Company for cancellation.

As a result of the Share Exchange Agreement, the Company issued 12,000,000 common shares for the acquisition of 100% of the issued and outstanding shares of Stevia Ventures International Ltd. Of the 12,000,000 common shares issued in connection with the Share Exchange Agreement, 6,000,000 of such shares are being held in escrow ("Escrow Shares") pending the achievement by the Company of certain post-Closing business milestones (the "Milestones"), pursuant to the terms of the Make Good Escrow Agreement, between the Company, Greenberg Traurig, LLP, as escrow agent and the Ventures' Stockholder (the "Escrow Agreement").


Make Good Agreement Shares

(i) Duration of Escrow Agreement

The Make Good Escrow Agreement shall terminate on the sooner of (i) the distribution of all escrow shares, or (ii) December 31, 2013.

(ii) Disbursement of Make Good Shares

Upon achievement of any Milestone on or before the date associated with such Milestone on Exhibit A, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such achievement (each a "COMPLETION NOTICE"). Upon the passage of any Milestone date set forth on Exhibit A for which the Company has not achieved the associated Milestone, the Company shall promptly provide written notice to the Escrow Agent and the Selling Shareholder of such failure to achieve the milestone (each a "NON-COMPLETION NOTICE").

(iii) Exhibit A - Schedule of Milestones

  Milestones    
Completion Date
   
Number of
Escrow Shares
 
               
I.
 
(1)Enter into exclusive international license agreement for all Agro Genesis intellectual property and products as it applies to stevia
(2)Enter into cooperative agreements to work with Vietnam Institutes (a) Medical Plant Institute in Hanoi; (b) Agricultural Science Institute of Northern Central Vietnam
(3)Enter into farm management agreements with local growers including the Provincial and National projects;
(4)Take over management of three existing nurseries
   
Within 180 days
of the Closing Date
   
3,000,000 shares
only if and when ALL four (4) milestones reached (*)
 
               
II.   Achieve 100 Ha field trials and first test shipment of dry leaf
   
Within two (2) years
of the Closing Date
   
1,500,000 shares (**)
 
               
III.  Test shipment of dry leaf to achieve minimum specs for contracted base price (currently $2.00 per kilogram)
   
Within two (2) years
of the Closing Date
   
1,500,000 shares (**)
 

*
On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.  These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation.

**
On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.

Common Shares Surrendered for Cancellation

On October 4, 2011, a significant stockholder of the Company, Mohanad Shurrab, surrendered another 3,000,000 shares of the Company's common stock to the Company for cancellation.  The Company recorded this transaction by debiting common stock at par of $3,000 and crediting additional paid-in capital of the same.

Common Shares Issued for Cash

On October 4, 2011 the Company sold 400,000 shares of its common stock to one investor at $0.25 per share or $100,000.
 
Common Shares Issued for Obtaining Employee and Director Services

On October 14, 2011 the Company issued 1,500,000 shares each to two (2) newly appointed members of the board of directors or 3,000,000 shares of its common stock in aggregate as compensation for future services. These shares shall vest with respect to 750,000 shares of restricted stock on each of the first two anniversaries of the date of grant, subject to the director's continuous service to the Company as directors.  These shares were valued at $0.25 per share or $750,000 on the date of grant and are being amortized over the vesting period of two (2) years or $93,750 per quarter.  The Company recorded $187,500 in directors' fees for the period from April 11, 2011 (inception) through March 31, 2012.  The Company recorded $375,000 in directors' fees for the fiscal year ended March 31, 2013.

Common Shares Issued to Parties other than Employees for Acquiring Goods or Services

Equity Purchase Agreement and Related Registration Rights Agreement

(i) Equity Purchase Agreement

On January 26, 2012, the Company entered into an equity purchase agreement ("Equity Purchase Agreement") with Southridge Partners II, LP, a Delaware limited partnership (The "Investor"). Upon the terms and subject to the conditions contained in the agreement, the Company shall issue and sell to the Investor, and the Investor shall purchase, up to Twenty Million Dollars ($20,000,000) of its common stock, par value $0.001 per share.

At any time and from time to time during the Commitment Period, the period commencing on the effective date, and ending on the earlier of (i) the date on which investor shall have purchased put shares pursuant to this agreement for an aggregate purchase price of the maximum commitment amount, or (ii) the date occurring thirty six (36) months from the date of commencement of the commitment period. the Company may exercise a put by the delivery of a put notice, the number of put shares that investor shall purchase pursuant to such put shall be determined by dividing the investment amount specified in the put notice by the purchase price with respect to such put notice. However, that the investment amount identified in the applicable put notice shall not be greater than the maximum put amount and, when taken together with any prior put notices, shall not exceed the maximum commitment The purchase price shall mean 93% of the market price on such date on which the purchase price is calculated in accordance with the terms and conditions of this Agreement.

(ii) Registration Rights Agreement

In connection with the Equity Purchase Agreement, on January 26, 2012, the Company entered into a registration rights agreement ("Registration Rights Agreement") with Southridge Partners II, LP, a Delaware limited partnership (the "Investor"). To induce the investor to execute and deliver the equity purchase agreement which the Company has agreed to issue and sell to the investor shares (the "put shares") of its common stock, par value $0.001 per share (the "common stock") from time to time for an aggregate investment price of up to twenty million dollars ($20,000,000) (the "registrable securities"), the Company has agreed to provide certain registration rights under the securities act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, "securities act"), and applicable state securities laws with respect to the registrable securities.

(iii) Common Shares Issued Upon Signing

As a condition for the execution of this agreement by the investor, the company issued to the investor 35,000 shares of restricted common stock (the "restricted shares") upon the signing of this agreement. The restricted shares shall have no registration rights.  These shares were valued at $1.50 per share or $52,500 on the date of issuance and recorded as financing cost.

Marketing Service Agreement - Empire Relations Group, Inc.

On March 14, 2012 the Company entered into a consulting agreement (the "Consulting Agreement") with Empire Relations Group, Inc. ("Empire").

(i) Scope of Services

Under the terms of the Consulting Agreement, the Company engaged Empire to introduce interested investors to the Company, advise the Company on available financing options, provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake.

(ii) Term

The term of this agreement were consummated from the date hereof, and automatically terminated on May 30, 20 12.

(iii) Compensation

For the term of this agreement, the consultant shall be paid an upfront, non-refundable, non-cancellable retainer fee of 27,500 restricted shares. For the purposes of this agreement, these shares shall be considered to be fully earned by March 31, 2012. These shares were valued at $1.39 per share or $38,225 on March 31, 2012, the date when they were earned.

Common Shares Issued in Connection with Entry into Technology Acquisition Agreement

On July 5, 2012, the Company entered into a Technology Acquisition Agreement (the "Technology Acquisition Agreement") with Technew Technology Limited ("Technew"), pursuant to which the Company acquired the rights to certain technology from Technew in exchange for 3,000,000 restricted shares of the Company's common stock. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market or $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years.

Common Shares Issued to a Related Party

On July 5, 2012, the Company issued 500,000 restricted shares of its common shares to Growers Synergy Pte Ltd., a corporation organized under the laws of the Republic of Singapore ("Singapore"), owned and controlled by George Blankenbaker, the president, director and a significant stockholder of the Company ("Growers Synergy"), as consideration for services rendered by Growers Synergy to the Company. These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration of its restricted nature and lack of liquidity and consistent trading in the market or $272,550 and included in the farm management services - related party in the consolidated statements of operations.

Sale of Equity Unit Inclusive of Common Stock and Warrants

Entry into Securities Purchase Agreement

On August 1, 2012, the Company entered into a Securities Purchase Agreement (the "SPA") with two (2) accredited institutional investors (the "Purchasers") to raise $500,000 in a private placement financing. On August 6, 2012, after the satisfaction of certain closing conditions, the Offering closed and the Company issued to the Purchasers: (i) an aggregate of 1,066,667  shares of the Company's common stock at $0.46875 per share and (ii) warrants to purchase 1,066,667 shares of the Company's common stock at an exercise price of $0.6405 expiring five (5) years from the date of issuance for a gross proceeds of $500,000.

At closing, the Company reimbursed the investor for legal fees of $12,500 and paid Garden State Securities, Inc,("GSS"), who served as placement agent for the Company in the offering, (i) cash commissions equal to 8.0% of the gross proceeds received in the equity financing or $40,000, and (ii) a warrant to purchase 85,333 shares of the Company's common stock representing 8% of the Shares sold in the Offering with an exercise price of $0.6405 per share expiring five (5) years from the date of issuance (the  "agent warrants") to GSS  or its  designee.

The units were sold at $0.46875 per unit consisting one common share and the warrant to purchase one (1) common share for gross proceeds of $500,000.  In connection with the August 6, 2012 equity unit offering the Company paid (i) GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000 and (ii) $12,500 in legal fees and resulted in a net proceeds of $447,500.

The Company intended to use the net  proceeds  from the Offering to advance the Company's  ability to execute its growth  strategy and to aid in the commercial  development  of the  recently  announced  launch  of  the  Company's majority-owned subsidiary, Stevia Technew Limited.

Entry into Registration Rights Agreement

In connection with the equity financing on August 1, 2012, the Company also entered into a registration rights agreement with the Purchasers (the "rights agreement").  The Rights Agreement requires the Company to file a registration statement (the "Registration Statement") with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company's entrance into the rights agreement (the "filing date") for the resale by the Purchasers of all of the Shares and all of the shares of common stock issuable upon exercise of the Warrants (the "registrable securities"). The Company filed the Registration Statement with the Securities and Exchange Commission (the "SEC") within thirty (30) days of the Company's entrance into the rights agreement.

The registration statement must be declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments.  If the  registration statement is not filed prior to the filing date, the Company will be required to pay certain liquidated damages, not to exceed in the aggregate 6% of the purchase price paid by the Purchasers pursuant to the SPA. The Registration Statement was declared effective by the SEC within one hundred and twenty (120) days of the closing date of the Offering subject to certain adjustments.

Warrants

Issuances of Warrants in Connection with Entry into Securities Purchase Agreement

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares, in the aggregate, of the Company's common stock to the investors with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance in connection with the sale of common shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

Issuance of Warrants to the Placement Agent as Compensation

Garden State Securities, Inc. (the "GSS") served as the placement agent of the Company for the equity financing on August 1, 2012. Per the engagement agreement signed between GSS and the Company, in consideration for services rendered as the placement agent, the Company agreed to: (i) pay GSS cash commissions equal to 8.0% of the gross proceeds received in the equity financing, or $40,000, and (ii) issue to GSS  or its  designee,  a warrant  to  purchase  85,333  shares  of  the  Company's  common  stock representing  8% of the warrants sold in the Offering) with an exercise price of $0.6405 per share subject to certain adjustments per Section 3(b) Subsequent Equity Sales of the SPA expiring five (5) years from the date of issuance (the "agent warrants"). The agent warrants also provide for the same registration rights and obligations as set forth in the Rights Agreement with respect to the Warrants and Warrant Shares. The exercise price and number of warrant shares were reset to $0.25 per share and 2,732,801 shares, respectively, due to the occurrence of the February 26, 2013 reset event.

XML 61 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Dec. 31, 2013
Document and Entity Information  
Entity Registrant Name Stevia Corp
Document Type S-1
Document Period End Date Dec. 31, 2013
Amendment Flag false
Entity Central Index Key 0001439813
Entity Filer Category Smaller Reporting Company
XML 62 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
NON-CONTROLLING INTEREST
12 Months Ended
Mar. 31, 2013
NON-CONTROLLING INTEREST  
NON-CONTROLLING INTEREST
Note 12 - Non-controlling Interest

Non-controlling interest consisted of the following:

   
Contributed
and additional
paid-in
capital
   
Earnings
and losses
   
Other
Comprehensive
Income
   
Total
non-controlling
interest
 
                         
Balance at March 31, 2012
  $ -     $ -     $ -     $ -  
                                 
Current period earnings and losses
    -       (214,082 )     -       (214,082 )
                                 
Balance at March 31, 2013
  $ -     $ (214,082 )   $ -     $ (214,082 )

XML 63 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (USD $)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
INCOME STATEMENT            
Revenues $ 388,746 $ 8,142 $ 1,893,865 $ 120,939 $ 2,168,093 $ 1,300
Cost of revenues            
Farm Produce 0 0 758,809 0 1,789,034 0
Farm expenses 4,925 66,743 318,234 66,743 94,547 523,746
Farm field lease 0 6,250 0 21,250 21,250 7,500
Farm Management Services Related Parties 60,000 60,000 180,000 652,550 712,550 180,000
Total cost of revenues 64,925 132,993 1,257,043 740,543 2,617,381 711,246
Gross margin 323,821 (124,851) 636,822 (619,604) (449,288) (709,946)
Operating expenses:            
Directors' fees 7,813 93,750 195,313 281,250 375,000 187,500
Professional fees 178,135 123,356 487,867 352,031 454,958 255,959
Research and development 71,930 0 262,810 118,669 177,169 206,191
Salary and compensation - officer 0 0 600,000 0 0 750,000
Salary and compensation - others 378 59,105 66,556 110,982 190,549 0
General and administrative expenses 133,641 69,302 387,040 204,616 412,409 113,742
Total operating expenses 391,897 345,513 1,999,586 1,067,548 1,610,085 1,513,392
Income (Loss) from operations (68,076) (470,364) (1,362,764) (1,687,152) (2,059,373) (2,223,338)
Other (income) expense:            
Change in fair value of derivative liability (40,105) (73,723) (675,949) (305,244) 74,308 0
Debt discount 63,263 0 626,446 0    
Debt settlement loss 561,077 0 561,077 0    
Excess of fair value of warrants over notes, net of OID 38,075 0 38,075 0    
Financing cost 8,000 2,807 30,000 16,125 28,625 70,500
Foreign currency transaction gain (loss) 0 1 0 1,316 1,316 0
Interest expense 75,613 10,130 123,516 40,462 86,400 29,757
Interest income         0 (44)
Other (income) expense 83,343 0 83,343 0    
Total other (income) expense 789,266 (60,785) 786,508 (247,341) 190,649 100,213
Loss before income tax provision and non-controlling interest (857,342) (409,579) (2,149,272) (1,439,811) (2,250,022) (2,323,551)
Income tax provisions 0 0 0 0 0 0
Net loss before non-controlling interest (857,342) (409,579) (2,149,272) (1,439,811) (2,250,022) (2,323,551)
Net loss attributable to the non-controlling interest (25,932) (44,978) (131,788) (97,338) (214,158) 0
Net income (loss) attributable to Stevia Corp. $ (831,410) $ (364,601) $ (2,017,484) $ (1,342,473) $ (2,035,864) $ (2,323,551)
Net loss per common share - Basic and diluted $ (0.01) $ (0.01) $ (0.03) $ (0.02) $ (0.03) $ (0.05)
Weighted average common shares outstanding - basic and diluted 79,632,959 63,225,253 72,842,975 61,613,572 62,092,487 45,093,271
XML 64 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
ACQUIRED TECHNOLOGY
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]    
ACQUIRED TECHNOLOGY
Note 6 - Acquired Technology

On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company's common stock.  These restricted shares were valued at $0.79 per share, discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market, for a total value of $1,635,300, which was recorded as acquired technology and is being amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years.

(i)  Amortization Expense

Amortization expense was $81,765 and $54,510 for the interim period ended December 31, 2013 and 2012, respectively.

Note 6 - Acquired Technology

On July 5, 2012, the Company acquired the rights to certain technology from Technew Technology Limited in exchange for 3,000,000 restricted shares of the Company's common stock.  These restricted shares were valued at $0.79 per share discounted at 69% taking into consideration its restricted nature and lack of liquidity and consistent trading in the market for a total value of $1,635,300, which was recorded as acquired technology and amortized on a straight-line basis over the acquired technology's estimated useful life of fifteen (15) years.

 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Technology right
15
 
$
1,635,300
   
$
-
 
               
Less accumulated amortization
     
(81,765
)
   
(-
)
               
     
$
1,553,535
   
$
-
 

Amortization Expense

Amortization expense for the fiscal year ended March 31, 2013 was $81,765.
XML 65 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
PROPERTY AND EQUIPMENT
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Property Plant and Equipment [Abstract]    
PROPERTY AND EQUIPMENT
Note 5 - Property and Equipment

(i)  Depreciation Expense

Depreciation expense was $3,100 and $762 for the interim period ended December 31, 2013 and 2012, respectively.

Note 5 - Property and Equipment

Property and equipment, stated at cost, less accumulated depreciation consisted of the following:

 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Property and equipment
5
 
7,925
   
$
3,036
 
               
Less accumulated depreciation
     
(1,234
)
   
(-
)
               
     
6,691
   
$
3,036
 

Depreciation Expense

The Company acquired furniture and fixture near the end of February 2012 and started to depreciate as of April 1, 2012. Depreciation expense for the fiscal year ended March 31, 2013 was $1,234.
XML 66 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
SUBSEQUENT EVENTS
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
SUBSEQUENT EVENTS    
SUBSEQUENT EVENTS
Note 15 - Subsequent Events

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.  The Management of the Company determined that there were certain reportable subsequent event(s) to be disclosed as follows:

On January 21, 2014 and February 4, 2014, a convertible note holder converted part of the accrued interest through the date of conversion of $23,400 and $26,325, respectively, at $0.0585 per share to 400,000 and 450, 000 shares of the Company's common stock, respectively.

On February 7, 2014, the Company issued a convertible note in the principal amount of $80,000 convertible at $0.10 per share with interest at 8%, per annum, maturing one year from the date of issuance on February 7, 2015. In connection with the issuance of the convertible note,the Company issued the note holder a warrant to purchase 1,000,000 common shares at an exercise price of $0.10 per share with full reset features, expiring five (5) years from the date of issuance.

On February 13, 2014, one investor exercised warrants to purchase 1,877,333 shares of the Company's common stock with an exercise price of $0.0585 per share for $109,824 in cash.

Entry into Service Agreement

On January 27, 2014, the Company entered into a Farm Management and Technology Agreement (the "Agreement") with Ebbu LLC ("Ebbu"), that is developing proprietary marijuana farming and extraction technologies. Under the terms of the Agreement, Ebbu wishes to engage the Company to provide technical support for farm management operations and extraction for both cash and assignable warrants. The scope of work and exact compensation is still under negotiation and will be completed by the end of next week.
Note 16 - Subsequent Events

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported.  The Management of the Company determined that there were certain reportable subsequent events to be disclosed as follows:

On April 30, 2013, the Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation ("Mountain Sky"), in partial consideration for consulting services rendered by Mountain Sky.  500,000 of the shares vested at the time of grant, and 500,000 will vest on the one year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.

On May 3, 2013, the Company entered into a Warrant Exercise Reset Offer Letter Agreement (the "Reset Letter") with an investor (the  "Investor")  whereby the Company and the Investor agreed that the Investor would immediately exercise his warrant to purchase 853,333  shares of common stock of the Company at an exercise price of $0.20 per share for the aggregate of $170,667.  In  consideration  for the Investor's  immediate  exercise,  the Company agreed to issue to the Investor three new warrants in the amounts of 1,877,333, 1,066,666  and  2,346,666,  with exercise  prices of $0.20,  $0.25 and $0.25 per share, respectively (the "Series A Warrants",  "Series B Warrants" and "Series C Warrants",  respectively,  and collectively  the "New  Warrants").  The Series A Warrants are subject to the Company's call right, and the Series C Warrants are only exercisable upon the Investor's exercise in full of the Series A Warrants. In connection with the Reset Letter, the Company agreed to use its best efforts to file a registration statement (the "Registration Statement") with the Securities  and Exchange  Commission  (the "SEC") within ten (10) business days. The Company will  use its best  efforts  to have  the  Registration  Statement declared effective by the SEC within thirty (30) days. The Company filed a registration statement (the "Registration Statement") with the Securities  and Exchange  Commission  (the "SEC") within ten (10) business days which was declared effective by the SEC within thirty (30) days.

Garden State Securities, Inc. (the "Placement  Agent")  served  as the placement agent of the Company for the Offering.  In consideration for services rendered as the Placement Agent, the Company agreed to: (i) pay to the Placement Agent cash commissions equal to $13,600, (ii) warrants equal to eight percent (8%) of the aggregate number of shares exercised by the Investor, and (iii) upon exercise of the New Warrants by the Company,  the  Placement  Agent will receive additional  warrants  equal to eight percent (8%) of the number of shares issued upon exercise of the New Warrants (collectively, the "Agent Warrants").

On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned by Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.

XML 67 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESEARCH AND DEVELOPMENT
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
RESEARCH AND DEVELOPMENT [Abstract]    
RESEARCH AND DEVELOPMENT
Note 13 - Research and Development

Lease of Agricultural Land

On December 14, 2011, the Company and Stevia Ventures Corporation ("Stevia Ventures") entered into a Land Lease Agreement with Vinh Phuc Province People's Committee Tam Dao Agriculture & Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the "Leased Property") for a term expiring five (5) years from the date of signing expiring December 14, 2016.

The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement.

Future minimum payments required under this agreement at December 31, 2013 were as follows:

Fiscal Year Ending March 31:
       
         
2014 (remainder of the year)
 
$
7,500
 
2015
   
30,000
 
2016
   
30,000
 
       
   
$
67,500
 

Supply and Cooperative Agreement - Guangzhou Health Technology Development Company Limited

Entry into Supply Agreement

On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People's Republic of China (the "Guangzhou Health").

Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years.

Entry into Cooperative Agreement

On February 21, 2012, the Company also entered into Cooperative Agreement (the "Cooperative Agreement") with Guangzhou Health Technology Development Company Limited.

Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company's business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing.

Note 13 - Research and Development

Agribusiness Development Agreement - Agro Genesis Pte Ltd.

Entry into Agribusiness Development Agreement

On July 16, 2011, the Company entered into an Agribusiness Development Agreement (the "Agribusiness Development Agreement") with Agro Genesis Pte Ltd. ("AGPL"), a corporation organized under the laws of the Republic of Singapore expiring two (2) years from the date of signing.

Under the terms of the Agreement, the Company engaged AGPL to be the Company's technology provider consultant for stevia propagation and cultivation in Vietnam, and potentially other countries for a period of two (2) years. AGPL will be tasked with developing stevia propagation and cultivation technology in Vietnam, recommend quality agronomic programs for stevia cultivation, harvest and post harvest, alert findings on stevia propagation and cultivation that may impact profitability and develop a successful model in Vietnam that can be replicated elsewhere (the "Project"). The Project will be on-site at stevia fields in Vietnam and will have a term of at least two (2) years. For its services, AGPL could receive a fee of up to 275,000 Singapore dollars, plus related expenses estimated at $274,000 as specified in Appendix A to the Agribusiness Development Agreement. Additionally, the Company will be AGPL's exclusive distributor
 
for AGPL's g'farm system (a novel crop production system) for stevia growing resulting from the Project. AGPL will receive a commission of no less than 2% of the price paid for crops other than stevia, from cropping systems that utilize the g'farm system resulting from the Project. All technology-related patents resulting from the Project will be jointly owned by AGPL and the Company, with the Company holding a right of first offer for the use and distribution rights to registered patents resulting from the Project.

Addendum to Agribusiness Development Agreement

On August 26, 2011, in accordance with Appendix A , 3(a), the Company and AGPL have mutually agreed to add to the current Project budget $100,000 per annum for one, on-site resident AGPL expert for 2 (two) years effective September 1, 2011, or $200,000 in aggregate for the term of the contract as specified in Appendix C.  In-country accommodation for the resident expert will be born separately by the Company and is excluded from the above amount.  The expert, Dr. Cho, Young-Cheol, Director, Life Sciences has been appointed and commenced on September 1, 2011.

Termination of Agribusiness Development Agreement

On March 31, 2012, the Company and AGPL mutually agreed to terminate the Agribusiness Development Agreement, effective immediately.

Lease of Agricultural Land

On December 14, 2011, the Company and Stevia Ventures Corporation ("Stevia Ventures") entered into a Land Lease Agreement with Vinh Phuc Province People's Committee Tam Dao Agriculture & Industry Co., Ltd. pursuant to which Stevia Ventures has leased l0 hectares of land (the "Leased Property") for a term expiring five (5) years from the date of signing.

The Company has begun development of a research facility on the Leased Property and has prepaid (i) the first year lease payment of $30,000 and (ii) the six month lease payment of $15,000 as security deposit, or $45,000 in aggregate upon signing of the agreement.

Future minimum payments required under this agreement at March 31, 2013 were as follows:

Fiscal Year Ending March 31:
       
         
2014
 
$
30,000
 
         
2015
   
30,000
 
         
2016
   
30,000
 
       
   
$
90,000
 

Supply and Cooperative Agreement - Guangzhou Health Technology Development Company Limited

Entry into Supply Agreement

On February 21, 2012, the Company entered into a Supply Agreement (the "Supply Agreement") with Guangzhou Health China Technology Development Company Limited, a foreign-invested limited liability company incorporated in the People's Republic of China (the "Guangzhou Health").

Under the terms of the Supply Agreement, the Company will sell dry stevia plant materials, including stems and leaves ("Product") exclusively to Guangzhou Health. For the first two years of the agreement, Guangzhou Health will purchase all Product produced by the Company. Starting with the third year of the agreement, the Company and Guangzhou Health will review and agree on the quantity of Product to be supplied in the forthcoming year, and Guangzhou Health will be obliged to purchase up to 130 percent of that amount. The specifications and price of Product will also be revised annually according to the mutual agreement of the parties. The term of the Supply Agreement is five years with an option to renew for an additional four years.

Entry into Cooperative Agreement

On February 21, 2012, the Company also entered into Cooperative Agreement (the "Cooperative Agreement") with Guangzhou Health Technology Development Company Limited.

 
Under the terms of the Cooperative Agreement, the parties agree to explore potential technology partnerships with the intent of formalizing a joint venture to pursue the most promising technologies and businesses. The parties also agree to conduct trials to test the efficacy of certain technologies as applied specifically to the Company's business model as well as the marketability of harvests produced utilizing such technologies. Guangzhou Health will share all available information of its business structure and technologies with the Company, subject to the confidentiality provisions of the Cooperative Agreement. Guangzhou Health will also permit the Company to enter its premises and grow-out sites for purposes of inspection and will, as reasonably requested by the Company, supply without cost, random samples of products and harvests for testing.

XML 68 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE NOTES PAYABLE
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
CONVERTIBLE NOTES PAYABLE    
CONVERTIBLE NOTES PAYABLE
Note 9 - Convertible Notes Payable

(i) February 26, 2013 issuance of convertible notes with warrants

On February 26, 2013, the Company entered into two (2) 12% convertible notes payable of $350,000 in aggregate ("Convertible Notes") with two investors (the "Payees") maturing on September 30, 2013. The Payees have the option to convert the outstanding notes and interest due into the Company's common shares at $0.25 per share at any time prior to September 30, 2013. In connection with the issuance of the Convertible Notes, the Company granted to the Payees a warrant to purchase 1,400,000 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance. The notes were currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.

The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
Expected volatility
   
74.53
%
Risk-free interest rate
   
0.37
%
Dividend yield
   
0.00
%

The relative fair value of these warrants granted, estimated on the date of grant, was $110,425, which was recorded as a discount to the convertible notes payable. After allocating the $110,425 portion of the proceeds to the warrants as a discount to the Convertible Notes, an additional $113,925 was allocated to a beneficial conversion feature by crediting $113,925 to additional paid-in capital and debiting the same amount to the beneficial conversion feature.  The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Notes. The amortization of the discount and beneficial conversion feature were fully amortized as of September 30, 2013.

(ii) March 15, 2013 issuance of convertible note with warrant

On March 15, 2013, the Company cancelled a prior convertible note and entered into a 12% convertible note payable of $220,438, which is the total amount of the prior note principal and accrued interest, with the existing investor (the "Payee"), maturing on September 30, 2013. The Payee has the option to convert the outstanding note into the Company's common shares at $0.25 per share at any time prior to payment in full of the principal balance of the convertible note. In connection with the issuance of the convertible note, the Company granted the Payee a warrant to purchase 881,753 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance. The note is currently past due with no penalty and the Company continues to accrue the interest at 12% per annum.

The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
Expected volatility
   
75.11
%
Risk-free interest rate
   
0.40
%
Dividend yield
   
0.00
%

 

The relative fair value of these warrants was $98,095, which was recorded as a discount to the convertible note payable. After allocating the $98,095, portion of the proceeds to the warrants as a discount to the convertible note, the effective conversion price of the convertible notes payable was lower than the market price at the date of issuance and per calculation the remaining balance of the face amount was allocated to a beneficial conversion feature by crediting $122,343 to additional paid-in capital and debiting the same amount to the beneficial conversion feature. The Company amortizes the discount and beneficial conversion feature over the term of the convertible note and the amounts were fully amortized as of September 30, 2013.

(iii) October 15, 2013 issuance of convertible note with derivative warrant

General Terms

On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company. The restricted shares will be issued in the name of Black Mountain Equities, Inc. upon closing.

Events of Defaults

An "Event of Default", wherever used herein, means any one of the following events: (i) An "Event of Default", wherever used herein, means any one of the following events, (ii) A Conversion Failure; (iii) The Company or any subsidiary of the Company shall commence, or there shall be commenced against the Company or any subsidiary of the Company under any applicable bankruptcy or insolvency laws; (iv) (a) The Company or any subsidiary of the Company shall default in any of its obligations under any other indebtness in an amount exceeding $100,000, whether such indebtedness now exists or shall hereafter be created and (b) The Common Stock is suspended or delisted for trading on the Over the Counter Bulletin Board market (the "Primary Market"), (c) The Company loses its ability to deliver shares via "DWAC/FAST" electronic transfer, (d) The Company loses its status as "DTC Eligible.", (e) The Company shall become late or delinquent in its filing requirements as a fully-reporting issuer registered with the Securities & Exchange Commission.

Piggyback Registration Rights

The Company shall include on the next registration statement the Company files with SEC (or on the subsequent registration statement if such registration statement is withdrawn) all shares issuable upon conversion of this Note. Failure to do so will result in liquidated damages of 25% of the outstanding principal balance of this Note, but not less than $25,000, being immediately due and payable to the Holder at its election in the form of cash payment or addition to the balance of this Note.

Warrants

In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.

Pursuant to Section 3 (b) Subsequent Equity Sales if the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell or grant any option to purchase, or sell or grant any right to re-price, or otherwise dispose of or issue (or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents entitling any Person to acquire shares of Common Stock, at an effective price per share less than the then Exercise Price (such lower price, the "Base Share Price" and such issuances collectively, a "Dilutive Issuance") (if the holder of the Common Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance, be entitled to receive shares of Common Stock at an effective price per share which is less than the Exercise Price, such issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance), then the Exercise Price shall be reduced and only reduced to equal the Base Share Price and the number of Warrant Shares issuable hereunder shall be increased such that the aggregate Exercise Price payable hereunder, after taking into account the decrease in the Exercise Price, shall be equal to the aggregate Exercise Price prior to such adjustment.

Pursuant to Section 3 (c) Subsequent Rights Offerings if the Company, at any time while the Warrant is outstanding, shall issue rights, options or warrants to all holders of Common Stock (and not to Holders) entitling them to subscribe for or purchase shares of Common Stock at a price per share less than the VWAP at the record date, then the Exercise Price shall be multiplied by a fraction, of which the denominator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of additional shares of Common Stock offered for subscription or purchase, and of which the numerator shall be the number of shares of the Common Stock outstanding on the date of issuance of such rights or warrants plus the number of shares which the aggregate offering price of the total number of shares so offered (assuming receipt by the Company in full of all consideration payable upon exercise of such rights, options or warrants) would purchase at such VWAP.

The fair value of note derivative liability and the warrant liability were $11,428 and $76,647, respectively, or $88,075 in aggregate; $50,000 of which was recorded as a discount to the convertible note and the $38,075 remaining balance was recorded as other expense. The Company amortizes OID and the discount to the note over the term of the convertible note and marks to market the warrant value as of each quarter end.

Convertible notes payable consisted of the following:

   
December 31, 2013
   
March 31, 2013
 
On May 30, 2012, the Company issued a convertible note in the principal amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the unpaid principal of this note and any accrued and unpaid interest thereon, as of the Conversion Date, at the lower of (a) the price per share at which shares of capital stock issued in the Financing are sold in the Financing, or (b) the closing price of the Company's securities if traded on a securities exchange, or if actively traded over-the-counter, the average closing bid price for the securi1ies, in each case over the thirty (30) day period prior to the Conversion Date; provided however, that if no active trading market for the securities exists at the time of the conversion, such amount shall be the fair market value of a share of the Company's common stock as determined in good faith by Company's Board of Directors. A "Financing" means the closing of the sale of shares of capital stock of the Company in the first equity financing transaction after the date first set forth above, in which the Company receives gross proceeds of at least $100,000, excluding conversion of this Note. The note is currently past due with no penalty and the Company continues to accrue the interest at 10% per annum.
    200,000       200,000  
                 
February 26, 2013 convertible notes
    350,000       350,000  
                 
March 15, 2013 convertible note
    220,438       220,438  
                 
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    111,111       -  
                 
On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014.
    153,500       -  
                 
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    27,778       -  
                 
On October 15, 2013, the Company issued a convertible note in the principal amount of $58,000 convertible at $0.20 per share, with an $8,000 Original Issue Discount ("OID") and interest at 10% per annum maturing on May 1, 2014. The Debenture is secured by 1,250,000 restricted common shares of the Company.  In connection with the issuance of the convertible note, the Company granted the note holder a warrant to purchase 1,000,000 common shares with an exercise price of $0.25 per share, subject to certain adjustments pursuant to Section 3(b) Subsequent Equity Sales and Section 3(c) Subsequent Rights Offerings of the warrant ("full price and share reset provisions") expiring five (5) years from the date of issuance.
    58,000       -  
 
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014.
    53,000       -  
                 
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date .
    55,556       -  
                 
Sub-total: convertible notes payable
    1,229,383       770,438  
                 
Discount representing (i) the relative fair value of the warrants issued, (ii) the beneficial conversion features and (iii) the derivative liability on conversion features
    (816,310 )     (444,788 )
                 
Accumulated amortization of discount on convertible notes payable
    658,496       32,050  
                 
Remaining discount
    (157,814 )     (412,738 )
                 
    $ 1,071,569     $ 357,770  

Note 9 - Convertible Notes Payable

On February 14, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,890.41 at $0.25 per share to 1,000,000 shares and 63,561 shares of the Company's common stock, respectively.

On June 23, 2011, the Company issued a convertible note in the amount of $100,000 with interest at 10% per annum due one (1) year from the date of issuance. On October 4, 2011, the note holder converted the entire principal of $100,000 and accrued interest through the date of conversion of $2,821.92 at $0.25 per share to 400,000 shares and 11,288 shares of the Company's common stock.

On October 4, 2011, the Company issued a convertible note in the amount of $150,000 with interest at 10% per annum due one (1) year from the date of issuance.  On January 18, 2012, the note holder converted the entire principal of $150,000 and accrued interest through the date of conversion of $4,356 at $0.25 per share to 617,425 shares of the Company's common stock.

(i) February 26, 2013 issuance of convertible notes with warrants

On February 26, 2013, the Company entered into two (2) 12% convertible notes payable of $350,000 in aggregate ("Convertible Notes") with two investors (the "Payees") maturing on September 30, 2013. The Payees have the option to convert the outstanding notes and interest due into the Company's common shares at $0.25 per share at any time prior to September 30, 2013. In connection with the issuance of the Convertible Notes, the Company granted to the Payees a warrant to purchase 1,400,000 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance.

The Company estimated the relative fair value of these warrants on the date of grant, using the Black-Scholes option-pricing model with the following weighted-average assumptions:


Expected option life (year)
   
3.00
 
         
Expected volatility
   
74.53
%
         
Risk-free interest rate
   
0.37
%
         
Dividend yield
   
0.00
%
       

The relative fair value of these warrants granted, estimated on the date of grant, was $110,425 in aggregate, which was recorded as a discount to the convertible notes payable. After allocating the $110,425 portion of the proceeds to the warrants as a discount to the Convertible Note, an additional $113,925 was allocated to a beneficial conversion feature by crediting additional $113,925 to additional paid-in capital and debiting the same amount to the beneficial conversion feature.  The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Notes. The amortization of the discount and beneficial conversion feature amounted to $32,050 for the fiscal year ended March 31, 2013.

(ii) March 15, 2013 issuance of convertible note with warrant

On March 15, 2013, the Company cancelled a prior convertible note and entered into a 12% convertible note payable of $220,438, which is the total amount of the prior note principal and accrued interest, with the existing investor (the "Payee"), maturing on September 30, 2013. The Payee has the option to convert the outstanding note into the Company's common shares at $0.25 per share at any time prior to payment in full of the principal balance of the Convertible Note. In connection with the issuance of the Convertible Note, the Company granted the Payee a warrant to purchase 881,753 common shares exercisable at $0.25 per share expiring three (3) years from the date of issuance.

The Company estimated the relative fair value of these warrants on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Expected option life (year)
   
3.00
 
         
Expected volatility
   
75.11
%
         
Risk-free interest rate
   
0.40
%
         
Dividend yield
   
0.00
%
       

The relative fair value of these warrants was $98,095, which was recorded as a discount to the convertible note payable. After allocating the $98,095, portion of the proceeds to the warrants as a discount to the Convertible Note, the effective conversion price of the convertible notes payable was lower than the market price at the date of issuance and per calculation the remaining balance of the face amount was allocated to a beneficial conversion feature by crediting $122,343 to additional paid-in capital and debiting the same amount to the beneficial conversion feature. The Company amortizes the discount and beneficial conversion feature over the term of the Convertible Note and began to amortize the amount from April 1, 2013.

Convertible notes payable consisted of the following:

 
 
   
 
   
   
March 31, 2013
   
March 31, 2012
 
             
On November 16, 2011, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.  On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $15,959 to 319,607 shares of the Company's common stock at $0.83 per share.
-
 
250,000
 
             
On January 16, 2012, the Company issued a convertible note in the amount of $250,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the private placement price on a per share basis provided the Company completes a private placement with gross proceeds of at least $100,000.  On July 6, 2012, the note holder converted the entire principal of $250,000 and accrued interest through the date of conversion of $11,781 to 314,586 shares of the Company's common stock at $0.83 per share.
 
-
   
250,000
 
 
 
On March 7, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000. On March 15, 2013, the above note was cancelled and reissued with a new convertible note consisting of the prior principal amount and all the accrued unpaid interest for a total amount of $220,438 with interest at 12% per annum due on September 30, 2013 with the conversion price $0.25 per share
 
220,438
   
200,000
 
             
On May 30, 2012, the Company issued a convertible note in the amount of $200,000 with interest at 10% per annum due one (1) year from the date of issuance with the conversion price to be the same as the next private placement price on a per share basis provided that the Company completes a private placement with gross proceeds of at least $100,000. On August 6, 2012, the Company completed the very next private placement at $0.46875 per share with gross proceeds of at least $100,000.
 
200,000
   
-
 
             
On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company's common stock.
 
350,000
   
-
 
             
Sub-total: convertible notes payable
 
770,438
   
700,000
 
             
Discount representing (i) the relative fair value of the warrants issued and (ii) the beneficial conversion features
 
(444,788
)
 
-
 
             
Accumulated amortization of discount on convertible notes payable
 
32,050
   
-
 
             
Remaining discount
 
(412,738
)
 
-
 
             
 
$
357,770
 
$
700,000
 

XML 69 R60.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMON SHARES ISSUED FOR SERVICES (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Jan. 26, 2012
Oct. 14, 2011
COMMON SHARES ISSUED FOR OBTAINING EMPLOYEE AND DIRECTOR SERVICES        
Common shares issued to two new members of BOD       1,500,000
Common stock in aggregate as compensation for future services       3,000,000
Restricted stock shares       750,000
Stock price value       $ 0.25
Amortized value over the vesting period       $ 750,000
Amortized value over per quarter       93,750
Common shares value to issue and sell     20,000,000  
Commons shares par value     $ 0.001  
Restricted common stock issued 35,000   35,000  
Share value $ 1.50   $ 1.50  
Financing costs 52,500   52,500  
Restricted shares for non cancellable retainer fee 27,500 27,500    
Share par value $ 1.39 $ 1.39    
Shares value $ 38,225 $ 38,225    
XML 70 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
WEBSITE DEVELOPMENT COSTS
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Website Development Costs [Abstract]    
WEBSITE DEVELOPMENT COSTS
Note 7 - Website Development Costs

(i)  Amortization expense

Amortization expense was $801 each for the interim period ended December 31, 2013 and 2012, respectively.
 
Note 7 - Website Development Costs

Website development costs, stated at cost, less accumulated amortization consisted of the following:


 
Estimated Useful Life (Years)
 
March 31, 2013
   
March 31, 2012
 
                   
Website development costs
5
 
5,315
   
$
5,315
 
               
Accumulated amortization
     
(1,869
)
   
(801
)
               
     
3,446
   
$
4,514
 

Amortization expense

Amortization expense was $1,068 and $801 for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through December 31, 2012, respectively.
XML 71 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
RELATED PARTY TRANSACTIONS
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
RELATED PARTY TRANSACTIONS    
RELATED PARTY TRANSACTIONS
Note 8 - Related Party Transactions

Related parties

Related parties with whom the Company had transactions are:
 
Related Parties
 
Relationship
     
George Blankenbaker
 
President and significant stockholder of the Company
     
Leverage Investments LLC
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Technew Technology Limited
 
Non-controlling interest holder
 
Growers  Synergy Pte Ltd.
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Guangzhou Health Technology Development Company Limited
 
An entity owned and controlled by Non-controlling interest holder
 
Advances from Stockholder

From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.

Lease of Certain Office Space from Leverage Investments, LLC

The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011.  For the interim periods ended December 31, 2013 and 2012, the Company recorded $4,500 each in rent expense, respectively.

Farm Management and Off-Take Agreement with Growers Synergy Pte Ltd.

On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a Singapore corporation.  Under the terms of the Management Agreement,  the Company will engage GSPL to supervise the Company's farm management operations, recommend quality farm management  programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization  targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services at $20,000 per month for a term of two (2) years from the date of signing expiring on November 1, 2013.  The Management Agreement may be terminated by the Company upon 30 day notice.  In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company's GSPL supervised farms.

On October 31, 2013 ("Effective Date"), the Company extended the Management and Off-Take Agreement (the "Management Agreement") with GSPL with the same terms and conditions for a period of two (2) years ("Term") from the Effective Date expiring October 31, 2015 and shall automatically be extended for subsequent period of one (1) year expiring October 31, 2016 ("Extended Term") unless earlier terminated in writing.

Farm management services provided by Growers Synergy Pte Ltd. were as follows:

   
For the interim
period ended
December 31, 2013
   
For the interim
period ended
December 31, 2012
 
                 
Farm management services - related parties
 
$
180,000
   
$
180,000
 
             
   
$
180,000
   
$
180,000
 

Future minimum payments required under this agreement were as follows:

Fiscal Year Ending March 31:
       
         
2014 (remainder of the fiscal year)
 
$
240,000
 
2015
   
240,000
 
2016
   
240,000
 
2017
   
140,000
 
       
   
$
860,000
 
 
Cash Commitment in Connection with the Operations of Stevia Technew

For the fiscal year ended March 31, 2013, Stevia Asia provided Stevia Technew $200,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related parties. On March 1, 2013, the partners agreed to terminate the Cooperative Agreement specific to the investment in an agricultural project and no further obligation by either party related to the payment of $200,000.
Note 8 - Related Party Transactions

Related parties

Related parties with whom the Company had transactions are:

Related Parties
 
Relationship
     
George Blankenbaker
 
President and significant stockholder of the Company
     
Leverage Investments LLC
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Technew Technology Limited
 
Non-controlling interest holder
     
Growers  Synergy Pte Ltd.
 
An entity owned and controlled by the president and significant stockholder of the Company
     
Guangzhou Health Technology Development Company Limited
 
An entity owned and controlled by Non-controlling interest holder

Advances from Stockholder

From time to time, stockholder of the Company advances funds to the Company for working capital purpose. Those advances are unsecured, non-interest bearing and due on demand.

Lease of Certain Office Space from Leverage Investments, LLC

The Company leases certain office space with Leverage Investments, LLC for $500 per month on a month-to-month basis since July 1, 2011.  For the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through December 31, 2012, the Company recorded $6,000 and $4,500 in rent expenses due Leverage Investment LLC, respectively.

Farm Management and Off-Take Agreement with Growers Synergy Pte Ltd.

For the period from July 1, 2011 through October 31, 2011, the Company engaged Growers Synergy Pte Ltd. to provide farm management services on a month-to-month basis, at $20,000 per month.

On November 1, 2011, the Company entered into a Management and Off-Take Agreement (the "Management Agreement") with Growers Synergy Pte Ltd. ("GSPL"), a Singapore corporation owned and controlled by the president and major stockholder of the Company.  Under the terms of the Management Agreement,  the Company will engage GSPL to supervise the Company's farm management operations, recommend quality farm management  programs for stevia cultivation, assist in the hiring of employees and provide training to help the Company meet its commercialization  targets, develop successful models to propagate future agribusiness services, and provide back-office and regional logistical support for the development of proprietary stevia farm systems in Vietnam, Indonesia and potentially other countries. GSPL will provide services for a term of two (2) years from the date of signing, at $20,000 per month.  The Management Agreement may be terminated by the Company upon 30 day notice.  In connection with the Management Agreement, the parties agreed to enter into an off-take agreement whereby GSPL agreed to purchase all of the non-stevia crops produced at the Company's GSPL supervised farms.

Farm management services provided by Growers Synergy Pte Ltd. is as follows:

   
For the Fiscal Year
Ended
March 31, 2013
   
For the Period from
April 11, 2011 (inception)
through
March 31, 2012
 
                 
Farm management services - related parties
 
$
240,000
   
$
180,000
 
             
   
$
240,000
   
$
180,000
 

Future minimum payments required under this agreement were as follows:

Fiscal Year Ending March 31:
       
         
2014
 
$
140,000
 
       
   
$
140,000
 

Cash Commitment in Connection with the Operations of Stevia Technew

On July 5, 2012, Stevia Asia, entered into a Cooperative Agreement (the "Cooperative Agreement") with Technew Technology Limited ("Technew"), a company incorporated under the companies ordinance of Hong Kong and an associate of Guangzhou Health China Technology Development Company Limited, and Zhang Jia, a Chinese citizen (together with Technew, the "Partners") pursuant to which Stevia Asia and Partners have agreed to make Stevia Technew, a joint venture, of which Stevia Asia legally and beneficially owns 70% shares (representing 70% of the issued shares) and Technew legally and beneficially owns 30% shares (representing 30% of the of the issued shares). The Partners will be responsible for managing Stevia Technew and Stevia Asia has agreed to provide $200,000 per month, up to a total of $2,000,000 in financing, subject to the performance of Stevia Technew and Stevia Asia's financial capabilities.

For the fiscal year ended March 31, 2013, Stevia Asia provided Stevia Technew $230,000, all of which has been paid to Guangzhou Health and expended and recorded as farm management services - related parties.

XML 72 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Derivative Instruments And Hedging Activities [Abstract]    
DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS
Note 10 - Derivative Instruments and the Fair Value of Financial Instruments

(i) Warrants Issued

Description of Warrants and Fair Value on Date of Grant

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants")with an exercise price of $0.6405 per share, subject to certain adjustments, pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance.

On February 26, 2013 and March 15, 2013 the Company issued warrants with an exercise price of $0.25 per share. Pursuant to Section 3(b), the previously issued warrants' exercise price was reset to $0.25 per share and the number of warrant shares was increased to 2,732,801 and 218,623, respectively, for a total of 2,951,424.

On May 6, 2013, the Company issued warrants with an exercise price of $0.25 per share. Pursuant to Section 3(b), the previously issued warrants' exercise price was reset again to $0.20 per share and the number of warrant shares was increased to 3,416,001 and 273,279, respectively, for a total of 3,689,280. On May 6, 2013, investors exercised warrants to purchase 2,732,799 (out of 3,416,001) shares of the Company's common stock at $0.20 per share.

On May 6, 2013, the Company issued (i) warrants to purchase 1,877,333 (Series A), 1,066,667 (Series B) and 2,346,666 (Series C), in aggregate 5,290,665 shares of the Company's common stock to the investors (the "investor warrants") and (ii) warrants to purchase 150,187 (Series A), 85,333 (Series B) and 187,733 (Series C) shares of the Company's  common  stock to the placement agent (the "agent warrants")with an exercise price of $0.20 (Series A) per share, $0.25 (Series B) per share and $0.25 (Series C) per share subject to certain adjustments, pursuant to Section 3(b), expiring five (5) years from the date of issuance.

On October 15, 2013, the Company issued a warrant to purchase 1,000,000 common shares with an exercise price at $0.25 per share with full ratchet reset features expiring five (5) years from the date of issuance in connection with the issuance of a convertible note.

Derivative Analysis

Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification ("Section 815-40-15").
 
Valuation of Derivative Liability

(a)  Valuation Methodology

The Company's August 6, 2012 and May 6, 2013 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset.

Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections.

Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability.

(b)  Valuation Assumptions

The Company's 2013 derivative warrants were valued at each period ending date with the following assumptions:

·  
The stock price would fluctuate with the Company projected volatility.

·  
The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods.

·  
The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price.

·  
The Holder would exercise the warrant at maturity if the stock price was above the project reset prices.

·  
A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market

·  
The Warrants with an exercise price of $0.25 exercise price is projected to reset to $0.047 at maturity; the Warrants with an exercise price of  $0.20 per share  is projected to reset to $0.043at maturity

·  
The Company had no reset event during this quarter period ending 12/31/2013. Prior reset events occurred on 2/26/2013 to $0.25 and 5/6/2013 to $0.20.

·  
No warrants have expired. Warrants with full reset feature issued during this quarter period ending 12/31/2013

·  
The projected volatility curve for the valuation dates was:

     
1 Year
   
2 Year
   
3 Year
   
4 Year
   
5 Year
 
                                 
August 6, 2012
   
129%
   
178%
   
218%
   
252%
   
281%
 
September 30, 2012
   
127%
   
173%
   
211%
   
244%
   
272%
 
March 31, 2013
   
122%
   
167%
   
205%
   
236%
   
264%
 
December 31, 2013
   
111%
   
168%
   
202%
   
233%
   
261%
 

 
(c)  Fair Value of Derivative Warrants

The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 (reset to 6,247,146 on May 1, 2013) shares of the Company's common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).

 
Derivative warrants
Assets (Liability)
 
Total
       
Balance, September 30, 2012
 
$
(180,284
)
   
$
(180,284
)
Total gains or losses (realized/unrealized) included in:
                 
Net income (loss)
   
(305,829
)
     
(305,829
)
Other comprehensive income (loss)
   
-
       
-
 
Purchases, issuances and settlements
   
-
       
-
 
Transfers in and/or out of Level 3
   
-
       
-
 
                   
Balance, March 31, 2013
   
(486,113
)
     
(486,113
)
Total gains or losses (realized/unrealized) included in:
                 
Net income (loss)
   
675,949
       
675,949
 
Other comprehensive income (loss)
   
-
       
-
 
Purchases, issuances and settlements
   
(787,355
)
     
(787,355
)
Transfers in and/or out of Level 3
   
-
       
-
 
                   
Balance, December 31, 2013
 
$
(597,519
)
   
$
(597,519
)

(d)  Warrants Outstanding

As of December 31, 2013, 853,333 warrants (2,732,799 warrants after the exercise price being reset to $0.20 per share) have been exercised and warrants to purchase 9,952,152 shares of Company common stock remain outstanding.

The table below summarizes the Company's derivative warrant activity:

   
 
 
 
 
 
 
 
 
   
Warrant Activities
 
APIC
 
(Gain) Loss
 
   
Derivative
Shares
 
Non-derivative
Shares
 
Total Warrant
Shares
 
Fair Value of
Derivative
Warrants
 
Reclassification
of Derivative
Liability
 
Change in
Fair Value of
Derivative
Liability
 
                                       
Derivative warrant at August 6, 2012
   
1,152,000
   
-
   
1,152,000
   
(411,805
 
-
   
-
 
Mark to market
                     
231,521
         
(231,521
)
Derivative warrant at September 30, 2012
   
1,152,000
   
-
   
1,152,000
   
(180,284
)
           
Mark to market
                     
(73,723
)
       
(73,723
)
Derivative warrant at December 31, 2012
   
1,152,000
   
-
   
1,152,000
   
(106,561
)
           
 
Reset of warrant shares
   
1,799,424
                               
Mark to market
                     
(379,552
)
       
379,552
 
Derivative warrant at March 31, 2013
   
2,951,424
   
-
   
2,951,424
   
(486,113
)
           
Exercise of warrants  on May 6, 2013
   
(2,732,799
 
-
   
(2,732,799
 
-
   
-
   
-
 
Issuance of warrants  on May 6, 2013
   
5,713,918
   
-
   
5,713,918
   
(106,360
 
-
   
-
 
Reset of warrant shares
   
737,856
         
737,856
                   
Issuance of warrants on Oct 15, 2013
   
1,000,000
         
1,000,000
   
(76,647
)
           
Mark to market
                     
299,373
         
(299,373)
 
Derivative warrant at December 31, 2013
   
7,670,399
   
-
   
7,670,399
   
(369,747
)
           

(ii) Warrant Activities

The table below summarizes the Company's warrant activities through December 31, 2013:

Summary of the Company's Warrant Activities

The table below summarizes the Company's warrant activities:

   
Number of
Warrant Shares
   
Exercise Price
Range
Per Share
   
Weighted
Average
Exercise Price
   
Fair Value
at Date
of Issuance
   
Aggregate
Intrinsic
Value
 
                               
Balance, March 31, 2013
    5,233,177     $ 0.20     $ 0.20     $ 620,325     $ -  
Issuance of warrant shares Pursuant to Section 3(b) Subsequent Equity Sales
    737,856       0.20       0.20               -  
Granted
    6,713,918       0.20 - 0.25       0.23       183,007       -  
Canceled
    -       -       -               -  
Exercised
    (2,732,799 )     0.20       -               -  
Expired
    -       -       -               -  
Balance, December 31, 2013
    9,952,152     $ 0.20 - 0.25     $ 0.23     $ 803,332     $ -  
Earned and exercisable, December 31, 2013
    9,952,152     $ 0.20 - 0.25     $ 0.23     $ 803,332     $ -  
                                         
Unvested, December 31, 2013
    -     $ -     $ -     $ -     $ -  

The following table summarizes information concerning outstanding and exercisable warrants as of December 31, 2013:

   
Warrants Outstanding
 
Warrants Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Average
Remaining
Contractual
Life (in years)
 
Weighted
Average
Exercise Price
 
Number
Exercisable
 
Average
Remaining
Contractual
Life (in years)
 
Weighted
Average
Exercise Price
 
                               
$0.20 - 0.25
 
9,952,152
 
4.36
 
$
0.23
 
9,952,152
 
4.36
 
$
0.23
 
$0.20 - 0.25
 
9,952,152
 
4.36
 
$
0.23
 
9,952,152
 
4.36
 
$
0.23
 
 
Note 10 - Derivative Instruments and the Fair Value of Financial Instruments

(i) Warrants Issued on August 6, 2012

Description of Warrants and Fair Value on Date of Grant

On August 6, 2012, the Company issued (i) warrants to purchase 1,066,667 shares of the Company's common stock to the investors (the "investors warrants") and (ii) warrants to purchase 85,333 shares of the Company's  common  stock to the placement agent (the "agent warrants") with an exercise price of $0.6405 per share, subject to certain adjustments, pursuant to Section 3(b) Subsequent Equity Sales of the SPA, expiring five (5) years from the date of issuance. The Company issued the warrants on February 26 and March 15, 2013 with an exercise price of $0.25 per share. Pursuant to Section 3(b) Subsequent Equity Sales of the SPA those warrants' exercise price was reset to $0.25 per share and the number of warrant shares was increased to 2,732,801 and 218,623, respectively, for a total of 2,951,424.

Derivative Analysis

The exercise price of the August 6, 2012 warrants and the number of shares issuable upon exercise is subject to reset adjustment in the event of stock splits, stock dividends, recapitalization, most favored nation status and similar corporate events.  Pursuant to Section 3(b) Subsequent Equity Sales of the SPA, if the Company issues any common stock or securities other than the excepted issuances,  to any person or entity at a purchase or exercise price per share less than the share purchase price of the August 6, 2012 Unit Offering without the consent of the subscriber holding purchased shares, warrants or warrant shares of the August 6, 2012 Unit Offering, then the subscriber shall have the right to apply the lowest such purchase price or exercise price of the offering or sale of such new securities to the purchase price of the purchased shares then held by the subscriber (and, if necessary, the Company will issue additional shares), the reset adjustments are also referred to as full reset adjustments.

Because these warrants have full reset adjustments tied to future issuances of equity securities by the Company, they are subject to derivative liability treatment under Section 815-40-15 of the FASB Accounting Standard Codification ("Section 815-40-15") (formerly FASB Emerging Issues Task Force ("EITF") Issue No. 07-5: Determining Whether an Instrument (or Embedded Feature) Is Indexed to an Entity's Own Stock ("EITF 07-5")). Section 815-40-15 became effective on January 1, 2009 and the Warrants issued in the August 6, 2012 Unit Offering have been measured at fair value using a Lattice model at each reporting period with gains and losses from the change in fair value of derivative liabilities recognized on the consolidated statement of income and comprehensive income.

Valuation of Derivative Liability

(a) Valuation Methodology

The Company's August 6, 2012 warrants do not trade in an active securities market, as such, the Company developed a Lattice model that values the derivative liability of the warrants based on a probability weighted discounted cash flow model. This model is based on future projections of the various potential outcomes. The features that were analyzed and incorporated into the model included the exercise feature and the full ratchet reset.

Based on these features, there are two primary events that can occur; the Holder exercises the Warrants or the Warrants are held to expiration. The model analyzed the underlying economic factors that influenced which of these events would occur, when they were likely to occur, and the specific terms that would be in effect at the time (i.e. stock price, exercise price, volatility, etc.). Projections were then made on these underlying factors which led to a set of potential scenarios. As the result of the large Warrant overhang we accounted for the dilution affects, volatility and market cap to adjust the projections.

Probabilities were assigned to each of these scenarios based on management projections. This led to a cash flow projection and a probability associated with that cash flow. A discounted weighted average cash flow over the various scenarios was completed to determine the value of the derivative warrant liability.

(b) Valuation Assumptions

The Company's 2012 derivative warrants were valued at each period ending date with the following assumptions:

·  
The stock price would fluctuate with the Company projected volatility.

·  
The stock price would fluctuate with an annual volatility. The projected volatility curve was based on historical volatilities of the Company for the valuation periods.

·  
The Holder would exercise the warrant as they become exercisable (effective registration is projected 4 months from issuance and the earliest exercise is projected 180 days from issuance) at target prices of 2 times the higher of the projected reset price or stock price.

·  
The Holder would exercise the warrant at maturity if the stock price was above the project reset prices.

·  
A 100% probability of a reset event and a projected financing each quarter for 3 years at prices approximating 93% of market

·  
The 2,732,801 Investor Warrants with an exercise price of $0.25 per share (1,066,667 Investor Warrants with an exercise price  of $0.6405 per share prior to the occurrence of the February 26, 2013 reset event) is projected to reset to $0.095 at maturity; and the 218,623 Placement Agent Warrants with an exercise price of  $0.25 per share (85,333 Placement Agent Warrants with an exercise price of $0.6405 per share prior to the occurrence of the February 26, 2013 reset event) is projected to reset to $0.095 at maturity.

·  
No warrants have been exercised or expired.

·  
The projected volatility curve for the valuation dates was:


 
 
1 Year
   
2 Tear
   
3 Year
   
4 Year
   
5 Year
 
                               
August 6, 2012
 
129%
   
178%
   
218%
   
252%
   
281%
 
                               
September 30, 2012
 
127%
   
173%
   
211%
   
244%
   
272%
 
                               
March 31, 2013
 
122%
   
167%
   
205%
   
236%
   
264%
 
 
(c) Fair Value of Derivative Warrants
The table below provides a summary of the fair value of the derivative warrant liability and the changes in the fair value of the derivative warrants to purchase 2,951,424 shares of the Company's common stock, including net transfers in and/or out, of derivative warrants measured at fair value on a recurring basis using significant unobservable inputs (Level 3).
 
     Fair Value Measurement Using Level 3 Inputs
    Derivative warrants         
   
Assets (Liability)
   
Total
 
             
Balance, August 6, 2012
  $ (411,805 )   $ (411,805 )
                 
Total gains or losses (realized/unrealized) included in:
               
                 
Net income (loss)
    231,521       231,521  
                 
Other comprehensive income (loss)
    -       -  
                 
Purchases, issuances and settlements
    -       -  
                 
Transfers in and/or out of Level 3
    -       -  
                 
Balance, August 6, 2012
    (180,284 )     (180,284 )
                 
Total gains or losses (realized/unrealized) included in:
               
                 
Net income (loss)
    (305,829 )     (305,829 )
                 
Other comprehensive income (loss)
    -       -  
                 
Purchases, issuances and settlements
    -       -  
                 
Transfers in and/or out of Level 3
    -       -  
                 
Balance, March 31, 2013
  $ (486,113 )   $ (486,113 )

(d) Warrants Outstanding

As of March 31, 2013 no warrants have been exercised and warrants to purchase 2,951,424shares of Company common stock remain outstanding.

The table below summarizes the Company's derivative warrant activity:


   
2012 Warrant Activities
 
APIC
 
(Gain) Loss
 
   
Derivative
Shares
 
Non-derivative
Shares
 
Total Warrant
Shares
 
Fair Value of
Derivative
Warrants
 
Reclassification
of Derivative
Liability
 
Change in
Fair Value of
Derivative
Liability
 
                                       
Derivative warrant at August 6, 2012
   
1,152,000
   
-
   
1,152,000
   
(411,805
 
-
   
-
 
                                       
Mark to market
                     
231,521
         
(231,521
)
                                       
Derivative warrant at September 30, 2012
   
1,152,000
   
-
   
1,152,000
   
(180,284
)
       
(231,521
)
                                       
Mark to market
                     
(73,723
)
       
(73,723
)
                                       
Derivative warrant at December 31, 2012
   
1,152,000
   
-
   
1,152,000
   
(106,561
)
       
(305,244
)
                                       
Reset of warrant shares
   
1,799,424
                               
                                       
Mark to market
                     
(379,552
)
       
379,552
 
                                       
Derivative warrant at March 31, 2013
   
2,951,424
   
-
   
2,951,424
   
(486,113
)
       
74,308
 

(ii) Warrant Activities

The table below summarizes the Company's warrant activities through March 31, 2013:

Summary of the Company's Warrant Activities

The table below summarizes the Company's warrant activities:

    Number of     Exercise Price      Weighted Average     Fair Value at Date     Aggregate  
   
Warrant Shares
   
Range Per Share
   
Exercise Price
   
of Issuance
   
Intrinsic Value
 
                               
Balance, March 31, 2012
    -     $ -     $ -     $ -     $ -  
                                         
Granted
    5,233,177       0.25       0.25       620,350       -  
                                         
Canceled
    -       -       -               -  
                                         
Exercised
    -       -       -               -  
                                         
Expired
    -       -       -               -  
                                         
Balance, March 31, 2013
    5,233,177     $ 0.25     $ 0.25     $ 620,350     $ -  
                                         
Earned and exercisable, March 31, 2013
    5,233,177     $ 0.25     $ 0.25     $ 620,350     $ -  
                                         
Unvested, March 31, 2013
    -     $ -     $ -     $ -     $ -  

The following table summarizes information concerning outstanding and exercisable warrants as of March 31, 2013:

   
Warrants Outstanding
 
Warrants Exercisable
 
Range of Exercise Prices
 
Number
Outstanding
 
Average Remaining
Contractual Life
(in years)
 
Weighted Average Exercise Price
 
Number
Exercisable
 
Average Remaining Contractual Life
(in years)
 
Weighted Average Exercise Price
 
                                       
$0.25
   
5,233,177
   
3.73
 
$
0.25
   
5,233,177
   
3.73
 
$
0.25
 
                                       
$0.25
   
5,233,177
   
3.73
 
$
0.25
   
5,233,177
   
3.73
 
$
0.25
 

XML 73 R64.htm IDEA: XBRL DOCUMENT v2.4.0.8
NON-CONTROLLING INTEREST (Details) (USD $)
12 Months Ended
Mar. 31, 2013
Contributed and additional paid-in capital [Member]
 
Balance 0f non controlling interest $ 0
Balance 0f non controlling interests 0
Current period earnings and losses 0
Earnings and losses [Member]
 
Balance 0f non controlling interest 0
Balance 0f non controlling interests (214,082)
Current period earnings and losses (214,082)
Other Comprehensive Income [Member]
 
Balance 0f non controlling interest 0
Balance 0f non controlling interests 0
Current period earnings and losses 0
Total non-controlling interest [Member]
 
Balance 0f non controlling interest 0
Balance 0f non controlling interests (214,082)
Current period earnings and losses $ (214,082)
XML 74 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESEARCH AND DEVELOPMENT PAYMENTS QUARTERLY (Details) (USD $)
Dec. 14, 2011
Aug. 26, 2011
Jul. 16, 2011
stevia entered with Agro Genesis pte ltd (AGPL) and details of Agpl      
stevia will receive fee from AGPL in singapore dollars     $ 275,000
AGPl related expenses     274,000
Agpl receives commission     0.02
AGPL 's Current project budget per annum   100,000  
Lease payment to Vinh Phuc PPCTDA 30,000    
six month lease payment To Vinh Phuc PPCTDA 15,000    
Security Deposit to Vinh Phuc PPCTDA $ 45,000    
XML 75 R63.htm IDEA: XBRL DOCUMENT v2.4.0.8
OUTSTANDING AND EXERCISABLE WARRANTS (Details)
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
Warrants Outstanding Number Outstanding [Member]
   
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Ending Balance 9,952,152 5,233,177
Warrants Outstanding Average Remaining Contractual Life (in years) [Member]
   
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term 4 years 4 months 10 days 3 years 8 months 23 days
Warrants Outstanding Weighted Average Exercise Price [Member]
   
Range of Exercise Prices 0.25., 0.23 0.25
Warrants Exercisable Number Exercisable [Member]
   
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Ending Balance 9,952,152 5,233,177
Warrants Exercisable Average Remaining Contractual Life (in years) [Member]
   
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term 4 years 4 months 10 days 3 years 8 months 23 days
Warrants Exercisable Weighted Average Exercise Price [Member]
   
Range of Exercise Prices 0.25., 0.23 0.25
XML 76 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Mar. 31, 2013
STOCKHOLDERS' EQUITY (Tables)  
Schedule of Milestones

  Milestones    
Completion Date
   
Number of
Escrow Shares
 
               
I.
 
(1)Enter into exclusive international license agreement for all Agro Genesis intellectual property and products as it applies to stevia
(2)Enter into cooperative agreements to work with Vietnam Institutes (a) Medical Plant Institute in Hanoi; (b) Agricultural Science Institute of Northern Central Vietnam
(3)Enter into farm management agreements with local growers including the Provincial and National projects;
(4)Take over management of three existing nurseries
   
Within 180 days
of the Closing Date
   
3,000,000 shares
only if and when ALL four (4) milestones reached (*)
 
               
II.   Achieve 100 Ha field trials and first test shipment of dry leaf
   
Within two (2) years
of the Closing Date
   
1,500,000 shares (**)
 
               
III.  Test shipment of dry leaf to achieve minimum specs for contracted base price (currently $2.00 per kilogram)
   
Within two (2) years
of the Closing Date
   
1,500,000 shares (**)
 

*
On December 23, 2011, 3,000,000 out of the 6,000,000 Escrow Shares have been earned and released to Ventures stockholder upon achievement of the First Milestone within 180 days of June 23, 2011, the Closing Date associated with the First Milestone.  These shares were valued at $0.25 per share or $750,000 on the date of release and recorded as compensation.

**
On June 23, 2013, the remaining 3,000,000 Escrow Shares have been earned to Ventures stockholder upon achievement of the Second and the Third Milestones within two (2) years of June 23, 2011, the Closing Date associated with the Milestones.  These shares were valued at $0.20 per share or $600,000 on June 23, 2013 and recorded as compensation.
XML 77 R51.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Derivative Warrants (Details) (USD $)
2 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2012
Mar. 31, 2013
Dec. 31, 2013
Dec. 31, 2013
Dec. 31, 2012
BalanceFair Value of Derivative Warrants (411,805) (180,284) (486,113) (597,519)  
Net income (loss) $ 231,521 $ (305,829) $ 675,949    
Other comprehensive income (loss) 0 0 0    
Purchases, issuances and settlements 0 0 (787,355)    
Transfers in and/or out of Level 3 0 0 0    
Derivative warrants Assets (Liability) [Member]
         
BalanceFair Value of Derivative Warrants (411,805) (180,284) (486,113) (597,519) (106,561)
Net income (loss) (305,829) 231,521 675,949    
Other comprehensive income (loss) $ 0 $ 0 $ 0    
Purchases, issuances and settlements 0 0 (787,355)    
Transfers in and/or out of Level 3 0 0 0    
XML 78 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES
9 Months Ended 12 Months Ended
Dec. 31, 2013
Mar. 31, 2013
COMMITMENTS AND CONTINGENCIES    
COMMITMENTS AND CONTINGENCIES
Note 11 - Commitments and Contingencies

Supply Agreement - between Stevia Ventures International Ltd. and Asia Stevia Investment Development Company Ltd.

On April 12, 2011, Stevia Ventures International Ltd., a subsidiary of the Company entered into a Supply Agreement (the "Supply Agreement") with Asia Stevia Investment Development Company Ltd. ("ASID"), a foreign-invested limited liability company incorporated in Vietnam.

(i)  Scope of Services

Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID.

(ii)  Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") expiring on April 1, 2014 and thereafter automatically renew on its anniversary for an additional period of one (1) year expiring on April 1, 2015 ("Extended Term").

(iii)  Purchase Price

ASID and the Company shall review and agree, on or before September 30th of each year, on the quantity of the Products to be supplied by ASID to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Supply Agreement - between Stevia Ventures International Ltd. And Stevia Ventures Corporation

On April 12, 2011, Stevia Ventures International Ltd., a subsidiary of the Company also entered into a Supply Agreement (the "Supply Agreement") with Stevia Ventures Corporation ("SVC"), a foreign-invested limited liability company incorporated in Vietnam.

(i)  Scope of Services

Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC.

(ii)  Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years expiring April 1, 2014 ("Term") and thereafter automatically renew on its anniversary for an additional period of one (1) year expiring April 1, 2015 ("Extended Term").

(iii)  Purchase Price

SVC and the Company shall review and agree, on or before September 30th, of each Year on the quantity of the Products to be supplied by SVC to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Engagement Agreement - Garden State Securities Inc.

On June 18, 2012, the Company entered into an engagement agreement (the "Agreement") with Garden State Securities Inc. ("GSS") for GSS to act as a selling/placement agent for the Company.

(i)  Scope of Services

Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company on a "best efforts" Private Placement offering of debt or equity securities to fulfill the Company's business plan, and contacts for the Company possible financing sources.

(ii)  Term

GSS shall act as the Company's exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the "Exclusive Period"). GSS shall act as the Company's non-exclusive placement agent after the Exclusive Period until terminated.

(iii)  Compensation

The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company's common stock (the "Securities Financing") during the Exclusive Period;(i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the "Warrants") with "piggy back" registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investors' warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors.  The Company will also pay, at closing, the expense of GSS's legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company.  In addition, the Company shall cause, at its cost and expense, the "Blue sky filing" and Form D in due and proper form and substance and in a timely manner.

Consulting Agreement - Mountain Sky International Limited

On April 18, 2013, the Company entered into a consulting agreement (the "Consulting Agreement") with Mountain Sky International Limited ("Mountain Sky") to perform consulting certain services for the Company. In consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged by the parties hereto, the parties agree as follows.

(i)  Scope of Services

The Consultant agrees to perform certain consulting, advisory and related services to the Company.

(ii)  Term

This Agreement shall commence on April 18, 2013 (the "Commencement Date") and shall continue until April 30, 2015 unless terminated. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Services performed by Consultant through the date of termination.

(iii)  Compensation

The Company issued 1,000,000 shares of its common stock to Mountain Sky International Limited, a Hong Kong corporation ("Mountain Sky"), in partial consideration for consulting services to be rendered by Mountain Sky.  500,000 of the 1,000,000 shares vested at the time of grant, and 500,000 will vest on the one (1) year anniversary of the date of grant. The 500,000 shares vested on April 30, 2013 were valued at $0.20 per share or $100,000 and recorded as consulting fee.

Note 14 - Commitments and Contingencies

Supply Agreement - between Stevia Ventures International Ltd. and Asia Stevia Investment Development Company Ltd.

On April 12, 2011, Stevia Ventures International Ltd, a subsidiary of the Company entered into a Supply Agreement (the "Supply Agreement") with Asia Stevia Investment Development Company Ltd ("ASID"), a foreign-invested limited liability company incorporated in Vietnam.

(I) Scope of Services

Under the terms of the Agreement, the Company engaged ASID to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from ASID.

(ii) Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term").

(iii) Purchase Price

ASID and the Company shall review and agree, on or before September 30th of each year, on the quantity of the Products to be supplied by ASID to the Company in the forthcoming year and ASID shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Supply Agreement - between Stevia Ventures International Ltd. And Stevia Ventures Corporation

On April 12, 2011, Stevia Ventures International Ltd, a subsidiary of the Company also entered into a Supply Agreement (the "Supply Agreement") with Stevia Ventures Corporation ("SVC"), a foreign-invested limited liability company incorporated in Vietnam.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged SVC to plant the Stevia Seedlings and supply the Products only to the Company to the exclusion of other customers and the Company is desirous to purchase the same, on the terms and conditions as set out in this Agreement produce Products and the Company purchase the Products from SVC.

(ii) Term

This Agreement shall come into force on the date of signing and, subject to earlier termination pursuant to certain clauses specified in the Agreement, shall continue in force for a period of three (3) years ("Term") and thereafter automatically renew on its anniversary each year for an additional period of one (1) year ("Extended Term").

(iii) Purchase Price

SVC and the Company shall review and agree, on or before September 30th, of each Year on the quantity of the Products to be supplied by SVC to the Company in the forthcoming year and SVC shall provide the Company with prior written notice at any time during the year following the revision if it has reason to believe that it would be unable to fulfill its forecast volumes under this clause.

Consulting Agreement - Dorian Banks

Entry into Consulting Agreement

On July 1, 2011 the Company entered into a consulting agreement (the "Consulting Agreement") with Dorian Banks ("Banks").

(i) Scope of Services

Under the terms of the Consulting Agreement, the Company engaged the Consultant to provide advice in general business development, strategy, assistance with new business and land acquisition, introductions, and assistance with Public Relations ("PR") and Investor Relations ("IR").

(ii) Term

The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continue until December 31, 2011. This Agreement may be terminated by either the Company or the Consultant at any time prior to the end of the Consulting Period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Consultant for all Service performed by Consultant through the date of termination.

(iii) Compensation

The Company shall pay the Consultant a fee of $3,000 per month.

Extension of the Consulting Agreement

On December 30, 2011, the Consulting Agreement was extended with the same terms and conditions to expire on March 31, 2013.

Expiration of the Consulting Agreement

The Consulting Agreement expired on March 31, 2013 with no further extension.

Summary of the Consulting Fees

For the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, the Company recorded $41,250 and $27,000 in consulting fees under the Consulting Agreement, respectively.

Financing Consulting Agreement - David Clifton

Entry into Financial Consulting Agreement

On July 1, 2011 the Company entered into a consulting agreement (the "Consulting Agreement") with David Clifton ( "Clifton").

(i) Scope of Services

Under the terms of the Consulting Agreement, the Company engaged Clifton to introduce interested investors to the Company, advise the Company on available financing options and provide periodic updates on the stevia sector and provide insights and strategies for the Company to undertake.

(ii) Term

The term of this Agreement shall be six (6) months, commencing on July 1, 2011 and continuing until December 31, 2011. This Agreement may be terminated by either the Company or Clifton at any time prior to the end of the consulting period by giving thirty (30) days written notice of termination. Such notice may be given at any time for any reason, with or without cause. The Company will pay Clifton for all service performed by him through the date of termination.

On December 31, 2011, the financial consulting agreement expired.

(iii) Compensation

The Company shall pay Clifton a fee of $3,000 per month.

 
Summary of the Consulting Fees

For the period from April 11, 2011 (inception) through December 31, 2011, the Company recorded $18,000 in financing cost under this Financing Consulting Agreement.

Entry into Engagement Agreement - Garden State Securities Inc.

On June 18, 2012, the Company entered into an engagement agreement (the "Agreement") with Garden State Securities Inc. ("GSS") for GSS to act as a selling/placement agent for the Company.

(i) Scope of Services

Under the terms of the Agreement, the Company engaged GSS to review the business and operations of the Company and its historical and projected financial condition, advise the Company on a "best efforts" Private Placement offering of debt or equity securities to fulfill the Company's business plan, and contacts for the Company possible financing sources.

(ii) Term

GSS shall act as the Company's exclusive placement agent for the period of the later of; (i) 60 days from the execution of the term sheet; or (ii) the final termination date of the securities financing (the "Exclusive Period"). GSS shall act as the Company's non-exclusive placement agent after the Exclusive Period until terminated.

(iii) Compensation

The Company agrees to pay to GSS at each full or incremental closing of any equity financing, convertible debt financing, debt conversion or any instrument convertible into the Company's common stock (the "Securities Financing") during the Exclusive Period; (i) a cash transaction fee in the amount of 8% of the amount received by the Company under the Securities Financing; and (ii) warrants (the "Warrants") with "piggy back" registration rights, equal to 8% of the stock issued in the Securities Financing at an exercise price equal to the investors' warrant exercise price of the Securities Financing or the price of the Securities Financing if no warrants are issued to investors.  The Company will also pay, at closing, the expense of GSS's legal counsel pursuant to the Securities Financing and/or Shelf equal to $25,000 for Securities Financing and/or Shelf resulting in equal to or greater than $500,000 of gross proceeds to the Company, and $18,000 for a Securities Financing and/or Shelf resulting in less than $500,000 of gross proceeds to the Company.  In addition, the Company shall cause, at its cost and expense, the "Blue sky filing" and Form D in due and proper form and substance and in a timely manner.

XML 79 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
PREPAID EXPENSES. (Tables)
12 Months Ended
Mar. 31, 2013
Going Concern Tables [Abstract]  
Prepaid expenses consists

   
March 31, 2013
   
March 31, 2012
 
                 
Prepaid research and development
 
$
25,546
   
$
128,445
 
                 
Prepaid rent
   
6,667
     
21,250
 
                 
Retainer
   
451
     
15,000
 
                 
Other
   
432
     
4,179
 
             
   
$
33,096
   
$
168,874
 

XML 80 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES QUARTERLY (Details) (USD $)
Dec. 31, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Mar. 31, 2012
CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATE [Abstract]          
Note issuance   $ 0   $ 0 $ 250,000
Note issuance   0   0 250,000
Issuance of notes   220,438   220,438 200,000
Issuance of notes 200,000 200,000 200,000 200,000 0
On February 26, 2013, the Company issued two (2) convertible notes in the amount of $250,000 and $100,000, respectively, for an aggregate of $350,000 with interest at 12% per annum, due on September 30, 2013, with the conversion price at $0.25 per share. In connection with the issuance of the convertible notes, the Company issued to both notes holders a warrant to purchase 1,000,000 shares and 400,000 shares, respectively, in the aggregate of 1,400,000 shares of the Company?s common stock. 350,000 350,000 350,000 350,000 0
March 15, 2013 convertible note 220,438   220,438    
On July 16, 2013, the Company issued a convertible note in the principal amount of $111,111 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12% after 90 days. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . 111,111   0    
On August 27, 2013, the Company issued a convertible notes in the principal amount of $153,500 convertible at 65% of the three lowest bids for 30 trading days before the conversion date with interest at 8% per annum due on May 26, 2014. 153,500   0    
On September 26, 2013, the Company issued a convertible note in the principal amount of $27,778 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . 27,778   0    
Note issuance 58,000   0    
On November 21, 2013, the Company issued a convertible note in the principal amount of $53,000, convertible at 65% of the three lowest bids for 30 trading days before the conversion date, with interest at 8% per annum, due on August 25, 2014. 53,000   0    
On December 9, 2013, the Company issued a convertible note in the principal amount of $55,556 with a 10% Original Issuance Discount ("OID") and a one-time interest charge of 12%. The note is due one (1) year from the date of issuance with the conversion price at 65% of the lowest trade price for the 25 trade day period before the conversion date . 55,556   0    
Sub Total Convertible Notes Payable 1 1,229,383 770,438 770,438   700,000
Discount Representing IThe Relative Fair Value Of The Warrants Issued And Ii The Beneficial Conversion Features 1 (816,310) (444,788) (444,788) (645,829) 0
Accumulated Amortization Of Discount On Convertible Notes Payable 1 658,496 32,050 32,050 595,233 0
Remaining Discount 1 (157,814) (412,738) (412,738) (50,596) 0
Total Amt Outstanding For Notes 1 $ 1,071,569 $ 357,770 $ 357,770 $ 997,842 $ 700,000
XML 81 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
PREPAID EXPENSE. (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Prepaid expenses consisted of the following    
Prepaid research and development, $ 25,546 $ 128,445
Prepaid rent 6,667 21,250
Retainer, 451 15,000
Other 432 4,179
Total Prepaid Expenses $ 33,096 $ 168,874
XML 82 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statement of Stock Holders Equity (Deficit) (USD $)
Total
Common Stock, $0.001 Par Value Number of Shares [Member]
Common Stock, $0.001 Par Value Amount [Member]
Additional paid-in Capital [Member]
Common stock to be Issued [Member]
Accumulated Deficit [Member]
Stockholders Equity Deficit [Member]
Non- controlling Interest [Member]
Balance at Apr. 11, 2011 $ 100   $ 6,000 $ (5,900)          
Balance, shares at Apr. 11, 2011     6,000,000          
Common shares deemed issued in reverse acquisition (118,288) 79,800,000 79,800 (198,088)          
Common shares issued for cash at $0.25 per share on October 04, 2011 100,000 400,000 400 99,600          
Common shares issued for notes conversion at $0.25 per share on October 4, 2011 350,000 1,400,000 1,400 348,600          
Common shares issued for conversion of accrued interest at $0.25 per share on October 4, 2011 18,713 74,850 75 18,638          
Stock Issued During Period Shares Restricted Stock Award Gross 750,000 3,000,000 3,000 747,000          
Common shares issued for future director services (750,000)       (750,000)          
Common Shares Issued For Future Director Services Earned During The Period 187,500      187,500          
Make good shares released to officer 750,000 3,000,000 3,000 747,000          
Balance at Mar. 31, 2012 (790,445)   58,355 1,474,751   (2,323,551) (790,445)   
Balance, shares at Mar. 31, 2012     58,354,775          
Restricted Common Shares Issued For Farm Management Services To ARelated Party 272,550 500,000 500 272,050      272,550   
Restriced Common Shares Issued For Technology Rights Valued 1,635,300 3,000,000 3,000 1,632,300      1,635,300   
Common Shares Issued For Notes Conversion 500,000 600,858 601 499,399      500,000   
Common Shares Issued For Conversion Of Accrued Interest 27,740 33,335 33 27,707      27,740   
Common Shares And Warrants Issued For Cash To Two Investors 500,000 1,066,667 1,067 498,933      500,000   
Warrants Issued To Investors In Connection With The Sale Of Equity Units On August 6, 2012 (381,300)       (381,300)      (381,300)   
Commissions And Legal Fees In Connection With The Stock Sales (52,500)      (52,500)      (52,500)   
Warrants Issued To Placement Agent In Connection With The Sale Of Equity Units On August 6, 2012 (30,504)      (30,504)      (30,504)   
Issuance Of Warrants In Connection Withconvertible Note Payable Issued In February And March 2013 220,438      220,438      220,438   
Beneficial Conversion Feature In Connection With Convertible Note Payable Issued In February And March 2013 224,350      224,350      224,350   
Common Shares Issued For Future Director Services on October 4, 2011 During the Period 375,000       375,000      375,000   
Net Loss for 2013 (2,250,022)           (2,035,864) (2,035,864) (214,158)
Balance at Mar. 31, 2013 464,765   63,556 4,760,624   (4,359,415) 464,765 (214,158)
Balance, shares at Mar. 31, 2013     63,555,635          
Common shares issued for conversion of accrued interest at $0.25 per share on October 4, 2011 15,538,882              
Stock Issued During Period Shares Restricted Stock Award Gross   1,500,000            
Common shares issued for future director services 187,500   1,500 186,000       187,500   
Common Shares Issued For Future Director Services Earned During The Period 7,811      7,811       7,811   
Common Shares Issued For Future Director Services on October 4, 2011 During the Period 93,750      93,750       93,750   
Common shares issued for consulting services valued at $0.20 per share on April 30, 2013 100,000 500,000 500 99,500       100,000   
Exercise of warrant with exercise price adjusted to $0.20 per share on May 6, 2013 170,666 853,333 853 169,813       170,666   
Commissions and legal fees paid in connection with the sale of equity units on May 6, 2013 (18,653)      (18,653)       (18,653)   
Reclassification Of Derivative Liability To Additional Paid In Capital Associated With The Exercise Of Warrants 595,852      595,852       595,852   
Warrants issued to investors in connection with warrants exercised on May 6, 2013 classified as derivative liability (833,106)      (833,106)       (833,106)   
Make good shares released to officer 600,000 3,000,000 3,000 597,000       600,000   
Reclassification Of Derivative Liability To Additional Paid In Capital Associated With Reclassification Of Warrants (167,949)      (167,949)       (167,949)   
Common shares issued for future director services on October 4, 2011 earned during the period ending September 30,2013 93,750      93,750       93,750   
Anti-dilution shares issued in accordance with the Security Purchase Agreement dated August 1, 2012 on October 1, 2013    286,666 286 (286)            
Common shares issued for future director service on December 4, 2013 (187,500)      (187,500)            
Common shares issued per debt settlement agreement for past due accounts payable and related settlement costs 1,708,937 13,000,000 13,000 1,416,715 279,222    1,708,937   
Net Loss For December Nine Months Ended (2,149,272)            (2,017,484) (2,017,484) (131,788)
Balance at Dec. 31, 2013 $ 798,339   $ 82,695 $ 6,813,321 $ 279,222 $ (6,376,899) $ 798,339 $ (345,946)
Balance, shares at Dec. 31, 2013     82,695,634          
XML 83 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
PREPAID EXPENSES
12 Months Ended
Mar. 31, 2013
PREPAID EXPENSES [Abstract]  
PREPAID EXPENSES
Note 4 - Prepaid Expenses

Prepaid expenses consisted of the following:

   
March 31, 2013
   
March 31, 2012
 
                 
Prepaid research and development
 
$
25,546
   
$
128,445
 
                 
Prepaid rent
   
6,667
     
21,250
 
                 
Retainer
   
451
     
15,000
 
                 
Other
   
432
     
4,179
 
             
   
$
33,096
   
$
168,874
 

Note 4 - Prepaid Expenses

Prepaid expenses consisted of the following:

   
March 31, 2013
   
March 31, 2012
 
                 
Prepaid research and development
 
$
25,546
   
$
128,445
 
                 
Prepaid rent
   
6,667
     
21,250
 
                 
Retainer
   
451
     
15,000
 
                 
Other
   
432
     
4,179
 
             
   
$
33,096
   
$
168,874
 

XML 84 R58.htm IDEA: XBRL DOCUMENT v2.4.0.8
ENTRY INTO SECURITIES AND TECHNOLOGY PURCHASE AGREEMENT (Details) (USD $)
Aug. 06, 2012
Aug. 01, 2012
Jul. 06, 2012
Jul. 05, 2012
ENTRY INTO SECURITIES AND TECHNOLOGY PURCHASE AGREEMENT        
Financing for private placement   $ 500,000    
Aggregate common shares 1,066,667 1,066,667    
Common stock per share under Securities agreement $ 0.47 $ 0.46875    
Common shares purchased under Securities agreement 1,066,667 1,066,667    
Common stock exercise price under Securities agreement $ 0.64 $ 0.6405    
Issuance of gross proceeds 500,000 500,000    
Common shares exchanged under technology agreement     500,000 3,000,000
Common shares par value under technology agreement     $ 0.79 $ 0.79
Market total value under technology agreement     $ 272,550 $ 1,635,300
ZIP 85 0001144204-14-021344-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-14-021344-xbrl.zip M4$L#!!0````(`&ILB$2<)S6K-=\"`!;@+@`1`!P`"#XD2'R)E4@\W M,TF-3`+@.>=>W`L"(/G+/[[-3.$94X?8UE5-NA!K`K9TVR#6Y*KV>5#O#JY[ MO9K@,&09R+0M?%6S[-H_?OWO__KE;_7Z-<6(84,8+84OQ&)H@H4[8D)=1WA7 M^W)7^ZE>]TO.J6TL="AJ6X(L2FI=A'_;PO\(DG0IRD+WDU?RVXB:`D"RG$MH MYL^KVI2Q^66C\?+R:,X/T"0;M/YA6[/ M&ORBHBJV@_*\-9+2/K$X9WW5_KVQ*\1B.@3WJ M@14NOCE&36AX#0'7R^X,6P;\Q^Y,-!&(<57;.'+1$E5PSO7_:H)N6PQ_8T^\ M[3&U9W6/N\KI,]O[2Y)!B4A=J/WK&)D._J41N?0:T8VM+_C11TR);=Q:Q@VX MNHLL]DSA"->G/9BQ5XW"'8(!-E#R`X6#&]2W4/&KK,'<6HRPY34FUR#JQ*9AL!O'BU=RADQH7WC" M1CKYE4] ML+SO7W9UW5Y8S'E$2S0R<9=]I/8+9)[!TL)TLGQD^)X93]CD&>414>;9('KZ@$,8,K!,P$\1&!7SK0A/!^?>C=!PY M6AGDD-=RM/+)(375LY)#U3+)L7)\+;,<,I=#U?N^0FITD`1)1'8IYN1U!4Q/CPK&9E^?SGLT[2H',A_;@8W="[2'6 MIUXOD>(8QQ0KU;OYN"*>90R2DMB59\=7L*,+;/0`!]B7!53"Q[C,[=TC#WEK MY+$R43N1Q.?!S18'397;H704AI$?=&Z%#LZ.0`K;2U=J<@T(6. M\=)`2[*B2:VB4,MY_2/DY'(.U"I8)C?H:]MZQA32](>E_Y-`OWBP&?[--@T8 MO,>0VE4'@'>RI".7LBQ%BN_@*2NJ*,;SW(7LT#I(HIA-!^X`D>*[=&@JLE:T M#L,IM1>3J5>+SYPY<,:4!@+-E'`4XBLVZ[(2*;[#M@G^G8SG,(Q30EF8,:0-*5+\ M+!F7Z=,29$:XIY(.05S*Q]R-R5F,+?,0+K4CQ7>E*D5KYJ6=,C)+KB3GXRV7 MW*TAC*7'L#A,A^*=,B0,\X;1B1HIOFM`Q5W]5(F?8A_?B[N2C[MR`CD[#M8F M]<5L82)F=&=\"OG?[NUU5_]K02@V^%V;99OV9#5AEJEPH7?245]O2ZUF:%B6 M"=(A*!SIJ(I17#&&W4V*6Z>*]EG(86'IS;C M$+P>?XD.V`XO6^R'OC^^(8X[.=2WMNZ9@MDB*8UAEOHE6U&112WBEOE1GHY6 MAPQ99ZQ3F;&NJ;753O,MB578-//;[X#-C!VP4U?$2/%=L]D=35:40XCU%8\< MPO`-?L:F/><[.JYMASEI^B14*3E^[T["";@.K<$Q,_EI2%!FR)6;K1U!)(L& M"0/H`]\,>4/E-9W447$.R`<9&10$MOQ;D3TA/V"6@!K.E.T8F@;(M43@@.!U MV(_B(:]%7:JKJ"VIU$SBW(S4GP7*TGIK%?!=J(IB6$SF]W`VR0M4CRKM^4B-V:8=DW3UOV! MU".U=8P-/]TEG2W=6**Z-E82B$)H',0B61A,)A1/((%?V[.9;0VFB&(??=P9 M#B5+U(7(U:Z+S4CQ#>2.V^2V#:!&L[G:)Q`'XE7PVQF7C0"^%"E>&OP!UA>4 ML.4-GMLP=-IDL'6RY,RG:N(Z82=`"%/X^'A_;2],XPGKF#SC[AW&_?'G^="6 M6[RE`;$F:&Y3?&.;)J*^<7)6*IFRW%)#G'-BVS#GW/1K.=SBQ%DOZL:>X@Z6 MLCTKO*S5JDO-2/$=*QQP?K6\$7O]33N:_H[8VV]S;#EX9:KMXV6BCK'&]N6W MG&]PO:"4/YQ![7]AG7U8&!/,G]3H6M9BMO*VU%(<8<;5Q;:75MJYTHHH;KI7 M*I@-?Z(8\]LGN+E:6.PK8=/-C60/1WN:=K).J2`/+0@AXH! MH46`4];C<`'B3/0X5.0H3@]L?$'F`O>?,87[@_]=(,J"O?XI!?@-2I9E9'?C MG+M;LIUG&;FCM+2MP!@+(Y7.<(J_8(<_=>T]59]`:KM8R=3<._QD;MMHP@PM MFTTQ]:9X!N[]G8$A/7B\$DX6NL,Q=CY*$3=N/A-P;/!@Q"#F@GNL5Z[G..[& M2/YL&C7X6RCXG5PP(_2XH/H403H,;O;"4NF;PZY MM(AY56-T@?<1/MID1'G_K40.B7LGD2R*4N/W3_<#]T4^]?5KCQKGH6@3,E+1 MDD;;_)XT59JR4K"D,4U^3XIN#)5>JV7ZN.L-JZBJ($+!73W:9!F*,D;):,'X M5LS@T9[^>,`P>49=AZ![,N,W8K_9UN2?\-\`^3=7N:L5ND(9\X*(U0UE;F1' M4J.XK4+'4,.=U,,O>PB26+-4#Y'X8F\K@RJ)\(XJ3'G.R4YJ4NJ<05U+@'5V9;.)\0"9/3BY9_[=G*K6I2&+*+6"2@>/J MI=_W\<<9I%;0%7P0NR&VLD/CR9(FY]6/FUAN M;P]ULIDX6B\%HKO?9[5[,9=],^*+V#<7OCWLZXDGM_<3+U*O)/&RX8N*EP?? MOITCLWA;G6,/\92]C"NE332F&#=2KV#/:V4'%[5LR>#4^(MDM&S9RGD!+VU: M,RW@Y9O+;,JBHNUGVVP(8T)>/H3[V3:K?-NVS0FN+2J*LC.CC1&AW@K8^`93 M&/(P\HR_(LK?,^R$X:<6#%Q#;77VDTF#=S>/O6XQ+[>+LDM47M1)BW*KM.3R-U,NP43@54;'<6MFY10>V M)\[-M5NKN9_=(O72WC4E2ZK8EH]DO6P,H];+P_!(UE.D_29RHO5.BULK.[>8 M&=+3YN;:K;E?M(S6.]5>EY%AU'IY&.:V'K;PF.@$F>MW3]YAQ!<;>OQM0Q;6 MW7>M$#;=>O>0_^JA8+W_#H_H`M%EUS(^(:I/N:T\;00;;];:E/*:3L M;XMY_%!60Q-"9?)[1/2[[>3=$>W2=Y)6DF_EGZ_[9&ITJ=MCZRD7TN?."50[-L#3BPA/-HFT9=# MX/K!M/4_=XF]5;QHY7[]T63O_U:OW_2OAW\\W@K\P[?"X^/'SR/J(K\I5"$H)#EN:^*IVTQL\WG?_ MN!1&7*/WPAV,@NMWW4^]>S@V)#/L"`_X17BR9\CRSPYZ_W=[*4C2G`4'AG_< MPQ'^?BFBOQ<^=9]@!%V_O[T;7@HB+^4?>>I]_"TXQ'6O0_F)=2F8>`Q'AK>_ M#^LWM]?]I^ZPUW^X!,\T,#6)A?USO8>;VP>O?LVELK:]L#:^X%N?\VQL29-$ M.K9Y7F=$A<:J@:RMY90PMUS_6CB,C)=)JGR=8DM@4QQ\/E4@O.,Y`K*@=X^8 M8%,!_[4@;"DX_F9C*(T8%./](>BX`K&8#0?XBY*`*.]N4`8)AO^*58'W%_.;3A8(]=H]LU^+'#/[-8/='`@:W54SGWAN$%A#)A=_&0\QA3SM>(19B_8%SNJ@B__CV@V?_]WI?/> MV=(%KLF+86A.YQ.L88QS2O150PF*70@][SQ8BD*N(_KF]>/9C[W>P>E/W&^6 M&O+>4>9JG0/C9/8G<]\FLT`8.@AP'W'7=QDX\IK?9,RB_V6QN M;!6L1E<(X6"/W;GT*UD=:"$6.QWD*N$6"7$*B%6";%*B&>?$(\1 M]79T8]=OK)$SCZ;9P^5B$^E_#O2I;6*G/^?9YQ$O0 M')K@+H29F5O(Z?/W//`;8#X?,72_);R9M(MOM[K=/8/4-`QE)?XFDYG7C^$H MY6_9Y$$P$D%A0..XQYWW:KN^Y5@NSY3GWN>)&U#''GA)UY\=ZLCS]]XX`H<[O)PHXCM`5%M5XW+_GR#""OU^(P:97-4D4?PA=D`JCB6Z; M-KVJ_5V'L#L>ATX:W#P`\ZHVLAFS9ZM&VNT?:H)_:I-!5H_<@K_+(Z5VOL%E M8)MZ)W!(_E8DG?N@YRR0@L98>+?$B/X4#:C,R"""],/*[&.(/W%FDW:9[;VP M4HE8?``4P9V`2M+^? M'+2/Y)RJC'#](95GE6XK<%6ZK=)MQG3[1)P_ZV.*W>E=]YT?`D4LNJIQ-F8\ M4W#GEW+%"_45=Z55QJTR[EL'5V7<*N-&,^X->28&M@QA2;!I5(FV2K0[$^UK MIG^K1#N+:G`BKCDCAF'BDX47J`^HMG=4VSNJ[1TG`N[\QO?5]HZS[>_5&G75SZLU MZL)NY-_V**%::CL-<.<7.:JEMN]XL%&M%U31HEHO>&VTV#'_&IUC27XL;F,> MYNW,MA8XP5H],E?-J<+1GP\\J;K1,:L9UK\ M4%I5QJTR;@6NRKA5QJT6Q,\$W#DFVFI!_)6)]I0>JSKQI[ZJ!^BJ!^CVW"EQ MXKLXJB?C\L7^:A=']6A;=PXV_Y>K3Y7_;Q:?:X>C:L6 MT;%0K`56TJ%8"2GXT[JW-K%[SI^=,N$/A MKVRTD7*4S09VA[('`.LI*[<+4#;22$G*9@*[2]GRP7K*2JT"E(TT4I*RF<#N M4K9(L,ZTRS[@";$L"-?]\7"*[XBC(_,/C*A/(:U(T<\-KZE\'MQL\9"T9J>] MXI*&JFB&G4V,WQQR:1'SJL;H`L<3ECAAH.T1EM>$.^F$O\U,R[F$"US%+)O) MHB@U?O]T#YD6SU"=6`[C)JT)C8()%[J(F&9255;5EG8,FZIR7J^5UQ3E'!1? MX;4P#DOF%CUYR+X88[@HH"((=783VK>O[3!3*7P.UK/:FM)L'H#/H;J1UFGE M-(_[T7:'?]OZ$5,=[F7XJG9`)^XD0&JGT$%.W1[[?-K`)U)\@\%\07&8@@QY M^$(,4XB#D$C!B4'N`().,P-@<"@->D6D^*XNH31%,1:PLX7SSK1?G"<\MRF# ML.9]0WSK2^(K_!G*5B\C*6$;BW>@T._4W]Q>]Y^ZPU[_X1+\R,"43UPES75P MVPNN\865]0^WK^2$]P`APY[SQ=@Y`O-3-)\*LB+6);&N:G59]3<`"7?=P0>A MJ^OVPN+*">`PEH&HX4`[!AD3';E;-\8V%72N]-A5F@9*_RSH)H*^.R;`U"U` ML8[)G#D"M`/77G+'@S_@"M1PMQ+9PLL4\[<9\>LO04@\$WC7$^PYILAKE%C/ M?`L3_PD7'A,+QJ.\,M(9>89.@/WFJC8&&V%G=+BS#E$3>JZP%PG%2QP3X,?YWCB8IGH&*_B8O M/!X#;U?$=PAHFR;GC2F%X,T/SI'#0BVE61S^X-7!\G3AU\;!!H'Q@D$>R][0 MNY&'A8"S<#,B)L`-*>=O+@Q^3VQMZ,'/&R""#<5<0IFN=!&:%5_]"O]-I8G;+BV]]O=T>?6FF+3E6@+$K<_"?HRB`@^C@0' M<^=FV)6:5_+(;O03N.`HN-=PP6#+[=HC9/+[1M?4[H7Y.??'6AH/?7`5<[GN MP\0"?#/O"FAD+]@Z"KAU8J,`-S'%SL)TBQ%KR[S0QU=^Y',!1R#0R6$BJ!EW5H*L:=%6#KFK0 M50VZ2AQT'6B8Y-JZ9WU!YL(%TN6/NW`S]*T'S/J!W]_;CG.-*%W>V?3%1>\. MG/:M7=Y$?,RL8EV\4-1`H7T1GX9FYO:MBR( M0G#B*V%3")<#!AXZ0/S)+%>N/2KZ"]]M[=7+WI$F4B:#ZYJLK6>#]X!]9+F: M35%]_3Z!:"-O5S));&_O,\BP\)TJ8$R3A2]_'\.W-+E@H6*:?`-"*4U9*5BH MF";?@%!E#!V.$I\>$3'BFH#:_?$MC'O9\C,`=/K6)[1L&+%W)84.DF3)-K4QD3 M@H?L<0LVM2GY-S;\O\<,T^X,6P9?_84FIKA+&='YX^/CGJ7;=&Y3Y#TB#HWK M%",'\T*K=AX6LQ&F_;'7WM".JEOZ)?EH7DRV3.CIB]7@7\QG#-FS1KP]2N?W MG=FRF=++PK:4ZI(6*7[VMH1V>*].D=XOP6-*QF>.@A"4_,Q1PG`RBU(^G$*) ME>P"I1![1/2+^Z+8G02#DH5:$.XG__\_[%UI<^)(MOT^$?,?LCT]$S,1EM'" M6M75$93!U;SP0ABJJOM]>2%0&FM&EFA)V.7Y]2]3@!%HQY(R)6YU3(Q!*7'. MS7.O)AA2CXF%'B-ZX2(2K(2J!XBI@FR=V0`;U0 M-$6PBTD9\[.3!:D9*)[,KJVTVF'>7!*[3IKFI413K,5FH'CJ]]'[^/VUD M#IVY;;T$>/DO%J_%=B0?/XX4/((5M'>U^"90.B9IJB29"A>5$D5EW=4D?<^[ ME4N[X5XF]2&CL$+%$^OTNE',P@#%$J3S'_,_5_IZ"=/=`_%,TM!/SSWU_26\ M$.3("L^(-1^+!1T@ZP-*Z/'D9K-X/RK7:)416J+1R+MPLXAB@NUG?8X=K^FN M]5U1%L?8]HK?F?VEK1N*N#<1G<.SUK/&Z:;!8J>=LTZ#1;9CWT&F"J9..8EV M='Y@E+%/S]+%9A&&VKG7.TU+EYM!6,Q$"V<6+3J!,*;3=GH"+CE[\`0$'-DX M>T?R($C6'R'*S1PL7K+/V':\IG2?+EO'I/>^.0S*VX]FX&WZ8]G;-E"T5<++L]FV0*')[;&&"4=;FDT8K*7L M4:-P;!)&VS540BH,5BU60"[5W:JB4+54=]U[P<&EJOMU%!Q;JKK(O%"U5'?3 MDD+54MW5W(6J)3@8]5ZQQ`QO5<4H1?2"JME^2[1$+@OV>6^QU6%5?1+-._.. M?)QANTFS7(:J;6)ML+)U3HC'M?MBMU;DJ]W'S+BG MT*AFJ=QT0R&Q2LTT%")UPS<_R(%0Q8S/8!RJTY7"DNM/SO14]T?UO>+]@*N^ M%U-=U[UCR]:XY8](0N!X"QS'=<-C`P=?W7"6VJ[]&`=+Y29VA?,YUA4:>#L] MES/Z`-%Y]W*$40YMZ*VQF>"EB^F>%$G)EOG^#I,N>\&9*E6N"18+/HX;##V6 M9ZUKKU:+2*I=$TP6GX`OY5:#]5K/4N6:**)5#-Y3@%%(B[4`DT6T[=#- M0-D8@,EY!SVEU^/'`IR=8L#*"G5:V_H^6]1K#>O[;)'XHBS\C(%C_6$[IG"/ M#=7%VEBUW==H\F&ER\Q3ESMR*WX<*`QA.38H:UJ>3_JEM1;;B1[`S@8Q1XV% MNX&\LT&FL^#R=X,QM@=XYDZPZQK>?MIO&VN3IXU5QQVL<'\^MU:FZXS55W5F MX+ZI;1Z_N^O2B-VO-G6;\:8[(_I%=G4&%'51B#K`.I M*;4[4O0V4U!AL156GT2#BMJ?S=Z6';';4Z*WU`*GB:NT&F445-+^170=P$WR MCVW!*<9"<@4..CL]69;9UYAW6N,M?KGQ,BJ(=<(&S9/PE6F' MW$[0*M$.*WO^J#HA$XIO5R[R/&H]5-_=EA*ZL>H;A"3P'ND)GJ]LW=6Q$U.+ M27?0>DESKLF:;#M0/(4S1YZCG@BN5#,47.?YFV%B&202WIEX>_!N@':@Q$7A MQXDUHR)W`$L4JY5M8VJ(]8:5M*%H&-@-F\F(+GI1^,$S2O3H632L",I3:RN! M[>'*`:K!(NRB5!!+!"\O/F].NB0ME0DQ0X!82!D*-4WER;1E)K<#Q9.&G*// M7PT!$Z#FK(M>[6^F.K9U)5&N*-2:"*)APSN93#68UAIQDR M9EQPP`V>3GDLWY`#=0^NY.V9&0[0/4`2C#BN-?_/\`>VY[J#"=DZ]QWR_1*;CG>6 M^EN*7MC.9MGN++Z?'-H&R08RW#S;\TS2ZB6I?(GNT^P$S9$$KS0CE.`O+<\( M[6XGQ&&.M`-UKP!9^F6N;[?X:I7#Z%`,X9B=+57I$/CN2J[-K^SH=T#>1R&W M!A4S"BPUE$3!:VT$X*^_S1MZBA.S=C^^#W>IFJ_;GJ;6)XX1.+N;]&>&WE$/ M],0'JR_)!]JU&UM'YI'E"+IB!FZG4:*7K"BU M`L63NLRRV%2Z)5G9=]_TQ9(#MV[G/OQF3'M/P4)46OL>FP5:Z88H4C"YV>`+ M'5_R)GP>J68P::QL!IUVHU#^$1R_+;+>2^?UTMGD;1HPVB81^4!B4"!983(W M4GX>%&JDJILG/[\*'Y7M2IV6DK>-KC$IXEP2GU1U\^[A@2Y*6ZIS_%UW'Z\Q M\55UL1FXI_T$Y]J8DW;3#6'VZ+?6\4\I,_6^'7#!XW'S:SG$5DH[S?.K_\PW(\_"<+@[G+ZQWB('MTG`XV_?KX>7:(SH='XKEPV&H/I M`/W^V_3F&I'@@*;D#>WH=%A6-1J-X>T9"DF>G-XW?M!G2?3FS9^"Z[OS0G.U M,R0(_UBX'RD&37^F?R+?WQMH$U>UW2LB=ZKS]0W;4LAQ7PW\Z6PPFHRO^W]\ M0#-JHX]H.OQ]*HQN!\/;Z0-F-FJ\/:!Q\)O;IU%K"JJA+\P/R,`/ MZ[N]0J[7<=D4N[J[G0J3T?\./R")_,9'Y'UQU;\971,DKOY$VF0F?D&D2E23 M5!/I=CK$@4G54NUXGY>JIFT_O^B:^_CI3!+%O_M^T-[]J6U_>-P?#$:W7X3/ M=]/IW@FWH!2GY8? MS9FS])[>H(_?V=/5*H_V\]W]8'C_!G9FJ,0Q"63D6(:N!8`3YZ.5:M*ANC3" MC.<0H'S3O_\RNA6NAU=K';]]K`O5%)!P8ITCFB`3B`NPZ^4BVT)^'9FSVA:3.@.J[2 M7]JZ01[MN8J$_JF;<[RDK81_58>#^VA;J\5C=0#OQ2>Y1O&IX6\SV6BV((YL MV9_._C:?8_SP<.:G=>CSFS98I_UWYC2BT4D`[DAP/9[!<6TY``>:*S=0?Y`CC:7]GOR!;V7>RG>RQ1(9#M.M9\0^1UUL<[5M9U["& M9J_HBVV]8-M!DU<3VXM7-'8QNG:U"T2^Q4AUT(-E&-:+\R$@0XW@.O:IH M3R+'1Z>%]`KE]RS724FX6@E\`SSW]FF$'#Y^T()_\PB\'OX-.7`\#AKRVR&K M*#C(1P)PH#F^+`-@&6=H$+>1_C&'K(U(Y#X/<3<&].]1RKMOL:R<%?J!0^<83\8/;)T2.( M7.\,HOY\;J^\?:"QC1UW:AWN`[VEFN&6,G>.W=\&/0O*LBU2U@ZP8C[6V.T; M_T2/MY5\K`\OE;N%>QB"=Z+/]9_Q=R?-W9.W0!B+_1)T?]A."C)>S):E0/$,9X>)K6XKG-4^I'S) MQ;R2_.3HZSA0/,.1-E)$A15'C828U-2:@>*EUMO;D8=7ZAS[CS9,*)5W_?FI M":3:NH>-J7@XT00WQZ&'L=I<*O=@F#`$[T7/Z&V9$WI6;\M\X#-[WZ2%OTT] M[5$)QW#9*Y?K.2]!8BWRKQU+:P]-<1S3G#WIVV0_^NS)I&;_^_AY^V=*K01V MOE(%UU^*F.8#4PR]`JLN9WJWUK-7U[*4P'"_8-$^J"2%EGTX1=)DYH89*=[- M78N43I3J7KFBZ[&;5(][:(KCR*P2,_(S^ZO%RG'E#BT>VIL,+UEP/4HMI954 MD?N`BJ7*KCHSL[S",WNEVJ]R.YGG05DZF)?FU&7?:&CLJ/+^)?'G.)(%AEZDH?TRB%99,0II"9?%3$-QVVQHL6: MKAZW:(IBR+`I7SBY0D%V.-![BTKQ-`_*,FZ:'Z`I MGBOKUGG9A%DVT+-SG>"ENQ[8;B<-XQZ6+3KP=CJ=I);!`:+B^3)LM,=P7=DV M-MWU*8M#U39U<^'T3>W:N@8?$,,KN6#>N_'&U5VW M*TE-^8UH,K@B2<=D.87KUO>^R9+R)![+=VF3QZBN90Y_++%)Y'QGCFV+2,A] M)0H?_KG2E]X..6O2*4N7N?)`DI7F&_F4^$JQ0&F"5R2?7W-E@;+4WVG+[S'` M\'[TK3\=?1N.;B?3^Z\WP]OI9$TV[$K>XJ[GSN(UW6";\UU)-K_J&;]_/?IR MN]VAE+OM0W=@#QZ3>7&K]\7WX7HEZ\PRM(WXXOD?[HARNZ*OS1UZZR&=>;V: M#SS-% MO02QOQM7BKU#0KXB'A=;$O6IN&K%[E5#"+X_]G7;/._=@ M@*>"IU;V[1,UR@":!DU75=/6`]K.0X*.0@0]`AZ!!T"#H$'9Z.#M\SR^'K_+&F$>M.'("K M=%\LLZ_P![MJ;@EZ!CV#GKDV,9^H0<^@9]`S<]B@9^8FYA,UZ!EF-`N:T?Q" M5Z9AS:,/,YC,49<^0M4ZEQ7E7.ITZNG2(-WZ2E>\D%N@6O900;6@6E!MO57; MEL5SI26"<-E#!>'"#"S,P(*OP0@2?VX)>@8]@YZY-C&?J$'/H&?0,W/8H&?F M)N83->@99F`+FH&]I"M*#9B"Y04U#%'!J"I(%B0+D@7)5ERR'("KM$BA!\"7 MGB$$0PCF3[(P%PN^!F\2[MP2]`QZ!CUS;6(^48.>0<^@9^:P0<_,3[/2L+)F,Y00UC5#"L"I(%R8)D0;(5ERP'X"HM4N@"\*5G",$0@OF3 M+$S&@J_!FX0[MP0]@YY!SUR;F$_4H&?0,^B9.6S0,W,3\XD:],S99.P&W+@_ M&(QNOPB?[Z;3NYL/2%[^B.1;R8G:I6XG3],>80R.1[8^W]T/AO=O+&:&.O\/ MY8(X@KX"/@(^`CX"/@(^`@3'^$'^&EZ147[ M0<^@9^:P0<_, M38I@C32_YDC/<(IK2!%D")($:3HER*<`@QJY$>-L((99CE/M'\&HS2@9]`S M5[!!S\Q-S"=JT#/H&?3,'#;HF;F)^40->N9LEO.(//@*SH`.5=O$&E)-#>'U MKM/JS,@\(0IK!O@/-MRM&4@QV5J[M0,GYRL02M6?41M-/S$M['CD'Z('V0/D@?I`_2!^F#]$'Z(/W\AQ4:+DU$WWWT]Z)C MQ@'V.NCBW*5A=/V'0%87O'?L=]\^&7!NGG/W\@(AE] MZT]'WX:CV\GT_NL-^;W)KW_]"T*_1%]'ND8`AUVYZ(A-Z4+<_7>&YL1(^(=[ MCQ\^G3T0XPIT/$$0FX(H":ZU_B3)@B(%[B5W_[KA-;B[G/XQ'J)']\E`XZ^? MKT>7Z$QH-+XKEXW&8#I`O_\VO;E&Y'8TM573T5W=,E6CT1C>GJ&S1]==?F@T M7EY>+EZ4"\M>-*;WC1_T61*]>?.GX/KNO-!<[0SM;'A0:]NO";2)J]KNOM$S MC?%,/>7=$N7=IQGC$5,,\?Q[Y;CZPVN$B-#T$2-/E&B&#>L%.:NG)]76_TM@ MN.32I?6T5,U73^M_4WH?'?2BVL0T+E+GKOY,#(2=#P5+V?>TP[$KWZB MU>_#M3YGEA%,SRHF82WXDIA;M)[)%W(1PZ\A/#-[ZYS$#6Q'.>OMZFF&[9V= MK(_K4++C,WE4;>P<.;Z<,JTN_]9!.LZ#[^$%`@H%0TH/07"QLOJNZ+ M(].U==/1YY5F$1[73RR6[*=X^IGS-TC+/:+#\,3'H#8+F4)50U5#54-50U5# M54-5U[BJ<]KYHF(+@>!`0:Z7\O"XQV65$_8J*5V.TDU9;+L'YV9Q`!6D"%($ M*?(B16]#1CC>D@>HH,93.U"PSN?+;R>FZ23U=C6`XV7NHO'*IM=&?*]U]11/52$[UK9Z/0Q])W7HZ-4BWOM*EO0$DH/C3RD"\(%Y.Q:N`:ME#!=5F4:W45-?(-G3>0.= M:,(EJ+;2JJUINPFZKG5O#4#7%4(PA&".)7N*\ZW#'TO=AFXK+ZC!E>'M`Y(% MR8)D0;(5ERP'X"HM4NBS\J5G",$0@OF3[&E.M[YM]CO`OIY):5[RGL)POI54"1WBH1%J1Q`!2E^[(K*N:+`JYH#J*#&4^L: M!JI^NJ,^.8/N01YN+8\^//>\WNV=5@Q6/_ M],@33?F-0"?G*QR]1;ES@%0=8G`!<(%:NT!,#QRT#]JOK_83N_P@?Y!_?>4? M,\90.^'G-"?-F@9D-T%V4YW&`T'/H&?0,],+-1(_QI/PG"T-2N;'7QA$U7$+9W M['?7-Q]^:9`._O,'HI'1M_YT]&TXNIU,[[_>D-^;_/K7OR#TR_HZMO5GU=6? M\7?5ID<.;]9G(UTCF",N7G1$I7TA[OX[0W-B*OS#O<!#J8((B* MH$B!XO2&E:FO2SN/JHV=,Z3AN?ZD&LZG,_'L5[G7DIIR`A[WBTLO&0I)8LBF+Q/-II="4+8E<0VX'B//'H MI./1$Q0Q4)PC'L1QF^U6LWW1DMJ];.X>=E\\JQ+X-,-QI7%[/OFTTO,Y<'\N M^;0SZ.T@#/#)IY.)CS\<<,G'BP=M63XJ'@3OXZ<5D('5053(RJK,-D%J5H'8 MD)55F2V$#*P.(@2_K#J96.W'"6Y9>=&BV6L=%2V"]\6S$IK=MB0I)46+U*P. MHD5F5DJ[UVEV2HH6*5D%HD5F5I+8;K6EDJ)%:E8'T2*[`B6I*[9*BA;I6>U' MB^QUU17E;@EOX75?0^P>U]<(W,>\K=0,QY6RK\$AGU9Z/L&^!G]\VAGT%NQK M<,BGDXG/05^#/S[KUH,H'M=Z"-S'G$\S'%?*=@.'?%KI^01;#/SQ:6?06["M MP"&?3B8^!ZV$`OGHSMQ:F>[=PZ5E/F/;U6<&OK5<[(S5_V?O6GO;QI7V7^&; M`RQ:($XLWY-B#Y#FLAL@%R-Q=[?OEP-:HF.=RI)7E))X?_V9(259LBZ6;,EV M6Q4+K"-1Y#PSPYGA9<@%+J9(8.M*85\?^.3%H4UL:^8AZS2:2L.Q5NQ$Y-L( MP"_/5_'(KM5O#WR,ZTBK!NS9>K`*@@7($FQK"?:L`-CF7F%VE/4PVRLR#6R+ M4@!FK]7K='K[Q=HJJK\A.]K:D4B?V!RZ.S,=W7RY'4W9$S-$_[ZANOT'-5SV M.(&G7F_GMYR[3+LPM5L=GGYF)IOHJDX-V1[7+?.&4<>%&I4(FRIKI=3%RB3+ MT.GT!ZN6H3(T/Z9\,U!Z;:66SU;R*6W9 MO[9L5Y/.J:\S4ONK,T#Q>AIX`D&Y&K!KVN*U&JQM;I4P6IO-N,>_VQ>,3C(Y^?1J`QCM*J6A]#>31NR[?/,UE8@B+X95 M41P&!J]S;[9J'?\N&T.OU6QW*Q5&7B"KPB@(9-!LM]M;F-L_=6=Z3]_UF3OS MGK*AK:OLB9HOZ2@SOUJR(*>ACK&@5$.=26L>[NCF)MQ)^VH/W,G2\TQ:P]SY MV]6=Q:W)'=O%??!>##NRAM1V=,8?G2FS1U-J7L_FAK5@C`\M0U<7(T#T&??> M2VYM6TO9L\__]G;X7SU>CKX.K\G4F1ED^.7SW>TE.6J6D2480PG/=@2"=&J>GUP]'Y&CJ.//ST].WM[>3M_:)9;^/D@_^ZW-$GBY04"[*:-R)*75U?/CY=C&X?'\Y!BS5F MRYR9I"21ZTAJR+:U"34D(3TD4A&)8Q%/%8F%ND@<4$82:".96#:Y4.%S&P9Z MY#?+TJ"@39Z9_0J=AL>(K#`OI3SYERUK&-.22VLVI^:"4%6,CR7GF.2['N*[ M'O!]'N<[B_"=!GQ_\?G./;Y+>9,75]?$$ITU(<_NV+'FNDJZS6ZCV\1'4#&Y MN7C^#!(41&%5T+M,C=I0W:6EZ3`,I]@_R8>CE>^//I[\M/(/"34,(LP;%:]`KB9YF^KJ-$%6X*2$*,!P[:(A`,9;4%O[!GR"),U*A1AQ&7RPZ@ M,8?9,S!1!0E"*L1["A8/B/**B[HM7PSX9,YLX--,+F)S8`AT+X:%[(0/=*R> MS&UK+.)=Z(].I((W'41NJ:IK)R*]G1`9COCD!`9!2!]L\0(51D/H4\$#+"@^ M@4:%GC"..7XZGR)$,UR):.9?[;-/R'[N"&$".^9B#1R^-Z@J^3MC(![HX.X, M>O1P>'_T\1C1OC'V#=J'7S.PU5/X*9HDUAB5E$H-?K-<0R,OS`25,:#(F$E9 MTSDP!C7J)Y<&>6$N\!5CR>JJ!MJ1)LGY_X,E.S$H*C-&@@=%((2 M@]HO(%$^MQG%\@Y0+AL@DA-;.TL[(3C,A M+Z*U:EE8`\0]350+?`U-BN-T,S2F)%J*&P,P47_H=#/9W.I M26CI='/N^B80GQB&]<;/JQ?H,LE8V(2$%.#FNA1@B->98?`Y15;@"%;\/:>: MYO_MYQ\WO1.M_>/#_#QE\,I)9X?]>7LU^OVK30X)>6 MYMGR-!&M#=>!8]0.>^;S2+P`T32%OC&?DKXR:"A-#!A:!8,QX=PVH@4\@[B72B.2.-V/FT!4D0P1ODV.N=][1.J66C_+(<`2X`0=X+^'MURB,%AW+$H&QXSZ3`<`V.Y@-ZA.L*9 M:>Q=`M'12,+GS!`U'T7(L-QZI&U9C"^EU$R%@MQU!<@A@)25O+CR&=",PY]=%T[X-H![\T!4]-$ M*V-[DQ5_N]`SF`V=0O-V2R4/"S9QJWZ-HK$2'&M`85ZOF@UI-$TH2A9RSQJ/ MSB''9QM5UXZ"E!]Z=FL,_G'I(P$$F,#_)K:$%DN.1<&"ZFB!\[D&;V8J9>11 M&YW:Z.S?Z#SI_%MC8C,F+,`'_O&$;&)'[$@U/--8K)9%2Y$^K1H4UDTP0]AG MA5U<[?U?3IY/R,@6JS4+K]]"_W_%[P@#,E6'`.585$PF!9/`*9W[A^K3!SJU MGSCSR/V%RE:W,3@F^H1,7`P(_/J M-,A/_&9B=,N\63J(?($*)I>C4#/BZZ$?3`MB4*9BJ+JZ1F(T_Q1C)[,8_!**O4";^%C#%`R,YBBQ%&`!2/*%^^)U%4<6"U' M,[C$:N,C.0BDMIF\'LF/1:]>6=[$<=@8`VOH2NH4.B:Y")@F.[7-5.O%U/]A M*=7"(%7&Y8NP(#[HIES]4Z'7\N.@4(C?N&`C^K@FA`&6Z,\I\[87(#!PYGQN MR8E<%:O"N4B3Z+,9TW1_4LWD8H64@C=G M*HQ%H+>#'?A'SBC*_M_PX,D-"W)\*T0LD6+0$,R8>VK;Z3:4CU#_7$1!GH0" MA9E`(W)LHNJVZLYP9AJTZB2V:I]8+TK,%\:,+I!(U7`U;[T7E=<#N]R407&F MP&.)7$7'7O,Q+&=O:5W'WXX+ZH**7[C321(J[7GXZ0:]3\=Y:2&_]=WPA#SC MT#1@I51YG&P!)0%W-C?H(DE!PDU:P:)^O($3L9XI]EZ`YZ1C.6Y&[11C590; MLR8?TRL(442E5Q.QK)?LSJ>,.3Z=?B4""38,/`KVW,!O-"W>,DGR9I`4T^I3 M;\MO$W<`H=-]ATZ%+C]1FB?Q?2G^-'J(2G_9UMMK$5FJB9DN,046!A*H9,BO M<]6:>]856.!O&RIA>3T]*/R>';#HKLN_SW#.SH\.T0)Y,=3&QH*%-FFO=%L+ MY[GH!"T$]?L\:-S*HJ`NE0'U(UAT6AH2?V%&;&?S-MP$3O M&,&&6PS,C(K^1V@7QLG^#B(Q!N2!#PXIH===QVSI-H/M,9S._#5.B+L%I\-O MH$$3L7.?1(_M4PHDH6<#3SH-YGWCYA)^BS&X*&:SL8BU*8;RG.(^!\U+AA." MP2DUX^$Q>N-V,>`3H8V_#`=-ZK;85N@_TG[>_3)K`XEVL_%\=H;!A!Y= MH_4B`=20@,?>,^CAF."X5*Y5^^X&EZ5E]_SC5-?KN18F)GTI"M,+).1FTF#7 MP=RUYQ87TG9T0ZZKKQ!'Q1X_+ZSY()<+^'%\'1^*H3+Z&P'$WCS19%"U-&H0 M%5Q"&:`9OC,6Q])->Y/I8ZS$[P=R;.@D^R5NIUY=KG,2ZIR$.B>ASDDXN)T,M?_X.?U'G9-0YR1\)SD),4_HU)D(=29" MG8E0N]WOS^W6F0AU)D)E1B=SQU1M<7XJBU.G(=1I"(>P.%FG(3AU&D*=AE"G M(=1I"'4:PO>8AO##^N!8)D*=B%`G(M2)"-]'EZX3$>I$A,-)1."J;;T]BSG_ MX)*%)V8P',B/K#^@>KS,ZQDM@=RI(#,/"G^&MV)EI!H$MT8HC6:OT6K'BJ^_ M3Z3=%/]\)A6F<$]>Y^4S!G`O!E7[ZS6<_$E<&S1Q<:0>Z$BV^9ZY\7N1G M16+9_>-/)"L%-%@=<4]@#*'_HM2N_^7YZC\0GOU'P,JX,":!CBWH+Z^3KJ&_ M6PW]Y:E32?Q_AY"`/TY"ETSZ-TP^0@0J+IA^@&&S@)2O["YO`F\/FOU`4OG( MJQ[\KJ\&/QC@[3Q25YJ)4F]_[U+OY)%Z&'Q(ZIT=23V831@R6Y@$#V3L>=D7 M2.>RM'$R-B:^O%ML4XF/B*(\RLN[X+9,MC,M3#+3Y#UHZZZ$S7656O'[85?8 MSK1<]()?R4MOIFLJ3F^CU6^W^F=G&Y$MV)Q]T5].-A>Z]6\[-N>C=PV;M[FE M<`,69UY"FY?%16ZDW9+%N>A=Q^*=T"OYFWFS;%[^;GK-[`;\S47O.OY60&_( MS9OW=-'#=B,0D@I4%Y,7L7A)E)6+L-/K=GK;RRU>23&Y[0(H=-[M@<8K.5C! M=LZR;D/.B3=>R>$)MM,L(4:)5W)X0+O-$EQ8O))J@>)EQY%;CB\T7'+"Z0>2%X+H;%JUAS-WBW#?_2>%84QJ$R5FD.MO;V"76L9>V/ MSM?.]@H;KR*;JU!TH/SXC.UU5QWW.]?/3=WX]U2F;T0:N)>.FD"-R>KA<[#4[)011L4K6J&B_V>OU?G05 M;?=:[9)5-*'*'UU%=S9D^SF4LM-IKTXJ;6TWXU56J)0":L"$&\N^>!';PT,L M2BZ"BXD9"U/!U'*KT1P`UECQ?%/+'9R&@\''RN1R"DUK\?$,8!Q(/.OE0`32 MZS::[5CQC593DTG9'L@@!Y`.KE0,>:W4&V MCJ5"0=/`5-?&G5O>.7.KB&)%#J#SQ&B*X).9EH]B@^B=/F%?&?4VNB2^*G6% M;.[&%L:6\7=2ZUM27MX*61F4_[%,[P]3O7Q<*:^%RO0[W56RE\UO2')U3)8D M=Q4E)\DB:\6C$W\?R-*CH&4MI?M;="Q*Z2&L,Q;@Z>Y7&#?FZ7X7%HOP=+]+ MBD5XNM_%Q"(\W>\RXBJE-]2>W5.3OHB-]_[QWC%I)[1--@]Q:T$_,7&`CG\L>CKH:,%=@NXKK6XW&W24N"I!9\0P M/F@%00-T?W];`#HSRE^5]&"MI'<&>F?[6`\*]*[VK_:ZAZ/>.]N[VCL@0>]J MR^J6F(>VI;DJ"Z!Y?^_4_?0'9\UV)X3!(R(_J;NRG\TMB-R9O>MW!X/FV3:4 M[GJ3_49$[LJH;$7DKC>NIQ"I3YPISK$,Y3%CF"HJB(T_QQZ1<^+7[T#I$[^K MTQ.MHW^W3GI!3X^WOC'-Y6VH3Z99J8#F7AX^RUG/7JSX>IH'E=#?2LA2EFRB!6/$^<&N#?D,8T+O$X=%YJ7X_C@0@T&0\O2.0@3UYE"VVHF.(= M%'&6Q8B\L4`AQ84QP^"^F`C)"07*7M]8!1#.<!9LHBV9[(HCM&ZK(K*K M#=(ZG9QDBSGC>]W49^[,GSH&QR0B&*Y2`[_$'0L22][2I:I3W!NU(I/A>8G: M!+92#'>\/U?HAG,3M2/@54J\W]T-[FXAV-U#U//N)K"+B;M[B'K>W4C>&P"O M4N([`]XKA+MWB(K>VP1V,7GW#E'1>QO)>P/@AZ;H&P'O%\+=KQBVLHFB]]?! M'ED.-3($+-]7#*VWSD=+*D)8?A.'JLIM(][OO6YNZ[;:;:7O#PH]BM;2N[\M M;KV^TCY3!@7IW=-&M^BA*\6(W?D.LLV(W=,F,DEL>R/.[G,?63&V[G,?6<&N ME2?G1Z<1' MJ$A#X@OCUH3"\G3J8+DM#BRK])ZT*9.F--0C"\H&UVZOH@R_W9OJA8D(P;@U M5;R5BUTQ^?];IUE^BRR2H;XJXW>Q5`)^]=>Z(.>S0O M+?.5V8X^-I@X?M-#EU7DI,I4*YGRV0I`91%2-JC2SIE>!:4(4'O!E,<@RCV< M2JSX@6+JYU$^16S_Z\2*[QR3D@,4LKZZA,LB74HI'==!]*H*8!U"QZH`5KZS MZC$7OA,K?KBP#L)D1&!QO-('<_\APII9IK@IX<:RY3=]VF7/0ZO<[04!2G-3],6A7F0ZM=K,W^`X9M+.(_7O4GIW%^M"]VF>5 M,FA(N7/EX@Y1/%R=9S)EI>PNM40!OH4&=OD(K![^SL=\6P"/SWBEO"MUP]Z: M"8@4$K8&L+.=XD4`>*?^R'MNGMVQ=QV=G$%ZIG']6__!7M+//!=Y4 MGF1V:]ZPL>U2>W%A:O?45J0\BG?-OH&,HWAKD1042<*!YCG.2LT44-89Z4(^VQ^4^ATR>K/#O-?TA/3# MO']>1F]V)'4FH[..I/YY&5UPY+[I!.E>[??*`=59!:J;S4G>QQO9%YM%6+D` M]WSYTBZ![N7RI?W)=2]W+S649J_=VX=T]WH#TT[[ZSYO8-H"Z*/J6&-F*]U, MM)%2NYU13Y[&3"&M*K#5V^,\L^D[!UVU;3Y@>5=MI^/0&_U>K],_`.05F^R# MU/2JS79+RO.)FV,5#ZO6Z`)I6,\L#D/,3#!Y-^ MB$>ZIFV$XXK-;:@L%4?X?=5"45K!N:$95)2'9?!'C=,>VC*%EZ.IB!-1^-BSUFP2[925EST?\^Q?#^?1_ MC<;5X^7HZ_":3)V9089?/M_=7I*CQNGIG^W+T].KT17YZ_?1_1T!$TM&8!^Y MCE13X_3T^N&(),P$C9Y.W[$N!3_V?C:Z0].]1V;FSZ@H9,?N"7(MQ9&.S7HZO;Y^'=Q==S,D8>?2(WCP^CQLW%_>T= M/!OI,\;)`WLC3]:,FM[;Y]O_OSXGBC)W_`>CKW?P!*0##/]$[B^>?KM]:-Q= MWXS.21-+>4^>;G_[W7^$?&]`^1?SG.!M7?ID\8F,KO\:-:ZN+Q^?+D:WCP_G MH($:LPW=9-Z[VX>KZP=9Q9%`LU0*`O^%U()8$_+P>,>)YC+B6$3J!M%-XFD' M\N%TA75I3$EL&[\9V^0TJ"!O;059O"4[8RP;NC9Z;`>YXDP9$=N80*W($WME M)G#KTM(8>?8.;FH/6N3#4>BOHX_'1&6V0X&5UIO);#[5YT05[.5D1A>$NV,\ M7DE4#B+XA<[FG_[5/OO$L45JFBZT901RX^1MJJM3Z(NNH1&;B;-I+1O,S839 M?ATGHA)SS.>?EK_").JSN<6A_7"]\(I"M?;[J4JJ+)M/4>K,I$IMJQ-/ M==LN2YU)]DN*%B&)"4UJ"X!7TKM%"";[<\SM'^D@B?_)J3N$YPFI&&@*-P%C9 M!CW?P7XE-M9(`0>AWCL];XDRM_5,>]_Y+Z,J<;V7I>E=!N:,JF#@/^)DS[W/ M:*,.JH6T'/PJGY"?CJ@]22.@>XQH"M&5^1X:Z54SB69MZC@<&$+SM>>2JA5B M2/F!/(E>UU8KTF;1V5_.M*U%C[Z)<[6_>^AO]+)R.6))=,6-K'>":XT)@C1@ MZE'":T:B7X,4\$Q*R-'^T.&H37&F-:?D[9YJC8VMC+B`J7XII[A6,=I8E/QM MS^<8$2%Y.28H;(\(49%-F/L5:J:%-X7;XLA]*P+YZ]7DBILCW1-L<`MY`I$\ M@6P:7MTC#B(U`J])]8SA>D/D99;M4O6A^9PZ4[/TQ/N\6T*4R#M[)##@I5_% MJ?=()4?TL9;FALY\)A5H;GCJBAYQU7!+3?K)L:4G>\E4H?"/,.PY,!9I86Q4 MZY08Q$80&T%L!+$1Q$80&T%LQ#(V.G(T\T7["_ULV_H8SQS[+@8)C2_9`'-+?B)//KI93XUG,(\#89L)DM>]FIFD[1@"R7 M]YR:Z9K9Z'4^E;>A4Z;.0GO-G'W%4GO.7\CU,HO^2L,^__@=-%M:MFDOWI.' M"I4M3'<=%F@J_A5)[?%*JOBNU1)]29%BAB@'B@7I`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`[QWMDE7B4GPNJ3G)L/!G[0K4/,7+!T'Y%%MT+@6]BVV!2#/-*,F[:%47- MHIN'KEG>+%MQ.:M+.PYOEO56[&>UV$?BS;!Q%GAI?]Z;=:)/QF+ICK%+'DT: M\*\8S=?F9V..!.5WNLDJI%_ZAH8SX0B*(BGQ>*4T,)8&8)`^9U_JF5/O61O# M2Y6$S#@GN/N;>+XWV[B>"WU_MGN[I[%]GG-B%/L-PWW,Y*&8 M5%N=M@W$PN0_5+J8@GW63#K0Y_`2(7+ES7"7P4W(.Z.#P_Z.X4OR#\K81>9[ ML,-Z8Y/8#O#X-NKH.`JU1=V3@--+>=&DEHCD5NQG2CKVEC M[.VFUSF;_.805[\0LRT1:==>HRW+W]-B/WBE"E'0BX:U1M[VXF?$::[K&,]K MRL#;!1ZB"-Y*=ZS3CV5=#T(YW2][-X(X^,3[<*=2$):Z9)Q[NOMDD:<;Q",QH( MY-]..@N:+BL[A]3#W"7--,USA2\3.9Y>M+^(#:RD^S7?_03%BC3DF##SLC!Y M/0]&":"Y&:O"%VBZO:)]QR;^426>-`D]D<0_DL'`T>/`2]CE>BC2:!FSE6?T_*#N7W(1F]])> MJ.7]NQTTLXD@_T/O][+NT21\%I6E'PTZ_G?;@(C_/I/$08X//%XDHDA+K9#C MJ2D;!I4T:2,T7_;)(`G1S'(T0GM;(B_^BE@C\B60P(23\@AMFYU; MSZ\@,2RZ[=5@]Y!7^8U"S!?;XO!,-".QWX+\YJ=JHT9O:;S&+AHZJ[@/IFX@ M[H.X#^(^B/L@[H.X#^(^B/O\]S[,X_D)R;NB>N]':;F_D[AHJ)1;623[NZ:3 MQ7=G5TP>P5@`)4'(1;]X<]$W_M'02*>)%HGR'?3H&-;,6&GFR*N:P2;K"C=0 M#@5+RN)KB82>,$@5W[F8*D&W/*ZJ_!_F%;B3PC0Q8D'X'#NPC^_W1"E5?!=O MOBIO@HD%YX+EHG'.P2&%_?P5HAE)`2K[F@UGE2_%F>88D%/%2_GY(-*OWBX> M4:#MRDWR[/?P^,J`<8F2+/#XV'PR6P58UL-D&U2$JDYVK&M;65[6:+T@HW]1 MI>5(ZQL,`()*''*1=IOF>^5B1D=M7OOC'EAA(__A.R])L5*0M MGR&:\#K\^CQR!X_(&5G6^N5VC;SSX45Z0+SLF[)=F%AJ4Z1+Z:,<<"TS!,BF MJFR85_IVF0`$4U4PS9SY`.W,B#-G(83 MAXH@B_*6]YFQ/4__,CR\:[M>@V>;]"S+4\6&2E\>".!>ENYE>/*90,?W/%1? MIOYE>#`;5%_V[F5X>%R;JN\G].RL-<O]KULC2_>G5)T27 M_KC&*]U6Y;NRN1SUEQM1V');W11/+;9GR#PX0:%N`_J M?O8QPB(QZ8RZ*77?(<<+D<`76[Y@'BY!Y=CA$(:ADRS2-;'@D&*'L(ZEH(;L M<`C#N.H(->1=XIOR1_V/9AQ>I=Q1/Z.N>^-(L14XXHB!E:!*0T$"=[0UK`)O M'#&F@LK1[HBJ>6]DKRM?.@A)$T1/]7J8A\MM'N;^E='&X/O=86\__^N)>]@GM9Q[."(@R'PSUM%F`^ MOL4ZT)*UQE8L`\+34%<'6J^Z;'5S@*UN6,=BBB1+!ZKKYO@6ZTS;U0);L8R_ M3D-=G6F[DK::H)7KIV7W'K0]0L7Q%-&5(FP.OMC#UUD/*<.X`%V-+%6I M-$OBT$&/5SJU'Z6<@66R78__-2BRJUGR:Q98J_1,JU-OCC;RJMR MI[HEQX9X/6KO".%?M%=$.MZ'%=V',;6#!I=>6;N8GOQG6`LOM\?(TL,YW=LU M>:)K;_KK<%FBU\][-FGJX53#?+X]8Z=U19+GBTSXQPHY?WCQ2=R8(C'FE:@$ M]FR*RPGX0BESM)1$CY82^ZGBY7P1$S8X(M<1_7*5@K0K@I(JWM9*@9P9LEQM M@6XTO*2%#(SIT:.>+7-^).0&)<^V(SV)D"J>L,5JG6$"/MS#F`6+XA/XSS4'J^DBA?R$"@/-4UC&T0Y*L(N+D(KR`A%;*9HMK306S:3X,?F M64AY+`($)1CD."/\]?@NB\#1^'-W= MCG]['-]/QA,??/):W2NG?PI.YJ:G9'_[3>P/+O;OX+SMB:LY;O+$[5T'>W]Z MN)_V/HV^W'TFUZ;&"_'(/6DXG^P7S0I^G=S][_@#)P@K-[CP[_'=S[],R2-( M_/,C]V7T]//=?>_S^)-_-'ATY<0\4Y&N]S M,M?C'AVTT@R=&_OGE>.&SRNOSTAU6R0T1'!P.Z:"P@81I,[9_I'R<]LT[3<2 M;7U@9Z0X`1/-`ZRTD$M/;P^+Q:W#1Q(*C>EZQJ1=M4.-2>H*,DV\TF:$"QV[ M>W^O-%T/_WXS='=)^B:>_R[V0F?S3SU\\>/H]O;N_N?>QX?I].'+!TY<_7W! MO7J`_WGQ;+NN_1(1GI,:F@58V`7X1RXRJF&9AH4"4-K+ZD?K&:_\$^_IXS?V M=/7.H_WX\'0[?HK`/IO:["\*F<.V:>@IX$2PU*D6;6XKU[<4A\/K&XUDD)-7 MW;S-0)PD7'*T94Y5@5/P7[?0GH_:Q!-2VW6\57:XYP5QB^W\\^*_9S.$YO.+ M.*UM#P:MO-K_[N@T\M$)`&Y/<,,V@VNUY0`<:(YM<_VV-%Q4MK'F@I^2XX&& M^EYA4*+SI4BVNM[><'M@16>QO6Y8LW1.1Z_(M%=T"+VK-VZO-PO!,?52F0@I MPTE1?/0_>SIAN.'I&(ME.XAZ2/*8BLJE(O=/5'.M!@<5HI450A`'E[*L=+=& MP!`(P$$X"N!:`@XT!T.@_"'0R0YWV@NN>R%9_[+?5T$G`*[+(A:%2U'ANZMB M&%8`.`CQ`%Q+P('F8%BQ/:QX0JY&#.5TMY/M*+CN16.R(H!*`%R7)2PHESP/ M`XICTVBUC3L*#H([``>::Y?ER@\H*BP7[O!@PTM8LJOWW<,4+7#U_HO@3XA# M]P)"6:IS)7\K?=E9X%"1NE21+@5U>)I5Z9!!UW;_W))0Z<70=1.U%E[&_K!T M=6@)UL"4[4,$SCU-4QX\J)!W#"J.37`_Y"WH*'9T^P0]I]OK9RJH0$*D1/T!"I&I&@H1(D*+F]%/40$*DXZ,]'[5!0J0VSJ.T M-V+M*#A8\0#@0'/MLMPY+MN'A$CMF'*"_"\4&R1$@@H!%0(2(L$0Z`S`03@* MX$!S[;+<>0^!3G:XTUYPW0O)("$2@.N\B"$A$@PK3A04@8$B+!@.)$P4%P!^!`<^VR'"1$@H1(D,>ES0$A)$1J+W"H M2%VJ2)`0"1(BG7'.G/8A`N>>IBDA(5);.PK(NU*W/;H7!T%"I%8#AXIYKA43 M$B(5.Z?IA$C??A/_ZQ_7V$6O'QZ?QH^CN]OQ;X_C^\EX\M.WWW#W*&3EQ45.)*Y:7^%;_Y/XTW+2J6)S3_YX6&>_:\1[.&]'BI M)PFIXO2&M67XI;].;B\X'AFI)1B)&T9J!4:" M.)!E93]*$X1T'&?@76C8!7P2J_?*"M!DOA0T8DX/6K+X+EL.>)7G=P(T9N@1 M.5_)&08\74L6W"?RQ0LX?>*DY*$Y% M(5:^DOL#=:.+?$@):O:?:.8B_5?;U%S#)&5NULXKFM*&:4I`?J1-3D"R3%&J MC4$^W3EI0@.V,F';<^TM70VVN/\4M%ZW#S?3WQ_'W-)],;G'KQ\_W]UP%[WK MZW]+-]?7M]-;[K=?IE\^<\(5STT=S<*&:]B69EY?C^\ON(NEZZX^7%^_O;U= MO4E7MK.XGCY=_TV?)=";@W_VW-B=5[JK7W";EG*O#'&;[HI]^JZH#W3M57RL M6=C#^#W:T;.S39>(6X5ZXUXCP7$SJCAN;CM>BC;"<*U1=W&ZYA*(;QI.)VO; MI_--=*20[:W$Y*_(,PZ[1?703YQ;$=O)38;7\6FC#6.%XEQ?`O<[B7S`@R?+ MH1,J%+GI&:BPL\!/67K2632`G05^RM*3ST)ZY]3WTK%BIR2HU";!./46^*Z& M_0,B?WP:K5[T"\NESPPG8W.G8"5JYZ.49 M.9S$PY3LD:=D51A$@S(RIV0E4`8H(W-*MOP,2Y>,WVIPW5"&+(,R8$HV)0NU M_$Q]1\)SF)*%V0``!VX%<.#6$P<';CT-<#`E"U.RN5.R7VAB)TX2O.E8Z13' M<)T8*0DBK&D"963G*X2)>E!&YNP*KX`R0!E9RI#ZH`R8CDW)HE]^EK[%H7FM MB6WST[15RFH;)<8LD\:RX129LK`[1::TE2(SRF\J0(I,2)%Y]!29D!6S3%;, MP?';9FW0!F0?JLUX#JA#$B_!CCG]%NG_-7A]%,QM!I<)ZHT MY(D`94">B-:`ZX0R($\$*`/R1,"XX=SR1)S/5X=;-`L^.L#@`9K[_!`1)A!! M&3F#!UB8`LK('CS`A`,H(WOP`!\J8?"0,7@XB25+S66G.G[&N15RW/>1I8__ M;VVLZ*O&F!A2(P_YBM%\;7XVYDBA^ZMQF'BN_!U7*B_U\_//:;AGSX,$=)*? MS5@@'ODYE(EOS7LU7Y_*!20(@`.AW\\GVS!7SNSI881OL-XK5DSA$G9"7)= M$]'"@>)V%/(S-*4)_>$"RQZR'1%SQ4G,0WJ+;4P>JI$35<`?4!JBK M4FGJQ*.#'J\&U,E?PY[$^X_8ASI_1-)R!=("'_=W*&KRB(Z1KC65:0=DO9-L MH9XKD#VND$O0+%!PLS2?-&N!'N;COY$S,S!Z=`Q2FA<5CU[>CWZ')_>EPOJ9 MUTUFW1?Q6JT=%&V[VN- MATH22GFH(J%*'G))B3LZ3$38?43.R++6+P&=K)\(K+Y2*KXD[8*@I(H7PA[1-8_:>S"Z^UYVT>A10CW5:U?F/[^ MF5PQ7(T8_.#\WK?CFX>GT?3NX?X#D9J.'#_)>/8$3J@$SI<"M]$"EQ1#S?,B M%9Y6T:)U9T>_L[A_:=9:<]Z]CZV77B[T3Z/)1\X(3#;YRMW;5YRO=N&2N\B> MUDHZ.6ONZJ-FTG"%FRP1&>)^/[57QHP3!?Z'#]R-J3D$)/4+??]D1D:>G#WG M;@T\,VU,&A+,:<_VVN4>YG-,8IW_9^]KFQO%L4;_"C<[4]5=E:0!O_?<>:K< M2:8`#$,F`_`)L+.$J";B<.%[,7T%(R4;1)NNLJ% M8^)S\I!^ARNN/\9R(:)/E!D!I\$5.Z`BX1Q=.V(FAK(9`_8OT#T7UP(0^-,, M`GX;4`@D1:`QF<#<++@@8`(<(Y;R@M4G22B&CHO-E#G\UP'@$#4QAP-4#<:- MZ2.S;01'`DPF"&*H;D%[P_E;-CU7=,QSVQY]#VV\<&9S3J<4O"2P]-HVG!F- ME%)'I;RC?53XX_B=WNFR)5#G4%5M8#D'&B'"@FTF=G/MC8+<",TJSM*RG,?63 MBA=U%FF=PE1O]0)([?2.V6"C&5`OT_A^ZHZUL",HS'E?]U6"!/]^C8`/9PEA=EN/``4C:>I\R8"E0? M'`_1%#J.0HS?+=X"L2(0XP<@%T0)"\MP"7*>4)_SDY@$1']%(0;1%E'ZJS"A!74/PI$.)Z1^`9%".+E%Q8LCS)/)_1#;VHC`2P(J2J2!+`L+@UW_!G$)*N`^L>W3W4-!= M'&EYFEQ?)RKW6N7QH)T]]//*X10`4BY\L-FV\0*O]8`7D;+V6^A%1Q`[@6J@ M*ORC-?C%C1N3\*:E"^DQ4$Q$QFM)Z1J:B*J(V'QP"<#DF,*@3EP$.G'OCUUF M,HCF,0#FRA?N^'-7N&89.P"=1QKX+@N'&:)V$3)J%1Y_)P!^B!10D23BP5FB@!"DV4LQ5W*GC M6R;8`#"`%EA-D29`S+\($J0=<06*M@F_0[@AE`!&40M"?QOLMN+B2+"R0&5$ M@^'+N6!#C)-SM(?,H+&\,6'7@!B8O^#?D'@U%NTP%DU:L][IKK;L9`2:`)PG MH6E9!#\0\7B!!PW3`Q&%W+"_49C%`Y^(R]P@%0@$Y_PD&58O99=!1(VV)]!< M$$T(D]$."#U?Z*F[``!U3!9$K-C;Q^';8V(K="D^"+5A!H(O4MV;[!_D4W+Z M[Z`G4\<1:@11B0/Z$E5)`HB?&9@E3CV?VS(`B;\/Y3ZP9N_(>[1E%N"*^K$$ M%9F#"CU)'<7)04EQ".9>Z&203VS"X@=AI(&1+#Y!?X`_ MM.@I6G/'`I:AV1T3^SOWYY[Q\OYL,S<<.*B:R/+#@2\[*/0%(NS(GI M@$F5,2_R*',T6$TZ%[,GP4-3"8GLDEF:)`Q23% M(]YG8FHRX"B/P9TY2O`S292$F&:AF2KVA.J8J76!6II;J)]49K0HPD<]$>&N M`?19H!VBR!8'D1O_T5*8IU>^?W\_ESY,AR.('KP@AC#"^!TA:]>A$/+5``I\%T!D1./DL/0 MW6]T[( MZ,K3Z=H'07Y\>%GP>@IP2<4;'[D:)T6E;$P\9C-`8)D@+\P M867S;9?>WIW69`^Z&MQ7T<:/J.KSX`Q-,RC_CP@SK^T+,L=`$#)#!X@$)/X3;$QZKC]% M?238_5S-J^1:B:;V>TL;.'^X[*/-K%]//.[3'19?,J9,;:_^,;-L]R.\Z=>, ME15=5;4/__IZ,1LD"QATHGQX_?QH]]?MP\UW%$=JB@TG%FC=WJ`] M6.A)!KJK8*5*V/*1KGR M\J.X;HU&G0YA&]O`C()]57K*(U8- M?236%:4AW5+?`V!]?;5@QD\^[@-6J>$;3C[6](ZJ1G*8>GL"9M'N.Y*+X]E[ M#M:,:$Z:>Y5["V0+>,#R-[MFB`O-%W)A3IDXEN4\N]AGY\GVR(YZIJGAVGS. MD[["OD)FXAKUX@"P"789")J'72KI#N+XB)?$@65O=U5W!';-Q]X,SU'NJ:!& MP!BP,\&Z>I*N82<$.5^T=Y/)!%P7#'-#=@9<_T49QX8E^IYE\_FBFS,X=0WW M0>!*/K9>+$Z9>UXT/(I5?O-4(6/17"+Z.JP`\N#E$P*3/!'+![;+)7S9;2'D M#'_[0_QV*W_#YMG%\Q$1](X\DO4423..5JN!$@A]T*H50#JCWM2)^K$QMBLVD\&HZFUO."\5#^V17%_8=@'T->LEDU^D9 M>EMYX)Z8)SIJ;R;6YV6[%8\A+,;!I%,F^EEGT3+^+XIY#I,"/]D#8U;!(;ENP6$[UKBYT&H3F8D1?PN-B%.U$4&/`#2@;#"@]A4&W85N[\( MKCVN)(P`HB@DLS`0$D:\H'7"#CB,A0 M=.[B_'G9RB6?#D_:#'KB9*^.PTV`F*.R8U"-`(6]\^?*;\XS;MTY77+=*TX7 M#3O9HRY0V:@8Q01@3EQ0%%/NQQ.;\<;B:-%,FC'9U!2Z&"7J4(^U$0F*Q\F9 M(/3'K+U/<4>),`+`_D(A!`L0+=#+=^Y[V0_[1$WTG`H!$^D:G,WCWBW)IL6F MIB2-G,#FVD[0!.G*K1%(,"OZZIEB!S:^8HP^5?3^$7@J[`<.VN_B_EIL+XA1 M#1D1M$,*MXP;I=![20F(MWR:>-JJJ=@4I,1%`9`60[@JS`;-8'.G<*RBO2MM MWA"WH.-D-*E@-L.T3$AC!&/.L+^IF+@B("H`N+U MB.LX.(W8%:<1)U`1K7>H!8)]S\P5+)?)/(U])\-XE\D\@WB7R3 MR#>)?-&)//9*_#EU9J#O07U]^^ M1.0"0F63J'MX"N4)Z=912)YGH.EZOY]AUS+)LXLP==7ZD^HN%CBM)=6'N`Y" MYOYH.);#?SWYAV%0<-HG<9JNTKS0RN2_=2M%H*S3J)7![A42?ZR0J8<' M;17C(:[S:"ZVEZTC"870^KMIQ-D@5(DO%!PT53Y!=/>=VF/RG?)-1J1^4E4I M3_8U4G@ZEBA5R[QH44,!8`$X/&A.AM"QTEACS(X.LL:856_,;L19K(\T=L:D MJ]S<7#06[:`6;;@X,O/9#LH?X3F9L;/H&KOW2H3ST*"].;OW0(TIOD[\"[@^ MOB@W\C3!QO(=U/)]<^RS^(G`T2*:M&:-^3HZR!KS=8`Q&KGX>,S+YELN9A_5LGK37[^=PE7?QG:WU+<2 M](P&QV^']A%/1D\T[Q!./VZC.46#O60:#P6%5;\>AP"7X[)"?5L<1!10L`%WU(`*P2C&W%(#M&Q2:_.>-Y3_;)+YU MRX":AH0CRVXJ:TC(G]4?*VN/%[+&F#4-"8U%.\XR=F/W&KOWNNQ>TY!PI):O MI#IT6$Q<7=PZ0(7I36A:LW9>%]5K@HXFZ&B"CF;MO#&+]5H[KW`%\!@7X%^N M")\M;N2]I_R)&=%A^9N&%;U#?=U!^GI;56,GZ6\"K2QT!YO1U1!=0%JBJR_0 M'6R!KM8_!G1+NK+C:-%=K*D\U&G&&:]=4QJ;6@2A&S(0'4U<2+;M&(B8>Z M#;TZK8$6)U<1,&^D*IC5F6/?8V0^M,VE"UCR/U#R#2.ZVNOU];7$R89K'?XC MRH.'\$Z6;)238XK&\C]SRO\C;H2)XZN?_(]ZKO=689L$:0."`1U6(A?\7B%B M6G\-8@$X":1FA-D@SI?,%4<1:@$NRU^C\^GFTL[(5W77H;!\S+ MK]\5Y%X^JH<@][8`62T:V#*MWYG6Z?6U=N$@=W+1-P*YLPW(Y8A$-Z=(#,Y: M:FKX)I`[:F?0S0>Q2[WHKBQA:MP0Z(Q?*K[ZK-?J]3L+/#(`VA>5=K?3[NY_ M$6)ZDO6(J>7BU-67+\3UN#L\NM45,8L9HKSU@[(VT,]U7?': MXD)ZBO74:*EJ(C';'O3#DBSC4NRM:9;G8NT4T6I+L7QW8J\EV+9W8FO=EMZJ M,\ERWH.\GFA;WX,,9.O4FVR[7.*]@8C57.)=.:UVNZUY+:VJNJVYBN>SZZ`/SC!>+(T3;J^)#A9O=#+"C;TP.6X*'R0\Z;PA`A\@FM%[ MNMIY0Q0^3/`#5.Z\*2K7.U8Z)EK6/98Z)EI6%FM5JN^X+BAGRR;7XO="%Y*R MBPF=-0'1`I#"T.FOJ M.M,ZJ>%K`6])P-OYX+XW/G%BF^[(HS>>><_L1S)W@LZ6%;\5NJJ_#+V&T(>OX$9*`7OJVC+@.LCV>3>"/./U>X!='KTEV/UR MP.[FH;;L#^JFAF\&NU<6V(5U4V2#W@J=59`D\.*`]#!L(ZR>;_7:[46NI`%Q48,/O^@W&`NQ?Y5N@:=Q+A"<=O0 MDJFNQ2\!5@K93ZO9M?Q3!>P"\PS_2Z"S#,5&#%:Q:^VX*MG568O?>G9=K&;7 M\D_ELTMOM5/L6H9B(P:KV+5VW.'8M1:L.+(XV8C(#F*)5OR;HE.RE0AHYZU! MB$`<@.U`+3)9VQO41?5M:!@<_@K3C@O'?J(7)?<#]K@(IZEY8K`VYM%J.S4\!^$Z%1`NU/Y0 M[6$&>0"1DTFD-]M("QNK7(O"-F/K_#BZ0UJXXB\B%,W!*P9/Y0LC?%5EJS7;P`[N^R58V#) MM:]-:*TK@,%_&!FZC(RX\\1,7*3#;X(SVW"G]`SWLPTMZW;RYY09T]^(^XE2 M>T28^>!$IZP$AZP(@A0Z97F-%%E;HQ/VM5`\4C3_DUD6>":*VW8IO0(\AE]& M-]=VM)QSZ8`AYVZ,IGD?0?E90[.X*^J=:=W4\$UDZG66J907L@05'..[*$'$ MS%?RNT(7JO.63)(@Q`'VQRXS&<&22KA-'H]1R;AP)-_0HD7[==XLLL-M-76[ MS&)Q;\'8\3QG=NB[*_*<:[3^ZH)O9$;Q7#J09X$AR3I:JTX(N:%&OR@.#\ZH MVG16V.H;.58SO)"CQ#+(4>10Y[GA3RI6_?,Y,9S:N/YL[@?\T.:9;%(^4/,.$^;ED0B]TVD56% MK8ZI3TM;BA3'*7J5387GV_"?L'G6G"W+\P?@C MLQ>?KUT+.]8;=AX;.X=SSBR8^%3!0NJKYP]:^EKQ!XN+3;QZO,`UI&M(U\2K M;RM>Q37A;2\,J:W'K%U$\YMC/RK_Q/_<#^\:]AP;>[X2;DP5;2`"3OW5\Z<) M.!O7WT1-QP%<0[HFX*QEP!G>H-O$G$?J-)N8\ZC9(XN<>K^).8^3/UD7%B_^ MZFT1D.YXK>,.3::)7W:YGC%?DW#)#(J$\>RG&?WXS9:4>%E MIU5"4;@IB,VV;/%B<6F=&]%;\8GKU/_5-*(W?8QQM`8UE>,UC>BU%N>L!N2F M$?U-B7;3B%Y&([KV.J5<@T`$G#E&0S9NW:RE2,2;TFLMV[D:ZM?*;S#S\.;Z MR[<@8EXCT8KM/',R__5$_GN,$IZL4N4<*W5$#=]2D M*\9YE054<1>#JT6;-[DWHX'ZJ5IMI:1.-8<+T== MB78@HYJJ5@/-+B'&SWG]?NZNGB9_>J5)0$.ZFN=/M3;;6YO=XP.[20'?4@KX M.CGCL8F[2PYFEA[W5FA6L<[;'):WT,Z!IS5Q=0 MZP-I?8C:^(`F)WQ[.>&^SC%]VD&XER$*\-;FBVF5BW!5RB#E_87RB6.OGS+R M*+:!)BA::Q-;6+`K>$Y8\H5V179:CQE746F MT&SI&/W?S[LXP'4'WNRTK[#Z$T[6'`M2U;DZ#XY'K`O'?J+<8S#LF^-1>25T M>)S.ZA'EW5";>0NXWE/[;6VP0'8U9,7BN.9Z^Q!'#7$$3"6.L6NYM[SK7JT< MNT+/0=J`G:9VNIK:.P"2^K9BJB^0U+=#LM]IM5KMZE%LY>&CIF;RL547/K;S M\#&.9(R/[/6UO-Q;=()M4M<--T?=#JMPZ(7)XKR6,*M_9*\H*%\BOY3K\XCOG9-;CS MG&%2L@94',"TU"SIS`*L2`0KC%ZZAT"PR@"F:M0J#%L.(IQ5!BU5HU9AJ+(7 M[_XDG!/;R\`L\4O%MK*CMUI:K[>$4@*B_7`Y8%)7'!95VK[!H*-K';T\7"HT M=AH@DE:8`G&IT*Z5SI<*#=EV?!%-?H[E/+[<857TL^O!3!XU?W?IQ+=NV(1J MG7]3PB5^N4>7G'YIW5:G%>&8&ZIJ\"XQ-=L/8SZ[G01RX'[!_U+S3^9-ES*$ M`.%\@P&!P1J/%N$+%@=0[J6&X[G?H\Z_([3RO36.U90.9P[\)$_\%"7;2^8: MCF][0]O\1&TZ808+\R`7QEQ1@L?=P&,^SB_QW7L:0*VSQA_&)5X_T[NIX7DY MOS>@1TJ\KIJ/>&#D.ZGAF[/^5KM5$@7OJ`43/=$KPO@?Q/*IF-&E2V(BM MC2^$OVXGXJ>0A/O.4[(`:AI$")T%#?<%]VB)6*8@#OKJH"P:,FZBR1]QYR\J MCG8.:)+ZOE#?/`>]B".IG_P/Q)$+'%-OWQGFXLJ"V3#K)<#=\,L.NOU M^X!=6+"X#'8+P>XM-+%8N(LK8V?"W5UXZSQPS[Q;WW,]8N.=%E<.%X5N+09_ M]H"2DY16I]>+UO?6P5$D/E6M"U6$3ZEK06I/ZW0'%2-4XOK/(02N.&^1$2T- M>OVVO@,^$+G+,](C3[?\+8*RIKX4A[QWIG92PS=`KJLI78F_?1V\(B:DYHAP M[R4;]OB(DDV8WEJ'1AR00E$Z(&O6X91:ODA]B\"L*2='L&L0[YWIK=3P_'7P MU*MW`K:7)V'4T!H)8'M[K646`W(_GT<(Z9L M4_[$#.J"F5K`OW)(>:M!&5+?7L9J)5A%HUC.(E&&.^\?"L625I"."L5R%I:* M1=''(MU79K.9/X-4`8?'[$CFSU5RK]]-H98%TC):-Y2XL5Q,?*S2='22,(OW MYX2Q.L78!\C*1#L/D-^H-_*Y,86?8K(;_[8\WF>FXGU=BP,=AV0WV,OQ!YFP MZ[U!H;"7),_9=&_WBX6]'#'/+M^HN67F%F\DO+8-9T8__YA3.ZZAZ=^JM'O: M0.VV$_*3AF=_;"J+CE15UUHE8U.9O>_UNQVU7S8V53F&,[W=:[6ULM$IIY\F MBSD#O=LM&YMR.FHRF--5>_W.=MB,'`_OUB66]1(K5UTRR\?5O@MG-G/LY30W M_S,5=Q%JZJ"M=08)AN8'MGK2'*Q7^]@I4V6CHZYVM):NZW4A385]DY`%=!:; MHHZ>,A5V8=9-:"ILZBQ6:#B=$V8&SBN.?O*'LM='6^J25TF^?A^P2UP&U;K] M?J^=$VY.;'="N7MM#VWSE@.C;B@OG'2PM]EJU0+2]!:))LQI*:Z]=!T0/L:6L M.F'-$RVLEM(C1FUKG[8DE^6A]KO]1-VPY3C\('U.N]O2U#4:M_)T\G2R7P"?KI?6TG^J6?*X=^N>%;HE\%\$GZZ?W=Z)=ZKB3ZY85O MF7[EPR?II_5VHU_JN9+HEQ>^9?J5#U^@OYT=]7?YN;+T-R=\*?TM#+Z@P?[" ML5W?\L3>CRM*\2,S*0_@WC0((!ODZ>`3D8UP^(-M.OBT>#UI$RQIW&2Z=^VZ M/C6O'!YN(_C\@W*#N=3\]'(MZ.+P.++YGT)T+I` M41ZK8BQ`3GZ/@6<>F#41M;93PY=A_L^<\O\(VY+:!!!M?\H`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`B7L.#UU?2.UKROH[BWM&2]W64^8Z6O%45_*HQR73L,H]> M8F^L,\8K'ZI_+WLG1;D<1\TH8BL*CQ*T=[8[6+@"/Z)K`==A$ M@XJ6T_\)KCZ\O+UX^/?HLS+U9I8R^OW3S?6%FYYYHBRN65RZ M/S+\&D"[]PCWDOCUZRID2,%B)<5@1+-[F M%LW,=^`S8ZY\J-N=G"%%S!A%#*3(*0",QZLI1'YQJEC4=15B&/[,M^0OL;.Y M41%<)II*G8GB3:DR<2S+>6;VX\<4.1*$*HW2<2I$%_O*ZV'%F:D9-[JJFVYT M!86GEN7.B0&(H2$2G^?$-,//X76RJOIS[(4\XVK:\&;Q3[>["-@Q>,KO"++B.A8S,P'?2O0+NDHZSO255TD+X**CNA5Y M%8."=S$H[\1=#._3=\]F$N55LQ!4&B7=QI;*XV?G5\*-J=**W_[]VOA7+VC? MCK3IKTC:XE>.>UP9/P);'/[KR3\,@]+)Y"2.UHJ;U#O=H[B-?@5TNGK,T&D- M<#L"-SAFX(Z:<@UPCIY!RYG4E2O!3,H4K*3+0^CE"`X1D*3`X&VQ, MJ#<%"1O\U5'&0V=(+PE>9T?\CD!,#P+<3X68GU`Y.-XM>!1R(B!9%39W3EM: M(R@'`*Y2(YI'3#)L:"0E/^TH(6].'U)_MF-L,52W\%5C^/K$BW`^3'$0CN6()_ M13C4+Q9\IYWVNX,2E*ENX7^1BZ^O2:1?`PXU5,N^JC5*N4$IF]SO54?"=L5T_#$:L^->F]H3B_H% MA*W3=KN[8T18&Z&L+>![:%.MXO&-:V1O3B_;IQVM78Y>'E4\&8]&/HB=#(N/ M==C!(K]X^/<-?,,\H*R14Q($U,.;ZR_?$JIQ^?GB]F[X<'T+7_NV23F2=)60 M#.-;5JB\!:@VE"MZ[T\6,91GXBH_::=JMZ\0VU1^ZJN:,G&XW-+#7(-8R@LE M7*%`:G.IZUX\$0Z>4\X<^`@RKPSGG%F`A1BF*>^8;=`YOO8]#.6._SA5+JE! M9V/*HZ;J4X53=XZ[+Y^H]7*>HNO_.3O[;)O)K6EI]0\^K-\J&&WP*V'#8*'' MH30;!D,#4OZ&P84]/I*=@VDD5\Z7WS>M('?2/&?ZJW?L?<)1+;_WXO;F]BZ( M.'Y1;CX_/$`<Z" M$O`)H1M@V#;*9J$[D&YCV=A+SY''ZL=HLHM@)\U&GCBL&I?CNV>/A,P_#@UQ MLKT[(B\8V5WXG*.E05^3_5/)QP4,VGVUU_J_'];#5P`.)1X5H+=Z>K]?/@YM M-1$;)FBJW?U3J];!+9WX#78$S[TC7I96&8-*%ENM4Y?53.,2Q8H!6-5 MHH!F"&?Y")5J/[OM098/R(45]ZD9GI68UJ_L7\L6NT%/33(I&XS"<"E1V#KM M2E$I4\P&W=U0"?LJ+^FIQQ+/!*`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`EZV8/"I@%B`@--R'U\KD7C$;C!100FNODN^\YX:/A?MGV+\ MYQ_&E-B/PJ;/F.NBF+T[N?]\`5!XCG(%+U0@9_I_8O`0DAW#HDH?I[Z+WJ3< MG_WK/+91*?IK**@%Q+%>3A&4%\5TD+R`B6'Y)E6`1B&4,>2"C;N.)SG!Z=\^ M0_J/7Y2(2()$!O@ABWHTDZ?GL;U3NXK%Q.10O/55L M:E#7)?P%&4"4"6%\`5-(+C`+OH409FYLE=18(;0*F)/S*W*AP!/B5F9[OAY\[#7!PIV5W)NOM=B\!J3O=`$V9U9=. M=]#?!I@R6=COM+K=3<`,#>G>KVV(1<#[W$Y&Y"5<\I&_??)=,,.16&[U3)6W MN:M)7+>`\B!DJ:J]N:4-!D52QC;Q']RZ\$0L?&@D@IYKVX#0P:675/Z[($O. M!ZH4E;;:[_5Z2U3)"6?%)*E*3#),UW%2I+*5T[-6:Z"IR[ISG#2I:FWU;-#3 ME^ULD12!Y,)X29ZKE&MD4_I_A64X$2S%>/ZFZVIA1BTJ'D`X5Q1#INQQ"OFL MQ8!*F"@_T;`T(O+>&?'"4R6Y3C1AP;K2 MH^.8[FEH@BSGF7+\'>_H1OLT(_P[]3(75O#@/H6YD!UYE,_$,H5C!TL=W/7. M6+".)CXXOJ>\.[FZOKH]>:_,J#=US/,$P)R:OA&'.%HX,1E,[GO!0I5`[#18 M"D)DQ(FZ<^[`XP#QV'7`I!K4-F"026;DD2(:#BZI`+`N$H5,)GBB(CPKL9/G MT0")P,@2"ZVN?"T,XS@1&&'O&1=BY?J/ZRV6#$-8$5$&%A],/V2*N#0DIY;@ M9I+OBACPJ*L`9J*J'*[QA.0D(<;9I%XC@BGBDUJ?!XKTAEJB?<&G>!6Z) M5]D>!)_""`+Y?+'V+^K7,@1ED3V@P`5GQ@SDAMS'`M,:`!T0B@?60@EZ&H29 M``RD#92SX[FVANP#JI&U*$'^N3S;UW9B;(W[G6W/^H716)=K:"IHNB("2?2\ M5$#@HL[3WB;[.509"!NO)&7Q24?8-!!DR#-P,XGE8("P5`_:ZI&F,EV6Q)5_ M[+^BM94S)<9OX:\3'*^-W3IT+>W>G\_!5P\?.95!R5F46=Q[](D1Y0_X%J-Q MV5PK4P#PZ#<>)$NB_]&%0<'8ZZC0M'0+@PS.\)G:<*9HR;VUPSM6='G'RNEF M"D.FI+C^&`)5AO'54A2ZH@:X'=\@41[>7U^> MO$>0P-=10/E,UA4!`@O28?EOD+>*B`T?Q:"7SQU.@G[?/QCU;#*KCQA4445[ M=_T^=9O&.E7.NA3AWG#FHE)[3_D3,P(3^.:OP?@=J28KV93/HD;82!M.ES3J MD3R"H**H8UHTMT3FA6VJ4E'N*36!Y(_2Y;A2M?#WD2SVP`MLZR4LUX33!A_I M#\/RW:""(M/+,->1\\6?$44LEW''=P4D4?T=QKAD1D_#PI;$"Q]?)%&86KH0 MH&*%BP7IZL(NR,)4#.;E=R=>%HV2UT0!91KE32@OUK'VU=X'8&*CL#+Q2LBJ M.\7E+%$X$6X.7`](;B#ZV/".NB3J#KBO`(LTX"__PDT),)@2(#FJ?ZQX&:^G M&)1C+SM6;WP7\,1;;=B$+>J>,3,1`H)!IJAT!J!@WD?";"]:3'O7>B^ZZEWP MF\A;<+J!DG%*)@"/0GQ0?`#)$%MB.,6[!P$\)M319D]@$]#EBXMZ1'^^>)$- M.6=XX$?LI8X-K]3D*^&-GW]X,N^4KV[T=4E?"U#846@B1QR<;:.Z")WPFLN^ M1.H-!^\)D."/!'5*>"\0Z#'%6!+3G_D:MQ=`R<.&1 M7Y(KTL(7,[DA*G3?"7\:+`,YW)N".4%S(;1%I#`X7@(*OO&)F33QJ`B7(70' M>)\Y\T"W<$\,P_J[IPC_CHODIB]JR?A@H*^6Y3R'7R$!A.MG$Y!L!40'ZZVN MK,B.*4#^A"^%">'7YW#7CV^+]2T^UR66Z^R9\*YA%.[N_..B26[+\;=-I/;9N6V0)A&=9O4MDEMF]2VMOK:I+:EJ"[ZS+TSVV7&Q*#NJ3__HOSQ M^>[A^F)X$S:$"?@\9Y[-)F^:8LT^7#]-S!:EX/]&M=L^`P]BC+P).`YO\N]7 M8I:VV\L!$5W0-!O/P2\=SL`C?"+V]V8M/R\M/]L>?Y&Q1!99:T/'$JH1\G@9 M68M8MX9N+.A&ELH*620-2PMQ<84@1?S;!"=-'>"P=8`LB) MB71&YQVT2]W`Z#]Z!IV])6(E/-!" M]K#AT5^>#"5D`[#X?6F6D3\&J53$5>2B"O#N9'07I!ZR>P6B@_BOUW>-`C;9 M?,F[#E#=I+9E9/88$K,?RKON^V!O)>YWFLVP01'W.RTYI:#()5-P[.&W4EW# MVOER"6%&7O`U81%`QMZ4B?);7,\=OJSB\,=I( M<'X)!@I&.W`;$D)]@<8^+D(F&-J(1ROS],[-9HETC8L`5 MK=$VG**%\6J;`Y;#K8/!HI?LLY;M,V%V\([9>&8ZB.;[*&Q-S*0G$WM.\9!Q M>-U/;>U4[ZCB/3_]?_;>M;EQ8\G)PJC^U)9G=F M[&?LG&Q>_:M%MB1F*%+AQ1Z?3_\`W\(^@&;AQ^5H?W M9=:GI8+*_LP^MBY"XGYVAQK;:F!1Q-O/BWB/K4EU0MUO&OAJI`-?21^=7!-) M117*PSG:)"@O2O,W"6*UMJ_=@:V*I!X>IA30VEU`:\,8U0+=.A^F:O2CT%1B M/HMJ6ZG\<[9I^"5/-/-,%.U88S)OD\HTPXQWHQ<&<+23`8<%AP_QB()_@L=?GE`@[V/AB,*&8^?<0[9U^A(EI)H.JH)1CTW<*>S1<(C.G"_;#T&M^CVAN)Y,7>&MBNJ;-Y ML](A-0&3'65$85LFNUMC3$.=&603K&J.H^W_%,FX^@X\2`X/$X'.]+J9)#3D MD?1STH'@F7GP4FQ:+@;PA_H8F>8G4VLT>M$&S/A^@GWD+;$!@_1Y8E,FU:`A MH4UR1'1VB,];YY$AX\"H]3P#+1+L@,"S'1_B;:B8[Q'%L[>I=^>^)]+%*R^T ML%M[PA,L^*Z&$;@)+8MZFF<#U*)D"P!:-/)0B-65FD?Y%Y0`TE.(LOE(F&HA M_&IGSK,O9J%C7L#P'L;<'B:L>]?LB'@"KD*K;TL:=\!DQ<^`GT$NF53K,$WO M.O6Z>"@6Z!<-H<'.-#@W<[8(G22D(4_1;TB$:,&TV5L7]+2/3]5G36]UYA_W M%L3\B&X)&&]!TM7\R#M./F!G#_\[ZA=T-D_$):*E^PV2:H8\,KHQ\(C[#JJ` MR$`=X!%6.AK8N-]A8V<$Q^%>47O6;51&?/]5RZF=W9N$X_91M;Q!5'0/]\^/MY^JSW<7UU_^OKK>^TRHC:[A1B7&YE]V@P).U%0B]4,A72I@GI5 M*Z@73HU47H]0$+GR!>]$\I?*953FD;".VEN6PEN[`-ZB%W<.6AJO>#JF\DJ& MBO11_7FJ?W?LD0RJ/[^WJ`45H"_'TE_UA9^B%#N,4E`I_$*4PB^<$JF\%J$8 M155C%'&$(!N7>&6M_LT#%!2=H.@$12?2GE[A6PCH5/6?HAY[.H%&Q\[HV%F5 MU_BJK_`4AJ#S;T=S_JUPVJ7RZH7B$W00KU('\8JG0BJO0ZB,$)TY7'#FD(X< MTI%#.G)(1PX+J_GW4:QO=HW>O$Q?7DWSY7;`IN_X@AH7M\P>``PS*3LR*X96 M]FS"DXP2MI9%";>M^;UZ,K33D_1%<"/:%[(8:?JMT4:HJE!4B;#H658W#'$UL?SV`+#R/+%DV'EA]79<9]M;HX22V#* M/*%N\9+`U3/?"4:C3R-W*(XZ?+%/S^.M1O%:S28"J+M5EDNCL4>O(J6QF+14 M2_R?2#]%V1FQGE*A4M>3D58/VXN"M,=::]8:.EZ)KGPP@0*2JQ*FL+P[3YU+ M4H9(;%?("^1A;1`CE8HTD^8D(W3R":H/70>^E+Y)$K>C/JA;]$'U2]`(M7B* MK?*:C<*DR\*D*A35P'B(B(F`PL*S&^Y0Q2]2X4C0'*M=)#SA\9L+FN-_75'B M.GT$).L[85]TZ3ZH'@2),X22G7*GT@;)`+T8G&$IY>E'YH9K4K$>%/^Y@:HS M*$SFQPOU),)"##>S48-'#Q`:"*^.$L:'I9%+UJDC3B&=);=;)?7>\IJ@5 MH:4]P_"$(RU<_;\JR]^)&5)7O&NI1TG!39<:9/]/Y[KB*4-V[H!%>UBY` M-7/Y>:_>ZJ\N/M6<*3Y5;\GB4]E[J?A4,3+QDNDO<3FJMUP`5+@&8\N!.[4, MK=VI`[`C)?;QZN&#=F7@_H'0*8`8QV2>B:?[3&MH&5)AB^P>T/3`Y>1:I<43 MAI]KUXD/&IWQ02N1_[!\L2&>5IWX!VHSD%*399-]?$SI4T7&XOT47<6P\($R M\B]#Y#9&^&?2=@=@9-/ MXJ6N880>_C9DEMS8P"]6[N$PW^>^.!B!5G+,FB`^^0@\TE5P#BZ0EPOL6@[& MW)S`QCW%)Z31SVQS`=_^"LV1[!.Q8--"/`WG13`D,S&QZP]#D1M&:D=$G!$3 M"<3(9["C3!E49;BS.>MZA`Z^P\/G&#:S)NK.['R(D:6>/A/(%=%+;!NG4CK4 M5N0$_)+`C_9FYTG,?3O@Z9GCKMGBIV6W0CW,F!YB`M9H+)._?DQEGIG*!9<_ M!#+X6I[=EEWKCT^*<0D^<6)2D$*4FJ@;N!^GGUMBFVT@4\\%H@`98$"B/`M$ M8O;Z``^&6PX($]IWT7&"9(9$:D]R3!A$`*8%K"@+'V4*+$GC+/XN=7F<``\Z MRDOM(^?MPJ]0._E"-L>6&2XP;>J"[RP,WNS8,ZS##*`@81;J*BM*[(=ODJ1! M7>0P^-E+@2EX^P*^@+F.>BQI!C>K@M16*RH7=7MT,5@8(_$ASEE$TE%C69@N MJ1QJ_!X?$(U/3]AN2M/NF`N$?YY7O9'GP]&.GV`A352U\"LX0WAF#2"701B%#%X.+J7#4NF9$!U^37W-G(@?'7Y@3Y=B;+I=H5(=)=&W`!!E3 M/'3B8+1%&@!)>U#A20$HT972)>Z!#!_#04&`1X3%BCMF0'A*`S`3O2>.V;EX MV-#=4#(!DFI'7JXT0KFG\XH]F0TS%%M3X*`^PV`\7:IR*7$HMZ$G=M<%T6*A MRM",?(@(MF7(7)&-GR3ARS."]5R2I0NWFNP]>%\S+M'^/"\J^TN>UQ'H?_*\ MR/-Z$\^K=EC7:^[UY'N1[T6^%_E>!9(<\KW(]RJU[^4Z#[@/>\^\.T\<:C?_ MA5N$]]Q[$-N"D=.UXCKMDW_"E?5&=N@K2'O3,??6&',S&7.O`F-NU]>:Y]B1KA]Z MS.)7_RH,QJYG_1O-A.Q89W_?*9;EKGQZ.1I.QD+&^+NDZ_U6GW>OL9 MRQL#K=_L7L*\M%\[EKLPP&-=PL'/'5#J@D*@+47/CH=V0?!.[;4\A*Q/,/ABCCJ7_ZOMG7UT=>R(KHZI65:-'3UN6H&&4UZ:B-+!M\1*R+-=@^IC M'(1)BF.H$&TL!>&=GS,9(+&M"S M;)&5+>(YHAP7_H$5/IZ8+4/*QSH=5R+L]85YQEAK-:*SU:K0@)H+/&.3+((A/*ZI=35$!BG-, M%KH)>>4/W(\26!K-UP$^K#B8Q1>S/:D^'CSZ1IK-><$ M8M-ARAB!N$V"D4C!4L'9!:TTO-Q]605YA"7JWQ#!"^/[ZG!= M5'\'A#HI8S`$(P_D2U9$%U7/LQHDV3V,A$$6%9(;98F09^_*E<,KN!7K,8LJ MQTY$!]9Q`UK$_AT6K!>[^M$@Y%;+MKL<^;L!.*"<8I,DANN*X;\`)ZX2PJL( M%??L14""Q#'%HZ1OB3%O=L<"-56LRUI!N#V0U.!XOS].ID=I\V&J!$\@R,PY MR%J?.\@:"(YCBP8/.0YN(K=M?\JPLA/ZL.+S%*LOJ<_/EAF,?SEIU.L_I5[H M)7^:T8OOKVYN/GW]M?;A[O'Q[LM[K3G]<8(G[(#@7TX&;@":8XN3MS,$+RJE ML>1T[$5@EI[:#W??;FZ_Q<2*L\)(LB9VB^<(!\CBI,(7W9.-A7)N#*\72D-4 M#YH1@%JC'YO(L]J*!?,;O>M.HWJ-:E\@)&6./X[[[+'I+R?ROU68Z%YQ)SJ) M=O`@[NLQOP15>8(OTAJSDLHS.RD2!P4>P7(Y6VLPB>PU2R![63_@J(2/<%L5 MW#8)MX3;$N*6]"WAMHRX/2Y]FS72M<$()L[U?CGY;\/@?#@\20]\=BCJ8QR7 M.3!Z%Y`GJK\7D;Z4B!2.UG0IU3+!F6!`,"`8$`P(!@2#E3;.\]@*^%(+1VT$ M=9H_S5L[;VG2XB[!2IL6*5F\O?"KYSYC=L+#B\.]T8MV'_!S[7-@GFNU^'`X M5LE\667N+N!)XZ<2`S090S&IEAQ=1/;EVY'=J9\WUB5X>=7=U8C?9)KR5,I/ M!-9"4'TPL#:ZYVT"*X&U%&!M$E@)K&4!:Z-UWBDM6%\3TDP9_`6`1-GP2E)6 M(&87S0LG/!.>"<^%9G$QJ28\$YX)SP&R/Q(/'8 MS?9;>W_;;R0=)!TEDX[.>8^D@Z2CT*,ZG&G5WM\&XWZD@S9RBNKK%Y-J"JP0 MG@G/!R>;\'QP%A>3:L(SX9GP?'"RRX;G5V_DM%=LY!QZ@-M17K8H`(Q%,]UP M8/-*A0$6#>M@RJ';.Z\?*@[0WG.4C.2#Y&/3BKG+R\>VJ/&_=Z71U9Z"W;3K4;JQN.M2: M:3H4MU9J4-.A>9B++_;1=*A-38>HZ1`U'5HU'=F5NQQS(3L.W7"#3P;PZ ME'CPAVTNM,"?;_4+'ZU9TK5%#:+9_ND86O44.MY6:.*.!%[;-0@J[LPM[O93 M96W6:/Q4LEKW2%7=.)>":UZV:"U6?N/0D]=H8D[-EQ]5)[Z-SYUO0#L MZ*V]H+V3?B^#"K<85"@/U;M:(XJ16TFR7"!HD2P?6)97MC,TPMEY!P11Y@CXLI"7*$Q1_9S)8DK-.8*P+D=U/U`RZ]L]1GWT+'IT#.[ M5";FL^T//F&"E,4SUNZHHW:K2V=NFI%_D*'/$KEXY#]5$8.%)JZ4`A*W$R,! MJ0(&"TW][>' M287$X=7M:LOH_+RB.#V)YYZLN<;E^?L^"0C[+VB64TAWZ5;L:>:[V MR(TQ;@3A/M":AL6VJ82%$.[7C:&41F-MS7E]=<^%*EB16XA_%8!=A3&0<))P M5A+851A#^:SG3O-\92K[%H"LG*-)0EG:,91/*%^Q7*Y3A[4"$KFCW,:"8SLI MVEIB`5UC$*6T:;MMVL8K8^"3!*ZL`M>C-&$2N'(.HGPV:+^]=1Y9Y9R_*B.S M$H,HGWAUUTCI/SI/KII=$T1T0MQQ#W\9+W/=$A9><-ZKM_JKNR0T9[HDU%NR M2T+V7NJ24(RBM_>>Y1C6%$L6NT,M,_UO#/KB%KE]3)4^9].I;8F:Z%P;A<`9 MK-$.G'ITIY:A]1MU+7^MRLYHWH*4E;63[**DBEI_O'KX$!4JM9R1!GAT3.:9 MF$IMBOKKHJ9NX&HF#[@W@6=KSV,.MWJB%N_8?<8?C?A-'+YVQ<_8R"!XR2UH M?1]Z?HB5W>'6JX=K[9Z!!'AL.L;QUO#_._!O47Q;5,V'Y]3<9X>;HBR_95K, M`Y;5\'?Q%N2?Y0!A%M:'Q^.N6&X>2]4SH4$\U[9Q=.GB^S`:[@@BLRUQ6JL=[88$*QH*+\H6ZJLLO"=:08.]G[;1YIEG# MU&58[)YI`\_]SKV:R9F-Y;KA29:LQNT;[C0%@,MV7?864!3`S;;UG=NB%P20 M'?`)9KQ[@+73UEEJ%#AM`X`7E@Q_`FI%!7Y#@6[9^[KX@<$HG5IR9RVZ4W[% M^=;SVA=O#>&Z5`UQ66M]Q5SAV`53_;$UE43&S'YR!7RC2T4_!3$?'H='I:TE!#-QG$,/L?.;R''7) M%(^`*SD4*)DP[%GANP!D*P(J`ZO%]^$Z12T;B6F/V:"+2>`_X,DV,`R8(I[& M#."FS9F/3!QY7+9R$$^4`_$#4*ECUX9UP->14^+.T`M`91AP_7E&W:7$S!<" MCD35D)&U):*NHPC![7HBYHE`I0K7SS%"C+]$K2+><*5)=RQ)Z[HTGU%L+EPO MT:I'6TS]=7MP6$_Z#?P4\<4K.UZM*"O-)D(KI!&R-=R+,*`8W4*)2Z7[-@D` M.P@KY+#C\'712SGM8,>"*0HS+M>HOT+/\DW+4'VR2HUH<*=2'9QPB-Z(.=:_ MUSKU2-`N/;1O!+*'\S@`\VVRL5]=N.&=FFI\S/@[M&1$19I_Z"@;:!6<$>:G ML>_CN*^='PPNDKU:7.*(=<0ZLE>/RUZ]\N%?GZV)E;>K4;45LW06S6^N,]+^ M%__U^E6S. M@BZ:9',6>GIDD+/9)YNSF/.3EY"<_-7;P"#=WUFHS"_%SMS-Y.DF"?$^)K=A M&C:>>C#LT.0BDYK)8QQ^M+<3GS!Q3/%Y@ZQ?\8PD'WXJ>QASF=*.#SCUS\1S MAZHQ\^RU^'N`)R&B,B;1$7QNS)ZX- M.#+-!GO!P7EZ:\YM?S!PX2F^W1X(;#=6'PALS1P(;#3E@<#LO70@D`X$%E5- MT(%`.A!(!P+I0"`="*0#@94]$+CKHBXBW!,^N'IZ*E93X>V4H_N$RG M$NAX))VN20_KLJ0X7G(\LM1PSCL61\,FJ\;+$$'IG2+JN)OH$K?).=L27/(^?KD:RUOZQ.YN/9Z?29M[2C.]>YIVM_(D=KIM-/1X$6(B`S6:F)BA5^QBQ/&>=6[ MBS?-ZS3-*`;5,X_9&"/I4(X7X,K.LL0&WA+_<5Y MD8O'JKT%*Q^NM0\>YOII]P''--`,1TNM@M]B1E_A@ZT,!L8C>["<$9NZ'B?V M[](]6C4!=T;@#KBGR:S(%JV4987,3KVE(JY_/VVS`"XKPUB2"B?;E04Y,-%4 M[;$*Q76HVJ/K/'%`!NB0KV[`_7OV@OKD.O1DH3-9[W'))>>]>JN[N.(C\VON M4)5\;,DBC]G+\8;0L>35OS_GUZO7,R)80\P9CZZTQ MMF8RMMX&8X.!U0\YMG9]K7F+BW/6-QA;H]YK=+J7VP[.#^Z&W_@3=T*NQI+Z M!OG<7UUDM#E39#2>H_X&XVAV&[U6OY$>1XJ2C;EY2:L?N#>DX7+>4)V]-4^UO1[8G?&^JI-7H-UOM'1*^+V72[?;F=U\*90-VW_!!(*T8'ZQJ9<]P\Y/C!UZ(YOG5!/V[AAC1NA?O4PEU9NS- M=6G<$QOVIM,*S8:]:,\]!CJHR]DQ(%T8VWS4[=1U$4]8HCXO'LT!KU'_""*;&'"><:":X(UCV M'8O\OW#F:2@YXEE1S45\*8;SSI'`:"OZR?MQLXFG?U\V9'C$<4E\>J MYPU\NGB#JC>/+^JV]$ZWD:I`'RRH"3Z9P&M$-7<=^QM,N1%83]Q^.=X`+TS[ M_X0`D6;KM9ALU(N*R8BR;3'9U/O-QOEEWH8OJXE!^<7A6CZ=6F?) M>M[LRM2))5"5@]24FGYD']F$P7V.LJ)Q^2T,H8EQ6WD4BBY0$5PN>7=%? MJ-'\*8>E4VE5"F%H*6$"IKYTB!2=@ MI7)QQ80%H8?;P2`:#WP:\`FJIU9=TBO[OQ9]$BR>'B\W:I*]3&K*2A!EV M9>=FA.!%E28)5BQ@$:SQ^VGH&6/FAC%:9TVR%`$[CNT7KC<9NA;:L-F>5A[DX833',3*2$$-UI MAHK9U;70E^SGV@>L.EY[,&!)PS5$`+P&,,-&*]K$-;F=($DVT,$?GCEF'W&S M!I+A80\F!A,U$3?G]-=9MWMIA?K.+$_)79!HU=]W*]W7]PR__8$>%B!2J4;; M&H)`HS2OK.A?Z(2],A*7.H$ADP/?&C[KJ#=!R2+EUCI713Y*"9-7G^Y">3_T M(`K-X9(25XQC+L7EW":G5RJX5#ZY:+C9:W0M*^X4EI2X\BV1O?9YI[4]3O8J M(^L,=ED=AY^6CI.66R*.EEM:;M=<;K]9_O?:$.-+<23.8\'\]G1IIK&DQ)5O MR:V?MWJTXM**2\31BDLK[OHK[HWU9)G<,;47B]O;5MHKP.R5E+@R+K2O"?_2 M0CLI7'6&B+R)99HV+RQY$?=2+2SG1:<@M!:1E>M67SBF3?KUMN-5=H6>VLO/ MWZ%_9K[VKM&HBPRO=,(+_#2VC+&XP..&ZYF8.8<9&J;EB_(*4>K&PF2:<^UJ M&&"FG`W<8T&4"A"_3A1*D`EH^/W4<\%L,?WHN?%@F7\!8<@*)`IILP;<`=/K1$!8E4'MR08ZH.UP8OFN%Q?!`0G/=$?$;R]919 M9@TX9[`IYH^)I!R3#ZQXO#Z;Q)F%BOBE!.0F"J;S,^!9,/!_`Z/%A$:,P1@E+S]`&KY+CE0Q_UVKJ]4X]+I$QA,?`72)=4E3% M4*TX6JIP4'FR<`Z?/&B=17U,.FND#F8R!TO#Y3=(',SR+)N99B#W;%LD"LM$ MN#DV(OXSR84L-ZTPDU78;(+6:_4CO6I)Z0U

9J^> MY$SQ'Y8O-$Z4B)C.0SPYT]?/0]3&S-\@"W'W.8?`M(FHK`':)+3M%%<4*U3A MF$4*;.L,Q04)BC%C\I,3^_V&WNNT*#6Q3*F)>\Y,I&3$*@6@*!FQ.,25+QI% MR8@''T2A.5Q2XFBOAO9J*!FQB,25;XGL=66B*/EEI9;2D8L&W'E M6W+KYVW*D:`5EXBC%9=67$I&+`MQ95QH*1F1DA$I&;%TK*1DQ&V3$46.X65? MKU]VML\J7)54&#U_QTF%(K=F.)3E/=.);I@A$&>2+*XGA@.UW6>1=\=D(L*$ M>=]YH![`@MQL#Y'N@^DB!K.-T)99>#+E8<(L!T<]DP4S9$:<9?BZE,=WC693 M;[5;;Y[GF,GL>-ND1O6<$1/Y3-&[TC4?1>*-[/U>NC3$78OV]4(X8^Y M#\-L1LP>DEZ2E6+_N2UKF&?=0EO*#>R-FUK[BV`\+NPTFC?F[>SEF1$7=&X( M.`28F<*=%0DW6ATL3K(B)>G=_N'M\O/OR7FM.?RSL_UH0_;D%Y84B_,/= MMYO;;S'=`TQO1>HUT:!: ML(5L\7)1["6AT'*TOC`4D]#BJ52:[K?E8I$(W<&N97??^S*OW[6\<[2O[I,\ M`MCH%JZ'5'+@:B[@&KC:@*?"C7YT-O`)GS$%ZX&+PX,J/.O@&<[XU-V`^9:/ M(6'#D?'#VX$GVW)K^CFGY'0^_U&]+O M:.N=?K>"?L>Q6X[D=A!VR.N86=)G,D35V)9D)JR^HBP5?7JN0WB3-; MF6W+URK3*G0PRS;!#5;,9',U`J-2@CD@:\Z#+*?:WQ),S12J(VNK<"NFG'NR MN0A!VR*H7E&;BR*]%/HCK4?371(5=00NU4MD93O$#R[VFGS M+*?TQN)$$0RY1Y:KKH$?,95U/>P778;:4_W/Q(VMA1DFZ4"[OCC2KB]Q-N;; MPJS=N69NT/DL`F_&A2=(MLBD#W]!%YN&X`F.->K6`[QJ9[Z:Y5C$YS3'&GKV MGO7R/%9Z$6N=%:S"><=USS:6S*)LK;?-7Z4#N835DF)UI?=3M7.XY!F1J5P* MS4K339Y1M3=-'L)!363[O%]<4I`B[D6S&'H]2LDY-'$E1Q"EY)!U>53F!FF] MHYKNDJBH:EN7-U%198]//>[C@3]GI)U:9RN::2=%LZ.\'<>$V]1]2ZLS^V2M M%LW6.&VWVWJOOR-SM50-*2K9GKO<:*1<$[)YC\4((IOWJ*:[)"JJVC;OE6&$ M$VR@@F:K;/O!HOXP<9,1UZ%P:WE,AE93KW6YT>\/KDUVK%8@GWY<8]Y=&2 M!4XF&5G@1S;=)5%1&UC@[=+T;,Q=9X%\S73#`?:37S)G9;*=WKW&=EJ#'^4V M/%J=GM[K;7O8;!G:BZ?*"?@$_$VSB+<`?H$7M9E"RV_8@?Z_:K5;Q_SHL1$6 M3JK5HCNRO%8?_G$1^K418]/W-WP08.:=[?JAQQ]A,C\@"?_\S__0M'^LN$BS M3"`]_[?S7KW=.*\G_\,IKM6;]0"5WYJ-&NMQMR] MW<#N5V1<7MU]/M)-Q$$S?7UP\/S^?/[?.76]T\?CMX@<^JX$WJS]K M0>K.H&/`'ZI5;3KE-[SU_%WO/]@KWGW0)ZQVQ[>/SS,WQC!<`' MX]5\N[F]OOMV]?CI[NM[+71,[J&:6!ACL\[FRT9DJB;,[^^+X@I19FMI.+UK M-*ZNMR$Z&,NV'VY<=0/K7RQ,FX2KY<7:F#W)"G[N5.1Y`-&*4/EM&/@!<[#P MO2(:DYGCTAY8R$,.=&G1"E4B8ZZ`!WZ%/,/E3M7]AF?E4;QFH8\Y=F7G9H3@ ME94^@H0%BRI\1*4YLJ/@/[AG6+Z8N)P1\1]32[`^&'L<9K`ERROZB^LKRNE0 M0@9LU8S0\P!%]@L`1/%8#-@!ZC@L`,&+F(1L_4),3@_A"3`$61U=\F=1#9;Y M$B+'(L&/:5F%*R*6/RT=YPXR\TNH-;Y9 M_O?:$'V*V*CWP`8ES4&:8X7FJ)^W>J0XCM38N+&PLX)C:B\6MTW2%J0M5FJ+ M5Q76J::VV-^N6;$#9^N%R%2854_%U_*C9M@S\EVC4=?;S0Y\&EO&6'SG<PBE$9T#[\_:)W-]'M= MNCN8V1PL#9??8&\PKT=NO$>3-,=5>UUS;$3`9_8/6>[.86;C4#4XC=2G)<5U MM@=NTEA7/B#IKHMM=54[W:P`<>6+%-#.8VGEG78>2<[7WWGLG#<:%!*DG4?:>23- ML>%>0IOV$H[5V*"=1](6M//XQCN/\S&6+'#2EV?B,,6.DJT7#Q/;AY=]O7[Y MBMW#59N'T?-?M7F8'Q(&DU&VAYUO=KNH<6T<^L>!VNZSV&EC,BXX8=YW'B3= MR,8C MX/^H3WS.PBZW>SB;!Z#J^)W:;$UZK'?ZZFQAG)W:>;D[/LX4S<>*NG-MXR>[5?V(O6$,-I2WUYPT$="L5G M^9K/C1`WH0=X4=0.'A\*:PNJ_NRF9+9I^;E:P>.+U57/EFV#RHWXI9CCH'*' M!XC-*^T+C@;6(>WV[Q`6`$RR^>08YUHXQ9KCMHM[7:0TUQ7@VR2\]*(TJ?;0N! MY;!0ZGA#@`2I'P8\_@UTV`ADSP\R]Z]\@8"AN(9-IX!Q89X.F//="Z>!(1X` M#W5M&!U\LMFSC^-X.M-.V59#,267Q4EY1UQC(<@'@`-ASOHIBEP<*EP)]F3@ M<-^7-T5ZF/]`$UZ:IO*LMY@Y<8\?8C*-N)&;XE;'?9;I,#Y2*FE!1C+A-B`? MX>\@:O&BO(A$-5)0+&&_I0[Z)S`,TQNP^/@[R%.BL=,I9MQS'>1]7F- MI,+?'\"FY&`3:Q]">>ZUB&)NJ/#+D'#S87/=@/8'D1 M_L_)S>.U=@OS@%$$/D,%SX9)B?ADN+!A2/D)RY<<:+#`ZYD8BF1KC'^H]W^,,!I&LGI M@9L!-;2JK+NJW%NCT="*_86CG>!>8>7B#T6>')H\$VH%G*80J MCJ'`"%1GE!R`/JJV\G![K9V"9*@GH&+D4D`6/,<:2KVUZ&?Y7--CS\X9.O*1 MY`LW"M6VM+.2A43O);D'>G7J9K@S!`*UJS4?>*&,>[9D?JZ`$70@^K%BP3`0=7&Q/5 M1&1#14=4F.`WUQ8K02#4B=!G."IE>H+6%7Z]P?QQG!V(BY"*3<3!AASZ2%VL MJR[^./:203O/&A6^Y5A!>T'MFGIN[9K(FU19I#P)-LXDDNJH;/X"DD6:+I"% M/ADS<:1R&897(?F!K-%.]\E"986%C^+\UR$&?$X[J]-?CQ:6]WDS MJ"V;0FN8YQ@\).:Z\"O M.!#V+MYV#PNP?`(98^Y`^:O$O][<>VI ML!GD9H)BE_`J/N#('L1#Q(4G4O:$8Z3$!W/Q;5N^V7X!8L#V!QM!$/))70-B M>:J@HY16XM:MQQJP-%302$(CA:?$81O@Q'`O/DD4SXU2&XGRTN)R?`92`%YH@,%W1/I"N8"*N]*2"2R9%;E8Q+QT-FUTD M,HQ&HT=!1.Z\>-S@R.5\6*Q$17Q8)`N/+#+T+`U)Q,#D8%`*,D3Y.-<0YP:D M'[OL@6C)BD=&:A@OF0/,F2YAFG-_3`&\+324K^TZ8`%&7P!-H+O`JA09\3,( MCG=KG%#LPP`%D1)ZF+&$497).$+\3K!7P_GO$5RYE<9:0BR.B&>.,8L8`A):$CYR7Z%+&+#A%<)_T:_RRU:``% M$SG5`]_PK(%P;_#YL1Y(86&`)R*X&! M'<8$TW4D0^H@B7O'G5@."]R4N&7E=&ZK(;5TI+S*F2,R:2-;>L9R;M-\G]JA M/_.RU.[T`JX)ZT!I/,5R:16D.*Y+[90>*+P"EZB"##/R"F+R$DWB*O!GTQ'D MJ<*Y!\#Z'/'C5)P>DE$[6*"F`=,>W9#VTS`#F@5]R!TCU?=/8YG,VB$[YC:$[>M*!X<+8V1TY7\(E(:WC4: M>KO9%Y>]ZW7U;KLG[*AI8OS!?+SK]_5ZKY.I8ONS]DYM(,:BL$663D3>NY9\ MPWR^RNQ#I4$.'B%W_(4Y(7>?;N)'S](@WKM^%@A&Y(465Z'Y-#,E_V4:"&?` M`5B_/;0$N&,>+SRO%V8W";4@MD9F=\D*<22QJ.<6TYF26[0+ZS4+D="ZF'(U MHU>?/_WZ]3TP!3?&JM#2;K-QY;15.72NJR1YD9S?@"D@\]YDQLG*,H;K(D`( MW+*<8,=]]MCTEQ/YWP+A@.FW(O8W%6QO)5E/H8(YUZK713F9L MNPJC6%6!P<_JCI@,&=EW=&7"RM'&N\0W(AB@`@0RC@P787J/&FTFM@#722\@ M\76CU&]?I6!ZW7:JI_!Q+X@^RS73")Z.3/PLPQH(UUCF(,G M20X360&.JVB/TXR4DY*E2`U:Y#BIZ11!KHS;(V/C,J0HX9N)90A_4ST]=CN9 MFON%TQ'M4\J0E`\N*OI;H(;$;(]<&#L\&/`\>,FY6Z9$80:>!1X@=D0YUZZT MDQ@@)RKU+HT/10KN[V0#+UDPSJ2@1:D#E@=2P>7NV#!&J$B3DA&N*-(;"::\ MPYZ_O)41-D)"9$8&F>)&,-0&J'9G;O8B9Q MXW'\]B5^ZDM+_&Q\C"LYLU8,&V>3Q;DX5,\\9N/%,SUJ.2,+AZW&W4PUU7LU M(XMFY1!R";GE1.ZK#Z`7)#94!NB64^`V%YCBT5TVJ21`$Z`K!>@C"P/-]U"= M.[!/GE`QJ-Z_/:DZNE93T`FYA-QR(I<\(1(X,AR+)I4$:`)TI0!]9)[03+.8 M63>(O*!B4'V`J+IL3U--(2?D$G++B5SR@DC@R&@LFE02H`G0E0+TD7E!=X[V M/Z']HC6ZNRL4VF@T=/A'U6X1>7:9*J`BU3>W$"C#1.&:2.",,_6,,?-&(N$1 M>_+)',7+.J:8^MDTP6WRC.>J6+-`ZR;5GS`S&'.),7=V)B$6V]V*KU.YK@,. MO_+9!XNW4WYA0:C>OU6NQ*&:ZI*06V'DUJJ)6?(D2=3(\"Z:5!*@"="5`O3Q M>9)7X0@NTIJ]C7Q)?[DSV6GIG?FV$RDG33:.5Z[:P#)]X:.UZO'!0705E_EF M<^=7^_/'5\7A694SV29GKB!4'\"9DW"LIL8BY%88N>3,D3-WE*)&MB\!F@!= M,+K+!NCC<^:2WI_-'>X-@F_8Z_7?8FN0-@/+(MO%H?H`*7H"_]74D03<"@.7 MW$=R'X]2U,C:)D`3H`M&=]D`?7SN(W6@WZ@#?0I(\5_4AK%4;1C)%3H25TBJ MH6HN5`3<"@/W"'SX"]'#)ODXTRA'D)I][,:M=`[0)><8#,:O[I/:;FCLT&)L MR8KC;Y<]IB]/'].C_+$H-ZY#*61'KH4E)JNIB@FX%0;N$9@/M`5`HD81TR)( M)0&:`%TI0&^R!:#(VZ83:DF\O;C!YN4.G;V.WNET*;=LN6.Y!;8*;+MOTLBS M//IYU:@.X+0*V=H(3N5N#TJ20I*R:R^Y!@&:`%T`NLL& M:'*=8]?Y(1S4`C=@]ON<.AI3]B)VO\D#)+MV]Y4O]&;S4F_U6T=DWY*PD+!L M)2R]WHI*_)43%7(%BVG+%9-JLIP)T`3H`M!=-D`?V4&J>+O2XU,\M>($F))Z M:IV)O3^/VRS`\RI#9GDXW)#/G(#QU5:J#O>HFP;UV6^_U^Z5%+'E@)&AE$+3C,E@)T`3H2@&:-N-B[^S*,,)) M"#X8YJI.7"^P_LU$G0)PPLS(0D%M/**R;59%,3H`G0!:"[;(`F)S%V$K_Q";,<44E&N83D M]57?E"V&TCEM='IZO]%>=U2O-<#?Q%S.VYHC$2$1V=6V7Z.I]UI[V_;;CXB0 MFU=,.ZV85)-53(`F0!>`[K(!>@=N7GL--Z\8$[4)Y64S-F$LFNF&`YOO-@J_ MCOIX5Q!:UST&5^\U]$[WG[&SX( M\!2![?JAQQ_YC^`#DO#/__P/3?M'QXWKUT_\*_9U`I@9O[-S7N/3YEE M7CGF73#FWI7O\\#/>9IFF3#&5S[DO%=O]<_KR?].,'$&0ZW?^/"7$RRR5FO6 M&\U:O5VK-VJ!BY]:M7JKUFK,W0MW_U-Q[>;N^O'/^UMM'$QL[?[W#Y\_76LG MM8N+/UK7%QD)W2-T!. M4:O:;QG0.[0N*"NUR^-Q\]H8;'F85/BB^>9[+?7YK9;Z[#Z+P;$TXP(!T+XP MSQAK+=4Z8(<[+,69OW)1>SQH:U8(;;LX7MDMA-->Z)!5&8F[+#)QA>8<$4>8 M*VHV9S<)TF3]@3UFU1J%Y7%+BR+@CX@ASQ>+<^@[%-O60RN=LB+-`JU;?[:0XA*^HW[%.^91J MI+B_DA_ELX-:+;U^N?)L2-GQ75K"23"/53`;W;[>[[6K*9GKEBHJ2'6BU]4, MRB]C],A^R#L^JY[%%O>_\B!3I6C!-5A(J+NX"!'S:^YPINY0=Z;ND!8ZEKSZ M]X>;$\WDAC5AMH^59&2]-4;63$;6.\3([J;<8]CF^K/K`R0\ M[V7H>L_,,_W\42Z^_HWGLM%J-#J=YI)Q+R9MKSQXPUGO7=;K]=Y;L.!?S`Y% M,[TKVW:?F6/P_*'/7_?&TUY;/>_S-+WI8-]P?FLK)WCU6*>N;P6^O/JKZQBA MA^=6U`#S?WQKR>W`H-)CRJ=B1P-YP^G9ZT#:];5F!,8B!I*]_(T&XL%#9,M- M17S\Q:ZK"2ZEOMEJ9XB/J=B0X,O5!#>08"!;$IS"S>4&!-=W06V[L9K:U@Q[ M8W`T-J"VU:COAN#FIGAH)@0W-R"XUVVN1Z]G/<'W3SQE(%UGA''Q!?LT5!=3 ML>,![`WE)E[FY`STM6\__P,WXBPD+%[QL[&Z<15-[?7=]^N'C_=?7T/XFQR3U95SPO*G5IG\\&X MUSSP#_"0&<[H)]\/N8G-XZ_"$0Q"ZZ9JC4:O.^:Y7,#4_'F^X;[A65-A&()@ MQ%Q&N4G+C*/=L$#(SJ]X06GXNVNYN)N%G2[4R[4[F3+G1;,D.`']VG/$RL#5 MIJ%GC)D/JDJO=T71`1[/]N7?[LP_(SF0#7_0"7,'@$7F4Y ML'X%KN=KI_CQ)/DSD3,SBJC'?TF"\G[)T#BUF<%1 MGVILA/^6E,J_4U0^6P'6)]3X#^X9%A`V]2Q#X.M=_;S;KG>T*?PH'/_P[QW;=_AU;P MHCTP.QGWP_V5#A1,+0^;D`YQ[3CMG&DOG`%+<_Y$/O)!Y+UJS*V9$UD5N=&05[N7#;Z8&?Z[=;S\X^*_K)W3%\SO[VF?F MBZ*1XATS!,0KJ!-.!O`E/%T]+P(1WFTYALK?9 MTO$-4Z3_B=LONC9T/8W!U:#S\)E-_;+3T-O-]GEI5,OA57=L\5R!Y??B6^4Q M87:MEE$BYV4)89O5UHF,SL-:P5F(.79\"*=N2D`M/ZV&I+0D2@@$0#R-/^$' M?)C0B?X4?!=04/(3L,\RN6/Z*`M&M*4GPA^Z-G&!RB%[NA1A*O\L_S%/(K5(:N6,DN22"^/@>'3/AFFHM[ MD7`?4VSX8?!I``.)=*:OY]$)Y.%S0=?X:'YX&A"&1#%@;;)DX??9J4V4$Q#O M)Z^5W\4W+L/![^"-:G?#(1>J']6Q&P;B0O#[?#6)XIG`,K"0$"-C<&'PZN@% MIH*,GM+\WJQV7./UPH1P9M\&]]NV-F8@WOB+V+;'"673J?TBOK+=9UC^X1Y8 M668'/<8!4?@)OLJ0F-5O-<7LXR0-(_YK:I#5YFQW$*\!6H MD*I3+'2QGNHW.K5VO=;H1&#[>/7P0;LR1']X M!.Y#`(!BG@GO-*VA94A5>7HR]P"P,D_STTVR:W:>MPG6R016WQ?Y]EOX>X3O M_B25X2/SOVL?70\DXO3D]M/C1WB5^$G[ZIYK]5ZM\QY6YX![$]G>_H\Q%_H1 MU%02;]!.001O8?$Q36#X1^`&L!N?`]>8(+P2THYV*W1BRC.X>W:`":B#Y0Y#!P"&"2AG4`'"#$,[]7^8(\Q4T;"C?ADOB[$CJ.Q;M;XMU:(" M50,.JF`"MF"(4LEP30,O\DEXD:&/ES'M,PL"5"<3U^0V7L,9:""/P\HFIACT MN^6:TD@>@;4OET#;]7V>LLM!!3DC=(K2KP#0Y,`-D0I+KCMR,(4&QQUI>CQ@ MPG"EPK56^BUHZCNPUDG3%_Z8>ASTFX\/E#^41Y\X=.9J(\(MI^6*UA#\-YH^U(1B*\GT8N@!'1K[;2CU)+?;P MN+_DLA$;KD\,=#$X(5,W0.L$2+%@P9" MW8%[69-XHG17.? MN(`#2NTL&=[R"=A\K M5M3N4JWY/MPI)T\8K#%FXWE+%"I0R4;2GDSS4^K?&`&)>DXN$I.3U>SP9A?S M9+BRB94\JWL!+&F5'R\#8(U[0$/J)8B8C%)/",<@+IJZ-@\D<:;R7[BZ01G7 M,XM4%.R(%ZOR(&8O!MW@30RZ*_#))F+/SB>#;K%!)\RX>;`J<1:0-F/O4_F< MW!$A/K'GHV0-EED7,WB%[YIP_OW;:=E_WCT\WC;^^U M5A<&L\$AIZ@3.T*V-F03RWYYKSV\3`:NK<."Z%G#.;BD#OG@26,W^#DOEKSB MR-):1!4`Q2E+1)DN8"@909C!8^17J$4#4)RL[?,*^/!'H`C*!.4<**,C[3@A M&+XI^(I;\X"M@:G_)/>J8RL+C"DPK"TC_0AK+J\AMHF?XA54:OL<^Y:$A83E M$,*BW'$I)[$'F@K[8&1)N,`#+F+3ZAH!D-,DI._Q$\4[N;O3K8!2]S-Q])GQI]$H#*>A"])H*C/C8,4!# M;J\'&;F6^T[Q9F5*5Y!,DDR61B8#HSPHOO\=\B\`(0%3:V6RJ!D M\:+`IG#C#VLBSCMKEZV?\/DR`$D"0`)P<`%`;9]DK7Y2:=7)]L?:Z;K::9+A MO>YC\GB:EP>-5Z,C(W?0Q-:'AULH<:),DG*LLHQ3\GN6->?B%$:9\%N_[*37 MLI]CJU`E[VKW<5;WE%T1UIL/T>$6C-B7G-]HV0:_&2R^V;[8;.6YDT.B M/`?8FQ25;M;W7,ZOV7MMZX2U)::D1;9W43+]K6=Q'5UA@,W%O85%"+4_P7^D M&:SL&$J!PJ;V>`0H+"WA589>ZR@48&D)KS+TVD]'%+14$.SN#8'KH M!9B['?0E;=8//XQ"-Q.D-HQ'1AQ-:R6)HVFM)'$TK=4@+L>H+"!E!>#9^GW( MJA.%SZG+N,20+P7>R^C*-YJ7/U61^84FKAS(Z/4)&82,O$V/!B&#D)&+C$Z3 MD'$(N[K@L.@WUH9%24QS"L=2)("(HVDEXFA:*TX<36LUB*-P+(5C%X9C'[`4 MNRARWZI32/;`(=D>.=&$C-R0;(N004J-).4V$C%QD="E03\C(C:[4.X0,0D8>,EI=0@:%8^=@T5T_2E]@TWRG MM2$7EVE;\JBUYB5_#C9CXH+BB*N[1FNGQMGCRKJ9>9_[4-868++&XH"KAGI/EHFUQS4_G(ANF*H2<+9;]*J&=G$I M9-ENVH\Z8:_S%!\+"$]#\/68CP6F+SL-O=ULJ^;V,UUJ4HW+#'`^9:O M^G-CET/16%WT9G<'/O>>!&,M9QK"$T\_8SM;K76V4:^_'6O5]51(8?/_WZ-9J.N=)(Q2%VN9Y=O>RO,5@03)QX^**7LX[-L>"/ M6PGM@6N;^<-,Z>DO4DY%%?3?A1PJ,=,^";&;U]@+8V@$M$,3FP"EF4OX:[$Z M!R\YEIMY_?^ZX0F8S`W.<9\]-OWE1/ZW"#.S`.5)R>Z"T9>"1^%H+2L,%NO` M3:H5%E,_YI"^UH)5G!$LKU:XX>K;?`NW/V?)WK'->N7[7-C/D6]QMBHNL.[T MET)`"<[5@O.C&S#[J!#\FO3$@BTL9#&1Q40P(!@LT6IK)^#TNGM.P>7YN` M\X'9V+]8WUFMNJ*B<9=1L7PT9[>KWNV'%,GF%=O%I^U&0^_7.\7@3I[8GQ'& M"&/[QM@.#MF@QB\`_@J=L+"V.5!TJM>2@^*1O8VL$)X)ST4ENVQX/D:W0H3$ MM!&S'!\;\-JN[P,!IQZ'F__-S8O0B?X\4VD=W(0_EG3OG? M>YR]V6KHG6:CFJ)-P"7@EA*XY/J0Q)&I6#BQ)#P3GJN$YV-T?>Z",??P)/#4 MXV/N^'BHBURA`NJ#O5N4M6H*.4&6(%LRR)+[0[)&YF+AQ)+P3'BN$IZ/T?VY M5U63?%VS?#_$PSJ^*,7D\R"P19D4GSR@8E!-YB1Y0`39HX0L>4`D:V0Q%DXL M"<^$YRKA>7T/2!&W5JVO\GI'C_E%8+$&K*H:N"<]5PO,Q[G\=38$ZT@); MDWW:Z-?U9K^]+M&%JT1&@"7`E@JPY/"0I)5"TH[+0"0\$YZKA.=C='BH=!XI MAL(QNVB*@?!,>*X2GLF?*BI2BDDUB27AF?!\<+++AN=C]*>H=%Y!Y7_O&4FG MK7I'[SAS9B*U?"BV2$9(1DA+R_`A!'UG*Q MF5TTL20\$YZKA.=7>W_M:GE_<0F\+\PSQEJK(4K@;>OR+6-.V4)AYDQV2')B]S7DH@C7!NFJP3J]X%P$#9B8? MTQI^R1*563OJTP3C`T^[V/AI&2X]"BY]!2Y]6\`E^<7CGY_A&RL`7A@SBV!] MC37PK]`/K.'+@J%HI^:9-BNSXLJ;V^N[;U>/G^Y@-D+'Y)ZKO9]L?,X^+1U^YDRIP7/.$P<1W@`HQ:\_B$60Z& MLJ/9.#_:&7@<)DO!I;AR,Y9FBA>,8"<%;6^:D4]T0QNV_Z4&8""7T[J\O.4 MF6;T.=*I]?I/*2?`2RO]!6JX6:R@T\0R39L7S-U=P+IV"Y8P\+]@8N#'1N,M MW"7QQ1^W4FP&KFUN(5P&=P+N+9(MK!BN*>6O74DAL?@K$@J+.V&7Z?EJEG.Z MKNX_75=Q;OH5F)O37V'%/M,^NWZ)Q2<;85K#NURV!UB0U64=R@NY\JRUL[?8 MQ:I70*AN8E-N:X.U",-X$-;^EG')%=OL!-0BS/!7UZF9!-;*@[4*5J0LI*VL M?H(J0;6X$_R169[V+V:'7'.'I89J12R9*%!,,E=9F?O OYOC6T#,"KZY0: MK^ZP*I+WV6(#R[:"%Q*]RL:0KL?,&6%YJU(CE1;M@@VCXJIC!]G7!0E5%CH< MN8AU12:N7V3B"CVMA2:N&!G%9>1F`4R/`'-@D.#A@&N>]SKZ537%G MI-#$%0$NF^F7TW:CH??KG1VJF4./-\>>BX=[-C/'%1..\N&/UC<"S+X`<^AI MH-TZ\FAIM^Z8B*/=NDH21X'B2A)'TUI)XFA:*TD<3>MVWD:5=^N^,.\[5IV9 MP'_Y_`$O\F+(BR'BR(LAXF@!K2QQY0OI-EL-O=-LK+M.D72+RK\B_.B;BR+^J)'%D7E62.)K62A)'TUI)XFA:EQ-W MC+M$^6>Z'O@TX),!][16G*(3Q% M]U^+2URAI[70Q-'^7"6)(_.JDL31M%:2.)K62A)'T[J3&5)(X6T$H25\(@<:^E]YJM=9?K2L>(RPNZXA)7:,X5FCC2)8[(8;ZCA8@XZ# M'Z=(*CW*@K M+G&%YERAB2NA,FG5.WJS36=+ESG,M#U'_FN1B2OTM!::.-J>JR1Q9%Y5DCB: MUDH21]-:2>)H6I<3=XS;<]^XSP/-'<:;<_Z8>=Q?U_LD=V9W[DS)`A4-O7=Y MJ;>;KXA4%')H6BM)'$WK=CX2[1M5WB7*+ZOWA7G&.*JIMW:% M=_)M=N?;E"S2T-0O.XW7'>*A$FE44X\`WWV[>OQT]_6]%CHF]Y"K"Q<3RSK3_E!N\I4!7K,56#E%+HK*OU?R:HX? MCV.N"1AI`VZ[SYH?3B;,L_X-9`3PT[4[F3+G1:#SOUN7/_M)B"'F'5SHN>%H M/!-R>%\:GAX:DP^"YR]8>B6?YX377>)UC\"*IA_]?G3KR!%!G<" M[IW,4EX<8F<>L[&=([[XXU:*Q<"U306^Y>/7#!>Q`%\T!>%?0^REDE#O#M=C MKYCYN8<[[K/'IK^+FPG]5T_<8R-.`#DTL<4`R$=F>=J_F!URT>&+!82,@Q-;#&1< MC48>'U4+$-FD@YP1W5_=W'SZ^FOMP]WCX]V7]UIS^F-^4,4TP7-(7VO>BS." M#W??;FZ_Q0,8V,SXCL/0?->VM@/QCB.<.9*UL=LL*5_D-:L`0L*\A[5*NZZ+ M@5)(*6%ZGYC>,8!?R?8<"QI$38Z7B-I]>4FF4<'H2^F"PM%:UM@:P8!@0#`@&!`,"`8$`X+!3@_[MNNE.^S[@=D8 M<]"SR;8[J#57/C06)RE_=YOLZ5'+&5E19:>V&PX63;1+"=E=3OXZD']'."0< M$@X)AX1#PB'AD'!X/#C<0579=KT0CD,9O)IR^F(;RTKQR"Z;6!*>"<^$YT*S MN)A4$YX)SX3G@Y-->#XXBXM)->&9=C3?:$?S5SR9QDTQ?-K!/#C5>X]0=?1F MJZ4W>KUJBC1!M[K0K9\W.X3:PY-*J"74$FJKC=INLZZW.G4"[N%))>#2#BSM MP)*L402I>&))>"8\$YX+S>)B4DUX)CP3G@].-N'YX"PN)M6$9]J!?:,=V&L\ M46K3%FQ1J*80%455";($68(L0;;DD"T`<:4&*7D`Q<(SJ6!2P<6#+.W%DJS1 M2E(XL20\$YX)SX5F<3&I)CP3G@G/!R>;\'QP%A>3:L(S[<6^T5YLU"N+-F,+ M0C7%J"BL2I`ER!)D";(EAVP!B"LU2,D%*!:>2063"BX>9&DSEF2-5I+"B27A MF?!,>"XTBXM)->&9\$QX/CC9A.>#L[B85!.>"[89JXB[O[JY^?3UU]J'N\?' MNR_OM>;TQ\+QEG*C=FIYJ[=IMV!&@2-;'^Z^W=Q^BTB^:YMF9MW MRBK'J(H4&(1DA&2$9(1DA&2$9.8B,%(?PXY2*DOIR)$"TR!1Q M5+3(T-X^Q28+0G6)UK,RBR7AF?!,>"XTBXM)->&9\$QX/CC9A.>#L[B85!.> M"[:W7YW]^P_,QK+7NO:%><98:S5TK5EOM`0[Z-CUP:G>>QB+VA`7#[J[!,$Z MT']7(#Q2EU:"(D&1H$A03$.1N@`3&HN#1CK!3+N<1^J?492&\$QX+A39A.># ML[B85!.>"<^$YX.337@^.(N+237AN6"[G%ODP9=P!_26>0XW->:8&I=5I]G` MWGA#E,X,%%_9%.[,P!J;K94[.W!TLE*@R'#A!&#YEAIAG[!/V"?L$_:KAOV5 M^]<$?X)_=>%/9X5I%_WP@:EB4DU10,(SX?G@9!.>#\[B8E)->"8\$YX/3C;A M^>`L+B;5A.=R[**WJ[6+_KOSQ/V`FSO:-U_&G;(%Q6`LFNF&`YM7:N,\/:PB M1]#:98^@'9^4%#UV3-`GZ!/T"?H$?8(^09^@3]`GZ.\^K'`18")Z\C'M12^) M`V0<]/HTD8.!IUUL_+3,6!_%6+_"6+^M$U6HKQ%4^"OT`VOXLH!L[7',M:%K MV^ZSY8PTP1#-#R<3YEG_!E(L9^AZ$Q98KJ,9KF-PS\'KW##P`^:8^/=,7K_V MS#R/.8&O,5]SA]K*R)\.4)30NY MWT*%9[@X[_!C_RVBBN*+/VZEL`]A',/G9S88=8J+S]OL,JT!QN=W.0PR);\P9<5S)%22X M=N]9!O=W`8L*K@$9+=`LIQ;X&DX&W-O:BBW"$-Y\\2H]4!OU"B#UZHE[#-33 M-SYAEI,WV64:S35,ML>,(&2V]MD:SJ^\91K,J>5H+YQY_AD)8&57BC\X!IBX M&0MBUDB@F:_LS%?`1GAS'X>`6H!9GC,1:)D]*@SW*X#AHUQF=W"PL2#A\$*' M.Q:QKLC$]8I,7`%$IZ3$%2-YOHR<*S1Q)*V5)(ZFM9+$T;16DCB:UNV\C9U4 M;=W'/O!.-WW?Q<73:(>WF)[1Z\;0R\OE?4M`KA,#$90L0F2VE&OE@AVOW\ZM MP!@N2X?*UGGOC2M7%R(_:A?HW.OZM\[$+EW_UIS4HU&_N[('C@#HI1]#^=!) MQ@&ALGBH?#OCH/232?9`R;%])/8`[4'3'C0%5(^).-J#KB1Q)*V5)(ZFM9+$ MT;16DCB:UNV\C9W4/#VJ/>AVJ?>@DVI`)=Z$7F,0Y0M[O#;0O**^5OFGM!*# M.*I]Z#5+OA4B'+<3?!Y/X+F2*GA75L$Q0+W\@R@?/LE$(%P6$9=O9R*4?S;) M*B@[NH_$*CA,^=K_JM5N'?.CQT83[@2U6G1'EMGJPS\N0K\V8FSZ_H9[UA,+ MK"?N7\'MS/+^Q>R0/\*J,6N/)3HUEK->;NA;O_J89_N+BYO'&^W_?GO\\EF#V[5'CSF^A15SF7UQWWW[>KQ MT]W7]UKHF-R3I<07U1`Y2RI_?O+]D)O$NS5Y=\-]P[.FHD(V`#%F(^(TC5%' MNV&!P.JO>$%I^+MK2;]SM*MP!-=H75'=NZD+<;YV)U/FO&B60)]`9%Q(/'"U M:>@98^9SK:'7NUV]V^UI_IAY7)083]TO=,A_MRY_]D'O3R;`=3_`M0,>@5=9 MHHF:Z_G:*7X\23Y'+SLY$S-W:BTBH-_16ZW6JK>GUO/X+TE0WB\9&J=@I''4 M7QH;X;\EI?+OA,IG*Q@#I5'E=;@-"\$@/>_JY]UVO:--N2>IU#4_'/S%C0#? M8'`O8):C,1/G2:A)'0?GA_!M`=F M)\-^N+_2@8*IY6%9I2&JZM/.F2Q'I.%:*ZXR%>YQ:D%)\_-CQOY'/O!"YKUH M30G_EH";K'??Z*BO<@0BQN+2B6^FIOU$<-X]B7/ MS-<`]5P\<>9U\<+LB,)P2)!Z7B0K>+?E&!X',3+Q"4V]UVKJ_7I#W-ML]/5N MLZ7C&Z9([1.W7W1MZ'H:@ZM!M>,SF_IEIZ&WF^VC1M$7]J+49RM7?18,+6R$ M*D=AIOXJS+3T=J.KUR/,]%IZLW>Y`C,MO=N_U)O]^OD<[Y(%("+>S%?[$JN] MRTOMU`T#^51%R=EF2Q$+9ME`4%X"Y2660+_7$VOQZ0.X"D#Y%6`UL0^B;S_( M%;VIM]KX0S?^X?H,YQ_`.?+X"->HCMZ\K,,EG9W:%NN;%HU.76_T>YGQ*'-C M9C!P%>"QE1I*L0T20'LRJ+1E(K50:G19W9#]^3K]\[8V#1DLF\GGG1&XJ)LC MXR172%FLMV=L]7H=_XGE12GU?*@HQ9BV*<25P]"V-8\%QAB6$KF@##D+0GS4 MQG.)$F^XCJ,0(5X@I#?Z':YE>,43@,K"]C^.&Y0(`8=WA^.HS97#[!??*D\8 M9M?2\X$;+`1X`[[\5%^L,0/F2%!+ZRA16UI@23-G&"*^8U0*OK MAP_:E6&XH1.@F#U@3P7FF?!.TQI:ANP,=GHR]X"3LQW(3#8H7DV!P?`0BZ)' M*>GY'$W6_L1G?M@+G[?^_L>"&<@R/'=/Y)2=939#9M][???Y[IO:U/I9^WS[ M^'C[K?9P?W7]Z>NO(OLT#T29G97TTV9(V`F.%J-A=NZ_\&#LFJ[MCE[FQGR4 MNO,QU^[.1@Y5Z"3V'Q(5:[JX;(.:8Z98\<'88,([3&O/"?.^\T#'/H5^:(RS MAHW)P95TI\*V^(^M)#.69"V,;UNI_XVB!I>!PN][4!9.+XP?E M!B@*',,.32[=]MB`4T^,_?EYDZT\%M3.K8!HPJ09$#%?P`U9!O\$SR[:P!., M"P+NA"&`4V,`;ET#`/NSX.IOKHV+=<1U";]XPP$\SL%%GH/YZTXL0QN"T*!#*XBQG"%@'HP14WL>6\98H0V&I$A^ M=D-XFZ!7ATNX(^T1@2_;^L[M%R1%_1XA!<,V:$@`1[U)A$CQH(&07#X^M_`<]!E/0M>>7!M&BR(&OP7&^=FY=I^2$T%2@!1.4$'$ MB"1^J*;.M.Q0K`9,#-I/CT,P3&HL@,544"/L1A6=BP=WO()V'RM6 MU.Y2K?D^W"DGC[,T9N-Y2Q0J4,E&,M"1YJ?4OS$"$O6<7"0F)ZO9X"S,*W`E)V*;VB<+<[&%*>S(>6E1^D3(E(FKD=`F M4[C.-34N&V&+4%,<4$J::K.$\Q5O7AUGT07N-.^XXA^?;AY_>Z]UVC"8#?(+ M(WE!R-:&;&+9+^^UAY?)P+5U6)$]:S@'EU16'9[^ ML#7P-9[D3G1LYH$U!Y:]9:0?8Z1@#D5'K6:.-X?`0R(>,#&&)*)*FM38#W8[6?%N^1 M172+`RGH0O2:"HSXV#%`0V:#!!FY MEMLE:E_92^L*DDF2R=+(9*!-,`2(RY,E(9Y9]4!FV0#<_C3XT]"G!8C`7@"P M7VDX"9F8ETB=D$@5(>$D+*84^%">TL`0,[K/?X?,"T!8T-1JJ<0-%B\*;`HW M_K!`5O"&R]9/^'P9`24!(`$XN``\IC=;5N79SGR?,9,"-Y-476_WTFO$S]E= MG84ORN/R3)YIWB7+*6FE""&A(Z$KA-!%'OJ8F9KC9A8<,Q3)@`'NV$2K2S9( MVVA>M!H7&.7%+4$+5I[4_;[Q>R/,8T6D'7-`Z%]EOZV2/D60< M7C*^NC,9AF+/GYOG,VM'*O$PRMI02;R;"`]!GB!_<,BOB/K.1W!QAT[LF\_O MPQ4"O]'39LN`G!P2V#E8WJCU9;](!6*.L,]*Z<=P^=-R%;FG\C,&&(C<6Z2+ M&MJ?G'DKE"JAL+QC*`4*FX1"0N'!4=@B%!(*#X["-J&P8BA$S[I4$.SL#(+I MH1=@[G;1%J\8?F&AY:.,Q%'_M$H21]-:2>)H6BM)'$UK-8C+L7@+2%D!>+9^ MY[0EYNA>2\`W>VNX%SDUX&N7<09>IAC"*B^C%'@O$W&E\$`;S=;CAAMIT(.>!U/UB$Y$"B(2,!ZQ48U M_N;&?[2MG62EM`%7G=J>+!-K2FM^.!%M%E5S@2$R=.U.:7'C`P.;^,'S+&?M MI_B9UNA-_;+3T-O-MG8:5]SMZLUV3V^TNUA\%-N:*C?Y+.J;GNU0DFI:%;57 MQS+RNFK1B?4:'2YZH#K^D'N^[(-J7K@>M@/5\6EY5$XX\T-/-KE*C\L1M;VQ M.BH^>9;SC2$)YY^QEZJ6FL7':'7!625 M*NCUNH=?=%Y?<*3Y$_#+1?;!C^VW,!'$%W_<2I4Q<&USYU;#S;R\;*T5BS"> M*Q]4#PIHI.#.5ME$!RN7D\,,`O2K`?#H@N&Q=,ZSH>HU').":*L-9JV@E!(; M][JA@KC=ZX9*H__:#94/S,:&6OI.SW/,UZ8N*`3S2#UTT$%0LDC9OMMR4BY+ M-]+31K^N-_OMUZ-P+Y*XSGAS!#$>[DJKJ90JON#$E4PD2/B/4OA?G2%>0K-$ M.!7:B%F.CVTZ;1>\3!_C7'#SO[EY$3K1GVLBE)E MXAP15TGB2"#(S9Y?S[[R`-D?O-R_)""XOZH@X MDM>CE-=C=%KO@C'W,)%BZO$Q=WS MJV1'7Q<=IG&KVA<9E#X/`IM/>%[Z5&GFM*3$D=P78AJ(N$H21])5@%5UWDW= M,NFZ9.OM8WZF/R;ZJPS\57-]L.S>`Z?R5F`,%=0\94J(.)+7HY3735QI.C9$QX;HV$#!M%E% MCPT0X:63G2J,@>2_(#.YDWC$H0=14I.^T,11H@D11\210-!F\7K'AFZXH5HA M5?OD4,G,MB/J?]*Y[.F=!I62+;=\%9JXDHD$"?]1"O]^.M4O>5K1^M.;5>]/ M'[6AU^["P`^8@YVQYX9\E"WIKT3[]CGC5-?ZG9;>:K62!NRG3;W7@G\N+Y/O MV#"`F[#Y.__!/;.N3>%:T3+^3!NS)[R(._&- MILCXR&U*?ZE?=IIZH]-,-9Q7S>8S+>;A?1-F.;A+%$WR'EN[%VQB'V%29$_Y M`;?=9\T/)Q/F6?\&,G"^%/^$T/YWZ_)G7S/GFHAKS("/5O`R?ZYQYUQ,%B%! MW_*C*CO/7Z>,M.,/D>K6;W^4\K=7*=[=+-84S(W&F]A/(@OWK0C^0P?*N977*:GJ$DS5+P9ZM,,%6*&EO@.:CQ+1KG6 M%=&H9GV=U(IUV"5RBXW,@BR?ZU!>R*5UK2> MONFN114DXB:.W6P=H2K",!Y$>*^\SD'%4?;5=6HF(8V0]N;3(^OO*>N>@$9` M>ZOI^<@L3_L7LT.NN<-2`ZTB)D"T4TL24]`)^L8-F_F^-;0,0)OKE!IM8NN[ M$G+SV6(#R[:"%Q*<@L[0]9@Y(ZP456J)H6K?S-M:N:-$LWRGDFYS<_D"["D>A'VA= M<>2CN:[_2+[-[@2U9*<(&W@(1Z_7Z]O'&N8$IYAS0\`I2D%F`DPU`-,X[W7V MK6R*.R.%)JX(<-GP>'N[T=#[]>,I)5N!DS15PA^M;P28?0'FT-.PH]VZDGG0 M7YCW'8L23."_?#XED7QE"FH1<32M1!Q-:V6)*Y^9U6PU]$ZS45YCJZ3$D0*H M)''E4P"GK]8`)0L,+1LG[7Q&.Y\/?!JH@G=UVOTD74*[GP2<0@;["##5``SM M?I:&N"+`94,CM]&OZ\U^FXS<4J.NN,05FG.%)HZF=3EQM)E(FXDDE*7A7*&) MHVFM)'$TK94DKH1N5J^E]YJOZ-M'7E8!0%=J)G\'Z,YW+/NFWT0_:7<8^\S^1MT5R$L^6F.D@7W+]7;S%3E2Q9V. M0A-':TTEB:-IK21Q-*V5)(ZFM9+$T;2N[\<=R\XBY9:22):2,!LGA.Y`V11W1@I- M7!'@LFF3CGY7;ZQOPY"/6TC4%9>X0G.NT,31M&[GD%9Y(_'V!_<,R^>I?$L_ MQ:_X+]JXD)F4=C"5"[KD(AD#S=HP?,QI[N+K16 M$03CK]`/K.$+Z2K25069$P(,`88`4TK`''H:CG.C^)/OA\PQR#,O-G'ETP0= MO==HZ9>-/BTA!!RR.0@P;^E0[T#9%'=&"DU<$>"R12VA5G>7->X./5X*&)<( M?[2^$6".W:>N\EXW%18J!G'E$_1>JZ?W.]WRBGM)B:.,I4H25P0%L+$G2SJ` M=$"Y.%=HXFA:*TD<3>MV?M?Q[65JKJ/=&8'6Z-#.Y=%:89O6=ZW7Z]28@-1Z MB3A7:.**H`*V:$]"6N!XX;)I![ZNWFWWMD=*R784*R@1M/14DCB:UNT7FIMWJO*/A3W,DH-'&D`"I)7/D4 MP*G2`"4./QSGMEQ^+=H;;O#)@'M4CI94P-K)47JW5]=;.RWV4\RY(>`4)86> M`%,-P&R>B?EZ95/<&2DT<46`RZ8M5[J7>H]V`$N.NN(25VC.%9HXFM;U?=*+ M@`ULGGS,2'CZPQ*]E*LQ\)Z!IUUL_+3,P!_%P+_"P+\MT'+RB\<_/\,W5@`\ M-UY=U>[F]OKNV]7CI[NO[[70,;F'+%ZX#EC6F?:'&K8>&Y8-@^POF1>>SG2"[2\CN$9BS%ELJA"C&D+.@U%: MP6W;GS+#ASM'K5ZS^E7IB*;9K1B^^O;FX^??VU]N'N\?'N MRWNM.?UQ,KL8'GH%W#NUXM<_;B4^!ZYM[FP`'^Z^W=Q^B^D?V,SXCJ/0?->V MS+FQ:(:+\PQ?--_"Y\@9Y\;2:G`GX-XB8?T:XHJ0JE(WW%K3%&$X2@TGXWE8 MJW3`8O2J%UU]_O3K5Z4@YC#@N,\>F_YR(O];;'R3@)8,T5'CAX13]YYE\%)+ MZ3?FC,H]@ONTSA0ZAE0,J9B2JI@_.$9FN5EJB;QZXAXKN5995]>3:B'54@Y$ M?V26I_V+V6&Y!1.S;5A0[C&XP_AX/RD44B@E52A7HY''1V67Q4].X%F.;QFE M'D6^7C\R79+-2%VR8UF`(&WA*9I53\4(:A\"IC35--4TU335--4TU335%9[J M'9QH:M=+=Z+I`[,Q$*%C*0ECO/$)IL79OTFZC-5DMO]'J[X631A+R4T-TE"-:!_KL"X;%^WJP3%`]/*D&1H$A0+`H4 MN\VZWFIV"(V')Y70^'.MFCA\=4'!$KJ#.77G5=,O[3[T\+<`ZPT^<".P7$=K MG0[.M(=PX/._0PX_W?X=6L&+]L#L];N$E4?&R85<2QVD^_Y43BD0<*L+7#+P M";6$VI*@M@#$E1JG&^.L>&17"L^DA4NMA8_,!Z[VINBOZ/?F',,A83X.8>[J MO49+OVSTJRG4!-WJ0A>]`:VFP7]H=Z``I!)X-P1OBU![>%()M9N@MM%OZ?4Z M)4P5@%0"+OFL1[EO>XV;MC:YK$6AFF29EA^"+$&6($N0+3ED"T!/<;HV+_8:PG2^55"9.$028=2"T`J0?'G?KVEMUJT5!>`5$+CL;F& M\]N9BKAU6I>6V&F\99[#38TYIL9ENBX;V-OXD%NPJ\"2O[S?Z^:278Y1%=$_ MW;*C:7$UT-')2H%6T<()P%H.,8D`B4"E16")!T[8)^Q7%_LK77Z"/\&_NO!? M$F.H'/!WM"=]Z&%0=A-E-U4I'DAX)CP3G@O-XF)237@F/!.>#TXVX?G@+"XF MU81GVD\_P'[Z[\X3]P-NT@XZ[:!3"(UBQX5!$\6."?B%&08!GX!/P"?@$_`) M^`1\`GY^/.$BP%STY&/:=UX2`,AXYO5I(@4#3[O8^&F9L3Z*L7Z%L7Y;)YQ0 M7R.:\%?H!];P90'9VN.8:T/7MMUGRQEI@B&:'TXFS+/^#:18SM#U)BRP7$^9U'[MF7G8`-G7F*^Y0VWE9.=-9WYL(YK4]V\_6XDH M2([,TUY?!=03S>"V[4^9`5SZY:0N/T^9:4:?(RFIJ[P+%>1ZI9)N=HH4T-AP M>=D!X>+7/VZE.`Q<>UZCOLT:LWA"0,V"\"`4X,?N6P09<\:\L:(PN!-P;Y&> M^".2ZKM$]-\VX!@'9(L!Y&TGOU^ER;]-]/P13'YV[V&'F.B\_;;#*E!<;K<1 M$4/B&W-&'-?WJ`F'=N]9!O??!A957!8N?RJG,O@:HF6VM8E;A"&\^1IV:,WU M:G`VZB5%Y]43]]AH?G4JTQB^\0FSG#QPEFD4UP!.CQE!R.Q2C^.S->3:J>5H M+YQY_ADIC-PQ9,S<9CEUQQ\C;X@\[$@@ZB"`CP&\W%Q;+K8VX+%Y>ABXHIQF*.,G&M018%*$MJY$WJ^FR9+;;7(Y"O33QX-UO2DDX\K@S%S8_H+6=X'0=. M4+)HBK-5>ROGNNUD<[YD4]H^;W7?5EH+D3'V^JG=LS9>9V*7:N,U)W5+=O1* M!_2XVBP!G5:EHUJ5RC>CM"C1HD2+4G6`O@-7N4VN\MK\*)NK#&/13#<2V$NM[!W!Z38;(&/X[*,CDNJ-/*5+F5J7Q32@L3 M+4RT,%4)ZF]6#B?[_O2C_JM6NW7,CQX;3;@3U&H1"[*<5A_^<1'ZM1%CT_6&`]6]R]FA_P1)O0#$O+/__P/3?M'SM7WKFT9+_%UFF7"&!;^ M?-ZKM_KG]>1_F)?L(&R^\>$O)T-@>JU9;S1K]7:MWJ@%+GYJU>JM6JLQ=R_< M_4\UY)N[Z\<_[V^U<3"QM?O?/WS^=*V=U"XN_FA=7USGY_/GUOGKC>Z>/QV\0.?U<";U9^U M('7GN1F8)UK"WIP"-XJTAX!Y078^-A+-U46+Y!>/?WZ&;ZP`\&^\NI#1S>WU MW;>KQT]W7]]KH6-R3Y;*RA?F9+JUSQ8;6+85O+P>XG9Y*SY=NY,I@I\!/H3]P(+*QZ9?!#HFCM%,/EZ4M3)]30W&'-/2`6>SX`?K:$&#].U MP(7;`NY-8"KPRV#L^CRY$._%JDZFR4WX=C)U'2X>.7_EWR&,9?B"):3,1%3Q M!0.N^7S*/"#:AM\-PPU!.DUM"`^W'/&%9S+'X*!Q@[&&5XX\-AUK_4:]!O]? M[]3:HF35`S=$5:M^`[ZIUYH=20?7/EX]?-"NY(.QOM4#5@I@GND#UTQK:!FB M&M9Y2L/%?R%K/>Z'=B`?9OD1A:*XEL=9@#*FP??!F`7B=4/09+A:A#PB(.91 M,G2\8\*\[]Q$C2/^"C3.C+$V8+88K3_F\)4);!&C\SCR`1MO^QJWQ(0QX([O MPT7`*:;9D1SD#N23(REY0FKS2`5ZTJ](/4\7EQIC41\$9F3!399\`TRY"+8S MG$,_@/\(!@$GW"GW!*=],2#$B\?''/0;LL.!SUP[M5W?/Q.%QL00U=>(LQ]3 MN)3G#N[WJ2QF!ECWX?EZ5+U,W&@@-VU;5CP#,EAF%AP_\$*D4(XR^9Q,$((T M-6;%.C$Q\+BU7HOCA9NMP6'YIAIPY0")N5K^=^AF-!CU6R`6L/RC'"" MQ3T,>/DS@()G92J9`*7W,O_UX M881:/!(L(U8$^3S64>?8H2B$"&@3T^^'H)?3\^"/W=`V<0[3.C/2F!87*R,J M:B&_ND1=#94U_+\9J1`.,P5T"*WO\:GKB44%M*3EFKEZ[E8\+D-)C"W+@1:.ZB9O'C+,?+9L&YF=(DM)7':QA.$:H><)*CS-<9U:]''`D.]`132EXO<` MO*Z@9C!_#"9($-CQ4B44?"Y9,).X$ADH?VB/`!V-IC8!.V?L1W?.K^#'+7J1 M;2IYCO' M(5B#H#`_I/@$"0O$R_Z[=?DS8.79`5+1/\V3B7D633WWR3)Y)/'P M6N`1B*1212%8'4P+GMV:'_"IQJ9P/>H5-"*42Y`>A=0*->`"&CA#RP'`@O:8 M'=VJH:&/$0\DK3G5.X61G%$/*0Z@IS'17!C_TCP&VG%2V)"IW@0 M%=Z-\!>D*@Y)V_;4PL>FK(&!ZP"*+=\/@8S!"[Z:@_B@*O8MTV*>5'/@W\!J M'GC6]^@-)G=<@*`P"H1=$]TI-9MQQ,9A6K6@I2Z\2>5)K>^')<6-U_&__!E? M:)OW+/1MEKM0_F8^%.$"<1$&8$/\F\MI^\R"`&5JXIK!&>&9&-F` M1RG%":\86MYD25""^0.-8A.`K@E>!X3)(8.I-V$O:%A-0CNP MIC:?4_C"D!4@CS\/%_LJ?O0\<)P0FC;_H98K[0-N+-0>C+%KPV7)($T78]^N MT+"@"7%U`ELOX@LLO_Z\B;F(*1Y'Y:C/"B72A&\`NL2R"(I5QIH,-L4Q"87L M6TBNY%C^8@.^J)3;9]0#>O8.Z2*`:&?'F?_J>"9\*PB5-(^`?4[,M,QB$G-A MWM,]Y>>C<^'W#(_R57U'@6GF"I5YR/*Q;P_"U_:8?;+OY5[C3K*`U='+6C*/%(4"/-!K=,9 MDV`8`BC@J3Q99W-']2$:`#S!3XC14UX]F$BXM,(Z\2*C8=$*#U:1:\"J^K-X M_6^NC6",J)!R]4R7(Z9@??+,/>+,)A@D"`?Y)*-8N,S(G6!"('(**)82MTG]PF.9U<*(,$U+!:Y MCQ'VU+VY[[E*KRKQ2L-D69?4>UWX)B.C,7]@_?*5;@DDO8EK(V](&2\YR]Y; MVQ*97UZ_FSBS`;B[?<1V8_4^8FMF'['1E/N(V7MI'Y'V$0MM.-,^(NTCTCXB M[2-60[/1/B+M(](^(NTCTCYBF45O+_N(M.]'^WZT[U<654#[?K3O1_M^M.]' M^WZT[T?[?K3O1_M^;[OOM[_-N6]1(.-NF'Q[!>Q]$J&+[%;=THOI`&"U-^X^ MI0.;('B_<7.$6D3-OY73PO@836+E`/O"_5T4%P;VC17[6,R^];?/-HV_W.<] MY>3L7,O](8I[2YW&'$MN_*&'-G+`VA@1R'?%DVFV";"%6UL3?4D5"'6^9>I("WOTMPQ?Q16$&[++N!U'$O. MI5'LW48ORP3,F9I7<.L!ULG=@LSY.]3BC2Q3EN/4]=%\'7"\$&_(;G.FYT+\ MJJ=64?$%HD+]@=QS.)IBL+ZHS=ET'";VR.<7R8RF**YR^`@+G[3RT!J'_^H9 MMQ)]&`ZF@_LR%WO"+\!&,%/[\H$;Q;U`=^/U/N=8?&#^7OY#A5$\D5Z`FZ+6 M#[D+M>S"A>(7T1M[E&$&F5+?H>D;1GNW`%^/B6#?-`2?Q%_P\.ME@IQ^@=KK MD/LWPKZ4>R]X9[1QP)F'#?R4"^&YX6@:J'XAK!?NG^1[44LA MN7BS"<WEQAL7@9?D2)FZ":S-JEJ*.0@59IM!` M!5*;0ON)201?$GQG[%F)&\9PYQ<&VL,LYD,L[?!,!N7C:(,LUU?:S9C.Z>^R3#KO79K^V'>*D_SGGL/ M8]`4'YAO&5>.>6/9H?`888PKKMGU+D%FM/\/A/O_^?C6]+B;)_^LP:6I<:^@ M\4T&?;EZT`T<-`Q=#CJ%Y,NM!]TYZ*!W:K^79:;;S4WAW4P&W=QZT,W##KJU MSDRC09@STZVM!]TX[*#;Z\QT>M"IF6X??-!YYS)77$-[O!7TR;^"N?Q)Y39^ M%N>Y`'WH?T[`0AN/[5\_4JIMVS>$EM>I35,RV4DAUDY-S,E^\ MO[ZJ>#^8'=RV_2DS8,[0LQ6?I\PTH\]Q$ZOZ3ZD7IMK<+6Q=WZD7HD?*`NJZ MA2!.O57`XNKSIU_!S#!`G+BWO)N8X>*<;OFH*T6>=G7C:&D;]NFM!E);)9`$G'G MXJ/<5_\3]]5O<5]]:TMD[^1G$P"6BMD1H[*91F6[)*A$0_!>.`#E@:.P8*^F MGF7#\P4F&^4A_A1,;2Z\G+/(1RH/\4(1)!*E-,+R-G^;M&8N]G);:.6U2"MU MTUJI561*N;O14?> M9+VNL<6?XB-)Z9.)N.FI2G=-73^H7=LN5J[4!B'\A_N^-K%L[@>N@V>K\,:3 M+_$7)SD%DM96L?,=K\NG'(I#]&338D*NV6M=LX=P M4`O<@-F[#Q^3`U-JRY8*%_=@%Z]GSM'G;7LR8-5V4+[4:)=IG&DXP9QN7$VP9(LF/;VKBD#PS+1SL(S M7=P7=44;]9]$?0?F..%$,[$ZJ,.UT\:9K/B<5(=0[<;C:AUQREZJRYAL02F; M2XO&46S"58$(X-P/;)&$-22Y-K69$35-PEMD@SSL="SR_P;,MWP]:F%J)EW+ MHZ%'O8E\T2UI]IF"M)'G^CX^`LP-4Q0\@6?8G,&PWS4D-\Z1P5?A"(M\=O,X MG&J!A%V/N/>R:!CP['?U\W:WW^NDQK$1(7*F&QUYJE82P@;NDYI3T9))]G17 MV94>5PA0?4`1FW-0$&WR?%&71Y7K`>)=#__M&-:4V1%*1.LIVXYZGGKXX-"9 M,LM,\"(:?FMRCS$-KF9=;[?Z.>!JSH-+>^#3@(L*-JVZ*B&^&$N6CWQMIIA* M:9@%H7KOVUO]?D/O=9IEL]!IDC>9Y!I95X6QKLA5/Q(`D*M>JE$4%C'DJI,N M.697_25R:V>Q0FF1R2,MI0Y!# M>B0`((>T5*,H+&+((25== M=J1WBKN%D0.D:^"B3F6K;_M%?XMM0+F]FMX&)*>K&%3OW1YOZ&TZRUC]:2:W MJS@K);E=1P(`^7C0:QIZQICY7&OH]:XXMZ(:MNEQFM]HY/$1"[@> ME0I1CQ3S\=^MRY]]/&?H_2=G(F'PU%I$ M4[^CMUJMJ(/X0^CS MOT-\\^W?H16\:`_,3D;]<'\%KY]:'I9L&5I/7#OMR"-^_N(S?N>YZ9X2%RLE M-$\&$='Q3$E$964Q``4\XIXXU0ASQH.(?EFR)KYWAI/`C)E$3H$,<0113KX\ MDZA`'#HF7(>_Q@]\YGB/8#2^W#!<#\/M]@N=PRL(U0?86;WL-/1VLUTV,YVF MF796RVEBD;]^)``@?[U4HR@L8LA?)UURO/[Z`M=LQF5?Y*[7DS-WZNQ3Y"QE M#][%1Z/B5NRO<.R?774(<.S:X(2)A^5U;(_+S&!W]=D3A.23%81J.J9'TTP^ M6;674?+)C@0`Y).5:A2%10SY9*1+CMP4[EDVD7*HUK'H4J*H21.%?E4!:'Z0`T06F1(D2&UZ6)>3F87<#$GYXMT1F5T!CE? M1=77Y81,`?5UH77)D3I?28V479W?(\>FU(Y-1V^V6GJC1Z7T*SW-M%E4G"6& M_)4C`0#Y*Z4:16$10_X*Z9(C]5<>A:\R=0/N!!:S[1?-#0,_8`X>/-),RPXQ M`R_>[R%?ID!4[S_QK:Y?MAMZY[);-AN&YGF3>>Y&>;FT#AUT'9JI]YC5N>D/ M2U:8C-ZO3Q.M._"TB_RG_5>M=NN8'STVPN.^M5IT1^[[_W$1^K418]/WM\QS M8-'P[[DG8E[WKFT9+X^P$GU`4O[YG_^A:?]8\V+-,G\Y67'->:_>;IS7D_^= M8#X!KGS?^/"7$SQ07,/TAUJ]7:LW:H$K/S6:M59C[EZX^Y]J[#=WUX]_WM]J MXV!B:_>_?_C\Z5H[J5U<_-&ZOKBX>;S1_N^WQR^?-;A=>_28XUN8X\#LBXO; MKR?:R3@(IN\O+IZ?G\^?6^>N-[IX_';Q`Y_5P)O5G[4@=>>Y&9@G6L+GF9F- MO@;2'@+F!=F)V!10_0I0_;:LM-G#XY^?X1L+3`/+F+$ZZO-&1WW6XL`# MS-;P18'OYO;Z[MO5XZ<[4!7BT+-48KG`!-H"[9,#Y@;73C^[OG^&AZFOI?7Q MD-L<9[?8WQTG7\FU7,Y8BC,V3Y_1]U4>3K-;KS7J MM78GRK_Y>/7P0;LR#.R!A/;>`QI^S#-]8+EI#2V#X7WGV@?F6P:HN(TH&+R` M_?AD"4-R_E;X59Q]Y[@@83[2$P=<<\T)1>,D(##)09Y7K6$&[1BX17%H!^/NBRRMQ?<,C=,G%2/#VU1HP&_C9ZG+';7D=V*86)M M4W,-(U1-E#-VO$S'PMRK8.RYX6@L]">\">LWI"_!C"VQFS$2=2;T:":F^"8@ MUXN/]\PG#["-`Q=VW:?Q53)PLMC]]G/3M!:#I;&?QAVB#VGDZH8ZV/8 M8+81VD)R5=OK%U59`BBH16]\O[^9FG5&:\WICX4V;Z]03L\FE!?``$X(_W#W[>;V6TSWP&:@=(!ZS0=#T%PX MAB8&8@P7YQU^;+]Y'&8=Y6%P[!FX2'?1AFGO]#$%0";Q+E]Y%:^(K)0A/R8_,#N$BOA:N1Q M67`Y%23'+0#'U,;<-I/SSES>(&LQ+S@3+6P.[?:',<;X>NKA<+$?3B8,P[YP MP_^$#M>:+6'B-;0IER$B40/+&%O\2=ZDMB6BP]ZXDZ`*.$]=/ZA=VZZ/MPU" M^`_W?6UBV5C0&OY6=:._Q%^4K,DC)ZX`-A%QKL#6Y%Y3KUO=G1X5W3(.5?:EK[2$'\V: M3=97569R<^MK6?+QZL[SI4[_.>Y=D>M44;:O6-.-=D6.U6XCSM&N2/FFO]#$ M%0";Q+D#5IPHT\Y'7$FVMZ09)YNKXAKUYIAZEF-84W!PV01/F(A>DTW5QD/L M?UB8U\+]0&,!V',_B5QVYCCA1#-#KKD.UTX;LD'DXOZ0R4Z*I,/'W96X(^.` MRP:,;,)5,CRP\4>`%SSA@Y+FF:H=I@,#2AHX#IAO^3K\YCY9F(\O3E6DF8"G M16R.O418SC,%:2//]7U\!&#$%(<[X!DV9S#L=PW)C?-5C4^CU\AVDC#*ET7# M@&>_JY^WN_U>NA'E1H3D50^6K2_%[#X#'PWDO&VK32^/1UU>1(]1`=0Y4.!V MEN6+8T;J]!$0[WKS*(F:9F)*-)Y:,`Q/]LN<,LM,(#-T9?=,&4))(ZQ9U]NM M?@["FFF$I0F43,NT[I0`U![X-%#9577)CW-QU$/B'!@1>AX0:K]H4^0CWB7> MZ[BX13S*7>,@FY*(7CAR=ZC6[0!BVK8I<:&U>:.+*Y]_+^LG+4_]H M,O8T&>VF:$*]=JB%'`0BKDAF+G&.'(3U'827R#0JNG^@+,C4:QVT7U]B$Q,_ MSYJ9<*/'72<]"!T]B;@U1NQSW(@NA,H_L-UG>0K\E)U%@S5XNC4\>`=C"^SL MU)EO-L62"^ITM6*?XM5'RX'!H/&,-_NN/?^+C@>Q3P?R=89*]%)>S:(^'CX' M`]8*+$QB@VL\9LID,Y;^A:O<-/$"N(RIKHSQ]<"!&CR_)NH(<$]Y#.I`?$3) M0++>X+'E+E_1@%?H.!C.@!L&=B'!!TK;?FQY8$&?MNIG,*\OT>EWZ3BHMB,S M,_!SXJR-80Z>)#G`;2#<<17M@G(D:L*\[SR8H4@-&IP5/YI.E*]LTQ)\H:[Y M(="LT`L3:=N1PSEDEA<]'00]%'X0PP/!C@/ M7G+N_N`RS\2'WX#?9`2NYY]K5]I)#)`3;<*9XV?PH4CQF MT/)`0OC?H063-(P1*FJ;,)GFR(:!FDLAE_(.7[(7[LC0=Y+F1@!>= MN`+X'\0Y\MS6]=S6:]R.S=)/FV?S_<^7>W&=I*][8J-E6[HO#\#KJ^+W!P[0 M-\G0(\MB`\LBKS#=/O[*-JNO&$;+!X/E&;5D6A)Q1360B'-D6JYK6OY/"/96 M8YE9N>&N0*/1T.&?*,$$PVQWH&2A0368K?S4Q1"Q8T!W%;`T/E, M/!S,7_EU*M0]X/`KGWTPOIV,3K(VUH@N=IMZL]FO(E;*-QUD_!%QY31AB'-D M_*UK_*D\YF9OA^9?IZ5W,((X$S-,V57!V..Q=36P3%^85:UZO-6/UMT2WLL0N`:+*@"#;DX@KIP5% MG"/;RU0I>9^YU^LD)-.9H[^3'-4V^Y>?6Z^FL MQU2[Q<8OGBO!G=S,UF]Y-GLUZOQ75,*/IF,)5C1MM%=6-*7Y+,E\ MDH5*Q)73SB+.%=A"+7/?ORT[+95]R2LMX4>S5C?J>J?;T.N]E3N[-*4EF=)^ MIZ6W5D1K=]?^CYKV[;EIWQ_,\Q@($_7J.U9;BSA'O?K*-_V%)JX`V"3.48;* MAH47Y:F@JAN.@T]8XPM%\#8[XK2UZH%@![MB[#1R.,CT=IB MO;8%\%0+W%H?^P]HIWC#2?0Y?K7:)3FU%I'3[X"QVDJU(\A]<5XRHJ0E[Y>8 M/+'=DS3,&^&_):'R[Q2540XX_\$]P_)YTD_C7?V\VZYG"M;ZX>`O;@3X"@/< M>@8<9";.&[['Q\'A?H[X_8'+]@@M[-?Q$`Y\_G>(K[Z5O10>F)T,^^'^"ML; M3"T/TWV&V+[BM"/WC/S%FT;G"TK\1H-3@/"3=TO.^#R^)`"'8L0]L6T&T\`# M15'JDEG&P#-F&^E%U7757,J>C.KMH6.J[A#Q`Y\YWB/8AM6'7:VI7W8:>KO9 MCI[`#,/UT!NP7\ZC#C3]O#V_I&EB7F_&^>1[+:]+XD1ND>$Y`%7'^&?94X(_ M":;%/,(WI[DTOUF7^3ZU`ZF85M\ATUIZMW^I-_OUM9B6R<G6;V^6G1;.J] M%OQS>1D]^E2ZEBW-C?9&Y0]G.2RFO#)*95H5J;CL=/5VGTZ1%F(R&GJCTUQY MQ(,\*"*NJ'X`<8X\J'4]J/5:8BQRH.I)SPM5\PMN* M.G0(6W+LVF`=BN>!G>DH-R-.((M3RK##VVQ'#S+.R!Y8;0]0.XD"309,JRM.7YM0ZUE1>9(\, M*EK!UTES!XA6$2GEFPPRIXBX)#>ND@"@Y1AV:/)E:17]7F^=5(9<$S3.FUB> M+-'HU/5&OU?P;(G,_O;FZ0Q5-)`*35SYK+>F7F_V]$Z38I.%F`XRIHFXPW5,2^07P-WSH>;4C=PDBY5,I-71T$ZKK;?(8BW&=)#%2L25T^XBSI7` M8BV"F;EN.[85YVA>$U=0/N!!:S[1?-#0,_8(YLX6K9(1:'B4-;KS', MEC&O&-@M.^&YRSA0KYEN.+!YA=;Q9EWO-%IZL[FM:49S6K@Y[8!=UME9*XC7 M'06$>P:>=I'_M/^JU6X=\Z/'1IC`4:M%=^2^_Q\7H5\;,39]?\L\!Y2J?\\] MX>#>@VUMO#P">SX@*?_\S__0M'_$%P^'LB[7)P=T+W]D/[ZQ@%\#7BPGA*?< M3;G'<'_`URSSEY/U+S_OU5O]\WKROQ/<3,!)^L:'OYQ@ND@-JS37ZNU:O0&. M.7YJU>JM6JLQ=R_>'3J6O'4:>@!'DQO6A-D^=L3X9STU^K4IW",C+EN]9"Y>PJ&-GK,_##6! M=>>M]BKN;41]H=FZ'T2^/5L_,LO[%[-#_H4S']Z.FE(JO!FU)YBW]M6[1MX_ ME3Z_N;M^_//^5AL'$UN[__W#YT_7VDGMXN*/UO7%QN-+AZ_7?S`9S7P9O5G+4C= M>6X&YHF6K!UY78PD: MU[0;+@K3H_,7A>53%Y2&S:]DZ1S;'E-9(Z$/+X_XJ+)"AHCE)X'EL07*TC/& M+Y@+,I&@G;U&W64FS+93LX#(][BX$JP;$(74=5%5L>CZ%RQJ#[1X+W#+U/4" M%`G53UL^QW!'CO5O>-*(66`MN9YFN[Z?E'@%12K"O0Q+]?N@X[EL#P$TNHF1 MA<_"_@4>'W/09D^8KH*K@':*3SO#C@2!R`EF0>!9@U`V7%-9S\:8.:.XL_E2 M/LR-;S[%I1!6_=I+U[[6QW9C]?K8FED?8<$4ZV/V7EH?BZ&J:7TLW?HH)B5U MR>=82\.D7"?]5SYR,*4]7II9.:;E%*[.>9"8P9DN.D,YBWM:@7>UPJ98,[^V M'F@UO!O&\O;)\0,O%`R0]V97PF57DI=8086\:!5,S3ZI45"C0]>VW6=?FS)` M@\>F8ZW?K-<:]5JK4VOU(CWP\>KA@W9E&&[H"#WU@%M^S#-]>(YI#2U#*!OM M].0^]S$G9\NU,&K783Q%5C)%0A.F2>O@,SOXY`U)&X+Z-"W?`!4:BD9B`S<, MUB7C7,L?E\9]5*>6/\8G:D./3?BSZWT7;Y/#%6QXD4%(0>>RTS-1NL!5K.>!.XR?L.R%B'46:DPPQ8_*OW=]M8IDF;L`6 M:M@[E`W*=/(!8WER3Z_?TNUJ/3AO!94M5.$G:G6,EW97:)(AR4>95H> M-P),],/V(7:C5%*A:523<2,IHSCHHGGG5)J MZB+T;!TW`%?8\]R!ZPD7%]P\96N"FF/KJ[EE^8?'$GI*`G'*[,89$($'4W2? MCP+ZSV,NHA_@;2.FZ"$%@A`4N,)@_UH;@ M;6L3'HQ=$U3-2'2"\#3?FH"#X*7C!SC;``J;,S_07`<\9AB2""&!Y(FG(]7A M9"K+6WD2)9KE:Z&38.>M=YZ+.[F/B[9@1F!WR`C.V!J-N1]$D1VQ.Y,U5$Y# MAYGX(FZ>;>N[.:9X&]H/)@$U092\JUK)IO7?-# M-)U]H73T*,R+39,-;@G`Z0!%/F4O2=14FNNXY2YJ^XD'IVZ%:^5]\(V')6?X MCREW?'R9T%7J6PMTG0>X@&^G4\_]84TPS71>>PZXP0#*T1C],5CK(%A!**1# M?NOS3.#[J'597LV>F5[3T12E.>_G['`(;"2,55(=3D&N83QL)"0S]:(!BCG\ M(Z<2]R;4'&N>>@-(_;,;VAA-3@6[E.0GNSO)0I<",&Y>CZ+@?:#Z4K8:LM:1 M@%;FJR;!(`N#R$I)6)I6_&H?94F6FBH@!0O#53@"`@23Q61)_QNU`E9P`HS% MRD&9G'B1%%,?4W7D&P6Z!"3D"Z6!Q*(JG"DH>OSOT,)]H?1R\5=HCN3*X$68 M@SL7[HM$X!)/E"LM"P,7[S*2\I_`E"3G08<7UY2==F&ZST[-`PUGZE$"@JQ1 M%7BN_3/NIK#0#@0,Y>YD30QCR#UI[;E/EB]2&Z3YQS2;!0$6QQ(FFIZ4P`)] M:N'A1%D$B\%WEB>V$X.7U`82MK2'*;10?R93D$BEW&L6AQRE9&=,R45<\A4Y M(L[B>E/A.VABMY[)2ETP32"U?KQL1&R5!<&$-:1+KL`-(;`39Q4T?Z2P@:>6 M_UT;XB:54`HZ/N69V[A"I0S5>`\P%%DG"K/."*Y_(+?\RE1W3$!O"G0`HM(&D,EAJ`'Y=\G&\T5D$W MQ[Y+SA+!S"=DI*K!"Y:"+^Q

X6Z[^(`7O^MP.:EX4?Q2'9F;!7E-;!@XOT"T;+^`6& MZQ?7G[^^[8-W>,D9LHT3`9=&ND,YX.N0-U$0>=JDANN(3J_=)_W*9=7M.JEF MV*$$08HBH"3!.@",*"!4`28+CG3E72Z%(.9SQGX_2IM9U>YFGY3@`CD;]*S% MXAML6F35OBKJX-J9_\=7M$Z"Q?UJ_?CUR_Q^O0*+U>KK_`:LE^!AAMS#^0HL MUS_-'\'ZI]D]F']YN%O^93Y?B6GIK>N%/[O[`_P"W>@0DH?\\MW5Z:@SR5E! MU;B0W&S(Z:B$M,GZR4\"'^2,IW1"[;ZL5ELFW>MA7<:9Z-.@PG[E-$9$G$1%2MIT!@.[SY$K>=<-^2H&'/(! M(%]<*3L?XYAF+4<'S:'VXN2@N$U_,NU9GJ!;S;R1LX%*-ISY?^)SK:^+U4_8 MITEER0KBU7OU:(!RZ7^-O;WW=_K#[C[81S<'N`ZNR9/&"_\Z\&,DUJ6O/>QW M^`\$9/N3A+-Z:8^HER6-LZ''M%RWY8E1JD75OA*HY=+^]6X`;M<=9+M',W][AS9:^*V&#?2^N4][.-OO@^\NFLW;(,3?W`51E)Q=(&=J.,A; M1!7YAC58DM1;-8-P7%OKD",;66:T[2X0HD(\[6NH/(\.\U%Q6/9ZOOAY]NEN M3@X09G=WRU]F]]=S<+M\!#?+KY_6MU_O$I=6\-C@/D@,`OK+%K3RJ/THH"';LSEFO)HUL+ZC#EH$8@U0HDS>2=043Y$>X. M_I9HXO8;UL,']YTASV!2X]&F9/6O4;',:7#!OD@^9&TFD/'[K/$ M1L?%@$UI3#ABFTZ]`]8]2/H'B`%29R8"RQ`D/."M[2<(,!MX;TL9`0DG`+$" M4KR`$S.MM7B<]SK^8?+X![)!FT>O1G?LOJ#2Z+CPVSRY.RY-"EEP30:Q]"$L ML8B[HT4,4A8Q#L`3LXC>I45T"RUB*ZP?WTGA/XP?]S@V8OO&%/_T.GO'[@L9 MS0Z,D0A?HR(Z]\O[#X_SVZ_W-_04YN9GCM5WQS"CS.5_/9X_5/Y"CG9O[S_&[YP$*2Z\7/ M)"U$S,KAPR4_WB=%R3<;7`P<)_^'@8_^N2')*WE:)E(DH58GJ37LWAEN6 MFIR#KHE`:DPI,5GM$./SI`5E[7!:Q("^G=BQ^_Z*D!SZEPQ^9ASV\?&*B8(% M@`L*O(:^: MVQLR\6AW\Y/K;W'4#.="7J2@HJU,7A!73=8$'Q-R(*\M:()V3@(D:=1NAT10 M$MU&6HP=9_73XN$!>Q-X$_P3^I\[_,/UZF+[^S]QC@`;VQ7$I"+[S&^ M^`Z/%]]Q:W>#FH>8Y',2,XO8D793>>^TR&M4 M\14SSZ7W^],E%_3_#ZE++JB)CR^Y;`\0VX`-O>3B^?@Y5]RYUGQ=[EBT9?FZ M%^<4_'S2?%)FM>U.6JDOE)$3C-KLD7@INPY"=G:+^_7\<;Y::\4Z?]:996`O M6',$1GY"1][N+(7Z0AE=/>IPR+5$)(GM9WGM@OLZR<@=IY*T+R19H$02`6&W M5=!$Q)EW#`52RZ0ZDXPG*9;S[&53&>+X+6/V1D$;GK52*JSN8)5RCD7>8OPA M(?VCX",2;N1%R]V)Q8^C?B_O?J&:<.Y%=W*:QL%]HCR%'!`[V*&7L;KVEI`0 MDD$WU'D9<4C%.8S?!YR@?$]+/XC'8F?^%O\'GX)_<_=Y/MQH,LA[+UT-:KE8 MD`_:UI#R'-U\9/"+>NQ%^Z[=$5LIN4QI01WF:'U\7!7UY]F=>,HC?B#1B\D. M`_<<$.6#_B;'S4.]Z;/G_'Q(JH>$O!%PC6#W=SXCPAI*^0HW]3PWOB>'1$"\X; M?$2E$.,E;?'%O,Z4#K_=P3UQ84SAFYLC)_7EL>1O[53Z%+%C4MMR=_HMNX[Y MCO`QR#L_4H[W4BZ4H5]0UA)=**=$W%9Z9;5K=R!05K0&]$2$O_3#0^EG%$BN M\_SF,\E[KGG9=^Z&/N(B>H`A>;/Z7'^GG=PK5&I4IZ)SR?1-4(NPO`>KGV:BKXD> MWV98[FX]W_7QXZ:I)$_*S8*7PY)K2"">N)%&W>/E-0+MA^[G?Y0W]VO=%>2L"]G^@+>Z<]Q2LZ` MG=O9'3+C8=\86(MY<&X7JVL$P;_,9X]@?G\CAK_%ZQO2`XSX97CC16]!Y.Z7 MN[O`?[Y#OM-V%D4PYYF,;J>KSV[784D.SXH&X1SWM<@2+Y56T>C9?9E7I9BF M]$@!K\[U[/'Q+WA[0-:!*USX>?GS_)&]74HV$(LO#VBA($>K:)FX6]Y__G"' M-AHW[(4I017U-\$K7+N_72*P.]6W!2_J5E+5^(6Y4*>BIB1(2L^U>^V(./.* M8DPM^/AQV`YA/?M/7&'DY\4*/S7P/]W_50UH+:])-07HBUL2?*-.7WGHM2.@ MS"L*/Z`E;D0(,I6+ZIJ(_HK&-(Q=SS]E"&(@C/5%!LJZ5H1L/J$*T9W7'+NP M+*^EUXY(L(@XQLUV-4\.+@;UN)XM[BG.EZL%CGX)NR(QXL?#Q1V)IX0VSEX, MB>MTQ,5PI"_<6]F_+.+%Q;N$?14-;'TF]$BAUX[PK[!,YA1`C#%DZM>S^\\+ M4AZ4/O::>B09UP;]97$G^#;20QB\(>5[?]CCW%1_BW.6WDY/T:8<@F&O,]6F M&KQLR&F(A+#GBL)-BMSOIP_N]-H13*XKFBFUJX`1!'D98-@:TJ4[AA$)LWFB#0:T>4N:YH1C<4-9DLT!OA&Z5[-XK('0@\ M8Q'"2WYQ:#7*<=&?G!;PL'\.]\LV^"2N3T/XO79$ARME,&7SJQC!U63OD$]$ M;L6()\;EUVZ?__8&_0@FSO-PHO&)>PX.9"%<1\1+4%=3(77(:("GUXY(;PVI MS`%?E#6GL/J_L*T98])X.[.^IH72PJ^I?5"7'Q+C6BB@:YST'/-OKM"!4+RV1ND1!C M#*G!S_/[KW,2_/U\OQ!WF$A2WB/"QQ4QO&\0[S6. MA^ZCZ41G;6AACN2T1,T0G.M-':IX56>U7E[_GP^? M9OB1INOEEX?Y_8H^*QD6'5`-B,]F.6'8MN8PI4PWFG-773ZOY M?WS%.QB\;*U7XAL90=!HVHQGZ(=4?!:Z]N#",$C\E$7Z`OVYD MRH7S=45N%\Q7Z\67V7I.[Z3-5JNO7QYJY&Q@A?"VGAOB8NJ[]0O$7ICKOZ_Q M&YWI&G.CCDCM23ZR\M:X'NMG-;ZXR)"##I(P,[0\+T-"*GZ$*RB85XM%!_WU ML'=#L,U4T(M2M/#/\0L$C)QPW3PQ5/$6R+-/'RY?5A*8D!Z=$+LS+NH)I-O, MU^+*2;<"RQU8GQ`._DJ:UG\@3Q0Y?!7I;<3\A4O./1F]SG1()\/NE(EZ`AEQ MPFNQE@5^UK3KJ(A*F(E2!4)'N6EY4H50LWW(:H`2J4[Z4(,==F=ER!(1[_Z?7T5,-0S+*G`)@;PX@1* M?:?DWC$SV^U(2]$_",;.?75+XCP$,8[#N/L],BJ'.(I=?XO-R`WK"R_)KX$/ M"!7!A\Y^@6B%CV$JQP"_.QIEW#=:48_/\:RB)Z>O-;C-G#=4ML>GCU.RX1VT MX>$*47F,N)IU.'-^F7]:+=;S3$Y7C?=L^0'">9AF"YX+#M#XAGE`A]GNE:&6 M/$8/S029<_`Q`3;<(4R?F)%W*O=[_#8E?L\RV59Y/OK#*WWR+F2O3\0!^$[[ M!-M3IV"#>Q4\6N-'&M]FRQ:]N/"R^":I1R?)[EQ%45%T>SR"_#CL>Y!J`$@+ MB2*8)V\K=:/P_++AV:%&=S3H]PWL:;@Y4K5ID1F"XZ%#'6KC_H#M$KY+D_`Q:F-/W;[@\%@ M3.K?T9ML0\LS(Q5*:>:L7!F_QR7PPGV[`F@;CWT\E_Y"A3>7?EDKMXRMD"^G MYHAZ:'27NU_< M,'3].%KZRTTW[4^FO9'=B;C\0NA& M+SMP:DY.+8' M?Z44:C^_PI3PD[O':HE!-'M3L=T>%N0<\LK MAQ$@AXH\4P`^U(U-+L=J[%Y8D\`G!,ZCG:GP0K)P0_.-U)O?A6[82P1 MI.7DRR1.^?SEQG":'X4M&TN`5I=+$_YZ8$H(*Q?`X$G-Y&MQ2B)P9%,#J@@]F" M1!9N0437_+F_U;#BG[-E%JQRB[X!L(HM^VPPAW0P6Q"8X!;$BH7_G"OM*W^/ M($'@QF$A(3U(S>./"Z@].I+4T;?\32,Q01I=^<^Y*3.FBJQI"@*22[]^C`HN M_6PTIW0T[X@\*&"T](V#=X">UL]P/30VO)+R,*R&+6Z`HRI M1_&MZX4_N_L#ZOW"^D>GG/VI0-85!TDY2-?C.0-L'A(DO;U+A[X%0:\:(ADQ MTN)\.;@)(&TPSE/.QO'R3;T+!)]=S[\+HNCZ!7$+%WXN:YW M+N5U#'L"\;PR6G*:(\AE1D-*VY+M$@V16OYXB;`L1A`OP%#A[>+:+A$?*B3N M%9L$;X%C7SW`;#5N0C1JO$D;.``6^Y3B0B0VKC[8NF>>\JH$<:).\D5#%1R'<6&8\#4'V M6Q`U*V7>N.4ZY^`,:5=*T%3#>.F!$X?Y8@-"HX3]%@2V2IEOS("=Y_[^ZZ^MM$P;B7X4/D$XDN"EY09I6:2];-K63]IPJ=(M4A0J2 M5M.T[S[_(8X!V_AL;."EJLC9_AW^<;;O#DZ&0\FX.K^W]AS,("JE!1_<@K41 MM)@&3-]7S**%!?-#)P,+5M\0]EXCFD&<2`M^-`O61A+&@E%'0@*(_30:#T:]0+`=XB5G;D1D4(O@8KU0WIK65I`F@&`0=C18)8 M/U,T&1:\V5_9R40M(V0/>96?N&>8=47F/P5$QF1]N%'3$%6#E=(V=+?"7)!H M!C$$$QV"<-$`2$9EA$!!5%$QH'=$/]6&"W1H!BJ6:_5=8TY+-(,0@HD.01=O M`T`J*KHSD;K)4D#>C;23X:DHP]5+1>9^6M6W;091"",E1K.';20J%@*=+3W3 M[6`1_?(08!/K.\>\4V@&X0DC)4:WBFU$PYC%'\5I]](8AY\2UBM`-%_5CQLI M`>@:M%2VHPEK+*T'S2#08:I'$"MI"":C+ZW6'3Y[_(?,*'O^(9M?E'^ MN>V6*9(%9KPQ=Z#R?4"E-.05FL7QQ#]";P)_!/*V,0CDO0HY MU(HUFVPO=2G'9G"GTJ2N&2M>2&,CV(A,VX$/TL.ZF':N'JN+;G@/Q-,H4\Q:+ MJ&XS8&EB4[)XKD<\K2=#4WE8WT5=V';%+-BT8VG6.@59)VS1R9\'Y]?3GD%=E`K/U5Z^X;?J"=D;ERY&GH;Y9NXA0A-A_3 MW>B#]?#.>BBBS(71V_Q$)G@I2[`9F+U;U_>)>D!W]NQ$;+-93]LO+4$;[$S) MA\R$K<46^K:9?%K\6D)/7%*?_ZA8@N)E?2B9=CQ8!SOLZ:X+0.3:T9IKO8N5 M7ULV\DJLMGG*IG$\\2Q84Q6"64<]#I'&6#+BHM'NN(\NPHOH`JGNV/4@PY&S_;(@I.,_G2SQ[\- M1SR_ZWD`XJG7=D$X00FI79:NUK,@3 M^9`1:WF`9M@\GO!IGWQY(]_?G\O#\==W^L%?EA?Q[?0[+XGO#-%7W5(?I.T' MX.BFLE'P0FISD!^23;RZH_Z29.+IC?9*F3\$;WGY5-@^!M8`LSJ=YT#;+**" MR'2>!_'"%_P?OGBYA/\\[:H<7_D/4$L#!!0````(`&ILB$3:'V<+AF<``"&T M!0`5`!P`&UL550)``-8,T136#-$4W5X"P`! M!"4.```$.0$``.0]77?BN)+O>\[^!S;WI>]#$LQW^DSO73HA/>PFD`&ZY_:^ M['&,"+IC;$:VH3._?DNR#09D(QD+BYDY7Q)T&%GS4=2JU MJM&XKL*_GJ@"N#G>1\]'JT]7<]]??KR] M7:_7-_0'V+1=_O!)[ZF^^0?]ZXY(W^%RU>1O^X`36V!.T.S3%05U''%T@;VW9Z"I/5[@`F: M3I`U=US;?7L7P\8_!RH3\]5&@NSQ%6#TV3:MWT`QX?^]X9(*;DFP!2;[[$Z1 M_2O";W.P:!.V!+#FKN<%"_8A4.M7NK0`VJ_N8FV>'7'LSQ]=VW;7\)-T*F2T MD](Q6YL*%/3>72RPOT".[X$1W;N.#TC#MHL%%<,RK;,B!;^BMLW,7(:#@*>E MA'VPPSH^8?@P9,'"L#_"WF^B:)&S8O40D#R\(]/S,J_/G)=#*(IPP&7+H*R,7A]"0S1]=,D8D16V)*7MX9FGAG&;S7SLPY\L*!O.[DUO_@C6)(J=:\W. MA]QPB2)O+8J=>R;DAK.Q[UJ__>S:4T2\'B1D/EC(#'('7Q15;ZXB3WUPK8`B M".%-#Z)M_[WOS%RR8%P4PFQJ(JP`+43P"I!8(1H0DB!."1Y-3+Z9=H"<?L M0(B!33OQ"3&,L3E;N;-S82VQUTRQ@JTF%*L'"2B$8C);"U*1=@(V!'3,=\?( M"@CV(;,#L6Y+$R\!L>:FA[IO!#'+D<(80WZX-*=&30'B/^;X%?NTQC8-P.O- MGC&(U7<=M!??2B'L05:K!-W'P`\(>L8.7@0+\'I,%650FP%B"M!"L/^9-MT7 M`]^EF@"_`G?\8P0;I11Z'O:)"@2W&\S6FG\U"3%E^;=RIVL%"'YQ(9!EJ2D1 MVZ#?%-1IOIADBASFW9@=4S,&4]L+N&C=!44?G:F.P+<5?8$XT3L*\@?][@ M(N%DL8J*]@"!HYHA0LOLY@]Y7^M,?17>=@#[A`L>%Q)@V#7`[2+(-\0B3D=! M?,1'1XI/*O8,/EH2*N6HB-N&@<]./`$E&IS_0,2"\`9PRK.)N29:3PT%2)(W MT]F>Q4DF8*ZI(/]*14F.7ZX"11O.(.-#XR7L\=0;/:'P;*@/CLH+3SV>;"DG MZGIK&]L*,(6]'?CFOU/-@V1U29$3PFAIHO-@(V&>@),"^WPA:&GB:73D+(B) M$N8D\9#1GJ6*@L(>6V3$I$9*[K^0Y:/I-]*:8JB@[\U&5L`5`3($QC)!- MJY(OP*GWF&^`8IZZ,UDN315UYR2*$PAS/-,2CR>(BE)]&D:T$K[M5^@[D&\Z MB/V*^O9MV$%+OQ0JJW&AM1R3?P`JV%L)E\`]I"`7.&2*A")Y M*IS_'F^2.BZE1$B)#@6+A4G>::%JL32==R_.Z[J`X8I5QJ60=*VUJ2+%V^`Y MQF\.A@0&<.Q:EANPYJP7U\;"/6.>ZYD*JD!B&'9]G^#7@/40YBD],.1-%?4' M,?P'R`_+74^NY[T@DCA"EB;#P?;24N&^Q4B15YK2M$9F"Z.(*MC%?D6O'J:G M(YM`\A[B`3&>=(T1F@H6 MJ!7TYNVB(5,M]Q0(:A<;J7,-D4UK"5L[P&?A]Q/\(/X"]FWX1K5:;=2JE>O* M`_8LV_4"@N`OW>?A:-+_W^ZD/QQ4NH.'RD/O9=2[[X<_Z/WSI3<8]RH?(ES_ M'B-!R2G^PD)(&OKA(X=>3F"DQ<39KA5]RC9?D?WI"G[P?TGL`?DD[A'JW5?/ M)Q#[W#1:M5KMQJC=M$08+@%Y%WF;7CAQ22R83.PW#-GPPQLZO)H?1;YU)XZ\ M,&`AW)-JU24Q'3/B+@H0@N^>P@N70-#-KD[1?ZXJ2X(A<_+?0=NO*H$'-+GL M[H%IQ^N9Q#K0W=VK.M$G;I>LN^':FA\4FN$30O*-]1\G:3J\E<*X8DBHIAA8 M?62;AP^19&MZ2];?(2F*#Z;[`0(05K^3,%\YZ/K).0=7(G'72Q/W3[=<%RKC M70V.=[W_Y6M_U'NH3'KW/P^&3\,OW^4\Z!&KEG"57UQWNL:V#7LI9(&F\T8; M1*(#^PW*&R'7&GU[\4^H:M>O MJT9T5?)OT8_E4,GO7M-A3X!OG^$CO]T81K/35$:H``:%6.^)LHWM5Y9A)7I? MX$C8=?(4RCL5'@/F(^(A]LD"S;W6$3'WRH7Q`/?RC7KTR4/A3ZYHHZTM/^0MP<8W605`HX.+6V)]7@$N567QC M-]/G?(:^(Y/0R$P& M0SZ40HP^%SMCBQ:@3F]O$!/`FAPQ;7)DR-?E1;.%H(]84J@J?9_,%`D=$_)( MT*;5@%YPH[0V)`(X'HSRQ7*4LM*+F-FG37B%I[!+?\?(GE*%:DN8RX+[?&TL%`0+SKZ1] M>@9,3OW1J+;OE)5V-21+WG(-Z*NR*TDNB<1V*L>C2Z()*\X;)>"N(2XM/A3-A"5` MJMX9QA="&X&):]$F.HJWT107T0J,3U0*;CH7U'A&B=Q^>@2-S M2G53XKPB!8QF`A,A-A)72T]Q;?8%VMXV0A;%=OH5XEX"VI?X):.33K>(1WU1 M&F7Z`W,OI)G(BV%8I!3MBZ[X'+8.0@)W#]G?@Z.JU"(SL$7[XZLT,`X!^B3[&/D4_V MO34E*AT2H//;^`#Y\:!-#R+$-_*S\3U M33M)%,6])2'``P`:"2N;.+TK0#N*]@7B=)=`>3XD,9_D,Y148R$>H[.B#1["4.^81K$N&\ALV[ M*;Z`YZY59:X@RBZ@VC*/"V5SJ^(DWN@=U1S0EN75:S(7!<0A:RQI,6Y<0(RS M1QF-!)H2ULN#H8_8CE*H=ZRSA_G$W??^!FM>/=.)W1SSVL,%VM>&,KO+YG37EP@HN2=Q1 M;K6JO$NBQ51IKJI$+SA6 M=E^5%+7@[+_*;5X=[9+NC0 M!%8HQ+[$>+TY"]DCK'3+$(I91LA">$5WBP'R(U)OFJT6KX&J('W*6+D$L8DR M0N\<87?6?(R^T6BW>)T\Q0B2NV8)$CQ.N^;I0Y+:FU:UPRN-*MC+RS"V-%+U M[I7+)%+)P7_!3C90Y:#%)1+S&1/+670$#9MGRI M\6IV16J9E'J)"3<5>^Y&P-DV-`^>&/;TL:Q]`NJJ]^[#1<\OMDS"]8Z3GK#Y M2N]/AX^M'L[IWQ!4KW('@!0C2E$LSBG:/)S1.ZZ*9\6^V&;XJG,\,)9U@M\8 MS1JWTZ.HX#AK\0(%*[`+;5VI,$,N>_]MUK3;@-.2\&`1L'/'Y"AL^'\;,:D[ MT^0$U53YW33;X7U:1807A.99M'[+@D2&7SR72W1S@M'G71A].NB-4BX;?Z8S M^.XR;"M5C`/DTZTNG&ZFA)BLI<]B`W?"._\^,TKTZ)))%3TREE!JWFSQ^IW, MC'5%X]1EG?@12C0OI,1;\DJ\J*AX8]T$5TG53GD8B6U5U3QV+02^;.O.P8-( M+SKZZD5>&W_$#E#_A%?H8`0]BSJJ]7`(MI(0+'OQ+%:,,J2M6DX`)\*#N/Q2U32,8ZC?M*K-MN*,L"1W?D!? M+)`+N+DJZ;^/\$;AZ6:1V?Z]N<3T3?L_T)2.'`A\1,;NS%\#9\/B9JO=44?/ ML=7/HL6'E[,E>+(9F=#47;WE#E,3IQK[AXWU:DO=R6KZNB=5BY.-UML>)94- M(]PU"]%G&=&D])IS6*#YP<4N_HD[1ULN`#7<.;Q*!,K%0!?Q'F6/WF?-0`T) M8%L[8,1-L]WB71\L3,+\9PW3$>E%A)5QH2/01HX@YG,VS!]X8DV>D1L^&NJC(;/[I^:1N5'&NT M'Q6X0N`X:4.[ZZ/]D*E=5]C?E+UV:>(59XG>8P4?$,$KX,P*<5QJI]%0E]9D MK5R>U0JRH_2Q@*=&&$KJ;"HB#(XU`Z/T*[_>4^^.F*";$Z) M"KBE+N')7#J_$G.WE9M.ORU:DT7$D[FU)GF@=[F%2S4U1X77&[EK MEBG#XTS0NXPB1K9JMU+DSI*T)2J'L_C%,ZI@ED_<(?C/VFWXJTF(&4[#'M$W MS;QAX-,995/Z1(#1`5J5;3]92Y>Y"PFS9.-1SG\2E3Z.%D M)/BR$7"M6:Z`)5@A>5X]KRANVG580598?9Q+EW.<)1=K9S`.S%KAT#>UM[95NYCT MG93'/FU"%*X*/&.'81-3?6/4JQUU!YC[RUV4O#-YM8FZM,R]%+%(B0I2 MR+,;HPU.2'-FZ6R&!ZY;@5S^K,4T/NE]YYM),&5._).>X[.8I][HJ)MY)X>, MSBIY^'Q%?C[KG:V_Q-K)./G-M`-T8S1:'76Q(6=%1:J0'NLFYJ=E4J]W:$>? MEG2=!.IM0^&(K?W52A-:%MEZ&UMW.L7AZB\FGO:=Z!+*3;.C6?7@33VZ9WR)&HKJ6ZM;2B\`"F`@/[Z(,E%W>]*;H@Y M\&UM@_M4=>&J<'E!@2#7]+Y+>4!$Y-A`=U7>C^4N>H$B/^26WK. M,J#$PLJIDTB*>&S9J!V8X]:0*LR2*I$IP>^B";QH6ODPH18J_>0RST0W0">C27WUXH*>EMOS#YSPV#YU'U[;=-<0<#Y!M M>A'L_.:XI801$M$Q'&RH8$0D7]'F!HAIFBT'OCB3C()R^NCW"8988$YR.J/3 M#)!#:NEF)S1\;00*/'3VR:&$W$G(+!N:9K*3(%WO0X1HGF%,SV1.W.!M/IDC MNBL-9R%E'J#'7H#@#3Y)?^U`#+!FDLW'$+W/"_@T;4EA"FM(/2!T!.!%"#6- M`7K7_..Z=%3&8-7I1JO>EK!-#@C-!':,R-)K\(7$H\9)\>@O7[NC26_T]%UM M9/I+8!(P&_O]/"%J,G-I\V:XGA2AJ@I0A\[`72%:HC1:@!ML)31[XKVI+A6Q M'H`]HYEF""([@LWFQ047@'+IQ7^;#AC0.V-%+60%KQ@HJ1:[4"]#*S(XH?\+ MI,4JQ3,L/6]O^<8>T*L00+T43 MN!RXG"D/Q2C"(WHE=(.LT0VR'O+".%T;]L!>ADID\>)R+@`4%$$$=N@T(S[4 M"P@?MB`O0Q_2>'`Y3Y$6HPO=X"WP_%I[RPF9%$D$Z&7H0SH?2NS94:L1.5E: MY/E.`??:@M<)O1:54GN@HFQ5>9?94_`^!J]4;3X<4"1#?>GM1]F]+MAC[UN- M4,0].F=A,@_?N<(K]&CBL$5K.(.?QA-30_/M.M,^AI]^1@Z[9!HSA%9B'Y'I MTS8N9M3*'$/02Y!$*RWSL5T`^S!UV%WZB!??1 M)4S=F#*]'ID@J"Y9>,A.F.I:>ILT#:='Y&"U]=@`0IN^4I&8!)1 MJ63QXL_Z4G$*+RS?I8="S0T?3J]U)D%>A#ZD\F"C"^VSCY(O01?B$\*:L6'$ MR8>ENS`O01LRN+!1AP[5AS^[.K"SH(11M$_5A03`2U"$-/HWI>Z_A(-X0!8S MA[L-'SJGZL$.R$O0A'0>;':$NSIL"1>E"T4T2TE<9*/-4M^ZH_[PZUA-ZSX= M(^H&GMK&_8B"PXXYWGMOLF5='G#5/5$,>8E\3@RJ6J,6%()<0]0.(_1N\1?J MY6'TR!PVB`"]"+FFLT'OKO_C/3F,&(GR^W&(%R'0%`;HW=Y_M*^&T2+1'WX4 MX(7(DD>^WLW]8OTP[([8"==I^5`O0J@9C"C]3L#Q2G=\?VA+UVXP28]66A*' M$T)`M9*K/!OTGKFC^AR6LE+F:H]J?+12IK,R7^]A0/G/<]G5-XFKX/E7TDIW M"F*8WETZ!X?#=&>M2Q00#@!H)<-L\O1N6LDX`V;N3R*?S@"EE;A$22Z_IZ20 M@J7<[<[=@J6RNYW),*NXFYTIHV220V@DFCJ/@"NL3@G[?M0OTS@AFXJ@%&-I MTHQ,R9=XI.E=:J,&:FFH2]:@CX$J6E@RQ>E<2A<=EU%C;H$1N*PZY9&'F M9('N-<7-X`4/G#1/11LUJ3T]&U[IVZ<$N;J7$"DIWAXM'LMM7@AV++PT;490 M0^HP3@2J%E*4(EWOHF%B5*T7CR(/\9?82+E`M)!4%F%ZE_THN3^S^<01#]`4 M-OR>XV."-IHVG#%/WI"(+47AEBR^7.1K7T`3\^)UYL4E7)\XY$L)9'99H'<) M+-Y=6!V8*:3,W,O=;Y)11E;>EJ-B2F[&6+R:EEB$PZWPQJW$J9TXY$N).'=9$`M6 MTPK,3IQ69W&:A/!VOZU3R+E+2BP$?4LG^RX]=/BA"Y!IHD^%I(?3.T9B+*CR M2BF%O)PBC(;B=PW*I4EX6M/P'HV-KCJ:!#5LN?<*' M0=V^WF.TZMQK&P4]LYVQM!+[.BJ!37X@RI32#U:+:%?H<.SK^7DXJ(Q_[H[` MMOKC\=?>0^5Q.*J,>Z-O_?L3KE5MSUK"@!W2YC$B*VP5<9V*(AWB'*(,&`\_ M3[K]07_PI??\\C3\WNMU!P\/_5'O?C([;&T%O$"1W M/1H%(,=C3`9#>@QHZVIL3HP^J8=SY$L.7OO&C->B$E MCIZX0+07[7'2_[^];^MNVS?V_2IZV]UKG>,CZFH_,K+L:->65$E.FOW&2)#- MEB9=DG+B?OH#@'<1)#$4*(Z<=JWFG]C2`/.;`3`8S`5WG$70=9IR$%RQV,PA M_KFCKZ,75QF[N,,JXKYX04(!-2DW+^0;U3[3?J:W9-/AG;MZD$#Z2HKHQ0D$ M!7>P19X9RD(8(\O9`(3+E-&Z0*D6`($[1F/ZMZ?9YL?R:37YJJ^G^OUJ.GV< MSC<4D]7T?K;>K/3-;#%?S>Z_;M;);U/PC`&&TTF#H=<(=5#B#@))7QJX\F\< M?G?0[=V:6!9'"!YY540.O=@A<.".`LE$!D;=X_G\P3&L1T0N1(AEK.,.'LEC M\[2D_Y[=,V@H)/3WR^E\S7>@#!R0@@TBO=Q/%\[A>#E$S/ M?AN]B$J811Y/DG*%1<&(<\>>4&ZHK<9>KU;L;<4F[AWAZM<'7&\@M-&+N#90 MR.-..#&]=.XLYU=\],E&H\04$X*+/2.7H09^ M(==W_SAX/B>W<59DZ]#3SB)SXL]L.CIY<#SZ34KSR\>3QV+T%F_$ M-9AG5]_ZYKOIFZDHBF%7=-M2$R'2Q(3K/[K?LEI#6Y-KQ]6UV%!5PW=Z)"4+ M_BR2CVLS%>"$^Y$]70IH^IL]#A-]^Z^#Z9+=AFQ?;,=RGC_8CG8#,)ZDB%Z> MA.%8X7Y%%_#C+>SOY*=G^JPP]SNQG#>&;70SZ-]`.D>!J'\*;9!%#_<+?5P/ M+%>T,*D'-K@&O-E7$KP\X<,P0O[0WR!PP][G-Y#NZ=69#;FP;XEKOO-"C#.; M4CWP&=)I+5UZO_Y]I76'XP91D9T'^M66P!,MMWH0X^^;?1/GK>#M!,1 M1!2G@_MX^19X&&0Q0?1*(Q$/6X81[LB.HZ"_T-RXTH8W/=$YK&8_$0]Z>8H@ M`=[E!&GD\@=XZ5^R6QJNS^X>`XB36YKPY0F]'F:X8SH8'\QGO]AS1=;M753A M.<7;PIU8AOGJ704MUIK:'$!SN3SUJ0\U[M@29DAY#"IV5YW^9J@<3.^%H1ID M?5$+:A2DAS5GI)9.`+VNB*U3`*CQ;1!MC[NZ9NGT-UT5WF*?*D,?+1L65,OO MQU0(=,L=]0'O0))DT6M./LJT!EZQ]IR_;:I44=NM2PR/W)+@OQ07_X6X"3AT MD?@>W4X?3..G:7&8*(&]]H\%DN7O!GF+K[?:.'M]ESJE!W_ MXE2I#+X6WW'.KD;U$&[FDH%OOXZ*9+C&CF\U#3Z'RTT"U3H3U'T'`XG[<:R2 MH91O@8)$.>MKHD?3,ZE(=C87KBLET.)^81-RQNJ`I2!B['1%19H:U)2C*5R@ M>I2!B#SY-EL)CI=[@S4E2W\=M^C*>,7]\*(*DIM/91Y1(I(ND"NM'W:B;00! M^8F@6B`WQPND)J`M/EM)7DOZP;7$9XW0%-QMUX3L/.X.&XINMH6MDX=*LL3K@CLM-LI((+(RX:=+>4C(Q:V&4HX8[`3G.1 M/#FGTIJOM&&W+ZIEJ%[BPO%1R[T:,=R^I!-P.:R>-!F];=22W42%6\1YZ_DM%_7UD1BT" MKR`:HS\,XCZ;>1>%3^B$FX'Q$4:JA'EH=%1ZX_0_EA85([UM3NE/>0X2E6B8 MD=@,U_(S:7(IP*0>KX6:*'[>V(($D3"-;>WL_5]T2@R`&^T<:G0T,&:M*<7H M\T8.G(#F.5TRC6R\;*`H]7=F1V%\N8WDR\$S;?JKJ]&UL/^*&L:!DVE[*>5# M]>N#>9'W.QF0SGG5:62%R(_%[B9!N926F6Y[8[ZHP_*SW._E'LC2TS5WY MX/,Y:3FQT/,[A]4;CPN-#R'UK@0DFM1XD%A2&E_*)AK/_3E!:3@E`8V'_)R8 M*@QUN4@;1`:T\2?9-+^0O>,25O#0L7T**_W80U#>6HP7NJ[#3J*SY[!4U: MR<9-A).*&5'SX/&HP>`!V5FH63#UA9L4<(.CUN):D2H5 MBW@/55#U``AU+%(^`1,TEI(X:$[T&LY+GD0JG>.7;?L]0->`&D-@$?NIZ""W M\L``-6/<-7^T%EUU?WJZ3)-N2-N=,NCHHX'^NJF?6K0]O M;Q:O%FQ84;'@F4UMW==``O&-M]>@#UYR$B?H?;@I+0USQTH":-JX07:.1E.B M]K7EE-S9BR%`XQ@JBF=W7LG&^,W*0YH[.G-MU&BJ5WHT+,(KA@"W7;583EFW MM_F]/MG,OLTVLTP]^+X&:-Q20DJ)E&!3A2>?B/QJ:%;>6<&1?.A$H]EG!4"((WDV/O]M7HNM]<&B)D)N?;YG*O MJ74!^ZS/J1P/_PMY-FV;KM7%?O-"[DQO:U@_B,':W@XT2$/!4FHMGFX`-G$G MC`>,3.V=B`7`.W`1G=9E5,$:FD3Q9C"H86&CJ5K;D'51Q^O7>@57%>V6!H!V M2Z&93C\03>FD=DMY'1L(UGOL4+2J";P3/G M#:`BKPS-MK8_$*^XZX:5<]_,95[M29HA1[>Z(#.[^9F?0?GR#H8B7O'WH:E= MIL=Y);'UF`1'T@769-$KT:#U5?3>=3R/VDQ[D]5I'X^;6UNID93HIS3^<:'Z M`E9;/,!:5=`&G]\4*FBXHU";8Z0U&)<8#7,6U10TZ1$PB>;6HIS=2KL&^54@ M>AN,&E\FKIC1=7-WM\)AV]%9*11PET^(64AR2>C59GC37,E&P8CM'(95K'_6 M=Y^Y8SM9UJ->QHD[]::Y-5PY?#MK&80*[H>B1)^#E(_I;\H`G;)I&^Y'X#BW M=Y/#Z\'B?32G^SW9LD:V+X;]G!3=IC@L7=/>FF^\IT9W=-VP2:]RPNWL*`T# MW^(#V!FL](WQ.UQQ7XA-^`U%T_J-]I80C=K.[B,#`9K7/J$0@UME<(@.M6M1 M=(RR0EOA0.TL\@)&6WQW;#KI/MG6=-]WS9\'GS?N<-C[K""54.OW&DPJ`\^G M)7/B)-AP]Y#,\,;KD0^;K-[1]CVAF-W(/='];(M^:K@L5HH%Q_$.NE\,S]Q2 MV^76M`X^V5W==,>B/$$U(J\8O)WU#$`DTHKVO59"V7XGYO,+G;+^3F\[SV1^ M>/U)W,6><[4X^)YOV-1@?3YF4+ON]IOSF=:;5#NJH`#`2$60>O=8/UNVV2WL M6^*:[_RRDF1!LSH82Y?XQN\KK3L<-^Y9G.)U+?P&>Q MX7HZZ#67G@:82=MRKPL:[H"@Z,J1=#H=#9OTLV1&:UND9L&_?5%P[8O2`DX<#OJ"[FGYTK_IKD=N'#-!$-?'O#-/]9EB'5*N>Q3OS3/B\.BUO!@K(XI`D MV[8DZW"?R',\Q"=/"H:9O8?>FB[94EB].\*3B_K7C18@+1M=B;@!`:(IXU\: M%-S>4Q8B0#66CQ],?:A=-[<5'P_7E@!+V<;M'5U1,.AG67V0L)L/.R?BR^?P MNL'E6#IV6[*4!P2WKW-M6(9K$N^[\4Q8]-UBOS>WU-*:.*^,%0[9E3;J]9I[ MSY:90EMB!L.#VT4:L4,YX1SQJ3?G:SD>KFTI"MG&[0*])S9EUZ(SUW>OIFTR M5M.7=&JC-]C%O6+TMN0)`06W,[2:^69S3&KE"8E#RJ1%P*@KU#.4*];`Z/;Q$<^>K8U'`O`ZK0.=_=/YR2^B!:_K_'?%7 MOW;/8L]'"`<(Z(?4L^`!*OD$5)@QX-ATB%OGU3"I/7#=8'RO<,CZRW9BO)E4 M\$^VZ7N/A$5J75U?-]F*\7@X)!RK(M2$A"(>X;[[B M-*"0C?ZHUV`*52>@.PI@:N^,0`AKE#5TK)>/WLX!+X\([L(M\;U_P[BY M&FJCY@Z,[%CU-YB8SI'4//VWZ3$6&G35EPVM1!.K!))8,)(@X+ZH%[#;R#FG M7/\>J)'/ZW&P>0^:GW<\7I.:ECO[RMEMT;'0;#NX8JZ;W5E@0BZ^O['>?F1W M>W!9(1C>G82GEGKZEFX8'O%?:N-=K[NB6GH=:?2Z16.;^!T8(M\\E]/]Q M%B:LJZ-EL2Y*K#@@U?P44RQD69B85]B@5Y+PV<58C^4+<+X4J>:<_.*_XGHY M;FGEQI/`M6S%V.#VWI0RE.XIG&HHO29;^E%>@IPQVF#$T4F3PZ4<,"QQNXA* M&>5Y#(R909.V2M4$<`D_CPGN(FC"8^W+Q]I\MLV]N35L/^5QX$<;P!L/(H[C M1)=BO?6.3?77[(IXOFMN>1@&_9C^RW!WO,8ZU]GF7LSJ30K7VI;##G\OP>M"<)Z^!"9]= MJQH&O48O"05WTKW8JCBG;9U1)OQN.6#-*2:>$ZRF3QBURN-RVD MF9^L(V3KV+OJVQ@+P`!L*"K&1*8,-8"*-H\+<%#&VV::0WV[=0_,@1>$;NA^ MMS>,*F4N[/\Q[(/A?FC75/P]OFE"^DHK'!O'>:,"N$AAD+I"Q>=LU+LW.F*? MWBC"SRX)ZF[ZVK";8[TWBEF'=+A6.SP.M5$$7Z0Y2/VJ12O&.UA^BG?*;O\F M8?>1I:KVM8A98&E]O>.&\Y\.!!E8A<(-_OM MLTNJ9/(1[$@=F8ES1KP7"=NLTMMXJM/J!^/W!B`L%6.>7<3*@8H4`ZD[-.2W M@-T-V;[8CN4\?ZQ8C6R/5VMA]^2AL.)=N2*`QFA+\/6!B`2-U+4I9(N7VDGL M5VY8B)*S(&?M$4TR\;9_'*"ZKB.R[N=]VK>M^5&:%7`-4"(1(PTI3++SB9A8F93 M);8)+S_^W?1?-B]D;5ADL0\"B7FV[\+6#\\'SX_N?:,>8'M6-_+95:(AT")5 M0>R7,WG!+;8.'LAS4'=+Q#/S6#+&^5+0`#4"ZXS1RHYP$A"1H)'ZTX[5>VD9 MV\#M\TQ8_?,Z.@XPR!4/W_KNH!*^2'.0^M,8RRP:)RF9>1+BON06+O>#P?&K"%-#&'L^M0XT!&BH34$1=T)-V:AI68 MTG?$8$_GQT!,Z@#!-$9:HQJ=S-E5ZWS01CJ&U.L(",_@E[::P9,5I'%<6"78 MCJ2)U%68\7[SO6X`<#-DO]VNZSX[^22*`R7L)5QJW69B>!0GP&7*>UQIXWZW MU^3LCT=L6M<2/HJ+FF2YOIA4S;<@#L8W7!^0L!F$^B>=,RGSW>&H09$?#]B" MQ,MYC@6.O6E%/8&7(*5=]`[5T.S/OD-IH!U*2Q)L\7?"#C1V:N_4;%#-2/SL M&U1>X.4\1_)NXYFD<7E+!M@$;[HL9"\5>*53("RZ,,*;5[\K7S9)T;!-ZTJN MS$03<"4VMH9'9]4@M1HDF]SZ5)*[*U#,_CR96^&?12C%KYVQ-%H(4 MNKQSJ#-?PU"8I%X8MM/PA%J(\3DGQ(FF#C#Z%2!/K.%G0X9WR=*A#$SBF:UOMQ0[]NX8(1Z/%*=^4&M[:7C^[8&P3Q_HSA$^"_'C MI0>P%7%S<_:U@!N.C'"3!3;^7`M,I0F6IY6QPP"19U47;NY)@)XI[C='H M55LP8,H]:4?[`/=[C$YT$ZF=$@X74H,P)UIW\[FVR_#9FJ)W2[:<^SE%_]&Q M_1=ORIH^\9=L0#AX)<&V7N8E64Q)6D.XO^BV;^Y,Z\!FD%;_8^,@K!OPL3RX MVQ?#([%]$'R)M[X&G%^*ACV[[)N`*[T7(&P5GM\:Z2;'VM=#C$5JFH8)A\FW M)H[G!TBM9N/A!:A9T0F\/OSTMJ[YDV^TH\&IZ7\58R!0 M"2`0:4&/>D-L@C[N%YEYU(^[@5)XFNM7+S4%M8*',9LKH)]KZ8"F-X,T`G(M M-^(WN*JV*JT#H*)[J\:ZM]XZVT/8O#7^JV'O.E-J:_@?G9F]=]S73)-VJ1ZM M$2U6)BKA M44=6:;(89%3`)NZ&J]&D8T_'+=W?K[1154OTVQ.GB4B:IV%L"%*!P&CP@K8<#=F2)@XIMC'2A0;J"0;/:J M[@E"^GBD5\PX\O8.P?2_$\OZJ^W\LM?$\!R;[+@GVJ5LJ#T-"\;!(\=J()#W M78A02(RT._H3[ZHG+))_RHW]:`0,,JQF/I(>HA84'4W+!P#GP3% M`"!O7A"PO3S\M,SMG>48/MT\5+E?`>7 ML'],5[-O^F;V;=J9S=>;U=/C=+Y9=_3Y;6?S==JYTV>KSC?]X6G:6=QU[F9S M?3Z9Z0_IS\(>=^*PR)E-Y<&EQ>+E[PS3Y7F.BWU8KI]Y5>)/U'_W*1CO*]D] M4]M4W])?\:XB*?48C$4-V8L>@:`#U'\12H;*(+:A<'RAO__GU?5PV%PK^:K1 MU2Q@!>**=V``7"T^*YT:U:A@6^CW9+>%O_#W?.^_3U_S&T%F`F1=Q_-+32^S MQ6N`-5Q&K/YZ76]?R.[`\GR$",SLK778L1"\C6OL,MJ=Z*@V&EZ+TJ<4Q9.< M/D,URQXHS3C,1#'"%[P-J%@MDF$/K:R6M,`&E5$0C2V)5O0^'UY5!RO<[[Q" M*#@$@$8H0B*M2JJ:+=SONXFFY<,`61W-*#5IX0;M.C+[ZHVH!H+J90J<%Y)U M>PJ:N)^6EZ[S#\+:^GQS+`J@%;P(O!-N\"4,#4:C$2`"6HYJJ\*MP7CK$5,* M+@\#+7=YH(#--C_^:]W1U^LINS7<$M\P+>"U(?#&>+KG$=\+*=2^+^B3OSW- M5M/;S73R=;YX6-S_6,WNOV[6]ZO%>CV?;M+RA13YEZ5;WRXZ:H@T]7SSE:5, M/'ED?[`>S#W1ALQ!S)(F^D-`U1EIPDI6U0D"B!98/21P1XP^$,_3M]O#ZX'G MP>BO[,WTWQQ%QD478/R4D,(B05EN6]\7JU)%0:H(Z>H,H8U%JK7QP'TC6:X6 MR^EJ\T.?WTXI1DMF!Z30Z$,:!)71JG\T4(OCC;@^JUK/;,@WGJV2ASY!O@F9/KDE[\1RWN*T\-0D M1WW`^TX%N3,NL7S)0@"G+?I]&GV=D,9`LN>:`FF+?0B%-Y>>)@K.+G(9-'A' M@T,9[W,2S.$^APMX#P\L8?PN3(-4G<;UA23)(IHS62BGL.B9^6_>`?SM0'>+ MM;/W?U'"]Z[C>5>C\?5`L+FK>3BH&OV\$L[7\P*`$U]?+J_XK`J_\[@G\#NO M?G1F\\VBLYY.GE:SS6P:AK+%UEMG^;2:?-77TXY^OYI.V3%=WS_M?LQLWPEK M)ID\SBCQA.1**)WJPP8/F`Z2$D9N%E6^KSM0_;,U#/JSGUFQ(/ZD3>)>HZPL M&<016D9+R?)6*8AHX4L#@-MIH3]3GI_IY-/5@-CA=`/0/R$1M)*K9AFWW91* MF8PZ0CS1'R"KP$1 M;O=/2J$SO6%*68,WC)6FCUT!Z@&%.T@GZ;4H),1B$A[>9!Q-$*N3Y$N*M"9,XC(TAF*6.K;G7: M*MH7(7@00+B+2SP:[C^)OW%\PZIB:0CQD\O212OO6L"T7GQ"B>M+R[F^_OYU M]F6VZ>CT[^O)U^GMTP//V'R:EHO;Y MO@00('P$?!(^$27<;K`T_-"6,V^Q3[4 M0*Z+K)<%Z]S('L^([45OV.)4I`(I@@?`)^+3,&K=?Z7`1AH.1\0GG* MER#4(_YQ&S2R3(T"I@"VK#SE2Q#J$?^XC1\A4_SF%7`!,%9+2*$3FX##3V&D M#'*YLW>$LF58'8]53:6H?W1,F]H7JFBL!W75$=L:I;HS?*X,% MJIUHMI013T?(7P-:U$L1K6_(3/=[UI&;%AJ(A453%#-.JXIW/BZJ1;HSUJC!PBSY![?[!J:\,>UFWU`,]7:`[6Q`O(/4TI@PFUMBE?Y MQ+$I8P?*6\BD8WMT,6O-%8:1GP<*U:@'6^LVJHI'K&$N?IO5:.QP=V3'V7>2 MTE:=J"Y.7=LG*2Z:$(UHGOQ05=7PKP$=%PU9?Q?/8Q+47(D;US_R9M&\U"8@ MID"2K!KGJ9P0\J5!Y3G&[<$I;KBI7OVR8]77.V"'S498$`VM1".K!)+KE%H% MPD7J7S-52U7KWT.NN7&S\X[':U+3\L522]EMT;IL]%I5PK76121EX>2_&!:[ M)>S+[!=V2'6%_!2MOLB:A`;;FW M]IY:8-["97=:XJU(D-/Z9+OAWY+:S.FL6`U@7]8;I6G-%H=%G09&Z]>]JG)H MP>65<<=]]'W`6U+VVV>73LGD6W]@*$5]X;\0EUF++GDAMA=[$!@?C`UA'\\" M&931.KM$I!G#G6$3!31[4$]^W.!",G]H[>2,>9OMI&>,/$,E1U896ZO';:V18L.R M\:.IGF%YQ&R;'5N169:]C"D%Z1%2;QCDEJ48CDA?D#J4,M99GUMG`$%FO]VN M:9F=?`0[4M]0F?W%;>0AP,`O)8;*M,RR%LD(J7^HRN[BS(P!]DHE072F99;% M2%Y(*YJ46&#<``-<`DI(83(L,VQ%TD'JPY`QM?K/)8<#Y?R#/[[>!G,_`A M*RF$^FJWDTME2T^;U# MX9TX=%=QCX*R`5'E:2+II$FM*Y]`)Z)1_QWKP:0+>T<%F\"4:D_;"Q6GD<#) MLJ&5K!))M..^5;)07$R(6D,5^ONY5:6O;J?SSGJC;Z9!C7Y>HG\VG]1,[;@W M*,0VWYUX93E66([>8DY-ZB@@FTE?!H2J59"KORA7Q'S]>:"RVSV09\.Z(R2( MNP#,34!"S9H"0Q@MKRJF6C]QRB^CQ-TR7)[)Q/!>6$U*T_/""CM#2#^X`CHM M"T>*/=PF7J;V[XIL";7U=S-6*RFP7>-6#/P(`+AWI`FW+,-Z`.".0A56:^<5 MN0&=0X1$6A96-6.X`U4SI=.7<>'T#^;("ABY`81!EE-K650`5I$'KX8,/-FF MO]CGV!@*,_.*SK$26FV?9;)LX@Y?3>T0=XY[7-E^T*NW`1Z3PK,-EC*).Y(U MR\6<^!D>ZK58R1)"):8B!G$77,_RH"=,,!X@&4J%A%`)J8A!W)&6*V)Q)WVJ MM@.U7U,M6W1[E\H;'%X#'I4@M%N_*]>$`7E$9XZO)7^JCM26LP)PO%>0PR;$ M$F:11WF*6`GUC[,!R*0I(8507B(FVX_P5%*G9W#LQ8UB$%B5GHECOQ.*W4^+ M=.:.3[S.+]-_.;5B3]*H*46?D_].J:LJW2,W2EHA($&O,.KU?<#LJ=6P/Z:V M3USFQO&=S2^GI_6.1UT:'_SMCKD.`)%C0/)*EN;)@DE9.K6QP>UF#CF;,)@L MB^ST)9O>$5_T\$^QKN?X#ME>[#GC`$^GVM%1ZDP3R.+VB],Y$^)]-=X)-2$7 M?"(;)^2+_>3@>[YA[TS[F<-*(9AQ"#S_]D#XVN*6)P-O?=0+=S@$[#A-S0.7 MFIT%;?0^>S;]>P89:R!#.0I0T4,<-T[D\3[B<#"`7,M1W:Q3[F#^Y!F?86$<$E7CE_<;Q1)252= MW?J=`SM;N+&1@8:'M`/2JB7)XI)G'2QP/V[HNYT9C+XT3&I23HPWTS M$M9^[-7GJ@IXDJ^FB$NF0`1P/X-07=1?'0K&O\,-AQT5H:92CKX0F^S-K6E8 M`6@L4NN.&*S#"OW:@1TS_#0!/!&?/B(N=5",8/OO*BI\OM>Y!L.S]?I)GT]X M4^'O^FJEL\YYFT5G\W7:63[HDRGKI=?1[_F?Z\YD\;B@'N*2<,=8*?.!.OF<1Q\D=?@%^[ MB([B9:U""/'E689UW/[>=,1+%++)PS,!DA/10"RU2I9QNU/3;IC$.9.N93R` M=,`II898B@`8<'LKDVV#V1P)4VO'"J(%`494&2W$LI2&X"(\C4&<;HP0"X5B MJ/`X78"+JIP:8FD"8,#MEQ0[U#@7$5X\YY7^\`N%[)_K[0L=V`L>71CW]'>/ MSHY8/'H#L"DK&QBQEC0#+FZW92:\F/.[V.^)&V7$`+Q>Q900BUR2_=;=F`IN MNG30W$UW3B^OT\Y&_WMGN5I\FZWI%19V<8U:N5$(W\U\SA[D3LKG0J<2SR23 MG@QX!"VF5/]&&3,JS(.F_Q-%^ZE)"2\;6LW*@B`?+1QI0%J_:RI8.OU1V=+Y M"R\4`77Y1/@%7SY]V:0[,-X`XIMR!.HO$GH>DMW!XI5E@HQ\RE_0;DZW=U'' M.9->CAC/*749]:]%5JBB"N?U9J5V:95()ZX[H@"]UA>;I'[(-$K.LRG,]5>M M)/"IM:@I)^+8NE=)16/Y?FYOGA._LPO7$&\F;_!55-,Y3ZGE%N2I#O@<03K( MG,KLX#+0)A:=L+DWMUDK5A.'@JE9`'5F5/^DR(V6;PR]CQI#CV^$T1,-L5T\ M$27+7(W@D^:NM6#$?4KDF,KW$K^Z[@HCJQK2B?P$+D$7RF%K?>N'Z4#*_*$H M4646ON,W)/_LX)<@^V*X6G]X4'#D:]?Y(W\Q_[^3Q7RS6CP\L&IVL_EFNIJN M-["3G@K`L7WZ=_J=YR@&O?8A+R872[,?EM]OI(Y<^=CU#^Y'T^;J$@?HBV[_ M_>[HNC'.)&:@9(5"I1>M12A"?W;AO*$FO93KFN]".9YJP%>6?E6O^,(A3XB1 M8:"8/P\^V>GVKB!2\)&\_B0NNXI"FFP"2"M9JI+"2)[IZW&.VVR>&JY-%9S[ MBGA;B(2#,>`5IX!,&W*2X0BW&5O4=D"+.>E#6I14D&M#1A`.6S<]J]O,T,-B MDC\L$EY&D/:H503;D!>,2]RQ+<6%NAOP#V?&.N&)!%9IOA$61$,KT<4J@>0J MK%>!@/O$+6"WD5N/#Z#VPC4U+7<9*V>W1>/AU*M772%K7412 M%DX^;%-";X&I2V!T!V2V7[\K8J2\%XN8FEI5+`/[J`>+#',7XQ<(6J]0&%Q? MC8I>2I_S2BF"V@6UI*)%;8)DF+N8_;-&UTF9;EA8]7,2O"(L`ZZ/;]%,AB-( M`:12:DTK:-Y[(\\IY MK0[\<9?=NEA\A@4WS$?R+YXV=">:W[+%1O_3F?Y]NIK,UOJ7AVF2PU[O`2U5 MGHV5`DS*.JFJ37KY;VD1$NE*=@?F34W]('&OC@$[BCSE-KS)-?EN?0U"A:F_ M$]=X)BO"X`CZY_$-ZF!8#^:>S.P?Q'"]%*>`G??$X9"(O39"N!_P!)Q^)^;S M"WLZ#CC.9):F^`/D*]4:!(G<@6B@N9&52CMUQ@7;6>H'*:8`Y2CD*;T_R_EF=MR^L]72ZEE!0_4T_^"^4T7^3W9--$>!M M!\/R3Y9A>QG4.)*A.W2?NM'$WJ"_4D)Z?AXWS:V@K\FG1<74>A?^I M"-`\D$=W2Y%O84/<5XKSJ-<3;IH*%T3[;+:T8-IG/"O?%IV'*A?4?R)[A'E/ MR6LT_3/U%AT]1:=?^"&EW:0)*UEEI[#Q9X3^=,?Y2(05!6OVOT$Y?!:*L%A. M5_Q?:UC8@?MLV&&G`MW>A95-&EG>W=!EW5DV8I_^G[%F>W`#K#%Q* M#^%V4MJRH!*3UBT6:?&N>9+`CC4MOG/G7RS``GK=M=[`O5&M89ONY0EZ8:IR").[PKS>578NUF]M2CM']Q M%FIN"6DZER;I0@QP!W:E.[,$C*Q(B"K9\1+^:3VU4XK:[P%ZG=0:F^*Z9QJ<"T#CDQ)2%R;K4B1PAW3EN-B0[8M-?G$6`%&: M170N4I(B#%IO5")7<\[DK0D?Z3]?>(DU0)ZGB,8EB*^2=]S-E'GAJ#0/O%`4 MI+W],8%+$%HYUZWW2U;1_[8WS#F]]GMS2SK>FT'__&7Z+YT'$KSM=6;V._%\ M#M[_Z3P\3.HZP?@(:S8`:V$%\(L5E!VHUS?S#LYW^_.(>OQ+"X#HZZ`'&J'1V?2C2(;NON+!6U\O,% MMIW"N'KW]H%Y(6/L0.P]):Y^6RJ7?P&E*-;[IU8?NSWZ][^6`<\5*O M5X5'M.9/K,%33#+=@7*L"59%D8.GDF(#JSFCC$$J%4S_08#;'[1BVX\=E-08 M`#PYT?=PR4#(3>N>D^JV/%D`PJK"5(OH-:JY`-C"@7')5!(@W'%"W%=\!`E_ MO@/$_8EHX!)5)9>M!^JH\&R,*N])5W6=&AGD3O1GW#M!WN.6N';^QBQL65R@ M>,64ZAM\49?8B>/Y7MCFCF5^AABP:"^V[L,.YP)7V_CZNOFNRW5GIV19@@1X MW'U7!:ZMFYPJKG'#7$C!TG7^0;9T?^N\.Y;!\/$_.MN#^TYJ7^A"@M]B>A-& M[O2KG9ANQO,%L-FJZ-5?S7>FZ_FL'%\X1!"<,NP"-AD!"54.1"B(T5JJXJKU M]5'^TDNVCKW+3_\&$%0BHM&V5"KYPGWAVKR8;G[V(PT@%0&)MH52Q17N.]B= MLBX=`$&EIA<(L-AT"6@D??3\K'KFV(1W311FQ?; M.?C$73M[_Q=5`G'PPO5-#SE+_P?Y; MMZ"!6,Q+XR.H.'%J;YCY9O5C-M\L]/O5[,O3>C:?KM>IV=,?3Z?\+\DIT(.T MWP`/4'^;T.^7#Q/G8.U69$M,>G#=$;+8/[UMG-YX2(6V-NUGX\VANNU8EN'R M7G:0XDA0^DI6N0H!12O_)(!PWPS3*9,_$,_;O!@\L002I5U) M$)UT81#@OE$^3/7U='''4)D\/6R>5OK#`]U7TRC<`%9N!3ETHH2PC_P:&OF; M>#!Z>&KQ^0/6HI`(.J%5LXK[:KHV?_,DG*/I]P>`NZF(!CI!53+:^G6UW,QY M?G;)L^&3-=D>V+1NR9OCF9QC#2"K(CKHY"7%<.OY]4IN%1K\5O&W)WVUF:X> M?C1RO_C;P7#I#>>V,0SO:5/'OP=LT[Y)/A` MB[W^_&:EM&,$>7DY;;3Z5Y!@W.^F984F-K6P[^BB8*/-;(%]/>H"JBO`J"M9 MQ\K%EDTKJX44[IL(98"R9-'M*A,O<@,(]A20P"W,*IYQ7S88DZ$2>LG%B3,` M""L64T$NMVK.<5\O&-_K,'0N?'OXAG7;/KQR7@#NJDJ"R`4*P@/Y M?82#](U2H:8054^7G@<T[W(1G`'XS[9?ERV'+V;M07Q;);1PJXDT"JW?[E#$WSO#NR8?S1M\_7PRG+/#"MR1]TY;EC1WWX.RMOPT5,A"J-!=]A8 MP(>2.388_%$EW7@%*\?ZSPX'&?3S.T3@#NG0R?L?],\`TXYA[SH><=]9U\?: M#EM.>>0W'B&K:37\-<&654SLAUN/9)9QD M4'R*'6_WKO.+"G?]81/W^8--%/+>7TE0R;(%@YMX:B#\XO:0IA58#`C?N@". M\6J*[4H/R#%N=RG/B"R`XI6?.B-(X'\IM7;%!N`4MYM4S$-P]D='",NINPG(;GN(F%Q-,Y=$-FLP@+!^]OH%71%F-N[)V)OO[:F2P>'V<;_F`VF]-_S>=3_NO.]]GF:V?S=9KN`[VXZZPW MTV\SO;.93K[.I]\5^,W3TIT8WDL0;<*V]AEKS,RYHTD%[L,XT/3O6S MUYL./74*9Y1.U!<6DI+PGJJ=2?WMJZ2MGL8K^JKI,*@UNN,T(DJ)QH-9A'`_ M!A1UW0MX4-!Z\#.)6(@-[M<"45N^-)B\\PRH*7PYO8QP/TO4;OK&]1FPP=<>Z')U1`VVK;^7J(C!R[4[3O+\XK5>=0);\:N]RPR>68,0,PT$\: MK-'572DD@>O@1+QPF^NLD/;!8B&!D0LUQTH/U@6UG!X.Z8*XQFV/0[&0C0QN M=CMZLEVR9<#NGFQ6*M4,`%P>W.T+/1L7/RWSV2CVU8VOAZ(>9VK\FR?-K17] MSCD^U<';XKT$@RLTWR%P_55?3=<=_6GS=;&:_2^U5UC*0,I:J>G-7+]0-#S] MX+]0?/]-6!7TE.A/KM;`9YU,FLYY-?TV7:VG^N1O3[/UC,T\Q41:QP:`[;_N M./5W$F:K._8Q>AMGYGD'UO2X!XD[+26F)HE'G2!2EPI)!+";(B5\T+WPFV&% M_,"ZLE<3O4C)"A'!;:ND^>$\\%X/!]_S#7I&V<^<%9#OL)S>)+L)_[WWBZJ_4``DJK6U>B.[ZYM8B'KUNVMND"*.W<>B_ M7193Q#X4TYD?7G\2=[$/Z&T<%D/4`^1SG7=V2)9.[BFU11G%SGSM3WQ[U01O MKYO%Y*]?%P_T!K;^K\Z42G3S`_;(RG;`%VI7T`E/_W4PC^--(8VV^-=C!=*N M@U#>1B(2LF/5WV_R[,\=7]P9;MS7NLV579.=AY)-H4I2297;.NC\V;EBO7RA MM/73ES5=FBP7C&Z]\PTL'W1]^.F1?QWHH-/W?`$32,3#$:%8_L.>UF!!P8)1 M3UBS1Q0S6MAO+@JJ<%PU![6T=.+5*87#G[T:^X+5*#@RZX53Y[?'$P.I.<&O M>8(9HPQ28[F"W@EK,"ZO^>7@F3;QO-0+D/?E(_4OE@!BVL]43"S&U-R%N0+I M(IO]D[MBAAB\^\!'C>%1!"(J)HYW&&`X;S#)`P.TATAT=;-7]OZ M8X`;MHH>`I&!6,8=\1=I'3O93;Y%\,D#-NH\!3P2*F(+=\A>$+(2;`13P^6U M!:)V/2F[G7G]QX"32I(L`NG5`2`.W#M_22^9O"[#)\R)S+I]>.EV7\,Q(`!# M3`6!P"38PQUS=4M^!OH5=4\)S*69S>K(.>[K8K^BC+GFUB>[]!L"?R5@CL6O MD48.('NGHF$1:$`3`.*.JJ)VM$FOOM\-ER+E>_?L3W[,C$80-X>0"@*!2K`7 M;[GGK[SV-`ILC1UQ%(I(RAQ'KLCGI#;*+0MUN7'Z:!?44OFN_$ M]9E5'/[5_&EE#]'1&!!;""2/0)2G`(([X#>7FP)G%)+@?=)H"!1!(5S(HXF/ M.(W.E>EOXFY-C[&8"JP=06Z5\I3Q"5P6!O3QQ1GM7+JFO37?6'>C+8G2PD=C M4.)6!4$$HH0QC3SZ^,C.8R6FCOCCW`#2X:LI(I`AD&WDL'AP-/:4B8XRQ`_.=B,@B$)L-@LO10>FN.U"OX)[NG,=#=.^TJZ%+FR5*5A'0YX03AKF_878!"?_(V$_9#JL`4S7$E)*EITD MV''\J"1GN.-',_O"RK"?211T&;/2@UBE5?3:D!2(1]P1I7K0,R'#4<)$#^!X M*:;4AH@D^<(=,'IGF$&E4MV_#:*^Z`V'E49,J1G@\:&"7!MB@G"(.Y!4?WYV MR3/E8<;ZV-B>N>5\)7QH`']T*;%6EI,T=[B+.JXI(KSM+4^FNAIJPKYJJG*U MTV/5MWAB.D_L$`LGC-M^C-\JN,T+\&+$7SP[RN(I MXS8`I[_?S+`L*<13&WZM!8CST\5=#[N$.TW#?I)\,2RV^-"2L6D/9JV^7IXS;N^6>:I M!BB.*4.S:=GF+GU@1F.#_?(J3$I+W/A=`D2OGL2+:+8J<2E&8XGW/I?$1<=0 M%2H#2,P1>(#S6]DG01"?TN??"DX1;\DV-X#$(H$'P"->*0AB\9Y_W4N(-WHO M.PH;2$7\<'_YVK!XH:,1I)$%A/;9A5J;\=B#VW;,IS0:PA?R$) MPJP6=YNOTRC&*@JQ2B*L,F%K@(=5&'4U2GTJ0[F'B=Q36>L251!QU[TNB[A; MS^[GL[O9A(+6T2>3Q=-\,YO?=Y:+A]F$HE-_N5AVIG--]/5=+TY-=RV5(:Z[[OFSX//]MPHU_WT M$JYU1TX=$Z,NP)0[?<3ZNXB(*BL72,QW(ZHTQW]N&X':/_B[+^\F,\*[D,H: M]891<\8W(=`X]DH!?JU;"+4U1/=,X\%\-7VR^^K8SW^E_U_SWG2#+N`E&C[" M9>N%!&K(XY)+F-N0[8M-?A7P!_!,U1KDLA5##CO')=[:V\@Y_W=G M.5UU@E[#'=[NK%&[<4Y\UL?LE3PXGK'GQO'-ZPLNTD#@"$D^[J$UL7( M71H0W';B47F/L+MDJF\\Q#M<2NQB)"L/"7(S3SU6DNULVS_F%O8CA>EE3"?7 MHWMNF!`>;L='`N9UO_579G\L]OR1LLNVZMB@]+5NJDI\7]C#KP")AJ:!=2GE MO+OG$$.+EGJC<24,NP]J'C0`W0BFP>IG<5$*W+`06HSW;UA_[\A/]T!O>KT1 M>YHZQF_SR^D=0>AE,>0!!M1XYG%!W17QW@@KY$&L#PX@X";2Y%RPZG+.KCF; M0)`G6(2&N]#,X_!!ZH&5$;L8S9"'!'=GG$PD4YIO2#EB(9&+$64U!+@[U2QL M_?!\\/R1Z,B=106=-L[R0.U*PR-:=T3_-P[=+7RWBDHM+/;)]]>A^Y`UY.)M M?*)ZAER]-5$SZ\*CY,P3Q*IZ`ENI3=%=3!J)8C-*A&LW/*<'_"\!P.G36DO_ M(HL\QQ20C7+FZ5W08FA/;&UVAVC\2DS!TH8B1*-RIPFBU]?:>-@/X"K:43AP MHN"[W0Z5Z1/,<5\'0")'\QW.<0?Q(QK]G6=24+AH%_O^*+PIZ_PC"]=\-BD8G!`+=V3/%1Q1D%_O M?'.[(&UN26#Q$]*G.\D#'VEO+`-I]OE-&[+M(/41W1\-'P^6;[Y9)NO1PS[K M_I/X/!$_^_9\'3T]WQX(WZ*X5VK`,>_"G=](IG]!ZP@5;AFQQTOMTQDT:_+F M\P+;@0OV.%XC+(#`$@4&UY`U($?W@I2S!E"QUHP^F=9L?8<"$?@XRX"X`6B, M!,W+T18H0+&F7'\N39D[[\&:T2J0@!RP4D0O1E?@$,7*-)@]5-6OAB>Z2WVR4A7 MHWY/](*HIBQ0;C@U&X)B025UNDO`P9TYR5QAE-T=QXPC\)'4-1KW^J)H8S4B M+AL9M;1E(<.=6KDB6\OP/(X+[Q5[I0V'PDAD->+.C8=:QN7HX,ZL?/+(8C_U M?//5\`F=^/CZNKD>8MG!4,NT!)?6ZVG(-8I<[.],FUJ6IF'-;,KO@>7R!_;+ MQ]7-N-=<0R>I*:"6/AA$W)UN9J]OE"$V]85+K>HWQS.LQ?[!L9\?S'>RTSV/ M1$REZA1J7:TY':DS)=0J630SO1;=W[#^L0/2[825[6J*:H^M!NFB*8)(MJM..5 M6+K.&W']CZ7%QK-W3&YO;,/.[R3G^HL M$Y+R>74]'#3G2).=!29MRNT0=:!$GH*58NEX=5R+8WV5Z\,E[2=R<+699-7H M7L+2RDR?NY[8G3\Z:J8K<@[L0]D1;8.A5CT'JF-NM>B M3B*J'O4JQL>D2()'/@AZD1(A]>:N*(;TL\R#=4OYLAQ^=Y_^?B.V1Z);U_#Z M6A1+KDH9*F>`21T$-QP8@I%"X._$#BT(P9+=OQ@>V;%$$,I]D"?%>:'@S.PM MRY=_)\Q3%#V<::.;Z^;>#VK,").JY>M-G(API'I(7<]!D\K4ZVJ88^J$WH.% M_T+#B/P)@VN`47/R@)BT);ZT;J^8=J)3Y,A,!;U&5*L+8*A,6F, MP*.ATDI4@>:2-J?KJW&^O#3 M(_\Z,+_#>Q)]E#/2QOU^`8-GMD>R"&QU[OMZSQ+`OUL>@F MSM)>[QR7?89UQDPN"+WAH#D;I\Z4,*E?SO`Y&>,X>6&(T1J**7\'ER11 MACD+[[A+;B-)+5730*TKM<",]:-W]F1TF61C8A,*D!GU?/'H3.Z(X1_R5P#6 MUQI0[$:>,B:9YXZGF@`ET32?K'#=W+%79'^P=WR3W+VS+7)I?/!#FFZ5K`.J MMW#7Q'TWM\3;.%_(DT=V,_ONP"`3/_R%(6CB8,?!&!1Q<;[)H5;;]L24O-5^ M,LU_(,]L$_`$B6B];H./_87CHE9`.;22`.;S6T\-/^R;;V\40-;RV[!W]-?/ M#(S\Q;@[:O(M7V82F-1(\'P/QC&)'FK+(E=1Q&=X4A&?#=OV&RGA$U#.LJZ\ M@$\P2$H]1A#+L\X8]1/CF`?,W)E&4,X[*>G*Z:>/R%$7E.4G0_6,2[=2)&F/ M(!"/%NOV-.QB/@59E46JE"G[]H7L#A99['5*?Q5/R6;%TGIY)04'JM;/':C?IU_6 ML\VTC8_$[H?N>3U#V)6[VU3\@">FDMZ`.*@U:0 MJ[\5%!#.[/!]0(W**GI*UATA"V>APB6 M]V#8SRWOL(E1)]75K_.76^(;I@5=VE%GMU1_P(!.[74=!'4SN\>Q*6>WSJMA MVE?:];C?7"B8:,CZ:W[NV$D2;]`@\9%7R>:>5T!)VT)"2A:D)-`I'[4$5[B+ MNN9[F<8LC'JBHB5E;3\%=-J0BQ1/K=\)9.LX)BH6;2TQ-X,;D>^U0$(2)-L0 M%I13W`55]3=S>UP0-F'KP31^FA:=;,)75^0Z*)`@B'@;LJS//>ZJJO>4:Q8_ M$T6H"W4VS]Y0&)!2(-PZ8[0AXY.QP%TL=4V!XG$QW'R^&FJCYHRL[%@GW*@B M.D>B]/3?IL=8:*ZF<^G0:CR-%0*)[T2R(."VQPK8;>;>JUK_Z'6+S.A?.=ZB M7KJ*YQV/UZ2FY6_?I>Q>\-VZKI"U+B(I"R>?LRR_&%;8=F+2L"M+T6+7^&H?BI@`;F!:XSN8)KN#'3'5XM6PSA8V MM7?R&UAZ+6E\,8EN&Q*[0./B*]T&LE/'?<$KTKH>U[J1@J74P[.4CIAJLE_H\7U!9(]);&F-+Z/2 M+2T[==SM&XI6?Y^O_K&"+:V/9TL[8NIBN@K4V-*FOXF[-5DKLOA1V7XT/GAK M>UZG"Q!F64;K[`M-FC'D]?ZC[KT%?`R%Q9@+!%1&Z^P"DF:LS0+^-8T";JP* M"]T"K(+SV]O5K"`O>I\^7;D2]0&/UYDOMVH89*?>9M'Y$RR#`3]$KQ58!@,\ MEL$14VU6;&_<-!!MT)G^\KRA/,`^J"2(X@PJ9C'9_-HN8R&-@=QK;;:R:\DS M/>YW34%89"9H'1`&4T)*35@N:*JY5\'<.W7K@E&1?=(='L?,SFQ6,,MQ/UAJ M)R&[V%,B%28;?SOS57!H;$PFF5HLJ]Z-UMS;>G762U3)+M,3\U,^UV)-DC!B\I.#ZT8G0"83 M<2RJ`:,Z>:5\&NTMXEI`_=D+>B!QW-;,3\FNZ%-34S[7DHZ)KHQ?C]2<W-\LD'CMR&HS'JQH>P3DL`\P%+UTY[9@3GS&L-=DH(AD*@=2/&?ZL M,8XQP]]=EI?I_+(9V\/FNH'G!T0@;3'S+49WG4?F)5A=7\P)MO:I(154(KX] MN*P41Q!7R9\+>/.?*VW<&PP:XZIZ`F?3\.N<(0H#YV("S]Z)^].1-D+#W[`_ M?AH>H3_Y_U!+`P04````"`!J;(A$CF045:TO``"S4@(`$0`<`'-T978M,C`Q M-#`T,#@N>'-D550)``-8,T136#-$4W5X"P`!!"4.```$.0$``.Q=;7/;.)+^ M?E7W'WC^LIFJ_/TQC8PX)13CY?-1^WSHR8!+B""7C MST=#_]CT.[9]9%`&D@C$.(&?CQ)\]/??_O,_?OVOX^,.@8#!R+A_-&Y1PL`8 M&CT4\[;4>'=TVSOZZ?@XIYP1'*4A)\6)<=IJGQ^W^'^_&/]CM-N?6J>&>9-1 M/M#H$PTG<`H,!L@8,@=,(9V!D/_NA+'9IY.3Q6+QGC(X1R#$9/8^Q-,3T6'K MO/4+YSV&4YBP'B;3+AR!-&:?C[ZG($8C!*,C@PN;T$^B]7[=9?0/]R1&A0;B MR7M,QIRT=7:"$C$\(5S2)^FTG#IBY(0]SN`)IX`$A4\-<+)'&YP<;[3CHU5H MM#A;,M4^^?.F[\N!/.+C:AAR9$&28`88GVKY;/ET-D/)".>/^$,^@=\^B7_N M`84>'!D/\@G!,=PR"N+KDQ#$81K+G^BO.CC*>Y@0./I\)$;[>#G&7WF+]UR: M)8D0E9.@Z2R&RV>`A,IOYZ*V/W[\>"*I3CC"9I`P!.G)DO>G<1(/MC=?DBJ4 M12%7/9_4,EX1'*$$'3!XX4I_TW'JD9@90KPD/>1-[D+S%@ M@L.`,V^(/X:>O4W5R[$RIYAS^W]RK,PDZD(^$B&2'ZV'&4PH[$(&4$R/#!3E MHP9`M%I0]F7UB=$EJZO7_[=6JW5^VC*.C2ZB88QI2B#_8-ZX7F#_PPQLUS%, MIVMTK8%G=>SL@?7GP')\RWB7\_?3KR>;W6[^8DIAY":_R;\WE'7>.*?8UK"H MM?9OMPG*_5L^O?C[-^$(AX3;,K"Z6?YT"9@?QE'X/44$1@$,)PF.\?AQ'3"L M9K2T2]#2^6-H>U;7"*S.M>/VW:N[!A%Z(2(`]S$L*!)6-S!.?]D'&,:[C)5& M9[PJ0BYC$'[C'@__F[HS(>2,&_C<@[K!$8R_0#2><`<+<`^-.UE4$G&' MXUXLRT\PNL?3!:@92&?M]B:0)+O'?L:O@24OQSG'QE2PS(D6.=?'.=L&6/'] M+C`O^U8#.IU!A]BDA^,8+_B3:@2J-I'`X&@!:C>+/BCZ;`\8+K@4!IM`8[04 M92LN/S5&E![8[.#I%#$1Q*'<%N_@A/&IXQR@PJH9@K#N5;.MH*SCWMS8P8WE M!+ZTO3NN$]C.E>5T;,MO4*(I2OA7PF>3DJLZB@,GK%M!79R>'@0=\:UPW#(G MKM$[FB"*_UK"B)1/@HK;[8AYB'XKPH?4K7A4/XZCI<.AXTF`Y`#BUKL=&)[M M_][@1%.<=%-2K75(5+O:N3@0.$9WZ#4ZYVU@R99[2JP<2JAV**DF]@XHV8X? MF$[0($E[)"D1)X&@NF-.9S\?"J`F_*0);BB.421V\2]!+':Q_0F$K("7>UHS M6EK2Y/'YJ,K=>@&6-3Z,G!$CXZ0!B)8`&0#.")M`AOB0;\!E5C=>S@[`BU'D MK('/*\-G+K:"N:IW,(,<-8\;@>LPJ1LM[5*[^-;R`ONR;QF.&W`7?&#>B4!T M@PX-T9'OQ\,H4+%2^S;J65L-WJS8,B1?1LZ8V$E;\F8T.QGZ(LA-GC8PNGR) M*-FKX%#"H]I=\O/S_56/P?WPGMOONU]LY\KHFN*KQIMZ2ZCZ(P6$01(_5L'K M>_WX4G9D#\+7'T/3"RRO?]<@37.DW0*"<$JW:*]Y_=KK`,-)H.O6]&QWZ#>Z MZ\TA:H?FFK^`YKHX3',5L=7HK;>!,C76F,SJ-]@/T%)-E%$/M$RG./$G@(MI M4YK"J(>)#\DEQR-B^/[2ZW&3R#-_R;NU. MLZ;I@Y]5M.\I"DC=40?028\;Y$7PX'!4=_SQP];XXXHE`X\,P90AN6I`HR-H MW!G,M\F*J,%U@^;\`-"LF&I`HQUHW)'/<1"A$K0HA. M:C\3U+K8#T4"1))+(V?3R/@42YCDM%G"7A5871RF8I[,)+(2QB?&3D:83*6X M:R"*`$1U(RBSE_/?7_\3))&1,6.L<=/@Y%5Q`@F:<^'F4&0`D729XMH#B-R" M.(7NJ(<2D(0(Q&L4ZQ!"8#3'H[IAU%93A+J69]^:@7UKR70@;[C*=PVN+:-G MVA[WX_M#[M#WC)[MF$['-OOKM`W6M,.:XL)'J'8/7LUXK8!2X[[K@)-LC:`F MI9"5N.NP_A,_:HB'P\$.[O[&M8OO6T'CF>L##<)-&89]&*8$B3/_?+%:'7<= MI"2<\!DWQP1*.[4$/H@"-@-1^[1N%/VL[.R+?,0[KF$"U_"M#A/``*ZD6,Z*(D=I1HR8;Y6R)+^K?D%?M(L&5(OD0\<<69L62M MP8\>^+G"*!G+0S]D/7PXKOM4?.NCHF.N7)%/)D_W>$Z#@E=%`2`13.0>@/2_ MA/O%5R)5?XPIK?W,X/G/9PHT3*]K.88?F(&5.5C2O[*=3J,W]$",R+X09V7< MT68&CZCZ4KT`(1PFBQ=8@\ MDO\VE3JTQ!O7"HEP;GP(HP*,ZCZGVFY=*/A9_KB([HC?;["@#Q9*-$O]>81[ M8*+1%#JB0]G91+3VTIL?]@%'LZFI!3;RB-V`X#FBQ30U5>L_4?)HU0#0Z0@<\.)!UQ8^*"L[@H2K_ M(8E8[1D0%V<*.C@S1I1S(^/Y0/+3V!J:8`5SY9$P_C=O/[83QG^?KN<')[5G MY*DG6AS7.1:E)CVWWQ=16ML)+,_R@P8:^D&C1)'47]=-3:2J@DBC1W0&BV*0 M)/5G9:K;R=58:R\9Q(HX5/$`2(BHFICJ.CP%<1.VZM8SJV[C# M0-2'[`K4B/0ZZT_+Z]B^/)/[%'9M-(X>,")CD*RN/RH]'X=![R`VC!MVMF8M!IA0;5# M9O7?[KH3$N\;0T-'<*B)`[/ZEQ)U-W!37[QO5A%-P('_"4,&HUO,1Q7$B#UV M4C(OTR'S^C,:+Q1'YHD?8_[$D!$*CAIUH@=B/"X=(.%$WBT^AS'>]%Q([?O' M;?72FN*^;P)3BA7,$53['K1:@;P2/XTUK`=68E&(<,#US.-2 MZW#<5!?W);,9J#\I7TV7RQDS9H(S_F_&FJQY1W/F&GVC'X8"`A(*PLW]9U)[ M&?&VFN[B67TSL+JB/$MP9P2>Z?AFI]E^UA8?HM+RZB)P.^G@)('R*['CN-JE M%O5;1:^R+!5NWR<,-VQ$E[QY)?&U_L MX%J>5%S;[G9[AA]8M[:9E;"ROC1:36_4JG;4K/[#!6JL>0OH&DM*![QDUR.8 M*9M@(BZ8$W7T5K!1E18%H'YEI>YHYK&@:`C%%J&U[VR>E<"B1%$T1H@>$"EJ MC'6[M<0"@;4;(!'-C>G="5]9>,^BJ(_IW/FKDRC"DKW-BD$W@-(+ M4#X:)VB$0@XF,PQQFC"4C`#'9(R@^Y0)TZ/Z7*Z$%JC]<.[91V6S=']T&680 M>/;E4%Y"WQSB?9/H86[-1M4OB545JVMM5=$4C?@#D#=NR6;#:;>`*;4.(-`5.U) MU&KVR"&(:@(0&N#I"[RG2%RA\)1WU,&T$+E<1'47.6^K(:HOUJ5O!U8AX:CC M^DT$4TMT*.J%8Z1VY:(:294@:72)'FC)8U!K=5)4NWI1>[V"\PNE,/Y3R?(U M5AJKN%:4_'KR0*-/W$Q%R0C+9_F3),$9[]E#\0Q-9Y@P(P%3*,__;YETE(CY M"N&10<,)G((^#F5G6YJ(3\?+=L?BT7'[]/BL_?Y!>&XG>[`A^Z,P?#_&\Y,( M(MYO^^RXU>:=5/)1VD;\<;QJ?"`'N407\I/(]=US")8-A.P7^_]FH9N(D1/& M9_%^#*RW=+*&@I&/8A+:'WZ8G>>Q\@-\C`"]E[VE]'@,P&QO M,)0V/($QH\LGSX+&YFQ_S)1M`LCB M$&&S/,9;3L'7%=KAJQTF&U>(JU)N::25>`'VK\PQP2)-,YN+=K58I<2O+@[_ MU4@M_?E5^::Z0,B0PTDC, M8`*[7/DM+P>BBF+9M\V;%[O]'+DK-=`;$OST.8*?_@4$/WN.X&=:"YY.A9\8 MF5-NR"VK]X7?4R3*F3_=T%T4>\\FV@L-"R*4R;A)H>]Z5,:O.Q+Q!6$0N4I-;?O7MUY]M5UX%]YKN\[5F#R'R4@+`BX=Y--F4'^ M3;4C^"Q/BGJ.?#;TX+8NY!K.V[-N(F MDAG'>;3''0T(#HO7\GW=0J.M6.,QD9&IM92<@DCEW]<=?\A1)WL_A&MNN'*@ M4A3*J[QOX/2^Z*MOI]LMQ8$O3X(3$4F)\!2@Y!`YY*7&B#UVX0Q3Q,I$4$AT M57]7@WX'IW'DP1"B.31[D'L2PUF`3W^^:+5:/E"FNH[! M>!;G,E!Y;IMN1A@J"+15$U>#.(\7JT5%OY9^J^O4<(SYG90043PH*RAWF49C MR`9<=8NW=P./.VAUE9(KC>Q6XJDP[D65@.(60`&+.VFUC>+FUCOO=`D\=X?G MOV\+;46^<;T@OQ#`=+I=:^!9'5M^S.MGEMF7!S32SL)<\]#R*=MKAG?0:SN_ M*OL0BI32"4; M6T54B;45-,%L`DGF+_AR"8T@@07Q*DE>V[M(&(I0+/O,N+,IE5%RL35+(C&T M8I5<6N2#E(03P-7,JS=8SET:&8HY'9K#+B]*E*@1=]=_NMS_M<< M]A&X1Z(JK^J('=;N]1VSS04C2W,L6UIW46JWGI8R',`'=AGC\-M.T=8H7VJ: MV/(G]A&GY&";+(/%L652!/IH*M:_:YR,?^?_^Z``RVVL,K"Y[=TY1?>`@'!(4E0:XM1*^N2"\S M2V2-W:7UX7O9W=/7]MX@M#U@^EIFIAS32 MP6*]C$'XS0\GF+L)[DST+I9L;KS?X`C&7R`:3T1B0K:JFWP>IY*(NL);%O,J M)JG2:'^1WM_RL$E92ARWFOK3S;W[(;'J!)2.&.H(<,>%*-3JT6O'5D219Y-= MPC%*$CZ\[BB8P!ZB(8CO8,&'VT6HJW;/^+:2:)=H920Z"[7:P1UDKAU_$S:$ M*B=Y7>^RR!>MY%C?S5S!9R_&"^I!<89K68?AL=I8V+N%%NIJ`A)QD;2P][,, MY9BS+H;<31S(\KKOR5A4U>EP%^"QA\D"D$).T@_T4?\0'`;/%0"Y]=J'8Q#W MH`C3%.U?KB=DN4\?%$[&?WU>\V<['B^N9\K%R1/I%)&X-.XH*WTZ3!"C;G(# M'C]L>!DU]JGWN+'E;2U<*`%VF(A:+:*"(TQH]E:H!N+!+74S!==2]OA+;?*W M/<]'W!"R@D97'[S(,N^7TI)0-BB5=I&:W*8A1<"+$H M!SA88)O[[Y1A4B'OWHU?W91?Y_GIGH/\LTP2YL21O&L,<\UJSJU3`,N$Y\T0*$@>NK'245PWQUE_06X:K#^!3_\RM'&891:R8_7M`&YW$LQY"Z4Q$0Y&HLTH+>,I2J1!QCW8:O8%B2=DX"=>N$*R< M5"-9KF',<671D.!%A0Q%$DUYKYJ`#1J-N,_,$VZOK-7!JA"BG%0[681[L-), M[JC=:G&SX5`Q#^CE[8Y`%5P/[T;',5AW?G<)6J35-H9;SGI"TUCX_,LK7DW6 M/OLXR"T@$?P@X>2L?=IJG^X>AD/ZTFG-WR*"-#,CD[5.6RM!S!E!\5FK)-!4 M2X^Z#DV^[>R.JDLC'=[TK0DK)NYB-7'_"Q*1>=#^9<\WY'G=:CE(/91PE;:& M[.$,)ZMS5JQ]T5($.OVPSSC]2,]Z#E4J$C6ZB,"08;*4:NVYGGL9F+9C M.U?6S:#OWEF6.!)J>U8G<#W?\F[MCN67[8?]>%\:[Y"M)G'Y7E?45CV@S=N! M.E=377C/?,A81OED4G#A!H"R;@HWRZTFRPJRJU:;9U)?^H=>_?52Y),[40Y< M9`$>>*O^'B7D'+\;/SY/MHBGV:ZZP< MEKLJ!T:^=S?3:)/F_[N[MNY&<67]DT[;F>Z>L]9Y(39)6,[._/JM$AGB"O6QY4# M+22\&QN:\7J(4'II3'<*)R'U([<$E8!.-XK67N!M7->TEZ;+1(>%82_,U:H. M2B$4+Q8&_6%X@[FT4+!:21/ZSN`,+ALE@UQ9.+4^BGG)N*Z5M],&=[P6GG%E M$U`"HRS"PVM6=ZS@1;=;CH=KMFU).*[+$!\]+T'RVEA%&71.]*QLZ`%JLL"-*C=E<[`/K[/@^>-.&D7=@"X;_,YWWD`ABIT^NB;P+[D%>9`J6/0PI$I)U-NS6]!_D`#?E3%)9^"L!(QY68S'61^K2AWD`[X"@^5L0=D/(BIX M[N#A`1)ZN92RRD`H=O.87!GAG7$(`SCPK$CIH5LJ!IA7RRK>JO?#4!M8O0// M141/]<]!Q[8=J^RW0^'BA]7'-I M^:[E_>]RX\IUU!-JH5OOK M;5(M[<';&FXC%K9`,`<%Q7B%Q#ZWTB?^,5+$($'QFHOL*/VT>Y/C(4^JB-A, MC+_1"^X[8@+<0]KP>U*MNW0^RG%UZ;2KIWA%2OTH<$>%Y[X:?I3V2@:K\M$4 MRB9#=`CE$6[]E\H".9Z&X$K&J>)W2;;LZ/WOGC&H`O5U064.)[//2D`YVNN" M::<_V!C-9TI(N^37!;8R0U8MPG4#5AGA7HUK@UQ[-O4=@93HKQJNR@!W*UP=X"(NF5>:SASUM4%E(L-7 MQ7G<)KY>H"ICRE%?']17YKBD-J0-[=7"5!O0$_&U`:V%7;;)J(#M5KANP-,1 M7R'DQN5066[LU;@6R+6WT*BRI4^)7=U2,USG@U/`=B)%\E@RR*4L1OO$>NC& MT;&?3->W;E>F[?BFMS:^&_1OQ[YS5BOGFV7?+PU?E*]S:L7K!"YV,IU8\VJ@ M/QFNY6R\R<#%]=#![JS4H5?Y04)TP*KTS^R#X-Q/J[%HR6G&)\$>(T3[8K8D M?Y&DM(J?)8]%-ZE@P:U:Z)AY(^$Q;,+:TJ'0Q$D"=7AOY_& M4DZB_=`2,S938%Z_,:^,L[D"]_IS.LHXNU'@7G_N1AEGOREP_QL^[C.#"MYY M)D]*KEQ#NR'F,LI82!QG-^[&I4"+5@ZH6'=!,LL(2[ABT2L!L[VDPW1WRGU* M?^4S0=`#QHKHKP/9(#-!+[W?IY`:8K\W\-D'=O*X0EY?+_^(0I*$WR,2AUR/ M<+_KS?^V3+=,."N]7N&:GNSH[5R6#TF-')LH5\9C!)[+``B=W5):?Y&DKPD82GL*Z MU2[AIW#,@FXXOPUTW<$R`;;N^'5`0_"1H;A81FE_'R3FX25.P7M>GI;S#=K" MH`TR_]A8_O?UQET\&)YYFM+VTC7O+:_RO72M^P??&UPLE[6#;J:P!"U5,J!Z MQZ9"(#A3TS%^*A\+,G$^J',JZ][C>RS?ODX%*:F!")D@@):X6/-+B/EK2[+, MV;5N&_55PZ$7"G8UM@FW_%1K8+U(MZ2A.D(1!T]0JGV02DDM[/.)(3=[S4IK M(H@2Z@Z3H0,!DC(G(AOAOXJ,1;SA4K"H()W>%I;N8-PV."`[TS/_4#A&B&3I M\.QEHP#>(5S1)9ROF\AUKSWWPC%"3#C8-;.>[_W+W2BI_EO>KWU$SRW#V^Y) M6$"TL\&>Y-$V$$93.J?6+[K.AD?R,?!GDI,S/ M!T)=;T&/4FI?SPV'C_3*1"\44+3)Z%*`@%7QC96\%+EH*4^LAVT5MX3W_D.? M?!B'J!$,Y?'P&"3!,_NQR24H&KMA0GR#)>*W#-.[#EZ92F@47I<M,OW(,#0`?D7%1$B+KN`L%2OW-#D0(0L0"[9IL>PSBV^)ZW".HR8*'CV M!6T@?7+F$&4RJ)<8HG\4`,@$Q8Y@LHZ#K73DA&1XP1VS')81BR!:G5$<*F$Y M>CB2/4-0JGG/2(OCT"XG+-;,,A-GJI?L:D:(3IU!,G2'C8!;R!C"=MUL&\0P M!O-/L]]&$$KJ8-V;51',SH&-UPQ*%<+G,V!_OG[4YXSVY^L?[2]GP/YR_:C/ M&>TOUS_:7\^`_?6Z4/MISN?#&J1"BNP^B!*P-UOLX57"2H0:,;DQ_7G5M6O4 M[@-Z\4O@REXZJX(RA=[;!7+6*"4V4>L^+6^P6W(4F?.*BS&#D/J4#Q&A`U3F ME&ES7_^B^]&C8D35TEB-'!,H!8-B-7+]H.A.2V^J6T)"EVP)W5KY&24JQJI+ M:'.;25`@5EMQ;#)'%F>W([`;R+!TB*X"6#V-6`R'TEJW4<3)<`[7N0K8+")% ME?M&!I.GP0K+LA?.H^D;?PK.3T$9MF.S87'M.D^6)\[I,T2$#E!"IT*0D24I M_V\EZR-Y":+0ZVR#8X1H8W)8291'0>R1/"]_+^V"G=W7SX=#.\II&6F.RX=2 MD\Y/E$U@.A9P\<9*C"V\V@!*.*WI&CQ]J7FM@3>"(,N7!0'J@M["*B=8OH=Q M,ZI;VJCS@,`SII,,)!$9(]2K3Q_F;J:,X_URO:H"J2R,P,.[B3K4R;K=2>'2 M!G=.;;R;C`1-M9A$JUVUQE5@YJ04J`5RQJ& MJ^XO#Q2/?HS\NZ!TI=SL!;))K%)-^P'2Y3:S8%=-RG=6F'M;89[E.FQ<'=F? MGKPL@G;'%^%]FL=JE=1'*W30&";#-R.<1):^1('VG>!<-"IEUNC:,H6YBA@9 M7!-)DLE"+%S4"K;=>F4:GNG<@;_W8K/R-ZZQ6AGV4@![E!(=M):1CI\^1$_)V>9+,WR1G#\_L+;8T<&V"38@, M8]6K8%T*@,!/2QP=8*>?T5[NVFS.).Q?DHCB(_F?2_B_)"O,1_)_(^'_DJP8 M[\V_3?+2[P",,=H3J%N`]7[#\3F7`1B?0C@`W,@`(+YA4CZ!PUNR2X_TOEP? M\S'(QGU]HA(U`^V64Y66.()&J8EHU#&H),<=R98PB/5YH4J-=-7*$$_5DSEYJ M@7JF\`,TVNW=*6\NW>V2$+@PPA^PG[4<,4#5E3G'.LB`G]X2NCO"&QGS:'!) M1N"%S$C")00!25E^G%-&C\%Y_)'?Q;$>G%U;3TAAUOBXCAF@TASM\92*J[(7 M("%H.),\.H(Y=+*-7H+8.("Y$J=IF%0-JQI1"86SFPR<5<$+NDQX.Y^II0U3 MI,=[E2F`^XX517]#'Z+2OJ5S;^'C0Z9&_EXO%ZKG+,=EU>]C8'ID:*>=DQC% ME'JYF<&`OMPPZ>[Q^>;3IT\M$B/_\OD1HI2\Q!'$#09: MT%(SAQ5XE:IE*R/_?4V.!LRN95&&XF06K6U?>W2[2CK9+]17ZEG MG[[0_[Y69SWKM^?G(WEF0>-.];V652(S_K!H=V9YREUF-7Q;]U.FTYAIE5;8 M7=3^SW0^.#OGG^GD_$0ER!G\_Q,5*2$>(I70XU>N9]_S,]@[431S/E5X?F-_ ME%.HC6K6+N#GUH1^??,OZ^]J\!B8"<%VMU$J\Y=08$]DV@L()%8:7=Q\J7K! M8"3.,7J.DB!F#=7YE;A^_LC/(MZY]OOOLZ^?;VI?#O&& MR'7R.[2N?\(R4%]%1TIWYO`[7C.'3L?Y[%-]GO>[[>V_@*'K7IFWSSOVW'M\ M`$7'B<_9_9&0&X]R`FNF,?S=E;\8W;XYKXUK@U_^^_8"\$T+UPE]<3'T!0;H MC8=@*0LIW-F5J^`]D=4.D) M$EZ#><^LIT`:I=2O1))P"&8)"D!*,KR3;X#MF2(\S$:70WS/%?%A-LIT-KX' MV<]@8["7YI^FN[`\XW9E?C-&-F=^3G$/L-"4[6![O^1*.=>;;%,*^M#L=<@?X#^L3.C8Q/ M):?NC^.SWKYE[)[*=7/MFFO#HN+NVK0]TVOSVRW!8"/584H@QDLIT`GM950N M2+.69&`RS8Q0JV/^+HWC]"?D$1$@G%@1*7"QC5X?IXP.JX-K4M#"!X]*(X_A#E7QHGQ;=TVAQ'#<=2@W?5 M"CCV=M#F^M]!^_+'QEI+3NXC)WD?5P?UW,ENF;RW=K#JVV#("/3>^B'& M=I+'M3%(&3N6[@QTJTKHGV78L`&_G#/K8Y`O*.MQD&71+MI61FN"1"-^>HK5 MNZ8"NY4L@I>("H=&EJ40U:F,]=]OJS8;X/OJ0SZH?1V_(4[P?ZD6^[OWJ>1; M^KLS.OQ5'#,2KLAS$-\1PG>`H!2IL,3G'![:5`;I<&P>;199^-M]>C@]:CX$ MH4_G3Q:P&*)R#^0+VT'6%:_B7--BO%)BK#$XVKRW!Z5Y!'\%VMY!AE5Z@5"N@!$I/I%92,^9M0"GJE5 M;>$PA+=+J5D%*^*OZO\1%`V5=@1@!DD7C,!C1E"&5OSJ<#H;@H$WTZ3X!8B= M`<(S0X$:WX&1D;SC,-[!U"_6?U'I*6S;CS7!-#I!GS*V M-84\JC.J(P&=2]@6B^;T'BV)S?8VS:'K%*'MVB"5YH@K)][*$:!]#W&28+\N M^7+I)ALEY'A'B!"22C4\&*'G19NCJ%P[UV4/U\5FW^ MA<5Z]=G>]I8>+F%6AE#TZ&D;O*2B1%JW2/Q8+BF^>?BP;#O3>.>_BTQ4QLCQ*:!8!U`[V7LPMK&P?^.H?L] M8^,_.*[U?^;2L)>N^62ZGFDL_MA8GN5;$,;8L#UP"!(=.\.O-*@DT2V"8EY^]IAO0R9V<-X?D.X^J'>_^J-C_)=QU638QZLA`*? M+))1?[(.4.)``B%SELR\RZ7E04:,)'0)).TF(9]ML8]M2ET4:+WB>"20U(O- MLUI')`0W1(H"B_!PRP:/-@07HL9KK,LYDC,Y^L52JK2S5[8Y%1:C[6P!MT.W M;"5RI.J^DQ/P^IC^B$)0H+;L2)JX8$8<.[MO^VB[?PBR6T(2L*GST_LB2)[_ MV:?%`PGB?-_NE3=N&*N!4(G*9'(&LRB$A"[W)"%95*D;C?OUBCU$YD$4TX/- M>'Z)13+IA0VADTQEV6`JB!`0A"T9P-JL%I@K$.:?I"\Q\4KCIYP0/S@L@Y3V M2+0M8FC0.+Q825A0;JA`!WTCZ]"/9P#G0'RC7('A-EA;$')W3`\PG:RD488O M4\HVYW\TM2+:_1P$QSV3\[,RQ_V2[*)ME/=B;HU2:H^YQ3A\:',H-9P;)\4W M4YM7U64!==;LTY5@R5Y#RMM;QJR^6S>YDZJ^VP$7-Z?[@9JA8(JOGOS7+=$M M!-(VR;\+\%+\`3)0RUA3-#U5J-'-4-IF%$9!&2;R=$65VGJK5L!@U$UY93F< M.QJ2WF/[")WV!2-F+Z.B.;`U&T?2(L4JME>,\ZG&I2,E)L,R4#*+-TFY?K8/ M!SI*SLZ+GA/FA`1II1HG./!<@6>]G.XI?Q4Y<-H$4A;M@I&_=UK M8I$.!46>6A$;\'/2M5Y_KE:?'`\G-]3J\;O*M-$64#C0JE7>R5N^F@8JZ)C. MC[+T3^6V"\\@E>>!D82W)&&7[5H<@UO9'0E*90O0<-8.;]$85H4%A2+V9\I( MUS"BGN.M-Z7[CI/-F[2&MZNBH]R"4EBJUX"22;35053?,]H<"XLQL'S(6P&> MF;%XSDGK@U1HIX^NK;7EWZ*R,?MG5P)#XHXS0H88WK):6DVC7 M1Y>LB;4/@C+-%@",([%C$EW=7=8'"+&^1I9\L_S7CU$2'8I#G3"[!TY,A!K8 M/9V3F7.$S!,0%3V(HW^H=)\0=P1ZSN^"J']&F:6%,VB1O8M5U`?!E;W_@31>%P4T2Q(PTCF%T*GVL M^-0>IL5Q?'-/GTRH=9*G@/)09'`'[(W(.#UJ68LE-"IS&%7QLWL`!12H#\8U M'80DCX(X?FU=49917,"M7Y+.9W)-W0\O)<-\Y/,>GFXQ5DU?[V%+O'\(2?1O M&_!8OR/'C)Z)2>@!4^Z>?M)\8:R4I9!?H8ASU@EWA-1YKSF>QTF1;D5<,I*)'BAGU$7>"V!3 M%77#?X@*L+D1GU"XY?Y@J4/7HIUT`ZV3H+A,6EHHP'SZ0) MR<5N#?1&603LY=)*V,ME3TBXN"7MLH0`@5T`;ZT?5&!+*V%$^(W`"S4)J['B M_)M5P*K41X-;Z1U;WPNVLC#`R>("99*D')NNJ.[I*O%Y6A_-F2#`K!?$$'J? M/3U`JA]ZTS>*YR++(:/X7#!\;]$H6EW5%)`5;;4RPU/F^445NQQO-K.7R4YGMX3FA&VG MWF9B4.L'%=C22A@1GB4[3:RO'S?Y*Z/U6]%K%ZG0@'R,$-WR%?(K%*?&**\$ M&I_L;(@(ZVU5S++(W6F<%(.C4V<',*@8<'B1^:FI$&N`L``00E#@``!#D!``!0 M2P$"'@,4````"`!J;(A$Y9(`KIT'``!J-P``%0`8```````!````I(&`WP(` M&UL550%``-8,T13=7@+``$$)0X```0Y`0`` M4$L!`AX#%`````@`:FR(1!C[J"9A&```>UH!`!4`&````````0```*2!;.<" M`'-T978M,C`Q-#`T,#A?9&5F+GAM;%54!0`#6#-$4W5X"P`!!"4.```$.0$` M`%!+`0(>`Q0````(`&ILB$1Y+'4EJ@H!`"9S#@`5`!@```````$```"D@1P` M`P!S=&5V+3(P,30P-#`X7VQA8BYX;6Q55`4``U@S1%-U>`L``00E#@``!#D! M``!02P$"'@,4````"`!J;(A$VA]G"X9G```AM`4`%0`8```````!````I($5 M"P0`&UL550%``-8,T13=7@+``$$)0X```0Y M`0``4$L!`AX#%`````@`:FR(1(YD%%6M+P``LU("`!$`&````````0```*2! MZG($`'-T978M,C`Q-#`T,#@N>'-D550%``-8,T13=7@+``$$)0X```0Y`0`` 64$L%!@`````&``8`&@(``.*B!``````` ` end XML 86 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Federal statutory income tax rate (Details)
12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Federal statutory income tax rate    
Federal statutory income tax rate 34.00% 34.00%
Change in valuation allowance on net operating loss carry-forwards (34.00%) (34.00%)
Effective income tax rate 0.00% 0.00%

XML 87 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Inventory - Seeds (Tables)
9 Months Ended
Dec. 31, 2013
Inventory - Seeds [Abstract]  
Schedule of Inventory - Seeds
Inventory - seeds consisted of the following:

   
December 31, 2013
   
March 31, 2013
 
                 
Seeds (*)
 
$
1,807,000
   
$
-
 
             
   
$
1,807,000
   
$
-
 
 
* The company acquired certain seeds in the amount of $1,807,000 in aggregate which was used for preparation of the fall planting for this spring harvest which will start from the second half of February, 2014 and last through April, 2014, $1,042,000 of which was in default. The vendor sold its accounts receivable of $1,042,000 to a third party, which sued the Company and settled the accounts payable and related legal costs and fees with the Company for the issuance of 15,538,882 common shares in aggregate.
 
XML 88 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 180 486 1 false 28 0 false 4 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.steviacorp.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - Consolidated Balance Sheets Sheet http://www.steviacorp.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 000030 - Statement - Consolidated Balance Sheets Parentheticals Sheet http://www.steviacorp.com/role/ConsolidatedBalanceSheetsParentheticals Consolidated Balance Sheets Parentheticals false false R4.htm 000040 - Statement - Consolidated Statements of Operations Sheet http://www.steviacorp.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations false false R5.htm 000050 - Statement - Consolidated Statement of Stock Holders Equity (Deficit) Sheet http://www.steviacorp.com/role/ConsolidatedStatementOfStockHoldersEquityDeficit Consolidated Statement of Stock Holders Equity (Deficit) false false R6.htm 000060 - Statement - Consolidated Statements of Cash Flows Sheet http://www.steviacorp.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R7.htm 000070 - Disclosure - ORGANIZATION AND OPERATIONS Sheet http://www.steviacorp.com/role/OrganizationAndOperations ORGANIZATION AND OPERATIONS false false R8.htm 000080 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.steviacorp.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 000090 - Disclosure - GOING CONCERN Sheet http://www.steviacorp.com/role/GoingConcern GOING CONCERN false false R10.htm 000100 - Disclosure - PREPAID EXPENSES Sheet http://www.steviacorp.com/role/PrepaidExpenses PREPAID EXPENSES false false R11.htm 000110 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.steviacorp.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT false false R12.htm 000120 - Disclosure - ACQUIRED TECHNOLOGY Sheet http://www.steviacorp.com/role/AcquiredTechnology ACQUIRED TECHNOLOGY false false R13.htm 000130 - Disclosure - WEBSITE DEVELOPMENT COSTS Sheet http://www.steviacorp.com/role/WebsiteDevelopmentCosts WEBSITE DEVELOPMENT COSTS false false R14.htm 000140 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://www.steviacorp.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS false false R15.htm 000150 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://www.steviacorp.com/role/ConvertibleNotesPayable CONVERTIBLE NOTES PAYABLE false false R16.htm 000160 - Disclosure - DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS Sheet http://www.steviacorp.com/role/DerivativeInstrumentsAndFairValueOfFinancialInstruments DERIVATIVE INSTRUMENTS AND THE FAIR VALUE OF FINANCIAL INSTRUMENTS false false R17.htm 000170 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.steviacorp.com/role/StockholdersEquity STOCKHOLDERS' EQUITY false false R18.htm 000180 - Disclosure - NON-CONTROLLING INTEREST Sheet http://www.steviacorp.com/role/NoncontrollingInterest NON-CONTROLLING INTEREST false false R19.htm 000190 - Disclosure - RESEARCH AND DEVELOPMENT Sheet http://www.steviacorp.com/role/ResearchAndDevelopment RESEARCH AND DEVELOPMENT false false R20.htm 000200 - Disclosure - INCOME TAX PROVISION Sheet http://www.steviacorp.com/role/IncomeTaxProvision INCOME TAX PROVISION false false R21.htm 000210 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.steviacorp.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES false false R22.htm 000220 - Disclosure - CONCENTRATIONS AND CREDIT RISK Sheet http://www.steviacorp.com/role/ConcentrationsAndCreditRisk CONCENTRATIONS AND CREDIT RISK false false R23.htm 000230 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.steviacorp.com/role/SubsequentEvents SUBSEQUENT EVENTS false false R24.htm 000240 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.steviacorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R25.htm 000250 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.steviacorp.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R26.htm 000260 - Disclosure - PREPAID EXPENSES. (Tables) Sheet http://www.steviacorp.com/role/PrepaidExpensesTables PREPAID EXPENSES. (Tables) false false R27.htm 000265 - Disclosure - Inventory - Seeds (Tables) Sheet http://www.steviacorp.com/role/InventorySeedsTables Inventory - Seeds (Tables) false false R28.htm 000270 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.steviacorp.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) false false R29.htm 000290 - Disclosure - WEBSITE DEVELOPMENT COSTS (Tables) Sheet http://www.steviacorp.com/role/WebsiteDevelopmentCostsTables WEBSITE DEVELOPMENT COSTS (Tables) false false R30.htm 000300 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://www.steviacorp.com/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) false false R31.htm 000310 - Disclosure - CONVERTIBLE NOTES PAYABLE (Tables) Notes http://www.steviacorp.com/role/ConvertibleNotesPayableTables CONVERTIBLE NOTES PAYABLE (Tables) false false R32.htm 000311 - Disclosure - Black-Scholes option-pricing model - weighted-average assumptions(TABLE) Sheet http://www.steviacorp.com/role/BlackscholesOptionpricingModelWeightedaverageAssumptionstable Black-Scholes option-pricing model - weighted-average assumptions(TABLE) false false R33.htm 000320 - Disclosure - DERIVATIVE INSTRUMENTS (Tables) Sheet http://www.steviacorp.com/role/DerivativeInstrumentsTables DERIVATIVE INSTRUMENTS (Tables) false false R34.htm 000330 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.steviacorp.com/role/StockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) false false R35.htm 000350 - Disclosure - RESEARCH AND DEVELOPMENT (Tables) Sheet http://www.steviacorp.com/role/ResearchAndDevelopmentTables RESEARCH AND DEVELOPMENT (Tables) false false R36.htm 000360 - Disclosure - INCOME TAX (Tables) Sheet http://www.steviacorp.com/role/IncomeTaxTables INCOME TAX (Tables) false false R37.htm 000370 - Disclosure - CONCENTRATIONS AND CREDIT RISK (Tables) Sheet http://www.steviacorp.com/role/ConcentrationsAndCreditRiskTables CONCENTRATIONS AND CREDIT RISK (Tables) false false R38.htm 000380 - Disclosure - ORGANIZATION AND OPERATIONS (Details) Sheet http://www.steviacorp.com/role/OrganizationAndOperationsDetails ORGANIZATION AND OPERATIONS (Details) false false R39.htm 000390 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) Sheet http://www.steviacorp.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerCommonShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NET INCOME (LOSS) PER COMMON SHARE (Details) false false R40.htm 000391 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ATTRIBUTABLE INTEREST (Details) Sheet http://www.steviacorp.com/role/SummaryOfSignificantAccountingPoliciesAttributableInterestDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ATTRIBUTABLE INTEREST (Details) false false R41.htm 000400 - Disclosure - PREPAID EXPENSE. (Details) Sheet http://www.steviacorp.com/role/PrepaidExpenseDetails PREPAID EXPENSE. (Details) false false R42.htm 000405 - Disclosure - Inventory - Seeds (Details) Sheet http://www.steviacorp.com/role/InventorySeedsDetails Inventory - Seeds (Details) false false R43.htm 000410 - Disclosure - ENTITY'S ASSETS (Details) Sheet http://www.steviacorp.com/role/EntitysAssetsDetails ENTITY'S ASSETS (Details) false false R44.htm 000420 - Disclosure - AMORTIZATION AND DEPRECIATION EXPENSE (Details) Sheet http://www.steviacorp.com/role/AmortizationAndDepreciationExpenseDetails AMORTIZATION AND DEPRECIATION EXPENSE (Details) false false R45.htm 000425 - Disclosure - Office space with Leverage Investments, LLC (Details) Sheet http://www.steviacorp.com/role/OfficeSpaceWithLeverageInvestmentsLlcDetails Office space with Leverage Investments, LLC (Details) false false R46.htm 000430 - Disclosure - Related party payments and services (Details) Sheet http://www.steviacorp.com/role/RelatedPartyPaymentsAndServicesDetails Related party payments and services (Details) false false R47.htm 000435 - Disclosure - RELATED PARTY TRANSACTIONS CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW (Details) Sheet http://www.steviacorp.com/role/RelatedPartyTransactionsCashCommitmentInConnectionWithOperationsOfSteviaTechnewDetails RELATED PARTY TRANSACTIONS CASH COMMITMENT IN CONNECTION WITH THE OPERATIONS OF STEVIA TECHNEW (Details) false false R48.htm 000440 - Disclosure - CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES (Details) Notes http://www.steviacorp.com/role/ConvertibleNotesPayableOnFollowingDatesDetails CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES (Details) false false R49.htm 000441 - Disclosure - CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES QUARTERLY (Details) Notes http://www.steviacorp.com/role/ConvertibleNotesPayableOnFollowingDatesQuarterlyDetails CONVERTIBLE NOTES PAYABLE ON FOLLOWING DATES QUARTERLY (Details) false false R50.htm 000451 - Disclosure - CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES QUARTERLY (Details) Notes http://www.steviacorp.com/role/ConvertibleNotesPayableOnVariousDatesQuarterlyDetails CONVERTIBLE NOTES PAYABLE ON VARIOUS DATES QUARTERLY (Details) false false R51.htm 000452 - Disclosure - Fair Value of Derivative Warrants (Details) Sheet http://www.steviacorp.com/role/FairValueOfDerivativeWarrantsDetails Fair Value of Derivative Warrants (Details) false false R52.htm 000453 - Disclosure - Warrants Outstanding (Details) Sheet http://www.steviacorp.com/role/WarrantsOutstandingDetails Warrants Outstanding (Details) false false R53.htm 000454 - Disclosure - Issuance of Convertible Notes with Warrants (Details) Notes http://www.steviacorp.com/role/IssuanceOfConvertibleNotesWithWarrantsDetails Issuance of Convertible Notes with Warrants (Details) false false R54.htm 000455 - Disclosure - Projected volatality curve (Details) Sheet http://www.steviacorp.com/role/ProjectedVolatalityCurveDetails Projected volatality curve (Details) false false R55.htm 000460 - Disclosure - Black-Scholes option-pricing model with the following weighted-average assumptions: (Details) Sheet http://www.steviacorp.com/role/BlackscholesOptionpricingModelWithFollowingWeightedaverageAssumptionsDetails Black-Scholes option-pricing model with the following weighted-average assumptions: (Details) false false R56.htm 000470 - Disclosure - SHARES AUTHORIZED AND TRANSACTION (Details) Sheet http://www.steviacorp.com/role/SharesAuthorizedAndTransactionDetails SHARES AUTHORIZED AND TRANSACTION (Details) false false R57.htm 000471 - Disclosure - EXHIBIT A - SCHEDULE OF MILESTONES PARENTHETICALS (Details) Sheet http://www.steviacorp.com/role/ExhibitScheduleOfMilestonesParentheticalsDetails EXHIBIT A - SCHEDULE OF MILESTONES PARENTHETICALS (Details) false false R58.htm 000472 - Disclosure - ENTRY INTO SECURITIES AND TECHNOLOGY PURCHASE AGREEMENT (Details) Sheet http://www.steviacorp.com/role/EntryIntoSecuritiesAndTechnologyPurchaseAgreementDetails ENTRY INTO SECURITIES AND TECHNOLOGY PURCHASE AGREEMENT (Details) false false R59.htm 000473 - Disclosure - GARDEN STATE SECURTIES INC (Details) Sheet http://www.steviacorp.com/role/GardenStateSecurtiesIncDetails GARDEN STATE SECURTIES INC (Details) false false R60.htm 000480 - Disclosure - COMMON SHARES ISSUED FOR SERVICES (Details) Sheet http://www.steviacorp.com/role/CommonSharesIssuedForServicesDetails COMMON SHARES ISSUED FOR SERVICES (Details) false false R61.htm 000481 - Disclosure - ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION (Details) Sheet http://www.steviacorp.com/role/IssuanceOfWarrantsToPlacementAgentAsCompensationDetails ISSUANCE OF WARRANTS TO THE PLACEMENT AGENT AS COMPENSATION (Details) false false R62.htm 000490 - Disclosure - SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details) Sheet http://www.steviacorp.com/role/SummaryOfCompanysWarrantsActivitiesDetails SUMMARY OF THE COMPANYS WARRANTS ACTIVITIES (Details) false false R63.htm 000500 - Disclosure - OUTSTANDING AND EXERCISABLE WARRANTS (Details) Sheet http://www.steviacorp.com/role/OutstandingAndExercisableWarrantsDetails OUTSTANDING AND EXERCISABLE WARRANTS (Details) false false R64.htm 000510 - Disclosure - NON-CONTROLLING INTEREST (Details) Sheet http://www.steviacorp.com/role/NoncontrollingInterestDetails NON-CONTROLLING INTEREST (Details) false false R65.htm 000520 - Disclosure - RESEARCH AND DEVELOPMENT PAYMENTS (Details) Sheet http://www.steviacorp.com/role/ResearchAndDevelopmentPaymentsDetails RESEARCH AND DEVELOPMENT PAYMENTS (Details) false false R66.htm 000521 - Disclosure - RESEARCH AND DEVELOPMENT PAYMENTS QUARTERLY (Details) Sheet http://www.steviacorp.com/role/ResearchAndDevelopmentPaymentsQuarterlyDetails RESEARCH AND DEVELOPMENT PAYMENTS QUARTERLY (Details) false false R67.htm 000522 - Disclosure - COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) Sheet http://www.steviacorp.com/role/CommitmentsAndContingenciesCompensationDetails COMMITMENTS AND CONTINGENCIES COMPENSATION (Details) false false R68.htm 000530 - Disclosure - Net deferred tax assets (Details) Sheet http://www.steviacorp.com/role/NetDeferredTaxAssetsDetails Net deferred tax assets (Details) false false R69.htm 000540 - Disclosure - Federal statutory income tax rate (Details) Sheet http://www.steviacorp.com/role/FederalStatutoryIncomeTaxRateDetails Federal statutory income tax rate (Details) false false R70.htm 000550 - Disclosure - CONCENTRATIONS AND CREDIT RISK DURATION (Details) Sheet http://www.steviacorp.com/role/ConcentrationsAndCreditRiskDurationDetails CONCENTRATIONS AND CREDIT RISK DURATION (Details) false false R71.htm 000556 - Disclosure - FUTURE MINIMUM PAYMENTS (Details) Sheet http://www.steviacorp.com/role/FutureMinimumPaymentsDetails FUTURE MINIMUM PAYMENTS (Details) false false R72.htm 000560 - Disclosure - CONCENTRATIONS AND CREDIT RISK INSTANT (Details) Sheet http://www.steviacorp.com/role/ConcentrationsAndCreditRiskInstantDetails CONCENTRATIONS AND CREDIT RISK INSTANT (Details) false false R73.htm 000570 - Disclosure - Subsequent Event Transactions (Details) Sheet http://www.steviacorp.com/role/SubsequentEventTransactionsDetails Subsequent Event Transactions (Details) false false All Reports Book All Reports Element stev_AccruedInterestThroughTheDateOfConversion had a mix of decimals attribute values: 0 2. Element stev_AccruedInterestThroughTheDateOfConversion2 had a mix of decimals attribute values: 0 2. Element stev_Balance had a mix of decimals attribute values: 0 2. Element stev_EarnedAndExercisable had a mix of decimals attribute values: 0 2. Element stev_ExercisablePerShare had a mix of decimals attribute values: 0 2. Element stev_Exercised had a mix of decimals attribute values: 0 2. Element stev_ExercisePriceOfWarrants had a mix of decimals attribute values: 2 4. Element stev_Granted had a mix of decimals attribute values: 0 2. Element stev_InterestRateOnConvertibleNotes had a mix of decimals attribute values: 1 2. Element stev_InterestRateOnConvertibleNotes1 had a mix of decimals attribute values: 1 2. Element stev_IssuanceOfWarrantSharesSubsequentEquitySales had a mix of decimals attribute values: 0 2. Element stev_NetPurchasesSGAgroTechPteLtd had a mix of decimals attribute values: 0 3. Element stev_PayeesHaveTheOptionToConvertTheOutstandingNotesAndInterestDueIntoTheCompanySCommonShares had a mix of decimals attribute values: 0 2. Element stev_RateOfInterestPerAnnum had a mix of decimals attribute values: 1 2. Process Flow-Through: 000020 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Apr. 11, 2011' Process Flow-Through: 000030 - Statement - Consolidated Balance Sheets Parentheticals Process Flow-Through: 000040 - Statement - Consolidated Statements of Operations Process Flow-Through: 000060 - Statement - Consolidated Statements of Cash Flows stev-20140408.xml stev-20140408.xsd stev-20140408_cal.xml stev-20140408_def.xml stev-20140408_lab.xml stev-20140408_pre.xml true true XML 89 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND OPERATIONS (Details) (USD $)
Jul. 05, 2012
Jun. 23, 2011
ORGANIZATION AND OPERATIONS    
Common shares issued and outstanding   79,800,000
Common shares surrendered for cancelletion   33,000,000
Common shares issued for acquisition of 100% of issued and outstanding   12,000,000
Common shares held in escrow   6,000,000
Percentage of shares represented of the issued and outnstanding   20.40%
Percentage owned by Stevia Asia 70.00%  
Percentage owned by Technew 30.00%  
Contribution per month $ 200,000  
Total contribution $ 2,000,000  
XML 90 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
INCOME TAX PROVISION
12 Months Ended
Mar. 31, 2013
INCOME TAX PROVISION [Abstract]  
INCOME TAX PROVISION
Note 14 - Income Tax Provision

United States Income Tax

Stevia Corp is the parent Company which incorporated in the State of Nevada and is subjected to United States of America tax law.

Hong Kong SAR Income Tax

Stevia Asia Limited, a wholly-owned subsidiary of the Company, is registered in the Hong Kong Special Administrative Region ("HK SAR") of the People's Republic of China ("PRC") and is subject to HK SAR tax law.  Armco HK's statutory income tax rate is 16.5% and there were no significant differences between income reported for financial reporting purposes and income reported for income tax purposes for the year ended March 31, 2013.

Stevia Technew Limited, a majority owned subsidiary of the Company, is registered in the Hong Kong Special Administrative Region ("HK SAR") of the People's Republic of China ("PRC") and is subject to HK SAR tax law.  Armco HK's statutory income tax rate is 16.5% and there were no significant differences between income reported for financial reporting purposes and income reported for income tax purposes for the year ended March 31, 2013.

Deferred Tax Assets

At March 31, 2013, the Company has available for federal income tax purposes net operating loss ("NOL") carry-forwards of $3,857,505 that may be used to offset future taxable income through the fiscal year ending March 31, 2033.  No tax benefit has been reported with respect to these net operating loss carry-forwards in the accompanying financial statements since the Company believes that the realization of its net deferred tax asset of approximately $1,317,552 was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are fully offset by the full valuation allowance.

Deferred tax assets consist primarily of the tax effect of NOL carry-forwards.  The Company has provided a full valuation allowance on the deferred tax assets because of the uncertainty regarding its realizability.  The valuation allowance increased approximately $521,545 and $790,007 for the fiscal year ended March 31, 2013 and for the period from April 11, 2011 (inception) through March 31, 2012, respectively.

Components of deferred tax assets are as follows:

   
March 31, 2013
   
March 31, 2012
 
Net deferred tax assets - Non-current:
               
                 
Expected income tax benefit from NOL carry-forwards
   
1,311,552
     
790,007
 
                 
Less valuation allowance
   
(1,311,552
)
   
(790,007
)
             
Deferred tax assets, net of valuation allowance
 
$
-
   
$
-
 

Limitation on Utilization of NOLs due to Change in Control

The Company had ownership changes as defined by the Internal Revenue Code Section 382 ("Section 382"), which may subject the NOL's to annual limitations which could reduce or defer the NOL.  Section 382 imposes limitations on a corporation's ability to utilize NOLs if it experiences an "ownership change."  In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.  In the event of an ownership change, utilization of the NOLs would be subject to an annual limitation under Section 382 determined by multiplying the value of its stock at the time of the ownership change by the applicable long-term tax-exempt rate. Any unused annual limitation may be carried over to later years.  The imposition of this limitation on its ability to use the NOLs to offset future taxable income could cause the Company to pay U.S. federal income taxes earlier than if such limitation were not in effect and could cause such NOLs to expire unused, reducing or eliminating the benefit of such NOLs.

 
Income Tax Provision in the Consolidated Statement of Operations

A reconciliation of the federal statutory income tax rate and the effective income tax rate as a percentage of income before income taxes is as follows:

   
For the Fiscal Year
Ended
 March 31, 2013
   
For the Period from
April 11, 2011 (inception)
through
March 31, 2012
 
                 
Federal statutory income tax rate
   
34.0
%
   
34.0
%
                 
Change in valuation allowance on net operating loss carry-forwards
   
(34.0
)
   
(34.0
)
                 
Effective income tax rate
   
0.0
%
   
0.0
%

FTM`I\R)G2-0ONJF,4D)EC[DX/=!BJ/;"]8 MW;C-#8P41'8IKC$R#2M7#RC)?'Q-#_E5G.9]?W/W`8'1:\EVIA_>O? MKF/"O'G3:#72)NGZ1.Z5&V_3Z&">&_7"LV*GRTG)6='<5$::"2N:&["B%#+2 M;JT#C$8]%QBM:@&CO0XPTJQ(`:.]"3!VP(KHYSLGJ0"="G.`5WGO\4#Q8=V+ M][F"]-JM>C]AQ+HD[HD+!U@YBL6!O2T8M6ZO<]F^+"P?]K5:U%KU3K/=+BP? M]K5.U-KU1KU36#;L:XVH]5J]9FL7;/`_B_KO=\[M#TS6#"U_C+?<#6_X((C' MO_2J?>J#3K=1[_6R`U]*W)N->%^27R_"8/NWG0L>Y-([?Z MN/=UV+'N2QEA+N7K?K6XNJ!QK[WW*&E M5I?D\S[5:ZW=OFSVTRYS0L=&!.]+1]9Z]O?F M,G8;E]UZ^_4$[TOCM)JM?K/Q>GKWYH2!1=/OK$/PI\F469XPY+P;RY^Z/K/O MAI]=9R22/F2J1U[7Q6UNI"20"FX/7T>IZ2)Y3<>>BNX3]]*=XA*L8(H=8J0F M0**:--*.LO.BC3>72GJI*5*M/1ZD9E.AJ;5KL1AU`"7[.1W;9@MTS?[+X,S?7'4 MUY#'"%1.\NQGH2+\(8=$NT5Y0CHCPZKX MT!Q`\(BA+,.##,<;`2)_R MKCE/::RDZ-SL.2?^`Q`8)Q#/X4X1-M=FTO5Y)(AYJ=4?4U6!TG67YDX4J@1P MGCZ/@0=O!/=5+G3>*4,A4"I'_TFJ;!BAQYEII5XC!2/_T-G\+,P<>0S<&1'3 MM4$HQ=/AS]G!K)XU3YT!B@H&N)XU`@*1*?$MNGHXR+;K?H].$JFI643OU.,* MA?%D;4P>*0]4'M'A6'6F2!QJ$!@50/"Q`SK_`1"RY:2`LH?Y%.=+I/YV/756 M"#5T`/,[@OF`J4ZM"G*U>*^=6F<)&--G0X2A4H,%2N18B3,1<0M97`3DS`LU M@S(/I,72,@8_VO7$84VX)]%A2HI4>UD8#^B,T`[\GX&*162DEBIQEH(Y(,'X M6'6D+3D-JJZ87XB%U-BV)IQ[/GJ12E+IJ^CLU-R#A3Z(5N+D+3/T+'[;`-4* M*K3HM6*4BX;I\)'D(\P@X,03A3=`X!UW8ADPA=PQ!9N>4O='I=QD[38>6.(! M6/I3%&2#R]-7L\S)'W!OT`A=/(S4J1)A4,#M0!<30JSZ#".30$Q^%K;)Z5-Z M:!X?A3;B\"5BV,K305R>L$$--<-U?/W4#?#\+Q;J2S"<0GM\A!NF,92%]8`H M<01WB$>?X'+X3N0-XGA=0YZN,I)C>M(Z.F[]\YV_9`X"B3/0UH+#BI$"%^H@ M$?+D^+W)\7P<\T;<5C*'&2SPNSQO"PXNW*N*[>%LC="IQJ44EJ-EYZ22I^"Z M$[Q,4=/`*V)K(J5_I.3($VWLNZH,J`[:BB.Z0A9B<]I/'XG*'?749HY\'I[- M=`2?$I M=SQ0C^?`\)`HB(2P'O`(>5H1IUD?>27R6"DS\00>3AC*F9$V,W-'>:7-*VOA M5B3F4=0>7"I_29A4_.*H?V954C:IEO&OCEHD4\P![H(L^1D+.EW-*5E7HP/C M$>\1\`(W^.-:C=_?FNF97[9,KMXF9';8:!T=YJ!H'47K*%I'T;J"X:_ZT3H* MUFT8K*/`'`7F*#!'@3D*S%%@[N#ZAP)S%)BCP%RA1+*B@;G#Q>(<8`5/3KK> M_H#EV?5,L("]ET_`"__*,:_#22CMFMOA$$3F;G@MD/W)24("]U&;)1FIV_EC M]YKKVVQVZO5T+NKNQU/B:=A;!G.SU6QUT@F@-`W)-.SOB'"ST;YL]D@:\J=A M;^GFC7;KLM\@:JTV"4/^+.SM:$"[?MGI7>Y[%A[9CYNX]^+, MWN22"^C$P%OM0?YQ*UV)@6N;NW$L!/HIOH4;83;WS#T\K_XKX>K;X3; M&+=7/OSKLS6QQ,X8`["ZMOU2R98^P:WB+;7O_TOSL/)6?3<>^[",IT*_7WCTW``$,$+KL>P\F.O[&_7 M<$=62%!$Y,,2@\7)>/AZ8WN>>>GJ(J_Q[5G M_)?C9O<9+"R0ST4>P8`'SYP[T:-D/S^5FI!T.DC:_$U#T`4^CZ*M\S>E:(JO M5?T+XDJ>J6J?Q]YK0J'Y$1-(X+4I0$_87[*-$4&:(%WXY>T5EMD-AZE#Y*)A M>^2)<5?!#(ST3'O<9!%=D[=3@ M`<\B?PX$^UU+[W=Z>J?>2;(4!CQNA>8.AYB3I#:,X#6JHYI\Z]ASP]%8]4F; M*\Z>'E&KE:L3OKJ"]`%W.)[WQW$.4(9C.*_!_\737\$O&#D?TBD9#LN:?X%61R\J/T_VTZUMV&8TX)I)>517KL6P)O47*;R-&320]3D:>K!M'J6 M'2_%.!=<1'.$4W3W>68"5B9:(.!%MR)<2-C">8E2\.81-]?K+83+/I=UO5[OQ4ODC$:86RE5 M]R9YL4ICP6B4=@5\MF&>Q64-[10E5"1!G,4:)_.DIIY*;K1?CA?$B"K7B3:0 M\\"""H'Y*HO-?[\_3LVZQ*GFSV)%R>EV7%_5[?A$,[AM^U.&K:HP,BL^3YEI M1I^CULKU^D^I%Z:Z4IO1B^^O;FX^??VU]N'N\?'NRWNM.?UQ$C=#'KA!X$Z* MT)ZYE-1^N/MV<_LM)G9@,^,[DJR)U(SRY7H2OU;2OKE-3W4#G5^F9:5[`C\9/!Y_5DA)W663B"LTY M(HXPM]\%XGEL!7S=Y>'0@R@TATM*'`D.$4>8*Q;GRFC--WNOM>9OHS.7J4V9 M:&=#!#;G`\1DVN]?=9H_/:P6L?G%Y0LL6I!WH([!9C_[3<$*S2& M\AF)IVN[.]O!TB^2VM[FO]EIOY!"E=G@`9[M"=6<:TXML; M0+UFNN$``%R5-?;=FA.Y+3_*9X#5J@[MTA).,DDRN5-HSZ&B*";)A3BNDWPL MPS$K^<7A#CJ+P_WJ]*BC_1Y8Z<.D7^\^^YH9BJ+=UW')UFN8"\^U2\/BMVT4 M8HI:")X_MJ9QS6_F8^:\*(&M#K5^PH,3#K.U;U@^.L0'F%Q[P&.!P.I6OZF= MGJ0^G9Q%U7;QR'-!%.2JE&`-8I%'6O-CN?15W=&!73-4)9D%[G\T3-R MCUBFR<%2\7A>._U@2#9MJ(N M&I8J(Y^B2Q4/$66NU8EM/'Z!C'5EZ`&F, M4ORBXO7XB%V?08R/LI;&G[#,;:V8]D[\+1;]*`^Y"?2._4Q_0;9"CDS&[Y,2..41FL6U M>LHS!E54J#P$4Q4(RK$_-N(HWWEMXM3R74SB"LTYPMQ.U/5&!Z+*L`&*E7Z4 ML;8JIK)J-2[N;):4N-+L&2<@:K7/Z]OCI`P"$YNJ/ZT[3EJTCDT>ZB0.Y/X0 M<62*DOM33.((<[MR?\IPP/C5KE&2O;:@@OW*K@T[C&06""9TW+%,5FF"Y]-U M[-*C/^RXV99BE2!=A3&41BSK))6[.(),GN31$T=6/7F2A+EB<>[5GF2ACGR_ MVI.\792.O.6Z?PSG2,L_B-+8H@E0ZUN;HIN>_SPT'UZUQ[<.#PJYUI)8ED@L MZR25VVTU[N],]W_5:K>.^=%C(SR^5:M%=V3)5!_^<1'ZM1%CT_?R9-@C^W%C M^8;M^J'''X$+'Y".?_[G?VC:/^:NY/X]LTS-,G\YF?GNO%=O]<_KR?\P7=Q! MKG[CPU].,/VZAFFUM7J[5F_4`A<_M6KU5JW5F+L7[PX=2][Z^\/-B69RPYHP MV\<30O^LYXQ!4K$5V9>KR6X@V4"\)+N9D'UY,++;C=5DMV:X#90+LK/W[I?L MYJ8@:29D-]^2;.PSX?C\@SIWFB$_^]NAL9ZE9B?#.:0,['XX!Y6--QC.(67F M#8;36F=V&O7UBXL_6M<7%S>/-]K__?;XY;,&PJ<]8AT, M40J!V1<7MU]/M)-Q$$S?7UP\/S^?/[?.76]T\?CMX@<^JX$WJS]K0>K._&M`O`D&-BL@66Q[&&EB$2-:)2.![_.[0\ M>"I6%!@Y<9F/W%[RCJG9EJST87%)F2@F$+7!2DI\H&3Z\&A9G@:>)^JQ^%BM M(]#&[`FK"7`L]F#8H2D::,D"!I;#',-2Z?:BY(./%3A$.)##PYW\,B6_"Y:( MTB03'HQ=4U]K``R('3`LF.+*]P-_X"Y)](`'STCC`KID*05L^,5\.<0%+PE% MI1SN,,&B*+#II^J21'P4I6W@:SDSL_0@L3&G`Q?X\<0]G^?R(Z>"IKA?%BX2 M%6I8;M(./%?.:(!#!-2SD1PMEIO`J?*Q]!"R&4M!V-9W;K_($BR.&\C9%05K MY"N?+=L6/PSPU0PK&.47[R)IRA+V@N9&J:05@U1Q22F2DYH[`FBMZD MV>UB"1H^P<)$WLM2UHOA&%A#!Z'C:4!O8"\8VF-<;0-!M@XJ986D.+S.9>GP,"W(JR'Z*&5EGT8-D324YAU8TV0(,R&4! M`GS)K@O=E%0[F^Y4,#RKA9N=S;1PJD!9_(23L_-9Y0Z/9:8)6MI74Q(5FXJK MOSR/0>UQ+]V!T-<,FP&3!$)GT!O_@L7'$N6J^>.H`!8"S5NAF9>HXKD!Z)GJ M3K*^F(*R+(,UVSJ189&MJ)P8_IH4H7)`K&4-M)6**'.C4$>BN)>/3Y7CYS]8 MS$A5;@MNPBEC(>@$3\BDGETF`FZ,'0OK&LH34,7K333OTLJODC M>6F-7=`%,*P!1U9$REL+IUC\S`[`]`^XTGM(YM+2=RD4V[ZK3='.0^4R"D%M MJ511D]=2%HB."/7]E+5BX?%X'!%J,W`LF"UUI9.QC?3(;$*B+4?>94V4;I.J M-K9X5!T[&)491QEW7L>K7.H-&"QF-F/*R=5+@CQW>4Q;2LHBLI991-(2@0<% M"?1QWH1NP)G+K&D#9@N0^&,N"H$#B)\Y"#+\5QB:@'T`N,PK'C#CNWQ?-L_X M/*.\)1I0?FU40T\6?Y9J52WJ42V[!69PK!I5Z;LEU$JT1GC/,;A$^:R4F65R M/L$M`_C%!S8?+QJ_)#R9L._P\K]" MFT`F52_4G5J.((69H.-004\CESK'C4R\L`E<+WX'!JE:D-HGD%XCP"*2,]8S MKI'`A31)`&Q/^(.X4L7\TF/>P$-2@(?W2-<%%@/D*2A=[CUQ/RI1N3?POW9O M:B8\M9L(UT[CPQ3AH@A7L=0Z1;@HPK5QA.O-HUD4S*)@UC$K8@IF43"+@ED4 MS,I1;_NH0T^1+(ID57>EI4@61;(J$K\/KNT/&Q MR1*:,PN-M[I)>WTW+E"X`+!P:$_V=\KP(J7BQ;9H#&M?$%\@%!A0PKNNI M0Y49W]Q+[/=IZ/DA1CZJS:S>@/B<#,.ZCNN=OK48SO[Q6I^8HP]WJ5=HI($U(FK`X MFE#Z@6@3*STGU>&L%A,:,5^;[4/EB"`!T"3^^\E103W_GKV@:?R-8T-`\QXD M#=FBM-`F]^SS`%*W?]EK9?BP":4'8J7"S8' M.F7UAFP!XP$\];6X(2[=IUKI->J]?F<#3@@*]\"`?2F/1KO1:6T"A3TQ8'\J MHMUN=-L%9,"^]$"[T6PTW@P!W\`DLIYD*&[I\),+]RG_C4Z_7N^O,_B$OC<> M^F'.0!]XU'L3]^YEOU@#WY>8-YKU;N=RYT/W0FY^3GE7"X<^<^%>A;S=JJ^: M]!GRWGCD^Y)Q>,!EH4:^-SD'A[U1K$G?FZ1WZ^U5%NV&`[_W^)19ICKEOV#0 MV8OV*=^U1JO3ZRU=Q;/$O=%X]V:S=_O]WE*3=1_#W9LHMQO]SE))WLMH]R6] MM4:[V>^\`LP!`K%FCOZN>]2]RAD+^+;$&T M\.6OWJ7A;OMIR$\O4NB:-=%85=H8DCF2BD3-2VEX6Y&2VB MN;"&[WEHT@M-D6H=5B"*%L1\"D)=\?A5/(IH!O?1MG190^Z]^T;-WFM]H\_< MQ^U((YR$XC!$M`4I]DMW&$0M6*QONV[KQ2%\TTA^A<90/F/PM-_0>]V57OEV MF"R5`[#+3=PJ8;H*8RBA7*[TTHY>),G_J[0U3-Y#A2BB&=R'_[>LWW9!TBRV MH+S8;MF*'N?%(7S;AO5E,QI6!O)?R8_RV9(-O=-IZ9W6MEY>:2!>6L))-H]5 M-K=U\U9`N[`;=1?B,$7RL0PGH^07AZM<=Y4*>VOJ#&)IF+?K8V499G!UI'3M M>IEXV.F=#'GNL$+I17,MI90!)`3S M7:>M=QKUV(+*ML%96&47;Y6J&=0.]HNRGKA=W$X,KS30/EH.+!B?88QFIH+X MBJNHG$<%G;%DUC4Y[=J=:*?VB#VR?G5=$UN'':W.21<5%SW$5/.[*0-,>&P* MKE@'FXW6FIU::\,&>+(S3(G MYH=JHF:X?M0H<0T"9%-$T3\1NULML(F>^0">CAWZ0'>Z4]4Z4[QGE6ED86\< MFS]A(?4<.^A)&JP90PC?.$2*3B.K:%9WYS$-&R`-P+Z;X+S`P^V$2::NN"ES M\Y!R62=D0<*>:NK/DEA9%RC_LK8GS[ M\Z*?!8\.44QZXY@TQ]R0;/N%S'?[;!W2[[:S76(RE&Q%^M[:?E[V.KV=DKZ_ MGGO-5J?1W2WM>VN75V]WF[LEO;4.VQOU7+:W-B"]U^DV6KLEO;T.U].DI[C> MWH#T!@QZ4SF]9Y;YE0<9TM5W^U0Q.60K*K8B^R#M`5]-]MY4RX[)/D@SWK7( M%JTXKT//0Z\C2WWZ)YSV[N)!,+_F#F?`W=V`[F:CV\Q9A+(T[&`(O36&D`)Z M;X,A-#J=9N/MA]"NKS4+,7KJFPRAW6FTVYN.X0F^<[V7!/W)%SFH^>%;[QW+ M_N4D\$+^:A#]F-B._QZ>^4O.1GZS7F]<_-^7SP_&F$]8S7)\,#$->.G%9D-X M4Y;WZ[UZUG1,WKV`S&_L^0O#A$9XR)5C/H33J9TT$5Q^4R@XJ_W:E##:I,_IIB<^5'X`3IZGQSP77FD,>*QY/UX,*LI MGYP=C6AOO5BS&GJM,?E^B')V-WS``QV`R3^8YS$'O&S7>^#>DV5P_\Z[MIDU M4;*UR1V'FL]-:-P[0_8%A\MZK]DI"5/VIL>:]4Z_6Q:H',0YV)XAG_F(V=>X M/2'CS/"F9\WO[`K,30\L=BTRI)5#S:+,_HD&=3GO)LR=`]F("8 M5:E=NZ$71*F,`(]`I-(C?7^ZWG<=?W>"E_1WVBET>2*>=7*FY_TH]H^X MF?<31#8(EDT[UI\OG;R$%^C78T\ M+O[*?_:`!\^8UY_).G5,[3?FB-S0WUP;$R%][9.N??Y\K6LL89(MS[[F/=96 M[&\D1M/00R,LP.\6T+`F9/#Y`^9C MROQ4)MA/P>X;6OD:,3J"K]X;GY5_2T;G'+=6 MB11T5#I!K4W)VHR\,OD@`,40C./"#A*J>`P%57G&BHNN%RD&(G1ESE["DA,I M^*>'^%EPV"Y+(_PWHA!AE[/JX5NC3(?4(.1R)X8@2N(PRTLJ.&0')27M7/L` M"USH\S6OEV?(.UU8G'L]#20+(WCR[,H6E,XO5&-+[AMM'E9:_3[;V:Q+>,=+<:__[MWR': MX#.$YU[TYEN-E^UFIY$[FEQZWFB(;XBI9KW7:#8//<(WA62WW>CU=S&)Z4W7 M^:_?6D&U.[U.*W\8N;NM&Q%^&*WU:KK?$C?-SF6CW[W[C73J52X-KQ[`&^*F_L:TOR5V.H#Y1CYT%@]`U2=;5`QQV054:.>M(N9O M7P51:VDU[5<7C?%KP`;WYCM['9.3BIZ.<(60(>BIXDEIX3@-+8`I.#7"8V3@I$UDX)EE0ZTBWH6"83D8106/5ANYZCW(^*BH MGY"=R13]-3^ZWI+!=G>J2@Z*ZC$P+)5'CV5N1#*Z+JL."F&-?[+3!KF,ECJN M!^H"GAYZOO`T!Z%O.=S?9ZV^@DW_E1\%VF1MRF!C.&1]Z3$S,6:1/OM@\J%E M6`$6E,P6QL4]`H<'TIO&&<0/!O/'6%I"4*-F7L0Q`NM)3F9>W5WX[$B'6H34 ML3HOW.%Z,#IF^3)P%3!'Q&2QG#=0,W###%)30:QH2T*6O%R$W.,%S1]CR^:9 M:;>`.P'*KY@LX-N(.SAUR/DA3C]:!AY_XL#*+&+254UQZJ>N*EPR82\@L")X MFGH&=]QP-,8W^.$4`RH+GF4RRWY):8[I+[A$/NP=A7O6?`;8L_IU0+LB%7)PSP*7X:K@>-R/VUA*#1%Y_I<0?2;?(KJ!VB?W9O+URN[ MF-3C54`X5:OM%-,5"D34Q<,(,89ZXQTS/PX.JYT,M?\;S9'8Q+4!04D9)P!% MJNPP&!YXK$_$G)4011_S[TT;)`*+$]RV$5#E`%&?>2^:/W9#VYP1)O!Z1$3[ ML,O1ME'H)2[4;KTQRE\B;^PX%!LY8-69\3P';*<^U]P&XRO=KKE]3/*]#I54 ML(G7];,V=I_A3^\UWE?*[4)S=<[)>CM7H+2>P`S!.[#[)2O6X<-Q2PDY"%5S M$%PPDZ\<\S-G/O>_`4^L)QSW%>87HG!_=#V\YC,L;-Q/U;[>YD9R*"IX(.(J M2A)+,"!D,0:"L')NT$C!XJK1Y4>K1F-^>2E^>3REY0+5P.7)M0Q9YPBNUX5) MB=X!+&89UIH1:Y-R1RN2$E7QZ'0=[D8=:XUTZK7+#>MP@WZ,RE=+=?Q*VL#P M@1LGF`I84ZH6?#$PNSGF,DJ;*+)S#."T.^&>5/YRF?&CZ\4!"3^=)#QE+\(Z M&%L^GN\5-PG70#TF;;BIC7?UK&>PSL;"FM!Q$3!YP#WP#.'!*OD?S`@+,"19 M9WFS]UL.CDD0_[-X;?P$?QVFJ4'`$"3I%N[1/./QY)H['(J60)Z%AS3T>"Q1 MOK$A'`?)(`"8XT[@*_BO-&J.V)JY3Z6BY\E!8P8!0'2C43EV1K(]VJ>M% MAI3P7U)YT5@2+>`KA6Y!`$/#@T#@R M!3Y!NOLL[A&[-TIRTU$:^3SPCX\6P7=A@#$`,TI)GT.?5$HB_`"CL,R088D] M1(N"F#*[%_MK*]22Y2_P>P=8/2!>%A1VY#HF#H!Y[@"1$&EJ82)&WNS\T_@/ MT'JI4::7SG/M`S-EAGC4&+?2Z[/5$@&`M(1[C,>_U!V@U"U<5]^\ M[5EQL?0H?'L\#X"._8IIAZOF&\G!E=E,A*-F9JQ931=KB8)#+#27.">QD0!H%)X:KD@9ZV9WIQ>V\-FR[N(7RP'S(WC)E`B9_?*-,T)KS4:[ MT4GEYL^^?TN2]Y,#NAMBWS+IL]9J=R[;W6U)7K33N,9UE/Y9X@W'1E.KP5]. M#:?,`P,#5^QHLH]V+9AEB!4)=M2YV8S,H_A(+_5T*E5;G;)26^F>3M#] MO!&_KJ:9[[TQ+\*.^^RQZ2\G\K\%TD6D.0L#Q%OF.5ASJ#RB(]*DA,=*TD/2 M'K)EX5>2=I+VP^+PT9QZS,>=7XSG;:O?=?DB1;%[1T[CV&C%-36W!))9P2#@D'!(."8>$0\)A M<7#XBH!=VI8^]#"6BE,!B-L"*<6D>BU9*1[991-+PC/AF?!<:!87DVK",^&9 M\'QPLLN&Y_4#ZALD])0XV!XUOX@Z-*G\TIVD;2[%14$]_^4949M[]N4859&" M#%OF!Q57Y9",5$)&"K%8GS8;;;W>;^XKD/DFPGA&$E))":%5A%81DA%:10ZT MBM`.3U&#`,6DFB(NA&?"\\'))CP?G,7%I)KP3'@F/!^<[++A^=4[/.UJ[?`L M.D[1$LS:?&-G&7O*%FZ`L8@*JC;?;?3JE3F?>Z5UUY&V=G4C;03](X1^)EBV ME_#83B1H@TT6@O41PIHT.D'_2*%?%8V>]G0N1$G@Y&/AFIZM46`\6[G\*P^N MF3^^EVW:+?;K?YEPH;U MR=PC-RY72&ZD"NU?;L*-5KW>K->+S8V=]L!;QHU.KU5O]`K.C.:F M@M),F-'<@!G=]F7W#9'QR7GBHDO->LS(N7R?6J/6[J^A,W*(W",O]J4S:IU& MIUEL7NQ-8]0:W7:O4W!F[$MCO*V0W$4-P=?C1<[E>U48C7JKWFNV5K(CA\X] MLF-O.J/1[%VV.JN7DX.R8W]JHW_9Z78:!>?&WO1&MP,V^6ZX(4L=8T.N:,#) M-WN5_V:]U>EWVYE!):1L3/?>!+79:K8Z,]#S<]EJEI%#>UNEVNW+W@XQE'O-)^=?S+/P*=$WMTY@ M!2^2/1O=LN\&MIM1MW]F[+7;["N9$?6*N)6]O6\LCQN!Z_D?>>0S+K]FG^9+ MJ]>I9T+2RTE[D['N;6>FCX,]Z%CW9E8T+CNM1NNP8]V7?=#L-YJ=`\_KOE;Z M7O_0L[JO%?L25=/V0W6CR)94;3Y;<TU`Z3;J]7YJSW".FJV'L#?;I--HM2Z; M;S"$/9H=?OV\Q@GVI)/#&.FDC M9]T1S`3$<[[?\VY5!TR8O'$LBHYO.)+][5\UFZU,`&['(]EGK+7;[*5W$'<] MDOWM<77[O4S.T*Y'LK?09;=?[^4M&CL:Q_X"C!B"VPA:WH@YUK_A&M>Y=AU1 M.T=\N'+,>_!SN!.(CW=#E1#([`?XAF-&LI^362RYL..'[EIE_E-E5]_<73_^ M>7^KC8.)K=W__N'SIVOMI'9Q\4?K^N+BYO%&^[_?'K]\UD"ZM4>/.;Z%1#/[ MXN+VZXEV,@Z"Z?N+B^?GY_/GUKGKC2X>OUW\P&!:YL+!ZU\T$J[VA3EL M)`1!7G-6&LZ^DHLYS1/W':G MH%J%*+C#(??PPS,?:`.&%_GN,'AF'@<"6"`(-;D/(X>?`E<;<+@/'H1@T>#9 M?W$CT";)4`/7M37Q,KB8.V-YLASN2`FAH/"_6Y<_^QH?#BW#XH[Q`J_SW'`T MUJ8V8!DV%Y/W*98! MX*@NIMP`S(S4I0[I:M-61)E<:"=?Z1>QZNU0>9L84_A9+B MRU&!6C9#0^I=(-H.A9:+[F,^KOFX8:_Q'_"CC](V#4&[PPHJW!@/1%"*.17^_BL'&QLT!VB*[]P9L._K]=CZU&:2?G& MYKGV8$U"&SYQ-_2!$H$L\5`%ULA!7``;75/^3!KN`G(=QZ'EL``:W MI$.A`UZNH]I0#\_>FQI2RH$;BE"`%N43Z!H&RBQ3D/#H<88!,?%@[8$;8+F! M!.FP1&!/&7@CC+S50JX(SB06=OZ[,G:WFI6(R6CC&^ALVK;0A\<+X"M4^\!' M@,]JE*19J*#8:,83DH7J4+E;,RYRHU[_*7K12MA3<-SSW&;P-^39)X]B"E4\HV,%+9ICHP"DC9^KZ02U">1P+ MF%C@G`:N$ZO(+_$7N#RDU3K^#$OP)`;M%U"[VJ^N:VJWDJ@4KP<\>$:')J/" M?X6?G0'W1JA00K#6=.WSYWLAA6I8;(2#0);BC1$#8[%(ZVU%[^RK%QB,MT^" M&!%T$>M$AO&N`VK'XU,9]\9)G8+%^,.:2-78K)^W5TU[1EZME%YEPT`9P>@( MAI,)B\"T#*U+%S-XU]3FXNF!ZW[7W">E=J)D5"[Y-W#1^8<[S2@#2L:9D@A6 M5OW(R%`*\J184HI%31&(DF)S+!1CP%:>::$+-9+C\B/67$_X*"!A()GLI^S>MM+)FFHGH,I76,#!,(8*/>'VT M=*7?N?1RGO+OTF^<<)`S`;O4/>AEP2?/%#%2093/I4'1KW=P7ZW3B1C]\>KA M`]CP\;T/*&.`9!_H,JVA9:A%+T?,,2::QP4K'CJ#E7.*[DW&F(T&[O``W3L> M^//68P[#SC247H.!0XNQ'15MFUFMQ>.H+ M_O+$[!!7`7@\GV7V0B:D!P^JS!!QW\"RP5GR)9H5%_S``\<81CFK"R(2%3M$ M"SR+#>`1XDASFCW/8\L8"U:`FH$Y1C9'PQA;/L:T#7B5`2O00H(YT!N\S!)A M26)3#TFNBU^?BI$)-2[$3$R#QX>V")GAU(:3@=2C6=T_LV*JH%T*'#M0@MF2 M9NE'971C=7QYW#1C,Y[\E0__^FQ-+)BQ^*= M`/$M>,KYP;7?T&_^7_S7PY2+1>?*G%@.R`]N.SQQ[1L?X;2:^XQ;97XX`#?( M`G>G/`9#$27DD1MC+*073WF\]_P;]USM$?11]-O9Q;6KM@:?4F9C:=C_!G(E M@\_-?B17:2%2M&F MS`L<-%9_!4]O]&_PD8!/S(9;I=0_)I?>R`UUM<\O55;,R3@G/,4XT#HFE_S` MQ]00$A\LMY9ZI@CG16].4IY/^"14G?<;'CPA M5\]G"1"O5*Y0O*W4L,O-0%$_2XLVL*6G)AEDO(^.#WU\R]'L\T9)P4?^+^H+ M]HO#$4:\7>!1$[#.O\&K.X_\/GA1`&(66<7"9P]*7O$,+AN>43HI2VM\37*Q M.F.6YU32,AYB[&:2ORO3RJ2"J,X^5KHRKA+HI)F4)B^.ZV*2#_PT`I7IX(D>>NPR M0*(\SPD%(".[&4J@%SXFJ8P*8'6X8.],'6($>/N[YF#?G@&;E\)9RZ&*1NM3N,.X.N17M+Y4GGZ!K@#&('' MD8\FF249#2.=0$!83!D4$XX4Q^SJ`Z,DBV`)'NH#9\P9FSAG@+6=EC/)8J]X M:?H6Z8=7ES.C.BM%BQ01G1^1O2V]03E4E,N M->52GU0N]IF0+,,<>(*P;CK8R2XB%0*4<$4.9%$LFHYA*PY^'%G7*:*:,9LIH+D9&\UK)=WO,<;8HQYERG"G' MF7*<2Y;C7-E"DO/B#8ZRG"G+F;*<*0$;/D3.NL>/LZQ8A>X`0!)\I(0:%![O3B0 M+.J#J=A7ULPX2U>EVF8.6Q64KTG$*:'QZ:I)2KC>).&ZJ-Q1+(_BEGT(9(K& M`S#,E^BDG>Y[*_(QZ#.A+Z>][FF"H8V>?)?K<3^"?'&P)F"3G+:R<1.;JN7) M;(%RO&#/^1Q@P[>]6*$&R6T MYWP7,O[_+()(;H<@5"*8EP;X+H3EI#1L+JF3(8*64NW+$4/J'!N_3"Z M[SV*X!ETB>YG/_O]/N=7F),SU7*@>1,:^QI>,3GQ;\M8[&UPQ0Y1V-N0OIWR MT][&5>P0A7U-JFAML!#9V6#9&6;S?MRKINH`1E,(Y8"T):SVIKAJLYIK9UCM M39'5:[4]8K6WL6$M8W\OUL7E0@9GPR;]1V0D/`:YE]/K@ M'<8^DV->N5P<)*#8I]C=.L]5H-PM. MBWUML-N6$'W(\9B4SDUB/O7K/E5!+0_+*7BVAM2^A+I9-W(9>3%>@>@)T/BV M3$E\X,%]((,J]C\PH^Q!!"K[5"*YTJ7;WHS_#UCN_V1\+(MN'=;PLE8S,OBN M!-T>D-_FYETVY!NUE58^54ZU8B`O+PAOXFC@![)Z;!;IZ4NVRN8J_#LS)+DV MZ<4M!F@'^&V-DXN)W_:8=3_X?59GW?-P4S_OGB^78*3`V"(VN^7"/6.S8Y[; M$C;WF:J5>2AEKCDXSV5@V0ER!V7!'2-W6(Y<$3FYD^<@)+_?H=QGMU!O54;[VU0SPFN'2)(6*_7KEL3T"^-J:T/_P[YQ6AU.NW&CA'8)>NT M&]>-C1;@VQ34WW;/+*U6JST#ZK=U`=PA-TR=(B^`T+>$L,-/@3^\'>>5W(EN M`O'PO2-NI&\Q#X[2UK8QOKA]8] MIA'?]VYEI;D:<3R-9>Y5^Q3&SK5I3H29EP&W,XSW)IX+5G>O&!\BD>IPR.[M MU*31GJN<-L;X-QX$7(Y!GXMN3\N:2*=EN":0[0#1?2WJTO5R(, M96/`3T*DJF7BR[UFGC1AJ3H3J$S`LB'X>Q.E9O.Z>;UM\/?G/'3:G4E_>RO@ M[TL*ZK#EUHVM@[^O]$:CW3'JS:V#OZ]$1L.LUYNM=#N;]\UC<:UV7XC=?>F/:I&HW[=,=Y* MW7UIBVJGV:XWWDKMT]3,II MLBI+%EO6?Z8K?;(UN1/D$`DY*DRW;..1;!)782[VJ^.6%0]CU47`QO:+8T>#'\ZP$VWFA<'XHYV\^.'F M[N[SUY^J'^Z?GNY_?<_,T?D9T#[8?[;W^IJMOQP&Z_F\G+P(G$JEL)TS]-NG`[L@R,S@JF`4(R M91A4KQ<[T,LLA"6;52&-H2H22X'7W!"_`O#H08![MQ7=DTB&'-Q7"#Z1D,RS MF=N5:Y,8Y0#`[56#KL(F.0HTY9)W&W)(^>2A7JG56YO+P\RJ%G&G7\5M+!(> ML^`5"**A8]NN*#K!I@,Y!8&NX,0K.'@Y:SNK;0L":Q%)N;HGM$:L\&!>DME^ MJY?T9='QX1;#J06+^FT`>3&,RPUC^D>$0_GLRW.C8M8;.Q"FLKD4VSS-/2:6 M/@8<2BB651+))2))WN2)FLGD39X$>.1-'MB;;"SQ)@^-X&:0%]O)6P1Y\2TQ M@)[9?MQ%42CV>=D;L2B?0=FJM*Z-#6W*TC!E:0%_@S25RJ)?>FYW M9NQ=6&OD2I96C/\L0PF-^N)PTP'OLI4SNF=::8BWF\&;:E0?5YWO;1QFZCER M@C8F5?6<[_*S)[@:^R<\66?T272#F`>O,B5;7AEBI9J:<)J>+PB<*PY7JYGD M.H'[-7_G6;+/9%$^R4TG M5_E+G5ZO&+6:E)!W[9:9;@@.IL,Z0YP?[OBVWA-F9[;B?;B]5.08="$GMKJO MNYZ;7)P-YZ<@TR)@P24[[OC:OC:;*^`I0=D!9CML%3LU2FK/F.VRH[#9:$SU MGWH[:E]%M!@QN&#GS8>OC16P`D"VC-/AF7#K..V4_6JUUG:1>O!ADWY=T?"> MNIB:C!RAVW]H^[M@-EA^W11S0K"=+#^PQ\U'+C-&=OI)VK.V#!*$TDP;\M_A MO]B8`UDOE(_MB@CL-CF9C>%X+8N/Y,KC2**\A_[*T=##KRK?`UNE9V/`^_XD3EJ;?FQ/9`*0M?SB*,7;1?9469PABA,'&*K(4 M&XIH`';G.>\!/BSB?\B1(Q[`PBW+CX%N<(\39,Q.)M)V%_"E8\?J,X6)G#(06'W3>O)"1D#`7P;^/`+&0NW`]OCYR`B'7 M$>X>S6DM@V\.5$])N;[R][FM99#V\$R`&>@%BD\!KK!6JXRAHSZL'$+@2F,& M>:CG`B%P2I"GZ0F/5IP`H(U7L&S&^=1.L9_-B")`M!G19D2;$6U&^]Z,BK%] MK+AQD/^RUI9!W>X.?9)-W>[62E(XJB4L&A/A]NHVUT1TZ6+G1)= MZ$3-,@)'G<<(..*Y8E&.NMU1M[NB\RAUNZ-N=\5E%.IV=[SR0-WNJ#]!Z0NO MJ3_!28!'_0FHVQUUNZ-N=]16JSSV)76[HVYW));%$TOJ=D?=[@H`41'-9/(F M3P(\\B:IV]V&KA)UNRMR?ZY=(4'=[JC;74D!IVYWIRJ7U.VN3&6CL**F(\0C'S9^Q"+#D51R]IG-,NF MZH@JTDD=D3HJL3K:E0*1Y^T/("RO4D2Y):^:UPEUC>O)!MJ5TME](U36856F MUYK)Q6;9U2Z-JCF\CE8D'`$)'5$>NFV;IZ;H`*YK-&`O`]T/(FEGC4HQRK`9 M=H]XOWN:C?WO0O0!6/7D._)'XU!W8_?AH66JY_J-$:.LNLF3E0U.Q;,DVD-2 MW#:4\R(*2;/BOPW3['1RMOXWI5%,4*I6?E))9D(=,G!&"TFU26[!M.0=.N(V M![1B'-S-X[!#@[9^,>*^%>Z6*Q%_$F#M"O;!Y=X?PNOR/T2P3(F4CZM*=4;R M('M[H6,I9W'`]=)-DT0%X`:@%D6`#:\R1A(IL\)!1LIL_\KLBW@6X&<+]ME[ M%F&DXCE?OMR21CNH1KOQ&*R$$[TR_\7#'I">+8,^@>^ZX^Z((])[1\*D[`&^#KY?\"U_\J^.$-`UB;-=U#-]]7WJHFFT^U=!:BYB"EM1NJK<)"1 M^CJ`#QKX+R((\T[*'E\]$8`Z>X@$^Q+9LP=@I>>V4NDSLN1(%9(JW*4JC+G7 M__?`C]G/@KO1(&O2W8%WZ_JJI7YR.$9F7CG4XK8,01H4/><0;(J+%QW*Y['L MC?V,$R)".8Y@EFG?\NC'\9XW\>#2K-^VU^J3G/@`KY6)5/#_R@*[@/%T98#. M89)[E?R*4T)>_$#.SM"30-@H#D9^*"[9TP#^-WX`3IV(O5!8<2#L"O-`)%,Q M[`H>X#-0I#&+V1?!03B%)LO/N>V`9"O8XXO#?[ M7D"XDD:$3UX2LU/C75R:D%EZ87RU,*%<&)F8,Y>64@C?-6LUS(1D0R#J`.6' MJX^8PJ>^Z_+0"<$=P$D\O\3NJYXB;^0F2WY:=8:\G+FC+T[2.E'!Z$'U^AWL M'%\[PL/_"[@T\./^8&;RL%F9T"WIS*)WK4HM&6?AU!DY M!$+R['>*<:'UR5I9)_"';3#X3Z6O*FCB"PI>&" MHA)[ZWMLCD1D92Z5@7LK\C,B8$R*@/#Z'`=DS:,O;L>CP'\&;Y_U<+V&X_4* M1?#LX+X[5Q=4[:/<>^`G/2B7-60XT5VP])6P%X3C'N\\R MUZ4_G5TLEAQV?O83$.?L`A:)/8)IQ$<^3DSSP;8*].BSE4-`:H[;?",O?PH9 M*@AY%N_"J%&HR7RAL/D/+P"(>V4"R"ZW_JAJ6T)-W^O+['GF^GW`U<&]'18"JQS27=S.Q#GTR+G` M$0#C:T(U2>SP%?X:RL*.?\#/'A]68.>U?8`&+I%`^!&ZY=P%O>?#DP,F)\S! MP\)+Q0:2+Q)84X6%@'#)=9+I7GQV;NIY>>-Q=382`GZ6X4VO/T^7Y5=_Y'(Q ML,\K."+RQ8[',X,#DU6-<3!?O0;O?@7W!:@G)*,X_O`][(&:.,#T1.)146&@:9+WORJ:F`VG+!=UZ,5]R-X=.\K56SKF24N9KZ"?_9=P M#YGSR=-HM![-]3K*N5Z)0"F&8_SYX^TBW7$7,@&8&4$CB;:$7#$<\6BW$YGA[3W M/3ODK57C-F+Z;:>6J92.8>.YPSC(1OQ5]4U*1!_Q@[F&LV@T"DWCD@)'HK/C0,JB2/4^]L2)#=!LOW4#-&M&8T.#N.`Q>SJ2 M.ODCJ6,^*C[>(ZD"053"DXI"+>Y.CRT*8L*6,UQ$\5"*A[YM?RPX@Y<]'JJ^ M.%R7DEL>#K"`>>BHAB^.!W_-UE[?I\T#L"KZ455#Z[;-I:'U#OI=R)XDS:3[ MCJ;+3>CPRG2SBUM?-V!XGFUPD?M;TN%B?G-L=GZF?U1M+BQ=9N]X29N+3/Q; MZ)^Q3MX/;#DY4C8`^-GW^NS_^;IY&/>PC8-O.;H]P$Q#Q]L!W+IB6T?52^%_ M!_`(]@O2A,O;<7BDY43.OX4'!/#[0O8VR"*KROK/<&B6)X(02#&*@S#&%JQ` M3#`KK$&6V/(UR<5J`.:XI'^(A?^3'(N`_.[#PK!G@#H.1`51G7VL*_JR^0(^ MOBL\T7,LW8WA!02A7?L+"P<\`(*>!T*/S\30,OZ@>P)&4D-%D2#'BV MK4+2:N*=69OJ%%%A\8A)1H]\;&('L+TS\1)Y&6@5/:L4.TV$^'! M,W`L:<*/BP'*-CA)IY]:?,2[CNM@0OP)=UE8L>78A)X:MV"8HOL[LR[7KI*T MPE#B@?P@A\N.N"-98D9!X(+)OF*V[JZ3]B'CLTUIYABGJTA87,E)F MAU!F-*6VD!JM8+/-2.^1WCLNO4=3:@NJ^78TG"R).,\/;AT@PG02DD8#5F1TD-%!1@<-5"6U6*Z!JGL\`2S/D35-9>V7]^BK)C15-9"26()IK)* M"76&>KQDJ-,DI^>IJN&LBP:KJFFJ@EN#Z9&J-#65IJ;2`,Z%`SAI:B9-S2S0 MU,R\^9<;C=+$+4"OXHP\UFFB)DW4W(ZFGYI\70>%^['74Q8'NP-F0=4[H?R_ M1\K.F5KZS56_$B;-3"$?)DI;ASML1Z4G*R'2H[QGQ`B+V((A/#.5ITDTQN(T MA7%319,'R%@\CH#R4K.X4F129*7:C;NA^#-&),90@,I@Y\:%KI.9\XX64C5Y ME(8S]EQ4?7";Z^!>-19.4$HO@8-E6J?+F6^;]4J-^5R:]EJP%.TCF0FI?=Z- M5`=>J6I1KX.M,$&'944PI):91B/<8Y[->`2`DUR27!Z=7!YO@^JB@D-EG!-#,U(*F9M', MU&4*H[A*H:3`T9G8[L)1Q1HX55P:EQ0X$IUM!5*.:RXJ#E@9:Y5VSD@)'TET8Z3YR&Z%5WA4K*7`D MVX61[;R=>X-I8S:V<;26FEQZ%\.N9MHYP+SI.;VQ8%.P8N6(), MN=.+"K6X6]@B%YV5%B3R7,Y37DICH#2&3HO2&%:86W`\[0)O>3C`!D=#1[:. MQ`X\MSF-KN[3+FZS$\;7H5YX[;#SPK$GE@(\A3OI9.9AKZ%Q2[*T M8Y-NCZ5[_#UGNU]A[TX<4I"T!G;2]J3(8]R3;?"PCU\<<-E,3DZT1_`]G_7B M0#:>\[NP$)+OL.F1<.27(SDF.H%>/U[GX"#=$D+.MI#:_\CR4"!!;SP[TVK^ MHVIPJH>4+[CBLEVK=Y:/)3>GQI+7ZFHL^>2]>'?L.>K6OS_>G3$;%FC(W1"3 M=7XTVFVC=9W%>0%@6\?R>CF6!F()N"HLS3&6UVM@:=9:QK5Q("RW.F)^(98M MLV/4#H6EN2['FF,LS36P-(Q.ZV`_?_CR^9:= M5:^N?JO?7EW=/=VQ?_[\].L7!L+-Y,8B^SUR]^KJX]VI%]QL8[6YY9JT![C&`[F]P*C\RT3=9= M&A69E3]9>S7;5UXG(:,Q!888'PU8NUY#63:;52/)XOET\_B!W5BR_2^FKP+/ M>#8/[!`>8\L)5-(T.^_YP1#6XA4OB$1BAWT"$]'#%LKYC_CJ7S*3Y?N#DTR3 MY_2=99Z)'4KG+39`&D;AV81C>*':'$]@;BK,]X=ZJ[,Y[G.1O0E`%RA+?P9G MI%*0O3';,-I"*N5V/OZV\!8YO<,:8"-LU>18;R\<&TQ;<1`(>Y.G@O*5/;U' M`6P2@8.-J'L`_##VM!NZ&)LPXKT>MN4>@2ODJ!OP&DQ2BP0NC4@@#=63YSP( M\_E'JJGSD&-W.%A1O"8"5T;.-I'0+H0%*/$BL,%NN.":S+(IGSOV4O]FX`1V MZO/,>8#C`3Q1++V277?.G?AE8X]JZ9:\R[U^JY8X[?6TU]->3WL][?6PU].^ M7N1]??Z!QK[W\V[R;_?U9Z_H()R"[O8 M5S\2S*BS:ODW^$-;2#?9J4,3^TAZ9%/%SS[[2>`LH+!\T\`.3>*/7A2\J@D_ MRZE=&JKN8/*.&C/86CY@S5N%;=647)E-WUB5?ED;%M<\.<<753T[3&W(&S MZ&R&2X4F:'?>%+IH/.1;G[<'TOB,73#,H^PHN60\6V)+9D;+305U:`*(-7%KC9P7K@[OB>/P2^7#H_#RQZ/)K7 M&.($;?4%)B(('##GR.8%(4YC6P7$`5=SUQQ8%`MM?;\'VKCK*+C&%BZ0:WI@ M7@8I]1P+5``0+!`C%]TP()IP0R$GI6FY?U"9`V<7E]+GU7^FI,9!:0[(&H\2 MV'N.<.WL_#L)D[Q^P)]%9EH=W(/C5Z/IM<2\#QP2.)[=)U<7>,&5R1?"D8_I M"2GB\0@YU6PWY62\L8JPP2N'QU78R(W#-)TA=5_0$QG*K^1ADZL M4-.R;D:8]^%\9S=)(L1R/0C,:-O:GG1?)P4L(1LBE!$G\=T"(!$M&]PW?$'D MSXY8+ZZ6V4LJU[:!1GF=6H=^^CDSRY&=<^;YL-!R%J`>!2A%4?U^D95\4`LO MJ&O`Y429Q8A*LB=ITER4KG*KT2*])P@Q`\] M0#\9TAF':J!G*D9(4'F'G!6*;J69A.*(-KRGX>[SD55C_G4U,RD;VET,C==!A'L;27QMF#W$ZS M]F34$&B?2&$WMOL"MCNC-IXCRST/5@X%R/=$)=W002[`JL-UPW?AMJEGX9I@ M&+SXB<4MTE&8CV(434UVQ@'I.EE0(MH'&-6D7G]LDR;*#0-&`1HT<_?@VSFC M8ZO*2GR5E!R"H3,.=>*#4TPT$HDJZOH!J$R!L>M(X%#.UQDZ.WIKEG,Z$_7` MNSZJ["&^=.ZT7/6N"KL++MGMP*^P?\'E_>KM0/@N?.N`YH4( M#Y-&TV14/AJAHM0)I\KXQ/&S@-8,G4E/K:JGGG1>K=YE254M4E43.=;F'!V4 MHWXFDY>7T[B2T2$.\+GM2'$DKEZ5J[\(G%ZM^3G-^/X":U0:$NZ`?=,Q>$8C M+PZ&'*P+!/X!3!C#)@&_C<-2YV=3OYY=3,7.)(4U\J",[%X%6GOT7=0&`B%O5Z]E%=IA\ M&F#KH5R>-RG"MDHF@-J_^[$W<ZB1U7+XZCZ;%1/Z$V M=[3#GA1PM,/2#INWPU)K9VK_2MLB;8LG"AQMB]O:%LO0-GD[6^;2CNGE[%%+ M?9./>',N)TN^9>,N4F]=:IQ\@HV3MS*DO2!V9SF[RE+;Y&W3HWS;XS5U32YL M/LVATQ\?X]'(56E3^9URJ[,M?9_&97Z3_4U4&M<79PA:OSSIDX=>@DQAMEX- MRJ"^]]@GT0UB#I0Q'Q%SL8B[)X?"$"D MJAI'8Z:H^@W^GQ236OHNQTLJME5%ABR2FDYHS19J*U@4`M.`GEV<;J[@G&KL MZ37.J1D-L1>.#;R45`B[F`"<--<)L9`(ZU1TF3,\&O6A*SBL+3O'(EZL6<0< MYJ32%-Z7T^S\,M-T/="5N2KQ=SKALS++@1+041Q8`TPWQ2[K^KVZ9E(5_&50 MNV2RBPH"G1;\J;X],LUU]I73&=SY(`1`(5A4O$#>FV3:_HE)TS+SMI="IHK< M0UP`9\S<(!O1`+@?(4-0*@O>AD70V$9=53^DZ*NR9*,NBZPLG7_[)$7!9Y9D"4;X$U]E6E]K,3RK(@3Q=>R.HQV0I!U7RIDHQ,JFE2 M/)JTH7^:*KR:43Q.J+*^U<++E>$>\T>J_!RK*-'VD;;?VH;ROUM[F:ZVC::R^:S1"]CL&F?/ MJKQ%J]DP5A5F0U\VO`-E'4HMF+Q#P@+Z-*D^2U1?"B>R3PJLY7MJ/Y#;J:IC MP_T/2SE[J*`MN6U8(HBXXTV])<1Z3;E_I/K<5?MK?O>4M"!.->7(M+J3"/'@ M#Y$V]("7ZGXAX7@;557\++EU5+,4V2(F3*;;S.6C M>:#+E1IA66$TH0`B+?X2\%$@@`/TFF,7AJH?@S\/8JHZLP#'C'S=M]#Q<)W2 M[BKXDHIJ-,A#V,FZ[JNLWE!F\:3)4E&VPJLD`KX!6QE66`#/\8V'%R[!V!1&A%2\^&=V$C4B+`D%B65`U,Y\,'+ M@<ZN1U79MK19)RU*TTJEBJC_J!22"J%/-52 M2*KG.KKB&:KG.F(-4TZ6I'HNJN>B>JY#(UC:>A>JYZ)ZKM9*[G4Y^9OJN:B> MJ^1+0/5<5,]%]5Q4ST7U7%3/1?5<5,]UTO5<)[$Z5.Y%Y5Y4[D7E7F\H]P)1 MLH"`CQ'\^%%-V4YJN7)^NFS7ZIWEA5KF5*%6K:X*M2;OQ;MCSU&W_OWQ[HS9 M()>@4$),'OZQWF[6:K4)G',@V@)"U\L1,A`A0$LA9(X1NEX#(:.#&.T>H:V6 MTBU$Z+I9-\P](&2NRW+F&"%S#83J'<-LKKU"N-<(^R,/L'`BO+&L>!C+"=MW M`C894(<*N667(3NUYB/*PZK?FQ*GUAJX51OUYG7#:&:Q6P;2#C%MKX!I1L[: MZV!JULUZLVD4`]-&;:4U3?FUM@ZFK7J[U;F^?@NF8*_%XINP_+XG/<@''[RO MU^G"WB57;7M?H`+>`CC%>M599ME/UM/*%@'JZBWT4<`SX:,!:]6:5:-6?;R^ MKAJ)\?SIYO$#`_'#*!/Z`,`OGLT#&XM&[338)&W-0!,Z&!-Z[H3R!`A][;]% MF-[^,A`>O!V$&NB7/5`"@ M\Z))H`B%R%N!(T.D#-V;H8C>RZI'\!;"F&,8E(EG=$54Q`W#60'(9%\%#L1W M!XSRRKCN41OMX['KZ)^.%&"R+E($SXZ:RPY/EE<$`IE=3[I&WP=6VQ^*0#XU M*:?DZ!2HN)^,O7U7C[2%GHT-V%9T!>;S!:9XN%B2JSU`9\(QX2%:W3N/3&SL M/2Q1Y[O:(ZC)`^T1M$?0'G$B>\3);1%A=B<(]QDL,HU6IW9=GT$@7!'.O<6` MZI,1H'6`W%]>"(\,:S?^-]#>STE_N4>^.ZUFQD6&`: ME@W!WYE9IK71JVY M+O3R)[CD'D]YP2)$"U1XH3*/LQ@MNG"?>BE'L!>!MF.L]Z7.Y(E=H5#?GSZL M%0[U?2G38F&]+QU<+*SWI;W?AK4U$';LBOO>C1'$ZQ;6%DX6!Z]0\+,/"0\'`C_N#\@`_TWY8U?2L ML?%NU):N(-MMH977/*W4RFJE>I$AS=G5B[$A9)T$Z?\M:E+B^2\!'_UPIOY? M!"S*T39CHWZWJ!@.W>@=.])-J]7V9;NY2C>[Z[%B_4.PGWS?9A]#*_!?LN[- M^NT*22.11B*-=*`>NF2LD&H@U7`ZJJ%0QLH>+)-Q4P99;QXR)PQCVZ9H]Q MMQKY$7>W'SXF!Z;4EBTY,">QS.3`%&_/(0?F1!B`')A285%8CB$'AG1)*1R8 MO23"W/K>LP@B!^MJOOJ1..9$F$(`1WM8>;`H+,?0'D:ZA!RB$V<`VDQ*A45A M.88V$](EI7"(MN_]W'NZUK*=-RPI2;3#W+C42?+02=(CS]14,DQ[>V>JP+!* MM'/D@*4P8CQB1NTOV!93#A\;,CO&R6J"G1L7:EZ;K*W#9]D\DKTR\:4<^V:F M*7OJ[3CK1?>R5//75(?+H4AFW'B`-%[PC`\:N=Q2*7IZ-)H':"`8:F9-EX=. M6%%#9&QLHHDSUJ*)9J$X=04'O?"<9TK0^H$?RODY8&[8_JUTV6IUV,X/'6H"HE3::JJI6`<*[ M_K->TQ>@HX64=UV=71D(S0%JG)ODS1E6D&U5Y?29=&A$4^44 ME\C1>JZKR/NV&-^D?/AF#ICS#*76:LTZITNJ,-85N>HG MP@#DJI<*B\)R#+GJI$M.V55_35P:\M0+[*GG32)YB_-.#FDQH-Z[K](P6Y56 MJUTV.Y06F1S2"`.00UHJ+`K+,>20DBXY78?TD^@&,0=7R&SI@[9< MMS1Z\=FY>3'CG(9YWFE3>:=X6I@X0!4&+NH(.[D\"_>ULHMC0'6\FCT&)*>K M&%#OW1XW*@VJ93S^92:WJS@[);E=)\(`Y':5"HO"<@RY7:1+3M3M&C=AV7KI M(CDNI;9HS4J[UJDTC.NRV2NTS.2XE&>ON9)#&+-[A81N_F3'`PQM)-?JY%B4 M7*M285%8CB'7BG1)*5PK^<6NV\/\QH.`PR)05YAB270Y]1!M7;1UT=9%1TSD M!Q5*QLJI&6@SHH%$IG]9T[%^Q%N4\8A M:4$R-&W\=_+^LPN9,'CNS(.ITZS4Z_5D@MR\M^<5;BF`\GZ9@#%3_R7'SRE( MU><,E*J3BL?$=Q%83BB2HK<>IA^V&K5L?5@8=W\75H1O2*;*N3O&^O'A!EX_<@)LV=)SG@4[ M;ZH2OW!^C=]E;KJGXHNE$IHG@\C1Z4HICIJ4Q0@4<%\$LJH1UDQ$"?RJ94UZ M[Q0E@1A3B9R2,V0)HEI\59.HF3CV;+@.?TT?^"+P'DEH?+EE^0&&V]U7JL,K M"-0'.%F];AJ5AMDHFYE.RTPGJ^4TLNU\8U=[KV*7&6)@OOTM*H=!3[&QS[%U\7`0Y\%YPP^;"\B>UIFQF< MKCY=04@^64&@IC(]6F;RR8Y[&R6?[$08@'RR4F%16(XAGXQTR>GZ9'GS%F8: M=FJ7;/*P4O:A7WI:F7M6BEZ1]JA6<:C&S5#&3A7Y5`6!^D`#$.ID2)$AM>YF M7DYB%W`S)^>+=,;1Z`QROHJJK\O),@74UX76)2?J?(U[I&RK?H\2OG`@#D+]2*BP*RS'DKY`N.5%_Y4GZ*B,_$E[D M<-=]97X>MY#ODR!H-Y_XENM3ETCYTT'UHJM_CI,[-_K%@AYG0^[716.MV`W:5_[3_JE8_>O:G@/>QW+=: M3>[(??_?KN*PVN=\]/[1&@@[=L5][P;VDF3K>!16'#B1(\*/WRTWM@4\V!]B M1D$<<L#0O_C?_X'8W_;W?.98_]PMOW'7K9K M#>.R-O[G#!,=<$O^)GH_G&&EE+O[ MVZ=_/7QD@VCHLH>_?_CR^9:=5:^N?JO?7EW=/=VQ?_[\].L7!K>SIX![H8-P M7RY?ZI1_TKYZ^77W'9QEXL_Y8C3)W7MJ1?<;& M###%I`Q]!1GZMHKI4YNU?&K39@]643N]USD2P)X& M@O5\U_5?T-#1C5('_HN:$[N>0<2$YI%,%3M>"%]X(@(U`%<+=N[Z87@AJ\.S M=S.+NU;L2J;28VI?=24X0%!-WOA^QT*?>=JT\9AKR;N[O/ M7W^J?KA_>KK_]3TS1]_G[E'M0ADIZT!>@`UK#/B'^V]W'[^E<'==#BH6H&>A M[SKV7!Q,=)S`VX)UAQ\;._>;5E$>EL`97_-TQT-&.]QGM,-=HAUNE7RO!-HMP^$%DHPGEV?F!W M@95PTP^$:I":]([1)9">S0;"M#CD&/:%&WZ)/<',NC3Q##82*D0D>]98`T<\JYNZKQ/%F=AH1C=<'?EA5+UU M_1!OZ\;P/Q&&;.BXV(`6/NL^K[^F7YQ=+"V?++M75EK`-PR-7N>E3!S:NY&0 MS'-NJL?.@B>SDO6))(!UW5.R)D\TV5K+>V6MJU81RJ[%M? M:0$_F3V;K*]C6L'?ACB(X!';-D#$Y[A"@YHOS,4-2Z7#2I,7J/& MOP&6K_/0@&>_JUTV6IUV=G#<6H#D=?M4H^KDZKX`'2VDO.OJ0Z]`)%,9Y$Q` MR:@S3(''60[PF]=/NG4"\'XPRR7)D#M,B<:J!B>'P\PLAV4!5$2;&+6G&)`]BE&DLZMJBAZ7LM1#\3D0(@X"`-1] M92.D(]XEW^OY>$3'W>@UQ6>\EH"8%PLYNT)AIV=#SA&&3;N8%EJ;%QJX\OGW MJM_IXM0_6HP]+4;#E$-C5PZUD(-`P!7)S"7*D8.PNH/PFIA&1?:V' M]NMK:F+BW]-F)MP8"-_+(E%!3R)M99_Z''=R:ICV#US_!6"%B\[Y18(LP)(9 MY0S>P<`!.WO<&M_B(P=M6=4%7Y-/T^J3XP$R:#S+>=J^._M+A8%%C%.SI2^D M$[W2H=SY???#M"R=.7!-P&V5;,:SOPB=FR9?`)=Q/44MO1XH4(7G5RU<11%H MCP&^Y?TQ)%U%>DNDEKMZA>'HN>J"`S4LG!J`#U2V_<`)P((^K]=('DZ"'HL[^9Z[5<;@P!,9H/+%PQ!"\G5 M[N,),3P8V+G[FG/W!Y\'-C[\#OPF"Z?*7[(;=I8RR!D;"NZ%$_RA00FY*\&: MQXR3$">LUW,"D!"A)K/W4@Z5)?]>VZJ>VVJ#EG&X\;EY,3NO>+$7UQS/81[;:),CF!<'X"O+ MXO<'#M";9.B19;&&99'!>:^?)H=+'QF/EH\-%F?4DFE)P!750"+*D6FYJFGY M2PSVEK'(K%SS5,`PC`K\FR288)CM'O2L`P8<^YP$^N^<4$:@V?G9_>>[LPL5 MW\=C@JJ,WZ;VFP4&9E_&.]&,4R'*ZQI&F,-)XW$K64A@+;::?TE"J'@P@,<* M&#J?BH>#^:N^SH2ZNP)^%=,/QK>3T4G6Q@K1Q999,N5)D80IV*&&;LJ&@0BM:ZZCAU*LZI>2X_ZT;I; M8$[-AAL[F0A?)0DW8KJ+CIJMN?X-'CAH?:Z.X;BTW MZ[&6S7K,Q!D-"C/29E_LJ))Y3;F%)\\$9&D2<.6TEXAR9&FN:FE^]9]U9-'8 MHJFI^O(>_EP[.;1ODLU)YL:*+:<,L]*J-XZ14\JW&&2#$7#EM"2(<@6>JE(B M^RP=@WR]1?.L66DV6QL<_&)="9[D3AS]EN>PE]'DOZ("?C(32["CJ=%8VM&4 MUK,DZTD6*@%73CN+*%=@"[7,<_\VG+14]BVOM("?S%YMU"K-EE&IM9>>[-*2 MEF1).\UZI;XD6KN]\7\TM&_/0_M^XT'`09AH5M^IVEI$.9K55[[E+S1P!>!- MHAQEJ*S9>"%W@)P^_SAW+MB+,A5D=]-1'%@#'+D`QGY+MK[6(P`JR;D([_<# MT9>C+58;6P!/=<"M#7'^`#O'&\Z2O]-7ZU.2.)TF&*OUS#B"W!?G)2,J M6/)^2<&3QSWC@7E]_*\"5'W.0)GD@(OO(K"<4(SG:;RK7;8:M8F&M6'<_5U8 M$;["`K>>`P6YC>N&[PD1.3S/D;\_"C4>H8[S.A[C;BC^C/'5']4LA4?NCM%^ M?+C!\08C)\!TGQZ.KSAOJC.C6<%K\)FI@WFW$V^9[E34DJ75N:Z8G=I*1!O+:[*<]N3S MLZ)I5MIU^/?Z.GGTN7(MZ\Q/SD;5#QUJ@>UVDB,>0Y4;3SS0O?<3TRDR<$7X`BE7?F3 M*][@;243.J0M.?!=L`[E\\#.]+2;D2:0I2EE..%M>J('&6=D#RRW!VB<1(&6 M@Y*J"+AR&A=$.3++5C7+?N5@9"UK\:&MLLDPHM)M+X\BS)E62IZ_,J56L MJ;S('AE4M(.ODN8.+'J,G%*^Q2!SBH`KIU%`E"-S:G5SZI4M'/DJ6TZ-2Y>RV=FE3-+Q&?B2\R.&N^\K\.`HC[JD1KHX;8W.8 M-+3U%L-L$?&*P;ME!SQW&P?HF>W'75<C]HS40 M=NR*^]X-Z-I$M3X**PZ[`_Q<"&..!X`W/<^\L`#;1P^B$!Z MQD]`T0\(_8__^1^,_6WV^1_B$#@N#&^L/V,GE+D;X8?7S%^WP'?P1(`>/H6. M+0+YJO3!S+%_.-OB\R[;M7KGLC;^YPQ/,)`SOHG>#V>8HU+%UM#56J-:,ZJ1 MCW_5J[5ZM6[,W`MW_ZB7X>[^]NE?#Q_9(!JZ[.'O'[Y\OF5GU:NKW^JW5U=W M3W?LGS\__?J%&97EXN7^J7?M"_>OIV M]1V?9>#-^F,URMQY:4?@#HV7/&_XB`+M,>)!-,DC.V#%`X\V6=N5G%&+:^L< M2:2;+Y]_^OH>H,0!IG-58"M1Y*G29;O0Z;\Z+N:4>=HP2G3Z=L($]2+M14<: MWUB+J7!?!<8 MD;9B6`R%UK*KJ\IB`EHP::+E/JGEWD+R:*XZW>4>GY=).K/)YP3*TRW^\VR& M9?'+M/+2,U;!NHKD4GB?&Q*!@(-?>EQ%19CK@($48I?X M0*BJIA[66+DNN^D'/OM)@'/LA/(FUQ56%..90^"/1!"]RE(L^,..+:PF@JLB MQD4A2DH=B=B+'_RADGO_X8C(XT/VV0LC M)XHC`/B<7[!?A>U80*@'%W-BTA\Q/?AG[OD.O*I[@01VK-B-X@`N?;0<@1G" MXXO]'OOJ!]$`%HO=PJOQ*OV^,M&TGJ5ICP=#!B_F_:2"+J6KI">`#%@"X[VH M@0,85L73+$RB?@C\9_C&@0N0[[XF'`P,B"/2PE+)9N/BB?\!:_P,E,G00R:H M8Z<\\=T),2[+O#A0'?.6F?9D4^[>R"BV+_L;2!!H&*-38S9_G668P@*>E&6X M?H@LOTJLJQSV%G'^?ABH/E7H4R+6]]Q7YO3DCO8R$!Z[^?(%++`XP"V"#=/S M"18(CH=Z[/Q_+HY#-MZ6 M\:<;:^`(<-D-L`9^YJSG"-?&D4NVW.",((7PG_"@3-*W"X[>(4W\]FC M*U+W9&SFN5G)B$39JZ=$!B?Y6H4"KG3L;U2:DTT5SO^'7!)R24Y-2(L):,$$ MBI;[I);[9%V2?)_D:9Z/(3L,:3=EZ'C.,!XR'.8=RK-73*\/N!4)FW5YVFSH MW(J#`)[COK)WYF5-#;[YPW']?L"'F^Z_M"._I9I94MYMO<*J=F@]W&PXG:GLT"`290B",A??8/6,@8KY2-%W6WQ7CD>XEY M-$Z*$>R3#-RF)5LR82B3[H"7_1+#]V-@I[<,QL/0MQR.IE7:FW'JL?F6W$"` M(:8UQXL(!#*9'!$>S;2`!`ON7;NI:>1-]._6J&LR6,B]-J;-6?YP)+Q0)C0M M;@=)LGXTLEXT8<_*CNZQ&H@A=[!^.2/V2R1\7:%^%-BC7DH$_ODT<`([4Y:9 M"/F$V;JII(\?NY&0UZ:$O%5+A7R"=GL0[S>7L;^Y+'Q>_?J=Z$9/"/B\@O39 M"ZC"_(C4=D8YESY>;M3*YN4LJ%,HI6M34N^8&*=`:X.F88&X9G[]Z@:UN071 MGU2S7][`V*\\L`:L;BC;=9GT;[#29N$T`['KD;#KCIK[%HE=-VIW<&B@2VJV ME>;8OW@JE9:;LCR*G.6Q:1.!B4%47_UG=1QBM";BCI.3J/C,A"3SG:D/"&1L4A;D8ZX(CQBXCC+,R#TO'C([%@R/.LX-%?JYDL`P\YVD2GG[@A_)NX`Q;QFT!13P#B=@[0X5/G7CNM*JM=<;(J:"QIWZF)8%'/3U;NM:M&2-:Q=/ M(+VQV<&C7=@>2-^;N!_#=[DF7?(:968`DJ_SL%#;?:/5:6=ST#]9_UVKY@*BNN@.NFJ?R:$^3[N&30&9:P,']4];+4%@Q@X0<9JTESBS28 M7%>]5AM.L3?B3L9^DKUIF1HYG&4RLU9IU#LY3&;.,AE[%*-(!?+K-9VR.Y^G MIM+[R98JW'ZHUIXL*N*@C2<2'JE%17%<"NR1UJ/E+HF*.@&7ZC4Q./<;42!E)J\;$5],42^BY_@U(_XJ,P8IXEXPBZ'=II2<0P-7<@ZBE!RR+D_*W""M=U++ M71(5==S6Y9T36C(F'HA1($(A6QZS<^="=[]V.89V68\[@>H%G41O=<`X3/-V M/!MNT_=UA2=ZCN5P-QOB[@DNNV*3M5HT6^.\T6A4VITMF:M[%8%5<,^1@!3U M-TQ`(6ZD7!.R>0L)7&F,(+)Y3VJY2Z*BCMOFO;&L>!B[]CW*-Q:'I.A;E9J3\/?GUN&*QQ/?EYGO*HR4+G$PRLL!/;+E+ MHJ+6L,`;I9G(F+O/`OC,]N.N*Q9N*V6RG=Z]Q79:@1[E-CSJS7:EW=ZTV&P1 MMQ=/E1/C$^.OFT6\`>,7>%.;:J,\@?A_5:L?/7MR\/PL=?0??[N*PVJ?\]'[ M1VL@[-@5][T[T8V>\/E/L`8?<(E__,__8.QOJUS)'/N'LT477+9K#>.R-OX' M:>SA:G\3O1_.L']5%6O(J[5&M694(U_]99C5NC%S+]S]HT;Y[O[VZ5\/']D@ M&KKLX>\?OGR^96?5JZO?ZK=75W=/=^R?/S_]^H7![>PIX%[HX'DH=Z^N/GX] M8V>#*!J]O[IZ>7FY?*E?^D'_ZNG;U7=\EH$WZX_5*'/GI1V!$SLF;Y:Z25MK M!=ICQ(-H/-H\$G*24%;M&^ZODO`1_]<*;^7R!^ M(.8^%N;>UM#[,[RX%:N>?#`Q6RH: M.*$"2LY*`+"3.0GX]_2L!'A*('RO@EU;TZY#:3W*';RYPG0S5C#3`%BXZ)Q? M)-@",./VIW#=R\`!F1EW,;+XR,$Q#&KLE*:?)M8GQP-L\%`7;P:-,OM+A?D! M.^^JUUFN'^+5NH/LO!9)H;#B`&QL[&D%UP0<.\K*?K.97\1W:\"]OI`O@,NX M[L^47@\4J,+SJ_*P601ZS@5\R_MC2+J*]I:0?;!D`USY"L/!OD^`C.!`#0L[ M1>$#Y16P/$'TRL[KM0M8V%MQ%Y.>MP%_'G7$'L`;/"AR@-@#N^1IV M"3D"->3!'R*:@D@C#99WF"PG"MAD9RQ\886%,<"LV1<6TG63YKZRPDD_/2UT MXGKM5YP[%C);`#F'H(;D:O=]P!T>#/S2,#06X5!/\H4$)N2O!FL>,DQ`GK-=S`I`*\6?LP"+U4@Z5CAM7_<5X+])K M*053W1$JDN.$$QR&(E=?"4/V)8"#@+4*5VD27$$F=6.YII/3WZ2$?P4)OV1/ MR>@Y^`;6.8`-#9AXA,]!?2(5!;#(2(##"0BA!IAL>(S5;#$`%/E:3:C.:?.T MU!LZ%\^&A8IAXZRS.1<'ZJG'K+UY9K%6*S(7;8UWMD/RFPE9-"N'.)@$G3B7.+>$`D<&8Y%DTIB:&+HHV+H$_.$5!:$T9SC!I$75`RH M#Q!5-\?]NX].R(ESB7/+R;GD!9'`D=%8-*DDAB:&/BJ&/C$OZ-YCO\3N*S,6 M#5==,R_8,(P*_*N2]+C,L[L']G4\N.QSDNJ;=I\_/[O_?'=VH9)Z,5&X*A,X MTTP]:\"#OIHF:OY%YRA>US#%-)Q,$]PDSSAO"FNK^9I[D3=R'BYC97LN7#!<[D\UZI5FK3=PUZ:1%@T"DKEK7L4/I MH]5K:>$@NHJ+?+.9^M7.;/FJ+)[5.9,-IL8ASCYASR9DC M9^XD18UL7V)H8NB"P5TVACX]9^Y1C"+5`\W)*B1M8V,30Q=,'@+AM#GY[[>&]%/CJ/28'= M-IS'9D?VFYTZ"GQ7NS1KXVZM%>U<>NR=NGS"P9SC7<[O7COD41S([IOJ#-#0 M1X#2V[P37>'![]+EE`U)`:DN7F2JA@0,'PJN(LX%2!J&IFT[,P2YS#!2^NFS MG$/O"=6=,W534\=UHL?IF(23E.X'W,.W1XES//!=&[%C+SS`W[!#YB@.P)<. M!0!>TTU])Z%-2"J^B\!R0C'N58O4;V:I'\;=WP%D?*P%8'%84&XCP^"0AQ!? MA>#+WQ\U:G7LA/L8=T/Q9PP7L8^J2^DC=^'5N#SC"ZV)"[^A^@K9?:\G<(U2 MJB:HG9_U8M=-O'EXD.KI"AB)2/6>1:<\!"80WT>.7.8>MIP];ZJH03@_;$`^ M?$&@WK\KI-30<6Y4Q+A'S+@GX,,OFO^4#!^:?.S:HW0.,"7G%`S&K_ZS/FXP MMF@QUE7'\=UECU46IX]5DORQ)#>N22ED)ZZ%%4\>IRHFQCUBQCT!\X&.`$C4 M*&):!*DDAB:&/BJ&7N<(0(.WR234DGA[Z8#-ZRTZ>\U*L]FBW++%CN4&O%5@ MVWV=09[ET<_+L#J`TRIE:RUV*O=X4)(4DI1M>\E')R3D.A?3]BTFU.1I$$,3 M0Q<`[K(Q-+G.J>O\&'>KD1]Q]WU.'XT1?Y6GW^0!DEV[_TDG_J,3%7(%BVG+%1-JLIR)H8FA"P!WV1CZQ`JITN/*0(RP M:L6+,"7UW+F09W^!<'F$]2H][@2(;BRF*F!"?91:@7OT35WAB9YC.=S-GAWV M!-8YZ7(;N%9?;(O`>5;O=5RLR_&]O#N7>9WE,Y9)*VT.]WG':%7J1FU5 MJ+=IHF^BTRZ(8PL!]0$YMM%H5-J=3FDYECPP$K0R"-II&:S$T,301\70=!B7 M>F1\V\N^Q2`$V8GGEOJ+=%)'1T^[.7PH=7L5!K7E*Q) MHD*BLD14ZF:EUEQ0BWMTDD).8C&MO&)"338U,30Q=`'@+AM#DY.8.HG?Q)`[ MGNPDHUU"\OJ.WY0MAM(Y-YKM2L=HK(K56PWPG9C+>4=S)"(D(MLZ]C/,2KN^ MMV.__8@(N7G%M-.*"359Q<30Q-`%@+ML#+T%-Z^Q@IM7C(5:!_*R&9N`"[/] MN.N*[4;A5U$?[PH"ZZIE<+6V46FVKM=BE'(?&I`,D`Q,G)HU<8K=&L=FI9>` M55N,S^LF/AV8G(@5UD9CV>@&["K_:?]5K7[T[$\![^,@C6HUN2/W_7^[BL-J MG_/1^T=K(.S8%?>].]&-GA#T)_$]^H!P_/B?_\'8W_*N[(D@$/83_WX3AB(* M;SS[BT[_=T0X^1#FV#^<;7CO9;M6[US6QO^<8:X,1E>_B=X/9]A7K6K6#+-: M:U1K1C7R\:]ZM5:OUHV9>^'N'S6A[NYOG_[U\)$-HJ'+'O[^XS=KA[=?7QZQD[&T31Z/W5U!!-KN(.F*6HC>PW MC.$=6OS+"NWB$-RL`@;S'185OC!W?KQ2FSU=J4T?K5@"NS'.$0#V*P^L`:OK M:0%;/%0ISOJ5"]K3X3;SB+AM&Q65K;&I/[G%[/%L=F8]$9*YI[)?1<1L;:JP MB']G7!HKK,J^^E[5BN%[+WJ_;)D+'1]?:U#:RM+]O MU?Z'69]-%:F2L&3Y1DZ2*@)DERH"%/%N=C_*UMC6OK+DHTL(^^O?D2_8@"^R M;..>T5/Y$`Q(/#/]=$_W]'0/.$?UR&C]\(,@/<.2@H/B`!PX1VOF9/3F*XUM MO?F+'T,^NF/9]3O!@(\<^G&?DWA\.#\-X.G2W:E1Q:Q)*" M.UF4#CITS#]"LBSD-S7+-+5:;6VT+Z,X`*XX1&ZZ-^2E,4(0@(,["'`D MP(%SNPM!\M1^R1>>7/$H&K5G''<'L3TON$^OAUNW(.>K[XJM7T=DLL[%`91\GXRU44]DQ2*B:&0.XPBMF[CB1`*FGB`:NXWB< M$J(EYW6(H*,W7_0008($BIE>.VZQZMO&+>73BSIH;DT+3( M7(FAS!K[:T9!YIT/^1PP775J2PL<.@F=W"FU7[""BDNRJNR,7*79!C5@RXO0 MIE?/7/I1'"8IENC2[WB)PYU+OQ7::;'1:4?\QOBM2PO2^!.0+Z;@V\68VNW`>]FT M>/2"S^E]7'^.[N/ZPNTH"7FJ4.R/*&T#>,6_T5BL';%,T06UC@,<%C`@U`@Q56;:.B"GRRO303K;'3I)=$,:MG:])@Z.2<6Q'95^$^"?#`'6/4E=3R4%94%8RRB+\@:[! M722GEN`S^*P2GXL8_MPF8:=O1SS2F!M%25JL$S';%_+D<>R-VJ1L<347W$FX MD_3T')0%926C+"(@Z!H\1G)J"3Z#SRKQ.7L$-`%'^J*P'=09I5U;NSR,Q&RF M45$Y"%F0C/KM3[I&KHN-1U(2`R!CJK1$6$*]`AN'3FW M#GP&GU7B4"JDD%G)05E05C+*(OR!KL%=)*>6X#/XK!*?BQC^ MH,V=/"8![B0B(%"VD)1%!`1=@\=(3BW!9_!9)3ZCS1W:W*T:!EIX'=J)5:Z% M%W0$.@(=0?1'`!R\9=J334TMP6?P624^;QW]5=6*_AY;X'VQPTZ?6>:H!5[> MD&_5Y,CFSHJQ,"=(VA[?K>>7Q3S]2@1KMEJ3:K.NF1/.["5#LH!F^ZF'`JU! M:]5H/;_BE6-;3.;LX[R%7[%$/5D[C.&,X^V0E1>_[1==O_"=SZ'=2X]7Z/KT MB:>+RN3#^W(2Z3W;'K[[VNES)_'X3?>??V+L_0Y?R%SG0VD'[SEN&%7SV)C]*[&. M4&+QXSO>_5#J"IKHZ=JK&U7=,/4X&'\R*[IEOGA6//UQ,L_G-V>MOV\O6#\> M>.SVCT]7EV>LI)?+WZRSN7QQ76*E?AP/ MWY7+]_?WQ_?6<1#VRJV[\H_T76;Z\.1+/9Y[\MB)G1*;R?09BZ;?%M"^QG88 M/R7!1NY0:Z1#UT*'[K*X0T8&;^B?)(K=[L,24K-6G[.1DK`V]X)[-@R#[ZZ3 MGA=B43(8V.%#NC$>B]_JVFZ8ZF;"I]]Q'IG![NU03%C,/-=NNYX;/XS.&Z6_ MU.G;?H^/-MNSOB5B<<"&DT-,K**=U$RM6JFF?;LB'J<_K&N5:D,SJW46^,*3 M>V`3-^XMB_JV^*WIN\^"P=#V'T9+R7^LD_]&:5'(0#P3Q6+RM4G/+T%?8;?$ MBQ=G!K3T;8M0#K@=)2%WF!T_&9=XF(6\DX1A^N:V';D12Z+TZTB(Q.VZG72J M$C]H1SS\/II\UQ\FXHU'DPS$V^,]FZNYMSUWG>>"@A&T!4NZL6Y)%YK./2\: MVATQZ@\E8_QY:#O.]//4J!O&F[D_&&9P3M:EHXC[(X_[J\L7NLJ;U%*FTR=^ M6-U'4#7ZQK>+L!9,!0F]-@%$KR94R?[K5(O_^_0*I$46*:7SUO).LVWY?^3#F@S8/ MF64H=_O%)E#W*:\LUG:$9)FQ_36G4$ZD&^F3VPNV8N&K:&*6\2Y0Q,?A;E%Y M3UJ_2(.33"6@_(54_B)6ZA6R/[V,X&B<1Y!QY@!.27!0"(39>^T/?&@!2@I. M0B=XOG5KT9U@25D'<-#70NIK$8/6/7;7I*NGI,')9T1T<`3@)`$'[4+])B`'@E`0'[2*PJJ('T.OV`#HT#[8_RJO`&!2T/+*S$<`E MT1T5Q@#])R))M$`".!PO`3B`@T+@GH]7ZV5$5XB2@I//H7S2ZZ7H9S@D91W` M05\+J:_%3!&C5$@2-3%.00!">?UA\UF@W-JM7R M4T6AO(VDK`,XZ&LA]7634!IE0R@;0MD`,6NF:-D`@$NG.RJ,`?I/1)([V8\X M]"`D=>E)@\-!$X`#."@$DL79RH;.>6=R%9+:E4.2N6T%NO^D=M+0:B9:R/V@*JA*5\"?;3=D?]I>PEG0E9JJBG@R$ZL!G5-7Y^YXQ[.CR.VZ'3O= M9)6:KT%7%W(95-'&5R3,CC28B4-#F=WE037H`R.],R1!@>Q*@D.8E42',2:+]K(7&%9 MD:\J9A8'L_O)83$[9J=)+XEB5A_5QU36Q9:(;?9P:$JN4^VF9M8JFF$86;F2 MX5@[3=F09K5\Y1!;-`@$87;B$AR<,.9QH_;:QH:N1$B#HT"7#BS"'%@.R=8AHD:TK$CADZY0$AXUB)<%!K$J"@UB5 M!`>QYHLV5,[6?;'#_V-QP`;B?_ZRP`M1#*(8@$,4`W!80)4%)]^6;L4RM5K% MS+IZ4D.(A5 M27`0JY+@(-;5X(J8)5I\3RDHXN.-(S1QH<;,GAAXM\$R(U1&H`ATBM ML.#@72D)#F)5$AS$JB0XB'4UN"+FFQ;7@YWSSJ0Q*@D.8E42',2Z&EP1TW-W/.(Q M"[J/R;FH;X<\RAI](IS973@CV4:%J35.3K1J98N="KKB(`T.,9*2X+`\*PD. M8E42',2J)#B(-5^,A(P,0AC*X$B+E30X1!M*@L-"IR0XB%5)?,=G:EAQ:&,@2(;Y"?%4D<(BOE`0'ETA)8#W')L MMST^^S@_H!7SOW!BTF?:(2LO?MLONG[A.Y]#NS?@?JSKTR>>SN'DP_MR$ND] MVQZ^^]KI^E$<)NEKHI80VJ<4T\>??V+L_:9/,=?Y4,KZR\<- MHVH>&[-_)=81['TI=(1L]#91UHZH;IAX'XT]F1;?,%\^*IS].IN7\ MYJSU]^T%Z\<#C]W^\>GJ\HR5]'+YFW56+I^WSME?O[>^7`D'R6`M$9I';NP& MONV5RQ?7)5;JQ_'P7;E\?W]_?&\=!V&OW+HK_TC?9:8/3[[4X[DGCYW8*;&9 M")X)??IM`>UK;(?Q4YEMI)JM$7&O!7'O=J6:_R11['8?EBEGJ\_9B-.LS;W@ MGD7)8&"'[K\"1BQ^=!8,AK;_,%*5_U@G_XV8LV#KHR,^NO'#NSVKQ/S78\P+ MK(&QSAH(%G+/BX9VQ_5['TK&^//0=ISIYZGI,8PW<_M7809KA;1Y[G6M:KU) M[4,J&/%#T]S'NC;ZQK>+L::T`\_)H4\=H=D\7*9.S^9!RO5N]4;)HX@JD!`] M"34A(1(26N$S3CV&Y:/,]!O343V/<>=6K,,ND9,_?'MZ?GYY_9O^Z:;5NOGR MCE6&/TK$E\\LR$DNK9._^NGF[OSB[A%WV[.%YR[0LRCP7&>B=J=7E[]=3U5Q MJ41,0X55^=O$43T=.ZKN^@Y[.0>;%DOG1;[;KOV570:2H MNC\]>8'P=*][PBIHQ&R_;I.=&G+#^+I1DUQZ>JLXRZX#7W?`-#!M[^)I!;'M M3;U[$`U$VY=X/MMNR/ZTO82SH"LUT11Q`28Z#XVA*J`[WO'L*'*[;L=.LZA2 MLRWHJJ(W5Z[==CTW?H#B$)706=_V>US,C-0\PX));!@**#[:&N!0).K?BP0. M8E42',2J)#B(54EP$*N2X"#6?-%&\=H:G":])(I9?=36('-;/,0VNU-4R0J^ M3,VL533#,/+O-:!*O8C$05N#PA-FX[8&.S`V="5"&AP%NFS:UL`TM:91VZ&9 M.?1X5[-''J\A6OJCHA9 M27`0ZVIP2"8BF0BEE&;F2(.#6)4$![$J"4[",*MA:8T*KLZ2FW1TP9&>.=+@ M8$L./URD)3>)`!>G)<]Y9Y*5-)&5A"5!5A+$0582A$%6$G2A0)=-LY)&7:O5 MN9(@Y//F&QM2PXM MC&)6!2X^$RKBN4Y_>B`T\X%AQ'.%U?Z*=E(SMTMUX7Q?$8F#`Z&%)\S&!T)W M8&SH2H0T.`ITV?22CF9=,[/[,(AQ2;*.+CC2,T<:',2:+R!5.9%X\8.''3?B M<^OPJ\$6,^C"Y11(!*OR`]3V9M89520]D%L83P'5=I!B(2+?PA-DX MTMV%U:*@&/\D4>QV'V"K8*N(R`2$`6%`&"D)UW$)G3!B>? M):AI#=/23LPFEA`0!SX'"+//@'H'QH:N1$B#HT"7'+V$K/HN>]P=>KS8,):( M?UC?0)BBQ]0JY[K16(@&./D4O6$UM&:M+J^Z2PH.)Y:4!$?!`&P=F)DU9"X+ZX5MVM_5,`Q<3`"S+M',D09' MP03DN)X$5J"X=-GT!KZZ5J\V\C-%LHRB@AJ!I4=)TQ:CNVVQVLO/AMO^CZA>]\#NW>@/NQKD^?6/CWWY>32._9]O#=UTZ?.XG';[JS M"//2C^(P25\3M80Q^Y1B^OCS3XR]?_G41;?+.^.'.L&`M^P?=W;,[W@G\#NN MYXKW!7XKG9#'-S'7^5#:Y@7'#<-J'ANS?R4F?CDUNW>\^Z'4%0+512Q_66?E M\GGKG/WU>^O+E?"!#-82`7CDIM!LKUR^N"ZQ4C^.A^_*Y?O[^^-[ZS@(>^76 M7?E'^BXS?7CRI1[//7GLQ$Z)S43UC!S3;PMH7V,[C)_*=@\4FGO;\T5L;E\:&AW7+_WH62,/P]MQYE^GBJT8;R9^X/AO`V8_.';T_/S MR^O?]$\WK=;-EW>L,OQ1>FX?#FT49$7[Z>;N_.+N$6S;LX72"L@L"CS7>0%< M*%\J5/&-"@F?JR-4A(?+O*[/0?W:AC>^QO;H>;&.;#@A<&GCORP)U1 M;[,[LZ34FI5H)]NM=-`60L=OA4<3."QU".11FM-AZ'KBU2-5,=F1ZW?X,/47 M7L:+9,<0]\,@Z?7E`?S$/JV]IU$B^[2#9%FC?OCXBG3P)RDXQ/29P2%;"L[) M<9*\\=HG&W+N@J<'(B;.&G=X*"*Q*+;C)`["!S%QZ480B^T?++1CKN(V.6EP MTF2.9B2RJL=%:47Y)NLXL6@531\,J`/"'X"#*XKPAR8X<&Y7X<\&6W#RAD9G M?=OO<3&3Z9"2429<#,`+[L?]F7P!)6;!4(1/L>OWF!=$$>O88?B@=X/PW@Z= MM?UR25:4BR<=#UILFUW+,#@'IK_'B!'KF!$D[M40J M#T(:7W1&5".W*[J&DC+H:_8<7Y8Y(+G60BTE4DL#6IDOU;BJ!(Q8U=?FY5?+ M*L$^N[[PK:[$JYQ+/[;]GBN>.HTB'DZKX5\0`T8X?/7N?<3*1C# M-<5(D?B3PE8X[(^(=Q./7;E=SH[2BJIH)SOH&)31T0@0902''66``^=HS=S6Y4`U^1J=?N-M$2=SYO#OW`N&:>`K M7)LHSGSW^Y+UBJ0_I,]VOFLYQT>`I@5X]LJDTMHUL3CN=9)!X MHY2)/0C"V/UWE%[=X>XGL4TZE!=).P;Y?,$C4VO6U_:9+WPA`]12YC%(J)9- MPX12[J^ZB`"EZ2(BX@G+%CF0VA>!.&6?K[T6XQ`Y+9$#.>T@#24^KY.;*EPQ M@:55J_6<'J$TI)06^!;:))4_OC9'5CB]K&HUL[H?O23E3TI:J).Y3&9I?4X2 M)R'_(EXS2`9W`H3MW=H/HUN>/@?AS;2-U!6W([ZF8B?_FU##LR=^R5"WL\1` M-)O[7SM&W_AV,;:+[^AAD)YC2<%!=7:UK77`A>_)*F?5MU[EA#NV-DB@*S*< M\90O+K4,S3"V:&=_:,YAA04XK+!883=885'B@3M>L"QB62PH."R+NUH6WK,>+\I_IH7[@J&JN/W!D/3MP9%;&!XZ>/JOL@:,G M^M`:Z<.UT(>[75F#?Y(H=KL/R^S!6+YL,!8P&TYDRT+^O\0-N<,2W^$AB_MN MQ.Q>R/FH*Y0=LW/>X8.V^-&T;RF[Y^)%=L2Z07I18O3RP`V.7>'8E41[/9*" MPQ8>=K\!#JJ#I/#NCEVQHY`/;'?D"@5=X0UQ]B!6O;7M'NB*$L>QY(O=&UH- M:6<9[0<.E>!025$/E2`SKEP:$IEQA2V,G)1$9AR9<63&#SU`:3.'R(PC,U[/ M%%[+R6]DQJ>OO/2_B\>#\.$L"4/QUQDC=IV*G@Q__SGT=:G1 M'8SED3E,9Q'G3I12(W*CM`'Y9`-YG"87]-TH4;[]4)=/OMRY]AR!2Z-R>-,L M;_K,GR!9)-$&`0X6R9Q/_W*K!2!`D;(60L*[[TQ;$E"HRLK*K3)_V:S6J2LY M+T_3F7X"$W\V+'EOO:-W:%OOX.)H1R3][M*XJ9/;[=FUDWN2D]OMV3W^Y.[U M+A!%><,:ZUZ2![C_?]OV,&WP=!-R]!L7/.UWSGMG3_=Z\0E,O#V:S_1H=I_F MD7QZ3J&^LMX=&J\Q,BL")3LRTYTFXTY/KMWC'&,GWA[.9WLX;^NA[#AOWT'2U;UE>Q27\#TI8#N8F[/N^/U?[\M, M@54[!Z-VZ?DC0;D8J23S@TAR=>`?F*'CS^,<6">>>#\8_8%_\Z?31$W]3'E@ MW8UFWK6?>GD*HTSBQ%LD:N%C7EHA'F*Q&#Q&<1KI(\.>9GURI M---C!?!LBBE0'B:0T?NI&L71&!X,)SCD+VJ8Y'ZR['!IJ@]_"GT8()LE<3Z= M>1\<#FCF\:N<+RQBKB9^'V2%1Y$I%8YA8"A3W@BP%RHQP\0@$ M,E+!%:7V,"'T<%GL^;B09.S!@C.8#H^>YD`)G/9K36288*JR+)3?FZ$7_I+& MQ0<2%?J8'!4"84/8GQ3G`+^?*&"8ZR";%89D&BHO2-/9O#'&E;.!_9\D./K[PUG7HI%[)2K M?LLH]U'?C?R1=Z?GUFE!8YWL<\`X5*^$3W$PK?J2*C[][\P^0)TX>'[#LY7=:_I_]:$J&HK"$\CXEP4BE=\$63U`' MO+SW3-C[EP(?>`*=>7"EP")3WF6"FJC:[2:MY M#9N=^*,L!U?^?3!9U;Q-6LQ^$!'85]IF[SU=3?&GPK"$&IN#6#02VIU_LCO_ M!&R$>_=Q6D;=@5U>,1%:-?NL>/C\"?#PLU2S=Y"INB/A\)T.=]21;I/*^S,.&K^9K3W0<-Y^)O9`>P?= MWD&W`=7G-+GV#OI)3JX]K4]R^@:6W*EP7`M[V8K@N[(*G@.K M-W\1S>//UD1H^7(7^?+^3(3F[V9K%32=NY^)57`'V-BWP$3];D#=+<%M=P5A M][A_,\+N40EAMS]@A-WBNT\68;?`ZS=C/6]]Z/_*TRR8+.N./4)P3^(PC*\1 MV$/P>O/YW$^"?Q.$]21.Y@PJ#ILW4@D!@,06'([`LI4%@O&N-0*FGR+HX8V' MO>HX5_<[UX?ZQWL^K2V"\0,A&-^+)41_+8*)[!*N[>E]F`(5:VY!C7:$&-6[6@\^0:)PR>`&YABVV\";9Q([=6\-T:S9Y/#HNYT>M` M@,L6)/(Y@40VFEV?@@!\#N"/YL<:^?'',^!>G9FH^[M([6?&S-QP8M MXBD(P.=@/M;'IG?[6G!W*=I6--_#Y'H[/;MV<7%N'V,J2EG)-H=Q.3ZX5 M)=L8>NL!E&Z9+=:XHN:>UWT`_"R;N-UHU[IYM9@O.R]/!IW^R>!INFYW;%ZJYF> MG&9JWI:VBJE53*UB>DJL?F]P2,7O[QX64OIQ\AKQ;##)'-%M/DX^!^G75TO\ MWU_\418GU2A(6[QW>-8[.K\9_VA0PC_J'3'^4?'=)XM_=#M\'CU:6<`Y,9[& M`/<\M@QHZFRW#=_>+PK+W>2P=_OG)A-_-(IS!%WYY"^)E_WL]C%<^_ M?I"3LD*?*+Y._,7/>_S?I[#19[N[T;8<4F7>ISP9S?ST>]!3&KC!-\+K-$L< MW;@IS`<[O(+UYVRCQ=QS$=<=G[W??3AW18S!YW+X6KY]*GS['?DH+=^V?-O* MVY9O6[YMY>T]]._>I4!G_?1V)G=ES1'9N;G*5QO'SBT;M&S0LD'+!BT;M&QP MHXVSVC6XYE;W9/#`]_UX2W";"W_G>N'7)+Y62>I=+B.53)?>ITP=>N^S\:'7 M]1(5^ID:>PL_R98WF;O-RPZ^F4%W,S5FW_-SR<\O/CS[MIO'SYE'_+=*1 MFWPC<)FIJ\#W_J&B+$_@VZ_C9!%SE1/1JP7:K,AO:HZ(V695CQFR]5X^5&3A MEAE:V\?&VN/1'H^[N7X[?KCKM_9TM*>C8:?CY/"L/1WMZ=CI53V>:77\, M#W,ZVHN<7?7U=W/6;6"EY>>6GQ]]VBT_/SJ)=W/6+3^W_-SR\Z-/NVG\_-T7 M.>L`^W;$0;C%S)L6!;`PDD\J#%"WK$<3#J=GA[W'B@,/=P?9GH_V?.SZ^1B<'3Y:!LO]G(][`PD/UZ$\?R=. M^!9`W8^)$'[.!-?Z$Q\@#/Q^:ZPO_[*TRR8 M+.O`O_ZAHG&<>`O!Z,4=LIN;>GXT]GP-U;P0J.;",YZ?*,]/O4DW.G)/?@!V20V5W4^3&CN]&;M4>\8 M/*AUL\E2*\Y#KST-[6G8]#0T^#^[TY)IY0`P*:WM"G@(3[O3DFF?A#4X/3UN'I[D>M<-3==]34W"\#M:UD>[0K][%-(F]+VHTPXL@O`?:T+"X;2KA3ASN M[UM#(XW&[H;[^MW8L$_!BKS%\7\*C/T4UM`>SO9P/DG&?@IK:)[U?#(XO#&5 M_18,^>0@(G\HYR&W>WK< M7N,U,?#9'KBF'KBS-DVX/7#-7$3S;-#SXUOGD3TYY^\I<^:36$3SCM?I!BG] MS\Z3>P;HKC,_4:_\5(U?Q_.%BE)^?8'_>Q&-W]&8P97Z%/I1^BD.@]&2T5VW M?^_PK'=T?C.ZZZ"$[MH[8G37XKLMNJLC!2^__/,]_";(@/E'WXWX^N;MZX^? M+[Z\^PAF8!Z-5<)0S-5GZ3*#67>)$3R7$[Q)G'@?AYD?1$$T]=[.%V&\5,J[ M5,E5,*H`1+QST-<[(O!=P^=^F2DBE!\M+4XN$BN`_Z9(36](U!RYU`PB[WH6 MC&:$L:-?CXF\J:X@'M\E`+?XD,Z!$3@S0@H%[:6AHO4:-X&@6, MS1N-O;GRTSQ1],HB":)1L``)X\43>GKB!PEJ@KSXXB*)KX*41H8'4T5?\<[Z MY]U^KWO4TV__$H#H!+O`:Q6@40;TV[A MGX,4ISA2.!7UKSS(0#1&:9;D2#D>17987N+=@*%*=)2EU'Q.OK;Z_,HW:49J MW.&%J2O8WR#UYG&"6Q4&H,N6LKFHU@X=<\C\"]G3W?^QGRDOQVG#1HQ5II(Y M2(,M)X2SH+_[($M@4O(XC1V[G+U0"=!I3D2%=_`(A`H?2BI>"'!XY+LA8?=F M,S\K#'`=P);'HU&>5*[TW83/B&%L]]^O3[ MWD$'5WNMU%?X/OQK#BIR!O^D3\*11R85J.WK.`_'WE1%P#(A/#)4O-?^`H@" MS^.7@"J1._^Q'U0/YH/TR8&J0I,1C0TC@@+#4Q30%X)HPO7J8]AT8`C?"_UD M"CN:+A+EX_,9S)P_.`S&#`:>?H47_I7'F6)T<+*A82K$[FDF@@EQM#41YW[R M566'SUI'%$]7%$==D`S(/2`3O'C!POH:!!T>`F#$8$X;(\*%3\K$`[$)Y,U3 M)*[OO4+2=\%FC$F>TR!=Y`7\,WZ+)<\\'JNP5CK`B%,^-#X<[OF"V8U'[^@4%K.%1ZC[7Z"+VIWXJ';S!Q=MH4H]\.MY^6X!U@6(9E)&5R?'"-B!( M`Z"8G[CJ^$J8V-%)[`J``;[LP#&#Q3: M^-DL'A?"8)U;CQLE%043#\_+!9F2:-R-8Q3[<>;!!H.JR"=HV^#VS\`4@;%A8RV[@!;U::/0 MMQG#=L!Y\-,X(C4#QCQHWGQA#=C8Z.'2<1-K";Y3!0Z,9ZV?\&'Z<-#7YELZ!9[L@U79U MMERP1C>'B*UI<4$J7R5CD9["P6NIAXP6LM53P\DL`H"7*-D`.5@UZ!\_[MJ:C\_6?+R*X3P%(1Q7BFR"_EXZC# M(8;+@^Q&77]Q^7J]40P0U?"#B#5P.]C\2]S8Q%E1$79#-$SA'F'H3<. MTE$8B\W`)S:%,[J4R`F>_@5J4#CLR/@ZK*4%DKO"@@E9))S5+115Z-"SKN$2 M1&/8D61)04&RJ<;JFY:U)+Y3%=+(G<),)Q22P[^0^J?P#D8C<,4R2H>V9A9? MZY$<@CB"S)DPN\+\<1RAULU=$R(D^@NB'-=?+-7RZ\ M1CRRZV&K5LNU6N[1M)P?12AE$@D(_BN'DZ$2.!0P>;#EHG&UGWH1K6H%!?)+XK<&H*FM-H2%@$B\*_*+Z'$ M8NM/+F\>4-)IIT)XE2=/CWTX-#[S8B)"D,DZZ5 M$^5G44C4WUJ8AP/LJH+'E41B^>#_<7@);GE"-Z!+.;)P]*_P/4_!-$>9!S.G MJ`D&;LP=RY,\U_4R&I2Q0@DKR%?ZMBDL4(;VIQ'^E>C;<1^")< MZLP`U&/CP.ESC'N/IK..4::2CH7ITL43*G$2XPLD&.Y+@\QD;>B0 MH';#\.R@-8USN>^KT-MFGVV?!/:8V6=M;_$V^ZS-/FNSS]KLLS;[K,T^:[// MVNRS-OOL600Z3H[;0$>;?=9FG[799VWV69M]UF:?M=EG;?99>T_6FH]M]EF; M?=9FG[799VWVV?=JN;47Q:V*>YXJKDT]:U//6I.ZE3=MZEF;>O;$[\O:A+,F M)YS1;].+',1#`ILT_@.34RBWB(>FX=Y*/.H3N@^?41)\R.=#E7R1.W0BAW?TT=6/_2D^]`6[T)_5G+-T M7UM'_0L8K`.[T8\_%X8?Q0T]6\,(&R&85@SR]T]'_SS_?7#TIK3QC[_NEC%N M9HSC_L:,L;:XH)(QCO]Y_'N_US)&$QE#),;174B,HU9B/!W&$(FQ"6/<*#%6 M&*-!$B-U1K-;Y/Z6;>)^[WR==*TSI"M>6V]^G1Z=G)S`_Y1HYT[HUJLXVW@5 M`[N*L]NLXN3\Z.3X[.P^5G%<.9U-;.&M5W$^.'T)>W%\#ZLX'6R\BCX>OWZ? M7[H-1_7H_]MB$<%B`;^]B,:_P=]#.D=IQI$L@^`O*]ODT;;J\2E6/K3M+W)?LN[/MWPHA\`_=W]T/\29\@9>U[O,YW,_H6PV9\?= M`Z?WO#%B[K%5Q2N^`YQXG[B0A@148ZCW,#>UF%*'_9I)D$Z""+1!X(>P!/@% MYSPZU1")`A7!LK6L.WS+IT[=NLU0A+^K16:+=?^(J!;C,J,4`MBC"U`#P/+> M_AZE`OQZN?"F`!K\VNMAPO9M%B$0:23CS-@[$&#_@2+X*1 M=][OW;IL:J]`[+UB+=:6U8)NG?_U3,&KB4FSEBH].:SPZYC^S*D^6R;!PWHQ M";X/]EV/X!GF_E]Q`N-TX^L(CF6:#]-@'/@)D*R+?Z>O!,J!;O#17*2J%3^E MW.8H2^*0[4LC1G3.3Y?SB8:J*&_4-Q0*WG[_`%<;Z4%LA0SE"Y%\H1)(^F!' M$GYYPAY../G)VQ\<8,69?0R33WQOF,1?5=(=*S\$6CGY0>DH7C@,\/*X1X36 M,X"7P^"K"I=2-PG"Z[YUR3CA6 ME]LWN_I-_I6J!HK89%_/)?4[YW(]SJ/A=)L;]@K73D1%B8&C5\8@71.I[">7FF*&`3'&$5CM0DBM`B74[WCA(U"CCI/<@TC]U M\-N4U4Z9["<]3-DA*`*%D+X-#.P06$8PJF@-_,DPZ`+/%^L:'..64H''"?514)V MUQQU*MJ$USM%T!L^4(7TKA(A:/T5F7//4-/4V58NG77%NI&JSPJWH2(QN++3 M[&#QS2/ZU3::'1S?2\/PNW#[\.BC7JKQ^GQ.874YY-;LO@L+,MQ-0ER*^=9G M5^NU?;IX\^;=AU_-YL.VUV_XG;1'KB#'?79,?L)\3.X;[CCKJ+_R)$C'P4A` M)!K-T>!.Q0G:?+P86&(R]:/@W]4N5D/C3_T%&FJN2#ELLWY?+^>4.Y_"++DF"8LQ6HW;J-"V`R\$*FHSB, MDY_W_F,T4FHR*91]W2`3OI,+OG?+[Y5%[VMR+>E:TCWXY+1X>\S9U';M-*X2"OJ@D";(X,=@DK^#'()U9O=MOM?.3MO%@D00@#=SS,B'OR^X.2OE'[@\'%UE[=WO4CA?]XSVNJ3UYB-LVA^BZ.I]]_X/Y<7G]OMV;7M^=U/1C.O M_Y(,SL&3WY_6X&Q5?VLU[<;D6M*U!FX:5$_!.547K<\F_O@BE?L$44`S]$$M\ MI(&$VWS4UK,I[`@4X3XUAW*/76?V6>D:Z]'S+BY[K1)L`6RJVJ7.!S2I`22^ MJ9XR44Z].E=38'*A[E>ED<]EL(53Q%I9HE(H5DF5,_S(UZP_QA9*`J=,C6Y1 MGF!/OCA-58,*.![[&/S!/37>"O(\BYD+VY2S,82\#WW*=<*FE6"-1M7LCN59 M=UM"3&#/F"\#2_:G7$D%9VKN?U6F5X!`2CMM5`D9W>>C874M]C^8&WT/SRMI M>H@]G;%;BBAVC96>)[JP`Q>"7ZY[)RMTBZ5&AU6$TF9%U70T'`9W8?R&^%;% M_@]E>Z$Y!_QA*K3<3G7UG*&MO]7.VV[UI`&0_TGZ0R7)4C?W51U"04>4L"&W MV,%O!#"=()E+22,VMNN&U':<6:8C']:;20.AU8BS9HVAF<,V(SGX/*](W;M$<`Z8><$#)4O#@C."^4; M[ZO377/BD]SD"6$Y(_Q?CA]%*TDD7N8C8C^_@=.H^Q[30-ZMGQ5^`EM88%LR MEO#4/H(*DNBP/%]Q][O5?(A^*&W++"&C8K-)U`X*SQ/2'?YX!0YKG*<5^C%! MVS4,U)5I*>STHR2$IM!@&=3JM`PT<<3L>8T-T=G>8K$9)*-\CG7=(POSE,+^ MLC2CFF0VDF>ZR0,ZQW/N9?Q7/IZ*VAS&>58AB->I<;/"B*`'_#'V//,7@B>` M$$JZ%CO.DU&3S.5[9*]$3;$I(%!*L8`6D(VO:DDR(4Y6%:J6D:*4"BH,_HIR M]]\DM=@#PEVX\D%8,X^9`JR.VU(6O\5?*K%0/:,[G.O,[M"[F&1*>MLIHW2X M.'Z,A?ECM\]>9T6643'W&"F(3Q).#BPF7#Y?=KG@#F3Z('.G0&X^Q,>J1,+F M4.JQ_=!?T!S]AS9'?S'"]ITU:AI#R_N$_Q%D!0?B\'Q`4"E')]VCLRUA>O;W M/E4.LW?@&B&KW@+JX$J/@:21.[43:5';[VTY-=2%UA/5:G##:1QZU>O"@PE2 M,DAGU$ELDOAS=1TG7UGSTG()2L9^10#"[@80S."!'72THXNU$NO7*;L@Z_H2 MHZ^!\E[9)J*CI4#^<-]8-O9)DU2.(BI#NIG:;WF\#:N?,%NBZ&R]'K\O)B:?3BONJ_>Y8WX?]@/>2R=CKF/D$[!!/-(IA M'WMJM\EM;;[PVS@CIE&\U*B-P"8KDI!%SY<=%E' M0UB"N:("&JH:@E`WO.<(02LI&\3=CSVUYRDICUI)^=@;49*4)J9M/6]'J,E# MZ-EBS'L4)TD\1*PK=O/$U@0QY[==L;<)/=E`G+YJ2"3P,%9X52FGA5&/0:>` MMVU=;KG8TD#0>*4H413:V'D\!B^]0R$(C+!@`PP_G7D3\+;E$A)$S33@^S)] MR^G$#R@:GQ'8;$:(O.YM((WNWC&20@0N00C=/+*\TYP8[7W$%2L#)%.Z=$<3 M819,9WBS+I$=0I$N&BK[>:3O"`YNZ[O)A3#L>_E;[D;)(:^,_[R;N`&G']7.]^K<. MZCA>OWWC](I5Z3E4(S]/3595.@-K'0Y6EB M8!#LL;)A)9?410_D<$6L5?C5HV:#(!MI*L21U!;_137*9];[R*?P@2(R+19!EL>^WMAJP'$$(U\]PZM'_-7#2BI%[E68QOC6PK`6ZO M`*>%<]<2U14[[<4XOHZZ"4BXL5C_N- MQFJAB^](^]_9LB83W<FXI0LEK);G2CQ)3!7IL*RT<\OT:Y$`;A< M+>/D<227/O6F/MC%Y,)3J95.>RE6B]H466P9!`/Y-E\=\U02-0/'"&FF1_NU=K'_P?4>GU?K/=X5ZCW>8[W' M>ZKW8)G;&%+?Y_&F;G+C>"&*7;*,CDYUEE%_VV0]BJ3!@5HIKSFL\7HJZG#8 M5M9E0)CZJQ+94W0TJ*JFPYT4J!`%8ZUH.(N]65N#0T<69$V@KA47>3LE01@; M1M&"\B7BZ)^3[EQ(5I6(>3M.8Q7-0-6XY3ZDJS"=5E)G'T3,DZ5^.$AXZ$LMI M#5<*UF(3Q]1X4"M\)Q-;T3N8\"T'LN1<0#5FY8R91;B3-8 M=55"!TJB#5*B%TQ,U8<)+M#!J(Z8(];QAE*4$JGKXF)NWK5$ M0IDZ\2%.@BE,$(EB7NG(X'"VX_BK4_'"4?7J^8)5(5QH-FOKZ;7"0W==Q!L^ M"8U25(>[3"(CI&BP2>-'VI0`>XIF%"EC^1TG$O)$"0V&W'1*_5]=K<#:XD=O M/SBPS.CZS62H=$%!49D,!86,S6E+G[A,ZXIL1'-:G$H9Q#`P,DQ.D=BCL!XI MY/@)9E$W#4=5<;O6"$XP#BN1>7NE)4^L*F(Z-2$6CF'<9RI5XB*OM'&[,C#) M`ZV)[5=*\ZG_VA#%"@HT_5E:9=TR(S5E.L(.`I](^SO@@W@>C&`+L:(3![AR MWM>9Z&S2*P2#N:*B^93RR>%Q]VF_$!49JQ$:H?7+<,)JTNTUA7GY=(C%,4$B MP3'ABM+]*W=I7,Q%G0N$8#>&1VW55YGJ^/E%G.$E)M896!YVN-W<0W-A;,A& M%=TC3C"(R]5?=(%`+5]'4EML;QO8.GK>\@=K[5;JZX*:.Q>G"G3B''*;0X#- MDKW03Z;8_IC.'!9VP]_9+>4:<*D5P-T"LR1%K`7L:+$N4&Q'0;V3+1A+[XT7C%%'&E7]5I5`^$AM$>&)[Z1$OZ;(T7W3?1[ M0G5[[.#-+^`@@-3Y)\(1]F,`^QHO4L8#`U=LG-R8&+4T>R*D9I3=@M:YMV4>3^YP<^W.OC9&/+= M-0M_JHP%HX;'L$^"&M[G8&^E&?86%?XXX.Y^C&/R%]J48TXN88-UJ#*,P["9 MBZ:8OZ"=_S?B5E8,^KM/)JYO82[0%)%WR18AX]*]7B*#!#VKZA'?Z!B1SK3) MDX@FS=DKP3?Z=Y"2;9Q+\CCEWH$/#4AS$;)=&"'[PN&5'^-XS%":#6&FH]P$W?2ZQ[UNH.3[M%M+N(L M]75HSE;R387ZU2?4($1);I\`MKEIH/X<;^`UBH+3V%QNVSB_].8)L'=&U^RZ M07KQ6N^&6SU*D2F*/D:J*MS2@!OOP@ZN0O=-`I"3*O+V^R>"`ET09!U'3B*X M4)U8&X(BFA,^1T[Q-2'2>`,1)L]N(,):`;0Y@#+3]I.?M#D])72>-!]F\2(8 M>>>WQ;ZAB@^JFS&_)IQ4FRE8C==:S"5T\<*;P]EW;MOF"6;!TE7+I>)L7MZ8 M[J!7$!Z:K@8FWY%&_F02A(&.-SOB^B=OZ#QF0/%M;K+K]@6Z3`Z%/^R0DQ5N MR@-$,8!@\X>I8FN2HQC"!N5K:"YPL]B#3DKD1_[;90XCF?<-$1B?J7_2$7=2 MI*#D<(CM*S,5HU=^R6NB6!_!B?[DC1PB9$F>RL4)P1NJ2$T"LD+5?!'&2^76 MWV"HD.0R8DG`PF&E\KHJ4 M1XPLP-=EWG-4[+CQ"P+-S;1&9`V[P'-#K@W:`M6[MVDM86@2 M=[7(JA40A\$W"(P>DPEHAY$/3`5.$-U$!LI*O&&2:RF<\$W??5+Z^8KO+W7H MJR`EM(T[5@44-9(!0+B`P!KK-&+'M9GI-@S^)":BK;CJZ-L,!R*ZXU0#&OAE MF):Y\""H3!]OGV/86N(,?1]_Z/VF:PV*JKO0W,.(/-O;PW9F**#2%ZY34*3$ M\R'=DE?#U:<""BN^`(U)2,KF&.6%F[<+5;<9L<^/`"C6*1N5%LZT$3#U,6L)Q)_^J:4)RE M>)=KAJ@21C[%R01%?4TIR2YV?:)TVPI2RUCB@=J+.*7H MJ:+.J;`4NL#$4T#;=QVDRH`C=YSI4@*'9.5,0")G6:CNJ/SZF;B(3A7(NQ)( MZ&]J/,4]OT"WORT*,9$?'4DE_%-+OC+&ZDS(YQOR::C29$QL3Q:I@\3:)W>G M=](]_AZ,6#O*WD$!9-49WI2L\I4_68&Q+2"A:[&ZE:4:QJH:*$(D1O%H^RY< M:FV6EX/B.EG-HBM5]E7/#P/AE,R#65R4N(BI[6)!%*I/,.)(C9$P@V;*RAMW M[5\Y<,1$A!;*+_Z:WDQ73;*2P;1$EDC+!4VMZM'JM&,RC%&QU]#:&!B5<\0T M+/.Q0F,)W].=R>98"6W>IFFNON%6SG.2]8(-GJ'"!_$%2K0Q&U^H@<*_=IR, M+OH%8:`K_+8::T45EGWRU MZPG\XAH$@BEJ3J6W%T(J@/#'YU.EJ$)K?<<4>G$2?..XPKH';\S2',>*+=B\ MP-HL,#&*G$O;!N3_Q&>[(D^`Z6H&?[U.$K@?X+"QW(62B2%IJ$%DBOZ5GV!N MN;BE29Q/M8U85?36$8E")F%DA$E1_*2%`UH6&\42=6VFN=*B\$0M>4&)DVE' M";P8*V=3G%(8<)!4WP1+0YV*-=^X=2@5.?&/(CTZD0$H,0\D.C96;+R+MU-B MEKKR_5]N9EQJXB*H0$P5IWBDW`RFKL"P--ERB>(DS+'P7[=:*A^!_3TG+/<; M$164Z-8L65(UCJ0M@:--)BE)1@G7%0U\JO2YZ3/HT1;D]/.5H@41%##(W`Z) M31-I+>6T.5EO`A8#SS4+(6:'?!A=P;YL#/'N-:W2U$L$61%I::R&X$C'N@66 MU&*34M3*4$Z&324N@&T$NJ[.'B$,8T+=9>Y/^O`;S"'8SJ>JU922E4Z#!:GKLV2)\C.=D65J8U=%MJ%1 MT82@\L!Q-XN[4BA8`P5C:OTYXJ. M)YAZ1@O7O+06<6!+P`$_-4$\^C7R&8=[ZQ,17)PD]4TE(XP@\64.=ELPD=D: M/[(C&MDH;K-!)._MFDN=-3?ZK)B`3DL]'2];(6:A92]?\C5'+=PY%%"Y$OV: M,+T*9\IN@+YR)6?3%7W%7351=A8^PV`"1J_O!%2EO:`?IK&P8>4!=MQVR_M5 MWS1.?>V7F?F4_HX%MEF7`EGV(F&] M.Q)HOO5`Z[`&ZMO:ER"$G4+PC&?`*NI*\_$ M*HD(L7&LDS?PLY3AHT41!MY\+[N.NVFF%@RDBG(%C0AQ"=Q5L%3`Y-&OA3OI MTNIN6II)C,"%N))3-[:4FT8[;!$&5C':HVAA*BNI1-Q%7%5.H3)D MHS1C"J)ID,WBE0/>%^A.P`@":6Z#C7_$R3(P5VH6K"?*)?",L4U3%0JE]H;` MM0:&,5Y1"&+IT(8G0!2GP3CP$Y.O1*F]P5?]A5+LS5^).;2BA0/FR5?R)L63 MVMP/,_OL;^)_I25?Z#;?J?5M[A2TK>4+@O.C9K^2LO_>1;CE[KXZG!YV;')9A>!)JV\SOE2QB>%N0640:`A.?>)=T*W;+?)*G&Q)_U$S0PT:@%?23LF`>9C8AQ.63U;N:I7 M#G)8:B?3<;QZ,)%0MR M9+J'8$6$E.HF?]<7D835/4$`(>*L(@H^&CED+Q5JG/>#0W58!-4NFD)%&&R5 MC0ZK^>Z3PU+7$LO!TS!6VG%TB*)IP6L/V>:TG)>.5(3L6,T+GXQ\)MN*TPWQ MSE9":ZCK]0B6\YVL9X?[:XY0D.I)^8ZXM^]QQ5-!4ZR"\OD.FDH-F(JC58RF M\1%0:JJ<[YJ*57UU`?Z4B6S*>;Q%"^P:\UF<-^^$TP]KJANH555>04_7: MRNU?6"(]6]OL3Q%1QF@AEPCU'-U/D3%<*,&1R%60EH*K='D[G\?B>WID9.AS M8@L(5VWS\ELFEL^\7ST'/GT)6VATZJ<<:J/$`SE3)G>";0'[]OYKDY_@O8%/ M8:-QJ;XA_G#T.A?0T]V#1D0O7/Y8D\\=T%PTCP-L\$#5$4.572M5YZ%4-65Q MZ5+(+";P3CM'=DR-M*BDV*%G>C^!-PN6W:CX_>K5B[XF2$Z\6M-5`!DE),`8KJ+4D@F!;@6@#N\&XBA<\FU,2B4L;`J[ M16#BT6BP:S2(\6\@&4-C(=^8*V?0FTG"._'+0@@'IV^NXA?DJE2RB]NIJ$<2#G"CZ,HC6@";YK[Z&93^7T0B5X;$9S#?IOPA1''BKX3)35X'O?4&0*ECX>W:'.Y0!0*B"='%V MC2ZUN=->;G"A6;AM375*#5D`QF7F4^8D"9OP3@U`/??U2\VO31YEA;`L\YIM M$:ND/#E=3QS^6!%Z6XIU4/DB:(J]&.8UU09A-"6[94IV:C;@<.6LV$U+/=T" MW,2'[F813CF5='YPNC"OR^H5<[!V%JQ8A7P5G3G.2D?; M3)Y%MM;"F-S',05VLOJO"@NVXGESC#$@?*ZH!]DT(B78&-H]K&0^[1&4T^7+ MEUN+Y@E!A3*A$TOH&V,43D]`_3H%0P+MA!"R*P.1XK^-P8_'NL:@=,>W2,IV M=C>,R1-P[O5MZYH12#NTQQA'2F5>!=42Q#GO!$Z-[3^F#P,8K/8%](%1BX[4CV&V06$F'N[+P:U0=R5'O()72 M+P("L"Z3+@R_PK2O$$'!M--:]/S(1FV2`_7XLB955"N']'UCL3`;0\"'%3AG M1PR@M[TIN(^^(%Z\XP.V:,?IW%LUQ(?XT!MXM\V]W;LH!IOK-AMF"B=]KY"@ MR^9$<>4#7OG#+?WT_/9KKUWLA0-S55XS:P7GQ15XV$H!_GGM*V7H;H.L=0-N M]PVCDJ9(,\FV":CZ&4,D>23^\?K5@)\PF71*.-<4F++XXZ:C"8U<,Y"#JFW# M%917Q5")/-NUW3O6_@/8?6\X[R8+W[ZU?LE3H")Z3>D=7IGW:,[T[EP M9![NQ%2I,ZX4K]FZVI#-ZK.P-I)"/4$9+X8O_C.W)'7,_9 M%M:+(9HFREQSW=0UXY(NA`4[3X/6"&R++W?!1NMF3H$P+X2_A]CMB?5G]"-F MB7S'2ZTYUWAR3HIC(>"R4B=4N-C]MM#A<9X1LT!A3FF1/31MU]VUS2NN*K[C M4U*J;O>BS!PUID[KCVVJ82\QOMKE/.O7+C@K'J"/PTS:^+X50&DC,AI#X`?# M$:2()F7;#6WC1TU-`LS+P.!HEX?2S%[`&\V=%A'YK'^._N?1EOE'AP4T>$?'ZN&ZI]L- MV*%P4V']AJ2KJL%/;+82QK9\B2)+NHE!_D]QBAR+4JNEV*O%^85&YE6IJ)6? MTQ4WJV5EY6\6$Z?P1I0R1V-2+Y@0$"YE/=&!3U#4)BB]4Y:"X`W`F6&TB%V@<.B-EH'G9_0!3 MR!";3M=F<%86WSE0\"^U"+KK]@1TW>N8'N`8_,Y8GA^ M^GWO@))`KI7Z&BXY6RW*L#F=9-D.D4GE-IFO_VUF`19NX5Z[I44F7U;F/_:# MZL%\R6(3FHQ,;DU"S2T",=LGTFTJ5USF0(U[$=,/6]D7DHR'`5M"8+$J!*R, M,[D8PHHH#8D=I)D(IC'?P8@5@$6;S5'"]X*E7CA=:`X[A1A2[N43@EG@-B,3 MX:+1:*8)-6FG-,%RT1T/TD5>P#_;&CRJ3*JO-&0\NGA2Z`'-Z$R+7,N]5`5/(9/;PY37!3]SP$YTD7/I+BY[T>_[S`SGCR M\W4PSF8_[_5[O;_MV0_2%L&6_KR7Q0OG]V,]BS_?O?GRVX_>T2DLQI-'$RS9 MV5M+#W;0?O+0->I._#D!P7H`R*H`8N MS5YD8V?:&TWJD4_'6Y/$"*F`,5LTQ@.AZ`)5!>H.2;/I[+)@TG<^Y.#_<$!7HAM MF=7A+GPKHFV\_/H1UA.BT):Q:/\X*8T(&8>]&/7X*"THF!"%\@7!@[;1!7HSC?-)VC;X/;/ MP!2!L1&7T[`+:%&?-HJQ5D"#FJM;W6./0HEBP,8VQ;:X#+&6.-F9ZX9*)PF= M/YW@Q`:8O9->Y&!CCHPU^A-?<-LE%?OA:+Q8_)BI%'>R95A:30MURXA$G!;Z M/K$U+2Y(Y:MD+$HN>%I//:YX]\(X0C/Q.PGYDT<(+<7EX^V^2>VG`!!OK:4* M(J@@Z&^"7&/A=''>.I'S499S6(2FT%7E*Z>4D&FUP+FM))@U6#WC4^ M7F2)\V\<>FNSO34?6_-Q<_/1`A28^`5!:+G9HRR+=:*B'$<=#C%<'E07:;FZ M_N+R]7JC#F2:+V&'KH0=&+..Q;^&]]*->>0TE\P0/4-N!:6K`B3(AR<6L1.6 M$CGAHA0,AXTTS'4A#N*NL&!"%@EG=8L`/U#-3`'=9`P[DG#J+ME48XT#$W!R M5JJX[W2G,%/J%<`-%0DV#,,[&(W`%30:D%,'E,I1U7^ZD7T:K&\8T]BK]B7R$U&!.9&5&Z'8SS1.,]KCCQ50I* MER,:P69FR!I7:V$->=/5$GGUA5JIOO*HMPP0I\D%NZHI5!/DV-*+(K>&6#C@ M%EA*VLKJEU!BZ=9^;G5+V:I?50M'YI@U[+^[D_Y2J1NH!3:5=A1Z*!8R.#"KF!'ZKRE"3QG!A%,B:0*/V\?!@ MHJF.L])#NMLF4I<+TN):HJ@/VV$('^WM$X).RV97W'&15\1\2M!3+3 M'ONMB=_B1E^,L+T$LLY*QN;*)!NQ_P^6BU61S1,8NB]6Z:X*=/<-W5=3BSCK M:IH'8YTY=*F!FDYZ)]V3;8&:]O=*[^\]8Z3G.5WC<>L"$<+;V!%UU-Z,6P(=$D^_ MA^?D[96F[6U*2*L_GJ?^N/>4D-O$Q,VD@KNX5"N,MN&]V@T9!A=MWLICYJVT MV2IMMDJ;K=(JX*>@@-MLE69EJ]2I!EL4U::LM$)G-X5.F[)2?;B?U)G>T=!^ M9>0QU1>5@Y/N.=6N89_+)26`H).!T7_8LXD*6$#57#;*95NYEQGM.74H'_._ M%7FW2J)T"*8Z!6;CYM65B$G[46P!NTIW=)1Q(KU3S=>4XH08:A'$N$ZK9$"4#G@!QY3?2!0SL`^O-.$W9J*-C4D`.=[[9H5-= MNMXT,+$)]H)$+.T+0S0^U#:UIWI8I^.FLQ'[V-X5;_^HT:YMR^G0&R]LZ(QS M#U201'\ZF$NC&)1YNH@YD$N)1`%!1`7SN1H'.JB&8%&XOZ#-U<)'QR#%!JD8 M;W41G,9J"$ZGM(D?,OH1G':0`X(]Q>>_*\MS86)HBPU4NRU?%;8]/NGV#Q"@ MD:P@V2'#,-B\4[I4!\DHGW/+X_1PY=:^&H.W'V6J_4`_YWE222P7UL>.M-/Z?Y.'KYZB],78%R:]N_F M8WCH,2:9)B6SO+2>`76V"/UE%8.XGXS-I?[J![C:D7(O0'-J.&3D3O)5<=]4 M/#FH'\"9D=.G>=I6D'A2O##V$%0Y]R4NO=5)H/4B%8]>T&(KLP`0J7[ M33K"5^[FX6I>B@ZC.[/4U[;*K4N79:V(+@J!N0LQ+.GH]704+T2Z`@ETVM`= M7*\W,9'S9@5,Q]7^_+)#H'QL':($$AOJUL)"KE+XPJ1X;"DMU)^@A/#UF:^H M&:]HBFX%B;Z8H70V2;@QGQ0H\DGAJZ#TL"506ORB$3,V/17MY*5M2$H*2;[O M,*$ZO5+1F)EI#,B`VM7%]AJ.FHM36J'^58/2 M>>\[_6_%D#BR$!O%.UJQ!)!##(TU^(&@@+K8>@7YGD?Z]*\_^9U:U2NJ15'0 MU\?-%$."DTE-UL$B3Q9Q2KN=89O*V>KD!$F4S9I]:97<6;W'3Q0QH].K3#YI MAF:A!E;!:W@&YJP074(WV#*-QR*3[\Z^85:MG\1\@9_Q.L68GKJ-<7-8]K'A M-M]Q`YTO_C?ODP9<;`SQ'@Y*DZF4^=],QK4VN[/&5D3YD(P%BN;+&@D6""=CG,F.K;\A_ATU%8<8UN=C1:`4J,0>;+MQ=-B?_'5>7$\',;&`72N8-5'^/), M13[GB.!*2'W;6):FXU)1!,K)&W;G4TZ'$J5;28\W58LG23K.1^Q5^4XV)';U MON;&@K'L*%VP%8&4::M2N;.FJ\8P^(K=RLA?0.EKE+U\TC0E'-HF.IO/MV*S MC(E61U270/YB$5+\U?,*ADA6N%);-.,J\1Q2L+*'_ MZG:D[$P&DXT$4>%%C8V?PC[#J+Q^]5Y0$QGV**04 ME&*C;OVE6D%0V)[5LURI_H@:W&[=+L5NE!&)A1E2@@6V_A.2BMY-*>B(=KE$ M>2;!!&-6)[T#[CY.?9:!EL$L9L=\J)`4I@,:I4#FH5RTLMRK[>E>P<5A&E>' MAL:JZU@@'>30-'6L%7-C1(B'())"EI51P3;JN-X%(J+A6\'<7`IQ(UNQ>.!% MO&.B.V*ZVP(R-JB'[7V(-UMDX9ARK+V8R2O5HVLIB444K+.(V!+![IN6]7'? M2#;PC8"CTXH-5#MNJR(R-('W`[R*2))E=^B/ODI(GGX&RXJ*DXO`=,P->'Y# M%$-7@;K6+2E(J>MP4HT9;$1CS)![:V;+W*KYO<+@HBB.VR-"J3G>OL-?4B#S M\^5&I\4WM[[Y*Q]/;99W+!$`C"CA/8`;3,:M"OUK<3;F%/[@:Z$P5-%42S&\ M%\B1=9A=\*+.0$VBD`*^B'-;=\3\CT/K/O2'X+RB7A:)Y>HW[I"MS"WT'$7F M(C2JY:\\"5+@0)O.'F"9VO`ON@2(96)\-&!>A!%$W!I@##*. MZO%L#X,5-])Z87-?PJH8TB.S&+XQ\73"4-%Z1AT)5'"G!(R=D#^(FLK0JV-H M@^W(+,-+V\\D!66@VYHE&*H2B-@&,O]C!U'^,(82Q5'$2&A;DE`12#!FDQ"D M"-VY5UN54@KD4UB/VTK+]49,0MX>G:*OEEA[;N%$:\D:+#00636&M-L_`>O# MYX/G89N?,0@_[,YTU.]X@U[_"#^BG]6H%WC2+A9)$`(%Z:F^M_\.%D9!=^SJ MFL3Y=.:]@;,T'X*Q)V,-VC.UZ9FB_N,F->,/S(K^MU$S'SZ^3W4V\VOCJ;_F MYMN-(?%]7E<@L[Y#]8S27_?3!M=7F8-P=#YPW%_X"4O$]='$]O`)=C"()(##&6L<%IQC,^8K"'9?< M9J=6SIF(MAT1W)QX1C&SL+^*;CBH2C;\(F^OO,S#OSLN,4S-[27?Y4V*ZT4C@/QN\B%/>MIW MQ&S@11Q0^.F*[GI!$"G5)='&HJNZ1D+2FC!&+'VPR\OK"#D+EAY1UES=N/93 MM,H.I;@Y[JW!?:"(J!AI2TTD4Z1N&UF5L@Z+I)1]D"`"1A^EG@?!M;N4=PWJ MHZN^@1/%F8]\[YQ'DE]=GK`81.C*X-TUU['$7DCN.]MI=8$&XMK`TBIP&5@[ M+BZO2F(G410302833)FQ7J!K`O*!8I/9M7H)2F;)Z9L3-2:&+9B<^MJ>V`9. M!$4UG'E=*[G&<_(\*7AIOT>OZ%GR9;$0L,-'G#I@)C;93C93!T+BB1VB588; MMYT%7I";NOWW%#2&TXS[/H==N\3:G\:0\JZ5'I*F&$]'THR8-%Q0)H@O.;5) M<'2D#AX/3LDD/-XR>%QY^.V_7H&X'X$WM=7TAE*8@E]=?55$FZX`,35Y44Y& M9NR6NNE/L`)QZO:=NI0U*N%-$-*$=F/^W&8%[\2XHLU=3\TK*\OD.[M)J`T8 M,Q[,.,QML@Q+.\+W847N+I9ANP07B&U\;G$Z59R48Q[!()33`+A32,M)'8B5 M!HG!>\&C(0P7!I2@(IE9+-'`N@WG[;I2I8U1W^0NFZTONKW=F(?=:DO.C5JR M-H0-"KKZB]\/-'/32X^#B>D.&*J),]5'*%QR:Y5T#=,PSK)X;EXYD3?PJ=6> M0&6]73/!:GS$,L4*_8>*)4EULSO=BJPJG` M/8,_GFW$K^O7\/T"A*>\*;3F79#XDR-U/CI2YXW(@%7"W_4,7+/N!ES-NHJH MXBF2N7VZ>//FW8=?NZ\^?OGR\? M0RI,@-E[=&&UX4D<-.`D_@+VS"\<1_TG!AO>8ASUUI;(@T^_&/"]H13UV7+E MP.7*XX9P)1J"G\@!:`X[5EPO-&?R^\'*/4AS)D^"P)XH?6VSA>+UAE,X(W'R M\]Y_C$9*32:%XOO=5K<[+;SJI-*I*Y6.=GFF%5I]-Q2"ZR20_U>[!%A!%%\G M_N+G/?[O+JRB?K*//;DZT7`]"S*UJ6#0Z!Q%S_SN1"C]XL^W+"^'<3@N2=7^ M^:I8/3L\.RE+5IQ?2:YV7UK!^E51UP#O;3I*XFO7O5EC:K42J95(K41Z`(G4 M&BNM:&A%0RL:=MU8>0#+Y,)`'CCW>0+`-T,L+.JT10DS_()/EW\!MN2*(KE3 M-L^0G>.]U07>=G!,6\_GIJ7"?^61\@9'DDR(B#?Z^E)@%.@EN4$U>V@1 MIUGW=1A3CI'I0C\/0I5F<820+_CBWN_F%U5]?386L:N(<Q3:W M#LSNZ9S6@7DF#-`Z,(U:Q*?[)UQ5RQ/QA_&5[.DUM:F/$!9"LBL3)1Q`G_&)-U=801J0$\Z4P'XG M`38>38)H%"P0[)2YA-J8AZ&&-TZX&PVU>S+\0JBK'M\QNLPUZ'6.C\XKF&NP MRES>I5ID`O/8$\C(>EX*4J3KP"%JFX:Y([-^\.NM\_-^Y^QDT#0+O=WD;3:Y MVUI7.V-=M:[Z,V&`UE5OU"IVEF-:5[V5)<_955]JEZ;UU'?84Z\"Y[UU M2'=CU@_NJQP/3CNGIV=-LT/;36X=TF;:$*U#^DP8H'5(&[6*G>68UB%M9%FH'"%O9I-BP.;A2 MX;)S']>`?+WJ7@.V3M=NS/K![?%^Y[BM97SZV]RZ7;NC*5NWZYDP0.MV-6H5 M.\LQK=O5RI)GZG99$)8[+UUL'9=&6[2#SEGOO'/Z7=YM9Q:8ZN>4%- M&%U=0;-;V]GQAB<>H:UCZWP].R9NG:]&K6)G.:9UOEI9T@CGBWYQWP`R?W+; M\!8W9L=.=#/E4*NZ6M75JJ[V$JKU@W;JC#53,K3*I%4FK3)I_:![R?U;5RPE M>7_[P8%WS>Y1BJ5@BSP9S?Q4>?U.[Y0J6Z2E6\IH,!$9DO;C M/XY>_I1B)=8\CH`T0`H<%9\*HBMLHY;HMFKV9_W]O0-**=P/ZN9T?M(Y.CK2 M/>;JOEY5VL43JOI+88Y.A1@UJ..9\K^=63+62N2I;RH9!:G297$33%`\/>ZY M%61I/OQ+C3+\@NX[YX__@FW!SZ2X-JS0H[]?2B.\H_WA`=XAINI?.7[Y[;_R M(%MZEWYH5WWYZ0(^OP@2!'69!%?*VS_A(L"TO@KPL#(AE/GBQA-:=0:1H\U. M,4<5SV(&`GBJ$JI[A#U3F9X_@]J8=TN4!&*44CV),ZA(D3>?JQ:%B?-H#,_A M7\V`UPK?(4+CQT>C.,%P>[AL*_5V9-:/YO7MMIHG5 M^NO/A`%:?[U1J]A9CFG]]5:6/%]_O<8U*[GL=>YZSU;E2764=I:*I7FF>,HT M:_\.Q_XZEC+!61R"$T:#5?5T-T`TV'^]7&/8^F0[,NNVD*_=YM8G>]IJM/7) MG@D#M#Y9HU:QLQS3^F2M+'F^/EE51X852$]QR8J7E814?^-M9>5=*7I%XE%M MXE!9N!3K5+4^U8[,^I%:)!RUAE1K2&VKS)M)[!U4YJWSUGC;-AFGW>9M]/M5YN:T>>E0]5$*$+,K< M$A)DG88IR/W>PDK=8>*]V'JTPL*_T,(_P,(_KP/*NOSRS_?PFP`433`JZ;#> MJ@KKE?47EL,&DZ4LY*-D-(3HG2B*=WQ1J&?IO`@ MK)0>2-1(!8LLI7S_A;_D!)$?(4@I#`.F2I#AQVAX[NR:>F,%SP0X4TIH4?YH!K/)U#1.EAUZ-$]5 M*N7^XR#!PG<8&/X;P\!AP(N_]TX_P[_!^G_Y!M!SN*PFZ+J5R''^/+P41&&V*1^*5P/HHVV>+(1,U!RKBSL#8^45;31_&O]$_+&EX]OHKX(N8 M,QQ$,+\Y?\$?@HMBI0"]4RD%<(O!7BR(2ML+9]SPD:P%&"&`0^[B6]CC M?`['&8\TG.?^=L=Y-:UM5W7.8RML%T#D"G>F,92[3VT]B4,ZV\AQTSP84PIE M$!GLE?.3$U0T)[U;*&Z"7`G241BG)'4G"/ZB]T#1'AP6)G,=@*Q5<&!SE`0K M#\.`29Q/9Q;+!30ZG2XK-^6T^B'0'IX049YH:)1*6?O).9,7EW]@8FNOVWNY MW8J+F;`HTX"(;U^#^`C!Y``YE@9<#PCSJ9RDKF:4)2T][K<^1F$%5,R28)A3 M+_<8C8H$I'F:@[GA6[+`IT2\SU$&OWWSZ\7G5CYL*A\^@_".,B#V.]X(9\<_ M)7$$_V8HI.(F5_FT MKUBE>YOSC9)*J MC';P(H5_L0WP/O"'<%!0C1?JO(J_ M=\28`H-.S/DX2>)K;3$Y?PC%1,L2/TK]$7M*QHY6`?EC,:T(M0Z[:T0+2NS' M,FV4L-X(QH-I^RA($3.,;>\-=1&H(@=US/?FX$S`9R.A(B733!GF#!\-Y@%L MOUTNZR@?_CEV+#KA%%H&V<,8RYZ0UYB.0+(3]!@3BMJ^!G,Q`5-:&HT1`U7E M.6O8\H3]"4Y1'[<^5ULT1YC?@^BQ8``;R)[!=YQ&U.&)`C6$_K_U841_/.88I&/+)>A9)2(M MD.O90TY<&L1,`]^A04PT&!5H(,[S<$F_CR-"&V1/,\!G$T1KB%F,:,_3=;L/ M#;W@2!:/XB(?PBY[>/]$TJA\/%UWDL[;&[`!J/VRKF^Z@Q.WMLE.LXZ;,5LK M9>ZK&/Y#@3,\EYWJ@WG\'0?3T7'Z/![W3N`\?H1MGOJL7#X;KYRB3_\5!\)/ MEZC/8.YZE*5W804_\\;U+!BQ=\%WEQ>FQS?^SGX%3$0@QC>,7;!Q8`7"&^#S MPO$YW*L.[VC],1X#?^L@(08\IAQ0['ASY>-9P^FQ'BGZ4AH],W86GQ07_Y=9 M?"J+]]TEY3E\*[S(6T`9%D(1,`M$<+@K_^",8E+ MDAS]D?0[#NAM].?]G>3FZDXNVMQ$<9Y\Q_G\1>)\KW7H\7<_R]#GE<-Z?H3* M\Y./@4>GX-,1)CIJ\)HU!K+)%[0<0^:N"P,4Z^6@$F"3G0.#9^*UG`F,]03C M`(QX1<&X7\%!7E!\4$QF82'?TW-^BRRXQ&=19<$)IQ@@?:KBN=()]VJ.L[^Z MLI%=6>:LS$+@<@#`Q^`@13[81$ZQ8QK_EHQ4#$HCD"V=XN),=;15F15%L1?& M<+(3*J'%8>A8QV'(8+E:JM,Y@[%XG%33D,:8(@6)-DQ`LN$#'"N*HT423X), MQT?I>=\;8K`9:&%I79P9BP432:"S-SCHU1O3-PFSO$^(S@[.I98NU?BYMT$Z[!62& MO`_^A=Q,+[SRTR`5%T`XYW"O:%>7O$HQJ0E'FX\N7A$D>&.AZJ.&]D8G=+X^ MU%]W^)8.D_L0'H\^7-'$OR371$9DP!W$1E M>1*Q!>)^CVYL6)S1'1^BBW.@N#0K?X&7,WQ(Y>HD9:^8_Y7:JG\_AS.3"+'F M_EVQY*?75UPRJ^J5&N]UOPSR->%,@6XGV>%1M'*(Q%P=!%8>V"AHIN MB<"[2=WWX4F\M=K'-]0W4(BAHBOH.(0M0[D[]*.O2;[(1LN#0^_=I.X+UWZJ M(R4<%[$[XJC9*9`T(7DRCD&FLM&KD=%7G@:QJ18T>G%Z*"O!D^N&P409N^V@ MXS*!2&,,.RTWXDP*3`6"@Z[WOG*EXP!VU$5TKWR*]K-(E`*;5BUS)-,`B9(05CJKR(H"$4&P#R8 M^6.Z-X5GKX(X3\.E]G?^;3#K_SB\//1^O;CX!.9#)D9&)O,D@$?''BI3`;@@ M3VE&Y)C@XD/78RSP,9@28S7WDZ_IPZWO;]3M13-A=0`D`@B50[9'<68KIZX0HBD9);8API*75.`FA1:3JQS> M^DDHB3VRT@42`(S[\?,U0G[W(U^BQN-84@*&H%S4E6@49'X6](F^6F(#I4/, MC<\OP4!UE)1K9+HW3AV4CI)7U?&N::-G/KX!.H_BXJ$3&M.>!]U$%BU\*\)6 M]^W_=+MOH_$OB3_%![I=O3>5J8'_^2)/NU/?7_QX";2B4'N465/G4PQV%7#E M%R#G*]RMO__O_^5Y_[G=.UXP_GEOLT_7][Y.+`GS^KR<][R.]= MB3]U>_UN%O-/_4'WJ+_R+KS]=R'(FX^OO_SSTUMOELU#[],?K]Z_>^WM=5^\ M^//H]8L7;[Z\\?[GMR^_O_?@=?93R1'UPQ%UPV.=S\C0GGK/CA3M8V?.'DS>UX7+'8=@-483ZRQ%'16@M-G0Q MA)X2&):.1(`*E1P/R5,DO8WFUP($2E841T)\8T<[SY&/7[1URH\'"5]"ZI2E MBH#H:[PP1"^Y;ACM=K-Z9D_97"0.0A;`[.#9F=`>C+:)L&(WBAHV\;0:93.!Q%<:B^86!TJJ.K MH/8CSGSCK^C918I3/,B7P2PT%/#ZZK>4*3F7\)J3EXAF`6D:U!T4"RMDV#AS M3IUC1OERVVV`Q*+1G5&8ZND;BYD0T:[@?D8`$TJU-"N MF@^/G9YB`@J%N$37^R/R\S&Z9-X[L19MH.*=]2\:0^?[D(VYH9&VJ#$?"YA[ M3+>2U3EC=.CYVC)B1'>TN(8*SJUQ_RI2%BK9O.H\B)_^1T03HY@2!XSF,,.1 M[^WO&6=H[X#O6&7R;L36;#![#"8PDN2ATHN8YJ%OZ_X\>O@"W9`1*Y1R'_FR^Y%UV_Z=2S%_8 MQF,=SG*3?&GM3TI@FS/F'>\8$W'C...=<"6-]1@G1M1FU6[[H5?,K[X-6TSR M)`K2&7GC$U2@G&SN!*/W*=D!$:X!?4`,)7,6,2>F'\AU(S"2Z248+X)( M/&BK:#J@%$#LIF@?4?[*Q`>%:N:DR:6UE=;OY1BSN.@U.9#OC*LI.B\AV$SS MZ0"]%U".(X[$UWQSD@,QG'!W76I[JC8@M1O5]\>"^_D7*+8B\.?-`Y7L(3-9 M.T^/+P4XJ'PDV3;$=,QPY&YCQT(W^ZC:F+A@GY]OA-$=TP?FOU%'8C:H^:\Y=NFN[2WQ*A('9FSQ^Q[<>S-UF>ANR-I@6XP?%P( M2%>D],2T$+IPKGDG,\4/^V!!B&:K-6#K9H2YO5$N<\#H>H0I"Q*U+I:9L?D` M'WM`P="?Y.S[F>P\>?;R)`9L3%AWG"L=R0AAT[B> MT<07\!1(RA5%%DJ6(L^)/CP+IC,W+&""!SH:E*=T$R:I33`!>]X(TX5@;X`$/^_U^.>%/Q[KGS4F04\P MRC0TC<8NR.)%`9=&9O'GNS=??F-TF*KE5Z(YR#M'I_#.*D9+F51;ICAOFLR! M;=VK7)'5^XW"&M9N9B5BQL-+H%ODM]R8"6Y-$@Y13F,J.(Y1>$2%));RU[?\ MTH_%C!@GADW'V:V_*=0(LJ($T;@ZO8[(6+K_F2]"$A#RO$@VD4*4QPJN91C\ MNW1OW1&]Z]PM3PIJ6&P)\>U!(B5L"^JO)[%H6J%\U,3C2P<( MZY6Z87!%\%#HDMVC1'*^'+B18Y/FZZ9YTVRJDK,%6@P#NG@Z=5(U(V>!&,!< M8Y7Q=RB?$R\U`^/:JKV8KR,$Y.':"8,`,N7P4ZSR'F.$\E(0A.*/%Q21J M[K-AI$46I7^AH8J?X+'3&0:-,3;H8^0N`*G)`EF_TI'!,V\8QU]Y7<8TK9OO M`F88<"7X%0/Q;3^]HLEH@77(@",T(TFW'TI!E^1\T^1L>IA<9L>)8_1FL$XL MDX,E8V@S2.:-U0B%2OTRN%/I`G:1%3Z6 M3J:2)B"H;T@DD-+L?^U?N4N3]!Q2[DRP&_$`M9N4KE"=:JJU^>3RL,/MF.VO M$$Z1JQ-"OD&8QUCKDC#>%EX4+,0TB4<"VZ?,I8!`=[7FQTZ;'ZWUL87U\0_C M-Y1".`1"B@K6_W;_ELBZ^' M`1@N2;+LPO*O"=<#Z?"+&E/,2".=PM"+/,%Z1D=]#I6&YI9IW:U$_%!QYI)-#L)0C<86P%<2!AWQAI,8@K4V"6R.%ZZ*UE): M@Y^8N2&:+2>J7:UN^J&[!W-_K!CIR8:>K-^F+W&U5)[Y5$Z8$^UMNA_;`1VZ M,UT3>>,HW_[H@#;'B;$E?H#86^.Q5(C`U*,Q7 M^Q04]#7*!AD8B/Q%I%`)^<'^/,8\1:Y'Y6!;*]AW7+"W(:TM)/O;VBR!G'$B MO$+,").`"/H!+,OE;QWQ8O)7R@J`>,;H$=$-M>,I)>35*8AZIQ9=NQ[ M5S$Z&OI.H%I1%)JNF%0A`2+7P76;D)(YP^NB5@EU_2OWT5$DD%($5`;AQ+(L M"=*O:%$R.#1F*\&0[&9OM*([$T/?EZ-T=P!L)M4-Y'FA^J8JI07]"(=7AYBU M268`4A53Q3@;QTD/0NEMS`7$D4B43?>1Y+','\UX;S.:1MWW>`=UJE#MK+@0 M2,J>*%F.(:OP.=KIF^Y*GF.NHR,!T);@Y%R'Q(6;01MWIAV)45HE6#Q?D82( M=7!V8M#"RB: M;<3@-A>KECESU"O_MMT',%+@7X'M*3SF5",YT1_\%G^IQ$+UC.YPKC.[0^^" MX!(D"J'U-M?'CQ&M=>Q6IG:D3+28D,FU.JK@6CQ?=KE@;#]]D$=4;BHZP=*9$Z;E78AI\?,&DS@H0M'-@^AZ.+[VN!I,5Y[!KUG_"+;=S6T&7B,0HF[_T:=N/GULM4#U MA'/_+T*UZL;7&$5.'3C#+O[=X-&`=)4J0@T8./-O!OCK@@'.F%:%XCF\;%]D MWG[_0)#W>!`+;T+@@*9XC3_8D3L!GK"'$T[`21T<:$0GF1=A!0Z3^*M*NF/E M8U,$@WIGT=6%`5X>]UA?R`S@91T<(L,&,SOCQ$_PIN#HP%F%H"'A!8Z%11R9 MU-'Z[YURJ"2*HZY]LZO?Y%^IZONY3?;UG+Z:IWDA(YYO"VX"8TR9J.DL8`!& M2^RK6-K/\*-DM7?8_$>LQ8ZDQTK4"4N"G:$0ABQR*SV8=3L>]Z`*EWQ3I'_J M4%%J3-@+0-Z3'MYMC)SZ4[>YITQ,W$M"U'2/!S.#I<,"<6KYU@[#=<7]K+T. M6<37:)G&ADLH;RU,\7HMT(SJ>R'B<29ZMIA]@2G`F@P=KP`+12C4#'G;H6L2 M)*(&@N<1Q<[$2Q^$TZ1.'#`$O9DG=%\$SZ_>4LHQ2^F`XZ2Z2,CNFJ/.L#_1 MLF./N3U0CC._0@A:_S.V@6MJ2%Q9Y](9C\T+%^6+S,14]\;9JDSDSD-BM[*6 M[B,P=V_,4VXH[(1K'SYN7!'V??7Q\YNWG[NO/G[Y\O%W7+,_^NH-%M\\XJ;: M[J1'[L";GI6;.Z[>!2H3"D+4TC6@3/Y<5R.:\W+KP[\+"RHB&2N+X%P?+==K M^W3QYLV[#[^:S8=MK]WPP9UT>*T@QQWU^KTE'P]>-I2/J<27J@Y)8_^5)T$Z M#D;;^F`[MR[*61W%"5K`IK`RF?J17`^WK/WD6?N-7+ZL\,&M\)YV;GG[8UD? MY3>ET@\CF&@4.;`*#NZ!R^^F1??.<7D?#!$L%@)K"/XX:";'7V3<`)%N^IK, MV]I9OSW_RL@7[]_]^D$LYC4<[47Q=>(O?M[C_^XBA[MWN44+_`;3^CO7\;W' M\EZ5Y7U-[N5.SVZG)[?3I+L;Y75?DZM008\\4_GJ(XO2.Y2;WG`*%(Z3G_?^ M8S12RG3U6[O<#=7;BBI[X*#'YI,LK*W.+U17@>_]`]0TM54EZ,/(E_3*]UD% MIOW&TDNG!9HXUFYR^5UO^STY4G>Z[1@4_J*2)*!:"[FT>(6X0NG,4O0?03(- M(J?X*@W]:+R*S/:4.$(;K$^3)V[P*Q9)$'I]AOSLWW*;^XW8YIO4V^[,>GU> M\LT\XJZ:$[3KEBT\VN_U'F8VMS$Q_K:IWK^>!9G:VX!?6__IB3H!+>D:[C\U M6FQO+79W;]JM"_B<7,"+%/[G/7X+QU"W=HU@_N%IX]3:]PC:+=-7YMC@!=(^Z: M,M7FS+0Y1&UU0.L3/C^?\'N58\&:>XF_T;4,QL!;ZR^N'CFS5N\^2'GYVGN5 M8*Z?]RE3F`9:H&BC1?!][.AW^&`W!@/-RBZ#:.HOXD2UY+]+]^BF#?@XRN*A M2CQIA-YJRJ:RS)UZ2[NH__YV&P6X#B^T(0@G#P*B=A^P+`40EIH>WZ,P'U,[ M-]LXKPAD:P!KMX!TD;[7Q;;6\'?"*]+]M''95V`B'4'>P%Q6\"Q3/1)KI0EEO\20TO&-P7)P5BUC(4K<*9Z M,.P,@V!AM?AC!22R5#G#CWS-^F-0@I[B/IIQ)/($OLX=`=ICL.DQH/Y<_]"= MP7XQ^_RNA-'>!%K>)Z:FP)4A/IS&'QP0_N#12??H;$OLR_V]3Y7#[!VX.-^, M.^XV;D,P:Q?$T&P1*0=W:@AVV3W!D;><&O5E"=(1G".JWV0\Z0VG<>A5KPL1 M;L$J#-(9CNA-$G^NKN/D*T-8TW()G]'I%1>YR.T+"_AJ.\C!W]4BXRX#N,`_ M(KQ29F`BLD;G/% MG5723$6CI>!HSI'TTE6$()DK1Q'LY9#L*>?;G0VI9D>=!4"#9#1;"G`AR6HP MQ?XMH*]!M,BS5+<$$+Q5O'H/_H5(X!J&6C-:@>XDL[&Q`&)_#I,8)"TW^*R% MBK2/2R=0H'WE9,=J0GV[ALNZ%7,CNW24!$-\3L&1VPH@\!:8R)7_?HR>*FO# MAF[#%3W":44\X#$NC@\&(]#M6.A@ZI].*^*BNWR1OR_ M/$81)$TSJ;=>6D":]]#%N%+R!'<:P.XC&:')VR:$;A,!W_B1UK=#SV_S3B.; MWD295UP1ZC)0^CB1M1]-$GB(6*GLK\GMB:(.?^16L\U\4['AN.< M1N].8UVP$3K$4VM5Y/`9?O4.!"(RS8/MN/YUY$_"Y MI5*0,VM=+MK;';AMMVCT=W.KJ0-@46P.T4>6<9I3J3V M/J*+E6&2*1@=',>9!=,9=BF1^`XU:"E:*?MYI%MN'=S6<9/K/MCW\K?C=QPT[E\%*Q'5Y-#[H)WDA*#QG;"`79BH)*3E3('\97JB,M[C(UA=E* MYV9@+=-`V%D1#\#<1T(,GG-YU;1XK(K::5/-1CF?-\>:KH+ZNJBV"^I-6][A M3G-^2G*G8Z^CP6)6`?%F#_>R^<1_65?DY5",?F%DO,9UA0VAX-D]L^]=4>6O;JCXGWJCL M"G.EP,-!^0%F@3([Y%(^K;CI(-:PA)5SG2_@9,]-#T;G0T,\Z*:E+H&W2X>G M1+X`Y_Z:^N\-E1/KDK-O;WFLJG/X-TFPW:)P8>:]`0:=8PK7D>1P$7C>! MT@BPE9H1#V)T2LX)-@;&QO'\16(PW=#76$FF4[7#C0EVK<8K(E=GZ(:KU/.$ MV8Y:W8LN=1:@E[G46HG/1$J7;0J%277C,_?RD2;"(_MY%N/'G/;VW/5,QNS` M?+MBX[T8Q]=1-P'1.-8M0Z7U##:R^@GO8WSL+9=QW:KP]MY;CS*3=1`C2=T(9DMG2NH=*%PYP.4O';G['GF MVVKJ&GVCR4IMQMB2ZIC.9-A$#ID! M=(86]9U2N^V4>K]=*\RA*O8*EEO$/*-K-6;U:`K/V[;A'6ERB,W-0!;-_*N` M&C\;WM<"+,6^=]*Q5?DP<\D$`CVDV)5JD/&\JVD.%]8T>>_(H]_9`"1+TL=4 M(9`H>`)>8>/EEN@;$EW+?$MNE\9=T*-&2OXI8OY]R3%Q'GGO"M+75HC^PD*T M,;MRGUDJ.;8\UV07@5+I8ZY-,ZG18'I/$B7V,>:!5*AJJ_'PZ>U4(9I7,/UD MN9I-RI\>Q:"$,<]AZH-Y2+XL97SI+)!BTJI-5L.VE#"07^KI[CN=3TRZ&FM* M&7!3TK2R>%.Q<*&]M<_&T:/-O4`+A#0<&@=OXGR83?+0/-X8^MY]%_$5QYAX M%P]#@O=18L0&T54,ILQ87/..%ZF,V\-BNK=#VK$FK?:;;S1`5[/?CKC[[DFO M^W+[QL_&42/;\3OG!J<:DTWAB$?=:8P?'H'F#C*WA[W.6AL!I>,YB!R.!U#D M+-7/8Q)UEKJNIH0>0&ZFA&MO,N-E&-?3%9]#QKH&V36#,Y"RK>A$88=+N?J[ M"H"'F'1!4GX_B$RSL9]$C,H(Z29$LW$PGCJ%_Z[!EE5=,.\I+)($*B*[5];" MUCGL$DB\D9A$P&!1/'=]C0:)N;L^AFXGZJIS,-CR',A>.0G^">F>9(H[![OD MDXK+2OOM3S)LE(Y]S)7/G#V"TZG8U7%J`K[-?(H+&ZY=Q!E&@H$3D&=0>I"B M#5+W2B%1\SB[V2.E1NCCF/(OJXAQNBTQ7!;G^PPK[9@T"[QG&.?4=!+B?"ZW00-"TGJ,%Z32B3NFH,_.DW$*[F/A1*%66`5P3BG6S[D M%F$QL=]JV>,FL12D-<'BE?@=,3WI,?QID<1#Y`0MJ0LFW^IHU*+;6:6K.@_! MB4->&V8Z.HRSC2=S\_#GRTM?*-YV[5/`[:9MAZ=6 M8Z;P9!LR777AQC'>\<<92R[\#>B"KAS3+L=^M('S;1&S"Q<7K9OF4/*Q?9'7 M^CJ+8D,==$E0*[H.[#O8ER#1=X'OXVC:?8]Z1&)'C2'U?3)MC3EPJE/[^]M6 MR-#%-;!TB.0.B=Q\V7=8<[^P\J!.S=,5KZ!"P.B5/<60_@*WM,-=<-'RH=0& MC#5+B/9:#5,PF$%57*DPIJ=!#:9925723"V+H.F"`0R,8D1\V<[Q!%)7HR`9 MY7..E*>D94?L!HD+5[I=U=X;+LB;^TN2"T.E;;0Q_@N,'/3^(B\D=P^Z=) MG"]P%JLSP&F*_P=V-UC[.!-M!6'"CD(UBJ^DCC-`3Z.W1B9)^4+^T!%8VDSI MK*1&J&_`@.;.887M9%XKP:\X5?H<5IF`OSB%1&ZIUDH2DMP9J:Q@M"V8^')] M4I681.=)KO6N6&('6'CNCP/G,W0NWE41O)01!7JS>)HZWC#GDQBIZ^+$;]H@ M&IM2!'0^,;C=4Y@,$L"\TI'!X1C'\5>=:"#;4#??1:*$X&:B0,BA*J1'7\O`T*.3SL<+O)\(1M MY'``3HHR]":8&<'A%HJ6XGKC$0RY0(E3;BL#";SR>'8HO]5"H=U4(G#<*[EG+H9$Y6K7H08S<3Q,'4KDF!S MQ5P_4@H@!JF!/VT28<6AY;1C'\\D5V[+H1RK-'#-P^J#"I0?YR,63I@$B_FV MF":".61P),AZP`Q35Q"[I-<."&>=^6.\Z<0-PW,V>*O"FCP(:PKI M"TH6_CPQ%OR4"5S02F)^>@57ZED?28E7'_S3MD>&);^C: M:9.KY^80_?%#,\#I;T%C@?YJ84A6#%@TA;`^`"1*&`"5D%/!SL^8YT@K2/Y: MH#T,S%^;QU$VX[P)M*$D[H#F!FF;/('#D"HQB$G8*+L%6S'OX[/;'0&[W?DL M&D>W=Q':<#%BOS7F%-Z:+IOVN=!$65+L^'ECB*TD*Z:S,1:R%C M$*DCSJH8^W-_2IX]5ZQ0^CJ(6P(LH_([6IT8H1T4LFA4Q_)93,$F)VJHLFNE M=&I;ZI0CZ;F2Q9RE3MC'C8_5A.G(=O9RS$C^MT506LF"KQ[3A-3W@X.BLZ(C M=PJX;LQ1=`Q`E-QHKC\T[O0SL(BV%RD?'6[2U25?,9V_.0+X/F6,C6GPO2?G M3G&A'Q7_:#IJ>PDYSO%>V4^S!67B37K$MDZ@'&2,S2(#0<8PA$OG`W.]+_H0 M81'"7%G[GTH$Z`3$D7AB^B"3`/1@H\=H>)GD(HN-=++N75SX,Y#BFF!V"0E#J)J141J!F MC3RH2"-S\LY86E`(T''<60;RZ!S_;)K_=*\9%W9;7;UC%!=5OP5S!XA7C:M3 M,+",JJ4IT;3&`I&3Q$S]``2^`Z6TM?>S:PKSCD((G]P[_[?ZSO_9L0W^KY4EW+F211P;0GY!-_H MWY3U.E_DF4W)QOLDA/'OT@4.>PK>/N?;9OY7AD)QHMPK5_'67(9?4O:D.$,' M]N)6KEXJ+FDGBKTC&&C_Y,!;*C^I#@W_@9A>NJ--V0;F;#,&,[AY M`E2J6I1A0RQ7M;*G)G'%@-$90::S3U)=^','(+R;\E89GO7QRY>/O__H#1;?5GJUZ`4_?H^;9LWVU8*N'_27+ZX18O95C;\Y/U95\/37$YHZ.0:(2&>B(!X(-SDAD2' M*%PZ5*-X3CD;.>6P2\QEO$%H5)[=(#3:G'NTQXYG?A:"?_*3K$E)90_182[- MAUF\"$;>^6W[M]$%):$^FU]3>U:F^8)ISI`;I@M9^8EEH==HF.^@5A(>FJVFQZT2$_/;:WZA5&T#8FO$`5884J%/,"$8 M=#Z4@MW*%7-^5,K%":()[!M>I4KEG9E-XA0Q+&*0]X%E1;E+B+%D!`X&,XW/ MF/[RB)$%^+K,>X[W#+CQBX1*O+1&9`U+"4UT98JW%=UV`B49@-D]E-!6IQ$[[A4<):[!G\1$M&CA'8,Q9"!R!(N> MW]98X^"CSDT&89R,8<:4O`A;2YRA:UX/O=_B:X27Z)14=Z$QN!%YMB^X[>K, MS"'"O%"RQ!EX0TJGKFX>S\`T6L7PF`@)8)_AS&J7G`5"_UAU2>HJ2JIM9R10 M\5I(43=I+$L,MT!^L M!5Y!O`G$9O`Y9=./'%1LR:`GQ4J9Y*OBC<`.=2[\ZAZ65"WN%9B=P(%N.P=W MK.]>L8&?:IP(`N/6SA8PMJZ=%78>J;$%B16LQ$.S M',2+HU=CDK\K-O`*['8%TG9A*50DB*>`MN\Z2*F5@9^8-!N>+A5)2^7[!"1R MEH6J6<7\3ESOIWWCX\6B60]VBLO8-.U1\I@*;&E8(< M\\'0K*X=^"/^>>^@\N4%]1N00V]/3-6S.+ZW=VF>\2ZFB:)_58_M5M&8M!LX MH;_Y$27'_!:'*$12[UW'>__^-0AI2R1"A:U>K\6S'CG5X^6Y[LE7:NBIYP!# MS-%@E#8/[&2Y$*!ZXK&P07\@2<8DUPC"QONAW^D=#SJ]'H4-$#&SBQ*PW!^G MY)UTO$68@XA5VIREO*-Z[@C]8+YWP*J^:A.H<.@S-$:SW8>)>KCTN9F.J_DBG;JS=+23PNR@@0!!G M:R_!IR97%?%7*KDBS8>(@5#UIRRN/.\FJ[[JKW%4.5(U1X+!@IQ5]:>Q7WDH M`SAK8XS'A)5_MO\R$$$UT_%>^^$H9PO5^\3%`'0>*1?6JYFP0;@P5I7K\I(5 M$8/*]:*%1?%)^W0>R6=X39[G@J,?C@Y!>5\=N;!R?(-1MPM M9EK*'KZ)BF[!,M9%<[Y^7+LU\%\]U8X)PJXTXZ@I>&K.>7EL]\9I;//.]@]D M6TB-ITCJ"[2=@O9^3'.Z/B2$,6W)%Y3(-Q/R^89\W!@590EY]732;6W`.8/6 M]TZZQUO>M>WO?:H:!4WCRC_85G+L+Y#&CVU3&\)TJ5M9JAO,5W=QE8!(,7(! MQH253O6@[7:ADU4@OJ)X\ZOGA_5#A`>&1@)A'R(0K@1("QUSL#Z#X/@1A&O* ML4G<-<0_0+5-*T5SB+^F-].-`CK``B3LEPN:6M6CU?`')-0P;EE#:Q,_K9PC M(KF9CSFO=:3,FRYOL/3:O$W37'W#M:LH0*;AO(>*RM7A!<+J,AM?:.6$?^TX MH'#T"^0*^0=2#^N][04BBW\$>8-IV7JLYPGJ\_@+N:VZ,'W06JVPB@3A])M% M:Z8C]]L(8\#=R5*+R:([/CK`;R"-;1>20",>FP<).Q0,GO%88`8)TB&UV,CV M24=66"F3:J!9N:$+EZ5;\XT5%8HC%=!*<%8'6;N>.K4=D=2<4PVLAL$#*ILV;= M(E+-,>+N'N@M5*+@&L"J"B<*:=IHB3O MD%YW15]Q5\U]+0N?83#)DY'O7,TEW$_.#]-8V+#R`#L6DN7]JF\:^ZGVR\Q\ MSDSJK-ZDG%=$1Q4QY$/JV0LB.(]J7G^^;(127!\LFP!836/WAES;[*7NZWB) M;_/+K,QT_0_>&CZ_'>:ZKG1E,`T*530V5ZSEB$(UX@1GCU7:Y@%'J4&%.B+$ M3(&?HZQ?BOS])8CD5N#HQF/<2+$@A9P&IG4:SN%VL=Y71N8&S94`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`P6 M9'*,3#\75O_V[?W7]!C)D3?PJ0.\O1Y:_G!4.:.PTO4`V'1DCQ3N9ZR5YP[H M]%"H;&:P2H75$$21+H4R$NI\:N?(OJ@1$)44._3>:4,-'%@PYD;%[U>O7E0T M]3,M)&Y1]4D\4FI,O7ABMC5U!X?J*;#I9WO[,GV$05SAO]%\)#-=/U\<=NNY MM6D`#4@#<`X9GH?7.D(U:I/$:D`4CD^H4'_K]@E\/[&2&^42_-![+8$YV]>` M/"KU+4BS;K&Q;LP@/P)Z/I[6^]+M(1L-](8(4-L9<-N-=#JI%+0VIQL?<(!&: M.28*5A79($(`76`E%"O!DA>G]:_=$%J:,WPQ.]=FIY!,AN4I:L`X!QO6ED*N MSK'Z\TX+S;KABHH`Z!"HB9?&.1:02R!OE)D+6?D#.9_!=HE@3TJ"B&'@<"CE M35BF6NJ6N#IP$)#]QXY3J'00R=2-$T^:5$<-5V]LF**J=LK(?$0J*G4+ET06 M@QYK'S<^,4BI)+>7A%66U`V"I_J8K9"E1`7?<7:+:R^0C@-HAE@HK>B"&".$ M\)LEC`)'F=JO8PY46GP4B"(AJBJZ%(O%*X30LB.(]>9U4UE.07*LDY//2Q=N M2@=S>\E+-2^OKV/)+F7NV(?@N9Z<]ZO"UZD60:2LC,-:\%=JW\WQ1D,Y$'/4 MAY*B0J(+O&GNHUM/0"]!I!L0^5)O8?]:N1,5?/R[C9F8<.X01>.5ZKA)N&XM MOG\%NI`W'P4DQJB!N!V3T$0=D[#5A=S6,X:(/072[U?'JN(M3R:P9,`]IZ25 M>^ERA1*N3`-ABPK!<40Z<=1P.O$9@P0F39JJ,&>D@YZP-/:V;8KY4K)FUAJ/ MHE,Y978/;YYV8T[-8YO]'S"S@Y%_0K18W@FP2V,(^!`F_TJB[.E)MW]KPY]T M2XGL!D\'I1(:7-0`AV[DKM%Q+UR6WWQ76KC(375V#2E[XYKS@7+RA4T8:?50 M4IQD1O<"J?FU2:FLD(MEMK+K2Y2`7J1K">'QUYPYX!T2YG7%5/=`57#FTID7 M51OMT<3LKA+S<.4$6("F5)(<)#_P[J;K)Y&VQ=DN<'![UN;RBI%7.PM6E[G) M!@>1G`1#ZD04,#(1ST*^BDX:YZ*CQ27/(K-J$4MNX9AB15G]5X7;6J&[.48E M$#Y7\%\JSVK[^];*V]/>B;2IW%K@3JB%%1,ZL82^,?9@:N92\SH%.0+M6G!C M6QK=]+NDIEAPK&O,1'=\VV?=SNZ&,7D"3G:`P0[P1B#7T,IB'$*5<84C?=<-BXEUCHMN")T>VI2JX"S!TGDY2>2+!< M-[$A8-U[DT:58;DE*@?2@823X!L/Z3I"NO+NZF`$:\.>G.*)%MTY,CR;Y!4] MMJBYQ!VD4!1#H8Q)=+^N!"K?51H^6.EOZA)KIHE%X#5KRZ=02AW3_]_?LIUN MI;3X$JS5:.K81X=29)$&D!DZY"44L7Q$(2>$7OX$)#Q*:P MRV,?N<]@WOH)AJ4CQ#$P[0$:0\"'5?%G1PQYO+U+M8\Q%4R885`R'5W]Q<0- M*H?X$!]Z`Z+8*J!^D6FJ4//W+HK7-G6;S2)VCW9)(^NS`5]<^8!7_G!+/SV_ M_=IK%WOA`).6U\QVF//B2L>,2B'X>>TKY2:N!@O5$5@WC$!V6)I)1EP0+OE: M8YY'$E-:/W-PN">33JF[*05S;==9F57*(]<,Y/12M2$^RGUD(&N>[=JY.+@NBBYGHC=?D*_TH764R1&M M0GYQ]#UZ]2W\AZ!%WG'BVA<__>K]$B?`Q/0;TBB]L^[1G>E3.#(/=V*J5!6C M+=1L76VL<_59!-RR]()D4]9UL4(D:4F2AS M%7Q3;_1+2IL0#T,*53GJ,3;P:D:CNLX#+X2_ASU^$QL=L*ABLD3.A$B(F^KC M(D[:<2%\N5*[5\A^H&P#OK2C&3$+%.:4%ME#TW;=??2\XCKO.SXE<`]V+\K, M46/&M+[6QN$-O)CH2OM/8S(:`R!'RSV0?<#E`[+ MU]:%Q@/FJKR0R$3D34WO%'L*`D$I[/)0FMD+Z.^YT[_=T%=QJJ6?Y MF\7T0LP:H-3NF-0+)LV$2]E<5)3U"L'9?\IO).VX4KFQ^82X#)#NW<*`06]- M[F3LX!C\SE"#G[Z?>^`$J6N ME?H:+CFG,\IFF$?%:?!#9%+)N.`4&9M]@\64N-=NN9]):)?YC_V@>C!?G$FUZS4 M^5T:E(#_+X)I+""F;`5@(75SE/"]=+8IG"XTAYWB*"G!]*]!T!&,A\D@%.&B M$9VFF$[EY91,6RZ$Y4&ZR`N$XVSJ8JE:L+[ZER$D\38+#O=\87N)!-$BUW(O MU8'&'^]_%\V_J3=F58?.WDT=.O<\!+A*%SZ2XN>]'O^\\,=C_;-N!]KK.=U. ML\2T#R3%VVY5'$RRC6]\RE1VTGSQTC;H3?PZ']D?O M3`>QX403WVPI]@%=:-)/?+I>&L2G4$969DL:("< ME*Y[+UEU_".=*I,D'083Q0EL:]\J9\N4<,?Q5_HL1N,7*+BY;)%;-!4SLF,X M'(+P45TTZI@\G\HF#Y8Z[$\.]@<'>+V\9>:3N_"MB+;Q\NM'6$\(+_._2BI+ M7+)_G+1?A%W,_=#,G2N]BM#`IH&@DQZE/UNHYUZ`/NZ:)H7T%AO'?!5.WQZJ MF7\5D$B3:W5''.]3IB.W!E!C_N5!Q;1NW.05NY:R+#IHV`B604&3QYZ&);]M MK(=@`_BZD9LR%<(OG5N/BP7:G<)8MQZJR*<_>_O[>JOH%_\?F$3!E-IXE1GC MP'OA#0Y**PHFE(YQ8=![352!,BC2?(*V#6[_#$P1&!LVUK(+:%&?-HKQCT"# MFDP(ZIP02"A1#-C8IJ$7ER'6$A<$<&%?Z22A\ZBQQLS)&Q1G_B M=!&[I&)W0@WQC!\SZ`U.[AE+JVD!2P!AENDY:(%S6TDN8<3'/`>K!OV#=#EOS.HPZ'&"X/JDL975U_(3?FU)4S$N3#$XMX)DN)G'#A%H;#1L3X.JRE!9*[PH()622CU32K'B]M8$Y8?A'8Q&X(IE M%$Y:G,77>B2'((X@9S427(R%U:WX^8XEVUCL#;*]2CA)WS,H>C(Z;[%N\8O%UXC M'MGUL-6#:+FUZ1RMBGN>*LZ/(A0QB40#_Y7#L:"\`I@\9J6/JYW4BVA5W?C& M&,5?L:.0&@28S(Q('\/FO(D&8%WQX*NTDZ[7-5+-S)#5K5;!&H.JJ\7QZ@NU M(GWE46\9('":BSY74\DIT,NE%T5H#;$&QZU`EIR5U2^AN-)=EMV:L+))OZH+ M:LSZUJ1NY6#_\?A)?CD"5U_+N7(PM&_JD,F-!%YX8-*!Q+LVY_7P0!+!2.'E=HE)56/EM(2[\ MO:-QH-;M[?C.M.G]).U^8TF9`__GK8FJXD9?C+!Q"K+.2A[ERB0;L?\/EB%5 MD6-CVR,O5NFN"G3W#=U7$WXX%VJ:!V.=SW.I0<9.>B?=DVU!QO;W2N_O/6-, M]'(83#=*8,ITCWIM5AL5>'91@=OF:=V8 M!]6F/U5T1B_#'ZTF/]U?4M/*?9ES1Z9S!TQ\=(N9KJL4LHCNU`S[.J3&5G.Z M7.,F'R*$M[$CZJB]&;<$.E:=?@_/R=NOVT2-5G^T^N-!$C5N$ZPVDPKNXK:K M,-J&%UXWW/M?M-DD#Y]-TF:.M)DC3N,=#9UQ;A`,DNA/!_QH%(,F3Q6 MY^*UT!:;9@.VCE38%G%P#Q`9D4P@V2'#,-C95EJX!\DHGW,_\/1PY:*^XO0%&(JF_;OY&!YZ#`ZF2O0"?5R;]H-+]QO6>U;MYN)J*HB/GSBSU3:UR"\1E62NBBZ)> M[D(,2SIZ/1W%"Y&N0`*=*?1\;]1OUL%T8NW/+SN^L0]1!HD5=6MQ(?=K!*BU\T M@L;FI**EO+3->S6">*8/.+.A'-AA`650,Z,_UQ>;^]+AQ/T+?##"M:=ZBD+V MF8^P8L%8>CY)L'=58&*W0T(SP\<2-21K&P$.I2F!:9&+&X,1-=)GU($=3TR' M!X`?.[72[**(G0B"IJ/5,+U>^E!!G")`>T*PE1/*WD7X-3&O=3>PHCDSTW", M`757C.W=&WPR2"B74/^J03F\]YWSMV)*'%FTB^+%K-@"R"&&QAJ'0``Y79B[ M@H3/(WWZUY_\3JWR%>6B*.;KXV:**<$9I";58)$GBSBEW^L7MXGBIC1::TGGS1#LU`#N^`U/`-S5@CTH/O!F3YYD4ER9^\PJ]90 M8L#`SWB'8HQ/W?*[.2S[V,B7[[@SU!?_F_=)8Q\VAG@/AVK)5,K\;R;-6AM= M9\>]VV!#ZN;)8FJG!:['BR(-PPO?9'4@MS"V<[$MN-"Q4SF\^,I('[*18*)< M66/!@K*X73[H]%=U?,:OP(CLTE2'EO\0KPY3@2FZU=EH`2@U"K$G'0;#2;N7 M4A7SXG`XC(T#Z`3!JH_PW9F*?$X,P960^K;1+$W'I:(8E),L[,ZGG`,E2O?P M3=5"26J.\Q'[4+Z3[HC=[J^YYV4LNT=W:47\8MJ6E"^EZ5(Q#+YBV$53E5E5.MV)?C#561S^7%OYB$5*0!/Y,VDH.C+`5$C9U*4N1 M3/!QXL1/EFNI+$+=@4C.LG!-E--V,]V$`?E&F%4OSM4R1UIA9*[IE"CKI7#$ MFLY[,I#8W7+C+GO-9BE0V6BYYFBQ>Q7$@E&?%@7NX&3[:I;R"'L'AV4Y#L/Z MXW'";>,K/683_$+9HR(UP60$ZG_.'%KB7O,7C"!9.5IAM*P3PFND[LH"RCT$ MEJ5`HS-Q;M8)(B6'PY=P0`?^JAOELM\83"0Y9KT@*KRH$>E3V&<8E=>OOOD6 MFVZI7Z)D\1QD0D)GLE/4")D:S2)*-BFVD-=?JA4$A>U9/D4OEV* MW2@C$@LSI%0*;%\I)!45FU*$$4UP">E,@@D&J$YZU%>/:C6(EL$L9A]\J)`4 MIHL?I3CFH5RILMS#:58#\:]R<9C&U7&@L>HZQD;'M._2AHFY'B*<01!)(4^9)NMH'!,-E9= MS.&5NM&UB,3R"=99/FR%8/M8R_>X:208./;O*+1BL]^.VPV(#$I@_``O'9)D MV1WZHZ\2?*>?P8*BRN,B%ARS`A[>$&705:"N=1<(TN@Z;%1C[AJY&#/*W9K9 M,JMJ9J\PMBA:X[9E4&J.]^SPEQ3(_'PUK=-YGKO-_)6/IS:%.Q9/'R-'&/%W MP\:X5:%_+4[%G,(3E(3BIJ)1%7+G*C1NW*W/?/$=YN0B-7ODK3X(4.-#FJ@=8@S;\B\+]L4R, MCP;,J_`X?=:RC),*$R^"B-'XQR#@J-C.M@U8<1>MMS7W)7R*H3NRB>$;$T_G M!15-9U200`5W2L#8U+B;U)2A5\?0!CM^68:7OK5)"II`=PY+,"0EJ*P-9/[' M#I;\8:PDBI>(A=!V`:$*CV#,]B!($;I=KS8II<['I_`=]T67:XR8A+P].D5' M+;'&W,*)RI(I6.C9L6H):?>>52'%/=G_PO8ZV--II.9#L-*.^AUOT.L?X._PH_80VW/E[Q=012?A8LC%Y%"6^T'`P.6^"H+\H1 MB#@=2^];*J$9SA_GT!7WUIY(N@:,L=;SP"D&<[Y.<,A.=VQ<0U@:FX:^=YM4EPO*G)RG,D)/.EIYP\3=Q=Q0/&C*[J7 MS6:)4ET*0K*`JBYGD"0DC.=*,_;R\CI"SH*U1I0UURRN#12MLD,IQHU[:X`9 M**(IAM92$\E4D=O^3Z4(M\1 MYY&D0IV@1-!80EG7M=*KMR< MK$R*/MKOT2MZEGRQ*P3L\!&GQI&)38V3S=21C'ABAVB5X<;=6H$7Y%9M_SU& M?>$PX[;/8=,NL4JG,92\:YV'E"G&PY$T(R8-EWX)(DM.S04<%:F#OX-3LNJ. MMPS^'GJO0*"/P.?9:@9#J1+!@5=?%>&ERS%,@5R4DSD9NW5G^A.L(IS2>:=( M9(W0?Q.$-*'=F#_W'\%;*RXO<]=3\\K*,OD&;1)J$\6,!S,.0L@>9)XGPZD]Z?4\4I,N81#!4YG7$[A229U$$Y:9"@NQ=(&()184P' M*EJ9Q1*SJ]MPWJXK5=H8]4UNEMF^HKO4C7G8+7WD3*4EZSO8H*"KO_@`6"]Z M-)>*H9I45\G4/_0(!4`5-3^?+MZ\>??AU^ZKCU^^?/S]1V^P^+9GZH2&<9;% MG?#(56&^"4M6W-Y*MA![U2U+[0;*=8]G.;F?=W:>*O/GY^\_:SF?>0 M4I-A]AX%LFO7,("]A!.!^PY_/%Y?DU4E/%;6\_W"8T0IYK7NK",=/CK2X8V6 M#JX!M!HPJZOM:?FXG?@]'D#AYHOW[W[]H#F\=ETO_]:`<_@+6#+O^";VUI;' MPPL/L@C?8C2V.9->"1O?4,+:'J7V*#W44?(:?I8&6Q@(WG`*EE*<_+SW'Z.1 M4I-)H=Q]C5F@R]YK[?GOI!']XL^W3)!A'(Y+9.N?K]+M[/#LI$PZG%^)<-V7 M]OK^JR($;N]M.DKBZTT,K'JR[(:\:>+D7N[RY%K*K9]#-EG)W?:JKS(3OB"S)T@N$%,S!'RA M#C)TS\PO^!11#[#53!3)78QYAFP.[ZVN8;2#8\9F/C=0X?^51\H;')&)U\?, MXK&^$Y!*87I)KB5,BI^]=*>>YZ_#F*[F3<_C>1"J-(LCQ#7`%_=^-[^HZE?Q MQ+RRQD[\EJ'1EW_;!J_J@;P;FDF=<]-]ZBSX;';RJ-/K]?#_;N6>MM;D,Y_< M#MA$+>5VV)J\[X!401@>G=Y!].DR'W:S.//#V\:AFJ[Z&COQ9Z.S6^OKJ>SD M]M;7#=^*O(ZC*Y5D`9+]`X(VMKG([P)LMY1["CWT"-Q\?(W!-D]',.^/$DB)\@+[UP(L*8S!$<6:`JQ9)$(V" M!1;6SPEV,YYX/PS8#.7[#PN6DH$]]S?*9& MJ4PP-RD\#ZQEEAY!C"%D<$P%MC,""E0T^I6V0EAPB=/@7'H"">EH<(RQQ>O1 M1-`=D%."^BZ/25.;)G%*;9"!1\:,.)*!!>;#LG_H,S4.D=07^13VPSNMHK7^ M#/&\97L[C5UQ8K0EI9+ MKT0)+]!GJ!7C*E-(YR.JFIMH_L"F!V4NT9U:,"6:.W0G#(5)6+.&971A.H=0 M7`X;]#K'1^<5'#9P.;1QJ:1V$=G*[9.:VE&L=A,T=A*4VC7;=/Q`+TODL=NID MM.I$)W"5S4QNA1*YBR!T/]-+W/@<;^##'0W<$<;77`6^[Q_HQ8Z48U_"XM44\/7=GLD* M#%@&B4(,?ND2C#Z0\Q>-KT\?"`AR+;A2MO4KPH5T8?RN=$D0CT$*XO5,ADSZ MD6T+S)_H$VPIXG#X"*'C8^,DW?(VFP78<&'_J'<`^ZHQ$<5Q$.R?T@[\9)VU M&>S!%4\'H8(G!)I%]5[GI:FE&LFAP5M(J'!;K9G8$[G3N-)40AW/B!XD> MW<"[^+I%;]UV%($"4AQGQ`6ZAOPF[`Q,C7&V#,, MLH<8K%%:X`_=.M@/50FSH,",Q1E;&-@$&U=R!X6)X5"WZPBW33'GDM](F>3H M*Z);V2G"AJ]T@=C`;^U(R;S@(W1^FW/P@)HF*L`7MO1RT[_:/V] M;+L=K>?6'O!=G]P.^!\MY5K/;5//[1_N!@Q8E+ MUWMQ)^S%H0UE;31LG*K$>>C<$(#OW!2_?^0`_:`U]%K+8@O+HK)O^P/\J]\Y MWB#QKV6#G['$C8Q^O";K_$V'4/%B`*\5,'1>BH>#^OH<".F MNTB\]+BUP%J5OZMA/_NO0><(3\_9C1"[+4,\989H;<]V>ZF];4[R6>?L[/P^@H]MN+$5($_'MCD^[H&AV7^*G-*\S6@-OG9RS31; M6LJU!M^F!M_'41:CN5=$*_@^<^_DW%:@^9'W`_^XH5!B_;W,)GSP2MI=E.KIGV4DNYUM+4=FFS M(?O96JCMY)II9[64VV$+M7?N_MFG?`S?M^]-/$A\.4]NK[[G:6BWEVEY]S=O^G9[< M#O!F2[DV0V5+X(7*!G)R_[$?''C7;"H0NNDB3T8S;+D`QOXI05]+"X".OA?Q MI]-$3:FUQ69M"V#4`-S:%/L/>/OXPI[^V7Q:;DGV@[KIG)^`L7KDM".H_'!5 M,B+/I>HO9GITW6,;YDWQ?WFB_&]GECH'7'U3R2A(E>VG\4/O\/2X5P"L3?/A M7VJ4X2=&X-;[0$%_C/N&WTEQ<7B?0W^_5-P>X0C[=5SFPU3]*\=/O^5>"I=^ M:)=]^>D"VQLL@@33?2;8OF+_A.^,TOI+H\,:B%^].&&(U'Z;*9,J\T@&#L54 M)71M!MN@,IF1\TB9,#!&N9&>1M>5O>2>C/+U/!I+=P@SX+7"=XALB#X<>X/. MRY-^YWAPK$?P1Z,X06\@7![J#C3G57=^MFEB56_&U>1[KZI+XIROR+`.0'", M?^*>$NJ*B&9HA%]VJ;1Z65?XO7,#*43KW2'1CCJGYR\[@_/>1D2SYU5OY[@X MOGLT!YVS(_B_ER_UT/OL6AYYL;X;Y3\<5)"XS2MK4YENBE2\/#GM')^W5:0[ ML1G]3O]D<&.)1^M!M9/;53^@I5SK06WJ06W6$J/.@>K9GA>"N:]-I&+C"W"$ M#"J_?N([O"W=H8-LR5D<@G5(XX&=&8F;81+(3$H9=G@K=_1HC;/6'KC9'FC; M2>S0=K1)5>WDFFE:U"U&GR3-'=@T:?(*NM%+)KLD9WG'273(T+&P`,HE&8C]6ZM(KS ML[--4ADJ35"3-[$^6:)_TNOTS\]V/%NB<+^]?3K#4S20=GIRS;/>!IW>X*QS M,FACDSNQ':TQW4ZNF29A2[D&&--/T[A\M95QR3F[I_=I7#8B$[>0<-K:ECL_ MN>89,Y@'U^^\?/GR*?)*\[:CM2W;R3730FHIU]J6CV1;OM["MAQTCH[OW;;L MGY]USIZZ<4F@?V;Y/`9]A2`2;#'/*([&`>47P-NKH6;G135N+=;61+HY&GIR M=-PY:BW6W=B.UF)M)]=,NZNE7`,LUETP,S=MQW9#_UBO[F2&&OK9#9G>UH[:YV4>T?@ZWB7CZ_CD#HRO+V1X+>), M15G@A^'2B_,LS?R(6[@&88[@,":T]3V&V3KB[0;O-GWBE6H<9N^-XWP8JB>D MQP>]SDG_J#,8W-8T:_=TY_;T!.RRDSMK!?%]I8#PSC#Q7FP]6H&`7XB`'X"` MG]=U8+C\\L_W\)L`!'$PN@51B[I-/QFG,,XXF`0CGVYPL-7E""D](4HGFM(= M;Q3Z:0H/PDKI@42-5+#`I)H(O[UD?&8#D8N72M!)$?89#AQVCX)+X*QO##6,$SE.!#=UO*'\U@-IF: MQLFR0X_F*4+]4OK4.$@021H&AO_&,'`8\"+G,*UX[.WOO=//\&\045N^`?0< M+JM)>K(E28$03$:03YDE;HD6[I*'2\$AQM_C2T$$1HWBD7@EL#Y":=EBR$3- M@8JX,S!W,")AW43$?1^6'8:X;I4D?DB_7/AIYHRT;L?A!WP==C[)Y6WU#9'Z M@(:3/,L3M?E`B.2-@X'O.L=M]#./;QDITVZ,UXTN/?#OXQAO%3V?%K31EPZK M,M[<$\7;E0H:M9P`;Y0GB8I&2T_]*P]`DRGN;XOM7^'(VC_;X],!;M0$YS]G M0)K1S(^F,##FN,'\\8^HO@S^C3U]&L!:R=HFI;?YWT#QB-^:J9!(5)H2[G^@ MSS+"_,#(7JJ0N;&++IY+04XLG1/XX%!-@R@B9H+)*#:UAWZ(E[NTU?1A_!O] MPY*&9Z^_`K:Z.<-!!/.;\Q?\(9CP5@K0.Y52`+<8S/D\I,>"J+2]<,8-'^E> MQ-R?UP6,M\?Y'(XS'FDXS_WMCO/J[?7#I,!NIKY<&[!DU-V)PJ]7VR8^;E#X M$=H]+9B.K;H&X3*)0SK?[T!`/!.+_C-([R@#8K_CC7!V_%,21_!O3CM?#>+L*D7O6FZ\<]&43288 M'0]A7CP]'^)#^FNW-^AX>]6A@.(N5_G[>)`2!6X6^F'$,QM['G*P4V,A\GH<^'IZ/Y`%4#7Y8T`U[))=@.?YX MS)Z\(\@2M"L2.;8HZ-@^3-QOQ_QMW_EV3-\>%;XMIN.0.YO$$94UL)T5X+,) MPDS';.=HN\LU.@_U/-&DX@=P6)S4(A\"=3V,3I+-,B&7)AV!U.'Z!L>8FF0P MLS=P`.9NIE]S9,<#<;H1VY7:X%4,_R'/$8]$I_I,''_'F7@?^$,0\;2;R=P%#["3D]]]D,_&[.4W*__B@-AJ4M0HN!/>7J4I7>!.0-3AX^O9\&(M2L' MM_E4:3UHOP(B$HCQ#8UW]ACL67P#K%XX28=[U?X-\"M2!LX7L+CVDM'BG[)' MW0$OV,?CAM-C9[IH2^A^3+&S^*2X^+_,XE-9O.\NF?TXBM:K85;X6\>O_M9AC:?'%9P\^"P?O+1\W:2 MGQUAHJWFUZPTD$V^`%.F(7/7A6D]YN6@%6"3G0.#9^*UG`ET?()QX#/46^+] M"@;B@ASD"SAKF6$AW]-S?HLLN,1G46O!"2.DFH8TQA0I2+1A`E*P)T@I4SU:)/$DR'2`@)[W MO2%&6X`6EM;%F;%8,#X7&`S(2$PX\7>(%#=2+/7269R'8^PGEJ@0I":%IB0< M)Q8&R9&4EAB-.9Q(AP">4F$P!QJ@QX5/@I0%*N,R@LC$B9R=7*`\#+@*4G:] M(->`&+8S1BO1'DFBL30[ZZS$83859GN?L/-=E)G8F[5^+JW3JBUR,D/>!_]" M;J877OEID(KU+9QSN%>\N4/V]V&8,0\E5C45>O#1Q1A9@B$[5>\UVY!FZ'Q] MJ+_N\"T=)O;^5R5!`1[;'DH=N[UA%=_4*-?[+;76$2\*9`OQ/L^*C2,4QJ)@*%)>NZ"A MHC`I.#BI^SX\B6';?7Q#??.QLR/=P<0A;!G*W:$??4WR139:'AQZ[R9U7[CV M002"R&'/2P*NO"..FIT"21.2)^,89"H;O;K$>^5I$)MJ0:,7IX>R$IRY;AA, ME+';#CHN$X@TAET,EQMQ9AS!@P%3W.Q]Y4K'`>RH6YI>^13M9Y$H!3:M6N9A MW7&L/'5R+,=;'#\^S"A12$E=^:2OR[%W<_B=.9KK&W@]SHEE@N))!HYB9T$' M[>5+]"/K:R&`7_!HS,@4OC?]0O0KB/`V7VM_YMVD!^L?AY:'WZ\7%)S`?,C$R,IDG%=4HS(L<$%Q^Z'F.!C\&4&*NYGWQ-#U:VGG`)"GZ*<5#XCDN!/D;Y6"=.O;'> MB@@=)WMII?7]C;J]:":L#H!$`*%RR/8HSFSEU!6B-"6CQ"([+'E)!6Y2:#&Y MRN&MGX1RLRTK72`!P+BO@&UX+D;([W[DL[<,`E7NQ(:@7-25:!1D?A;TB0ZM MLH'2(>;&YY=@H#I*RC4RW8AK!Z6C)!9TO&O:Z)F/;X#.0Q8!)K/1,>UY4"2^ M:.%;$591]NG^\'^ZW;?1^)?$G^+3W6[E?9'^X3]?Y&EWZON+'R^!<'0C$&76 M[OD4@Y$%+/H%:/L*M^[O__M_>=Y_FG>PZ%5ZO$FOZ&#\\][JKP_/>D>GASW[ M__;(CX%1/ZO)SWM^VHTG7;;[CKI'_97'\84W\_/CT^.SUQUK(R@>^8]]D&\Q[8>9]M,>_NV\?$]3?RXMQ'!8>XT\>+C M-TS\[.7YT='+^YGWZ6"#>?>[O>-NO[_R^`WS[O=Z]\0EIX?]WOG9X4G_].5V M/%[QVIH%G!Z=G)S>&Z-ONH02NV^WA)-S6,.]L?SFNU!@_.V6<#XX?7E/2P!V MWG0)I3.P)2/U[O$H')^?W.(DK+ZU3N2?G<*RC^_M*&RXA-))V&H)_>.SX[.3 M_KT=A8UWH7`2MEK"Z7G_Z&AP3TL`KMYP":63L-42NBB>""V6\7IT=GI^'%]?7UX?708)],7 M@UZO_^)_?G]_.9J!(]X-(JP=&L&G7WS783DZ'1S=XK!4O+:6S?IP5,[O[:Q4 MS&:3_2D=G1O7].#[;%S@_5ON3^G\[-[^D+(Y[1W? M2MNLOO=XWO;&JUC1-ENMXKY][RTVHZ1NMEK&?7KBN(ICF-DM%K'ZVIHU#,Y> M#@:#[UG#.YT.\PF#K7%TD7'.*5:*?8D_Q)%S:_[.7)57KOLV0]US>&MPTCOM MG:VCSVTFW0":/F[H[6D2]3[#@L\2BG_S\?67?WYZZ\VR>>A]^N/5^W>OO;WN MBQ=_'KU^\>+-ES?>__SVY??W7O^PQ^E2E`_EAR]>O/VPYU68#E\^O_B&8_7Q M9?EG-W/>/!QGXSW/AOU+-S+ZUS"UR\Q/LN(]P7WDQ?_YEB]IAK`+=W^5@]L) M7_.Z'F]O8^ZT'KMF@.&VO`O.POBW&C>&A>Z-L1??XR4]QOL"J8>_!Z`@,/\C#YC<^+_ M'\323^6Z)M7$9T!6I2>19`,]=[J4F*'5GB9_U\Y'/G!$66% M](LU=IA/<_:RH>/]'L-S,)W+69XD_K"#Z<,X@@!8P\<[6*BG\:\+[U8C M8J,HQ<08`@2(DXZ'Z9C!F*;P)>'*B$3J.D:)PG0Y+`C$;%WX(JS\Z.C6Z-LN MD1F!(1JI,+RK@N.&,O`%)GMS@![_T#/I[CK\CLCWRV9KWWV?C0^\A#U4Y#OE$#H5Z_U%,S'A7X M@BZ7`?$%SOS42``J'27QM;>_]Y;_P>;3W@$H9UX0DV&&.4246"0)L)J23M7/ M(DZSKCY()M5^'H38I`C3Z+DMT._F%WL'G4+U/5DH*IF;<_$[9L_^BIFQ,CMG MC4.572M)!);)=+Q?X<\1V#93E%EY$DP[WOOWG^B@RT*Y*9'.O=6;8TZ>YSA6 M,M_RI_<.[OO`%?[R=-2PW4U#RSIPW%T58/=`PA4R8;.P]9M6+?,P?'\7C!^D0]`HO(FP'7:+'4GS[)F?(@.N4J<"PZ5G M5+/'N>M#A?5Q%MO#3]-X%%#E/%DA9%H47GK[;18,@\R[*-I;?)P6"?R86:0? M[SK!A.T(\XZQ>XR8`.8PNIKZ4G%IX*5CPVOCQEW)/B%^^=[>ZX^_?WK_%IG& M^_#QR[O7;T%O\\*I2`.6`J;`ZL)IG:G*T`2$%;I+*M5C6Y^'$ZUE%CQ=AU)F M[($+A]A:9;(WP2D2[>O_L5M@JK'U12"SAZJF%3#3Q"3=7F]R&HKMOY[P;E M/]HEY-UV/ZOMOH-6S97B]#YU?%7?YA4E7]&6QEZS/Q8B M]/>LNJH9XB:K[B*Y)&C2/WB+I@\#7ZEOHS`7@$WW(C0,P$!*E>>;V/M$P,0N MIDGL_:K`.1:4K#!4#/NW2!#%/5MJZ/]QCE`,OJ'WB_JW&`^%Z?0KQ: M-7_$"]_?_"@.?B)T("!P,,K#+$<8QLM1H!#TS#X<3[P/&`2%S?)>*P1=#/7W MFD33(Y>F$S^9>W,+D^'0E>@)4X95`N-=$S"T0:/$X.DG#-$R:`7RW0?-P<"` M?R$63*/.YO'!%[P:00`FEQYT\0XD@>,:2'<)O$Y!T,*;3/O6IKQ_(V.W?=D_ M&3*P?]Y#%)^M;O4?=^(526"WY/8=L[=:SG\8!BHG]C6(]07H#C4:`2M>O'\/ M%EB>H(IPD[<2O#!48V___QX\C;/QW7UQ3W?Z#+5ZMW7N=VBBNSNY=KN?3RSG M#CRG=^\J&Q;9?UU(ODT?K('??&\28*9UAH"(J70O2](,/IABEF&PT&[7.%G" ME_W5JZM6W+?&9I6;E5W'&#!B;/8&&9RMK[53DVL<^_<[)\4BJOW_V[HDK4OR MW`[I;DYTQPY4N]W/:KN?K4M2[9-\J?,QW+*`>1`%\WQ.C2FX\%4W6,.^('Z* MW8.P$F%?^@Z%2^^'P2%H7T1O^!J$\33QY[?5OZU&>#9F6^NU[*3(;-F_]5KN M4.N^H$HB^^/3*E_2AH'.FQ_&R5@E^)AK=NA=R^)%P>*0^?WY[LV7WSBM;#W? M5E8YW5&Q:#63_M\;&/(^IEM1A<>3^1C9BFF+-F-O6J6=,XIEBW=10+'@AC1# M1(D`;1,)6H?IQPA&D`'G2!W8A[RB.I9[#6/@UI:*7A?3'?"Q*F@<1V6L%-!6 M#%MMR+%W(,$+N M'6/:'#;F45%:@R;3GO4G>=9W[;"[9TTJS$DO>M2>CCI'T=9C%K]6)\>WTMME[;"L2T"I%6@NKGX:G[$O>WN M"V:M^LR:%\R1R[`)<^:`Y@V7V,X^H'S:PB?A9",J)LSO!YHT'=T1K(6?1=6D MDXS]8-Q%(#!_@8RMEY3Z\Q8]\Y;'\QVCJ_')3&>-H>+]G\@B4`F<1.]XY4!A MB]7R\4&KF'N_8PE'M6DJT+`[41/38([].,S$-'H[7X3Q4K%5K\$IP:Y)KH)1 M@Z#5[I&K^U5LK2$@RW$9PL5!52`6'[@/V&AVL8BQ!&GLSK--#*@0%I[D^GB9JRO5@PTVB/)SG:L5XJ6TE-@:V%R`!">-C8PH3? M83M=G+MV_^S'$6\^"2BFSQ^/(UZI+$.2DF#-?A0%")?K)X'5G-J!G()2RU#I M#O^23S$&&B^]H%BQSVH>YZF>?EF]PH(-R>[3YZ4IT]FPX)?^'%'Z$+)`B]?E\X>-]T!T?XN23.IS/O=S^!C110N<$64SHZ.R&*;3"E29!B M8132PD-S:US\:@MEMQ;485N@J"JIOQJ#_9XOP&'\!!Q,1YQLY@SL:J-*>-\) M+IN:AB.`'AV!@E9I'(S>8RMSZ4OT*8>3@V$X"S>)XNFS"BE<\%E-$5.2U<#G M8#H#O5$$[WRFM+X7I-3:/6DFB]^#%?5??@3*;ND-3EG!%&$,*3I*&-684P!& M!=-SH>EIR[KW]VIIO7?`)LQEG(-2"\931=(I0COKW;N.1Q#.WALX(->HQ,-@ M'N!)6<@SLV#A[:.*VWLGSDP6C/R1?\WV"MC3#+9-`([5P.%L M=''S"QI1(4PL#Z<_WC'11/T;#?8H"^]X^0)?^G(-XR]-UXPW<1BBJ;'_P\#I MGE%A.3Z-5AIW#@:?$90G!OTYSQ[-)_H)]P?_.\X37"0)&;.IDN` MF`II\,W;/SH]\(#?LEDJ='0L:J%.(8SN?(EI>%@X-G,?),4WE8P"%`FT6,&1 M'ZL0W0T"DN<_1(1\ROMA.]4X]`%3)2M3T]+!(1XAHO8E\I?],#,!?NO0^RV^QEXD'5Y#]6>IHT3A MNP1I,:)[+V<*O"CX`1<&_.!GVHQS60!?D(&IY075>&;^5_S?>*K(]J-IXS9Q M$Q#[C;3C?$5]&RE!MZW@KR^KU.!7YPIF]/+H;Y8WDZ\JT_P:,8V*)Z6"LG`* MP/\8Y6PBH><\0B\&P[/V?L4*>D>RTV<#QX1JCH1\&!OJ#HRHFTW69V](O:ON MX5%K$E%7FVU,+Y`[SB8DO`FN];5VD^["`LO*%MB7&.8VSD?*D73<9`ATP0@A M9O"LB@9@)5IK/5;C;M/?G7YD99/,U1*)Z4!B=UO:5#.$^#H.LVAHKFMH1 M]$97LQF8L1DX%S-P7&D&\F?U'E,*!)`P"="%QSXJ]931R.*Z34L5G]#YY@LE M,RJ(6%+O_9='1]1!Q9]3Y,>:MTD>JE1NFZ@:NI`')VB"K&=@%UH2R M'I1*BON1^80QM#^*"=4)."!<=KR]XN=Q812YLPH07RS,$C@R75&\G#Q01:M6 M^M\]KGGE)06Y7Y=XK1M-6Q5`#@IVJS*6B0FMLBR4]B$E>U_,S,!XEF)KNS<8 M95%W=%(?^R_N<\OZMSHSN(KR5=UW?)HJK1,WVH?[^X4DY M\^5D0*'T4J0?Z4$&83G_91)$/GMSHSA]WO;?E@V;T%2G%A-RAV,CEET,%@>P M'Q2V),'_:Q+GBPY8.J/FD/@>XF5\,2)WCH-U%AO(`FQ=1S=2UE"C4_G:_FG% M1EM'>(RRT9_;#AYW'RN^',4+DC3-O@;9FK3KP$W_,)9CH7-?%?^6O9>I/X6S M(-R,)CQV2"=W(9`.Z7146*VEI?MC,`S'5QA-*C0C!(/[R@=3$VT^*_5CNC#% M#L1B"G.(*AB!HD/ED9KV7MRR,>44"@$7I3>"*!6/"CT,5&F@VIS[43T#F"0Q M$498V@-XYX&&+\!C[:$CVPN/6X7%2-83*9;YG&)EQ?`M^F;Q1+RJ/(NQ-_@( M3+:E[74WQM/PN[_TCGJHPCQ,*6@*E1OE,YEDGV?"T3?0]9?8ZI%5QM:N#ZD5 M/W)B^I@9BZ&6?`&LC@]&<=1-U`0V`/4`_ZP3>5$Q8&OF`-LX3A1I\P$GYJPX M,X=F2HL\6<2I2FNF5<[)&O)$`\Y*!I4`OYCD>,BD2`'#"W3TLN0" M'9UW!H,3/JKN2!U[UCG4/U-+'H^__:S/\O>G7@81FC:%,.Y;,%N6;-)_4:-9 M%(?Q=%GH-=^\[(W[2"/(@?]/-HACWT1$\9!N>DQ[2_0<+-5Y_KU$K_?WY(_E M1M2KP69J!)[(]9<$31&B76*JF1V<]*W^*#;8UOVY)X6\T-70R49%"EI0K+Z^ MFB%YYLJ,<9".\!:0_WKZ\F]X"8C&L4#-L[CB2`W&PYT/@%&`::AH,E`S*9AH M&``YQH$@\-/;8#LC\1)_S*.ZEWV4]]TY/3KI','RA;S7?EJ(TE@26V*2F6*3 M-2.L%(%/(/V[>'81H`+$L+)1E*>@'[#WP(0TP"289%A#MM\_ MD7S/5DQ^EYBD@ZP3VO`B:=D8>CZHZ),0[LDZH>#>3DD"1(PA'^I0<+D$0P8. MRB?0]^^S\6&'PDI@K>C^W\G4C^CPV"L>NC$1:?-9+?(A\`Q%->#@^@ML^+N_ M9_Z-HC&^UK73!`V#-S9DP_RJ8'CEO0K]Z*N*AN#R2H1Z`;.D-(:.22SFH[QA MG1=,H+1`N@E*2W(*):I.CO=,%1A.K$2=8NC@062H;-R=B]'!V:!S MPN:)E)M;&-ITL?+;UQ>V2_T\?A";`OI<%@#_X4X8,#/I/`(/M))P4TEXZ7,[ M7[G3_R,*L/6*[GH#?]"BDDO_8`/_]!.L3FA.DNLU7),BNIX]/S,[<:"A=&X=9KD2^4!J(WV$Q\ZT]A M>K=.XC0Y+/#]T^/>"?QEP<4B$Y1V^]J07DT?-=>TE"*#O9;2%./LF%U(D]'\ MT1S-.;J&`^Q'Y,X^*5/U(R!,X,N6@+:=CG*W*ZP\``V:\^^%FH M>W`7[+FG6\,.F%N7EVAB7<]BLAK8([-'$BP*R3XN'!@V(V(Y5QTZ)R,_G7%B M:)K2[:3Z%[9L`PX\/^R9+-#2KH.-J((K:\E('IASA0.FSS&G0UGV]C6#%_C[ M'+S,HZ/MF#M1:+)BWBU\Z]S,4IP:JH"6F1DA(DFS:TZ$/9#;GPV4GU69$GN\ M$_I@LUB%S:MZ%F@&)FC57\8*[7#5H!NJNSYA>(.21VBAD\U/.UP6IOAW;91S MHK\J.&)&@51Q(3Z\WS\HOH`':)V\J]BJFKS1HE;4YX5FK(]CX:B2#,#C";QR M/T>TXYQ1>T2U'(*7'`'%"3H8R9=D;B^BE'"')L?'%)5_WAQJ!6W&1;=XO2QW MWD"Q*G[11*SZFQ$W1HBA%3B^(HE3*26K1O&'08@[[Z3QXCG"GHG9K.H%N2YG M)Q>_&(RM!SJ?H_CTPVHQ=:7"F-!K*^4;\6G57Y!7$:FV8]D&97.[1_U M#@P69+7927UT(\YQBMW;I'(&("P'-P4M0RPP$-,;UHU1)LD+=NB*Y7-A6#)< M*>9J?VM-XB(."1J=>#%.:;_&GI67=(SJA@J$PX+"PKT82X"YBN*[1._F2-K[ M,#%JCLLXY;ER*\IU].C4V-BE*D>RTE?/=K$@&$C_Z8*/ M6]WA0FR=W=FXIAROQS9DVMN`+0GV3J(EQ*9&3ZU/T6FO#=9?&U16FDID?'_3 MD')G1>9UML/@M!<)VX39U@LB>O!2V.)H?WC@78(7!E(=1:;$5GA%Z(&9O M$;D+JJWM5"X'"S?Y+,5+2T-!;'$/=&S)O:'&4"6ML@R#AJ\..F='@\YYKV_V M0NHBI<1RG!LH-H9^0"@'`W&NAHE;<7PDWP)'O$F&TJX(IH)X9+Z M[[E?Z%0&X+1,JPRHQ95!35$T57_CZY[*N"/)O[L/YE4]Q&*].OI9OF"J7(79 M.Z-@JVZ=#IJG#_GDEJ^M6/,5?\L1)EUQI0\N(EQ7QYF`3^,AR!:I@O01:I0N M*;.9IMM*\*@**,!(:"[;:/Q+XD^1EMUN9;F*_N$_7^1I M=^K[BQ\O;9Y?RGSU(<[4FR!%KS)/U!=0$J]P4G__W__+\_YSZ]>\8/SSWL9/ M'Y[UCON'/?O_]BBK$?[\64U^WD-&[B)AN[WC;J_?S6+^J3_H'O57WH6W_RZ4 M>?/Q]9=_?GKKS;)YZ'WZX]7[=Z^]O>Z+%W\>O7[QXLV7-][__/;E]_<>O.Y] M06AX`79_\>+MASUO;Y9EBQ]?O+B^OCZ\/CJ,D^F++Y]??,.Q^OBR_+.;.6\> MCK/QGF=WH;3O^MOT!%I[3]C;&4'IL8U1B MP1=Y-HL33`5N#.7NFH4(D@3TPYSU",K3+,9F"E::UX3(5PM"L`C,4-0"$,&O M/T;*^TV":AK:<5]0[QG+1\O]%L6Q,A+Q(;[BKE_]$[<9D+&,%V@B4,22(8E( ML8O&O$BR8"0V"S@.-A,^Y0KS44(-L"@V8;=O9?\)G#,NQ$:Q1L2"-.T/3I[H MACZVN'*3I%NB;4BTSX@JB9%,IQ+NBVU`TQ@ZWOG5]WRNQMB%*UP6KWM(*=K; M1NL@E)II]>I?!G&J659RGX=*& M!'6_,/?.MF)*'8U.X?87J^B$Y/,\I*"&P#Y]>S%:>+1AZJ=1F"*JJM"YO5+ MM?T^464C@*SK?7./CYGB\(GB?H'[>X7&@7L'H)LC`_[K-@:4:U*#*6,+"Q9Q MFG7U21KF\!^5IF@2Z&:!'.NP;?[*=<5D<;HP.;_[7Q5U5]!M#9U%ZDAC(<+X M*_PY`EMEBN(]3X)IQWM/V)RI7BC'5'1H4N^.;>OA.,HRW_*G'P0ZROR[B?T\ M!V^OH?!PV?84KNXIG/HAQBFYL-5I M;-7%!/5@A+V3UO%&VVBX%4QM]^-MNQ]_KSAZ#MV0FRJ8GDBHXOETM'QL2J^T MOW334HK;@/1O+J';UJ%MZ]`&M@Y]KL?++119;4:*Y-ZF6>I-G4GY\N8N.JL6 M$S7:_2OUO'<-UB'86*)HS%[J/2!PYV"N]X+WS#CF;4/9;=6\(=VQ,'RKYC=6 M\RNTVT3-4^5CM6Y?H]J?HY;VS9NW4=/]%3VM1FSSGF?K^VI^^$=2*'Z MH,GNGHQJ#W?HJN16PF]/NU M>T'8KVHFU!@BWT>I+DU66.-W.*L6*.UBENW!B'.Z=`P[E M!C=7DAN^PR2UL<@N;_'PY5&.X%,HLP'KJE*0&^)K@IMWD^+FX=^#>3E8M%8IQ MIYCNZ^'OMK8-1/YE,Y_0"4.L**'`NJ0KR!$H`@5V^)'`J6Y#%L<$=BI9,:@8 MU,HG03Q"YX+.VE2=M5]A[CFGR5?"YJ(7>T8^K"OE-A:U%$)G1;: MV)JOCO$78U.Y:PQ#1%`>)0$E;.!E'TS#P"=219!9Y6$AGTMB)@WBZ"]EEAM[ M@W.T1$]7`]<%\P88OCL.PISP(/&(-$=0/+K3Z^#B&L084BQN MO@6NP/QU(;)(8\I\)J@6,H4:0_9[<(VIMW15[++D%VNR&JPP]T+*? MS(_P'_E1.^K>PE M($Z-)L5Z>"Q#H:H_ZM55HH45B*$QT2PT66$WLAG\W=L_HLQ;Z\5KDI"22#EJ M<'YVAKO0,6[]:76O@,HN`8/.T3&]4SECXCF]INH6#8%@EM(N5@["6:J4"UG, M5VV2YFID[DLC)^TFINJ(H:+\K@NCCO8J&4T_]\H^1VRG?__ZAO<+V&4U9P@D M7!CJA^H.^1[0J^IO?UK,N+H6`2M+]4KH=S6V.)J8!";7,2)_9=4T5!Q9R6Z1 M\JO%GQ76('>PZ[NMK2K-\K"N,X.KQ&I0(:D-#/KA0[S&4A-$O4OOK@L"WIG` M=^AOZ6TQ^JFA+C[X1-GJYQ4!5 M@X/'ZC9125FGK?;M%M@8F_2Q78&J!&LRWK3!?PE'-]0@O^UE&*=H#0IH7I?Y M(@&Z`/WRQ):?9F*QXOS^&2=?._AW;$G@_*X^R$MC[1U4JB'Q+:HUE$NP(!A,3$;WY$2_*5&GKJ.5`'KV@D5RMR#>A/?;R2+.*H M"!O@[2&GVL>4[8"#_`!6^/%`)W>HXRW"/+6A MT5&<2IN::NX(_6"ND6>K-@$4T`C!9JW0Q%&'`FU@X79/&A#0>JQ##LFSV:(*?E8LRM&,?9#7-Y"[7'DV# M"K11Y+;.92/(/X,!R%-Z78L,33JCYGBM10VJ9%X#BRC\1LSW?-FK>,BK2&PU MDZPA&TO#0"0XF0;7"U?E53KBE_P%=*JK`P&;;&"MF-QT3ZMEH[E-,C>V?(4TAR]S M7A'^_*\\!G9#,!1"HF!1"A(NH,W:OSAP[93]0NZ#79M<11G81;`Y#CHXT/ZK M`^_T!*^)MSC#LM>5LF";<>"T@G-=]9?C7M5OD9_NI'-"S9Z6=K?R2[#T.C;J M#WI=C%"3O543))`S!J).6+[2RG6"1*!;5)36!`]L?4<5@U5:[^ZM@!&8U6DK MPBWU*F8?+YD9YS!&\(`U*^[6"'2KW$LQY:Q6JWJ( M%=W>026?4UI'S9>UX*E<>H4LJAS_HG+B/PPHD:1S8P.2_7[-^R?BEE7]53C$ M*HM*V5-(8*EZ0GW#LNCJ5BU!1"TP*M\KX(96(F;Q!*N[W!Z.QE$5^>_BJZ*(K538IEYY(W:K9#;)(RKI MM4W9BU2=I"ZJ;1KH_'!^U#DZK;[08@I4_06)4OV-NGU!TFWWQ@W6Q;;Z9Z.= MJ;XNB7.JALX7V@J)%$KX#'-(0RF&=XPZ`U=[2&#`E4-21EB=R;6&KROU7`A6 M8:T'4*\Y='?4&I%+=EOUW];(%3).,TQ:0:.R@7+AN5- M)D*==86Q-NXR4*W9,%-I6#W\4(%A4'NU5&?$$*=,0HQ`Q@S@-DI2T:=UINTL([RH5.!N[M=6L!LO+PJ6SSS5VDXF,UDC=(F_4 MB"9FEP>1%PE]P>8[(GWB]52A>Y';W/&;]CBBK3UW=BX6A'*'5LGI4F[ MEL-*=<%]K:W6O*8KOJC69"$^`SLB3Z*;6L)4;SFHYAOO!@H1X/MAKZJ_W$JH MU*B$6WR\ZK?USM!-VUDIIQWKD.IA.,1>O0G6?`VR[2U7]]+3L?9T!8P&A4%S ME/JBKK?XGO45Z?8G?J-;T]KC"7L;Q=RLML:.$L:Y\1QOZ0%5?6TM:V%1KW** MS06XGDPL\K1KHP[PUE!%:A*,:L,6#/GDA-C)7JTVT?W))`CQ&J'RK_M^=3MJ M8?-JL]&],],-H/M'^V-S@6C3$JM>MQV91G31U7]Y=$SX4=2-$18F;86.;$HJ%ZMZ-)-;4J3QC(]O`Z8[H4$E]1WC"K,@O)^/@Y>'+EW^KBDT_7UGY M$2B@%ID@6/9ND[)DFZ"M-97N*O,'`>=&7*>Y^3WCC8:<\?(]?PC?[)C5C15P M"24[VQK-U22J`E@(:X2,,I;Q8BH+E:2)4,DT3(8E[9')]5HWM8XD9$B6GDVD MH;Z&<$Q6Y\YG3')+7")1Y&$M'9Q]Y1HPF*MGY8K^&[N%VOBH%"LVK.*TKZ<) M'A80BON5)7,W,=UV-.1N?Y'W7W[$3>8Y5_-XNV_BLUC?'@++GQR==\[/!P_# M\L]6.GUQ=D=7[DE&KLU()CAJ-10PZ6+I,"IO3&#%&&<>I+/"\X0MN5B$&.XL M/2(9N@2XK*N-PVKTMN(FSS<_3^+HAY/3?J=W=N8!Q_F9QKJ]Q4Q76E>OIV)'9(B@4_I> MB&`2<>W6$`P&3[5C<&82M4#L:XMTW0(P?V?!1XL0=\L*F;10+5\![=GBQZW' MCSM=@VN\?\=0927\B'0KK";G_D@CP%D3C*$0M!]TM#\\\"YMWJG@-")LHXO8 M<@OXIYK042J`D`5QSW4@I:6A*+>A!UV^[^(7)U2;":LL]Q'"5P>=LZ-!Y[S7 MEU>*'6,ZWM@6K<N8U5=:<&XX)?P^"_^5@])GK MMEN#U%4'W+1,JPP75::O:*U2]3?&#*R)Y-9<:FR;05[46)7!SMK[ZE64PLI5 MF+TSVK0*NO"@>?J03VX9^Y`U7_&WGA^FL,PNWP0_^H^SV>O0L\4SZ-_Z?;?1N-?TG\*5*@V]7GM]@U M6G[XSQ=YVIWZ_N+'2]N3)64I_R'.U)L@19S)/%%?X-2]PD/]]__]OSSO/PNO M<7N,-W25S3?7+":IY5+*"-M>,/YY;^.G#\]Z1R\/>_;_[5$'&IC#9S7Y>0_5 M2A=;8W9[Q]W^H)O%^-.@VSOJ'O57WL6W$4>57N5-V$,*F@P24V?6#='QZ,BBMZEL:_!@%X<][69*KV]!I=<@50GV; MAU'Z(WSIY[U9EBU^?/'B^OKZ\/KH,$ZF+P:]7O_%__S^_G(T4W._BQ`E:";O M>2\>D#!'IX.C.R9,Q9"/0)C7<83HR;#2CQ/^=Q8,0^5$>&^DUHU#/+#*.CK9 M0@#=./F=I.4C"/;^\39RO9ED?10[`@G[I*GZ",KVZ/C\]*E3]:FJZH2RCSZP$JZOXTV,9-\$!H\BA;87`D\+#$>P=+8RM!X6&H\@BI[ M^7)S3?;`Q'BJ&NCV)'FR&N4CY:/>2`YZ[*$UR?E9_VC#`T+SN[]E'_=O7O81 M+KO7EV4?(05HV<5W-UCVR;AE0?@`!/52%N3XHGJP@_2YVJ&M-C%]=^,OZ5DH=N)$_MJP^L,,^V MB8_63GHG:/8(.N>HMXU[LL/D`X-C,_*MM5BV#B.?/!'R/9;"/WHJU'L$<^'L M^.S)4.^IVAKW1[(G:Y/0_[[".EHW+WY#HJUY>9?MDC73W@W*/60LX'0;G;KS ME&N`9MUY&@(';4C#M3SXK&G8!/]BYXGX.%[&$R-B`ZSEG:/OO4L?VYN/K+__\]-:;9?/0^_3'J_?O7GM[W1+%FR]O MO/_Y[O'C[8<^K(,^7SR^^X5A]?%G^VXT#\8:VT47 MS)^?G'3[O>Y)SU1F7UR^\BXL%ADP3C3VDS'">XRI*:$I`V;89UUPR6!_9@^H MDKNJ1;U"R#"LPUUY&`9,XGPZLP7XUX*?;@M8!>P!8=!U$_C4`TFC$<,.\-B]/C$UTBEAF59.DB=HEK2D65_#2R&V MB\(8^3`7P,<\A9$Z#)WH6[(@0"K#'\ZQ3OOMFU\O/M]WK?QMJW,W$/O M--C;RO@:&=]*ZE92MY+Z.4OJ]=*YM;KO72+_^9;%SS`.QWMU6 M<%<*;FQIJD7EF+H:&"'I9QK["/XPR027;>B')-S3F5(9B\]:>5HMH0B=2<04 M2"'3:UBZUBR].0+"#35^;8VTQ47\[D<:(ZX$%.0T,-;`WB@&\7\T"A>/3L"] M%2J"FG*)UF&((%%Q/VZST7>]^H M0G$++[\NO7<@A)/(%TSQ]PBBC@V&?.^W&)38?^/_C.($MIH-BOT]]^V]`\(+ M7("@0R9=!8O"WP@,\RINU'!9F$HEFVJT=>%/6=@5MWX3Q'G=>&&*,$,,VZ1? M(U,&G]9P]M@[$='>X*D($==3Q"&3P37L&XW#)M%)D:#RW;B\'7PR"`Z;9H60 M:3T',@VA"?LR%*-<(\8WGPN'1!.EGB_\V4<&'ZM$YU?(I(3]".SK&_BRMQJ0 MZK/%,?/>JPQEK87+8^0T?N3_;^]JF]O&1N9]*9I+7E]_;:F31I]WK7 M-CM]N9W[="/+=**M+'DE.6GVUQ\`4A)E2XZ=1+*88#]M8ULBP8<@``(/Y(<' M&05A0M)+WRH"X$'"!W90V/OC&A5CGOPKI=1,?IF2GR4M$M(/9,L#O<%]RK%U MZ48I+9_.23SJ=S=S1>H$O;3C5U0[=2LIIE[,839Q'3+N-/Q29]A&0N3"O?JA MD#LRIQ2*OI"\*)'*9I+*5%B%#&=J5F7\:^MT=!E!:&YAX$@6V%+Z.J.94VR, M]ER2UF._GJ/1<(B+<90R10]V:#]F'75[])O"T1)`D_D4]XAR%2\XK5SA0R1U M(^)QA<0QS]>HMLA7$6(M_TG&V%;V MF`>@GHH^TPGG2BR?M:F2FY?OW5I$\XT&'E%W'J6[?&W6]*C`SS8SV4C$H%<, M\VPS`L9F2]E\-"X:94+)N,;,K6NW$N)%=%?)')C@<2AFR#%*AAJZQJ!4<_2D MJ;F9:D_MPZ_)AXD>C6]M=87"VM2IZ33E>RQLSB7A^>Y4O1"W(EC(AYWVL]9D M&8&9&D5P>M\4Q#&*'J<+HE"+2-D44_N"Q5_<*K?D_-`E5_1Y*DR\@?1L/.7@ M_1+Z":LD!C"2>5^Z80P;M@M37Y\Q+N7TD:PE>$&NU$)%O* M.EIL[TBZV4)8[,1`FW#.EA@2S>.=159QYIU]++RS3T45@%/UKR6XO%;.K0K% M''QN]#B[:2$P77220P/.3@?08N`KZQZ;/X'A+K$#\FMD.R[8[);Q^3/XR>/514_E$!YUSKTBF;Z/1(T:=-*GI)ZTX;M6-" M7(A]2D5+'8+J[]BN&-1+:OPY3KB404M8HRA>QQ1%ZA)>1(KDP%G34S'BOUN# MHZ[57^VL(0^M=G^DM^2`A>UIX>5>'XS5_#U`23Q#BQ/F7_2D3:9T[8>;VK:N MPT&%"!?@V#CN`C2$#!;2RH[D\NB_D4O9T>T/LFE2P,`71K\V#R;R46MN MQTO5JD/=8Y0WK0G6)M(OC1]E/Y)069W:48$`R&[7=H%=&*_.+J56.J66AZ'7 M)4)!L9!B7#-ADQ5ZM'L;'\8T0D'U/P90(X;2^X_,'RUIA:ABW;NU0MS8Z6E% MBSN< MZQ88'J;?A'/I!UYP<;-VIYC^.PF>OIM,EJV/'T];AP?XOW@]+INS8PP3CM5@ M@?IJ$0:P#42,PYK;H?L':">[-;/1N+N@=\(,PZ2Y>_)ZY$AN?4<8R$MOO;=W M.I`C.81K%TQ9VL"R#6!NSG'6GXP>[CIHRRX7:#K2)L21P,`R.W2AXG#1ZN#P MVY,`NV!C\(SZ6T?8-8\LT.OTT@+MVLB!QU"OL2#\H9X#3\DYT2@G6$_0]03W MEB\N@MB5'^$O*!XU$?0;3\19[$Q@&[49?/]G#`:Q^/%PC8:V<\"_^TE,^S#F\%/8K(2;_7$SBYKGK-IFL=3\RTA"+E;\FOZ2JMG9X+B0:, M20/BM7*(&A"627A>M+"Q@246GM&_%QAI5?^^=J?QY>N#3KO]B_;",/O?*0:S M8%"O#V`?QL$\_(=71&6ZAP'-S*XAR/$P7^'L`. MVNF_:.G"_D7]^,F&+9'YS-W.NN_Z(IYN(:'.+RD"9@$V/UQ?P-Q*'D_M?&PXP'75\X)":#M?+M17)WVOZ&S30L6<\]7T:ZOW2[SB M;LU=WYTOYYBT++.,0O'GTL7KJJ6Z!G(CF>!,US24";27E!Z.C7-L_&F%J3C` MQ['QYLK8T,'QUGDH;_UQQ;];A[)@92HKA&02-IU]F/#W[)$><8_+>7\T3KFU MG5/>7-`]T`%LGA[IF[MFA@Z.=W=C=OMI9OK`0V3'&#\'\W3,DTQIN=VV:%+.`R>T/,&$EAV.2$YIX9063FFIZ'P< M#3BE)4U/R#^V86DJ\/79NP@$9,="=B#+_XEK#G?>;,TO(O\N2=:R=<>JVY,H M6LX7!)LB*#^)0O)O1.LA%K8B)`0A%7?:$]G"PF/2A2Q`&2/BL!1S+V*7(7SY9> M"Y]#$+D6$]#?(F%5H)TJ]:D>T1 MKVB\#!7'@8TI=,@9`P^$W2Q@:"VB#?,=I'66Y+?J#3"=8`YBM'_2'X[T/Q#1 M0D1]B:9B)HAW#/^N[1Y)5$84!\E+<88%7W]%F\&A[D,BG*=LF:U@D;$S1.[< M]>Q07[FC['=7@0?OHJ52NQ.^`/_2P:/X>=0:S$5\&=`"T-(D2P+'D_989"<" MM(1JU_^YA(,23AKLF(0\$_XTDJRFH1O]:,V06AV_>A@]>Y6^)T-FQI.?:T@E M=<^24ASMUD7@4F<*D%;H(\-$@!R/&NXUM9MM`>3BUW;`!%/G2*'@N%"_R76= M9HSP,YOT9DJWAN)>^HIO36F\V'8NI71B&D;9^Z0,$JZVTE'A*Z;N#.:Q]*2& M%[94P&J+/EUUIU&S3&P\%)#&6Q.DCVT3XB`D2A-$9^@*W$\H=_CPRH;38AD5 MG(\ALIUZ2&(Z52QY(0@]D$0F1*SGR3V:P*+H3(OA)/8E/*\O`^1\3]E:'#=T MEG/9X#9*2%BQ[8?49L1TC5:#HB.,W(BX5>!L1P#_L9Q>J&-S$BSC`D6\Z1A/ M9^@',4YKZJ+5L0!;!N5(;%D!@KL5!>`HB"=,G*W!*Q072U"C2.*OF"0EV?0/ M<4,Z(0C7#]1$1ZI#*7>$P:>H=_\BK44'28RK<&6#LI88P^57+>RD&B)K$M\E MW[0"H7*@:\C51O>\=4)\E]2M3J2'#A['>-C`K*<("J(FHE-L59W+Z[U^_G'__?'9\>O[Q_,O+ MUM]F])\6>FX&<-/M7>A(H3&0_0M-56G#'MK/)"\LD;2F/F;J-"(&P0K!!=6< M+`\-IDAU)OZ#*(B38$)B^K9\`68/=>O#`($<$[WXTKVXA-V0.F7XAAA;_*I. M(]$RPGWB3E*WETR@Y%OP-.7U4=N-B1P_QC"<>&W\2'F8(C*-L..;%$>BA!69 MW7<)LOHDKV=]X$*+R<.G0+^_3<N@8JO\C:*Y%6K5,$JDSV+,JV'D7*W>ZMOW_%-+_-7A3JG+`XA<H]6"69NQ'AEH8[U MJ!;EHMD5]WQ%9O*H9A:;9X>6#D9DIRLQ6+I9R06KP">(E,$GE9&-W,ZV=X,Q MS[3[`+7TLC.3S?7I)F&9V4G12C(&/DKY1BWL/17,721\29-LW]]5TN98T63N:NP01,^&#>D[:P$@C$,G%B5_\`>+5K)R-4LZL MG5>$@AT4?=A4-ZWS201X!K\OB8E_LL,?T^#:KU(-%_MWNB)=!#%>MU+T1OQ$ M?U9>V<+N/IX'5[BC734'LL4TG9I%[*4Z3&:J7&?2(A?P`+3[KEQ8K-RWLHOM M5=VL71Y$92ZJ/@5LPA)>R5,@>WYT&;K^#VPTH(\9%8_V/NW":W$)ZMZA_(+D M$(DX0@=Y;>,2>OP;U7W.>W M0!PR_4%K=:=NXU6:D0>OF*@K<-BC^HR?LE!HTQ-FACY,X%K2D5 M&C^8N;1A;IB41WO$BMY[<&RC9\B7LC*>\K>E M##9S)I[ABF?VV'4ZE4WHLI MQ8STI-UEN`@BH1V?$U01,VP_:5_8F%F;'&/P=15RH5]?VQ%EV25GMU#JQW-_ M".]&FASX.;EK60J5M#@R]8:#F("U-G/CU/#`6=%<5N9`^;]R;!-0>+)59D%. M\7-]#>8VY7V[>BIDYKF*?^-,O:%]' MY\L804/5L%A=L>D+2)LP**^UL*/C8+;"LC!8*:\`I>?*;W__>G:`$4`8I1>A MO_&F-QIT.MUL'IN&\L"S&FXQ*RN;U7"'6;7W,:%>>ZME2JM@VCM,J#L8#WO# M.\U*X.=B>H+1Z0OQ>3F?B/!\]A5M5NU';^&`<^!I9ZZWI/("G.^=?OK0'"&9 M6*1YOR*9@=4>6[V1+IL[#;L!4AO?+K4.2@UD)Z6F[8[Q;E+K]=OCKC7LF"^U M!RU$NT5J0VO4L\;#_B.0FK7K#K4RJ5F[26W0&72Z_:'U"*36W09KG78AUKH[ M8FT\Z%KC_O@12*VW#=9TJ6E8Z^V(M:YE]:U^]V&D]G,2>NY+?"-)8+$,Q0%] MDGZF(@1OY+_P"_]XD?^$'O0B>U+AD_'`+WZP&P4]JS-\"=^XTY.5E#:-6G[E MKN/^'S@Z_Z-'K+Q$QL_4WW(_A37`P'X0IA_N.FWZQ8M-3]1>=R;P=L+?_,+; M1+'ZQO6')I]J\RZ3G]H!),*=]49>RI+)977:&+@$-\E%Y]*Y!$?RM5X='0GG M^45P]>+TP[_!5&ZW.[WN>(1.P.J/5V:6>Y=ZD\P(6'U_A-729^`)O"9'05[H M*FRG,(R?"\]UW/B30'T&+BY\#RF'7A\DBN]K$@5[1W<`�/?(Q8G?QT06W^ MG'M^]%(^+1TL_I,JYZUV>_!"?GCP)GGBJ;W`:PLL.8[D>__QHG`X:SLF/X][ MXXE6SQ0\]1A/)7@Z26^!?[/=Z0=?X8NAM36T!@/+8G#EP!7%XNKEMP!PI&(D M9.FQOMH%5.T>@VH=5%\Q,?(R\#`]5S[Q3,RR$3"VML%6OS=@;*UCZW/@GPG* M9G*O!&NLG5'%IV"QB?5%R,SM=W:(-0@,JEU`U1XQJM95U:\`J(]!%)W2C?@' M'^N-,-]8G,\R%?91)3O<,."V!UQOS)YB`>`*`99<@#*^=L#7<,SX6L?7.JA. M*&N+==A=,-9N,\;6,7:R<)TOPO&0\![S9#'LQ:?EO9#6'0X9:>M(2W28=K>I MKCZ_))7(IR#LT*9,N8_N#$RX_PH[Y)-T)^QU&7OEV'OW4X2.&V&^*V/OP;'7 MX1.V*(*F$CLXZG]'7%E\3[G1^SRAY3N??8BB)2;\,[9VP5:'L;6.+75.BM^0 M;.,+AM-^$R%I+@;7#N"R.$Y;Y')*RRN',8;5#K#JL']9!*N+BQ`IB\!TCT,7 MWN70Z(CL20UF@A(2&$QGK;%D^%5#0V4=:>HHG;8YU3A MN\)U!Q.J<9Z9R&H8HS[TS/O#,+<)QY9UKFG6'XXJPH8[.B M&H8T:Z5./$5:CZU\0ZQ\ZRX%\?L$%5OY!ECYYJ&*K7RCK7SC`,=6OE%6OGGX MXOH:T^IKS,,8>Y)F>I*&(';>'&4?N^+C; M1EQW.4)2KD$;%B&A)=P-5+3.>P(51TB,B)"8ABJ.D!@>(3$,\,YV:V[9,-7''';@"?F9#>' MD]TT:#%]MCGTV<9ABXF.FT]T;!RHF$GOT3#I&8@]KE9_)$QZYF%OP%Y`V4WP MY\`_;117@GGHZO#E70&ZSN-+$>)#0G&)K[H"S>4$<]%A;.V"+8YQ&\`!:ARN MF`/4&`Y0`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`J&Z.K M;&J&"U?9&%5E4SM"J;NA'"539F5MG4C!.NLC&\RJ9VO+`9:UZ53>T@ M8>/5Z"J;VO'"P57SJFSJ!@DW8&]T`_:]8H/;IS>X??I^D<%^L`&U>36C@FOS MC*G-JQT97%1A2FU>W=#@MN$-;!N^5T1PTV]#FG[O%25FO%!9=MFE.V62LPN&RSX66;M:+!["*?ZB4EBQ'-+['K5ER,:!U;`Y!4W_#F M:&HFE4E*:U[>Y_J@!U(\)3ODW..6_=KAPRK]! M*?_UHX,3=#GU8T)]O.,]O-JA@O[>4;Y>76C@_T\T_R\NA'"?IZ9?EZM.#':SZM<4J/C M-MY\#ICOSQ@_#Y>L/DBPGV>"GU9Y>?5C`[V\XSS\VI& M"/MYAOIY=>+$;#^O!DGAS>?(>@R2JO3F4L.*,07/I_SR[F.05'7Y MY1:VB.F,L#&)X9GX:B952BJI[J`(+Y-3&-*8Q*JXF&45&-R%PI0N%+4C@SL. M-+WC0.V08,(\8PCSZL<&$^:909BW!V1PU*GQA'FUHX()\PPAS-L#,I@PSPS" MO/JAP81YS2;,JQ\13)AG'F%>_2AAPKS&$^;5#PHFS#.!,*]F7#!AGBF$>34# M@PGS&DV85S,:S+Y\KEI2'4D#!XZ\Z9+J5$L#!\^7"0WFIQ-UJDQHZ"!1`QS, MP_;0<&I!-9-J)=7IX>XS/)E/S:1*2;65I`RG,5$SJ592;934T/#$*S63"B75 M'JFSSW@]13.I4E+#XPY):F2\I'`F54IJ(,^^@>'VE)I)E9+J'7?01A]8G/9H M4-JC6KC:@,');8U/;JL9$ASV,R7L5S,P..S7Z+!?S6@PV_BJ6E(J\#`PW_6Y M9^!!_@7^Y_]02P,$%`````@`:FR(1.62`*Z=!P``:C<``!4`'`!S=&5V+3(P M,30P-#`X7V-A;"YX;6Q55`D``U@S1%-8,T13=7@+``$$)0X```0Y`0``Q9M9 M<]LV$(#?.]/_P"HO[0-UV#D:3]Q6L>/4,W;L6JG3MPX$+B4T()8!0%'JK^\" M.NW8'D(M6(]'MDB0_+!8[`7BS<_S0B8ST$:@.NX,NOU.`HIC)M3DN//[*!V. M3L[/.XFQ3&5,HH+CCL+.SS]]^\V;[]+T1`.SD"7C17(KE&432,Z$I&M-\GWG M]JSS0YJN6I8:LXI34U3)07_P/.W3[X_)+\E@<-0_2(:7RY9T[>]7EW777=`,(ZZ['(L>NYV_>?]'SNK]O.QEIG=7.&^=E%/ MJ%W_16]YK.O>M#WW;P^O7KGC^[:6K$0PWIIH/>'Y<7(SZ%@J5".4EQ MH*N,.#+^X`5R9KUX=R[?I3KL;7K\:`OW+5TW2]VA='"0'@ZZ@#)R" M94(:8O(/F&K(CSON5NEZG!SR,W^$L0RR=4N[*$FYC"A*2>+K_1M(_J42&K*/ MP*<*)4X6S6AL&R@?V5A"0_'8"$1O)>.?23'I?W-5NH$KM>`T92\Q`_D)Q&1* M,YJ12:#9/#2F*GPC4NNQ>W0#[#$6-6L=7-CI&4J)-1UYO! M8%$(6X"RAB;1"2I+T&1V14/%X(RW"D6GW-SVTSQ$@L3)HXB/+*RRVO-X6)IA MPMX(\[DIEFZ5ZK32^\A.9^T*[]P[+QM**=JE##"@CBZ""24X@U)D+O1YRZ3S M]Z,I@&T(-38M(ETS37*<@A6<-1W3L2FC$)(UMH(&[P-:(+!%8X_"57M`JPB' M7'8(7HS8X1'`*[7QTMWUJ9T0^RW*J/,JZ)`-9J2933G%!I"=H9Z!'HF>.!H&Y&;.(+; M&/.1I4\?E%WE)\Q,SV@V-:5#GK<'=U7"RELWI<.6X*[RD47^^5>4&6CSCA(R M2S,DI]S!-D4UTQAYZBGRR@%2>/..HFV[.%<]T!LI[-S^/W32FH0R1S\28&$F["Z9%M/Y"=0/*XE`"3U2"W"Y1O-(LX583X MZ&&<(#G%L!D/8P6HE(H1MUU5UJ]X$I(+SN>@.84WQ+2/$4,&=3:(`*DG3&W7 MX@(3,&01\J]'D<+DA1$4[2JGC`]&)=EXYXTN8+DV=$Z.RBQ7/2YDD!-%4TLA M(Y"2;2>YV873/$I62P?7B*ADT`Y-P/0DI@CS\UI#R42V6G)N2!)%.+L<(=I3 MQB@HW!-+R##%&27\"[B%[!8ELTQ2*GQ2Z5F8G&8QXJ@;,,`HV?6O,,Q`8O-) MIF/$"@_S[),Z$EZ,W/%IP+T*SXXT1MGY8=2`N4!@$2;##4A7E;PF22W6K.NBQ9C+KS+N)'"G,,X\WC"1VC5/\8D:N$;]]7.%>4;RKPIYQOWX8=KO3K M[NIK7%"'"=ER+GB-:&R+L@[1TS)&-K5<%QE6=HK:+8.Z"N&6+T2"AK$8DO/% M_.EN,;\9303W/ZK&!KY4I(+O9HU+X`8BY`)?"R5`D4P,YW]/-KLZ'J1$$$6' MJJ)@>N$*547)U,*L\[HA$RRW'6!QER#WEE"#NZ& M$K+D,=QWLZZ$*\W_IC4A)LR!1K!BGV!LA%L=V022)Q0/-&.JLPC5_T>``D1% M6#$$M3*@.Y6SD)E1QRCYN-J.S:#_=]_9V)XP">;)UR5-UX7_\!65 M93]@;D&YG0B^'^N>2.2K5I*-01YWZ,"?JUNX2O7:'70'AR]>'W0'S[LO[XIQ M=_])SLS8[\2H3#IAK'2;5@Y[(*U9'W$"/TS[@]6>CF>KPP\]\2Z]=-M+4*^' MX4G\]]KY+XVYL-U!_]6KE]&P=Y[4"'=';X9Z39YK+$+D;O'I;J*F^-COMI)*D.LZ#<-,+F^/]/\*P6\N\=FU:)GG(-S%Z=D MK(N[$J`VC09KT^=U/<_U^%4_OJ;=+ZNV-W!/=WDU?`?WAR_]W\;O3>\AH^UH!`!4`'`!S=&5V M+3(P,30P-#`X7V1E9BYX;6Q55`D``U@S1%-8,T13=7@+``$$)0X```0Y`0`` M[5W;<^(XNG\_5?L_<+(ONP])N":D:_KLH7/I92L)6:"[=YY."2-`V\9F)#F7 M_>O/)V%C&VR0'&24&::FT@G8TN^[2/INDG[YV^ODPCCRQLCU/?SYQ/-/_O8_?_JO7_[[]/2:8L3QN#)Z MJWPG'D=37+DC+KS+*G\Y^7YW\M?3T_#)!?7'@0./^EZE7JTU3ZOP?[OROY5: M[5.U7ND\+)^$=W]^$C]&B.$*8//8)\;Q\^>3&>>+3^?G+R\O9^(#@AR?+LX< M?WXNFJLVJ^V3\/G7$77'?/6&^//,IU-XKMHZ7WZY>E1TE6K[I2&?K5U=79W+ M;U>/,I+U(#1:.__7P_W`F>$Y.B6>X)2#X2U&/C'YX;WO("[9FW@]B:IQOJ(X M]PGQUVGTV*GXZ+16/VW4SE[9.(*X04QV)R?`Z$IER6KJN[B/)Q7Q[[=^=QN; MQ2/GG;E/.?F/I*?CC6_P@F*'R#]O7Q?88_@&,A=F:>[_K3-S4TO`PH0S1R ML2)[N`%$7USD_`3%A-]9;R$$MZ#$@2'[X(^Q^P.3Z0Q&-((I`49SA[%@+A\" MM1Z)KA5@C_SY"RH=..&S.]]U_1?X))\*'>T4=$Q>D`$%O?;G<\+GV.,,!M&U M[W$`#=,N450,!SFE@H*OQ-B6PUR'@X#3,<(^F&$]3B4>"19&&.%]PGZJPJ*E MHKH):!'>T7&YS.O*Q8OKHB3EHM280`4Z`U,H@&.^2\;"]/F"7+'>#V88E%<4QRL/4&CAP)*M`\^$ M[9`#L.>MUKD;$+?6D@9(_8FA644%ZS\#1#FF[IL^Z-_*1/T=4>('K!!_GTOE M;Q)I8>X^E\E=G?G;6Q@95_.Y[PUF,#.R+IB&>'SGTP&FS\31E#8C$V:&<:O) M?,#AIS3*>I-KQ&9W,)I4T?G.I#QPO04.5VM5='Y)X'J3`?>=GW_WW3&F[!8< M,@XC9`*^`U>%RF8F_-0;WPD$0#!O;L':YF]=;^+3N>2B$K(QPL0`+$S),X!X MQL(@I$'D$MPA0K\C-\"]R1WQP,0@R$T\H8:8H,FS/RD+M<9<,R8&IIJE6!DX MH&"*Z4PMV(3;"6@HZ!CW!]@)*.'@V8%8X]#$4T"=&6*X,Z58CAPMQ`3\PP4: MU^H&@+_.R(AP$6,;![#J31X(B)7['EZS;[4`,_!JC<"]"WA`\0/QR#R8PZHG M55$'V@2`&8"%8?Y#KI@7`^X+38"O8#E^[<-$J06/$4Y-`(PGF'@T_T"4(EW^ M/?OC%P,`O_I@R$K7E*I-T%,#<9JOB(ZQ)U8=%89(F)B/8CAH5J@JD(LZ-7_;76&W,3J^TCS!,^K+C@ M`,.L`+T#-A'V7"T^&1BSLB&I:%2G@F[K1=PF?$$2,(X?\74`?,& M,!69Q'R$7\8U`R#I%'EQ+D[3`?.1`?\K%Y(>OWP#BM:;@,>'!PN8X\5J=(^7 MN:$N+%1LF?6X=[4649^]N,0U@!3F=N`;?Q.:!\[J0H!30K1`N!PT&L,3,!D8 MGT\4+Q`9AREG121&F)/$H:,]"Q,!A36VZ(C)C)3\?V.'X_%WWT4`*7P?T M68]/SR;LJ#YF&(&S*TL8GK'KJP\R:L)6R,93Q'4$>"9\Q^T`"P6>!5(38>=L MJ!IC`8`9&`Q][(JHY!-PZBWB&T`L$G>FBP4R$7=.0AR"F<.0HVY/4!.A^CQ$ M(A(>URMT/?`W/2R_$FM[;':(T*]H5<:X\(L>D[GC$.?%]QDOD=KHPX4TM M\R*=@,]\*M*@(D(8X]/A($/(!.=D,'^6#.:KH3&P_`^"$<._!:""M\_*(7"& M#?@"FTS14"1F8O%?XTU2Q[64"!O1H6`^1_1-!*KF"^2]L9^P)TT0*69L,C[@+Q\3RK4:*OM(<3&MTIC`!U,`L M]@./&!'9D94A>0WV@!JFE[&!Z'\.(`U6`2P3C`HGT$3D3&=DO)@(^8C8CB6D8.M%R9D!0:31:>0V520L\KPA1^&L2U&I#`O'X^9C,S\-G MSI'KIC'D[&*(-G"('1`M"2WQYMY1>3[O%`:6?GGOV&;0('6"$3Z%3[&WF0M2 M!KJEI;VC7O5P.O;GB!2%G-?,_O'*YD_G>#["M"C8K#9,$28]O?P9_0XX2X\7X7_6M7*:655C@6_)\NT$E_XDXKT8RIAJ59EZ`@=#H'7JNU+8Z):[ZU\26VA-Y14W4Y)=<9CLNS]"1S7KA?J7$A% MT]SXVMIQZ0)49$,HRX:=LNP+*]G#XUM$/;&Y.4)_T:J;DF)VEZ6+;R?EH>": M=@IN,RP:+O8K.BZJS4T19CM`NUHK73@:U(5B:MDIINPBH)"*QD7=F"&UK>/2 MQ:G(A5"4%W:*]!!W<((UZPU1A@T`?=&>S3UK][L`^[\*LD(,.8VK,$ M5]V]1P]AT"]W?MX$5"2<,#!X'%8^B!-;F)0T.ZM=UNO&YD9E&/M4T'QII:Q* M7>ZL?/%ZL]6^LFVN3.[XO1;;/EP7@R_:%S7`#"=H@E6]65>W4I3;+5>"AF8G#M/[R6$C@9;MI+&1L M`&^Y"F66X:&R7=FI;)E'/RV/Z[@A%#L\/@BJY_7@3^BI"8I0$_FO:``.9W@Y M!L7DVRCF+;Z_\\,M2OME7!3KJMJI,5NG7_GSR_HP64W`EX@LFCI4N1= MI!Z6UN-L)Q$[OCQ)=X>W)?*TZM/(/KJT20_TF13IA*65/YES99+`CN/00$3D MEAG>#J_66\`2^4;/^P?R`D3?:FT0?5W.E!GVK\X24[!K"Q:8/3`MTA5+XYK9 MZ^KR=#UO&BVIWQ;`W^A0M@ZOM:H;E-6.%!2Y/D`[4-JYB:A_$IOA&+:*U?O7N646Y/PL4HRA[(E6P-/[YB+G8DCCQ M:0B\U:PJRS7]<=S2J&0<@!"=/R`/324?(ET#1SNYX5^0>Z4N MIWUT6:YT]\VD2".-H[WE,)6*SH3]\\9>G^_F429.NF!^MUL'A9*O/@$BZ MEL;4TM0,8QK6SWD:SO``B>/`E^64[J*O/Q_OKN%QM,,.P M2$LLCK(1QL+KH>[Q%+EW&&>2+,*/@FXY","OT)D%=+LH?QYX#Q,B&5L:'5M7 M[/0)W<6T6]WDWG/OAYT3]LBZ2&DLC8YM'NV^3JV3/IT^O)=HR:FN=X='5(0% M84#)F)!(PXHV4+O-'=)$>"M#3PEXIBRPFN MJ1X^2+]\P/!["GC$<4O#<'DT7GV$;6>;FP1-PU;?L5E,M:XV52N7S%"SJM%^ MVN7)4Y\QZ_\UI4MP1#"T^4)[7O4QHV3X[2*?E+G+IS5 M+AM5LV7*F2<>EUB_DTNOW5^ M=L6L_3)O)*I_$H4<'2#%!84,K<"&>FIU3[U:8$N]CU61;ER=U6Q4CKCL/'1' MA8L0??@DLH[+JG81Z4B1^X#>+B):-3+N[^ZO7(78*WMB5:C;J`I][+B(,;D5 MBLL\5GQ7Y#U!(R*NFO$CX;TCN.A]9UR$Z8B5D&*V5@55W;RH!D;_)J'TR.=:YIH\[E M9'3"4:80M$].Z36]6I2]]&M%`NQ][(I5Q$I+N2LXA]P!YGSI'H=6_^2R-9\O MAU'/^T?@+@N;&\"7>+:.'JW'3P[P@DLT2ZNPZXF+&.A81/\CMJUZ6E52@\'Y MA!B_"7!X;0,+([1R?J^K6UIV$U-RTL5J7B0%&X^02QM'R#Z-F,VV4I:,^@Q; M#JB/:RVJ,3K6O+:-FK???;*W,H:S-HZEVZY7Q&(8D071#W,LCA7NRD:%"Q,Y MP((;[,AV'H&##[['9^Q67&`@',:!29[ZG7_9\+=/,(=>+DPQ-JEAEZT/H&%YZZ:XNM.A9"1G MUXOF.S>T[.CBT-J@QP2[;X=1.%_XPG#!0>$#EK/S/OEG>QLBI/C52HHZJB2: M56)G!_TFU7'K%6M[U,CV[T4C#1%R0(UL:VEDVW0UR/:;Z1(J^4:&CAU^0*V(#:!)I]VPG;XKZ"JVP'A4Q M2W$Z+W+)?_#XFT?#W[J>XP9C&<<:,4Z1P^4]4NIK5[%.RA7K^QEA=TGQ(^8` MWY]C05Q-!*`UTC'IETL/IN<`M_OR#WENO5B)*)Z)]>`9QV0(*EKJAV=N:ZI< M8:@29?=]'5'@G44;1D493APC7:9NU;-/NYHK5T0ZQ-E]3<80UE(VP:*H#DCH MT5[`>Y-[_(S=QG)KM\;-C%N:*GF=423*[ELN5(R@FK2"U&6DU*9]MEZ*3+MO ML]"S<6HI(T<]GU*P%YO-O4Q6V'U#1`I7)LOQ*A%UFD:0E*\9S%9LLO MDQ66G[2?LJ#D,2D-=1FF7SZ@Z9<";OF!]MN,)&G"MM1M[ZUMV6/[I82=)*4C?0M[1DC>67),GRD^15+*+E:7;J M4YU2F_89?BDR+3],_GCRV/'DL<.?/'8L\/ZXY;3'`N^/K9''`N_?28%WJU9= M+_!^[#V>7O<>A_W>_7WW\6NE^SB\[=\.A@7KNA]]3RPD\#N\,XVN6/G#%W1? M"YZ04<#Q.'5Z1>I8@%69CY3T,+;W"[H)4VUWN*';3@VK+8W=D["\F MX%(]8)W32NDB4J#&[J+$O`!3;45(0R/\O*.UTL6C09W=I8PR9`Z+P_7FXA"3 M$)2.NFCZ#C0N/0AZV-E2L?=<+LMN:.L>9CK/D8:S[& MFH^QYF.L^?>BD7_46'-U(];<^S8<##N/-R+.#/]4;O]UV[_N#CI?[F\K/SK] M?N=Q."@8=TY<_0)F3WA0NEBACF>*K!WJG^#48R`LM<0'<:!"XR((]89+C\D4 MH]EN'R:#ILXSIFB*^U@T#G_+$!1R>(#<>S+!7>]7C"A+$*I_-7C!WFR0>%'N MV.TI91#Z`Y/I3.1:E@2G[L%)D*=_$;16'S:(7(\3=D?.(_(2:]IR#DM\D*!) MO015O>&#B52/9KN#ZADT:<],ZJ6K[^S-!HD7Y8[=)Q)D$*HX6ZDGQPKU88/( M]3AA]_D&QR3:,8EF8Q+M&$H_AM)+#Z7??[A$;A]Y4W%G6G()8M5Z2RQ`&CG< MO&;*30^J$&-WU$.>7/\%@?Z+21GF111?D=$)^`R@RNVW0(.\M;LGL3ZYR&,I MJB4GPAC0).$Q+I]GXMKHFME+LLT34:YN'4`R=COLDO31GABRR8@U&SG+/1IB M.J^?U2[J6?<1[E&5#T_D`53]\$0G)6MWS..82O_(B( MOO4F@K?(>V.KRQD<3IX!+#[FU"-S-63-TA)(;,U0]Q.WM%1Z8%:1*KL=QDV# MZPFL,D%*O,.I75/?K[6CN=*%I$.?W9GLK<'^>EV]$,6BW(8:37;[L9WIE.(I MK,E=L8L3%CI''F<2DZ%QH._6MLJ7CBIE=GM7JSNT.OP&B.E-HL.;$C.`>M)P M1VNE"TF#.KLSOL=$X#$1:&,B\`,D8;X*^U->1%N_4M];'[Y5;FPP`ZK=9M>U MF$O=)>*&NB$1J MIF-]W^EOJ[56*^OBXK=*HDR[8*%=!GG$QP+YWPOOA1GK<"LU51/ M]>6V4W[1G`I%=EL3\@3C[**_B[JZSY;73.DB4:''[ASMW;8[I%;$-*\*5/GD MMWBX2A\U*NW.^W86Q.ECQT6,D0EQY`ZAF*I[@D;$!;`Q657UW+!6V^57U16E MW.XTL[CG51RC>ST3;G[7R]363>I:576WN4@7I8OWO7RP.^%]+-([%ND=B_0* MZ>'&FAU79#0UCB/+:Z;<.*$*,79;\0^(_ASZXB?F\OYK=U:0BJ6>D4N\>3OU3L.TVC?,4IBX51CV* MD]N.'?J?(L=N,[:/&>9K.2ZA3VWUK5I9390KAUU$V%W>F1S+=3F6U6V@U+N' MFX)2L.VNY,P;L_*"=8USKG/;L6,*2I%C=_%G5!JQ&L"LYSV@MPOAB<@B"?5Z MVVU-E5P.HDA4*)HK.T6S4021IJ)55Q\OVYHZ<&5'#E&1UU:U4S99BYXT!=OJ M<<3,-@Z_=J?(B,3P`;QGJ3X-=3[A5N\4[(C='\R#;LKU3EWS<]NQ8_E. MD1.)Q%(7^KAYX[AYX]";-[+6])[#?5#J6BMH'+/@[EJ!^;(T\EJ#:7H(:?BY^B).#X9/_!U!+`P04````"`!J;(A$ M>2QU):H*`0`F`L``00E#@``!#D!``#<76USVSB2_GY5]Q^PO@^75$6VJ'>E)MK3 MV$[6M8[MLY69G=NZNH))2.(.16I)RH[FZO[[H0%2(B6^`"1(4]G:FB0BT'@: M>+KQU@!^^O/WE85>B.N9COWI3#MOGR%BZXYAVHM/9]^>6M.GRYN;,^3YV#:P MY=CDTYGMG/UY\J__\M.?6JU+EV"?&.AYBWXQ;1\O"/IL6C2OA]Z=_?+Y['VK M%:1G_1^@_D*9];'?0]"M/2?/^_A'^\XP]@B@VV_OX M_=FU#/_3V=+WUQ\O+N"?YXZ[N.BTV_T+_O$L3`I9=RE?7U_/7[LLK38>CR_8 MUUU2STQ*2(5J%W_[>OND+\D*MTP;--<)S>69'SWVXZVC8Y]55R1[%%7W8J=! M:@KX5RM,UH*?6EJGU=7.OWM&"/%(F>1"SFC%(<2KSG4L\DCF"/[\]GBSRSW' MWC/+N?%:"XS7%Y#@PL+/Q+K`WTWOBLSQQH)Z9&*6+IG'*_Q(`&W$[@6Q?`]^ M`6E>"WYJM;5`BW]+D.MOUY1`GKE:6[1*+TH"UY?87I!;^#LMNJ,4?(ILM0K, M7;Q8$=N_V8LS)8JL!_^1C-\.U%(=_+%BU`C/'QY9:Z,A!*E;*IS/ZP_],5X[KFW^P\<;U]S6Q/>+=V[^29\\$YTQ>B.6L MH5._=#S?.^\-NN/QN::=#^(UXOGD!?K37KO7'C&=X1=)Z7$E+!B^.VY8/[$: MFKJA*G/762G2Q'>H(/PL*Z@S;O?[@_/N:-0=:V?(<0WBTAG:&5I3M^6:_O;3 M&9VL;3RJDK,&F7C'`^SJ.0TO]X^SFOZ:SF_N[Z=W5U?7#X_7E#?OG]=\>KN^>KJ?/ MGN]BW6>LZDAT#,*22QI%&0WB9B$NB39/>]CES=,[`)-H3D2S MHFA>%&0NUD/(#L,E.XHFSRARN@V9`>Z0-U7_!&RDE'9OTHD4@AJ?:40[D]=P MIF%$9AJZ_$SCBJV-FI2J$70/KK,FKK^=VL8U[;.8<'#(`XG9N+#@I;E6D=*/ M2+9/,`H>_G!FL5>LUMZC*,I*S>.+XQBOIF71\F^H=O;"?+;(U/.([UV9GFXY MWL8E^U%@;SQ(Z#;$]T_AE\/MT^!G.2CE;*JDUJ%5%4+.AP4:M&ZGVVZT<2G1 MK^JN1P7(29B9F=(^.^+YT5X`^GLHXK_E#"T=TXQ\]W^F27ZG'.N/^I79EP"" M0,U>^NDA%;B%N&G[.Q7818[?$EF(;D&=K@> M/<.T?"^VD)HT`$M;\\H65W*12QIK?%$K)SNKVC8;`X]&C29T$77J6=Z5PI3H MU-_Q+.]5T'AO-D"-85D:*W+1\E@%:!SU$.U^6^-U/#Y5&J>J\X8T3L,TN716 M:VQO4;BYAV9+@A[-Q9*.XWT'S8INV(GR1'0_HA&D3MMQ$*GR#E^@:/84MH@Z M]>XI2&&;T*\;"[O(V,](G3G"P=8"3%G-W;C%0YB-7#[0WRCU?![2L>MNX26/[+!_6J;*T<-BIP)&]C',T MC0I$)LU.;=#QX##0/((G@$.+P3XMP4;/K+C-&O;1G06AQ;OT-QU3X@"6+<)4 M/<]!ZK(`:)NH5S.:O_V<+Z M[T_Z$L+^[QF3'UQ3IQ7SU3&(]2L!MT*,Z0LM:P'CQ,V*)?+N`>H-_3><+3HR M/OH_\=ZO`@CEG$L]=1+ZHRI*H_U$9]SLWKA*M:ONM2O$/F&R42`<<>DH$(^8 M?!06@((24*0(Q,I`82'H[ZP8!.4@5I#DJEY158_HW],D8C_5E/HV7B!7\[*& M?T0EJ[)@M6LWY3E=ZQB82:0CKC3GO4 MYXPY@;6@2I2N9:I=!7)NX*W0P'D#M=:!@:^8@;?0:R"[A0,3QWOI[V;3GV^O MWW^4#/PP7TR#V,9O)K$,F/$.NQ(13]',)>,W+GN#[&O#Z:/2+*!U]OY$X&D@DL+\:I MA5SL1QT87_`P/:A:`]8G7K"U88LK=N`.(9K']*ES?+61M\04E^0Z!004Z=1] M*APVLB2>;Z[8EMN* MX'"[#_:WUH26P6_D>]ZBUZ6I+Q'F@T>H?YW`@).$W/4=-+USMA^_MR6^.W>`&Q+S&PE==BK*Y(>F@F(H)7S3WC@; MS]KRK<8-7%K"AMW>OF3D\)U`+MMY(2X41"O$G)LT=:C\+!B6%BSW?TW[EF'EI;&X]FYY,%V'JENMO; M#QQ32]WS^[A-S8/D7E^8^T&N!,84]B1R%)1CD7(X@JYF,2\U"C M&`73K=X)'/D5T:&6GDT`R`32M.8T$>S2LU3,B%3R3["'JYN`*;U<:J4-V[S2 M3N!`K8@.M?9T`H!87^E93T1>[(GD=79E4E7V(YHA="'&.]@`18].KP MM=3>"1R4E=>H%I\L#6NRV_I,VAB18_:ELUJ9/MBR-[6-2S:(6M!1C$F2#DAI M[6'2"7$U!R^DH)2SCI):'Y[%D!,'`_IP$:/9YVB5Z%>U#:D`.;F\__KU9O;U M^F[VQ&XNN;R_F]W$ML; M\@9M]K:H&@4;959I*+/M2OYT8$&.57).\`1L*_7P8)%X?S=XC5J.@N&TI M.%)8"FI-'1<Q?$QA?2;$>R#N5PIM"83J2YSG2!%3 MU@A$L1V0/3D;U"A;)J0U>@*[VH)JU$1>$2R32#(T)[`U0%RT@I2*22FX_OHV MK$Q9AI7\P* MB@MFC:GQQCR!C7EEBM;BX%6AG>S2LKL^D1N(0K"9S7>#]RGVXM!>7NUV*-B7 MG*XAIO1')9N\PYO\!#:OE2E::Y^F"G7=%LDZV8>@CZ4D[&M)R\,I1A;+7,YP M\G#$;"&>F(UJ@ZG7"6R-9X*OI??(0G`PZE)")D&773V;4EQK0GWT>'V=8++2"5I--=!93\6KZ M2Y;(=['M8?ZC:;\XUDMX;8B'+18&N`[OI*53!FP[[+3]&H>7U$)*B\"[N<]P MZ#>85GC$LHA;QGG.'*IC,#MAE)-8K$P5I-`,IL]NZLG")OY\\S4*EDZ\,NHOQ^_@11 MRW!+"H%#IOV!1"AQBIAR1!7'%F-I6C:HQ'ZP&-OL74X9-6KQHV)8)OMD,"K@ M0?`F2ZF8E((.]&U8F>(\L^IPP!=A.R>PERBH1JV.4PR3,GH^$7U#&\8DWFYE M`%I_+'&8,$%$.5:*88H1,BD+J[$^K[$3V`,44*$6_YB/8[)/@N9A&H6T$_2( M]?(NQ1.FUM:`U]8)[/()J%"K!\S'HY:`CAMO[EXAUQ>1HHR%V!C-Q>J- M[]AT3F`C34R+NMU@.I08$1VW*C+*.\3:V)CO%H]JCV]7=$Y@-TE,B[=RCNF0 M%-'R$BK2]ODMQ'`&+C%^MY-X;:"JN.5\!*4C?`KH>!RC+""E,VZ/^6U>_7:S M)T=EU*K:.9?`-KF\O[N\OIL]LMC)(+;R\?KJ9H8>;Y[^6B3$7X(\%07V-\I` M,H+X15MKS%NKV1.V,FJ)&XB2@'UI@#E6(G^T'F*@OU$8KH]-&_JD2"3[*&F? M2XUI9!9=SB8DM3HTANSL<*Z(] M?9DN7`>>QGCPR:W/%E9[$O/++%GE*"R),J1P9C8Z".UK[-ZI8<,O\))1HVK" M2F"9T+1HEQCQU.Q!($33(YJA"JH*SC[?FJO',]'\FNWRFFWVRHB,&G7-124P M'9$6E61MW%E37\U=-7CJJV_\U^@;?GV)K5\)T25'U:5TB)\UD1`%W1Z_&7#8 M/8%HQQ*JU;)&6!Q?WE0TS%[*B)!I.R:"<0T%E&MUI7^4L`K=]RGGRX7_07 MJO'&A0/N[MKAZTV,:T5GNVE"%4XE)'"GFDBZ$+BU26OS9CF!,-)"2M7>C8@B M.YQTL&PHS(_DA`.6*+X(EQ^#@#W%C9'_'UBF9OS(HI4(M7SD,Q80E0C(7*F";H M5^NC6HJ_3*FD,:^D9N]QBBE0JQ_,0U.>\98]].H>+FQJ[BEAB MW21?8CE2%D(-AL3RRO3%U>61I9X*%W-/<=M`Z8KD=#54K1>^H+K()U MVA(W,TD7H)3[A?2)C4/D!4),4+O#FZW9>_EJ%*QES%P6Y7'W@/VJ5OA*<+!8 M#])@HTH9W1=LSBYOSF8'':A1L-;905FT;VI=66MRR1'VHE95T8)B*0VRS2AK MB4MKCX>\P4[@_$AQS=ZF.Q*%EV@IRE88BS"K:)?3(.,0[61R&HF?=AB>0'1/ M<MEL1A5FME63$'MWX'$)8;IPXFH&4CS8OVJQ%Z6L."2`X,2^`^?81`4U(&75]C(K3LZ MA6%!4<7J&1441)]R7@G'<_8E8 M;3!H#RL[F5H`43F#4E,%A\=8BTAE1XTUWN#-'L,HU+)JHU,'=4+GI8;CHG40 M/1'?E)./I=BL-A;VC>G*<7WS#_[HE?[/C4G]`>P1VH[E+%A(>N(Y\/1%'"&Y MI9=PBJ*/;$*+B6!S(S8&H%;7:*LHJE(-D19%<$WV^5`T(PISHGW6JLG?%U[" M;"3[^TDQ&*)MHFG=+F^39G<*1542H/^8T]\F"]A3NJW:"J+PHE:`J[$"$D/T M*WGV3)]#\1Y$<1`8A)J,=.9/N,!AM*1O\AVF34I_5XDS7[U$DYQ>KN M2XJ`C!D,3C(8(V(P>BF#N2)KE^@F$T__;A'6Y]DQU`_!HRX/5%6??KNF_1HK M^[P_'(Z3+$G-3%\53&4FJ;JR$FRU9!&]P6@P8G3J\0%*\Z/.J]2\?FNO0(N8 M.S`B\F6-/FGZ,9:XWT7]-$D`T=Y&DF:CPU%034V/0<\#7_T(+@?!1,%TY;"( M.\(V&?@+<.."'*-"5-,L&5_\ M7:H/R":^)/G@_3KO?-#N#Q/(IF@\PLHH2<84G#OR\>^LCOJ\CIH=ZIP,N!YZ M)14=[`&S]PPEA\67>&W2O.8?Q(`7M#8^<9^V3H?#$=)1[4574:< M4WK)76%IW4)&YN;L=+2@%VEV4+&<(E5WR%)H)I'4*$R.PO0?$,M1$=FKN7F[ M&60_NG$[OU6HL^F,>+LT.TI85A4)EUW\9FU)4!-%"QY7Q#5?Z)SIA=R:^-FT MV.,.=[26-ZX+\ZY1MS^HS+'G%%Z.ZM*:A4S/RPB/80R:/?005:%J5RZ(8[)/ MAVR'DMK:IY:C\V?3ID9Q"R\XW]@^A61":#T;\<``6VMW.X/*1L'9A9=CL[1B M(9MS,K(A(O]*T0;^Z1T&2 M"RW':V%%0CZG9>BW!]T1NQ6@PP>'HV:O14CI43(R65(VHVY)"=T53,_,>\QIH]7,A`78L?32\_6+,H/!Z(2)[: M!GOW=NE8M"$\V%KPM]"4W:1%6.7L2RQ>&25%E4O@:7)6:(9^AS=#LQ/?XP*5\3M=@01&AXF9 M*^&Q`Z-FKTCD@Z^;M-S8OV#7A+%'^,NU M[3,_UNU5^*"7')ARE"ZM^.X-&CE!+(R&[P0T_!Q2.<6J7M`HA6X2S[T;.[,K M7^`I,3J>)MBUZ3>/?H1#$IYCF08+;_`V=/9HF+0<66-[<,D:F\83(0;$Q?4' M$F?!-\0^ZB"-H+'C:OFS?'Q MXN-:T'@M-#MF,PNV.''*'2+.P+`CT!IOH0#^[K/'4JJ@T[`1;#I:9#JND6"H MWNQ0^2S8M2PA90"8%')!*>&`;,F[W]&TRN8R6467I:"44GM*9F1CHW1^K&#< M[+!6&35JF?-(`)J$:=GDG(0)B\1D21^#$[^(K)&G^-(O(9,X7AE$QC5[_E)* MK[IZ_#(@)[,E04%.V+#%*[A2!#GS^(&,=^$MEKZ#$@(9WR-_B7VTQ!YZ)L2F M$R#=6=@LBH?.?'Q:A$GG2BN"/*HB82'@]1Q]DC6T!A]]RC,ZB2-K0>LW>Q*F M0+NW,<`B4`N88>H&=`W&F'Z>0=C@ZCMBD6HXR2<%^/+H*5Q=E:]!S0:0`V?R MM%D!I8&""XB"0SIVW2TLGG&^`V'IC)32/^U@(.5T(.`94R0Z)?&2$!_!JAJS M%LN"A;@@>".(CJ:F\`*%`-\WE%5;VK*(>+ZY8@70]IQO8%?RA7CG"`P1+Q8N M.R>5#!.]HP9D;0SVB[VE["`OIK/QK&W,UE9T\N1RLUQB=T&H80)"M,+_H.7/ M6;1)"THUCB`CW:)_GJ-ID)C]$YD4B;-:.Q[-024=Z\GL7L73(2RO9,U>FA=T/B)@\P1:^F2ZR,=PZ"I6T^PDR!LX#!LW\ MHA>N#D"BM5#:A\0.JQ0]J%7U(9JTNZF3SW^TQR.^]C)L]K*5N!)5KWX*(U%U MG":[N0OW9E7S4+A/V]5N&<[1C2)=QP>[^H.^H\7;&V(9"_P M`5F$RDCO$FV#]4+'_J; M#[Z6I<%<&$$X1'#W.ERY3D>,^SS_SM8((8#'*!3`P17-88A5?U#AV=GD,DNO1PKI<7BQ:TH^6-?2>,3ON-EQTG**5#WSD4*S M?S1D7>3J[X,R(J]=16(%^X-ATJ7?E1`Y$8%26@OJF$/R9"G0-GV^E#MN=G1U M&;7>R`!$L!V9`VK!HIQG&C`;@@G2Y?5],1-Y)#HQ7T`FG?+M:3-(6J52:QI) M):LQ"3&=TDPA,3>;"_/S1.-F!V<74:=NZ@M@VE/>W2669CB<^4J($N\/!TD/ M02FC=W*QI;DMJDT"L5.RPDM=P>44XV;'*4CK4B.EA0#MCB"2[VMB>[)1TCYL=M5"UZC7:;17X5=WQ:!@F;^8';!HW=G#= MRGE_I%5WOTE*H26-4523(]M*R<@FBD%]-SN&05*3VI@O!&>R3X8@2+H%)WQX MRO]G[UV8&\>1=-&_@MC8N=,=X:K5^[$;P1LJ6Z[6'I?EM53=.V=BXP8M03:W M9=)#4E7MV=C_?O&B1$I\`,2#8/><.#M=MHE$)O!E(H%,)*0*^NE!KOJ"?L6X M3(K5=28]=N!F=_"[G'%CJ,OK7:+&'Z5W?$)KU,M[,4$ENM0\ZE;!=C[8TJ^' M3H9$1=&TM`AT10*8!5\!%P[]*_B?[O_6@6#B[H\Z.L_%TUVI0&`AU_D(3.W1 MA[T>'3F[@[)<_)O%7SX39Y?4Z]M"1OYD6W2ZBGD]*L1EH1"E\$PK^(A>*^UU M[(Y<"LG1"%P+F'&N,X#]USJ(/976.\UW7[<1O>Q4!6XY1,F';DY#?'`T[=*! M;DF$D5,4LP"NY`=7./BPD<'QM1N]?!Q->OJV-K@'.8#F\WB.1O(5&1ZV,K4C MT)?'MBF4Y?3MX-^)/E/]^AKX)`WD9YP]^7'9TWH0/ MR;7#K1>1^+)H_?&W(/+BZ-S!^#CI]_,>8%)5>#R_5SGD\\MRCOG"EN3J]9!. M0SO"6+RBF,(Y)S_."J(_X.3.+6V@H(P^FG>-H>'<+F4!S"7%)7KSFI'Q98MG M.\)*7'*8PVTU,^FZ^7=U:S'F=I0L`Y/!0%\8H*QG#4`NE(D+S^F"F+T1G8%V MA*E$Q&D4W?D\'<_%WFCV/O$U3KA/:I`*/LEW1L81LLP?6D@86/: MT>F!5/8OJ0$UY+O0@VH:)/!#IZK;COB9N%#&=$*4,V>V_88K&D0`S_M9_G+D M/?L>HN6BGU.7TO0\IZ)%16QX3J50-ZJ?_NATJ7/9;4=83TP@4SHAQ)71%U:T M0+Z)%U8*(5[0D!R*L3%O1RB03Q!3D.;BQDF^`NPSP+Y3\,Z*%N3J?6>E$*-G M>Z/IA(93N^V(\I5P;PJ-Q2R8>WI%-R`;?7J%![I%3X1T1AT:6NVV(W8H*E(# M(.?A2_=K++D\'"/J_8X9,UW*A5[M*)955$DR>0A=>C#6;4?4LZYHMBA-`7_. MN=K(U4`I>P-(MX9H?\2(!_:9'$>V.++)X+'Z>0K5@4E[^X\UX=V;$?U<5G^<5 MHP3)V?CQ=-"GH]R.^":7'`W@MY`99I;]5%*I"M./V:ZH':%.(7D:17H!4R2!6MY@?_%\,D>G;]SD1?,/.\.SE,^V(2U:)8`JM%7S0#/^\1PP]__1&H6`P_@%A$2+,;U.YM]W! M:*+O$D!.CW*@Y1/A'+=YK?`2.)[2\6Y'Z)!#"E/HK6;%.7Y2G,C]KZ![U>ET M\/^!Z,4-\4G&(7Y!H_]WN/TWY(Y`X$41KCT3A"`XQ%'L^KB^9*T7\>:T?,WQ M<&`PSGV@4QGN+_N41CZ7&#G8SVE'#I-HAD.O'=%%+CD,XK^2&?JF(WO.$9_0 M!:08M\Q]V<)B+I]Q-7/\JEU'WPV<\LYEP2THV"7*2PG@YTXZ8SHS[8A9B@ED M#O<"7!6\XZ?C;4JS@#?T-J4XV-GC!T-:J*37:TOD M<_8X>:;4%XGJ?.R..D-];DLU`W*XKR7@.?HYB.#-?H^YHNV(4HH+94H3A#D[ MJR1'/E'WA(@6W)M\0J00U_G/8'2F-,+0:TGRPJX5_*LCAK.THN&[9JN:^%4.VYZ%#\;.&5. M4SNBTWH'H%V&H$`*1\X4_.*&H>O'.&'UT7M^B:/E*3CSL3OI=/2EX)5U+:>G M@D(E:E?:K#^9=D=VQU>X^-<->AXFTE48OM/OZZVI$#TETT.X;D$5X&1BK\G7>L3!.J)2K1@(O&>$T=3>E$ MM,,U$I"F`<17L'2&](N,$4F<+TBJ";:).@L"YG:J&-]%DE1BFS4DU_2(KSB8 MMB.KCU.2QC"=RTX^GFG&DR26T^[3N#LR:+25N>-B,E5".]T:QP&&0SH-[4C] M$Q&G,9`7\Y2/=)F,OE3V8:&?U!V,]*;X<3"A,MM50-#R!-@RS[)#'V\=6/YP MNIQ@YK)(:G"7RIQ5Y=-G^;APL[J#<4=G&E59YRH5A$.P8,B`C6C"!5<72J`I*N?USOSR)#IG.I,F2WJ6#WL"P7B@?S1/T6&:$3GH2VY M@[S"-`GU7(X*85YG!Y#7:^;\>C#NZCN4K^A=/=C+1>-!?-99[8QZ$SHO[4@7 M%)2H2>P7LU6H`+4W!I%WLGI MMN2=(CY!3.D&%S?.]?+^Y_GC>O'I;@[NE^OY"CS,_C)#/\E@>`U_BS^A7__Z M<3R:Z,M^+^A4)8I+)"F'\:DA=IXG]`'FECQ(Q"E),T`N8J<8R>+O#%=A8/R[ M0?.X%II[=-#;D?;.*0D_FF/D&<`[?9`^\J3*.!<\Y35[Q>EX^!AK,!KD!ARB M&'[#+FX0X/W<+&46D%^Y,ZY=L/P'1?! M8V>%$3Y"C%\@V+HQQ/_6C?[U"[Q!72UW)R8)J/+.9(24((>P#F7@XY]#)_(( MX:ZX#N:JQCZ:-J"5R^" M(`[`F_N._H!UX`K@!TD]=[]_!UM,;A?CQ`$?@G=(DZ&?X'N`>,$]X.I[:#A0 MWYOW#5(B;P?V@?\,PROP_<7;(`_(]='W`/ZV>4&#@I:#'2+@@N@-;KR=AWYV M7X,#D@;QA;M`?WP-0L0Q1&+2!Y9^0"/L;0@[&WJ5@53/^?$*ES6F/"1O9N.? MB`(3-O%/-`OBHZ`^GV(6)&3!(A;+^]OEW=WRE\7]YYL9^G7J(+.7>\VG2,_% MR$L:`&E9LH9!D!SQ"2BP)VT(5,B)9V9ED^*Q),:\O`='$H#0J/><\"-V#/US M2X>1-17PSO3@^,.;TZ&W!&.71LFU MM\&H/Q8X0'V;ZT]2P-HHLA-Q%(XI'H2OH<7Z&,B5;)4.U->]BM02B9 M6F[S%4JI>UE0QVJF!'V:%ECN0$(-+'U0G"/457'\>@,W$%]YF>)<903%D7Q@ M($-2Q[EL%<^)^O"T1JK7&]I]2"LBAFX%$.`E)[N-?@V2S\'T"N`6&G$\;B&. M+S+U>0=]9/V9OKOR?/`+H7VU#\'";^ M$,V'O_'>W'WJ+/^?A\.KX7`$OGOQ"VK:[?P)+$/OV4.31)2%A"6.J\$/_[1< MW/S3CR3"X>(XP(?8>X6GR/$&.6?/Q('K]O[T$:Q?$@8B$J'`@8,?NC_2^`3& M9C9!*>F.\$("*L>@,^8=.YDQ&`W_E#B(^^`["5>'[A:R#W8LG-`;LE]OW7?L M-GK!%CS!'8Y8G!$FO8O&'42422JHV)0%N-Q?<4/5[NB!B!BF]ED"//$L:]KCI'H@@8,KY$`"$J$_^1.)TKN\?7J_8L0^8'9X/Z,\]ZCT-E)RW%*%"Z'=+8U'O1! M&X]?\L5HQGO*Y:48Q^QSI8V-,L4L*.76D M;7"6J!9,5_)=`>JS]F3LV^@C%PG2I"W.9PGO89--WEAH!QN5;F&[:`\[['0T M;F'+=[#)!O:+^PYZ(X6[UT*,2_GY#>HFKZ]_UIXD)?9H4N+O047/Y&G(^R]E MJF0-2BDQ#7,I2?%<^K?P*3RXX7MO=$)-5WXE.B.K!^_5O%+?4[">NEF7'_ MW/G8&Z;N2(`%N9'F8[;0=\>VQSP[MH!>")T_1`%X"A`%.BS)HP7N\95Q7)H` M3=^+&T'0)6."94T>I4)C-;M53<:_,Y!;QP3-B5@3:&@"HE:FI]+F>K=(5.F32E:_2_NSXFV\4<]2AX M\BK0"P(_2U4/[BLYKX+]&0%R[-_&5/9"21I=GO-YTG!^5P@$.=O=)(2Y+?<9 M`6)/F,??REA*A4!-V>U2KDK--FL)NL1J]Y19[<.>C63-]R1#>0>%?(]"JRTKI=KM7Z/]T7#EB-="F'7+H]T>[ M@%2@6)*+7R/&@'_92[4FIUP=:HQ;&<0JDZ:Q!:^0I?+5CEH-I1L4DJP\/CE( M`_FE+D52#[K+>:Y"=[HU<9O;>6B8)T:C2UT.0\YQZ4'&G1QR:02MG$EN!K3< M)CG=FOC'`VHQ6ID*4R9-4R:YF*52DTSO>HR5[CZ^N._]S@DH\@E>*8JZL%W" M<36TCXV)A]S.,Z(<*1JVQN?\Z#/&EY,O:XO-PU7`$A\;$SLQHG:BC<5FRH1I MS@X7<%1AAM]Q=HI**YQDH1,_O4N1(GU-Z8*L'H!7\UZ%\G,*Q*%K8Q6*8E$: M-<\%3.DXOR\$@YR1;A;(W.;ZG`(Q*G2[/?U]X/E,HJ8,=SE;I=;[>.&'GFUT M59GP8[8'#0B31&X%6\4SLGJ07\U[%?+/*6`3TV^GFU(D2E-8+^"G%.2GU".6 M8J`9XW)N2K,8YW93\B9BT,Z=/E^1*/S&0RC#GXL,O)V."6B_O2QY7-'=[7^A]\2P5.D-].D-V7^&O+9-19:G!8.84@]U< MOKS2K["V5_%=4TD5:/:BK*`:9.G0."(S57;[51)26:$*I2PZ"W^S/Y#:+^3( M^A"&B`MR].ZCP6,_ON&U(_"C*[!!.XEW_#5]9=`]7C1_WHE!1_@D\/[(`1/\#U` MO.`>@C<8NF2[LWG?(-7U=F`?^,\PO`+?7[S-"^+-1]\#^-OF!0T2TF=26@#@ MJ_/>SJ-K(`M(X"[0'U_Q47T$D9B("V0'?D`C[FT(.^GK\C]>X9@`Y2%9/Y/J M`)"PB7^B]_Q5W4XIN.,H:3&:O)XI:"\R9"AJF0FW^XYF?:&LL!9E'):NG*<[ MFV3I[&F\I26K!(UFID160+Z0O5+(L[LQ*JU\7N:^-.+-7S80QCLC M04=_3$??[E2^>@)9@O9\[BK`_I[4%%.$]<+<9TG`-YNX+0C]+!TZ(5T:);`[ MDT="*BN4H)3%4DU(97,3=1",VQ@,P7,JTC]R%BX'+*.\NCF@?O:8HL_NA*5& MQL.HP3`LW"F1(4PG,OS@_4C.TL(DEV&'Y#(DFV7R[TX7X!#"J)E7'HTO/EM^"WQ(CZ+3P=CO%: M#&W!T^;5X6D=Q(EZYB8/C#HB+ZE6$92#>QUV,^"O($!MTI#.70L2&@3%,:H8 M8KPYBE(.2)>SUWAYB*,8K01([VZ#D'1,T-$5.2\N(R8'9%$V,R`N:4R-3Y^. M:@O2"01$,0I>?KX<\BEP7Y'M/GU,(HT4QC2$>;+0N@PT7S:E+?;Y(M.RLBFQ M%P,Z['8'_$1%X4=VO2Q,07X<]#V@J+Z\WL/:B"9I\MD[/@@W;94OH%O:C%B+ M'AU;NV-U(F+HAJP`+\P`HX]!ZFN`/F>0-99/C"#2ZPK4':C?4U/)Q#D2JDLE M[@QH2MZP#9ZW.DEUJY):=DVG$*O`JO;D_N;544=J/YKV`9WV%FPDU$EJ=)^A MC&U;4OO/#5":VF]6!603^SNC08=.B=T;=PFIK(CEE[+XC\3^%B3V8YU3\9)MAJB! MK/XPU=H&%8$?!.ZI'@IIO MK^3P*WQWI=OIL8%O01*OL$`-&_1\K@S?6I!?"7G]>YE=<9LM]1M092^GE2-&OA2UG3> MQQ+%D=+;B6950/9N(IJ2,9V2%D3&ZTEEQ1I0RJ)672@J^/SS['&Q_+K"M9I7 MJ7K=/:'7\$2(2RJ&I!Q9]1`BAB=KU*63U8;(MXQP9A8,"0[+:Y`S`J0"^1NR$8:%:<&_7G-I94FB@ M+5:JN3(#",$TI;G;@CP#T^-AU/RW(+A`0Q8BIY>>GZKJ_!L3* M%ZLP`-E:I2K0P-+CW%X+\@0$1#%JL_GYTERJ@E!?[LX/\Y?^SRZ:T$-TXR:( M$7C]BXNH`GS7X/L2Z)5$\%ZD2^_L]5J0.5!+*',&6Y`S!O\SIX0B'[D=WVA+ M7]8O$$]6,I=XZ:7/]@D<^O!3EC,94A(D9D.`""[VTF=EXNP^ M.JHOE.XELS9G#FL)DJ:`M24OQ>+6^$'94_L:M7;X&.L1,`GXC?R4#:E#G@3" MZD`JU?>[K/B(E+FZ2'T M_(WWYNX)/`9"5PMXJ*J`=`W.L\"N)$#F@+X$8/F%FGH"F0&Y(%<,ZM$EUHFM M1I;[V+0>XE=X+QT]P)!T0&$BX,'G$E%BHBOY.K/+9]^389S28;3[((N+?T,6 MN)2)H]DE7P'T&45E#>"]N?X[RPXZ,_8+'[DEL]?DE8S!4*C.#B=A:8#6YC\% M6DX:9*]/'ZJP_")+;9D,@+L68PYK"&A+,#OW,I!/3;QHVKRF'JQ2ND>M/`6. MR&650DI*D,['X1FT\QJ1X67VQ.[K)OQ"&`)O-2='M*[2=CIQ'.3N&:8-6OU* MH8JL+R=G)SSF-B#UR=G@V7T+@D\`_3CDX,*YL)#U3&-R5O&(#S-VPGTS4<3/C!+$);#MF24B0P%R)#UC1Z>-FWVRS+B*5; M`21X/.Q=QR1R$EX&WPTC6@%/G<"RD$)D%.\IF= MLOL*5%V1K%"$2[Y$E&"Y$U6`Y("%W)@B0!D)/$B3;2T'YDI.$LB>?4A&BY[' M]^W.]RAG7#?\2GMW3B=HY.]2,.J3R1,X,\BV5@BC/$YR840CE7UZUMVW.T^B MG'&C,#KO_0)&@@'U2PGIP*E(KQFH5K,:O% MY3&%S$L.RF*60H93[)-K!75OI-7)1E2M(@TD5,JJ"+->]$'@-M1KJ"^9G4IR MSJ;CBFG)E?XL?-5JTD`:OJR:L.QP-DMV;S(E);-33<[9%%U,_JPK'9F[-*X= M^[M<7Z@&@"_&X3%Q^0+_$;NL^Y:T5)JV+&;5#>8ME]OO3"OJ M6';H4-J=:L\M0Q.6NHPAY];=P./E\Q!$,7F4^UA,,'W5'+S!D.+XW\`S]&%( M+J,C"XY\F*VWH;4(V?5S4I+PU0U_A3$C=FPL_!2I<)HQ/_@MS9,N5A(N2O3< MHD?GV.ZL?RFY3"M3'2:/Z:A))ZTF#8TDCQ=CO?+IF2, M!\R(V7T;0$R0)A!=R54"X3]'V>6`NC1J$ZKK/=1B)*.:[R&6E!'HLA&T.V>5 M7PC#X*SFZ.)5E9HV-+N!?7#?7?3OU$LC@Y'824DI/:4@Y6&V]-F@\_8DCYWM M7EH0B&L&VWROPN6-]X"F-O;L3JFN(X[N M'((:/)4\Y/,_O?_5=!.&TTC;<16FP$B7MZ>+(-M@M"#@*2:-41,MQ-KI?DQ( MHC.^[$%VO7LEG`"W_7I,`?0%B-&--@VH]5H0T900S:A2U.>37A>@M283Y8"T M0":DUP6.A]VU/'7Q.R:K_Z+0AZUA3+/N6XX%%$,8*= MFELTG-`W<8VF`,:9S^F(T;!QOP7ARE+FC4*RC!-R*8)L(6D41LW-FCK0TG2U MA@=:[&HGW6KW6Q!(+.>^.7"=L^*\9=$%!'/Y>"ZT<&*MR3LW!1@LSY#IL5%L M07B.6Q"CR.3E*KG.H"#SB/MJBQ!HF[Z'4PK?HO;4$M"3^'X+(G!BTC0`9$[6 M$C2S-(O\0V.Y(^(U/M*+,@^M"U5"+*.F]H"XDM/2\^&SUO@1?-WN*5O#2.E0V[Z?QS< M,(8AMH(]@=+,9;3DL"O(9?9>2UE;_$K0!/MWD]ZP!99:1!8C=EJ`(>?X;9(2 MBKXFJ9Q_H]_K`"[O=:V&D5MT):MR=*=T=.VVN<*R&/69!1C3#F'DM_\,(_SX M%^+!"[8$(0*%C*HIJD8S!\<5D+Z@@)V[*7GMNS=J0:A!7**&+',%6_G@QCO# M;[05!CIJI@_CM8UUOGER_)^]=/L M<;Y:K%9?YS>WR\?EI_5L<;^X_SS_\G"W_,M\/KN_N5D\SJ_7R\?5_/'GQ?5\ ME3YX&(C4YY?M4/(418.\V8,6Z0YZTVYG-*;3WH)XC7*!S1S7*.;:H00!I0@H M28!H@B-1D%`%B"Q(Z(*$>=!Z@_[^,+]?S=:+Y7W&E>G)N&[5?:CVUFI)5>&@<=#$BSTIVHMFL@TW MVA3(V)`;)LQHON>%R0!&A_A;:4KUUQFR65L'1.=G_G8%]WN"-_'7\HK(J5M8 M^'@M7%#RFF.#-F8&K16WB(3$,>Y'5?-TMF;0C3]:,LCB`5Q_"R+42!.>:SA, MS0&:PT4J&NY)APYW*ZY\"HG3F%-4S9LS>WX.X3.^3/3FAGG55YB#Y`=^"+<0 MON+H8&O(["5PK!.#3LC..2I4)<=.7::WX+H-Y<0#:POY1RUHJ)7 MDMVZ\(]KX"S"R:S0C\CXW`;A[2%&2\$*AM^\#8P(Y`2>AZO5B1)'35JNHL)X M`D1Q"L20.AKC%H3CE0AIEQ1T-4$'LW1S_0)8G<1TK$H]H16LCUH<2, MZIIX&W2Z6U!6H`2(9O85TEQ;%+KYO_Q=;'^R\/7Q^N?9JOY M[//C?/YE?K^>W=\\SC\O5NM'<@;WN/C\TWIU^FOJ]'8LL-))=2:GA*KES.BB M''$T^0.6)S5N00J!4F&-K(0J.78H,9!0`\<&Y.`Z31!0BJ8,RHH/2@BAY.?=&'9125AS\C-K&C5Y`<(AW^^`[<3#V M@>N3P\\M?(K)>2RB`"G^!#?4CQ!956^#MOEI1XF<'>,79/H")YDEI.20*<9C M!J5E3=%(#_O,QVM!5%I`%"-6D9\?Y_1I]@B)QB@T`);3?#:+V`+#6CFNS/5I M00190!2C)I>?+TW0/1:@N`_\:VR[]WLOY,+R%D,!$8"I`!PTK@G"*7B#(M*.6K".V9UR6Z MW0Z+AK0@#,PEA&EC7\A)!J"UG^FHF&UQ&VT(AM56]WS@Z`9GTH(@*9<03=G1 M0H[4X)&03F6?]`<")4XRC>7@5\7'906U=);&<$R=KTD+@H2ES!NQ=F43+#@CU2R8M"'"5,F_4:I5Q8G_R5"JYF`!&X-I%JJD" MV!;RD%-%\CC4XR'-ZY^T(&A5PKHY^Y?;?U($LJ[I.Y\ZH7*ENO!36H;T-`HC MZNE.6A"?*F'=O,'+Y>,?-Q`LN(&0*MZ.E4$@6'=JJ4`?BSBXU,83DKKTFOND M!9&W8L[-&?.\[IDG6]>4G\V:B"77!)PR.YX:`+:8M2``5LRY>2N>QT8+?%;< M]4/H;4Y8&0K42SIK+@G92EZRL#W['-_@Z[-M:`OB5Q7LFS%]I3PX*XI+_/=: M5K!H/GE-H1%P%1G%O*%AF]$6!'PJV#=K'DMYD479;+,)D1^ZRUY.`T-M=T+;"UY MM".W!E-.NA%@K4#2#)S:"5X]RY\#=XBP]O(/WO MQ]&D3VS8-(MV->\SB'`BIR-R,B>:(D0%VZ9QE\ZEW3Z#C%C\>A,'L;N_JZ4\ M$@PZ]VB7M'E!5,EI$<[VKJ$M\2?X[/F^YS^3YX!NO6CC[O\"75QU?M`5J5-6 M2DT!QD4XS<"ZN"$V2L,Q'5"[TT+$!-%M\H6X$XQT>]#VX8XXW70.2N`3=A#>#FY+\4Y+DT\%HW MHCY9U^Z)8!V`%`F2W2"8 M*7N#W"8<"5SNSGEY<-]Q'@2&U$0@^E9)4$X?ZO";J$!U6UP"AF:-]KMV9PP) MRZ(;Z*(,.4D##.P+$`/62+".SF]HW8B6NUO7H^F:R]TO;ABZ?ASAYX((Y7N( M0R`XUL-?,8>/K!RPZ_.>P)N70G\R[5I>XT94%-W@%N3'H=_CS`B2%7',K?C. M&M&7J,B3\E?`AS'^VW(A^("!,&(X0]QVPOTR)"XT*7;[,**BF`J5"_*5X!Y9 M=-P"D";XIZ01P*VHA;\"J*$8X#^[GG\7('[\&QAZWTCVT<*/XI!(B!EYP!(9X-?$A7C[D-$1&VD1%^&E,>OUIGP0I1C1PW;,[XB\I&8<" M3:D"^23?>5LO0B3'I7-]#!!EEY'MD1C8>^Z3M_=$-\B8L0AS!A%O\]_P8X@' M+WK!7-&7R3_B6\QY/I(Z%2KM7UYW1,5+ZTQY6VSMIG8?CO(+H=MUXN;$P3^` M",8QS]1(&ZKUK0QVP#I_+2AOW.OV)^36T+1K>>%_85D,VGL1OA1@_CS1 M8.'/-F1?'3W"#43+!-YZ=[L]6G]*#^QY>)!#?ETI$_#SM,=/H/4'>"M$EF%Z M4M&S.ZE,2BY#2B'#HY-\"L+CM[+Z@5RN-]?;LL0UA!<6+36E&]G^5>M%M73% M.I%MB^=DV)MTQW1.1G1.[%X8:LO4F"[P\>>0S][IK<73!<3-(0SQLN&B%4>T M#&TA*RL(MQ$Y>!GRGY&64],$\B).*Q%.&Y)%V.[4,4X)=#OQ?&PXR6<@^0XL M?,"^!.13/1`]M]P68U3`#)_&UO(W63@E:-K$9KAQ-,*1\YS=!CA>GJKS#)_= M9Q^<$I@Z0^=CAQ3]]A+[^<.6??PCV!Y"G'6+;]BB9OCB!?KIC>28DSH#]![O M]@"3$@.!#\$[=$-2:0'_\'2(/!\?RV_>-WM$$:,$>0Y1'+SBM[-Q#01,_>WH M8>`CQH@P)Z@?K"@Y#@$?2^R2'#B2Q9"7`H&0..P))*K7Z$)2D93(=%2N&M1P MTF!G0AU!RYT5>>FT.S+2+#H)"9JW0)/8R&U1FKF9T,G+UU&C3@]N%-\<(,N0 MB`CA(UI1+E;)6K`6X+4.,DC4?4 MT1)%#Z_'927T1]NQ-Z:DIDS$>KQ9Z#$QG8P23$WA@"F;LE-53P M_13R3)P?A][3@21PQD%2\(E<6(E#UX]<6AWJU7T'3Q"X('+WM`B+^^;%[IY5 M84$:Y5[0PB[D!W)WD'RJR%AC=MWS34T\B?@5#'DP$:^[( M:_%V6F'.BQ+A'MU@IS#V-\A^PA#+YY6[C]]/XUPA[?\5VF&=++ M;U[L(:ZZ_=ZPK^VN.3\C_2* M.5Z(WEA;7`QQ=WRYSCTV5*(Z"[3QB>(+)-%BG295)X<1+:K#)W"%ZN01(9$? MNM_LVWT)H;Y03:I.-7LGU3E$Q+%#_Y^U4:TVRS<8NI/"> M*-BCSY[3IZ\B;]]PD)36@QH\IQ2@LC69!;;NVYVU74,:W<=?XBP1F.,V@#8" MJ!5(-:MYW"N$$\X#+[O`?7G0Q3WX]-YXW^[DHQK2F#K@$F?-(7766:5T''I$ MWY#LHY@&*H-7",BSQ$@/:$01D?3\`U8`9N@#/P(_/%$=\9(KRZPISF$Z_@[2 MY*U(%7&+^00"MV_TCVU15`_(%\ MJ:XN1+I*B,?N;_C.$_PM#ET$8;0+"]])%7O,A4\JYF]2)L33;T+X#O3LLB`7 M!WGS@";^1H7?9BP+W!\16//.WN.3C&_[D8W?`WC+0DT'.SXD' MU';0ZFX#NV/X"J3C4!`5:9#RG#H/[!4='(!Y8ZVOP!MN3WP6F%"HJUDWR%O; M!V^K8!=_Q\]$(%A-NR84Z:QC57K#(<^EFEPT&@_'XPZ="UH):&!WZ%%4%.,* MP,66\PM\BI!#CG83Y&NR[=D$D>BU"J1F&YP[>8OP<0I\)@40$"2FDZZV:]7E MG4O"7%2P(]3+&Y*H%74;AJ=SK> M033Q/;@M.9G!CU.](R#C]"C!G"C!%RMXP6W=4QM%BL#_%@1-`^W:'6RH+Y19 MI:G!(5&E"UUQT^]R,.T`Z)]N\C1'+/,T!T<)?TZ-L.&U@0(=X"F.3],$NG8? M)=:0QBCJA5C#+\XPHT]O/&_>,:Y?\";4C93^Z>).IZ,4FDC3Z"1?**++U2_:OG;TGE/C>I/!"_N#'JZQLD M*Q%[!A$_WA&Z&[30>8C8)J)EF3+]?P0S'*`XOE(;O2#U_(!:O%Z!%^_Y9?\. M]A[2S$QX@?:&G_A\0OP@'7>W'OIPDRJ0&0?@5S_XGMS]BDX)QZASU*&/+W\A M5LESC/$!PY)21;][!RR.@P?!>_:]G;?!VWDDQ:^$#JDXA9=45FWJ"6[<`W44 M4W\[ACE"%U>M!?/?F(Q'/L@_X.E5E.1VVM:+T.B@\7L.@\,;^12_HDMC1\A$ M':,S@FMW];L-0L;)_+,2I0:IX$6$+HU)=^T.BPK)T8`1JF3J'^;G'^:GROSP M/\K!:X>L>46DR#+Q/7?!"C[;'=>J)Y!96R7(7?+``GV_'GCT@05\=6)C\G41 M&;1;\;R("/J+W[V@!W$]NX-; M"#$SKY!PZXS]SY`4:H_XJQCL!K[=L3`%TAG6(PE6,\^34)>5E#LXNF?(54Q[ MCJ3>/3A@]<+Y0,Q;HZG@HKHE\`X(ISK9\W!)@=)POK#!:L;9'4JK)Y!1U1#E M[O2@"8FAG,%41"L>V@GPG!PHMF#`WL]LE,#H-NK3AD' MY-^9^@OR5\=)K(\EPBS\Y&&SBRSY3ZQ8ZL?19)A7_ER-"1%D1D'L64;R<\T7 M)4B\)88`NQU011*:TE25DA+3^0*^.<7*B0,%JRYRK7;S4R!$4R_*VV]-5(9Y1O:K'(ZV!LWLFK@309I?MQ/!KG77M5HSR\7$B>B=>6]5QIN"GA M$R:6V3.P.WU95C13RE*3/Y'#O8O3=%&5>D.KG$>S)";LYJHFM3GU)*L:93Q? MPC_U-4E>HW4\!G8G*?.P;P[&A3PXZ;\EB?6ZGR[6]NRJC2\7%P*;FQ2:L?&` M7>:T.QU65C13"E&3/XV/%M-3B#4^,'_`M[NZY*5`7;IRUIMDS+.2]7/DG[<@ M=^F82;([F9)3`E,X+F?#61S#,.3*H*K'5UF.0"H5C12Z[/:[>;4)=3_#FLN- M-*(E1<]!O!!%;';IR5:6\@(^X#<`(V\+6=V0Z_GR MWQ3KV3ITM^0!8(W./1\3FK6J2%!A9:*$R)Z,&L.AW9F5QS:L',T\`5Y#,5)D\$'Y@$:YAW8G4LJ(U;Q2%/*6]^ZW"J7`.6)W;/?! MO)*.UBU$)0L:E*):2"ZE."=#[F33Y+QA.V+S=<1J5"G*>7.2]P23RB?2&K'$ M=TY/P7ORBOC,3[.`MOFG2/ZXIR]<)\F<:C62')EJ!1/L`-]B8BYV.T+HBB5N M3BUEV&:'8=%9"@NA0;9"^Q,5P;2YPF>%60T9!$=V?]>0NF:[5ZV/E<)5:]P9 M"1*WIN7 M,,ZV(!X!S3P?MB-^72&!.9"6L>$D?ZYS"'R\Z$*NN*"U(2G"F+J3O`RO]Z[W MBIQQC#-]:!7A11++DF)?(%V('@DZT7IHPW8$N:7D,Z8E$DP6WZT/#C$^_CW> ML=?_5J<6Y;+YKW3N0).:6;\;A]\9_6R\]1.<+]>YQ59 MDPIGQ;.YHAJ6_Y0KKG\#MW?*7%;A]7'X!"DJ-W*.Y0$R=EE%_>]P4+O!; MO"FXC30ZC+QL2&I9?6DOE(N;%+EB3@^Q1NU(5*@MFS%5JLF@EFQPF7O0CLP';EG,([^0MU.CR,=2K^J^AILKHXIH!^,50 MC?FD)3U+HEM(I`M\E[0F1Z,4KTXI\&F1SR%S;=N0F",O4A(;P,':F)Y&[ MOZC9HDH]TB]W)`958Y6CLJ[5*06'4&7Z<-$<6[$Q.^EO1^J`B#A-:$$%3\YL M^PTK"5.`'W#Z\GM2P?)'\J39Z7(ST8>78(\F14P/'M$6/?0VB`^BA,=,]^%4 M8^PROU,Y[',+2H!OZ MZ(^I9[MI:7,QO*\.;V][2(JS[_%1\>T^^+[P48^OI,[2J0YQ3V-V/R<3<@I1 M6])S!>$E1-9O&L$:MR,T7U,R4RI4CSTGW8R\,[D/HD,(CR]FTOB\=R(D6CH] M]>#WC%ZC_<1R]PB_0?\`/XX'=!\YU8'F3%=RR*W@.D%I M]C,\:'33U;7\G')P&W!J!))6@#4#K)TXPA_"8'O8$%,U M%7@K+]54'J_%/*1AF7R%LU7HZ4/7\F?O2K@V`;+\KBF6V-\$R[N'010]D&GT!MLGN`M"M+C'H8LFP?/=\)WF@?K;Z\/K84_7_MT.;O#CU:0"U;'DHN<_ M/X2>O_'>2+7,SFBB#:KJ&99#O)$!3!1'0V<$26SEL_O(4K_P1M18NQ@.I@V> M"/'4>\"TX@-Y_`9'E'V6X#:/BN;_>!&P?W9M%9R$?RSLP/=\2*DD0R M!M;`%\^81#L+.K'#[F2L#9NGCJ2S(8L93I"8^H@,'3T.[]L=4RAFV@CN"KLG M"_<^Y5VJ<2+%SE`YXUFV'?U>1KVXV:2GDRR08_39@G>WNH<)1,_EM2KR,6_[M6:APDE>_QP]P'"%K[U^["9U91M\`*0IR1C9TL:"1YE!"+UG__H0AM#?O*]#UX]P@<#`_^QZ_BD+ M9NW^]K';&?3T7J?-L^^KY'G:FTON8TQ.XTO>4TL#MR)2B) M646I8L=9W%\OO\S!:CU;S[_,[]=U`(RV/\SU^X1+B=+M]?968"WI5@6`> M4?(A?-F2G"LRNV)W*H"@)&8A7,5.D@B=,=*".XKDL?;C9K,[&NK$;Z8W6=Q6 ML7Z)UVP+XB#3>P^#=H1B*R0PA\\R-ISDS_5R`NCK+-AT4WPGU-#43J;ZPEM% MW]7O:2P?+\R/ M0HS7%+]4#[AHDFFFWMRP'9%?:1D;T:<:C!;K'*[1K:B,0.![63_JAM4'CVXA MN0/=GVA].;&L=TG]$A8MYYG$4@KDZ(JFK@S;$?45E,B8I@BQY1S_^&>P@\*/ M]09^D+W>>]R[]?M3C=Y14;_2*.<6)P??!6VQ"\HJ#`[;$:SEEL4@IKD84 M%'#1`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`?HW0"F"A0].-`$F6J;Q5ZRUX.4L>MM[X[G[Z\!'[@*.K=Q"-SZ$<.&C7_F0 M%%/#O=,/8N]I#^^#&#ZX[_B>2B+^+7P*#V@3@-R2+_BT$%L7_*Q))V\76Z#G M6IF1TW[3XY28!+W]XB2Q`4F[Z4_M#J@;'0?=OH-)89Q39^#4&V#=82-SZI`: MF527`/<)6*@P*+4Z4/.4"B2*M'_6N1(VOV`(L#N!`05XNG65@4\.BD:1&<( M%8#)Y&G@&COWF!8@Q)2HU8/K;?-81ATL=_._'1`JOOI>'"W]+^[[*%F5N@)[ MFAC:9&])?:<;+E!H3+]1LU`-8[@#M M`Y!.P-)'Z^@[&"E;1F7PSKDM__TJ_.767#&()A1$=N<):)/9U&9=EP`9S<=' MYWNB^3@A$;QAS?=\L#EI_O'`+L*:'^P`I)I_()H?,,VO1N$UV[TL@[6 MWP-:>RP(R0ZSEW=5KT2_Q7J05V1IB=(:*T@,9Z!UAW2B[X8$@+J]>*8<.51)7ISYUY,C3G&HZ^*"Q.Z"S9G=P64HND_HBRMR9JAR; M@T_O($4`I"@HT)"%CU-TT?H\VZ`E+?)(2AA&55Y9)1'MR".L03,X^2_5BEP: MQ(ZQ;8+=\=?:,C6B#1R,%6K"P@>L,4BUKJ\%IW4,N8&'/;Y$F5P'GL7=_C1Y M$@Z[D>'FI=_%J1<$77FYB1S:4:M#=5JC2MX\;:I'FY2)8R;0[NH+RF4UJ7TJ M&#[3RK3W=B0*$JI@%H-_[G[L3P$B39O0 MS4K>!?@MXZ.B1XFB?Z.*[J+%O/.QUR%O'M/'CH.3KLL>>RH!/'^LX_>G[+EQ M#F708=LRNW,*-4EL+,:AGG?+%9TE+RYWL\TF)`F0K*`^1G5>03=!C2ZBKT=U M!:2ITM%"4N1F&'78NO:G%\F(UI0+S:?HES\/4M\(_WAV9Q=]BY$+4W.BI!WH-, M(J:@?O<:K('2L2@U"!(]X2(+0YI]TK4_4U"CY(V8!67L%UN&4Y7-XRD9[B1U MC9>>B`\[^<:A-U)G'`[X.E#RXLZQOBT&>\V4APK2.I2:5X9RA%4(*Q&5^4@>T@A=<-;-DDZ7@'3,]YB._=WR$ M.J#)J]WV)'T9&HUV&1H>D6I8GV7*$SGU?6F-`.T?'!E0%Q37I7$R`?,_K)GB M#+3K@#$[D&YAEHW>T6@T0*]5M.*8WH[:JVUBKZ*2G1.D)FM[VD"]49,%+TW6 ME>4V2R+L_XD\0'W*, M!H+E5$3[,&502J42MQ`IN>S9#UTR)ZQZ6/-NX(8JTD!9I@\W MY)1O/NS0))GMP?FL_EX<_1RY['/9+YD4/BP`)QH*-`F7[XM.^0?$G9-=@LYH M:E"4:JY+]>*\.8[&3KO4OVAA0FJ%.(TL*.4\%8.>M$LEQ,A"'+F5-_`I7L$X MWM.P?!(Y1[T]N%%\.9&Q['6#E,)VU+Q]4R M`LTYVSK$R?=0<(X=[@J<6J52\;#_@KL#J#^0='BLC8V+%+$^T\VOQ>W._#<8 M;KP(+G>LZ!&N4Y;\\B%$>X39]K\/R"9LUT'F6D^ZEMU4X+*Z=(=RQD.'O(EY MD*=-[D>Q5$Z[;ZXJEU6WBZ&:82=IB]/L&4E:=??X!T(5)&1Q\;#SN^@UB_`J M!#&G/_#[T=K+55T-,OH=@HR>W>NW%J[JJ9"2/-%F'\_*GP1'58$#GJDU+/[YJIR68U$=E5SW;CZ+GPO M]MS]R?FFSOUR-QZ^OE(/?^G_^V%/+^GTD<,^VVX]BISDT][IR[,H]?G[7KAP ML,".!&]BAST!I]QN:>0,C]VRY0*1O*`B?#XC>`9C^8P< M+13G7M%NUEG8-I*G]>:M&)6]584%!M)T8?T0L M)]'!X+BNT%T""?FYIZ7EU*R7:91)^:0M"][5%@\[_DZ7%[YC#+NE^6.L+A<' M,)8S3K2?7N@=V'T/NUT#:>3HJ%5#3_4NGJG=U'F='!=] MYC^ZTL"#I!4W,RI'VZNC.U)MC%[J&]A]/\*$^-J/9/3+X"1]I,+5>:]!;PP] MQWX/X[L@BI`UZM$R9_C0AUOILZWEU+62DT31SC[$6`_DW6I)UQ=+$.<6,F!0&7>;&N%,,KC)!=&?5ILAIUWVGU?H)QQHS`Z M[_T"1O6L$7+SD@MF]YX/OP1^_!+-_2VY+H6]/%%D%1-4`C8A?L_P5]*6#*K= MZ6?\0AC"934G)XSBV,'Q(B/^&M#/`?E>#+F/B([WC?CNMP@>J9?WOA#Z'P?Y MM5ONU%$7I6, M2<'D&Q@B3F+O&[SSW"=OC^9K'9RV^^S-9??-B]W]+(J"C8=3I+%?>TDK<8*Q MJ1P+7%,TPY6TYC0S#[8,!/FGDP8.?4/<\A^3UAH MSH:M7^!%`C#5P4DS?E?&#??#\_N@]O\3LQ4RL0A.!8D!U^I"U(DJD.MF% M&N1P0'M"*W<.;3^ZE1=/OULAS:-SI`$*:W"="`%*B;W,7DNIX@)N;]WP]8OK MN\\T/XQ5:D4FA]7(>'##^!W#4:10A8H^E2B=:JG/E%"./'XW*4&$W8E".L0U MI*0J>79.-(NU%A,&)\JGMR6PRY\4GB'4Q?3X$_0A6K4]=W^JRG<+75R;\CSC MZ;I.CAQ68'[/72LWV4NF/;M//LT/ABF?W;ADSJDSL#D] M4;NCW>$,YLTI$9&XX^E,1!]G(B9%]U@JM)?*1'0E,A&Q$40D4;\1XO\./KO[ M6P@O,C!Q8C@.;*]<>A5BT!5]D4:T$SD+HDJLC&&H110!8=2C#QKU[#X[5":C M4356P+"3HD&4:8^I(.W$93(O59-<+B!9'A$FAF\ES`[/AR@&TD_$(@F..=") MFW/M1B_K8/T]6""+@/H-"5![O9KU+/FZD-<^>9$N=$^0)-JN=;LT!;QG]^&8 M(@F-ZYT4NV?U:+'>)6=.Z><0-H@./LJ*OP=(&1DIX)*'W`>CR7A(2MH%.C6PG^$ MV!6&L\W?#EY$3JH)'(>R>I5'68-.\0I0K4^YE(B]I"4W>W:?+LD)UKP><7!9 M4X?>#B&^>1:3:,R)N&@^2NX!&/)PH\,^)L]\T1.J6=SM3]/EX]"FL-]E-[L& M/;D:Z((]JM,W90(7ZF&]'O`M'/96;<_N.W!Z!&Y,;U5P?ZG/IY.5O0GGU M:..KG&?`JKI$B_,WZ&^),^SC)@=.A3!:A#86I783IK4/^<^5$R>H> MEE?0UF%-N(7@L!3YM,CY+,WI[=M]=5=6-`LTG(=/X?>X2=QWB7YS>H^["Z`; M^GG^@C;-6OJ,A0'N?TZZOR&]KU_@`^F;X+;NB;I\]\;TL^90U%5AGNY(F1X& ML1;D>NF5WE9#("Z*<_V".J;)(6]NN(W`#]%A\X(W%S2P0$$1_4B6:6Q-W%=Z MZ;7"?DOROD1E:EZCRQDL7M-]\C9Z:JNNXXA/;R54WNC]Q&"&+W-WRX M]/W%0]CT<)(E/3(B0&:'4V]H6?1C06>QJ#IL'=1J*E3+@UI6=Y4^I-)O0496 M.??-H?:<%3M16^N.\/'6-W?]C'9=9B_0D_KWJ>D=J7X+\J=4R&A4YQ0PG+KD MOBG:3,6G2^XAO>3^C9!BFZKQ-+6AVGH1>7,#_74T_=-Q?S6LL[]2$%< M3%]_-_?BR_59P=5K!J46Y$+ID+D)?53X> M@[YA\GRF`?U5VCJ0VQ!4=GJ:2X]RZ9BL2*Y&.FLD=<5W=E%V?KL?FW5AW]W"YH_U]];TX6OKT@FN2NC;JB837U'4MIP!ZAR"C M,PJ[(J:/O;G3@I0=?9(;7;6TB>'\%6Q4*R5(E#7G:WP] M>TRKB0SM/CVN9IY?4>AV:A6[85S/X:UDQOGD[G'$6R$@NZT'9)<7D*S2I-W' MG=7,BP)R[F_5PO'(BBHX7FRU.P/^:K@5Y%0#KXK78A">;U_1$D:CK$.[C]@$ M)>&'9PY7M5!9QHZ3_CPY'F`-:C[^I_885P#DOZ/#ZWQU47("2J=^9/=AFPYQ MC2B>6IZI=B;UG2E50,DFM9\I87"BC%]H2=$&)^*J#Z+Y5+.I@^@+%2H_*:6+ M]LCNTS%>$71#G9./[*&SW*I2\`A),NN3/$2J<=9+>Y9#L9A0"9"Y&".69$K/ M`$9V'^?4DD:J;Z3DE)/V9:[;Z497`4S%D!W:*( M7^(6O/1(F22'Q.+ M)K@V'#ME'-E]`8E;!F,HKF"D"L0S>HN]'G3I1@BO#H&/EI*;X-7U_(_=R5B? M/Y;;I1R$.:4XAW%^,WP:.:6O:X_LOI4D)(TJ#_JZ0-Q6<]R6!:3Z1S2I:U)A2UVDF=WC+>..*8`+L"3 M@[[]`%)?@^3SFN;Z$<9(2^`6UU5!Y!*O!]_7UP;U_#YE;]WPR7$.[X)VY/XC MLRYVQXK%!#$%:2YNG-EFJQBIF>50/*V:DL",P?(R!:QB**G6 MC^T.R7++()I_(Y$0QLM3`M&DS*@ZJ.I)#S,'U8ODL$(>_K\N'53Z"L78[D"I M@!2B<*V=+L;/DR1<8^0TX*/JL\UA-/O-BSX.NZ.IOJ6_K&O9_!HAJ2[@7-J< MU%YCUJ(=L5(A>8QY"@),.<>/K\#Y`44$_HI;".>=,8)WR+M>H'\26.1E2BH& M^[$_10@OX;\0UJ[_<[)S06A.@+&*=R2:>/45QZ&YB/.<:#Q%X6%`$ M8S$I"Y%=2H;D==(M\[@=(;M:!'P5[;TO.U$Z&/-A)7HL_DEKC MNFT8,?I"(=F^%"E``=^%2*??DT<(:.!TW([07;D`QK&;QT7:P2!_5WGY8I9^ MQ+4[[O6Z&G'*R8PEO7EJDSA1]>FO;=G,*44]!L_2YK;XZ:-M MJG)Q2-]&3K]?K%"AJN]S(-B-)\UH69,7GNH,C)`^$\=-^Y?K44:]0R_@%I[^.>P.=9[15#&A4I"(!A92($L'Q MH1Z=R4E+PL3"0EFA/'F<23Z^;6Z).A6\)9_-\,-M"7JKT94*Y26GU_GB_LK!,]!D+SX MB`NS0_)F9!R@E7?G;6#8?"E;OGH8O^=*MA3M/+B=13?(HGU#ENL;O//<)V_OD1=*1KV\0U\%%J$N3^9LA<)1 MJV-%:G??F_:&?;;DV)V.TL1PV&1Y%,E4RR:Q-B#I'-LCU#TXZQ_,(G#B`!Q9 ML-E8::C$_T>P5I?5N8E3NS.OFAB./C-E5SU[@9DJU7\GSW_"R`K1;/% M!Y'$;A$GJ@\V)]/EXC#ZT73MVV"Z^)[$^8?E*A@U\X:+G:W;G0G9Q'`822!N M0#!AJW5\L+PQDZ7L_8YZN\#?YULFE7L[%4]?=-BY@]VY>9HE-[UC4\M^WN;L MV`,@79@\-F)/@-\&X0WAB^F**?`M1C& M.LG''"T?;V\F@J`4)K8+8BPYZ$N`/P7H6[!"@T&^!OAS0+\'I(%@/5G$^Q;S M?[MWGS]V*S-O(KCY^!Q\^Y.B4_JN`7GO M<&BY7UG)NV[37<6`<_PCP'\5K,]X"$-,UHLV[OXOT`T13&_<&'[L#JO*C?*B MK:@+.>!Q,Y[&8&$C4LZ'C:C=YS,B8IA`)BYVJ*XZ\F"WL0PZT_*RG45O2"I=T'=,QMMM]%I+#!&YYF7&2 M#Q/DL@0D\JT,<+$&)'.ORM06]*`2M,5L%T,VU6;:F0X&=&SMON8A((5YN!:Q M<@%68F8EH/J0%-&A2^NHZB*%*%`S]-7`M)SE/)!F6^!LXC$;4;MO/W#+8!*@ M98RQU.XHQBKTR%A-[=VK\[!N$F\Y M_9]@AO\H6/3;CW$M)-0X=/<+M&7_[?_`]X_=B2K',I>^'-KX6$[#+K\%<=BG M=!#MSHGGEL$$$'D8<>A'@'T%R&<`?5<+G*>B^#FU`J>JS&%U9TI@*R),#H;+ MFI/"ZGTZ!W9GC-<3R""Z^;DZ0CWS,@.[KI%J5@OY]`SA$;X%88QHX.H;R`?N M3JHN2PEB/K<;)6CG$R`'Y_D-B7O%AM[N+&M140QBFX>?(ZK9*=;Q:T`_KX/F M6V\/PVOD_3X'(5ZOJ\H0B8$X0UT%=LO9O81L]GN<8#[JT.&T.U^74P)S`"UC M(\$E^08D']5!X\/A:>]M;O>!&Z/)515INJ"M`HEEK%[B,/TU"9S0H[VI_5&G M2O[-8;"8B02!]`M`/JF#OT?X[.%"<'Y\[[Y"-*^JSD3SR*M`807#ET`\:T"> M0Z'QD:G](2<>$?/4_OB2D"SF,,S'4()E_/6'7_'G M(/F>9@$*WO%.#FWQ$[R$\L+?!>$K?98WJ1$[&.476RA(V^.AJ>:H7Y#K!-'< M7-)`WY`.OMUAJ=HRZ49X7<9.\037QS$K`OM4,T&<'U/?%S[JCA".$#<_P>VS MYS_/-NA/I-A>"CZ#W#='BT`OVH&D!BB0)U$'<5IX,S(@Z^NH9_<)F+1LNM5# MED$G=84V10$@$H#1`",'.WKA>2MW[7\+?X$_K[KQ\GPZ&^ MBMY5O:O2)5[9SLOK5%(@!7E[=,[L/HBK*Y)N/:G)EW,S?US\/%LO?IZ#Q?UJ M_?CUR_Q^O0*S^QNP_FD.;F>+1_#S[.[K'"QOP>WB?G9_O9C=9;[]G^[_:E(6 M+4^96*(LA<^<\,T@,W!VGQ?6%8E?610\@2+(G`*-$=.6AS#X;XB+R:'].6)S M3Z-#WR`I[7_B@+ M*IL7N#W@JZJYVY>%O]D?MG"[\->AN\WL8DYL=D?#R5C?>V[R',KIDYXA2G1- M!75#W3=`_#=<33NY`"ZX/3DZ>"F?C1R7YL4P MBLZ[\HA(;BTX^X^8VPHF@R"*04;,["9%?"#,'M1R<.*O#ZRL.HRUWF7IO M)_@JP&/F&#\O_BN"2T5GKH)\5N,T??0]G-"C[[[=!ZKBPC2'VP*."G:X#;I` M>HJ8_ZY$A"%E?$880S M<1%=>Z$TE`>5Z77:M-V,2I<)*ZBW9W--KYGU[4[9DQ7-$@TLXL^1=?1._5X^ M2'P?Q$D=O6@9/GK/+UDX#:<:GXBLRY M_^08/A6`JWW%:[;9'%X/>_S<]^P57Z[Y.SF;Q+N9KD#V2P$9.?W@YRVSTRIJ M1EY;('!D:JA[!+A]!N[T9$ M#%,A$0&>''Q4Y3X_A_`9?0G@;_@Y)0@V+V[XC/'Z['K(!0+0#7UD12-+]R%/[N97W(D/T2_]3?`*P?<7Z(.-N]]@8?`&A=!Y"X-O'FGQ M#GXX1*3G'T'P!D,B9H3`@;_%/'IH!0CA)@:O,'X)MJ)Z=_T?7Q>/\YOU_/JG M^^7=\O-?'A>??UJO/C\N5ZO[^3I]U-7-*\U0I(><="45LS[W647EI8/358W.F`#J[=]SA$13$"8GY^'/PI?@LWUUW2@%=.CZE9P!9X3I7#.J3# MVH+[&0*B&/6@^/DJ]/&Q:Q3@AZ'!%NY@B!TD[#%%R(=Y\V)W[_T=-XB)FP+] M+?X<_S,\EG1X(\7)/H*;`$;(AR).$3ZQ/=';>;Z+9H+2O3K]GGADD4>XH'TB MXLB9.X3L\]"3M394-[` M-^20>2>D"X0R2T@IU<8*'LN4,=,4%^_HDD/YCN6EU$1%:6+Y*.'GW`@\0;3A1MT&SSY9GSR?;:/)=IRL!)B2X!)P#^,UW+SXP3YX M?B)-L>3@-J#/2(`ND/PCDF8T!7^ M]V.L5I:"%4M\PB9TPEJ0.28CF]$U38)1_5KS\+A\F#^N_S*[OYG_Q]?%`\Y? M2YUO]GLB%Z5*:$E>*1'C,J,#I6WQ#>@Q\RGLSEP7EL7(BB#`D)-\2^[_';\& M_],7O!/[P%PU7`$B\=!R-.ID(D5>AQ7MXC#[^P0@/N M@$7#26L?%P;:XS=RMX<-.5)XPH%Q`\00OP?(3GLC=P\_@C6.SF]< M_WC>C,\(\-F!M\='!M$5>'4W+XA0^'Y^OH!_I&?>>.C(L?/N$/I>?`CAF5DX M'D&<3B7VWJM'SS&PF#L/29ZBG26T\W[#_XYHG_A$^Q"C;D_T\:^C8!=_=T,H M>%R1-Y'(@R5Z*/`V;P$9]98CG[=*$X&;X7S6$8T>6UYD442,QM;*2UZ*5D4? M"I:GK9QXB55./RH%5J[C&+)#EQ;$W3G%:'PUNN3)66%TADWM_T[-OC/0;"E*TP$PV_(B",;39<7 M),\>'U*3%8(&'_$?W.VKYY,2N>0$_.T0O@41I"2.[.#M2A8 MJ04GB-S(Z%I>HDE.,*.K>5TN]>K'+_`I0LO7#?P&]P%9@ZYQ[E#J2'O4[^94 MM"E0B@IR2VG.N+P M8UVB.$P-QASV.4A]#T@#)4!F6YC_`>WUSO9"J"KF1AF^3L6X((7QQ#&^"`WSD3?*;X[RS#'R0 M_00QYXB=0J9-B3NEB/JEKBR]S##H6@W6D,@I+H7H_$ MV#FN1ZGO`6E0NQK^++$4[(E6\LXJ-O=3@6=2.*,+APRG1E7GP:4OFI0!KB^0R21"6YW>U)"B4&LJ:9'9 MZM+9:D$JL8QLQI<900;/5.7-#=E!4[.J4F.1L5%7.)88OOGJT?EJ00JQC&R- M+3""C)I5&B3,BQNQQ6\%-X>0OLB8AMM`X+Q2B+A"K:DA1['65!(CSG2?SE@+ MDFVEA#._R`AR>*XP27.F,"<"AA6FSC)CI<;P+#1\!I:"3B#0($I?B?[(2).G0?STR.P-Z>RU(%-55CZ3 M2T]=)H\JA`D`R"C@"=E`"]1(;!&R7H_*ER+!.1R1.1RU(+555KXF%J2ZS)I6 MJ`?$%%[^2L$G4,9(@+0R+:HA0Y'^5)(BLT6/>$8MB)Y+B&9Z^1'D+ZLH;T@O MB!O7K(Z(KS<6*DGU*L,W5?1,9]2"V+Z$:$VM+8)\ZM:6N1^'[PL_#E*L^-O3 M<5^R-3ORE\JR&TP$MCRU.Y)3))7R9;2J/F%R;DH=\5$+,@J4"6ID75+%K3._ M7S_^!2SNUTNPFE]_?5RL%_,5*;F4*FS_\/7Q^J?9:@YFGQ_GA%9C#I&`HRI M1?`BB@ZXM-%R1PH?/83!!L(M3HD=]@1VS05DY&#+SUL&L$7-B$/)#$$+@N6< M8A@QL'R\.,EGIQM*;^Q+Q:#DM*C-H++`CI:.(=/N%@2C.<4P:CWY>"J!I[)M MY!V2\=.6@+<%]!NK<=,A>@V8"C%H05:XKEQ$;79,Y MA[8#,6ZH.%5)'$^H*9G,()W$D2[T'R>%&%1-ES17&*>)\T MH7=D!BTXM)>7T,Q)HBR;#J4`5NS&!:%!R@N$C`JN)9C0H2?\E)`YK>)<=]JD M5@5K4WXE0B;\:%MP$`#FL<';0:,1[T(+#=!X9&K.D M!0PY#\?[.,$.9&&IW7[^]N(]>?%LM7F!V\,>+G=?O#U$Y'S"+J+_`F/\AD"Z M@L]@VA>PKL(]2$)?A419O1"G2":8QJL'+3C6EY?0C%679=.9_^=/BT^+-9B! M#V!U_=/\YNO='"QOP9?%W7RU7M[/5^!A]CB_7_\T7R^N9W>"E2*IMB[]]0N\ M<6/$'W.9B/.TP2C8SJ+KX/4-^E'R'.MP*E`P6[@#.5U2(4]&E<0)D@FD!X.# M%D0BI`4THDBR7#IL60IHE;LM>0)\ERQ-;)FB=(!+"_$EE(PI%*?OU1Z-*O#: M:LXE/5,*2[-V!4XSKT@(*<9//QDB\Y?-"!' M?#3R/VA!I*)2`"-K0147#OD`P/2V1!G2>!]$,`:UH@<.\@>)AO&'+;CM52F` M42-9Q8T\YFX/>&/\Q?.]U\/K@_M^ECT^[`CL8,MH2>9`BG&90+*T&8X8D@=I MI]V^W<`4$4.W*13@Q:'?`O8Q8%_7KHZ;UW5T&X3(@[CU(K2;Q4]W8%1V"20$ MKG7P4U8/8VX)RD!=0(3,QXC.A]W7!>L+U03@N3@K@'\$4&.`Z\+3Y@"W!Y@` MZ.K1AR%%DT!",#]E,_J0*X&H/@S9!$WH!-F=8U!?*%OTX8(S47T8ZM*'$463 MP`Z.G[(9?R4HA:NA-5`-'+?1WO%;R&MY]%5_#R MQC:[92)QMVZO!6D#0L(8/2H1X>TH+N`["MX`^0`3F?@Q#^O!2`.AA M\G_X+>'@Y;,`#?CD97T5Y@,';'OX9MW]]]>(80K!V7\&-&X#9<^AM M#GNB*_^/^_KV;_C_P,+?'A!'[ZC!QRMP%V\_&MT-2RB2+=MA$27+(T61,*9( M:$'&06W!FE<^#BZ=V6MP\,FSXJ]L0:$:]Y8L*Z_XV3!\798]%!;"5]TULO25U;T@G?THGOP4Y"K4%LU+WSKG\G>M>>H^L6/>:V.9+ZMZ(NO%= M.ODM2&:H+9B5NG?.Y>])]\YWZS+*9NQ(042=2%LZ@7TZ@2W(F>"7I'F%R6.K M6D.DT7Q-W@Y:^#C5G(@TPUI$2A'X]S!>TB=I_>>[((JN\6.]2+&_NR&I%M'K M]P2JDM;M2$X15,J7K<58FW!OVAF3C)E)K]^"TPYE@AI)4%+%K4,)X97G6T(* MN`DMG'#GPSAYL1FM.?OC:]8?=HRB<47D+7W:6DTL*HLJ-^<3.N0[ MZP5R$>E-NYU1A\Y0&PXSZ@AE9-VJPYG#&H$H:85T`S<#L?L;0%H@>CUUMX.; MV/L&,YU?!SY2IP/2**:I@1]]G':[>9AGPT.&9N=&3V1\#M&'9]=]0^/4[?\+ MW,=1\ANL'?T/G>Z'?I?H!_NU`!]R>B(C;Z(KXCQCJS89=>DDVGT((2^<;MV1 MYM`YMM2A._@2A[_Q]AY=]^)2+4<@RWWH3J=2"3&H0]LD1XA/#<4ZP0#I]2E` M[#[DT"AULXHKPWKUJ@C^I_N_S6GW^!_:S3M"VK1[0,`RL/O&@T:I^;4[AF$$ M[^Q0\2/_JAW?3^X>;R%WKD=+;BQW-Y`4I49,_X(VD*X?XU.(@#<8BM!71[M0#_?J;IUZ,\_*^>? MA1&=!;O3QVO+9/0$O`:##4*_2T`D<%..BZA^[.?Q+8Q]DNK?';%Y:$%XMI90 MUK@[YYQQP_Y**^Z[W98"_\1X7>2/Z52T(!I:2RA1KV?N;S7[/. MPRI0W_%A4S&A4]&">&8MH:QS?[09'VAK/%]SCGCAOV_:<6]0M_'+/`E?!\V%5,Z%78'_>H+99_O<\ZB+2J@ MSO]SSF&#OD^?X$B@(`874?WXS^-;&/Y] M,@]3-@]VUPFK+Y0UOL\Y9]RP_U>MN%?H^Y@%OH3OPZ:B2Z?B=Q+?O1#*/M_G MG$5;5$"=[V-8!>K[/FPJ>G0J?B?QW@NAK/-]SCG4Y/M<=CR+(AA'=Y[[Y.W1 MW'Z!KT_TW3FT$^'V?CC)RNE`?=XS2L!+ALP'33Z9M"#P6U,L(UY0/=Z<%-J_ MLW:`-@0_')O^"/Y*6XN62TJT\0MTHT-(WGW]&N&K5_`;W/<7_MLA52X*/W0D M4C]8A+B<5LC*D;WH)$2,3->03E<+HL-2PAG1$QD.G=1*D6H.2'M`"(`^H"3$ M-.4>QC0!%5]*)"43^@)!@6QK.:Q7$'C!/6A#1+>?>"!Q+67#0 M7Y-,XQ_P]=(?U:"*T^9<;$/7-N&[E"OZ'7G72KU'497X/N+MWD!7@3<.`Z]IT/L M/NTA?OZ1M"3OW@F6",FPW"-0$3@DS+96"-H\3HHQRR(-[,"I!;'-6`(,G*'`)8(R6G*`%N0R@^[2 MMB1KD3I$TQ;$S41D,6)2!1ARR+?D`=/CQS([<3Y,<%K?IJ%;8)FKAY?Z6M,6 M!+Q$9#%JM048<];N;P"2R_#8.`=5B+ZPTT^H"3/4`/T?FB3RPJ^/1CGP8R31 MGM;*Q4\W1"IM.3D?&@H<@)82TZ<2>7QRJP0]C!DSGZX%T2\A81HWZ.<<55MT MP?,$3F`HL.EF$%S#JK,Q9EYC"\)30L)88]?/.6NO82=G74.!T]Q28OK4(H]/ M;JU@*;:TJL"T!6$P(6$:-^SG'%4;=L&S$4Y@*##L9A!7#3SMRL8QWN2!4$VB&.!"OU5].24HP:W M&?6H;$\V6\R];$%\3U0>(W9>D"GG^/T5\)(6!.'1J8TN4'/:>UM076#U^4:< MN9HMB"Z*RF/4]@LRUP"\R?YOW%=GM"7WJG7X%<(WVTL1[W'::4$H4E@@*PSW M.5=; MND4TZ@HAA_XAN+"(<=O+X%(@N[9F-R9UKDPV"9WK92:8/+&, M)K@%`6!%8EJHI6P*J(MLDH6^CZT0Z&$6+$WR[#Y2%>[N@%9HR[GL"!;@DI2;41XC&K&R5- MB76;T/%N06!:0!0S*.?FQSE^BE_`17N@?T%X#@XD,LVNNNM`+>=.OUG8%NSN M*P>7><(M"!<+B&)T1\_/EU'\=@DV!(YARVAI`W`>E[P`9F?=[$"P!9%A$5F: M-KWG#'%@5S!8QH<*>>-K!+SBYI<-,/73NBT(^XK(8HL!/F?,J`7N$7@(7``L MHZ4-Q'E<\F*8'E:/:$R]VX+@KH@L35O@)##]$G7L-OA-[QY-.1`R\E5@M7H0 M!VQH^8,,/.SK-J<W@;='XWWC19A_@FGMK^%O\ M"?WM5V2'\DM&JGGDO*QK.<`*"G7^+GEI\]ZT,Z)/F@XM?U:ACCBZ@5V#)^?S M:87YD M+`MS,8A?!Z^O@;]Z<4-X&X2S>Q@_A,$&PBTNEBL2_RLD)(=6$?XR'F]Q0^2) M#?HXM7_:&=MMAL4$,;)1X^7&H1^""'])JA*YI!;1&_U:.4@YMV?-H;1@8U8Q MG@,ZGG;;4C%!C&[)>+FZA&L*K()YA=D^/X=!%+%.R:/L/8$-60DIE8"MXK$$ ML=FF>%![4SJH+3A)$!"E`>-:QL\E7I_QUSH16\O"FH8LEY6]'-A^APYL"]*Z M!41IT-*6\:43NR<#3T'1K6MK4X14PK:S2X6Q!-C6W(`W8V&)N M]'D$N1BH95U-@I3+LEX,9X\.9PORC[D%:="J%G.E":U1<1'6>[LPIJ2&/4!@NQIAS0GUTT<_X*"0!)Q[$'HX6_22>;=`3"6!7D M)+-AA'G-(+JJ.1[I`=W`6IY?4$<<(\99C"?G\^SQ9GX/5NO9>@Y6\^NOC^O% M?`46]]>"($X?ESW"#?2^X:MLZQZ40/$!;L*2P);@ M/PMQ;D+$K+"9:$%XK+9@9F!?DSOG<^;D%H2L*4YJQ&_)0-(:[)+FVK6"TVVQ M5RT*G!G!":+G0I,6A.!J"V;4Q:G+I5[]0+[6!LOU#*_=Z`7OVBZ-@$Y:$*CCE<.(@>=DQCE]!S;H0USBFGVI&IJ\ M=<,:PF91E;"R<>S1$.>D!3$Y7CF,6EE.IM2!E&U8O_I>O-Q='"\,1R(VM(26 M)%;%N,S"M:PM&=4Q'=46!.A$9#%C4_D9;7V?^]A.8U[WFC33W2:0M"?(+B-&O$2WDS!&RV:A"<")1-*R&E'L_% M/%9".6E*QI:&GJ8MB.<)B-*83<[GIQ"VS+70@%@),VP.L@+F-SVP`QJ)FK8@ MS"<@2N-F-Y\OM=B=;;<>G94'U]LN_&OWS8O=/?+4;^"3%\]>,3KZ(HG\U13E M@%R+XPR<.2B@(>_1$--/G@^V-!&9.>WQ]O`^ MB"%:&N:HZQ"G3L?!K-L[^_N#^^ZB?RYWY#:UP"T7M;W+J9+VD3B_5JZR-PRJ M`;.`+=C>ZI7>R&JD502'44=N%B,/7#J58'.B`'Q$@GA@D'8"/-0+^K+;^]/E M=V^T+V0G[+`0_(4@?OJ4WZ@QH%<5"6Y&28_T]Z%V( M$C%9B`8(O`XL2%Z)LDO(DJ?,W.3P)/?IRVO#%B1*2XIG-1SS(*%'\/ MP`^]'W/5*$KTR)`2B:VHEFM1^9HH-(35M#I]IKOG M=8`VW(@C"*,9"URM@Z0`5;HH%4&B6!G].MTHT2X%LN4IF3!9,L,L2M*")'9% M8II(*"DD#?(#IOP[Y-R:YD<&?&*E'+X%%O26J9\Y4M< MO:EF09L6I-$G/+P\917%R[3 MA`PL?1UUU(($"`X1C*PFU7PX\/0)K?4FGB)9.L=B=0H-`:^\(N'E<$WH<+4@ M)X%#!*.6M)H?%0C$]Z'QJ=AR=[XI^<6+7Y)+'NDR?D*/=HN1E\.MO"@92`N2 M(TF1XJ@%"4!RTAEQ9:18=)+66$U2[0$A`+XC"B`A M(5CHA?CR/[G?(-HC+,E4K@/6`_[-(8YBU]]Z_C/I:N;C`S2BPC<'2,[2R)5$ MO$U8G>T>AT,!QUT7'W(Z:'!TLJ5I=/5+7)<^A54+\B],C8,1"V!(&(=MSU]0 M1V1YI1.)-^GLI)K^]M0=.[7&0=?C^KP]0';2C;YEO?XYDMG=Z]@7^+GKX.#'2-9/ MT(<[;^.Y^^OCUN,6NO$AQ,T.^,P3J<^H*_`LE7R/Z&@!^+["AEW)R0;DZ/.;V$WY,B M%ZS\J@#"CGE:D+:B7F*CJ[ER]AO5Z/SZ1A%,#C)8]'*>W")9XG+X-^A?R]UG M=L]^U!5X?U=!E](JK4'F*%6`I4AS6HR(0S,)A[(_Y5 MF9.LG)+6YSVCA[QDR,31`]EQ"[)]:HIE9)6LQYMS5`47YZD=O=GCV5(V@J99 M$3B7,CLUH6!)$IH7>DXX;D'Z44VQC"XM]7C4JA+9YW1.S^?@C+6N0'Y%$1W) M!&A^[K()SD7M2`4Q^AS]M`61#5XYC!AT3F:)2']$WN:0O.#L6D,6*7A5ARDJ_Q^-*^GDD7N!TX8\&G+@Y>0J@]C< M-F1=&]+A:\&Q&8\,1NPL!R,.^28IM`I"]I5*^'&:4=/X*S"9Q6,VHF/6@@M` M/#(8-8\<#"D'8D0"C,O=#H:>_TSF72`05TQ)'28K.2P$YEE+LKPPE6[!/4]^ M28Q;R5)VLA"-DNRP@'VM'JHU+*=IK')8T;PQ96K?@DM7_)(T9E%+V5(*VM.U MS>3,@593V;L;B`4BWNXLPK<5H!\1\3)7<@6N0$IT)8=ZM3(67#L6)TUF=4QG MM051-H6B&ED$U/'K+%:KK[/[ZSE8WH)?9H^/L_OU"JR78/W3'#SK&\%[Q#>(ROX&O4IY/!5;`G?NY(X*9.&2TY?1+D M,GL;KZPM\1^G=-A;$-H3D<4(Y`48GLY)5(EE`OD;(OT*__(36D%]7FQ)30O2W+\$6[LG[B`+A;&4=R^F&3ODY'E^OTQ'!0Y_BH05A2&V"&UE<='%? M]I8[.3@_Y7T?,'WR!]+#!]8%H'T`U@D@O32N_'5?;%"^[?T04!7H`QY,27)LPP1#A.] M*VG4FW:&](9=KV_W03._$+J70VY.'/HE0)^"X[?U2__YR,6%:_#(FG1&=#+O/I>N(HQOE-7C*Q7M-"YPR M:[VIP%.&%P04V=L2?K(GPA<-T!B->Z0D07_<@E!SI0!F3F\KN$A![5_%$(:\ M!;@]X`>\;N`.AB'<(FS/H@C&N#S4G><^>7LO]F"TQA6/4\9HU)_D)4.JL;`U MN9(#M[JA.+?+=2F3];-+)]EN=T2QI*:LN1IVG:0Q0*T!;4Y*J:0(U-7*^6X' M-W@C<%QX'MT8/D(\:X@TV;I4D"T MP[E2*:YY=97FV3E2`)0$T5U,!&2IB"GNA1E)F8![&'\<3W/+"ZI1S8K.Y;1/ M6+)S_:HB@.8'OW>!YL?VX^N:$IG2$C&V3HM7C!3`)0VN@`]C?-R$SYUHI3!W MOP^^XP0"27U`#-RC.3B@7_KQ]1[UY^V\33;?H)O_Q)TF)>'@2+'FU!J#2G7B MH=K#T>XNG7J[SXA5BMF8XHGSZJ`F8'NID>`#0)0^,%*">[P+OI9O,$1<^,]W M011=NV'XO@O"[VZXC9`9G_;-Z5XQ(XI53D3B2DTK(88W!CU20K7;M?O&D0+I M&M,K;A:=^6]OR,LC3]$0)P]K%"UP&0,,%W"_O`,;3.%#0D)2MWY.ELQ9LF)^ MG'1R"U=JTJE+!A3K$H^$E3J40P0?:4VF=.KLO@4E(55C.E/)FG,'HTC>X_OB M^62RCI7E\R(9_Q.`960RI1* MB+/FW"_O/UPO[]>/R[N[Q?UGL+A?SQ_GJS7XG^[_:E2+\>]?+<;2:M&ELV1W M>JF$5/QJ@4A&\,Z,;ASY*]0-,;W`^Z/`CY$"[Z;"[:<5@F)I"I-4&(*T60_^3NL5N%B*5H):1P0+TO<*^E ME)@D)[%M^"REY`P1A("1#ARV,>@LP,^KV`WC>AZ(,'/-P9DOA=T"..>G MFG,,\I@.LMT^M;@P_'!6D!(NPMD1RT8]B],YE.U`[HH#^?_KTC%FN7%V.\=U MQ!&US7-_J\LR7S#'8YN%JXPB$M[3(8;;F;^=;;<>G;$'U]LN_&OWS8O=_1?X M^@1##)QA7MIW8<51;M)R<)>3X:P4*3\IO'N9,#?0[FBOK&A&?.[Z_#FIIB0Q MT#TV!F^H]0AKBF@>$'JO%NZ".-(RF,01215X%[(X&L\7)J MDKH@RFD6_N6ML34:]`KC0`LN\)QO>DA1X8\Y:4 MM@#'126E.<:Y3\?9[EAH#6F,NN-"K"D']$6'IU5^+%"MKX",'(+Y>Y\ZE)7OR.`SG)JDG$444XS6*UH MC<9W-*9>VL3N^S4UI#&"7"&62L+I?<%P^C)^@2$N5A;"%^A'QXL`W:,-ZW<% MBO%5D).#L#BO&0Q7-<=CW&_DKJZSD-@H,1\>GIT>EIP3&)C&Q&#TTD&'707P][ M-R1OSM(40GR3L$AS/JK0&,)0E-D4"CC_/#1U*$@EUQQZ<48#7R8;C^E4M.`, MIHY,#:X1I8P5;VY_H.U^%*S!B)C#%]W3#R]%G=X0XT0D0;"(CARB!;A+4%S8 M!)=+&MB-UDK>=:.RB@&'?`"6.W!\>XM^`]!'@K5'<,G@3VX$M^EB\+3N\.P0 MOZ"9^3O8BCV/6W2)OH]]''[KB3 M^V"-HC(E9J20TZ+FACI12F,<3'I3NT]8#8^$;H-A5AR'$/[PA/L#Z0ZO`.T2 MG/H$!]PI(+T>BY3B?J_.;!<@?5\!VCMV(E/]LY:B=95,*]QYJMT_C)N)L6[" MNME]2&EX)/BMFV2.HEFYFC-SJ!']F258UC![3XI&Z7)T?H'>\PO.BOL&0_<9 M/L)7U\.!:K*%0CNE@[M?P_"U][&+-DKZRE]9(J4"J]F\$#E3E3&J-G`X[O3M MWC5:-E)&7$YKQ-5JJW,M=,(@8!R"(XL@Q2/`3+;/*69 M#@B)O+'"35@RFTV"_VQ>&SX\W9PX?\%NN'I#AO:-O#[SI+=R:%?O:P9'9$E3VY(LD6U!54$%(MKQ"=7 MR[.3D`,I>A7[6$P3_.#YX!V3_;%FIG^.'#2JE?I%"K1YE1WY%;2`LG)=Y)>@ M2NV**)$G`.CT#5N0X5]?LJ:4B8^]?+UA8=GTKY0IQ]DQ6&:13:%,X.)7K4Z4 MJTPMN:JTAX,H]DBZ;#Y;<%"D1,BF=$J8TWSUNCAG/3NCE=.UU-&NL$LE<`M- MLCLU^J=.UEQ-K$L>WYWMC"D([`[7ZQ#7J':JX?FDI^G`B$GW,=4O2\DZ_2(% M6H$K/OR4E>LBOP15:E=$"=<:ZW;I]+7@5+F^9$TI$Q][^7K#W,?TKY0I!Z>; M)1!#K-6)5]G#Z*T-F!UMPY*U$R*9T2IC3?/72XSXNPV?7]_Y.3O[Q MI==@[VWIVTG^]@$)G40%EKM;SW?]C>?N5^@W$(<+3O<#^V.-]YN4L"B9":!G ME,Y?PE#3#7X7CA:ZZ`WM#@=HE5NWNNMDWED^?I[=+_[O;+U8WI,4A.7#_)'\ M))AX(,5=_K-&HT'/3EU7_LR3@<%3:@(*GC(:]QFP['Z[P=00M,(P5,M19B/$ M'VW3!W4M+[S]4>Q$X=MQ6L`UH"EP0[L?Q3`U!/QV0L&K=)J%4>=07`>OKTEZ M]$]POUWX\PA-[G?RE(70BP3Y=.0T48"[L[<&"MKA>/.`U$,#Z`Y%O5X.0MI]X0.HM*J)>.Y(".I-U[/2$YC*8NXM2BUYC-M:#J;. MP.R1%J38>G!JHPO4-6QPDZCFL,G%(]ZE(VZW1UU+GL9L-`=S7/`6K,=XR<)M M$,XV?SMXD4<]\VZGL]P58DD@ABO1E6JED)&Q0EWX2>.H_6!()[<%K]PI%+6A MM:,NO_EZMPM"X)[(X<1Y1/!/^+]Z%IX:H*V])K5),[E7,L'Y']'Y;T'*O$)1 M&U[_ZO+=N(JNR+M3""9$AFM31D,<[%5?[CQ.DV>*6=T)6V M#0G@/#(8LM:5C#CI;_";E>`5?Z42?MQ6URS^"BUJT9B-Z9BU(#^:1P;#UK*2 M(25`1+0WF%-\WYS:YD?X1J.\<+O MERQ>V:83.GLM".`J$M.(V5;#JW,B@[>;S.<(3Y3P;^,7>+81]>OM1*71R;E* MM%/U"M8:J8EFVZL61*<5B6ETQ5+#.9HU MI/E,J4,I>2H\?>Q#WGP7.(>Y("`'2QY^+M^@SS3`Z5+T0<_QJ`61QDH!C)C' M*B[8F_*;U!?*@,9I!\TAK<#R%8P1/>T9M2"F5RF`45M7Q8TTY/`+`Z[_?@?= M"$;7,(Q=SU_N=MX&KM[<#7Q$[-]`],M]^O7FP5!DPR/>A73(6H%(Y^%K49*] M::_;(_,T:4=$&Z1ZN`_4C^&O2CV#]#1FP%D)#<7I)=ET&`6P)R3`AM)`&H6)@`A3`2%6QRVEHU29?O'B MESM(J^Z0ZVJ5DM>$"G/-I:;?$560D`4INE?@[NZZ?HJ.,DBK<4];I,/UG%=.=/0[%!TMB.,J M%]@FUU:8>P7*+/B&YS&N\1`&W[PMW-+?L+.W]0NYN4G M-_H$H?_@>MMU\/F`AN;O+\'A)^CN";Q'G;R7E`O466WOJZX-X*B M/D51"T+5>J4WLHQK%<%)!1#1%%+Z2521]4"VM2[IXPJX^SW>Z7['_8`7-P)/ MJ">T*?:V(`[`L3-`>[/#1'`N^7\$&U'@#.C`V(!BK`6Y`7JE-^HF:!7%*F-! MCKB).X31W1/P!4XM%81!BCBX#'_0+\F(=NF(MB`1H9AS<[&UO.Y9A(,XK_*X M$0FC:0).6>`L-0`].@`M2!(HYMQ\J"R/#16G&?,L4T,D\-LG8[.>R-]E; MI8])UOBQ3>V(62$7N854A[U^GL.@63^45YB5%)I;;0HJB8ZF0SJI=OOX*L1K M7)FJ>70>'G'UUO5?Z./T__%U\?!E?K\6+_I<#U5:"CK;KDJ%A9C%YW%$Y]'N M/8$*\?A524$!90E&"_2IGBZENU[C=__2:0[#L[DWK@30A,6NE3!K/[C0:407QOD5Y^NQUZ M5;,SMCLWMKY0C>\CBCBKV)7C9H"T$UTJ'NK^0K[#KE'4T7> M3K:Y))`K>3F:\+,O<7K]A,1!1EV[H5G!N78/I;1[A_T9)']7!ZRT*]`&P%8T87GO)&A!RQ=N_<[/.P;C6.6\^*0 M9?0)+Z,@?G%C`'][V[N>'Y%TC+<0'F\ML5M*Z-]>C;@CQ+D;\]_>H(^S4`,_ M\J*DH-!ML-\'WSW_.;7:]7L"=9O%J,MN:20ER<)UQCI#FN-[L[3]\4Y?0J*6OCS""*(Q?T';L!OX#>X#LJ2G50TR-1;\-7K&(,&8]&`'.G#7.(GU^#N&S&T-DD"/DNGC^!I<O3G_9P"C"?XEQJJSWMP/Z&_H)D7D*$05"Y"DXQ*A!Y#W[ MW@X)XL?`>\6IMO0Z>AP@E48+%5J=\.>IWACY?\/__J'W(_X2+79^M,?C=[0' M.X\49B1;%#9\A22TN,H"XV_^& M&YR_A]"T/VP38A1A"!.I&=T$KV\'M#D$4;"+O^-%M4',4(6 M;N=N7CSXC9##LQOL@V>"PQUT(^_)VR,9K@@WM"=W3VP<)(]%NIL-SI?&C>EP M/ATBS\>C@UAX\GR*8=2SYW](QBT1!#$,7ZG0+^XW"'PTXGO$-&Z$?F1%"]#8 M"?KZC_BFM0]#;#T'`LG523LY@U[2>\9T'[\C91[I\4Z_!3O+(KZ-N!0%G3O) M[P6]A,NYXG0(=$&E8)G/BCVA8MM]F%_*M]'%NX`)Y]H-PW>R#-O1XXJ,LZEQAC4UL33Y.OD;V]812YO4<"$+1G1: M\M\0MZS*,37H(67`18NH]_P,R:*#5@8D8;!!7D@D:$U)%OK9+I44S1)X_C&/ MAH)["-5<75Y(.&]#RD;3PZB^W5$*;AF,6&(.1MA%EV1GEWRE$GXBMU\,XJ_L M1DSNF+&5K`6E"'AD,&K>.1CZXYIZ<$LD+9+SZE01GQZW^P'=J.+M!MZAT(<3 MW\Y/&7\@HIU]B"])HNT4^C2D&U\"N1\%EYLEWE)EI_.:=O01:74O+SRN)A6I MN&,Y2R$DT'GJ44EC7!MVQ+R9=EP#XA?&5*H1-T<.^;+F$229Z?$XKPJ7JBRZ M8T^*#B-S6;[,BSM]3<[`.G2XVG*EII![4_`K9B%U'"Z:T_DY0*O`-1ZIT+], M?N\*I.L74Y)#F1"'">A*&I&\\2F]^V!W4))?"-T0Y.;$(5\"]JEL]OT-W$%\ M#GZ-3Q*O3]>+&=SQFS[8T,ZB",91WCV7\622AV`U=E26.SFU4#\VYP9;N@>\ M*([[-'/#[I"H+I%-+0V*^2Y,%!#L/'4V8CGM>D-^WU1L3L32V_T,(K@I%SH&H^'/()J2J=A'Z$B[J7SC'G(9!9 MX!4<`14-U[A#AZL%A_H<(A@]`*KF)Q^!X%NP=[%9C=]%P1A&\<6\#SL"KG4. M"5DL\O!T!L7+)D1SNW3<6G`:SB&"(2-8Q8=#/I$U@B5SS&T$30*OT`@6#%>/ M#E<+CL$Y1#!L!*OXR4=@?2.(V,I9_88=@8<<\FA(HI&/JRP:\]J0L1O3L;/[ M=)5;!C.6L)H1AWXC:0M+)YK7&!K&7Y$Y+!RS"1TSNP]4N64P:Q"K&2H`8FV3 MR#J"VY^/!*X/X3>8*3XBD(]614_VK%^8V[/4XXKVQ`=G#I#=I8%JR6/$G`HR MY1R_3X$8!VJ_"58:7>%X]O;2CDT%5O<\&G*0Y>0J6QXZKPVQ`WTZ:G9'#+AE M,`)'#D8<^HW>&8D=H"TXG=!^G<,AA=W3D8*@!B[=5] M_>*%EW,_Z@I8Q!P2DEEH7#QE<]!RFI"!&]*!:\$](0X1C%C#:CX<\HF<+2R= M8][\1Z/`*\I^+!JN$1VN%@1=.$0P:@:K^)IOX%L0>?B$N=<5R!PKHB.G*@+<9;8SA>VP%S*D MKSUU6Q`ZY)7#R)::DQGG^!V(V(=@2[]4#4W.'793V"S8:Y>/(WU(JMN"L"*O M'$9WW9Q,J0/IYX>[Z^"PWS["#?2^P=DMA,O=U[=UT!L/.YW.RO.?W;<`6?1@ MOW?#B*`CKV9W$78%Z4MB6EZ:+-1%Z>$U;LQFJ05Q25GYS-AM.28=W!YL,`$0 M4@K`!3M(KKK2RC6(SA4B!(Z4P):2N@)O^T.$FNU)39IC@CLNH?2*?V5*V7A7 MBI9H6]'*4FNFZ:/-W1;$6F7E,[L2R3%KD=JA3<7C7Q;WZ^7L\^/BT]?5XGZ^ M6J5V'.C7\SGYQRD]I3<6*)8NW(&]%H0J>82P@AN>3A)9XB3MX`!*[VM%(:B%Q6,X;#JLL+ER-&%M->"P#67 M$$9=%QZ."@$I6%/F;CY;S9>WV-Y>?[U;?WVB0[(!)&XI-"HICQ)2*\>20S\'R%J0;`-Q"$X@Y#:P=*"XPNEQC M/*9C;'="11UQC!IB,=ZXVBD@`^5>Y2)ZT-%2J%!3)B MM$6YXL2Y-G#S/DQ@#;J+'BC@&W?J\K6A_J6P0$:-N2AW6F"^\G[[$OCQR]DV MJS\0B/7GT9##,B=7V;L;>6UP?2R:(S&QO/`BMPQ&3#`'(P[Z!KSBCV0.(,IG MFO?VD&$`%MT>*APTML-H01"?1P:C5I*#(35(G#V_[5EH)CJ98SSI4X'7Y?*I MR&:6<')VEE:2VZHW[0T[N-K.M-N&)9Q/"C-Q:3PFQ#(^/5@G6:0P0S1K&2#YRXL+_(/5"(._Y<'H/`*\[(R1^N*1VN M=N2X58E@UOY5\J,(@77>#\=-@^PQAMRF>^?W@E4R^0XU))4#Z73)3? MB]RQ<@)DA>G106Y)LIB00*;LIQ!7-`WLSQ&X3E[TH(W`$VF%WR$!+FZG#=X" MJ9-VX+LD.9)CY/MDY`#EL'AZNUST@0[D\B84-`S=HE2"RN$=T>%M0SJ,@"QFDPCX&5.-X;-+6'GX$#ELK2`G M&0(0YO6\E%AI>`?6\0SOQ5\"S`PQ5M\'D-JN<6NMX^6.QQ13.6( MCT2>U)'K35)A5$N:U20YZF1EIU';00NBD&JE-;/FJ&39B0@U`"DY^OHW)@@8 M1?`60["/M^`'3/5'\I;XEA+&.9R8=!T]_1EUB)\YOP["MR`D-HA)M/#C@!@4 M+-K1EH3!-P_-^0,,WO9P1;($XAC"M?MZXP:(7V]SV&."L]>WA;\](%G?KP,\ M%&G4BY23;X1+%7;!@I'-L2?&N2++SH#"O`4Q:3M&R:#]:EA4AW(!$C9`B@_` M&`$>XH2Y*<0NIAP4Q@Z@_.`@3\(10"P!Q!-(,07^'_?U[=]`PACZ^.,50,P) MWBRE//_B[9-TJ5L(;Y'Z8\N\\'.*JXPZ?5&3QTM=A:F2D"3'Q'!3([D5[(2X M!6%_.>D,JG1-%A,7Y#MJ?BP,@\O"8+@`$D3U?!"=EX0QHSJ\N^06Z$[1SKG& MW-'#C&$+4@KDI#.[FY9A-5G/M"I1?D'TM?NT3[_CU>\+)--RD)33EGH\9S2$ MAP2^M]QCI6Q;H!8U1#*RD(CS55S5^P?2+/I1<*'8O,#M80^7N]L#=MV^>+[W M>GA]Q+J]9V=ED+$[:4BKW+I56"?S#B4%7BFMY-PX$B_>KQBZ6@KY__XTO+#` MOSJP]#L4+':G5FF5FU_#%13^UR%!D9H+%H5+\Y/B9/T";[UHX^YQ*3#LC)+2 M0+T<-2YP5[D)R^F>#/^)?O'30%N(GN57%\6%,:()PFPY^`?P0PA?7<]'HXU# M*/$+VJ61KTGM.4%_E9>%(8%*7SW4AV:@GL>_*-2'=!KL#DN*"V,5U(]L8:@/ M]6!Y1+"0]XR2))9'9K"4N/6@ODR0"@XTG9?FA`7QE3X3Y@S MS89\]AQ"B`G.7H.#'^,\G,]A\!UI[.K=A^'S._9?1WIVF M99@O>O**=QXF'3H/+E!H/ZP"\>[59[5&X^6E]@_KD)$;/4H2^7 MV7WJ(B>8F86@)G?GIS#'E+1=$)Y']?$IS$"[6B@^@C2O%T5+A-@,L?=/6W!. M4ULPLXM%32XM49!4ZHC:=<-\ZHOZ'APP_@]__R,W"06V&A44Y33B%HF;>:PC95O:O; M"_+)=EZ-II("SMTFY>PGXY'=WG)=D72;ZYI\.8_SN]EZ?@,>9H_KOX#UX^Q^ M-;M>+Y;W*S4*<.-%FWT0(0U+E2\:CH?ZZK@)<*)'+_A$YM61/&JDN@^U8R.[ M?7(%TC6M.=4LEBB1>"&U6JC24B[-;D4J+'TF/(_,&-J].U`@';\B*2AC5I]/ M94O2`T2L(E?R&2Z_^W#[Z9U6\YU%GMO%3Q^)G$.6T9(#OR"7"=I+F_6FO>Z` M)@Q:'CP2$4/W0B#`BW/Z%I"/P:=WP(I%X^]!5Q*J:[AY\>%WB@"!LYE"0HI! M6L)?(4*/;'US_7=:7_(:AK'K^*I3YA, M)KD8-QG9;;C5"FKD,%,5MPXC1!^QB<"&D@(!H04B3(S>-D_(@12]*W!W=VU< M$3G/2]NKB06GK7)S/J2WDD9V+U)J!35Z5JN*ZP94TH]#[^F`14=++GFP,[WE M(<`4N$E?14]6OX2Y/=.BBO;$0-),<\O/;VO)8VAY$F+*27\/WF#('H`-TSD] MND#-O9S8@>K"Q8%GQ$=TQ.T^9ZTECV%3+\21&A#@4!> M.9K%:SY3N6!EGZJ)8%V[T0M]T!5+M/"1A?.D9HL*T?,5=$T"Q/5D+KON:&PFC^FY,+">UE*$I#KYY M6V0UV"^3,V=\08P68+P"[GZ/GV;Y_N)M7L"+&X$G")%OYWI;$`?@\P&)]/>7 MX`!^@NX>N7I_3?K]+_OLC_A-M#^:^:F^^:8!G$,:H6M#N55S(V'D],*8.&7) M-M>SU4_@>OGERV)-'BM=W*.?[N_GY,_@E\7Z)[#^:0Z6#_/'&6VQO`6K]?SG MQ0RLY]<_W<]_J9&JG-ZIGIT_C+H"A0Y*B2G(5Q;@\S)CN;`Q61/&='9:4,1` M2!@CFB/"$4M9WJ3/1B1.1#AA(9)LWRA^RU+NRT=X0D>X!<4&A(0QZGB*<*88 MR*C7Z+#'KV$F-ZK.WL,+BZ`O'``_H`+^& M8'M,U\4[]QR,?ZR]-_=@A+<`O[P$KV@;P`+X/[G;].[A`E+]OD#2KE1GRG;8 M2N0LVD37($[N&8_H3+<@#*146--;86F.,R4Z$#6:Q/(=T2,G:TG:RXN[!7&* M9B-**7XFWU*MK#Y9KSOO8SKO+0AU*16VJ?-Q:PL]@?:\D^_9+;X<.)X,N]KN0TKQ)J=4JH]5*B>_/DK^G4P;1S(@8RU$!"#J3H@1-!\%=,$A":@BD3.$(;^*L7%\D\.\0O"!I_AUOV M\PZ9L1DR&%ML--8!\I1GR'7>H,5]N5L@!L.W@$5PUP'Z.<17,/!'1SKWA]E/R&GX<&#W86VS`Z/;(C4J MG4-[!_3/X-3N^!O,`3BR`-8!>5@]X0(L=R#+!_XBX81^>J))F<%M&/5UT`ZK MQW\9\Q]FCWLHF[1[`ZH`=A_;-3LPIH[X&I4RL7\1M4?NR58EOR'VSSW:OS@@ MQ_A'^Q=Z+I4_N'VC#J<4OLW_@?YD_U2#9I_884_G;'$IL= M&"-'1HV*V#+3-_,#1#*DPJP.88C8@B')FA2V MPT4_1V,Z5RV(D_#*820RPLF,P[Y+$!F=OE0-3<[]0U/8+`B/EX_CA(ZCW6$$ M(3F,!K4YF5(&TORU!BT=472`&`HB#W:5$M/AF!7S>5X\J*0QKEHY9:Z_W4?K MXL(8RK#EYZC8O`FZ@!;]2)S4F`5Q<_JIJB)D'UX*;#T+"&,ZNY>?,P:>8 MK^YO)!)[\F,W&7R_P?#5BV,*[R=($4YNY+L^0+RBN?ES!#;H8^)4^_A/>_>[ M:)91*=\/;OBSNV<@$[H[P4%4HU*4\,VO&T`7'[@^5L/`0GN-\N_'F$YI;4_>GU1_56C@PA=2I3Q5^AEF0;XMLR M?39%K;A@QRF(\96@C)LSZ_^"/D4X!I!\K!ZC-6R\69!RV/* M1/%/^+_L"[QE#DYD&]'/&@M.&Q648]FJ!X(N!8'=63?*96UL\9-DO'E-705[ MM-=:^JR4?!!BC`YJQBDNB*E3-1X^"U7ILC%V4\8T3#EL0>Q72!CCRU451V7+ M\G[UT^QQOEI]?7R5OR$F`I_TUX.47, MJ`0;B=B1PXYAIY9!HP24H:V0GR*TL09XK]ZE6O'97+H!IHY;+119H];,4 M\B96W*QI1EJU84N/$0WRM>.MN`H!FC)MN=PXL^?G$#Z[,TV85A]&<`_W;` M7(FI[0U\\G#QK]1DS>('EYR"C";\RT01'3D=%N`NH\F%[7!)M-Z((K`%869> M.8PL(9S,.,EW6<5$:HA`KQJT+;AV3M>.8PN.YQ,*80I M.7>8_^?U3[/[S_/99_1O_*)'NGS@0*`2<#DU.<0*9!*3QJ@%%F+-65U< M[R..],9%([7?$S9J/Z]&3X1G7]<_+1\7_W=^,[N_>9S_/']>Z(`<7(TL?\>"3P#=IIB+"V>U7E[_GY^6 M=S?(H_@SF".'8OT706.;.M>F?>&3]OR:U/UN7C!3#52Y^9`TUA+BGB.G[!7;2YJ$-:'IPC^[8!\N/DW',@]+FS#7C=OFZI(2PIZE50*;EDN5*"H M)5G>Z7G=Q.XD"%%1C*T+?/PXJZ^?5@C`^#GX^<_H?U=R.,X8P+Z^%TT*^U4+ MY3)QJL"F- M.5S:1'`2TCAC^8NWQU=E$7W!*N";37B`VX6/EF!$`'7\#88QW'YZ9__TD%7! MNWEJG]!Z,1J+W`07I"^GF@J$P?HG2J8_F?9[]EZ>JBN.B3!:3=XSEDY#Z@V`P]C<8;KP(DON`R]TO;ABZ:#-"YDODFF@!'71C M7%]A-!&Z@%]"3!)2@GR>7NXK:T<6*+LOYO,)H!U\/%PX%X;L]!W`'TI!$_D. M_L9[<_>XX@8^(2_Z$,(5W!SP!-$ZG@M__0)O@_!UN7M$+@#RA-'RGZX<1YZ/ MS'A\@W%>)+SXXK"*;N5T0)_LB::HZJ$W[0UII:3>U.X50)/$NG50#]O.D2Q( MZ`)*&#G7Y"E[3!MO,4_4`2L8PW+1UP'YKK:GK1SC_)4!?H<*?GFI0REPNA0X M=B>#:9+8Q-&//O93FAXEFLZJ['@^?6L':WJP`^%)T[/OO;''D'VLZ2\U-+WR M!)%O96[F=/-BY2P[I>O9'2"M8EWW6E;1O[(#3KQ)P@^'TU.B!QC.?/_PBN9T M.!:XA)I/10YNW)PE:"MH@'6\2ZZ']3MVYW_Q":`;>5Q<./@KC+KC^2+Z$)`O MU>*/TU-I`H"7?D39T$WIT-E]DXY/`%.K/! MC&:)'?V,_Y<\ASX:B:0;YE*1S(CBY2P!8D$#X?^&*B-$,5'-Y*<8MR/J1 M=6#\*<)R4&\[R72^,C MD'K!05('!JMX+@=DCG;;O:41$:,9J.;R4HQ;!0;S.L\L"81=\JFH`"L'9UE\ M7C0@>F_WT6<%YV906-1]`KQK)0;SO)=+XR-2QJ^:I`X,5O%<#L@<[;9[!RXB M1C-0S>6E&+=R!O/\P4KQ#$81A$OU)@E^U9(>]4*.,+%+=A_5*Y)0NS8I83,I M;\8BT(@0,)#J><9[HN.):B.F4P]$CD0B!_R4E>J7F`0%NE1&A,1I+'>$Q*4Q MK",<+.7HPW$%.C;#>I`T%(S'1FC`O],^YF[H8Q9^IC'B*%64!S]J(!2?Y2,K M&:^MS7OFACHO&?R"P'1(8^EVG^+)B*5;`R1X@+'/+E$Y&#+RU<&K_F-\!.W@RD=1GL+"X@)8<2P\G#BX"PU`L;3.YH4FTIQ MR&E%S0.QP'(6#]V078.P^_(VOQ!&K24/1\6(E+>69Q7[UJ'K1RYY(S53GFXH M$GNL)BEY3E>+YVQ)/0X2^+'=#O.T[#[=KBN2$9LKSI=S:@)(&Y!N)(9OIE>X MEM=A3Q7U%L*DM!<)7_=%,I&JZ,DANP:W&5A7ML?%RZ8L+];N),]:\A@!M"!3 MSL^)S=ZD6H`=)*]4LS:Z0,WI9=B"Z@+?@V?$IYT.'7&[4_%JR6/4(Q%DC@O> M^&Z<*H\E\93PL1PE1O`CX*!<4E""[W*.\@"=;H&/)9,;"W;'!#DE,&F+B]DX MP3,Z?:,.<&+VU0CBRFWH^4CUF"*W(!I7+4$3=K*8G5SH21B^-<27EL\RK7[Q MXI>S9!"2G##A-X>\=.4@*\%]@F-N$B3N;_?!F+`LNLVI*$,.;I"^4WQ,YL.- M+E**ZIEH+I5LO:G/&S#_2$+WI1YPF M->\]T@+ET+T4U.(X@3^OA;([JT)`"MT`YV?%T6'JJ^XM\[X&W<"5ZJRG778M MV%XP5G!MPJ,N9Z&1^]12H&OJ0C4/'',N9MB;ZB`B0G-`S>6GH=O40K@U>YTZ M#YWY5X+M31BKX-HU,7%$EG1)>4L-J>.]3U-,ZJ2]2EFE1YP=?B_:*X M)`UH"`=;FF]0B\>&.4%O:V@["WBQT*N]7I6P'";`+LJ4UKBV2.2+$^(V!>NR ML.8=GC-[%8>$>\8&`.1 M^K3"'<@A6X4\QU<,A&GUIKW!E%QY&`WMSL27EDUW!%N608<2`(@"2)&@.L.( MG&VN`:%C3']X2V6T1H$NDU1K3F*/3J*].VEIWF$JY2*5@2J6^ M8Y5Z92H%$Y5Z(RH5*E0ISR]!H$`%8.$.-&F4@#R5"E5(B\QEG\ZEW>F"TK(U MMB1Q,EB^)%$B.I>D:KS)+DG6*9#`DE0^B0,ZB7;?J)"6K?$EB9-1SB6)J93\ MDI3:G)7Y0<.NP,:(AZ:*?7NI\8SAP89=M>,;#4<&!LP'BY`U,^`R,Z`W8?`M41IPD' MAI.W(@=&R\ZT&C[B#HP-H"]U8,HG8DPGPNY(0AUQC#LPG(PYFG".DY12M6A^]L!S>G*W9.REZ.10*T,$=IRN)>4(L&_$!FHP MY22-<(&8[[194B/KX1#BO\4@#L`*DK*'H/_#TX\@71B1D`2$I@G]X/2";%>0 M2Z](?/+LO$PB]OBEK@2)2WPN@ MAB1F$,O+CL.^/#]YJ8?53^X>&W,R[0)/X+!F0SK+5=>AHUM#=+ MN8IM(V#*[]MAOP;_T_U?292<'JIO`":GSHMQ0@]RAG9'MLO8YL?)&T1R;>?^ MMMY900D3"6!DP<*W6=$$EOP"K!F!Z2'(T.YH61G;IC8,)3PXRT,?@R`02ZU\VT(K$@D>@"\>,9J6/ M[`ZQ<>,V8-L`4&:RLZ#1.,6K!B7HAXV9- M4P$7)WN4)+4HV#!<9-4D+XB>HBDB#V%4T5,#00%NP;0A:>7T[[->2".%>375`I'`E30G,3HY:<,A?P+;A532/A_0: M2OXNO8+>NEY(,VBL:HZ&>CAFVZ<6 MQ!$$Q3%BX<1XDQP2W>FOGJ7QX;SH2OI0EA]#BOC-(3#[# MB27LRL.X!>&(`K:-("N_[R1I7A(A8G>:%$.D8.W,"$RWW^,6!`T*V#:Z=N;S M<%H[G]E-"]FU\_Z`S=-9\NYQ+>IW!4[%2DC)P4V,QPP"RYKBK7V?&O)Q"R() M`J(8L6;\_#CT4[PN9I.]:ZZ.JZ]?OLP>_[*\7?\TOUY^>9C=_V7UR^SQ<7:_ M7LVNUXN?%^O%?#5[BN+0W<08(D.!;&\QZG+(EI8D`W9!:CCWAL7"QRV(7\A) M9T0EI%AT6&NPO`6H/4@(@(0".)$0TY>OI(0W?5%\))"@F[23PWA)[QGT'K_# M#G:/E;QI08RCB&\CB"OHW$E^+PL4SH0!74@I2`S(2LT*QK0@N%'$-S]45"0` M%'"A#C-\.Q%MF,G?BV2D9B>7XQ8$&(KX-KH;*6#BM!TYL`_D`O*SS28X^#': MT#P$>V^#G^8\NC[=O!@"$YP(O7.C)R+Y(?KP[+IO:`2Z_7^!^SA*?H-!V/_0 MZ7[H=PD,V:]+NI7#IH`X"52K62([PCY)U1D.[#YP$1=&]YHIS%':*5LM/M\O M;A?7R!=#KMCU\NO]>G'_&3PL[Q;7PC[9RGOVO9VW0=ISR))TL%1)EKZ>+4^Q->UUZY7%B MN>8HDM#(X88TFTZ:`O"25Q[1!H42`9@*8&3`!X`I`4P*K&:/YA2+<\/<)LTJ MV(37G=$QG=$6G%++2VAT8R_-;J6*_8P8/)"7)O'??)=.$;B+L<)]^GFA3LW6 M_^R^!2$I"C\5.(HL("-Y M*,_-6S8WKZ`9'N=>AXYS"ZX5<8IA9'WAX\5970/Z'4`?,D0>/U:,2T[CWPPP M"XQWZ3!VZ3"VX"H1IQA&C2\?3TH1>GA]=<-W9.'+PDYYBT(JR7C4$:D/+]^E M).ZUB)Q5$?DNR'I*TDHFEC]MKDEBLXJGFGUGZ8/9X?F`G)[>^`K@I(`KDN5V M';R^N?X[\*+H@-/?`)J#;S",/>PH^4&,7"+/)U^ZK[A[[#/]/BT]?U[-/='"SNU_/'^6HMIKPW<$-N5DVQI;H^F9E[9)&2 MN\D8K$.![10/33D%K,EUHF)V8?DB=8][V'MVYQL)R6$D,4^$(^SVG3`MY/LX>/S(Z5(VZ\B*PWX(=_6BYN_NE'4ONPV_L3\O`@ MB+W7TSG<1[!^23J-F!,(P0_='\$[=$.`,7F\D8&[]Y(N2/_X+Y3Y"+]*1A_I M8]XHN\JQ#[YC=Q.M:]OD%;]=$)(_]8;LUUOD=-+;2>`)HK_"<\*D=\$+(6)* MQ+EAM4WW+S>=_!"U>RLI)(>I#:((4\ZY\@-%:]I]\(W0Q2>5Y1`1*<#`0U0. MV77Y3I#-UYZX$W9'8\4$T>VD"7'C)%^#B\\-0IK/3[,/TA>>FL#8VQW@$1/$ MB*\FQ!)VUE+05NBMD=.ZJ[SC.N8@Q0C$1S?IR=M&Q#_J=XAOA.OS(.\H*O.+ M2L_UKI*#O>0$Z4"#,.^QA:NTI'1;BWG20S:G+Z3;1IYZ3GQ`\?N8V@A.4SY M32),.>"$VY\Y/C@$`N?88<( M^2C#DX^"?2:.P3K4Y-S?DO%A"N%:QW=I0*LJ?)5<,-A]G9F+ M_T9\DP)FE!M]GQYP]L:8V/H%,B5;$/V.?D':=4S8BB/1;*(IB= M[P'Q_3N2#$3Y!,L=N.`4S'#HZL0K^/1.FY`\<_H"'&88)!SC!IAG0)@&B&NP M3)+,,>._$R//Z_?8Q?_OU,KG>'>6L4KNA]!;AAW+#Q'L'CEC'JW5P]#>"T:_ M$_//>99D%_N_4^M_>6)F&:=$=^D%WH[E@0^[1\[,*:'58U#?\I>&6_$2,+0B M:TW!:H''K7<^<8OD]8EU\,".:[N=$?I_8_JZ&)W'Y^<0/I-W/$_M5]?DS':% MCVS7`?K]@CQ?$801>4].X!Z1<0;56/PFQ_/F+F""C[,D:H*;'\F1^S')"@&AW=G%30V+(]#0B'/;NDHX3+ZA6^!EGP0VR MH>@PQJJ.GP=?P_`#[T?TT'LJ$YL.A)V]?[]@$8T=V[. M7?3;(*0CC_UM]+?(0UR24Z'EKC]BDS8CGR3YA810DEI(=IH"E0],\B9K7QL= MQ9-Q-<@&B9O0-Q\ZED?X&QP6_=&TQF3#-A9W#HZ]5P;*`&(!G'@`&29PV.S( M!LCR02D>DY3;8..X`UO_,')\P]B.F5-' MU-$5ZHG[RDN< VZ87CN/!D=NI?9Z&C-\Z+)9VO1)F8?N^X)IUB]=U.$JPG M>C84MCVJV5!B?PR,S9D-4MXCN?]J^[&>7M%-VB)=0CB+E/*3^("XLK_W.SKP M/!+3=?5^8RQ,TJ(P"+FTK=3'?,:T_Z^SJK?UG7DID-.=L M*N#V3`]%U?!?CTIXTDS/W^P/6]3"^[$H]6XR'E_U^V+'8![+/"81@A^\0N+# MSE5W,LXG_>=\TF][=P.Q303N,_[?'_`O_XG^.^GDGWZLJ#B3JHJ'OGCS0GS/ M8^=]0P,QI)&(J#@44>.`3F3VZ<^?B(8+/&->LQNS]JM8MKK6*Z%(8F3T'FG7 M[@?!%$EHFPN?SV9]!Y[]ZI-A9=/DN]NA;?)^>V:6Z>4]VVM>JI'05I\]GUU9 MC_UC4^JGQUNW0_ND/?7,7-,W%6VO9ZY&0BN]]'Q>5?GHGX1\],YH=#4:C73X MZ)-AL?>OTT4?6N^B7Q/5'NAVT:^;,%MYLLF9K6NJ*/0M:=M+UZN1T$X7_9Q- M:1?]VK"R:771F]8V52XZF^4!G>46!)3E);3;13]G5YF+;EK]=+KH36N?(A>= MS?60SK7]:5L*)+3813_G596+?BW@HO>N^@-M+GIW,KX:M\]')S5P/-%QE^UW?'M-5,.X=^%V&HB\?;:(M;8] M54U0%G-[9S'&G$L+H>K)M[.>Z86RV5.$E&R#KWSWAF-^AZ^4F!RV1?E,\%S- M%]H7=3MC4D!F/+:[FH:X,+J=.V&.G`O0U#'H=P1N!\CT)8=YQ5)F5$**=F_:&4[Z M=$KMOBN@7%8C"J6080?3`I@8H!^!([EC84#F7B+7[P61/'EID#8@QR%-Z">G M<]5V!;UTPA2!8$!!8/=YA7)933EQJAE7I:E%-^X)3V#^&]K*^6@K=R*."S\= M7E_1=FF+2[3_^P%MYGI]XF9VT1;+)^7?,05W\^+!;[01>R\DV:+BHI]H57=1 MWV]!%'^XW@<1;O9T0/^!401>O3T^Q$7_9H>L7XZ_^* MSXSI,\\04L4QO>HS'MN]J;5C@(RX04U+F7J-@^ZZ>[GGXWM+)7$0&MR*$_0!O[MU]_$Z83$N.&(L]_P") M<78WF_``F54MX$5X`V_"@'#[H']L.UOH6>K617KR-;'[XJ3QL3#L+QH3+-?@ M@GH65\S.MN2%-S5>X3]>>*OO.ZIF!RO`<$P5P.ZK7C8,CQ4>IEX9S3T`5_GZ M6TN,HB(?[A]64<+3TZ(3])!]8O>M(!N&QRI_4*^L+3:/&E]XX+]5_\=Y]:+( MOU/?)4+H(#G?MOO^L*DA,.2GZ99#WZ,89R$)BTR)0,V`/XXM*?2*M"!P2*O" MC29/8K,%MPR M,#0,3?@TFF5J@='1^>R50&'#/]B#8,7.C89><:[AB&W@6Y&D;V(4C+DVVD5) M*E*Q-*8_F(T1J>?X!S,R)5Z-)E".Z8Y^VHH$=Q.C8-RGT2Z2W=9F=7A:![&[ MSRVM@#5#Y'W#4F)RJB_*9T:!RQOWIMUNA]:-F+8@&5M(&".+M@A'#OKX0XR_ MOBPL4Z=`!R]Y@%(&M!6\94+UFPC-("C M`;V6-FU!@A&7$$9-:QDG*3RRSW3`4-"&FL-AA=7,&3EZ76?:@N04+B$:L9-E M')V\4RD\?OWR9?;XE^7M:O'Y?G&[N)[=KV?7U\NO]^O%_>>'Y=WB>C%?W<_1 M3]?++_.[Y6KU,']$__RRO%_]-'NX<1!LM;D"(-3K1!0AP@ZH"2!S_@#GX$J`M`^P"D$S&= M)X;C`6UC_=AS]_OWY2&.8I<49[OQ]@>3G]E9$8T3HY'MBJ^G=J#X$0`;!F%8P9DC26S-N0XG;MVZ$^! M0UAK]IA5;$$@7E(\HTZD'*\&%"GCW:;]J+%`JDPN$3F=X.4K`_S\1MAE[]*' MLCHMB`!S"6%D%>#AQ)'9^'R"/MQY&R\)!>"'/FZA&Q]"^!#LO4U".H+I1O;M3ES3BW!J2E@;<%? M:6N`FP/2_K_TJP.G/V.S/EQZ,:(SU*4S9/=Y:WVA3'DLM3ET&/)CC/PG_`%Y MX*E47?2K!M]C;S9KQL6#;Z(SU*,S9'>XK+Y0_(HA\01<;?:<3_/[^>WB>C&[ M`]?+^Y_GCZO%\A[EP*N/S$:T/&W.^914R+=KE$]MAS<#)!VX-@0L#5!VBL2A@^?W;<3 M^A<6GW]&>IUIG\Z(W0&)FA(9L?7U>'.N9ZN?P.W=\I<5>)P_+!]QZ$`,Y#